data_1bm6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bm6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.519 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.08 0.467 . . . . 0.0 109.897 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.627 ' CZ3' ' ND2' ' A' ' 175' ' ' ASN . 9.7 m95 -99.73 143.16 30.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 110.207 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 1.6 ptp180 -109.3 -40.86 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.388 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.553 ' HG3' ' CD2' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.58 170.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.331 -0.855 . . . . 0.0 110.019 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.495 ' C ' ' CD1' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -110.14 1.19 18.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.502 -0.749 . . . . 0.0 109.585 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 66.8 m80 -137.96 95.99 3.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.368 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.613 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.1 mm? -92.37 170.82 9.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.51 -0.744 . . . . 0.0 109.512 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -147.24 157.17 43.5 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.692 ' CE1' ' CD2' ' A' ' 121' ' ' LEU . 4.4 p90 -137.11 166.31 24.02 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.505 -1.372 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.56 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -125.19 124.36 41.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.628 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -83.12 83.54 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.883 -1.135 . . . . 0.0 110.106 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.604 ' N ' ' O ' ' A' ' 144' ' ' ILE . 46.7 t -98.72 7.25 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.254 -0.903 . . . . 0.0 110.001 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.565 ' ND2' ' N ' ' A' ' 145' ' ' SER . 34.0 m-80 -97.01 160.91 14.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.841 -1.162 . . . . 0.0 109.461 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.6 ' CG ' ' N ' ' A' ' 105' ' ' THR . 2.8 t80 178.09 167.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.62 ' CG2' ' CE3' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -176.53 159.54 1.66 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.487 ' HD2' ' OG1' ' A' ' 105' ' ' THR . 37.7 Cg_endo -66.12 -25.94 50.48 Favored 'Trans proline' 0 C--N 1.298 -2.089 0 N-CA-C 107.791 -1.657 . . . . 0.0 107.791 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -74.17 -10.98 60.15 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.637 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 79.6 mt -153.23 111.18 2.63 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.598 -0.689 . . . . 0.0 110.224 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.81 178.37 2.34 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.8 1.421 . . . . 0.0 109.341 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.93 -65.35 0.37 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.809 0.814 . . . . 0.0 110.296 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -58.67 -26.79 64.18 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.637 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -74.42 -60.45 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.31 -1.494 . . . . 0.0 109.605 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.531 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 11.3 p -58.16 -42.42 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.516 ' N ' HG12 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -60.04 -29.79 68.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -57.68 -64.1 1.02 Allowed 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.611 ' HB1' ' CD1' ' A' ' 195' ' ' LEU . . . -49.19 -33.0 11.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 110.158 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.573 HG13 ' CE2' ' A' ' 99' ' ' TYR . 5.7 t -73.0 -24.33 20.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.7 tt0 -90.64 -34.07 15.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.342 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.664 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -79.12 -39.44 33.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -64.84 -62.23 1.69 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.692 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 14.5 tp -48.99 -47.94 43.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.489 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -70.34 -34.25 72.43 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.791 -178.049 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.617 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 2.8 t -53.71 -44.81 59.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.66 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 30.9 m95 -92.11 -21.33 20.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.716 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.528 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 33.6 tt0 -72.14 -27.55 62.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.8 pt-20 -88.88 -44.49 10.43 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.435 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.608 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 14.2 m -56.77 -26.89 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.248 -1.381 . . . . 0.0 108.324 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.572 HG21 HG22 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -118.35 166.33 14.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 108.092 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.572 ' HG2' ' CD1' ' A' ' 246' ' ' TYR . 48.1 Cg_endo -82.5 -10.94 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.528 1.485 . . . . 0.0 109.824 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.641 ' CD2' ' CZ ' ' A' ' 132' ' ' PHE . 41.9 tp -52.38 158.87 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.727 . . . . 0.0 110.893 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.5 p -108.37 170.39 8.05 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' A' ' 130' ' ' LEU . 71.2 m-85 -151.41 146.36 25.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.938 -1.101 . . . . 0.0 110.929 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.599 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 4.0 t -125.66 -174.24 3.03 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.628 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -148.13 164.58 33.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.612 -1.305 . . . . 0.0 111.017 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.535 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -164.81 -163.73 0.74 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 29.7 t80 -160.95 28.31 0.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 5.0 pm0 -144.87 178.57 7.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.678 -0.639 . . . . 0.0 109.324 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.26 -97.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' GLU . 7.7 pt-20 178.83 121.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -1.109 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -77.58 -151.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.6 ' O ' ' O ' ' A' ' 176' ' ' GLY . 16.7 t70 -89.75 -36.74 14.99 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.533 ' CD1' HD21 ' A' ' 207' ' ' LEU . 4.1 mp -123.23 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.543 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 8.8 ttm -65.13 98.24 0.3 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.044 . . . . 0.0 109.059 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 102' ' ' VAL . 6.2 mm -82.73 111.52 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.72 153.64 51.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 0.0 111.856 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.516 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 19.8 p90 -90.47 141.42 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.769 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.628 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -168.82 179.96 3.97 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.003 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.533 ' HA ' ' CB ' ' A' ' 157' ' ' PHE . 1.4 p -151.19 -164.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.453 ' HG2' HG12 ' A' ' 148' ' ' VAL . 1.1 ptt85 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.785 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 C--O 1.215 -0.659 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.776 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m-85 -78.33 -169.42 1.64 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.067 -1.021 . . . . 0.0 109.557 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.598 ' O ' ' C ' ' A' ' 159' ' ' GLY . 11.0 p30 178.64 58.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.559 -0.713 . . . . 0.0 110.097 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.615 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -20.36 -58.96 0.01 OUTLIER Glycine 0 N--CA 1.511 3.679 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 41.3 Cg_endo -71.17 56.17 1.98 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.589 1.31 . . . . 0.0 109.135 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.84 156.81 27.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 164' ' ' LEU . 84.7 m-20 -51.9 -33.68 38.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.364 -1.08 . . . . 0.0 110.588 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.524 ' CG2' ' OD2' ' A' ' 158' ' ' ASP . 2.9 t -55.54 84.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.105 -0.997 . . . . 0.0 110.111 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.576 ' CD2' ' CG2' ' A' ' 193' ' ' THR . 0.3 OUTLIER -74.35 -46.38 41.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.507 -0.746 . . . . 0.0 111.765 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.709 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -168.67 179.84 4.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.35 -1.469 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.776 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.4 p-80 178.94 167.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.154 -1.591 . . . . 0.0 111.252 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.78 -169.07 2.13 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.556 -0.715 . . . . 0.0 110.093 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.597 ' CD2' ' HB ' ' A' ' 174' ' ' ILE . 55.2 m-85 -110.3 -166.51 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.632 -1.292 . . . . 0.0 110.515 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.608 ' CB ' ' HD2' ' A' ' 170' ' ' PRO . . . -120.92 -170.25 0.18 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.411 -0.805 . . . . 0.0 109.086 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.608 ' HD2' ' CB ' ' A' ' 169' ' ' ALA . 41.6 Cg_endo -74.8 112.94 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.418 1.22 . . . . 0.0 110.505 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . -157.65 -140.63 2.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.6 -93.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.054 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -92.34 -26.99 16.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.597 ' HB ' ' CD2' ' A' ' 168' ' ' TYR . 0.2 OUTLIER -74.04 9.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.515 -0.991 . . . . 0.0 108.816 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.627 ' ND2' ' CZ3' ' A' ' 92' ' ' TRP . 6.2 t30 -63.18 62.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 104.43 103.4 2.83 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.622 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.5 m-20 -163.27 118.33 1.69 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.601 -1.529 . . . . 0.0 107.377 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.543 ' HB1' ' CD1' ' A' ' 144' ' ' ILE . . . -110.46 166.46 10.97 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.78 -1.2 . . . . 0.0 108.801 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.742 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -158.63 134.61 9.03 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.281 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.578 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 22.4 m-85 -94.19 137.31 33.52 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.625 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.607 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 7.6 t0 -50.87 151.36 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.779 -1.201 . . . . 0.0 108.628 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.19 20.45 8.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.5 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.615 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.5 OUTLIER -107.98 -16.7 14.23 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 1.2 pt-20 -112.54 -98.52 0.42 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.848 -1.158 . . . . 0.0 108.281 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.567 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 1.0 OUTLIER 178.53 165.28 0.81 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.014 -1.054 . . . . 0.0 109.045 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.62 ' CE3' ' CG2' ' A' ' 105' ' ' THR . 0.0 OUTLIER -137.51 130.91 31.04 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.179 -0.951 . . . . 0.0 109.229 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.517 HG22 ' N ' ' A' ' 192' ' ' GLY . 47.3 p -131.64 149.51 52.47 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.608 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 41.3 pttt -74.42 -37.77 63.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.528 ' O ' ' CG2' ' A' ' 227' ' ' THR . 3.3 t70 -83.28 -149.14 0.09 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.56 ' N ' HD13 ' A' ' 229' ' ' LEU . 27.0 m -111.45 46.46 1.1 Allowed 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.542 -1.263 . . . . 0.0 107.849 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.448 ' HB ' HG22 ' A' ' 187' ' ' THR . 91.2 m -98.45 -32.32 11.55 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 111.411 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.517 ' N ' HG22 ' A' ' 187' ' ' THR . . . -118.58 -85.57 1.02 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.755 -1.688 . . . . 0.0 109.489 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.576 ' CG2' ' CD2' ' A' ' 164' ' ' LEU . 23.7 m -122.67 -98.16 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.603 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 3.7 m120 -160.45 68.14 0.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.611 ' CD1' ' HB1' ' A' ' 116' ' ' ALA . 15.4 tp -29.73 -97.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.669 ' CD1' ' O ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -56.77 -19.97 19.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.973 -1.079 . . . . 0.0 111.106 -178.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.603 ' CB ' ' HB3' ' A' ' 194' ' ' ASN . 12.9 tp -60.15 -62.29 1.97 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.146 -1.821 . . . . 0.0 107.517 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 165' ' ' ALA . 1.7 t -71.32 -8.12 10.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.666 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -77.09 -58.09 3.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -65.56 -14.68 61.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.567 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 15.2 t60 -68.32 -48.93 63.57 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 117.878 -1.529 . . . . 0.0 107.913 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.578 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 1.3 mt-10 -80.39 -45.87 16.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 111.092 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.574 ' CD1' ' HB2' ' A' ' 120' ' ' ALA . 3.2 mt -62.14 -30.99 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.66 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.88 -31.55 55.52 Favored Glycine 0 C--N 1.291 -1.933 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.5 -49.62 76.0 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 121.965 -0.726 . . . . 0.0 110.952 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.519 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 42.5 m -86.25 -53.05 5.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 112.206 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.563 ' HA ' ' CD1' ' A' ' 92' ' ' TRP . 3.1 pp -104.54 24.7 11.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.123 . . . . 0.0 110.605 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -127.02 -79.57 0.3 Allowed Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.123 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.02 -162.25 0.36 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.961 -1.317 . . . . 0.0 110.233 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 1.7 t80 -99.61 -72.64 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.78 . . . . 0.0 109.538 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.588 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 68.3 m80 -161.13 101.79 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 4.0 m -93.33 -178.12 4.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.371 -0.83 . . . . 0.0 109.247 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' A' ' 237' ' ' ASP . . . -61.9 86.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.709 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -89.66 10.18 24.2 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.576 -178.027 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.4 -28.1 4.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 175.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.509 ' C ' ' HB2' ' A' ' 235' ' ' SER . 5.4 mt-10 -116.25 -36.05 4.16 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.709 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -63.72 -170.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.383 1.087 . . . . 0.0 112.813 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.629 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.0 OUTLIER -90.44 -16.12 29.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.146 -177.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.588 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -78.38 -7.39 57.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 119.119 -2.238 . . . . 0.0 112.105 -177.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.9 t80 -137.29 15.65 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.526 -1.358 . . . . 0.0 113.604 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.43 -37.0 0.79 Allowed 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 108.473 -1.395 . . . . 0.0 108.473 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.546 ' CD2' HD21 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -21.47 -59.21 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.202 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 224' ' ' HIS . 38.5 t80 -68.0 56.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.3 t-80 179.16 -124.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.449 ' HB3' ' OG1' ' A' ' 190' ' ' THR . 18.4 m -161.0 121.63 2.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.787 -1.196 . . . . 0.0 109.426 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER 179.38 43.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 110.102 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 189' ' ' ASP . 0.0 OUTLIER -99.93 -10.45 21.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.815 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 24.3 t70 179.62 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 109.923 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.56 HD13 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -25.74 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.809 -0.557 . . . . 0.0 111.399 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.34 -6.09 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.731 -1.23 . . . . 0.0 110.261 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.55 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -117.67 -38.18 3.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.001 -1.062 . . . . 0.0 109.069 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.6 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 13.3 p90 1.04 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.829 0.824 . . . . 0.0 112.947 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 178.34 174.62 0.59 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.359 -0.838 . . . . 0.0 109.657 178.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.646 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 3.9 mp -91.18 168.99 11.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 0.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.627 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 30.2 t -101.87 -169.88 1.74 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.188 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.51 ' N ' ' OG ' ' A' ' 235' ' ' SER . 12.5 tm0? -85.25 -12.65 51.98 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.911 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.2 OUTLIER -84.69 -47.79 10.11 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.701 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.0 OUTLIER -66.71 -36.96 83.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.626 177.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -58.0 -35.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.91 -50.79 54.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.47 ' HA3' HD23 ' A' ' 209' ' ' LEU . . . -55.94 -55.07 30.99 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.589 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.6 tp -63.44 -43.37 98.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.83 -1.394 . . . . 0.0 109.589 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 6.2 mt-30 -54.13 -31.35 52.03 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 241' ' ' GLY . 4.0 p -75.5 -22.35 57.25 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -66.84 -64.57 0.83 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.591 ' CD2' ' HB2' ' A' ' 130' ' ' LEU . 5.7 t80 . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.983 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.491 ' HB3' ' HG ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.618 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 69.6 m95 -73.87 155.6 38.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.742 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.1 -34.55 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.542 ' HG3' ' CD2' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -55.17 -165.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.264 -0.897 . . . . 0.0 109.548 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.545 ' HA ' ' CG ' ' A' ' 130' ' ' LEU . 66.2 p -124.33 4.24 8.44 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.607 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.571 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 59.4 m80 -148.15 97.08 2.73 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.451 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.4 mm? -97.5 175.02 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -142.64 155.7 44.97 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.232 -0.918 . . . . 0.0 108.569 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.644 ' CD1' ' CE2' ' A' ' 132' ' ' PHE . 24.6 p90 -133.49 171.07 14.58 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.794 -1.192 . . . . 0.0 109.233 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -131.35 145.87 52.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 109.412 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.6 mp -100.22 61.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.965 -1.084 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 144' ' ' ILE . 18.1 t -73.86 2.44 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 0.0 110.021 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.533 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 0.5 OUTLIER -101.45 164.37 11.8 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.804 -1.185 . . . . 0.0 109.025 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.558 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 1.2 p90 177.94 46.37 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.637 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 24.8 p -40.15 149.88 0.28 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.595 -0.69 . . . . 0.0 109.36 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 -25.77 42.67 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.946 1.498 . . . . 0.0 109.044 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.6 OUTLIER -65.76 -12.16 51.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.599 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 32.3 mt -138.53 124.02 12.28 Favored Pre-proline 0 N--CA 1.484 1.251 0 O-C-N 121.543 -0.723 . . . . 0.0 109.827 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.3 Cg_endo -65.6 167.35 17.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 123.773 1.407 . . . . 0.0 108.867 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -37.8 -65.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.747 0.784 . . . . 0.0 110.263 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -28.57 49.73 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.75 -0.594 . . . . 0.0 111.725 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.599 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -73.19 -61.15 1.92 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.487 -1.383 . . . . 0.0 109.448 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.558 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 5.6 p -51.19 -39.4 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.512 ' N ' HG11 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -66.33 -26.22 67.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 112' ' ' ALA . 13.9 p -67.35 -37.37 83.14 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.609 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -75.18 -34.81 61.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.331 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.595 HG13 ' CE2' ' A' ' 99' ' ' TYR . 3.5 t -74.94 -23.72 17.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.549 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 1.8 tt0 -85.82 -36.33 20.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.693 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -79.41 -38.84 33.87 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -63.49 -61.65 2.19 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.642 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.0 OUTLIER -51.56 -40.91 60.63 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.128 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.519 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -76.72 -33.64 58.17 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.738 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 196' ' ' PHE . 2.1 t -56.19 -40.8 67.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.647 ' CH2' ' CD2' ' A' ' 234' ' ' LEU . 44.4 m95 -91.43 -24.8 19.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.316 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 9.6 tm-20 -69.55 -27.45 65.16 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.757 -1.214 . . . . 0.0 107.996 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.2 pt-20 -89.9 -42.89 10.95 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.674 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.618 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 15.3 m -59.8 -24.11 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 118.259 -1.376 . . . . 0.0 109.159 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.93 162.94 20.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.012 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -84.46 1.54 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.249 1.966 . . . . 0.0 110.116 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 246' ' ' TYR . 0.2 OUTLIER -80.92 -176.16 5.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.026 -1.046 . . . . 0.0 110.603 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.3 p -121.71 165.55 15.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.778 . . . . 0.0 109.947 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.644 ' CE2' ' CD1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -140.93 158.22 44.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.426 -0.796 . . . . 0.0 109.698 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.58 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.5 m -146.59 179.6 7.44 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.594 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -148.12 -179.76 7.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.805 -1.184 . . . . 0.0 110.246 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -163.61 -130.63 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 27.2 t80 178.24 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.833 -1.167 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -162.61 -171.81 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 37.66 -99.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 178.46 107.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -1.135 . . . . 0.0 110.296 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.533 ' CB ' HD23 ' A' ' 135' ' ' LEU . . . -59.91 -150.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.572 ' O ' ' HA3' ' A' ' 176' ' ' GLY . 80.0 m-20 -88.06 -34.43 17.96 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 142' ' ' ILE . 2.8 mp -124.23 77.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.529 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 2.8 ptm -67.54 102.87 1.22 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.596 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.1 mm -81.98 117.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -133.19 156.58 47.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.429 -1.42 . . . . 0.0 112.119 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 39.6 p90 -79.94 133.61 36.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.474 -0.767 . . . . 0.0 109.14 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.571 ' HB2' ' CE1' ' A' ' 179' ' ' HIS . . . -155.92 -178.08 7.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 149' ' ' ARG . 1.0 OUTLIER 179.78 -155.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.44 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.534 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 2.8 mtm-85 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.462 -0.774 . . . . 0.0 109.641 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 109.208 -1.112 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.733 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -98.24 -170.43 1.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.912 -1.118 . . . . 0.0 111.257 -178.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.562 ' O ' ' C ' ' A' ' 159' ' ' GLY . 15.5 p30 178.5 62.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -18.86 -59.0 0.01 OUTLIER Glycine 0 N--CA 1.501 2.982 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 183' ' ' ASP . 37.9 Cg_endo -65.87 60.19 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.297 1.156 . . . . 0.0 109.743 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -177.42 164.07 33.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' LEU . 0.6 OUTLIER -45.56 -59.95 2.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.312 -1.111 . . . . 0.0 110.123 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.653 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 61.0 t -33.85 90.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.354 0.597 . . . . 0.0 110.88 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 162' ' ' ASN . 1.1 mp -80.08 -75.48 0.26 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.238 -0.914 . . . . 0.0 112.186 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.597 ' CB ' ' CG1' ' A' ' 198' ' ' VAL . . . -145.64 -168.25 2.92 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.196 -1.565 . . . . 0.0 111.38 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.733 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER 179.67 -179.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.957 -1.714 . . . . 0.0 111.133 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -154.75 177.61 11.06 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.536 -0.728 . . . . 0.0 110.23 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.622 ' CD1' ' CD1' ' A' ' 174' ' ' ILE . 76.7 m-85 -114.39 -167.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.16 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.536 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -171.21 -60.51 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.495 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 44.6 Cg_endo -77.29 147.97 26.46 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.796 1.419 . . . . 0.0 109.875 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 118.83 -178.75 16.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 175' ' ' ASN . 44.1 Cg_endo -75.97 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.063 1.559 . . . . 0.0 110.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.16 -33.25 21.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.622 ' CD1' ' CD1' ' A' ' 168' ' ' TYR . 1.9 tt -62.16 -7.75 2.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.352 -1.087 . . . . 0.0 108.8 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 169' ' ' ALA . 50.7 p-10 -67.29 65.92 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.127 -0.983 . . . . 0.0 109.405 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 128.74 78.7 0.23 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.1 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -152.16 115.15 4.65 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.217 -1.166 . . . . 0.0 107.975 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -106.31 164.83 11.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.262 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.69 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -155.96 133.77 11.16 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.571 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.573 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 12.2 m-85 -96.55 135.94 37.75 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.539 ' CG ' ' CD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -58.02 115.81 3.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.788 -1.195 . . . . 0.0 107.985 177.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.48 ' OD1' ' HB ' ' A' ' 148' ' ' VAL . 11.9 p-10 -83.91 13.51 4.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.719 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.531 ' HB3' ' CD ' ' A' ' 160' ' ' PRO . 2.0 t70 -121.05 14.09 11.4 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.076 -1.015 . . . . 0.0 110.725 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.519 ' OE2' ' CD1' ' A' ' 164' ' ' LEU . 15.7 tt0 -117.66 -132.1 0.32 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.814 -1.179 . . . . 0.0 108.944 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.612 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.9 mt-30 -122.1 166.57 14.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 109.111 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.637 ' CD1' ' CG2' ' A' ' 105' ' ' THR . 94.5 m95 -159.42 107.44 1.78 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 195' ' ' LEU . 19.6 p -135.35 153.52 51.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.849 -1.157 . . . . 0.0 109.533 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.535 ' HA ' ' CD2' ' A' ' 195' ' ' LEU . 1.6 pttt -76.79 -28.97 55.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 0.3 OUTLIER -99.85 -151.18 0.39 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.568 ' N ' ' CD1' ' A' ' 229' ' ' LEU . 10.2 t -105.71 45.4 0.97 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.453 ' HB ' HG23 ' A' ' 187' ' ' THR . 87.6 m -99.77 -31.25 11.62 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.394 -0.816 . . . . 0.0 111.204 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.526 ' N ' HG23 ' A' ' 187' ' ' THR . . . -118.21 -96.75 1.81 Allowed Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.804 -1.665 . . . . 0.0 109.064 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.52 ' CG2' HD22 ' A' ' 164' ' ' LEU . 48.3 m -104.31 -106.22 0.29 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.659 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 10.5 m120 -159.14 74.23 0.63 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.688 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 0.9 OUTLIER -27.01 -95.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.661 0.743 . . . . 0.0 112.55 -178.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.693 ' CG ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -64.34 -12.17 39.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.013 -1.054 . . . . 0.0 110.983 -176.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.659 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 5.5 tt -62.03 -62.08 2.03 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.884 -1.526 . . . . 0.0 107.078 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.597 ' CG1' ' CB ' ' A' ' 165' ' ' ALA . 39.4 t -72.79 -9.32 12.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.666 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -77.88 -57.43 3.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.576 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -65.38 -15.38 62.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.526 ' HA ' ' CE ' ' A' ' 219' ' ' MET . 20.5 t60 -68.74 -46.13 69.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.962 -1.495 . . . . 0.0 107.81 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.573 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 1.3 mt-10 -82.32 -47.42 12.38 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.046 -1.034 . . . . 0.0 110.834 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.609 HG23 ' HA ' ' A' ' 121' ' ' LEU . 2.3 mt -61.48 -31.46 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.631 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.0 -33.29 46.09 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.93 -49.52 75.81 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.819 -0.813 . . . . 0.0 110.798 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 27.4 p -83.73 -56.88 3.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 112.2 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.583 HD21 ' CZ ' ' A' ' 132' ' ' PHE . 0.8 OUTLIER -104.16 22.94 13.83 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.016 -1.052 . . . . 0.0 110.84 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.55 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -121.71 -78.92 0.5 Allowed Glycine 0 C--N 1.291 -1.923 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.4 pp -167.5 -160.09 0.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.019 -1.283 . . . . 0.0 109.76 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 1.0 OUTLIER -98.12 -73.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.585 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.565 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.1 m-70 -163.01 93.49 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.913 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.637 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -81.78 179.33 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -0.836 . . . . 0.0 109.806 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.53 83.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.735 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -87.0 12.06 12.17 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.861 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -49.78 -28.25 6.01 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.495 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.1 mp0 -116.29 -36.16 4.11 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.735 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -62.45 -164.72 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.292 1.044 . . . . 0.0 112.681 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.594 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.1 OUTLIER -99.85 -13.01 19.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.074 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.565 ' HG2' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -80.3 -6.63 58.25 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 119.552 -1.967 . . . . 0.0 111.978 -177.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.649 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.2 OUTLIER -137.53 14.57 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.617 -1.302 . . . . 0.0 113.502 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 54.2 Cg_endo -77.41 -42.05 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.6 ' C ' ' O ' ' A' ' 221' ' ' PRO . 4.0 tp -0.26 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 CA-C-O 121.494 0.664 . . . . 0.0 111.039 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.541 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 9.8 t80 -67.46 58.4 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 109.754 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.2 OUTLIER 179.57 172.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 109.778 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.8 128.83 55.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.253 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 232' ' ' PHE . 0.3 OUTLIER 178.83 -73.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.835 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.565 ' CG2' ' CD2' ' A' ' 218' ' ' LEU . 1.5 p -66.44 53.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 0.0 110.442 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.522 ' CA ' ' O ' ' A' ' 188' ' ' LYS . 5.0 m-20 -162.54 -53.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -60.74 -142.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.755 . . . . 0.0 109.458 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.4 p -94.46 -22.76 18.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 0.0 110.049 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -79.97 -16.55 54.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 108.786 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.601 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 23.2 p90 -30.75 106.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.602 0.715 . . . . 0.0 111.291 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.532 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 7.6 ttt-85 -161.04 153.15 20.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.214 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.647 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 3.8 mp -77.65 173.94 11.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.281 -0.887 . . . . 0.0 110.463 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.615 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 21.7 t -102.81 -172.0 2.05 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.909 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.38 -12.89 53.67 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.778 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.637 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.6 m-20 -84.11 -49.28 9.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.769 -1.207 . . . . 0.0 108.15 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.726 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.8 OUTLIER -64.68 -39.48 93.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 117.197 -1.801 . . . . 0.0 106.616 178.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.8 OUTLIER -55.19 -36.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.47 -56.92 8.66 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.646 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -52.23 -51.58 40.94 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.598 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.8 tp -63.86 -47.93 88.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.85 -1.382 . . . . 0.0 109.656 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 21.3 tt0 -53.58 -28.29 31.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 t -82.42 -18.12 42.98 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.53 ' CD2' ' C ' ' A' ' 245' ' ' LEU . 5.7 tt -73.3 -60.57 2.18 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.626 ' CD1' ' CD1' ' A' ' 130' ' ' LEU . 11.1 m-85 . . . . . 0 N--CA 1.493 1.723 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.445 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.57 ' CD1' HD12 ' A' ' 207' ' ' LEU . 72.7 m95 -107.27 169.13 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.963 -1.085 . . . . 0.0 109.617 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -135.4 -36.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.598 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.535 ' HG3' ' CD1' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -47.58 177.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.475 ' HA ' HD21 ' A' ' 130' ' ' LEU . 71.2 p -116.7 5.58 13.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.501 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.523 ' O ' ' CE ' ' A' ' 94' ' ' LYS . 4.5 m-70 -126.63 91.14 3.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.99 -1.069 . . . . 0.0 110.073 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -99.31 158.29 15.81 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.6 -0.688 . . . . 0.0 109.988 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -129.54 154.86 46.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.643 ' CE1' ' CD2' ' A' ' 121' ' ' LEU . 3.0 p90 -140.77 167.69 21.58 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.724 -1.235 . . . . 0.0 109.364 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -132.12 138.11 47.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.095 . . . . 0.0 109.47 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.5 mp -93.32 66.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.14 -0.975 . . . . 0.0 109.746 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 144' ' ' ILE . 6.0 t -78.38 8.82 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 109.93 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.564 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 8.5 m120 -105.35 153.25 21.9 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.0 -1.062 . . . . 0.0 109.392 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.568 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 178.68 41.04 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.717 -0.614 . . . . 0.0 109.697 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 104' ' ' TYR . 61.4 p -41.57 156.1 0.22 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.42 -0.8 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -22.87 41.73 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.877 1.462 . . . . 0.0 108.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.487 ' O ' HD22 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -72.04 -6.3 41.34 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 83.1 mt -143.5 116.48 5.91 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.517 -0.74 . . . . 0.0 109.707 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.68 171.48 9.58 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 O-C-N 123.856 1.45 . . . . 0.0 109.06 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.01 -65.38 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.84 0.829 . . . . 0.0 110.295 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 115' ' ' SER . 26.0 t0 -57.43 -28.23 63.12 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.821 -0.549 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.59 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -73.18 -61.95 1.64 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.248 -1.532 . . . . 0.0 109.265 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.568 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.8 p -54.25 -40.67 48.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.512 ' N ' HG11 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -64.9 -27.86 69.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 112' ' ' ALA . 1.2 p -62.14 -41.84 98.67 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.662 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -73.72 -34.16 64.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.059 . . . . 0.0 110.639 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.528 ' CG1' HG13 ' A' ' 144' ' ' ILE . 5.8 t -74.36 -24.08 18.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -91.64 -34.82 14.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.637 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -79.02 -37.48 39.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.662 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -67.36 -62.02 1.63 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.643 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 8.1 tp -49.67 -45.04 48.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -73.41 -34.72 65.65 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.798 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.608 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 1.5 t -55.53 -40.6 59.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.675 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 51.0 m95 -92.27 -20.01 21.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.091 -1.005 . . . . 0.0 110.517 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 37.1 tt0 -75.24 -27.58 59.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.018 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.5 pt-20 -90.15 -45.19 9.28 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.551 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.613 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 16.5 m -57.3 -27.07 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.447 -1.301 . . . . 0.0 108.357 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.61 ' CG2' HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -121.22 155.86 58.01 Favored Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.223 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.49 25.95 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.091 1.86 . . . . 0.0 111.946 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.638 ' CD1' ' CD1' ' A' ' 246' ' ' TYR . 5.0 mt -100.89 169.86 8.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.399 . . . . 0.0 110.093 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.465 ' O ' HD21 ' A' ' 97' ' ' LEU . 1.5 p -119.12 166.45 12.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.624 ' CG ' ' CD1' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -141.18 159.44 42.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.117 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -155.9 122.4 5.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 108.746 179.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 3.2 ppt_? -108.38 174.59 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.076 . . . . 0.0 110.64 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.81 -95.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 100' ' ' ARG . 3.5 t80 177.51 33.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.975 . . . . 0.0 109.098 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.57 179.43 5.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -45.75 -42.3 10.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 140' ' ' ALA . 2.0 pt-20 -176.13 105.02 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -1.102 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -59.14 -150.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.29 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 176' ' ' GLY . 45.3 t0 -81.28 -35.8 30.64 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.541 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 51.6 mt -127.97 81.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.441 ' HG2' HG22 ' A' ' 102' ' ' VAL . 2.6 ttt -67.13 100.26 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 102' ' ' VAL . 6.1 mm -82.26 115.02 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.04 -1.037 . . . . 0.0 108.348 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.3 OUTLIER -134.11 159.22 41.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.37 -1.456 . . . . 0.0 112.447 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.501 ' CA ' ' ND2' ' A' ' 103' ' ' ASN . 13.2 p90 -100.17 133.09 45.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.716 -0.615 . . . . 0.0 110.252 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.649 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -160.28 -159.07 0.67 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.096 -1.003 . . . . 0.0 110.724 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.453 HG12 ' HG2' ' A' ' 149' ' ' ARG . 2.3 p -166.38 -170.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.979 -1.076 . . . . 0.0 109.185 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.453 ' HG2' HG12 ' A' ' 148' ' ' VAL . 7.9 ptt-85 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.172 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--O 1.214 -0.69 0 N-CA-C 109.474 -1.01 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.778 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 5.5 m-85 -113.42 -169.64 1.54 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.105 -0.997 . . . . 0.0 110.282 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.572 ' O ' ' C ' ' A' ' 159' ' ' GLY . 9.5 p30 178.96 61.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -10.88 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.506 3.341 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 38.4 Cg_endo -67.23 59.16 0.65 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.573 1.302 . . . . 0.0 109.692 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 162' ' ' ASN . . . -173.81 146.65 8.9 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -41.95 -27.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -1.052 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.467 ' HB ' ' OD1' ' A' ' 158' ' ' ASP . 2.8 t -52.44 82.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.519 -0.738 . . . . 0.0 110.781 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 162' ' ' ASN . 0.7 OUTLIER -70.59 -81.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.346 -0.846 . . . . 0.0 111.619 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.669 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -145.33 -179.63 6.77 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.65 -1.281 . . . . 0.0 111.409 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.778 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 2.0 p-80 179.28 162.39 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.808 -1.807 . . . . 0.0 110.383 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.43 -167.99 1.94 Allowed 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.191 -0.943 . . . . 0.0 110.418 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 206' ' ' SER . 95.4 m-85 -125.37 -163.05 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 0.0 110.344 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.539 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -172.23 -60.59 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.294 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 45.6 Cg_endo -76.57 118.56 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.831 1.437 . . . . 0.0 109.981 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 148.22 173.94 19.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -74.47 -91.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.128 1.594 . . . . 0.0 110.146 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -73.64 -28.16 65.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -75.32 8.29 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -1.149 . . . . 0.0 108.407 178.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 171' ' ' GLY . 20.5 p-10 -65.83 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 112.41 97.57 2.34 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.601 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -160.11 124.23 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.755 -1.439 . . . . 0.0 107.62 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.591 ' CB ' ' CB ' ' A' ' 202' ' ' GLU . . . -109.01 159.2 17.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 108.589 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.695 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -156.96 131.53 8.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.591 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.572 ' CD1' ' OE2' ' A' ' 202' ' ' GLU . 37.0 m-85 -93.08 142.45 27.28 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.188 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.565 ' O ' ' CZ2' ' A' ' 186' ' ' TRP . 5.7 t0 -64.39 144.12 57.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.451 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 4.6 p30 -109.91 24.23 13.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.637 -1.289 . . . . 0.0 110.139 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.562 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 20.1 m-20 -131.06 15.41 5.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.044 -1.035 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 7.6 tt0 -118.95 -132.88 0.32 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.598 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 88.6 mt-30 -114.44 163.04 15.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.821 -1.174 . . . . 0.0 108.514 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.598 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 98.8 m95 -158.44 105.37 1.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.93 -1.106 . . . . 0.0 110.398 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.578 ' CG2' ' N ' ' A' ' 192' ' ' GLY . 80.8 p -146.6 154.25 41.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.352 -0.843 . . . . 0.0 109.399 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 4.5 pttm -81.06 -30.31 34.81 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 229' ' ' LEU . 3.2 t70 -98.17 -148.13 0.33 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.609 ' N ' ' CD1' ' A' ' 229' ' ' LEU . 12.8 t -99.86 37.48 1.61 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.536 ' CB ' HG23 ' A' ' 187' ' ' THR . 21.4 m -86.23 -35.61 19.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.436 -0.79 . . . . 0.0 111.072 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.578 ' N ' ' CG2' ' A' ' 187' ' ' THR . . . -133.75 -95.78 0.56 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.612 -1.756 . . . . 0.0 109.706 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 185' ' ' GLN . 77.5 m -100.83 -108.35 0.22 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.565 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 34.2 m-80 -159.52 71.55 0.5 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.662 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 7.9 tp -29.29 -96.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.647 ' HA ' ' CB ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -49.89 -24.2 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.071 . . . . 0.0 111.391 -178.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.565 ' CB ' ' HB3' ' A' ' 194' ' ' ASN . 13.8 tp -58.05 -61.3 2.65 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 117.381 -1.727 . . . . 0.0 107.807 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 202' ' ' GLU . 1.4 t -73.59 -5.65 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.816 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.662 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -78.14 -57.67 3.66 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.488 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -65.55 -17.26 64.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.596 ' CE1' ' HA ' ' A' ' 219' ' ' MET . 3.3 t-160 -69.59 -41.76 75.36 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 117.079 -1.848 . . . . 0.0 108.135 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.591 ' CB ' ' CB ' ' A' ' 178' ' ' ALA . 0.8 OUTLIER -83.4 -49.52 9.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 0.0 110.464 179.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 120' ' ' ALA . 2.8 mt -59.11 -31.62 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.675 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.41 -34.85 39.04 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -58.49 -48.49 80.63 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.8 -0.823 . . . . 0.0 110.744 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.524 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 68.7 p -87.0 -55.74 3.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 112.104 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 207' ' ' LEU . 0.6 OUTLIER -103.95 31.3 4.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.256 -0.902 . . . . 0.0 110.095 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.609 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -135.04 -80.97 0.13 Allowed Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.556 ' CD1' ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -169.07 -165.9 0.58 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.264 . . . . 0.0 110.352 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.531 ' N ' HD11 ' A' ' 209' ' ' LEU . 75.7 t80 -93.53 -83.91 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.567 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.3 m-70 -151.61 122.64 7.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.651 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -113.13 -178.11 3.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -0.925 . . . . 0.0 109.388 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.418 ' HB1' ' CG ' ' A' ' 237' ' ' ASP . . . -60.87 85.92 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.782 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -91.0 12.39 19.88 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.395 -1.322 . . . . 0.0 112.115 -177.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.444 ' C ' ' O ' ' A' ' 214' ' ' ASN . 1.7 p -50.74 -27.74 7.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.495 ' N ' ' C ' ' A' ' 214' ' ' ASN . 4.6 mm-40 -116.6 -35.59 4.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.706 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.782 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -59.02 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 122.076 0.941 . . . . 0.0 112.755 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.626 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.1 OUTLIER -115.71 -13.29 11.45 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.776 -177.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.596 ' HA ' ' CE1' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -81.38 -7.01 59.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.312 -2.117 . . . . 0.0 111.799 -178.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -134.08 13.37 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.594 -1.316 . . . . 0.0 113.475 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 51.3 Cg_endo -76.26 -36.07 2.01 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 N-CA-C 109.099 -1.154 . . . . 0.0 109.099 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.56 ' C ' ' O ' ' A' ' 221' ' ' PRO . 1.6 tt -17.41 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.291 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.504 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 0.5 OUTLIER -68.02 54.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 223' ' ' TYR . 33.1 t60 178.77 -129.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 108.658 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.431 ' C ' HD22 ' A' ' 229' ' ' LEU . 0.1 OUTLIER -154.29 136.46 14.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.799 -1.188 . . . . 0.0 108.913 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 229' ' ' LEU . 0.1 OUTLIER 179.53 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 110.704 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -103.83 -28.74 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 108.825 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 7.6 t70 -172.26 3.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.892 . . . . 0.0 110.792 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.609 ' CD1' ' N ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -44.55 -51.98 8.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.821 -1.175 . . . . 0.0 108.99 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.74 -28.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.557 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.8 mtp180 -104.0 -39.74 6.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.474 -0.766 . . . . 0.0 109.43 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.58 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 21.9 p90 0.59 109.7 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.349 0.595 . . . . 0.0 112.443 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.79 177.27 0.49 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.316 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.665 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -89.52 175.04 7.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.009 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.661 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 16.4 t -111.96 -169.22 1.43 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.131 -0.981 . . . . 0.0 110.257 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.546 ' N ' ' OG ' ' A' ' 235' ' ' SER . 68.1 tp60 -84.49 -15.79 44.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.575 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.636 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 5.4 m-20 -84.25 -46.44 11.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.505 -1.372 . . . . 0.0 108.339 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -67.55 -35.77 79.69 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 117.381 -1.728 . . . . 0.0 106.543 177.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.5 OUTLIER -58.67 -34.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -45.96 73.91 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -63.88 -50.58 60.05 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.61 HG13 ' CG2' ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.74 -47.81 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.723 -1.457 . . . . 0.0 109.586 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.423 ' N ' ' CG2' ' A' ' 242' ' ' ILE . 40.4 tt0 -53.98 -29.49 43.25 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.8 t -77.21 -22.47 52.27 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -64.66 -63.37 1.14 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.638 ' CD1' ' CD1' ' A' ' 130' ' ' LEU . 24.1 m-85 . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.535 ' CB ' HD22 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.608 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 90.3 m95 -90.2 148.69 22.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -126.31 -32.67 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.0 109.346 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.544 ' CE ' HD12 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -51.57 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.462 -0.774 . . . . 0.0 110.129 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.7 p -116.93 -0.05 12.32 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.576 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 40.1 m80 -146.96 93.2 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.599 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 132' ' ' PHE . 2.8 mm? -82.91 177.62 8.55 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.304 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -144.78 155.24 43.42 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.959 -1.088 . . . . 0.0 108.893 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.682 ' CE1' ' CD2' ' A' ' 121' ' ' LEU . 4.9 p90 -136.63 166.17 24.18 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.629 -1.294 . . . . 0.0 109.385 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.521 ' HD3' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -129.76 125.53 36.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.65 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -85.11 83.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 144' ' ' ILE . 1.7 t -99.98 6.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.892 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -101.79 157.79 16.59 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.619 -1.301 . . . . 0.0 109.459 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 20.7 t80 178.33 70.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.767 . . . . 0.0 109.413 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.487 HG22 ' CD1' ' A' ' 186' ' ' TRP . 38.6 p -66.28 158.35 77.85 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 108.584 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -22.12 40.88 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.885 1.466 . . . . 0.0 108.68 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.2 OUTLIER -74.14 -4.72 37.45 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.562 ' CD1' HD11 ' A' ' 195' ' ' LEU . 83.7 mt -141.56 117.44 7.2 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.497 -0.752 . . . . 0.0 109.871 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.07 165.33 17.03 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.76 1.4 . . . . 0.0 109.171 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -35.99 -65.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.811 0.815 . . . . 0.0 110.332 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.98 -10.25 5.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.774 -0.579 . . . . 0.0 111.517 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.586 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -86.43 -61.68 1.68 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.478 -1.389 . . . . 0.0 108.949 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.566 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 7.5 p -54.67 -40.56 51.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.489 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -63.3 -27.01 69.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.523 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -67.39 -38.49 84.77 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.666 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -72.86 -33.95 66.44 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.901 -1.124 . . . . 0.0 109.66 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.545 ' CG1' HG13 ' A' ' 144' ' ' ILE . 57.3 t -76.06 -22.9 15.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.9 OUTLIER -89.11 -34.38 16.76 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.64 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.44 -38.02 27.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -64.49 -61.24 2.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.682 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 14.2 tp -53.45 -46.65 69.97 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.765 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 126' ' ' GLU . 0.5 OUTLIER -66.39 -35.3 79.97 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.138 -178.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.63 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 2.0 t -57.09 -36.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.688 ' CZ2' ' HA3' ' A' ' 204' ' ' GLY . 56.2 m95 -92.61 -25.17 18.43 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.931 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -71.83 -27.34 62.84 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.627 -1.296 . . . . 0.0 108.29 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.0 pt-20 -92.44 -42.82 9.54 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.029 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.633 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 19.8 m -63.9 -21.16 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.25 -1.38 . . . . 0.0 109.971 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.608 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.0 OUTLIER -108.35 162.67 19.11 Favored Pre-proline 0 N--CA 1.5 2.046 0 C-N-CA 117.472 -1.691 . . . . 0.0 109.883 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.47 ' O ' HD22 ' A' ' 130' ' ' LEU . 50.2 Cg_endo -81.02 21.74 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.1 1.867 . . . . 0.0 111.729 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.591 HD13 ' CD2' ' A' ' 246' ' ' TYR . 21.7 mt -122.22 -173.7 2.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.5 -1.375 . . . . 0.0 110.561 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -124.07 -168.22 1.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.973 -179.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -153.02 175.77 12.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.554 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -149.17 -173.44 4.38 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.61 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.34 163.04 39.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.49 -1.381 . . . . 0.0 110.768 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.6 OUTLIER -151.19 -131.9 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.47 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.726 -1.234 . . . . 0.0 109.444 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 139' ' ' GLU . 7.0 pm0 -166.79 -164.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 109.928 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 36.3 -97.43 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER 178.38 107.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -1.105 . . . . 0.0 110.398 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.522 ' CB ' HD23 ' A' ' 135' ' ' LEU . . . -63.15 -151.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 108.699 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.608 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 63.2 m-20 -87.7 -32.62 19.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 132' ' ' PHE . 4.4 mp -128.54 83.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.1 ttt -66.51 98.77 0.52 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 108.905 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.611 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.6 mm -82.42 115.79 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.819 -1.176 . . . . 0.0 108.149 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.93 153.01 52.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.55 -1.344 . . . . 0.0 111.48 -179.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.2 p90 -93.79 139.18 31.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.637 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -163.72 -159.96 0.54 Allowed 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.351 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' A' ' 157' ' ' PHE . 1.7 p -173.32 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 109.064 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.51 ' N ' HG11 ' A' ' 148' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.753 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 C--O 1.214 -0.688 0 N-CA-C 109.849 -0.866 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.767 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.3 OUTLIER -81.08 -165.9 1.02 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 110.341 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.578 ' O ' ' C ' ' A' ' 159' ' ' GLY . 48.4 p-10 179.29 57.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.712 -0.617 . . . . 0.0 110.366 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -21.34 -67.71 0.01 OUTLIER Glycine 0 N--CA 1.509 3.53 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.528 ' CD ' ' HB3' ' A' ' 183' ' ' ASP . 43.7 Cg_endo -74.04 52.87 2.75 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.525 1.277 . . . . 0.0 109.401 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -155.89 156.78 27.3 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 164' ' ' LEU . 20.4 m-80 -47.61 -41.71 22.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.66 -0.906 . . . . 0.0 110.507 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.454 ' HB ' ' CG ' ' A' ' 158' ' ' ASP . 78.6 t -59.89 78.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 110.136 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.631 ' CD2' ' CH2' ' A' ' 186' ' ' TRP . 0.2 OUTLIER -59.1 -55.05 40.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.416 -0.802 . . . . 0.0 111.784 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.673 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -163.68 -174.91 3.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.723 -1.236 . . . . 0.0 111.245 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.767 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.5 p-80 178.42 165.06 0.78 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.141 -1.599 . . . . 0.0 110.989 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -129.29 -158.97 0.92 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.405 -0.809 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.593 ' CG ' ' CG1' ' A' ' 174' ' ' ILE . 3.7 m-85 -122.83 -169.37 1.91 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.582 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.606 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . . . -117.54 -166.39 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 41.0 Cg_endo -74.97 123.51 7.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.05 1.026 . . . . 0.0 110.825 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . -172.15 -171.32 36.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.68 101.82 1.34 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.569 1.3 . . . . 0.0 109.91 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.46 ' HA2' ' OE2' ' A' ' 139' ' ' GLU . . . 81.5 -51.16 4.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.593 ' CG1' ' CG ' ' A' ' 168' ' ' TYR . 1.7 tt -68.67 2.58 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.623 -0.928 . . . . 0.0 109.346 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.579 ' O ' ' CH2' ' A' ' 92' ' ' TRP . 8.1 p-10 -63.52 63.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.56 -0.712 . . . . 0.0 109.227 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.02 101.73 2.69 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.4 m-20 -157.16 120.33 4.07 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.56 161.8 15.01 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.889 -1.132 . . . . 0.0 108.916 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.74 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -156.09 133.16 10.6 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.056 -1.058 . . . . 0.0 108.811 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 73.1 m-85 -93.71 141.28 28.67 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.741 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.577 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 23.7 p30 -63.51 144.55 56.9 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.667 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.57 22.27 11.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.669 -1.269 . . . . 0.0 110.447 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.533 ' HB3' ' HA3' ' A' ' 159' ' ' GLY . 27.2 t0 -115.95 11.21 15.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.957 -1.09 . . . . 0.0 110.359 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.5 ' HG2' ' CA ' ' A' ' 159' ' ' GLY . 2.9 pt-20 -126.43 -108.21 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.772 -1.205 . . . . 0.0 109.282 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 3.9 mt-30 -148.31 173.91 12.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.712 -1.242 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.631 ' CH2' ' CD2' ' A' ' 164' ' ' LEU . 88.7 m95 -162.54 132.58 4.57 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.039 -1.038 . . . . 0.0 110.029 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 192' ' ' GLY . 31.0 p -153.64 153.26 31.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.077 -1.014 . . . . 0.0 109.51 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -73.43 -37.38 65.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 227' ' ' THR . 1.3 t70 -86.04 -145.3 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.553 ' N ' HD13 ' A' ' 229' ' ' LEU . 11.7 t -115.61 46.26 1.54 Allowed 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 118.761 -1.176 . . . . 0.0 108.196 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.448 ' HB ' HG22 ' A' ' 187' ' ' THR . 97.8 m -101.58 -31.06 11.03 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.382 -0.824 . . . . 0.0 111.186 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 187' ' ' THR . . . -111.95 -86.99 1.66 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.878 -1.63 . . . . 0.0 109.096 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.573 ' CG2' ' ND2' ' A' ' 194' ' ' ASN . 35.4 m -125.01 -97.21 0.43 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.608 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.8 OUTLIER -158.12 67.53 0.48 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.107 -0.995 . . . . 0.0 108.42 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.666 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -27.79 -94.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.54 0.686 . . . . 0.0 111.553 -179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.64 ' CE1' ' CD2' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -67.63 -12.66 60.95 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 111.013 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.608 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 8.5 tp -63.06 -64.25 0.97 Allowed 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.906 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.531 HG23 ' CD2' ' A' ' 164' ' ' LEU . 2.5 t -69.46 -12.02 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.67 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -73.76 -57.4 4.01 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -66.99 -14.61 63.05 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.556 ' CG ' ' SD ' ' A' ' 219' ' ' MET . 11.4 t60 -69.93 -43.97 70.56 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 117.821 -1.551 . . . . 0.0 107.743 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.58 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 2.3 mt-10 -82.53 -49.05 10.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.4 mt -59.95 -30.74 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.688 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -80.32 -29.68 44.11 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -62.2 -42.84 99.66 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.701 -0.882 . . . . 0.0 110.558 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.489 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 68.5 m -90.57 -51.71 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.108 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.53 ' CD2' HG12 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -104.78 20.66 18.32 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.008 -1.057 . . . . 0.0 110.828 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -124.48 -79.25 0.39 Allowed Glycine 0 C--N 1.291 -1.96 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.256 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.552 HD22 ' CZ3' ' A' ' 124' ' ' TRP . 1.0 OUTLIER -171.25 -156.29 0.11 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.428 -1.631 . . . . 0.0 110.939 -178.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.568 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.5 OUTLIER -101.49 -86.58 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.576 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.1 m-70 -152.32 89.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.457 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.585 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.0 m -79.47 178.72 7.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.116 -0.99 . . . . 0.0 108.574 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.09 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.767 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.16 11.9 10.91 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.213 -1.395 . . . . 0.0 111.978 -177.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.92 -28.22 6.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 175.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.476 ' C ' ' HB2' ' A' ' 235' ' ' SER . 34.9 mt-10 -117.41 -34.58 4.25 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.767 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -57.8 -145.63 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.206 -0.934 . . . . 0.0 111.557 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.701 ' CB ' HD12 ' A' ' 234' ' ' LEU . 0.7 OUTLIER -132.35 -0.5 3.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.74 . . . . 0.0 111.082 -178.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.576 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 9.2 tpp -93.35 -3.46 53.35 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.072 -1.642 . . . . 0.0 110.073 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.65 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 4.4 t80 -139.86 12.08 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.04 -1.064 . . . . 0.0 113.322 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 53.7 Cg_endo -74.31 -36.75 2.96 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 108.988 -1.197 . . . . 0.0 108.988 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.583 ' C ' ' O ' ' A' ' 221' ' ' PRO . 2.6 tt -13.06 -60.05 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.201 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.529 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 9.5 t80 -69.57 56.48 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.078 -1.014 . . . . 0.0 109.494 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.4 t-160 179.21 -142.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.1 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 226' ' ' LEU . 4.0 m -149.51 121.62 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 109.58 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER -176.28 56.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 109.897 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 189' ' ' ASP . 0.0 OUTLIER -116.17 -16.23 11.01 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.1 t0 -169.51 -25.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.681 -0.637 . . . . 0.0 109.527 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -27.93 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.667 -0.646 . . . . 0.0 110.719 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.411 ' C ' ' HG3' ' A' ' 231' ' ' ARG . 0.6 OUTLIER -145.11 1.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.887 -1.133 . . . . 0.0 110.139 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.555 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER -129.55 -44.74 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.885 -1.135 . . . . 0.0 109.382 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 23.0 p90 1.12 106.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.482 0.658 . . . . 0.0 112.58 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.25 171.05 0.94 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.474 179.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.701 HD12 ' CB ' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -82.01 179.61 7.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.334 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.683 ' N ' ' HA ' ' A' ' 217' ' ' ALA . 3.2 t -116.5 -169.93 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.042 -1.036 . . . . 0.0 110.575 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.597 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.4 OUTLIER -85.57 -25.07 26.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.542 -0.724 . . . . 0.0 109.983 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.585 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 19.6 m-20 -77.14 -45.07 28.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.932 -1.105 . . . . 0.0 108.204 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.608 ' CB ' HD13 ' A' ' 234' ' ' LEU . 7.8 t70 -67.85 -45.93 73.2 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.282 -1.367 . . . . 0.0 107.909 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.549 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.8 OUTLIER -51.61 -34.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -47.13 78.74 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -60.51 -56.05 26.56 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.608 ' CD1' HG23 ' A' ' 128' ' ' THR . 0.7 OUTLIER -63.77 -46.14 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.821 -1.399 . . . . 0.0 109.954 -178.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 30.4 mt-30 -54.27 -26.66 30.28 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -90.02 -10.93 43.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.535 HD22 ' CB ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -80.02 -54.37 5.85 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.591 ' CD2' HD13 ' A' ' 130' ' ' LEU . 3.9 m-30 . . . . . 0 N--CA 1.49 1.571 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.172 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.577 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 27.9 m95 -97.65 140.55 31.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.978 -1.076 . . . . 0.0 109.641 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.78 -28.25 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.98 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.778 0.799 . . . . 0.0 110.192 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.53 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 66.8 p -127.33 3.71 6.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.595 ' CE1' ' CG2' ' A' ' 131' ' ' THR . 7.8 m80 -148.91 102.94 3.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.9 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.634 ' CD1' ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -121.19 -166.51 1.36 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.3 OUTLIER -168.21 171.67 9.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.14 -0.975 . . . . 0.0 109.238 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.634 ' CZ ' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -139.38 177.19 8.1 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.84 -1.163 . . . . 0.0 110.48 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -127.45 126.76 42.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 109.9 -178.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.634 ' CD1' ' CZ ' ' A' ' 99' ' ' TYR . 1.9 mp -85.06 83.33 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.932 -1.105 . . . . 0.0 109.837 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.609 ' N ' ' O ' ' A' ' 144' ' ' ILE . 0.1 OUTLIER -101.22 8.67 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.186 -0.946 . . . . 0.0 110.077 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.507 ' ND2' ' N ' ' A' ' 145' ' ' SER . 0.1 OUTLIER -100.48 157.29 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.635 -1.291 . . . . 0.0 109.968 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER 178.16 75.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.62 0.724 . . . . 0.0 109.507 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.634 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 0.8 OUTLIER -67.77 157.2 87.19 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.23 -23.44 39.0 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 O-C-N 123.79 1.416 . . . . 0.0 108.952 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 1.5 t0 -69.93 -9.8 56.28 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 52.2 mt -143.45 123.97 7.92 Favored Pre-proline 0 N--CA 1.485 1.278 0 O-C-N 121.622 -0.673 . . . . 0.0 109.898 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -66.42 168.87 15.21 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.781 1.411 . . . . 0.0 109.184 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.91 -64.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.756 0.789 . . . . 0.0 110.516 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 112' ' ' ALA . 2.4 p-10 -55.5 -32.08 62.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.701 -0.625 . . . . 0.0 111.954 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.622 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -70.87 -61.91 1.59 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.524 -1.36 . . . . 0.0 109.437 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.56 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.6 p -52.21 -41.68 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.505 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -63.63 -26.34 68.63 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 112' ' ' ALA . 1.0 OUTLIER -68.21 -35.71 78.39 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.401 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.692 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -76.15 -35.11 59.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.937 -1.102 . . . . 0.0 109.005 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.607 HG13 ' CE2' ' A' ' 99' ' ' TYR . 1.7 t -73.11 -26.13 22.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 1.5 tt0 -86.48 -36.35 19.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -75.93 -39.27 56.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.642 ' HB3' ' CB ' ' A' ' 199' ' ' ALA . . . -66.15 -62.96 1.2 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.473 1.13 . . . . 0.0 108.167 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.617 ' CD1' ' CZ ' ' A' ' 99' ' ' TYR . 1.3 tt -46.51 -51.57 15.12 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.189 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.52 ' N ' ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -67.63 -35.47 78.97 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.947 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.595 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 3.1 t -52.44 -42.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.65 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 30.1 m95 -92.43 -23.38 19.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.928 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 46.9 tt0 -69.81 -26.93 64.49 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.762 -1.211 . . . . 0.0 107.801 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -91.06 -43.12 10.11 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.804 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.64 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 17.7 m -59.18 -24.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.766 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.604 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -105.9 160.48 25.98 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 117.696 -1.601 . . . . 0.0 110.222 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.435 ' C ' HD23 ' A' ' 130' ' ' LEU . 51.7 Cg_endo -85.56 22.48 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.259 1.973 . . . . 0.0 111.962 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 95' ' ' THR . 3.6 mm? -116.36 -169.96 1.72 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.32 -1.488 . . . . 0.0 110.51 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.595 ' CG2' ' CE1' ' A' ' 96' ' ' HIS . 1.3 p -117.04 164.96 13.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.634 ' CE2' ' CD1' ' A' ' 97' ' ' LEU . 1.2 m-85 -144.26 139.27 28.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.693 -0.63 . . . . 0.0 109.492 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.523 ' CB ' ' HB ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -115.28 -166.31 1.11 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.129 -0.982 . . . . 0.0 108.486 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.49 157.31 35.22 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.964 -1.085 . . . . 0.0 110.014 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.46 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -159.64 -164.96 1.43 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.387 -0.821 . . . . 0.0 109.604 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 101' ' ' ILE . 1.8 t80 -154.17 22.09 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.514 ' HA ' ' NH2' ' A' ' 100' ' ' ARG . 11.6 pm0 -138.44 179.58 6.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.43 -100.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.68 119.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 110.296 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -77.94 -154.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 108.87 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 98' ' ' THR . 2.3 m-20 -84.24 -38.32 20.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 109.364 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.529 ' CG2' HD13 ' A' ' 144' ' ' ILE . 4.0 mp -120.77 84.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.649 -0.657 . . . . 0.0 109.254 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.43 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.45 98.5 0.25 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.133 -0.979 . . . . 0.0 109.044 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.9 mm -84.29 114.89 25.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.01 155.66 50.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.517 -1.365 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -81.15 141.11 34.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 108.826 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.574 ' HB1' ' CD2' ' A' ' 179' ' ' HIS . . . -160.03 178.25 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.85 -1.156 . . . . 0.0 110.828 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 149' ' ' ARG . 1.5 p -167.26 -150.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.554 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 3.7 mmm180 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.765 -0.584 . . . . 0.0 110.477 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 C--O 1.215 -0.664 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.687 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -106.92 -164.12 0.96 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.081 -1.012 . . . . 0.0 110.243 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 1.3 p30 179.91 46.08 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.362 -0.836 . . . . 0.0 110.553 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.588 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 38.4 -97.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.482 ' N ' ' O ' ' A' ' 158' ' ' ASP . 40.2 Cg_endo -69.51 56.9 1.32 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.992 1.522 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.471 ' HA3' ' OD1' ' A' ' 158' ' ' ASP . . . -132.84 143.02 14.61 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 161' ' ' GLY . 2.9 m120 -42.6 -31.32 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -1.066 . . . . 0.0 109.877 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.571 ' HB ' ' CE1' ' A' ' 157' ' ' PHE . 31.8 m -68.76 83.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.169 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.559 ' O ' ' CE2' ' A' ' 157' ' ' PHE . 1.6 tp -64.21 -71.19 0.18 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 0.0 111.658 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.549 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -150.02 -168.41 3.1 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.532 -1.355 . . . . 0.0 110.426 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 179.21 -178.22 0.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 119.73 -1.856 . . . . 0.0 111.353 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -154.92 178.91 9.64 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.475 -0.765 . . . . 0.0 110.134 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.628 ' CG ' ' CG1' ' A' ' 174' ' ' ILE . 81.5 m-85 -121.51 -167.82 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.449 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.527 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -175.3 -58.65 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 109.423 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -78.62 133.05 11.35 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.886 1.466 . . . . 0.0 109.969 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 132.67 -173.9 20.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -78.48 -92.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.089 1.573 . . . . 0.0 110.312 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -82.97 -34.62 20.93 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.628 ' CG1' ' CG ' ' A' ' 168' ' ' TYR . 0.8 OUTLIER -61.93 -6.98 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.466 -1.02 . . . . 0.0 108.816 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.568 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -65.81 64.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.466 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 126.36 82.3 0.43 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.0 m-20 -158.68 120.24 3.46 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.012 -1.287 . . . . 0.0 107.95 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -111.9 156.97 21.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.677 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.634 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -145.08 134.08 22.58 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.624 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 65.7 m-85 -95.57 133.75 39.25 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.158 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.579 ' OD2' ' CD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -49.34 148.66 2.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.026 177.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.462 ' OD2' ' HB ' ' A' ' 148' ' ' VAL . 2.6 p30 -124.05 21.04 9.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.809 -1.182 . . . . 0.0 109.558 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.588 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 1.8 m-20 -131.05 9.73 4.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.493 ' CG ' ' HB3' ' A' ' 181' ' ' ASP . 1.0 OUTLIER -114.04 -98.28 0.44 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.657 -1.277 . . . . 0.0 109.515 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 66.9 mt-30 -154.26 165.94 34.72 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 109.202 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.634 ' CD1' ' CG2' ' A' ' 105' ' ' THR . 97.8 m95 -160.3 118.97 2.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 110.11 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 195' ' ' LEU . 22.2 p -140.79 152.1 44.94 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.034 -1.041 . . . . 0.0 109.039 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.592 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.0 OUTLIER -75.09 -33.44 61.64 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.538 ' O ' ' CG2' ' A' ' 227' ' ' THR . 1.3 t70 -91.52 -141.19 0.18 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.567 ' N ' HD13 ' A' ' 229' ' ' LEU . 11.8 t -117.59 46.77 1.66 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.003 -1.06 . . . . 0.0 108.243 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.452 ' HB ' HG22 ' A' ' 187' ' ' THR . 58.4 m -104.71 -29.46 10.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.273 -0.892 . . . . 0.0 111.303 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.529 ' N ' HG22 ' A' ' 187' ' ' THR . . . -110.26 -91.29 2.09 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.91 -1.614 . . . . 0.0 109.48 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.529 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 64.8 m -114.44 -84.35 0.61 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.692 ' HB2' ' CB ' ' A' ' 197' ' ' LEU . 5.1 p30 178.6 68.56 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.862 1.315 . . . . 0.0 108.139 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.692 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -21.73 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.303 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.684 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -68.01 -6.39 22.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 110.835 -175.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.692 ' CB ' ' HB2' ' A' ' 194' ' ' ASN . 7.5 tp -66.11 -61.49 2.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 117.601 -1.64 . . . . 0.0 106.642 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.563 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 0.7 OUTLIER -70.81 -14.49 18.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.121 -1.032 . . . . 0.0 108.426 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.642 ' CB ' ' HB3' ' A' ' 120' ' ' ALA . . . -73.23 -61.05 1.96 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.618 -1.233 . . . . 0.0 108.211 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.538 ' CB ' ' CD2' ' A' ' 218' ' ' LEU . . . -63.58 -15.75 58.93 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.311 -1.493 . . . . 0.0 107.527 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.525 ' HA ' ' CE ' ' A' ' 219' ' ' MET . 6.8 t60 -70.6 -44.01 68.17 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.684 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.588 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 8.3 mt-10 -82.58 -46.16 13.69 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 0.0 111.374 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.555 HD11 ' N ' ' A' ' 121' ' ' LEU . 4.0 mt -63.69 -30.31 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.65 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.47 -31.38 54.58 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -64.04 -47.16 81.29 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.796 -0.826 . . . . 0.0 111.232 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.525 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 33.9 p -85.37 -52.52 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.16 -0.963 . . . . 0.0 112.63 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.567 HD21 ' CZ ' ' A' ' 132' ' ' PHE . 1.3 pp -104.4 7.44 35.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.871 -1.143 . . . . 0.0 111.097 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.551 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -109.83 -84.01 1.5 Allowed Glycine 0 C--N 1.29 -1.975 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 238' ' ' ASP . 1.8 pp -158.89 -161.13 0.93 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.922 -1.34 . . . . 0.0 109.942 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.563 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 44.8 t80 -98.43 -71.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.6 m-70 -161.06 94.17 1.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.64 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 2.1 m -84.03 -179.26 7.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.7 78.6 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.764 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -82.72 9.34 9.85 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.281 -177.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -50.44 -27.84 7.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.479 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.6 mt-10 -114.07 -36.45 4.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.764 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -61.39 -159.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.272 1.034 . . . . 0.0 112.276 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.636 ' CD2' ' CE2' ' A' ' 196' ' ' PHE . 0.6 OUTLIER -106.04 -11.81 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.562 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.532 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -80.57 -10.2 59.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.24 -1.537 . . . . 0.0 111.932 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.679 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.8 t80 -131.39 8.5 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.447 -1.408 . . . . 0.0 113.953 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 43.7 Cg_endo -72.48 -41.84 1.55 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 N-CA-C 109.261 -1.092 . . . . 0.0 109.261 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.59 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -0.5 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.204 0.526 . . . . 0.0 111.756 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.561 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 48.4 t80 -67.19 58.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.827 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.13 -155.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 109.329 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.508 ' CB ' HD22 ' A' ' 229' ' ' LEU . 0.7 OUTLIER -128.69 126.39 40.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.091 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 231' ' ' ARG . 1.2 tt -179.85 40.35 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.58 ' HA ' ' CE1' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -103.16 -40.03 6.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.9 t70 -149.38 -13.43 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.551 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -42.65 -98.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.851 -1.156 . . . . 0.0 110.349 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.5 p -139.03 -0.31 1.88 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.48 -1.388 . . . . 0.0 109.933 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.534 ' HB2' ' CD1' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -116.7 -18.21 10.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.012 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 232' ' ' PHE . 19.5 p90 -30.15 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.478 0.656 . . . . 0.0 111.477 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.568 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 8.5 ttt180 179.13 149.53 0.26 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.628 HD22 ' CZ3' ' A' ' 124' ' ' TRP . 3.1 tp -70.11 164.43 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 108.755 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.64 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 7.7 t -102.46 178.15 4.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.068 -1.02 . . . . 0.0 109.578 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.509 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -70.36 -14.6 62.64 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.75 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.64 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 0.8 OUTLIER -87.32 -49.6 7.14 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.716 -1.24 . . . . 0.0 109.548 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.744 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.2 m-20 -63.94 -42.56 97.29 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 116.908 -1.917 . . . . 0.0 107.17 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.574 ' CD1' ' O ' ' A' ' 235' ' ' SER . 3.0 mt -54.83 -39.83 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.483 ' HA ' ' HG2' ' A' ' 243' ' ' GLN . 24.5 t-20 -60.84 -48.97 79.36 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.62 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.06 -55.53 30.37 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.604 ' CD1' HG23 ' A' ' 128' ' ' THR . 1.4 tp -63.46 -50.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.032 -1.276 . . . . 0.0 110.521 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.512 ' HG3' ' N ' ' A' ' 244' ' ' SER . 1.0 OUTLIER -53.33 -25.1 13.76 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.512 ' N ' ' HG3' ' A' ' 243' ' ' GLN . 37.4 t -90.83 -11.4 39.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.2 OUTLIER -78.98 -49.97 11.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 5.0 m-30 . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.504 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.636 ' CD1' HD22 ' A' ' 207' ' ' LEU . 36.3 m95 -105.48 160.14 15.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.889 -1.132 . . . . 0.0 109.284 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -121.97 -28.99 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.044 -1.035 . . . . 0.0 110.682 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.542 ' CE ' HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -42.9 169.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 110.323 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.527 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 2.1 p -106.19 -0.66 24.38 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.439 -0.788 . . . . 0.0 109.459 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 69.2 m80 -140.19 93.89 2.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.1 mm? -85.82 164.66 17.41 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.762 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -143.33 156.64 44.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.629 ' CZ ' ' CD2' ' A' ' 121' ' ' LEU . 8.8 p90 -135.85 170.28 16.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.61 -1.306 . . . . 0.0 109.642 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.525 ' CD ' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -132.25 123.25 26.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.369 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.541 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -80.01 83.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 0.0 109.705 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 144' ' ' ILE . 0.6 OUTLIER -99.12 8.39 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.557 ' OD1' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -107.06 173.01 6.51 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.424 -1.422 . . . . 0.0 110.119 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.619 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 11.3 t80 176.94 70.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.712 0.768 . . . . 0.0 109.342 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.568 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 56.3 p -56.25 148.86 39.88 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 120.985 -1.072 . . . . 0.0 108.246 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 -28.96 40.5 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 108.52 -1.377 . . . . 0.0 108.52 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 5.6 t0 -71.28 -9.12 57.59 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 33.1 mt -131.69 120.51 17.67 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.644 -0.66 . . . . 0.0 110.21 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.6 Cg_endo -62.99 163.69 21.64 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 123.811 1.427 . . . . 0.0 108.979 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.3 -65.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.781 0.801 . . . . 0.0 110.034 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.7 OUTLIER -57.65 -15.2 6.95 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 111.056 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.59 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -81.23 -62.22 1.72 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.555 -1.341 . . . . 0.0 108.942 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.535 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 7.3 p -50.64 -40.02 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 118.294 -1.362 . . . . 0.0 107.481 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.465 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -65.12 -27.09 68.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 112' ' ' ALA . 14.6 p -66.91 -38.43 86.21 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.618 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -73.19 -33.59 65.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.329 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.594 HG13 ' CE2' ' A' ' 99' ' ' TYR . 47.8 t -75.45 -24.09 17.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.533 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -84.36 -36.4 22.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.641 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.2 OUTLIER -79.69 -38.82 32.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.661 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -63.39 -60.76 2.95 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 122.425 1.107 . . . . 0.0 108.247 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.629 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.2 pp -52.59 -41.04 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.937 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.537 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -75.88 -32.07 59.52 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.986 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.599 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 2.9 t -53.81 -45.11 61.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.662 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 31.8 m95 -91.7 -23.12 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.902 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 5.4 tm-20 -70.96 -26.59 63.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.847 -1.158 . . . . 0.0 107.935 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -90.76 -42.71 10.53 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.689 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.62 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 16.9 m -58.78 -25.67 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 118.323 -1.351 . . . . 0.0 108.809 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.579 ' CG2' HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -112.56 172.15 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 117.94 -1.504 . . . . 0.0 110.056 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 128' ' ' THR . 51.7 Cg_endo -87.21 -7.94 6.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.642 2.228 . . . . 0.0 110.78 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.575 ' HB2' ' CD2' ' A' ' 246' ' ' TYR . 1.1 tp -73.8 -179.76 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.982 -1.074 . . . . 0.0 110.594 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 5.5 p -119.33 175.68 5.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 110.154 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.477 ' CZ ' HD12 ' A' ' 207' ' ' LEU . 0.5 OUTLIER -144.56 159.56 42.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.97 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.578 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -145.25 179.74 7.18 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.69 157.85 44.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.797 -1.189 . . . . 0.0 110.427 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.53 HD22 ' CB ' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -150.55 -140.03 0.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 5.5 t80 178.92 40.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.743 -1.223 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 7.5 pm0 -165.22 -178.18 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.609 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.44 -96.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 137' ' ' GLU . 1.7 pt-20 178.84 105.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.199 -1.177 . . . . 0.0 110.163 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.53 ' CB ' HD22 ' A' ' 135' ' ' LEU . . . -60.21 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 108.671 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.594 ' O ' ' HA3' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -92.49 -27.97 17.09 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.532 179.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.539 ' CG2' HD12 ' A' ' 144' ' ' ILE . 31.1 mm -130.9 77.14 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.503 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 1.9 ttt -64.87 97.07 0.21 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.136 -0.978 . . . . 0.0 108.962 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 102' ' ' VAL . 6.9 mm -79.55 123.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.092 . . . . 0.0 108.456 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -138.47 153.07 48.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.446 -1.409 . . . . 0.0 111.825 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 14.3 p90 -87.34 139.9 30.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.207 -0.933 . . . . 0.0 108.943 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.607 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -162.15 -160.21 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.702 -1.249 . . . . 0.0 111.36 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.549 ' CG2' ' HA3' ' A' ' 159' ' ' GLY . 5.7 p -170.0 179.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.521 ' HA ' ' N ' ' A' ' 157' ' ' PHE . 3.0 ptt180 . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 0.0 110.705 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 C--O 1.216 -0.606 0 N-CA-C 109.865 -0.859 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.682 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -91.16 -149.9 0.23 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.054 -1.028 . . . . 0.0 109.419 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 160' ' ' PRO . 8.9 p-10 -137.04 -2.85 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.258 -1.526 . . . . 0.0 111.718 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 39.48 -95.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.528 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.2 Cg_endo -61.45 72.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.338 1.178 . . . . 0.0 110.077 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -172.51 -164.06 27.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' VAL . 69.0 m-20 -90.69 -29.82 17.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.086 -1.244 . . . . 0.0 110.111 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.655 ' CG1' ' CD1' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -36.73 130.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.593 -0.692 . . . . 0.0 110.713 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.522 ' CD1' HG23 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -92.23 -80.89 0.35 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.582 -0.699 . . . . 0.0 112.24 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.603 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -161.35 -170.9 2.79 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.263 -1.523 . . . . 0.0 111.026 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.682 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -179.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 119.542 -1.974 . . . . 0.0 111.313 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -160.41 -163.41 1.09 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.603 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -130.17 -157.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 0.0 110.704 -178.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.553 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -170.56 -59.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.661 -0.65 . . . . 0.0 109.562 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 46.4 Cg_endo -79.6 -172.32 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.405 1.403 . . . . 0.0 110.232 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.55 144.07 0.71 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.17 135.14 28.75 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.425 1.417 . . . . 0.0 110.002 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 72.54 -64.12 1.44 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.603 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.0 tp -63.78 -8.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.494 -1.003 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.7 OUTLIER -65.77 66.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.763 179.329 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 129.53 79.49 0.23 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -153.53 128.76 9.76 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.859 -1.377 . . . . 0.0 108.205 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -112.59 172.57 6.84 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.983 -1.073 . . . . 0.0 108.961 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.607 ' CE1' ' CB ' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -164.66 134.38 3.8 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.577 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.682 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 12.2 m-85 -88.69 123.38 33.08 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 164' ' ' LEU . 17.0 t70 -67.2 144.66 55.86 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.129 -0.982 . . . . 0.0 108.945 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -61.18 -4.18 1.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.283 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.0 OUTLIER 4.62 -94.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 161' ' ' GLY . 1.4 pm0 -166.3 -33.61 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.692 -1.255 . . . . 0.0 110.906 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.449 ' OE1' ' HA2' ' A' ' 192' ' ' GLY . 66.4 mt-30 -141.66 158.67 43.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.708 -1.245 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.682 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 84.9 m95 -158.02 119.53 3.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.57 ' CG2' ' N ' ' A' ' 192' ' ' GLY . 47.2 p -144.43 154.64 43.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.473 -1.392 . . . . 0.0 110.476 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.7 OUTLIER -75.7 -35.0 60.42 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.541 ' O ' ' CG2' ' A' ' 227' ' ' THR . 1.0 OUTLIER -93.86 -144.21 0.24 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.562 ' N ' HD13 ' A' ' 229' ' ' LEU . 15.1 t -109.69 37.78 2.55 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.49 ' HB ' HG23 ' A' ' 187' ' ' THR . 11.8 m -84.83 -35.58 22.19 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.63 -0.669 . . . . 0.0 110.94 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.57 ' N ' ' CG2' ' A' ' 187' ' ' THR . . . -120.82 -87.39 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 118.852 -1.642 . . . . 0.0 109.024 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.461 ' O ' ' CG ' ' A' ' 194' ' ' ASN . 90.9 m -114.85 -105.91 0.39 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.57 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 52.3 m-80 -157.62 70.76 0.6 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.113 -0.992 . . . . 0.0 108.744 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.69 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 0.7 OUTLIER -19.58 -91.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.812 0.815 . . . . 0.0 112.618 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.69 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -66.95 -11.81 57.7 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.045 -1.034 . . . . 0.0 111.656 -176.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.582 ' CA ' HD12 ' A' ' 218' ' ' LEU . 11.7 tp -64.2 -55.48 21.34 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.526 HG13 ' CB ' ' A' ' 165' ' ' ALA . 2.8 t -76.08 -9.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.661 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -78.97 -57.2 3.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.391 -1.324 . . . . 0.0 107.534 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -65.22 -19.02 65.78 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.582 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 3.7 t-160 -68.22 -41.12 81.78 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.672 177.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.584 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 28.4 mt-10 -83.64 -49.11 9.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 110.778 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -58.73 -31.85 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.662 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.39 -35.69 36.56 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -56.18 -53.68 54.21 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.674 -0.897 . . . . 0.0 110.319 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.574 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.7 OUTLIER -83.72 -56.83 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 111.579 -178.23 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.636 HD22 ' CD1' ' A' ' 92' ' ' TRP . 7.4 mt -102.54 37.6 1.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 110.971 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -141.63 -75.34 0.04 OUTLIER Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.7 pp -170.31 -164.28 0.39 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.994 -1.297 . . . . 0.0 109.657 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 0.1 OUTLIER -98.48 -79.55 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.276 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.476 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 0.7 OUTLIER -154.29 105.9 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 0.0 109.164 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.647 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -94.54 -176.45 3.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.287 -0.883 . . . . 0.0 109.096 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.455 ' H ' ' HB3' ' A' ' 237' ' ' ASP . . . -62.4 81.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.734 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.84 10.5 18.37 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.64 -177.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.3 OUTLIER -50.28 -27.82 6.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 174.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.488 ' C ' ' HB2' ' A' ' 235' ' ' SER . 23.5 mm-40 -115.81 -36.85 4.06 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.734 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -173.01 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.517 1.151 . . . . 0.0 112.766 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.617 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.0 OUTLIER -85.73 -17.06 36.96 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.977 -177.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.582 ' HG3' ' CE1' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -78.51 -8.11 58.21 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.461 -2.024 . . . . 0.0 112.366 -177.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.682 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 7.0 t80 -133.01 14.74 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 120.25 -1.531 . . . . 0.0 113.472 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 52.2 Cg_endo -77.77 -41.88 0.29 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 N-CA-C 109.541 -0.984 . . . . 0.0 109.541 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.5 OUTLIER -8.73 -69.0 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.578 -178.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.546 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 7.9 t80 -65.91 59.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.71 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.9 t-160 179.77 -143.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.316 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 226' ' ' LEU . 49.4 m -152.59 123.48 7.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.066 -1.021 . . . . 0.0 109.556 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 179.52 59.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.851 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.568 ' O ' ' CD2' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -109.02 -45.98 3.68 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 33.0 t70 -138.3 -13.55 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 0.0 110.432 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -37.6 -100.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.264 -0.897 . . . . 0.0 111.055 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.46 -16.41 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.434 -1.416 . . . . 0.0 110.383 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.535 ' O ' ' CD ' ' A' ' 233' ' ' ARG . 2.1 mtp180 -114.54 -22.19 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 108.849 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 30.4 p90 -30.65 115.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.419 0.628 . . . . 0.0 111.944 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.541 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.42 166.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 178.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.641 HD23 ' CH2' ' A' ' 124' ' ' TRP . 2.6 mp -77.87 165.32 24.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.173 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 31.1 t -99.88 -170.17 1.85 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 118.699 -1.201 . . . . 0.0 110.302 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.8 pp0? -83.93 -16.93 42.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.637 -0.665 . . . . 0.0 109.968 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.647 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 1.1 m-20 -81.95 -48.57 11.31 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.257 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.72 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.8 OUTLIER -64.47 -38.34 90.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 117.328 -1.749 . . . . 0.0 106.728 177.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.42 -35.93 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.47 -60.12 3.28 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.454 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -49.51 -49.53 32.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.585 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.4 tp -65.09 -46.69 90.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.772 -1.428 . . . . 0.0 110.015 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -53.34 -27.1 21.73 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.4 t -84.96 -17.91 36.22 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -75.37 -60.58 2.24 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.553 -0.717 . . . . 0.0 109.592 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 130' ' ' LEU . 10.2 m-30 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.581 ' CD1' HD12 ' A' ' 207' ' ' LEU . 59.3 m95 -97.72 174.44 6.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.189 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.4 ppt_? -135.35 -38.81 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.636 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -43.08 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.284 -0.885 . . . . 0.0 110.073 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.527 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 30.7 p -105.98 3.34 28.24 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.328 -0.857 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.539 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 65.4 m-70 -136.11 91.04 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.882 -1.136 . . . . 0.0 109.946 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.641 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.6 mm? -94.98 168.22 10.92 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -142.86 156.51 44.94 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.872 -1.142 . . . . 0.0 109.0 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.61 ' CE2' HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -136.5 172.59 12.78 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.994 -1.066 . . . . 0.0 109.927 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.52 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -136.77 144.27 43.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.585 HD12 ' CZ ' ' A' ' 99' ' ' TYR . 1.8 mp -100.68 76.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 0.0 110.041 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' A' ' 144' ' ' ILE . 29.1 t -94.21 8.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.995 . . . . 0.0 109.699 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.548 ' ND2' ' N ' ' A' ' 145' ' ' SER . 8.6 m-80 -99.36 163.06 12.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.952 -1.092 . . . . 0.0 109.243 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 104' ' ' TYR . 17.7 p90 179.33 55.44 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.531 -0.731 . . . . 0.0 109.917 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.519 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 46.9 p -42.94 150.24 0.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.008 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.93 -25.99 44.39 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.886 1.466 . . . . 0.0 109.203 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.2 OUTLIER -77.44 -1.21 29.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.601 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 99.1 mt -141.15 115.89 7.16 Favored Pre-proline 0 N--CA 1.484 1.258 0 O-C-N 121.473 -0.767 . . . . 0.0 109.613 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.5 Cg_endo -66.09 173.87 6.67 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.807 1.425 . . . . 0.0 109.141 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.48 -65.35 0.32 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.805 0.812 . . . . 0.0 110.421 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -29.64 64.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.861 -0.525 . . . . 0.0 112.336 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.601 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -71.68 -61.98 1.58 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.261 -1.525 . . . . 0.0 109.064 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.588 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 8.3 p -52.23 -39.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.49 ' N ' HG11 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -63.09 -28.15 69.88 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.548 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 16.4 p -64.96 -40.4 94.93 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.672 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -73.56 -33.15 64.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.962 -1.087 . . . . 0.0 109.892 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.61 HG13 ' CE2' ' A' ' 99' ' ' TYR . 2.0 t -74.86 -24.82 18.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -88.52 -35.04 17.19 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.641 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -77.89 -39.66 42.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.653 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -65.28 -62.99 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 122.399 1.095 . . . . 0.0 108.439 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.578 HD23 ' CG ' ' A' ' 99' ' ' TYR . 10.0 tp -50.63 -44.76 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -73.18 -32.89 65.11 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.385 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.584 HG22 ' CE1' ' A' ' 196' ' ' PHE . 2.3 t -54.63 -43.16 64.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.679 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 42.9 m95 -91.71 -23.57 19.74 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.646 -1.221 . . . . 0.0 110.808 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 132' ' ' PHE . 3.5 tp10 -70.45 -27.73 64.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.595 -1.316 . . . . 0.0 107.966 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 13.2 pt-20 -89.61 -42.92 11.12 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.977 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 17.1 m -59.91 -24.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.354 -1.339 . . . . 0.0 109.291 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.593 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -110.04 155.99 40.77 Favored Pre-proline 0 N--CA 1.495 1.795 0 C-N-CA 117.963 -1.495 . . . . 0.0 109.891 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.15 10.62 3.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.14 1.894 . . . . 0.0 110.742 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.591 HD23 ' CG ' ' A' ' 246' ' ' TYR . 3.9 mp -96.46 -178.98 4.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.86 -1.15 . . . . 0.0 110.405 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.444 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -118.78 167.56 11.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.401 -0.812 . . . . 0.0 110.198 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.574 ' CE2' ' HB2' ' A' ' 97' ' ' LEU . 8.3 m-85 -141.7 -179.43 6.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.54 -0.725 . . . . 0.0 109.447 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 -162.64 1.37 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -162.05 -178.58 6.51 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.91 -1.119 . . . . 0.0 110.534 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.534 ' CD2' ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -164.17 -128.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER 177.19 31.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.621 -1.299 . . . . 0.0 109.532 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 138' ' ' GLY . 3.2 pm0 -171.28 -161.78 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.106 -0.996 . . . . 0.0 109.729 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 35.5 -98.35 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.507 ' OE2' ' CA ' ' A' ' 173' ' ' GLY . 0.0 OUTLIER 177.81 107.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 110.634 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.534 ' HB1' ' CD2' ' A' ' 135' ' ' LEU . . . -67.26 -155.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.579 ' O ' ' O ' ' A' ' 176' ' ' GLY . 8.5 t0 -81.47 -32.3 32.57 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 1.7 mt -126.86 85.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.581 ' CG ' ' O ' ' A' ' 143' ' ' MET . 5.5 ptm -76.65 100.18 5.29 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.615 ' O ' ' N ' ' A' ' 102' ' ' VAL . 4.4 mm -79.39 114.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 108.087 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -135.95 159.79 40.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.475 -1.391 . . . . 0.0 112.065 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.49 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 17.2 p90 -80.19 140.16 36.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.613 ' CB ' ' CD2' ' A' ' 179' ' ' HIS . . . -170.47 177.94 3.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 110.625 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.574 ' CG2' ' CA ' ' A' ' 159' ' ' GLY . 11.5 p 179.44 143.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.42 0 CA-C-O 121.399 0.618 . . . . 0.0 112.096 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 C--O 1.214 -0.676 0 N-CA-C 108.867 -1.243 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.681 ' CD1' ' CE1' ' A' ' 166' ' ' HIS . 1.8 t80 -76.11 -136.87 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.901 -1.124 . . . . 0.0 109.97 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.547 ' HB3' ' CB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -135.31 -30.55 1.02 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.796 -1.19 . . . . 0.0 110.879 -178.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.574 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 52.9 -107.67 0.59 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.533 ' HD2' ' CD ' ' A' ' 149' ' ' ARG . 31.5 Cg_endo -56.43 91.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 121.164 1.242 . . . . 0.0 110.829 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.52 ' HA3' ' OD2' ' A' ' 158' ' ' ASP . . . 161.73 -164.15 35.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 163' ' ' VAL . 41.8 m-80 -86.19 -30.53 22.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -1.226 . . . . 0.0 110.486 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.639 ' CG1' ' CZ ' ' A' ' 157' ' ' PHE . 7.9 t -39.92 100.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.591 ' HG ' ' CH2' ' A' ' 186' ' ' TRP . 0.9 OUTLIER -71.23 -70.36 0.32 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.447 -0.783 . . . . 0.0 111.723 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.546 ' HB2' ' CG1' ' A' ' 198' ' ' VAL . . . -161.37 -165.96 1.43 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.42 -1.425 . . . . 0.0 111.071 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.681 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.6 OUTLIER 179.49 -165.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.897 -1.752 . . . . 0.0 110.646 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -165.05 -167.05 1.11 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.528 ' O ' ' CB ' ' A' ' 206' ' ' SER . 86.7 m-85 -133.11 -159.71 0.99 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.97 . . . . 0.0 110.053 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.545 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -161.9 -63.26 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.062 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 46.5 Cg_endo -77.05 174.86 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.814 1.428 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.519 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 102.05 172.03 27.5 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.5 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 40.8 Cg_endo -74.81 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.665 1.577 . . . . 0.0 109.664 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.507 ' CA ' ' OE2' ' A' ' 139' ' ' GLU . . . -79.58 -35.1 29.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.3 tt -69.85 3.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 121.81 -0.817 . . . . 0.0 109.011 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 172' ' ' PRO . 5.5 t30 -64.94 61.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.391 -0.818 . . . . 0.0 109.105 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 107.47 89.51 2.08 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.606 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 76.1 m-20 -141.69 126.13 17.71 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.569 ' HB1' ' CD1' ' A' ' 144' ' ' ILE . . . -108.82 149.19 29.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.817 -1.177 . . . . 0.0 108.106 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.613 ' CD2' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -144.07 130.48 19.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.955 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.581 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 18.6 m-85 -85.17 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.574 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 p-10 -75.18 132.03 40.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.415 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 183' ' ' ASP . 6.4 t0 -75.44 -0.87 21.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.477 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 47.4 t0 -30.84 -72.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.512 0.672 . . . . 0.0 112.074 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -114.83 -110.96 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.084 -176.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.577 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 2.1 mt-30 -133.84 -168.77 2.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.817 -1.177 . . . . 0.0 109.739 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.591 ' CH2' ' HG ' ' A' ' 164' ' ' LEU . 85.2 m95 -155.07 136.13 13.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 192' ' ' GLY . 81.6 p -145.45 152.88 40.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.204 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.651 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -73.04 -34.01 66.04 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 228' ' ' ASP . 1.3 t70 -90.54 -151.07 0.24 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.593 ' N ' HD13 ' A' ' 229' ' ' LEU . 1.4 p -103.76 35.11 2.73 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.286 -1.365 . . . . 0.0 107.927 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.523 ' CB ' HG22 ' A' ' 187' ' ' THR . 13.2 m -81.6 -36.16 29.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.263 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 187' ' ' THR . . . -119.96 -81.05 0.67 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.155 -1.498 . . . . 0.0 109.699 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.526 ' CG2' HD22 ' A' ' 164' ' ' LEU . 85.0 m -127.51 -79.08 0.58 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.373 -1.074 . . . . 0.0 108.704 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.646 ' HB2' ' CB ' ' A' ' 197' ' ' LEU . 42.9 p30 179.26 60.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.672 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -18.44 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.591 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.657 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -64.34 -16.95 63.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.127 -176.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.646 ' CB ' ' HB2' ' A' ' 194' ' ' ASN . 13.3 tp -60.94 -61.17 2.77 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 117.208 -1.797 . . . . 0.0 107.724 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.583 HG22 ' CZ3' ' A' ' 186' ' ' TRP . 13.7 t -74.54 -7.66 10.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.629 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.653 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -74.89 -57.83 3.66 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -66.36 -16.47 64.09 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.549 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 8.5 t60 -70.12 -39.63 75.34 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.18 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.581 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 30.0 mt-10 -87.48 -46.96 9.13 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.028 -1.045 . . . . 0.0 110.366 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 120' ' ' ALA . 3.2 mt -61.41 -30.91 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.679 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.3 -34.85 44.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -58.68 -54.24 49.35 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.686 -0.891 . . . . 0.0 110.292 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.57 ' OG ' ' CD2' ' A' ' 207' ' ' LEU . 30.4 t -77.24 -60.21 2.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 112.486 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.617 ' CD2' ' N ' ' A' ' 207' ' ' LEU . 1.1 mm? -104.01 31.49 4.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.236 -0.915 . . . . 0.0 110.529 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.552 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -132.59 -77.95 0.14 Allowed Glycine 0 C--N 1.292 -1.912 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.83 -166.01 0.54 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.945 -1.327 . . . . 0.0 110.054 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -98.51 -74.82 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.29 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 79.2 m80 -160.12 110.38 1.85 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.773 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 2.0 m -98.81 -172.59 2.33 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.528 ' CB ' ' CG ' ' A' ' 237' ' ' ASP . . . -65.95 78.84 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.684 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.22 9.52 12.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.624 -177.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 214' ' ' ASN . 30.5 p -48.4 -28.88 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.519 ' C ' ' HB3' ' A' ' 235' ' ' SER . 9.5 mt-10 -113.98 -37.66 4.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.684 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -67.58 162.46 23.41 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.456 1.122 . . . . 0.0 112.367 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.616 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.0 OUTLIER -56.97 -20.78 25.69 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.243 -178.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.571 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -77.59 -9.21 58.82 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 118.984 -2.323 . . . . 0.0 112.182 -177.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 34.3 t80 -133.62 17.77 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 120.178 -1.576 . . . . 0.0 113.568 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.3 Cg_endo -78.23 -36.51 0.98 Allowed 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -24.63 -57.93 0.05 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.942 -179.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.597 ' O ' ' CG ' ' A' ' 224' ' ' HIS . 0.4 OUTLIER -73.45 54.53 0.45 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.068 -1.02 . . . . 0.0 109.883 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.597 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 2.7 m170 -175.31 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.511 ' O ' ' NH1' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 179.57 121.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.994 -1.066 . . . . 0.0 109.117 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.552 ' CD2' ' CD1' ' A' ' 197' ' ' LEU . 3.1 tp 178.9 119.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER 179.12 -34.69 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 38.6 t0 -159.95 -22.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.81 -0.556 . . . . 0.0 109.596 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 190' ' ' THR . 0.2 OUTLIER -34.5 -59.17 0.47 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.195 -0.941 . . . . 0.0 110.434 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.96 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 108.791 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.511 ' NH1' ' O ' ' A' ' 225' ' ' SER . 0.3 OUTLIER -90.32 -12.97 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.581 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 21.2 p90 -30.43 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.672 0.749 . . . . 0.0 111.221 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.537 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 2.1 ttt-85 178.79 154.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.637 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 2.3 mp -76.69 163.8 26.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.229 -0.919 . . . . 0.0 109.84 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.626 ' HB3' ' HA ' ' A' ' 217' ' ' ALA . 8.3 p -101.99 -168.69 1.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.076 -1.45 . . . . 0.0 110.485 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 236' ' ' GLN . 38.9 tp60 -84.25 -14.1 50.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.839 . . . . 0.0 111.313 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.773 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.1 OUTLIER -84.46 -44.02 14.05 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.451 -1.406 . . . . 0.0 107.882 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.648 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.7 OUTLIER -67.63 -40.63 84.62 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.55 ' CD1' HG13 ' A' ' 127' ' ' VAL . 0.6 OUTLIER -55.06 -35.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.07 -47.65 70.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.462 ' HA3' HD23 ' A' ' 209' ' ' LEU . . . -60.12 -54.53 36.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.598 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.4 tp -62.01 -46.08 97.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 120.929 -1.336 . . . . 0.0 109.792 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -31.38 44.4 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 4.0 t -77.56 -20.02 54.76 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.4 OUTLIER -70.03 -61.25 1.85 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.591 ' CG ' HD23 ' A' ' 130' ' ' LEU . 23.4 m-85 . . . . . 0 N--CA 1.49 1.574 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.442 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.994 0.426 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.632 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 26.7 m95 -94.95 177.18 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 109.909 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -139.66 -31.46 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.592 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -50.7 -172.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.022 -1.049 . . . . 0.0 110.401 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.52 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 9.6 p -123.55 -0.67 8.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.559 -0.713 . . . . 0.0 109.211 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 64.4 m80 -136.94 91.01 2.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.188 -0.945 . . . . 0.0 110.002 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.5 mm? -88.55 164.47 15.39 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.586 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -142.51 155.84 45.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.618 ' CE2' ' CD1' ' A' ' 101' ' ' ILE . 5.6 p90 -137.23 163.48 30.81 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.655 -1.278 . . . . 0.0 109.276 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.534 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.2 OUTLIER -123.27 126.2 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.2 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.618 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -81.93 77.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.95 -1.094 . . . . 0.0 109.835 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' A' ' 144' ' ' ILE . 9.3 t -89.39 4.62 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.309 -0.869 . . . . 0.0 109.714 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.544 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -101.35 155.11 18.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.671 -1.268 . . . . 0.0 109.393 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 9.1 t80 177.85 76.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.622 0.725 . . . . 0.0 109.224 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.439 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 2.6 p -75.61 161.98 74.17 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.184 -0.947 . . . . 0.0 108.957 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.56 -21.45 39.78 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.921 1.485 . . . . 0.0 108.573 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -71.09 -7.38 46.15 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.613 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 84.3 mt -148.13 123.3 5.11 Favored Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.7 167.83 14.6 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.862 1.454 . . . . 0.0 108.828 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.472 ' O ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -38.3 -64.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.818 0.818 . . . . 0.0 110.361 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 115' ' ' SER . 7.6 t0 -56.17 -26.63 51.36 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.675 -0.641 . . . . 0.0 111.736 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.613 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -74.06 -61.15 1.95 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.474 -1.391 . . . . 0.0 109.442 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 103' ' ' ASN . 7.6 p -53.14 -40.09 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.471 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 1.0 OUTLIER -66.25 -27.14 67.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.55 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 7.5 p -62.01 -43.47 98.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.621 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -71.28 -34.01 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.997 -1.064 . . . . 0.0 109.41 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.539 ' CG1' HG13 ' A' ' 144' ' ' ILE . 2.9 t -71.93 -23.27 21.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 -34.89 14.36 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.649 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 1.7 tppt? -75.59 -40.77 56.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.658 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -64.89 -60.67 2.81 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' A' ' 99' ' ' TYR . 8.5 tp -44.73 -50.85 9.81 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.546 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.8 OUTLIER -73.25 -34.23 65.72 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.464 -177.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.624 ' CG2' ' CE1' ' A' ' 196' ' ' PHE . 1.5 t -54.04 -42.23 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.648 ' CE2' ' CA ' ' A' ' 204' ' ' GLY . 42.7 m95 -91.74 -23.13 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.445 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.572 ' HA ' ' CE1' ' A' ' 132' ' ' PHE . 2.5 tm-20 -70.3 -27.3 64.28 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -90.38 -43.22 10.46 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.712 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.622 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 16.3 m -58.17 -25.7 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.819 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.574 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -113.7 152.37 45.44 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.955 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.47 2.01 6.2 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.878 1.719 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.635 ' CD1' ' CG ' ' A' ' 246' ' ' TYR . 20.5 mt -84.2 -178.06 6.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.7 p -124.25 167.37 14.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.148 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.572 ' CE1' ' HA ' ' A' ' 125' ' ' GLU . 20.0 m-85 -135.96 170.47 15.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.566 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.27 175.04 12.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 108.7 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.593 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -142.43 156.91 45.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.95 -1.094 . . . . 0.0 110.075 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.8 OUTLIER -146.77 -134.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 178.46 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.862 -1.148 . . . . 0.0 109.347 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 139' ' ' GLU . 7.8 pm0 -158.4 -177.82 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.873 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.03 -97.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 137' ' ' GLU . 2.2 pt-20 178.8 107.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 135' ' ' LEU . . . -59.59 -151.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 108.95 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 98' ' ' THR . 31.3 m-20 -89.87 -30.71 17.72 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.572 ' CG1' ' CD1' ' A' ' 207' ' ' LEU . 20.3 mm -127.18 82.13 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.521 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.64 96.75 0.18 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 108.813 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.616 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.9 mm -81.31 117.17 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.64 150.65 49.69 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.249 -1.532 . . . . 0.0 111.867 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.572 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 17.1 p90 -81.68 141.28 33.76 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.485 -0.759 . . . . 0.0 109.117 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.461 ' HB1' ' CD2' ' A' ' 179' ' ' HIS . . . -166.1 -179.04 4.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.886 -1.134 . . . . 0.0 110.675 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 149' ' ' ARG . 1.7 p -165.36 -148.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 109.247 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.555 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.004 0 O-C-N 121.645 -0.659 . . . . 0.0 110.339 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 C--O 1.215 -0.634 0 N-CA-C 109.969 -0.82 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.729 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -111.04 -170.59 1.66 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.205 -0.934 . . . . 0.0 110.44 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 160' ' ' PRO . 58.7 p30 -179.79 54.8 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.698 -0.626 . . . . 0.0 110.062 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.613 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 15.23 -79.89 0.0 OUTLIER Glycine 0 N--CA 1.507 3.385 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.584 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.7 Cg_endo -63.71 65.24 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.679 1.357 . . . . 0.0 110.118 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.1 135.63 3.81 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.518 ' O ' ' CD1' ' A' ' 164' ' ' LEU . 82.6 m-20 -39.44 -36.97 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 109.975 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.642 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 2.6 t -54.73 87.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 109.168 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.585 ' CD2' ' CG2' ' A' ' 193' ' ' THR . 1.4 mp -83.65 -48.94 9.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.11 -0.994 . . . . 0.0 112.76 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.509 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -159.0 -173.14 4.09 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.096 -1.627 . . . . 0.0 111.261 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.729 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 178.24 -175.46 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.772 -1.83 . . . . 0.0 111.552 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.656 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.45 -177.82 6.6 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.581 ' CD2' ' HB2' ' A' ' 177' ' ' ASP . 22.3 m-30 -116.73 -169.59 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.756 -1.215 . . . . 0.0 111.708 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.612 ' CB ' ' HD2' ' A' ' 170' ' ' PRO . . . -116.91 -165.87 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 169' ' ' ALA . 41.5 Cg_endo -74.05 129.76 13.59 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.073 1.039 . . . . 0.0 111.039 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . -175.19 -169.88 37.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.99 98.26 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.696 1.366 . . . . 0.0 109.772 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . 83.27 -49.1 4.17 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.2 tt -71.46 6.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.557 -0.966 . . . . 0.0 109.225 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.601 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 2.4 t-20 -64.55 62.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.79 . . . . 0.0 108.876 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.84 104.19 2.91 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.581 ' HB2' ' CD2' ' A' ' 168' ' ' TYR . 3.8 m-20 -159.04 120.5 3.37 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.881 -1.364 . . . . 0.0 107.682 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.656 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.99 172.12 7.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.59 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -162.65 137.67 6.8 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.237 1.018 . . . . 0.0 110.401 178.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.583 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 61.6 m-85 -100.49 136.75 39.88 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.746 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.495 ' O ' ' NE1' ' A' ' 186' ' ' TRP . 28.3 t0 -58.32 151.9 18.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.799 -1.188 . . . . 0.0 108.763 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.51 ' OD2' ' CD1' ' A' ' 146' ' ' PHE . 1.2 m-20 -115.73 4.05 13.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.158 -0.964 . . . . 0.0 110.194 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.613 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 17.4 m-20 -112.13 26.51 10.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.095 -1.003 . . . . 0.0 109.927 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 5.5 mt-10 -129.42 -94.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 108.702 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CD2' ' A' ' 186' ' ' TRP . 2.0 mt-30 179.05 169.56 0.94 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.604 ' CZ3' HG22 ' A' ' 198' ' ' VAL . 65.4 m95 -159.15 131.98 6.94 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.04 -1.038 . . . . 0.0 109.539 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.537 ' HA ' ' CD2' ' A' ' 108' ' ' LEU . 68.1 p -157.68 149.86 22.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.984 -1.072 . . . . 0.0 110.067 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.571 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.2 OUTLIER -80.19 -31.86 38.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.4 t70 -85.27 61.26 6.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.571 ' O ' ' CG2' ' A' ' 190' ' ' THR . 5.9 t 3.71 60.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 CA-C-O 121.958 0.885 . . . . 0.0 111.878 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.7 m -123.55 -32.0 3.42 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.32 -0.863 . . . . 0.0 109.392 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 187' ' ' THR . . . -91.03 -74.06 1.28 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.585 ' CG2' ' CD2' ' A' ' 164' ' ' LEU . 48.1 m -135.02 -79.74 0.44 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.666 ' HB2' ' CB ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER 179.9 68.68 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.296 1.046 . . . . 0.0 108.861 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.686 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 2.2 tp -30.06 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.082 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.686 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -63.58 -6.73 5.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.81 -177.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.666 ' CB ' ' HB2' ' A' ' 194' ' ' ASN . 6.1 tp -67.7 -62.43 1.42 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.265 -1.774 . . . . 0.0 107.127 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.604 HG22 ' CZ3' ' A' ' 186' ' ' TRP . 3.0 m -68.29 -15.4 19.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.658 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -71.45 -61.97 1.58 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.697 -1.201 . . . . 0.0 107.938 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.572 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -63.66 -15.8 59.31 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 120.266 -1.521 . . . . 0.0 106.946 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.41 ' CE1' ' O ' ' A' ' 219' ' ' MET . 7.5 t60 -68.19 -48.62 64.77 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.025 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.583 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 13.6 mt-10 -81.26 -45.39 16.32 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.179 -0.951 . . . . 0.0 111.098 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.571 ' CD1' ' HB2' ' A' ' 120' ' ' ALA . 2.1 mt -62.07 -31.31 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.648 ' CA ' ' CE2' ' A' ' 124' ' ' TRP . . . -75.8 -30.77 57.31 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -61.79 -51.01 70.04 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.87 -0.782 . . . . 0.0 110.746 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.523 ' CB ' HD13 ' A' ' 142' ' ' ILE . 72.8 m -82.89 -54.93 4.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.362 -0.836 . . . . 0.0 112.174 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.632 ' CD2' ' CD1' ' A' ' 92' ' ' TRP . 7.0 mt -104.25 23.71 12.67 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.019 -1.051 . . . . 0.0 110.828 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -125.11 -79.16 0.36 Allowed Glycine 0 C--N 1.291 -1.938 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.837 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.5 pp -169.02 -160.35 0.27 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.857 -1.378 . . . . 0.0 110.02 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.576 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 1.7 t80 -97.77 -70.0 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.758 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 0.2 OUTLIER -162.59 90.81 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.624 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.4 m -79.93 176.6 9.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 0.0 109.323 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.57 81.37 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.736 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.45 9.34 13.62 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.061 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.32 -28.33 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 175.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.495 ' C ' ' HB2' ' A' ' 235' ' ' SER . 0.7 OUTLIER -114.79 -36.19 4.58 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.736 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -62.34 -165.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.159 0.98 . . . . 0.0 112.227 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.63 ' CD2' ' CE1' ' A' ' 196' ' ' PHE . 0.4 OUTLIER -102.8 -10.76 18.84 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.548 -177.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.532 ' CB ' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -81.32 -8.07 59.68 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.064 -1.647 . . . . 0.0 111.636 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.664 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -139.82 16.06 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 120.462 -1.399 . . . . 0.0 113.221 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 50.3 Cg_endo -73.98 -36.37 3.53 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.189 -1.504 . . . . 0.0 108.189 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.587 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -5.0 -73.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.168 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 221' ' ' PRO . 1.9 m-85 -67.52 60.06 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -169.79 -144.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.239 -0.913 . . . . 0.0 109.536 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 72.7 m -148.61 104.51 3.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.095 -1.003 . . . . 0.0 109.969 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.53 49.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 108.978 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.548 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 11.3 t -99.25 -12.08 20.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.615 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.4 OUTLIER 177.5 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.04 -1.038 . . . . 0.0 111.244 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.557 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -33.17 -100.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.426 -0.796 . . . . 0.0 111.241 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.6 -16.28 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.637 -1.29 . . . . 0.0 109.746 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -106.33 -22.02 12.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.164 -0.96 . . . . 0.0 108.549 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.615 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.3 p90 -24.24 116.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.362 0.601 . . . . 0.0 111.388 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.76 171.61 0.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.64 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 5.2 mp -87.61 172.14 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 111.089 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.611 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 14.5 t -104.98 -170.14 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.785 0.803 . . . . 0.0 109.985 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.548 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.0 OUTLIER -82.72 -16.38 48.27 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.66 -0.65 . . . . 0.0 109.711 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.624 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 1.0 OUTLIER -82.19 -50.6 8.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.102 -0.999 . . . . 0.0 108.34 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.731 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.2 m-20 -63.86 -38.38 90.87 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 117.053 -1.859 . . . . 0.0 106.915 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 1.0 OUTLIER -57.76 -34.82 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.57 -52.04 43.45 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.361 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.43 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -55.75 -54.46 34.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.574 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.5 tp -64.3 -44.71 97.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 120.897 -1.355 . . . . 0.0 109.716 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -54.61 -28.42 46.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 42.5 t -80.16 -20.04 45.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.564 HD23 ' CE1' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -70.4 -66.61 0.58 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.635 ' CG ' ' CD1' ' A' ' 130' ' ' LEU . 16.5 m-85 . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.527 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.634 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 49.5 m95 -100.62 177.45 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.116 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -138.56 -36.33 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -46.66 177.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.191 -0.943 . . . . 0.0 110.132 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.552 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -116.59 1.65 12.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.405 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.529 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 46.9 m170 -132.74 92.82 3.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.64 ' CB ' ' CE2' ' A' ' 132' ' ' PHE . 2.5 mm? -94.72 173.62 7.51 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.531 ' OG1' ' CD2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -149.61 155.98 41.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.666 ' CZ ' ' CD2' ' A' ' 121' ' ' LEU . 6.1 p90 -135.52 165.65 25.02 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.483 -1.386 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.543 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -124.65 122.78 38.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -82.38 84.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 109.802 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 144' ' ' ILE . 0.4 OUTLIER -102.08 8.47 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 0.0 110.097 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 145' ' ' SER . 25.4 m-80 -98.65 159.19 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.959 -1.088 . . . . 0.0 109.155 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.592 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 6.0 t80 177.56 80.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.674 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.537 HG22 ' CD1' ' A' ' 186' ' ' TRP . 33.0 p -73.72 159.34 84.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.65 -22.2 38.08 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 123.774 1.407 . . . . 0.0 108.651 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -79.53 0.75 28.46 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 95.9 mt -148.33 118.44 4.22 Favored Pre-proline 0 N--CA 1.485 1.297 0 O-C-N 121.423 -0.798 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.09 174.25 6.16 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.885 1.466 . . . . 0.0 109.139 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.16 -66.06 0.32 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.783 0.802 . . . . 0.0 110.164 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 115' ' ' SER . 2.2 m-20 -56.39 -28.47 59.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.822 -0.548 . . . . 0.0 112.358 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.628 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -72.25 -61.15 1.9 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.317 -1.489 . . . . 0.0 109.468 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.545 ' CG2' ' HB3' ' A' ' 103' ' ' ASN . 8.4 p -56.08 -44.06 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.539 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 1.1 m-20 -60.89 -28.22 68.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -58.83 -63.83 1.15 Allowed 'General case' 0 C--O 1.194 -1.822 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.579 ' HB1' ' CD1' ' A' ' 195' ' ' LEU . . . -49.28 -32.52 11.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 99' ' ' TYR . 12.1 t -73.82 -24.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -90.65 -33.65 15.74 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.75 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.661 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -82.34 -37.04 26.28 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.651 ' HB3' ' CB ' ' A' ' 199' ' ' ALA . . . -65.46 -62.16 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.666 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.0 OUTLIER -53.41 -42.04 66.61 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.547 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -70.9 -34.2 71.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.131 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.575 ' CG1' HD23 ' A' ' 234' ' ' LEU . 1.7 t -57.34 -36.88 54.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.665 ' CZ2' ' HA3' ' A' ' 204' ' ' GLY . 46.9 m95 -92.23 -24.25 19.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.929 -1.109 . . . . 0.0 110.667 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -73.11 -27.37 61.66 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.927 -1.108 . . . . 0.0 108.308 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -92.42 -42.82 9.54 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.994 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.637 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 22.7 m -62.26 -23.4 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.255 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.608 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -113.05 163.31 18.35 Favored Pre-proline 0 N--CA 1.495 1.783 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.403 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.436 ' C ' HD23 ' A' ' 130' ' ' LEU . 48.6 Cg_endo -81.52 22.05 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.034 1.823 . . . . 0.0 111.51 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.567 HD21 ' CG ' ' A' ' 246' ' ' TYR . 2.6 mm? -115.86 178.1 4.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.653 -1.279 . . . . 0.0 110.347 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.547 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.9 p -121.01 177.81 4.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' A' ' 97' ' ' LEU . 11.2 m-85 -146.96 146.03 29.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.765 . . . . 0.0 110.053 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.604 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 68.0 m -114.59 -170.55 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -149.82 165.45 32.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.612 -1.305 . . . . 0.0 110.992 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.531 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.3 OUTLIER -163.15 -164.54 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 78.8 t80 -160.61 25.66 0.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' GLU . 8.7 pm0 -147.11 176.76 9.7 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.78 -97.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' GLU . 18.3 tt0 178.73 145.51 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -1.143 . . . . 0.0 110.45 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -101.09 -150.75 0.4 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.607 ' O ' ' O ' ' A' ' 176' ' ' GLY . 18.2 m-20 -90.55 -34.02 15.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.549 ' CD1' HD21 ' A' ' 207' ' ' LEU . 20.1 mm -124.04 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.528 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 5.9 ttp -66.11 97.87 0.41 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 109.195 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.8 mm -81.87 114.63 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.592 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -136.3 155.57 49.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.434 -1.416 . . . . 0.0 112.371 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.1 p90 -92.89 138.04 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.688 . . . . 0.0 109.265 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.628 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -167.57 -158.65 0.28 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.29 -0.881 . . . . 0.0 110.47 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.469 HG12 ' HG2' ' A' ' 149' ' ' ARG . 0.6 OUTLIER -173.38 -165.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.05 -1.031 . . . . 0.0 109.159 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.532 ' O ' ' CG ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 0.0 109.759 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 C--O 1.214 -0.7 0 N-CA-C 109.943 -0.829 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.765 ' CD2' ' CE1' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -80.83 -166.15 1.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.099 -1.001 . . . . 0.0 110.134 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.55 ' O ' ' C ' ' A' ' 159' ' ' GLY . 24.7 p30 179.64 60.2 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.647 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -29.3 -51.31 0.13 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.829 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 39.6 Cg_endo -66.54 60.04 0.52 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 109.301 -1.076 . . . . 0.0 109.301 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -179.27 159.96 25.07 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 164' ' ' LEU . 73.7 m-20 -52.74 -38.41 60.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.127 . . . . 0.0 110.223 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.497 ' HB ' ' OD1' ' A' ' 158' ' ' ASP . 42.8 t -53.3 81.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.341 -0.849 . . . . 0.0 110.545 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 162' ' ' ASN . 15.9 mt -68.63 -74.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.341 -0.849 . . . . 0.0 111.85 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.668 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -135.41 -176.26 4.21 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.491 -1.381 . . . . 0.0 111.614 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.754 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.5 p-80 178.98 168.55 0.94 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.564 -1.335 . . . . 0.0 110.107 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -132.92 -168.08 2.02 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.529 ' HB3' HG13 ' A' ' 174' ' ' ILE . 77.5 m-85 -114.4 -167.27 1.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.8 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.605 ' CB ' ' HD2' ' A' ' 170' ' ' PRO . . . -126.15 -175.62 0.43 Allowed Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.605 ' HD2' ' CB ' ' A' ' 169' ' ' ALA . 38.8 Cg_endo -68.9 140.19 45.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.537 1.283 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.437 ' C ' ' OD1' ' A' ' 175' ' ' ASN . . . 171.76 -125.49 1.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.499 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.0 Cg_endo -73.98 -93.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.812 1.427 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -108.37 -18.34 9.8 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.4 OUTLIER -73.3 12.17 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -1.064 . . . . 0.0 108.951 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 175' ' ' ASN . 0.6 OUTLIER -64.34 63.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.607 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 106.35 101.55 2.73 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.6 m-20 -163.16 120.11 1.86 Allowed 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.566 -1.549 . . . . 0.0 107.659 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -112.07 164.85 12.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.894 -1.129 . . . . 0.0 109.184 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.765 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -162.15 134.75 5.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.867 -1.133 . . . . 0.0 109.778 178.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.601 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 34.4 m-85 -95.48 132.67 40.32 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.514 ' HB3' ' CD1' ' A' ' 157' ' ' PHE . 24.5 p30 -66.72 130.19 42.37 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 182' ' ' ASP . 48.1 p30 -96.09 22.73 7.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.976 -1.077 . . . . 0.0 110.437 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.647 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.4 OUTLIER -90.75 -19.61 23.32 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.907 -1.121 . . . . 0.0 109.889 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.496 ' OE2' ' O ' ' A' ' 159' ' ' GLY . 0.9 OUTLIER -112.11 -130.78 0.31 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.896 -1.127 . . . . 0.0 108.595 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 35.3 mt-30 -130.97 -175.46 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.161 . . . . 0.0 109.097 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.585 ' CD1' ' O ' ' A' ' 185' ' ' GLN . 86.0 m95 -160.83 126.03 3.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 108.954 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.476 HG21 ' HA3' ' A' ' 192' ' ' GLY . 50.7 p -145.66 150.07 35.64 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.828 -1.17 . . . . 0.0 110.453 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 2.7 pttm -84.45 -33.18 23.71 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 27.9 t70 -82.31 63.72 6.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.618 ' O ' ' CG2' ' A' ' 190' ' ' THR . 1.7 t 2.82 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 122.311 1.053 . . . . 0.0 112.016 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.0 m -127.31 -31.05 2.58 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.783 -1.198 . . . . 0.0 109.927 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 187' ' ' THR . . . -96.98 -80.41 1.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.517 ' CG2' HD11 ' A' ' 164' ' ' LEU . 37.5 m -125.12 -96.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.59 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -161.77 67.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.579 ' CD1' ' HB1' ' A' ' 116' ' ' ALA . 14.7 tp -37.97 -98.91 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.757 -0.589 . . . . 0.0 110.93 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.661 ' CD1' ' HB3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -58.73 -11.53 3.26 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.722 -1.236 . . . . 0.0 110.461 -178.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.59 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 6.2 tp -64.92 -71.29 0.19 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 116.807 -1.957 . . . . 0.0 106.595 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' A' ' 201' ' ' HIS . 3.3 t -67.55 -4.57 3.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.433 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.651 ' CB ' ' HB3' ' A' ' 120' ' ' ALA . . . -75.21 -57.94 3.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.592 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -66.55 -16.91 64.51 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.551 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 3.0 t60 -69.5 -37.44 77.19 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.069 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.578 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 2.8 mt-10 -87.65 -48.65 7.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.9 mt -59.16 -31.55 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.665 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -82.21 -34.4 23.63 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -56.31 -45.81 80.1 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.524 -0.986 . . . . 0.0 110.374 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 167' ' ' ALA . 1.0 OUTLIER -89.56 -54.1 4.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 111.582 -178.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -104.16 36.31 2.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.198 -0.939 . . . . 0.0 110.753 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.564 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -141.89 -78.14 0.05 OUTLIER Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.047 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.2 -160.35 0.26 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.89 -1.359 . . . . 0.0 110.27 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.3 OUTLIER -102.54 -77.72 0.55 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.473 -0.767 . . . . 0.0 109.36 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.582 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.6 m-70 -159.44 121.75 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.453 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.618 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -109.56 -168.37 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.38 74.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.749 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -79.71 7.36 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.289 -176.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.449 ' C ' ' O ' ' A' ' 214' ' ' ASN . 2.7 p -50.47 -27.66 6.92 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.483 ' N ' ' C ' ' A' ' 214' ' ' ASN . 4.9 mp0 -114.84 -34.72 5.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.749 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -159.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.296 1.046 . . . . 0.0 112.247 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.629 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 3.3 tm? -96.7 -19.96 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.38 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.582 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -78.99 -8.49 58.97 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.249 -1.532 . . . . 0.0 112.319 -177.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.687 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 41.0 t80 -132.42 14.49 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 120.412 -1.43 . . . . 0.0 113.312 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -76.97 -37.97 0.96 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 N-CA-C 109.157 -1.132 . . . . 0.0 109.157 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 223' ' ' TYR . 1.4 tt -19.48 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.526 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.579 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 0.2 OUTLIER -67.69 59.88 0.06 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.303 -0.873 . . . . 0.0 109.004 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' LEU . 9.2 t-160 179.89 -133.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.072 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 226' ' ' LEU . 49.8 m -160.57 114.92 2.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 109.929 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.529 ' CD1' ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER 179.51 57.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 188' ' ' LYS . 4.8 t -113.92 -8.61 13.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.873 . . . . 0.0 109.516 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 1.0 OUTLIER 178.06 -21.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.742 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.549 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.2 OUTLIER -37.03 -60.59 0.62 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.15 -0.969 . . . . 0.0 110.127 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.22 -31.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.5 ' HB2' ' CG ' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -89.33 -21.84 22.93 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.586 ' CD2' ' O ' ' A' ' 232' ' ' PHE . 45.4 p90 -38.25 116.44 0.53 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.501 0.667 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.58 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.4 ttt180 179.3 152.86 0.41 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 109.126 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.651 HD23 ' CH2' ' A' ' 124' ' ' TRP . 4.0 mp -68.69 167.47 15.18 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.082 -1.011 . . . . 0.0 110.044 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.632 ' HB3' ' CB ' ' A' ' 217' ' ' ALA . 10.2 t -101.04 -169.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.571 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.3 OUTLIER -83.92 -23.08 31.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.924 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.618 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 4.6 m-20 -81.32 -40.06 24.2 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.847 -1.141 . . . . 0.0 107.934 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.598 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 17.2 t0 -70.46 -35.49 73.35 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 117.828 -1.549 . . . . 0.0 107.766 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.608 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.8 OUTLIER -61.25 -34.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.69 -45.33 79.16 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.29 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -60.68 -58.93 11.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.608 ' CD1' HG23 ' A' ' 128' ' ' THR . 0.7 OUTLIER -61.69 -44.68 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.742 -1.446 . . . . 0.0 109.623 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -54.76 -24.96 24.81 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -87.0 -14.59 41.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.526 ' HB3' HD13 ' A' ' 242' ' ' ILE . 0.4 OUTLIER -74.9 -56.34 4.85 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.567 ' CG ' HD21 ' A' ' 130' ' ' LEU . 16.4 m-85 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.215 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.517 ' N ' HD22 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.638 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 7.0 m95 -98.67 -165.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.86 -1.15 . . . . 0.0 109.606 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.9 ppt_? -145.24 -40.61 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.984 -1.073 . . . . 0.0 110.582 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -45.26 174.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.085 -1.009 . . . . 0.0 110.377 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.544 ' HA ' ' CG ' ' A' ' 130' ' ' LEU . 11.6 p -112.15 2.66 16.81 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.529 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 17.8 m-70 -144.09 98.18 3.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.949 -1.094 . . . . 0.0 109.863 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.629 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.5 mm? -95.11 168.08 10.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.508 -0.745 . . . . 0.0 109.9 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -142.37 156.42 45.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.633 ' CE2' ' CD1' ' A' ' 101' ' ' ILE . 7.9 p90 -135.98 165.53 25.46 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.668 -1.27 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 121.94 35.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.889 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.633 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.2 mp -77.7 84.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.933 -1.104 . . . . 0.0 109.29 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.666 ' N ' ' O ' ' A' ' 144' ' ' ILE . 1.4 t -96.66 8.81 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 110.552 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -111.78 169.22 8.98 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.308 -1.495 . . . . 0.0 109.41 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.474 ' HA ' HG13 ' A' ' 113' ' ' VAL . 4.3 p90 178.77 44.72 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.651 -0.656 . . . . 0.0 109.531 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 104' ' ' TYR . 70.5 p -41.26 153.79 0.24 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.474 -0.766 . . . . 0.0 109.048 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.03 -23.96 45.82 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 123.829 1.436 . . . . 0.0 108.766 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -69.19 -9.94 55.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.593 ' CD1' ' CD1' ' A' ' 195' ' ' LEU . 85.7 mt -144.42 115.83 5.4 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.8 Cg_endo -64.09 167.69 13.8 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 123.81 1.426 . . . . 0.0 109.295 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.513 ' NZ ' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -35.49 -64.6 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.8 0.809 . . . . 0.0 110.477 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -59.76 -19.32 49.54 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.685 -0.635 . . . . 0.0 111.777 -178.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.592 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -80.36 -62.74 1.59 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.312 -1.493 . . . . 0.0 109.021 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 103' ' ' ASN . 9.6 p -49.41 -40.5 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.513 ' OD2' ' NZ ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -67.19 -27.52 67.33 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 112' ' ' ALA . 21.6 p -64.42 -42.5 96.0 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.654 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -71.42 -33.33 69.33 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.625 ' CG1' HG13 ' A' ' 144' ' ' ILE . 2.4 t -73.73 -25.18 20.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.572 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 2.0 tt0 -84.66 -36.67 21.77 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.744 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.69 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -78.83 -38.94 36.83 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.656 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -62.93 -61.48 2.37 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.632 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.0 OUTLIER -50.26 -40.15 47.13 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.988 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -77.51 -33.45 54.34 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.37 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.604 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 3.8 t -52.49 -44.5 44.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.684 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 33.4 m95 -92.2 -23.14 19.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 26.8 tt0 -69.67 -26.74 64.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.3 pt-20 -90.96 -42.99 10.25 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.648 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 14.5 m -59.57 -23.78 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.274 -1.37 . . . . 0.0 108.988 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -116.89 163.42 22.84 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.519 -1.272 . . . . 0.0 109.289 179.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -77.58 -8.47 17.09 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.336 1.703 . . . . 0.0 109.883 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.544 ' CG ' ' HA ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -70.19 179.55 2.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 110.536 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.467 ' OG1' ' ND1' ' A' ' 96' ' ' HIS . 6.7 p -127.3 174.38 9.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 1.1 m-85 -145.44 161.89 38.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.586 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -143.38 -174.36 4.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.592 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -152.04 155.6 38.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.901 -1.124 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.8 OUTLIER -147.41 -135.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.417 -0.802 . . . . 0.0 108.912 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 45.3 t80 178.94 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.793 -1.192 . . . . 0.0 109.23 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 139' ' ' GLU . 1.8 pm0 -158.57 -176.65 6.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.779 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.49 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -1.103 . . . . 0.0 110.184 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' A' ' 135' ' ' LEU . . . -60.15 -151.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 108.722 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 98' ' ' THR . 0.9 OUTLIER -91.65 -25.82 18.96 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 206' ' ' SER . 17.7 mm -127.81 86.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.528 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -67.15 97.17 0.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 102' ' ' VAL . 0.7 OUTLIER -82.37 116.19 26.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -134.49 153.18 52.06 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 119.944 -1.722 . . . . 0.0 112.388 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 147' ' ' ALA . 1.6 t80 -90.7 135.71 33.53 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.569 ' HB2' ' CE1' ' A' ' 179' ' ' HIS . . . -168.57 -152.65 0.11 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.725 -1.234 . . . . 0.0 111.17 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.557 ' CG2' ' HA3' ' A' ' 159' ' ' GLY . 2.1 p -178.3 -169.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.507 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.684 -0.635 . . . . 0.0 111.118 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 149' ' ' ARG . 42.0 Cg_endo . . . . . 0 C--O 1.215 -0.632 0 N-CA-C 109.13 -1.142 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.645 ' CE1' ' CG1' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.5 -140.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.532 ' O ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER -134.75 -23.54 1.58 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.496 -1.377 . . . . 0.0 111.312 -178.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 41.52 -96.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 158' ' ' ASP . 34.3 Cg_endo -59.68 76.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.265 1.14 . . . . 0.0 110.052 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 175.98 -167.31 38.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 163' ' ' VAL . 58.3 m-80 -87.25 -27.75 22.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -1.192 . . . . 0.0 109.964 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.645 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 16.9 t -35.79 140.58 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.426 0.631 . . . . 0.0 110.862 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.62 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 0.4 OUTLIER -105.17 -90.81 0.4 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.465 -0.772 . . . . 0.0 112.31 -179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -147.27 -168.89 3.17 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.113 -1.617 . . . . 0.0 111.541 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.641 ' CD2' ' CE2' ' A' ' 157' ' ' PHE . 0.5 OUTLIER 179.95 171.98 1.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 119.682 -1.886 . . . . 0.0 111.024 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -147.55 -164.54 2.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.399 -0.813 . . . . 0.0 109.99 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.646 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -131.9 -163.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.883 -1.136 . . . . 0.0 110.643 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.559 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -163.98 -62.84 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.093 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 45.8 Cg_endo -77.09 158.95 33.98 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.779 1.41 . . . . 0.0 109.966 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . 115.32 173.69 17.71 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -76.55 -89.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.683 1.589 . . . . 0.0 110.138 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -78.13 -35.44 34.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.646 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.5 tp -68.96 -0.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.925 . . . . 0.0 108.967 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 172' ' ' PRO . 2.6 t30 -65.82 64.22 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 119.81 90.63 1.25 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.587 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -158.07 127.01 5.64 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.839 -1.389 . . . . 0.0 108.159 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -115.88 168.16 10.3 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.117 -0.99 . . . . 0.0 108.714 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.97 134.39 4.28 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.205 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.587 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 53.1 m-85 -90.08 127.99 36.2 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.24 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 1.0 OUTLIER -76.62 144.78 39.31 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.949 -1.094 . . . . 0.0 109.205 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 183' ' ' ASP . 27.3 t0 -62.44 -2.16 0.98 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.21 -0.931 . . . . 0.0 110.381 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.571 ' OD2' ' CZ2' ' A' ' 186' ' ' TRP . 1.2 p30 3.9 -95.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 183' ' ' ASP . 7.5 mp0 -147.59 -51.15 0.19 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.873 -1.142 . . . . 0.0 110.509 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -140.79 172.0 13.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 0.0 110.926 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.62 ' CH2' ' CD1' ' A' ' 164' ' ' LEU . 85.8 m95 -160.58 129.77 4.9 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.529 HG22 ' N ' ' A' ' 192' ' ' GLY . 33.4 p -146.88 155.93 42.7 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.555 -1.341 . . . . 0.0 110.428 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.596 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 3.2 pttt -78.02 -33.11 51.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.545 ' O ' ' CG2' ' A' ' 227' ' ' THR . 2.9 t0 -90.48 -143.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.564 ' N ' HD13 ' A' ' 229' ' ' LEU . 11.4 t -115.37 45.64 1.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.851 -1.155 . . . . 0.0 108.264 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.479 ' HB ' HG22 ' A' ' 187' ' ' THR . 53.7 m -102.69 -30.3 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.326 -0.859 . . . . 0.0 111.084 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.529 ' N ' HG22 ' A' ' 187' ' ' THR . . . -108.52 -90.59 2.12 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.363 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.517 HG23 ' CD1' ' A' ' 164' ' ' LEU . 89.6 m -120.68 -80.21 0.62 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.703 ' HB2' ' CB ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER 178.15 66.79 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.582 1.182 . . . . 0.0 108.435 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.664 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 1.2 tp -20.03 -95.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.952 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.69 ' CG ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -62.06 -15.01 41.75 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.055 -1.028 . . . . 0.0 110.883 -176.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.703 ' CB ' ' HB2' ' A' ' 194' ' ' ASN . 13.3 tp -60.75 -57.46 12.58 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.251 -1.78 . . . . 0.0 107.199 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.548 ' CG2' ' ND2' ' A' ' 194' ' ' ASN . 2.4 t -74.72 -9.25 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.749 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.656 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -78.24 -57.85 3.57 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.35 -1.34 . . . . 0.0 107.503 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 120' ' ' ALA . . . -64.03 -17.91 63.81 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 219' ' ' MET . 3.3 t-160 -69.39 -40.95 77.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.17 -1.812 . . . . 0.0 107.849 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.587 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 3.5 mt-10 -82.89 -49.12 9.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.954 -1.091 . . . . 0.0 110.79 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.56 HD11 ' N ' ' A' ' 121' ' ' LEU . 3.2 mt -60.59 -31.47 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.684 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.79 -34.09 49.46 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -57.24 -53.15 61.34 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.61 -0.935 . . . . 0.0 109.773 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.594 ' HB2' ' CD1' ' A' ' 142' ' ' ILE . 2.6 m -77.81 -64.19 1.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.583 -0.698 . . . . 0.0 111.671 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.638 ' CD1' ' CD1' ' A' ' 92' ' ' TRP . 2.8 mm? -101.36 37.99 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -0.802 . . . . 0.0 110.614 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -135.83 -69.22 0.06 OUTLIER Glycine 0 C--N 1.289 -2.046 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.5 pp 179.75 -161.86 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.933 0 O-C-N 120.633 -1.51 . . . . 0.0 109.387 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.581 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 16.3 t80 -102.11 -71.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.259 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 54.4 m80 -162.16 102.05 1.11 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.788 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.5 m -93.07 -174.68 3.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.517 ' CB ' ' CG ' ' A' ' 237' ' ' ASP . . . -64.95 78.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.713 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.43 9.3 13.69 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.422 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 214' ' ' ASN . 73.7 p -50.42 -27.72 6.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.492 ' C ' ' HB2' ' A' ' 235' ' ' SER . 8.3 mt-10 -113.75 -37.01 4.67 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.716 ' HB3' ' HB2' ' A' ' 238' ' ' ASP . . . -64.35 -171.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.45 1.119 . . . . 0.0 112.72 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.626 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.0 OUTLIER -84.64 -18.9 33.95 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.937 -177.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.572 ' HA ' ' CE1' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 119.262 -2.149 . . . . 0.0 112.171 -177.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.671 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 35.3 t80 -134.99 15.63 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.257 -1.527 . . . . 0.0 113.39 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.671 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.8 Cg_endo -77.97 -41.17 0.32 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.58 ' C ' ' O ' ' A' ' 221' ' ' PRO . 18.9 tp -6.87 -74.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.5 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -65.45 63.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.492 -0.755 . . . . 0.0 109.779 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.82 -162.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.451 ' O ' HD11 ' A' ' 226' ' ' LEU . 16.2 m -131.99 116.17 16.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.103 -0.998 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.53 ' CD1' ' HD3' ' A' ' 231' ' ' ARG . 5.5 tp 179.49 31.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.627 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 6.6 t -77.61 -52.77 8.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.625 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 5.2 t0 -151.49 3.22 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.745 -1.222 . . . . 0.0 110.952 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.564 HD13 ' N ' ' A' ' 190' ' ' THR . 1.2 mm? -41.41 -101.04 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.906 -1.121 . . . . 0.0 110.912 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -18.22 3.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.701 -1.249 . . . . 0.0 109.85 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.544 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -105.48 -42.03 5.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 108.386 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.625 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 9.5 p90 0.36 117.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.05 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.641 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 2.5 mp -80.27 166.49 21.32 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.756 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 28.9 t -98.38 -171.84 2.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.354 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.484 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.08 -11.83 54.38 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.726 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.1 OUTLIER -85.34 -46.99 10.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.889 -1.132 . . . . 0.0 107.971 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.716 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.2 m-20 -66.87 -38.04 85.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 117.201 -1.8 . . . . 0.0 106.554 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -58.04 -34.55 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 1.3 t-20 -66.69 -49.23 66.76 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.88 -50.62 65.76 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.28 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 208' ' ' GLY . 1.9 tp -68.27 -48.44 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 120.741 -1.447 . . . . 0.0 110.665 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 240' ' ' ASN . 15.0 pt20 -54.77 -23.08 16.3 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.1 p -88.66 -17.07 30.8 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -74.22 -59.36 2.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.497 ' CD1' HD23 ' A' ' 130' ' ' LEU . 15.2 m-85 . . . . . 0 N--CA 1.493 1.688 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.502 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 206' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.646 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 50.7 m95 -111.42 163.69 13.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.028 -1.045 . . . . 0.0 109.532 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -131.95 -28.01 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.537 -179.325 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.561 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -40.13 165.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.373 -0.829 . . . . 0.0 110.625 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.581 ' O ' ' CD2' ' A' ' 96' ' ' HIS . 2.1 p -107.63 5.21 26.67 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.462 -0.774 . . . . 0.0 109.185 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.632 ' CE1' ' CG2' ' A' ' 131' ' ' THR . 33.4 m-70 -150.72 103.49 3.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.453 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.59 ' CD1' ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -116.33 -165.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 109.91 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.575 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -161.43 162.35 30.55 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.594 ' CE1' HD23 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -137.9 160.78 38.38 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.875 -1.141 . . . . 0.0 109.181 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.529 ' HG3' ' CD1' ' A' ' 135' ' ' LEU . 1.2 ttp180 -123.09 126.63 47.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 109.807 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.5 mp -85.09 84.37 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.005 -1.059 . . . . 0.0 109.677 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.59 ' N ' ' O ' ' A' ' 144' ' ' ILE . 2.6 t -100.35 8.03 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.007 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.535 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -100.99 157.04 17.05 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.783 -1.198 . . . . 0.0 109.353 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.594 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.6 OUTLIER 177.99 75.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 108' ' ' LEU . 11.5 p -70.6 159.5 84.85 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -68.14 -21.86 41.78 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.808 1.425 . . . . 0.0 108.686 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 1.5 t0 -70.28 -8.73 52.6 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.618 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 93.5 mt -147.07 124.14 5.76 Favored Pre-proline 0 N--CA 1.484 1.233 0 O-C-N 121.585 -0.697 . . . . 0.0 109.848 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.11 169.84 12.88 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 O-C-N 123.811 1.427 . . . . 0.0 109.007 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' O ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -38.08 -65.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.971 0.891 . . . . 0.0 110.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 115' ' ' SER . 1.6 p-10 -53.97 -32.32 53.58 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.743 -0.598 . . . . 0.0 112.033 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.618 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -70.91 -61.4 1.78 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.533 -1.354 . . . . 0.0 109.635 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.542 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 8.7 p -53.3 -41.2 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.501 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 1.1 m-20 -64.35 -27.27 68.9 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.536 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 6.2 p -63.51 -43.73 96.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.589 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -68.23 -33.1 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.108 -0.995 . . . . 0.0 109.492 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.539 ' CG1' HG13 ' A' ' 101' ' ' ILE . 5.0 t -76.26 -22.0 15.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.521 ' HA ' HD22 ' A' ' 121' ' ' LEU . 1.2 tt0 -88.24 -34.12 17.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.649 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.8 OUTLIER -82.45 -36.33 26.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -67.28 -61.18 2.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.338 1.066 . . . . 0.0 108.588 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.594 HD23 ' CE1' ' A' ' 99' ' ' TYR . 1.6 pp -57.0 -40.8 77.29 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.526 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.47 -32.69 62.66 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.898 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.586 HG23 ' CE1' ' A' ' 196' ' ' PHE . 0.9 OUTLIER -55.41 -42.04 65.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.658 ' CH2' ' CD2' ' A' ' 234' ' ' LEU . 37.7 m95 -91.23 -23.97 20.03 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.536 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 132' ' ' PHE . 3.5 tm-20 -69.57 -27.44 65.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.851 -1.156 . . . . 0.0 107.89 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 13.9 pt-20 -90.58 -42.84 10.57 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.738 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.629 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 15.8 m -59.2 -24.52 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.139 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -114.26 154.82 46.27 Favored Pre-proline 0 N--CA 1.494 1.731 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.573 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -82.49 29.31 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.136 1.891 . . . . 0.0 110.472 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.53 ' CG ' ' HA ' ' A' ' 95' ' ' THR . 0.8 OUTLIER -99.44 -179.95 4.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.95 -1.094 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.632 ' CG2' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -112.9 161.18 17.28 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.59 ' CE2' ' CD1' ' A' ' 97' ' ' LEU . 53.2 m-85 -147.72 148.74 31.32 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.061 -1.024 . . . . 0.0 110.901 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.575 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -130.2 -179.23 5.12 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.812 -1.18 . . . . 0.0 110.207 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.529 ' CD1' ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.49 -163.78 1.52 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.215 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.517 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 69.5 t80 -155.79 21.22 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 26.0 pm0 -143.98 -174.62 4.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.637 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.04 -97.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 137' ' ' GLU . 11.6 pt-20 178.8 130.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -1.133 . . . . 0.0 110.157 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.481 ' HB3' ' OG1' ' A' ' 98' ' ' THR . . . -89.78 -147.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.227 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 98' ' ' THR . 12.9 t0 -92.89 -33.16 14.32 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.541 ' CG2' HD12 ' A' ' 144' ' ' ILE . 22.1 mt -126.64 80.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.457 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.8 ttp -64.26 94.04 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.121 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.4 mm -79.17 118.76 27.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -137.76 158.16 44.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.349 -1.469 . . . . 0.0 111.983 -179.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.52 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 23.6 p90 -90.91 138.62 31.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 109.591 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.633 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -162.27 -159.05 0.56 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.178 -0.951 . . . . 0.0 110.003 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.486 ' CG2' ' CG ' ' A' ' 183' ' ' ASP . 1.5 p -174.85 -168.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.923 -1.11 . . . . 0.0 109.274 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.453 ' HB3' ' O ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 0.0 109.972 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 109.743 -0.907 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.715 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -95.08 -160.63 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.982 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 160' ' ' PRO . 20.5 p30 178.86 50.59 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.567 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.69 -74.38 0.0 OUTLIER Glycine 0 N--CA 1.509 3.512 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.582 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.7 Cg_endo -65.17 61.28 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.237 1.292 . . . . 0.0 109.99 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.42 143.9 8.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -42.12 -41.17 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -1.115 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.522 ' CG2' ' OD1' ' A' ' 158' ' ' ASP . 31.0 m -55.01 84.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.802 . . . . 0.0 109.871 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 162' ' ' ASN . 15.8 mt -71.84 -80.27 0.06 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.311 -0.868 . . . . 0.0 112.822 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.595 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -136.2 -174.65 3.74 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.469 -1.395 . . . . 0.0 111.489 -177.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.715 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.5 p-80 -179.99 167.62 1.28 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.273 -1.517 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -141.43 -166.13 2.12 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.215 -0.928 . . . . 0.0 110.391 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.618 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -128.59 -160.86 1.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.1 -1.0 . . . . 0.0 110.73 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.545 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -166.06 -60.3 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.493 -0.755 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 46.6 Cg_endo -79.16 -172.31 1.5 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.725 1.382 . . . . 0.0 110.083 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.18 144.37 0.64 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.6 Cg_endo -70.37 136.88 32.43 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.854 1.449 . . . . 0.0 110.061 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 71.3 -64.15 1.02 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.618 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 0.6 OUTLIER -64.31 -7.82 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.969 . . . . 0.0 109.164 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -65.72 66.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.894 . . . . 0.0 108.958 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 126.88 81.58 0.37 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.7 m-20 -155.87 126.83 6.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.935 -1.332 . . . . 0.0 108.016 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -113.43 168.26 9.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.325 -0.86 . . . . 0.0 109.086 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.633 ' CE1' ' CB ' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.27 135.14 5.07 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.751 178.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.596 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 58.1 m-85 -95.29 134.4 38.11 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.896 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.497 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -68.65 132.64 47.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.028 -1.469 . . . . 0.0 107.41 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -105.8 37.0 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.87 -1.144 . . . . 0.0 110.332 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.567 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 1.9 m-20 -114.25 -2.76 13.27 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.379 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.524 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 5.5 pt-20 -119.24 -111.65 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.056 -1.027 . . . . 0.0 108.627 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 48.6 mt-30 -148.22 174.7 11.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.818 -1.176 . . . . 0.0 109.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.585 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 90.3 m95 -162.14 126.49 3.23 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.464 HG21 ' HA3' ' A' ' 192' ' ' GLY . 71.3 p -150.14 155.38 39.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.724 -1.235 . . . . 0.0 110.627 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 1.1 ptpt -83.67 -30.58 26.7 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.65 ' O ' ' N ' ' A' ' 191' ' ' THR . 30.7 t0 -87.28 63.7 7.91 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.573 ' C ' ' O ' ' A' ' 189' ' ' ASP . 6.2 t 4.41 59.68 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.883 0.849 . . . . 0.0 111.789 -177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.65 ' N ' ' O ' ' A' ' 189' ' ' ASP . 47.7 m -124.49 -31.49 3.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.252 -0.905 . . . . 0.0 109.682 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.464 ' HA3' HG21 ' A' ' 187' ' ' THR . . . -94.9 -78.69 1.42 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.529 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 18.4 m -129.9 -95.16 0.39 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.605 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -161.37 73.43 0.44 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.666 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 2.4 tp -34.4 -96.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.631 0.729 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.666 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.4 OUTLIER -67.56 -8.13 31.7 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -177.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.605 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 12.2 tp -68.7 -63.13 1.12 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 116.42 -2.112 . . . . 0.0 106.924 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.545 ' HA ' ' CB ' ' A' ' 201' ' ' HIS . 9.2 t -71.41 -8.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.67 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -74.49 -58.59 3.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -65.96 -15.08 62.67 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.563 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 9.1 t60 -69.33 -42.03 75.87 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.957 -1.497 . . . . 0.0 107.96 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.58 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 6.8 mt-10 -85.43 -46.77 10.6 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.05 -1.031 . . . . 0.0 110.603 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.542 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -61.15 -30.87 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.652 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.23 -33.89 38.67 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.5 -50.23 73.73 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.825 -0.809 . . . . 0.0 110.41 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.487 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 58.3 p -83.82 -57.1 3.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.424 -0.798 . . . . 0.0 112.027 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.646 ' CD2' ' CD1' ' A' ' 92' ' ' TRP . 13.1 mt -104.56 34.99 2.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -136.94 -77.74 0.08 OUTLIER Glycine 0 C--N 1.292 -1.889 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.514 HD11 ' N ' ' A' ' 210' ' ' PHE . 4.1 pp -172.02 -165.72 0.37 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.77 -1.429 . . . . 0.0 109.995 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.58 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 3.3 t80 -96.92 -73.37 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.845 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.587 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 81.0 m80 -160.6 103.93 1.39 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.128 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.65 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -91.43 -171.34 2.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.856 . . . . 0.0 108.85 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.495 ' H ' ' HB3' ' A' ' 237' ' ' ASP . . . -64.74 76.16 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.691 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.06 9.58 12.17 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.634 -176.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -51.1 -27.49 8.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.485 ' C ' ' HB2' ' A' ' 235' ' ' SER . 14.9 mt-10 -114.95 -38.44 3.9 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.691 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -63.64 -178.98 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.301 1.048 . . . . 0.0 112.262 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.619 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -78.18 -18.35 55.62 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.463 -177.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.587 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -77.63 -7.84 56.99 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 119.19 -2.194 . . . . 0.0 112.056 -177.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.658 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 39.6 t80 -135.56 15.79 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.362 -1.461 . . . . 0.0 113.622 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -78.3 -37.24 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.53 -1.373 . . . . 0.0 108.53 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 223' ' ' TYR . 0.6 OUTLIER -15.58 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.01 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.584 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.63 59.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.496 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.6 OUTLIER -175.65 -159.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 74.3 m -126.4 104.15 8.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 109.722 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER 178.56 40.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.843 . . . . 0.0 109.023 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.562 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 10.0 t -84.87 -51.02 7.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.237 -0.914 . . . . 0.0 110.111 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.3 OUTLIER -152.64 6.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.096 . . . . 0.0 110.903 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.569 HD13 ' CG2' ' A' ' 190' ' ' THR . 0.4 OUTLIER -49.07 -108.8 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.949 -1.095 . . . . 0.0 110.796 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -23.94 5.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.589 -1.319 . . . . 0.0 109.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.538 ' O ' ' C ' ' A' ' 232' ' ' PHE . 5.3 mtp180 -98.24 -31.95 11.81 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.617 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 4.9 p90 -17.09 118.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.824 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.515 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.32 171.63 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.381 -0.825 . . . . 0.0 110.516 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.658 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 3.2 mp -81.78 166.17 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.853 . . . . 0.0 110.427 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.664 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 37.9 t -101.77 -166.89 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.122 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.52 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.2 OUTLIER -84.97 -17.71 36.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.644 -0.66 . . . . 0.0 110.262 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.65 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 0.9 OUTLIER -81.62 -48.54 11.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.659 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.0 OUTLIER -63.98 -40.06 95.53 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.508 -1.677 . . . . 0.0 106.659 177.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.42 -35.41 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.7 -54.38 19.95 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.468 ' HA3' HD23 ' A' ' 209' ' ' LEU . . . -50.79 -53.91 24.1 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.582 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.1 tp -64.86 -43.19 96.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.886 -1.361 . . . . 0.0 109.995 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.455 ' CG ' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -54.54 -28.45 45.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.2 t -80.27 -21.16 42.98 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -67.52 -64.11 0.92 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.528 ' OH ' ' CD2' ' A' ' 97' ' ' LEU . 27.9 m-85 . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.209 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.532 ' CG ' ' HB3' ' A' ' 169' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 12.7 m95 -88.13 -167.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.957 -1.089 . . . . 0.0 109.608 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -162.42 -37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.418 -0.801 . . . . 0.0 109.087 179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.559 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -52.4 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.434 -0.791 . . . . 0.0 110.08 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.55 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 65.7 p -122.34 -0.97 9.22 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.602 -0.686 . . . . 0.0 109.312 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.574 ' CG ' ' OG1' ' A' ' 131' ' ' THR . 15.0 m-70 -140.56 92.59 2.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.463 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.591 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.9 mm? -85.19 162.8 19.05 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.512 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.566 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -141.05 155.83 46.1 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.663 ' CZ ' ' CD2' ' A' ' 121' ' ' LEU . 8.4 p90 -134.47 168.56 18.72 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.452 -1.405 . . . . 0.0 109.826 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.529 ' NE ' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.5 124.06 31.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -0.766 . . . . 0.0 109.235 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.611 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.5 mp -80.69 81.48 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' A' ' 144' ' ' ILE . 4.8 t -94.71 5.08 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -103.29 163.99 11.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.761 -1.212 . . . . 0.0 108.6 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.604 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 7.2 p90 -178.2 58.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.119 -0.988 . . . . 0.0 110.5 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.637 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 69.0 p -45.48 145.57 2.0 Allowed Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.1 -32.47 34.2 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 124.002 1.528 . . . . 0.0 109.232 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.526 ' C ' ' CD2' ' A' ' 108' ' ' LEU . 14.9 m-20 -65.89 -19.37 65.85 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.585 ' CD1' ' CD2' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -115.62 114.28 42.34 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.4 Cg_endo -62.75 168.17 10.65 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.565 1.297 . . . . 0.0 108.996 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 109' ' ' PRO . 1.3 mppt? -39.73 -64.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.877 0.846 . . . . 0.0 109.54 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -57.73 -10.87 1.8 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.845 -0.535 . . . . 0.0 111.392 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -87.75 -58.44 2.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.576 -1.327 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.604 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 5.9 p -59.68 -43.39 91.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.548 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -60.92 -26.83 67.76 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -63.26 -65.24 0.71 Allowed 'General case' 0 C--O 1.195 -1.768 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB1' ' CD1' ' A' ' 195' ' ' LEU . . . -49.46 -31.99 11.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.578 HG13 ' CE2' ' A' ' 99' ' ' TYR . 2.6 t -74.34 -24.62 19.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -87.18 -37.19 17.52 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.345 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.672 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -77.82 -39.1 44.79 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.644 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -65.71 -61.57 2.0 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.214 1.007 . . . . 0.0 108.553 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.663 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.3 pp -53.8 -41.4 67.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.381 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.567 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -76.19 -32.85 59.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.806 -178.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.6 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 2.1 t -53.76 -45.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.66 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 33.5 m95 -91.69 -22.31 20.3 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.758 -1.177 . . . . 0.0 110.532 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.516 ' CG ' ' HB2' ' A' ' 132' ' ' PHE . 9.3 tm-20 -69.79 -27.03 64.57 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.782 -1.199 . . . . 0.0 107.815 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -91.17 -42.95 10.16 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.63 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.62 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 14.0 m -58.07 -25.56 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.308 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.582 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -109.36 155.0 41.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 118.073 -1.451 . . . . 0.0 109.249 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.425 ' C ' HD23 ' A' ' 130' ' ' LEU . 51.2 Cg_endo -82.06 26.2 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.054 1.836 . . . . 0.0 111.395 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 95' ' ' THR . 4.4 mm? -108.6 -169.54 1.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.595 -1.316 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.574 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 2.0 p -117.7 169.22 9.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.808 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CE2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -139.17 163.34 32.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.637 -0.664 . . . . 0.0 109.921 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.579 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -143.08 -172.8 3.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.615 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -159.81 165.46 32.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.562 -1.336 . . . . 0.0 110.798 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.527 HD23 ' CB ' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -163.37 -163.63 0.85 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.592 -0.692 . . . . 0.0 109.134 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 75.0 t80 -158.2 22.07 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 108.768 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 1.6 pm0 -148.8 -178.95 6.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -0.761 . . . . 0.0 108.97 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.87 -97.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 137' ' ' GLU . 20.2 tt0 178.5 146.22 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -1.175 . . . . 0.0 110.531 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.527 ' CB ' HD23 ' A' ' 135' ' ' LEU . . . -103.18 -150.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 41.4 m-20 -88.74 -36.58 16.06 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.534 HG13 ' CD2' ' A' ' 207' ' ' LEU . 18.4 mm -122.28 82.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.551 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 3.3 ptt? -67.1 100.12 0.73 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.582 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.625 ' O ' ' N ' ' A' ' 102' ' ' VAL . 6.1 mm -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -135.41 154.93 51.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.336 -1.477 . . . . 0.0 111.939 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -77.06 135.99 38.65 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.645 ' CB ' ' CD2' ' A' ' 179' ' ' HIS . . . -152.83 164.68 37.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 110.485 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 183' ' ' ASP . 2.6 p -160.2 -174.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.255 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.471 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.279 -0.888 . . . . 0.0 110.334 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 C--O 1.215 -0.63 0 N-CA-C 109.795 -0.887 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.652 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -117.13 -162.15 0.85 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 110.326 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 160' ' ' PRO . 33.0 p30 -173.79 55.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 110.041 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 14.49 -76.86 0.0 OUTLIER Glycine 0 N--CA 1.508 3.446 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.615 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.2 Cg_endo -66.9 59.19 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.322 1.348 . . . . 0.0 109.866 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -151.89 142.71 9.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 161' ' ' GLY . 2.7 m120 -41.43 -34.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.021 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 157' ' ' PHE . 10.9 m -66.66 84.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.97 . . . . 0.0 109.646 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.579 ' CD2' ' CG2' ' A' ' 193' ' ' THR . 1.2 tp -64.03 -56.07 17.67 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.335 -0.853 . . . . 0.0 111.462 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.558 ' HB1' ' CG1' ' A' ' 198' ' ' VAL . . . -163.1 -164.35 0.95 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.394 -1.441 . . . . 0.0 110.622 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.652 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 0.9 OUTLIER 178.92 -179.17 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.157 -1.589 . . . . 0.0 111.356 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -151.32 174.46 13.28 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.804 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.517 ' O ' ' CB ' ' A' ' 206' ' ' SER . 0.1 OUTLIER -113.97 -170.17 1.66 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.082 -1.011 . . . . 0.0 110.168 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.584 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . . . -156.78 -66.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 109.197 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 43.8 Cg_endo -73.03 -160.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.704 1.371 . . . . 0.0 109.718 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 175' ' ' ASN . . . 76.33 164.21 17.45 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.8 Cg_endo -73.85 -92.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.012 1.533 . . . . 0.0 110.215 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -68.51 -23.7 75.22 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -77.88 9.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.569 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -65.78 64.82 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 110.73 96.59 2.37 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -152.96 114.53 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.197 -1.178 . . . . 0.0 107.872 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.76 157.41 19.17 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.558 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.645 ' CD2' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -147.08 134.88 21.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.816 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.539 ' HB3' ' CZ2' ' A' ' 186' ' ' TRP . 19.1 m-85 -96.79 130.7 44.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.096 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 164' ' ' LEU . 0.2 OUTLIER -47.97 143.27 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.721 -1.237 . . . . 0.0 109.343 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -119.26 29.58 7.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.551 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 4.7 m-20 -135.97 3.34 2.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 110.598 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.53 ' OE1' ' CD1' ' A' ' 164' ' ' LEU . 1.6 pt-20 -112.35 -96.39 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.606 -1.309 . . . . 0.0 109.492 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.601 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -162.36 173.4 14.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.081 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.637 ' CD1' ' CG2' ' A' ' 105' ' ' THR . 86.1 m95 -161.15 133.8 6.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.006 -1.059 . . . . 0.0 109.799 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 186' ' ' TRP . 74.9 p -162.02 150.08 14.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.577 -0.702 . . . . 0.0 109.374 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 13.3 pttt -83.38 -31.9 26.48 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.655 ' O ' ' N ' ' A' ' 191' ' ' THR . 9.4 t70 -83.77 64.01 7.79 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.6 ' O ' ' CG2' ' A' ' 190' ' ' THR . 3.9 t 3.44 60.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.123 0.963 . . . . 0.0 111.975 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.655 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.7 m -121.88 -32.25 3.78 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.076 -1.015 . . . . 0.0 109.545 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.473 ' HA3' HG22 ' A' ' 187' ' ' THR . . . -98.55 -75.97 1.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.579 ' CG2' ' CD2' ' A' ' 164' ' ' LEU . 3.0 m -124.28 -88.86 0.6 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.761 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 4.3 m-20 178.06 72.37 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.599 ' CD1' ' HB1' ' A' ' 116' ' ' ALA . 30.6 tp -28.82 -102.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.514 0.673 . . . . 0.0 112.541 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.696 ' CD1' ' O ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -57.44 -16.08 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.015 -1.053 . . . . 0.0 111.604 -177.372 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.761 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.8 tp -63.02 -63.04 1.32 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.32 -2.112 . . . . 0.0 107.245 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.558 ' CG1' ' HB1' ' A' ' 165' ' ' ALA . 3.2 t -69.88 -8.32 10.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.644 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -76.84 -59.54 2.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -64.95 -14.22 59.5 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.478 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 22.0 t60 -66.73 -50.66 62.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.589 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 205' ' ' HIS . 2.3 mm-40 -79.42 -46.44 17.52 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.282 -0.886 . . . . 0.0 110.925 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.4 mt -60.2 -30.35 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.66 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.3 -32.74 42.07 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -59.23 -49.05 79.32 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.892 -0.769 . . . . 0.0 110.496 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.519 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 5.0 m -84.63 -56.16 3.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 112.333 -177.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.534 ' CD2' HG13 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -104.39 27.0 8.25 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.94 -1.1 . . . . 0.0 110.987 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -130.11 -78.26 0.19 Allowed Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.539 HD11 ' N ' ' A' ' 210' ' ' PHE . 2.1 pp -167.48 -162.82 0.47 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.853 -1.381 . . . . 0.0 110.208 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 4.1 t80 -98.98 -70.78 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.802 . . . . 0.0 109.471 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 44.9 m80 -161.31 87.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.627 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -76.98 179.75 6.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 109.306 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.442 ' CB ' ' OD2' ' A' ' 237' ' ' ASP . . . -61.63 81.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.73 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.08 11.12 12.41 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.366 -177.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 214' ' ' ASN . 47.6 p -49.41 -28.27 4.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.516 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.0 mm-40 -115.99 -36.14 4.22 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.73 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -63.63 -166.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.507 1.146 . . . . 0.0 112.773 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.618 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -95.26 -15.3 23.3 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.354 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.543 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -79.77 -5.98 56.39 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.284 -2.135 . . . . 0.0 112.054 -177.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.64 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 43.3 t80 -138.78 15.75 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.444 -1.41 . . . . 0.0 113.347 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.14 -37.46 0.79 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 N-CA-C 108.631 -1.334 . . . . 0.0 108.631 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.577 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.7 OUTLIER -14.76 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.085 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.573 ' N ' ' CD1' ' A' ' 222' ' ' LEU . 2.1 t80 -73.42 56.32 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.154 -0.966 . . . . 0.0 109.321 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -173.68 -145.72 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.574 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 18.6 m -143.2 110.6 5.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.855 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER 179.4 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.34 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.546 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 11.3 t -93.36 -13.24 28.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.581 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER 178.37 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.564 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.561 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.4 OUTLIER -26.83 -99.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.811 -0.555 . . . . 0.0 111.426 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 p -135.05 -2.98 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.759 -1.213 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.565 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.7 OUTLIER -119.32 -40.28 2.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 108.744 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 2.0 p90 0.38 111.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.357 0.599 . . . . 0.0 111.958 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.586 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.5 ttt180 179.42 154.28 0.47 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.166 -0.959 . . . . 0.0 110.035 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.65 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -74.77 169.31 18.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.469 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.644 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 30.4 t -104.6 -169.63 1.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.353 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.517 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.98 -11.91 54.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 110.104 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.627 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 0.5 OUTLIER -84.18 -50.81 7.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.66 -1.275 . . . . 0.0 107.748 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.693 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.2 m-20 -63.81 -38.33 90.71 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.679 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -57.07 -35.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -68.42 -56.91 6.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -47.88 -53.33 14.24 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.594 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -63.91 -43.39 97.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.977 -1.308 . . . . 0.0 109.746 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.54 -27.35 37.82 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -82.71 -19.17 38.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -70.11 -63.45 1.08 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.539 ' HB3' ' CD2' ' A' ' 130' ' ' LEU . 15.9 m-30 . . . . . 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.275 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' CE ' ' CB ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.57 ' CH2' ' HB2' ' A' ' 141' ' ' ASP . 70.9 m95 -94.06 162.64 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 0.0 109.258 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -133.02 -35.19 1.06 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 110.237 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.561 ' HG3' ' HG ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -50.7 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.177 -0.952 . . . . 0.0 110.283 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.548 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 32.3 p -124.72 1.49 8.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.461 -0.774 . . . . 0.0 109.561 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.555 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 35.6 m80 -146.02 99.66 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.992 -1.067 . . . . 0.0 110.484 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.661 ' CD1' ' CZ ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -127.59 -153.09 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 141' ' ' ASP . 1.2 t -173.75 -178.91 1.67 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.947 -1.096 . . . . 0.0 111.179 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.639 ' CD1' ' CD2' ' A' ' 121' ' ' LEU . 10.4 p90 -135.82 179.16 6.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.371 -0.831 . . . . 0.0 109.678 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' NH1' ' HA ' ' A' ' 136' ' ' TYR . 2.0 ttp85 -131.85 144.1 50.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -0.758 . . . . 0.0 109.394 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.8 mp -101.53 78.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.879 -1.138 . . . . 0.0 109.503 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' A' ' 144' ' ' ILE . 1.8 t -92.77 9.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.44 -0.787 . . . . 0.0 110.616 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -109.81 174.47 5.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.508 -1.37 . . . . 0.0 110.108 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 1.1 t80 177.16 86.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.397 0.618 . . . . 0.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 33.2 p -67.44 154.09 93.67 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.459 ' HG2' ' CG ' ' A' ' 185' ' ' GLN . 38.3 Cg_endo -67.87 -26.53 38.05 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.827 1.435 . . . . 0.0 108.65 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -81.86 2.23 31.33 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.642 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 95.1 mt -145.23 117.27 5.23 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.486 -0.759 . . . . 0.0 110.236 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.06 175.6 5.44 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.853 1.449 . . . . 0.0 108.872 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.465 ' O ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -39.97 -64.96 0.44 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.829 0.823 . . . . 0.0 110.108 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -30.63 55.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 112.282 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.642 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -73.29 -60.69 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.31 -1.494 . . . . 0.0 109.356 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.523 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.5 p -52.25 -38.48 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.505 ' OD1' ' CG2' ' A' ' 101' ' ' ILE . 1.0 OUTLIER -65.6 -28.64 69.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 112' ' ' ALA . 10.8 p -62.37 -39.68 93.96 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.707 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -72.48 -34.13 67.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 0.0 109.544 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.594 HG13 ' CE2' ' A' ' 99' ' ' TYR . 71.8 t -74.12 -23.2 18.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 1.6 tt0 -91.23 -33.48 15.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.646 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 6.5 tppt? -82.57 -33.77 27.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.653 ' HB3' ' CB ' ' A' ' 199' ' ' ALA . . . -68.08 -65.21 0.72 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.639 ' CD2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.731 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.09 -36.78 63.54 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.239 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.57 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.34 -36.98 48.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.734 ' CZ2' ' HA3' ' A' ' 204' ' ' GLY . 46.6 m95 -91.61 -23.16 19.95 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.627 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -74.21 -27.74 60.94 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.755 -1.216 . . . . 0.0 108.312 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -91.37 -44.22 9.29 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.888 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.612 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 20.2 m -60.47 -24.6 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.186 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.652 ' CG2' ' CE1' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -106.22 165.08 13.64 Favored Pre-proline 0 N--CA 1.501 2.107 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.975 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 246' ' ' TYR . 52.3 Cg_endo -83.66 25.82 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.242 1.961 . . . . 0.0 111.723 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 95' ' ' THR . 3.7 mm? -127.09 -177.89 4.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.468 -1.395 . . . . 0.0 110.781 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.555 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.5 p -125.59 167.12 15.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 111.488 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.661 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 25.1 m-85 -148.68 162.72 39.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.307 0.575 . . . . 0.0 109.801 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.573 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -133.12 -159.21 0.95 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.41 152.94 33.77 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.052 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -136.1 -129.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.067 -1.021 . . . . 0.0 109.318 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 40.4 t80 178.24 31.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.67 -1.269 . . . . 0.0 109.423 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.459 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 5.0 pm0 -167.37 -174.25 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.014 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.53 -98.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 4.6 pt-20 178.86 124.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -1.156 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.496 ' HB2' ' CA ' ' A' ' 99' ' ' TYR . . . -81.98 -151.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 109.219 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.57 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -81.1 -48.7 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.544 ' CG2' HD12 ' A' ' 144' ' ' ILE . 13.1 mm -112.52 80.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 4.4 ttp -63.8 97.69 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.938 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.573 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.7 mm -78.23 130.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.066 -1.021 . . . . 0.0 108.488 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -145.34 154.92 42.83 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.562 -1.336 . . . . 0.0 111.881 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -91.19 135.88 33.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.121 -0.987 . . . . 0.0 108.577 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -169.52 -164.0 0.42 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.381 -1.328 . . . . 0.0 111.338 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.592 ' CG2' ' CA ' ' A' ' 159' ' ' GLY . 3.0 p -177.51 -171.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.215 -0.636 0 N-CA-C 108.855 -1.248 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.666 ' CZ ' ' CG1' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -69.33 -141.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 110.479 -178.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 160' ' ' PRO . 3.9 p-10 -128.12 -31.77 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 111.782 -177.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.592 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 50.61 -105.91 0.22 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.292 -2.323 . . . . 0.0 107.292 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.26 61.45 0.25 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.582 1.306 . . . . 0.0 109.879 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -156.73 -176.13 28.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 163' ' ' VAL . 50.9 m-20 -78.1 -41.35 35.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -1.194 . . . . 0.0 110.272 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.666 ' CG1' ' CZ ' ' A' ' 157' ' ' PHE . 4.6 t -42.1 130.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.57 ' HG ' ' CH2' ' A' ' 186' ' ' TRP . 0.8 OUTLIER -96.08 -56.5 2.62 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.46 -0.775 . . . . 0.0 112.543 -178.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -162.74 -172.04 2.95 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.22 -1.55 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER 179.93 173.96 0.91 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 119.956 -1.715 . . . . 0.0 111.371 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.23 -170.78 2.73 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.477 -0.765 . . . . 0.0 109.667 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.627 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 49.3 m-85 -118.28 -166.19 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.836 -1.165 . . . . 0.0 110.432 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.551 ' CB ' ' CE ' ' A' ' 91' ' ' LYS . . . -177.51 -62.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.8 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 42.9 Cg_endo -73.77 145.23 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.956 1.503 . . . . 0.0 110.305 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . 94.17 144.23 15.43 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.8 Cg_endo -70.4 152.37 65.94 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.969 1.51 . . . . 0.0 109.99 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 68.38 -63.94 0.41 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.627 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -65.69 -8.73 6.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.533 -0.981 . . . . 0.0 108.842 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.483 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 10.4 t30 -67.41 66.39 0.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.951 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 131.45 76.58 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.165 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -149.1 119.32 7.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.699 -1.471 . . . . 0.0 108.288 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.559 ' HB1' ' CD1' ' A' ' 144' ' ' ILE . . . -101.83 166.1 10.84 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.012 -1.055 . . . . 0.0 109.054 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.644 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -163.27 132.38 4.03 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.32 178.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.566 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 53.9 m-85 -92.06 136.24 33.33 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.756 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.484 ' OD1' ' CG2' ' A' ' 148' ' ' VAL . 51.6 t0 -70.03 126.49 29.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 183' ' ' ASP . 16.5 t70 -70.65 -5.03 26.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.628 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 61.9 t0 -34.32 -72.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 111.273 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.474 ' OE2' ' OD2' ' A' ' 183' ' ' ASP . 1.0 OUTLIER -111.87 -135.85 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.524 -177.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.543 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -122.91 -178.75 4.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.162 -0.961 . . . . 0.0 109.17 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.593 ' CD1' ' CG2' ' A' ' 105' ' ' THR . 29.4 m95 -144.7 151.2 38.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.45 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 192' ' ' GLY . 41.5 p -145.9 152.87 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 110.007 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.1 OUTLIER -70.08 -38.95 75.86 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.503 ' N ' ' CG ' ' A' ' 188' ' ' LYS . 0.8 OUTLIER -86.18 -150.17 0.14 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.532 HG21 ' CD1' ' A' ' 229' ' ' LEU . 17.3 p -109.51 43.1 1.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.069 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.471 ' HB ' HG22 ' A' ' 187' ' ' THR . 89.0 m -95.49 -31.84 13.16 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.352 -0.842 . . . . 0.0 111.25 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.522 ' N ' HG22 ' A' ' 187' ' ' THR . . . -114.18 -80.15 0.92 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.028 -1.558 . . . . 0.0 109.535 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.524 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 64.0 m -134.72 -94.02 0.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.584 -0.951 . . . . 0.0 108.435 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.594 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.8 OUTLIER -157.23 66.01 0.5 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.675 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.707 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -29.56 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.702 0.763 . . . . 0.0 111.019 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.646 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -67.78 -11.71 59.04 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 111.536 -177.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 13.0 tp -67.25 -59.94 3.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.06 -1.856 . . . . 0.0 106.895 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.563 ' CG2' ' CZ3' ' A' ' 186' ' ' TRP . 2.0 m -71.29 -12.87 16.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.653 ' CB ' ' HB3' ' A' ' 120' ' ' ALA . . . -73.5 -61.21 1.91 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.562 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -62.85 -17.13 60.97 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.511 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 15.5 t60 -68.71 -40.63 79.88 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.594 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.566 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 3.9 mt-10 -85.2 -49.36 8.28 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.853 . . . . 0.0 111.141 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 121' ' ' LEU . 3.2 mt -60.88 -30.6 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.734 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.78 -30.83 42.15 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -63.19 -44.64 94.8 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.742 -0.857 . . . . 0.0 110.699 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 168' ' ' TYR . 85.7 p -87.49 -55.61 3.72 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 112.61 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 132' ' ' PHE . 2.3 tp -104.56 7.35 35.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.134 -0.979 . . . . 0.0 110.964 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.581 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -104.65 -77.54 1.16 Allowed Glycine 0 N--CA 1.486 1.982 0 O-C-N 120.841 -1.162 . . . . 0.0 111.021 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.559 ' CD2' ' OD1' ' A' ' 238' ' ' ASP . 4.6 pp -172.59 -161.85 0.17 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.611 -1.523 . . . . 0.0 110.05 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.573 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 2.9 m-85 -94.32 -94.51 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 0.0 109.155 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 44.8 m170 -143.15 120.92 11.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.575 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.7 m -108.33 -179.12 3.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.179 -0.951 . . . . 0.0 109.291 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.53 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.757 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -91.01 13.26 17.24 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.536 -177.197 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 214' ' ' ASN . 31.0 p -50.73 -28.04 8.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.488 ' N ' ' C ' ' A' ' 214' ' ' ASN . 2.5 mt-10 -118.08 -36.42 3.6 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.517 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.757 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -58.78 -159.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 122.2 1.0 . . . . 0.0 112.756 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.618 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -112.15 -3.43 14.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.925 -177.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.532 ' HB2' ' CG ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -89.55 -5.36 57.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 119.152 -2.217 . . . . 0.0 110.732 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.647 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 33.4 t80 -140.0 14.91 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 118.845 -1.142 . . . . 0.0 113.252 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.1 Cg_endo -75.85 -35.21 2.68 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 N-CA-C 108.539 -1.37 . . . . 0.0 108.539 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 223' ' ' TYR . 0.4 OUTLIER -17.98 -57.94 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.53 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 222' ' ' LEU . 2.7 t80 -75.01 55.17 0.7 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 0.0 108.96 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 221' ' ' PRO . 7.2 t-160 -173.44 -138.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.523 ' HB3' ' CG2' ' A' ' 190' ' ' THR . 1.9 m -157.06 119.26 3.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.92 -1.112 . . . . 0.0 109.909 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.534 ' CD1' ' HB3' ' A' ' 221' ' ' PRO . 0.2 OUTLIER 178.92 62.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 110.021 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.504 ' C ' ' CB ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER -114.26 -18.69 11.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 14.5 t70 -167.42 -26.91 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 109.951 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.539 ' C ' ' O ' ' A' ' 228' ' ' ASP . 0.2 OUTLIER -28.61 -61.97 0.11 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.5 t 178.98 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.379 -0.826 . . . . 0.0 108.913 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -94.67 -18.46 21.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 27.8 p90 -37.49 107.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.522 0.677 . . . . 0.0 110.641 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.587 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 9.2 ttt180 179.79 153.26 0.48 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.442 -0.786 . . . . 0.0 109.573 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.625 HD23 ' CH2' ' A' ' 124' ' ' TRP . 2.2 mp -67.01 165.86 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.609 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 12.7 t -101.73 -169.51 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.492 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.56 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.5 tp60 -84.85 -21.69 29.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 110.117 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.575 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 6.5 m-20 -80.44 -41.74 23.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 19.0 t0 -70.73 -32.81 70.13 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.458 -1.297 . . . . 0.0 107.725 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.4 OUTLIER -62.92 -33.9 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -65.05 -51.26 62.5 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.508 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.532 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -58.38 -54.71 35.52 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.604 ' CG1' HG22 ' A' ' 127' ' ' VAL . 2.4 tp -61.24 -49.38 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.745 -1.444 . . . . 0.0 109.916 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -53.57 -29.88 39.36 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.0 t -80.09 -17.08 53.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.535 ' CD1' ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -70.39 -59.86 2.61 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.652 ' CE1' ' CG2' ' A' ' 128' ' ' THR . 41.7 m-85 . . . . . 0 N--CA 1.496 1.871 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.125 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.488 ' HD3' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.622 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 7.0 m95 -66.03 -164.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.834 -1.166 . . . . 0.0 109.076 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -152.03 -36.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.999 -1.063 . . . . 0.0 110.379 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.586 ' CD ' ' CE3' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -50.32 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.544 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 8.2 p -121.22 -5.64 9.42 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.606 ' CE1' ' CG2' ' A' ' 131' ' ' THR . 26.7 m-70 -146.06 100.41 3.39 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.58 ' CD1' ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -106.36 -165.33 1.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.842 . . . . 0.0 109.952 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -160.43 160.17 31.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.606 ' CZ ' ' CD2' ' A' ' 121' ' ' LEU . 2.6 p90 -131.16 167.23 19.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.801 -1.187 . . . . 0.0 108.816 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.528 ' CZ ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -126.11 123.14 37.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.121 . . . . 0.0 109.818 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.5 mp -82.14 84.43 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.779 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' A' ' 144' ' ' ILE . 38.2 t -99.52 6.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.401 -0.812 . . . . 0.0 109.775 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 145' ' ' SER . 35.1 m-80 -97.11 156.15 16.51 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.846 -1.159 . . . . 0.0 108.794 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.555 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 179.14 37.28 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 179.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 104' ' ' TYR . 41.3 p -42.86 156.31 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.401 -0.812 . . . . 0.0 108.913 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.88 -20.27 45.54 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.836 1.44 . . . . 0.0 109.054 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.4 OUTLIER -67.7 -9.85 47.27 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.587 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 63.6 mt -144.49 123.59 7.04 Favored Pre-proline 0 N--CA 1.483 1.221 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.41 166.25 17.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.833 1.438 . . . . 0.0 109.153 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' NZ ' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.94 -65.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.711 0.767 . . . . 0.0 110.345 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.3 m-20 -57.83 -22.92 50.23 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 111.764 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.587 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -76.16 -62.11 1.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.39 -1.443 . . . . 0.0 109.304 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.555 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.9 p -50.94 -39.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.512 ' OD2' ' NZ ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -66.96 -26.95 67.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' ALA . 17.1 p -65.67 -41.22 92.72 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 195' ' ' LEU . . . -73.78 -33.57 64.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.069 -1.019 . . . . 0.0 109.874 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.536 ' O ' ' CG ' ' A' ' 121' ' ' LEU . 12.0 t -74.82 -23.72 17.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.521 ' HA ' HD22 ' A' ' 121' ' ' LEU . 2.1 tt0 -88.35 -35.13 17.35 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.651 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -77.88 -39.57 42.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.643 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -67.41 -62.42 1.43 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.142 0.972 . . . . 0.0 109.086 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.606 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.7 pp -55.3 -40.82 71.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.538 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 7.1 tptm -75.7 -32.64 60.17 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.826 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.592 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 1.5 t -54.16 -44.42 63.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.651 ' CH2' ' CD2' ' A' ' 234' ' ' LEU . 32.7 m95 -91.1 -23.57 20.26 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.675 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 17.6 tp10 -69.79 -27.24 64.74 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.692 -1.255 . . . . 0.0 107.903 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.7 pt-20 -90.39 -42.93 10.63 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.889 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.622 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 16.6 m -57.9 -26.02 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.322 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.604 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -107.94 154.12 41.27 Favored Pre-proline 0 N--CA 1.495 1.818 0 C-N-CA 117.966 -1.493 . . . . 0.0 109.224 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.433 ' C ' HD23 ' A' ' 130' ' ' LEU . 48.6 Cg_endo -81.29 24.76 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.832 1.688 . . . . 0.0 111.415 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.555 ' HG ' ' CD1' ' A' ' 246' ' ' TYR . 4.6 mm? -106.13 -169.02 1.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.701 -1.25 . . . . 0.0 110.202 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.606 ' CG2' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -121.65 162.76 20.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.0 110.48 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.58 ' CE2' ' CD1' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -149.86 144.2 25.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.547 -0.721 . . . . 0.0 109.688 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.12 -162.5 1.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.24 -0.912 . . . . 0.0 108.856 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.598 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -156.46 153.28 28.57 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 110.057 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.538 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -145.06 -137.35 0.09 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.474 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.4 OUTLIER 179.29 33.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.689 -1.257 . . . . 0.0 108.995 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 5.4 pm0 -157.54 179.94 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.35 -95.99 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER 178.83 106.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -1.159 . . . . 0.0 110.193 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.524 ' CB ' HD22 ' A' ' 135' ' ' LEU . . . -60.67 -147.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 108.758 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 98' ' ' THR . 43.9 t0 -90.28 -45.03 9.32 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.53 ' CG2' HD13 ' A' ' 144' ' ' ILE . 44.3 mt -116.46 81.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.52 97.11 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.615 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.6 mm -82.52 114.83 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.582 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -135.71 157.33 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.369 -1.457 . . . . 0.0 112.08 -178.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 16.7 p90 -88.47 140.3 29.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.526 -0.734 . . . . 0.0 109.419 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.58 ' N ' ' CD2' ' A' ' 179' ' ' HIS . . . -168.29 -161.49 0.36 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 0.0 110.176 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' A' ' 149' ' ' ARG . 0.7 OUTLIER -179.51 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.052 . . . . 0.0 109.896 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.544 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 O-C-N 121.863 -0.523 . . . . 0.0 111.157 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 110.128 -0.759 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -92.12 -157.18 0.5 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.079 -1.013 . . . . 0.0 109.861 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.594 ' O ' ' C ' ' A' ' 159' ' ' GLY . 22.5 p30 179.88 54.72 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.427 -0.795 . . . . 0.0 109.858 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -10.48 -64.37 0.01 OUTLIER Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 40.1 Cg_endo -68.96 59.58 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.145 1.23 . . . . 0.0 109.955 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.08 164.86 37.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 164' ' ' LEU . 8.5 m120 -54.18 -58.98 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.598 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.53 ' CG2' ' OD1' ' A' ' 158' ' ' ASP . 33.6 m -45.46 93.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.579 ' CD1' ' CG2' ' A' ' 193' ' ' THR . 1.0 OUTLIER -77.82 -66.79 0.8 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.227 -0.921 . . . . 0.0 112.57 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 179' ' ' HIS . . . -143.2 -172.46 3.69 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.403 . . . . 0.0 111.184 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.69 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.6 p-80 179.47 167.94 1.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.246 -1.534 . . . . 0.0 110.937 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -138.02 -177.25 4.74 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.461 -0.774 . . . . 0.0 109.771 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.489 ' HB3' HG13 ' A' ' 174' ' ' ILE . 96.3 m-85 -114.31 -166.75 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.574 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.57 ' CB ' ' HD2' ' A' ' 170' ' ' PRO . . . -109.44 -174.51 0.3 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.492 -0.755 . . . . 0.0 109.26 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 169' ' ' ALA . 42.5 Cg_endo -75.21 53.35 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.666 1.351 . . . . 0.0 110.725 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 175' ' ' ASN . . . -93.32 -170.76 39.52 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.7 Cg_endo -70.79 124.69 10.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.827 1.435 . . . . 0.0 109.912 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . 69.34 -59.67 0.62 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -76.05 18.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.578 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 1.2 t-20 -63.49 63.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 103.14 102.99 2.74 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -158.97 115.12 2.63 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 120.737 -1.449 . . . . 0.0 107.976 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.79 160.82 16.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.862 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 180' ' ' PHE . 0.1 OUTLIER -155.96 135.66 12.57 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.516 178.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.627 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 23.1 m-85 -93.74 131.08 39.44 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.194 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.51 ' OD2' HD12 ' A' ' 164' ' ' LEU . 43.7 p-10 -65.48 122.26 16.77 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 2.8 p30 -88.47 -9.36 52.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.53 ' HB3' ' HD3' ' A' ' 160' ' ' PRO . 6.3 m-20 -79.66 2.95 20.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.972 -1.08 . . . . 0.0 109.607 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.513 ' HB2' ' CA ' ' A' ' 159' ' ' GLY . 33.0 tt0 -114.14 -129.91 0.31 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.606 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.1 mt-30 -137.22 176.29 8.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.758 -1.214 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.611 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.7 m95 -161.87 115.81 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.97 -1.081 . . . . 0.0 110.069 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.533 ' CG2' ' HA3' ' A' ' 192' ' ' GLY . 37.3 p -140.52 151.4 44.75 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.905 -1.122 . . . . 0.0 110.071 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.57 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 15.4 pttp -84.43 -31.72 24.48 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.2 t70 -84.51 64.12 8.25 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.602 ' O ' ' CG2' ' A' ' 190' ' ' THR . 3.1 t 3.38 60.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.129 0.966 . . . . 0.0 112.011 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.7 m -127.1 -30.19 2.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.055 -1.028 . . . . 0.0 110.028 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.533 ' HA3' ' CG2' ' A' ' 187' ' ' THR . . . -94.58 -84.67 1.64 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.579 ' CG2' ' CD1' ' A' ' 164' ' ' LEU . 5.0 m -119.48 -82.0 0.64 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.719 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 0.5 OUTLIER -179.81 72.78 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.979 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.674 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 3.3 tp -34.62 -97.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.61 0.719 . . . . 0.0 110.732 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.674 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -70.53 -9.66 57.25 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.963 -1.086 . . . . 0.0 111.358 -176.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.719 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.1 tp -68.29 -58.82 3.8 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 115.923 -2.311 . . . . 0.0 106.692 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 165' ' ' ALA . 1.4 t -72.49 -10.3 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.643 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -75.49 -61.6 1.86 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -63.08 -15.93 58.24 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.48 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 28.2 t60 -68.07 -43.69 78.02 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 117.921 -1.512 . . . . 0.0 107.835 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.602 ' OE2' ' CD1' ' A' ' 180' ' ' PHE . 31.5 mt-10 -83.47 -48.07 10.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.237 -0.915 . . . . 0.0 110.914 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.548 HD11 ' N ' ' A' ' 121' ' ' LEU . 2.3 mt -61.06 -29.8 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.643 ' CA ' ' CE2' ' A' ' 124' ' ' TRP . . . -78.26 -31.93 45.15 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.21 -52.3 65.86 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.691 -0.887 . . . . 0.0 109.816 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 207' ' ' LEU . 28.6 t -79.74 -59.52 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.492 -0.755 . . . . 0.0 111.827 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.622 ' CD1' ' CD1' ' A' ' 92' ' ' TRP . 1.4 mm? -104.58 38.82 1.8 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.253 -0.904 . . . . 0.0 110.586 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -139.56 -73.41 0.05 OUTLIER Glycine 0 C--N 1.292 -1.913 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 238' ' ' ASP . 3.5 pp 179.33 -162.42 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.655 -1.497 . . . . 0.0 109.818 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.579 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 16.1 t80 -99.37 -79.97 0.48 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.104 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 4.7 m-70 -153.92 77.22 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -62.18 -172.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 108.924 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.493 ' H ' ' HB3' ' A' ' 237' ' ' ASP . . . -64.26 77.81 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.724 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.01 13.14 8.06 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.789 -177.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER -50.27 -28.44 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 174.373 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.511 ' C ' ' HB3' ' A' ' 235' ' ' SER . 6.5 mt-10 -115.96 -39.65 3.43 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.724 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -63.15 164.8 8.03 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 122.451 1.12 . . . . 0.0 111.99 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.616 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -67.33 -15.5 63.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.339 -177.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.533 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.59 -9.72 59.1 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 118.976 -2.328 . . . . 0.0 112.294 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.646 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 45.7 t80 -137.42 17.27 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.293 -1.505 . . . . 0.0 113.506 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 57.5 Cg_endo -79.47 -36.35 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 N-CA-C 108.747 -1.29 . . . . 0.0 108.747 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.582 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -16.93 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.588 ' O ' ' CG ' ' A' ' 224' ' ' HIS . 28.2 t80 -75.74 49.73 0.53 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.254 -0.904 . . . . 0.0 109.394 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 95.7 m-70 -160.85 -120.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.071 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 226' ' ' LEU . 14.7 m -173.44 110.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.727 -1.233 . . . . 0.0 109.891 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.526 ' CG ' ' HA ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER 179.37 65.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 109.852 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 196' ' ' PHE . 10.1 t -116.88 -7.91 11.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.575 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 1.6 t0 178.09 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.037 . . . . 0.0 110.642 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.545 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -30.32 -61.06 0.17 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.571 -0.706 . . . . 0.0 110.604 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.33 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.475 -0.765 . . . . 0.0 109.098 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.4 mtp180 -100.21 -26.97 13.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 108.925 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.575 ' CD2' ' HA ' ' A' ' 228' ' ' ASP . 11.6 p90 -27.77 121.42 0.11 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.349 0.595 . . . . 0.0 111.598 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.13 170.52 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.443 -0.786 . . . . 0.0 109.809 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.651 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 1.8 mp -81.41 162.15 23.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 110.076 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 217' ' ' ALA . 9.0 p -103.5 -167.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.306 -1.357 . . . . 0.0 110.51 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -84.83 -14.48 47.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 111.723 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.636 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 1.3 m-20 -84.84 -45.2 12.54 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.2 -1.563 . . . . 0.0 107.809 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.618 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 2.6 m-20 -64.99 -41.4 95.43 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.39 -35.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.21 -47.4 73.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 244' ' ' SER . . . -57.94 -55.47 30.42 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.62 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.5 tp -60.14 -46.03 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.977 -1.308 . . . . 0.0 109.227 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 34.8 tt0 -56.3 -25.23 47.86 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 0.0 OUTLIER -78.16 -21.87 49.57 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 242' ' ' ILE . 9.0 mt -72.61 -66.42 0.66 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.555 ' CD1' ' HG ' ' A' ' 130' ' ' LEU . 71.5 m-85 . . . . . 0 C--N 1.29 -1.989 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.145 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.541 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.097 0.475 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.575 ' CD1' ' HA ' ' A' ' 207' ' ' LEU . 10.0 m95 -82.86 176.8 9.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 109.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.74 -41.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.148 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.53 ' CD ' HD12 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.24 172.04 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.681 0.753 . . . . 0.0 110.275 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.524 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 42.9 p -110.3 7.46 23.07 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.572 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 51.1 m80 -144.14 96.28 2.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.866 -1.147 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.9 mm? -96.59 164.45 12.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.53 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.525 ' OG1' ' CD2' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -136.89 155.98 49.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 108.519 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.683 ' CD1' ' CE2' ' A' ' 132' ' ' PHE . 7.7 p90 -135.18 170.3 16.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 109.473 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.53 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 1.1 ttm180 -131.56 128.12 38.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.613 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -86.81 82.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.198 . . . . 0.0 109.725 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 13.0 t -99.09 7.53 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.288 -0.883 . . . . 0.0 109.828 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.597 ' ND2' ' N ' ' A' ' 145' ' ' SER . 18.4 m-80 -98.9 160.46 14.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.978 -1.076 . . . . 0.0 109.166 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.598 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 7.5 t80 177.67 77.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.624 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 61.1 p -69.58 155.66 93.11 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 -25.39 39.73 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 123.766 1.403 . . . . 0.0 108.637 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 2.5 m-20 -74.26 -5.93 44.95 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.62 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 62.0 mt -140.16 121.21 9.34 Favored Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.454 -0.779 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.9 169.28 13.56 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 123.881 1.463 . . . . 0.0 108.716 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' O ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -38.62 -65.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.5 t0 -55.26 -26.93 43.03 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.716 -0.615 . . . . 0.0 111.799 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.62 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -73.9 -61.36 1.87 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.435 -1.415 . . . . 0.0 109.329 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.55 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 12.8 p -53.04 -41.33 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.492 ' N ' HG12 ' A' ' 113' ' ' VAL . 1.1 m-20 -64.45 -26.93 68.66 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.546 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 6.0 p -62.99 -42.37 99.83 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.603 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -70.7 -33.01 70.43 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 0.0 109.638 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.581 HG13 ' CE2' ' A' ' 99' ' ' TYR . 47.1 t -74.57 -23.26 17.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.513 ' HA ' HD22 ' A' ' 121' ' ' LEU . 1.1 tt0 -90.04 -33.77 16.2 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.662 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.59 -37.15 28.09 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.68 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -66.46 -62.1 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.637 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.4 pp -55.47 -41.89 73.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.097 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.576 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -71.52 -33.6 69.35 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.641 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.605 ' CG1' HD12 ' A' ' 234' ' ' LEU . 0.9 OUTLIER -55.18 -42.04 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.653 ' CE2' ' CA ' ' A' ' 204' ' ' GLY . 33.7 m95 -91.29 -22.88 20.34 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.471 ' OE2' ' CB ' ' A' ' 132' ' ' PHE . 28.3 tt0 -71.42 -27.47 63.32 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.2 pt-20 -90.46 -43.59 10.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.612 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.636 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 18.3 m -58.0 -25.91 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.072 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.586 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.0 OUTLIER -104.95 163.49 17.06 Favored Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 117.966 -1.494 . . . . 0.0 110.492 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -87.26 29.8 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.379 2.053 . . . . 0.0 111.289 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.635 ' CD1' ' CD2' ' A' ' 246' ' ' TYR . 34.5 mt -121.27 -166.6 1.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.61 -1.306 . . . . 0.0 110.474 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.2 p -123.01 176.68 5.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.645 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.683 ' CE2' ' CD1' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -139.25 167.98 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 109.671 -179.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.512 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -151.14 169.34 22.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 108.589 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.601 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -140.56 167.43 22.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.803 -1.186 . . . . 0.0 110.545 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.4 OUTLIER -156.76 -133.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 12.7 t80 178.01 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 138' ' ' GLY . 7.5 pm0 -161.39 -171.85 3.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 139' ' ' GLU . . . 38.02 -98.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 138' ' ' GLY . 3.1 pt-20 178.41 107.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -1.111 . . . . 0.0 110.34 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.532 ' CB ' HD23 ' A' ' 135' ' ' LEU . . . -60.24 -150.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 108.722 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.528 ' O ' ' HA3' ' A' ' 176' ' ' GLY . 72.3 m-20 -88.48 -33.88 17.65 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' A' ' 142' ' ' ILE . 3.4 mp -126.3 79.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.541 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -67.74 101.54 1.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.853 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.5 mm -81.61 119.69 31.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.597 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -138.35 158.5 44.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.347 -1.471 . . . . 0.0 112.063 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 22.2 p90 -90.67 139.77 30.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.472 -0.768 . . . . 0.0 109.625 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.627 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -162.1 -160.47 0.68 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.539 ' CG1' ' N ' ' A' ' 149' ' ' ARG . 0.8 OUTLIER 179.65 -157.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.918 -1.113 . . . . 0.0 109.531 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.539 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--O 1.215 -0.675 0 N-CA-C 109.57 -0.973 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.748 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -72.88 -163.08 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.097 -1.002 . . . . 0.0 109.927 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.578 ' O ' ' C ' ' A' ' 159' ' ' GLY . 23.3 p30 179.2 54.45 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.877 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -0.16 -68.72 0.0 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 112.274 -0.33 . . . . 0.0 112.274 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.4 Cg_endo -67.55 59.52 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.21 1.11 . . . . 0.0 109.664 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -168.79 160.62 34.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 164' ' ' LEU . 5.5 m120 -52.57 -47.72 66.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -1.199 . . . . 0.0 110.086 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.585 ' HB ' ' CE1' ' A' ' 157' ' ' PHE . 2.6 m -51.46 89.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 0.0 109.728 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.644 ' CD2' ' CH2' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -76.32 -82.53 0.07 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.63 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -137.33 -175.32 4.02 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.491 -1.38 . . . . 0.0 111.154 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.748 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.7 p-80 179.34 169.35 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 119.899 -1.751 . . . . 0.0 110.524 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.63 -172.51 3.18 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.498 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.523 ' CB ' HG13 ' A' ' 174' ' ' ILE . 64.1 m-85 -118.09 -167.28 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.072 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.566 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . . . -162.93 -64.72 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.639 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 43.0 Cg_endo -72.87 172.36 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.792 1.417 . . . . 0.0 110.362 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.547 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 90.4 165.25 40.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.8 Cg_endo -73.99 -94.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.629 1.553 . . . . 0.0 110.54 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -59.2 -35.0 82.48 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.547 ' CG2' ' HA3' ' A' ' 171' ' ' GLY . 9.4 tp -71.37 4.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.287 -1.125 . . . . 0.0 109.201 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 172' ' ' PRO . 1.2 p30 -66.08 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.89 . . . . 0.0 109.334 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 114.93 94.1 1.96 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -151.95 118.12 5.56 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -107.75 163.22 13.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.085 . . . . 0.0 109.201 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.627 ' CE1' ' CB ' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -159.78 134.62 7.9 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.11 178.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.604 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 17.1 m-85 -97.09 129.88 44.44 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.115 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.503 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -63.47 124.86 22.41 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.827 -1.549 . . . . 0.0 107.171 177.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.35 31.68 2.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 110.56 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.543 ' HB3' ' HA3' ' A' ' 159' ' ' GLY . 49.2 t0 -107.9 -3.97 18.41 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.436 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.536 ' HG2' ' CA ' ' A' ' 159' ' ' GLY . 4.5 pt-20 -116.32 -111.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.028 . . . . 0.0 108.872 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 15.2 mt-30 -148.58 177.88 9.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.723 -1.236 . . . . 0.0 109.15 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.644 ' CH2' ' CD2' ' A' ' 164' ' ' LEU . 88.2 m95 -161.98 126.14 3.23 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.115 -0.99 . . . . 0.0 108.998 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.463 HG21 ' HA3' ' A' ' 192' ' ' GLY . 65.7 p -147.2 153.7 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.676 -1.265 . . . . 0.0 110.723 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 17.4 pttt -85.09 -32.69 22.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.7 t70 -86.09 64.03 8.35 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.602 ' O ' ' CG2' ' A' ' 190' ' ' THR . 3.5 t 3.19 60.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.185 0.993 . . . . 0.0 111.94 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.2 m -125.44 -30.87 3.07 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.055 -1.028 . . . . 0.0 109.787 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.463 ' HA3' HG21 ' A' ' 187' ' ' THR . . . -95.31 -80.0 1.49 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.535 HG22 ' CD2' ' A' ' 164' ' ' LEU . 47.1 m -127.84 -95.89 0.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.623 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -160.5 72.79 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 108.971 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.673 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 2.2 tp -37.07 -96.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.671 0.748 . . . . 0.0 110.448 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.673 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.3 OUTLIER -68.61 -5.15 18.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.132 -0.98 . . . . 0.0 110.848 -177.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.623 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 6.1 tp -69.0 -67.7 0.45 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 116.836 -1.946 . . . . 0.0 106.479 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.523 ' HA ' ' CB ' ' A' ' 201' ' ' HIS . 2.4 t -68.03 -9.77 11.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.68 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -73.0 -59.04 2.89 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.602 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -65.15 -15.22 62.18 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 219' ' ' MET . 10.9 t60 -69.27 -42.96 74.85 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 117.76 -1.576 . . . . 0.0 107.95 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.583 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 1.3 mt-10 -83.97 -47.37 11.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.865 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 117' ' ' VAL . 3.0 mt -63.11 -29.51 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.653 ' CA ' ' CE2' ' A' ' 124' ' ' TRP . . . -77.31 -31.55 51.21 Favored Glycine 0 C--N 1.295 -1.737 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -64.26 -44.22 92.41 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 121.812 -0.817 . . . . 0.0 111.212 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.541 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 49.7 m -86.97 -53.12 5.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 112.61 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.575 ' HA ' ' CD1' ' A' ' 92' ' ' TRP . 2.2 pp -104.36 -2.61 25.24 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.861 -1.149 . . . . 0.0 111.388 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.55 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -96.92 -84.58 1.74 Allowed Glycine 0 C--N 1.291 -1.966 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 238' ' ' ASP . 1.8 pp -165.35 -159.33 0.42 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.037 -1.272 . . . . 0.0 109.658 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.538 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.2 OUTLIER -96.56 -84.94 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.529 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.8 m-70 -153.18 104.57 2.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.067 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.607 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -92.1 -167.33 1.74 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.213 -0.929 . . . . 0.0 109.56 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.17 81.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.773 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.4 6.62 22.53 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.761 -177.01 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 214' ' ' ASN . 7.8 p -50.82 -27.44 7.32 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.476 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.2 mt-10 -117.29 -36.05 3.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.773 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -58.95 179.17 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.162 0.982 . . . . 0.0 111.699 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.645 ' CD2' ' CZ ' ' A' ' 196' ' ' PHE . 1.4 tp -96.05 -10.16 29.14 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.393 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.614 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 9.1 mmt -74.26 -16.73 60.94 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.641 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.5 OUTLIER -143.5 23.6 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 C-N-CA 117.621 -1.631 . . . . 0.0 113.422 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.6 Cg_endo -75.39 -31.47 5.7 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 N-CA-C 106.795 -2.04 . . . . 0.0 106.795 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.569 ' C ' ' O ' ' A' ' 221' ' ' PRO . 1.9 tm? -8.06 -65.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.326 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.76 59.59 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.8 OUTLIER -175.57 -144.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.375 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 226' ' ' LEU . 44.5 m -146.41 112.81 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.048 -1.033 . . . . 0.0 109.956 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.529 ' CG ' ' O ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.61 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.431 -0.793 . . . . 0.0 109.26 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 197' ' ' LEU . 9.1 t -108.26 -9.09 15.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.296 -0.877 . . . . 0.0 109.591 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.583 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 177.59 -20.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 110.854 179.275 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.559 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.22 -61.1 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.446 -0.783 . . . . 0.0 110.651 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.35 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 232' ' ' PHE . 51.7 p90 -31.58 120.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.488 0.661 . . . . 0.0 111.028 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.12 168.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.641 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 4.5 mp -82.82 168.49 17.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.83 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.613 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 6.5 t -98.47 -171.13 2.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.737 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.576 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -83.08 -19.24 37.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.563 -0.71 . . . . 0.0 109.449 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.607 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 5.2 m-20 -82.76 -42.24 18.22 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.658 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.3 m-20 -66.62 -41.03 89.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 117.411 -1.715 . . . . 0.0 106.879 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.9 OUTLIER -56.75 -35.12 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -67.11 -45.01 78.48 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.444 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -62.03 -58.91 10.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.586 ' CD1' HG23 ' A' ' 128' ' ' THR . 1.9 tp -62.76 -50.41 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.987 -1.302 . . . . 0.0 110.116 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' A' ' 239' ' ' ILE . 15.1 tt0 -53.37 -26.12 18.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.2 t -90.4 -10.67 43.02 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -79.84 -52.79 7.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.635 ' CD2' ' CD1' ' A' ' 130' ' ' LEU . 5.2 m-30 . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.95 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.588 ' CE ' ' CB ' ' A' ' 169' ' ' ALA . 1.6 tttt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.629 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 2.8 m95 -74.53 -165.98 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -167.19 -33.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.8 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.538 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -50.54 -172.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.385 -0.822 . . . . 0.0 110.619 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.55 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 1.2 p -117.35 -4.79 11.32 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.618 -0.676 . . . . 0.0 109.242 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 131' ' ' THR . 21.7 m-70 -144.22 95.24 2.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.629 ' CD1' ' CD1' ' A' ' 92' ' ' TRP . 19.4 mt -86.56 -175.44 5.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -158.63 156.72 30.54 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.326 -0.859 . . . . 0.0 108.714 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 134' ' ' ARG . 13.4 p90 -134.62 164.83 26.63 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.535 -1.353 . . . . 0.0 110.151 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.529 ' HG3' ' CD1' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -131.38 128.38 39.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.5 mp -86.14 81.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.378 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.585 ' N ' ' O ' ' A' ' 144' ' ' ILE . 16.1 t -96.22 13.77 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.542 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 7.8 m120 -107.86 156.12 19.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.581 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER 178.97 42.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.64 -0.662 . . . . 0.0 109.914 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.453 ' CG2' ' OD1' ' A' ' 182' ' ' ASP . 13.8 p -43.74 155.84 0.31 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 108.911 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.91 -21.7 43.44 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.762 1.401 . . . . 0.0 108.94 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -69.97 -8.0 45.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.591 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 84.8 mt -144.83 120.66 6.01 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.534 -0.729 . . . . 0.0 109.756 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.74 172.09 8.74 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.748 1.394 . . . . 0.0 108.981 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -38.55 -65.29 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.801 0.81 . . . . 0.0 110.384 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -55.98 -30.81 62.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.64 . . . . 0.0 112.15 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.591 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -72.45 -59.84 2.53 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.439 -1.413 . . . . 0.0 109.793 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.581 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.8 p -55.13 -39.13 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' N ' HG11 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -66.9 -27.11 67.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.491 ' OG ' HD12 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -67.6 -41.0 84.74 Favored 'General case' 0 C--O 1.202 -1.43 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.336 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.628 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -72.6 -32.77 66.22 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 120.912 -1.117 . . . . 0.0 109.806 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.553 ' CG1' HG13 ' A' ' 144' ' ' ILE . 88.7 t -75.96 -23.65 16.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.518 ' HA ' HD22 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -90.69 -33.26 15.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.717 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.2 OUTLIER -81.47 -37.45 27.94 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.641 ' HB3' ' CB ' ' A' ' 199' ' ' ALA . . . -68.3 -61.92 1.63 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.604 HD23 ' CZ ' ' A' ' 99' ' ' TYR . 1.4 pp -54.71 -41.8 70.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.065 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.559 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.15 -33.23 63.45 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.265 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.58 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.22 -40.14 63.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.683 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 44.5 m95 -91.35 -23.22 20.16 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.486 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 79.9 tt0 -71.9 -28.25 63.37 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.757 -1.214 . . . . 0.0 108.279 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.4 pt-20 -89.92 -43.53 10.52 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.798 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.632 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 18.2 m -60.44 -24.26 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.511 -1.276 . . . . 0.0 109.172 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.607 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.6 OUTLIER -100.54 155.79 35.96 Favored Pre-proline 0 N--CA 1.5 2.065 0 C-N-CA 117.943 -1.503 . . . . 0.0 111.008 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -84.74 27.62 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 110.46 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -117.84 -175.39 2.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.704 -1.247 . . . . 0.0 110.66 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.57 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -109.64 169.85 8.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.436 -0.79 . . . . 0.0 110.09 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -149.05 162.14 40.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 110.082 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.57 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -140.2 -168.22 2.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.606 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -158.84 157.22 31.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 0.0 110.391 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.535 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -159.89 -165.21 1.45 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.406 -0.809 . . . . 0.0 109.307 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 15.8 t80 -153.33 19.78 0.56 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.385 -0.822 . . . . 0.0 108.914 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -141.4 -172.32 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -0.791 . . . . 0.0 109.341 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.18 -98.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER 178.45 117.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 110.509 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.477 ' HB3' ' OG1' ' A' ' 98' ' ' THR . . . -75.67 -148.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 108.899 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.599 ' O ' ' O ' ' A' ' 176' ' ' GLY . 59.8 m-20 -100.32 -25.03 14.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.56 HG12 ' CD2' ' A' ' 207' ' ' LEU . 2.9 mt -124.35 76.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 1.7 ttt -64.33 93.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 102' ' ' VAL . 9.1 mm -80.04 106.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.567 ' CB ' ' HB ' ' A' ' 102' ' ' VAL . 0.3 OUTLIER -131.76 162.56 30.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.24 -1.538 . . . . 0.0 112.342 -178.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.489 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 46.9 p90 -82.55 134.38 35.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.442 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.641 ' CB ' ' CD2' ' A' ' 179' ' ' HIS . . . -152.08 162.11 41.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.037 . . . . 0.0 110.418 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 149' ' ' ARG . 1.8 p -167.04 -163.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.484 ' HG2' ' HA ' ' A' ' 158' ' ' ASP . 5.3 mtm-85 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 C--O 1.216 -0.622 0 N-CA-C 109.377 -1.047 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.686 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -112.94 -170.41 1.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 110.978 -178.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.588 ' O ' ' C ' ' A' ' 159' ' ' GLY . 17.4 p30 -176.18 63.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.898 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -12.38 -61.35 0.01 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.493 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.0 Cg_endo -63.56 66.11 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.551 1.29 . . . . 0.0 109.651 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 177.87 143.88 5.24 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' LEU . 30.4 m-80 -37.79 -44.6 0.75 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.634 -0.921 . . . . 0.0 110.221 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.679 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 17.8 t -42.4 95.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 109.33 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.543 HD11 ' CD1' ' A' ' 222' ' ' LEU . 1.9 mt -90.17 -38.89 13.18 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 113.133 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.59 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . 179.43 -171.12 0.14 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.799 -1.813 . . . . 0.0 111.449 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.686 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.2 p-80 179.15 -170.28 0.12 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.376 -1.453 . . . . 0.0 111.33 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -153.45 179.2 9.01 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.437 -0.789 . . . . 0.0 110.235 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.59 ' O ' ' CB ' ' A' ' 206' ' ' SER . 11.0 m-85 -127.6 162.41 26.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.894 -1.129 . . . . 0.0 111.149 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.593 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . . . -144.49 -67.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 40.7 Cg_endo -70.75 94.89 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.489 1.257 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 159.09 145.14 4.16 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -71.57 145.86 48.06 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.511 1.474 . . . . 0.0 110.083 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 67.81 -64.05 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.3 OUTLIER -74.24 5.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.414 -1.051 . . . . 0.0 108.896 178.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 171' ' ' GLY . 0.5 OUTLIER -63.9 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 115.05 89.1 1.6 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.665 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -155.64 118.96 4.36 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 202' ' ' GLU . . . -108.76 128.57 54.99 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.186 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.641 ' CD2' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -113.59 132.46 55.73 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.894 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.683 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 16.0 m-85 -93.37 125.0 37.74 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.198 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 164' ' ' LEU . 22.6 t0 -50.1 135.05 21.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.667 -1.271 . . . . 0.0 108.262 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' CG2' ' A' ' 105' ' ' THR . 0.1 OUTLIER -106.22 24.27 12.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 110.232 -178.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.579 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.7 OUTLIER -129.13 24.37 5.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 159' ' ' GLY . 2.3 mt-10 -129.03 -90.26 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.138 -0.976 . . . . 0.0 109.408 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.628 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 1.7 mt-30 179.89 170.22 1.16 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.683 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.0 m95 -158.63 124.16 4.4 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.022 -1.049 . . . . 0.0 109.795 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.455 ' HA ' HD22 ' A' ' 108' ' ' LEU . 67.9 p -148.32 149.78 32.45 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.925 -1.109 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.569 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 8.5 pttt -84.14 -32.46 24.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.7 t70 -83.49 61.73 6.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.594 ' C ' ' O ' ' A' ' 189' ' ' ASP . 15.7 m 3.08 64.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.71 0.767 . . . . 0.0 111.384 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 189' ' ' ASP . 41.9 m -130.74 -31.64 1.74 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.762 -0.587 . . . . 0.0 109.635 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' ' 187' ' ' THR . . . -94.45 -77.89 1.39 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.535 ' CG2' HD23 ' A' ' 164' ' ' LEU . 13.4 m -128.35 -81.61 0.58 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.481 -1.011 . . . . 0.0 108.774 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.615 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 1.9 m-20 -177.47 67.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.586 -0.845 . . . . 0.0 108.991 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.628 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -32.4 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.58 0.705 . . . . 0.0 110.537 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.717 ' CG ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -71.78 -8.74 56.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.839 -1.163 . . . . 0.0 110.929 -178.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 14.8 tp -70.76 -56.29 6.71 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 116.262 -2.175 . . . . 0.0 107.207 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.517 ' CG1' ' OE2' ' A' ' 202' ' ' GLU . 9.1 t -77.87 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.641 ' CB ' ' HB3' ' A' ' 120' ' ' ALA . . . -75.26 -58.8 3.06 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.598 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -66.53 -19.71 65.85 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' ' 205' ' ' HIS . 4.7 t60 -66.17 -41.81 89.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 116.873 -1.931 . . . . 0.0 107.882 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.561 ' OE1' ' CD1' ' A' ' 180' ' ' PHE . 8.3 mt-10 -84.1 -49.1 9.2 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.145 -0.972 . . . . 0.0 110.792 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.556 HD11 ' N ' ' A' ' 121' ' ' LEU . 3.2 mt -57.85 -31.74 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.683 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -80.6 -35.3 26.02 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -57.95 -47.71 82.11 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.423 -1.045 . . . . 0.0 110.519 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.59 ' CB ' ' O ' ' A' ' 168' ' ' TYR . 1.4 p -86.08 -58.46 2.63 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 111.906 -177.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.584 HD23 ' CB ' ' A' ' 206' ' ' SER . 0.3 OUTLIER -104.43 33.97 3.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.81 -1.181 . . . . 0.0 110.114 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.579 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -132.06 -77.21 0.13 Allowed Glycine 0 C--N 1.29 -1.973 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.5 pp -165.69 -160.72 0.47 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.999 -1.295 . . . . 0.0 109.62 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.59 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 16.7 t80 -101.7 -71.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 20.7 m80 -163.78 100.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.865 . . . . 0.0 108.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.635 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.7 OUTLIER -90.27 -175.93 4.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.882 . . . . 0.0 109.249 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.446 ' H ' ' HB3' ' A' ' 237' ' ' ASP . . . -63.86 78.33 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.754 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.26 9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.56 -177.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -50.64 -27.78 7.58 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.488 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.0 OUTLIER -114.51 -37.58 4.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.754 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -62.33 -171.28 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.334 1.064 . . . . 0.0 112.418 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.623 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -89.95 -16.54 29.7 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.735 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.528 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.5 -9.57 58.98 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.476 -2.015 . . . . 0.0 112.436 -177.36 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.66 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 4.7 t80 -136.49 16.58 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.229 -1.545 . . . . 0.0 113.404 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.2 Cg_endo -78.81 -40.07 0.33 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 108.711 -1.304 . . . . 0.0 108.711 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.579 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -7.83 -77.07 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.257 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.99 59.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.244 -0.91 . . . . 0.0 108.955 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.5 t-80 -163.61 -124.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.339 -0.851 . . . . 0.0 108.974 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.482 ' HA ' HG22 ' A' ' 190' ' ' THR . 62.5 m -168.78 104.44 0.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.697 -1.252 . . . . 0.0 110.342 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' A' ' 197' ' ' LEU . 0.4 OUTLIER 178.92 48.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.523 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 9.2 t -98.69 -15.71 19.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.064 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 0.5 OUTLIER 178.09 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.429 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -32.95 -56.95 0.38 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.13 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -86.22 -16.63 37.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.6 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 25.4 p90 -32.34 111.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.719 0.771 . . . . 0.0 110.933 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.562 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.6 ttt180 179.22 149.73 0.28 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.657 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -73.03 167.22 21.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.99 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.637 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 28.8 t -99.56 -170.6 1.92 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.969 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.526 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.02 -13.35 50.82 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.011 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.635 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 3.1 m-20 -84.85 -46.75 11.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.657 -1.277 . . . . 0.0 107.783 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.735 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.8 OUTLIER -65.12 -39.3 92.89 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 117.226 -1.79 . . . . 0.0 106.549 177.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.66 -35.45 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.98 -50.36 62.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.14 60.75 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.607 ' CD1' HG23 ' A' ' 128' ' ' THR . 1.7 tp -66.37 -49.18 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.837 -1.39 . . . . 0.0 110.132 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -54.03 -25.05 19.33 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.7 p -92.73 -9.87 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.556 HD22 ' CB ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -77.86 -51.25 10.76 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.53 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 5.4 m-30 . . . . . 0 N--CA 1.494 1.73 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.83 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.583 ' HG3' ' CD1' ' A' ' 92' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 91' ' ' LYS . 89.9 m95 -105.02 149.56 25.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.883 -1.136 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.21 -33.29 5.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.734 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.553 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -44.75 175.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.438 -0.789 . . . . 0.0 110.345 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.533 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 7.1 p -109.11 5.05 23.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.47 -0.768 . . . . 0.0 109.78 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.539 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 47.9 m80 -146.88 94.44 2.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.831 -1.168 . . . . 0.0 110.538 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.634 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 1.9 mm? -93.6 -176.54 4.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -0.794 . . . . 0.0 108.872 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 141' ' ' ASP . 1.1 t -146.82 154.28 41.16 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.97 -1.081 . . . . 0.0 109.084 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.639 ' CD1' ' CD2' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -133.79 166.53 22.43 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.712 -1.242 . . . . 0.0 109.914 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.534 ' HD3' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.39 133.14 46.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.634 ' CD1' ' CZ ' ' A' ' 99' ' ' TYR . 2.4 mp -96.55 80.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 109.777 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.614 ' N ' ' O ' ' A' ' 144' ' ' ILE . 59.4 t -97.94 7.38 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.559 ' ND2' ' N ' ' A' ' 145' ' ' SER . 35.2 m-80 -92.95 158.13 15.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.697 -1.252 . . . . 0.0 109.647 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.576 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 1.8 t80 178.16 82.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.532 -0.73 . . . . 0.0 109.555 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.451 HG23 ' CD1' ' A' ' 186' ' ' TRP . 1.3 p -75.98 159.27 81.08 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.12 -21.48 42.47 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.82 1.432 . . . . 0.0 108.779 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.2 OUTLIER -78.1 -0.77 29.44 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.617 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 96.7 mt -150.63 120.64 3.73 Favored Pre-proline 0 N--CA 1.485 1.292 0 O-C-N 121.421 -0.799 . . . . 0.0 109.88 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.13 175.7 5.42 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.801 1.422 . . . . 0.0 109.334 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.22 -65.83 0.34 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.875 0.845 . . . . 0.0 110.341 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.65 -30.76 63.69 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.617 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -72.61 -60.68 2.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.25 -1.531 . . . . 0.0 109.54 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.576 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 7.2 p -53.17 -41.2 41.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.5 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -62.22 -28.1 69.45 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.531 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 7.7 p -64.02 -42.87 96.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.621 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -71.11 -33.77 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.598 ' CG1' HG13 ' A' ' 144' ' ' ILE . 1.5 t -75.55 -23.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -88.36 -34.94 17.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.64 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 3.5 tppt? -80.6 -36.39 32.84 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.646 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -65.44 -62.46 1.51 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.639 ' CD2' ' CD1' ' A' ' 99' ' ' TYR . 13.5 tp -52.47 -46.32 66.47 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.058 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -69.17 -33.82 73.99 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.33 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.585 ' CG2' ' CE1' ' A' ' 196' ' ' PHE . 0.9 OUTLIER -57.34 -36.69 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.707 ' CZ2' ' HA3' ' A' ' 204' ' ' GLY . 55.4 m95 -91.68 -24.13 19.59 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.874 -1.131 . . . . 0.0 110.495 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 132' ' ' PHE . 14.8 tt0 -71.81 -28.88 63.89 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.851 -1.155 . . . . 0.0 108.315 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.0 pt-20 -91.37 -42.93 10.06 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.646 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 21.7 m -61.83 -23.34 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.206 -1.398 . . . . 0.0 109.802 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.604 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.0 OUTLIER -104.29 161.73 22.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 117.14 -1.824 . . . . 0.0 110.298 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.463 ' HG2' ' CD2' ' A' ' 130' ' ' LEU . 50.0 Cg_endo -80.72 13.12 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.609 1.847 . . . . 0.0 110.655 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 130' ' ' LEU . 3.3 mm? -116.4 -176.94 3.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.953 -1.092 . . . . 0.0 110.093 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.509 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.4 p -124.72 170.42 11.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.604 ' CD1' ' HB2' ' A' ' 97' ' ' LEU . 21.6 m-85 -131.78 179.55 6.0 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.84 0.829 . . . . 0.0 110.023 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 m -142.44 -166.36 2.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 160.57 18.37 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.906 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.526 ' CD1' ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -159.63 -128.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.491 ' N ' HD11 ' A' ' 135' ' ' LEU . 0.1 OUTLIER 177.15 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.465 -1.397 . . . . 0.0 109.732 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 139' ' ' GLU . 7.5 pm0 -151.47 -177.65 6.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 109.917 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.76 -97.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.99 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -1.105 . . . . 0.0 110.003 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -58.9 -155.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 108.959 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' THR . 76.7 m-20 -83.52 -26.07 30.48 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.537 ' CD1' HD21 ' A' ' 207' ' ' LEU . 2.1 mp -130.17 77.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.412 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.6 ttt -62.01 93.2 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 109.26 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.614 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.3 mm -82.12 109.06 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.495 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -134.29 153.54 51.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.492 -1.38 . . . . 0.0 111.652 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 20.0 p90 -86.98 139.58 30.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.179 -0.95 . . . . 0.0 109.406 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -168.54 -158.23 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 110.556 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.594 ' CG2' ' CA ' ' A' ' 159' ' ' GLY . 1.4 p -173.22 -158.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.512 ' HA ' ' N ' ' A' ' 157' ' ' PHE . 10.8 ptt180 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 109.564 -0.975 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.679 ' CD2' ' CE1' ' A' ' 166' ' ' HIS . 0.9 OUTLIER -71.22 -131.88 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.375 -0.828 . . . . 0.0 109.875 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.527 ' HB3' ' CG2' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -148.69 -36.03 0.19 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.42 -1.425 . . . . 0.0 110.194 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 69.01 -110.01 3.18 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 34.8 Cg_endo -59.97 76.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.063 1.033 . . . . 0.0 110.268 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -166.24 -160.78 13.98 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' VAL . 9.8 m-80 -90.58 -48.91 6.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.259 -1.142 . . . . 0.0 110.477 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.58 HG22 ' CD1' ' A' ' 157' ' ' PHE . 27.7 m -41.02 127.25 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.842 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.541 ' CD1' ' CG2' ' A' ' 193' ' ' THR . 13.6 mt -96.62 -40.01 9.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.321 -0.862 . . . . 0.0 112.717 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -178.49 -167.08 0.12 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 119.79 -1.819 . . . . 0.0 111.223 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 1.1 p-80 178.95 -174.03 0.18 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.208 -1.558 . . . . 0.0 111.358 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -149.63 -175.15 4.9 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.453 -0.78 . . . . 0.0 109.787 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.629 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -122.25 -162.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.838 -1.164 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.517 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -172.43 -60.2 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.466 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 44.4 Cg_endo -75.33 -178.69 4.42 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.858 1.451 . . . . 0.0 110.217 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 67.96 140.67 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -70.4 152.19 65.87 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.964 1.507 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . 67.83 -65.33 0.32 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.629 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -67.62 -3.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.482 -1.01 . . . . 0.0 109.143 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.547 ' ND2' ' CZ2' ' A' ' 92' ' ' TRP . 5.3 p-10 -65.29 65.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.754 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 126.33 82.64 0.45 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.551 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 1.7 m-20 -152.22 123.83 7.85 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.918 -1.343 . . . . 0.0 107.735 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -111.74 156.18 22.34 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.599 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -151.29 132.65 14.6 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.735 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.693 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 19.9 m-30 -87.69 126.8 35.18 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.898 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.512 ' HB3' ' O ' ' A' ' 164' ' ' LEU . 34.2 t0 -68.67 134.38 49.79 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.449 -0.782 . . . . 0.0 109.295 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 183' ' ' ASP . 18.9 p-10 -61.45 -14.07 25.63 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.4 p30 3.96 -93.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.513 ' OE2' ' HB2' ' A' ' 183' ' ' ASP . 10.2 mp0 -127.26 -63.02 1.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.974 -1.079 . . . . 0.0 110.681 -177.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.539 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 28.4 mt-30 -158.58 176.7 12.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.873 -1.142 . . . . 0.0 110.393 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.693 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 43.2 m95 -148.85 128.67 13.36 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.478 ' CG2' ' HA3' ' A' ' 192' ' ' GLY . 81.1 p -145.77 150.84 36.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.37 -1.456 . . . . 0.0 111.34 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.6 OUTLIER -83.76 -34.08 24.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 38.4 t0 -85.53 62.06 7.24 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.569 ' C ' ' O ' ' A' ' 189' ' ' ASP . 6.1 t 3.73 60.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 122.002 0.906 . . . . 0.0 111.829 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 46.9 m -124.79 -31.31 3.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.419 -0.801 . . . . 0.0 109.57 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.478 ' HA3' ' CG2' ' A' ' 187' ' ' THR . . . -95.53 -70.52 1.07 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.541 ' CG2' ' CD1' ' A' ' 164' ' ' LEU . 23.4 m -140.07 -95.92 0.16 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.63 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -158.85 70.33 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 108.87 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.657 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 1.7 tp -34.51 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.54 0.686 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.657 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.3 OUTLIER -67.23 -6.95 20.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 110.845 -177.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.63 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 8.6 tp -68.11 -65.82 0.65 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 116.912 -1.915 . . . . 0.0 106.801 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.548 ' HB ' ' CZ3' ' A' ' 186' ' ' TRP . 5.4 t -69.14 -11.41 14.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.646 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -72.23 -57.53 4.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.587 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -68.01 -15.66 63.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.573 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 4.2 t60 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.229 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 205' ' ' HIS . 1.9 mm-40 -85.64 -45.23 11.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.938 -1.101 . . . . 0.0 110.616 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 121' ' ' LEU . 2.1 mt -61.32 -31.67 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.707 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.85 -34.42 30.88 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -56.81 -47.11 81.01 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.508 -0.995 . . . . 0.0 109.946 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.513 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 6.1 p -83.97 -57.77 3.06 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.735 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.537 HD21 ' CD1' ' A' ' 142' ' ' ILE . 7.8 mp -103.75 37.31 2.07 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.246 -0.909 . . . . 0.0 110.503 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -139.31 -78.47 0.06 OUTLIER Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.81 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.5 pp -173.18 -159.37 0.11 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.716 -1.461 . . . . 0.0 110.367 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.573 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 54.4 t80 -100.0 -91.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.664 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.579 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 3.2 m-70 -148.57 106.71 3.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 109.473 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.582 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -95.93 -172.53 2.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 109.214 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.41 85.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.744 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.68 10.13 19.17 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.247 -177.056 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 214' ' ' ASN . 28.9 p -50.88 -27.55 7.7 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.483 ' N ' ' C ' ' A' ' 214' ' ' ASN . 15.4 mt-10 -118.41 -35.13 3.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.802 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.744 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -58.1 -159.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.179 0.99 . . . . 0.0 112.575 -177.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.584 HD11 ' O ' ' A' ' 218' ' ' LEU . 0.2 OUTLIER -112.62 -1.72 14.76 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.111 -177.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.579 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -91.76 -9.71 42.65 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 119.997 -1.689 . . . . 0.0 110.637 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.677 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.2 t80 -137.11 14.31 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.79 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.921 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -74.2 -39.89 1.45 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 N-CA-C 108.883 -1.237 . . . . 0.0 108.883 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.583 ' C ' ' O ' ' A' ' 221' ' ' PRO . 2.9 tp -7.24 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.496 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 14.5 m-85 -67.57 59.86 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -163.25 -146.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 226' ' ' LEU . 65.5 m -144.65 101.05 3.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.975 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.44 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 109.074 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.559 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 9.3 t -92.06 -15.65 27.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.347 -0.845 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.574 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.4 OUTLIER 178.42 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.94 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.568 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.87 -98.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.453 -0.78 . . . . 0.0 111.242 -179.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.0 -13.87 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.78 -1.2 . . . . 0.0 109.77 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.573 ' O ' ' C ' ' A' ' 232' ' ' PHE . 2.4 mtp180 -106.2 -42.83 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 108.806 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.574 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 25.8 p90 0.36 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.244 0.545 . . . . 0.0 112.139 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 234' ' ' LEU . 0.0 OUTLIER 178.27 175.28 0.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.647 HD23 ' CH2' ' A' ' 124' ' ' TRP . 3.1 mp -85.66 163.53 18.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.569 -0.707 . . . . 0.0 110.98 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.636 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 5.3 t -98.34 178.74 4.95 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.392 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.536 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.4 OUTLIER -71.04 -24.37 62.33 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.475 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.582 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.3 m-20 -83.46 -42.2 17.2 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.575 -1.328 . . . . 0.0 108.94 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.586 ' CB ' ' HB3' ' A' ' 217' ' ' ALA . 5.8 t0 -70.76 -40.26 72.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.821 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.574 ' CD1' ' O ' ' A' ' 235' ' ' SER . 7.2 mt -54.82 -40.65 53.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.486 ' HA ' ' HG2' ' A' ' 243' ' ' GLN . 25.6 t-20 -60.21 -45.42 93.26 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.851 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.51 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -60.62 -54.57 35.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.604 ' CD1' HG23 ' A' ' 128' ' ' THR . 0.8 OUTLIER -65.2 -47.95 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.725 -1.456 . . . . 0.0 110.621 -178.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.486 ' HG2' ' HA ' ' A' ' 240' ' ' ASN . 15.9 pt20 -54.05 -25.09 19.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 t -88.18 -14.9 37.44 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.515 HD22 ' HB3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -76.06 -56.29 4.79 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.554 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 49.6 m-85 . . . . . 0 N--CA 1.492 1.652 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.291 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.527 ' CB ' HD23 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 98.7 m95 -82.6 151.95 26.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.115 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.92 -40.49 4.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.134 -179.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -50.7 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 -179.647 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.45 ' HA ' ' HG ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -118.17 2.11 11.97 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.496 -0.752 . . . . 0.0 109.369 179.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 38.5 m80 -140.68 89.64 2.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.955 -1.091 . . . . 0.0 110.219 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.582 ' HB2' ' CE2' ' A' ' 132' ' ' PHE . 2.3 mm? -87.68 173.09 9.23 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.652 -0.655 . . . . 0.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.604 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -142.16 155.85 45.33 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.087 -1.008 . . . . 0.0 108.73 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.698 ' CE1' ' CD2' ' A' ' 121' ' ' LEU . 5.4 p90 -137.88 164.79 28.09 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.714 -1.242 . . . . 0.0 108.667 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HD3' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.089 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.653 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 1.5 mp -96.87 61.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 109.698 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 144' ' ' ILE . 21.5 t -77.58 4.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.636 ' ND2' ' CD2' ' A' ' 180' ' ' PHE . 5.4 m-20 -92.92 155.94 17.25 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.983 -1.073 . . . . 0.0 110.073 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.546 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 2.4 t80 176.26 150.98 0.14 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.489 ' CG2' ' C ' ' A' ' 104' ' ' TYR . 3.9 p -156.23 161.11 30.16 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -67.71 -24.68 40.76 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 N-CA-C 108.079 -1.547 . . . . 0.0 108.079 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.5 ' O ' HD22 ' A' ' 108' ' ' LEU . 5.5 t0 -73.82 -12.24 60.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 76.2 mt -143.38 115.41 5.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.28 167.34 12.97 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.63 1.332 . . . . 0.0 109.101 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -36.25 -66.17 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.805 0.812 . . . . 0.0 110.322 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.32 -11.88 7.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.728 -0.607 . . . . 0.0 111.62 -178.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.566 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -85.32 -60.4 2.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.488 -1.383 . . . . 0.0 109.213 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.546 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 5.5 p -55.7 -39.49 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.466 ' HA ' HG22 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -64.62 -27.56 69.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.494 ' OG ' HD12 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -65.7 -41.61 92.14 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.672 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -69.7 -33.34 72.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.606 ' CG1' HG13 ' A' ' 144' ' ' ILE . 2.0 t -74.95 -24.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -87.32 -35.31 18.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 0.3 OUTLIER -80.26 -36.73 34.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.681 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -66.09 -60.8 2.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.532 1.158 . . . . 0.0 107.913 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.698 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 16.2 tp -54.12 -48.24 70.97 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.654 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -67.39 -33.72 75.79 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.241 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.59 ' CG1' HD11 ' A' ' 234' ' ' LEU . 1.0 OUTLIER -55.93 -42.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.643 ' CE2' ' CA ' ' A' ' 204' ' ' GLY . 42.0 m95 -91.21 -23.16 20.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.588 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 18.5 tt0 -71.16 -27.56 63.64 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.6 pt-20 -90.15 -43.55 10.37 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.63 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 16.6 m -58.49 -25.36 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.124 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.594 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -112.1 162.28 22.06 Favored Pre-proline 0 N--CA 1.497 1.922 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.834 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -84.91 27.98 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.134 1.889 . . . . 0.0 110.483 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 246' ' ' TYR . 1.9 mp -109.44 178.99 4.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.247 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.8 p -124.41 170.26 11.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.8 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 97' ' ' LEU . 12.5 m-85 -146.04 171.41 14.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.15 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.4 m -145.22 -175.13 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.622 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -163.83 149.94 11.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 0.0 110.501 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -167.59 -98.71 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.568 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 15.9 t80 177.06 30.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.955 -1.091 . . . . 0.0 109.195 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 138' ' ' GLY . 7.3 tp10 -65.63 169.63 6.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.566 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -41.79 -34.87 1.37 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -178.22 104.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.556 -0.967 . . . . 0.0 109.894 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -59.4 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 98' ' ' THR . 71.5 m-20 -80.67 -30.49 36.53 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.97 -1.081 . . . . 0.0 108.794 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.536 ' CG2' HD13 ' A' ' 144' ' ' ILE . 4.4 mp -129.14 78.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.431 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.9 ttp -62.66 98.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.207 -0.933 . . . . 0.0 109.297 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.606 HG13 ' CG1' ' A' ' 117' ' ' VAL . 3.9 mm -84.76 107.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -132.9 152.22 51.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 112.322 -178.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 24.5 p90 -77.44 146.6 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.561 -0.712 . . . . 0.0 109.586 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.565 ' N ' ' CD2' ' A' ' 179' ' ' HIS . . . -165.04 163.69 20.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -0.929 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.472 ' O ' ' C ' ' A' ' 149' ' ' ARG . 1.2 p -160.79 -160.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.96 . . . . 0.0 109.368 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 157' ' ' PHE . 36.7 mtm180 . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.115 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 C--O 1.215 -0.668 0 N-CA-C 109.379 -1.046 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.684 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -120.71 -171.53 2.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.079 -1.013 . . . . 0.0 110.848 -179.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.57 ' O ' ' C ' ' A' ' 159' ' ' GLY . 17.0 p30 -175.92 62.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.82 -0.55 . . . . 0.0 109.636 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.57 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -8.97 -63.53 0.01 OUTLIER Glycine 0 N--CA 1.505 3.283 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.504 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.1 Cg_endo -64.02 66.56 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.442 1.233 . . . . 0.0 109.94 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 178.02 151.59 9.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' LEU . 15.2 m-20 -42.58 -32.57 0.58 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.166 . . . . 0.0 109.667 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.645 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 39.6 t -44.68 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.7 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.534 ' CD2' HG13 ' A' ' 198' ' ' VAL . 3.1 tp -88.14 -52.01 5.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.12 -0.987 . . . . 0.0 112.286 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.594 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -176.48 -165.34 0.13 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.151 -1.593 . . . . 0.0 111.142 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.684 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.72 -175.29 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.01 -1.681 . . . . 0.0 111.43 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -155.51 176.82 12.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.562 -0.711 . . . . 0.0 109.907 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.527 ' O ' ' CB ' ' A' ' 206' ' ' SER . 25.4 m-85 -120.06 -168.89 1.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.312 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.553 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -159.74 -64.03 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 0.0 109.602 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -76.58 174.82 12.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.651 1.343 . . . . 0.0 110.051 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 105.98 170.82 23.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 175' ' ' ASN . 44.3 Cg_endo -76.43 -56.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 121.603 1.535 . . . . 0.0 109.874 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.62 -40.25 1.03 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.7 tp -62.88 -7.09 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.463 -1.022 . . . . 0.0 108.867 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.524 ' CA ' ' O ' ' A' ' 169' ' ' ALA . 4.4 p-10 -66.0 65.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 108.991 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 127.55 80.76 0.32 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.2 m-20 -156.83 120.94 4.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.102 -1.234 . . . . 0.0 108.158 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -107.19 164.27 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.508 -0.745 . . . . 0.0 109.107 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -153.09 137.58 16.76 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.893 -1.123 . . . . 0.0 109.89 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.636 ' CD2' ' ND2' ' A' ' 103' ' ' ASN . 8.3 m-85 -99.16 129.75 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.753 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.516 ' O ' ' CZ2' ' A' ' 186' ' ' TRP . 11.1 t0 -47.3 148.88 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.906 -1.121 . . . . 0.0 108.312 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -114.34 19.22 16.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 110.122 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.566 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.7 OUTLIER -135.45 17.86 3.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.979 -1.076 . . . . 0.0 110.325 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 4.4 tt0 -120.47 -139.2 0.34 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.909 -1.12 . . . . 0.0 108.548 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.618 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 3.4 mt-30 -117.66 168.06 10.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -0.96 . . . . 0.0 109.14 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.618 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 87.1 m95 -159.46 107.46 1.77 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.974 -1.079 . . . . 0.0 109.741 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.526 ' CG2' ' HA3' ' A' ' 192' ' ' GLY . 70.6 p -144.26 154.6 43.25 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.853 -1.155 . . . . 0.0 110.787 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.1 OUTLIER -91.68 -28.7 17.28 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 191' ' ' THR . 40.4 t0 -90.8 67.05 6.16 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.61 ' O ' ' CG2' ' A' ' 190' ' ' THR . 2.8 t 4.07 58.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.021 0.915 . . . . 0.0 112.036 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 189' ' ' ASP . 51.6 m -124.51 -31.25 3.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 0.0 109.733 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 187' ' ' THR . . . -98.85 -90.96 1.99 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.518 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 23.9 m -115.41 -97.01 0.45 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.608 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -161.45 68.54 0.3 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.23 -0.919 . . . . 0.0 108.706 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.672 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -28.63 -95.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.596 0.713 . . . . 0.0 111.407 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.655 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -67.57 -8.38 33.7 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 111.011 -177.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.608 ' CB ' ' HB3' ' A' ' 194' ' ' ASN . 6.3 tp -66.13 -66.64 0.52 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.224 -1.79 . . . . 0.0 106.668 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.534 HG13 ' CD2' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -66.75 -13.72 16.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.681 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -70.91 -58.8 3.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.588 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -66.67 -14.96 63.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.469 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 14.8 t60 -68.08 -45.47 73.71 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 117.798 -1.561 . . . . 0.0 107.625 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.578 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 2.2 mt-10 -82.8 -47.82 11.49 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.192 -0.943 . . . . 0.0 111.003 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.555 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -60.05 -31.27 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.643 ' CA ' ' CE2' ' A' ' 124' ' ' TRP . . . -76.9 -31.84 51.88 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -59.97 -51.01 71.48 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.85 -0.794 . . . . 0.0 110.58 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 168' ' ' TYR . 84.4 p -82.74 -56.88 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 112.362 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.53 ' CD2' HG12 ' A' ' 142' ' ' ILE . 1.0 OUTLIER -104.86 26.62 8.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.098 -1.001 . . . . 0.0 110.622 -177.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -126.52 -79.19 0.31 Allowed Glycine 0 C--N 1.292 -1.878 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.533 HD11 ' N ' ' A' ' 210' ' ' PHE . 2.1 pp -170.16 -162.67 0.31 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.678 -1.484 . . . . 0.0 110.015 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.567 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.3 OUTLIER -95.07 -75.34 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.5 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.3 m-70 -161.28 89.36 0.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.63 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.5 m -77.1 -178.67 5.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 108.987 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' A' ' 237' ' ' ASP . . . -61.92 80.45 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.74 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.08 7.56 18.29 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.216 -177.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 214' ' ' ASN . 7.8 p -50.63 -27.79 7.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.486 ' C ' ' HB2' ' A' ' 235' ' ' SER . 18.2 mt-10 -114.05 -37.65 4.4 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.74 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -61.69 -167.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.284 1.04 . . . . 0.0 112.195 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.633 ' CD2' ' CZ ' ' A' ' 196' ' ' PHE . 1.0 OUTLIER -102.47 -8.15 21.32 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.893 -177.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.566 ' HE2' ' CZ2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -81.31 -11.11 59.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.114 -1.616 . . . . 0.0 111.213 -178.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.657 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -136.47 12.61 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.33 -1.481 . . . . 0.0 113.808 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 48.5 Cg_endo -71.94 -37.96 4.48 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.591 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.3 OUTLIER 0.08 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.559 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 0.8 OUTLIER -67.72 59.55 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.8 t-160 -168.1 -145.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.442 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.527 ' O ' ' CD1' ' A' ' 226' ' ' LEU . 59.0 m -149.72 110.11 4.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.002 . . . . 0.0 109.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 225' ' ' SER . 0.1 OUTLIER 179.67 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.519 ' OG1' ' N ' ' A' ' 196' ' ' PHE . 4.8 t -111.95 -7.89 14.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.589 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 178.87 -23.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 110.463 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.562 HD13 ' CG2' ' A' ' 190' ' ' THR . 0.3 OUTLIER -28.89 -61.58 0.12 Allowed 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.443 0.639 . . . . 0.0 110.857 -179.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.411 ' OG1' ' C ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.92 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.415 -0.803 . . . . 0.0 108.838 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -98.1 -21.15 16.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.589 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.0 p90 -33.19 120.75 0.37 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.534 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.72 172.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.738 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.639 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 5.0 mp -83.02 169.56 15.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 14.4 t -102.69 -170.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.764 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.542 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -83.8 -13.36 53.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.63 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.1 m-20 -84.54 -48.37 9.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.829 -1.17 . . . . 0.0 108.005 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.731 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.8 OUTLIER -64.0 -40.01 95.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 117.166 -1.814 . . . . 0.0 106.749 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.9 OUTLIER -56.26 -35.72 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 3.6 t30 -67.69 -45.63 74.63 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.461 ' O ' ' OG ' ' A' ' 244' ' ' SER . . . -62.97 -52.48 47.66 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.594 ' CD1' HG23 ' A' ' 128' ' ' THR . 1.5 tp -66.31 -47.29 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.868 -1.372 . . . . 0.0 110.51 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 240' ' ' ASN . 9.9 pt20 -55.13 -26.83 41.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 241' ' ' GLY . 5.0 p -82.27 -18.86 40.9 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.531 ' CD1' ' O ' ' A' ' 208' ' ' GLY . 0.8 OUTLIER -70.09 -65.8 0.68 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.523 ' CD1' HD23 ' A' ' 130' ' ' LEU . 20.5 m-85 . . . . . 0 C--N 1.301 -1.539 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.104 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.528 ' HE3' ' NE1' ' A' ' 92' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.528 ' NE1' ' HE3' ' A' ' 91' ' ' LYS . 9.2 m95 -95.95 -169.05 1.86 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.847 -1.158 . . . . 0.0 110.037 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.513 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -161.81 -33.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.399 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.75 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.199 -0.938 . . . . 0.0 110.799 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.564 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -101.15 -8.53 22.15 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.715 . . . . 0.0 110.167 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.574 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 51.4 m80 -140.15 95.32 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.246 . . . . 0.0 110.865 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 132' ' ' PHE . 19.5 mt -82.02 177.64 8.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.646 -0.659 . . . . 0.0 109.886 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.52 ' N ' ' OD2' ' A' ' 141' ' ' ASP . 1.3 t -148.16 155.8 41.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.226 -0.921 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.658 ' CE1' ' CD2' ' A' ' 121' ' ' LEU . 1.3 p90 -138.43 161.83 35.99 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.614 -1.303 . . . . 0.0 110.053 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.525 ' HD3' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.43 123.0 28.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.515 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.5 mp -84.27 82.48 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.815 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 39.4 t -95.87 6.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.46 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.542 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -102.55 163.65 12.1 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.988 -1.07 . . . . 0.0 109.211 179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 2.0 t80 177.13 84.56 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.585 0.707 . . . . 0.0 109.117 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.651 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 17.9 p -72.85 155.99 90.2 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 108.876 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.98 -24.1 39.81 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 O-C-N 123.917 1.483 . . . . 0.0 108.667 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -78.37 -0.32 28.58 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.625 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 96.8 mt -147.45 120.03 4.74 Favored Pre-proline 0 N--CA 1.485 1.276 0 O-C-N 121.458 -0.776 . . . . 0.0 110.139 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -66.02 173.15 7.52 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.89 1.468 . . . . 0.0 109.037 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' O ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -39.14 -65.97 0.33 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.907 0.861 . . . . 0.0 110.091 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.2 OUTLIER -55.21 -29.41 57.89 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.857 -0.527 . . . . 0.0 112.251 -178.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.625 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -73.09 -61.03 1.96 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.446 . . . . 0.0 109.413 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.556 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.6 p -53.39 -42.31 47.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 1.0 OUTLIER -62.87 -27.94 69.7 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.537 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 4.4 p -61.23 -45.99 92.28 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -67.68 -31.28 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.055 -1.028 . . . . 0.0 109.663 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.528 ' CG1' HG13 ' A' ' 144' ' ' ILE . 45.9 t -75.07 -23.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -90.35 -33.13 16.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.63 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -79.65 -41.89 25.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.652 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -62.95 -61.92 2.07 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.658 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 11.1 tp -51.24 -44.5 61.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 126' ' ' GLU . 2.6 tptp -72.53 -32.73 66.35 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.55 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.609 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 3.4 t -56.16 -43.8 77.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.694 ' HA ' ' CG2' ' A' ' 127' ' ' VAL . 37.8 m95 -91.22 -19.08 23.41 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.452 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.7 OUTLIER -77.05 -27.58 54.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.971 -1.081 . . . . 0.0 108.24 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 17.1 pt-20 -89.99 -44.57 9.78 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.694 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 35.9 m -64.03 -21.44 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.612 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.682 ' CG2' HG13 ' A' ' 242' ' ' ILE . 1.7 p -113.0 152.26 44.79 Favored Pre-proline 0 N--CA 1.498 1.933 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.971 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.476 ' O ' HD23 ' A' ' 130' ' ' LEU . 53.9 Cg_endo -80.51 32.82 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.285 1.99 . . . . 0.0 111.661 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 246' ' ' TYR . 2.9 mm? -112.56 165.51 12.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.616 -1.302 . . . . 0.0 110.857 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -103.3 177.57 4.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.181 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.58 ' CG ' HD13 ' A' ' 121' ' ' LEU . 15.9 m-85 -154.35 160.61 41.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.913 -1.117 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -158.57 125.81 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.611 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -97.57 174.38 6.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.61 -1.306 . . . . 0.0 110.358 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.521 ' CD1' ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.16 -122.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 1.1 t80 177.04 42.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.3 -1.5 . . . . 0.0 109.921 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 139' ' ' GLU . 10.9 pm0 -169.47 -173.79 1.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.931 -1.106 . . . . 0.0 110.155 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.8 -97.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 137' ' ' GLU . 10.2 pt-20 179.0 105.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -1.094 . . . . 0.0 109.92 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -60.21 -151.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.63 ' O ' ' HA3' ' A' ' 176' ' ' GLY . 53.8 m-20 -93.46 -25.5 17.61 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.549 ' CG1' ' CD1' ' A' ' 207' ' ' LEU . 3.1 mp -132.22 79.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.525 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.5 ttp -66.14 93.77 0.22 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.231 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.9 mm -79.28 110.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.911 -1.118 . . . . 0.0 108.042 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -131.36 156.14 46.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.359 -1.463 . . . . 0.0 111.434 -178.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 19.7 p90 -79.85 138.2 37.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 0.0 109.432 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.639 ' CB ' ' CD2' ' A' ' 179' ' ' HIS . . . -157.85 164.2 37.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.037 . . . . 0.0 110.523 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.518 ' CG2' ' OD1' ' A' ' 181' ' ' ASP . 1.4 p -166.58 -161.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 157' ' ' PHE . 45.6 mtm180 . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 110.169 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.216 -0.607 0 N-CA-C 109.613 -0.956 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.679 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -96.64 -169.1 1.83 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 110.492 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 159' ' ' GLY . 16.9 p30 179.74 62.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.724 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.596 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -5.35 -65.58 0.01 OUTLIER Glycine 0 N--CA 1.51 3.579 0 N-CA-C 112.151 -0.38 . . . . 0.0 112.151 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.536 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.69 61.33 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.685 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -170.07 141.93 6.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 164' ' ' LEU . 18.6 m120 -40.15 -31.32 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.45 -1.029 . . . . 0.0 110.343 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.65 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 t -56.7 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.574 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -79.51 -40.9 28.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.32 -0.862 . . . . 0.0 112.306 -178.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.612 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -179.86 -168.5 0.11 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.198 -1.564 . . . . 0.0 110.859 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.91 -168.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.412 -1.43 . . . . 0.0 110.99 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -159.88 -164.63 1.34 Allowed 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.347 -0.845 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.54 ' CG ' ' CG1' ' A' ' 174' ' ' ILE . 88.6 m-85 -131.9 -163.64 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.058 . . . . 0.0 110.16 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 179.28 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.002 -1.061 . . . . 0.0 110.939 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 169' ' ' ALA . 40.1 Cg_endo -70.22 -64.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.491 1.46 . . . . 0.0 111.817 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 175' ' ' ASN . . . -37.86 144.75 0.17 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 174' ' ' ILE . 39.9 Cg_endo -69.47 144.53 55.9 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.085 1.571 . . . . 0.0 109.368 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 69.55 -63.28 0.63 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' A' ' 176' ' ' GLY . 1.5 tp -68.43 -4.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -63.79 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 129.81 80.62 0.24 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.612 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -157.41 128.91 6.88 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 120.755 -1.438 . . . . 0.0 107.676 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -117.55 156.68 27.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.888 -1.132 . . . . 0.0 109.538 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.639 ' CD2' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -142.15 133.84 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.303 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 199' ' ' ALA . 20.4 m-85 -96.03 134.19 39.35 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.857 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.518 ' OD1' ' CG2' ' A' ' 148' ' ' VAL . 9.5 t0 -53.26 145.9 12.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.892 -1.13 . . . . 0.0 108.85 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 147' ' ' ALA . 10.0 m-20 -114.7 21.54 14.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 0.0 110.255 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.596 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.4 OUTLIER -121.32 8.98 10.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.804 -1.185 . . . . 0.0 110.298 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.537 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 19.0 mt-10 -122.63 -131.68 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.94 -1.1 . . . . 0.0 108.534 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.3 mt-30 -133.36 175.42 9.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.134 -0.979 . . . . 0.0 108.761 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.651 ' CD1' ' CG2' ' A' ' 105' ' ' THR . 78.0 m95 -158.81 119.38 3.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.91 -1.119 . . . . 0.0 108.85 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.466 HG21 ' HA3' ' A' ' 192' ' ' GLY . 71.4 p -144.85 152.28 40.04 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.79 -1.194 . . . . 0.0 110.505 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 3.3 pttt -85.14 -31.75 23.12 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 12.7 t70 -87.16 63.44 7.85 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.573 HG22 ' N ' ' A' ' 226' ' ' LEU . 72.1 p 3.24 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.832 -177.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 37.0 m -125.34 -32.34 2.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.664 . . . . 0.0 109.408 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.466 ' HA3' HG21 ' A' ' 187' ' ' THR . . . -94.94 -82.27 1.58 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.534 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 21.8 m -125.31 -95.81 0.45 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.639 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -160.61 70.82 0.42 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.674 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 2.1 tp -33.5 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.674 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -69.62 -9.93 56.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 111.168 -177.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.639 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 12.0 tp -64.71 -62.01 1.84 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 116.852 -1.939 . . . . 0.0 106.544 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.541 ' CG1' ' HB1' ' A' ' 165' ' ' ALA . 2.7 t -70.48 -12.2 15.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.652 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -73.64 -59.43 2.72 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -63.99 -15.64 59.76 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.491 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 20.2 t60 -67.15 -49.2 65.62 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.806 -1.558 . . . . 0.0 107.676 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 205' ' ' HIS . 2.5 mm-40 -80.24 -47.12 15.1 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.159 -0.963 . . . . 0.0 111.077 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.569 HG23 ' HA ' ' A' ' 121' ' ' LEU . 3.3 mt -60.15 -31.53 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.657 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.94 -34.87 40.98 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.38 -50.31 73.4 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 121.78 -0.835 . . . . 0.0 110.598 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.532 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 1.5 m -84.81 -58.96 2.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.378 -0.826 . . . . 0.0 112.177 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 207' ' ' LEU . 1.2 mt -102.85 32.23 3.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -131.91 -81.53 0.21 Allowed Glycine 0 C--N 1.289 -2.073 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.6 pp -165.03 -164.65 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.127 -1.22 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -98.48 -70.76 0.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.238 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 21.8 m80 -162.85 96.8 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.226 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.762 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.8 m -87.69 -175.71 5.28 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.521 ' CB ' ' CG ' ' A' ' 237' ' ' ASP . . . -65.43 76.86 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.709 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -83.56 8.8 13.04 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.126 -177.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.458 ' C ' ' O ' ' A' ' 214' ' ' ASN . 21.3 p -50.35 -27.72 6.75 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.491 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.2 mp0 -112.51 -37.21 5.01 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.718 ' HB3' ' HB2' ' A' ' 238' ' ' ASP . . . -64.97 -168.48 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.319 1.057 . . . . 0.0 112.526 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.645 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.1 OUTLIER -89.77 -18.06 27.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.694 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.533 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.38 -7.26 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 119.182 -2.199 . . . . 0.0 112.175 -177.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 27.8 t80 -135.5 14.69 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.277 -1.514 . . . . 0.0 113.585 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.6 Cg_endo -79.88 -43.33 0.13 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 N-CA-C 109.279 -1.085 . . . . 0.0 109.279 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 221' ' ' PRO . 2.3 tp -1.08 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-O 121.355 0.597 . . . . 0.0 110.929 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 221' ' ' PRO . 8.2 m-85 -67.6 59.61 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.413 -0.804 . . . . 0.0 109.202 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.5 t-160 -170.43 -140.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.232 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 19.8 m -163.52 112.19 1.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.967 -1.083 . . . . 0.0 110.121 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.573 ' N ' HG22 ' A' ' 190' ' ' THR . 0.4 OUTLIER 179.69 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.577 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 5.2 t -104.75 -48.02 3.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.578 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 0.5 OUTLIER -138.57 -10.39 1.4 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 111.625 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -35.83 -64.68 0.29 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.844 -1.16 . . . . 0.0 110.792 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.84 -31.77 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 109.193 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER -97.58 -20.14 17.88 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 228' ' ' ASP . 50.7 p90 -34.53 130.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.542 0.687 . . . . 0.0 111.145 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.53 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.1 ttt-85 179.74 152.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.66 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 2.1 mp -68.75 169.04 12.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.97 -1.082 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.612 ' HB3' ' CB ' ' A' ' 217' ' ' ALA . 31.0 t -100.48 -171.76 2.08 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.254 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.499 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.5 -12.09 52.64 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.762 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.2 OUTLIER -84.69 -47.5 10.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 4.5 m-20 -67.01 -38.28 85.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 117.091 -1.844 . . . . 0.0 106.526 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -57.23 -34.69 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.468 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 244' ' ' SER . 12.6 t-20 -68.96 -47.22 66.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.279 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.454 ' O ' ' OG ' ' A' ' 244' ' ' SER . . . -64.3 -45.93 92.11 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.682 HG13 ' CG2' ' A' ' 128' ' ' THR . 0.0 OUTLIER -74.39 -50.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.532 -1.569 . . . . 0.0 109.803 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.53 ' N ' HG22 ' A' ' 242' ' ' ILE . 2.4 tt0 -55.27 -24.15 26.72 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 75.8 p -89.74 -13.55 36.55 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -72.26 -53.65 11.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.608 ' CD2' ' OG1' ' A' ' 128' ' ' THR . 7.5 m-30 . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.516 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.535 ' CB ' HD23 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.581 ' CD1' ' HG ' ' A' ' 207' ' ' LEU . 12.7 m95 -77.58 -126.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.858 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 178.84 -51.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.365 -1.459 . . . . 0.0 109.529 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.41 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.814 0.816 . . . . 0.0 110.771 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.53 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 26.2 p -100.06 -4.19 30.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.497 -0.752 . . . . 0.0 109.64 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.566 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 21.1 m-70 -141.93 88.82 2.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.105 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.581 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.9 mm? -76.71 169.54 18.1 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.709 -0.619 . . . . 0.0 109.481 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.566 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.2 OUTLIER -141.77 156.79 45.57 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.11 -0.994 . . . . 0.0 108.963 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.608 ' CG ' ' CD2' ' A' ' 121' ' ' LEU . 16.7 p90 -137.55 161.74 35.62 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.588 -1.32 . . . . 0.0 109.256 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.63 ' NH2' ' CZ ' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -125.13 138.6 54.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.6 mp -93.01 67.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.661 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.6 ' N ' ' O ' ' A' ' 144' ' ' ILE . 20.0 t -78.77 6.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 0.0 110.069 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.543 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -105.98 159.37 16.1 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.899 -1.126 . . . . 0.0 108.578 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.563 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 2.8 p90 177.94 47.01 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.748 -0.595 . . . . 0.0 110.246 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.462 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 22.6 p -44.11 156.8 0.31 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.163 -0.961 . . . . 0.0 108.802 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.04 -18.21 51.52 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.701 1.369 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.488 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 0.5 OUTLIER -70.93 -6.06 35.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.337 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.608 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 95.9 mt -151.67 127.16 4.88 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.401 -0.812 . . . . 0.0 110.432 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 38.2 Cg_endo -68.09 174.8 7.41 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.992 1.522 . . . . 0.0 109.288 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -40.88 -66.36 0.34 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.774 0.797 . . . . 0.0 110.206 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.5 OUTLIER -54.35 -33.8 59.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.608 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -70.46 -60.65 2.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.355 -1.465 . . . . 0.0 109.834 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 114' ' ' ASP . 5.6 p -55.18 -44.51 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.57 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 1.0 OUTLIER -61.8 -27.54 68.83 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 116' ' ' ALA . 1.4 p -58.89 -64.54 0.9 Allowed 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.583 ' HB1' ' CD1' ' A' ' 195' ' ' LEU . . . -50.1 -32.01 14.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.293 -0.879 . . . . 0.0 110.254 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.534 ' HA ' HD13 ' A' ' 203' ' ' ILE . 36.8 t -74.34 -23.34 18.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -93.08 -31.06 14.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.656 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -84.47 -35.11 23.21 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.672 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -69.26 -62.26 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.591 1.186 . . . . 0.0 107.928 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' CD2' ' CG ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -52.67 -55.1 24.98 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.699 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.522 ' O ' ' CG ' ' A' ' 126' ' ' GLU . 2.7 tptm -60.55 -35.42 75.97 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.835 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.604 ' CG1' HD11 ' A' ' 234' ' ' LEU . 0.9 OUTLIER -55.27 -40.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -179.575 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.65 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 42.7 m95 -91.05 -23.87 20.22 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.669 -1.212 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -70.37 -29.6 66.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.799 -1.188 . . . . 0.0 107.808 179.325 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -88.55 -40.34 13.47 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.201 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.633 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 18.7 m -61.63 -25.46 36.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.102 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -112.52 164.14 16.07 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.241 -1.384 . . . . 0.0 108.995 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -79.11 -6.17 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.687 1.591 . . . . 0.0 110.557 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.569 ' HG ' ' CD1' ' A' ' 246' ' ' TYR . 2.1 mm? -74.4 165.1 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 110.289 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.552 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -108.97 169.04 8.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 97' ' ' LEU . 50.9 m-85 -148.65 154.93 40.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 110.199 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -143.76 -179.52 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -156.7 161.37 39.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.82 -98.12 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.405 -0.809 . . . . 0.0 109.956 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CZ ' ' NH2' ' A' ' 100' ' ' ARG . 2.8 t80 177.68 32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.986 -1.071 . . . . 0.0 109.041 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.458 ' OE2' ' CD1' ' A' ' 135' ' ' LEU . 0.7 OUTLIER -72.21 174.51 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.967 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -43.62 -40.46 5.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 140' ' ' ALA . 4.1 pt-20 -174.21 105.3 0.11 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -1.062 . . . . 0.0 109.998 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -59.4 -148.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.018 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.576 ' HA ' ' CZ2' ' A' ' 92' ' ' TRP . 66.8 m-20 -88.02 -27.17 22.21 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.575 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.55 ' CD1' HD21 ' A' ' 207' ' ' LEU . 3.6 mt -130.73 77.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.512 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 23.4 ttp -65.29 98.19 0.31 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.645 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.6 mm -81.97 107.35 13.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -128.5 156.59 43.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.468 -1.395 . . . . 0.0 111.79 -178.512 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 34.7 p90 -79.17 137.39 37.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.623 ' CB ' ' CD2' ' A' ' 179' ' ' HIS . . . -158.37 165.57 34.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 0.0 109.731 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.519 ' CG1' ' N ' ' A' ' 149' ' ' ARG . 1.1 p -164.15 -155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.472 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.53 ' CD ' ' HB3' ' A' ' 158' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.68 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 C--O 1.215 -0.644 0 N-CA-C 109.761 -0.899 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.688 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -102.77 -166.79 1.31 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 110.517 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 160' ' ' PRO . 19.8 p30 179.29 58.57 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.72 -0.612 . . . . 0.0 109.837 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.607 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.19 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.508 3.444 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.593 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.4 Cg_endo -64.17 62.41 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 109.935 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -164.56 141.99 7.46 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' LEU . 70.5 m-80 -41.41 -32.77 0.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -1.087 . . . . 0.0 109.971 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.573 ' HB ' ' CE1' ' A' ' 157' ' ' PHE . 6.4 m -55.1 86.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 109.9 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.523 ' CD2' ' CG2' ' A' ' 193' ' ' THR . 0.8 OUTLIER -75.63 -38.33 59.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.337 -0.852 . . . . 0.0 111.618 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.594 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . 179.21 -169.64 0.11 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.585 -1.322 . . . . 0.0 110.406 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.688 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p-80 178.12 -170.37 0.1 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.017 -1.677 . . . . 0.0 111.426 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.56 -174.99 5.16 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.56 -0.713 . . . . 0.0 110.052 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.636 ' CD1' ' CD1' ' A' ' 174' ' ' ILE . 62.8 m-85 -121.06 -175.37 3.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.054 -1.029 . . . . 0.0 110.652 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.582 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . . . -152.02 -66.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.68 -0.638 . . . . 0.0 109.324 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 44.1 Cg_endo -74.19 177.25 8.5 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.609 1.321 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.519 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 95.62 168.1 35.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.0 Cg_endo -75.63 -87.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -74.58 -35.33 51.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.636 ' CD1' ' CD1' ' A' ' 168' ' ' TYR . 3.1 tt -66.71 -2.96 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 108.892 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.553 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 1.9 t30 -66.18 63.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.33 -0.856 . . . . 0.0 108.997 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 121.4 87.05 0.91 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.3 m-20 -155.08 124.47 6.37 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.826 -1.397 . . . . 0.0 107.998 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -110.13 152.45 26.0 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 109.329 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.623 ' CD2' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -139.48 131.24 27.46 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.901 -1.119 . . . . 0.0 109.336 179.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.548 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 52.9 m-85 -91.62 129.72 37.55 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.634 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 164' ' ' LEU . 15.6 t0 -47.15 145.55 2.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.966 -1.084 . . . . 0.0 108.371 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -114.74 20.96 14.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.607 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 6.5 m-20 -131.61 24.88 4.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.549 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 16.8 mt-10 -130.18 -93.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 109.108 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.0 mt-30 179.56 172.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . 0.594 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 94.9 m95 -158.95 125.42 4.6 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.533 ' CG2' ' HA3' ' A' ' 192' ' ' GLY . 81.2 p -144.77 150.71 37.67 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.829 -1.169 . . . . 0.0 109.944 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 6.0 ptpt -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.651 ' O ' ' N ' ' A' ' 191' ' ' THR . 24.4 t70 -89.4 64.93 6.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.607 ' O ' ' CG2' ' A' ' 190' ' ' THR . 3.3 t 3.69 59.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.101 0.953 . . . . 0.0 112.019 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.0 m -126.28 -30.56 2.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.866 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.533 ' HA3' ' CG2' ' A' ' 187' ' ' THR . . . -93.27 -81.92 1.51 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.523 ' CG2' ' CD2' ' A' ' 164' ' ' LEU . 19.8 m -123.63 -80.67 0.63 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.783 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 0.6 OUTLIER 179.33 68.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.595 ' CD1' ' CD1' ' A' ' 108' ' ' LEU . 12.7 tp -37.98 -101.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.725 -0.609 . . . . 0.0 111.55 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.658 ' HA ' ' CB ' ' A' ' 199' ' ' ALA . 0.8 OUTLIER -57.05 -9.56 0.9 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.879 -1.138 . . . . 0.0 111.233 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.783 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 5.6 tp -68.29 -66.98 0.5 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 116.778 -1.969 . . . . 0.0 106.703 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 165' ' ' ALA . 14.6 t -68.41 -6.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.672 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -77.04 -58.04 3.5 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.593 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -67.19 -15.93 64.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 219' ' ' MET . 11.2 t60 -69.65 -40.4 76.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.9 -1.52 . . . . 0.0 107.78 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . 0.548 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 12.6 mt-10 -85.61 -48.41 8.92 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.297 -0.877 . . . . 0.0 110.917 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.563 HD11 ' N ' ' A' ' 121' ' ' LEU . 4.0 mt -61.89 -30.06 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.65 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.69 -33.24 43.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 177.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.64 -49.69 75.61 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.675 -0.897 . . . . 0.0 110.065 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.514 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 40.4 p -81.22 -60.46 2.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.443 -0.786 . . . . 0.0 111.874 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.581 ' HG ' ' CD1' ' A' ' 92' ' ' TRP . 7.3 mp -104.2 36.74 2.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.252 -0.905 . . . . 0.0 110.872 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -136.26 -73.16 0.07 OUTLIER Glycine 0 C--N 1.292 -1.878 0 C-N-CA 119.435 -1.364 . . . . 0.0 109.929 -178.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.609 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.5 pp -179.87 -162.53 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.642 -1.505 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.609 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 0.2 OUTLIER -94.71 -83.86 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 0.0 109.397 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 2.0 m-70 -151.9 99.97 2.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.617 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -86.44 177.02 7.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 237' ' ' ASP . . . -58.23 89.52 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.792 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -90.02 11.85 19.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.981 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 214' ' ' ASN . 12.9 p -50.04 -29.04 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.485 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.7 mm-40 -118.07 -34.6 4.08 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.501 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.792 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -59.44 -169.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.223 1.011 . . . . 0.0 112.068 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.644 ' CD2' ' CZ ' ' A' ' 196' ' ' PHE . 1.4 tp -110.41 -3.89 15.87 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.152 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.577 ' HE3' ' CZ2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -83.02 -11.36 58.16 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.146 -1.596 . . . . 0.0 111.064 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.655 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 24.5 t80 -140.6 17.35 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 117.994 -1.483 . . . . 0.0 113.467 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 53.0 Cg_endo -73.43 -35.49 4.82 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.946 -1.598 . . . . 0.0 107.946 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.601 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.5 OUTLIER -4.09 -69.82 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.831 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . 0.564 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 24.0 t80 -69.35 58.84 0.12 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.989 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -168.69 -140.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 0.0 109.329 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' SER . . . . . 0.523 ' HB3' ' CG2' ' A' ' 190' ' ' THR . 15.2 m -153.41 108.83 3.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.943 -1.098 . . . . 0.0 110.328 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.53 ' HG ' ' CD1' ' A' ' 197' ' ' LEU . 0.2 OUTLIER 179.76 51.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -0.836 . . . . 0.0 109.335 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 196' ' ' PHE . 14.7 t -103.26 -9.75 19.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 0.0 109.237 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.597 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 0.3 OUTLIER 178.14 -23.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 178.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.562 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -27.97 -61.41 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.421 0.629 . . . . 0.0 111.008 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.97 -34.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.6 OUTLIER -87.31 -16.39 35.25 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.597 ' HB3' ' N ' ' A' ' 228' ' ' ASP . 36.7 p90 -33.17 112.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.535 0.683 . . . . 0.0 111.334 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 178.12 177.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 0.0 109.49 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.649 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 4.6 mp -93.85 170.12 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.46 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.625 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 7.0 t -101.24 -171.75 2.05 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.724 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . 0.572 ' N ' ' OG ' ' A' ' 235' ' ' SER . 25.6 tp60 -82.83 -14.65 53.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.369 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.617 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.7 m-20 -83.54 -47.16 11.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.719 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.5 OUTLIER -64.34 -39.21 93.44 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.005 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.9 OUTLIER -58.09 -34.73 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 244' ' ' SER . 59.6 t30 -68.65 -45.34 72.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.464 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -60.49 -56.56 23.74 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 208' ' ' GLY . 1.4 tp -64.1 -43.94 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.269 . . . . 0.0 109.605 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 239' ' ' ILE . 6.8 tt0 -55.97 -26.5 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 1.4 p -80.61 -20.66 42.74 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.535 HD23 ' CB ' ' A' ' 91' ' ' LYS . 2.4 mt -69.98 -69.49 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.569 ' CD1' ' HG ' ' A' ' 130' ' ' LEU . 38.6 m-85 . . . . . 0 C--N 1.298 -1.661 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 83' ' ' PHE . 5.5 p90 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.57 -162.18 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.463 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 5.1 m -50.33 160.09 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.537 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -95.13 105.84 22.02 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 85' ' ' THR . 41.6 Cg_endo -72.12 89.6 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.052 1.554 . . . . 0.0 110.07 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.45 ' O ' ' CD1' ' A' ' 89' ' ' ILE . . . 129.17 1.43 5.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.45 ' CD1' ' O ' ' A' ' 88' ' ' GLY . 7.9 mm -141.85 88.61 9.36 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.207 -1.172 . . . . 0.0 109.579 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.24 133.24 20.75 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.043 1.549 . . . . 0.0 109.974 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.519 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.1 OUTLIER -59.22 -75.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.897 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.627 ' CZ3' ' ND2' ' A' ' 175' ' ' ASN . 9.7 m95 -99.73 143.16 30.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 110.207 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 1.6 ptp180 -109.3 -40.86 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.388 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.553 ' HG3' ' CD2' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.58 170.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.331 -0.855 . . . . 0.0 110.019 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.495 ' C ' ' CD1' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -110.14 1.19 18.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.502 -0.749 . . . . 0.0 109.585 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 66.8 m80 -137.96 95.99 3.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.368 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.613 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.1 mm? -92.37 170.82 9.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.51 -0.744 . . . . 0.0 109.512 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -147.24 157.17 43.5 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.692 ' CE1' ' CD2' ' A' ' 121' ' ' LEU . 4.4 p90 -137.11 166.31 24.02 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.505 -1.372 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.56 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -125.19 124.36 41.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.628 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -83.12 83.54 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.883 -1.135 . . . . 0.0 110.106 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.604 ' N ' ' O ' ' A' ' 144' ' ' ILE . 46.7 t -98.72 7.25 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.254 -0.903 . . . . 0.0 110.001 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.565 ' ND2' ' N ' ' A' ' 145' ' ' SER . 34.0 m-80 -97.01 160.91 14.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.841 -1.162 . . . . 0.0 109.461 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.6 ' CG ' ' N ' ' A' ' 105' ' ' THR . 2.8 t80 178.09 167.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.62 ' CG2' ' CE3' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -176.53 159.54 1.66 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.487 ' HD2' ' OG1' ' A' ' 105' ' ' THR . 37.7 Cg_endo -66.12 -25.94 50.48 Favored 'Trans proline' 0 C--N 1.298 -2.089 0 N-CA-C 107.791 -1.657 . . . . 0.0 107.791 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -74.17 -10.98 60.15 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.637 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 79.6 mt -153.23 111.18 2.63 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.598 -0.689 . . . . 0.0 110.224 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.81 178.37 2.34 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.8 1.421 . . . . 0.0 109.341 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.93 -65.35 0.37 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.809 0.814 . . . . 0.0 110.296 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -58.67 -26.79 64.18 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.637 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -74.42 -60.45 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.31 -1.494 . . . . 0.0 109.605 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.531 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 11.3 p -58.16 -42.42 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.516 ' N ' HG12 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -60.04 -29.79 68.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -57.68 -64.1 1.02 Allowed 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.611 ' HB1' ' CD1' ' A' ' 195' ' ' LEU . . . -49.19 -33.0 11.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 110.158 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.573 HG13 ' CE2' ' A' ' 99' ' ' TYR . 5.7 t -73.0 -24.33 20.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.7 tt0 -90.64 -34.07 15.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.342 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.664 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -79.12 -39.44 33.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -64.84 -62.23 1.69 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.692 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 14.5 tp -48.99 -47.94 43.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.489 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -70.34 -34.25 72.43 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.791 -178.049 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.617 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 2.8 t -53.71 -44.81 59.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.66 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 30.9 m95 -92.11 -21.33 20.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.716 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.528 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 33.6 tt0 -72.14 -27.55 62.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.8 pt-20 -88.88 -44.49 10.43 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.435 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.608 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 14.2 m -56.77 -26.89 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.248 -1.381 . . . . 0.0 108.324 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.572 HG21 HG22 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -118.35 166.33 14.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 108.092 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.572 ' HG2' ' CD1' ' A' ' 246' ' ' TYR . 48.1 Cg_endo -82.5 -10.94 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.528 1.485 . . . . 0.0 109.824 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.641 ' CD2' ' CZ ' ' A' ' 132' ' ' PHE . 41.9 tp -52.38 158.87 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.727 . . . . 0.0 110.893 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.5 p -108.37 170.39 8.05 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' A' ' 130' ' ' LEU . 71.2 m-85 -151.41 146.36 25.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.938 -1.101 . . . . 0.0 110.929 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.599 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 4.0 t -125.66 -174.24 3.03 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.628 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -148.13 164.58 33.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.612 -1.305 . . . . 0.0 111.017 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.535 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -164.81 -163.73 0.74 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 29.7 t80 -160.95 28.31 0.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 5.0 pm0 -144.87 178.57 7.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.678 -0.639 . . . . 0.0 109.324 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.26 -97.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' GLU . 7.7 pt-20 178.83 121.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -1.109 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -77.58 -151.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.6 ' O ' ' O ' ' A' ' 176' ' ' GLY . 16.7 t70 -89.75 -36.74 14.99 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.533 ' CD1' HD21 ' A' ' 207' ' ' LEU . 4.1 mp -123.23 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.543 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 8.8 ttm -65.13 98.24 0.3 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.044 . . . . 0.0 109.059 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 102' ' ' VAL . 6.2 mm -82.73 111.52 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.72 153.64 51.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 0.0 111.856 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.516 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 19.8 p90 -90.47 141.42 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.769 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.628 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -168.82 179.96 3.97 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.003 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.533 ' HA ' ' CB ' ' A' ' 157' ' ' PHE . 1.4 p -151.19 -164.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.453 ' HG2' HG12 ' A' ' 148' ' ' VAL . 1.1 ptt85 -55.97 83.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.785 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER 179.85 32.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.565 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.472 ' CE1' ' HD1' ' A' ' 157' ' ' PHE . 58.4 m80 -73.25 -40.76 64.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.91 -67.0 0.32 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -159.84 24.96 0.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -1.138 . . . . 0.0 109.427 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.574 ' O ' ' C ' ' A' ' 155' ' ' TYR . 55.8 m-85 -153.5 -167.26 2.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.579 ' CE1' ' OH ' ' A' ' 168' ' ' TYR . 1.0 OUTLIER 1.54 69.6 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.461 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' A' ' 154' ' ' PHE . 44.8 Cg_endo -80.24 125.17 5.68 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.011 1.532 . . . . 0.0 109.805 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.776 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m-85 -78.33 -169.42 1.64 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.067 -1.021 . . . . 0.0 109.557 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.524 ' OD2' ' CG2' ' A' ' 163' ' ' VAL . 11.0 p30 178.64 58.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.559 -0.713 . . . . 0.0 110.097 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.615 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -20.36 -58.96 0.01 OUTLIER Glycine 0 N--CA 1.511 3.679 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 41.3 Cg_endo -71.17 56.17 1.98 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.589 1.31 . . . . 0.0 109.135 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.84 156.81 27.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 164' ' ' LEU . 84.7 m-20 -51.9 -33.68 38.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.364 -1.08 . . . . 0.0 110.588 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.524 ' CG2' ' OD2' ' A' ' 158' ' ' ASP . 2.9 t -55.54 84.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.105 -0.997 . . . . 0.0 110.111 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.576 ' CD2' ' CG2' ' A' ' 193' ' ' THR . 0.3 OUTLIER -74.35 -46.38 41.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.507 -0.746 . . . . 0.0 111.765 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.709 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -168.67 179.84 4.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.35 -1.469 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.776 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.4 p-80 178.94 167.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.154 -1.591 . . . . 0.0 111.252 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.78 -169.07 2.13 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.556 -0.715 . . . . 0.0 110.093 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.597 ' CD2' ' HB ' ' A' ' 174' ' ' ILE . 55.2 m-85 -110.3 -166.51 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.632 -1.292 . . . . 0.0 110.515 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.608 ' CB ' ' HD2' ' A' ' 170' ' ' PRO . . . -120.92 -170.25 0.18 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.411 -0.805 . . . . 0.0 109.086 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.608 ' HD2' ' CB ' ' A' ' 169' ' ' ALA . 41.6 Cg_endo -74.8 112.94 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.418 1.22 . . . . 0.0 110.505 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . -157.65 -140.63 2.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.6 -93.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.054 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -92.34 -26.99 16.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.597 ' HB ' ' CD2' ' A' ' 168' ' ' TYR . 0.2 OUTLIER -74.04 9.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.515 -0.991 . . . . 0.0 108.816 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.627 ' ND2' ' CZ3' ' A' ' 92' ' ' TRP . 6.2 t30 -63.18 62.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 104.43 103.4 2.83 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.622 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.5 m-20 -163.27 118.33 1.69 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.601 -1.529 . . . . 0.0 107.377 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.543 ' HB1' ' CD1' ' A' ' 144' ' ' ILE . . . -110.46 166.46 10.97 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.78 -1.2 . . . . 0.0 108.801 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.742 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -158.63 134.61 9.03 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.281 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.578 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 22.4 m-85 -94.19 137.31 33.52 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.625 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.607 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 7.6 t0 -50.87 151.36 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.779 -1.201 . . . . 0.0 108.628 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.19 20.45 8.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.5 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.615 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.5 OUTLIER -107.98 -16.7 14.23 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 1.2 pt-20 -112.54 -98.52 0.42 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.848 -1.158 . . . . 0.0 108.281 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.567 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 1.0 OUTLIER 178.53 165.28 0.81 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.014 -1.054 . . . . 0.0 109.045 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.62 ' CE3' ' CG2' ' A' ' 105' ' ' THR . 0.0 OUTLIER -137.51 130.91 31.04 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.179 -0.951 . . . . 0.0 109.229 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.517 HG22 ' N ' ' A' ' 192' ' ' GLY . 47.3 p -131.64 149.51 52.47 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.608 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 41.3 pttt -74.42 -37.77 63.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.528 ' O ' ' CG2' ' A' ' 227' ' ' THR . 3.3 t70 -83.28 -149.14 0.09 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.56 ' N ' HD13 ' A' ' 229' ' ' LEU . 27.0 m -111.45 46.46 1.1 Allowed 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.542 -1.263 . . . . 0.0 107.849 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.448 ' HB ' HG22 ' A' ' 187' ' ' THR . 91.2 m -98.45 -32.32 11.55 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 111.411 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.517 ' N ' HG22 ' A' ' 187' ' ' THR . . . -118.58 -85.57 1.02 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.755 -1.688 . . . . 0.0 109.489 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.576 ' CG2' ' CD2' ' A' ' 164' ' ' LEU . 23.7 m -122.67 -98.16 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.603 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 3.7 m120 -160.45 68.14 0.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.611 ' CD1' ' HB1' ' A' ' 116' ' ' ALA . 15.4 tp -29.73 -97.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.669 ' CD1' ' O ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -56.77 -19.97 19.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.973 -1.079 . . . . 0.0 111.106 -178.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.603 ' CB ' ' HB3' ' A' ' 194' ' ' ASN . 12.9 tp -60.15 -62.29 1.97 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.146 -1.821 . . . . 0.0 107.517 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 165' ' ' ALA . 1.7 t -71.32 -8.12 10.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.666 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -77.09 -58.09 3.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -65.56 -14.68 61.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.598 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 15.2 t60 -68.32 -48.93 63.57 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 117.878 -1.529 . . . . 0.0 107.913 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.578 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 1.3 mt-10 -80.39 -45.87 16.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 111.092 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.574 ' CD1' ' HB2' ' A' ' 120' ' ' ALA . 3.2 mt -62.14 -30.99 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.66 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.88 -31.55 55.52 Favored Glycine 0 C--N 1.291 -1.933 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.5 -49.62 76.0 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 121.965 -0.726 . . . . 0.0 110.952 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.519 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 42.5 m -86.25 -53.05 5.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 112.206 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.563 ' HA ' ' CD1' ' A' ' 92' ' ' TRP . 3.1 pp -104.54 24.7 11.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.123 . . . . 0.0 110.605 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -127.02 -79.57 0.3 Allowed Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.123 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.02 -162.25 0.36 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.961 -1.317 . . . . 0.0 110.233 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 1.7 t80 -99.61 -72.64 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.78 . . . . 0.0 109.538 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.588 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 68.3 m80 -161.13 101.79 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 4.0 m -93.33 -178.12 4.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.371 -0.83 . . . . 0.0 109.247 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' A' ' 237' ' ' ASP . . . -61.9 86.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.709 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -89.66 10.18 24.2 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.576 -178.027 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.4 -28.1 4.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 175.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.509 ' C ' ' HB2' ' A' ' 235' ' ' SER . 5.4 mt-10 -116.25 -36.05 4.16 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.709 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -63.72 -170.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.383 1.087 . . . . 0.0 112.813 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.629 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.0 OUTLIER -90.44 -16.12 29.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.146 -177.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.588 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -78.38 -7.39 57.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 119.119 -2.238 . . . . 0.0 112.105 -177.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.9 t80 -137.29 15.65 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.526 -1.358 . . . . 0.0 113.604 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.43 -37.0 0.79 Allowed 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 108.473 -1.395 . . . . 0.0 108.473 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.581 ' HB2' ' CE2' ' A' ' 3' ' ' MSB . 0.2 OUTLIER -21.47 -59.21 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.202 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 224' ' ' HIS . 38.5 t80 -68.0 56.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.3 t-80 179.16 -124.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.449 ' HB3' ' OG1' ' A' ' 190' ' ' THR . 18.4 m -161.0 121.63 2.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.787 -1.196 . . . . 0.0 109.426 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER 179.38 43.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 110.102 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 189' ' ' ASP . 0.0 OUTLIER -99.93 -10.45 21.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.815 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 24.3 t70 179.62 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 109.923 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.56 HD13 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -25.74 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.809 -0.557 . . . . 0.0 111.399 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.34 -6.09 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.731 -1.23 . . . . 0.0 110.261 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.55 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -117.67 -38.18 3.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.001 -1.062 . . . . 0.0 109.069 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.6 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 13.3 p90 1.04 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.829 0.824 . . . . 0.0 112.947 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 178.34 174.62 0.59 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.359 -0.838 . . . . 0.0 109.657 178.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.646 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 3.9 mp -91.18 168.99 11.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 0.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.627 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 30.2 t -101.87 -169.88 1.74 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.188 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.51 ' N ' ' OG ' ' A' ' 235' ' ' SER . 12.5 tm0? -85.25 -12.65 51.98 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.911 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.2 OUTLIER -84.69 -47.79 10.11 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.701 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.0 OUTLIER -66.71 -36.96 83.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.626 177.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -58.0 -35.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.91 -50.79 54.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.47 ' HA3' HD23 ' A' ' 209' ' ' LEU . . . -55.94 -55.07 30.99 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.589 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.6 tp -63.44 -43.37 98.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.83 -1.394 . . . . 0.0 109.589 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 6.2 mt-30 -54.13 -31.35 52.03 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 241' ' ' GLY . 4.0 p -75.5 -22.35 57.25 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -66.84 -64.57 0.83 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.591 ' CD2' ' HB2' ' A' ' 130' ' ' LEU . 5.7 t80 -100.32 -115.69 0.17 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.983 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 129' ' ' PRO . . . 121.09 177.1 15.55 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 120.247 -1.533 . . . . 0.0 109.902 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.2 146.14 45.33 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.946 1.498 . . . . 0.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.66 142.75 36.53 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.132 1.596 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.47 -59.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.013 1.533 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 252' ' ' SER . 0.4 OUTLIER -161.66 -64.98 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 251' ' ' ASP . 41.6 t -44.68 105.28 0.44 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.51 -24.25 19.18 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.953 1.501 . . . . 0.0 110.112 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -145.52 171.1 15.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.538 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.51 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.587 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.583 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.598 ' CE1' ' ND1' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.255 0.55 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -78.53 -148.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.477 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 84' ' ' ARG . 10.2 t -50.0 179.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -73.53 112.59 16.72 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.1 Cg_endo -72.67 141.88 35.01 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.877 1.462 . . . . 0.0 110.141 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.07 -53.43 2.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -151.94 144.85 17.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.243 -1.151 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.21 -167.99 0.35 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.006 1.53 . . . . 0.0 109.894 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.491 ' HB3' ' HG ' ' A' ' 245' ' ' LEU . 0.0 OUTLIER -89.45 -93.41 0.11 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.125 -0.985 . . . . 0.0 109.644 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.618 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 69.6 m95 -73.87 155.6 38.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.742 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.1 -34.55 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.542 ' HG3' ' CD2' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -55.17 -165.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.264 -0.897 . . . . 0.0 109.548 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.545 ' HA ' ' CG ' ' A' ' 130' ' ' LEU . 66.2 p -124.33 4.24 8.44 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.607 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.571 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 59.4 m80 -148.15 97.08 2.73 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.451 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.4 mm? -97.5 175.02 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -142.64 155.7 44.97 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.232 -0.918 . . . . 0.0 108.569 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.644 ' CD1' ' CE2' ' A' ' 132' ' ' PHE . 24.6 p90 -133.49 171.07 14.58 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.794 -1.192 . . . . 0.0 109.233 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' CZ ' HG21 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -131.35 145.87 52.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 109.412 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.597 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.6 mp -100.22 61.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.965 -1.084 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 144' ' ' ILE . 18.1 t -73.86 2.44 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 0.0 110.021 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.533 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 0.5 OUTLIER -101.45 164.37 11.8 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.804 -1.185 . . . . 0.0 109.025 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.558 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 1.2 p90 177.94 46.37 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.637 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 24.8 p -40.15 149.88 0.28 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.595 -0.69 . . . . 0.0 109.36 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 -25.77 42.67 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.946 1.498 . . . . 0.0 109.044 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.6 OUTLIER -65.76 -12.16 51.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.599 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 32.3 mt -138.53 124.02 12.28 Favored Pre-proline 0 N--CA 1.484 1.251 0 O-C-N 121.543 -0.723 . . . . 0.0 109.827 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.3 Cg_endo -65.6 167.35 17.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 123.773 1.407 . . . . 0.0 108.867 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -37.8 -65.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.747 0.784 . . . . 0.0 110.263 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -28.57 49.73 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.75 -0.594 . . . . 0.0 111.725 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.599 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -73.19 -61.15 1.92 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.487 -1.383 . . . . 0.0 109.448 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.558 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 5.6 p -51.19 -39.4 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.512 ' N ' HG11 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -66.33 -26.22 67.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 112' ' ' ALA . 13.9 p -67.35 -37.37 83.14 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.609 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -75.18 -34.81 61.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.331 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.595 HG13 ' CE2' ' A' ' 99' ' ' TYR . 3.5 t -74.94 -23.72 17.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.549 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 1.8 tt0 -85.82 -36.33 20.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.693 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -79.41 -38.84 33.87 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -63.49 -61.65 2.19 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.642 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.0 OUTLIER -51.56 -40.91 60.63 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.128 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.519 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -76.72 -33.64 58.17 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.738 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 196' ' ' PHE . 2.1 t -56.19 -40.8 67.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.647 ' CH2' ' CD2' ' A' ' 234' ' ' LEU . 44.4 m95 -91.43 -24.8 19.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.316 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 9.6 tm-20 -69.55 -27.45 65.16 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.757 -1.214 . . . . 0.0 107.996 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.2 pt-20 -89.9 -42.89 10.95 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.674 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.618 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 15.3 m -59.8 -24.11 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 118.259 -1.376 . . . . 0.0 109.159 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.93 162.94 20.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.012 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -84.46 1.54 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.249 1.966 . . . . 0.0 110.116 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 246' ' ' TYR . 0.2 OUTLIER -80.92 -176.16 5.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.026 -1.046 . . . . 0.0 110.603 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.3 p -121.71 165.55 15.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.778 . . . . 0.0 109.947 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.644 ' CE2' ' CD1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -140.93 158.22 44.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.426 -0.796 . . . . 0.0 109.698 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.58 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.5 m -146.59 179.6 7.44 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.594 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -148.12 -179.76 7.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.805 -1.184 . . . . 0.0 110.246 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -163.61 -130.63 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 27.2 t80 178.24 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.833 -1.167 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -162.61 -171.81 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 37.66 -99.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 178.46 107.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -1.135 . . . . 0.0 110.296 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.533 ' CB ' HD23 ' A' ' 135' ' ' LEU . . . -59.91 -150.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.572 ' O ' ' HA3' ' A' ' 176' ' ' GLY . 80.0 m-20 -88.06 -34.43 17.96 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 142' ' ' ILE . 2.8 mp -124.23 77.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.529 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 2.8 ptm -67.54 102.87 1.22 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.596 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.1 mm -81.98 117.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -133.19 156.58 47.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.429 -1.42 . . . . 0.0 112.119 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 39.6 p90 -79.94 133.61 36.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.474 -0.767 . . . . 0.0 109.14 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.571 ' HB2' ' CE1' ' A' ' 179' ' ' HIS . . . -155.92 -178.08 7.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 150' ' ' GLU . 1.0 OUTLIER 179.78 -155.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.44 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.534 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 2.8 mtm-85 -52.2 84.45 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.462 -0.774 . . . . 0.0 109.641 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 148' ' ' VAL . 2.6 tm-20 179.68 30.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 79.9 m80 -92.91 -142.4 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.893 . . . . 0.0 108.897 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -103.03 -54.72 0.84 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.71 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.826 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -94.28 6.81 47.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 110.005 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -149.43 42.44 0.25 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.046 . . . . 0.0 110.156 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 41.9 Cg_endo -72.39 121.47 7.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.526 1.277 . . . . 0.0 109.208 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.733 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -98.24 -170.43 1.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.912 -1.118 . . . . 0.0 111.257 -178.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 15.5 p30 178.5 62.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 183' ' ' ASP . . . -18.86 -59.0 0.01 OUTLIER Glycine 0 N--CA 1.501 2.982 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 183' ' ' ASP . 37.9 Cg_endo -65.87 60.19 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.297 1.156 . . . . 0.0 109.743 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -177.42 164.07 33.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' LEU . 0.6 OUTLIER -45.56 -59.95 2.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.312 -1.111 . . . . 0.0 110.123 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.653 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 61.0 t -33.85 90.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.354 0.597 . . . . 0.0 110.88 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.545 ' N ' ' OB2' ' A' ' 3' ' ' MSB . 1.1 mp -80.08 -75.48 0.26 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.238 -0.914 . . . . 0.0 112.186 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.597 ' CB ' ' CG1' ' A' ' 198' ' ' VAL . . . -145.64 -168.25 2.92 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.196 -1.565 . . . . 0.0 111.38 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.733 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER 179.67 -179.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.957 -1.714 . . . . 0.0 111.133 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -154.75 177.61 11.06 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.536 -0.728 . . . . 0.0 110.23 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.622 ' CD1' ' CD1' ' A' ' 174' ' ' ILE . 76.7 m-85 -114.39 -167.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.16 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.536 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -171.21 -60.51 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.495 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 44.6 Cg_endo -77.29 147.97 26.46 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.796 1.419 . . . . 0.0 109.875 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 118.83 -178.75 16.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 175' ' ' ASN . 44.1 Cg_endo -75.97 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.063 1.559 . . . . 0.0 110.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.16 -33.25 21.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.622 ' CD1' ' CD1' ' A' ' 168' ' ' TYR . 1.9 tt -62.16 -7.75 2.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.352 -1.087 . . . . 0.0 108.8 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 169' ' ' ALA . 50.7 p-10 -67.29 65.92 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.127 -0.983 . . . . 0.0 109.405 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 128.74 78.7 0.23 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.1 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -152.16 115.15 4.65 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.217 -1.166 . . . . 0.0 107.975 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -106.31 164.83 11.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.262 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.69 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -155.96 133.77 11.16 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.571 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.573 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 12.2 m-85 -96.55 135.94 37.75 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.539 ' CG ' ' CD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -58.02 115.81 3.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.788 -1.195 . . . . 0.0 107.985 177.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.48 ' OD1' ' HB ' ' A' ' 148' ' ' VAL . 11.9 p-10 -83.91 13.51 4.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.719 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.531 ' HB3' ' CD ' ' A' ' 160' ' ' PRO . 2.0 t70 -121.05 14.09 11.4 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.076 -1.015 . . . . 0.0 110.725 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.519 ' OE2' ' CD1' ' A' ' 164' ' ' LEU . 15.7 tt0 -117.66 -132.1 0.32 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.814 -1.179 . . . . 0.0 108.944 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.612 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.9 mt-30 -122.1 166.57 14.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 109.111 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.637 ' CD1' ' CG2' ' A' ' 105' ' ' THR . 94.5 m95 -159.42 107.44 1.78 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 195' ' ' LEU . 19.6 p -135.35 153.52 51.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.849 -1.157 . . . . 0.0 109.533 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.535 ' HA ' ' CD2' ' A' ' 195' ' ' LEU . 1.6 pttt -76.79 -28.97 55.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 228' ' ' ASP . 0.3 OUTLIER -99.85 -151.18 0.39 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.568 ' N ' ' CD1' ' A' ' 229' ' ' LEU . 10.2 t -105.71 45.4 0.97 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.453 ' HB ' HG23 ' A' ' 187' ' ' THR . 87.6 m -99.77 -31.25 11.62 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.394 -0.816 . . . . 0.0 111.204 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.526 ' N ' HG23 ' A' ' 187' ' ' THR . . . -118.21 -96.75 1.81 Allowed Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.804 -1.665 . . . . 0.0 109.064 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.52 ' CG2' HD22 ' A' ' 164' ' ' LEU . 48.3 m -104.31 -106.22 0.29 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.659 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 10.5 m120 -159.14 74.23 0.63 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.688 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 0.9 OUTLIER -27.01 -95.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.661 0.743 . . . . 0.0 112.55 -178.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.693 ' CG ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -64.34 -12.17 39.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.013 -1.054 . . . . 0.0 110.983 -176.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.659 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 5.5 tt -62.03 -62.08 2.03 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.884 -1.526 . . . . 0.0 107.078 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.597 ' CG1' ' CB ' ' A' ' 165' ' ' ALA . 39.4 t -72.79 -9.32 12.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.666 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -77.88 -57.43 3.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.576 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -65.38 -15.38 62.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.586 ' CG ' ' HE1' ' A' ' 3' ' ' MSB . 20.5 t60 -68.74 -46.13 69.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.962 -1.495 . . . . 0.0 107.81 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.573 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 1.3 mt-10 -82.32 -47.42 12.38 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.046 -1.034 . . . . 0.0 110.834 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.609 HG23 ' HA ' ' A' ' 121' ' ' LEU . 2.3 mt -61.48 -31.46 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.631 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.0 -33.29 46.09 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.93 -49.52 75.81 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.819 -0.813 . . . . 0.0 110.798 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 27.4 p -83.73 -56.88 3.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 112.2 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.583 HD21 ' CZ ' ' A' ' 132' ' ' PHE . 0.8 OUTLIER -104.16 22.94 13.83 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.016 -1.052 . . . . 0.0 110.84 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.55 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -121.71 -78.92 0.5 Allowed Glycine 0 C--N 1.291 -1.923 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.4 pp -167.5 -160.09 0.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.019 -1.283 . . . . 0.0 109.76 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 1.0 OUTLIER -98.12 -73.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.585 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.565 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.1 m-70 -163.01 93.49 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.913 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.637 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -81.78 179.33 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -0.836 . . . . 0.0 109.806 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.53 83.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.735 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -87.0 12.06 12.17 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.861 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -49.78 -28.25 6.01 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.495 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.1 mp0 -116.29 -36.16 4.11 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.735 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -62.45 -164.72 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.292 1.044 . . . . 0.0 112.681 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.594 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.1 OUTLIER -99.85 -13.01 19.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.074 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.565 ' HG2' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -80.3 -6.63 58.25 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 119.552 -1.967 . . . . 0.0 111.978 -177.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.649 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.2 OUTLIER -137.53 14.57 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.617 -1.302 . . . . 0.0 113.502 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 54.2 Cg_endo -77.41 -42.05 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.6 ' C ' ' O ' ' A' ' 221' ' ' PRO . 4.0 tp -0.26 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 CA-C-O 121.494 0.664 . . . . 0.0 111.039 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.541 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 9.8 t80 -67.46 58.4 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 109.754 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.465 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.2 OUTLIER 179.57 172.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 109.778 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.8 128.83 55.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.253 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 232' ' ' PHE . 0.3 OUTLIER 178.83 -73.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.835 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.565 ' CG2' ' CD2' ' A' ' 218' ' ' LEU . 1.5 p -66.44 53.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 0.0 110.442 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.522 ' CA ' ' O ' ' A' ' 188' ' ' LYS . 5.0 m-20 -162.54 -53.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -60.74 -142.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.755 . . . . 0.0 109.458 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.4 p -94.46 -22.76 18.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 0.0 110.049 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -79.97 -16.55 54.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 108.786 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.601 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 23.2 p90 -30.75 106.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.602 0.715 . . . . 0.0 111.291 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.532 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 7.6 ttt-85 -161.04 153.15 20.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.214 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.647 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 3.8 mp -77.65 173.94 11.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.281 -0.887 . . . . 0.0 110.463 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.615 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 21.7 t -102.81 -172.0 2.05 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.909 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.38 -12.89 53.67 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.778 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.637 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.6 m-20 -84.11 -49.28 9.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.769 -1.207 . . . . 0.0 108.15 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.726 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.8 OUTLIER -64.68 -39.48 93.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 117.197 -1.801 . . . . 0.0 106.616 178.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.8 OUTLIER -55.19 -36.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.47 -56.92 8.66 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.646 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -52.23 -51.58 40.94 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.598 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.8 tp -63.86 -47.93 88.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.85 -1.382 . . . . 0.0 109.656 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 21.3 tt0 -53.58 -28.29 31.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 t -82.42 -18.12 42.98 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.53 ' CD2' ' C ' ' A' ' 245' ' ' LEU . 5.7 tt -73.3 -60.57 2.18 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.626 ' CD1' ' CD1' ' A' ' 130' ' ' LEU . 11.1 m-85 -88.65 -112.97 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.445 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.466 ' N ' ' HD3' ' A' ' 248' ' ' PRO . . . 46.78 54.11 9.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.61 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 37.5 Cg_endo -71.86 -30.35 14.22 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.008 1.531 . . . . 0.0 112.136 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 44.4 Cg_endo -76.09 113.47 3.71 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 N-CA-C 109.751 -0.904 . . . . 0.0 109.751 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.55 -90.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.909 1.478 . . . . 0.0 110.126 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.22 -41.1 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 255' ' ' THR . 58.2 m -144.03 82.16 11.16 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.393 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.31 -24.13 19.98 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.053 1.554 . . . . 0.0 110.133 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.14 64.98 8.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.423 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 252' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.568 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.596 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.6 ' CD2' ' CD2' ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 212' ' ' SER . 12.2 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.321 0.581 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 85' ' ' THR . 4.7 ptp85 -123.61 -148.85 0.41 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.482 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.505 ' N ' ' HG3' ' A' ' 84' ' ' ARG . 8.7 t -51.65 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.59 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 210' ' ' PHE . 2.3 p90 -107.01 138.56 19.86 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -72.76 95.78 0.82 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.995 1.523 . . . . 0.0 110.053 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.3 -77.83 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.45 131.33 10.98 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.123 . . . . 0.0 109.541 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -73.01 -172.26 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.962 1.506 . . . . 0.0 109.916 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -99.48 -82.94 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.132 -0.98 . . . . 0.0 109.571 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.57 ' CD1' HD12 ' A' ' 207' ' ' LEU . 72.7 m95 -107.27 169.13 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.963 -1.085 . . . . 0.0 109.617 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -135.4 -36.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.598 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.535 ' HG3' ' CD1' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -47.58 177.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.475 ' HA ' HD21 ' A' ' 130' ' ' LEU . 71.2 p -116.7 5.58 13.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.501 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.523 ' O ' ' CE ' ' A' ' 94' ' ' LYS . 4.5 m-70 -126.63 91.14 3.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.99 -1.069 . . . . 0.0 110.073 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 132' ' ' PHE . 0.4 OUTLIER -99.31 158.29 15.81 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.6 -0.688 . . . . 0.0 109.988 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.55 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -129.54 154.86 46.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.643 ' CE1' ' CD2' ' A' ' 121' ' ' LEU . 3.0 p90 -140.77 167.69 21.58 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.724 -1.235 . . . . 0.0 109.364 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -132.12 138.11 47.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.095 . . . . 0.0 109.47 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.5 mp -93.32 66.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.14 -0.975 . . . . 0.0 109.746 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 144' ' ' ILE . 6.0 t -78.38 8.82 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 109.93 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.564 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 8.5 m120 -105.35 153.25 21.9 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.0 -1.062 . . . . 0.0 109.392 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.568 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 178.68 41.04 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.717 -0.614 . . . . 0.0 109.697 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 104' ' ' TYR . 61.4 p -41.57 156.1 0.22 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.42 -0.8 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -22.87 41.73 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.877 1.462 . . . . 0.0 108.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.487 ' O ' HD22 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -72.04 -6.3 41.34 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 83.1 mt -143.5 116.48 5.91 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.517 -0.74 . . . . 0.0 109.707 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.68 171.48 9.58 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 O-C-N 123.856 1.45 . . . . 0.0 109.06 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.01 -65.38 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.84 0.829 . . . . 0.0 110.295 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 115' ' ' SER . 26.0 t0 -57.43 -28.23 63.12 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.821 -0.549 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.59 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -73.18 -61.95 1.64 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.248 -1.532 . . . . 0.0 109.265 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.568 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.8 p -54.25 -40.67 48.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.512 ' N ' HG11 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -64.9 -27.86 69.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 112' ' ' ALA . 1.2 p -62.14 -41.84 98.67 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.662 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -73.72 -34.16 64.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.059 . . . . 0.0 110.639 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.528 ' CG1' HG13 ' A' ' 144' ' ' ILE . 5.8 t -74.36 -24.08 18.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -91.64 -34.82 14.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.637 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -79.02 -37.48 39.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.662 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -67.36 -62.02 1.63 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.643 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 8.1 tp -49.67 -45.04 48.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -73.41 -34.72 65.65 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.798 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.608 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 1.5 t -55.53 -40.6 59.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.675 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 51.0 m95 -92.27 -20.01 21.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.091 -1.005 . . . . 0.0 110.517 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 37.1 tt0 -75.24 -27.58 59.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.018 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.5 pt-20 -90.15 -45.19 9.28 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.551 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.613 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 16.5 m -57.3 -27.07 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.447 -1.301 . . . . 0.0 108.357 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.61 ' CG2' HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -121.22 155.86 58.01 Favored Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.223 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.54 ' CG ' ' HA2' ' A' ' 247' ' ' GLY . 48.6 Cg_endo -77.49 25.95 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.091 1.86 . . . . 0.0 111.946 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.638 ' CD1' ' CD1' ' A' ' 246' ' ' TYR . 5.0 mt -100.89 169.86 8.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.399 . . . . 0.0 110.093 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.465 ' O ' HD21 ' A' ' 97' ' ' LEU . 1.5 p -119.12 166.45 12.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.624 ' CG ' ' CD1' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -141.18 159.44 42.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.117 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -155.9 122.4 5.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 108.746 179.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 3.2 ppt_? -108.38 174.59 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.076 . . . . 0.0 110.64 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.81 -95.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 100' ' ' ARG . 3.5 t80 177.51 33.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.975 . . . . 0.0 109.098 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.57 179.43 5.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -45.75 -42.3 10.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 140' ' ' ALA . 2.0 pt-20 -176.13 105.02 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -1.102 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -59.14 -150.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.29 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 176' ' ' GLY . 45.3 t0 -81.28 -35.8 30.64 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.541 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 51.6 mt -127.97 81.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.441 ' HG2' HG22 ' A' ' 102' ' ' VAL . 2.6 ttt -67.13 100.26 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 102' ' ' VAL . 6.1 mm -82.26 115.02 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.04 -1.037 . . . . 0.0 108.348 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.3 OUTLIER -134.11 159.22 41.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.37 -1.456 . . . . 0.0 112.447 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.501 ' CA ' ' ND2' ' A' ' 103' ' ' ASN . 13.2 p90 -100.17 133.09 45.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.716 -0.615 . . . . 0.0 110.252 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.649 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -160.28 -159.07 0.67 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.096 -1.003 . . . . 0.0 110.724 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.521 ' O ' ' ND1' ' A' ' 151' ' ' HIS . 2.3 p -166.38 -170.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.979 -1.076 . . . . 0.0 109.185 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.453 ' HG2' HG12 ' A' ' 148' ' ' VAL . 7.9 ptt-85 -40.67 -26.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.172 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 148' ' ' VAL . 7.1 tp10 -40.83 -60.61 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 151' ' ' HIS . 1.6 p-80 -69.5 109.62 4.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.097 -1.002 . . . . 0.0 109.502 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.96 126.15 6.22 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 179.74 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -1.087 . . . . 0.0 109.484 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -158.75 -36.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.73 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.552 ' HB3' ' CE1' ' A' ' 166' ' ' HIS . 3.5 m-85 -139.8 74.67 32.06 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.978 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.94 155.58 52.99 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.936 1.493 . . . . 0.0 109.474 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.778 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 5.5 m-85 -113.42 -169.64 1.54 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.105 -0.997 . . . . 0.0 110.282 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.572 ' O ' ' C ' ' A' ' 159' ' ' GLY . 9.5 p30 178.96 61.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -10.88 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.506 3.341 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 38.4 Cg_endo -67.23 59.16 0.65 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.573 1.302 . . . . 0.0 109.692 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 162' ' ' ASN . . . -173.81 146.65 8.9 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -41.95 -27.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -1.052 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.467 ' HB ' ' OD1' ' A' ' 158' ' ' ASP . 2.8 t -52.44 82.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.519 -0.738 . . . . 0.0 110.781 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.597 ' N ' ' OB2' ' A' ' 3' ' ' MSB . 0.7 OUTLIER -70.59 -81.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.346 -0.846 . . . . 0.0 111.619 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.669 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -145.33 -179.63 6.77 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.65 -1.281 . . . . 0.0 111.409 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.778 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 2.0 p-80 179.28 162.39 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.808 -1.807 . . . . 0.0 110.383 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.43 -167.99 1.94 Allowed 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.191 -0.943 . . . . 0.0 110.418 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 206' ' ' SER . 95.4 m-85 -125.37 -163.05 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 0.0 110.344 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.539 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -172.23 -60.59 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.294 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 45.6 Cg_endo -76.57 118.56 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.831 1.437 . . . . 0.0 109.981 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 148.22 173.94 19.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -74.47 -91.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.128 1.594 . . . . 0.0 110.146 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -73.64 -28.16 65.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -75.32 8.29 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -1.149 . . . . 0.0 108.407 178.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 171' ' ' GLY . 20.5 p-10 -65.83 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 112.41 97.57 2.34 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.601 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -160.11 124.23 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.755 -1.439 . . . . 0.0 107.62 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.591 ' CB ' ' CB ' ' A' ' 202' ' ' GLU . . . -109.01 159.2 17.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 108.589 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.695 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -156.96 131.53 8.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.591 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.572 ' CD1' ' OE2' ' A' ' 202' ' ' GLU . 37.0 m-85 -93.08 142.45 27.28 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.188 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.565 ' O ' ' CZ2' ' A' ' 186' ' ' TRP . 5.7 t0 -64.39 144.12 57.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.451 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 4.6 p30 -109.91 24.23 13.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.637 -1.289 . . . . 0.0 110.139 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.562 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 20.1 m-20 -131.06 15.41 5.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.044 -1.035 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 7.6 tt0 -118.95 -132.88 0.32 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.598 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 88.6 mt-30 -114.44 163.04 15.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.821 -1.174 . . . . 0.0 108.514 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.598 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 98.8 m95 -158.44 105.37 1.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.93 -1.106 . . . . 0.0 110.398 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.578 ' CG2' ' N ' ' A' ' 192' ' ' GLY . 80.8 p -146.6 154.25 41.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.352 -0.843 . . . . 0.0 109.399 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 4.5 pttm -81.06 -30.31 34.81 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 229' ' ' LEU . 3.2 t70 -98.17 -148.13 0.33 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.609 ' N ' ' CD1' ' A' ' 229' ' ' LEU . 12.8 t -99.86 37.48 1.61 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.536 ' CB ' HG23 ' A' ' 187' ' ' THR . 21.4 m -86.23 -35.61 19.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.436 -0.79 . . . . 0.0 111.072 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.578 ' N ' ' CG2' ' A' ' 187' ' ' THR . . . -133.75 -95.78 0.56 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.612 -1.756 . . . . 0.0 109.706 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 185' ' ' GLN . 77.5 m -100.83 -108.35 0.22 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.565 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 34.2 m-80 -159.52 71.55 0.5 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.662 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 7.9 tp -29.29 -96.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.647 ' HA ' ' CB ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -49.89 -24.2 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.071 . . . . 0.0 111.391 -178.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.565 ' CB ' ' HB3' ' A' ' 194' ' ' ASN . 13.8 tp -58.05 -61.3 2.65 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 117.381 -1.727 . . . . 0.0 107.807 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 202' ' ' GLU . 1.4 t -73.59 -5.65 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.816 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.662 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -78.14 -57.67 3.66 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.488 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -65.55 -17.26 64.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.596 ' CE1' ' HA ' ' A' ' 219' ' ' MET . 3.3 t-160 -69.59 -41.76 75.36 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 117.079 -1.848 . . . . 0.0 108.135 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.591 ' CB ' ' CB ' ' A' ' 178' ' ' ALA . 0.8 OUTLIER -83.4 -49.52 9.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 0.0 110.464 179.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 120' ' ' ALA . 2.8 mt -59.11 -31.62 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.675 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.41 -34.85 39.04 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -58.49 -48.49 80.63 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.8 -0.823 . . . . 0.0 110.744 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.524 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 68.7 p -87.0 -55.74 3.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 112.104 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 207' ' ' LEU . 0.6 OUTLIER -103.95 31.3 4.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.256 -0.902 . . . . 0.0 110.095 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.609 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -135.04 -80.97 0.13 Allowed Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.556 ' CD1' ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -169.07 -165.9 0.58 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.264 . . . . 0.0 110.352 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 86' ' ' PHE . 75.7 t80 -93.53 -83.91 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.567 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.3 m-70 -151.61 122.64 7.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.651 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -113.13 -178.11 3.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -0.925 . . . . 0.0 109.388 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.418 ' HB1' ' CG ' ' A' ' 237' ' ' ASP . . . -60.87 85.92 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.782 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -91.0 12.39 19.88 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.395 -1.322 . . . . 0.0 112.115 -177.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.444 ' C ' ' O ' ' A' ' 214' ' ' ASN . 1.7 p -50.74 -27.74 7.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.495 ' N ' ' C ' ' A' ' 214' ' ' ASN . 4.6 mm-40 -116.6 -35.59 4.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.706 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.782 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -59.02 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 122.076 0.941 . . . . 0.0 112.755 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.626 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.1 OUTLIER -115.71 -13.29 11.45 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.776 -177.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.596 ' HA ' ' CE1' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -81.38 -7.01 59.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.312 -2.117 . . . . 0.0 111.799 -178.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -134.08 13.37 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.594 -1.316 . . . . 0.0 113.475 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 51.3 Cg_endo -76.26 -36.07 2.01 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 N-CA-C 109.099 -1.154 . . . . 0.0 109.099 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.602 ' CB ' ' CE2' ' A' ' 3' ' ' MSB . 1.6 tt -17.41 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.291 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.504 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 0.5 OUTLIER -68.02 54.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 223' ' ' TYR . 33.1 t60 178.77 -129.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 108.658 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.431 ' C ' HD22 ' A' ' 229' ' ' LEU . 0.1 OUTLIER -154.29 136.46 14.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.799 -1.188 . . . . 0.0 108.913 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 229' ' ' LEU . 0.1 OUTLIER 179.53 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 110.704 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -103.83 -28.74 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 108.825 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 7.6 t70 -172.26 3.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.892 . . . . 0.0 110.792 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.609 ' CD1' ' N ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -44.55 -51.98 8.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.821 -1.175 . . . . 0.0 108.99 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.74 -28.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.557 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.8 mtp180 -104.0 -39.74 6.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.474 -0.766 . . . . 0.0 109.43 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.58 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 21.9 p90 0.59 109.7 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.349 0.595 . . . . 0.0 112.443 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.79 177.27 0.49 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.316 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.665 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -89.52 175.04 7.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.009 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.661 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 16.4 t -111.96 -169.22 1.43 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.131 -0.981 . . . . 0.0 110.257 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.546 ' N ' ' OG ' ' A' ' 235' ' ' SER . 68.1 tp60 -84.49 -15.79 44.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.575 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.636 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 5.4 m-20 -84.25 -46.44 11.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.505 -1.372 . . . . 0.0 108.339 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.725 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -67.55 -35.77 79.69 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 117.381 -1.728 . . . . 0.0 106.543 177.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.5 OUTLIER -58.67 -34.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -45.96 73.91 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -63.88 -50.58 60.05 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.61 HG13 ' CG2' ' A' ' 128' ' ' THR . 0.0 OUTLIER -70.74 -47.81 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.723 -1.457 . . . . 0.0 109.586 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.423 ' N ' ' CG2' ' A' ' 242' ' ' ILE . 40.4 tt0 -53.98 -29.49 43.25 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.8 t -77.21 -22.47 52.27 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -64.66 -63.37 1.14 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.638 ' CD1' ' CD1' ' A' ' 130' ' ' LEU . 24.1 m-85 -101.08 -127.99 0.21 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.54 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 64.09 79.56 0.16 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.149 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.524 ' HD2' ' CG ' ' A' ' 129' ' ' PRO . 42.9 Cg_endo -75.69 173.38 14.59 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.993 1.522 . . . . 0.0 109.58 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 41.4 Cg_endo -72.13 110.35 2.92 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.847 1.446 . . . . 0.0 110.079 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 41.0 Cg_endo -75.6 -79.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.984 1.518 . . . . 0.0 110.566 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 253' ' ' PRO . 1.0 OUTLIER -42.38 -64.62 0.57 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.295 -0.878 . . . . 0.0 109.903 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.447 ' N ' ' OD1' ' A' ' 251' ' ' ASP . 1.5 m -42.79 102.13 0.27 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.897 . . . . 0.0 109.693 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 251' ' ' ASP . 42.9 Cg_endo -73.68 -30.65 9.39 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.982 1.517 . . . . 0.0 110.06 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 253' ' ' PRO . 4.0 tt0 -43.74 119.47 1.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.542 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.493 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.578 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.593 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.602 ' CE2' ' CB ' ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -69.91 -158.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.556 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 t -45.4 163.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.59 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -95.88 116.19 66.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.477 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.65 153.62 54.38 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.87 1.458 . . . . 0.0 110.059 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.44 -114.96 1.92 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.3 mm -87.86 123.91 68.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.257 -1.143 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.66 -161.07 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.876 1.461 . . . . 0.0 110.12 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.535 ' CB ' HD22 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -117.99 -89.0 0.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.367 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.608 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 90.3 m95 -90.2 148.69 22.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -126.31 -32.67 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.0 109.346 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.544 ' CE ' HD12 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -51.57 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.462 -0.774 . . . . 0.0 110.129 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.7 p -116.93 -0.05 12.32 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.576 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 40.1 m80 -146.96 93.2 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.599 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 132' ' ' PHE . 2.8 mm? -82.91 177.62 8.55 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.304 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -144.78 155.24 43.42 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.959 -1.088 . . . . 0.0 108.893 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.682 ' CE1' ' CD2' ' A' ' 121' ' ' LEU . 4.9 p90 -136.63 166.17 24.18 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.629 -1.294 . . . . 0.0 109.385 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' HD3' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -129.76 125.53 36.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.65 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -85.11 83.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' A' ' 144' ' ' ILE . 1.7 t -99.98 6.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.892 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -101.79 157.79 16.59 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.619 -1.301 . . . . 0.0 109.459 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 20.7 t80 178.33 70.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.767 . . . . 0.0 109.413 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.487 HG22 ' CD1' ' A' ' 186' ' ' TRP . 38.6 p -66.28 158.35 77.85 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 108.584 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -22.12 40.88 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.885 1.466 . . . . 0.0 108.68 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.2 OUTLIER -74.14 -4.72 37.45 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.562 ' CD1' HD11 ' A' ' 195' ' ' LEU . 83.7 mt -141.56 117.44 7.2 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.497 -0.752 . . . . 0.0 109.871 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.07 165.33 17.03 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.76 1.4 . . . . 0.0 109.171 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -35.99 -65.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.811 0.815 . . . . 0.0 110.332 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.98 -10.25 5.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.774 -0.579 . . . . 0.0 111.517 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.586 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -86.43 -61.68 1.68 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.478 -1.389 . . . . 0.0 108.949 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.566 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 7.5 p -54.67 -40.56 51.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.489 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -63.3 -27.01 69.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.523 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -67.39 -38.49 84.77 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.666 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -72.86 -33.95 66.44 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.901 -1.124 . . . . 0.0 109.66 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.545 ' CG1' HG13 ' A' ' 144' ' ' ILE . 57.3 t -76.06 -22.9 15.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.9 OUTLIER -89.11 -34.38 16.76 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.64 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.44 -38.02 27.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -64.49 -61.24 2.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.682 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 14.2 tp -53.45 -46.65 69.97 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.765 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 126' ' ' GLU . 0.5 OUTLIER -66.39 -35.3 79.97 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.138 -178.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.63 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 2.0 t -57.09 -36.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.688 ' CZ2' ' HA3' ' A' ' 204' ' ' GLY . 56.2 m95 -92.61 -25.17 18.43 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.931 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -71.83 -27.34 62.84 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.627 -1.296 . . . . 0.0 108.29 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.0 pt-20 -92.44 -42.82 9.54 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.029 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.633 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 19.8 m -63.9 -21.16 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.25 -1.38 . . . . 0.0 109.971 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.608 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.0 OUTLIER -108.35 162.67 19.11 Favored Pre-proline 0 N--CA 1.5 2.046 0 C-N-CA 117.472 -1.691 . . . . 0.0 109.883 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.47 ' O ' HD22 ' A' ' 130' ' ' LEU . 50.2 Cg_endo -81.02 21.74 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.1 1.867 . . . . 0.0 111.729 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.591 HD13 ' CD2' ' A' ' 246' ' ' TYR . 21.7 mt -122.22 -173.7 2.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.5 -1.375 . . . . 0.0 110.561 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -124.07 -168.22 1.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.973 -179.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -153.02 175.77 12.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.554 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -149.17 -173.44 4.38 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.61 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.34 163.04 39.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.49 -1.381 . . . . 0.0 110.768 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.6 OUTLIER -151.19 -131.9 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.47 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.726 -1.234 . . . . 0.0 109.444 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 139' ' ' GLU . 7.0 pm0 -166.79 -164.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 109.928 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 36.3 -97.43 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER 178.38 107.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -1.105 . . . . 0.0 110.398 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.522 ' CB ' HD23 ' A' ' 135' ' ' LEU . . . -63.15 -151.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 108.699 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.608 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 63.2 m-20 -87.7 -32.62 19.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 132' ' ' PHE . 4.4 mp -128.54 83.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.1 ttt -66.51 98.77 0.52 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 108.905 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.611 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.6 mm -82.42 115.79 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.819 -1.176 . . . . 0.0 108.149 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.93 153.01 52.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.55 -1.344 . . . . 0.0 111.48 -179.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.2 p90 -93.79 139.18 31.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.637 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -163.72 -159.96 0.54 Allowed 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.351 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' A' ' 157' ' ' PHE . 1.7 p -173.32 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 109.064 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.51 ' N ' HG11 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -48.31 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.753 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 148' ' ' VAL . 1.0 OUTLIER 179.77 31.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 55.1 m80 -81.31 -64.28 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.16 55.29 0.82 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 154' ' ' PHE . 3.9 t0 179.76 -85.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -1.131 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.513 ' N ' ' OD1' ' A' ' 153' ' ' ASP . 5.4 t80 -156.84 40.71 0.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.307 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CD2' ' OH ' ' A' ' 168' ' ' TYR . 1.2 m-85 -143.91 52.13 1.82 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.367 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 40.6 Cg_endo -69.95 119.28 6.24 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.963 1.507 . . . . 0.0 109.849 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.767 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.3 OUTLIER -81.08 -165.9 1.02 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 110.341 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.578 ' O ' ' C ' ' A' ' 159' ' ' GLY . 48.4 p-10 179.29 57.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.712 -0.617 . . . . 0.0 110.366 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -21.34 -67.71 0.01 OUTLIER Glycine 0 N--CA 1.509 3.53 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.528 ' CD ' ' HB3' ' A' ' 183' ' ' ASP . 43.7 Cg_endo -74.04 52.87 2.75 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.525 1.277 . . . . 0.0 109.401 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -155.89 156.78 27.3 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.536 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 20.4 m-80 -47.61 -41.71 22.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.66 -0.906 . . . . 0.0 110.507 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.532 ' HA ' ' CG2' ' A' ' 1' ' ' HAV . 78.6 t -59.89 78.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 110.136 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.631 ' CD2' ' CH2' ' A' ' 186' ' ' TRP . 0.2 OUTLIER -59.1 -55.05 40.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.416 -0.802 . . . . 0.0 111.784 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.673 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -163.68 -174.91 3.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.723 -1.236 . . . . 0.0 111.245 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.767 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.5 p-80 178.42 165.06 0.78 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.141 -1.599 . . . . 0.0 110.989 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -129.29 -158.97 0.92 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.405 -0.809 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.593 ' CG ' ' CG1' ' A' ' 174' ' ' ILE . 3.7 m-85 -122.83 -169.37 1.91 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.582 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.606 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . . . -117.54 -166.39 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 41.0 Cg_endo -74.97 123.51 7.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.05 1.026 . . . . 0.0 110.825 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . -172.15 -171.32 36.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.68 101.82 1.34 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.569 1.3 . . . . 0.0 109.91 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.46 ' HA2' ' OE2' ' A' ' 139' ' ' GLU . . . 81.5 -51.16 4.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.593 ' CG1' ' CG ' ' A' ' 168' ' ' TYR . 1.7 tt -68.67 2.58 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.623 -0.928 . . . . 0.0 109.346 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.579 ' O ' ' CH2' ' A' ' 92' ' ' TRP . 8.1 p-10 -63.52 63.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.56 -0.712 . . . . 0.0 109.227 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.02 101.73 2.69 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.4 m-20 -157.16 120.33 4.07 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.56 161.8 15.01 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.889 -1.132 . . . . 0.0 108.916 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.74 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -156.09 133.16 10.6 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.056 -1.058 . . . . 0.0 108.811 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 73.1 m-85 -93.71 141.28 28.67 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.741 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.577 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 23.7 p30 -63.51 144.55 56.9 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.667 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.57 22.27 11.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.669 -1.269 . . . . 0.0 110.447 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.533 ' HB3' ' HA3' ' A' ' 159' ' ' GLY . 27.2 t0 -115.95 11.21 15.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.957 -1.09 . . . . 0.0 110.359 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.5 ' HG2' ' CA ' ' A' ' 159' ' ' GLY . 2.9 pt-20 -126.43 -108.21 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.772 -1.205 . . . . 0.0 109.282 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 3.9 mt-30 -148.31 173.91 12.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.712 -1.242 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.631 ' CH2' ' CD2' ' A' ' 164' ' ' LEU . 88.7 m95 -162.54 132.58 4.57 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.039 -1.038 . . . . 0.0 110.029 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 192' ' ' GLY . 31.0 p -153.64 153.26 31.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.077 -1.014 . . . . 0.0 109.51 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -73.43 -37.38 65.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 227' ' ' THR . 1.3 t70 -86.04 -145.3 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.553 ' N ' HD13 ' A' ' 229' ' ' LEU . 11.7 t -115.61 46.26 1.54 Allowed 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 118.761 -1.176 . . . . 0.0 108.196 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.448 ' HB ' HG22 ' A' ' 187' ' ' THR . 97.8 m -101.58 -31.06 11.03 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.382 -0.824 . . . . 0.0 111.186 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 187' ' ' THR . . . -111.95 -86.99 1.66 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.878 -1.63 . . . . 0.0 109.096 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.573 ' CG2' ' ND2' ' A' ' 194' ' ' ASN . 35.4 m -125.01 -97.21 0.43 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.608 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.8 OUTLIER -158.12 67.53 0.48 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.107 -0.995 . . . . 0.0 108.42 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.666 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -27.79 -94.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.54 0.686 . . . . 0.0 111.553 -179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.64 ' CE1' ' CD2' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -67.63 -12.66 60.95 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 111.013 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.608 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 8.5 tp -63.06 -64.25 0.97 Allowed 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.906 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.531 HG23 ' CD2' ' A' ' 164' ' ' LEU . 2.5 t -69.46 -12.02 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.67 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -73.76 -57.4 4.01 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -66.99 -14.61 63.05 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.609 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 11.4 t60 -69.93 -43.97 70.56 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 117.821 -1.551 . . . . 0.0 107.743 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.58 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 2.3 mt-10 -82.53 -49.05 10.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.4 mt -59.95 -30.74 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.688 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -80.32 -29.68 44.11 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -62.2 -42.84 99.66 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.701 -0.882 . . . . 0.0 110.558 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.489 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 68.5 m -90.57 -51.71 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.108 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.53 ' CD2' HG12 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -104.78 20.66 18.32 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.008 -1.057 . . . . 0.0 110.828 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -124.48 -79.25 0.39 Allowed Glycine 0 C--N 1.291 -1.96 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.256 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.552 HD22 ' CZ3' ' A' ' 124' ' ' TRP . 1.0 OUTLIER -171.25 -156.29 0.11 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.428 -1.631 . . . . 0.0 110.939 -178.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.568 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.5 OUTLIER -101.49 -86.58 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.576 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.1 m-70 -152.32 89.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.457 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.585 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.0 m -79.47 178.72 7.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.116 -0.99 . . . . 0.0 108.574 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.09 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.767 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.16 11.9 10.91 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.213 -1.395 . . . . 0.0 111.978 -177.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.92 -28.22 6.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 175.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.476 ' C ' ' HB2' ' A' ' 235' ' ' SER . 34.9 mt-10 -117.41 -34.58 4.25 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.767 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -57.8 -145.63 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.206 -0.934 . . . . 0.0 111.557 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.701 ' CB ' HD12 ' A' ' 234' ' ' LEU . 0.7 OUTLIER -132.35 -0.5 3.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.74 . . . . 0.0 111.082 -178.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.576 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 9.2 tpp -93.35 -3.46 53.35 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.072 -1.642 . . . . 0.0 110.073 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.65 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 4.4 t80 -139.86 12.08 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.04 -1.064 . . . . 0.0 113.322 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 53.7 Cg_endo -74.31 -36.75 2.96 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 108.988 -1.197 . . . . 0.0 108.988 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.584 ' CB ' ' CE2' ' A' ' 3' ' ' MSB . 2.6 tt -13.06 -60.05 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.201 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.529 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 9.5 t80 -69.57 56.48 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.078 -1.014 . . . . 0.0 109.494 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.4 t-160 179.21 -142.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.1 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 226' ' ' LEU . 4.0 m -149.51 121.62 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 109.58 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER -176.28 56.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 109.897 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 189' ' ' ASP . 0.0 OUTLIER -116.17 -16.23 11.01 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.1 t0 -169.51 -25.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.681 -0.637 . . . . 0.0 109.527 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -27.93 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.667 -0.646 . . . . 0.0 110.719 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.411 ' C ' ' HG3' ' A' ' 231' ' ' ARG . 0.6 OUTLIER -145.11 1.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.887 -1.133 . . . . 0.0 110.139 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.555 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER -129.55 -44.74 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.885 -1.135 . . . . 0.0 109.382 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 23.0 p90 1.12 106.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.482 0.658 . . . . 0.0 112.58 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.25 171.05 0.94 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.474 179.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.701 HD12 ' CB ' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -82.01 179.61 7.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.334 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.683 ' N ' ' HA ' ' A' ' 217' ' ' ALA . 3.2 t -116.5 -169.93 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.042 -1.036 . . . . 0.0 110.575 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.597 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.4 OUTLIER -85.57 -25.07 26.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.542 -0.724 . . . . 0.0 109.983 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.585 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 19.6 m-20 -77.14 -45.07 28.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.932 -1.105 . . . . 0.0 108.204 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.608 ' CB ' HD13 ' A' ' 234' ' ' LEU . 7.8 t70 -67.85 -45.93 73.2 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.282 -1.367 . . . . 0.0 107.909 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.549 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.8 OUTLIER -51.61 -34.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -47.13 78.74 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -60.51 -56.05 26.56 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.608 ' CD1' HG23 ' A' ' 128' ' ' THR . 0.7 OUTLIER -63.77 -46.14 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.821 -1.399 . . . . 0.0 109.954 -178.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 30.4 mt-30 -54.27 -26.66 30.28 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -90.02 -10.93 43.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.535 HD22 ' CB ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -80.02 -54.37 5.85 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.591 ' CD2' HD13 ' A' ' 130' ' ' LEU . 3.9 m-30 -78.78 -83.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.172 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.46 ' C ' ' HD2' ' A' ' 249' ' ' PRO . . . -106.49 91.91 0.76 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.614 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 39.5 Cg_endo -73.01 -29.68 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.945 1.497 . . . . 0.0 112.479 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 42.6 Cg_endo -74.06 111.93 3.42 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 122.661 0.821 . . . . 0.0 110.282 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 45.4 Cg_endo -76.98 -59.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.011 1.532 . . . . 0.0 110.438 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.427 ' C ' ' HD3' ' A' ' 253' ' ' PRO . 32.6 t70 -87.28 13.98 8.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.259 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.527 ' CB ' ' HB2' ' A' ' 249' ' ' PRO . 0.0 OUTLIER -117.28 67.62 4.84 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.062 -1.024 . . . . 0.0 109.552 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 251' ' ' ASP . 42.9 Cg_endo -73.0 -49.18 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.979 1.515 . . . . 0.0 110.128 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -141.05 -47.54 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.613 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.515 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.579 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.599 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.609 ' CE1' ' ND1' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.465 ' NH1' HG23 ' A' ' 85' ' ' THR . 0.6 OUTLIER -150.29 -96.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.572 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -47.14 -93.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.042 -1.036 . . . . 0.0 109.412 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.479 ' N ' ' OG1' ' A' ' 85' ' ' THR . 1.6 t80 -163.56 99.0 0.98 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.0 109.542 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.62 77.3 2.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.043 1.549 . . . . 0.0 110.083 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.484 ' C ' ' CD1' ' A' ' 89' ' ' ILE . . . 172.7 -88.95 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 3.1 mm -126.73 142.22 42.67 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.295 -1.121 . . . . 0.0 109.468 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 89' ' ' ILE . 41.9 Cg_endo -72.03 -179.57 4.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.903 1.475 . . . . 0.0 110.101 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.2 OUTLIER -95.2 -84.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.75 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.577 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 27.9 m95 -97.65 140.55 31.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.978 -1.076 . . . . 0.0 109.641 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.78 -28.25 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.98 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.778 0.799 . . . . 0.0 110.192 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.53 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 66.8 p -127.33 3.71 6.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.595 ' CE1' ' CG2' ' A' ' 131' ' ' THR . 7.8 m80 -148.91 102.94 3.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.9 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.634 ' CD1' ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -121.19 -166.51 1.36 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.3 OUTLIER -168.21 171.67 9.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.14 -0.975 . . . . 0.0 109.238 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.634 ' CZ ' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -139.38 177.19 8.1 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.84 -1.163 . . . . 0.0 110.48 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' CD ' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -127.45 126.76 42.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 109.9 -178.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.634 ' CD1' ' CZ ' ' A' ' 99' ' ' TYR . 1.9 mp -85.06 83.33 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.932 -1.105 . . . . 0.0 109.837 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.609 ' N ' ' O ' ' A' ' 144' ' ' ILE . 0.1 OUTLIER -101.22 8.67 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.186 -0.946 . . . . 0.0 110.077 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.507 ' ND2' ' N ' ' A' ' 145' ' ' SER . 0.1 OUTLIER -100.48 157.29 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.635 -1.291 . . . . 0.0 109.968 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER 178.16 75.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.62 0.724 . . . . 0.0 109.507 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.634 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 0.8 OUTLIER -67.77 157.2 87.19 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.23 -23.44 39.0 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 O-C-N 123.79 1.416 . . . . 0.0 108.952 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 1.5 t0 -69.93 -9.8 56.28 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 52.2 mt -143.45 123.97 7.92 Favored Pre-proline 0 N--CA 1.485 1.278 0 O-C-N 121.622 -0.673 . . . . 0.0 109.898 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -66.42 168.87 15.21 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.781 1.411 . . . . 0.0 109.184 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.91 -64.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.756 0.789 . . . . 0.0 110.516 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 112' ' ' ALA . 2.4 p-10 -55.5 -32.08 62.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.701 -0.625 . . . . 0.0 111.954 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.622 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -70.87 -61.91 1.59 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.524 -1.36 . . . . 0.0 109.437 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.56 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.6 p -52.21 -41.68 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.505 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -63.63 -26.34 68.63 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 112' ' ' ALA . 1.0 OUTLIER -68.21 -35.71 78.39 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.401 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.692 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -76.15 -35.11 59.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.937 -1.102 . . . . 0.0 109.005 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.607 HG13 ' CE2' ' A' ' 99' ' ' TYR . 1.7 t -73.11 -26.13 22.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 1.5 tt0 -86.48 -36.35 19.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HB3' ' CD2' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -75.93 -39.27 56.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.642 ' HB3' ' CB ' ' A' ' 199' ' ' ALA . . . -66.15 -62.96 1.2 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.473 1.13 . . . . 0.0 108.167 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.617 ' CD1' ' CZ ' ' A' ' 99' ' ' TYR . 1.3 tt -46.51 -51.57 15.12 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.189 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.52 ' N ' ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -67.63 -35.47 78.97 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.947 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.595 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 3.1 t -52.44 -42.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.65 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 30.1 m95 -92.43 -23.38 19.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.928 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 46.9 tt0 -69.81 -26.93 64.49 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.762 -1.211 . . . . 0.0 107.801 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -91.06 -43.12 10.11 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.804 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.64 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 17.7 m -59.18 -24.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.766 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.604 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -105.9 160.48 25.98 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 117.696 -1.601 . . . . 0.0 110.222 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.435 ' C ' HD23 ' A' ' 130' ' ' LEU . 51.7 Cg_endo -85.56 22.48 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.259 1.973 . . . . 0.0 111.962 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 95' ' ' THR . 3.6 mm? -116.36 -169.96 1.72 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.32 -1.488 . . . . 0.0 110.51 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.595 ' CG2' ' CE1' ' A' ' 96' ' ' HIS . 1.3 p -117.04 164.96 13.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.634 ' CE2' ' CD1' ' A' ' 97' ' ' LEU . 1.2 m-85 -144.26 139.27 28.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.693 -0.63 . . . . 0.0 109.492 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.523 ' CB ' ' HB ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -115.28 -166.31 1.11 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.129 -0.982 . . . . 0.0 108.486 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.49 157.31 35.22 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.964 -1.085 . . . . 0.0 110.014 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.46 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -159.64 -164.96 1.43 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.387 -0.821 . . . . 0.0 109.604 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 101' ' ' ILE . 1.8 t80 -154.17 22.09 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.514 ' HA ' ' NH2' ' A' ' 100' ' ' ARG . 11.6 pm0 -138.44 179.58 6.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.43 -100.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.68 119.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 110.296 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -77.94 -154.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 108.87 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 98' ' ' THR . 2.3 m-20 -84.24 -38.32 20.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 109.364 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.529 ' CG2' HD13 ' A' ' 144' ' ' ILE . 4.0 mp -120.77 84.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.649 -0.657 . . . . 0.0 109.254 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.43 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.45 98.5 0.25 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.133 -0.979 . . . . 0.0 109.044 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.9 mm -84.29 114.89 25.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.01 155.66 50.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.517 -1.365 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -81.15 141.11 34.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 108.826 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.574 ' HB1' ' CD2' ' A' ' 179' ' ' HIS . . . -160.03 178.25 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.85 -1.156 . . . . 0.0 110.828 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 149' ' ' ARG . 1.5 p -167.26 -150.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.554 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 3.7 mmm180 -31.34 -57.48 0.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.765 -0.584 . . . . 0.0 110.477 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.72 121.27 4.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.142 -0.974 . . . . 0.0 109.323 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 148' ' ' VAL . 5.5 m80 -162.51 -91.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 153' ' ' ASP . . . -176.24 -70.69 0.05 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 48.5 p30 179.97 52.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -1.161 . . . . 0.0 109.79 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.487 ' C ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER 179.91 -32.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 109.755 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.588 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 98.1 m-85 -119.84 45.44 0.75 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.808 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 40.8 Cg_endo -70.59 127.38 13.85 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.899 1.473 . . . . 0.0 109.591 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.687 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -106.92 -164.12 0.96 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.081 -1.012 . . . . 0.0 110.243 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 1.3 p30 179.91 46.08 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.362 -0.836 . . . . 0.0 110.553 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.588 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 38.4 -97.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.482 ' N ' ' O ' ' A' ' 158' ' ' ASP . 40.2 Cg_endo -69.51 56.9 1.32 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.992 1.522 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.471 ' HA3' ' OD1' ' A' ' 158' ' ' ASP . . . -132.84 143.02 14.61 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.528 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 2.9 m120 -42.6 -31.32 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -1.066 . . . . 0.0 109.877 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.571 ' HB ' ' CE1' ' A' ' 157' ' ' PHE . 31.8 m -68.76 83.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.169 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.581 ' N ' ' OB2' ' A' ' 3' ' ' MSB . 1.6 tp -64.21 -71.19 0.18 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 0.0 111.658 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.549 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -150.02 -168.41 3.1 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.532 -1.355 . . . . 0.0 110.426 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 179.21 -178.22 0.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 119.73 -1.856 . . . . 0.0 111.353 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -154.92 178.91 9.64 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.475 -0.765 . . . . 0.0 110.134 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.628 ' CG ' ' CG1' ' A' ' 174' ' ' ILE . 81.5 m-85 -121.51 -167.82 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.449 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.527 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -175.3 -58.65 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 109.423 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -78.62 133.05 11.35 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.886 1.466 . . . . 0.0 109.969 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 132.67 -173.9 20.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -78.48 -92.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.089 1.573 . . . . 0.0 110.312 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -82.97 -34.62 20.93 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.628 ' CG1' ' CG ' ' A' ' 168' ' ' TYR . 0.8 OUTLIER -61.93 -6.98 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.466 -1.02 . . . . 0.0 108.816 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.568 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -65.81 64.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.466 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 126.36 82.3 0.43 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.0 m-20 -158.68 120.24 3.46 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.012 -1.287 . . . . 0.0 107.95 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -111.9 156.97 21.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.677 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.634 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -145.08 134.08 22.58 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.624 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 65.7 m-85 -95.57 133.75 39.25 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.158 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.579 ' OD2' ' CD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -49.34 148.66 2.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.026 177.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.462 ' OD2' ' HB ' ' A' ' 148' ' ' VAL . 2.6 p30 -124.05 21.04 9.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.809 -1.182 . . . . 0.0 109.558 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.588 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 1.8 m-20 -131.05 9.73 4.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.493 ' CG ' ' HB3' ' A' ' 181' ' ' ASP . 1.0 OUTLIER -114.04 -98.28 0.44 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.657 -1.277 . . . . 0.0 109.515 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 66.9 mt-30 -154.26 165.94 34.72 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 109.202 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.634 ' CD1' ' CG2' ' A' ' 105' ' ' THR . 97.8 m95 -160.3 118.97 2.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 110.11 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 195' ' ' LEU . 22.2 p -140.79 152.1 44.94 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.034 -1.041 . . . . 0.0 109.039 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.592 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.0 OUTLIER -75.09 -33.44 61.64 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.538 ' O ' ' CG2' ' A' ' 227' ' ' THR . 1.3 t70 -91.52 -141.19 0.18 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.567 ' N ' HD13 ' A' ' 229' ' ' LEU . 11.8 t -117.59 46.77 1.66 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.003 -1.06 . . . . 0.0 108.243 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.452 ' HB ' HG22 ' A' ' 187' ' ' THR . 58.4 m -104.71 -29.46 10.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.273 -0.892 . . . . 0.0 111.303 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.529 ' N ' HG22 ' A' ' 187' ' ' THR . . . -110.26 -91.29 2.09 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.91 -1.614 . . . . 0.0 109.48 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.529 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 64.8 m -114.44 -84.35 0.61 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.692 ' HB2' ' CB ' ' A' ' 197' ' ' LEU . 5.1 p30 178.6 68.56 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.862 1.315 . . . . 0.0 108.139 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.692 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -21.73 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.303 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.684 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -68.01 -6.39 22.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 110.835 -175.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.692 ' CB ' ' HB2' ' A' ' 194' ' ' ASN . 7.5 tp -66.11 -61.49 2.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 117.601 -1.64 . . . . 0.0 106.642 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.563 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 0.7 OUTLIER -70.81 -14.49 18.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.121 -1.032 . . . . 0.0 108.426 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.642 ' CB ' ' HB3' ' A' ' 120' ' ' ALA . . . -73.23 -61.05 1.96 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.618 -1.233 . . . . 0.0 108.211 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.538 ' CB ' ' CD2' ' A' ' 218' ' ' LEU . . . -63.58 -15.75 58.93 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.311 -1.493 . . . . 0.0 107.527 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.527 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 6.8 t60 -70.6 -44.01 68.17 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.684 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.588 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 8.3 mt-10 -82.58 -46.16 13.69 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 0.0 111.374 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.555 HD11 ' N ' ' A' ' 121' ' ' LEU . 4.0 mt -63.69 -30.31 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.65 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.47 -31.38 54.58 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -64.04 -47.16 81.29 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.796 -0.826 . . . . 0.0 111.232 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.525 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 33.9 p -85.37 -52.52 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.16 -0.963 . . . . 0.0 112.63 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.567 HD21 ' CZ ' ' A' ' 132' ' ' PHE . 1.3 pp -104.4 7.44 35.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.871 -1.143 . . . . 0.0 111.097 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.551 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -109.83 -84.01 1.5 Allowed Glycine 0 C--N 1.29 -1.975 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 238' ' ' ASP . 1.8 pp -158.89 -161.13 0.93 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.922 -1.34 . . . . 0.0 109.942 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.563 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 44.8 t80 -98.43 -71.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.6 m-70 -161.06 94.17 1.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.64 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 2.1 m -84.03 -179.26 7.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.7 78.6 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.764 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -82.72 9.34 9.85 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.281 -177.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -50.44 -27.84 7.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.479 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.6 mt-10 -114.07 -36.45 4.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.764 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -61.39 -159.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.272 1.034 . . . . 0.0 112.276 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.636 ' CD2' ' CE2' ' A' ' 196' ' ' PHE . 0.6 OUTLIER -106.04 -11.81 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.562 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.532 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -80.57 -10.2 59.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.24 -1.537 . . . . 0.0 111.932 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.679 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.8 t80 -131.39 8.5 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.447 -1.408 . . . . 0.0 113.953 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 43.7 Cg_endo -72.48 -41.84 1.55 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 N-CA-C 109.261 -1.092 . . . . 0.0 109.261 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.598 ' CB ' ' CE2' ' A' ' 3' ' ' MSB . 0.4 OUTLIER -0.5 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.204 0.526 . . . . 0.0 111.756 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.561 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 48.4 t80 -67.19 58.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.827 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.13 -155.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 109.329 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.508 ' CB ' HD22 ' A' ' 229' ' ' LEU . 0.7 OUTLIER -128.69 126.39 40.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.091 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 231' ' ' ARG . 1.2 tt -179.85 40.35 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.58 ' HA ' ' CE1' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -103.16 -40.03 6.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.9 t70 -149.38 -13.43 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.551 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -42.65 -98.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.851 -1.156 . . . . 0.0 110.349 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.5 p -139.03 -0.31 1.88 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.48 -1.388 . . . . 0.0 109.933 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.534 ' HB2' ' CD1' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -116.7 -18.21 10.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.012 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 232' ' ' PHE . 19.5 p90 -30.15 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.478 0.656 . . . . 0.0 111.477 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.568 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 8.5 ttt180 179.13 149.53 0.26 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.628 HD22 ' CZ3' ' A' ' 124' ' ' TRP . 3.1 tp -70.11 164.43 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 108.755 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.64 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 7.7 t -102.46 178.15 4.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.068 -1.02 . . . . 0.0 109.578 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.509 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -70.36 -14.6 62.64 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.75 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.64 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 0.8 OUTLIER -87.32 -49.6 7.14 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.716 -1.24 . . . . 0.0 109.548 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.744 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.2 m-20 -63.94 -42.56 97.29 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 116.908 -1.917 . . . . 0.0 107.17 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.574 ' CD1' ' O ' ' A' ' 235' ' ' SER . 3.0 mt -54.83 -39.83 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.483 ' HA ' ' HG2' ' A' ' 243' ' ' GLN . 24.5 t-20 -60.84 -48.97 79.36 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.62 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.06 -55.53 30.37 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.604 ' CD1' HG23 ' A' ' 128' ' ' THR . 1.4 tp -63.46 -50.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.032 -1.276 . . . . 0.0 110.521 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.512 ' HG3' ' N ' ' A' ' 244' ' ' SER . 1.0 OUTLIER -53.33 -25.1 13.76 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.512 ' N ' ' HG3' ' A' ' 243' ' ' GLN . 37.4 t -90.83 -11.4 39.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.2 OUTLIER -78.98 -49.97 11.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 5.0 m-30 -91.65 -104.09 0.11 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 246' ' ' TYR . . . 43.37 89.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.646 ' CD ' ' HD3' ' A' ' 249' ' ' PRO . 35.1 Cg_endo -61.99 -26.0 78.24 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.959 1.505 . . . . 0.0 113.036 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.646 ' HD3' ' CD ' ' A' ' 248' ' ' PRO . 55.2 Cg_endo -98.17 68.06 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.213 1.275 . . . . 0.0 111.496 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.587 ' CD ' ' O ' ' A' ' 248' ' ' PRO . 41.6 Cg_endo -70.91 -58.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 122.781 0.885 . . . . 0.0 109.946 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.58 -33.31 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.344 -0.847 . . . . 0.0 109.028 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.19 100.89 2.28 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.423 -0.798 . . . . 0.0 109.181 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.77 -31.12 13.47 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.042 1.548 . . . . 0.0 110.257 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -152.47 -70.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.555 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.543 ' O ' ' CB ' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.611 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.611 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.237 0.541 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 85' ' ' THR . 2.2 ptp180 -87.76 -167.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.621 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.472 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.9 t -43.83 163.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.514 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 1.7 t80 -86.6 109.85 27.24 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.4 Cg_endo -72.72 80.57 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.888 1.468 . . . . 0.0 110.079 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 159.34 -56.26 0.34 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 86' ' ' PHE . 14.7 mt -138.1 132.01 16.82 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.245 -1.15 . . . . 0.0 109.548 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.475 ' HB2' HD21 ' A' ' 245' ' ' LEU . 42.8 Cg_endo -73.3 174.14 12.59 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.003 1.528 . . . . 0.0 110.088 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.504 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.2 OUTLIER -67.96 -79.57 0.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.317 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.636 ' CD1' HD22 ' A' ' 207' ' ' LEU . 36.3 m95 -105.48 160.14 15.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.889 -1.132 . . . . 0.0 109.284 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -121.97 -28.99 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.044 -1.035 . . . . 0.0 110.682 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.542 ' CE ' HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -42.9 169.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 110.323 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.527 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 2.1 p -106.19 -0.66 24.38 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.439 -0.788 . . . . 0.0 109.459 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 69.2 m80 -140.19 93.89 2.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 3.1 mm? -85.82 164.66 17.41 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.762 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -143.33 156.64 44.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.629 ' CZ ' ' CD2' ' A' ' 121' ' ' LEU . 8.8 p90 -135.85 170.28 16.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.61 -1.306 . . . . 0.0 109.642 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.525 ' CD ' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -132.25 123.25 26.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.369 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.541 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -80.01 83.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 0.0 109.705 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 144' ' ' ILE . 0.6 OUTLIER -99.12 8.39 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.557 ' OD1' ' N ' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -107.06 173.01 6.51 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.424 -1.422 . . . . 0.0 110.119 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.619 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 11.3 t80 176.94 70.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.712 0.768 . . . . 0.0 109.342 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.568 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 56.3 p -56.25 148.86 39.88 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 120.985 -1.072 . . . . 0.0 108.246 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 -28.96 40.5 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 108.52 -1.377 . . . . 0.0 108.52 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 5.6 t0 -71.28 -9.12 57.59 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 33.1 mt -131.69 120.51 17.67 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.644 -0.66 . . . . 0.0 110.21 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.6 Cg_endo -62.99 163.69 21.64 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 123.811 1.427 . . . . 0.0 108.979 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.3 -65.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.781 0.801 . . . . 0.0 110.034 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.7 OUTLIER -57.65 -15.2 6.95 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 111.056 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.59 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -81.23 -62.22 1.72 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.555 -1.341 . . . . 0.0 108.942 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.535 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 7.3 p -50.64 -40.02 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 118.294 -1.362 . . . . 0.0 107.481 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.465 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -65.12 -27.09 68.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 112' ' ' ALA . 14.6 p -66.91 -38.43 86.21 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.618 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -73.19 -33.59 65.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.329 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.594 HG13 ' CE2' ' A' ' 99' ' ' TYR . 47.8 t -75.45 -24.09 17.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.533 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -84.36 -36.4 22.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.641 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.2 OUTLIER -79.69 -38.82 32.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.661 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -63.39 -60.76 2.95 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 122.425 1.107 . . . . 0.0 108.247 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.629 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.2 pp -52.59 -41.04 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.937 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.537 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -75.88 -32.07 59.52 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.986 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.599 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 2.9 t -53.81 -45.11 61.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.662 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 31.8 m95 -91.7 -23.12 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.902 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 5.4 tm-20 -70.96 -26.59 63.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.847 -1.158 . . . . 0.0 107.935 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -90.76 -42.71 10.53 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.689 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.62 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 16.9 m -58.78 -25.67 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 118.323 -1.351 . . . . 0.0 108.809 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.579 ' CG2' HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -112.56 172.15 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 117.94 -1.504 . . . . 0.0 110.056 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.54 ' CG ' ' HD3' ' A' ' 248' ' ' PRO . 51.7 Cg_endo -87.21 -7.94 6.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.642 2.228 . . . . 0.0 110.78 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.575 ' HB2' ' CD2' ' A' ' 246' ' ' TYR . 1.1 tp -73.8 -179.76 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.982 -1.074 . . . . 0.0 110.594 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 5.5 p -119.33 175.68 5.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 110.154 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.477 ' CZ ' HD12 ' A' ' 207' ' ' LEU . 0.5 OUTLIER -144.56 159.56 42.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.97 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.578 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -145.25 179.74 7.18 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.69 157.85 44.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.797 -1.189 . . . . 0.0 110.427 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.53 HD22 ' CB ' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -150.55 -140.03 0.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 5.5 t80 178.92 40.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.743 -1.223 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 7.5 pm0 -165.22 -178.18 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.609 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.44 -96.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 137' ' ' GLU . 1.7 pt-20 178.84 105.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.199 -1.177 . . . . 0.0 110.163 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.53 ' CB ' HD22 ' A' ' 135' ' ' LEU . . . -60.21 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 108.671 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.594 ' O ' ' HA3' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -92.49 -27.97 17.09 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.532 179.14 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.539 ' CG2' HD12 ' A' ' 144' ' ' ILE . 31.1 mm -130.9 77.14 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.503 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 1.9 ttt -64.87 97.07 0.21 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.136 -0.978 . . . . 0.0 108.962 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 102' ' ' VAL . 6.9 mm -79.55 123.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.092 . . . . 0.0 108.456 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -138.47 153.07 48.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.446 -1.409 . . . . 0.0 111.825 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 14.3 p90 -87.34 139.9 30.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.207 -0.933 . . . . 0.0 108.943 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.607 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -162.15 -160.21 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.702 -1.249 . . . . 0.0 111.36 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.549 ' CG2' ' HA3' ' A' ' 159' ' ' GLY . 5.7 p -170.0 179.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.521 ' HA ' ' N ' ' A' ' 157' ' ' PHE . 3.0 ptt180 -36.63 -29.39 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 0.0 110.705 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 148' ' ' VAL . 31.6 mt-10 -85.65 95.0 9.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.075 -1.015 . . . . 0.0 109.773 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.566 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 25.7 m80 -110.22 -79.58 0.58 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.462 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 134.48 -4.17 4.4 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 14.2 t70 -120.28 -91.98 0.55 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -1.162 . . . . 0.0 109.701 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -155.82 19.8 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.992 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -128.94 58.56 37.73 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 109.642 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.519 ' HA ' ' ND1' ' A' ' 151' ' ' HIS . 43.3 Cg_endo -73.83 124.95 9.57 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.018 1.536 . . . . 0.0 109.865 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.682 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -91.16 -149.9 0.23 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.054 -1.028 . . . . 0.0 109.419 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 160' ' ' PRO . 8.9 p-10 -137.04 -2.85 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.258 -1.526 . . . . 0.0 111.718 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 39.48 -95.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.528 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.2 Cg_endo -61.45 72.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.338 1.178 . . . . 0.0 110.077 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -172.51 -164.06 27.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' VAL . 69.0 m-20 -90.69 -29.82 17.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.086 -1.244 . . . . 0.0 110.111 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.655 ' CG1' ' CD1' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -36.73 130.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.593 -0.692 . . . . 0.0 110.713 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.563 ' N ' ' OB2' ' A' ' 3' ' ' MSB . 0.1 OUTLIER -92.23 -80.89 0.35 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.582 -0.699 . . . . 0.0 112.24 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.603 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -161.35 -170.9 2.79 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.263 -1.523 . . . . 0.0 111.026 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.682 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -179.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 119.542 -1.974 . . . . 0.0 111.313 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -160.41 -163.41 1.09 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.603 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -130.17 -157.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 0.0 110.704 -178.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.553 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -170.56 -59.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.661 -0.65 . . . . 0.0 109.562 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 46.4 Cg_endo -79.6 -172.32 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.405 1.403 . . . . 0.0 110.232 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.55 144.07 0.71 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.17 135.14 28.75 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.425 1.417 . . . . 0.0 110.002 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 72.54 -64.12 1.44 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.603 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.0 tp -63.78 -8.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.494 -1.003 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.7 OUTLIER -65.77 66.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.763 179.329 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 129.53 79.49 0.23 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -153.53 128.76 9.76 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.859 -1.377 . . . . 0.0 108.205 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -112.59 172.57 6.84 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.983 -1.073 . . . . 0.0 108.961 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.607 ' CE1' ' CB ' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -164.66 134.38 3.8 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.577 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.682 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 12.2 m-85 -88.69 123.38 33.08 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 164' ' ' LEU . 17.0 t70 -67.2 144.66 55.86 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.129 -0.982 . . . . 0.0 108.945 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -61.18 -4.18 1.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.283 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.0 OUTLIER 4.62 -94.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 161' ' ' GLY . 1.4 pm0 -166.3 -33.61 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.692 -1.255 . . . . 0.0 110.906 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.449 ' OE1' ' HA2' ' A' ' 192' ' ' GLY . 66.4 mt-30 -141.66 158.67 43.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.708 -1.245 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.682 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 84.9 m95 -158.02 119.53 3.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.57 ' CG2' ' N ' ' A' ' 192' ' ' GLY . 47.2 p -144.43 154.64 43.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.473 -1.392 . . . . 0.0 110.476 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.7 OUTLIER -75.7 -35.0 60.42 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.541 ' O ' ' CG2' ' A' ' 227' ' ' THR . 1.0 OUTLIER -93.86 -144.21 0.24 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.562 ' N ' HD13 ' A' ' 229' ' ' LEU . 15.1 t -109.69 37.78 2.55 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.49 ' HB ' HG23 ' A' ' 187' ' ' THR . 11.8 m -84.83 -35.58 22.19 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.63 -0.669 . . . . 0.0 110.94 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.57 ' N ' ' CG2' ' A' ' 187' ' ' THR . . . -120.82 -87.39 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 118.852 -1.642 . . . . 0.0 109.024 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.461 ' O ' ' CG ' ' A' ' 194' ' ' ASN . 90.9 m -114.85 -105.91 0.39 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.57 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 52.3 m-80 -157.62 70.76 0.6 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.113 -0.992 . . . . 0.0 108.744 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.69 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 0.7 OUTLIER -19.58 -91.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.812 0.815 . . . . 0.0 112.618 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.69 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -66.95 -11.81 57.7 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.045 -1.034 . . . . 0.0 111.656 -176.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.582 ' CA ' HD12 ' A' ' 218' ' ' LEU . 11.7 tp -64.2 -55.48 21.34 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.526 HG13 ' CB ' ' A' ' 165' ' ' ALA . 2.8 t -76.08 -9.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.661 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -78.97 -57.2 3.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.391 -1.324 . . . . 0.0 107.534 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -65.22 -19.02 65.78 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.582 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 3.7 t-160 -68.22 -41.12 81.78 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.672 177.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.584 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 28.4 mt-10 -83.64 -49.11 9.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 110.778 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.561 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -58.73 -31.85 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.662 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.39 -35.69 36.56 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -56.18 -53.68 54.21 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.674 -0.897 . . . . 0.0 110.319 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.574 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.7 OUTLIER -83.72 -56.83 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 111.579 -178.23 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.636 HD22 ' CD1' ' A' ' 92' ' ' TRP . 7.4 mt -102.54 37.6 1.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 110.971 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -141.63 -75.34 0.04 OUTLIER Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.7 pp -170.31 -164.28 0.39 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.994 -1.297 . . . . 0.0 109.657 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.571 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 0.1 OUTLIER -98.48 -79.55 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.276 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.476 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 0.7 OUTLIER -154.29 105.9 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 0.0 109.164 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.647 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -94.54 -176.45 3.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.287 -0.883 . . . . 0.0 109.096 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.455 ' H ' ' HB3' ' A' ' 237' ' ' ASP . . . -62.4 81.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.734 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.84 10.5 18.37 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.64 -177.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.3 OUTLIER -50.28 -27.82 6.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 174.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.488 ' C ' ' HB2' ' A' ' 235' ' ' SER . 23.5 mm-40 -115.81 -36.85 4.06 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.734 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -173.01 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.517 1.151 . . . . 0.0 112.766 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.617 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.0 OUTLIER -85.73 -17.06 36.96 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.977 -177.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.582 ' HG3' ' CE1' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -78.51 -8.11 58.21 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.461 -2.024 . . . . 0.0 112.366 -177.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.682 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 7.0 t80 -133.01 14.74 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 120.25 -1.531 . . . . 0.0 113.472 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 52.2 Cg_endo -77.77 -41.88 0.29 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 N-CA-C 109.541 -0.984 . . . . 0.0 109.541 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.592 ' CB ' ' CE2' ' A' ' 3' ' ' MSB . 0.5 OUTLIER -8.73 -69.0 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.578 -178.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.546 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 7.9 t80 -65.91 59.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.71 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.9 t-160 179.77 -143.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.316 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 226' ' ' LEU . 49.4 m -152.59 123.48 7.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.066 -1.021 . . . . 0.0 109.556 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 179.52 59.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.851 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.568 ' O ' ' CD2' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -109.02 -45.98 3.68 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 33.0 t70 -138.3 -13.55 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 0.0 110.432 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -37.6 -100.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.264 -0.897 . . . . 0.0 111.055 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.46 -16.41 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.434 -1.416 . . . . 0.0 110.383 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.535 ' O ' ' CD ' ' A' ' 233' ' ' ARG . 2.1 mtp180 -114.54 -22.19 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 108.849 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 30.4 p90 -30.65 115.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.419 0.628 . . . . 0.0 111.944 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.541 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.42 166.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 178.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.641 HD23 ' CH2' ' A' ' 124' ' ' TRP . 2.6 mp -77.87 165.32 24.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.173 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 31.1 t -99.88 -170.17 1.85 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 118.699 -1.201 . . . . 0.0 110.302 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.8 pp0? -83.93 -16.93 42.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.637 -0.665 . . . . 0.0 109.968 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.647 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 1.1 m-20 -81.95 -48.57 11.31 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.257 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.72 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.8 OUTLIER -64.47 -38.34 90.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 117.328 -1.749 . . . . 0.0 106.728 177.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.42 -35.93 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.47 -60.12 3.28 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.454 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -49.51 -49.53 32.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.585 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.4 tp -65.09 -46.69 90.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.772 -1.428 . . . . 0.0 110.015 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -53.34 -27.1 21.73 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.4 t -84.96 -17.91 36.22 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -75.37 -60.58 2.24 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.553 -0.717 . . . . 0.0 109.592 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.575 ' CD2' ' HB2' ' A' ' 130' ' ' LEU . 10.2 m-30 -84.87 -120.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.455 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 79.76 135.77 1.35 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.615 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 49.1 Cg_endo -72.78 174.74 11.33 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.92 1.484 . . . . 0.0 109.702 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 38.1 Cg_endo -66.52 -25.89 47.57 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.788 1.658 . . . . 0.0 114.487 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.615 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 42.8 Cg_endo -83.95 -71.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 120.465 0.777 . . . . 0.0 110.098 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 250' ' ' PRO . 11.5 t70 -43.31 -35.3 1.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 109.706 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.96 88.2 0.23 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.505 ' CG ' ' O ' ' A' ' 249' ' ' PRO . 42.1 Cg_endo -74.65 -45.13 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.032 1.543 . . . . 0.0 110.137 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.454 ' OE1' ' HB2' ' A' ' 253' ' ' PRO . 1.9 pm0 -153.19 -39.11 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.554 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.524 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.492 ' O ' ' HB1' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.572 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.592 ' CE2' ' CB ' ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.498 ' O ' ' CD2' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -80.99 -69.42 0.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 108.965 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 86' ' ' PHE . 71.0 p -60.97 -91.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.532 -0.73 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.498 ' N ' ' OG1' ' A' ' 85' ' ' THR . 0.4 OUTLIER 179.96 108.98 0.19 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.458 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.94 60.72 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.903 1.475 . . . . 0.0 110.066 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.65 -129.5 2.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.402 HG21 ' HD2' ' A' ' 90' ' ' PRO . 42.0 mt -67.47 125.01 90.56 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.244 -1.151 . . . . 0.0 109.517 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.464 ' HB2' HD21 ' A' ' 245' ' ' LEU . 42.6 Cg_endo -73.28 -162.13 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.882 1.464 . . . . 0.0 110.195 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -63.45 -85.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.652 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.581 ' CD1' HD12 ' A' ' 207' ' ' LEU . 59.3 m95 -97.72 174.44 6.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.189 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.4 ppt_? -135.35 -38.81 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.636 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -43.08 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.284 -0.885 . . . . 0.0 110.073 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.527 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 30.7 p -105.98 3.34 28.24 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.328 -0.857 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.539 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 65.4 m-70 -136.11 91.04 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.882 -1.136 . . . . 0.0 109.946 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.641 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.6 mm? -94.98 168.22 10.92 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -142.86 156.51 44.94 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.872 -1.142 . . . . 0.0 109.0 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.61 ' CE2' HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -136.5 172.59 12.78 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.994 -1.066 . . . . 0.0 109.927 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.52 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -136.77 144.27 43.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.585 HD12 ' CZ ' ' A' ' 99' ' ' TYR . 1.8 mp -100.68 76.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 0.0 110.041 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' A' ' 144' ' ' ILE . 29.1 t -94.21 8.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.995 . . . . 0.0 109.699 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.548 ' ND2' ' N ' ' A' ' 145' ' ' SER . 8.6 m-80 -99.36 163.06 12.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.952 -1.092 . . . . 0.0 109.243 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 104' ' ' TYR . 17.7 p90 179.33 55.44 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.531 -0.731 . . . . 0.0 109.917 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.519 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 46.9 p -42.94 150.24 0.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.008 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.93 -25.99 44.39 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.886 1.466 . . . . 0.0 109.203 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.2 OUTLIER -77.44 -1.21 29.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.601 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 99.1 mt -141.15 115.89 7.16 Favored Pre-proline 0 N--CA 1.484 1.258 0 O-C-N 121.473 -0.767 . . . . 0.0 109.613 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.5 Cg_endo -66.09 173.87 6.67 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.807 1.425 . . . . 0.0 109.141 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.48 -65.35 0.32 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.805 0.812 . . . . 0.0 110.421 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -29.64 64.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.861 -0.525 . . . . 0.0 112.336 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.601 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -71.68 -61.98 1.58 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.261 -1.525 . . . . 0.0 109.064 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.588 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 8.3 p -52.23 -39.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.49 ' N ' HG11 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -63.09 -28.15 69.88 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.548 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 16.4 p -64.96 -40.4 94.93 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.672 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -73.56 -33.15 64.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.962 -1.087 . . . . 0.0 109.892 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.61 HG13 ' CE2' ' A' ' 99' ' ' TYR . 2.0 t -74.86 -24.82 18.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -88.52 -35.04 17.19 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.641 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -77.89 -39.66 42.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.653 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -65.28 -62.99 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 122.399 1.095 . . . . 0.0 108.439 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.578 HD23 ' CG ' ' A' ' 99' ' ' TYR . 10.0 tp -50.63 -44.76 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -73.18 -32.89 65.11 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.385 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.584 HG22 ' CE1' ' A' ' 196' ' ' PHE . 2.3 t -54.63 -43.16 64.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.679 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 42.9 m95 -91.71 -23.57 19.74 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.646 -1.221 . . . . 0.0 110.808 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 132' ' ' PHE . 3.5 tp10 -70.45 -27.73 64.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.595 -1.316 . . . . 0.0 107.966 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 13.2 pt-20 -89.61 -42.92 11.12 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.977 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 17.1 m -59.91 -24.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.354 -1.339 . . . . 0.0 109.291 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.593 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -110.04 155.99 40.77 Favored Pre-proline 0 N--CA 1.495 1.795 0 C-N-CA 117.963 -1.495 . . . . 0.0 109.891 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.453 ' HG2' ' C ' ' A' ' 247' ' ' GLY . 53.9 Cg_endo -81.15 10.62 3.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.14 1.894 . . . . 0.0 110.742 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.591 HD23 ' CG ' ' A' ' 246' ' ' TYR . 3.9 mp -96.46 -178.98 4.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.86 -1.15 . . . . 0.0 110.405 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.444 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -118.78 167.56 11.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.401 -0.812 . . . . 0.0 110.198 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.574 ' CE2' ' HB2' ' A' ' 97' ' ' LEU . 8.3 m-85 -141.7 -179.43 6.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.54 -0.725 . . . . 0.0 109.447 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 -162.64 1.37 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -162.05 -178.58 6.51 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.91 -1.119 . . . . 0.0 110.534 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.534 ' CD2' ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -164.17 -128.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER 177.19 31.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.621 -1.299 . . . . 0.0 109.532 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 138' ' ' GLY . 3.2 pm0 -171.28 -161.78 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.106 -0.996 . . . . 0.0 109.729 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 35.5 -98.35 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.507 ' OE2' ' CA ' ' A' ' 173' ' ' GLY . 0.0 OUTLIER 177.81 107.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 110.634 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.534 ' HB1' ' CD2' ' A' ' 135' ' ' LEU . . . -67.26 -155.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.579 ' O ' ' O ' ' A' ' 176' ' ' GLY . 8.5 t0 -81.47 -32.3 32.57 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 1.7 mt -126.86 85.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.581 ' CG ' ' O ' ' A' ' 143' ' ' MET . 5.5 ptm -76.65 100.18 5.29 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.615 ' O ' ' N ' ' A' ' 102' ' ' VAL . 4.4 mm -79.39 114.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 108.087 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -135.95 159.79 40.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.475 -1.391 . . . . 0.0 112.065 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.49 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 17.2 p90 -80.19 140.16 36.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.613 ' CB ' ' CD2' ' A' ' 179' ' ' HIS . . . -170.47 177.94 3.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 110.625 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.574 ' CG2' ' CA ' ' A' ' 159' ' ' GLY . 11.5 p 179.44 143.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER 1.23 67.23 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.399 0.618 . . . . 0.0 112.096 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 148' ' ' VAL . 26.2 tt0 179.09 32.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.291 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 38.9 m80 -71.78 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.655 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -133.87 -50.96 0.08 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -169.18 -53.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -1.153 . . . . 0.0 109.96 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.47 ' C ' ' CD ' ' A' ' 156' ' ' PRO . 5.7 t80 -99.26 6.5 46.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 109.992 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.65 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 19.5 m-85 -118.13 34.71 0.21 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.092 -1.005 . . . . 0.0 110.928 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 43.7 Cg_endo -74.16 113.96 3.92 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 N-CA-C 108.867 -1.243 . . . . 0.0 108.867 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.681 ' CD1' ' CE1' ' A' ' 166' ' ' HIS . 1.8 t80 -76.11 -136.87 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.901 -1.124 . . . . 0.0 109.97 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.547 ' HB3' ' CB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -135.31 -30.55 1.02 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.796 -1.19 . . . . 0.0 110.879 -178.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.574 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 52.9 -107.67 0.59 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.533 ' HD2' ' CD ' ' A' ' 149' ' ' ARG . 31.5 Cg_endo -56.43 91.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 121.164 1.242 . . . . 0.0 110.829 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.52 ' HA3' ' OD2' ' A' ' 158' ' ' ASP . . . 161.73 -164.15 35.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 163' ' ' VAL . 41.8 m-80 -86.19 -30.53 22.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -1.226 . . . . 0.0 110.486 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.639 ' CG1' ' CZ ' ' A' ' 157' ' ' PHE . 7.9 t -39.92 100.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.591 ' HG ' ' CH2' ' A' ' 186' ' ' TRP . 0.9 OUTLIER -71.23 -70.36 0.32 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.447 -0.783 . . . . 0.0 111.723 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.546 ' HB2' ' CG1' ' A' ' 198' ' ' VAL . . . -161.37 -165.96 1.43 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.42 -1.425 . . . . 0.0 111.071 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.681 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.6 OUTLIER 179.49 -165.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.897 -1.752 . . . . 0.0 110.646 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -165.05 -167.05 1.11 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.528 ' O ' ' CB ' ' A' ' 206' ' ' SER . 86.7 m-85 -133.11 -159.71 0.99 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.97 . . . . 0.0 110.053 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.545 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -161.9 -63.26 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.062 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 46.5 Cg_endo -77.05 174.86 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.814 1.428 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.519 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 102.05 172.03 27.5 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.5 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 40.8 Cg_endo -74.81 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.665 1.577 . . . . 0.0 109.664 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.507 ' CA ' ' OE2' ' A' ' 139' ' ' GLU . . . -79.58 -35.1 29.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.3 tt -69.85 3.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 121.81 -0.817 . . . . 0.0 109.011 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 172' ' ' PRO . 5.5 t30 -64.94 61.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.391 -0.818 . . . . 0.0 109.105 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 107.47 89.51 2.08 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.606 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 76.1 m-20 -141.69 126.13 17.71 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.569 ' HB1' ' CD1' ' A' ' 144' ' ' ILE . . . -108.82 149.19 29.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.817 -1.177 . . . . 0.0 108.106 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.613 ' CD2' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -144.07 130.48 19.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.955 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.581 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 18.6 m-85 -85.17 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.574 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 p-10 -75.18 132.03 40.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.415 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 183' ' ' ASP . 6.4 t0 -75.44 -0.87 21.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.477 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 47.4 t0 -30.84 -72.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.512 0.672 . . . . 0.0 112.074 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -114.83 -110.96 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.084 -176.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.577 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 2.1 mt-30 -133.84 -168.77 2.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.817 -1.177 . . . . 0.0 109.739 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.591 ' CH2' ' HG ' ' A' ' 164' ' ' LEU . 85.2 m95 -155.07 136.13 13.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.571 ' CG2' ' N ' ' A' ' 192' ' ' GLY . 81.6 p -145.45 152.88 40.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.204 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.651 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -73.04 -34.01 66.04 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 228' ' ' ASP . 1.3 t70 -90.54 -151.07 0.24 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.593 ' N ' HD13 ' A' ' 229' ' ' LEU . 1.4 p -103.76 35.11 2.73 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.286 -1.365 . . . . 0.0 107.927 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.523 ' CB ' HG22 ' A' ' 187' ' ' THR . 13.2 m -81.6 -36.16 29.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.263 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 187' ' ' THR . . . -119.96 -81.05 0.67 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.155 -1.498 . . . . 0.0 109.699 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.526 ' CG2' HD22 ' A' ' 164' ' ' LEU . 85.0 m -127.51 -79.08 0.58 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.373 -1.074 . . . . 0.0 108.704 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.646 ' HB2' ' CB ' ' A' ' 197' ' ' LEU . 42.9 p30 179.26 60.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.672 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -18.44 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.591 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.657 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -64.34 -16.95 63.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.127 -176.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.646 ' CB ' ' HB2' ' A' ' 194' ' ' ASN . 13.3 tp -60.94 -61.17 2.77 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 117.208 -1.797 . . . . 0.0 107.724 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.583 HG22 ' CZ3' ' A' ' 186' ' ' TRP . 13.7 t -74.54 -7.66 10.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.629 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.653 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -74.89 -57.83 3.66 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -66.36 -16.47 64.09 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.585 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 8.5 t60 -70.12 -39.63 75.34 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.18 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.581 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 30.0 mt-10 -87.48 -46.96 9.13 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.028 -1.045 . . . . 0.0 110.366 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 120' ' ' ALA . 3.2 mt -61.41 -30.91 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.679 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.3 -34.85 44.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -58.68 -54.24 49.35 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.686 -0.891 . . . . 0.0 110.292 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.57 ' OG ' ' CD2' ' A' ' 207' ' ' LEU . 30.4 t -77.24 -60.21 2.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 112.486 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.617 ' CD2' ' N ' ' A' ' 207' ' ' LEU . 1.1 mm? -104.01 31.49 4.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.236 -0.915 . . . . 0.0 110.529 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.552 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -132.59 -77.95 0.14 Allowed Glycine 0 C--N 1.292 -1.912 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.83 -166.01 0.54 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.945 -1.327 . . . . 0.0 110.054 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.1 OUTLIER -98.51 -74.82 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.29 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 79.2 m80 -160.12 110.38 1.85 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.773 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 2.0 m -98.81 -172.59 2.33 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.528 ' CB ' ' CG ' ' A' ' 237' ' ' ASP . . . -65.95 78.84 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.684 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.22 9.52 12.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.624 -177.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 214' ' ' ASN . 30.5 p -48.4 -28.88 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.519 ' C ' ' HB3' ' A' ' 235' ' ' SER . 9.5 mt-10 -113.98 -37.66 4.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.684 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -67.58 162.46 23.41 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.456 1.122 . . . . 0.0 112.367 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.616 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.0 OUTLIER -56.97 -20.78 25.69 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.243 -178.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.571 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -77.59 -9.21 58.82 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 118.984 -2.323 . . . . 0.0 112.182 -177.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 34.3 t80 -133.62 17.77 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 120.178 -1.576 . . . . 0.0 113.568 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.3 Cg_endo -78.23 -36.51 0.98 Allowed 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -24.63 -57.93 0.05 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.942 -179.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.597 ' O ' ' CG ' ' A' ' 224' ' ' HIS . 0.4 OUTLIER -73.45 54.53 0.45 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.068 -1.02 . . . . 0.0 109.883 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.597 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 2.7 m170 -175.31 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.511 ' O ' ' NH1' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 179.57 121.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.994 -1.066 . . . . 0.0 109.117 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.552 ' CD2' ' CD1' ' A' ' 197' ' ' LEU . 3.1 tp 178.9 119.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER 179.12 -34.69 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 38.6 t0 -159.95 -22.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.81 -0.556 . . . . 0.0 109.596 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 190' ' ' THR . 0.2 OUTLIER -34.5 -59.17 0.47 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.195 -0.941 . . . . 0.0 110.434 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.96 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 108.791 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.511 ' NH1' ' O ' ' A' ' 225' ' ' SER . 0.3 OUTLIER -90.32 -12.97 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.581 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 21.2 p90 -30.43 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.672 0.749 . . . . 0.0 111.221 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.537 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 2.1 ttt-85 178.79 154.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.637 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 2.3 mp -76.69 163.8 26.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.229 -0.919 . . . . 0.0 109.84 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.626 ' HB3' ' HA ' ' A' ' 217' ' ' ALA . 8.3 p -101.99 -168.69 1.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.076 -1.45 . . . . 0.0 110.485 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 236' ' ' GLN . 38.9 tp60 -84.25 -14.1 50.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.839 . . . . 0.0 111.313 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.773 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.1 OUTLIER -84.46 -44.02 14.05 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.451 -1.406 . . . . 0.0 107.882 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.648 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.7 OUTLIER -67.63 -40.63 84.62 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.55 ' CD1' HG13 ' A' ' 127' ' ' VAL . 0.6 OUTLIER -55.06 -35.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.07 -47.65 70.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.462 ' HA3' HD23 ' A' ' 209' ' ' LEU . . . -60.12 -54.53 36.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.598 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.4 tp -62.01 -46.08 97.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 120.929 -1.336 . . . . 0.0 109.792 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -31.38 44.4 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 4.0 t -77.56 -20.02 54.76 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.4 OUTLIER -70.03 -61.25 1.85 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.591 ' CG ' HD23 ' A' ' 130' ' ' LEU . 23.4 m-85 -99.1 -122.84 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.442 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.453 ' C ' ' HG2' ' A' ' 129' ' ' PRO . . . 116.59 -170.27 13.32 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.92 117.7 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.024 1.539 . . . . 0.0 110.356 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.451 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 42.5 Cg_endo -73.09 173.32 13.85 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.086 1.572 . . . . 0.0 110.006 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 249' ' ' PRO . 41.2 Cg_endo -71.98 164.1 36.73 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.9 1.474 . . . . 0.0 110.129 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 252' ' ' SER . 0.9 OUTLIER -87.25 -82.46 0.22 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 251' ' ' ASP . 0.2 OUTLIER -43.45 126.8 3.76 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.88 -31.94 9.56 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.903 1.475 . . . . 0.0 110.072 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -120.83 -166.45 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.537 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.596 ' CG2' ' CG1' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.59 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.59 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.292 0.568 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 85' ' ' THR . 1.3 mtp85 -95.59 -49.36 5.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.435 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p -43.85 107.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.66 111.84 6.6 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.9 Cg_endo -73.03 156.51 51.94 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.99 1.521 . . . . 0.0 110.196 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 89' ' ' ILE . . . 79.16 -138.7 20.97 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 88' ' ' GLY . 67.5 mt -44.07 104.66 0.39 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.338 -1.095 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.535 ' HB2' ' CD2' ' A' ' 245' ' ' LEU . 42.8 Cg_endo -72.64 -162.81 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.054 1.555 . . . . 0.0 110.3 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -74.4 -78.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 109.879 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.632 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 26.7 m95 -94.95 177.18 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 109.909 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -139.66 -31.46 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.592 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -50.7 -172.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.022 -1.049 . . . . 0.0 110.401 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.52 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 9.6 p -123.55 -0.67 8.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.559 -0.713 . . . . 0.0 109.211 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 64.4 m80 -136.94 91.01 2.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.188 -0.945 . . . . 0.0 110.002 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.5 mm? -88.55 164.47 15.39 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.586 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.5 OUTLIER -142.51 155.84 45.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.618 ' CE2' ' CD1' ' A' ' 101' ' ' ILE . 5.6 p90 -137.23 163.48 30.81 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.655 -1.278 . . . . 0.0 109.276 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.534 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.2 OUTLIER -123.27 126.2 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.2 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.618 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -81.93 77.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.95 -1.094 . . . . 0.0 109.835 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' A' ' 144' ' ' ILE . 9.3 t -89.39 4.62 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.309 -0.869 . . . . 0.0 109.714 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.544 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -101.35 155.11 18.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.671 -1.268 . . . . 0.0 109.393 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 9.1 t80 177.85 76.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.622 0.725 . . . . 0.0 109.224 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.439 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 2.6 p -75.61 161.98 74.17 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.184 -0.947 . . . . 0.0 108.957 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.56 -21.45 39.78 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.921 1.485 . . . . 0.0 108.573 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -71.09 -7.38 46.15 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.613 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 84.3 mt -148.13 123.3 5.11 Favored Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.7 167.83 14.6 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.862 1.454 . . . . 0.0 108.828 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.472 ' O ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -38.3 -64.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.818 0.818 . . . . 0.0 110.361 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 115' ' ' SER . 7.6 t0 -56.17 -26.63 51.36 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.675 -0.641 . . . . 0.0 111.736 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.613 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -74.06 -61.15 1.95 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.474 -1.391 . . . . 0.0 109.442 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 103' ' ' ASN . 7.6 p -53.14 -40.09 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.471 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 1.0 OUTLIER -66.25 -27.14 67.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.55 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 7.5 p -62.01 -43.47 98.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.621 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -71.28 -34.01 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.997 -1.064 . . . . 0.0 109.41 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.539 ' CG1' HG13 ' A' ' 144' ' ' ILE . 2.9 t -71.93 -23.27 21.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 -34.89 14.36 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.649 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 1.7 tppt? -75.59 -40.77 56.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.658 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -64.89 -60.67 2.81 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' A' ' 99' ' ' TYR . 8.5 tp -44.73 -50.85 9.81 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.546 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.8 OUTLIER -73.25 -34.23 65.72 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.464 -177.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.624 ' CG2' ' CE1' ' A' ' 196' ' ' PHE . 1.5 t -54.04 -42.23 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.648 ' CE2' ' CA ' ' A' ' 204' ' ' GLY . 42.7 m95 -91.74 -23.13 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.445 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.572 ' HA ' ' CE1' ' A' ' 132' ' ' PHE . 2.5 tm-20 -70.3 -27.3 64.28 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -90.38 -43.22 10.46 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.712 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.622 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 16.3 m -58.17 -25.7 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.819 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.574 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -113.7 152.37 45.44 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.955 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.524 ' CG ' ' HA2' ' A' ' 247' ' ' GLY . 45.2 Cg_endo -73.47 2.01 6.2 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.878 1.719 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.635 ' CD1' ' CG ' ' A' ' 246' ' ' TYR . 20.5 mt -84.2 -178.06 6.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.7 p -124.25 167.37 14.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.148 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.572 ' CE1' ' HA ' ' A' ' 125' ' ' GLU . 20.0 m-85 -135.96 170.47 15.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.566 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.27 175.04 12.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 108.7 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.593 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -142.43 156.91 45.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.95 -1.094 . . . . 0.0 110.075 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.8 OUTLIER -146.77 -134.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 178.46 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.862 -1.148 . . . . 0.0 109.347 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 139' ' ' GLU . 7.8 pm0 -158.4 -177.82 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.873 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.03 -97.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 137' ' ' GLU . 2.2 pt-20 178.8 107.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.532 ' HB1' ' CD2' ' A' ' 135' ' ' LEU . . . -59.59 -151.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 108.95 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 98' ' ' THR . 31.3 m-20 -89.87 -30.71 17.72 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.572 ' CG1' ' CD1' ' A' ' 207' ' ' LEU . 20.3 mm -127.18 82.13 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.521 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.64 96.75 0.18 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 108.813 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.616 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.9 mm -81.31 117.17 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.64 150.65 49.69 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.249 -1.532 . . . . 0.0 111.867 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.572 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 17.1 p90 -81.68 141.28 33.76 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.485 -0.759 . . . . 0.0 109.117 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.461 ' HB1' ' CD2' ' A' ' 179' ' ' HIS . . . -166.1 -179.04 4.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.886 -1.134 . . . . 0.0 110.675 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 149' ' ' ARG . 1.7 p -165.36 -148.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 109.247 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.555 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 0.1 OUTLIER -31.61 -66.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.645 -0.659 . . . . 0.0 110.339 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -54.54 134.22 46.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.324 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -155.39 -84.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.766 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.84 37.16 0.59 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.484 ' OD1' ' CE2' ' A' ' 154' ' ' PHE . 8.0 t0 -179.89 -146.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.619 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.484 ' CE2' ' OD1' ' A' ' 153' ' ' ASP . 0.2 OUTLIER -102.84 47.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.141 -0.975 . . . . 0.0 109.286 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.68 ' CE2' ' CE1' ' A' ' 168' ' ' TYR . 24.8 m-85 -144.6 49.44 1.01 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.485 -0.76 . . . . 0.0 109.111 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 42.2 Cg_endo -72.0 133.86 22.33 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.177 1.619 . . . . 0.0 109.969 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.729 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -111.04 -170.59 1.66 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.205 -0.934 . . . . 0.0 110.44 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 160' ' ' PRO . 58.7 p30 -179.79 54.8 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.698 -0.626 . . . . 0.0 110.062 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.613 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 15.23 -79.89 0.0 OUTLIER Glycine 0 N--CA 1.507 3.385 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.584 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.7 Cg_endo -63.71 65.24 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.679 1.357 . . . . 0.0 110.118 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.1 135.63 3.81 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.528 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 82.6 m-20 -39.44 -36.97 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 109.975 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.642 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 2.6 t -54.73 87.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 109.168 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.585 ' CD2' ' CG2' ' A' ' 193' ' ' THR . 1.4 mp -83.65 -48.94 9.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.11 -0.994 . . . . 0.0 112.76 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.509 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -159.0 -173.14 4.09 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.096 -1.627 . . . . 0.0 111.261 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.729 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 178.24 -175.46 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.772 -1.83 . . . . 0.0 111.552 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.656 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.45 -177.82 6.6 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.68 ' CE1' ' CE2' ' A' ' 155' ' ' TYR . 22.3 m-30 -116.73 -169.59 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.756 -1.215 . . . . 0.0 111.708 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.612 ' CB ' ' HD2' ' A' ' 170' ' ' PRO . . . -116.91 -165.87 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.612 ' HD2' ' CB ' ' A' ' 169' ' ' ALA . 41.5 Cg_endo -74.05 129.76 13.59 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.073 1.039 . . . . 0.0 111.039 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . -175.19 -169.88 37.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.99 98.26 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.696 1.366 . . . . 0.0 109.772 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . 83.27 -49.1 4.17 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.2 tt -71.46 6.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.557 -0.966 . . . . 0.0 109.225 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.601 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 2.4 t-20 -64.55 62.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.79 . . . . 0.0 108.876 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.84 104.19 2.91 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.581 ' HB2' ' CD2' ' A' ' 168' ' ' TYR . 3.8 m-20 -159.04 120.5 3.37 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.881 -1.364 . . . . 0.0 107.682 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.656 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.99 172.12 7.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.59 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -162.65 137.67 6.8 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.237 1.018 . . . . 0.0 110.401 178.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.583 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 61.6 m-85 -100.49 136.75 39.88 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.746 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.495 ' O ' ' NE1' ' A' ' 186' ' ' TRP . 28.3 t0 -58.32 151.9 18.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.799 -1.188 . . . . 0.0 108.763 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.51 ' OD2' ' CD1' ' A' ' 146' ' ' PHE . 1.2 m-20 -115.73 4.05 13.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.158 -0.964 . . . . 0.0 110.194 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.613 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 17.4 m-20 -112.13 26.51 10.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.095 -1.003 . . . . 0.0 109.927 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 5.5 mt-10 -129.42 -94.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 108.702 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CD2' ' A' ' 186' ' ' TRP . 2.0 mt-30 179.05 169.56 0.94 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.604 ' CZ3' HG22 ' A' ' 198' ' ' VAL . 65.4 m95 -159.15 131.98 6.94 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.04 -1.038 . . . . 0.0 109.539 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.537 ' HA ' ' CD2' ' A' ' 108' ' ' LEU . 68.1 p -157.68 149.86 22.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.984 -1.072 . . . . 0.0 110.067 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.571 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.2 OUTLIER -80.19 -31.86 38.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.4 t70 -85.27 61.26 6.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.571 ' O ' ' CG2' ' A' ' 190' ' ' THR . 5.9 t 3.71 60.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 CA-C-O 121.958 0.885 . . . . 0.0 111.878 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.7 m -123.55 -32.0 3.42 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.32 -0.863 . . . . 0.0 109.392 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 187' ' ' THR . . . -91.03 -74.06 1.28 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.585 ' CG2' ' CD2' ' A' ' 164' ' ' LEU . 48.1 m -135.02 -79.74 0.44 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.666 ' HB2' ' CB ' ' A' ' 197' ' ' LEU . 0.0 OUTLIER 179.9 68.68 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.296 1.046 . . . . 0.0 108.861 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.686 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 2.2 tp -30.06 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.082 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.686 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -63.58 -6.73 5.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.81 -177.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.666 ' CB ' ' HB2' ' A' ' 194' ' ' ASN . 6.1 tp -67.7 -62.43 1.42 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.265 -1.774 . . . . 0.0 107.127 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.604 HG22 ' CZ3' ' A' ' 186' ' ' TRP . 3.0 m -68.29 -15.4 19.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.658 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -71.45 -61.97 1.58 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.697 -1.201 . . . . 0.0 107.938 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.572 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -63.66 -15.8 59.31 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 120.266 -1.521 . . . . 0.0 106.946 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.6 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 7.5 t60 -68.19 -48.62 64.77 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.025 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.583 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 13.6 mt-10 -81.26 -45.39 16.32 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.179 -0.951 . . . . 0.0 111.098 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.571 ' CD1' ' HB2' ' A' ' 120' ' ' ALA . 2.1 mt -62.07 -31.31 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.648 ' CA ' ' CE2' ' A' ' 124' ' ' TRP . . . -75.8 -30.77 57.31 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -61.79 -51.01 70.04 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.87 -0.782 . . . . 0.0 110.746 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.523 ' CB ' HD13 ' A' ' 142' ' ' ILE . 72.8 m -82.89 -54.93 4.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.362 -0.836 . . . . 0.0 112.174 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.632 ' CD2' ' CD1' ' A' ' 92' ' ' TRP . 7.0 mt -104.25 23.71 12.67 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.019 -1.051 . . . . 0.0 110.828 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -125.11 -79.16 0.36 Allowed Glycine 0 C--N 1.291 -1.938 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.837 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.5 pp -169.02 -160.35 0.27 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.857 -1.378 . . . . 0.0 110.02 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.576 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 1.7 t80 -97.77 -70.0 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.758 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 0.2 OUTLIER -162.59 90.81 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.624 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.4 m -79.93 176.6 9.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 0.0 109.323 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.57 81.37 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.736 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.45 9.34 13.62 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.061 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.32 -28.33 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 175.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.495 ' C ' ' HB2' ' A' ' 235' ' ' SER . 0.7 OUTLIER -114.79 -36.19 4.58 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.736 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -62.34 -165.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.159 0.98 . . . . 0.0 112.227 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.63 ' CD2' ' CE1' ' A' ' 196' ' ' PHE . 0.4 OUTLIER -102.8 -10.76 18.84 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.548 -177.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.532 ' CB ' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -81.32 -8.07 59.68 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.064 -1.647 . . . . 0.0 111.636 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.664 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -139.82 16.06 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 120.462 -1.399 . . . . 0.0 113.221 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.664 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 50.3 Cg_endo -73.98 -36.37 3.53 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.189 -1.504 . . . . 0.0 108.189 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.587 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -5.0 -73.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.168 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 221' ' ' PRO . 1.9 m-85 -67.52 60.06 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -169.79 -144.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.239 -0.913 . . . . 0.0 109.536 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 72.7 m -148.61 104.51 3.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.095 -1.003 . . . . 0.0 109.969 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.53 49.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 108.978 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.548 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 11.3 t -99.25 -12.08 20.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.615 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.4 OUTLIER 177.5 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.04 -1.038 . . . . 0.0 111.244 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.557 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -33.17 -100.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.426 -0.796 . . . . 0.0 111.241 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.6 -16.28 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.637 -1.29 . . . . 0.0 109.746 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -106.33 -22.02 12.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.164 -0.96 . . . . 0.0 108.549 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.615 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.3 p90 -24.24 116.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.362 0.601 . . . . 0.0 111.388 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.76 171.61 0.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.64 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 5.2 mp -87.61 172.14 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 111.089 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.611 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 14.5 t -104.98 -170.14 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.785 0.803 . . . . 0.0 109.985 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.548 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.0 OUTLIER -82.72 -16.38 48.27 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.66 -0.65 . . . . 0.0 109.711 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.624 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 1.0 OUTLIER -82.19 -50.6 8.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.102 -0.999 . . . . 0.0 108.34 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.731 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.2 m-20 -63.86 -38.38 90.87 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 117.053 -1.859 . . . . 0.0 106.915 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 1.0 OUTLIER -57.76 -34.82 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.57 -52.04 43.45 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.361 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.43 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -55.75 -54.46 34.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.574 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.5 tp -64.3 -44.71 97.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 120.897 -1.355 . . . . 0.0 109.716 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -54.61 -28.42 46.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 42.5 t -80.16 -20.04 45.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.564 HD23 ' CE1' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -70.4 -66.61 0.58 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.635 ' CG ' ' CD1' ' A' ' 130' ' ' LEU . 16.5 m-85 -101.52 -127.32 0.2 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.524 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 92.38 -145.27 17.57 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.175 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.487 ' HB2' ' HD2' ' A' ' 249' ' ' PRO . 41.2 Cg_endo -71.69 173.43 12.62 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.791 1.661 . . . . 0.0 110.433 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.51 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 39.5 Cg_endo -69.49 174.65 8.97 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.157 1.609 . . . . 0.0 110.171 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.511 ' O ' ' C ' ' A' ' 251' ' ' ASP . 38.1 Cg_endo -66.67 -156.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.875 1.46 . . . . 0.0 110.09 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 250' ' ' PRO . 1.8 p-10 -28.94 -52.76 0.11 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.888 -0.507 . . . . 0.0 110.923 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 251' ' ' ASP . 47.0 t -42.55 101.96 0.26 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.387 -0.821 . . . . 0.0 109.379 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 251' ' ' ASP . 42.3 Cg_endo -72.95 -43.69 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.028 1.541 . . . . 0.0 110.443 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.85 156.26 28.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.159 -0.963 . . . . 0.0 109.716 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.469 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.586 ' CG2' ' CG1' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.602 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.602 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.241 0.543 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -152.81 -169.08 3.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.535 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.515 ' HA ' ' CB ' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -44.9 113.46 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.495 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD2' ' HD2' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -45.93 171.0 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.571 ' HD2' ' CD2' ' A' ' 86' ' ' PHE . 41.8 Cg_endo -72.54 64.08 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.02 1.537 . . . . 0.0 109.96 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.64 94.41 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 89' ' ' ILE . 3.6 pt -137.5 95.14 11.56 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.254 -1.145 . . . . 0.0 109.772 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.459 ' HA ' HD22 ' A' ' 245' ' ' LEU . 42.1 Cg_endo -72.51 91.34 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.999 1.526 . . . . 0.0 109.824 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.527 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -50.34 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.966 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.634 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 49.5 m95 -100.62 177.45 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.116 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -138.56 -36.33 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -46.66 177.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.191 -0.943 . . . . 0.0 110.132 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.552 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -116.59 1.65 12.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.405 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.529 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 46.9 m170 -132.74 92.82 3.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.64 ' CB ' ' CE2' ' A' ' 132' ' ' PHE . 2.5 mm? -94.72 173.62 7.51 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.531 ' OG1' ' CD2' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -149.61 155.98 41.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.666 ' CZ ' ' CD2' ' A' ' 121' ' ' LEU . 6.1 p90 -135.52 165.65 25.02 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.483 -1.386 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.543 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -124.65 122.78 38.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -82.38 84.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 109.802 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.587 ' N ' ' O ' ' A' ' 144' ' ' ILE . 0.4 OUTLIER -102.08 8.47 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 0.0 110.097 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 145' ' ' SER . 25.4 m-80 -98.65 159.19 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.959 -1.088 . . . . 0.0 109.155 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.592 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 6.0 t80 177.56 80.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.674 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.537 HG22 ' CD1' ' A' ' 186' ' ' TRP . 33.0 p -73.72 159.34 84.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.65 -22.2 38.08 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 123.774 1.407 . . . . 0.0 108.651 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -79.53 0.75 28.46 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 95.9 mt -148.33 118.44 4.22 Favored Pre-proline 0 N--CA 1.485 1.297 0 O-C-N 121.423 -0.798 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.571 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.09 174.25 6.16 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.885 1.466 . . . . 0.0 109.139 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.16 -66.06 0.32 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.783 0.802 . . . . 0.0 110.164 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 115' ' ' SER . 2.2 m-20 -56.39 -28.47 59.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.822 -0.548 . . . . 0.0 112.358 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.628 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -72.25 -61.15 1.9 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.317 -1.489 . . . . 0.0 109.468 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.545 ' CG2' ' HB3' ' A' ' 103' ' ' ASN . 8.4 p -56.08 -44.06 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.539 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 1.1 m-20 -60.89 -28.22 68.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -58.83 -63.83 1.15 Allowed 'General case' 0 C--O 1.194 -1.822 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.579 ' HB1' ' CD1' ' A' ' 195' ' ' LEU . . . -49.28 -32.52 11.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 99' ' ' TYR . 12.1 t -73.82 -24.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -90.65 -33.65 15.74 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.75 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.661 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -82.34 -37.04 26.28 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.651 ' HB3' ' CB ' ' A' ' 199' ' ' ALA . . . -65.46 -62.16 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.666 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.0 OUTLIER -53.41 -42.04 66.61 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.547 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -70.9 -34.2 71.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.131 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.575 ' CG1' HD23 ' A' ' 234' ' ' LEU . 1.7 t -57.34 -36.88 54.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.665 ' CZ2' ' HA3' ' A' ' 204' ' ' GLY . 46.9 m95 -92.23 -24.25 19.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.929 -1.109 . . . . 0.0 110.667 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -73.11 -27.37 61.66 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.927 -1.108 . . . . 0.0 108.308 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -92.42 -42.82 9.54 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.994 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.637 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 22.7 m -62.26 -23.4 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.255 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.608 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -113.05 163.31 18.35 Favored Pre-proline 0 N--CA 1.495 1.783 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.403 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.516 ' HG3' ' N ' ' A' ' 248' ' ' PRO . 48.6 Cg_endo -81.52 22.05 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.034 1.823 . . . . 0.0 111.51 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.567 HD21 ' CG ' ' A' ' 246' ' ' TYR . 2.6 mm? -115.86 178.1 4.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.653 -1.279 . . . . 0.0 110.347 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.547 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.9 p -121.01 177.81 4.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' A' ' 97' ' ' LEU . 11.2 m-85 -146.96 146.03 29.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.765 . . . . 0.0 110.053 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.604 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 68.0 m -114.59 -170.55 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -149.82 165.45 32.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.612 -1.305 . . . . 0.0 110.992 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.531 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.3 OUTLIER -163.15 -164.54 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 78.8 t80 -160.61 25.66 0.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' GLU . 8.7 pm0 -147.11 176.76 9.7 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.78 -97.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' GLU . 18.3 tt0 178.73 145.51 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -1.143 . . . . 0.0 110.45 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -101.09 -150.75 0.4 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.607 ' O ' ' O ' ' A' ' 176' ' ' GLY . 18.2 m-20 -90.55 -34.02 15.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.549 ' CD1' HD21 ' A' ' 207' ' ' LEU . 20.1 mm -124.04 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.528 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 5.9 ttp -66.11 97.87 0.41 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 109.195 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.8 mm -81.87 114.63 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.592 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -136.3 155.57 49.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.434 -1.416 . . . . 0.0 112.371 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.1 p90 -92.89 138.04 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.688 . . . . 0.0 109.265 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.628 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -167.57 -158.65 0.28 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.29 -0.881 . . . . 0.0 110.47 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER -173.38 -165.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.05 -1.031 . . . . 0.0 109.159 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.532 ' O ' ' CG ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -49.87 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 0.0 109.759 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 148' ' ' VAL . 9.0 pt-20 179.58 32.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 0.0 109.643 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 45.5 m80 -77.98 -163.75 0.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.95 . . . . 0.0 109.428 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 153' ' ' ASP . . . -139.38 51.12 0.76 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 152' ' ' GLY . 1.1 m-20 -174.39 -91.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.648 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.421 ' C ' ' HD3' ' A' ' 156' ' ' PRO . 21.8 t80 -153.43 29.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.576 ' O ' ' CE1' ' A' ' 151' ' ' HIS . 82.0 m-85 -123.44 52.27 4.68 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.867 . . . . 0.0 109.496 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 41.1 Cg_endo -71.8 124.19 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.056 1.556 . . . . 0.0 109.943 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.765 ' CD2' ' CE1' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -80.83 -166.15 1.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.099 -1.001 . . . . 0.0 110.134 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.55 ' O ' ' C ' ' A' ' 159' ' ' GLY . 24.7 p30 179.64 60.2 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.647 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -29.3 -51.31 0.13 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.829 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 39.6 Cg_endo -66.54 60.04 0.52 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 109.301 -1.076 . . . . 0.0 109.301 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -179.27 159.96 25.07 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 164' ' ' LEU . 73.7 m-20 -52.74 -38.41 60.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.127 . . . . 0.0 110.223 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.53 ' CG2' HG22 ' A' ' 1' ' ' HAV . 42.8 t -53.3 81.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.341 -0.849 . . . . 0.0 110.545 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.566 ' N ' ' OB2' ' A' ' 3' ' ' MSB . 15.9 mt -68.63 -74.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.341 -0.849 . . . . 0.0 111.85 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.668 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -135.41 -176.26 4.21 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.491 -1.381 . . . . 0.0 111.614 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.746 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.5 p-80 178.98 168.55 0.94 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.564 -1.335 . . . . 0.0 110.107 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -132.92 -168.08 2.02 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.529 ' HB3' HG13 ' A' ' 174' ' ' ILE . 77.5 m-85 -114.4 -167.27 1.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.8 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.605 ' CB ' ' HD2' ' A' ' 170' ' ' PRO . . . -126.15 -175.62 0.43 Allowed Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.605 ' HD2' ' CB ' ' A' ' 169' ' ' ALA . 38.8 Cg_endo -68.9 140.19 45.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.537 1.283 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.437 ' C ' ' OD1' ' A' ' 175' ' ' ASN . . . 171.76 -125.49 1.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.499 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.0 Cg_endo -73.98 -93.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.812 1.427 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -108.37 -18.34 9.8 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.4 OUTLIER -73.3 12.17 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -1.064 . . . . 0.0 108.951 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 175' ' ' ASN . 0.6 OUTLIER -64.34 63.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.607 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 106.35 101.55 2.73 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.6 m-20 -163.16 120.11 1.86 Allowed 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.566 -1.549 . . . . 0.0 107.659 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -112.07 164.85 12.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.894 -1.129 . . . . 0.0 109.184 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.765 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 0.2 OUTLIER -162.15 134.75 5.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.867 -1.133 . . . . 0.0 109.778 178.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.601 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 34.4 m-85 -95.48 132.67 40.32 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.514 ' HB3' ' CD1' ' A' ' 157' ' ' PHE . 24.5 p30 -66.72 130.19 42.37 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 182' ' ' ASP . 48.1 p30 -96.09 22.73 7.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.976 -1.077 . . . . 0.0 110.437 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.647 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.4 OUTLIER -90.75 -19.61 23.32 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.907 -1.121 . . . . 0.0 109.889 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.496 ' OE2' ' O ' ' A' ' 159' ' ' GLY . 0.9 OUTLIER -112.11 -130.78 0.31 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.896 -1.127 . . . . 0.0 108.595 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 35.3 mt-30 -130.97 -175.46 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.161 . . . . 0.0 109.097 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.585 ' CD1' ' O ' ' A' ' 185' ' ' GLN . 86.0 m95 -160.83 126.03 3.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 108.954 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.476 HG21 ' HA3' ' A' ' 192' ' ' GLY . 50.7 p -145.66 150.07 35.64 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.828 -1.17 . . . . 0.0 110.453 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 2.7 pttm -84.45 -33.18 23.71 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 27.9 t70 -82.31 63.72 6.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.618 ' O ' ' CG2' ' A' ' 190' ' ' THR . 1.7 t 2.82 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 122.311 1.053 . . . . 0.0 112.016 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.0 m -127.31 -31.05 2.58 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.783 -1.198 . . . . 0.0 109.927 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 187' ' ' THR . . . -96.98 -80.41 1.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.517 ' CG2' HD11 ' A' ' 164' ' ' LEU . 37.5 m -125.12 -96.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.59 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -161.77 67.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.579 ' CD1' ' HB1' ' A' ' 116' ' ' ALA . 14.7 tp -37.97 -98.91 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.757 -0.589 . . . . 0.0 110.93 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.661 ' CD1' ' HB3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -58.73 -11.53 3.26 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.722 -1.236 . . . . 0.0 110.461 -178.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.59 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 6.2 tp -64.92 -71.29 0.19 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 116.807 -1.957 . . . . 0.0 106.595 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' A' ' 201' ' ' HIS . 3.3 t -67.55 -4.57 3.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.433 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.651 ' CB ' ' HB3' ' A' ' 120' ' ' ALA . . . -75.21 -57.94 3.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.592 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -66.55 -16.91 64.51 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.602 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 3.0 t60 -69.5 -37.44 77.19 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.069 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.578 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 2.8 mt-10 -87.65 -48.65 7.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.9 mt -59.16 -31.55 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.665 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -82.21 -34.4 23.63 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.565 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 0.1 OUTLIER -56.31 -45.81 80.1 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.524 -0.986 . . . . 0.0 110.374 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 167' ' ' ALA . 1.0 OUTLIER -89.56 -54.1 4.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 111.582 -178.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -104.16 36.31 2.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.198 -0.939 . . . . 0.0 110.753 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.564 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -141.89 -78.14 0.05 OUTLIER Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.047 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.2 -160.35 0.26 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.89 -1.359 . . . . 0.0 110.27 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.575 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.3 OUTLIER -102.54 -77.72 0.55 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.473 -0.767 . . . . 0.0 109.36 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.582 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.6 m-70 -159.44 121.75 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.453 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.618 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -109.56 -168.37 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.38 74.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.749 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -79.71 7.36 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.289 -176.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.449 ' C ' ' O ' ' A' ' 214' ' ' ASN . 2.7 p -50.47 -27.66 6.92 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.483 ' N ' ' C ' ' A' ' 214' ' ' ASN . 4.9 mp0 -114.84 -34.72 5.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.749 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -159.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.296 1.046 . . . . 0.0 112.247 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.629 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 3.3 tm? -96.7 -19.96 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.38 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.582 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -78.99 -8.49 58.97 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.249 -1.532 . . . . 0.0 112.319 -177.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.687 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 41.0 t80 -132.42 14.49 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 120.412 -1.43 . . . . 0.0 113.312 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -76.97 -37.97 0.96 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 N-CA-C 109.157 -1.132 . . . . 0.0 109.157 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.584 ' CB ' ' CE2' ' A' ' 3' ' ' MSB . 1.4 tt -19.48 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.526 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.579 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 0.2 OUTLIER -67.69 59.88 0.06 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.303 -0.873 . . . . 0.0 109.004 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' LEU . 9.2 t-160 179.89 -133.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.072 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.529 ' O ' ' CD1' ' A' ' 226' ' ' LEU . 49.8 m -160.57 114.92 2.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 109.929 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.529 ' CD1' ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER 179.51 57.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 188' ' ' LYS . 4.8 t -113.92 -8.61 13.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.873 . . . . 0.0 109.516 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.585 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 1.0 OUTLIER 178.06 -21.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.742 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.549 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.2 OUTLIER -37.03 -60.59 0.62 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.15 -0.969 . . . . 0.0 110.127 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.22 -31.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.5 ' HB2' ' CG ' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -89.33 -21.84 22.93 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.586 ' CD2' ' O ' ' A' ' 232' ' ' PHE . 45.4 p90 -38.25 116.44 0.53 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.501 0.667 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.58 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.4 ttt180 179.3 152.86 0.41 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 109.126 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.651 HD23 ' CH2' ' A' ' 124' ' ' TRP . 4.0 mp -68.69 167.47 15.18 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.082 -1.011 . . . . 0.0 110.044 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.632 ' HB3' ' CB ' ' A' ' 217' ' ' ALA . 10.2 t -101.04 -169.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.571 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.3 OUTLIER -83.92 -23.08 31.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.924 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.618 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 4.6 m-20 -81.32 -40.06 24.2 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.847 -1.141 . . . . 0.0 107.934 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.598 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 17.2 t0 -70.46 -35.49 73.35 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 117.828 -1.549 . . . . 0.0 107.766 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.608 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.8 OUTLIER -61.25 -34.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.69 -45.33 79.16 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.29 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.513 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -60.68 -58.93 11.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.608 ' CD1' HG23 ' A' ' 128' ' ' THR . 0.7 OUTLIER -61.69 -44.68 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.742 -1.446 . . . . 0.0 109.623 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -54.76 -24.96 24.81 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -87.0 -14.59 41.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.526 ' HB3' HD13 ' A' ' 242' ' ' ILE . 0.4 OUTLIER -74.9 -56.34 4.85 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.567 ' CG ' HD21 ' A' ' 130' ' ' LEU . 16.4 m-85 -92.09 -105.47 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.215 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.423 ' C ' ' HG3' ' A' ' 129' ' ' PRO . . . 131.72 133.1 3.43 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.408 -1.377 . . . . 0.0 109.842 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.516 ' N ' ' HG3' ' A' ' 129' ' ' PRO . 43.0 Cg_endo -73.97 129.88 13.79 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.991 1.522 . . . . 0.0 110.02 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.99 132.13 17.84 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.957 1.503 . . . . 0.0 110.054 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 251' ' ' ASP . 42.0 Cg_endo -72.38 -177.89 2.99 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.997 1.525 . . . . 0.0 110.051 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 250' ' ' PRO . 0.3 OUTLIER -44.03 -46.98 8.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.504 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 79.5 p -105.85 138.21 19.57 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.875 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.47 -10.19 25.09 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.032 1.543 . . . . 0.0 110.098 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.11 179.35 4.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.494 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.602 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.599 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.599 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.246 0.546 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -68.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.559 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 86' ' ' PHE . 1.5 t 179.86 -169.11 0.12 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.508 ' N ' ' OG1' ' A' ' 85' ' ' THR . 2.9 t80 -94.71 106.2 23.04 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.2 Cg_endo -72.88 148.91 46.65 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.943 1.496 . . . . 0.0 110.071 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.445 ' O ' ' CG2' ' A' ' 89' ' ' ILE . . . 107.09 -58.2 0.42 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.455 ' HB ' ' HD2' ' A' ' 90' ' ' PRO . 3.4 pt -160.2 163.19 22.63 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.161 -1.2 . . . . 0.0 109.659 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.466 ' HB2' HD21 ' A' ' 245' ' ' LEU . 42.0 Cg_endo -72.61 160.37 46.67 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.047 1.551 . . . . 0.0 110.058 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.517 ' N ' HD22 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -55.34 -80.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.638 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 7.0 m95 -98.67 -165.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.86 -1.15 . . . . 0.0 109.606 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.9 ppt_? -145.24 -40.61 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.984 -1.073 . . . . 0.0 110.582 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -45.26 174.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.085 -1.009 . . . . 0.0 110.377 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.544 ' HA ' ' CG ' ' A' ' 130' ' ' LEU . 11.6 p -112.15 2.66 16.81 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.529 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 17.8 m-70 -144.09 98.18 3.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.949 -1.094 . . . . 0.0 109.863 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.629 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.5 mm? -95.11 168.08 10.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.508 -0.745 . . . . 0.0 109.9 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -142.37 156.42 45.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.633 ' CE2' ' CD1' ' A' ' 101' ' ' ILE . 7.9 p90 -135.98 165.53 25.46 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.668 -1.27 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 121.94 35.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.889 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.633 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.2 mp -77.7 84.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.933 -1.104 . . . . 0.0 109.29 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.666 ' N ' ' O ' ' A' ' 144' ' ' ILE . 1.4 t -96.66 8.81 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 110.552 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -111.78 169.22 8.98 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.308 -1.495 . . . . 0.0 109.41 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.474 ' HA ' HG13 ' A' ' 113' ' ' VAL . 4.3 p90 178.77 44.72 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.651 -0.656 . . . . 0.0 109.531 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 104' ' ' TYR . 70.5 p -41.26 153.79 0.24 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.474 -0.766 . . . . 0.0 109.048 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.03 -23.96 45.82 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 123.829 1.436 . . . . 0.0 108.766 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -69.19 -9.94 55.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.593 ' CD1' ' CD1' ' A' ' 195' ' ' LEU . 85.7 mt -144.42 115.83 5.4 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.8 Cg_endo -64.09 167.69 13.8 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 123.81 1.426 . . . . 0.0 109.295 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.513 ' NZ ' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -35.49 -64.6 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.8 0.809 . . . . 0.0 110.477 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -59.76 -19.32 49.54 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.685 -0.635 . . . . 0.0 111.777 -178.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.592 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -80.36 -62.74 1.59 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.312 -1.493 . . . . 0.0 109.021 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 103' ' ' ASN . 9.6 p -49.41 -40.5 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.513 ' OD2' ' NZ ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -67.19 -27.52 67.33 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 112' ' ' ALA . 21.6 p -64.42 -42.5 96.0 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.654 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -71.42 -33.33 69.33 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.625 ' CG1' HG13 ' A' ' 144' ' ' ILE . 2.4 t -73.73 -25.18 20.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.572 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 2.0 tt0 -84.66 -36.67 21.77 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.744 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.69 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -78.83 -38.94 36.83 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.656 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -62.93 -61.48 2.37 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.632 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.0 OUTLIER -50.26 -40.15 47.13 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.988 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -77.51 -33.45 54.34 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.37 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.604 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 3.8 t -52.49 -44.5 44.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.684 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 33.4 m95 -92.2 -23.14 19.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 26.8 tt0 -69.67 -26.74 64.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.3 pt-20 -90.96 -42.99 10.25 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.648 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.631 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 14.5 m -59.57 -23.78 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.274 -1.37 . . . . 0.0 108.988 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -116.89 163.42 22.84 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.519 -1.272 . . . . 0.0 109.289 179.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.495 ' HG2' ' CD ' ' A' ' 248' ' ' PRO . 46.9 Cg_endo -77.58 -8.47 17.09 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.336 1.703 . . . . 0.0 109.883 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.544 ' CG ' ' HA ' ' A' ' 95' ' ' THR . 0.4 OUTLIER -70.19 179.55 2.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 110.536 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.467 ' OG1' ' ND1' ' A' ' 96' ' ' HIS . 6.7 p -127.3 174.38 9.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 1.1 m-85 -145.44 161.89 38.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.586 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -143.38 -174.36 4.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.592 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -152.04 155.6 38.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.901 -1.124 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.8 OUTLIER -147.41 -135.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.417 -0.802 . . . . 0.0 108.912 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 45.3 t80 178.94 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.793 -1.192 . . . . 0.0 109.23 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 139' ' ' GLU . 1.8 pm0 -158.57 -176.65 6.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.779 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.49 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -1.103 . . . . 0.0 110.184 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' A' ' 135' ' ' LEU . . . -60.15 -151.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 108.722 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 98' ' ' THR . 0.9 OUTLIER -91.65 -25.82 18.96 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 206' ' ' SER . 17.7 mm -127.81 86.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.528 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -67.15 97.17 0.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 102' ' ' VAL . 0.7 OUTLIER -82.37 116.19 26.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -134.49 153.18 52.06 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 119.944 -1.722 . . . . 0.0 112.388 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 147' ' ' ALA . 1.6 t80 -90.7 135.71 33.53 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.569 ' HB2' ' CE1' ' A' ' 179' ' ' HIS . . . -168.57 -152.65 0.11 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.725 -1.234 . . . . 0.0 111.17 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.557 ' CG2' ' HA3' ' A' ' 159' ' ' GLY . 2.1 p -178.3 -169.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.507 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.1 OUTLIER -30.12 -37.01 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.684 -0.635 . . . . 0.0 111.118 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 148' ' ' VAL . 3.9 mm-40 -81.2 110.54 16.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.026 . . . . 0.0 109.699 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.58 ' CD2' ' HB3' ' A' ' 155' ' ' TYR . 21.8 m80 -126.17 -91.51 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 109.554 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.93 -44.11 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.49 -95.25 0.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.074 -1.251 . . . . 0.0 109.888 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -117.47 67.33 0.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.032 . . . . 0.0 109.824 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.651 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -147.22 41.27 0.26 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.892 . . . . 0.0 109.902 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 42.0 Cg_endo -71.95 107.21 2.17 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.515 1.271 . . . . 0.0 109.13 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.645 ' CE1' ' CG1' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.5 -140.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.532 ' O ' ' CD ' ' A' ' 160' ' ' PRO . 0.0 OUTLIER -134.75 -23.54 1.58 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.496 -1.377 . . . . 0.0 111.312 -178.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 41.52 -96.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 158' ' ' ASP . 34.3 Cg_endo -59.68 76.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.265 1.14 . . . . 0.0 110.052 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 175.98 -167.31 38.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 163' ' ' VAL . 58.3 m-80 -87.25 -27.75 22.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -1.192 . . . . 0.0 109.964 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.645 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 16.9 t -35.79 140.58 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.426 0.631 . . . . 0.0 110.862 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.62 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 0.4 OUTLIER -105.17 -90.81 0.4 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.465 -0.772 . . . . 0.0 112.31 -179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -147.27 -168.89 3.17 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.113 -1.617 . . . . 0.0 111.541 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.651 ' CE1' ' CE1' ' A' ' 155' ' ' TYR . 0.5 OUTLIER 179.95 171.98 1.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 119.682 -1.886 . . . . 0.0 111.024 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -147.55 -164.54 2.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.399 -0.813 . . . . 0.0 109.99 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.646 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -131.9 -163.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.883 -1.136 . . . . 0.0 110.643 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.559 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -163.98 -62.84 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.093 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 45.8 Cg_endo -77.09 158.95 33.98 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.779 1.41 . . . . 0.0 109.966 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . 115.32 173.69 17.71 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -76.55 -89.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.683 1.589 . . . . 0.0 110.138 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -78.13 -35.44 34.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.646 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.5 tp -68.96 -0.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.925 . . . . 0.0 108.967 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 172' ' ' PRO . 2.6 t30 -65.82 64.22 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 119.81 90.63 1.25 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.587 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -158.07 127.01 5.64 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.839 -1.389 . . . . 0.0 108.159 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -115.88 168.16 10.3 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.117 -0.99 . . . . 0.0 108.714 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.97 134.39 4.28 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.205 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.587 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 53.1 m-85 -90.08 127.99 36.2 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.24 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 1.0 OUTLIER -76.62 144.78 39.31 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.949 -1.094 . . . . 0.0 109.205 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 183' ' ' ASP . 27.3 t0 -62.44 -2.16 0.98 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.21 -0.931 . . . . 0.0 110.381 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.571 ' OD2' ' CZ2' ' A' ' 186' ' ' TRP . 1.2 p30 3.9 -95.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 183' ' ' ASP . 7.5 mp0 -147.59 -51.15 0.19 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.873 -1.142 . . . . 0.0 110.509 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -140.79 172.0 13.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 0.0 110.926 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.62 ' CH2' ' CD1' ' A' ' 164' ' ' LEU . 85.8 m95 -160.58 129.77 4.9 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.529 HG22 ' N ' ' A' ' 192' ' ' GLY . 33.4 p -146.88 155.93 42.7 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.555 -1.341 . . . . 0.0 110.428 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.596 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 3.2 pttt -78.02 -33.11 51.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.545 ' O ' ' CG2' ' A' ' 227' ' ' THR . 2.9 t0 -90.48 -143.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.564 ' N ' HD13 ' A' ' 229' ' ' LEU . 11.4 t -115.37 45.64 1.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.851 -1.155 . . . . 0.0 108.264 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.479 ' HB ' HG22 ' A' ' 187' ' ' THR . 53.7 m -102.69 -30.3 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.326 -0.859 . . . . 0.0 111.084 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.529 ' N ' HG22 ' A' ' 187' ' ' THR . . . -108.52 -90.59 2.12 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.363 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.517 HG23 ' CD1' ' A' ' 164' ' ' LEU . 89.6 m -120.68 -80.21 0.62 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.703 ' HB2' ' CB ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER 178.15 66.79 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.582 1.182 . . . . 0.0 108.435 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.664 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 1.2 tp -20.03 -95.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.952 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.69 ' CG ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -62.06 -15.01 41.75 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.055 -1.028 . . . . 0.0 110.883 -176.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.703 ' CB ' ' HB2' ' A' ' 194' ' ' ASN . 13.3 tp -60.75 -57.46 12.58 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.251 -1.78 . . . . 0.0 107.199 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.548 ' CG2' ' ND2' ' A' ' 194' ' ' ASN . 2.4 t -74.72 -9.25 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.749 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.656 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -78.24 -57.85 3.57 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.35 -1.34 . . . . 0.0 107.503 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 120' ' ' ALA . . . -64.03 -17.91 63.81 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.583 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 3.3 t-160 -69.39 -40.95 77.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.17 -1.812 . . . . 0.0 107.849 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.587 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 3.5 mt-10 -82.89 -49.12 9.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.954 -1.091 . . . . 0.0 110.79 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.56 HD11 ' N ' ' A' ' 121' ' ' LEU . 3.2 mt -60.59 -31.47 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.684 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.79 -34.09 49.46 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -57.24 -53.15 61.34 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.61 -0.935 . . . . 0.0 109.773 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.594 ' HB2' ' CD1' ' A' ' 142' ' ' ILE . 2.6 m -77.81 -64.19 1.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.583 -0.698 . . . . 0.0 111.671 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.638 ' CD1' ' CD1' ' A' ' 92' ' ' TRP . 2.8 mm? -101.36 37.99 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -0.802 . . . . 0.0 110.614 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -135.83 -69.22 0.06 OUTLIER Glycine 0 C--N 1.289 -2.046 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.5 pp 179.75 -161.86 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.933 0 O-C-N 120.633 -1.51 . . . . 0.0 109.387 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.581 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 16.3 t80 -102.11 -71.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.259 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 54.4 m80 -162.16 102.05 1.11 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.788 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.5 m -93.07 -174.68 3.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.517 ' CB ' ' CG ' ' A' ' 237' ' ' ASP . . . -64.95 78.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.713 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.43 9.3 13.69 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.422 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 214' ' ' ASN . 73.7 p -50.42 -27.72 6.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.492 ' C ' ' HB2' ' A' ' 235' ' ' SER . 8.3 mt-10 -113.75 -37.01 4.67 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.716 ' HB3' ' HB2' ' A' ' 238' ' ' ASP . . . -64.35 -171.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.45 1.119 . . . . 0.0 112.72 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.626 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.0 OUTLIER -84.64 -18.9 33.95 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.937 -177.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.572 ' HA ' ' CE1' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 119.262 -2.149 . . . . 0.0 112.171 -177.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.671 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 35.3 t80 -134.99 15.63 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.257 -1.527 . . . . 0.0 113.39 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.671 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.8 Cg_endo -77.97 -41.17 0.32 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' A' ' 3' ' ' MSB . 18.9 tp -6.87 -74.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.5 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -65.45 63.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.492 -0.755 . . . . 0.0 109.779 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.82 -162.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.451 ' O ' HD11 ' A' ' 226' ' ' LEU . 16.2 m -131.99 116.17 16.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.103 -0.998 . . . . 0.0 109.693 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.53 ' CD1' ' HD3' ' A' ' 231' ' ' ARG . 5.5 tp 179.49 31.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.627 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 6.6 t -77.61 -52.77 8.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.625 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 5.2 t0 -151.49 3.22 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.745 -1.222 . . . . 0.0 110.952 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.564 HD13 ' N ' ' A' ' 190' ' ' THR . 1.2 mm? -41.41 -101.04 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.906 -1.121 . . . . 0.0 110.912 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -18.22 3.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.701 -1.249 . . . . 0.0 109.85 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.544 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -105.48 -42.03 5.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 108.386 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.625 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 9.5 p90 0.36 117.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.539 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.05 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.641 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 2.5 mp -80.27 166.49 21.32 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.756 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 28.9 t -98.38 -171.84 2.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.354 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.484 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.08 -11.83 54.38 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.726 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.1 OUTLIER -85.34 -46.99 10.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.889 -1.132 . . . . 0.0 107.971 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.716 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.2 m-20 -66.87 -38.04 85.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 117.201 -1.8 . . . . 0.0 106.554 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -58.04 -34.55 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 1.3 t-20 -66.69 -49.23 66.76 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.88 -50.62 65.76 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.28 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 208' ' ' GLY . 1.9 tp -68.27 -48.44 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 120.741 -1.447 . . . . 0.0 110.665 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 240' ' ' ASN . 15.0 pt20 -54.77 -23.08 16.3 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.1 p -88.66 -17.07 30.8 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -74.22 -59.36 2.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.497 ' CD1' HD23 ' A' ' 130' ' ' LEU . 15.2 m-85 -92.33 -120.94 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.502 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.469 ' HA2' ' HG3' ' A' ' 129' ' ' PRO . . . 63.37 91.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.495 ' CD ' ' HG2' ' A' ' 129' ' ' PRO . 39.8 Cg_endo -68.7 173.75 9.54 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.623 1.549 . . . . 0.0 110.18 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 40.5 Cg_endo -70.1 154.1 66.72 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.952 1.501 . . . . 0.0 110.347 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 251' ' ' ASP . 42.9 Cg_endo -73.24 -47.34 0.31 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.755 1.637 . . . . 0.0 110.229 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 250' ' ' PRO . 5.5 m-20 -56.14 -154.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.712 -0.618 . . . . 0.0 110.184 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.453 ' C ' ' O ' ' A' ' 251' ' ' ASP . 18.0 m -38.78 99.2 0.19 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.476 -0.765 . . . . 0.0 110.225 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 251' ' ' ASP . 43.7 Cg_endo -74.8 -44.85 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.119 1.589 . . . . 0.0 109.998 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 253' ' ' PRO . 0.0 OUTLIER -45.18 170.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.631 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.553 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.583 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.589 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.594 ' CD2' ' CD2' ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 -96.48 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 109.505 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -56.19 12.62 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.125 -0.985 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -164.05 141.65 5.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 86' ' ' PHE . 42.1 Cg_endo -72.54 -2.43 11.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.005 1.529 . . . . 0.0 110.145 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.44 -113.12 0.65 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.559 ' CD1' ' N ' ' A' ' 89' ' ' ILE . 1.7 mp -73.01 134.84 80.65 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.251 -1.146 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.455 ' HD2' HG21 ' A' ' 89' ' ' ILE . 41.9 Cg_endo -72.03 -171.31 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.993 1.523 . . . . 0.0 110.048 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 206' ' ' SER . 0.1 OUTLIER -73.4 -95.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 109.372 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.646 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 50.7 m95 -111.42 163.69 13.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.028 -1.045 . . . . 0.0 109.532 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -131.95 -28.01 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.537 -179.325 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.561 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -40.13 165.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.373 -0.829 . . . . 0.0 110.625 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.581 ' O ' ' CD2' ' A' ' 96' ' ' HIS . 2.1 p -107.63 5.21 26.67 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.462 -0.774 . . . . 0.0 109.185 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.632 ' CE1' ' CG2' ' A' ' 131' ' ' THR . 33.4 m-70 -150.72 103.49 3.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.453 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.59 ' CD1' ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -116.33 -165.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 109.91 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.575 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -161.43 162.35 30.55 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.594 ' CE1' HD23 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -137.9 160.78 38.38 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.875 -1.141 . . . . 0.0 109.181 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' HG3' ' CD1' ' A' ' 135' ' ' LEU . 1.2 ttp180 -123.09 126.63 47.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 109.807 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.5 mp -85.09 84.37 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.005 -1.059 . . . . 0.0 109.677 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.59 ' N ' ' O ' ' A' ' 144' ' ' ILE . 2.6 t -100.35 8.03 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.007 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.535 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -100.99 157.04 17.05 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.783 -1.198 . . . . 0.0 109.353 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.594 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.6 OUTLIER 177.99 75.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 108' ' ' LEU . 11.5 p -70.6 159.5 84.85 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -68.14 -21.86 41.78 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.808 1.425 . . . . 0.0 108.686 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 1.5 t0 -70.28 -8.73 52.6 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.618 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 93.5 mt -147.07 124.14 5.76 Favored Pre-proline 0 N--CA 1.484 1.233 0 O-C-N 121.585 -0.697 . . . . 0.0 109.848 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.11 169.84 12.88 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 O-C-N 123.811 1.427 . . . . 0.0 109.007 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' O ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -38.08 -65.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.971 0.891 . . . . 0.0 110.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 115' ' ' SER . 1.6 p-10 -53.97 -32.32 53.58 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.743 -0.598 . . . . 0.0 112.033 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.618 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -70.91 -61.4 1.78 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.533 -1.354 . . . . 0.0 109.635 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.542 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 8.7 p -53.3 -41.2 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.501 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 1.1 m-20 -64.35 -27.27 68.9 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.536 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 6.2 p -63.51 -43.73 96.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.589 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -68.23 -33.1 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.108 -0.995 . . . . 0.0 109.492 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.539 ' CG1' HG13 ' A' ' 101' ' ' ILE . 5.0 t -76.26 -22.0 15.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.521 ' HA ' HD22 ' A' ' 121' ' ' LEU . 1.2 tt0 -88.24 -34.12 17.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.649 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.8 OUTLIER -82.45 -36.33 26.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -67.28 -61.18 2.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.338 1.066 . . . . 0.0 108.588 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.594 HD23 ' CE1' ' A' ' 99' ' ' TYR . 1.6 pp -57.0 -40.8 77.29 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.526 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.47 -32.69 62.66 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.898 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.586 HG23 ' CE1' ' A' ' 196' ' ' PHE . 0.9 OUTLIER -55.41 -42.04 65.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.658 ' CH2' ' CD2' ' A' ' 234' ' ' LEU . 37.7 m95 -91.23 -23.97 20.03 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.536 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 132' ' ' PHE . 3.5 tm-20 -69.57 -27.44 65.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.851 -1.156 . . . . 0.0 107.89 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 13.9 pt-20 -90.58 -42.84 10.57 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.738 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.629 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 15.8 m -59.2 -24.52 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.139 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -114.26 154.82 46.27 Favored Pre-proline 0 N--CA 1.494 1.731 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.573 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.535 ' CG ' ' HA2' ' A' ' 247' ' ' GLY . 50.2 Cg_endo -82.49 29.31 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.136 1.891 . . . . 0.0 110.472 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.53 ' CG ' ' HA ' ' A' ' 95' ' ' THR . 0.8 OUTLIER -99.44 -179.95 4.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.95 -1.094 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.632 ' CG2' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -112.9 161.18 17.28 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.59 ' CE2' ' CD1' ' A' ' 97' ' ' LEU . 53.2 m-85 -147.72 148.74 31.32 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.061 -1.024 . . . . 0.0 110.901 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.575 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -130.2 -179.23 5.12 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.812 -1.18 . . . . 0.0 110.207 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.529 ' CD1' ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.49 -163.78 1.52 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.215 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.517 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 69.5 t80 -155.79 21.22 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 26.0 pm0 -143.98 -174.62 4.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.637 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.04 -97.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 137' ' ' GLU . 11.6 pt-20 178.8 130.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -1.133 . . . . 0.0 110.157 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.481 ' HB3' ' OG1' ' A' ' 98' ' ' THR . . . -89.78 -147.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.227 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 98' ' ' THR . 12.9 t0 -92.89 -33.16 14.32 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.541 ' CG2' HD12 ' A' ' 144' ' ' ILE . 22.1 mt -126.64 80.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.457 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.8 ttp -64.26 94.04 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.121 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.4 mm -79.17 118.76 27.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -137.76 158.16 44.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.349 -1.469 . . . . 0.0 111.983 -179.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.52 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 23.6 p90 -90.91 138.62 31.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 109.591 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.633 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -162.27 -159.05 0.56 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.178 -0.951 . . . . 0.0 110.003 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.524 ' O ' ' ND1' ' A' ' 151' ' ' HIS . 1.5 p -174.85 -168.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.923 -1.11 . . . . 0.0 109.274 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -41.89 -26.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 0.0 109.972 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 150' ' ' GLU . 5.3 pt-20 -67.41 59.12 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.939 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.687 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 34.7 m80 -97.22 -79.18 0.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.159 -0.963 . . . . 0.0 109.257 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 164.15 -61.69 0.25 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.57 ' O ' ' CG ' ' A' ' 154' ' ' PHE . 0.4 OUTLIER 179.59 53.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -1.171 . . . . 0.0 109.639 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.57 ' CG ' ' O ' ' A' ' 153' ' ' ASP . 93.4 m-85 -158.31 -39.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 110.094 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.687 ' CD1' ' CD2' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -151.91 71.23 7.95 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.11 -0.994 . . . . 0.0 109.9 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.82 118.35 5.4 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.03 1.542 . . . . 0.0 109.743 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.715 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -95.08 -160.63 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.982 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 160' ' ' PRO . 20.5 p30 178.86 50.59 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.567 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.69 -74.38 0.0 OUTLIER Glycine 0 N--CA 1.509 3.512 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.582 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.7 Cg_endo -65.17 61.28 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.237 1.292 . . . . 0.0 109.99 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.42 143.9 8.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -42.12 -41.17 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -1.115 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.522 ' CG2' ' OD1' ' A' ' 158' ' ' ASP . 31.0 m -55.01 84.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.802 . . . . 0.0 109.871 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.557 ' N ' ' OB2' ' A' ' 3' ' ' MSB . 15.8 mt -71.84 -80.27 0.06 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.311 -0.868 . . . . 0.0 112.822 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.595 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -136.2 -174.65 3.74 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.469 -1.395 . . . . 0.0 111.489 -177.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.715 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.5 p-80 -179.99 167.62 1.28 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.273 -1.517 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -141.43 -166.13 2.12 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.215 -0.928 . . . . 0.0 110.391 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.618 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -128.59 -160.86 1.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.1 -1.0 . . . . 0.0 110.73 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.545 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -166.06 -60.3 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.493 -0.755 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 46.6 Cg_endo -79.16 -172.31 1.5 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.725 1.382 . . . . 0.0 110.083 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.18 144.37 0.64 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.6 Cg_endo -70.37 136.88 32.43 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.854 1.449 . . . . 0.0 110.061 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 71.3 -64.15 1.02 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.618 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 0.6 OUTLIER -64.31 -7.82 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.969 . . . . 0.0 109.164 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -65.72 66.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.894 . . . . 0.0 108.958 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 126.88 81.58 0.37 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.7 m-20 -155.87 126.83 6.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.935 -1.332 . . . . 0.0 108.016 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -113.43 168.26 9.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.325 -0.86 . . . . 0.0 109.086 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.633 ' CE1' ' CB ' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.27 135.14 5.07 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.751 178.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.596 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 58.1 m-85 -95.29 134.4 38.11 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.896 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.497 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -68.65 132.64 47.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.028 -1.469 . . . . 0.0 107.41 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -105.8 37.0 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.87 -1.144 . . . . 0.0 110.332 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.567 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 1.9 m-20 -114.25 -2.76 13.27 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.379 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.524 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 5.5 pt-20 -119.24 -111.65 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.056 -1.027 . . . . 0.0 108.627 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 48.6 mt-30 -148.22 174.7 11.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.818 -1.176 . . . . 0.0 109.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.585 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 90.3 m95 -162.14 126.49 3.23 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.464 HG21 ' HA3' ' A' ' 192' ' ' GLY . 71.3 p -150.14 155.38 39.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.724 -1.235 . . . . 0.0 110.627 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 1.1 ptpt -83.67 -30.58 26.7 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.65 ' O ' ' N ' ' A' ' 191' ' ' THR . 30.7 t0 -87.28 63.7 7.91 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.573 ' C ' ' O ' ' A' ' 189' ' ' ASP . 6.2 t 4.41 59.68 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.883 0.849 . . . . 0.0 111.789 -177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.65 ' N ' ' O ' ' A' ' 189' ' ' ASP . 47.7 m -124.49 -31.49 3.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.252 -0.905 . . . . 0.0 109.682 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.464 ' HA3' HG21 ' A' ' 187' ' ' THR . . . -94.9 -78.69 1.42 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.529 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 18.4 m -129.9 -95.16 0.39 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.605 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -161.37 73.43 0.44 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.666 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 2.4 tp -34.4 -96.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.631 0.729 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.666 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.4 OUTLIER -67.56 -8.13 31.7 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -177.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.605 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 12.2 tp -68.7 -63.13 1.12 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 116.42 -2.112 . . . . 0.0 106.924 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.545 ' HA ' ' CB ' ' A' ' 201' ' ' HIS . 9.2 t -71.41 -8.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.67 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -74.49 -58.59 3.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.575 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -65.96 -15.08 62.67 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.595 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 9.1 t60 -69.33 -42.03 75.87 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.957 -1.497 . . . . 0.0 107.96 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.58 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 6.8 mt-10 -85.43 -46.77 10.6 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.05 -1.031 . . . . 0.0 110.603 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.542 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -61.15 -30.87 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.652 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.23 -33.89 38.67 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.5 -50.23 73.73 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.825 -0.809 . . . . 0.0 110.41 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.487 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 58.3 p -83.82 -57.1 3.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.424 -0.798 . . . . 0.0 112.027 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.646 ' CD2' ' CD1' ' A' ' 92' ' ' TRP . 13.1 mt -104.56 34.99 2.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -136.94 -77.74 0.08 OUTLIER Glycine 0 C--N 1.292 -1.889 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.514 HD11 ' N ' ' A' ' 210' ' ' PHE . 4.1 pp -172.02 -165.72 0.37 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.77 -1.429 . . . . 0.0 109.995 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.58 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 3.3 t80 -96.92 -73.37 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.845 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.587 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 81.0 m80 -160.6 103.93 1.39 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.128 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.65 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -91.43 -171.34 2.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.856 . . . . 0.0 108.85 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.495 ' H ' ' HB3' ' A' ' 237' ' ' ASP . . . -64.74 76.16 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.691 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.06 9.58 12.17 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.634 -176.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -51.1 -27.49 8.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.485 ' C ' ' HB2' ' A' ' 235' ' ' SER . 14.9 mt-10 -114.95 -38.44 3.9 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.691 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -63.64 -178.98 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.301 1.048 . . . . 0.0 112.262 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.619 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -78.18 -18.35 55.62 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.463 -177.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.587 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -77.63 -7.84 56.99 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 119.19 -2.194 . . . . 0.0 112.056 -177.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.658 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 39.6 t80 -135.56 15.79 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.362 -1.461 . . . . 0.0 113.622 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -78.3 -37.24 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.53 -1.373 . . . . 0.0 108.53 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 223' ' ' TYR . 0.6 OUTLIER -15.58 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.01 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.584 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.63 59.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.496 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.6 OUTLIER -175.65 -159.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 74.3 m -126.4 104.15 8.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 109.722 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER 178.56 40.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.843 . . . . 0.0 109.023 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.562 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 10.0 t -84.87 -51.02 7.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.237 -0.914 . . . . 0.0 110.111 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.617 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.3 OUTLIER -152.64 6.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.096 . . . . 0.0 110.903 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.569 HD13 ' CG2' ' A' ' 190' ' ' THR . 0.4 OUTLIER -49.07 -108.8 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.949 -1.095 . . . . 0.0 110.796 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -23.94 5.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.589 -1.319 . . . . 0.0 109.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.538 ' O ' ' C ' ' A' ' 232' ' ' PHE . 5.3 mtp180 -98.24 -31.95 11.81 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.617 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 4.9 p90 -17.09 118.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.824 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.515 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.32 171.63 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.381 -0.825 . . . . 0.0 110.516 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.658 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 3.2 mp -81.78 166.17 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.853 . . . . 0.0 110.427 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.664 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 37.9 t -101.77 -166.89 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.122 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.52 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.2 OUTLIER -84.97 -17.71 36.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.644 -0.66 . . . . 0.0 110.262 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.65 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 0.9 OUTLIER -81.62 -48.54 11.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.659 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.0 OUTLIER -63.98 -40.06 95.53 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.508 -1.677 . . . . 0.0 106.659 177.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.42 -35.41 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.7 -54.38 19.95 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.468 ' HA3' HD23 ' A' ' 209' ' ' LEU . . . -50.79 -53.91 24.1 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.582 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.1 tp -64.86 -43.19 96.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.886 -1.361 . . . . 0.0 109.995 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.455 ' CG ' ' O ' ' A' ' 239' ' ' ILE . 0.0 OUTLIER -54.54 -28.45 45.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.2 t -80.27 -21.16 42.98 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -67.52 -64.11 0.92 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.528 ' OH ' ' CD2' ' A' ' 97' ' ' LEU . 27.9 m-85 -100.39 -125.16 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.209 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.535 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 53.46 -107.69 0.64 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 246' ' ' TYR . 41.3 Cg_endo -71.49 134.77 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.857 1.451 . . . . 0.0 110.067 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.55 110.87 3.09 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.988 1.52 . . . . 0.0 110.211 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 42.6 Cg_endo -72.62 -59.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.972 1.512 . . . . 0.0 110.065 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -61.42 -155.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.31 142.8 51.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.564 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.7 -18.75 24.9 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.067 1.562 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -176.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.547 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.56 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.595 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.589 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.589 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.265 0.555 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 210' ' ' PHE . 3.7 ptt85 -157.43 -94.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 109.518 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.438 HG23 ' HD2' ' A' ' 84' ' ' ARG . 10.2 t -106.09 -178.01 3.53 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.112 -0.993 . . . . 0.0 109.555 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.56 ' CD2' ' HD2' ' A' ' 87' ' ' PRO . 1.0 OUTLIER -45.34 168.62 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 86' ' ' PHE . 41.9 Cg_endo -72.93 57.39 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.978 1.515 . . . . 0.0 110.047 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.442 ' O ' ' HD3' ' A' ' 90' ' ' PRO . . . 100.88 -52.2 0.93 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.9 mt -49.3 106.21 0.6 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.28 -1.129 . . . . 0.0 109.554 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 88' ' ' GLY . 42.3 Cg_endo -72.34 163.89 37.27 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.917 1.483 . . . . 0.0 110.099 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.532 ' CG ' ' HB3' ' A' ' 169' ' ' ALA . 1.0 OUTLIER -88.88 -81.81 0.26 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.583 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 12.7 m95 -88.13 -167.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.957 -1.089 . . . . 0.0 109.608 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -162.42 -37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.418 -0.801 . . . . 0.0 109.087 179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.559 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -52.4 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.434 -0.791 . . . . 0.0 110.08 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.55 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 65.7 p -122.34 -0.97 9.22 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.602 -0.686 . . . . 0.0 109.312 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.574 ' CG ' ' OG1' ' A' ' 131' ' ' THR . 15.0 m-70 -140.56 92.59 2.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.463 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.591 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.9 mm? -85.19 162.8 19.05 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.512 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.566 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -141.05 155.83 46.1 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.663 ' CZ ' ' CD2' ' A' ' 121' ' ' LEU . 8.4 p90 -134.47 168.56 18.72 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.452 -1.405 . . . . 0.0 109.826 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' NE ' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.5 124.06 31.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -0.766 . . . . 0.0 109.235 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.611 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.5 mp -80.69 81.48 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' A' ' 144' ' ' ILE . 4.8 t -94.71 5.08 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.553 ' HB2' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -103.29 163.99 11.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.761 -1.212 . . . . 0.0 108.6 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.604 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 7.2 p90 -178.2 58.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.119 -0.988 . . . . 0.0 110.5 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.637 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 69.0 p -45.48 145.57 2.0 Allowed Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.1 -32.47 34.2 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 124.002 1.528 . . . . 0.0 109.232 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.526 ' C ' ' CD2' ' A' ' 108' ' ' LEU . 14.9 m-20 -65.89 -19.37 65.85 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.585 ' CD1' ' CD2' ' A' ' 195' ' ' LEU . 0.1 OUTLIER -115.62 114.28 42.34 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.4 Cg_endo -62.75 168.17 10.65 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.565 1.297 . . . . 0.0 108.996 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 109' ' ' PRO . 1.3 mppt? -39.73 -64.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.877 0.846 . . . . 0.0 109.54 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -57.73 -10.87 1.8 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.845 -0.535 . . . . 0.0 111.392 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -87.75 -58.44 2.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.576 -1.327 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.604 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 5.9 p -59.68 -43.39 91.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.548 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -60.92 -26.83 67.76 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -63.26 -65.24 0.71 Allowed 'General case' 0 C--O 1.195 -1.768 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB1' ' CD1' ' A' ' 195' ' ' LEU . . . -49.46 -31.99 11.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.578 HG13 ' CE2' ' A' ' 99' ' ' TYR . 2.6 t -74.34 -24.62 19.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -87.18 -37.19 17.52 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.345 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.672 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -77.82 -39.1 44.79 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.644 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -65.71 -61.57 2.0 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.214 1.007 . . . . 0.0 108.553 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.663 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.3 pp -53.8 -41.4 67.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.381 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.567 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -76.19 -32.85 59.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.806 -178.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.6 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 2.1 t -53.76 -45.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.66 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 33.5 m95 -91.69 -22.31 20.3 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.758 -1.177 . . . . 0.0 110.532 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.516 ' CG ' ' HB2' ' A' ' 132' ' ' PHE . 9.3 tm-20 -69.79 -27.03 64.57 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.782 -1.199 . . . . 0.0 107.815 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -91.17 -42.95 10.16 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.63 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.62 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 14.0 m -58.07 -25.56 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.308 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.582 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -109.36 155.0 41.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 118.073 -1.451 . . . . 0.0 109.249 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.537 ' CG ' ' HA2' ' A' ' 247' ' ' GLY . 51.2 Cg_endo -82.06 26.2 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.054 1.836 . . . . 0.0 111.395 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 95' ' ' THR . 4.4 mm? -108.6 -169.54 1.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.595 -1.316 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.574 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 2.0 p -117.7 169.22 9.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.808 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CE2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -139.17 163.34 32.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.637 -0.664 . . . . 0.0 109.921 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.579 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -143.08 -172.8 3.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.615 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -159.81 165.46 32.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.562 -1.336 . . . . 0.0 110.798 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.527 HD23 ' CB ' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -163.37 -163.63 0.85 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.592 -0.692 . . . . 0.0 109.134 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 75.0 t80 -158.2 22.07 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 108.768 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 1.6 pm0 -148.8 -178.95 6.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -0.761 . . . . 0.0 108.97 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.87 -97.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 137' ' ' GLU . 20.2 tt0 178.5 146.22 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -1.175 . . . . 0.0 110.531 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.527 ' CB ' HD23 ' A' ' 135' ' ' LEU . . . -103.18 -150.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.583 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 41.4 m-20 -88.74 -36.58 16.06 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.534 HG13 ' CD2' ' A' ' 207' ' ' LEU . 18.4 mm -122.28 82.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.551 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 3.3 ptt? -67.1 100.12 0.73 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.582 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.625 ' O ' ' N ' ' A' ' 102' ' ' VAL . 6.1 mm -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -135.41 154.93 51.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.336 -1.477 . . . . 0.0 111.939 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -77.06 135.99 38.65 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.645 ' CB ' ' CD2' ' A' ' 179' ' ' HIS . . . -152.83 164.68 37.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 110.485 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.533 ' O ' ' ND1' ' A' ' 151' ' ' HIS . 2.6 p -160.2 -174.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.255 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.471 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER -38.15 -28.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.279 -0.888 . . . . 0.0 110.334 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.525 ' CG ' HG11 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -78.52 51.49 1.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 109.907 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 9.6 m80 -81.42 -85.13 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.304 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.21 -63.94 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.563 ' O ' ' CG ' ' A' ' 154' ' ' PHE . 0.2 OUTLIER 179.69 44.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -1.143 . . . . 0.0 109.575 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.563 ' CG ' ' O ' ' A' ' 153' ' ' ASP . 87.8 m-85 -158.7 -58.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.945 . . . . 0.0 110.02 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -117.59 61.93 3.57 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.178 -0.951 . . . . 0.0 109.752 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 154' ' ' PHE . 41.2 Cg_endo -70.79 128.03 14.56 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.92 1.484 . . . . 0.0 109.795 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.652 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -117.13 -162.15 0.85 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 110.326 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 160' ' ' PRO . 33.0 p30 -173.79 55.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 110.041 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 14.49 -76.86 0.0 OUTLIER Glycine 0 N--CA 1.508 3.446 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.615 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.2 Cg_endo -66.9 59.19 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.322 1.348 . . . . 0.0 109.866 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -151.89 142.71 9.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.523 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 2.7 m120 -41.43 -34.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.021 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.578 ' HB ' ' CZ ' ' A' ' 157' ' ' PHE . 10.9 m -66.66 84.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.97 . . . . 0.0 109.646 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.579 ' CD2' ' CG2' ' A' ' 193' ' ' THR . 1.2 tp -64.03 -56.07 17.67 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.335 -0.853 . . . . 0.0 111.462 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.558 ' HB1' ' CG1' ' A' ' 198' ' ' VAL . . . -163.1 -164.35 0.95 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.394 -1.441 . . . . 0.0 110.622 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.652 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 0.9 OUTLIER 178.92 -179.17 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.157 -1.589 . . . . 0.0 111.356 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -151.32 174.46 13.28 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.804 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.517 ' O ' ' CB ' ' A' ' 206' ' ' SER . 0.1 OUTLIER -113.97 -170.17 1.66 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.082 -1.011 . . . . 0.0 110.168 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.584 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . . . -156.78 -66.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 109.197 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 43.8 Cg_endo -73.03 -160.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.704 1.371 . . . . 0.0 109.718 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 175' ' ' ASN . . . 76.33 164.21 17.45 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.8 Cg_endo -73.85 -92.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.012 1.533 . . . . 0.0 110.215 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -68.51 -23.7 75.22 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -77.88 9.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.569 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -65.78 64.82 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 110.73 96.59 2.37 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -152.96 114.53 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.197 -1.178 . . . . 0.0 107.872 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.76 157.41 19.17 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.558 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.645 ' CD2' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -147.08 134.88 21.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.816 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.539 ' HB3' ' CZ2' ' A' ' 186' ' ' TRP . 19.1 m-85 -96.79 130.7 44.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.096 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 164' ' ' LEU . 0.2 OUTLIER -47.97 143.27 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.721 -1.237 . . . . 0.0 109.343 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -119.26 29.58 7.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.551 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 4.7 m-20 -135.97 3.34 2.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 110.598 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.53 ' OE1' ' CD1' ' A' ' 164' ' ' LEU . 1.6 pt-20 -112.35 -96.39 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.606 -1.309 . . . . 0.0 109.492 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.601 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -162.36 173.4 14.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.081 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.637 ' CD1' ' CG2' ' A' ' 105' ' ' THR . 86.1 m95 -161.15 133.8 6.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.006 -1.059 . . . . 0.0 109.799 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 186' ' ' TRP . 74.9 p -162.02 150.08 14.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.577 -0.702 . . . . 0.0 109.374 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 13.3 pttt -83.38 -31.9 26.48 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.655 ' O ' ' N ' ' A' ' 191' ' ' THR . 9.4 t70 -83.77 64.01 7.79 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.6 ' O ' ' CG2' ' A' ' 190' ' ' THR . 3.9 t 3.44 60.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.123 0.963 . . . . 0.0 111.975 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.655 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.7 m -121.88 -32.25 3.78 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.076 -1.015 . . . . 0.0 109.545 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.473 ' HA3' HG22 ' A' ' 187' ' ' THR . . . -98.55 -75.97 1.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.579 ' CG2' ' CD2' ' A' ' 164' ' ' LEU . 3.0 m -124.28 -88.86 0.6 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.761 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 4.3 m-20 178.06 72.37 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.599 ' CD1' ' HB1' ' A' ' 116' ' ' ALA . 30.6 tp -28.82 -102.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.514 0.673 . . . . 0.0 112.541 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.696 ' CD1' ' O ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -57.44 -16.08 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.015 -1.053 . . . . 0.0 111.604 -177.372 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.761 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.8 tp -63.02 -63.04 1.32 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.32 -2.112 . . . . 0.0 107.245 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.558 ' CG1' ' HB1' ' A' ' 165' ' ' ALA . 3.2 t -69.88 -8.32 10.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.644 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -76.84 -59.54 2.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -64.95 -14.22 59.5 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.59 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 22.0 t60 -66.73 -50.66 62.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.589 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 205' ' ' HIS . 2.3 mm-40 -79.42 -46.44 17.52 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.282 -0.886 . . . . 0.0 110.925 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.4 mt -60.2 -30.35 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.66 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.3 -32.74 42.07 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -59.23 -49.05 79.32 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.892 -0.769 . . . . 0.0 110.496 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.519 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 5.0 m -84.63 -56.16 3.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 112.333 -177.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.534 ' CD2' HG13 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -104.39 27.0 8.25 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.94 -1.1 . . . . 0.0 110.987 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -130.11 -78.26 0.19 Allowed Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.539 HD11 ' N ' ' A' ' 210' ' ' PHE . 2.1 pp -167.48 -162.82 0.47 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.853 -1.381 . . . . 0.0 110.208 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 4.1 t80 -98.98 -70.78 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.802 . . . . 0.0 109.471 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 44.9 m80 -161.31 87.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.627 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -76.98 179.75 6.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 109.306 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.442 ' CB ' ' OD2' ' A' ' 237' ' ' ASP . . . -61.63 81.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.73 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.08 11.12 12.41 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.366 -177.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 214' ' ' ASN . 47.6 p -49.41 -28.27 4.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.516 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.0 mm-40 -115.99 -36.14 4.22 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.73 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -63.63 -166.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.507 1.146 . . . . 0.0 112.773 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.618 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -95.26 -15.3 23.3 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.354 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.543 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -79.77 -5.98 56.39 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.284 -2.135 . . . . 0.0 112.054 -177.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.64 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 43.3 t80 -138.78 15.75 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.444 -1.41 . . . . 0.0 113.347 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.14 -37.46 0.79 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 N-CA-C 108.631 -1.334 . . . . 0.0 108.631 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.584 ' CB ' ' CE2' ' A' ' 3' ' ' MSB . 0.7 OUTLIER -14.76 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.085 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.573 ' N ' ' CD1' ' A' ' 222' ' ' LEU . 2.1 t80 -73.42 56.32 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.154 -0.966 . . . . 0.0 109.321 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -173.68 -145.72 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.574 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 18.6 m -143.2 110.6 5.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.855 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER 179.4 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.34 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.546 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 11.3 t -93.36 -13.24 28.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.581 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER 178.37 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.564 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.561 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.4 OUTLIER -26.83 -99.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.811 -0.555 . . . . 0.0 111.426 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 p -135.05 -2.98 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.759 -1.213 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.565 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.7 OUTLIER -119.32 -40.28 2.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 108.744 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.588 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 2.0 p90 0.38 111.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.357 0.599 . . . . 0.0 111.958 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.586 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.5 ttt180 179.42 154.28 0.47 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.166 -0.959 . . . . 0.0 110.035 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.65 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -74.77 169.31 18.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.469 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.644 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 30.4 t -104.6 -169.63 1.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.353 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.517 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.98 -11.91 54.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 110.104 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.627 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 0.5 OUTLIER -84.18 -50.81 7.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.66 -1.275 . . . . 0.0 107.748 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.693 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.2 m-20 -63.81 -38.33 90.71 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.679 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.544 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -57.07 -35.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -68.42 -56.91 6.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -47.88 -53.33 14.24 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.594 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -63.91 -43.39 97.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.977 -1.308 . . . . 0.0 109.746 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.54 -27.35 37.82 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -82.71 -19.17 38.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 242' ' ' ILE . 0.3 OUTLIER -70.11 -63.45 1.08 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.539 ' HB3' ' CD2' ' A' ' 130' ' ' LEU . 15.9 m-30 -100.45 -123.56 0.16 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.275 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.537 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 54.72 100.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 249' ' ' PRO . 42.7 Cg_endo -72.72 172.22 15.69 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.052 1.554 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 42.3 Cg_endo -72.85 163.04 39.54 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.989 1.52 . . . . 0.0 110.038 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.76 -58.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.985 1.519 . . . . 0.0 110.093 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.59 154.2 3.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.533 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 80.3 p -49.21 151.62 2.41 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.549 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.52 -9.49 24.14 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.948 1.499 . . . . 0.0 110.071 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -102.59 -168.15 1.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 109.573 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.43 ' OXT' ' CG2' ' A' ' 255' ' ' THR . 11.5 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.555 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.565 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.611 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.611 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.486 ' N ' ' HD3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.257 0.551 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.486 ' HD3' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -170.91 -73.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 109.588 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.469 ' CG2' ' HA2' ' A' ' 241' ' ' GLY . 1.0 OUTLIER -51.94 -93.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.946 . . . . 0.0 109.511 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.477 ' CZ ' ' O ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER 179.84 67.37 0.14 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.98 59.7 3.62 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.923 1.486 . . . . 0.0 110.094 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.21 -83.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.477 ' O ' ' CZ ' ' A' ' 86' ' ' PHE . 21.0 mt -115.81 117.46 39.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.311 -1.111 . . . . 0.0 109.572 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.08 -161.95 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.883 1.465 . . . . 0.0 110.133 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' CE ' ' CB ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -106.55 -75.51 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.012 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.57 ' CH2' ' HB2' ' A' ' 141' ' ' ASP . 70.9 m95 -94.06 162.64 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 0.0 109.258 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -133.02 -35.19 1.06 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 110.237 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.561 ' HG3' ' HG ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -50.7 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.177 -0.952 . . . . 0.0 110.283 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.548 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 32.3 p -124.72 1.49 8.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.461 -0.774 . . . . 0.0 109.561 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.555 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 35.6 m80 -146.02 99.66 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.992 -1.067 . . . . 0.0 110.484 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.661 ' CD1' ' CZ ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -127.59 -153.09 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 141' ' ' ASP . 1.2 t -173.75 -178.91 1.67 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.947 -1.096 . . . . 0.0 111.179 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.639 ' CD1' ' CD2' ' A' ' 121' ' ' LEU . 10.4 p90 -135.82 179.16 6.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.371 -0.831 . . . . 0.0 109.678 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' NH1' ' HA ' ' A' ' 136' ' ' TYR . 2.0 ttp85 -131.85 144.1 50.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -0.758 . . . . 0.0 109.394 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.8 mp -101.53 78.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.879 -1.138 . . . . 0.0 109.503 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' A' ' 144' ' ' ILE . 1.8 t -92.77 9.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.44 -0.787 . . . . 0.0 110.616 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 103' ' ' ASN . 0.1 OUTLIER -109.81 174.47 5.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.508 -1.37 . . . . 0.0 110.108 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 1.1 t80 177.16 86.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.397 0.618 . . . . 0.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 33.2 p -67.44 154.09 93.67 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.459 ' HG2' ' CG ' ' A' ' 185' ' ' GLN . 38.3 Cg_endo -67.87 -26.53 38.05 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.827 1.435 . . . . 0.0 108.65 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.478 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -81.86 2.23 31.33 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.642 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 95.1 mt -145.23 117.27 5.23 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.486 -0.759 . . . . 0.0 110.236 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.06 175.6 5.44 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.853 1.449 . . . . 0.0 108.872 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.465 ' O ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -39.97 -64.96 0.44 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.829 0.823 . . . . 0.0 110.108 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -30.63 55.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 112.282 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.642 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -73.29 -60.69 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.31 -1.494 . . . . 0.0 109.356 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.523 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.5 p -52.25 -38.48 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.505 ' OD1' ' CG2' ' A' ' 101' ' ' ILE . 1.0 OUTLIER -65.6 -28.64 69.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 112' ' ' ALA . 10.8 p -62.37 -39.68 93.96 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.707 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -72.48 -34.13 67.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 0.0 109.544 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.594 HG13 ' CE2' ' A' ' 99' ' ' TYR . 71.8 t -74.12 -23.2 18.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 1.6 tt0 -91.23 -33.48 15.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.646 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 6.5 tppt? -82.57 -33.77 27.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.653 ' HB3' ' CB ' ' A' ' 199' ' ' ALA . . . -68.08 -65.21 0.72 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.639 ' CD2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.731 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.09 -36.78 63.54 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.239 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.57 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.34 -36.98 48.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.734 ' CZ2' ' HA3' ' A' ' 204' ' ' GLY . 46.6 m95 -91.61 -23.16 19.95 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.627 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -74.21 -27.74 60.94 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.755 -1.216 . . . . 0.0 108.312 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -91.37 -44.22 9.29 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.888 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.612 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 20.2 m -60.47 -24.6 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.186 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.652 ' CG2' ' CE1' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -106.22 165.08 13.64 Favored Pre-proline 0 N--CA 1.501 2.107 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.975 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 246' ' ' TYR . 52.3 Cg_endo -83.66 25.82 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.242 1.961 . . . . 0.0 111.723 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 95' ' ' THR . 3.7 mm? -127.09 -177.89 4.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.468 -1.395 . . . . 0.0 110.781 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.555 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.5 p -125.59 167.12 15.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 111.488 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.661 ' CZ ' ' CD1' ' A' ' 97' ' ' LEU . 25.1 m-85 -148.68 162.72 39.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.307 0.575 . . . . 0.0 109.801 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.573 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -133.12 -159.21 0.95 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.41 152.94 33.77 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.052 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -136.1 -129.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.067 -1.021 . . . . 0.0 109.318 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 40.4 t80 178.24 31.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.67 -1.269 . . . . 0.0 109.423 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.459 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 5.0 pm0 -167.37 -174.25 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.014 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.53 -98.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 4.6 pt-20 178.86 124.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -1.156 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.496 ' HB2' ' CA ' ' A' ' 99' ' ' TYR . . . -81.98 -151.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 109.219 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.57 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -81.1 -48.7 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.544 ' CG2' HD12 ' A' ' 144' ' ' ILE . 13.1 mm -112.52 80.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 4.4 ttp -63.8 97.69 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.938 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.573 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.7 mm -78.23 130.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.066 -1.021 . . . . 0.0 108.488 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -145.34 154.92 42.83 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.562 -1.336 . . . . 0.0 111.881 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -91.19 135.88 33.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.121 -0.987 . . . . 0.0 108.577 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -169.52 -164.0 0.42 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.381 -1.328 . . . . 0.0 111.338 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.592 ' CG2' ' CA ' ' A' ' 159' ' ' GLY . 3.0 p -177.51 -171.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.4 OUTLIER -38.7 -25.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 148' ' ' VAL . 0.9 OUTLIER -54.37 -12.2 0.64 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.0 -1.062 . . . . 0.0 111.347 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 75.4 m80 -37.76 -89.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.075 -1.015 . . . . 0.0 109.981 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.2 -94.28 0.1 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -145.46 12.73 1.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -1.164 . . . . 0.0 109.603 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.498 ' C ' ' CD ' ' A' ' 156' ' ' PRO . 2.1 t80 -131.62 -32.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 109.792 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.9 m-85 -118.78 42.33 0.43 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.947 . . . . 0.0 110.142 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 39.9 Cg_endo -69.8 101.53 0.93 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.614 1.323 . . . . 0.0 108.855 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.666 ' CZ ' ' CG1' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -69.33 -141.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 110.479 -178.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 160' ' ' PRO . 3.9 p-10 -128.12 -31.77 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 111.782 -177.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.592 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 50.61 -105.91 0.22 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.292 -2.323 . . . . 0.0 107.292 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.26 61.45 0.25 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.582 1.306 . . . . 0.0 109.879 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -156.73 -176.13 28.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 163' ' ' VAL . 50.9 m-20 -78.1 -41.35 35.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -1.194 . . . . 0.0 110.272 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.666 ' CG1' ' CZ ' ' A' ' 157' ' ' PHE . 4.6 t -42.1 130.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.57 ' HG ' ' CH2' ' A' ' 186' ' ' TRP . 0.8 OUTLIER -96.08 -56.5 2.62 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.46 -0.775 . . . . 0.0 112.543 -178.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -162.74 -172.04 2.95 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.22 -1.55 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER 179.93 173.96 0.91 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 119.956 -1.715 . . . . 0.0 111.371 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.23 -170.78 2.73 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.477 -0.765 . . . . 0.0 109.667 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.627 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 49.3 m-85 -118.28 -166.19 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.836 -1.165 . . . . 0.0 110.432 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.551 ' CB ' ' CE ' ' A' ' 91' ' ' LYS . . . -177.51 -62.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.8 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.536 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 42.9 Cg_endo -73.77 145.23 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.956 1.503 . . . . 0.0 110.305 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . 94.17 144.23 15.43 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.8 Cg_endo -70.4 152.37 65.94 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.969 1.51 . . . . 0.0 109.99 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 68.38 -63.94 0.41 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.627 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -65.69 -8.73 6.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.533 -0.981 . . . . 0.0 108.842 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.483 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 10.4 t30 -67.41 66.39 0.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.951 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 131.45 76.58 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.165 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -149.1 119.32 7.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.699 -1.471 . . . . 0.0 108.288 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.559 ' HB1' ' CD1' ' A' ' 144' ' ' ILE . . . -101.83 166.1 10.84 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.012 -1.055 . . . . 0.0 109.054 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.644 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -163.27 132.38 4.03 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.32 178.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.566 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 53.9 m-85 -92.06 136.24 33.33 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.756 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.484 ' OD1' ' CG2' ' A' ' 148' ' ' VAL . 51.6 t0 -70.03 126.49 29.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 183' ' ' ASP . 16.5 t70 -70.65 -5.03 26.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.628 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 61.9 t0 -34.32 -72.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 111.273 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.474 ' OE2' ' OD2' ' A' ' 183' ' ' ASP . 1.0 OUTLIER -111.87 -135.85 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.524 -177.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.543 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -122.91 -178.75 4.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.162 -0.961 . . . . 0.0 109.17 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.593 ' CD1' ' CG2' ' A' ' 105' ' ' THR . 29.4 m95 -144.7 151.2 38.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.45 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 192' ' ' GLY . 41.5 p -145.9 152.87 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 110.007 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.618 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.1 OUTLIER -70.08 -38.95 75.86 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.503 ' N ' ' CG ' ' A' ' 188' ' ' LYS . 0.8 OUTLIER -86.18 -150.17 0.14 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.532 HG21 ' CD1' ' A' ' 229' ' ' LEU . 17.3 p -109.51 43.1 1.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.069 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.471 ' HB ' HG22 ' A' ' 187' ' ' THR . 89.0 m -95.49 -31.84 13.16 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.352 -0.842 . . . . 0.0 111.25 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.522 ' N ' HG22 ' A' ' 187' ' ' THR . . . -114.18 -80.15 0.92 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.028 -1.558 . . . . 0.0 109.535 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.524 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 64.0 m -134.72 -94.02 0.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.584 -0.951 . . . . 0.0 108.435 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.594 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.8 OUTLIER -157.23 66.01 0.5 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.675 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.707 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -29.56 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.702 0.763 . . . . 0.0 111.019 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.646 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -67.78 -11.71 59.04 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 111.536 -177.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 13.0 tp -67.25 -59.94 3.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.06 -1.856 . . . . 0.0 106.895 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.563 ' CG2' ' CZ3' ' A' ' 186' ' ' TRP . 2.0 m -71.29 -12.87 16.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.653 ' CB ' ' HB3' ' A' ' 120' ' ' ALA . . . -73.5 -61.21 1.91 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.562 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -62.85 -17.13 60.97 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.598 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 15.5 t60 -68.71 -40.63 79.88 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.594 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.566 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 3.9 mt-10 -85.2 -49.36 8.28 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.853 . . . . 0.0 111.141 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 121' ' ' LEU . 3.2 mt -60.88 -30.6 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.734 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.78 -30.83 42.15 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.567 ' CE1' ' O1 ' ' A' ' 1' ' ' HAV . 0.0 OUTLIER -63.19 -44.64 94.8 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.742 -0.857 . . . . 0.0 110.699 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 168' ' ' TYR . 85.7 p -87.49 -55.61 3.72 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 112.61 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 132' ' ' PHE . 2.3 tp -104.56 7.35 35.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.134 -0.979 . . . . 0.0 110.964 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.581 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -104.65 -77.54 1.16 Allowed Glycine 0 N--CA 1.486 1.982 0 O-C-N 120.841 -1.162 . . . . 0.0 111.021 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.559 ' CD2' ' OD1' ' A' ' 238' ' ' ASP . 4.6 pp -172.59 -161.85 0.17 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.611 -1.523 . . . . 0.0 110.05 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.573 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 2.9 m-85 -94.32 -94.51 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 0.0 109.155 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 44.8 m170 -143.15 120.92 11.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.575 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.7 m -108.33 -179.12 3.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.179 -0.951 . . . . 0.0 109.291 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.53 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.757 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -91.01 13.26 17.24 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.536 -177.197 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 214' ' ' ASN . 31.0 p -50.73 -28.04 8.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.488 ' N ' ' C ' ' A' ' 214' ' ' ASN . 2.5 mt-10 -118.08 -36.42 3.6 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.517 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.757 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -58.78 -159.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 122.2 1.0 . . . . 0.0 112.756 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.618 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -112.15 -3.43 14.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.925 -177.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.532 ' HB2' ' CG ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -89.55 -5.36 57.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 119.152 -2.217 . . . . 0.0 110.732 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.647 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 33.4 t80 -140.0 14.91 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 118.845 -1.142 . . . . 0.0 113.252 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.1 Cg_endo -75.85 -35.21 2.68 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 N-CA-C 108.539 -1.37 . . . . 0.0 108.539 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.595 ' CB ' ' CE2' ' A' ' 3' ' ' MSB . 0.4 OUTLIER -17.98 -57.94 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.53 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 222' ' ' LEU . 2.7 t80 -75.01 55.17 0.7 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 0.0 108.96 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 221' ' ' PRO . 7.2 t-160 -173.44 -138.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.523 ' HB3' ' CG2' ' A' ' 190' ' ' THR . 1.9 m -157.06 119.26 3.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.92 -1.112 . . . . 0.0 109.909 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.534 ' CD1' ' HB3' ' A' ' 221' ' ' PRO . 0.2 OUTLIER 178.92 62.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 110.021 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.504 ' C ' ' CB ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER -114.26 -18.69 11.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 14.5 t70 -167.42 -26.91 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 109.951 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.539 ' C ' ' O ' ' A' ' 228' ' ' ASP . 0.2 OUTLIER -28.61 -61.97 0.11 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.5 t 178.98 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.379 -0.826 . . . . 0.0 108.913 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -94.67 -18.46 21.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 27.8 p90 -37.49 107.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.522 0.677 . . . . 0.0 110.641 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.587 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 9.2 ttt180 179.79 153.26 0.48 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.442 -0.786 . . . . 0.0 109.573 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.625 HD23 ' CH2' ' A' ' 124' ' ' TRP . 2.2 mp -67.01 165.86 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.609 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 12.7 t -101.73 -169.51 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.492 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.56 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.5 tp60 -84.85 -21.69 29.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 110.117 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.575 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 6.5 m-20 -80.44 -41.74 23.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 19.0 t0 -70.73 -32.81 70.13 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.458 -1.297 . . . . 0.0 107.725 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.4 OUTLIER -62.92 -33.9 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -65.05 -51.26 62.5 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.508 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.532 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -58.38 -54.71 35.52 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.604 ' CG1' HG22 ' A' ' 127' ' ' VAL . 2.4 tp -61.24 -49.38 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.745 -1.444 . . . . 0.0 109.916 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -53.57 -29.88 39.36 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.0 t -80.09 -17.08 53.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.535 ' CD1' ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -70.39 -59.86 2.61 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.652 ' CE1' ' CG2' ' A' ' 128' ' ' THR . 41.7 m-85 -71.39 -91.94 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 246' ' ' TYR . . . -33.62 137.18 0.18 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.491 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 42.2 Cg_endo -72.02 136.09 26.57 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.707 1.605 . . . . 0.0 110.189 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.605 ' CD ' ' CD ' ' A' ' 250' ' ' PRO . 38.2 Cg_endo -72.58 -30.64 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.036 1.545 . . . . 0.0 112.584 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.605 ' CD ' ' CD ' ' A' ' 249' ' ' PRO . 43.1 Cg_endo -73.28 -164.62 0.2 Allowed 'Trans proline' 0 C--N 1.319 -0.996 0 N-CA-C 110.164 -0.745 . . . . 0.0 110.164 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' A' ' 253' ' ' PRO . 0.2 OUTLIER -78.88 -52.15 8.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.623 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 251' ' ' ASP . 1.4 p -43.6 103.47 0.32 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.888 . . . . 0.0 109.647 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 251' ' ' ASP . 42.1 Cg_endo -72.85 -43.89 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.07 1.563 . . . . 0.0 110.059 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.36 153.44 38.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.418 ' OXT' ' CG2' ' A' ' 255' ' ' THR . 3.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.484 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.598 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.591 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.595 ' CE2' ' CB ' ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.3 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.264 0.554 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -86.64 171.76 10.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.579 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -63.55 -166.45 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.281 -0.887 . . . . 0.0 109.655 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -50.01 -179.68 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.191 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 86' ' ' PHE . 38.3 Cg_endo -67.69 60.24 0.83 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.411 1.216 . . . . 0.0 109.69 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.501 ' C ' ' CG1' ' A' ' 89' ' ' ILE . . . 174.04 -136.84 3.73 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.521 HG13 ' CD ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -168.06 -62.54 0.01 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.105 -1.232 . . . . 0.0 109.564 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.521 ' CD ' HG13 ' A' ' 89' ' ' ILE . 41.7 Cg_endo -71.39 78.98 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.929 1.489 . . . . 0.0 110.401 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.488 ' HD3' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mttp -50.99 -97.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 108.917 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.622 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 7.0 m95 -66.03 -164.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.834 -1.166 . . . . 0.0 109.076 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -152.03 -36.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.999 -1.063 . . . . 0.0 110.379 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.586 ' CD ' ' CE3' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -50.32 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.544 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 8.2 p -121.22 -5.64 9.42 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.606 ' CE1' ' CG2' ' A' ' 131' ' ' THR . 26.7 m-70 -146.06 100.41 3.39 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.58 ' CD1' ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -106.36 -165.33 1.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.842 . . . . 0.0 109.952 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -160.43 160.17 31.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.606 ' CZ ' ' CD2' ' A' ' 121' ' ' LEU . 2.6 p90 -131.16 167.23 19.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.801 -1.187 . . . . 0.0 108.816 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.528 ' CZ ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -126.11 123.14 37.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.121 . . . . 0.0 109.818 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.5 mp -82.14 84.43 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.779 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' A' ' 144' ' ' ILE . 38.2 t -99.52 6.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.401 -0.812 . . . . 0.0 109.775 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' A' ' 145' ' ' SER . 35.1 m-80 -97.11 156.15 16.51 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.846 -1.159 . . . . 0.0 108.794 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.555 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 179.14 37.28 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 179.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 104' ' ' TYR . 41.3 p -42.86 156.31 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.401 -0.812 . . . . 0.0 108.913 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.88 -20.27 45.54 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.836 1.44 . . . . 0.0 109.054 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.4 OUTLIER -67.7 -9.85 47.27 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.587 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 63.6 mt -144.49 123.59 7.04 Favored Pre-proline 0 N--CA 1.483 1.221 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.41 166.25 17.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.833 1.438 . . . . 0.0 109.153 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' NZ ' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.94 -65.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.711 0.767 . . . . 0.0 110.345 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.3 m-20 -57.83 -22.92 50.23 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 111.764 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.587 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -76.16 -62.11 1.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.39 -1.443 . . . . 0.0 109.304 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.555 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.9 p -50.94 -39.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.512 ' OD2' ' NZ ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -66.96 -26.95 67.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' ALA . 17.1 p -65.67 -41.22 92.72 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 195' ' ' LEU . . . -73.78 -33.57 64.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.069 -1.019 . . . . 0.0 109.874 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.536 ' O ' ' CG ' ' A' ' 121' ' ' LEU . 12.0 t -74.82 -23.72 17.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.521 ' HA ' HD22 ' A' ' 121' ' ' LEU . 2.1 tt0 -88.35 -35.13 17.35 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.651 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -77.88 -39.57 42.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.643 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -67.41 -62.42 1.43 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.142 0.972 . . . . 0.0 109.086 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.606 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.7 pp -55.3 -40.82 71.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.538 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 7.1 tptm -75.7 -32.64 60.17 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.826 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.592 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 1.5 t -54.16 -44.42 63.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.651 ' CH2' ' CD2' ' A' ' 234' ' ' LEU . 32.7 m95 -91.1 -23.57 20.26 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.675 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 17.6 tp10 -69.79 -27.24 64.74 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.692 -1.255 . . . . 0.0 107.903 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.7 pt-20 -90.39 -42.93 10.63 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.889 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.622 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 16.6 m -57.9 -26.02 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.322 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.604 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -107.94 154.12 41.27 Favored Pre-proline 0 N--CA 1.495 1.818 0 C-N-CA 117.966 -1.493 . . . . 0.0 109.224 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.433 ' C ' HD23 ' A' ' 130' ' ' LEU . 48.6 Cg_endo -81.29 24.76 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.832 1.688 . . . . 0.0 111.415 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.555 ' HG ' ' CD1' ' A' ' 246' ' ' TYR . 4.6 mm? -106.13 -169.02 1.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.701 -1.25 . . . . 0.0 110.202 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.606 ' CG2' ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -121.65 162.76 20.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.0 110.48 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.58 ' CE2' ' CD1' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -149.86 144.2 25.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.547 -0.721 . . . . 0.0 109.688 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.12 -162.5 1.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.24 -0.912 . . . . 0.0 108.856 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.598 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -156.46 153.28 28.57 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 110.057 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.538 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -145.06 -137.35 0.09 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.474 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.4 OUTLIER 179.29 33.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.689 -1.257 . . . . 0.0 108.995 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 5.4 pm0 -157.54 179.94 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.35 -95.99 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER 178.83 106.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -1.159 . . . . 0.0 110.193 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.524 ' CB ' HD22 ' A' ' 135' ' ' LEU . . . -60.67 -147.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 108.758 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 98' ' ' THR . 43.9 t0 -90.28 -45.03 9.32 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.53 ' CG2' HD13 ' A' ' 144' ' ' ILE . 44.3 mt -116.46 81.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.52 97.11 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.615 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.6 mm -82.52 114.83 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.582 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -135.71 157.33 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.369 -1.457 . . . . 0.0 112.08 -178.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 16.7 p90 -88.47 140.3 29.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.526 -0.734 . . . . 0.0 109.419 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.58 ' N ' ' CD2' ' A' ' 179' ' ' HIS . . . -168.29 -161.49 0.36 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 0.0 110.176 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.581 ' O ' ' CE1' ' A' ' 151' ' ' HIS . 0.7 OUTLIER -179.51 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.052 . . . . 0.0 109.896 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.544 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 0.0 OUTLIER -29.69 -36.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.863 -0.523 . . . . 0.0 111.157 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 148' ' ' VAL . 5.2 mt-10 -82.01 124.88 30.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.966 -1.084 . . . . 0.0 109.818 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 148' ' ' VAL . 20.3 m80 -148.86 -91.48 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.504 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -151.29 -48.16 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.86 -29.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -1.218 . . . . 0.0 110.232 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 72.4 t80 -129.28 42.38 3.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.0 -1.063 . . . . 0.0 110.211 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.591 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.4 m-85 -154.97 45.25 0.25 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.118 -0.989 . . . . 0.0 109.793 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 43.1 Cg_endo -72.61 112.4 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.727 1.383 . . . . 0.0 110.128 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -92.12 -157.18 0.5 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.079 -1.013 . . . . 0.0 109.861 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.594 ' O ' ' C ' ' A' ' 159' ' ' GLY . 22.5 p30 179.88 54.72 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.427 -0.795 . . . . 0.0 109.858 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -10.48 -64.37 0.01 OUTLIER Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 40.1 Cg_endo -68.96 59.58 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.145 1.23 . . . . 0.0 109.955 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.08 164.86 37.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 164' ' ' LEU . 8.5 m120 -54.18 -58.98 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.598 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 1' ' ' HAV . 33.6 m -45.46 93.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.579 ' CD1' ' CG2' ' A' ' 193' ' ' THR . 1.0 OUTLIER -77.82 -66.79 0.8 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.227 -0.921 . . . . 0.0 112.57 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 179' ' ' HIS . . . -143.2 -172.46 3.69 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.403 . . . . 0.0 111.184 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.69 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.6 p-80 179.47 167.94 1.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.246 -1.534 . . . . 0.0 110.937 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -138.02 -177.25 4.74 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.461 -0.774 . . . . 0.0 109.771 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.489 ' HB3' HG13 ' A' ' 174' ' ' ILE . 96.3 m-85 -114.31 -166.75 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.574 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.57 ' CB ' ' HD2' ' A' ' 170' ' ' PRO . . . -109.44 -174.51 0.3 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.492 -0.755 . . . . 0.0 109.26 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 169' ' ' ALA . 42.5 Cg_endo -75.21 53.35 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.666 1.351 . . . . 0.0 110.725 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 175' ' ' ASN . . . -93.32 -170.76 39.52 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.7 Cg_endo -70.79 124.69 10.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.827 1.435 . . . . 0.0 109.912 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . 69.34 -59.67 0.62 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -76.05 18.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.578 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 1.2 t-20 -63.49 63.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 103.14 102.99 2.74 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -158.97 115.12 2.63 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 120.737 -1.449 . . . . 0.0 107.976 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.79 160.82 16.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.862 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.627 ' CD2' ' N ' ' A' ' 180' ' ' PHE . 0.1 OUTLIER -155.96 135.66 12.57 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.516 178.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.627 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 23.1 m-85 -93.74 131.08 39.44 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.194 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.51 ' OD2' HD12 ' A' ' 164' ' ' LEU . 43.7 p-10 -65.48 122.26 16.77 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 2.8 p30 -88.47 -9.36 52.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.53 ' HB3' ' HD3' ' A' ' 160' ' ' PRO . 6.3 m-20 -79.66 2.95 20.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.972 -1.08 . . . . 0.0 109.607 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.513 ' HB2' ' CA ' ' A' ' 159' ' ' GLY . 33.0 tt0 -114.14 -129.91 0.31 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.606 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.1 mt-30 -137.22 176.29 8.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.758 -1.214 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.611 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.7 m95 -161.87 115.81 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.97 -1.081 . . . . 0.0 110.069 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.533 ' CG2' ' HA3' ' A' ' 192' ' ' GLY . 37.3 p -140.52 151.4 44.75 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.905 -1.122 . . . . 0.0 110.071 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.57 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 15.4 pttp -84.43 -31.72 24.48 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.2 t70 -84.51 64.12 8.25 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.602 ' O ' ' CG2' ' A' ' 190' ' ' THR . 3.1 t 3.38 60.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.129 0.966 . . . . 0.0 112.011 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.7 m -127.1 -30.19 2.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.055 -1.028 . . . . 0.0 110.028 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.533 ' HA3' ' CG2' ' A' ' 187' ' ' THR . . . -94.58 -84.67 1.64 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.579 ' CG2' ' CD1' ' A' ' 164' ' ' LEU . 5.0 m -119.48 -82.0 0.64 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.719 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 0.5 OUTLIER -179.81 72.78 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.979 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.674 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 3.3 tp -34.62 -97.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.61 0.719 . . . . 0.0 110.732 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.674 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -70.53 -9.66 57.25 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.963 -1.086 . . . . 0.0 111.358 -176.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.719 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.1 tp -68.29 -58.82 3.8 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 115.923 -2.311 . . . . 0.0 106.692 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 165' ' ' ALA . 1.4 t -72.49 -10.3 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.643 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -75.49 -61.6 1.86 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -63.08 -15.93 58.24 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.636 ' CG ' ' CE1' ' A' ' 3' ' ' MSB . 28.2 t60 -68.07 -43.69 78.02 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 117.921 -1.512 . . . . 0.0 107.835 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.602 ' OE2' ' CD1' ' A' ' 180' ' ' PHE . 31.5 mt-10 -83.47 -48.07 10.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.237 -0.915 . . . . 0.0 110.914 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.548 HD11 ' N ' ' A' ' 121' ' ' LEU . 2.3 mt -61.06 -29.8 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.643 ' CA ' ' CE2' ' A' ' 124' ' ' TRP . . . -78.26 -31.93 45.15 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.21 -52.3 65.86 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.691 -0.887 . . . . 0.0 109.816 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 207' ' ' LEU . 28.6 t -79.74 -59.52 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.492 -0.755 . . . . 0.0 111.827 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.622 ' CD1' ' CD1' ' A' ' 92' ' ' TRP . 1.4 mm? -104.58 38.82 1.8 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.253 -0.904 . . . . 0.0 110.586 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -139.56 -73.41 0.05 OUTLIER Glycine 0 C--N 1.292 -1.913 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 238' ' ' ASP . 3.5 pp 179.33 -162.42 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.655 -1.497 . . . . 0.0 109.818 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.579 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 16.1 t80 -99.37 -79.97 0.48 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.104 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 4.7 m-70 -153.92 77.22 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -62.18 -172.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 108.924 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.493 ' H ' ' HB3' ' A' ' 237' ' ' ASP . . . -64.26 77.81 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.724 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.01 13.14 8.06 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.789 -177.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER -50.27 -28.44 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 174.373 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.511 ' C ' ' HB3' ' A' ' 235' ' ' SER . 6.5 mt-10 -115.96 -39.65 3.43 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.724 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -63.15 164.8 8.03 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 122.451 1.12 . . . . 0.0 111.99 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.616 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -67.33 -15.5 63.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.339 -177.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.533 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.59 -9.72 59.1 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 118.976 -2.328 . . . . 0.0 112.294 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.646 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 45.7 t80 -137.42 17.27 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.293 -1.505 . . . . 0.0 113.506 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 57.5 Cg_endo -79.47 -36.35 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 N-CA-C 108.747 -1.29 . . . . 0.0 108.747 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.616 ' CB ' ' CE2' ' A' ' 3' ' ' MSB . 0.4 OUTLIER -16.93 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.588 ' O ' ' CG ' ' A' ' 224' ' ' HIS . 28.2 t80 -75.74 49.73 0.53 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.254 -0.904 . . . . 0.0 109.394 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 95.7 m-70 -160.85 -120.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.071 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 226' ' ' LEU . 14.7 m -173.44 110.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.727 -1.233 . . . . 0.0 109.891 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.526 ' CG ' ' HA ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER 179.37 65.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 109.852 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 196' ' ' PHE . 10.1 t -116.88 -7.91 11.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.575 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 1.6 t0 178.09 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.037 . . . . 0.0 110.642 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.545 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -30.32 -61.06 0.17 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.571 -0.706 . . . . 0.0 110.604 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.33 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.475 -0.765 . . . . 0.0 109.098 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.4 mtp180 -100.21 -26.97 13.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 108.925 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.575 ' CD2' ' HA ' ' A' ' 228' ' ' ASP . 11.6 p90 -27.77 121.42 0.11 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.349 0.595 . . . . 0.0 111.598 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.13 170.52 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.443 -0.786 . . . . 0.0 109.809 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.651 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 1.8 mp -81.41 162.15 23.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 110.076 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 217' ' ' ALA . 9.0 p -103.5 -167.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.306 -1.357 . . . . 0.0 110.51 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -84.83 -14.48 47.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 111.723 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.636 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 1.3 m-20 -84.84 -45.2 12.54 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.2 -1.563 . . . . 0.0 107.809 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.618 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 2.6 m-20 -64.99 -41.4 95.43 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.39 -35.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.21 -47.4 73.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 244' ' ' SER . . . -57.94 -55.47 30.42 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.62 ' CG1' HG22 ' A' ' 127' ' ' VAL . 1.5 tp -60.14 -46.03 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.977 -1.308 . . . . 0.0 109.227 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 239' ' ' ILE . 34.8 tt0 -56.3 -25.23 47.86 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 0.0 OUTLIER -78.16 -21.87 49.57 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 242' ' ' ILE . 9.0 mt -72.61 -66.42 0.66 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.555 ' CD1' ' HG ' ' A' ' 130' ' ' LEU . 71.5 m-85 -91.61 -120.66 0.07 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.145 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.57 67.79 1.52 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.45 ' C ' ' HD2' ' A' ' 250' ' ' PRO . 41.8 Cg_endo -72.58 112.36 3.45 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.006 1.529 . . . . 0.0 110.013 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.613 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 38.0 Cg_endo -72.28 -30.01 13.42 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.928 1.488 . . . . 0.0 112.314 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 249' ' ' PRO . 43.5 Cg_endo -75.34 171.65 17.85 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 N-CA-C 110.054 -0.787 . . . . 0.0 110.054 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -144.3 -67.23 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.547 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.86 113.81 8.14 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.315 -0.865 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.43 -21.55 22.61 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.878 1.462 . . . . 0.0 110.129 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -123.63 -78.14 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.515 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.592 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.596 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.636 ' CE1' ' CG ' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.1 p90 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.266 0.555 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 85' ' ' THR . 5.4 ptm180 -168.73 167.59 11.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.518 HG22 ' CA ' ' A' ' 241' ' ' GLY . 0.2 OUTLIER -51.13 -178.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.522 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.72 109.18 30.36 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.901 . . . . 0.0 109.521 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.2 Cg_endo -72.38 101.42 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.895 1.471 . . . . 0.0 110.173 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.42 ' C ' HG22 ' A' ' 89' ' ' ILE . . . 174.22 -64.28 0.11 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.42 HG22 ' C ' ' A' ' 88' ' ' GLY . 16.4 pt -154.17 151.93 25.42 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -1.155 . . . . 0.0 109.562 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.11 159.14 48.18 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.029 1.541 . . . . 0.0 110.095 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.541 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -76.86 -92.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.964 . . . . 0.0 109.756 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.575 ' CD1' ' HA ' ' A' ' 207' ' ' LEU . 10.0 m95 -82.86 176.8 9.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 109.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.74 -41.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.148 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.53 ' CD ' HD12 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.24 172.04 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.681 0.753 . . . . 0.0 110.275 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.524 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 42.9 p -110.3 7.46 23.07 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.572 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 51.1 m80 -144.14 96.28 2.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.866 -1.147 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.9 mm? -96.59 164.45 12.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.53 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.525 ' OG1' ' CD2' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -136.89 155.98 49.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 108.519 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.683 ' CD1' ' CE2' ' A' ' 132' ' ' PHE . 7.7 p90 -135.18 170.3 16.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 109.473 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.53 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 1.1 ttm180 -131.56 128.12 38.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.613 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -86.81 82.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.198 . . . . 0.0 109.725 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 13.0 t -99.09 7.53 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.288 -0.883 . . . . 0.0 109.828 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.597 ' ND2' ' N ' ' A' ' 145' ' ' SER . 18.4 m-80 -98.9 160.46 14.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.978 -1.076 . . . . 0.0 109.166 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.598 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 7.5 t80 177.67 77.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.624 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 61.1 p -69.58 155.66 93.11 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 -25.39 39.73 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 123.766 1.403 . . . . 0.0 108.637 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 2.5 m-20 -74.26 -5.93 44.95 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.62 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 62.0 mt -140.16 121.21 9.34 Favored Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.454 -0.779 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.9 169.28 13.56 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 123.881 1.463 . . . . 0.0 108.716 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' O ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -38.62 -65.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.5 t0 -55.26 -26.93 43.03 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.716 -0.615 . . . . 0.0 111.799 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.62 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -73.9 -61.36 1.87 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.435 -1.415 . . . . 0.0 109.329 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.55 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 12.8 p -53.04 -41.33 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.492 ' N ' HG12 ' A' ' 113' ' ' VAL . 1.1 m-20 -64.45 -26.93 68.66 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.546 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 6.0 p -62.99 -42.37 99.83 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.603 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -70.7 -33.01 70.43 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 0.0 109.638 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.581 HG13 ' CE2' ' A' ' 99' ' ' TYR . 47.1 t -74.57 -23.26 17.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.513 ' HA ' HD22 ' A' ' 121' ' ' LEU . 1.1 tt0 -90.04 -33.77 16.2 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.662 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.59 -37.15 28.09 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.68 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -66.46 -62.1 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.637 ' CD2' ' CZ ' ' A' ' 99' ' ' TYR . 1.4 pp -55.47 -41.89 73.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.097 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.576 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -71.52 -33.6 69.35 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.641 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.605 ' CG1' HD12 ' A' ' 234' ' ' LEU . 0.9 OUTLIER -55.18 -42.04 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.653 ' CE2' ' CA ' ' A' ' 204' ' ' GLY . 33.7 m95 -91.29 -22.88 20.34 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.471 ' OE2' ' CB ' ' A' ' 132' ' ' PHE . 28.3 tt0 -71.42 -27.47 63.32 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.2 pt-20 -90.46 -43.59 10.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.612 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.636 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 18.3 m -58.0 -25.91 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.072 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.586 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.0 OUTLIER -104.95 163.49 17.06 Favored Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 117.966 -1.494 . . . . 0.0 110.492 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.478 ' HG2' ' HD3' ' A' ' 248' ' ' PRO . 50.6 Cg_endo -87.26 29.8 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.379 2.053 . . . . 0.0 111.289 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.635 ' CD1' ' CD2' ' A' ' 246' ' ' TYR . 34.5 mt -121.27 -166.6 1.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.61 -1.306 . . . . 0.0 110.474 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.2 p -123.01 176.68 5.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.645 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.683 ' CE2' ' CD1' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -139.25 167.98 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 109.671 -179.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.512 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -151.14 169.34 22.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 108.589 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.601 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -140.56 167.43 22.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.803 -1.186 . . . . 0.0 110.545 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 135' ' ' LEU . 0.4 OUTLIER -156.76 -133.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 12.7 t80 178.01 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 138' ' ' GLY . 7.5 pm0 -161.39 -171.85 3.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 139' ' ' GLU . . . 38.02 -98.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 138' ' ' GLY . 3.1 pt-20 178.41 107.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -1.111 . . . . 0.0 110.34 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.532 ' CB ' HD23 ' A' ' 135' ' ' LEU . . . -60.24 -150.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 108.722 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.528 ' O ' ' HA3' ' A' ' 176' ' ' GLY . 72.3 m-20 -88.48 -33.88 17.65 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' A' ' 142' ' ' ILE . 3.4 mp -126.3 79.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.541 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -67.74 101.54 1.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.853 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.5 mm -81.61 119.69 31.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.597 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -138.35 158.5 44.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.347 -1.471 . . . . 0.0 112.063 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 22.2 p90 -90.67 139.77 30.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.472 -0.768 . . . . 0.0 109.625 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.627 ' CB ' ' CE1' ' A' ' 179' ' ' HIS . . . -162.1 -160.47 0.68 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 150' ' ' GLU . 0.8 OUTLIER 179.65 -157.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.918 -1.113 . . . . 0.0 109.531 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.539 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 0.0 OUTLIER -63.14 59.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 148' ' ' VAL . 0.4 OUTLIER -158.55 21.91 0.23 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.015 -1.053 . . . . 0.0 109.368 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 74.8 m80 -58.87 168.54 1.23 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 151' ' ' HIS . . . -43.81 -52.27 6.7 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -176.62 48.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -1.11 . . . . 0.0 109.396 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.587 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -169.91 -154.91 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.393 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 154' ' ' PHE . 0.8 OUTLIER 1.87 69.04 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.522 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.531 ' N ' ' O ' ' A' ' 154' ' ' PHE . 44.9 Cg_endo -77.45 97.28 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.985 1.518 . . . . 0.0 109.57 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.748 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -72.88 -163.08 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.097 -1.002 . . . . 0.0 109.927 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.578 ' O ' ' C ' ' A' ' 159' ' ' GLY . 23.3 p30 179.2 54.45 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.877 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -0.16 -68.72 0.0 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 112.274 -0.33 . . . . 0.0 112.274 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.4 Cg_endo -67.55 59.52 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.21 1.11 . . . . 0.0 109.664 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -168.79 160.62 34.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.535 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 5.5 m120 -52.57 -47.72 66.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -1.199 . . . . 0.0 110.086 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.585 ' HB ' ' CE1' ' A' ' 157' ' ' PHE . 2.6 m -51.46 89.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 0.0 109.728 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.644 ' CD2' ' CH2' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -76.32 -82.53 0.07 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.63 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -137.33 -175.32 4.02 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.491 -1.38 . . . . 0.0 111.154 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.748 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.7 p-80 179.34 169.35 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 119.899 -1.751 . . . . 0.0 110.524 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.63 -172.51 3.18 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.498 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.582 ' OH ' ' CD2' ' A' ' 155' ' ' TYR . 64.1 m-85 -118.09 -167.28 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.072 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.566 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . . . -162.93 -64.72 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.639 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 43.0 Cg_endo -72.87 172.36 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.792 1.417 . . . . 0.0 110.362 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.547 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 90.4 165.25 40.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.8 Cg_endo -73.99 -94.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.629 1.553 . . . . 0.0 110.54 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -59.2 -35.0 82.48 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.547 ' CG2' ' HA3' ' A' ' 171' ' ' GLY . 9.4 tp -71.37 4.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.287 -1.125 . . . . 0.0 109.201 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 172' ' ' PRO . 1.2 p30 -66.08 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.89 . . . . 0.0 109.334 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 114.93 94.1 1.96 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -151.95 118.12 5.56 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -107.75 163.22 13.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.085 . . . . 0.0 109.201 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.627 ' CE1' ' CB ' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -159.78 134.62 7.9 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.11 178.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.604 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 17.1 m-85 -97.09 129.88 44.44 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.115 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.503 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -63.47 124.86 22.41 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.827 -1.549 . . . . 0.0 107.171 177.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.35 31.68 2.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 110.56 -178.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.543 ' HB3' ' HA3' ' A' ' 159' ' ' GLY . 49.2 t0 -107.9 -3.97 18.41 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.436 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.536 ' HG2' ' CA ' ' A' ' 159' ' ' GLY . 4.5 pt-20 -116.32 -111.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.028 . . . . 0.0 108.872 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 15.2 mt-30 -148.58 177.88 9.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.723 -1.236 . . . . 0.0 109.15 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.644 ' CH2' ' CD2' ' A' ' 164' ' ' LEU . 88.2 m95 -161.98 126.14 3.23 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.115 -0.99 . . . . 0.0 108.998 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.463 HG21 ' HA3' ' A' ' 192' ' ' GLY . 65.7 p -147.2 153.7 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.676 -1.265 . . . . 0.0 110.723 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 17.4 pttt -85.09 -32.69 22.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.7 t70 -86.09 64.03 8.35 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.602 ' O ' ' CG2' ' A' ' 190' ' ' THR . 3.5 t 3.19 60.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.185 0.993 . . . . 0.0 111.94 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.2 m -125.44 -30.87 3.07 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.055 -1.028 . . . . 0.0 109.787 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.463 ' HA3' HG21 ' A' ' 187' ' ' THR . . . -95.31 -80.0 1.49 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.535 HG22 ' CD2' ' A' ' 164' ' ' LEU . 47.1 m -127.84 -95.89 0.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.623 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -160.5 72.79 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 108.971 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.673 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 2.2 tp -37.07 -96.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.671 0.748 . . . . 0.0 110.448 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.673 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.3 OUTLIER -68.61 -5.15 18.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.132 -0.98 . . . . 0.0 110.848 -177.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.623 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 6.1 tp -69.0 -67.7 0.45 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 116.836 -1.946 . . . . 0.0 106.479 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.523 ' HA ' ' CB ' ' A' ' 201' ' ' HIS . 2.4 t -68.03 -9.77 11.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.68 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -73.0 -59.04 2.89 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.602 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -65.15 -15.22 62.18 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.59 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 10.9 t60 -69.27 -42.96 74.85 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 117.76 -1.576 . . . . 0.0 107.95 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.583 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 1.3 mt-10 -83.97 -47.37 11.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.865 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 117' ' ' VAL . 3.0 mt -63.11 -29.51 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.653 ' CA ' ' CE2' ' A' ' 124' ' ' TRP . . . -77.31 -31.55 51.21 Favored Glycine 0 C--N 1.295 -1.737 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -64.26 -44.22 92.41 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 121.812 -0.817 . . . . 0.0 111.212 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.541 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 49.7 m -86.97 -53.12 5.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 112.61 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.575 ' HA ' ' CD1' ' A' ' 92' ' ' TRP . 2.2 pp -104.36 -2.61 25.24 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.861 -1.149 . . . . 0.0 111.388 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.55 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -96.92 -84.58 1.74 Allowed Glycine 0 C--N 1.291 -1.966 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 238' ' ' ASP . 1.8 pp -165.35 -159.33 0.42 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.037 -1.272 . . . . 0.0 109.658 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.538 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.2 OUTLIER -96.56 -84.94 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.529 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.8 m-70 -153.18 104.57 2.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.067 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.607 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -92.1 -167.33 1.74 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.213 -0.929 . . . . 0.0 109.56 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.17 81.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.773 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.4 6.62 22.53 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.761 -177.01 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 214' ' ' ASN . 7.8 p -50.82 -27.44 7.32 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.476 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.2 mt-10 -117.29 -36.05 3.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.773 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -58.95 179.17 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.162 0.982 . . . . 0.0 111.699 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.645 ' CD2' ' CZ ' ' A' ' 196' ' ' PHE . 1.4 tp -96.05 -10.16 29.14 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.393 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.614 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 9.1 mmt -74.26 -16.73 60.94 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.641 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.5 OUTLIER -143.5 23.6 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 C-N-CA 117.621 -1.631 . . . . 0.0 113.422 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.6 Cg_endo -75.39 -31.47 5.7 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 N-CA-C 106.795 -2.04 . . . . 0.0 106.795 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.569 ' C ' ' O ' ' A' ' 221' ' ' PRO . 1.9 tm? -8.06 -65.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.326 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.76 59.59 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.8 OUTLIER -175.57 -144.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.375 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 226' ' ' LEU . 44.5 m -146.41 112.81 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.048 -1.033 . . . . 0.0 109.956 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.529 ' CG ' ' O ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.61 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.431 -0.793 . . . . 0.0 109.26 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 197' ' ' LEU . 9.1 t -108.26 -9.09 15.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.296 -0.877 . . . . 0.0 109.591 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.583 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 177.59 -20.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 110.854 179.275 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.559 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.22 -61.1 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.446 -0.783 . . . . 0.0 110.651 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.35 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 232' ' ' PHE . 51.7 p90 -31.58 120.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.488 0.661 . . . . 0.0 111.028 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.12 168.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.641 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 4.5 mp -82.82 168.49 17.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.83 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.613 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 6.5 t -98.47 -171.13 2.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.737 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.576 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -83.08 -19.24 37.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.563 -0.71 . . . . 0.0 109.449 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.607 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 5.2 m-20 -82.76 -42.24 18.22 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.658 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 1.3 m-20 -66.62 -41.03 89.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 117.411 -1.715 . . . . 0.0 106.879 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.9 OUTLIER -56.75 -35.12 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -67.11 -45.01 78.48 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.518 ' CA ' HG22 ' A' ' 85' ' ' THR . . . -62.03 -58.91 10.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.586 ' CD1' HG23 ' A' ' 128' ' ' THR . 1.9 tp -62.76 -50.41 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.987 -1.302 . . . . 0.0 110.116 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.46 ' CB ' ' O ' ' A' ' 239' ' ' ILE . 15.1 tt0 -53.37 -26.12 18.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.2 t -90.4 -10.67 43.02 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -79.84 -52.79 7.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.635 ' CD2' ' CD1' ' A' ' 130' ' ' LEU . 5.2 m-30 -82.05 -108.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.95 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.464 ' C ' ' HD2' ' A' ' 249' ' ' PRO . . . 56.98 101.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.617 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 38.6 Cg_endo -72.74 -29.79 12.34 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.009 1.531 . . . . 0.0 112.55 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 43.4 Cg_endo -74.28 111.83 3.4 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 122.581 0.78 . . . . 0.0 110.228 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 42.2 Cg_endo -73.48 -90.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.084 1.571 . . . . 0.0 110.106 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -104.78 -56.0 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.07 116.58 12.82 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.61 -33.78 8.01 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.906 1.477 . . . . 0.0 110.125 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.26 169.24 17.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.55 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.402 ' CG2' ' OXT' ' A' ' 255' ' ' THR . 4.6 t . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.541 ' O ' ' HB1' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.608 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.608 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.214 0.531 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 85' ' ' THR . 27.1 ptt180 -119.15 -156.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -43.7 155.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 109.569 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.521 ' CD2' HD13 ' A' ' 89' ' ' ILE . 1.2 m-85 -63.73 152.64 85.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.546 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.69 -13.12 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.063 1.56 . . . . 0.0 110.222 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 90' ' ' PRO . . . 177.6 -62.26 0.09 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -41.28 100.86 0.23 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.404 -1.056 . . . . 0.0 109.98 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 88' ' ' GLY . 44.4 Cg_endo -76.41 145.11 26.48 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.022 1.538 . . . . 0.0 110.161 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.588 ' CE ' ' CB ' ' A' ' 169' ' ' ALA . 1.6 tttt -57.18 -82.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.629 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 2.8 m95 -74.53 -165.98 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -167.19 -33.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.8 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.538 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -50.54 -172.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.385 -0.822 . . . . 0.0 110.619 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.55 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 1.2 p -117.35 -4.79 11.32 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.618 -0.676 . . . . 0.0 109.242 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 131' ' ' THR . 21.7 m-70 -144.22 95.24 2.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.629 ' CD1' ' CD1' ' A' ' 92' ' ' TRP . 19.4 mt -86.56 -175.44 5.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -158.63 156.72 30.54 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.326 -0.859 . . . . 0.0 108.714 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 134' ' ' ARG . 13.4 p90 -134.62 164.83 26.63 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.535 -1.353 . . . . 0.0 110.151 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' HG3' ' CD1' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -131.38 128.38 39.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.5 mp -86.14 81.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.378 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.585 ' N ' ' O ' ' A' ' 144' ' ' ILE . 16.1 t -96.22 13.77 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.542 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 7.8 m120 -107.86 156.12 19.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.581 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER 178.97 42.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.64 -0.662 . . . . 0.0 109.914 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.453 ' CG2' ' OD1' ' A' ' 182' ' ' ASP . 13.8 p -43.74 155.84 0.31 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 108.911 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.91 -21.7 43.44 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.762 1.401 . . . . 0.0 108.94 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -69.97 -8.0 45.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.591 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 84.8 mt -144.83 120.66 6.01 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.534 -0.729 . . . . 0.0 109.756 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.74 172.09 8.74 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.748 1.394 . . . . 0.0 108.981 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -38.55 -65.29 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.801 0.81 . . . . 0.0 110.384 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -55.98 -30.81 62.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.64 . . . . 0.0 112.15 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.591 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -72.45 -59.84 2.53 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.439 -1.413 . . . . 0.0 109.793 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.581 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.8 p -55.13 -39.13 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' N ' HG11 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -66.9 -27.11 67.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.491 ' OG ' HD12 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -67.6 -41.0 84.74 Favored 'General case' 0 C--O 1.202 -1.43 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.336 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.628 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -72.6 -32.77 66.22 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 120.912 -1.117 . . . . 0.0 109.806 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.553 ' CG1' HG13 ' A' ' 144' ' ' ILE . 88.7 t -75.96 -23.65 16.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.518 ' HA ' HD22 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -90.69 -33.26 15.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.717 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.2 OUTLIER -81.47 -37.45 27.94 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.641 ' HB3' ' CB ' ' A' ' 199' ' ' ALA . . . -68.3 -61.92 1.63 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.604 HD23 ' CZ ' ' A' ' 99' ' ' TYR . 1.4 pp -54.71 -41.8 70.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.065 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.559 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.15 -33.23 63.45 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.265 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.58 ' O ' ' CG1' ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.22 -40.14 63.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.683 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 44.5 m95 -91.35 -23.22 20.16 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.486 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 79.9 tt0 -71.9 -28.25 63.37 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.757 -1.214 . . . . 0.0 108.279 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.4 pt-20 -89.92 -43.53 10.52 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.798 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.632 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 18.2 m -60.44 -24.26 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.511 -1.276 . . . . 0.0 109.172 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.607 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.6 OUTLIER -100.54 155.79 35.96 Favored Pre-proline 0 N--CA 1.5 2.065 0 C-N-CA 117.943 -1.503 . . . . 0.0 111.008 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 247' ' ' GLY . 54.3 Cg_endo -84.74 27.62 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 110.46 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -117.84 -175.39 2.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.704 -1.247 . . . . 0.0 110.66 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.57 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -109.64 169.85 8.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.436 -0.79 . . . . 0.0 110.09 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.579 ' CE1' ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -149.05 162.14 40.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 110.082 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.57 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -140.2 -168.22 2.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.606 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -158.84 157.22 31.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 0.0 110.391 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.535 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -159.89 -165.21 1.45 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.406 -0.809 . . . . 0.0 109.307 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 15.8 t80 -153.33 19.78 0.56 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.385 -0.822 . . . . 0.0 108.914 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -141.4 -172.32 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -0.791 . . . . 0.0 109.341 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.18 -98.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER 178.45 117.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 110.509 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.477 ' HB3' ' OG1' ' A' ' 98' ' ' THR . . . -75.67 -148.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 108.899 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.599 ' O ' ' O ' ' A' ' 176' ' ' GLY . 59.8 m-20 -100.32 -25.03 14.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.56 HG12 ' CD2' ' A' ' 207' ' ' LEU . 2.9 mt -124.35 76.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 1.7 ttt -64.33 93.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 102' ' ' VAL . 9.1 mm -80.04 106.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.567 ' CB ' ' HB ' ' A' ' 102' ' ' VAL . 0.3 OUTLIER -131.76 162.56 30.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.24 -1.538 . . . . 0.0 112.342 -178.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.489 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 46.9 p90 -82.55 134.38 35.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.442 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.641 ' CB ' ' CD2' ' A' ' 179' ' ' HIS . . . -152.08 162.11 41.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.037 . . . . 0.0 110.418 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.523 ' O ' ' ND1' ' A' ' 151' ' ' HIS . 1.8 p -167.04 -163.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.484 ' HG2' ' HA ' ' A' ' 158' ' ' ASP . 5.3 mtm-85 -38.41 -43.87 0.87 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.39 58.21 0.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.308 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -85.8 -90.14 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.562 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 153' ' ' ASP . . . 129.56 38.27 0.34 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.644 ' CB ' ' CZ ' ' A' ' 155' ' ' TYR . 7.7 t0 -179.99 -142.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -1.227 . . . . 0.0 109.799 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.569 ' CE1' ' OH ' ' A' ' 168' ' ' TYR . 43.8 p90 -95.66 18.71 12.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.08 -1.012 . . . . 0.0 110.063 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.685 ' CD1' ' CD2' ' A' ' 151' ' ' HIS . 0.1 OUTLIER -119.61 50.31 1.51 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.331 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 39.2 Cg_endo -68.48 128.27 16.96 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.03 1.542 . . . . 0.0 109.377 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.686 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -112.94 -170.41 1.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 110.978 -178.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.484 ' HA ' ' HG2' ' A' ' 149' ' ' ARG . 17.4 p30 -176.18 63.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.898 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.579 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -12.38 -61.35 0.01 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.479 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.0 Cg_endo -63.56 66.11 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.551 1.29 . . . . 0.0 109.651 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 177.87 143.88 5.24 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.534 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 30.4 m-80 -37.79 -44.6 0.75 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.634 -0.921 . . . . 0.0 110.221 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.679 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 17.8 t -42.4 95.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 109.33 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.543 HD11 ' CD1' ' A' ' 222' ' ' LEU . 1.9 mt -90.17 -38.89 13.18 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 113.133 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.59 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . 179.43 -171.12 0.14 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.799 -1.813 . . . . 0.0 111.449 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.686 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.2 p-80 179.15 -170.28 0.12 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.376 -1.453 . . . . 0.0 111.33 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -153.45 179.2 9.01 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.437 -0.789 . . . . 0.0 110.235 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.59 ' O ' ' CB ' ' A' ' 206' ' ' SER . 11.0 m-85 -127.6 162.41 26.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.894 -1.129 . . . . 0.0 111.149 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.593 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . . . -144.49 -67.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 40.7 Cg_endo -70.75 94.89 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.489 1.257 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 159.09 145.14 4.16 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -71.57 145.86 48.06 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.511 1.474 . . . . 0.0 110.083 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 67.81 -64.05 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.3 OUTLIER -74.24 5.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.414 -1.051 . . . . 0.0 108.896 178.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 171' ' ' GLY . 0.5 OUTLIER -63.9 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 115.05 89.1 1.6 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.665 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -155.64 118.96 4.36 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 202' ' ' GLU . . . -108.76 128.57 54.99 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.186 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.641 ' CD2' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -113.59 132.46 55.73 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.894 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.683 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 16.0 m-85 -93.37 125.0 37.74 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.198 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 164' ' ' LEU . 22.6 t0 -50.1 135.05 21.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.667 -1.271 . . . . 0.0 108.262 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.453 ' OD1' ' CG2' ' A' ' 105' ' ' THR . 0.1 OUTLIER -106.22 24.27 12.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 110.232 -178.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.579 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.7 OUTLIER -129.13 24.37 5.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 159' ' ' GLY . 2.3 mt-10 -129.03 -90.26 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.138 -0.976 . . . . 0.0 109.408 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.628 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 1.7 mt-30 179.89 170.22 1.16 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.683 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.0 m95 -158.63 124.16 4.4 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.022 -1.049 . . . . 0.0 109.795 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.455 ' HA ' HD22 ' A' ' 108' ' ' LEU . 67.9 p -148.32 149.78 32.45 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.925 -1.109 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.569 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 8.5 pttt -84.14 -32.46 24.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.7 t70 -83.49 61.73 6.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.594 ' C ' ' O ' ' A' ' 189' ' ' ASP . 15.7 m 3.08 64.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.71 0.767 . . . . 0.0 111.384 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 189' ' ' ASP . 41.9 m -130.74 -31.64 1.74 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.762 -0.587 . . . . 0.0 109.635 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' ' 187' ' ' THR . . . -94.45 -77.89 1.39 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.535 ' CG2' HD23 ' A' ' 164' ' ' LEU . 13.4 m -128.35 -81.61 0.58 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.481 -1.011 . . . . 0.0 108.774 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.615 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 1.9 m-20 -177.47 67.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.586 -0.845 . . . . 0.0 108.991 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.628 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -32.4 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.58 0.705 . . . . 0.0 110.537 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.717 ' CG ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -71.78 -8.74 56.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.839 -1.163 . . . . 0.0 110.929 -178.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 14.8 tp -70.76 -56.29 6.71 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 116.262 -2.175 . . . . 0.0 107.207 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.517 ' CG1' ' OE2' ' A' ' 202' ' ' GLU . 9.1 t -77.87 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.641 ' CB ' ' HB3' ' A' ' 120' ' ' ALA . . . -75.26 -58.8 3.06 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.598 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -66.53 -19.71 65.85 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.6 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 4.7 t60 -66.17 -41.81 89.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 116.873 -1.931 . . . . 0.0 107.882 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.561 ' OE1' ' CD1' ' A' ' 180' ' ' PHE . 8.3 mt-10 -84.1 -49.1 9.2 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.145 -0.972 . . . . 0.0 110.792 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.556 HD11 ' N ' ' A' ' 121' ' ' LEU . 3.2 mt -57.85 -31.74 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.683 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -80.6 -35.3 26.02 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -57.95 -47.71 82.11 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.423 -1.045 . . . . 0.0 110.519 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.59 ' CB ' ' O ' ' A' ' 168' ' ' TYR . 1.4 p -86.08 -58.46 2.63 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 111.906 -177.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.584 HD23 ' CB ' ' A' ' 206' ' ' SER . 0.3 OUTLIER -104.43 33.97 3.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.81 -1.181 . . . . 0.0 110.114 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.579 ' HA2' ' CD1' ' A' ' 242' ' ' ILE . . . -132.06 -77.21 0.13 Allowed Glycine 0 C--N 1.29 -1.973 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.5 pp -165.69 -160.72 0.47 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.999 -1.295 . . . . 0.0 109.62 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.59 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 16.7 t80 -101.7 -71.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 20.7 m80 -163.78 100.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.865 . . . . 0.0 108.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.635 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.7 OUTLIER -90.27 -175.93 4.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.882 . . . . 0.0 109.249 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.446 ' H ' ' HB3' ' A' ' 237' ' ' ASP . . . -63.86 78.33 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.754 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.26 9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.56 -177.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -50.64 -27.78 7.58 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.488 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.0 OUTLIER -114.51 -37.58 4.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.754 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -62.33 -171.28 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.334 1.064 . . . . 0.0 112.418 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.623 ' O ' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -89.95 -16.54 29.7 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.735 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.528 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.5 -9.57 58.98 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.476 -2.015 . . . . 0.0 112.436 -177.36 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.66 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 4.7 t80 -136.49 16.58 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.229 -1.545 . . . . 0.0 113.404 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.2 Cg_endo -78.81 -40.07 0.33 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 108.711 -1.304 . . . . 0.0 108.711 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.579 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -7.83 -77.07 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.257 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.99 59.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.244 -0.91 . . . . 0.0 108.955 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.5 t-80 -163.61 -124.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.339 -0.851 . . . . 0.0 108.974 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.482 ' HA ' HG22 ' A' ' 190' ' ' THR . 62.5 m -168.78 104.44 0.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.697 -1.252 . . . . 0.0 110.342 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' A' ' 197' ' ' LEU . 0.4 OUTLIER 178.92 48.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.523 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 9.2 t -98.69 -15.71 19.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.064 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 0.5 OUTLIER 178.09 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.429 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -32.95 -56.95 0.38 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.13 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -86.22 -16.63 37.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.6 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 25.4 p90 -32.34 111.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.719 0.771 . . . . 0.0 110.933 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.562 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.6 ttt180 179.22 149.73 0.28 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.657 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -73.03 167.22 21.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.99 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.637 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 28.8 t -99.56 -170.6 1.92 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.969 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.526 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.02 -13.35 50.82 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.011 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.635 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 3.1 m-20 -84.85 -46.75 11.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.657 -1.277 . . . . 0.0 107.783 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.735 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.8 OUTLIER -65.12 -39.3 92.89 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 117.226 -1.79 . . . . 0.0 106.549 177.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.66 -35.45 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.98 -50.36 62.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.14 60.75 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.607 ' CD1' HG23 ' A' ' 128' ' ' THR . 1.7 tp -66.37 -49.18 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.837 -1.39 . . . . 0.0 110.132 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -54.03 -25.05 19.33 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.7 p -92.73 -9.87 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.556 HD22 ' CB ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -77.86 -51.25 10.76 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.53 ' CZ ' HD11 ' A' ' 97' ' ' LEU . 5.4 m-30 -81.75 -108.2 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.83 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 129' ' ' PRO . . . 154.08 143.44 3.68 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.953 -1.594 . . . . 0.0 110.238 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 39.2 Cg_endo -72.65 -29.52 12.89 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.72 1.614 . . . . 0.0 112.651 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 41.2 Cg_endo -73.12 128.37 12.95 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 N-CA-C 110.014 -0.802 . . . . 0.0 110.014 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.99 -91.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.54 1.493 . . . . 0.0 110.405 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 251' ' ' ASP . 0.6 OUTLIER -128.13 -44.85 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.886 -179.667 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.13 69.46 1.82 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.819 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.453 ' HD2' ' OE1' ' A' ' 254' ' ' GLU . 42.6 Cg_endo -72.73 -12.37 26.52 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.927 1.488 . . . . 0.0 109.909 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 253' ' ' PRO . 3.7 pm0 -98.98 -171.38 2.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.582 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 254' ' ' GLU . 98.9 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.566 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.6 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.636 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.636 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.9 p90 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.321 0.581 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' CZ ' ' CB ' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -165.1 -147.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.433 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.503 ' N ' ' HG3' ' A' ' 84' ' ' ARG . 0.1 OUTLIER -43.77 -91.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 109.491 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.451 ' N ' ' OG1' ' A' ' 85' ' ' THR . 12.5 m-85 -116.42 125.05 28.81 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.611 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.79 85.01 1.19 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.978 1.515 . . . . 0.0 110.105 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.45 -103.56 0.57 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.455 HG21 ' HD2' ' A' ' 90' ' ' PRO . 94.7 mt -91.41 138.99 25.2 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.278 -1.13 . . . . 0.0 109.546 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.465 ' HB2' HD21 ' A' ' 245' ' ' LEU . 42.0 Cg_endo -72.81 156.14 53.13 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.053 1.554 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.583 ' HG3' ' CD1' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -43.35 -87.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.959 . . . . 0.0 109.487 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 91' ' ' LYS . 89.9 m95 -105.02 149.56 25.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.883 -1.136 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.21 -33.29 5.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.734 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.553 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -44.75 175.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.438 -0.789 . . . . 0.0 110.345 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.533 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 7.1 p -109.11 5.05 23.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.47 -0.768 . . . . 0.0 109.78 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.539 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 47.9 m80 -146.88 94.44 2.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.831 -1.168 . . . . 0.0 110.538 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.634 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 1.9 mm? -93.6 -176.54 4.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -0.794 . . . . 0.0 108.872 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 141' ' ' ASP . 1.1 t -146.82 154.28 41.16 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.97 -1.081 . . . . 0.0 109.084 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.639 ' CD1' ' CD2' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -133.79 166.53 22.43 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.712 -1.242 . . . . 0.0 109.914 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.534 ' HD3' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.39 133.14 46.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.634 ' CD1' ' CZ ' ' A' ' 99' ' ' TYR . 2.4 mp -96.55 80.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 109.777 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.614 ' N ' ' O ' ' A' ' 144' ' ' ILE . 59.4 t -97.94 7.38 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.559 ' ND2' ' N ' ' A' ' 145' ' ' SER . 35.2 m-80 -92.95 158.13 15.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.697 -1.252 . . . . 0.0 109.647 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.576 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 1.8 t80 178.16 82.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.532 -0.73 . . . . 0.0 109.555 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.451 HG23 ' CD1' ' A' ' 186' ' ' TRP . 1.3 p -75.98 159.27 81.08 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.12 -21.48 42.47 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.82 1.432 . . . . 0.0 108.779 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.2 OUTLIER -78.1 -0.77 29.44 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.617 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 96.7 mt -150.63 120.64 3.73 Favored Pre-proline 0 N--CA 1.485 1.292 0 O-C-N 121.421 -0.799 . . . . 0.0 109.88 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.13 175.7 5.42 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.801 1.422 . . . . 0.0 109.334 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.22 -65.83 0.34 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.875 0.845 . . . . 0.0 110.341 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.65 -30.76 63.69 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.617 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -72.61 -60.68 2.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.25 -1.531 . . . . 0.0 109.54 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.576 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 7.2 p -53.17 -41.2 41.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.5 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -62.22 -28.1 69.45 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.531 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 7.7 p -64.02 -42.87 96.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.621 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -71.11 -33.77 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.598 ' CG1' HG13 ' A' ' 144' ' ' ILE . 1.5 t -75.55 -23.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -88.36 -34.94 17.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.64 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 3.5 tppt? -80.6 -36.39 32.84 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.646 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -65.44 -62.46 1.51 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.639 ' CD2' ' CD1' ' A' ' 99' ' ' TYR . 13.5 tp -52.47 -46.32 66.47 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.058 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -69.17 -33.82 73.99 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.33 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.585 ' CG2' ' CE1' ' A' ' 196' ' ' PHE . 0.9 OUTLIER -57.34 -36.69 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.707 ' CZ2' ' HA3' ' A' ' 204' ' ' GLY . 55.4 m95 -91.68 -24.13 19.59 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.874 -1.131 . . . . 0.0 110.495 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.581 ' HG3' ' CD2' ' A' ' 132' ' ' PHE . 14.8 tt0 -71.81 -28.88 63.89 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.851 -1.155 . . . . 0.0 108.315 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.0 pt-20 -91.37 -42.93 10.06 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.646 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 21.7 m -61.83 -23.34 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.206 -1.398 . . . . 0.0 109.802 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.604 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.0 OUTLIER -104.29 161.73 22.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 117.14 -1.824 . . . . 0.0 110.298 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.532 ' CG ' ' CA ' ' A' ' 247' ' ' GLY . 50.0 Cg_endo -80.72 13.12 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.609 1.847 . . . . 0.0 110.655 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 130' ' ' LEU . 3.3 mm? -116.4 -176.94 3.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.953 -1.092 . . . . 0.0 110.093 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.509 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.4 p -124.72 170.42 11.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.604 ' CD1' ' HB2' ' A' ' 97' ' ' LEU . 21.6 m-85 -131.78 179.55 6.0 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.84 0.829 . . . . 0.0 110.023 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 m -142.44 -166.36 2.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 160.57 18.37 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.906 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.526 ' CD1' ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -159.63 -128.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.491 ' N ' HD11 ' A' ' 135' ' ' LEU . 0.1 OUTLIER 177.15 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.465 -1.397 . . . . 0.0 109.732 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 139' ' ' GLU . 7.5 pm0 -151.47 -177.65 6.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 109.917 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.76 -97.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.99 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -1.105 . . . . 0.0 110.003 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -58.9 -155.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 108.959 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' THR . 76.7 m-20 -83.52 -26.07 30.48 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.537 ' CD1' HD21 ' A' ' 207' ' ' LEU . 2.1 mp -130.17 77.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.412 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.6 ttt -62.01 93.2 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 109.26 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.614 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.3 mm -82.12 109.06 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.495 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -134.29 153.54 51.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.492 -1.38 . . . . 0.0 111.652 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 20.0 p90 -86.98 139.58 30.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.179 -0.95 . . . . 0.0 109.406 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -168.54 -158.23 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 110.556 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.594 ' CG2' ' CA ' ' A' ' 159' ' ' GLY . 1.4 p -173.22 -158.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.512 ' HA ' ' N ' ' A' ' 157' ' ' PHE . 10.8 ptt180 -66.84 60.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 148' ' ' VAL . 1.4 tt0 -168.62 44.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.275 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 148' ' ' VAL . 14.5 m80 -74.27 -61.53 1.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.416 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.415 ' O ' ' CG ' ' A' ' 153' ' ' ASP . . . 127.84 33.92 0.58 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' GLY . 10.7 m-20 -167.48 -90.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -1.16 . . . . 0.0 109.56 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -145.43 28.65 1.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.499 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.577 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 0.9 OUTLIER -120.71 46.76 1.03 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.692 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 40.3 Cg_endo -70.05 99.12 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.93 1.489 . . . . 0.0 109.564 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.679 ' CD2' ' CE1' ' A' ' 166' ' ' HIS . 0.9 OUTLIER -71.22 -131.88 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.375 -0.828 . . . . 0.0 109.875 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.527 ' HB3' ' CG2' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -148.69 -36.03 0.19 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.42 -1.425 . . . . 0.0 110.194 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.595 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 69.01 -110.01 3.18 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 34.8 Cg_endo -59.97 76.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.063 1.033 . . . . 0.0 110.268 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -166.24 -160.78 13.98 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' VAL . 9.8 m-80 -90.58 -48.91 6.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.259 -1.142 . . . . 0.0 110.477 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.58 HG22 ' CD1' ' A' ' 157' ' ' PHE . 27.7 m -41.02 127.25 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.842 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.541 ' CD1' ' CG2' ' A' ' 193' ' ' THR . 13.6 mt -96.62 -40.01 9.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.321 -0.862 . . . . 0.0 112.717 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -178.49 -167.08 0.12 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 119.79 -1.819 . . . . 0.0 111.223 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 1.1 p-80 178.95 -174.03 0.18 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.208 -1.558 . . . . 0.0 111.358 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -149.63 -175.15 4.9 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.453 -0.78 . . . . 0.0 109.787 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.629 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -122.25 -162.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.838 -1.164 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.517 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -172.43 -60.2 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.466 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 44.4 Cg_endo -75.33 -178.69 4.42 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.858 1.451 . . . . 0.0 110.217 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 67.96 140.67 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -70.4 152.19 65.87 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.964 1.507 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . 67.83 -65.33 0.32 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.629 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -67.62 -3.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.482 -1.01 . . . . 0.0 109.143 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.547 ' ND2' ' CZ2' ' A' ' 92' ' ' TRP . 5.3 p-10 -65.29 65.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.754 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 126.33 82.64 0.45 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.551 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 1.7 m-20 -152.22 123.83 7.85 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.918 -1.343 . . . . 0.0 107.735 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -111.74 156.18 22.34 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.599 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -151.29 132.65 14.6 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.735 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.693 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 19.9 m-30 -87.69 126.8 35.18 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.898 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.512 ' HB3' ' O ' ' A' ' 164' ' ' LEU . 34.2 t0 -68.67 134.38 49.79 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.449 -0.782 . . . . 0.0 109.295 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 183' ' ' ASP . 18.9 p-10 -61.45 -14.07 25.63 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.4 p30 3.96 -93.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.513 ' OE2' ' HB2' ' A' ' 183' ' ' ASP . 10.2 mp0 -127.26 -63.02 1.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.974 -1.079 . . . . 0.0 110.681 -177.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.539 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 28.4 mt-30 -158.58 176.7 12.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.873 -1.142 . . . . 0.0 110.393 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.693 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 43.2 m95 -148.85 128.67 13.36 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.478 ' CG2' ' HA3' ' A' ' 192' ' ' GLY . 81.1 p -145.77 150.84 36.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.37 -1.456 . . . . 0.0 111.34 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.6 OUTLIER -83.76 -34.08 24.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 38.4 t0 -85.53 62.06 7.24 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.569 ' C ' ' O ' ' A' ' 189' ' ' ASP . 6.1 t 3.73 60.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 122.002 0.906 . . . . 0.0 111.829 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 46.9 m -124.79 -31.31 3.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.419 -0.801 . . . . 0.0 109.57 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.478 ' HA3' ' CG2' ' A' ' 187' ' ' THR . . . -95.53 -70.52 1.07 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.541 ' CG2' ' CD1' ' A' ' 164' ' ' LEU . 23.4 m -140.07 -95.92 0.16 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.63 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -158.85 70.33 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 108.87 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.657 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 1.7 tp -34.51 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.54 0.686 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.657 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.3 OUTLIER -67.23 -6.95 20.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 110.845 -177.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.63 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 8.6 tp -68.11 -65.82 0.65 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 116.912 -1.915 . . . . 0.0 106.801 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.548 ' HB ' ' CZ3' ' A' ' 186' ' ' TRP . 5.4 t -69.14 -11.41 14.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.646 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -72.23 -57.53 4.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.587 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -68.01 -15.66 63.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.586 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 4.2 t60 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.229 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 205' ' ' HIS . 1.9 mm-40 -85.64 -45.23 11.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.938 -1.101 . . . . 0.0 110.616 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 121' ' ' LEU . 2.1 mt -61.32 -31.67 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.707 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.85 -34.42 30.88 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -56.81 -47.11 81.01 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.508 -0.995 . . . . 0.0 109.946 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.513 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 6.1 p -83.97 -57.77 3.06 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.735 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.537 HD21 ' CD1' ' A' ' 142' ' ' ILE . 7.8 mp -103.75 37.31 2.07 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.246 -0.909 . . . . 0.0 110.503 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -139.31 -78.47 0.06 OUTLIER Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.81 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.5 pp -173.18 -159.37 0.11 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.716 -1.461 . . . . 0.0 110.367 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.573 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 54.4 t80 -100.0 -91.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.664 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.579 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 3.2 m-70 -148.57 106.71 3.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 109.473 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.582 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -95.93 -172.53 2.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 109.214 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.41 85.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.744 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.68 10.13 19.17 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.247 -177.056 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 214' ' ' ASN . 28.9 p -50.88 -27.55 7.7 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.483 ' N ' ' C ' ' A' ' 214' ' ' ASN . 15.4 mt-10 -118.41 -35.13 3.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.802 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.744 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -58.1 -159.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.179 0.99 . . . . 0.0 112.575 -177.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.584 HD11 ' O ' ' A' ' 218' ' ' LEU . 0.2 OUTLIER -112.62 -1.72 14.76 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.111 -177.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.579 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -91.76 -9.71 42.65 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 119.997 -1.689 . . . . 0.0 110.637 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.677 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.2 t80 -137.11 14.31 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.79 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.921 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -74.2 -39.89 1.45 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 N-CA-C 108.883 -1.237 . . . . 0.0 108.883 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.597 ' CD2' ' CD2' ' A' ' 3' ' ' MSB . 2.9 tp -7.24 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.496 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 14.5 m-85 -67.57 59.86 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -163.25 -146.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 226' ' ' LEU . 65.5 m -144.65 101.05 3.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.975 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.44 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 109.074 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.559 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 9.3 t -92.06 -15.65 27.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.347 -0.845 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.574 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.4 OUTLIER 178.42 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.94 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.568 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.87 -98.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.453 -0.78 . . . . 0.0 111.242 -179.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.0 -13.87 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.78 -1.2 . . . . 0.0 109.77 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.573 ' O ' ' C ' ' A' ' 232' ' ' PHE . 2.4 mtp180 -106.2 -42.83 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 108.806 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.574 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 25.8 p90 0.36 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.244 0.545 . . . . 0.0 112.139 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 234' ' ' LEU . 0.0 OUTLIER 178.27 175.28 0.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.647 HD23 ' CH2' ' A' ' 124' ' ' TRP . 3.1 mp -85.66 163.53 18.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.569 -0.707 . . . . 0.0 110.98 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.636 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 5.3 t -98.34 178.74 4.95 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.392 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.536 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.4 OUTLIER -71.04 -24.37 62.33 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.475 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.582 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.3 m-20 -83.46 -42.2 17.2 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.575 -1.328 . . . . 0.0 108.94 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.586 ' CB ' ' HB3' ' A' ' 217' ' ' ALA . 5.8 t0 -70.76 -40.26 72.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.821 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.574 ' CD1' ' O ' ' A' ' 235' ' ' SER . 7.2 mt -54.82 -40.65 53.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.486 ' HA ' ' HG2' ' A' ' 243' ' ' GLN . 25.6 t-20 -60.21 -45.42 93.26 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.851 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.51 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -60.62 -54.57 35.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.604 ' CD1' HG23 ' A' ' 128' ' ' THR . 0.8 OUTLIER -65.2 -47.95 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.725 -1.456 . . . . 0.0 110.621 -178.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.486 ' HG2' ' HA ' ' A' ' 240' ' ' ASN . 15.9 pt20 -54.05 -25.09 19.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 t -88.18 -14.9 37.44 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.515 HD22 ' HB3' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -76.06 -56.29 4.79 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.554 ' CE1' ' HB2' ' A' ' 92' ' ' TRP . 49.6 m-85 -91.91 -72.77 0.57 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.291 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.532 ' CA ' ' CG ' ' A' ' 129' ' ' PRO . . . -36.84 141.88 0.21 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.501 ' CB ' ' HB2' ' A' ' 252' ' ' SER . 42.2 Cg_endo -72.04 130.86 17.2 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.047 1.551 . . . . 0.0 110.393 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.61 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 39.0 Cg_endo -73.24 -29.52 11.42 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 124.047 1.551 . . . . 0.0 112.586 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 249' ' ' PRO . 43.0 Cg_endo -73.5 -94.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.944 0 O-C-N 122.477 0.725 . . . . 0.0 110.413 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 252' ' ' SER . 22.1 t70 -158.02 18.08 0.24 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.074 . . . . 0.0 110.15 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.501 ' HB2' ' CB ' ' A' ' 248' ' ' PRO . 0.3 OUTLIER -43.56 125.31 3.82 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.912 . . . . 0.0 109.421 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 255' ' ' THR . 42.1 Cg_endo -72.36 -9.43 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.88 1.463 . . . . 0.0 110.28 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.89 75.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.912 . . . . 0.0 109.531 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 253' ' ' PRO . 7.4 t . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.582 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.582 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.602 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.602 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -108.28 -122.37 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.389 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 84' ' ' ARG . 5.1 t -50.61 176.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.817 -1.177 . . . . 0.0 109.59 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 78.22 74.28 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.97 . . . . 0.0 109.57 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.64 139.93 31.81 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.991 1.522 . . . . 0.0 110.089 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.417 ' C ' HD12 ' A' ' 89' ' ' ILE . . . 105.17 -63.91 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.417 HD12 ' C ' ' A' ' 88' ' ' GLY . 8.8 mm -114.48 110.55 47.31 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.268 -1.136 . . . . 0.0 109.465 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.32 -161.73 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.969 1.51 . . . . 0.0 110.158 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.527 ' CB ' HD23 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -102.76 -92.35 0.33 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 109.065 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 98.7 m95 -82.6 151.95 26.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.115 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.92 -40.49 4.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.134 -179.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -50.7 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 -179.647 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.45 ' HA ' ' HG ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -118.17 2.11 11.97 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.496 -0.752 . . . . 0.0 109.369 179.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 38.5 m80 -140.68 89.64 2.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.955 -1.091 . . . . 0.0 110.219 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.582 ' HB2' ' CE2' ' A' ' 132' ' ' PHE . 2.3 mm? -87.68 173.09 9.23 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.652 -0.655 . . . . 0.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.604 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -142.16 155.85 45.33 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.087 -1.008 . . . . 0.0 108.73 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.698 ' CE1' ' CD2' ' A' ' 121' ' ' LEU . 5.4 p90 -137.88 164.79 28.09 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.714 -1.242 . . . . 0.0 108.667 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HD3' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.089 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.653 ' CD1' ' CE2' ' A' ' 99' ' ' TYR . 1.5 mp -96.87 61.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 109.698 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 144' ' ' ILE . 21.5 t -77.58 4.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.636 ' ND2' ' CD2' ' A' ' 180' ' ' PHE . 5.4 m-20 -92.92 155.94 17.25 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.983 -1.073 . . . . 0.0 110.073 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.546 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 2.4 t80 176.26 150.98 0.14 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.489 ' CG2' ' C ' ' A' ' 104' ' ' TYR . 3.9 p -156.23 161.11 30.16 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -67.71 -24.68 40.76 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 N-CA-C 108.079 -1.547 . . . . 0.0 108.079 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.5 ' O ' HD22 ' A' ' 108' ' ' LEU . 5.5 t0 -73.82 -12.24 60.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 76.2 mt -143.38 115.41 5.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.28 167.34 12.97 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.63 1.332 . . . . 0.0 109.101 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -36.25 -66.17 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.805 0.812 . . . . 0.0 110.322 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.32 -11.88 7.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.728 -0.607 . . . . 0.0 111.62 -178.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.566 ' CB ' ' HD2' ' A' ' 109' ' ' PRO . . . -85.32 -60.4 2.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.488 -1.383 . . . . 0.0 109.213 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.546 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 5.5 p -55.7 -39.49 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.466 ' HA ' HG22 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -64.62 -27.56 69.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.494 ' OG ' HD12 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -65.7 -41.61 92.14 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.672 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -69.7 -33.34 72.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.606 ' CG1' HG13 ' A' ' 144' ' ' ILE . 2.0 t -74.95 -24.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -87.32 -35.31 18.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 0.3 OUTLIER -80.26 -36.73 34.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.681 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -66.09 -60.8 2.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.532 1.158 . . . . 0.0 107.913 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.698 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 16.2 tp -54.12 -48.24 70.97 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.654 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -67.39 -33.72 75.79 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.241 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.59 ' CG1' HD11 ' A' ' 234' ' ' LEU . 1.0 OUTLIER -55.93 -42.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.643 ' CE2' ' CA ' ' A' ' 204' ' ' GLY . 42.0 m95 -91.21 -23.16 20.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.588 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 18.5 tt0 -71.16 -27.56 63.64 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.6 pt-20 -90.15 -43.55 10.37 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.63 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 16.6 m -58.49 -25.36 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.124 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.594 HG23 ' CD1' ' A' ' 242' ' ' ILE . 0.1 OUTLIER -112.1 162.28 22.06 Favored Pre-proline 0 N--CA 1.497 1.922 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.834 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -84.91 27.98 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.134 1.889 . . . . 0.0 110.483 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 246' ' ' TYR . 1.9 mp -109.44 178.99 4.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.247 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.8 p -124.41 170.26 11.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.8 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 97' ' ' LEU . 12.5 m-85 -146.04 171.41 14.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.15 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.4 m -145.22 -175.13 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.622 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -163.83 149.94 11.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 0.0 110.501 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -167.59 -98.71 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.568 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 15.9 t80 177.06 30.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.955 -1.091 . . . . 0.0 109.195 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 138' ' ' GLY . 7.3 tp10 -65.63 169.63 6.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.566 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -41.79 -34.87 1.37 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -178.22 104.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.556 -0.967 . . . . 0.0 109.894 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -59.4 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 98' ' ' THR . 71.5 m-20 -80.67 -30.49 36.53 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.97 -1.081 . . . . 0.0 108.794 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.536 ' CG2' HD13 ' A' ' 144' ' ' ILE . 4.4 mp -129.14 78.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.431 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.9 ttp -62.66 98.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.207 -0.933 . . . . 0.0 109.297 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.606 HG13 ' CG1' ' A' ' 117' ' ' VAL . 3.9 mm -84.76 107.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -132.9 152.22 51.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 112.322 -178.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 24.5 p90 -77.44 146.6 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.561 -0.712 . . . . 0.0 109.586 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.565 ' N ' ' CD2' ' A' ' 179' ' ' HIS . . . -165.04 163.69 20.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -0.929 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.523 ' O ' ' ND1' ' A' ' 151' ' ' HIS . 1.2 p -160.79 -160.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.96 . . . . 0.0 109.368 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 157' ' ' PHE . 36.7 mtm180 -36.24 -41.39 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.115 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.461 ' HG2' HG11 ' A' ' 148' ' ' VAL . 3.7 pt-20 -76.47 59.53 1.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.689 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 1.2 m80 -87.08 -91.16 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.19 39.36 0.38 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 155' ' ' TYR . 2.4 t70 -177.47 -143.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -1.163 . . . . 0.0 109.652 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.413 ' C ' ' HD3' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -94.41 15.87 16.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 110.0 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.689 ' CD1' ' CD2' ' A' ' 151' ' ' HIS . 0.1 OUTLIER -119.14 57.02 3.42 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.729 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 154' ' ' PHE . 40.5 Cg_endo -70.53 133.86 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.904 1.476 . . . . 0.0 109.379 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.684 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -120.71 -171.53 2.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.079 -1.013 . . . . 0.0 110.848 -179.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 160' ' ' PRO . 17.0 p30 -175.92 62.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.82 -0.55 . . . . 0.0 109.636 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.566 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -8.97 -63.53 0.01 OUTLIER Glycine 0 N--CA 1.505 3.283 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.504 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.1 Cg_endo -64.02 66.56 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.442 1.233 . . . . 0.0 109.94 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 178.02 151.59 9.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' LEU . 15.2 m-20 -42.58 -32.57 0.58 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.166 . . . . 0.0 109.667 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.645 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 39.6 t -44.68 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.7 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.56 ' CB ' ' OB2' ' A' ' 3' ' ' MSB . 3.1 tp -88.14 -52.01 5.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.12 -0.987 . . . . 0.0 112.286 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.594 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -176.48 -165.34 0.13 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.151 -1.593 . . . . 0.0 111.142 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.684 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.72 -175.29 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.01 -1.681 . . . . 0.0 111.43 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -155.51 176.82 12.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.562 -0.711 . . . . 0.0 109.907 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.527 ' O ' ' CB ' ' A' ' 206' ' ' SER . 25.4 m-85 -120.06 -168.89 1.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.312 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.553 ' CB ' ' HD3' ' A' ' 170' ' ' PRO . . . -159.74 -64.03 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 0.0 109.602 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -76.58 174.82 12.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.651 1.343 . . . . 0.0 110.051 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 105.98 170.82 23.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 175' ' ' ASN . 44.3 Cg_endo -76.43 -56.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 121.603 1.535 . . . . 0.0 109.874 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.62 -40.25 1.03 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.7 tp -62.88 -7.09 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.463 -1.022 . . . . 0.0 108.867 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.524 ' CA ' ' O ' ' A' ' 169' ' ' ALA . 4.4 p-10 -66.0 65.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 108.991 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 127.55 80.76 0.32 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.2 m-20 -156.83 120.94 4.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.102 -1.234 . . . . 0.0 108.158 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -107.19 164.27 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.508 -0.745 . . . . 0.0 109.107 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -153.09 137.58 16.76 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.893 -1.123 . . . . 0.0 109.89 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.636 ' CD2' ' ND2' ' A' ' 103' ' ' ASN . 8.3 m-85 -99.16 129.75 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.753 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.516 ' O ' ' CZ2' ' A' ' 186' ' ' TRP . 11.1 t0 -47.3 148.88 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.906 -1.121 . . . . 0.0 108.312 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -114.34 19.22 16.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 110.122 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.566 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.7 OUTLIER -135.45 17.86 3.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.979 -1.076 . . . . 0.0 110.325 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 4.4 tt0 -120.47 -139.2 0.34 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.909 -1.12 . . . . 0.0 108.548 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.618 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 3.4 mt-30 -117.66 168.06 10.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -0.96 . . . . 0.0 109.14 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.618 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 87.1 m95 -159.46 107.46 1.77 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.974 -1.079 . . . . 0.0 109.741 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.526 ' CG2' ' HA3' ' A' ' 192' ' ' GLY . 70.6 p -144.26 154.6 43.25 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.853 -1.155 . . . . 0.0 110.787 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 0.1 OUTLIER -91.68 -28.7 17.28 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 191' ' ' THR . 40.4 t0 -90.8 67.05 6.16 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.61 ' O ' ' CG2' ' A' ' 190' ' ' THR . 2.8 t 4.07 58.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.021 0.915 . . . . 0.0 112.036 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 189' ' ' ASP . 51.6 m -124.51 -31.25 3.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 0.0 109.733 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 187' ' ' THR . . . -98.85 -90.96 1.99 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.518 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 23.9 m -115.41 -97.01 0.45 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.608 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 0.6 OUTLIER -161.45 68.54 0.3 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.23 -0.919 . . . . 0.0 108.706 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.672 ' HG ' ' CB ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -28.63 -95.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.596 0.713 . . . . 0.0 111.407 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.655 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -67.57 -8.38 33.7 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 111.011 -177.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.608 ' CB ' ' HB3' ' A' ' 194' ' ' ASN . 6.3 tp -66.13 -66.64 0.52 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.224 -1.79 . . . . 0.0 106.668 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.534 HG13 ' CD2' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -66.75 -13.72 16.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.681 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -70.91 -58.8 3.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.588 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -66.67 -14.96 63.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.594 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 14.8 t60 -68.08 -45.47 73.71 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 117.798 -1.561 . . . . 0.0 107.625 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.578 ' OE1' ' CE1' ' A' ' 180' ' ' PHE . 2.2 mt-10 -82.8 -47.82 11.49 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.192 -0.943 . . . . 0.0 111.003 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.555 HG22 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -60.05 -31.27 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.643 ' CA ' ' CE2' ' A' ' 124' ' ' TRP . . . -76.9 -31.84 51.88 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.575 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -59.97 -51.01 71.48 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.85 -0.794 . . . . 0.0 110.58 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 168' ' ' TYR . 84.4 p -82.74 -56.88 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 112.362 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.53 ' CD2' HG12 ' A' ' 142' ' ' ILE . 1.0 OUTLIER -104.86 26.62 8.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.098 -1.001 . . . . 0.0 110.622 -177.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -126.52 -79.19 0.31 Allowed Glycine 0 C--N 1.292 -1.878 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.533 HD11 ' N ' ' A' ' 210' ' ' PHE . 2.1 pp -170.16 -162.67 0.31 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.678 -1.484 . . . . 0.0 110.015 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.567 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.3 OUTLIER -95.07 -75.34 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.5 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.3 m-70 -161.28 89.36 0.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.63 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.5 m -77.1 -178.67 5.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 108.987 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.408 ' H ' ' HB3' ' A' ' 237' ' ' ASP . . . -61.92 80.45 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.74 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.08 7.56 18.29 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.216 -177.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 214' ' ' ASN . 7.8 p -50.63 -27.79 7.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.486 ' C ' ' HB2' ' A' ' 235' ' ' SER . 18.2 mt-10 -114.05 -37.65 4.4 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.74 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -61.69 -167.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.284 1.04 . . . . 0.0 112.195 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.633 ' CD2' ' CZ ' ' A' ' 196' ' ' PHE . 1.0 OUTLIER -102.47 -8.15 21.32 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.893 -177.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.566 ' HE2' ' CZ2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -81.31 -11.11 59.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.114 -1.616 . . . . 0.0 111.213 -178.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.657 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -136.47 12.61 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.33 -1.481 . . . . 0.0 113.808 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 48.5 Cg_endo -71.94 -37.96 4.48 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.591 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.3 OUTLIER 0.08 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.559 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 0.8 OUTLIER -67.72 59.55 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.8 t-160 -168.1 -145.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.442 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.527 ' O ' ' CD1' ' A' ' 226' ' ' LEU . 59.0 m -149.72 110.11 4.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.002 . . . . 0.0 109.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 225' ' ' SER . 0.1 OUTLIER 179.67 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.519 ' OG1' ' N ' ' A' ' 196' ' ' PHE . 4.8 t -111.95 -7.89 14.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.589 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 178.87 -23.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 110.463 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.562 HD13 ' CG2' ' A' ' 190' ' ' THR . 0.3 OUTLIER -28.89 -61.58 0.12 Allowed 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.443 0.639 . . . . 0.0 110.857 -179.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.411 ' OG1' ' C ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.92 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.415 -0.803 . . . . 0.0 108.838 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -98.1 -21.15 16.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.589 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.0 p90 -33.19 120.75 0.37 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.534 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.72 172.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.738 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.639 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 5.0 mp -83.02 169.56 15.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.615 ' CB ' ' HA ' ' A' ' 217' ' ' ALA . 14.4 t -102.69 -170.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.764 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.542 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -83.8 -13.36 53.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.63 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.1 m-20 -84.54 -48.37 9.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.829 -1.17 . . . . 0.0 108.005 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.731 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.8 OUTLIER -64.0 -40.01 95.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 117.166 -1.814 . . . . 0.0 106.749 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.9 OUTLIER -56.26 -35.72 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 3.6 t30 -67.69 -45.63 74.63 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.461 ' O ' ' OG ' ' A' ' 244' ' ' SER . . . -62.97 -52.48 47.66 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.594 ' CD1' HG23 ' A' ' 128' ' ' THR . 1.5 tp -66.31 -47.29 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.868 -1.372 . . . . 0.0 110.51 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 240' ' ' ASN . 9.9 pt20 -55.13 -26.83 41.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 241' ' ' GLY . 5.0 p -82.27 -18.86 40.9 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.531 ' CD1' ' O ' ' A' ' 208' ' ' GLY . 0.8 OUTLIER -70.09 -65.8 0.68 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.523 ' CD1' HD23 ' A' ' 130' ' ' LEU . 20.5 m-85 -90.04 -123.24 0.06 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.104 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.493 ' N ' ' HD3' ' A' ' 248' ' ' PRO . . . 41.8 52.84 4.64 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.617 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 38.1 Cg_endo -72.1 -30.2 13.73 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.9 1.474 . . . . 0.0 112.453 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 43.4 Cg_endo -75.37 111.69 3.37 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 122.66 0.821 . . . . 0.0 110.052 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 42.6 Cg_endo -73.96 -59.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.954 1.502 . . . . 0.0 110.077 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -155.54 -39.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.866 . . . . 0.0 109.392 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 10.8 p -124.79 152.93 70.33 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.449 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -72.43 -9.16 23.8 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.028 1.541 . . . . 0.0 109.991 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.41 153.68 39.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.562 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.54 ' O ' ' CB ' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.604 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.604 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 4.5 p90 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -151.56 163.95 37.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.557 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' A' ' 210' ' ' PHE . 7.6 p -54.42 179.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.567 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.539 ' CD1' ' HD2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -45.56 134.6 6.07 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.967 . . . . 0.0 109.452 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 42.6 Cg_endo -73.2 55.57 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.014 1.534 . . . . 0.0 110.146 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.33 -126.61 2.27 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.504 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 1.6 mp -50.57 140.19 19.3 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.291 -1.123 . . . . 0.0 109.784 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.538 ' CB ' ' O ' ' A' ' 245' ' ' LEU . 42.6 Cg_endo -72.97 154.14 52.89 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.038 1.547 . . . . 0.0 109.981 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.528 ' HE3' ' NE1' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -44.29 -81.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.69 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.528 ' NE1' ' HE3' ' A' ' 91' ' ' LYS . 9.2 m95 -95.95 -169.05 1.86 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.847 -1.158 . . . . 0.0 110.037 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.513 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -161.81 -33.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.399 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.75 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.199 -0.938 . . . . 0.0 110.799 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.564 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -101.15 -8.53 22.15 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.715 . . . . 0.0 110.167 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.574 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 51.4 m80 -140.15 95.32 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.246 . . . . 0.0 110.865 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 132' ' ' PHE . 19.5 mt -82.02 177.64 8.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.646 -0.659 . . . . 0.0 109.886 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.52 ' N ' ' OD2' ' A' ' 141' ' ' ASP . 1.3 t -148.16 155.8 41.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.226 -0.921 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.658 ' CE1' ' CD2' ' A' ' 121' ' ' LEU . 1.3 p90 -138.43 161.83 35.99 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.614 -1.303 . . . . 0.0 110.053 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.525 ' HD3' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.43 123.0 28.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.515 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.5 mp -84.27 82.48 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.815 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 39.4 t -95.87 6.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.46 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.542 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -102.55 163.65 12.1 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.988 -1.07 . . . . 0.0 109.211 179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 2.0 t80 177.13 84.56 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.585 0.707 . . . . 0.0 109.117 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.651 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 17.9 p -72.85 155.99 90.2 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 108.876 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.98 -24.1 39.81 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 O-C-N 123.917 1.483 . . . . 0.0 108.667 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -78.37 -0.32 28.58 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.187 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.625 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 96.8 mt -147.45 120.03 4.74 Favored Pre-proline 0 N--CA 1.485 1.276 0 O-C-N 121.458 -0.776 . . . . 0.0 110.139 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -66.02 173.15 7.52 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.89 1.468 . . . . 0.0 109.037 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' O ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -39.14 -65.97 0.33 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.907 0.861 . . . . 0.0 110.091 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.2 OUTLIER -55.21 -29.41 57.89 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.857 -0.527 . . . . 0.0 112.251 -178.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.625 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -73.09 -61.03 1.96 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.446 . . . . 0.0 109.413 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.556 ' CB ' ' HA ' ' A' ' 104' ' ' TYR . 9.6 p -53.39 -42.31 47.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 1.0 OUTLIER -62.87 -27.94 69.7 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.537 ' OG ' ' CD2' ' A' ' 195' ' ' LEU . 4.4 p -61.23 -45.99 92.28 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 195' ' ' LEU . . . -67.68 -31.28 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.055 -1.028 . . . . 0.0 109.663 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.528 ' CG1' HG13 ' A' ' 144' ' ' ILE . 45.9 t -75.07 -23.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -90.35 -33.13 16.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.63 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -79.65 -41.89 25.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.652 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -62.95 -61.92 2.07 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.658 ' CD2' ' CE1' ' A' ' 99' ' ' TYR . 11.1 tp -51.24 -44.5 61.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 126' ' ' GLU . 2.6 tptp -72.53 -32.73 66.35 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.55 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.609 ' CG1' ' CD2' ' A' ' 234' ' ' LEU . 3.4 t -56.16 -43.8 77.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.694 ' HA ' ' CG2' ' A' ' 127' ' ' VAL . 37.8 m95 -91.22 -19.08 23.41 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.452 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.7 OUTLIER -77.05 -27.58 54.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.971 -1.081 . . . . 0.0 108.24 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 17.1 pt-20 -89.99 -44.57 9.78 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.694 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 35.9 m -64.03 -21.44 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.612 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.682 ' CG2' HG13 ' A' ' 242' ' ' ILE . 1.7 p -113.0 152.26 44.79 Favored Pre-proline 0 N--CA 1.498 1.933 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.971 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.477 ' HG2' ' O ' ' A' ' 247' ' ' GLY . 53.9 Cg_endo -80.51 32.82 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.285 1.99 . . . . 0.0 111.661 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 246' ' ' TYR . 2.9 mm? -112.56 165.51 12.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.616 -1.302 . . . . 0.0 110.857 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -103.3 177.57 4.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.181 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.58 ' CG ' HD13 ' A' ' 121' ' ' LEU . 15.9 m-85 -154.35 160.61 41.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.913 -1.117 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -158.57 125.81 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.611 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -97.57 174.38 6.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.61 -1.306 . . . . 0.0 110.358 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.521 ' CD1' ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.16 -122.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 1.1 t80 177.04 42.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.3 -1.5 . . . . 0.0 109.921 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 139' ' ' GLU . 10.9 pm0 -169.47 -173.79 1.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.931 -1.106 . . . . 0.0 110.155 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.8 -97.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 137' ' ' GLU . 10.2 pt-20 179.0 105.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -1.094 . . . . 0.0 109.92 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -60.21 -151.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.63 ' O ' ' HA3' ' A' ' 176' ' ' GLY . 53.8 m-20 -93.46 -25.5 17.61 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.549 ' CG1' ' CD1' ' A' ' 207' ' ' LEU . 3.1 mp -132.22 79.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.525 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.5 ttp -66.14 93.77 0.22 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.231 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.9 mm -79.28 110.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.911 -1.118 . . . . 0.0 108.042 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -131.36 156.14 46.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.359 -1.463 . . . . 0.0 111.434 -178.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 19.7 p90 -79.85 138.2 37.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 0.0 109.432 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.639 ' CB ' ' CD2' ' A' ' 179' ' ' HIS . . . -157.85 164.2 37.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.037 . . . . 0.0 110.523 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.518 ' CG2' ' OD1' ' A' ' 181' ' ' ASP . 1.4 p -166.58 -161.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 157' ' ' PHE . 45.6 mtm180 -36.57 -30.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 148' ' ' VAL . 0.2 OUTLIER -81.84 71.67 8.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 109.653 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 4.4 m80 -107.58 -166.51 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.5 -73.07 1.28 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -174.24 56.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -1.146 . . . . 0.0 109.537 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.492 ' HB3' ' CE1' ' A' ' 155' ' ' TYR . 0.2 OUTLIER 179.54 -30.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 109.637 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.602 ' O ' ' CG ' ' A' ' 151' ' ' HIS . 0.7 OUTLIER -113.75 54.66 0.64 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.848 . . . . 0.0 109.347 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 154' ' ' PHE . 38.1 Cg_endo -65.84 109.46 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.802 1.422 . . . . 0.0 109.613 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.679 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -96.64 -169.1 1.83 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 110.492 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 159' ' ' GLY . 16.9 p30 179.74 62.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.724 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.596 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -5.35 -65.58 0.01 OUTLIER Glycine 0 N--CA 1.51 3.579 0 N-CA-C 112.151 -0.38 . . . . 0.0 112.151 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.536 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.69 61.33 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.685 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -170.07 141.93 6.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.519 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 18.6 m120 -40.15 -31.32 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.45 -1.029 . . . . 0.0 110.343 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.65 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 t -56.7 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.574 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -79.51 -40.9 28.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.32 -0.862 . . . . 0.0 112.306 -178.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.612 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . -179.86 -168.5 0.11 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.198 -1.564 . . . . 0.0 110.859 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.91 -168.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.412 -1.43 . . . . 0.0 110.99 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -159.88 -164.63 1.34 Allowed 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.347 -0.845 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.571 ' OH ' ' CG ' ' A' ' 155' ' ' TYR . 88.6 m-85 -131.9 -163.64 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.058 . . . . 0.0 110.16 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 179.28 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.002 -1.061 . . . . 0.0 110.939 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 169' ' ' ALA . 40.1 Cg_endo -70.22 -64.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.491 1.46 . . . . 0.0 111.817 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 175' ' ' ASN . . . -37.86 144.75 0.17 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 174' ' ' ILE . 39.9 Cg_endo -69.47 144.53 55.9 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.085 1.571 . . . . 0.0 109.368 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 69.55 -63.28 0.63 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' A' ' 176' ' ' GLY . 1.5 tp -68.43 -4.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -63.79 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 129.81 80.62 0.24 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.612 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -157.41 128.91 6.88 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 120.755 -1.438 . . . . 0.0 107.676 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -117.55 156.68 27.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.888 -1.132 . . . . 0.0 109.538 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.639 ' CD2' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -142.15 133.84 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.303 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.549 ' CE1' ' HA ' ' A' ' 199' ' ' ALA . 20.4 m-85 -96.03 134.19 39.35 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.857 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.518 ' OD1' ' CG2' ' A' ' 148' ' ' VAL . 9.5 t0 -53.26 145.9 12.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.892 -1.13 . . . . 0.0 108.85 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 147' ' ' ALA . 10.0 m-20 -114.7 21.54 14.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 0.0 110.255 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.596 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.4 OUTLIER -121.32 8.98 10.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.804 -1.185 . . . . 0.0 110.298 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.537 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 19.0 mt-10 -122.63 -131.68 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.94 -1.1 . . . . 0.0 108.534 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.3 mt-30 -133.36 175.42 9.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.134 -0.979 . . . . 0.0 108.761 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.651 ' CD1' ' CG2' ' A' ' 105' ' ' THR . 78.0 m95 -158.81 119.38 3.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.91 -1.119 . . . . 0.0 108.85 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.466 HG21 ' HA3' ' A' ' 192' ' ' GLY . 71.4 p -144.85 152.28 40.04 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.79 -1.194 . . . . 0.0 110.505 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 3.3 pttt -85.14 -31.75 23.12 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 12.7 t70 -87.16 63.44 7.85 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.573 HG22 ' N ' ' A' ' 226' ' ' LEU . 72.1 p 3.24 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.832 -177.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 37.0 m -125.34 -32.34 2.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.664 . . . . 0.0 109.408 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.466 ' HA3' HG21 ' A' ' 187' ' ' THR . . . -94.94 -82.27 1.58 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.534 ' CG2' ' OD1' ' A' ' 194' ' ' ASN . 21.8 m -125.31 -95.81 0.45 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.639 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -160.61 70.82 0.42 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.674 ' HG ' ' N ' ' A' ' 196' ' ' PHE . 2.1 tp -33.5 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.674 ' N ' ' HG ' ' A' ' 195' ' ' LEU . 0.0 OUTLIER -69.62 -9.93 56.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 111.168 -177.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.639 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 12.0 tp -64.71 -62.01 1.84 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 116.852 -1.939 . . . . 0.0 106.544 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.541 ' CG1' ' HB1' ' A' ' 165' ' ' ALA . 2.7 t -70.48 -12.2 15.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.652 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -73.64 -59.43 2.72 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 120' ' ' ALA . . . -63.99 -15.64 59.76 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.592 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 20.2 t60 -67.15 -49.2 65.62 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.806 -1.558 . . . . 0.0 107.676 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 205' ' ' HIS . 2.5 mm-40 -80.24 -47.12 15.1 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.159 -0.963 . . . . 0.0 111.077 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.569 HG23 ' HA ' ' A' ' 121' ' ' LEU . 3.3 mt -60.15 -31.53 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.657 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.94 -34.87 40.98 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.38 -50.31 73.4 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 121.78 -0.835 . . . . 0.0 110.598 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.532 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 1.5 m -84.81 -58.96 2.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.378 -0.826 . . . . 0.0 112.177 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 207' ' ' LEU . 1.2 mt -102.85 32.23 3.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -131.91 -81.53 0.21 Allowed Glycine 0 C--N 1.289 -2.073 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.6 pp -165.03 -164.65 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.127 -1.22 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -98.48 -70.76 0.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.238 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 21.8 m80 -162.85 96.8 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.226 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.762 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.8 m -87.69 -175.71 5.28 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.521 ' CB ' ' CG ' ' A' ' 237' ' ' ASP . . . -65.43 76.86 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.709 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -83.56 8.8 13.04 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.126 -177.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.458 ' C ' ' O ' ' A' ' 214' ' ' ASN . 21.3 p -50.35 -27.72 6.75 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.491 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.2 mp0 -112.51 -37.21 5.01 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.718 ' HB3' ' HB2' ' A' ' 238' ' ' ASP . . . -64.97 -168.48 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.319 1.057 . . . . 0.0 112.526 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.645 ' HB2' ' CD1' ' A' ' 234' ' ' LEU . 0.1 OUTLIER -89.77 -18.06 27.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.694 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.533 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.38 -7.26 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 119.182 -2.199 . . . . 0.0 112.175 -177.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 27.8 t80 -135.5 14.69 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.277 -1.514 . . . . 0.0 113.585 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.6 Cg_endo -79.88 -43.33 0.13 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 N-CA-C 109.279 -1.085 . . . . 0.0 109.279 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 221' ' ' PRO . 2.3 tp -1.08 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-O 121.355 0.597 . . . . 0.0 110.929 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 221' ' ' PRO . 8.2 m-85 -67.6 59.61 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.413 -0.804 . . . . 0.0 109.202 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.5 t-160 -170.43 -140.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.232 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 19.8 m -163.52 112.19 1.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.967 -1.083 . . . . 0.0 110.121 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.573 ' N ' HG22 ' A' ' 190' ' ' THR . 0.4 OUTLIER 179.69 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.577 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 5.2 t -104.75 -48.02 3.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.578 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 0.5 OUTLIER -138.57 -10.39 1.4 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 111.625 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -35.83 -64.68 0.29 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.844 -1.16 . . . . 0.0 110.792 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.84 -31.77 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 109.193 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER -97.58 -20.14 17.88 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 228' ' ' ASP . 50.7 p90 -34.53 130.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.542 0.687 . . . . 0.0 111.145 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.53 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.1 ttt-85 179.74 152.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.66 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 2.1 mp -68.75 169.04 12.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.97 -1.082 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.612 ' HB3' ' CB ' ' A' ' 217' ' ' ALA . 31.0 t -100.48 -171.76 2.08 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.254 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.499 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.5 -12.09 52.64 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.762 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.2 OUTLIER -84.69 -47.5 10.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 4.5 m-20 -67.01 -38.28 85.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 117.091 -1.844 . . . . 0.0 106.526 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -57.23 -34.69 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.468 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 244' ' ' SER . 12.6 t-20 -68.96 -47.22 66.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.279 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.454 ' O ' ' OG ' ' A' ' 244' ' ' SER . . . -64.3 -45.93 92.11 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.682 HG13 ' CG2' ' A' ' 128' ' ' THR . 0.0 OUTLIER -74.39 -50.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.532 -1.569 . . . . 0.0 109.803 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.53 ' N ' HG22 ' A' ' 242' ' ' ILE . 2.4 tt0 -55.27 -24.15 26.72 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 75.8 p -89.74 -13.55 36.55 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -72.26 -53.65 11.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.608 ' CD2' ' OG1' ' A' ' 128' ' ' THR . 7.5 m-30 -83.33 -117.5 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.516 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 129' ' ' PRO . . . 169.66 131.18 1.28 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.393 -1.384 . . . . 0.0 109.97 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.62 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 45.8 Cg_endo -70.52 175.1 9.19 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.955 1.503 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 38.4 Cg_endo -67.14 -26.05 42.95 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.814 1.676 . . . . 0.0 114.523 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.62 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 42.4 Cg_endo -82.24 -57.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 120.435 0.757 . . . . 0.0 110.194 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 250' ' ' PRO . 0.1 OUTLIER -43.85 -26.89 0.29 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.392 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 250' ' ' PRO . 0.6 OUTLIER -145.88 89.49 6.1 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 255' ' ' THR . 42.3 Cg_endo -72.83 -35.14 5.95 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.185 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.419 ' C ' ' OG1' ' A' ' 255' ' ' THR . 0.6 OUTLIER -66.48 65.94 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.517 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 253' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.524 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.592 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.606 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.606 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.283 0.563 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.459 ' N ' ' CD ' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -138.19 -93.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -53.64 156.89 2.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 86' ' ' PHE . 5.0 p90 -138.46 106.85 7.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.524 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.71 96.36 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.949 1.499 . . . . 0.0 110.14 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.14 -99.45 0.14 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.1 mp -75.03 123.63 89.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.266 -1.138 . . . . 0.0 109.458 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.479 ' HB3' ' O ' ' A' ' 245' ' ' LEU . 42.6 Cg_endo -72.82 -175.62 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.983 1.517 . . . . 0.0 110.004 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.535 ' CB ' HD23 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -89.84 -85.15 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 108.76 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.581 ' CD1' ' HG ' ' A' ' 207' ' ' LEU . 12.7 m95 -77.58 -126.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.858 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 178.84 -51.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.365 -1.459 . . . . 0.0 109.529 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.41 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.814 0.816 . . . . 0.0 110.771 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.53 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 26.2 p -100.06 -4.19 30.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.497 -0.752 . . . . 0.0 109.64 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.566 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 21.1 m-70 -141.93 88.82 2.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.105 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.581 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 2.9 mm? -76.71 169.54 18.1 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.709 -0.619 . . . . 0.0 109.481 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.566 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.2 OUTLIER -141.77 156.79 45.57 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.11 -0.994 . . . . 0.0 108.963 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.608 ' CG ' ' CD2' ' A' ' 121' ' ' LEU . 16.7 p90 -137.55 161.74 35.62 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.588 -1.32 . . . . 0.0 109.256 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.63 ' NH2' ' CZ ' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -125.13 138.6 54.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 101' ' ' ILE . 1.6 mp -93.01 67.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.661 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.6 ' N ' ' O ' ' A' ' 144' ' ' ILE . 20.0 t -78.77 6.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 0.0 110.069 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.543 ' HB3' ' CG2' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -105.98 159.37 16.1 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.899 -1.126 . . . . 0.0 108.578 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.563 ' HA ' ' CB ' ' A' ' 113' ' ' VAL . 2.8 p90 177.94 47.01 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.748 -0.595 . . . . 0.0 110.246 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.462 ' CG2' ' CD1' ' A' ' 186' ' ' TRP . 22.6 p -44.11 156.8 0.31 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.163 -0.961 . . . . 0.0 108.802 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.04 -18.21 51.52 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.701 1.369 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.488 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 0.5 OUTLIER -70.93 -6.06 35.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.337 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.608 ' HB3' ' CB ' ' A' ' 112' ' ' ALA . 95.9 mt -151.67 127.16 4.88 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.401 -0.812 . . . . 0.0 110.432 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 38.2 Cg_endo -68.09 174.8 7.41 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.992 1.522 . . . . 0.0 109.288 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -40.88 -66.36 0.34 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.774 0.797 . . . . 0.0 110.206 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.5 OUTLIER -54.35 -33.8 59.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.608 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . . . -70.46 -60.65 2.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.355 -1.465 . . . . 0.0 109.834 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 114' ' ' ASP . 5.6 p -55.18 -44.51 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.57 ' N ' ' CG1' ' A' ' 113' ' ' VAL . 1.0 OUTLIER -61.8 -27.54 68.83 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 116' ' ' ALA . 1.4 p -58.89 -64.54 0.9 Allowed 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.583 ' HB1' ' CD1' ' A' ' 195' ' ' LEU . . . -50.1 -32.01 14.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.293 -0.879 . . . . 0.0 110.254 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.534 ' HA ' HD13 ' A' ' 203' ' ' ILE . 36.8 t -74.34 -23.34 18.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -93.08 -31.06 14.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.656 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -84.47 -35.11 23.21 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.672 ' HB1' ' CB ' ' A' ' 199' ' ' ALA . . . -69.26 -62.26 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.591 1.186 . . . . 0.0 107.928 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' CD2' ' CG ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -52.67 -55.1 24.98 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.699 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.522 ' O ' ' CG ' ' A' ' 126' ' ' GLU . 2.7 tptm -60.55 -35.42 75.97 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.835 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.604 ' CG1' HD11 ' A' ' 234' ' ' LEU . 0.9 OUTLIER -55.27 -40.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -179.575 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.65 ' CE2' ' HA3' ' A' ' 204' ' ' GLY . 42.7 m95 -91.05 -23.87 20.22 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.669 -1.212 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -70.37 -29.6 66.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.799 -1.188 . . . . 0.0 107.808 179.325 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -88.55 -40.34 13.47 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.201 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.633 ' CG2' ' HA ' ' A' ' 124' ' ' TRP . 18.7 m -61.63 -25.46 36.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.102 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -112.52 164.14 16.07 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.241 -1.384 . . . . 0.0 108.995 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.531 ' HG3' ' N ' ' A' ' 248' ' ' PRO . 48.0 Cg_endo -79.11 -6.17 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.687 1.591 . . . . 0.0 110.557 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.569 ' HG ' ' CD1' ' A' ' 246' ' ' TYR . 2.1 mm? -74.4 165.1 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 110.289 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.552 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -108.97 169.04 8.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 97' ' ' LEU . 50.9 m-85 -148.65 154.93 40.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 110.199 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -143.76 -179.52 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -156.7 161.37 39.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.82 -98.12 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.405 -0.809 . . . . 0.0 109.956 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CZ ' ' NH2' ' A' ' 100' ' ' ARG . 2.8 t80 177.68 32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.986 -1.071 . . . . 0.0 109.041 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.458 ' OE2' ' CD1' ' A' ' 135' ' ' LEU . 0.7 OUTLIER -72.21 174.51 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.967 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -43.62 -40.46 5.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 140' ' ' ALA . 4.1 pt-20 -174.21 105.3 0.11 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -1.062 . . . . 0.0 109.998 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 99' ' ' TYR . . . -59.4 -148.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.018 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.576 ' HA ' ' CZ2' ' A' ' 92' ' ' TRP . 66.8 m-20 -88.02 -27.17 22.21 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.575 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.55 ' CD1' HD21 ' A' ' 207' ' ' LEU . 3.6 mt -130.73 77.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.512 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 23.4 ttp -65.29 98.19 0.31 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.645 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 102' ' ' VAL . 5.6 mm -81.97 107.35 13.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -128.5 156.59 43.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.468 -1.395 . . . . 0.0 111.79 -178.512 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 34.7 p90 -79.17 137.39 37.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.623 ' CB ' ' CD2' ' A' ' 179' ' ' HIS . . . -158.37 165.57 34.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 0.0 109.731 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 150' ' ' GLU . 1.1 p -164.15 -155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.472 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.53 ' CD ' ' HB3' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -60.8 76.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.68 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 148' ' ' VAL . 56.6 tt0 179.8 32.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.393 -0.817 . . . . 0.0 109.201 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 68.1 m80 -75.25 -89.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.3 -0.875 . . . . 0.0 109.587 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.8 32.66 0.64 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.81 -92.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -1.11 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.415 ' C ' ' CD ' ' A' ' 156' ' ' PRO . 41.8 m-85 -145.98 14.28 1.32 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 0.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.588 ' O ' ' CE1' ' A' ' 151' ' ' HIS . 9.0 m-85 -124.43 47.34 1.89 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 109.502 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 41.4 Cg_endo -71.01 125.68 11.74 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.032 1.543 . . . . 0.0 109.761 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.688 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -102.77 -166.79 1.31 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 110.517 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 160' ' ' PRO . 19.8 p30 179.29 58.57 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.72 -0.612 . . . . 0.0 109.837 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.607 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.19 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.508 3.444 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.593 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.4 Cg_endo -64.17 62.41 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 109.935 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -164.56 141.99 7.46 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.532 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 70.5 m-80 -41.41 -32.77 0.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -1.087 . . . . 0.0 109.971 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.573 ' HB ' ' CE1' ' A' ' 157' ' ' PHE . 6.4 m -55.1 86.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 109.9 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.538 ' CB ' ' OB2' ' A' ' 3' ' ' MSB . 0.8 OUTLIER -75.63 -38.33 59.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.337 -0.852 . . . . 0.0 111.618 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.594 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . 179.21 -169.64 0.11 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.585 -1.322 . . . . 0.0 110.406 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.688 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p-80 178.12 -170.37 0.1 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.017 -1.677 . . . . 0.0 111.426 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.56 -174.99 5.16 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.56 -0.713 . . . . 0.0 110.052 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.636 ' CD1' ' CD1' ' A' ' 174' ' ' ILE . 62.8 m-85 -121.06 -175.37 3.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.054 -1.029 . . . . 0.0 110.652 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.582 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . . . -152.02 -66.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.68 -0.638 . . . . 0.0 109.324 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 169' ' ' ALA . 44.1 Cg_endo -74.19 177.25 8.5 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.609 1.321 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.519 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 95.62 168.1 35.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.0 Cg_endo -75.63 -87.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -74.58 -35.33 51.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.636 ' CD1' ' CD1' ' A' ' 168' ' ' TYR . 3.1 tt -66.71 -2.96 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 108.892 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.553 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 1.9 t30 -66.18 63.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.33 -0.856 . . . . 0.0 108.997 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 121.4 87.05 0.91 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.3 m-20 -155.08 124.47 6.37 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.826 -1.397 . . . . 0.0 107.998 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -110.13 152.45 26.0 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 109.329 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.623 ' CD2' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -139.48 131.24 27.46 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.901 -1.119 . . . . 0.0 109.336 179.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.548 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 52.9 m-85 -91.62 129.72 37.55 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.634 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 164' ' ' LEU . 15.6 t0 -47.15 145.55 2.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.966 -1.084 . . . . 0.0 108.371 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -114.74 20.96 14.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.607 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 6.5 m-20 -131.61 24.88 4.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.549 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 16.8 mt-10 -130.18 -93.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 109.108 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.0 mt-30 179.56 172.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . 0.594 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 94.9 m95 -158.95 125.42 4.6 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.533 ' CG2' ' HA3' ' A' ' 192' ' ' GLY . 81.2 p -144.77 150.71 37.67 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.829 -1.169 . . . . 0.0 109.944 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 6.0 ptpt -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.651 ' O ' ' N ' ' A' ' 191' ' ' THR . 24.4 t70 -89.4 64.93 6.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.607 ' O ' ' CG2' ' A' ' 190' ' ' THR . 3.3 t 3.69 59.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.101 0.953 . . . . 0.0 112.019 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.0 m -126.28 -30.56 2.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.866 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.533 ' HA3' ' CG2' ' A' ' 187' ' ' THR . . . -93.27 -81.92 1.51 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.523 ' CG2' ' CD2' ' A' ' 164' ' ' LEU . 19.8 m -123.63 -80.67 0.63 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.783 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 0.6 OUTLIER 179.33 68.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.595 ' CD1' ' CD1' ' A' ' 108' ' ' LEU . 12.7 tp -37.98 -101.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.725 -0.609 . . . . 0.0 111.55 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.658 ' HA ' ' CB ' ' A' ' 199' ' ' ALA . 0.8 OUTLIER -57.05 -9.56 0.9 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.879 -1.138 . . . . 0.0 111.233 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.783 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 5.6 tp -68.29 -66.98 0.5 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 116.778 -1.969 . . . . 0.0 106.703 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.518 ' CG1' ' HB2' ' A' ' 165' ' ' ALA . 14.6 t -68.41 -6.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.672 ' CB ' ' HB1' ' A' ' 120' ' ' ALA . . . -77.04 -58.04 3.5 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.593 ' HB1' ' CE1' ' A' ' 196' ' ' PHE . . . -67.19 -15.93 64.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.584 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 11.2 t60 -69.65 -40.4 76.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.9 -1.52 . . . . 0.0 107.78 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.548 ' OE2' ' CE1' ' A' ' 180' ' ' PHE . 12.6 mt-10 -85.61 -48.41 8.92 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.297 -0.877 . . . . 0.0 110.917 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.563 HD11 ' N ' ' A' ' 121' ' ' LEU . 4.0 mt -61.89 -30.06 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.65 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.69 -33.24 43.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 177.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.64 -49.69 75.61 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.675 -0.897 . . . . 0.0 110.065 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.514 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 40.4 p -81.22 -60.46 2.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.443 -0.786 . . . . 0.0 111.874 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.581 ' HG ' ' CD1' ' A' ' 92' ' ' TRP . 7.3 mp -104.2 36.74 2.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.252 -0.905 . . . . 0.0 110.872 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 242' ' ' ILE . . . -136.26 -73.16 0.07 OUTLIER Glycine 0 C--N 1.292 -1.878 0 C-N-CA 119.435 -1.364 . . . . 0.0 109.929 -178.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.609 ' CD1' ' N ' ' A' ' 210' ' ' PHE . 4.5 pp -179.87 -162.53 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.642 -1.505 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.609 ' N ' ' CD1' ' A' ' 209' ' ' LEU . 0.2 OUTLIER -94.71 -83.86 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 0.0 109.397 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 2.0 m-70 -151.9 99.97 2.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.617 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -86.44 177.02 7.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.405 ' HB2' ' CG ' ' A' ' 237' ' ' ASP . . . -58.23 89.52 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.792 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -90.02 11.85 19.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.981 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 214' ' ' ASN . 12.9 p -50.04 -29.04 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.485 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.7 mm-40 -118.07 -34.6 4.08 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.501 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.792 ' CB ' ' HA ' ' A' ' 214' ' ' ASN . . . -59.44 -169.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.223 1.011 . . . . 0.0 112.068 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.644 ' CD2' ' CZ ' ' A' ' 196' ' ' PHE . 1.4 tp -110.41 -3.89 15.87 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.152 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.577 ' HE3' ' CZ2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -83.02 -11.36 58.16 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.146 -1.596 . . . . 0.0 111.064 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.655 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 24.5 t80 -140.6 17.35 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 117.994 -1.483 . . . . 0.0 113.467 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 53.0 Cg_endo -73.43 -35.49 4.82 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.946 -1.598 . . . . 0.0 107.946 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.601 ' C ' ' O ' ' A' ' 221' ' ' PRO . 0.5 OUTLIER -4.09 -69.82 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.831 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . 0.564 ' N ' ' CD2' ' A' ' 222' ' ' LEU . 24.0 t80 -69.35 58.84 0.12 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.989 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -168.69 -140.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 0.0 109.329 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.523 ' HB3' ' CG2' ' A' ' 190' ' ' THR . 15.2 m -153.41 108.83 3.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.943 -1.098 . . . . 0.0 110.328 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.53 ' HG ' ' CD1' ' A' ' 197' ' ' LEU . 0.2 OUTLIER 179.76 51.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -0.836 . . . . 0.0 109.335 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 196' ' ' PHE . 14.7 t -103.26 -9.75 19.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 0.0 109.237 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.597 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 0.3 OUTLIER 178.14 -23.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 178.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.562 ' CD2' ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -27.97 -61.41 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.421 0.629 . . . . 0.0 111.008 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.97 -34.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.6 OUTLIER -87.31 -16.39 35.25 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.597 ' HB3' ' N ' ' A' ' 228' ' ' ASP . 36.7 p90 -33.17 112.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.535 0.683 . . . . 0.0 111.334 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 178.12 177.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 0.0 109.49 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.649 ' CD2' ' CH2' ' A' ' 124' ' ' TRP . 4.6 mp -93.85 170.12 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.46 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.625 ' HB3' ' CA ' ' A' ' 217' ' ' ALA . 7.0 t -101.24 -171.75 2.05 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.724 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . 0.572 ' N ' ' OG ' ' A' ' 235' ' ' SER . 25.6 tp60 -82.83 -14.65 53.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.369 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.617 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.7 m-20 -83.54 -47.16 11.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.719 ' HB2' ' HB3' ' A' ' 217' ' ' ALA . 0.5 OUTLIER -64.34 -39.21 93.44 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.005 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.9 OUTLIER -58.09 -34.73 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 244' ' ' SER . 59.6 t30 -68.65 -45.34 72.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.464 ' HA3' HD21 ' A' ' 209' ' ' LEU . . . -60.49 -56.56 23.74 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 208' ' ' GLY . 1.4 tp -64.1 -43.94 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.269 . . . . 0.0 109.605 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 239' ' ' ILE . 6.8 tt0 -55.97 -26.5 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 1.4 p -80.61 -20.66 42.74 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.535 HD23 ' CB ' ' A' ' 91' ' ' LYS . 2.4 mt -69.98 -69.49 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.569 ' CD1' ' HG ' ' A' ' 130' ' ' LEU . 38.6 m-85 -90.83 -97.7 0.11 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 90.24 134.34 5.63 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.458 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.531 ' N ' ' HG3' ' A' ' 129' ' ' PRO . 43.3 Cg_endo -76.11 174.07 13.44 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.132 1.596 . . . . 0.0 109.787 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 41.2 Cg_endo -70.92 159.57 52.11 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.849 1.447 . . . . 0.0 109.932 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -72.28 -63.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.0 1.527 . . . . 0.0 110.326 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 252' ' ' SER . 10.2 p30 -52.83 165.56 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 109.407 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 251' ' ' ASP . 70.8 p -43.65 147.17 0.86 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.533 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.34 -9.35 24.15 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.001 1.527 . . . . 0.0 110.131 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.06 -14.66 61.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.471 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.514 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.575 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.606 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.606 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.519 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.08 0.467 . . . . 0.0 109.897 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.627 ' CZ3' ' ND2' ' A' ' 175' ' ' ASN . 9.7 m95 -99.73 143.16 30.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 110.207 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 1.6 ptp180 -109.3 -40.86 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.388 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 1.06 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.58 170.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.331 -0.855 . . . . 0.0 110.019 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.59 ' O ' HD12 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -110.14 1.19 18.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.502 -0.749 . . . . 0.0 109.585 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.542 ' HD2' HG23 ' A' ' 95' ' ' THR . 57.8 m-70 -137.96 95.99 3.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.368 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.06 HD13 ' HE2' ' A' ' 94' ' ' LYS . 3.1 mm? -92.37 170.82 9.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.51 -0.744 . . . . 0.0 109.512 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.607 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -147.24 157.17 43.5 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 1.054 ' CE2' HD11 ' A' ' 101' ' ' ILE . 4.4 p90 -137.11 166.31 24.02 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.505 -1.372 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.59 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -125.19 124.36 41.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.054 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -83.12 83.54 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.883 -1.135 . . . . 0.0 110.106 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 102' ' ' VAL . 46.7 t -98.72 7.25 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.254 -0.903 . . . . 0.0 110.001 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.985 ' C ' HG21 ' A' ' 113' ' ' VAL . 34.0 m-80 -97.01 160.91 14.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.841 -1.162 . . . . 0.0 109.461 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.777 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.8 t80 178.09 167.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.648 HG22 ' CZ3' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -176.53 159.54 1.66 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 105' ' ' THR . 37.7 Cg_endo -66.12 -25.94 50.48 Favored 'Trans proline' 0 C--N 1.298 -2.089 0 N-CA-C 107.791 -1.657 . . . . 0.0 107.791 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.692 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -74.17 -10.98 60.15 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.929 ' CD1' HD13 ' A' ' 195' ' ' LEU . 79.6 mt -153.23 111.18 2.63 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.598 -0.689 . . . . 0.0 110.224 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.81 178.37 2.34 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.8 1.421 . . . . 0.0 109.341 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.93 -65.35 0.37 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.809 0.814 . . . . 0.0 110.296 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -58.67 -26.79 64.18 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.758 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -74.42 -60.45 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.31 -1.494 . . . . 0.0 109.605 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.985 HG21 ' C ' ' A' ' 103' ' ' ASN . 11.3 p -58.16 -42.42 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 1.041 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -60.04 -29.79 68.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -57.68 -64.1 1.02 Allowed 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.065 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -49.19 -33.0 11.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 110.158 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.936 HG13 HG13 ' A' ' 144' ' ' ILE . 5.7 t -73.0 -24.33 20.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.7 tt0 -90.64 -34.07 15.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.342 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.12 -39.44 33.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.885 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -64.84 -62.23 1.69 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.909 HD22 ' CE1' ' A' ' 99' ' ' TYR . 14.5 tp -48.99 -47.94 43.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.489 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -70.34 -34.25 72.43 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.791 -178.049 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.012 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.8 t -53.71 -44.81 59.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.027 ' CH2' HD21 ' A' ' 234' ' ' LEU . 30.9 m95 -92.11 -21.33 20.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.716 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 33.6 tt0 -72.14 -27.55 62.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.8 pt-20 -88.88 -44.49 10.43 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.435 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.084 HG21 HG21 ' A' ' 242' ' ' ILE . 14.2 m -56.77 -26.89 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.248 -1.381 . . . . 0.0 108.324 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.003 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -118.35 166.33 14.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 108.092 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.581 ' HG2' ' CD1' ' A' ' 246' ' ' TYR . 48.1 Cg_endo -82.5 -10.94 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.528 1.485 . . . . 0.0 109.824 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.932 HD23 ' CZ ' ' A' ' 132' ' ' PHE . 41.9 tp -52.38 158.87 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.727 . . . . 0.0 110.893 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.522 ' N ' ' HG ' ' A' ' 130' ' ' LEU . 1.5 p -108.37 170.39 8.05 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.932 ' CZ ' HD23 ' A' ' 130' ' ' LEU . 71.2 m-85 -151.41 146.36 25.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.938 -1.101 . . . . 0.0 110.929 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.599 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 4.0 t -125.66 -174.24 3.03 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.64 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -148.13 164.58 33.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.612 -1.305 . . . . 0.0 111.017 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.535 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -164.81 -163.73 0.74 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 136' ' ' TYR . 29.7 t80 -160.95 28.31 0.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 5.0 pm0 -144.87 178.57 7.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.678 -0.639 . . . . 0.0 109.324 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.26 -97.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' GLU . 7.7 pt-20 178.83 121.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -1.109 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.607 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -77.58 -151.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.866 ' CG ' HD12 ' A' ' 97' ' ' LEU . 16.7 t70 -89.75 -36.74 14.99 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.87 ' CD1' HD23 ' A' ' 207' ' ' LEU . 4.1 mp -123.23 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.543 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 8.8 ttm -65.13 98.24 0.3 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.044 . . . . 0.0 109.059 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.936 HG13 HG13 ' A' ' 117' ' ' VAL . 6.2 mm -82.73 111.52 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.652 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.72 153.64 51.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 0.0 111.856 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 19.8 p90 -90.47 141.42 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.769 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.088 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.82 179.96 3.97 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.003 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 149' ' ' ARG . 1.4 p -151.19 -164.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.716 ' H ' HG22 ' A' ' 148' ' ' VAL . 1.1 ptt85 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.785 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 C--O 1.215 -0.659 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.742 ' CD1' ' CE1' ' A' ' 179' ' ' HIS . 1.5 m-85 -78.33 -169.42 1.64 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.067 -1.021 . . . . 0.0 109.557 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.598 ' O ' ' C ' ' A' ' 159' ' ' GLY . 11.0 p30 178.64 58.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.559 -0.713 . . . . 0.0 110.097 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -20.36 -58.96 0.01 OUTLIER Glycine 0 N--CA 1.511 3.679 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 41.3 Cg_endo -71.17 56.17 1.98 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.589 1.31 . . . . 0.0 109.135 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.84 156.81 27.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 164' ' ' LEU . 84.7 m-20 -51.9 -33.68 38.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.364 -1.08 . . . . 0.0 110.588 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.524 ' CG2' ' OD2' ' A' ' 158' ' ' ASP . 2.9 t -55.54 84.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.105 -0.997 . . . . 0.0 110.111 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.983 HD21 ' CG2' ' A' ' 193' ' ' THR . 0.3 OUTLIER -74.35 -46.38 41.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.507 -0.746 . . . . 0.0 111.765 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.784 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -168.67 179.84 4.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.35 -1.469 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.666 ' CE1' ' HE1' ' A' ' 157' ' ' PHE . 10.8 p80 178.94 167.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.154 -1.591 . . . . 0.0 111.252 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.78 -169.07 2.13 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.556 -0.715 . . . . 0.0 110.093 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.602 ' CD2' ' HB ' ' A' ' 174' ' ' ILE . 55.2 m-85 -110.3 -166.51 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.632 -1.292 . . . . 0.0 110.515 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.045 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -120.92 -170.25 0.18 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.411 -0.805 . . . . 0.0 109.086 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 1.045 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.6 Cg_endo -74.8 112.94 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.418 1.22 . . . . 0.0 110.505 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . -157.65 -140.63 2.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.6 -93.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.054 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -92.34 -26.99 16.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.613 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -74.04 9.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.515 -0.991 . . . . 0.0 108.816 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.627 ' ND2' ' CZ3' ' A' ' 92' ' ' TRP . 6.2 t30 -63.18 62.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.43 103.4 2.83 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.654 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.5 m-20 -163.27 118.33 1.69 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.601 -1.529 . . . . 0.0 107.377 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.813 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -110.46 166.46 10.97 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.78 -1.2 . . . . 0.0 108.801 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.088 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -158.63 134.61 9.03 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.281 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.578 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 22.4 m-85 -94.19 137.31 33.52 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.625 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.624 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 7.6 t0 -50.87 151.36 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.779 -1.201 . . . . 0.0 108.628 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.19 20.45 8.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.5 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.628 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.5 OUTLIER -107.98 -16.7 14.23 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 1.2 pt-20 -112.54 -98.52 0.42 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.848 -1.158 . . . . 0.0 108.281 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.567 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 1.0 OUTLIER 178.53 165.28 0.81 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.014 -1.054 . . . . 0.0 109.045 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.648 ' CZ3' HG22 ' A' ' 105' ' ' THR . 0.0 OUTLIER -137.51 130.91 31.04 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.179 -0.951 . . . . 0.0 109.229 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.546 ' HA ' HD21 ' A' ' 108' ' ' LEU . 47.3 p -131.64 149.51 52.47 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 227' ' ' THR . 41.3 pttt -74.42 -37.77 63.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.528 ' O ' ' CG2' ' A' ' 227' ' ' THR . 3.3 t70 -83.28 -149.14 0.09 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.845 ' N ' HD11 ' A' ' 229' ' ' LEU . 27.0 m -111.45 46.46 1.1 Allowed 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.542 -1.263 . . . . 0.0 107.849 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.479 ' HB ' HG21 ' A' ' 187' ' ' THR . 91.2 m -98.45 -32.32 11.55 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 111.411 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -118.58 -85.57 1.02 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.755 -1.688 . . . . 0.0 109.489 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.983 ' CG2' HD21 ' A' ' 164' ' ' LEU . 23.7 m -122.67 -98.16 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.671 ' HA ' HG21 ' A' ' 227' ' ' THR . 3.7 m120 -160.45 68.14 0.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.065 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 15.4 tp -29.73 -97.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.843 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -56.77 -19.97 19.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.973 -1.079 . . . . 0.0 111.106 -178.18 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.64 ' CB ' ' HB3' ' A' ' 194' ' ' ASN . 12.9 tp -60.15 -62.29 1.97 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.146 -1.821 . . . . 0.0 107.517 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.837 HG21 HD23 ' A' ' 164' ' ' LEU . 1.7 t -71.32 -8.12 10.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.09 -58.09 3.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.56 -14.68 61.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.661 ' CD2' ' HA ' ' A' ' 219' ' ' MET . 52.7 t-80 -68.32 -48.93 63.57 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 117.878 -1.529 . . . . 0.0 107.913 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.813 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 1.3 mt-10 -80.39 -45.87 16.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 111.092 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.885 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -62.14 -30.99 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.71 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.88 -31.55 55.52 Favored Glycine 0 C--N 1.291 -1.933 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.5 -49.62 76.0 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 121.965 -0.726 . . . . 0.0 110.952 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.519 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 42.5 m -86.25 -53.05 5.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 112.206 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.889 HD22 ' CE2' ' A' ' 132' ' ' PHE . 3.1 pp -104.54 24.7 11.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.123 . . . . 0.0 110.605 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.965 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -127.02 -79.57 0.3 Allowed Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.123 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.02 -162.25 0.36 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.961 -1.317 . . . . 0.0 110.233 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.781 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.7 t80 -99.61 -72.64 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.78 . . . . 0.0 109.538 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.588 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 68.3 m80 -161.13 101.79 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 4.0 m -93.33 -178.12 4.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.371 -0.83 . . . . 0.0 109.247 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.764 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.9 86.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.95 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -89.66 10.18 24.2 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.576 -178.027 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.4 -28.1 4.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 175.326 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.538 ' C ' ' HB2' ' A' ' 235' ' ' SER . 5.4 mt-10 -116.25 -36.05 4.16 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.95 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.72 -170.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.383 1.087 . . . . 0.0 112.813 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.875 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -90.44 -16.12 29.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.146 -177.416 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.661 ' HA ' ' CD2' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -78.38 -7.39 57.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 119.119 -2.238 . . . . 0.0 112.105 -177.48 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.9 t80 -137.29 15.65 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.526 -1.358 . . . . 0.0 113.604 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.43 -37.0 0.79 Allowed 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 108.473 -1.395 . . . . 0.0 108.473 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.781 ' CD2' HG22 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -21.47 -59.21 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.202 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' HIS . 38.5 t80 -68.0 56.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.3 t-80 179.16 -124.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.45 ' HB3' ' OG1' ' A' ' 190' ' ' THR . 18.4 m -161.0 121.63 2.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.787 -1.196 . . . . 0.0 109.426 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER 179.38 43.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 110.102 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -99.93 -10.45 21.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.815 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.609 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 24.3 t70 179.62 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 109.923 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.845 HD11 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -25.74 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.809 -0.557 . . . . 0.0 111.399 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.34 -6.09 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.731 -1.23 . . . . 0.0 110.261 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.55 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -117.67 -38.18 3.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.001 -1.062 . . . . 0.0 109.069 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.658 ' HA ' HD23 ' A' ' 226' ' ' LEU . 13.3 p90 1.04 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.829 0.824 . . . . 0.0 112.947 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 178.34 174.62 0.59 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.359 -0.838 . . . . 0.0 109.657 178.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.027 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.9 mp -91.18 168.99 11.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 0.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.722 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 30.2 t -101.87 -169.88 1.74 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.188 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.51 ' N ' ' OG ' ' A' ' 235' ' ' SER . 12.5 tm0? -85.25 -12.65 51.98 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.911 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.2 OUTLIER -84.69 -47.79 10.11 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.684 ' O ' HG22 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -66.71 -36.96 83.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.626 177.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.601 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -58.0 -35.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.91 -50.79 54.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -55.94 -55.07 30.99 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.084 HG21 HG21 ' A' ' 127' ' ' VAL . 1.6 tp -63.44 -43.37 98.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.83 -1.394 . . . . 0.0 109.589 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.2 mt-30 -54.13 -31.35 52.03 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.0 p -75.5 -22.35 57.25 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.838 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -66.84 -64.57 0.83 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.596 ' CD2' ' HB2' ' A' ' 130' ' ' LEU . 5.7 t80 . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.983 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.766 ' CD ' ' HB1' ' A' ' 169' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.649 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 69.6 m95 -73.87 155.6 38.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.742 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.1 -34.55 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.776 ' O ' HD11 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -55.17 -165.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.264 -0.897 . . . . 0.0 109.548 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.57 ' HA ' HD11 ' A' ' 130' ' ' LEU . 66.2 p -124.33 4.24 8.44 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.607 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.571 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 59.4 m80 -148.15 97.08 2.73 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.451 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.679 ' N ' HD22 ' A' ' 97' ' ' LEU . 3.4 mm? -97.5 175.02 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.634 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -142.64 155.7 44.97 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.232 -0.918 . . . . 0.0 108.569 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.905 ' CE2' HD11 ' A' ' 101' ' ' ILE . 24.6 p90 -133.49 171.07 14.58 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.794 -1.192 . . . . 0.0 109.233 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.541 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -131.35 145.87 52.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 109.412 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.905 HD11 ' CE2' ' A' ' 99' ' ' TYR . 1.6 mp -100.22 61.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.965 -1.084 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 144' ' ' ILE . 18.1 t -73.86 2.44 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 0.0 110.021 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.605 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -101.45 164.37 11.8 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.804 -1.185 . . . . 0.0 109.025 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.633 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.2 p90 177.94 46.37 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.893 HG21 ' NE1' ' A' ' 186' ' ' TRP . 24.8 p -40.15 149.88 0.28 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.595 -0.69 . . . . 0.0 109.36 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 -25.77 42.67 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.946 1.498 . . . . 0.0 109.044 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -65.76 -12.16 51.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.079 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 187' ' ' THR . 32.3 mt -138.53 124.02 12.28 Favored Pre-proline 0 N--CA 1.484 1.251 0 O-C-N 121.543 -0.723 . . . . 0.0 109.827 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.3 Cg_endo -65.6 167.35 17.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 123.773 1.407 . . . . 0.0 108.867 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.504 ' O ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -37.8 -65.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.747 0.784 . . . . 0.0 110.263 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -28.57 49.73 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.75 -0.594 . . . . 0.0 111.725 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.776 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.19 -61.15 1.92 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.487 -1.383 . . . . 0.0 109.448 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.6 p -51.19 -39.4 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.535 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -66.33 -26.22 67.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.717 ' OG ' HD21 ' A' ' 195' ' ' LEU . 13.9 p -67.35 -37.37 83.14 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.071 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -75.18 -34.81 61.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.331 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.872 HG13 HG13 ' A' ' 144' ' ' ILE . 3.5 t -74.94 -23.72 17.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 1.8 tt0 -85.82 -36.33 20.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.721 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -79.41 -38.84 33.87 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.767 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -63.49 -61.65 2.19 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.85 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -51.56 -40.91 60.63 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.128 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.739 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -76.72 -33.64 58.17 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.738 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.07 HG21 ' CE1' ' A' ' 196' ' ' PHE . 2.1 t -56.19 -40.8 67.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.033 ' O ' HG23 ' A' ' 128' ' ' THR . 44.4 m95 -91.43 -24.8 19.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.316 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 9.6 tm-20 -69.55 -27.45 65.16 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.757 -1.214 . . . . 0.0 107.996 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.2 pt-20 -89.9 -42.89 10.95 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.674 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.027 HG13 ' O ' ' A' ' 123' ' ' VAL . 15.3 m -59.8 -24.11 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 118.259 -1.376 . . . . 0.0 109.159 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.033 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.93 162.94 20.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.012 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -84.46 1.54 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.249 1.966 . . . . 0.0 110.116 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.155 HD13 ' CD1' ' A' ' 246' ' ' TYR . 0.2 OUTLIER -80.92 -176.16 5.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.026 -1.046 . . . . 0.0 110.603 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.3 p -121.71 165.55 15.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.778 . . . . 0.0 109.947 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.826 ' CZ ' HD22 ' A' ' 207' ' ' LEU . 0.6 OUTLIER -140.93 158.22 44.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.426 -0.796 . . . . 0.0 109.698 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.58 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.5 m -146.59 179.6 7.44 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.897 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -148.12 -179.76 7.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.805 -1.184 . . . . 0.0 110.246 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.069 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -163.61 -130.63 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 27.2 t80 178.24 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.833 -1.167 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -162.61 -171.81 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 37.66 -99.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 178.46 107.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -1.135 . . . . 0.0 110.296 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 1.069 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -59.91 -150.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.827 ' C ' HD12 ' A' ' 142' ' ' ILE . 80.0 m-20 -88.06 -34.43 17.96 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.883 HG12 HD23 ' A' ' 207' ' ' LEU . 2.8 mp -124.23 77.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.532 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 2.8 ptm -67.54 102.87 1.22 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.872 HG13 HG13 ' A' ' 117' ' ' VAL . 5.1 mm -81.98 117.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -133.19 156.58 47.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.429 -1.42 . . . . 0.0 112.119 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 39.6 p90 -79.94 133.61 36.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.474 -0.767 . . . . 0.0 109.14 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.912 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -155.92 -178.08 7.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.958 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.0 OUTLIER 179.78 -155.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.44 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.815 ' N ' HG13 ' A' ' 148' ' ' VAL . 2.8 mtm-85 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.462 -0.774 . . . . 0.0 109.641 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 109.208 -1.112 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.733 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -98.24 -170.43 1.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.912 -1.118 . . . . 0.0 111.257 -178.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.562 ' O ' ' C ' ' A' ' 159' ' ' GLY . 15.5 p30 178.5 62.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -18.86 -59.0 0.01 OUTLIER Glycine 0 N--CA 1.501 2.982 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 183' ' ' ASP . 37.9 Cg_endo -65.87 60.19 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.297 1.156 . . . . 0.0 109.743 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -177.42 164.07 33.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' LEU . 0.6 OUTLIER -45.56 -59.95 2.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.312 -1.111 . . . . 0.0 110.123 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.653 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 61.0 t -33.85 90.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.354 0.597 . . . . 0.0 110.88 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.021 HD22 HD13 ' A' ' 222' ' ' LEU . 1.1 mp -80.08 -75.48 0.26 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.238 -0.914 . . . . 0.0 112.186 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.998 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -145.64 -168.25 2.92 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.196 -1.565 . . . . 0.0 111.38 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.733 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER 179.67 -179.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.957 -1.714 . . . . 0.0 111.133 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -154.75 177.61 11.06 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.536 -0.728 . . . . 0.0 110.23 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 1.009 ' CD1' HD11 ' A' ' 174' ' ' ILE . 76.7 m-85 -114.39 -167.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.16 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.953 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -171.21 -60.51 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.495 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.953 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.6 Cg_endo -77.29 147.97 26.46 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.796 1.419 . . . . 0.0 109.875 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 118.83 -178.75 16.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 174' ' ' ILE . 44.1 Cg_endo -75.97 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.063 1.559 . . . . 0.0 110.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.16 -33.25 21.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 1.009 HD11 ' CD1' ' A' ' 168' ' ' TYR . 1.9 tt -62.16 -7.75 2.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.352 -1.087 . . . . 0.0 108.8 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 169' ' ' ALA . 50.7 p-10 -67.29 65.92 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.127 -0.983 . . . . 0.0 109.405 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 128.74 78.7 0.23 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.1 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -152.16 115.15 4.65 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.217 -1.166 . . . . 0.0 107.975 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.646 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -106.31 164.83 11.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.262 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.912 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -155.96 133.77 11.16 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.571 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.573 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 12.2 m-85 -96.55 135.94 37.75 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.958 ' OD1' HG23 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -58.02 115.81 3.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.788 -1.195 . . . . 0.0 107.985 177.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.484 ' OD1' ' HB ' ' A' ' 148' ' ' VAL . 11.9 p-10 -83.91 13.51 4.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.719 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.889 ' HB2' HG21 ' A' ' 148' ' ' VAL . 2.0 t70 -121.05 14.09 11.4 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.076 -1.015 . . . . 0.0 110.725 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.542 ' OE2' HD11 ' A' ' 164' ' ' LEU . 15.7 tt0 -117.66 -132.1 0.32 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.814 -1.179 . . . . 0.0 108.944 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.612 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.9 mt-30 -122.1 166.57 14.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 109.111 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.893 ' NE1' HG21 ' A' ' 105' ' ' THR . 94.5 m95 -159.42 107.44 1.78 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.821 ' HA ' HD21 ' A' ' 108' ' ' LEU . 19.6 p -135.35 153.52 51.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.849 -1.157 . . . . 0.0 109.533 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.665 ' HA ' HD22 ' A' ' 195' ' ' LEU . 1.6 pttt -76.79 -28.97 55.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.645 ' OD2' HD12 ' A' ' 229' ' ' LEU . 0.3 OUTLIER -99.85 -151.18 0.39 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.87 ' HB ' HD11 ' A' ' 229' ' ' LEU . 10.2 t -105.71 45.4 0.97 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.459 ' HB ' HG21 ' A' ' 187' ' ' THR . 87.6 m -99.77 -31.25 11.62 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.394 -0.816 . . . . 0.0 111.204 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.537 ' N ' HG21 ' A' ' 187' ' ' THR . . . -118.21 -96.75 1.81 Allowed Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.804 -1.665 . . . . 0.0 109.064 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.768 ' CG2' HD21 ' A' ' 164' ' ' LEU . 48.3 m -104.31 -106.22 0.29 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.706 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 10.5 m120 -159.14 74.23 0.63 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.93 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.9 OUTLIER -27.01 -95.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.661 0.743 . . . . 0.0 112.55 -178.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 1.07 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -64.34 -12.17 39.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.013 -1.054 . . . . 0.0 110.983 -176.428 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.897 HD12 ' OG1' ' A' ' 227' ' ' THR . 5.5 tt -62.03 -62.08 2.03 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.884 -1.526 . . . . 0.0 107.078 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.998 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 39.4 t -72.79 -9.32 12.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.071 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.88 -57.43 3.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.38 -15.38 62.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.56 ' CD2' ' HA ' ' A' ' 219' ' ' MET . 58.1 t-80 -68.74 -46.13 69.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.962 -1.495 . . . . 0.0 107.81 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.761 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 1.3 mt-10 -82.32 -47.42 12.38 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.046 -1.034 . . . . 0.0 110.834 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.785 HG21 ' HA ' ' A' ' 121' ' ' LEU . 2.3 mt -61.48 -31.46 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.675 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.0 -33.29 46.09 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.93 -49.52 75.81 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.819 -0.813 . . . . 0.0 110.798 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.522 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 27.4 p -83.73 -56.88 3.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 112.2 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.883 HD23 HG12 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -104.16 22.94 13.83 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.016 -1.052 . . . . 0.0 110.84 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 1.117 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -121.71 -78.92 0.5 Allowed Glycine 0 C--N 1.291 -1.923 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.938 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.4 pp -167.5 -160.09 0.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.019 -1.283 . . . . 0.0 109.76 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.772 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.0 OUTLIER -98.12 -73.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.585 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.544 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 0.7 OUTLIER -163.01 93.49 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.913 . . . . 0.0 109.442 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.645 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -81.78 179.33 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -0.836 . . . . 0.0 109.806 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.871 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.53 83.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.944 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -87.0 12.06 12.17 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.861 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -49.78 -28.25 6.01 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.085 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.527 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.1 mp0 -116.29 -36.16 4.11 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.944 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.45 -164.72 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.292 1.044 . . . . 0.0 112.681 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.05 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.1 OUTLIER -99.85 -13.01 19.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.074 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.567 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -80.3 -6.63 58.25 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 119.552 -1.967 . . . . 0.0 111.978 -177.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.649 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.2 OUTLIER -137.53 14.57 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.617 -1.302 . . . . 0.0 113.502 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 54.2 Cg_endo -77.41 -42.05 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 1.021 HD13 HD22 ' A' ' 164' ' ' LEU . 4.0 tp -0.26 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 CA-C-O 121.494 0.664 . . . . 0.0 111.039 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 223' ' ' TYR . 9.8 t80 -67.46 58.4 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 109.754 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.57 172.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 109.778 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.8 128.83 55.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.253 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' ASP . 0.3 OUTLIER 178.83 -73.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.835 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . 1.008 HG21 HD22 ' A' ' 218' ' ' LEU . 1.5 p -66.44 53.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 0.0 110.442 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 226' ' ' LEU . 5.0 m-20 -162.54 -53.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -60.74 -142.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.755 . . . . 0.0 109.458 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.4 p -94.46 -22.76 18.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 0.0 110.049 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -79.97 -16.55 54.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 108.786 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.601 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 23.2 p90 -30.75 106.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.602 0.715 . . . . 0.0 111.291 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.532 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 7.6 ttt-85 -161.04 153.15 20.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.214 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.967 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.8 mp -77.65 173.94 11.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.281 -0.887 . . . . 0.0 110.463 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 21.7 t -102.81 -172.0 2.05 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.909 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.38 -12.89 53.67 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.778 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.871 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.6 m-20 -84.11 -49.28 9.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.769 -1.207 . . . . 0.0 108.15 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.938 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.68 -39.48 93.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 117.197 -1.801 . . . . 0.0 106.616 178.032 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 235' ' ' SER . 0.8 OUTLIER -55.19 -36.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.47 -56.92 8.66 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.646 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -52.23 -51.58 40.94 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.117 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.8 tp -63.86 -47.93 88.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.85 -1.382 . . . . 0.0 109.656 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.588 ' N ' HG23 ' A' ' 242' ' ' ILE . 21.3 tt0 -53.58 -28.29 31.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 t -82.42 -18.12 42.98 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.796 ' HB3' HD12 ' A' ' 242' ' ' ILE . 5.7 tt -73.3 -60.57 2.18 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 1.155 ' CD1' HD13 ' A' ' 130' ' ' LEU . 11.1 m-85 . . . . . 0 N--CA 1.493 1.723 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.445 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.465 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 72.7 m95 -107.27 169.13 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.963 -1.085 . . . . 0.0 109.617 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -135.4 -36.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.598 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.84 ' HE3' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -47.58 177.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.735 ' HA ' HD22 ' A' ' 130' ' ' LEU . 71.2 p -116.7 5.58 13.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.501 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.527 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 4.5 m-70 -126.63 91.14 3.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.99 -1.069 . . . . 0.0 110.073 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.84 HD13 ' HE3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -99.31 158.29 15.81 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.6 -0.688 . . . . 0.0 109.988 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.595 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -129.54 154.86 46.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.674 ' CE2' HD11 ' A' ' 101' ' ' ILE . 3.0 p90 -140.77 167.69 21.58 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.724 -1.235 . . . . 0.0 109.364 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -132.12 138.11 47.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.095 . . . . 0.0 109.47 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.766 HG22 ' O ' ' A' ' 101' ' ' ILE . 1.5 mp -93.32 66.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.14 -0.975 . . . . 0.0 109.746 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 144' ' ' ILE . 6.0 t -78.38 8.82 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 109.93 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.988 ' C ' HG21 ' A' ' 113' ' ' VAL . 8.5 m120 -105.35 153.25 21.9 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.0 -1.062 . . . . 0.0 109.392 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.785 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER 178.68 41.04 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.717 -0.614 . . . . 0.0 109.697 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 104' ' ' TYR . 61.4 p -41.57 156.1 0.22 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.42 -0.8 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -22.87 41.73 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.877 1.462 . . . . 0.0 108.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.688 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -72.04 -6.3 41.34 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.077 HD13 ' CD2' ' A' ' 195' ' ' LEU . 83.1 mt -143.5 116.48 5.91 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.517 -0.74 . . . . 0.0 109.707 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.68 171.48 9.58 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 O-C-N 123.856 1.45 . . . . 0.0 109.06 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.01 -65.38 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.84 0.829 . . . . 0.0 110.295 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 115' ' ' SER . 26.0 t0 -57.43 -28.23 63.12 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.821 -0.549 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.889 ' O ' HD21 ' A' ' 195' ' ' LEU . . . -73.18 -61.95 1.64 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.248 -1.532 . . . . 0.0 109.265 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.988 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.8 p -54.25 -40.67 48.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 1.0 OUTLIER -64.9 -27.86 69.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 112' ' ' ALA . 1.2 p -62.14 -41.84 98.67 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.036 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -73.72 -34.16 64.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.059 . . . . 0.0 110.639 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.955 HG13 HG13 ' A' ' 144' ' ' ILE . 5.8 t -74.36 -24.08 18.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -91.64 -34.82 14.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -79.02 -37.48 39.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.828 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -67.36 -62.02 1.63 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.848 HD11 ' CG ' ' A' ' 132' ' ' PHE . 8.1 tp -49.67 -45.04 48.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -73.41 -34.72 65.65 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.798 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.0 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -55.53 -40.6 59.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.066 ' CH2' HD21 ' A' ' 234' ' ' LEU . 51.0 m95 -92.27 -20.01 21.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.091 -1.005 . . . . 0.0 110.517 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 37.1 tt0 -75.24 -27.58 59.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.018 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.5 pt-20 -90.15 -45.19 9.28 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.551 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.0 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.5 m -57.3 -27.07 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.447 -1.301 . . . . 0.0 108.357 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -121.22 155.86 58.01 Favored Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.223 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.49 25.95 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.091 1.86 . . . . 0.0 111.946 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' A' ' 95' ' ' THR . 5.0 mt -100.89 169.86 8.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.399 . . . . 0.0 110.093 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.5 p -119.12 166.45 12.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.848 ' CG ' HD11 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -141.18 159.44 42.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.117 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -155.9 122.4 5.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 108.746 179.622 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 3.2 ppt_? -108.38 174.59 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.076 . . . . 0.0 110.64 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.797 ' N ' HD12 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.81 -95.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 100' ' ' ARG . 3.5 t80 177.51 33.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.975 . . . . 0.0 109.098 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.484 ' H ' HD13 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -76.57 179.43 5.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -45.75 -42.3 10.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 140' ' ' ALA . 2.0 pt-20 -176.13 105.02 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -1.102 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.595 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.14 -150.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.29 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 176' ' ' GLY . 45.3 t0 -81.28 -35.8 30.64 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 207' ' ' LEU . 51.6 mt -127.97 81.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.415 ' CE ' HG21 ' A' ' 102' ' ' VAL . 2.6 ttt -67.13 100.26 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.955 HG13 HG13 ' A' ' 117' ' ' VAL . 6.1 mm -82.26 115.02 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.04 -1.037 . . . . 0.0 108.348 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.3 OUTLIER -134.11 159.22 41.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.37 -1.456 . . . . 0.0 112.447 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.501 ' CA ' ' ND2' ' A' ' 103' ' ' ASN . 13.2 p90 -100.17 133.09 45.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.716 -0.615 . . . . 0.0 110.252 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.168 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -160.28 -159.07 0.67 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.096 -1.003 . . . . 0.0 110.724 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 149' ' ' ARG . 2.3 p -166.38 -170.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.979 -1.076 . . . . 0.0 109.185 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.741 ' H ' HG22 ' A' ' 148' ' ' VAL . 7.9 ptt-85 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.172 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--O 1.214 -0.69 0 N-CA-C 109.474 -1.01 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.778 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 5.5 m-85 -113.42 -169.64 1.54 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.105 -0.997 . . . . 0.0 110.282 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.641 ' OD2' HG21 ' A' ' 163' ' ' VAL . 9.5 p30 178.96 61.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.574 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -10.88 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.506 3.341 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 38.4 Cg_endo -67.23 59.16 0.65 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.573 1.302 . . . . 0.0 109.692 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -173.81 146.65 8.9 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -41.95 -27.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -1.052 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.641 HG21 ' OD2' ' A' ' 158' ' ' ASP . 2.8 t -52.44 82.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.519 -0.738 . . . . 0.0 110.781 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.073 HD21 HG21 ' A' ' 193' ' ' THR . 0.7 OUTLIER -70.59 -81.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.346 -0.846 . . . . 0.0 111.619 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.866 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -145.33 -179.63 6.77 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.65 -1.281 . . . . 0.0 111.409 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.778 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 2.0 p-80 179.28 162.39 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.808 -1.807 . . . . 0.0 110.383 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.43 -167.99 1.94 Allowed 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.191 -0.943 . . . . 0.0 110.418 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 206' ' ' SER . 95.4 m-85 -125.37 -163.05 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 0.0 110.344 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.009 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -172.23 -60.59 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.294 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 1.009 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.6 Cg_endo -76.57 118.56 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.831 1.437 . . . . 0.0 109.981 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 148.22 173.94 19.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -74.47 -91.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.128 1.594 . . . . 0.0 110.146 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -73.64 -28.16 65.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -75.32 8.29 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -1.149 . . . . 0.0 108.407 178.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 169' ' ' ALA . 20.5 p-10 -65.83 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 112.41 97.57 2.34 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -160.11 124.23 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.755 -1.439 . . . . 0.0 107.62 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.811 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.01 159.2 17.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 108.589 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.168 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -156.96 131.53 8.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.591 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.574 ' HB3' ' CH2' ' A' ' 186' ' ' TRP . 37.0 m-85 -93.08 142.45 27.28 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.188 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.718 ' OD1' HG23 ' A' ' 148' ' ' VAL . 5.7 t0 -64.39 144.12 57.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.451 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 4.6 p30 -109.91 24.23 13.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.637 -1.289 . . . . 0.0 110.139 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.574 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 20.1 m-20 -131.06 15.41 5.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.044 -1.035 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 7.6 tt0 -118.95 -132.88 0.32 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.598 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 88.6 mt-30 -114.44 163.04 15.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.821 -1.174 . . . . 0.0 108.514 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.598 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 98.8 m95 -158.44 105.37 1.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.93 -1.106 . . . . 0.0 110.398 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.967 ' HA ' HD21 ' A' ' 108' ' ' LEU . 80.8 p -146.6 154.25 41.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.352 -0.843 . . . . 0.0 109.399 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 227' ' ' THR . 4.5 pttm -81.06 -30.31 34.81 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 229' ' ' LEU . 3.2 t70 -98.17 -148.13 0.33 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.609 ' N ' ' CD1' ' A' ' 229' ' ' LEU . 12.8 t -99.86 37.48 1.61 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.531 HG22 HG21 ' A' ' 187' ' ' THR . 21.4 m -86.23 -35.61 19.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.436 -0.79 . . . . 0.0 111.072 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.626 ' N ' HG21 ' A' ' 187' ' ' THR . . . -133.75 -95.78 0.56 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.612 -1.756 . . . . 0.0 109.706 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.073 HG21 HD21 ' A' ' 164' ' ' LEU . 77.5 m -100.83 -108.35 0.22 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.709 ' HA ' HG21 ' A' ' 227' ' ' THR . 34.2 m-80 -159.52 71.55 0.5 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.077 ' CD2' HD13 ' A' ' 108' ' ' LEU . 7.9 tp -29.29 -96.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.854 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -49.89 -24.2 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.071 . . . . 0.0 111.391 -178.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.99 HD11 ' CG ' ' A' ' 221' ' ' PRO . 13.8 tp -58.05 -61.3 2.65 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 117.381 -1.727 . . . . 0.0 107.807 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.866 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 1.4 t -73.59 -5.65 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.816 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.014 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.14 -57.67 3.66 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.698 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.55 -17.26 64.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.606 ' CE1' ' HA ' ' A' ' 219' ' ' MET . 3.3 t-160 -69.59 -41.76 75.36 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 117.079 -1.848 . . . . 0.0 108.135 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.834 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 0.8 OUTLIER -83.4 -49.52 9.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 0.0 110.464 179.127 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.8 mt -59.11 -31.62 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.719 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.41 -34.85 39.04 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -58.49 -48.49 80.63 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.8 -0.823 . . . . 0.0 110.744 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.553 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 68.7 p -87.0 -55.74 3.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 112.104 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.915 ' HB2' HD11 ' A' ' 142' ' ' ILE . 0.6 OUTLIER -103.95 31.3 4.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.256 -0.902 . . . . 0.0 110.095 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.767 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -135.04 -80.97 0.13 Allowed Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.842 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -169.07 -165.9 0.58 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.264 . . . . 0.0 110.352 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.711 ' N ' HD12 ' A' ' 209' ' ' LEU . 75.7 t80 -93.53 -83.91 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.572 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.3 m-70 -151.61 122.64 7.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.651 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.642 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -113.13 -178.11 3.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -0.925 . . . . 0.0 109.388 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.91 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -60.87 85.92 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.963 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -91.0 12.39 19.88 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.395 -1.322 . . . . 0.0 112.115 -177.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.444 ' C ' ' O ' ' A' ' 214' ' ' ASN . 1.7 p -50.74 -27.74 7.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.51 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.6 mm-40 -116.6 -35.59 4.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.706 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.963 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -59.02 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 122.076 0.941 . . . . 0.0 112.755 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.983 ' HB2' HD13 ' A' ' 234' ' ' LEU . 0.1 OUTLIER -115.71 -13.29 11.45 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.776 -177.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.606 ' HA ' ' CE1' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -81.38 -7.01 59.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.312 -2.117 . . . . 0.0 111.799 -178.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -134.08 13.37 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.594 -1.316 . . . . 0.0 113.475 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.99 ' CG ' HD11 ' A' ' 197' ' ' LEU . 51.3 Cg_endo -76.26 -36.07 2.01 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 N-CA-C 109.099 -1.154 . . . . 0.0 109.099 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 1.036 HD12 HD12 ' A' ' 164' ' ' LEU . 1.6 tt -17.41 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.291 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.942 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.5 OUTLIER -68.02 54.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 222' ' ' LEU . 15.0 t-80 178.77 -129.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 108.658 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -154.29 136.46 14.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.799 -1.188 . . . . 0.0 108.913 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.773 ' N ' HD21 ' A' ' 229' ' ' LEU . 0.1 OUTLIER 179.53 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 110.704 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -103.83 -28.74 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 108.825 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.597 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 7.6 t70 -172.26 3.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.892 . . . . 0.0 110.792 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.804 HD13 ' N ' ' A' ' 229' ' ' LEU . 0.1 OUTLIER -44.55 -51.98 8.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.821 -1.175 . . . . 0.0 108.99 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.74 -28.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.557 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.8 mtp180 -104.0 -39.74 6.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.474 -0.766 . . . . 0.0 109.43 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.597 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 21.9 p90 0.59 109.7 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.349 0.595 . . . . 0.0 112.443 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.79 177.27 0.49 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.316 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.066 HD21 ' CH2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -89.52 175.04 7.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.009 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.87 ' H ' HD12 ' A' ' 234' ' ' LEU . 16.4 t -111.96 -169.22 1.43 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.131 -0.981 . . . . 0.0 110.257 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.546 ' N ' ' OG ' ' A' ' 235' ' ' SER . 10.5 tp-100 -84.49 -15.79 44.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.575 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.91 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 5.4 m-20 -84.25 -46.44 11.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.505 -1.372 . . . . 0.0 108.339 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.842 ' OD1' HD11 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -67.55 -35.77 79.69 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 117.381 -1.728 . . . . 0.0 106.543 177.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 234' ' ' LEU . 0.5 OUTLIER -58.67 -34.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -45.96 73.91 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -63.88 -50.58 60.05 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -70.74 -47.81 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.723 -1.457 . . . . 0.0 109.586 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.594 ' N ' HG23 ' A' ' 242' ' ' ILE . 40.4 tt0 -53.98 -29.49 43.25 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.8 t -77.21 -22.47 52.27 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.767 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -64.66 -63.37 1.14 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.219 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.663 ' CD1' HD11 ' A' ' 130' ' ' LEU . 24.1 m-85 . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.677 ' CB ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.603 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 90.3 m95 -90.2 148.69 22.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -126.31 -32.67 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.0 109.346 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.786 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -51.57 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.462 -0.774 . . . . 0.0 110.129 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.626 ' HA ' HD22 ' A' ' 130' ' ' LEU . 21.7 p -116.93 -0.05 12.32 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.576 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 40.1 m80 -146.96 93.2 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.599 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.789 ' N ' HD22 ' A' ' 97' ' ' LEU . 2.8 mm? -82.91 177.62 8.55 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.304 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.651 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -144.78 155.24 43.42 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.959 -1.088 . . . . 0.0 108.893 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 1.057 ' CE2' HD11 ' A' ' 101' ' ' ILE . 4.9 p90 -136.63 166.17 24.18 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.629 -1.294 . . . . 0.0 109.385 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.855 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -129.76 125.53 36.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.057 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -85.11 83.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.855 HG22 ' NE ' ' A' ' 100' ' ' ARG . 1.7 t -99.98 6.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.892 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.867 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -101.79 157.79 16.59 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.619 -1.301 . . . . 0.0 109.459 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.693 ' N ' HG21 ' A' ' 113' ' ' VAL . 20.7 t80 178.33 70.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.767 . . . . 0.0 109.413 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.67 HG21 ' CD1' ' A' ' 186' ' ' TRP . 38.6 p -66.28 158.35 77.85 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 108.584 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -22.12 40.88 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.885 1.466 . . . . 0.0 108.68 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.633 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -74.14 -4.72 37.45 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.075 HD13 HD12 ' A' ' 195' ' ' LEU . 83.7 mt -141.56 117.44 7.2 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.497 -0.752 . . . . 0.0 109.871 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.07 165.33 17.03 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.76 1.4 . . . . 0.0 109.171 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -35.99 -65.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.811 0.815 . . . . 0.0 110.332 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.98 -10.25 5.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.774 -0.579 . . . . 0.0 111.517 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.763 ' O ' HD11 ' A' ' 195' ' ' LEU . . . -86.43 -61.68 1.68 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.478 -1.389 . . . . 0.0 108.949 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.723 HG21 ' C ' ' A' ' 103' ' ' ASN . 7.5 p -54.67 -40.56 51.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.586 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.3 -27.01 69.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.891 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -67.39 -38.49 84.77 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.133 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -72.86 -33.95 66.44 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.901 -1.124 . . . . 0.0 109.66 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.971 HG13 HG13 ' A' ' 144' ' ' ILE . 57.3 t -76.06 -22.9 15.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.9 OUTLIER -89.11 -34.38 16.76 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.669 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.44 -38.02 27.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.759 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -64.49 -61.24 2.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.826 HD22 ' CD1' ' A' ' 99' ' ' TYR . 14.2 tp -53.45 -46.65 69.97 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.765 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -66.39 -35.3 79.97 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.138 -178.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.883 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.0 t -57.09 -36.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.089 ' O ' HG23 ' A' ' 128' ' ' THR . 56.2 m95 -92.61 -25.17 18.43 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.931 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -71.83 -27.34 62.84 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.627 -1.296 . . . . 0.0 108.29 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.0 pt-20 -92.44 -42.82 9.54 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.029 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 123' ' ' VAL . 19.8 m -63.9 -21.16 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.25 -1.38 . . . . 0.0 109.971 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.089 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -108.35 162.67 19.11 Favored Pre-proline 0 N--CA 1.5 2.046 0 C-N-CA 117.472 -1.691 . . . . 0.0 109.883 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.675 ' O ' HD23 ' A' ' 130' ' ' LEU . 50.2 Cg_endo -81.02 21.74 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.1 1.867 . . . . 0.0 111.729 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.786 HD13 ' O ' ' A' ' 94' ' ' LYS . 21.7 mt -122.22 -173.7 2.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.5 -1.375 . . . . 0.0 110.561 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -124.07 -168.22 1.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.973 -179.462 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.777 ' HE2' HD13 ' A' ' 207' ' ' LEU . 0.4 OUTLIER -153.02 175.77 12.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.554 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -149.17 -173.44 4.38 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.616 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.34 163.04 39.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.49 -1.381 . . . . 0.0 110.768 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.07 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -151.19 -131.9 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.47 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.726 -1.234 . . . . 0.0 109.444 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 139' ' ' GLU . 7.0 pm0 -166.79 -164.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 109.928 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 36.3 -97.43 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' OE2' ' HA2' ' A' ' 173' ' ' GLY . 0.9 OUTLIER 178.38 107.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -1.105 . . . . 0.0 110.398 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 1.07 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -63.15 -151.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 108.699 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.603 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 63.2 m-20 -87.7 -32.62 19.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 144' ' ' ILE . 4.4 mp -128.54 83.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.1 ttt -66.51 98.77 0.52 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 108.905 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.971 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -82.42 115.79 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.819 -1.176 . . . . 0.0 108.149 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.93 153.01 52.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.55 -1.344 . . . . 0.0 111.48 -179.447 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.2 p90 -93.79 139.18 31.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.149 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -163.72 -159.96 0.54 Allowed 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.351 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.78 HG21 ' HB2' ' A' ' 183' ' ' ASP . 1.7 p -173.32 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 109.064 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.711 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.753 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 C--O 1.214 -0.688 0 N-CA-C 109.849 -0.866 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.74 ' CD1' ' CE1' ' A' ' 179' ' ' HIS . 0.3 OUTLIER -81.08 -165.9 1.02 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 110.341 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.578 ' O ' ' C ' ' A' ' 159' ' ' GLY . 48.4 p-10 179.29 57.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.712 -0.617 . . . . 0.0 110.366 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -21.34 -67.71 0.01 OUTLIER Glycine 0 N--CA 1.509 3.53 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 183' ' ' ASP . 43.7 Cg_endo -74.04 52.87 2.75 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.525 1.277 . . . . 0.0 109.401 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -155.89 156.78 27.3 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 164' ' ' LEU . 11.8 m120 -47.61 -41.71 22.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.66 -0.906 . . . . 0.0 110.507 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 163' ' ' VAL . 78.6 t -59.89 78.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 110.136 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.064 ' CD2' HG21 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -59.1 -55.05 40.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.416 -0.802 . . . . 0.0 111.784 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.8 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -163.68 -174.91 3.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.723 -1.236 . . . . 0.0 111.245 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.636 ' CE1' ' HE1' ' A' ' 157' ' ' PHE . 11.1 p80 178.42 165.06 0.78 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.141 -1.599 . . . . 0.0 110.989 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -129.29 -158.97 0.92 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.405 -0.809 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.694 ' CD1' HD11 ' A' ' 174' ' ' ILE . 3.7 m-85 -122.83 -169.37 1.91 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.582 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -117.54 -166.39 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.0 Cg_endo -74.97 123.51 7.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.05 1.026 . . . . 0.0 110.825 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . -172.15 -171.32 36.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.68 101.82 1.34 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.569 1.3 . . . . 0.0 109.91 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.474 ' HA2' ' OE2' ' A' ' 139' ' ' GLU . . . 81.5 -51.16 4.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.694 HD11 ' CD1' ' A' ' 168' ' ' TYR . 1.7 tt -68.67 2.58 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.623 -0.928 . . . . 0.0 109.346 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.579 ' O ' ' CH2' ' A' ' 92' ' ' TRP . 8.1 p-10 -63.52 63.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.56 -0.712 . . . . 0.0 109.227 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.02 101.73 2.69 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.4 m-20 -157.16 120.33 4.07 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.718 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.56 161.8 15.01 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.889 -1.132 . . . . 0.0 108.916 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.149 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -156.09 133.16 10.6 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.056 -1.058 . . . . 0.0 108.811 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 73.1 m-85 -93.71 141.28 28.67 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.741 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.592 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 23.7 p30 -63.51 144.55 56.9 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.667 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.57 22.27 11.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.669 -1.269 . . . . 0.0 110.447 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.78 ' HB2' HG21 ' A' ' 148' ' ' VAL . 27.2 t0 -115.95 11.21 15.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.957 -1.09 . . . . 0.0 110.359 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.515 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 2.9 pt-20 -126.43 -108.21 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.772 -1.205 . . . . 0.0 109.282 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 3.9 mt-30 -148.31 173.91 12.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.712 -1.242 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.714 ' CH2' HD23 ' A' ' 164' ' ' LEU . 88.7 m95 -162.54 132.58 4.57 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.039 -1.038 . . . . 0.0 110.029 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.9 ' HA ' HD21 ' A' ' 108' ' ' LEU . 31.0 p -153.64 153.26 31.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.077 -1.014 . . . . 0.0 109.51 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 227' ' ' THR . 0.0 OUTLIER -73.43 -37.38 65.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 227' ' ' THR . 1.3 t70 -86.04 -145.3 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.876 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.7 t -115.61 46.26 1.54 Allowed 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 118.761 -1.176 . . . . 0.0 108.196 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.511 ' HB ' HG21 ' A' ' 187' ' ' THR . 97.8 m -101.58 -31.06 11.03 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.382 -0.824 . . . . 0.0 111.186 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.547 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -111.95 -86.99 1.66 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.878 -1.63 . . . . 0.0 109.096 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.052 HG21 HD21 ' A' ' 164' ' ' LEU . 35.4 m -125.01 -97.21 0.43 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.689 ' HB2' HG23 ' A' ' 198' ' ' VAL . 1.1 m120 -158.12 67.53 0.48 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.107 -0.995 . . . . 0.0 108.42 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.133 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -27.79 -94.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.54 0.686 . . . . 0.0 111.553 -179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.853 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -67.63 -12.66 60.95 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 111.013 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.806 ' HA ' HD11 ' A' ' 218' ' ' LEU . 8.5 tp -63.06 -64.25 0.97 Allowed 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.906 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.064 HG21 ' CD2' ' A' ' 164' ' ' LEU . 2.5 t -69.46 -12.02 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.049 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.76 -57.4 4.01 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.963 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -66.99 -14.61 63.05 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.681 ' CD2' ' HA ' ' A' ' 219' ' ' MET . 63.8 t-80 -69.93 -43.97 70.56 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 117.821 -1.551 . . . . 0.0 107.743 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.718 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 2.3 mt-10 -82.53 -49.05 10.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.768 HG22 HD21 ' A' ' 207' ' ' LEU . 1.4 mt -59.95 -30.74 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.735 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -80.32 -29.68 44.11 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -62.2 -42.84 99.66 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.701 -0.882 . . . . 0.0 110.558 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.523 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 68.5 m -90.57 -51.71 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.108 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.777 HD13 ' HE2' ' A' ' 132' ' ' PHE . 0.5 OUTLIER -104.78 20.66 18.32 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.008 -1.057 . . . . 0.0 110.828 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.939 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -124.48 -79.25 0.39 Allowed Glycine 0 C--N 1.291 -1.96 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.256 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.934 HD21 ' OD2' ' A' ' 238' ' ' ASP . 1.0 OUTLIER -171.25 -156.29 0.11 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.428 -1.631 . . . . 0.0 110.939 -178.062 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 219' ' ' MET . 0.5 OUTLIER -101.49 -86.58 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.669 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 5.6 m80 -152.32 89.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.457 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.588 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.0 m -79.47 178.72 7.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.116 -0.99 . . . . 0.0 108.574 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.495 ' HB3' ' OD2' ' A' ' 237' ' ' ASP . . . -59.09 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.94 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.16 11.9 10.91 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.213 -1.395 . . . . 0.0 111.978 -177.384 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.92 -28.22 6.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 175.088 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.511 ' C ' ' HB2' ' A' ' 235' ' ' SER . 34.9 mt-10 -117.41 -34.58 4.25 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -57.8 -145.63 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.206 -0.934 . . . . 0.0 111.557 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.963 ' CD2' ' HB3' ' A' ' 200' ' ' ALA . 0.7 OUTLIER -132.35 -0.5 3.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.74 . . . . 0.0 111.082 -178.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.681 ' HA ' ' CD2' ' A' ' 201' ' ' HIS . 9.2 tpp -93.35 -3.46 53.35 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.072 -1.642 . . . . 0.0 110.073 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.65 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 4.4 t80 -139.86 12.08 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.04 -1.064 . . . . 0.0 113.322 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 53.7 Cg_endo -74.31 -36.75 2.96 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 108.988 -1.197 . . . . 0.0 108.988 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 223' ' ' TYR . 2.6 tt -13.06 -60.05 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.201 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.954 ' N ' HD23 ' A' ' 222' ' ' LEU . 9.5 t80 -69.57 56.48 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.078 -1.014 . . . . 0.0 109.494 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.4 t-160 179.21 -142.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.1 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.932 ' O ' HD12 ' A' ' 226' ' ' LEU . 4.0 m -149.51 121.62 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 109.58 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER -176.28 56.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 109.897 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -116.17 -16.23 11.01 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.1 t0 -169.51 -25.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.681 -0.637 . . . . 0.0 109.527 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.876 HD11 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -27.93 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.667 -0.646 . . . . 0.0 110.719 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.421 ' C ' ' HG3' ' A' ' 231' ' ' ARG . 0.6 OUTLIER -145.11 1.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.887 -1.133 . . . . 0.0 110.139 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.61 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -129.55 -44.74 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.885 -1.135 . . . . 0.0 109.382 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 23.0 p90 1.12 106.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.482 0.658 . . . . 0.0 112.58 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.556 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.25 171.05 0.94 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.474 179.187 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.023 HD21 ' CH2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -82.01 179.61 7.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.334 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.77 ' H ' HD12 ' A' ' 234' ' ' LEU . 3.2 t -116.5 -169.93 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.042 -1.036 . . . . 0.0 110.575 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.597 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.57 -25.07 26.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.542 -0.724 . . . . 0.0 109.983 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.588 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 19.6 m-20 -77.14 -45.07 28.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.932 -1.105 . . . . 0.0 108.204 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.934 ' OD2' HD21 ' A' ' 209' ' ' LEU . 7.8 t70 -67.85 -45.93 73.2 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.282 -1.367 . . . . 0.0 107.909 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 234' ' ' LEU . 0.8 OUTLIER -51.61 -34.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.124 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -47.13 78.74 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -60.51 -56.05 26.56 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.947 HG13 HG22 ' A' ' 128' ' ' THR . 0.7 OUTLIER -63.77 -46.14 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.821 -1.399 . . . . 0.0 109.954 -178.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 242' ' ' ILE . 30.4 mt-30 -54.27 -26.66 30.28 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -90.02 -10.93 43.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.939 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -80.02 -54.37 5.85 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.62 ' CD2' HD12 ' A' ' 130' ' ' LEU . 3.9 m-30 . . . . . 0 N--CA 1.49 1.571 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.172 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.673 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.596 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 27.9 m95 -97.65 140.55 31.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.978 -1.076 . . . . 0.0 109.641 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.78 -28.25 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.98 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.778 0.799 . . . . 0.0 110.192 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.779 ' HB ' HD12 ' A' ' 130' ' ' LEU . 66.8 p -127.33 3.71 6.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.603 ' NE2' HG21 ' A' ' 131' ' ' THR . 7.8 m80 -148.91 102.94 3.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.9 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.157 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -121.19 -166.51 1.36 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.628 HG22 ' C ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -168.21 171.67 9.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.14 -0.975 . . . . 0.0 109.238 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 1.098 ' CE2' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -139.38 177.19 8.1 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.84 -1.163 . . . . 0.0 110.48 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.875 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -127.45 126.76 42.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 109.9 -178.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.093 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 1.9 mp -85.06 83.33 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.932 -1.105 . . . . 0.0 109.837 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.875 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -101.22 8.67 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.186 -0.946 . . . . 0.0 110.077 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.866 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -100.48 157.29 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.635 -1.291 . . . . 0.0 109.968 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.669 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.5 OUTLIER 178.16 75.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.62 0.724 . . . . 0.0 109.507 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 1.049 HG21 ' CD1' ' A' ' 186' ' ' TRP . 0.8 OUTLIER -67.77 157.2 87.19 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.23 -23.44 39.0 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 O-C-N 123.79 1.416 . . . . 0.0 108.952 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.562 ' O ' HD23 ' A' ' 108' ' ' LEU . 1.5 t0 -69.93 -9.8 56.28 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.837 HD22 ' HB1' ' A' ' 112' ' ' ALA . 52.2 mt -143.45 123.97 7.92 Favored Pre-proline 0 N--CA 1.485 1.278 0 O-C-N 121.622 -0.673 . . . . 0.0 109.898 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -66.42 168.87 15.21 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.781 1.411 . . . . 0.0 109.184 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.484 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.91 -64.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.756 0.789 . . . . 0.0 110.516 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 112' ' ' ALA . 2.4 p-10 -55.5 -32.08 62.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.701 -0.625 . . . . 0.0 111.954 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.837 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.87 -61.91 1.59 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.524 -1.36 . . . . 0.0 109.437 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.971 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.6 p -52.21 -41.68 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.591 ' OD2' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.63 -26.34 68.63 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.618 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -68.21 -35.71 78.39 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.401 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.048 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -76.15 -35.11 59.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.937 -1.102 . . . . 0.0 109.005 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.098 HG12 ' CE2' ' A' ' 99' ' ' TYR . 1.7 t -73.11 -26.13 22.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 1.5 tt0 -86.48 -36.35 19.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.897 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -75.93 -39.27 56.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -66.15 -62.96 1.2 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.473 1.13 . . . . 0.0 108.167 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.941 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.3 tt -46.51 -51.57 15.12 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.189 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.92 ' N ' HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -67.63 -35.47 78.97 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.947 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.118 ' CG1' HD22 ' A' ' 234' ' ' LEU . 3.1 t -52.44 -42.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.067 ' CH2' HD21 ' A' ' 234' ' ' LEU . 30.1 m95 -92.43 -23.38 19.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.928 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 46.9 tt0 -69.81 -26.93 64.49 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.762 -1.211 . . . . 0.0 107.801 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -91.06 -43.12 10.11 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.804 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.038 HG21 HG21 ' A' ' 242' ' ' ILE . 17.7 m -59.18 -24.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.766 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.036 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -105.9 160.48 25.98 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 117.696 -1.601 . . . . 0.0 110.222 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.724 ' C ' HD22 ' A' ' 130' ' ' LEU . 51.7 Cg_endo -85.56 22.48 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.259 1.973 . . . . 0.0 111.962 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.779 HD12 ' HB ' ' A' ' 95' ' ' THR . 3.6 mm? -116.36 -169.96 1.72 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.32 -1.488 . . . . 0.0 110.51 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.603 HG21 ' NE2' ' A' ' 96' ' ' HIS . 1.3 p -117.04 164.96 13.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 1.157 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 1.2 m-85 -144.26 139.27 28.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.693 -0.63 . . . . 0.0 109.492 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.531 ' CB ' ' HB ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -115.28 -166.31 1.11 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.129 -0.982 . . . . 0.0 108.486 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.49 157.31 35.22 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.964 -1.085 . . . . 0.0 110.014 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -159.64 -164.96 1.43 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.387 -0.821 . . . . 0.0 109.604 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 101' ' ' ILE . 1.8 t80 -154.17 22.09 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.524 ' HA ' ' NH2' ' A' ' 100' ' ' ARG . 11.6 pm0 -138.44 179.58 6.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.43 -100.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.68 119.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 110.296 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.561 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -77.94 -154.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 108.87 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 176' ' ' GLY . 2.3 m-20 -84.24 -38.32 20.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 109.364 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.737 HG22 ' CD1' ' A' ' 144' ' ' ILE . 4.0 mp -120.77 84.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.649 -0.657 . . . . 0.0 109.254 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.455 ' HB3' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.45 98.5 0.25 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.133 -0.979 . . . . 0.0 109.044 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.866 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.9 mm -84.29 114.89 25.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.627 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.01 155.66 50.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.517 -1.365 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -81.15 141.11 34.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 108.826 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.917 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -160.03 178.25 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.85 -1.156 . . . . 0.0 110.828 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.838 HG13 ' N ' ' A' ' 149' ' ' ARG . 1.5 p -167.26 -150.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.838 ' N ' HG13 ' A' ' 148' ' ' VAL . 3.7 mmm180 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.765 -0.584 . . . . 0.0 110.477 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 C--O 1.215 -0.664 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.687 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -106.92 -164.12 0.96 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.081 -1.012 . . . . 0.0 110.243 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.3 p30 179.91 46.08 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.362 -0.836 . . . . 0.0 110.553 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.613 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 38.4 -97.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 183' ' ' ASP . 40.2 Cg_endo -69.51 56.9 1.32 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.992 1.522 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.471 ' HA3' ' OD1' ' A' ' 158' ' ' ASP . . . -132.84 143.02 14.61 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 161' ' ' GLY . 2.9 m120 -42.6 -31.32 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -1.066 . . . . 0.0 109.877 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 163' ' ' VAL . 31.8 m -68.76 83.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.169 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.011 HD22 HD12 ' A' ' 222' ' ' LEU . 1.6 tp -64.21 -71.19 0.18 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 0.0 111.658 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.896 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -150.02 -168.41 3.1 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.532 -1.355 . . . . 0.0 110.426 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 179.21 -178.22 0.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 119.73 -1.856 . . . . 0.0 111.353 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.658 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -154.92 178.91 9.64 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.475 -0.765 . . . . 0.0 110.134 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.797 ' CE1' HD11 ' A' ' 174' ' ' ILE . 81.5 m-85 -121.51 -167.82 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.449 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.997 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -175.3 -58.65 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 109.423 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.997 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -78.62 133.05 11.35 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.886 1.466 . . . . 0.0 109.969 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 132.67 -173.9 20.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.592 ' HD2' HG22 ' A' ' 174' ' ' ILE . 45.8 Cg_endo -78.48 -92.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.089 1.573 . . . . 0.0 110.312 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -82.97 -34.62 20.93 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.797 HD11 ' CE1' ' A' ' 168' ' ' TYR . 0.8 OUTLIER -61.93 -6.98 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.466 -1.02 . . . . 0.0 108.816 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.568 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 34.4 p-10 -65.81 64.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.466 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 206' ' ' SER . . . 126.36 82.3 0.43 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.0 m-20 -158.68 120.24 3.46 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.012 -1.287 . . . . 0.0 107.95 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -111.9 156.97 21.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.677 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.917 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -145.08 134.08 22.58 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.624 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 65.7 m-85 -95.57 133.75 39.25 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.158 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.579 ' OD2' ' CD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -49.34 148.66 2.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.026 177.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD2' ' HB ' ' A' ' 148' ' ' VAL . 2.6 p30 -124.05 21.04 9.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.809 -1.182 . . . . 0.0 109.558 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.744 ' OD2' HG21 ' A' ' 148' ' ' VAL . 1.8 m-20 -131.05 9.73 4.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.509 ' CG ' ' HB3' ' A' ' 181' ' ' ASP . 1.0 OUTLIER -114.04 -98.28 0.44 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.657 -1.277 . . . . 0.0 109.515 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 66.9 mt-30 -154.26 165.94 34.72 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 109.202 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 1.049 ' CD1' HG21 ' A' ' 105' ' ' THR . 97.8 m95 -160.3 118.97 2.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 110.11 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.825 ' HA ' HD21 ' A' ' 108' ' ' LEU . 22.2 p -140.79 152.1 44.94 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.034 -1.041 . . . . 0.0 109.039 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.794 ' HA ' HD22 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -75.09 -33.44 61.64 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.627 ' OD2' HD12 ' A' ' 229' ' ' LEU . 1.3 t70 -91.52 -141.19 0.18 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.933 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.8 t -117.59 46.77 1.66 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.003 -1.06 . . . . 0.0 108.243 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.499 ' HB ' HG21 ' A' ' 187' ' ' THR . 58.4 m -104.71 -29.46 10.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.273 -0.892 . . . . 0.0 111.303 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.533 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -110.26 -91.29 2.09 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.91 -1.614 . . . . 0.0 109.48 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.038 HG22 ' OD1' ' A' ' 194' ' ' ASN . 64.8 m -114.44 -84.35 0.61 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 1.038 ' OD1' HG22 ' A' ' 193' ' ' THR . 5.1 p30 178.6 68.56 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.862 1.315 . . . . 0.0 108.139 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.048 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -21.73 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.303 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.868 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -68.01 -6.39 22.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 110.835 -175.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.975 ' HA ' HD11 ' A' ' 218' ' ' LEU . 7.5 tp -66.11 -61.49 2.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 117.601 -1.64 . . . . 0.0 106.642 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.896 HG12 ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -70.81 -14.49 18.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.121 -1.032 . . . . 0.0 108.426 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.936 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.23 -61.05 1.96 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.618 -1.233 . . . . 0.0 108.211 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 1.044 ' HB3' HD23 ' A' ' 218' ' ' LEU . . . -63.58 -15.75 58.93 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.311 -1.493 . . . . 0.0 107.527 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.814 ' HA ' ' HE2' ' A' ' 219' ' ' MET . 6.8 t60 -70.6 -44.01 68.17 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.684 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.722 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 8.3 mt-10 -82.58 -46.16 13.69 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 0.0 111.374 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.941 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.0 mt -63.69 -30.31 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.698 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.47 -31.38 54.58 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -64.04 -47.16 81.29 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.796 -0.826 . . . . 0.0 111.232 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.545 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 33.9 p -85.37 -52.52 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.16 -0.963 . . . . 0.0 112.63 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.89 ' O ' HD12 ' A' ' 207' ' ' LEU . 1.3 pp -104.4 7.44 35.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.871 -1.143 . . . . 0.0 111.097 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.995 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -109.83 -84.01 1.5 Allowed Glycine 0 C--N 1.29 -1.975 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.825 HD11 ' OD1' ' A' ' 238' ' ' ASP . 1.8 pp -158.89 -161.13 0.93 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.922 -1.34 . . . . 0.0 109.942 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.572 ' N ' HD12 ' A' ' 209' ' ' LEU . 44.8 t80 -98.43 -71.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -161.06 94.17 1.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.647 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 2.1 m -84.03 -179.26 7.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.871 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -62.7 78.6 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.999 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -82.72 9.34 9.85 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.281 -177.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -50.44 -27.84 7.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.511 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.6 mt-10 -114.07 -36.45 4.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.999 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -61.39 -159.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.272 1.034 . . . . 0.0 112.276 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.044 HD23 ' HB3' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -106.04 -11.81 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.562 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.814 ' HE2' ' HA ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -80.57 -10.2 59.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.24 -1.537 . . . . 0.0 111.932 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.679 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.8 t80 -131.39 8.5 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.447 -1.408 . . . . 0.0 113.953 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 43.7 Cg_endo -72.48 -41.84 1.55 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 N-CA-C 109.261 -1.092 . . . . 0.0 109.261 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 1.011 HD12 HD22 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -0.5 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.204 0.526 . . . . 0.0 111.756 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.877 ' N ' HD23 ' A' ' 222' ' ' LEU . 48.4 t80 -67.19 58.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.827 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.13 -155.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 109.329 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.458 ' HB3' ' OG1' ' A' ' 190' ' ' THR . 0.7 OUTLIER -128.69 126.39 40.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.091 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.95 HD12 ' HB2' ' A' ' 231' ' ' ARG . 1.2 tt -179.85 40.35 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.581 ' HA ' ' CE1' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -103.16 -40.03 6.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.9 t70 -149.38 -13.43 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.551 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.933 HD11 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -42.65 -98.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.851 -1.156 . . . . 0.0 110.349 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.5 p -139.03 -0.31 1.88 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.48 -1.388 . . . . 0.0 109.933 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.95 ' HB2' HD12 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -116.7 -18.21 10.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.012 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 232' ' ' PHE . 19.5 p90 -30.15 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.478 0.656 . . . . 0.0 111.477 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.58 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 8.5 ttt180 179.13 149.53 0.26 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.118 HD22 ' CG1' ' A' ' 123' ' ' VAL . 3.1 tp -70.11 164.43 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 108.755 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' SER . . . . . 1.085 ' O ' HD12 ' A' ' 239' ' ' ILE . 7.7 t -102.46 178.15 4.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.068 -1.02 . . . . 0.0 109.578 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.509 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -70.36 -14.6 62.64 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.75 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.871 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.8 OUTLIER -87.32 -49.6 7.14 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.716 -1.24 . . . . 0.0 109.548 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.825 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.94 -42.56 97.29 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 116.908 -1.917 . . . . 0.0 107.17 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.085 HD12 ' O ' ' A' ' 235' ' ' SER . 3.0 mt -54.83 -39.83 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.52 ' HA ' ' HG2' ' A' ' 243' ' ' GLN . 24.5 t-20 -60.84 -48.97 79.36 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.62 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.06 -55.53 30.37 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.038 HG21 HG21 ' A' ' 127' ' ' VAL . 1.4 tp -63.46 -50.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.032 -1.276 . . . . 0.0 110.521 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.567 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -53.33 -25.1 13.76 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.509 ' N ' ' HG3' ' A' ' 243' ' ' GLN . 37.4 t -90.83 -11.4 39.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -78.98 -49.97 11.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.74 ' HB3' HD23 ' A' ' 130' ' ' LEU . 5.0 m-30 . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.504 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.534 ' CE3' ' HD3' ' A' ' 94' ' ' LYS . 36.3 m95 -105.48 160.14 15.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.889 -1.132 . . . . 0.0 109.284 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -121.97 -28.99 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.044 -1.035 . . . . 0.0 110.682 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 1.06 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -42.9 169.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 110.323 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.652 ' HA ' HD11 ' A' ' 130' ' ' LEU . 2.1 p -106.19 -0.66 24.38 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.439 -0.788 . . . . 0.0 109.459 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.558 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 54.3 m-70 -140.19 93.89 2.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.904 HD23 HD23 ' A' ' 130' ' ' LEU . 3.1 mm? -85.82 164.66 17.41 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.762 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.608 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -143.33 156.64 44.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.918 ' CE2' HD11 ' A' ' 101' ' ' ILE . 8.8 p90 -135.85 170.28 16.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.61 -1.306 . . . . 0.0 109.642 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.838 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -132.25 123.25 26.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.369 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.918 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -80.01 83.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 0.0 109.705 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.838 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -99.12 8.39 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.629 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -107.06 173.01 6.51 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.424 -1.422 . . . . 0.0 110.119 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.619 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 11.3 t80 176.94 70.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.712 0.768 . . . . 0.0 109.342 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.8 HG21 ' CD1' ' A' ' 186' ' ' TRP . 56.3 p -56.25 148.86 39.88 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 120.985 -1.072 . . . . 0.0 108.246 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 -28.96 40.5 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 108.52 -1.377 . . . . 0.0 108.52 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.608 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.6 t0 -71.28 -9.12 57.59 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 187' ' ' THR . 33.1 mt -131.69 120.51 17.67 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.644 -0.66 . . . . 0.0 110.21 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.6 Cg_endo -62.99 163.69 21.64 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 123.811 1.427 . . . . 0.0 108.979 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.3 -65.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.781 0.801 . . . . 0.0 110.034 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.7 OUTLIER -57.65 -15.2 6.95 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 111.056 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . . . -81.23 -62.22 1.72 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.555 -1.341 . . . . 0.0 108.942 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.629 HG21 ' C ' ' A' ' 103' ' ' ASN . 7.3 p -50.64 -40.02 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 118.294 -1.362 . . . . 0.0 107.481 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.825 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -65.12 -27.09 68.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.738 ' OG ' HD21 ' A' ' 195' ' ' LEU . 14.6 p -66.91 -38.43 86.21 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.064 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.19 -33.59 65.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.329 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.863 HG13 HG13 ' A' ' 144' ' ' ILE . 47.8 t -75.45 -24.09 17.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -84.36 -36.4 22.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -79.69 -38.82 32.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -63.39 -60.76 2.95 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 122.425 1.107 . . . . 0.0 108.247 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.842 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.2 pp -52.59 -41.04 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.937 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.759 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -75.88 -32.07 59.52 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.986 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.028 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.9 t -53.81 -45.11 61.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.051 ' CH2' HD21 ' A' ' 234' ' ' LEU . 31.8 m95 -91.7 -23.12 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.902 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 5.4 tm-20 -70.96 -26.59 63.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.847 -1.158 . . . . 0.0 107.935 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -90.76 -42.71 10.53 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.689 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.028 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.9 m -58.78 -25.67 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 118.323 -1.351 . . . . 0.0 108.809 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.019 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -112.56 172.15 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 117.94 -1.504 . . . . 0.0 110.056 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 128' ' ' THR . 51.7 Cg_endo -87.21 -7.94 6.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.642 2.228 . . . . 0.0 110.78 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.06 HD21 ' O ' ' A' ' 94' ' ' LYS . 1.1 tp -73.8 -179.76 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.982 -1.074 . . . . 0.0 110.594 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.5 p -119.33 175.68 5.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 110.154 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.718 ' CZ ' HD13 ' A' ' 207' ' ' LEU . 0.5 OUTLIER -144.56 159.56 42.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.97 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.578 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -145.25 179.74 7.18 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.69 157.85 44.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.797 -1.189 . . . . 0.0 110.427 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.541 HD23 ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -150.55 -140.03 0.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 5.5 t80 178.92 40.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.743 -1.223 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 7.5 pm0 -165.22 -178.18 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.609 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.44 -96.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 137' ' ' GLU . 1.7 pt-20 178.84 105.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.199 -1.177 . . . . 0.0 110.163 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.608 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.21 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 108.671 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.607 ' O ' HD13 ' A' ' 142' ' ' ILE . 0.9 OUTLIER -92.49 -27.97 17.09 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.532 179.14 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.986 HD11 ' HG ' ' A' ' 207' ' ' LEU . 31.1 mm -130.9 77.14 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.695 ' HG2' HG21 ' A' ' 102' ' ' VAL . 1.9 ttt -64.87 97.07 0.21 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.136 -0.978 . . . . 0.0 108.962 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.863 HG13 HG13 ' A' ' 117' ' ' VAL . 6.9 mm -79.55 123.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.092 . . . . 0.0 108.456 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -138.47 153.07 48.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.446 -1.409 . . . . 0.0 111.825 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 14.3 p90 -87.34 139.9 30.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.207 -0.933 . . . . 0.0 108.943 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.097 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.15 -160.21 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.702 -1.249 . . . . 0.0 111.36 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.705 HG22 ' H ' ' A' ' 149' ' ' ARG . 5.7 p -170.0 179.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.705 ' H ' HG22 ' A' ' 148' ' ' VAL . 3.0 ptt180 . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 0.0 110.705 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 C--O 1.216 -0.606 0 N-CA-C 109.865 -0.859 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.687 ' CD1' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -91.16 -149.9 0.23 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.054 -1.028 . . . . 0.0 109.419 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.572 ' OD1' HG12 ' A' ' 163' ' ' VAL . 8.9 p-10 -137.04 -2.85 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.258 -1.526 . . . . 0.0 111.718 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.655 ' CA ' HG23 ' A' ' 148' ' ' VAL . . . 39.48 -95.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.528 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.2 Cg_endo -61.45 72.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.338 1.178 . . . . 0.0 110.077 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -172.51 -164.06 27.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' VAL . 69.0 m-20 -90.69 -29.82 17.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.086 -1.244 . . . . 0.0 110.111 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.687 HG11 ' CD1' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -36.73 130.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.593 -0.692 . . . . 0.0 110.713 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.839 HD12 HG11 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -92.23 -80.89 0.35 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.582 -0.699 . . . . 0.0 112.24 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.841 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -161.35 -170.9 2.79 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.263 -1.523 . . . . 0.0 111.026 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.682 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -179.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 119.542 -1.974 . . . . 0.0 111.313 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -160.41 -163.41 1.09 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.603 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -130.17 -157.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 0.0 110.704 -178.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.97 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -170.56 -59.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.661 -0.65 . . . . 0.0 109.562 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.97 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.4 Cg_endo -79.6 -172.32 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.405 1.403 . . . . 0.0 110.232 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.55 144.07 0.71 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.17 135.14 28.75 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.425 1.417 . . . . 0.0 110.002 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 72.54 -64.12 1.44 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.603 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.0 tp -63.78 -8.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.494 -1.003 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.7 OUTLIER -65.77 66.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.763 179.329 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 206' ' ' SER . . . 129.53 79.49 0.23 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -153.53 128.76 9.76 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.859 -1.377 . . . . 0.0 108.205 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.703 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -112.59 172.57 6.84 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.983 -1.073 . . . . 0.0 108.961 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.097 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -164.66 134.38 3.8 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.577 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.682 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 12.2 m-85 -88.69 123.38 33.08 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 164' ' ' LEU . 17.0 t70 -67.2 144.66 55.86 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.129 -0.982 . . . . 0.0 108.945 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -61.18 -4.18 1.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.283 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.649 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.0 OUTLIER 4.62 -94.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 161' ' ' GLY . 1.4 pm0 -166.3 -33.61 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.692 -1.255 . . . . 0.0 110.906 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.459 ' OE1' ' HA2' ' A' ' 192' ' ' GLY . 66.4 mt-30 -141.66 158.67 43.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.708 -1.245 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.8 ' CD1' HG21 ' A' ' 105' ' ' THR . 84.9 m95 -158.02 119.53 3.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.916 ' HA ' HD21 ' A' ' 108' ' ' LEU . 47.2 p -144.43 154.64 43.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.473 -1.392 . . . . 0.0 110.476 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 0.7 OUTLIER -75.7 -35.0 60.42 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.566 ' OD2' HD12 ' A' ' 229' ' ' LEU . 1.0 OUTLIER -93.86 -144.21 0.24 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.919 ' N ' HD11 ' A' ' 229' ' ' LEU . 15.1 t -109.69 37.78 2.55 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.447 ' HB ' HG21 ' A' ' 187' ' ' THR . 11.8 m -84.83 -35.58 22.19 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.63 -0.669 . . . . 0.0 110.94 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.623 ' N ' HG21 ' A' ' 187' ' ' THR . . . -120.82 -87.39 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 118.852 -1.642 . . . . 0.0 109.024 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.584 HG21 HD11 ' A' ' 164' ' ' LEU . 90.9 m -114.85 -105.91 0.39 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.606 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 52.3 m-80 -157.62 70.76 0.6 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.113 -0.992 . . . . 0.0 108.744 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.923 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -19.58 -91.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.812 0.815 . . . . 0.0 112.618 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.836 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -66.95 -11.81 57.7 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.045 -1.034 . . . . 0.0 111.656 -176.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 1.006 HD11 ' CG ' ' A' ' 221' ' ' PRO . 11.7 tp -64.2 -55.48 21.34 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.841 HG12 ' HB3' ' A' ' 165' ' ' ALA . 2.8 t -76.08 -9.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.064 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.97 -57.2 3.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.391 -1.324 . . . . 0.0 107.534 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.22 -19.02 65.78 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.602 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 3.7 t-160 -68.22 -41.12 81.78 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.672 177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.703 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 28.4 mt-10 -83.64 -49.11 9.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 110.778 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.733 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -58.73 -31.85 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.71 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.39 -35.69 36.56 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -56.18 -53.68 54.21 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.674 -0.897 . . . . 0.0 110.319 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.667 ' HB2' HD12 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -83.72 -56.83 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 111.579 -178.23 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.986 ' HG ' HD11 ' A' ' 142' ' ' ILE . 7.4 mt -102.54 37.6 1.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 110.971 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 1.03 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -141.63 -75.34 0.04 OUTLIER Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.7 pp -170.31 -164.28 0.39 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.994 -1.297 . . . . 0.0 109.657 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.1 OUTLIER -98.48 -79.55 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.276 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.633 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.1 m80 -154.29 105.9 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 0.0 109.164 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -94.54 -176.45 3.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.287 -0.883 . . . . 0.0 109.096 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.974 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -62.4 81.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.952 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.84 10.5 18.37 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.64 -177.249 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.3 OUTLIER -50.28 -27.82 6.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 174.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.516 ' C ' ' HB2' ' A' ' 235' ' ' SER . 23.5 mm-40 -115.81 -36.85 4.06 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.952 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -173.01 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.517 1.151 . . . . 0.0 112.766 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.926 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -85.73 -17.06 36.96 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.977 -177.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.742 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -78.51 -8.11 58.21 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.461 -2.024 . . . . 0.0 112.366 -177.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.682 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 7.0 t80 -133.01 14.74 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 120.25 -1.531 . . . . 0.0 113.472 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 1.006 ' CG ' HD11 ' A' ' 197' ' ' LEU . 52.2 Cg_endo -77.77 -41.88 0.29 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 N-CA-C 109.541 -0.984 . . . . 0.0 109.541 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.931 HD23 ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -8.73 -69.0 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.578 -178.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.931 ' N ' HD23 ' A' ' 222' ' ' LEU . 7.9 t80 -65.91 59.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.71 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.4 t-80 179.77 -143.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.316 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.42 ' C ' HD23 ' A' ' 226' ' ' LEU . 49.4 m -152.59 123.48 7.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.066 -1.021 . . . . 0.0 109.556 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.973 HD21 ' HB2' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 179.52 59.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.851 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.568 ' O ' ' CD2' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -109.02 -45.98 3.68 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.072 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 33.0 t70 -138.3 -13.55 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 0.0 110.432 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.919 HD11 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -37.6 -100.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.264 -0.897 . . . . 0.0 111.055 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.46 -16.41 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.434 -1.416 . . . . 0.0 110.383 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.535 ' O ' ' CD ' ' A' ' 233' ' ' ARG . 2.1 mtp180 -114.54 -22.19 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 108.849 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 30.4 p90 -30.65 115.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.419 0.628 . . . . 0.0 111.944 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.544 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.42 166.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 178.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.051 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.6 mp -77.87 165.32 24.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.173 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.737 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 31.1 t -99.88 -170.17 1.85 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 118.699 -1.201 . . . . 0.0 110.302 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.8 pp0? -83.93 -16.93 42.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.637 -0.665 . . . . 0.0 109.968 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.974 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.1 m-20 -81.95 -48.57 11.31 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.257 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.727 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.47 -38.34 90.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 117.328 -1.749 . . . . 0.0 106.728 177.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.605 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.42 -35.93 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -65.47 -60.12 3.28 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -49.51 -49.53 32.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.03 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.4 tp -65.09 -46.69 90.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.772 -1.428 . . . . 0.0 110.015 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.535 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.2 tt0 -53.34 -27.1 21.73 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.4 t -84.96 -17.91 36.22 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 1.003 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -75.37 -60.58 2.24 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.553 -0.717 . . . . 0.0 109.592 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.901 ' OH ' HD22 ' A' ' 207' ' ' LEU . 10.2 m-30 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.612 ' CD1' HD13 ' A' ' 207' ' ' LEU . 59.3 m95 -97.72 174.44 6.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.189 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.4 ppt_? -135.35 -38.81 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.636 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.913 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.08 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.284 -0.885 . . . . 0.0 110.073 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.539 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 30.7 p -105.98 3.34 28.24 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.328 -0.857 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.551 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 65.4 m-70 -136.11 91.04 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.882 -1.136 . . . . 0.0 109.946 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.913 HD13 ' HE2' ' A' ' 94' ' ' LYS . 2.6 mm? -94.98 168.22 10.92 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.599 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -142.86 156.51 44.94 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.872 -1.142 . . . . 0.0 109.0 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 1.025 ' CZ ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.5 172.59 12.78 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.994 -1.066 . . . . 0.0 109.927 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.52 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -136.77 144.27 43.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.025 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 1.8 mp -100.68 76.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 0.0 110.041 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' A' ' 144' ' ' ILE . 29.1 t -94.21 8.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.995 . . . . 0.0 109.699 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.853 ' C ' HG21 ' A' ' 113' ' ' VAL . 2.7 m120 -99.36 163.06 12.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.952 -1.092 . . . . 0.0 109.243 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.714 ' N ' HG21 ' A' ' 113' ' ' VAL . 17.7 p90 179.33 55.44 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.531 -0.731 . . . . 0.0 109.917 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.965 HG21 ' CD1' ' A' ' 186' ' ' TRP . 46.9 p -42.94 150.24 0.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.008 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.93 -25.99 44.39 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.886 1.466 . . . . 0.0 109.203 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.475 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -77.44 -1.21 29.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.965 HD13 ' CD1' ' A' ' 195' ' ' LEU . 99.1 mt -141.15 115.89 7.16 Favored Pre-proline 0 N--CA 1.484 1.258 0 O-C-N 121.473 -0.767 . . . . 0.0 109.613 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.5 Cg_endo -66.09 173.87 6.67 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.807 1.425 . . . . 0.0 109.141 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE3' ' CG ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -37.48 -65.35 0.32 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.805 0.812 . . . . 0.0 110.421 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -57.59 -29.64 64.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.861 -0.525 . . . . 0.0 112.336 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.83 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -71.68 -61.98 1.58 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.261 -1.525 . . . . 0.0 109.064 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.976 ' O ' HG23 ' A' ' 117' ' ' VAL . 8.3 p -52.23 -39.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' OD1' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.09 -28.15 69.88 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.863 ' OG ' HD21 ' A' ' 195' ' ' LEU . 16.4 p -64.96 -40.4 94.93 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.061 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.56 -33.15 64.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.962 -1.087 . . . . 0.0 109.892 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.998 HG12 ' CE2' ' A' ' 99' ' ' TYR . 2.0 t -74.86 -24.82 18.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -88.52 -35.04 17.19 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.818 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -77.89 -39.66 42.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.365 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.87 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.28 -62.99 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 122.399 1.095 . . . . 0.0 108.439 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.776 ' HA ' HG21 ' A' ' 203' ' ' ILE . 10.0 tp -50.63 -44.76 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -73.18 -32.89 65.11 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.385 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.02 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.3 t -54.63 -43.16 64.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.06 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.9 m95 -91.71 -23.57 19.74 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.646 -1.221 . . . . 0.0 110.808 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 3.5 tp10 -70.45 -27.73 64.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.595 -1.316 . . . . 0.0 107.966 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.461 ' OE1' ' HG3' ' A' ' 122' ' ' LYS . 13.2 pt-20 -89.61 -42.92 11.12 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.977 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.02 HG13 ' O ' ' A' ' 123' ' ' VAL . 17.1 m -59.91 -24.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.354 -1.339 . . . . 0.0 109.291 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.03 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -110.04 155.99 40.77 Favored Pre-proline 0 N--CA 1.495 1.795 0 C-N-CA 117.963 -1.495 . . . . 0.0 109.891 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.15 10.62 3.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.14 1.894 . . . . 0.0 110.742 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.743 HD13 ' HB3' ' A' ' 246' ' ' TYR . 3.9 mp -96.46 -178.98 4.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.86 -1.15 . . . . 0.0 110.405 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.444 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -118.78 167.56 11.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.401 -0.812 . . . . 0.0 110.198 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.603 ' HE2' HD11 ' A' ' 142' ' ' ILE . 8.3 m-85 -141.7 -179.43 6.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.54 -0.725 . . . . 0.0 109.447 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 -162.64 1.37 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.898 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -162.05 -178.58 6.51 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.91 -1.119 . . . . 0.0 110.534 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -164.17 -128.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER 177.19 31.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.621 -1.299 . . . . 0.0 109.532 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 138' ' ' GLY . 3.2 pm0 -171.28 -161.78 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.106 -0.996 . . . . 0.0 109.729 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 35.5 -98.35 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.507 ' OE2' ' CA ' ' A' ' 173' ' ' GLY . 0.0 OUTLIER 177.81 107.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 110.634 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 1.013 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -67.26 -155.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.78 ' OD2' HD12 ' A' ' 97' ' ' LEU . 8.5 t0 -81.47 -32.3 32.57 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.718 HD11 ' HG ' ' A' ' 207' ' ' LEU . 1.7 mt -126.86 85.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.581 ' O ' ' CG ' ' A' ' 143' ' ' MET . 5.5 ptm -76.65 100.18 5.29 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.89 HG13 HG13 ' A' ' 117' ' ' VAL . 4.4 mm -79.39 114.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 108.087 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -135.95 159.79 40.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.475 -1.391 . . . . 0.0 112.065 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.64 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 17.2 p90 -80.19 140.16 36.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.034 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -170.47 177.94 3.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 110.625 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.574 ' CG2' ' CA ' ' A' ' 159' ' ' GLY . 11.5 p 179.44 143.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.42 0 CA-C-O 121.399 0.618 . . . . 0.0 112.096 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 C--O 1.214 -0.676 0 N-CA-C 108.867 -1.243 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.003 ' CZ ' HG12 ' A' ' 163' ' ' VAL . 1.8 t80 -76.11 -136.87 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.901 -1.124 . . . . 0.0 109.97 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.603 ' CB ' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -135.31 -30.55 1.02 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.796 -1.19 . . . . 0.0 110.879 -178.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.574 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 52.9 -107.67 0.59 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.55 ' HD2' ' CD ' ' A' ' 149' ' ' ARG . 31.5 Cg_endo -56.43 91.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 121.164 1.242 . . . . 0.0 110.829 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.517 ' HA3' ' OD2' ' A' ' 158' ' ' ASP . . . 161.73 -164.15 35.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 163' ' ' VAL . 41.8 m-80 -86.19 -30.53 22.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -1.226 . . . . 0.0 110.486 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.003 HG12 ' CZ ' ' A' ' 157' ' ' PHE . 7.9 t -39.92 100.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.021 HD23 HG21 ' A' ' 198' ' ' VAL . 0.9 OUTLIER -71.23 -70.36 0.32 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.447 -0.783 . . . . 0.0 111.723 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.715 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -161.37 -165.96 1.43 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.42 -1.425 . . . . 0.0 111.071 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.681 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.6 OUTLIER 179.49 -165.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.897 -1.752 . . . . 0.0 110.646 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -165.05 -167.05 1.11 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.528 ' O ' ' CB ' ' A' ' 206' ' ' SER . 86.7 m-85 -133.11 -159.71 0.99 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.97 . . . . 0.0 110.053 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.985 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -161.9 -63.26 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.062 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.985 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.5 Cg_endo -77.05 174.86 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.814 1.428 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 102.05 172.03 27.5 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 174' ' ' ILE . 40.8 Cg_endo -74.81 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.665 1.577 . . . . 0.0 109.664 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.507 ' CA ' ' OE2' ' A' ' 139' ' ' GLU . . . -79.58 -35.1 29.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.3 tt -69.85 3.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 121.81 -0.817 . . . . 0.0 109.011 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 170' ' ' PRO . 5.5 t30 -64.94 61.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.391 -0.818 . . . . 0.0 109.105 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.59 ' HA2' ' OG ' ' A' ' 206' ' ' SER . . . 107.47 89.51 2.08 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 76.1 m-20 -141.69 126.13 17.71 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -108.82 149.19 29.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.817 -1.177 . . . . 0.0 108.106 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.034 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -144.07 130.48 19.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.955 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.589 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 18.6 m-85 -85.17 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.593 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 p-10 -75.18 132.03 40.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.415 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 183' ' ' ASP . 6.4 t0 -75.44 -0.87 21.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.477 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 47.4 t0 -30.84 -72.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.512 0.672 . . . . 0.0 112.074 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.467 ' OE1' ' OD2' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -114.83 -110.96 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.084 -176.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.577 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 2.1 mt-30 -133.84 -168.77 2.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.817 -1.177 . . . . 0.0 109.739 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.965 ' CD1' HG21 ' A' ' 105' ' ' THR . 85.2 m95 -155.07 136.13 13.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.792 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.6 p -145.45 152.88 40.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.204 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.757 ' O ' HG23 ' A' ' 227' ' ' THR . 0.0 OUTLIER -73.04 -34.01 66.04 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.522 ' HA ' HD13 ' A' ' 229' ' ' LEU . 1.3 t70 -90.54 -151.07 0.24 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.868 HG23 HD11 ' A' ' 229' ' ' LEU . 1.4 p -103.76 35.11 2.73 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.286 -1.365 . . . . 0.0 107.927 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.546 ' CB ' HG21 ' A' ' 187' ' ' THR . 13.2 m -81.6 -36.16 29.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.263 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 187' ' ' THR . . . -119.96 -81.05 0.67 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.155 -1.498 . . . . 0.0 109.699 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.807 ' CG2' HD21 ' A' ' 164' ' ' LEU . 85.0 m -127.51 -79.08 0.58 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.373 -1.074 . . . . 0.0 108.704 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.877 HD22 HD23 ' A' ' 197' ' ' LEU . 42.9 p30 179.26 60.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.033 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -18.44 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.591 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.829 ' HE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -64.34 -16.95 63.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.127 -176.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 1.057 HD11 HD23 ' A' ' 226' ' ' LEU . 13.3 tp -60.94 -61.17 2.77 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 117.208 -1.797 . . . . 0.0 107.724 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.021 HG21 HD23 ' A' ' 164' ' ' LEU . 13.7 t -74.54 -7.66 10.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.629 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.061 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -74.89 -57.83 3.66 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.752 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.36 -16.47 64.09 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.572 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 8.5 t60 -70.12 -39.63 75.34 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.18 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.757 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 30.0 mt-10 -87.48 -46.96 9.13 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.028 -1.045 . . . . 0.0 110.366 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.87 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -61.41 -30.91 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.728 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.3 -34.85 44.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -58.68 -54.24 49.35 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.686 -0.891 . . . . 0.0 110.292 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.59 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 30.4 t -77.24 -60.21 2.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 112.486 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.718 ' HG ' HD11 ' A' ' 142' ' ' ILE . 1.1 mm? -104.01 31.49 4.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.236 -0.915 . . . . 0.0 110.529 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 1.031 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -132.59 -77.95 0.14 Allowed Glycine 0 C--N 1.292 -1.912 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.83 -166.01 0.54 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.945 -1.327 . . . . 0.0 110.054 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.821 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.1 OUTLIER -98.51 -74.82 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.29 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 79.2 m80 -160.12 110.38 1.85 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.779 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 2.0 m -98.81 -172.59 2.33 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.823 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.95 78.84 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.925 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.22 9.52 12.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.624 -177.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 214' ' ' ASN . 30.5 p -48.4 -28.88 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.545 ' C ' ' HB3' ' A' ' 235' ' ' SER . 9.5 mt-10 -113.98 -37.66 4.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.925 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -67.58 162.46 23.41 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.456 1.122 . . . . 0.0 112.367 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.87 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -56.97 -20.78 25.69 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.243 -178.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.676 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -77.59 -9.21 58.82 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 118.984 -2.323 . . . . 0.0 112.182 -177.322 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 34.3 t80 -133.62 17.77 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 120.178 -1.576 . . . . 0.0 113.568 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.692 ' HG2' HD21 ' A' ' 197' ' ' LEU . 55.3 Cg_endo -78.23 -36.51 0.98 Allowed 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.975 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -24.63 -57.93 0.05 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.942 -179.239 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.975 ' N ' HD13 ' A' ' 222' ' ' LEU . 0.4 OUTLIER -73.45 54.53 0.45 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.068 -1.02 . . . . 0.0 109.883 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.597 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 2.7 m170 -175.31 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.511 ' O ' ' NH1' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 179.57 121.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.994 -1.066 . . . . 0.0 109.117 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 1.057 HD23 HD11 ' A' ' 197' ' ' LEU . 3.1 tp 178.9 119.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER 179.12 -34.69 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 38.6 t0 -159.95 -22.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.81 -0.556 . . . . 0.0 109.596 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.868 HD11 HG23 ' A' ' 190' ' ' THR . 0.2 OUTLIER -34.5 -59.17 0.47 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.195 -0.941 . . . . 0.0 110.434 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.96 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 108.791 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.527 ' O ' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -90.32 -12.97 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.581 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 21.2 p90 -30.43 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.672 0.749 . . . . 0.0 111.221 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.537 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 2.1 ttt-85 178.79 154.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.06 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.3 mp -76.69 163.8 26.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.229 -0.919 . . . . 0.0 109.84 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.88 ' OG ' ' HB2' ' A' ' 217' ' ' ALA . 8.3 p -101.99 -168.69 1.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.076 -1.45 . . . . 0.0 110.485 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 236' ' ' GLN . 38.9 tp60 -84.25 -14.1 50.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.839 . . . . 0.0 111.313 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.823 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.1 OUTLIER -84.46 -44.02 14.05 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.451 -1.406 . . . . 0.0 107.882 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.816 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 0.7 OUTLIER -67.63 -40.63 84.62 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.06 -35.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.07 -47.65 70.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.501 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.12 -54.53 36.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.031 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.4 tp -62.01 -46.08 97.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 120.929 -1.336 . . . . 0.0 109.792 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.529 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -53.37 -31.38 44.4 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 4.0 t -77.56 -20.02 54.76 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.921 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.4 OUTLIER -70.03 -61.25 1.85 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.743 ' HB3' HD13 ' A' ' 130' ' ' LEU . 23.4 m-85 . . . . . 0 N--CA 1.49 1.574 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.442 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.994 0.426 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.632 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 26.7 m95 -94.95 177.18 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 109.909 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -139.66 -31.46 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -50.7 -172.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.022 -1.049 . . . . 0.0 110.401 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.885 ' HA ' HD22 ' A' ' 130' ' ' LEU . 9.6 p -123.55 -0.67 8.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.559 -0.713 . . . . 0.0 109.211 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.574 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 81.7 m-70 -136.94 91.01 2.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.188 -0.945 . . . . 0.0 110.002 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.844 ' N ' HD22 ' A' ' 97' ' ' LEU . 2.5 mm? -88.55 164.47 15.39 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.586 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.609 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.5 OUTLIER -142.51 155.84 45.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 1.008 ' CE2' HD11 ' A' ' 101' ' ' ILE . 5.6 p90 -137.23 163.48 30.81 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.655 -1.278 . . . . 0.0 109.276 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.738 ' HD2' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -123.27 126.2 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.2 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.008 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -81.93 77.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.95 -1.094 . . . . 0.0 109.835 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.738 HG22 ' HD2' ' A' ' 100' ' ' ARG . 9.3 t -89.39 4.62 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.309 -0.869 . . . . 0.0 109.714 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.869 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -101.35 155.11 18.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.671 -1.268 . . . . 0.0 109.393 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.627 ' N ' HG21 ' A' ' 113' ' ' VAL . 9.1 t80 177.85 76.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.622 0.725 . . . . 0.0 109.224 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.81 HG21 ' CD1' ' A' ' 186' ' ' TRP . 2.6 p -75.61 161.98 74.17 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.184 -0.947 . . . . 0.0 108.957 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.56 -21.45 39.78 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.921 1.485 . . . . 0.0 108.573 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.544 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -71.09 -7.38 46.15 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.059 HD21 ' HA ' ' A' ' 187' ' ' THR . 84.3 mt -148.13 123.3 5.11 Favored Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.7 167.83 14.6 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.862 1.454 . . . . 0.0 108.828 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.3 -64.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.818 0.818 . . . . 0.0 110.361 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 115' ' ' SER . 7.6 t0 -56.17 -26.63 51.36 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.675 -0.641 . . . . 0.0 111.736 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.806 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -74.06 -61.15 1.95 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.474 -1.391 . . . . 0.0 109.442 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.92 ' O ' HG23 ' A' ' 117' ' ' VAL . 7.6 p -53.14 -40.09 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.782 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -66.25 -27.14 67.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.906 ' OG ' HD21 ' A' ' 195' ' ' LEU . 7.5 p -62.01 -43.47 98.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.068 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -71.28 -34.01 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.997 -1.064 . . . . 0.0 109.41 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.9 t -71.93 -23.27 21.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 -34.89 14.36 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 1.7 tppt? -75.59 -40.77 56.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -64.89 -60.67 2.81 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.007 HD22 ' CZ ' ' A' ' 99' ' ' TYR . 8.5 tp -44.73 -50.85 9.81 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.546 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.8 OUTLIER -73.25 -34.23 65.72 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.464 -177.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.016 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -54.04 -42.23 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.01 ' O ' HG23 ' A' ' 128' ' ' THR . 42.7 m95 -91.74 -23.13 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.445 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.59 ' HA ' ' CE1' ' A' ' 132' ' ' PHE . 2.5 tm-20 -70.3 -27.3 64.28 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -90.38 -43.22 10.46 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.712 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.016 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.3 m -58.17 -25.7 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.819 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.01 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.7 152.37 45.44 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.955 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.47 2.01 6.2 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.878 1.719 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.032 HD12 ' CG ' ' A' ' 246' ' ' TYR . 20.5 mt -84.2 -178.06 6.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.451 ' C ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -124.25 167.37 14.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.148 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.764 ' HB3' HD11 ' A' ' 121' ' ' LEU . 20.0 m-85 -135.96 170.47 15.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.566 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.27 175.04 12.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 108.7 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -142.43 156.91 45.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.95 -1.094 . . . . 0.0 110.075 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.958 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.8 OUTLIER -146.77 -134.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 178.46 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.862 -1.148 . . . . 0.0 109.347 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' OE2' ' HB2' ' A' ' 135' ' ' LEU . 7.8 pm0 -158.4 -177.82 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.873 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.03 -97.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 137' ' ' GLU . 2.2 pt-20 178.8 107.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.958 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -59.59 -151.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 108.95 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.843 ' O ' HD13 ' A' ' 142' ' ' ILE . 31.3 m-20 -89.87 -30.71 17.72 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.076 HD11 HD21 ' A' ' 207' ' ' LEU . 20.3 mm -127.18 82.13 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.521 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.64 96.75 0.18 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 108.813 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.869 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.9 mm -81.31 117.17 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.64 150.65 49.69 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.249 -1.532 . . . . 0.0 111.867 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.572 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 17.1 p90 -81.68 141.28 33.76 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.485 -0.759 . . . . 0.0 109.117 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.581 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -166.1 -179.04 4.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.886 -1.134 . . . . 0.0 110.675 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.961 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.7 p -165.36 -148.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 109.247 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.839 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.004 0 O-C-N 121.645 -0.659 . . . . 0.0 110.339 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 C--O 1.215 -0.634 0 N-CA-C 109.969 -0.82 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.996 ' CE1' HG12 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -111.04 -170.59 1.66 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.205 -0.934 . . . . 0.0 110.44 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 160' ' ' PRO . 58.7 p30 -179.79 54.8 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.698 -0.626 . . . . 0.0 110.062 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 15.23 -79.89 0.0 OUTLIER Glycine 0 N--CA 1.507 3.385 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.584 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.7 Cg_endo -63.71 65.24 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.679 1.357 . . . . 0.0 110.118 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.1 135.63 3.81 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 1.075 ' O ' HD12 ' A' ' 164' ' ' LEU . 82.6 m-20 -39.44 -36.97 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 109.975 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.996 HG12 ' CE1' ' A' ' 157' ' ' PHE . 2.6 t -54.73 87.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 109.168 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.075 HD12 ' O ' ' A' ' 162' ' ' ASN . 1.4 mp -83.65 -48.94 9.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.11 -0.994 . . . . 0.0 112.76 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.63 ' HB1' ' OE2' ' A' ' 202' ' ' GLU . . . -159.0 -173.14 4.09 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.096 -1.627 . . . . 0.0 111.261 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.729 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 178.24 -175.46 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.772 -1.83 . . . . 0.0 111.552 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.45 -177.82 6.6 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.601 ' CD2' ' HB2' ' A' ' 177' ' ' ASP . 22.3 m-30 -116.73 -169.59 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.756 -1.215 . . . . 0.0 111.708 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.988 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -116.91 -165.87 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.988 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.5 Cg_endo -74.05 129.76 13.59 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.073 1.039 . . . . 0.0 111.039 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . -175.19 -169.88 37.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.99 98.26 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.696 1.366 . . . . 0.0 109.772 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 83.27 -49.1 4.17 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.2 tt -71.46 6.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.557 -0.966 . . . . 0.0 109.225 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.601 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 2.4 t-20 -64.55 62.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.79 . . . . 0.0 108.876 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' A' ' 142' ' ' ILE . . . 104.84 104.19 2.91 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.8 m-20 -159.04 120.5 3.37 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.881 -1.364 . . . . 0.0 107.682 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.99 172.12 7.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.625 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -162.65 137.67 6.8 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.237 1.018 . . . . 0.0 110.401 178.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.622 ' CE1' HG23 ' A' ' 198' ' ' VAL . 61.6 m-85 -100.49 136.75 39.88 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.746 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.961 ' OD1' HG23 ' A' ' 148' ' ' VAL . 28.3 t0 -58.32 151.9 18.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.799 -1.188 . . . . 0.0 108.763 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.51 ' OD2' ' CD1' ' A' ' 146' ' ' PHE . 1.2 m-20 -115.73 4.05 13.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.158 -0.964 . . . . 0.0 110.194 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.628 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 17.4 m-20 -112.13 26.51 10.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.095 -1.003 . . . . 0.0 109.927 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.479 ' OE2' ' HG ' ' A' ' 164' ' ' LEU . 5.5 mt-10 -129.42 -94.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 108.702 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CD2' ' A' ' 186' ' ' TRP . 1.1 mt-30 179.05 169.56 0.94 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.81 ' CD1' HG21 ' A' ' 105' ' ' THR . 65.4 m95 -159.15 131.98 6.94 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.04 -1.038 . . . . 0.0 109.539 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . 1.059 ' HA ' HD21 ' A' ' 108' ' ' LEU . 68.1 p -157.68 149.86 22.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.984 -1.072 . . . . 0.0 110.067 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.829 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -80.19 -31.86 38.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.4 t70 -85.27 61.26 6.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.992 ' HB ' HD21 ' A' ' 229' ' ' LEU . 5.9 t 3.71 60.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 CA-C-O 121.958 0.885 . . . . 0.0 111.878 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.7 m -123.55 -32.0 3.42 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.32 -0.863 . . . . 0.0 109.392 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.407 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -91.03 -74.06 1.28 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.794 HG21 HD23 ' A' ' 164' ' ' LEU . 48.1 m -135.02 -79.74 0.44 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.737 ' ND2' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER 179.9 68.68 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.296 1.046 . . . . 0.0 108.861 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.068 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 2.2 tp -30.06 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.082 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 1.0 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.58 -6.73 5.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.81 -177.108 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 1.01 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.1 tp -67.7 -62.43 1.42 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.265 -1.774 . . . . 0.0 107.127 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.777 HG21 ' CZ3' ' A' ' 186' ' ' TRP . 3.0 m -68.29 -15.4 19.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.005 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -71.45 -61.97 1.58 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.697 -1.201 . . . . 0.0 107.938 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.718 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -63.66 -15.8 59.31 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 120.266 -1.521 . . . . 0.0 106.946 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.41 ' CE1' ' O ' ' A' ' 219' ' ' MET . 7.5 t60 -68.19 -48.62 64.77 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.025 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.659 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 13.6 mt-10 -81.26 -45.39 16.32 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.179 -0.951 . . . . 0.0 111.098 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.1 mt -62.07 -31.31 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.687 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.8 -30.77 57.31 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -61.79 -51.01 70.04 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.87 -0.782 . . . . 0.0 110.746 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.627 ' CB ' HD12 ' A' ' 142' ' ' ILE . 72.8 m -82.89 -54.93 4.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.362 -0.836 . . . . 0.0 112.174 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 1.076 HD21 HD11 ' A' ' 142' ' ' ILE . 7.0 mt -104.25 23.71 12.67 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.019 -1.051 . . . . 0.0 110.828 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.971 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -125.11 -79.16 0.36 Allowed Glycine 0 C--N 1.291 -1.938 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.837 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.944 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -169.02 -160.35 0.27 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.857 -1.378 . . . . 0.0 110.02 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.795 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.7 t80 -97.77 -70.0 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.758 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.59 90.81 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.631 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.4 m -79.93 176.6 9.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 0.0 109.323 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.84 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.57 81.37 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.961 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.45 9.34 13.62 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.061 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.32 -28.33 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 175.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.526 ' C ' ' HB2' ' A' ' 235' ' ' SER . 0.7 OUTLIER -114.79 -36.19 4.58 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.961 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.34 -165.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.159 0.98 . . . . 0.0 112.227 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.01 HD11 ' HA ' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -102.8 -10.76 18.84 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.548 -177.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.744 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -81.32 -8.07 59.68 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.064 -1.647 . . . . 0.0 111.636 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.664 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -139.82 16.06 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 120.462 -1.399 . . . . 0.0 113.221 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.898 ' HB3' HD11 ' A' ' 226' ' ' LEU . 50.3 Cg_endo -73.98 -36.37 3.53 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.189 -1.504 . . . . 0.0 108.189 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 1.069 ' CD1' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -5.0 -73.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.168 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.672 ' N ' HD23 ' A' ' 222' ' ' LEU . 1.9 m-85 -67.52 60.06 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -169.79 -144.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.239 -0.913 . . . . 0.0 109.536 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.402 ' C ' HD23 ' A' ' 226' ' ' LEU . 72.7 m -148.61 104.51 3.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.095 -1.003 . . . . 0.0 109.969 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.53 49.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 108.978 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.572 HG21 ' HA ' ' A' ' 194' ' ' ASN . 11.3 t -99.25 -12.08 20.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.704 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER 177.5 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.04 -1.038 . . . . 0.0 111.244 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.992 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -33.17 -100.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.426 -0.796 . . . . 0.0 111.241 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.6 -16.28 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.637 -1.29 . . . . 0.0 109.746 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -106.33 -22.02 12.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.164 -0.96 . . . . 0.0 108.549 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.642 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.3 p90 -24.24 116.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.362 0.601 . . . . 0.0 111.388 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.76 171.61 0.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.999 HD21 ' CH2' ' A' ' 124' ' ' TRP . 5.2 mp -87.61 172.14 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 111.089 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.719 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 14.5 t -104.98 -170.14 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.785 0.803 . . . . 0.0 109.985 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.548 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -82.72 -16.38 48.27 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.66 -0.65 . . . . 0.0 109.711 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.84 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.0 OUTLIER -82.19 -50.6 8.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.102 -0.999 . . . . 0.0 108.34 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.944 ' OD1' HD21 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.86 -38.38 90.87 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 117.053 -1.859 . . . . 0.0 106.915 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 235' ' ' SER . 1.0 OUTLIER -57.76 -34.82 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.57 -52.04 43.45 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.361 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -55.75 -54.46 34.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.005 HG21 HG21 ' A' ' 127' ' ' VAL . 1.5 tp -64.3 -44.71 97.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 120.897 -1.355 . . . . 0.0 109.716 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.54 ' N ' HG23 ' A' ' 242' ' ' ILE . 5.2 tt0 -54.61 -28.42 46.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 42.5 t -80.16 -20.04 45.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.688 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.5 OUTLIER -70.4 -66.61 0.58 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 1.032 ' CG ' HD12 ' A' ' 130' ' ' LEU . 16.5 m-85 . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.673 ' N ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.634 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 49.5 m95 -100.62 177.45 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.116 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -138.56 -36.33 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.585 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -46.66 177.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.191 -0.943 . . . . 0.0 110.132 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.812 ' CB ' HD12 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -116.59 1.65 12.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.405 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.545 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 7.0 m-70 -132.74 92.82 3.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.719 HD13 ' OD2' ' A' ' 141' ' ' ASP . 2.5 mm? -94.72 173.62 7.51 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.628 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -149.61 155.98 41.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 1.05 ' CE2' HD11 ' A' ' 101' ' ' ILE . 6.1 p90 -135.52 165.65 25.02 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.483 -1.386 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.752 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -124.65 122.78 38.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.05 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -82.38 84.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 109.802 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.752 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -102.08 8.47 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 0.0 110.097 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.918 ' C ' HG21 ' A' ' 113' ' ' VAL . 7.4 m120 -98.65 159.19 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.959 -1.088 . . . . 0.0 109.155 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.805 ' N ' HG21 ' A' ' 113' ' ' VAL . 6.0 t80 177.56 80.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.674 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.967 HG21 ' CD1' ' A' ' 186' ' ' TRP . 33.0 p -73.72 159.34 84.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.65 -22.2 38.08 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 123.774 1.407 . . . . 0.0 108.651 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.512 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -79.53 0.75 28.46 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.949 ' CD1' HD13 ' A' ' 195' ' ' LEU . 95.9 mt -148.33 118.44 4.22 Favored Pre-proline 0 N--CA 1.485 1.297 0 O-C-N 121.423 -0.798 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.09 174.25 6.16 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.885 1.466 . . . . 0.0 109.139 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.16 -66.06 0.32 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.783 0.802 . . . . 0.0 110.164 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 115' ' ' SER . 2.2 m-20 -56.39 -28.47 59.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.822 -0.548 . . . . 0.0 112.358 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.833 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.25 -61.15 1.9 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.317 -1.489 . . . . 0.0 109.468 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.918 HG21 ' C ' ' A' ' 103' ' ' ASN . 8.4 p -56.08 -44.06 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 1.035 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -60.89 -28.22 68.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -58.83 -63.83 1.15 Allowed 'General case' 0 C--O 1.194 -1.822 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.07 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -49.28 -32.52 11.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 144' ' ' ILE . 12.1 t -73.82 -24.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -90.65 -33.65 15.74 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.75 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -82.34 -37.04 26.28 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.46 -62.16 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.848 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -53.41 -42.04 66.61 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.766 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -70.9 -34.2 71.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.131 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.901 HG13 HD22 ' A' ' 234' ' ' LEU . 1.7 t -57.34 -36.88 54.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.049 ' O ' HG23 ' A' ' 128' ' ' THR . 46.9 m95 -92.23 -24.25 19.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.929 -1.109 . . . . 0.0 110.667 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -73.11 -27.37 61.66 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.927 -1.108 . . . . 0.0 108.308 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -92.42 -42.82 9.54 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.994 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.994 HG21 HG21 ' A' ' 242' ' ' ILE . 22.7 m -62.26 -23.4 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.255 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.049 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.05 163.31 18.35 Favored Pre-proline 0 N--CA 1.495 1.783 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.403 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.491 ' C ' HD22 ' A' ' 130' ' ' LEU . 48.6 Cg_endo -81.52 22.05 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.034 1.823 . . . . 0.0 111.51 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.812 HD12 ' CB ' ' A' ' 95' ' ' THR . 2.6 mm? -115.86 178.1 4.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.653 -1.279 . . . . 0.0 110.347 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.547 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.9 p -121.01 177.81 4.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' A' ' 97' ' ' LEU . 11.2 m-85 -146.96 146.03 29.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.765 . . . . 0.0 110.053 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.604 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 68.0 m -114.59 -170.55 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -149.82 165.45 32.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.612 -1.305 . . . . 0.0 110.992 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -163.15 -164.54 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 78.8 t80 -160.61 25.66 0.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' GLU . 8.7 pm0 -147.11 176.76 9.7 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.78 -97.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' GLU . 18.3 tt0 178.73 145.51 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -1.143 . . . . 0.0 110.45 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.628 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -101.09 -150.75 0.4 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.719 ' OD2' HD13 ' A' ' 97' ' ' LEU . 18.2 m-20 -90.55 -34.02 15.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.974 HD11 ' CG ' ' A' ' 207' ' ' LEU . 20.1 mm -124.04 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.528 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 5.9 ttp -66.11 97.87 0.41 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 109.195 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 1.014 HG13 HG13 ' A' ' 117' ' ' VAL . 5.8 mm -81.87 114.63 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -136.3 155.57 49.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.434 -1.416 . . . . 0.0 112.371 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.622 ' CA ' ' ND2' ' A' ' 103' ' ' ASN . 6.1 p90 -92.89 138.04 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.688 . . . . 0.0 109.265 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.081 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -167.57 -158.65 0.28 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.29 -0.881 . . . . 0.0 110.47 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.649 HG13 ' N ' ' A' ' 149' ' ' ARG . 0.6 OUTLIER -173.38 -165.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.05 -1.031 . . . . 0.0 109.159 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.649 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 0.0 109.759 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 C--O 1.214 -0.7 0 N-CA-C 109.943 -0.829 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.854 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -80.83 -166.15 1.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.099 -1.001 . . . . 0.0 110.134 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.55 ' O ' ' C ' ' A' ' 159' ' ' GLY . 24.7 p30 179.64 60.2 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.667 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -29.3 -51.31 0.13 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.829 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 39.6 Cg_endo -66.54 60.04 0.52 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 109.301 -1.076 . . . . 0.0 109.301 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -179.27 159.96 25.07 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 164' ' ' LEU . 73.7 m-20 -52.74 -38.41 60.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.127 . . . . 0.0 110.223 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 163' ' ' VAL . 42.8 t -53.3 81.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.341 -0.849 . . . . 0.0 110.545 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.719 HD12 HD12 ' A' ' 222' ' ' LEU . 15.9 mt -68.63 -74.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.341 -0.849 . . . . 0.0 111.85 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.974 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -135.41 -176.26 4.21 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.491 -1.381 . . . . 0.0 111.614 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.854 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 0.3 OUTLIER 178.98 168.55 0.94 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.564 -1.335 . . . . 0.0 110.107 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -132.92 -168.08 2.02 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.532 ' HB3' HG13 ' A' ' 174' ' ' ILE . 77.5 m-85 -114.4 -167.27 1.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.8 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.074 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -126.15 -175.62 0.43 Allowed Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 1.074 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 38.8 Cg_endo -68.9 140.19 45.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.537 1.283 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.437 ' C ' ' OD1' ' A' ' 175' ' ' ASN . . . 171.76 -125.49 1.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.499 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.0 Cg_endo -73.98 -93.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.812 1.427 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -108.37 -18.34 9.8 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.4 OUTLIER -73.3 12.17 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -1.064 . . . . 0.0 108.951 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 175' ' ' ASN . 0.6 OUTLIER -64.34 63.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.607 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 106.35 101.55 2.73 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.635 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.6 m-20 -163.16 120.11 1.86 Allowed 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.566 -1.549 . . . . 0.0 107.659 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.736 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -112.07 164.85 12.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.894 -1.129 . . . . 0.0 109.184 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.081 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -162.15 134.75 5.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.867 -1.133 . . . . 0.0 109.778 178.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.666 ' H ' HD22 ' A' ' 103' ' ' ASN . 34.4 m-85 -95.48 132.67 40.32 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.519 ' HB3' ' CD1' ' A' ' 157' ' ' PHE . 24.5 p30 -66.72 130.19 42.37 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 182' ' ' ASP . 48.1 p30 -96.09 22.73 7.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.976 -1.077 . . . . 0.0 110.437 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.667 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.4 OUTLIER -90.75 -19.61 23.32 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.907 -1.121 . . . . 0.0 109.889 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.496 ' OE2' ' O ' ' A' ' 159' ' ' GLY . 0.9 OUTLIER -112.11 -130.78 0.31 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.896 -1.127 . . . . 0.0 108.595 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 35.3 mt-30 -130.97 -175.46 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.161 . . . . 0.0 109.097 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.967 ' CD1' HG21 ' A' ' 105' ' ' THR . 86.0 m95 -160.83 126.03 3.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 108.954 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.792 ' HA ' HD21 ' A' ' 108' ' ' LEU . 50.7 p -145.66 150.07 35.64 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.828 -1.17 . . . . 0.0 110.453 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 1.046 ' O ' HG23 ' A' ' 227' ' ' THR . 2.7 pttm -84.45 -33.18 23.71 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 27.9 t70 -82.31 63.72 6.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . 1.05 ' HB ' HD21 ' A' ' 229' ' ' LEU . 1.7 t 2.82 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 122.311 1.053 . . . . 0.0 112.016 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.0 m -127.31 -31.05 2.58 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.783 -1.198 . . . . 0.0 109.927 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.627 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -96.98 -80.41 1.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.761 HG22 ' OD1' ' A' ' 194' ' ' ASN . 37.5 m -125.12 -96.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.781 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -161.77 67.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.025 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 14.7 tp -37.97 -98.91 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.757 -0.589 . . . . 0.0 110.93 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.829 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.7 OUTLIER -58.73 -11.53 3.26 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.722 -1.236 . . . . 0.0 110.461 -178.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 1.084 ' O ' HD11 ' A' ' 218' ' ' LEU . 6.2 tp -64.92 -71.29 0.19 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 116.807 -1.957 . . . . 0.0 106.595 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.974 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 3.3 t -67.55 -4.57 3.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.433 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.07 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.21 -57.94 3.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.773 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.55 -16.91 64.51 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.558 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 3.0 t60 -69.5 -37.44 77.19 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.069 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.924 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 2.8 mt-10 -87.65 -48.65 7.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 120' ' ' ALA . 1.9 mt -59.16 -31.55 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.709 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -82.21 -34.4 23.63 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -56.31 -45.81 80.1 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.524 -0.986 . . . . 0.0 110.374 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 167' ' ' ALA . 1.0 OUTLIER -89.56 -54.1 4.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 111.582 -178.164 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.974 ' CG ' HD11 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -104.16 36.31 2.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.198 -0.939 . . . . 0.0 110.753 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.993 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -141.89 -78.14 0.05 OUTLIER Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.047 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.876 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.2 -160.35 0.26 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.89 -1.359 . . . . 0.0 110.27 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.876 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.3 OUTLIER -102.54 -77.72 0.55 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.473 -0.767 . . . . 0.0 109.36 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.592 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.6 m-70 -159.44 121.75 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.453 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.622 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -109.56 -168.37 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.716 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.38 74.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.97 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -79.71 7.36 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.289 -176.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.449 ' C ' ' O ' ' A' ' 214' ' ' ASN . 2.7 p -50.47 -27.66 6.92 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.498 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.9 mp0 -114.84 -34.72 5.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.97 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -159.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.296 1.046 . . . . 0.0 112.247 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.13 HD13 ' O ' ' A' ' 218' ' ' LEU . 3.3 tm? -96.7 -19.96 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.38 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.592 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -78.99 -8.49 58.97 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.249 -1.532 . . . . 0.0 112.319 -177.117 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.687 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 41.0 t80 -132.42 14.49 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 120.412 -1.43 . . . . 0.0 113.312 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -76.97 -37.97 0.96 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 N-CA-C 109.157 -1.132 . . . . 0.0 109.157 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 1.013 HD23 ' N ' ' A' ' 223' ' ' TYR . 1.4 tt -19.48 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.526 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 1.013 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.2 OUTLIER -67.69 59.88 0.06 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.303 -0.873 . . . . 0.0 109.004 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' LEU . 9.2 t-160 179.89 -133.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.072 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.976 ' HB3' HG21 ' A' ' 190' ' ' THR . 49.8 m -160.57 114.92 2.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 109.929 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.935 HD12 ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER 179.51 57.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . 1.046 HG23 ' O ' ' A' ' 188' ' ' LYS . 4.8 t -113.92 -8.61 13.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.873 . . . . 0.0 109.516 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.591 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 1.0 OUTLIER 178.06 -21.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.742 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 1.05 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.2 OUTLIER -37.03 -60.59 0.62 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.15 -0.969 . . . . 0.0 110.127 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.524 HG23 ' HG3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 179.22 -31.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.833 HH11 HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -89.33 -21.84 22.93 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 45.4 p90 -38.25 116.44 0.53 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.501 0.667 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.597 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.4 ttt180 179.3 152.86 0.41 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 109.126 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.98 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.0 mp -68.69 167.47 15.18 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.082 -1.011 . . . . 0.0 110.044 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.806 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 10.2 t -101.04 -169.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.575 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -83.92 -23.08 31.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.924 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.716 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 4.6 m-20 -81.32 -40.06 24.2 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.847 -1.141 . . . . 0.0 107.934 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.844 ' OD1' HD21 ' A' ' 209' ' ' LEU . 17.2 t0 -70.46 -35.49 73.35 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 117.828 -1.549 . . . . 0.0 107.766 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.649 HD13 ' O ' ' A' ' 235' ' ' SER . 0.8 OUTLIER -61.25 -34.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 237' ' ' ASP . 21.6 t-20 -66.69 -45.33 79.16 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.29 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.68 -58.93 11.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.994 HG21 HG21 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -61.69 -44.68 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.742 -1.446 . . . . 0.0 109.623 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.462 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.6 tt0 -54.76 -24.96 24.81 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -87.0 -14.59 41.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.811 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.4 OUTLIER -74.9 -56.34 4.85 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.745 ' CG ' HD23 ' A' ' 130' ' ' LEU . 16.4 m-85 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.215 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.507 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.751 ' CD1' HD11 ' A' ' 207' ' ' LEU . 7.0 m95 -98.67 -165.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.86 -1.15 . . . . 0.0 109.606 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.9 ppt_? -145.24 -40.61 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.984 -1.073 . . . . 0.0 110.582 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.729 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -45.26 174.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.085 -1.009 . . . . 0.0 110.377 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.559 ' HA ' ' CG ' ' A' ' 130' ' ' LEU . 11.6 p -112.15 2.66 16.81 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.547 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 17.8 m-70 -144.09 98.18 3.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.949 -1.094 . . . . 0.0 109.863 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.845 HD23 HD23 ' A' ' 130' ' ' LEU . 2.5 mm? -95.11 168.08 10.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.508 -0.745 . . . . 0.0 109.9 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.612 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -142.37 156.42 45.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.978 ' CE2' HD11 ' A' ' 101' ' ' ILE . 7.9 p90 -135.98 165.53 25.46 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.668 -1.27 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.406 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -125.17 121.94 35.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.889 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.978 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.2 mp -77.7 84.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.933 -1.104 . . . . 0.0 109.29 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.666 ' N ' ' O ' ' A' ' 144' ' ' ILE . 1.4 t -96.66 8.81 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 110.552 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.683 ' HB2' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -111.78 169.22 8.98 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.308 -1.495 . . . . 0.0 109.41 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.47 ' O ' ' C ' ' A' ' 105' ' ' THR . 4.3 p90 178.77 44.72 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.651 -0.656 . . . . 0.0 109.531 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 104' ' ' TYR . 70.5 p -41.26 153.79 0.24 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.474 -0.766 . . . . 0.0 109.048 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.03 -23.96 45.82 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 123.829 1.436 . . . . 0.0 108.766 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.627 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -69.19 -9.94 55.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.981 HD13 ' CD1' ' A' ' 195' ' ' LEU . 85.7 mt -144.42 115.83 5.4 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.8 Cg_endo -64.09 167.69 13.8 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 123.81 1.426 . . . . 0.0 109.295 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -35.49 -64.6 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.8 0.809 . . . . 0.0 110.477 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -59.76 -19.32 49.54 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.685 -0.635 . . . . 0.0 111.777 -178.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -80.36 -62.74 1.59 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.312 -1.493 . . . . 0.0 109.021 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.956 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.6 p -49.41 -40.5 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.835 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -67.19 -27.52 67.33 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.835 ' OG ' HD21 ' A' ' 195' ' ' LEU . 21.6 p -64.42 -42.5 96.0 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.05 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -71.42 -33.33 69.33 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.4 t -73.73 -25.18 20.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.589 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 2.0 tt0 -84.66 -36.67 21.77 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.744 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.854 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -78.83 -38.94 36.83 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.823 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -62.93 -61.48 2.37 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.853 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.0 OUTLIER -50.26 -40.15 47.13 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.988 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.629 ' N ' HD12 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -77.51 -33.45 54.34 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.37 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.01 ' O ' HG13 ' A' ' 127' ' ' VAL . 3.8 t -52.49 -44.5 44.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.014 ' CH2' HD21 ' A' ' 234' ' ' LEU . 33.4 m95 -92.2 -23.14 19.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 26.8 tt0 -69.67 -26.74 64.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.3 pt-20 -90.96 -42.99 10.25 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.648 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.01 HG13 ' O ' ' A' ' 123' ' ' VAL . 14.5 m -59.57 -23.78 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.274 -1.37 . . . . 0.0 108.988 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -116.89 163.42 22.84 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.519 -1.272 . . . . 0.0 109.289 179.235 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -77.58 -8.47 17.09 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.336 1.703 . . . . 0.0 109.883 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.845 HD23 HD23 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -70.19 179.55 2.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 110.536 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.467 ' OG1' ' ND1' ' A' ' 96' ' ' HIS . 6.7 p -127.3 174.38 9.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 1.1 m-85 -145.44 161.89 38.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.586 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -143.38 -174.36 4.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -152.04 155.6 38.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.901 -1.124 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.97 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.8 OUTLIER -147.41 -135.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.417 -0.802 . . . . 0.0 108.912 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 45.3 t80 178.94 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.793 -1.192 . . . . 0.0 109.23 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 139' ' ' GLU . 1.8 pm0 -158.57 -176.65 6.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.779 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.49 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -1.103 . . . . 0.0 110.184 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.97 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -60.15 -151.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 108.722 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -91.65 -25.82 18.96 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.984 HD11 ' HB2' ' A' ' 206' ' ' SER . 17.7 mm -127.81 86.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.597 ' HG3' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -67.15 97.17 0.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 102' ' ' VAL . 0.7 OUTLIER -82.37 116.19 26.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -134.49 153.18 52.06 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 119.944 -1.722 . . . . 0.0 112.388 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 147' ' ' ALA . 1.6 t80 -90.7 135.71 33.53 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.714 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.57 -152.65 0.11 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.725 -1.234 . . . . 0.0 111.17 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 149' ' ' ARG . 2.1 p -178.3 -169.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.744 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.684 -0.635 . . . . 0.0 111.118 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 149' ' ' ARG . 42.0 Cg_endo . . . . . 0 C--O 1.215 -0.632 0 N-CA-C 109.13 -1.142 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.645 ' CE1' ' CG1' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.5 -140.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.67 ' CB ' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -134.75 -23.54 1.58 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.496 -1.377 . . . . 0.0 111.312 -178.153 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 41.52 -96.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 158' ' ' ASP . 34.3 Cg_endo -59.68 76.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.265 1.14 . . . . 0.0 110.052 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 175.98 -167.31 38.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 163' ' ' VAL . 58.3 m-80 -87.25 -27.75 22.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -1.192 . . . . 0.0 109.964 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.67 HG21 ' CB ' ' A' ' 158' ' ' ASP . 16.9 t -35.79 140.58 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.426 0.631 . . . . 0.0 110.862 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.046 HD11 HG21 ' A' ' 193' ' ' THR . 0.4 OUTLIER -105.17 -90.81 0.4 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.465 -0.772 . . . . 0.0 112.31 -179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.859 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -147.27 -168.89 3.17 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.113 -1.617 . . . . 0.0 111.541 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.641 ' CD2' ' CE2' ' A' ' 157' ' ' PHE . 0.5 OUTLIER 179.95 171.98 1.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 119.682 -1.886 . . . . 0.0 111.024 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 202' ' ' GLU . . . -147.55 -164.54 2.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.399 -0.813 . . . . 0.0 109.99 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.646 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -131.9 -163.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.883 -1.136 . . . . 0.0 110.643 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.001 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -163.98 -62.84 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.093 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 1.001 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.8 Cg_endo -77.09 158.95 33.98 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.779 1.41 . . . . 0.0 109.966 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.474 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . 115.32 173.69 17.71 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -76.55 -89.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.683 1.589 . . . . 0.0 110.138 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -78.13 -35.44 34.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.646 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.5 tp -68.96 -0.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.925 . . . . 0.0 108.967 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 172' ' ' PRO . 2.6 t30 -65.82 64.22 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 119.81 90.63 1.25 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.612 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -158.07 127.01 5.64 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.839 -1.389 . . . . 0.0 108.159 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.675 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -115.88 168.16 10.3 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.117 -0.99 . . . . 0.0 108.714 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.714 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.97 134.39 4.28 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.205 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.587 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 53.1 m-85 -90.08 127.99 36.2 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.24 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 1.0 OUTLIER -76.62 144.78 39.31 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.949 -1.094 . . . . 0.0 109.205 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 183' ' ' ASP . 27.3 t0 -62.44 -2.16 0.98 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.21 -0.931 . . . . 0.0 110.381 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.2 p30 3.9 -95.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 183' ' ' ASP . 7.5 mp0 -147.59 -51.15 0.19 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.873 -1.142 . . . . 0.0 110.509 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -140.79 172.0 13.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 0.0 110.926 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.976 ' CH2' HD12 ' A' ' 164' ' ' LEU . 85.8 m95 -160.58 129.77 4.9 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.696 ' HA ' HD21 ' A' ' 108' ' ' LEU . 33.4 p -146.88 155.93 42.7 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.555 -1.341 . . . . 0.0 110.428 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.596 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 3.2 pttt -78.02 -33.11 51.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.545 ' O ' ' CG2' ' A' ' 227' ' ' THR . 2.9 t0 -90.48 -143.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.917 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.4 t -115.37 45.64 1.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.851 -1.155 . . . . 0.0 108.264 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 187' ' ' THR . 53.7 m -102.69 -30.3 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.326 -0.859 . . . . 0.0 111.084 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.553 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -108.52 -90.59 2.12 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.363 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.046 HG21 HD11 ' A' ' 164' ' ' LEU . 89.6 m -120.68 -80.21 0.62 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.791 ' OD1' HG22 ' A' ' 193' ' ' THR . 3.2 p30 178.15 66.79 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.582 1.182 . . . . 0.0 108.435 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.004 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 1.2 tp -20.03 -95.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.952 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.911 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -62.06 -15.01 41.75 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.055 -1.028 . . . . 0.0 110.883 -176.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.873 HD11 ' CG ' ' A' ' 221' ' ' PRO . 13.3 tp -60.75 -57.46 12.58 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.251 -1.78 . . . . 0.0 107.199 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' A' ' 165' ' ' ALA . 2.4 t -74.72 -9.25 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.749 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.05 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.24 -57.85 3.57 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.35 -1.34 . . . . 0.0 107.503 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.705 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -64.03 -17.91 63.81 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.741 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 5.9 t-80 -69.39 -40.95 77.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.17 -1.812 . . . . 0.0 107.849 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.69 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 3.5 mt-10 -82.89 -49.12 9.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.954 -1.091 . . . . 0.0 110.79 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.853 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.2 mt -60.59 -31.47 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.734 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.79 -34.09 49.46 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.24 -53.15 61.34 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.61 -0.935 . . . . 0.0 109.773 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.984 ' HB2' HD11 ' A' ' 142' ' ' ILE . 2.6 m -77.81 -64.19 1.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.583 -0.698 . . . . 0.0 111.671 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.845 ' N ' HD22 ' A' ' 207' ' ' LEU . 2.8 mm? -101.36 37.99 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -0.802 . . . . 0.0 110.614 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.974 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -135.83 -69.22 0.06 OUTLIER Glycine 0 C--N 1.289 -2.046 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.868 HD11 ' SD ' ' A' ' 219' ' ' MET . 4.5 pp 179.75 -161.86 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.933 0 O-C-N 120.633 -1.51 . . . . 0.0 109.387 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.798 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.3 t80 -102.11 -71.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.259 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 54.4 m80 -162.16 102.05 1.11 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.795 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.5 m -93.07 -174.68 3.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.782 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.95 78.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.955 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.43 9.3 13.69 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.422 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 214' ' ' ASN . 73.7 p -50.42 -27.72 6.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.519 ' C ' ' HB2' ' A' ' 235' ' ' SER . 8.3 mt-10 -113.75 -37.01 4.67 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.955 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -64.35 -171.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.45 1.119 . . . . 0.0 112.72 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.907 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -84.64 -18.9 33.95 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.937 -177.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.868 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 119.262 -2.149 . . . . 0.0 112.171 -177.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.671 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 35.3 t80 -134.99 15.63 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.257 -1.527 . . . . 0.0 113.39 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.873 ' CG ' HD11 ' A' ' 197' ' ' LEU . 55.8 Cg_endo -77.97 -41.17 0.32 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.58 ' C ' ' O ' ' A' ' 221' ' ' PRO . 18.9 tp -6.87 -74.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.506 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -65.45 63.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.492 -0.755 . . . . 0.0 109.779 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.82 -162.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.2 m -131.99 116.17 16.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.103 -0.998 . . . . 0.0 109.693 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' A' ' 231' ' ' ARG . 5.5 tp 179.49 31.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.627 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 6.6 t -77.61 -52.77 8.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.649 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 5.2 t0 -151.49 3.22 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.745 -1.222 . . . . 0.0 110.952 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.917 HD11 ' N ' ' A' ' 190' ' ' THR . 1.2 mm? -41.41 -101.04 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.906 -1.121 . . . . 0.0 110.912 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -18.22 3.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.701 -1.249 . . . . 0.0 109.85 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.732 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -105.48 -42.03 5.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 108.386 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.649 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 9.5 p90 0.36 117.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.05 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.014 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.5 mp -80.27 166.49 21.32 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.756 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 28.9 t -98.38 -171.84 2.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.354 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.5 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.08 -11.83 54.38 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.726 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.1 OUTLIER -85.34 -46.99 10.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.889 -1.132 . . . . 0.0 107.971 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.68 ' OD1' HD21 ' A' ' 209' ' ' LEU . 1.2 m-20 -66.87 -38.04 85.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 117.201 -1.8 . . . . 0.0 106.554 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -58.04 -34.55 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.242 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.519 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 1.3 t-20 -66.69 -49.23 66.76 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.88 -50.62 65.76 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.28 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.997 HG13 HG22 ' A' ' 128' ' ' THR . 1.9 tp -68.27 -48.44 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 120.741 -1.447 . . . . 0.0 110.665 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.57 ' N ' HG23 ' A' ' 242' ' ' ILE . 15.0 pt20 -54.77 -23.08 16.3 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.1 p -88.66 -17.07 30.8 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.635 ' HB3' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -74.22 -59.36 2.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.74 ' CE1' HD22 ' A' ' 130' ' ' LEU . 15.2 m-85 . . . . . 0 N--CA 1.493 1.688 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.502 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.567 ' HB2' HD21 ' A' ' 245' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.646 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 50.7 m95 -111.42 163.69 13.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.028 -1.045 . . . . 0.0 109.532 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -131.95 -28.01 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.537 -179.325 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 1.037 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -40.13 165.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.373 -0.829 . . . . 0.0 110.625 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.581 ' O ' ' CD2' ' A' ' 96' ' ' HIS . 2.1 p -107.63 5.21 26.67 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.462 -0.774 . . . . 0.0 109.185 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 1.071 ' CE1' HG21 ' A' ' 131' ' ' THR . 33.4 m-70 -150.72 103.49 3.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.453 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.95 HD13 ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -116.33 -165.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 109.91 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.585 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -161.43 162.35 30.55 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.74 ' CZ ' HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -137.9 160.78 38.38 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.875 -1.141 . . . . 0.0 109.181 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.837 ' NE ' HG22 ' A' ' 102' ' ' VAL . 1.2 ttp180 -123.09 126.63 47.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 109.807 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.803 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.5 mp -85.09 84.37 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.005 -1.059 . . . . 0.0 109.677 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.837 HG22 ' NE ' ' A' ' 100' ' ' ARG . 2.6 t -100.35 8.03 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.007 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.886 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -100.99 157.04 17.05 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.783 -1.198 . . . . 0.0 109.353 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.656 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.6 OUTLIER 177.99 75.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.537 HG21 ' CD1' ' A' ' 186' ' ' TRP . 11.5 p -70.6 159.5 84.85 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -68.14 -21.86 41.78 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.808 1.425 . . . . 0.0 108.686 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 1.5 t0 -70.28 -8.73 52.6 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.961 HD13 HD13 ' A' ' 195' ' ' LEU . 93.5 mt -147.07 124.14 5.76 Favored Pre-proline 0 N--CA 1.484 1.233 0 O-C-N 121.585 -0.697 . . . . 0.0 109.848 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.11 169.84 12.88 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 O-C-N 123.811 1.427 . . . . 0.0 109.007 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.08 -65.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.971 0.891 . . . . 0.0 110.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 115' ' ' SER . 1.6 p-10 -53.97 -32.32 53.58 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.743 -0.598 . . . . 0.0 112.033 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.908 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.91 -61.4 1.78 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.533 -1.354 . . . . 0.0 109.635 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 117' ' ' VAL . 8.7 p -53.3 -41.2 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.803 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -64.35 -27.27 68.9 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.936 ' OG ' HD21 ' A' ' 195' ' ' LEU . 6.2 p -63.51 -43.73 96.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.055 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -68.23 -33.1 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.108 -0.995 . . . . 0.0 109.492 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.888 HG13 HG13 ' A' ' 144' ' ' ILE . 5.0 t -76.26 -22.0 15.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.2 tt0 -88.24 -34.12 17.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.8 OUTLIER -82.45 -36.33 26.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.73 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -67.28 -61.18 2.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.338 1.066 . . . . 0.0 108.588 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.872 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.6 pp -57.0 -40.8 77.29 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.779 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.47 -32.69 62.66 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.898 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.038 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.41 -42.04 65.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.103 ' CH2' HD21 ' A' ' 234' ' ' LEU . 37.7 m95 -91.23 -23.97 20.03 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.536 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 3.5 tm-20 -69.57 -27.44 65.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.851 -1.156 . . . . 0.0 107.89 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 13.9 pt-20 -90.58 -42.84 10.57 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.738 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.038 HG13 ' O ' ' A' ' 123' ' ' VAL . 15.8 m -59.2 -24.52 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.139 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.007 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -114.26 154.82 46.27 Favored Pre-proline 0 N--CA 1.494 1.731 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.573 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -82.49 29.31 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.136 1.891 . . . . 0.0 110.472 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.037 HD21 ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -99.44 -179.95 4.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.95 -1.094 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 1.071 HG21 ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -112.9 161.18 17.28 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.95 ' CE2' HD13 ' A' ' 97' ' ' LEU . 53.2 m-85 -147.72 148.74 31.32 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.061 -1.024 . . . . 0.0 110.901 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.575 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -130.2 -179.23 5.12 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.627 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.812 -1.18 . . . . 0.0 110.207 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.695 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.49 -163.78 1.52 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.215 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 136' ' ' TYR . 69.5 t80 -155.79 21.22 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 26.0 pm0 -143.98 -174.62 4.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.637 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.04 -97.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 137' ' ' GLU . 11.6 pt-20 178.8 130.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -1.133 . . . . 0.0 110.157 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.585 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -89.78 -147.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.227 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.591 ' CG ' HD11 ' A' ' 207' ' ' LEU . 12.9 t0 -92.89 -33.16 14.32 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.738 HG22 ' CD1' ' A' ' 144' ' ' ILE . 22.1 mt -126.64 80.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.457 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.8 ttp -64.26 94.04 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.121 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.888 HG13 HG13 ' A' ' 117' ' ' VAL . 5.4 mm -79.17 118.76 27.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -137.76 158.16 44.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.349 -1.469 . . . . 0.0 111.983 -179.126 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 23.6 p90 -90.91 138.62 31.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 109.591 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.124 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.27 -159.05 0.56 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.178 -0.951 . . . . 0.0 110.003 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.988 HG21 ' CG ' ' A' ' 183' ' ' ASP . 1.5 p -174.85 -168.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.923 -1.11 . . . . 0.0 109.274 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.722 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 0.0 109.972 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 109.743 -0.907 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CE2' ' HA ' ' A' ' 165' ' ' ALA . 0.1 OUTLIER -95.08 -160.63 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.982 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 160' ' ' PRO . 20.5 p30 178.86 50.59 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.574 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.69 -74.38 0.0 OUTLIER Glycine 0 N--CA 1.509 3.512 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.582 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.7 Cg_endo -65.17 61.28 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.237 1.292 . . . . 0.0 109.99 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.42 143.9 8.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -42.12 -41.17 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -1.115 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 163' ' ' VAL . 31.0 m -55.01 84.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.802 . . . . 0.0 109.871 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.695 HD12 HD12 ' A' ' 222' ' ' LEU . 15.8 mt -71.84 -80.27 0.06 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.311 -0.868 . . . . 0.0 112.822 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.856 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -136.2 -174.65 3.74 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.469 -1.395 . . . . 0.0 111.489 -177.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.587 ' CD2' ' CZ ' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -179.99 167.62 1.28 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.273 -1.517 . . . . 0.0 110.294 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -141.43 -166.13 2.12 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.215 -0.928 . . . . 0.0 110.391 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.623 ' CD2' HD11 ' A' ' 174' ' ' ILE . 0.1 OUTLIER -128.59 -160.86 1.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.1 -1.0 . . . . 0.0 110.73 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.005 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -166.06 -60.3 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.493 -0.755 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 1.005 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.6 Cg_endo -79.16 -172.31 1.5 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.725 1.382 . . . . 0.0 110.083 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.18 144.37 0.64 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.6 Cg_endo -70.37 136.88 32.43 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.854 1.449 . . . . 0.0 110.061 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 71.3 -64.15 1.02 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 168' ' ' TYR . 0.6 OUTLIER -64.31 -7.82 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.969 . . . . 0.0 109.164 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -65.72 66.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.894 . . . . 0.0 108.958 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 126.88 81.58 0.37 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.7 m-20 -155.87 126.83 6.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.935 -1.332 . . . . 0.0 108.016 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.684 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -113.43 168.26 9.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.325 -0.86 . . . . 0.0 109.086 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.124 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.27 135.14 5.07 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.751 178.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.596 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 58.1 m-85 -95.29 134.4 38.11 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.896 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -68.65 132.64 47.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.028 -1.469 . . . . 0.0 107.41 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -105.8 37.0 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.87 -1.144 . . . . 0.0 110.332 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.988 ' CG ' HG21 ' A' ' 148' ' ' VAL . 1.9 m-20 -114.25 -2.76 13.27 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.379 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.548 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 5.5 pt-20 -119.24 -111.65 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.056 -1.027 . . . . 0.0 108.627 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 48.6 mt-30 -148.22 174.7 11.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.818 -1.176 . . . . 0.0 109.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.585 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 90.3 m95 -162.14 126.49 3.23 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.82 ' HA ' HD21 ' A' ' 108' ' ' LEU . 71.3 p -150.14 155.38 39.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.724 -1.235 . . . . 0.0 110.627 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.937 ' HB3' HD22 ' A' ' 195' ' ' LEU . 1.1 ptpt -83.67 -30.58 26.7 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.65 ' O ' ' N ' ' A' ' 191' ' ' THR . 30.7 t0 -87.28 63.7 7.91 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.906 HG22 HD11 ' A' ' 229' ' ' LEU . 6.2 t 4.41 59.68 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.883 0.849 . . . . 0.0 111.789 -177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.65 ' N ' ' O ' ' A' ' 189' ' ' ASP . 47.7 m -124.49 -31.49 3.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.252 -0.905 . . . . 0.0 109.682 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.9 -78.69 1.42 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.705 HG22 ' OD1' ' A' ' 194' ' ' ASN . 18.4 m -129.9 -95.16 0.39 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.835 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.4 OUTLIER -161.37 73.43 0.44 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.961 HD13 HD13 ' A' ' 108' ' ' LEU . 2.4 tp -34.4 -96.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.631 0.729 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.895 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -67.56 -8.13 31.7 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -177.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.753 HD13 ' HA ' ' A' ' 227' ' ' THR . 12.2 tp -68.7 -63.13 1.12 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 116.42 -2.112 . . . . 0.0 106.924 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.856 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 9.2 t -71.41 -8.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.055 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -74.49 -58.59 3.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.96 -15.08 62.67 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.579 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 9.1 t60 -69.33 -42.03 75.87 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.957 -1.497 . . . . 0.0 107.96 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.684 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 6.8 mt-10 -85.43 -46.77 10.6 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.05 -1.031 . . . . 0.0 110.603 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.872 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -61.15 -30.87 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.706 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.23 -33.89 38.67 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.5 -50.23 73.73 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.825 -0.809 . . . . 0.0 110.41 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.54 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 58.3 p -83.82 -57.1 3.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.424 -0.798 . . . . 0.0 112.027 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.81 HD13 HD22 ' A' ' 97' ' ' LEU . 13.1 mt -104.56 34.99 2.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.945 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -136.94 -77.74 0.08 OUTLIER Glycine 0 C--N 1.292 -1.889 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.1 pp -172.02 -165.72 0.37 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.77 -1.429 . . . . 0.0 109.995 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.715 ' N ' HD12 ' A' ' 209' ' ' LEU . 3.3 t80 -96.92 -73.37 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.845 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.601 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 81.0 m80 -160.6 103.93 1.39 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.128 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.655 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -91.43 -171.34 2.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.856 . . . . 0.0 108.85 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.993 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.74 76.16 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.931 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.06 9.58 12.17 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.634 -176.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -51.1 -27.49 8.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.512 ' C ' ' HB2' ' A' ' 235' ' ' SER . 14.9 mt-10 -114.95 -38.44 3.9 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.64 -178.98 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.301 1.048 . . . . 0.0 112.262 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.806 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -78.18 -18.35 55.62 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.463 -177.483 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.601 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -77.63 -7.84 56.99 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 119.19 -2.194 . . . . 0.0 112.056 -177.577 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.658 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 39.6 t80 -135.56 15.79 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.362 -1.461 . . . . 0.0 113.622 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -78.3 -37.24 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.53 -1.373 . . . . 0.0 108.53 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.979 HD23 ' N ' ' A' ' 223' ' ' TYR . 0.6 OUTLIER -15.58 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.01 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.979 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.63 59.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.496 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.6 OUTLIER -175.65 -159.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 74.3 m -126.4 104.15 8.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 109.722 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 197' ' ' LEU . 0.0 OUTLIER 178.56 40.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.843 . . . . 0.0 109.023 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.753 ' HA ' HD13 ' A' ' 197' ' ' LEU . 10.0 t -84.87 -51.02 7.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.237 -0.914 . . . . 0.0 110.111 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.714 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.3 OUTLIER -152.64 6.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.096 . . . . 0.0 110.903 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.906 HD11 HG22 ' A' ' 190' ' ' THR . 0.4 OUTLIER -49.07 -108.8 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.949 -1.095 . . . . 0.0 110.796 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -23.94 5.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.589 -1.319 . . . . 0.0 109.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.538 ' O ' ' C ' ' A' ' 232' ' ' PHE . 5.3 mtp180 -98.24 -31.95 11.81 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.646 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 4.9 p90 -17.09 118.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.824 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.532 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.32 171.63 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.381 -0.825 . . . . 0.0 110.516 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.103 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.2 mp -81.78 166.17 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.853 . . . . 0.0 110.427 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 37.9 t -101.77 -166.89 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.122 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.52 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.2 OUTLIER -84.97 -17.71 36.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.644 -0.66 . . . . 0.0 110.262 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.993 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.9 OUTLIER -81.62 -48.54 11.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.725 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 1.0 OUTLIER -63.98 -40.06 95.53 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.508 -1.677 . . . . 0.0 106.659 177.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.42 -35.41 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.7 -54.38 19.95 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -50.79 -53.91 24.1 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.016 HG21 HG21 ' A' ' 127' ' ' VAL . 1.1 tp -64.86 -43.19 96.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.886 -1.361 . . . . 0.0 109.995 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.51 ' N ' HG23 ' A' ' 242' ' ' ILE . 3.3 mm-40 -54.54 -28.45 45.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.2 t -80.27 -21.16 42.98 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.839 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -67.52 -64.11 0.92 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.783 ' HB3' HD13 ' A' ' 130' ' ' LEU . 27.9 m-85 . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.209 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.927 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CZ2' ' O ' ' A' ' 175' ' ' ASN . 12.7 m95 -88.13 -167.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.957 -1.089 . . . . 0.0 109.608 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -162.42 -37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.418 -0.801 . . . . 0.0 109.087 179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.585 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -52.4 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.434 -0.791 . . . . 0.0 110.08 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.878 ' HA ' HD12 ' A' ' 130' ' ' LEU . 65.7 p -122.34 -0.97 9.22 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.602 -0.686 . . . . 0.0 109.312 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.585 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 15.0 m-70 -140.56 92.59 2.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.463 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.751 ' N ' HD22 ' A' ' 97' ' ' LEU . 2.9 mm? -85.19 162.8 19.05 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.512 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.6 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -141.05 155.83 46.1 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.934 ' CE2' HD11 ' A' ' 101' ' ' ILE . 8.4 p90 -134.47 168.56 18.72 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.452 -1.405 . . . . 0.0 109.826 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 1.011 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.5 124.06 31.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -0.766 . . . . 0.0 109.235 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.934 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.5 mp -80.69 81.48 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.011 HG22 ' NE ' ' A' ' 100' ' ' ARG . 4.8 t -94.71 5.08 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.873 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -103.29 163.99 11.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.761 -1.212 . . . . 0.0 108.6 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.71 ' N ' HG21 ' A' ' 113' ' ' VAL . 7.2 p90 -178.2 58.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.119 -0.988 . . . . 0.0 110.5 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.981 HG21 ' CD1' ' A' ' 186' ' ' TRP . 69.0 p -45.48 145.57 2.0 Allowed Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.1 -32.47 34.2 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 124.002 1.528 . . . . 0.0 109.232 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.62 ' C ' HD23 ' A' ' 108' ' ' LEU . 14.9 m-20 -65.89 -19.37 65.85 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.967 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -115.62 114.28 42.34 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 112' ' ' ALA . 36.4 Cg_endo -62.75 168.17 10.65 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.565 1.297 . . . . 0.0 108.996 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HE2' ' HB2' ' A' ' 110' ' ' LYS . 1.3 mppt? -39.73 -64.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.877 0.846 . . . . 0.0 109.54 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -57.73 -10.87 1.8 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.845 -0.535 . . . . 0.0 111.392 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.705 ' HB1' HD13 ' A' ' 108' ' ' LEU . . . -87.75 -58.44 2.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.576 -1.327 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 1.039 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.9 p -59.68 -43.39 91.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.612 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -60.92 -26.83 67.76 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.614 ' OG ' HD21 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -63.26 -65.24 0.71 Allowed 'General case' 0 C--O 1.195 -1.768 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.047 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -49.46 -31.99 11.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.039 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.6 t -74.34 -24.62 19.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -87.18 -37.19 17.52 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.345 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.764 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -77.82 -39.1 44.79 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.773 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.71 -61.57 2.0 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.214 1.007 . . . . 0.0 108.553 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.846 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.3 pp -53.8 -41.4 67.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.381 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.794 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -76.19 -32.85 59.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.806 -178.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.021 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.1 t -53.76 -45.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.064 ' CH2' HD21 ' A' ' 234' ' ' LEU . 33.5 m95 -91.69 -22.31 20.3 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.758 -1.177 . . . . 0.0 110.532 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.535 ' CG ' ' HB2' ' A' ' 132' ' ' PHE . 9.3 tm-20 -69.79 -27.03 64.57 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.782 -1.199 . . . . 0.0 107.815 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -91.17 -42.95 10.16 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.63 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.038 HG21 HG21 ' A' ' 242' ' ' ILE . 14.0 m -58.07 -25.56 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.308 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.01 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -109.36 155.0 41.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 118.073 -1.451 . . . . 0.0 109.249 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.68 ' C ' HD22 ' A' ' 130' ' ' LEU . 51.2 Cg_endo -82.06 26.2 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.054 1.836 . . . . 0.0 111.395 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 95' ' ' THR . 4.4 mm? -108.6 -169.54 1.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.595 -1.316 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.574 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 2.0 p -117.7 169.22 9.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.808 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CE2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -139.17 163.34 32.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.637 -0.664 . . . . 0.0 109.921 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.579 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -143.08 -172.8 3.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.638 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -159.81 165.46 32.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.562 -1.336 . . . . 0.0 110.798 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.722 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -163.37 -163.63 0.85 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.592 -0.692 . . . . 0.0 109.134 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 75.0 t80 -158.2 22.07 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 108.768 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 1.6 pm0 -148.8 -178.95 6.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -0.761 . . . . 0.0 108.97 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.87 -97.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 137' ' ' GLU . 20.2 tt0 178.5 146.22 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -1.175 . . . . 0.0 110.531 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.668 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -103.18 -150.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.698 ' O ' HD13 ' A' ' 142' ' ' ILE . 41.4 m-20 -88.74 -36.58 16.06 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.934 HG13 HD23 ' A' ' 207' ' ' LEU . 18.4 mm -122.28 82.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.552 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 3.3 ptt? -67.1 100.12 0.73 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.582 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.873 HG22 ' ND2' ' A' ' 103' ' ' ASN . 6.1 mm -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -135.41 154.93 51.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.336 -1.477 . . . . 0.0 111.939 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -77.06 135.99 38.65 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.064 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -152.83 164.68 37.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 110.485 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 1.001 HG21 ' CG ' ' A' ' 183' ' ' ASP . 2.6 p -160.2 -174.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.255 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.702 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.279 -0.888 . . . . 0.0 110.334 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 C--O 1.215 -0.63 0 N-CA-C 109.795 -0.887 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.652 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -117.13 -162.15 0.85 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 110.326 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 160' ' ' PRO . 33.0 p30 -173.79 55.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 110.041 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 14.49 -76.86 0.0 OUTLIER Glycine 0 N--CA 1.508 3.446 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.615 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.2 Cg_endo -66.9 59.19 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.322 1.348 . . . . 0.0 109.866 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -151.89 142.71 9.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 161' ' ' GLY . 2.7 m120 -41.43 -34.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.021 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 157' ' ' PHE . 10.9 m -66.66 84.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.97 . . . . 0.0 109.646 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.099 HD21 HG23 ' A' ' 193' ' ' THR . 1.2 tp -64.03 -56.07 17.67 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.335 -0.853 . . . . 0.0 111.462 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.783 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -163.1 -164.35 0.95 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.394 -1.441 . . . . 0.0 110.622 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.652 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 0.9 OUTLIER 178.92 -179.17 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.157 -1.589 . . . . 0.0 111.356 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 202' ' ' GLU . . . -151.32 174.46 13.28 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.804 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.559 ' CE2' HD12 ' A' ' 174' ' ' ILE . 0.1 OUTLIER -113.97 -170.17 1.66 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.082 -1.011 . . . . 0.0 110.168 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.957 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -156.78 -66.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 109.197 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.957 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 43.8 Cg_endo -73.03 -160.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.704 1.371 . . . . 0.0 109.718 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 175' ' ' ASN . . . 76.33 164.21 17.45 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.8 Cg_endo -73.85 -92.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.012 1.533 . . . . 0.0 110.215 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -68.51 -23.7 75.22 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -77.88 9.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.658 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.569 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -65.78 64.82 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 142' ' ' ILE . . . 110.73 96.59 2.37 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -152.96 114.53 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.197 -1.178 . . . . 0.0 107.872 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.675 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.76 157.41 19.17 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.558 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.064 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -147.08 134.88 21.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.816 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.541 ' HB3' ' CZ2' ' A' ' 186' ' ' TRP . 19.1 m-85 -96.79 130.7 44.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.096 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 164' ' ' LEU . 0.2 OUTLIER -47.97 143.27 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.721 -1.237 . . . . 0.0 109.343 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -119.26 29.58 7.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 1.001 ' CG ' HG21 ' A' ' 148' ' ' VAL . 4.7 m-20 -135.97 3.34 2.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 110.598 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.54 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 1.6 pt-20 -112.35 -96.39 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.606 -1.309 . . . . 0.0 109.492 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.601 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 1.0 OUTLIER -162.36 173.4 14.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.081 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.981 ' CD1' HG21 ' A' ' 105' ' ' THR . 86.1 m95 -161.15 133.8 6.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.006 -1.059 . . . . 0.0 109.799 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 186' ' ' TRP . 74.9 p -162.02 150.08 14.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.577 -0.702 . . . . 0.0 109.374 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.679 ' O ' HG23 ' A' ' 227' ' ' THR . 13.3 pttt -83.38 -31.9 26.48 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.655 ' O ' ' N ' ' A' ' 191' ' ' THR . 9.4 t70 -83.77 64.01 7.79 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' THR . . . . . 1.026 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.9 t 3.44 60.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.123 0.963 . . . . 0.0 111.975 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.655 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.7 m -121.88 -32.25 3.78 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.076 -1.015 . . . . 0.0 109.545 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.402 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -98.55 -75.97 1.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.099 HG23 HD21 ' A' ' 164' ' ' LEU . 3.0 m -124.28 -88.86 0.6 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.844 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 4.3 m-20 178.06 72.37 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.015 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 30.6 tp -28.82 -102.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.514 0.673 . . . . 0.0 112.541 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.844 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -57.44 -16.08 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.015 -1.053 . . . . 0.0 111.604 -177.372 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.844 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.8 tp -63.02 -63.04 1.32 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.32 -2.112 . . . . 0.0 107.245 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.032 HG21 HD23 ' A' ' 164' ' ' LEU . 3.2 t -69.88 -8.32 10.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.047 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -76.84 -59.54 2.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -64.95 -14.22 59.5 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.481 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 22.0 t60 -66.73 -50.66 62.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.589 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 167' ' ' ALA . 2.3 mm-40 -79.42 -46.44 17.52 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.282 -0.886 . . . . 0.0 110.925 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.773 HD12 ' HB3' ' A' ' 120' ' ' ALA . 1.4 mt -60.2 -30.35 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.713 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.3 -32.74 42.07 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -59.23 -49.05 79.32 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.892 -0.769 . . . . 0.0 110.496 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.644 ' OG ' ' HB1' ' A' ' 167' ' ' ALA . 5.0 m -84.63 -56.16 3.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 112.333 -177.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.934 HD23 HG13 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -104.39 27.0 8.25 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.94 -1.1 . . . . 0.0 110.987 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.907 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -130.11 -78.26 0.19 Allowed Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.838 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -167.48 -162.82 0.47 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.853 -1.381 . . . . 0.0 110.208 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 4.1 t80 -98.98 -70.78 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.802 . . . . 0.0 109.471 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 44.9 m80 -161.31 87.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.633 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -76.98 179.75 6.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 109.306 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.918 ' HB3' ' OD2' ' A' ' 237' ' ' ASP . . . -61.63 81.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.957 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.08 11.12 12.41 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.366 -177.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 214' ' ' ASN . 47.6 p -49.41 -28.27 4.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.545 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.0 mm-40 -115.99 -36.14 4.22 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.957 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.63 -166.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.507 1.146 . . . . 0.0 112.773 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -95.26 -15.3 23.3 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.354 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.573 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -79.77 -5.98 56.39 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.284 -2.135 . . . . 0.0 112.054 -177.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.656 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 43.3 t80 -138.78 15.75 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.444 -1.41 . . . . 0.0 113.347 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.14 -37.46 0.79 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 N-CA-C 108.631 -1.334 . . . . 0.0 108.631 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.978 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.7 OUTLIER -14.76 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.085 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.978 ' N ' HD13 ' A' ' 222' ' ' LEU . 2.1 t80 -73.42 56.32 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.154 -0.966 . . . . 0.0 109.321 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -173.68 -145.72 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.574 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.668 ' HB3' HG21 ' A' ' 190' ' ' THR . 18.6 m -143.2 110.6 5.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.855 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER 179.4 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.34 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 188' ' ' LYS . 11.3 t -93.36 -13.24 28.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.596 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER 178.37 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.564 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 1.026 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.4 OUTLIER -26.83 -99.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.811 -0.555 . . . . 0.0 111.426 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 p -135.05 -2.98 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.759 -1.213 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.565 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.7 OUTLIER -119.32 -40.28 2.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 108.744 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 2.0 p90 0.38 111.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.357 0.599 . . . . 0.0 111.958 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.6 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.5 ttt180 179.42 154.28 0.47 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.166 -0.959 . . . . 0.0 110.035 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.064 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -74.77 169.31 18.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.469 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 30.4 t -104.6 -169.63 1.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.353 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.517 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.98 -11.91 54.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 110.104 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.918 ' OD2' ' HB3' ' A' ' 213' ' ' ALA . 0.5 OUTLIER -84.18 -50.81 7.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.66 -1.275 . . . . 0.0 107.748 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.838 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.81 -38.33 90.71 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.679 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -57.07 -35.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 237' ' ' ASP . 3.5 m-20 -68.42 -56.91 6.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -47.88 -53.33 14.24 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.038 HG21 HG21 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -63.91 -43.39 97.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.977 -1.308 . . . . 0.0 109.746 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.536 ' N ' HG23 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -54.54 -27.35 37.82 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -82.71 -19.17 38.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.825 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -70.11 -63.45 1.08 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.558 ' HB3' ' CD2' ' A' ' 130' ' ' LEU . 15.9 m-30 . . . . . 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.275 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 1.036 ' CE ' ' HB1' ' A' ' 169' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' A' ' 141' ' ' ASP . 70.9 m95 -94.06 162.64 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 0.0 109.258 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -133.02 -35.19 1.06 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 110.237 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HD3' HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -50.7 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.177 -0.952 . . . . 0.0 110.283 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.797 ' CA ' HD12 ' A' ' 130' ' ' LEU . 32.3 p -124.72 1.49 8.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.461 -0.774 . . . . 0.0 109.561 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.555 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 35.6 m80 -146.02 99.66 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.992 -1.067 . . . . 0.0 110.484 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.212 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -127.59 -153.09 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 141' ' ' ASP . 1.2 t -173.75 -178.91 1.67 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.947 -1.096 . . . . 0.0 111.179 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.827 ' CG ' HD23 ' A' ' 121' ' ' LEU . 10.4 p90 -135.82 179.16 6.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.371 -0.831 . . . . 0.0 109.678 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.806 ' NH2' HG22 ' A' ' 102' ' ' VAL . 2.0 ttp85 -131.85 144.1 50.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -0.758 . . . . 0.0 109.394 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.98 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.8 mp -101.53 78.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.879 -1.138 . . . . 0.0 109.503 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.806 HG22 ' NH2' ' A' ' 100' ' ' ARG . 1.8 t -92.77 9.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.44 -0.787 . . . . 0.0 110.616 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.616 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.81 174.47 5.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.508 -1.37 . . . . 0.0 110.108 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.61 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.1 t80 177.16 86.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.397 0.618 . . . . 0.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.789 HG21 ' CD1' ' A' ' 186' ' ' TRP . 33.2 p -67.44 154.09 93.67 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 185' ' ' GLN . 38.3 Cg_endo -67.87 -26.53 38.05 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.827 1.435 . . . . 0.0 108.65 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.585 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -81.86 2.23 31.33 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.114 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.901 HD13 ' CD1' ' A' ' 195' ' ' LEU . 95.1 mt -145.23 117.27 5.23 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.486 -0.759 . . . . 0.0 110.236 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.06 175.6 5.44 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.853 1.449 . . . . 0.0 108.872 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.97 -64.96 0.44 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.829 0.823 . . . . 0.0 110.108 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -30.63 55.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 112.282 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.889 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.29 -60.69 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.31 -1.494 . . . . 0.0 109.356 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.616 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.5 p -52.25 -38.48 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.98 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -65.6 -28.64 69.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.7 ' OG ' HD21 ' A' ' 195' ' ' LEU . 10.8 p -62.37 -39.68 93.96 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.067 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -72.48 -34.13 67.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 0.0 109.544 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.891 HG22 HG21 ' A' ' 144' ' ' ILE . 71.8 t -74.12 -23.2 18.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 1.6 tt0 -91.23 -33.48 15.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 6.5 tppt? -82.57 -33.77 27.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.805 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -68.08 -65.21 0.72 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.853 ' HA ' HG21 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.731 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.09 -36.78 63.54 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.239 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.926 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.34 -36.98 48.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.117 ' O ' HG23 ' A' ' 128' ' ' THR . 46.6 m95 -91.61 -23.16 19.95 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.627 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -74.21 -27.74 60.94 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.755 -1.216 . . . . 0.0 108.312 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -91.37 -44.22 9.29 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.888 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 123' ' ' VAL . 20.2 m -60.47 -24.6 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.186 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.165 HG21 ' CE1' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -106.22 165.08 13.64 Favored Pre-proline 0 N--CA 1.501 2.107 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.975 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 1.013 ' C ' HD22 ' A' ' 130' ' ' LEU . 52.3 Cg_endo -83.66 25.82 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.242 1.961 . . . . 0.0 111.723 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.013 HD22 ' C ' ' A' ' 129' ' ' PRO . 3.7 mm? -127.09 -177.89 4.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.468 -1.395 . . . . 0.0 110.781 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.555 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.5 p -125.59 167.12 15.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 111.488 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 1.212 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 25.1 m-85 -148.68 162.72 39.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.307 0.575 . . . . 0.0 109.801 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.573 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -133.12 -159.21 0.95 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.54 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -151.41 152.94 33.77 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.052 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -136.1 -129.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.067 -1.021 . . . . 0.0 109.318 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 136' ' ' TYR . 40.4 t80 178.24 31.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.67 -1.269 . . . . 0.0 109.423 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.483 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 5.0 pm0 -167.37 -174.25 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.014 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.53 -98.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 4.6 pt-20 178.86 124.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -1.156 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 1.057 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -81.98 -151.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 109.219 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.565 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -81.1 -48.7 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.838 HG22 ' CD1' ' A' ' 144' ' ' ILE . 13.1 mm -112.52 80.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.535 ' HG2' HG21 ' A' ' 102' ' ' VAL . 4.4 ttp -63.8 97.69 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.938 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.891 HG21 HG22 ' A' ' 117' ' ' VAL . 5.7 mm -78.23 130.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.066 -1.021 . . . . 0.0 108.488 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -145.34 154.92 42.83 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.562 -1.336 . . . . 0.0 111.881 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -91.19 135.88 33.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.121 -0.987 . . . . 0.0 108.577 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -169.52 -164.0 0.42 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.381 -1.328 . . . . 0.0 111.338 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.959 HG23 ' OD1' ' A' ' 181' ' ' ASP . 3.0 p -177.51 -171.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.738 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.215 -0.636 0 N-CA-C 108.855 -1.248 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.666 ' CZ ' ' CG1' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -69.33 -141.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 110.479 -178.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.491 ' CG ' ' HB ' ' A' ' 163' ' ' VAL . 3.9 p-10 -128.12 -31.77 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 111.782 -177.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.594 ' HA3' HG21 ' A' ' 148' ' ' VAL . . . 50.61 -105.91 0.22 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.292 -2.323 . . . . 0.0 107.292 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.26 61.45 0.25 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.582 1.306 . . . . 0.0 109.879 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -156.73 -176.13 28.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 163' ' ' VAL . 50.9 m-20 -78.1 -41.35 35.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -1.194 . . . . 0.0 110.272 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.666 ' CG1' ' CZ ' ' A' ' 157' ' ' PHE . 4.6 t -42.1 130.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.873 HD22 HD23 ' A' ' 222' ' ' LEU . 0.8 OUTLIER -96.08 -56.5 2.62 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.46 -0.775 . . . . 0.0 112.543 -178.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.734 ' HB1' ' OE2' ' A' ' 202' ' ' GLU . . . -162.74 -172.04 2.95 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.22 -1.55 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER 179.93 173.96 0.91 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 119.956 -1.715 . . . . 0.0 111.371 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.23 -170.78 2.73 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.477 -0.765 . . . . 0.0 109.667 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.627 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 49.3 m-85 -118.28 -166.19 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.836 -1.165 . . . . 0.0 110.432 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.036 ' HB1' ' CE ' ' A' ' 91' ' ' LYS . . . -177.51 -62.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.8 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 1.002 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 42.9 Cg_endo -73.77 145.23 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.956 1.503 . . . . 0.0 110.305 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . 94.17 144.23 15.43 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.8 Cg_endo -70.4 152.37 65.94 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.969 1.51 . . . . 0.0 109.99 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 68.38 -63.94 0.41 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.627 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -65.69 -8.73 6.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.533 -0.981 . . . . 0.0 108.842 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 171' ' ' GLY . 10.4 t30 -67.41 66.39 0.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.951 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 131.45 76.58 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.165 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.594 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -149.1 119.32 7.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.699 -1.471 . . . . 0.0 108.288 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.603 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -101.83 166.1 10.84 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.012 -1.055 . . . . 0.0 109.054 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.678 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -163.27 132.38 4.03 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.32 178.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.691 ' HE1' HG23 ' A' ' 198' ' ' VAL . 53.9 m-85 -92.06 136.24 33.33 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.756 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.959 ' OD1' HG23 ' A' ' 148' ' ' VAL . 51.6 t0 -70.03 126.49 29.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 183' ' ' ASP . 16.5 t70 -70.65 -5.03 26.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.628 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 61.9 t0 -34.32 -72.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 111.273 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.474 ' OE2' ' OD2' ' A' ' 183' ' ' ASP . 1.0 OUTLIER -111.87 -135.85 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.524 -177.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.543 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -122.91 -178.75 4.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.162 -0.961 . . . . 0.0 109.17 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 1.073 ' CZ3' HG21 ' A' ' 198' ' ' VAL . 29.4 m95 -144.7 151.2 38.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.45 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.844 ' HA ' HD21 ' A' ' 108' ' ' LEU . 41.5 p -145.9 152.87 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 110.007 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.68 ' O ' HG23 ' A' ' 227' ' ' THR . 0.1 OUTLIER -70.08 -38.95 75.86 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.386 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.505 ' HA ' HD13 ' A' ' 229' ' ' LEU . 0.8 OUTLIER -86.18 -150.17 0.14 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.953 HG23 HD11 ' A' ' 229' ' ' LEU . 17.3 p -109.51 43.1 1.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.069 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.532 ' HB ' HG21 ' A' ' 187' ' ' THR . 89.0 m -95.49 -31.84 13.16 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.352 -0.842 . . . . 0.0 111.25 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -114.18 -80.15 0.92 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.028 -1.558 . . . . 0.0 109.535 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.848 HG22 ' OD1' ' A' ' 194' ' ' ASN . 64.0 m -134.72 -94.02 0.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.584 -0.951 . . . . 0.0 108.435 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.848 ' OD1' HG22 ' A' ' 193' ' ' THR . 0.8 OUTLIER -157.23 66.01 0.5 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.675 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.067 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -29.56 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.702 0.763 . . . . 0.0 111.019 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.822 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.3 OUTLIER -67.78 -11.71 59.04 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 111.536 -177.405 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 221' ' ' PRO . 13.0 tp -67.25 -59.94 3.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.06 -1.856 . . . . 0.0 106.895 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.073 HG21 ' CZ3' ' A' ' 186' ' ' TRP . 2.0 m -71.29 -12.87 16.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.039 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.5 -61.21 1.91 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -62.85 -17.13 60.97 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 15.5 t60 -68.71 -40.63 79.88 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.594 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.734 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 3.9 mt-10 -85.2 -49.36 8.28 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.853 . . . . 0.0 111.141 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.853 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.2 mt -60.88 -30.6 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.781 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.78 -30.83 42.15 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -63.19 -44.64 94.8 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.742 -0.857 . . . . 0.0 110.699 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.674 ' OG ' HD12 ' A' ' 142' ' ' ILE . 85.7 p -87.49 -55.61 3.72 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 112.61 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 1.009 HD11 ' OH ' ' A' ' 246' ' ' TYR . 2.3 tp -104.56 7.35 35.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.134 -0.979 . . . . 0.0 110.964 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 1.026 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -104.65 -77.54 1.16 Allowed Glycine 0 N--CA 1.486 1.982 0 O-C-N 120.841 -1.162 . . . . 0.0 111.021 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.899 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.6 pp -172.59 -161.85 0.17 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.611 -1.523 . . . . 0.0 110.05 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.827 ' N ' HD12 ' A' ' 209' ' ' LEU . 2.9 m-85 -94.32 -94.51 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 0.0 109.155 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 44.8 m170 -143.15 120.92 11.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.575 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.7 m -108.33 -179.12 3.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.179 -0.951 . . . . 0.0 109.291 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.69 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -59.53 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.951 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -91.01 13.26 17.24 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.536 -177.197 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 214' ' ' ASN . 31.0 p -50.73 -28.04 8.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.492 ' C ' ' HB2' ' A' ' 235' ' ' SER . 2.5 mt-10 -118.08 -36.42 3.6 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.517 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.78 -159.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 122.2 1.0 . . . . 0.0 112.756 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -112.15 -3.43 14.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.925 -177.432 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.541 ' HB2' ' CG ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -89.55 -5.36 57.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 119.152 -2.217 . . . . 0.0 110.732 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.647 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 33.4 t80 -140.0 14.91 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 118.845 -1.142 . . . . 0.0 113.252 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 1.081 ' HB3' HD11 ' A' ' 226' ' ' LEU . 56.1 Cg_endo -75.85 -35.21 2.68 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 N-CA-C 108.539 -1.37 . . . . 0.0 108.539 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.978 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.4 OUTLIER -17.98 -57.94 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.53 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.978 ' N ' HD13 ' A' ' 222' ' ' LEU . 2.7 t80 -75.01 55.17 0.7 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 0.0 108.96 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 221' ' ' PRO . 7.2 t-160 -173.44 -138.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.899 ' C ' HD23 ' A' ' 226' ' ' LEU . 1.9 m -157.06 119.26 3.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.92 -1.112 . . . . 0.0 109.909 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 1.081 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.2 OUTLIER 178.92 62.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 110.021 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER -114.26 -18.69 11.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 14.5 t70 -167.42 -26.91 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 109.951 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.953 HD11 HG23 ' A' ' 190' ' ' THR . 0.2 OUTLIER -28.61 -61.97 0.11 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.849 HG23 ' HG3' ' A' ' 231' ' ' ARG . 1.5 t 178.98 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.379 -0.826 . . . . 0.0 108.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.849 ' HG3' HG23 ' A' ' 230' ' ' THR . 0.0 OUTLIER -94.67 -18.46 21.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.578 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 27.8 p90 -37.49 107.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.522 0.677 . . . . 0.0 110.641 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.601 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 9.2 ttt180 179.79 153.26 0.48 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.442 -0.786 . . . . 0.0 109.573 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.112 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.2 mp -67.01 165.86 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 12.7 t -101.73 -169.51 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.492 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.56 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.1 OUTLIER -84.85 -21.69 29.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 110.117 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.69 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 6.5 m-20 -80.44 -41.74 23.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.899 ' OD1' HD21 ' A' ' 209' ' ' LEU . 19.0 t0 -70.73 -32.81 70.13 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.458 -1.297 . . . . 0.0 107.725 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.623 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.4 OUTLIER -62.92 -33.9 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -65.05 -51.26 62.5 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.508 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.431 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -58.38 -54.71 35.52 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.026 HD13 ' HA2' ' A' ' 208' ' ' GLY . 2.4 tp -61.24 -49.38 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.745 -1.444 . . . . 0.0 109.916 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 242' ' ' ILE . 9.1 tt0 -53.57 -29.88 39.36 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.0 t -80.09 -17.08 53.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -70.39 -59.86 2.61 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 1.165 ' CE1' HG21 ' A' ' 128' ' ' THR . 41.7 m-85 . . . . . 0 N--CA 1.496 1.871 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.125 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.513 ' HD3' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.858 ' CD1' HD11 ' A' ' 207' ' ' LEU . 7.0 m95 -66.03 -164.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.834 -1.166 . . . . 0.0 109.076 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -152.03 -36.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.999 -1.063 . . . . 0.0 110.379 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -50.32 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.916 ' HA ' HD12 ' A' ' 130' ' ' LEU . 8.2 p -121.22 -5.64 9.42 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 1.033 ' CE1' HG21 ' A' ' 131' ' ' THR . 26.7 m-70 -146.06 100.41 3.39 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.089 HD13 ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -106.36 -165.33 1.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.842 . . . . 0.0 109.952 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -160.43 160.17 31.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 1.044 ' CZ ' HD22 ' A' ' 121' ' ' LEU . 2.6 p90 -131.16 167.23 19.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.801 -1.187 . . . . 0.0 108.816 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.891 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -126.11 123.14 37.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.121 . . . . 0.0 109.818 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.727 HG13 HG11 ' A' ' 117' ' ' VAL . 1.5 mp -82.14 84.43 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.779 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.891 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 38.2 t -99.52 6.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.401 -0.812 . . . . 0.0 109.775 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.983 ' C ' HG21 ' A' ' 113' ' ' VAL . 35.1 m-80 -97.11 156.15 16.51 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.846 -1.159 . . . . 0.0 108.794 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.78 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER 179.14 37.28 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 179.2 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 104' ' ' TYR . 41.3 p -42.86 156.31 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.401 -0.812 . . . . 0.0 108.913 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.88 -20.27 45.54 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.836 1.44 . . . . 0.0 109.054 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.557 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -67.7 -9.85 47.27 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.275 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.851 HD13 ' CD1' ' A' ' 195' ' ' LEU . 63.6 mt -144.49 123.59 7.04 Favored Pre-proline 0 N--CA 1.483 1.221 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.41 166.25 17.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.833 1.438 . . . . 0.0 109.153 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.94 -65.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.711 0.767 . . . . 0.0 110.345 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.3 m-20 -57.83 -22.92 50.23 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 111.764 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.744 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -76.16 -62.11 1.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.39 -1.443 . . . . 0.0 109.304 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.983 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.9 p -50.94 -39.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -66.96 -26.95 67.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.509 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.824 ' OG ' HD21 ' A' ' 195' ' ' LEU . 17.1 p -65.67 -41.22 92.72 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.087 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.78 -33.57 64.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.069 -1.019 . . . . 0.0 109.874 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.882 HG13 HG13 ' A' ' 144' ' ' ILE . 12.0 t -74.82 -23.72 17.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 2.1 tt0 -88.35 -35.13 17.35 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -77.88 -39.57 42.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -67.41 -62.42 1.43 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.142 0.972 . . . . 0.0 109.086 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.044 HD22 ' CZ ' ' A' ' 99' ' ' TYR . 1.7 pp -55.3 -40.82 71.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.793 ' N ' HD12 ' A' ' 121' ' ' LEU . 7.1 tptm -75.7 -32.64 60.17 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.826 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.037 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -54.16 -44.42 63.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.118 ' CH2' HD21 ' A' ' 234' ' ' LEU . 32.7 m95 -91.1 -23.57 20.26 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.675 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 17.6 tp10 -69.79 -27.24 64.74 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.692 -1.255 . . . . 0.0 107.903 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.7 pt-20 -90.39 -42.93 10.63 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.889 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.037 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.6 m -57.9 -26.02 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.322 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.988 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -107.94 154.12 41.27 Favored Pre-proline 0 N--CA 1.495 1.818 0 C-N-CA 117.966 -1.493 . . . . 0.0 109.224 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.596 ' C ' HD22 ' A' ' 130' ' ' LEU . 48.6 Cg_endo -81.29 24.76 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.832 1.688 . . . . 0.0 111.415 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 95' ' ' THR . 4.6 mm? -106.13 -169.02 1.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.701 -1.25 . . . . 0.0 110.202 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 1.033 HG21 ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -121.65 162.76 20.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.0 110.48 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 1.089 ' CE2' HD13 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -149.86 144.2 25.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.547 -0.721 . . . . 0.0 109.688 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.12 -162.5 1.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.24 -0.912 . . . . 0.0 108.856 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.625 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -156.46 153.28 28.57 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 110.057 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.607 HD12 ' H ' ' A' ' 137' ' ' GLU . 0.4 OUTLIER -145.06 -137.35 0.09 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.474 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.4 OUTLIER 179.29 33.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.689 -1.257 . . . . 0.0 108.995 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.607 ' H ' HD12 ' A' ' 135' ' ' LEU . 5.4 pm0 -157.54 179.94 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.35 -95.99 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER 178.83 106.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -1.159 . . . . 0.0 110.193 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.536 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.67 -147.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 108.758 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 98' ' ' THR . 43.9 t0 -90.28 -45.03 9.32 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.766 HG22 ' CD1' ' A' ' 144' ' ' ILE . 44.3 mt -116.46 81.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.493 ' SD ' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -64.52 97.11 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.882 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -82.52 114.83 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -135.71 157.33 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.369 -1.457 . . . . 0.0 112.08 -178.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 16.7 p90 -88.47 140.3 29.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.526 -0.734 . . . . 0.0 109.419 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.913 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.29 -161.49 0.36 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 0.0 110.176 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 1.01 HG21 ' CG ' ' A' ' 183' ' ' ASP . 0.7 OUTLIER -179.51 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.052 . . . . 0.0 109.896 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.808 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 O-C-N 121.863 -0.523 . . . . 0.0 111.157 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 110.128 -0.759 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.573 ' CE2' ' CD2' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -92.12 -157.18 0.5 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.079 -1.013 . . . . 0.0 109.861 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.594 ' O ' ' C ' ' A' ' 159' ' ' GLY . 22.5 p30 179.88 54.72 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.427 -0.795 . . . . 0.0 109.858 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -10.48 -64.37 0.01 OUTLIER Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 40.1 Cg_endo -68.96 59.58 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.145 1.23 . . . . 0.0 109.955 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.08 164.86 37.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 164' ' ' LEU . 8.5 m120 -54.18 -58.98 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.598 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 163' ' ' VAL . 33.6 m -45.46 93.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.744 ' CD1' HG21 ' A' ' 193' ' ' THR . 1.0 OUTLIER -77.82 -66.79 0.8 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.227 -0.921 . . . . 0.0 112.57 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.783 ' HB1' ' CD ' ' A' ' 202' ' ' GLU . . . -143.2 -172.46 3.69 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.403 . . . . 0.0 111.184 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.573 ' CD2' ' CE2' ' A' ' 157' ' ' PHE . 1.0 OUTLIER 179.47 167.94 1.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.246 -1.534 . . . . 0.0 110.937 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -138.02 -177.25 4.74 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.461 -0.774 . . . . 0.0 109.771 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.502 ' HB3' HG13 ' A' ' 174' ' ' ILE . 96.3 m-85 -114.31 -166.75 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.574 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -109.44 -174.51 0.3 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.492 -0.755 . . . . 0.0 109.26 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 42.5 Cg_endo -75.21 53.35 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.666 1.351 . . . . 0.0 110.725 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 175' ' ' ASN . . . -93.32 -170.76 39.52 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.7 Cg_endo -70.79 124.69 10.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.827 1.435 . . . . 0.0 109.912 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . 69.34 -59.67 0.62 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -76.05 18.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.578 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 1.2 t-20 -63.49 63.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 103.14 102.99 2.74 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.646 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -158.97 115.12 2.63 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 120.737 -1.449 . . . . 0.0 107.976 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -109.79 160.82 16.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.862 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.913 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -155.96 135.66 12.57 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.516 178.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.627 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 23.1 m-85 -93.74 131.08 39.44 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.194 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.529 ' OD2' HD13 ' A' ' 164' ' ' LEU . 43.7 p-10 -65.48 122.26 16.77 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 2.8 p30 -88.47 -9.36 52.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 1.01 ' CG ' HG21 ' A' ' 148' ' ' VAL . 6.3 m-20 -79.66 2.95 20.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.972 -1.08 . . . . 0.0 109.607 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 164' ' ' LEU . 33.0 tt0 -114.14 -129.91 0.31 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.606 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.1 mt-30 -137.22 176.29 8.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.758 -1.214 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.611 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.7 m95 -161.87 115.81 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.97 -1.081 . . . . 0.0 110.069 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.802 ' HA ' HD21 ' A' ' 108' ' ' LEU . 37.3 p -140.52 151.4 44.75 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.905 -1.122 . . . . 0.0 110.071 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.88 ' O ' HG23 ' A' ' 227' ' ' THR . 15.4 pttp -84.43 -31.72 24.48 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.2 t70 -84.51 64.12 8.25 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.982 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.1 t 3.38 60.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.129 0.966 . . . . 0.0 112.011 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.7 m -127.1 -30.19 2.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.055 -1.028 . . . . 0.0 110.028 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.794 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.58 -84.67 1.64 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.744 HG21 ' CD1' ' A' ' 164' ' ' LEU . 5.0 m -119.48 -82.0 0.64 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 0.5 OUTLIER -179.81 72.78 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.979 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.905 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 3.3 tp -34.62 -97.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.61 0.719 . . . . 0.0 110.732 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.848 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -70.53 -9.66 57.25 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.963 -1.086 . . . . 0.0 111.358 -176.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.1 tp -68.29 -58.82 3.8 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 115.923 -2.311 . . . . 0.0 106.692 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.703 HG23 ' HB3' ' A' ' 194' ' ' ASN . 1.4 t -72.49 -10.3 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.087 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.49 -61.6 1.86 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -63.08 -15.93 58.24 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.521 ' CD2' ' HA ' ' A' ' 219' ' ' MET . 53.8 t-80 -68.07 -43.69 78.02 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 117.921 -1.512 . . . . 0.0 107.835 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.783 ' CD ' ' HB1' ' A' ' 165' ' ' ALA . 31.5 mt-10 -83.47 -48.07 10.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.237 -0.915 . . . . 0.0 110.914 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.88 HG21 ' HA ' ' A' ' 121' ' ' LEU . 2.3 mt -61.06 -29.8 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.682 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.26 -31.93 45.15 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -57.21 -52.3 65.86 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.691 -0.887 . . . . 0.0 109.816 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.534 ' C ' HD22 ' A' ' 207' ' ' LEU . 28.6 t -79.74 -59.52 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.492 -0.755 . . . . 0.0 111.827 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.858 HD11 ' CD1' ' A' ' 92' ' ' TRP . 1.4 mm? -104.58 38.82 1.8 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.253 -0.904 . . . . 0.0 110.586 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.882 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -139.56 -73.41 0.05 OUTLIER Glycine 0 C--N 1.292 -1.913 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 210' ' ' PHE . 3.5 pp 179.33 -162.42 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.655 -1.497 . . . . 0.0 109.818 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.709 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.1 t80 -99.37 -79.97 0.48 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.104 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.497 ' CG ' ' HG2' ' A' ' 219' ' ' MET . 11.5 m80 -153.92 77.22 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -62.18 -172.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 108.924 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.991 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.26 77.81 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.946 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.01 13.14 8.06 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.789 -177.027 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER -50.27 -28.44 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 174.373 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.538 ' C ' ' HB3' ' A' ' 235' ' ' SER . 6.5 mt-10 -115.96 -39.65 3.43 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.946 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.15 164.8 8.03 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 122.451 1.12 . . . . 0.0 111.99 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.711 HD21 HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -67.33 -15.5 63.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.339 -177.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -77.59 -9.72 59.1 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 118.976 -2.328 . . . . 0.0 112.294 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.663 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 45.7 t80 -137.42 17.27 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.293 -1.505 . . . . 0.0 113.506 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.648 ' HG3' ' HA ' ' A' ' 218' ' ' LEU . 57.5 Cg_endo -79.47 -36.35 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 N-CA-C 108.747 -1.29 . . . . 0.0 108.747 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.983 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.4 OUTLIER -16.93 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.983 ' N ' HD13 ' A' ' 222' ' ' LEU . 28.2 t80 -75.74 49.73 0.53 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.254 -0.904 . . . . 0.0 109.394 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 95.7 m-70 -160.85 -120.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.071 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.826 ' O ' HD12 ' A' ' 226' ' ' LEU . 14.7 m -173.44 110.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.727 -1.233 . . . . 0.0 109.891 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.37 65.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 109.852 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 188' ' ' LYS . 10.1 t -116.88 -7.91 11.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.591 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 1.6 t0 178.09 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.037 . . . . 0.0 110.642 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.982 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -30.32 -61.06 0.17 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.571 -0.706 . . . . 0.0 110.604 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.33 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.475 -0.765 . . . . 0.0 109.098 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.4 mtp180 -100.21 -26.97 13.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 108.925 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.689 ' HA ' HD23 ' A' ' 226' ' ' LEU . 11.6 p90 -27.77 121.42 0.11 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.349 0.595 . . . . 0.0 111.598 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.13 170.52 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.443 -0.786 . . . . 0.0 109.809 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.118 HD21 ' CH2' ' A' ' 124' ' ' TRP . 1.8 mp -81.41 162.15 23.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 110.076 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.823 ' OG ' ' HB2' ' A' ' 217' ' ' ALA . 9.0 p -103.5 -167.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.306 -1.357 . . . . 0.0 110.51 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -84.83 -14.48 47.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 111.723 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.991 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.3 m-20 -84.84 -45.2 12.54 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.2 -1.563 . . . . 0.0 107.809 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.653 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 2.6 m-20 -64.99 -41.4 95.43 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.39 -35.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.21 -47.4 73.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 244' ' ' SER . . . -57.94 -55.47 30.42 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.024 HG21 HG21 ' A' ' 127' ' ' VAL . 1.5 tp -60.14 -46.03 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.977 -1.308 . . . . 0.0 109.227 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.572 ' N ' HG23 ' A' ' 242' ' ' ILE . 34.8 tt0 -56.3 -25.23 47.86 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 0.0 OUTLIER -78.16 -21.87 49.57 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.476 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.666 ' HB2' HD12 ' A' ' 242' ' ' ILE . 9.0 mt -72.61 -66.42 0.66 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.881 ' OH ' HD21 ' A' ' 97' ' ' LEU . 71.5 m-85 . . . . . 0 C--N 1.29 -1.989 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.145 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 1.034 ' CE ' ' HB1' ' A' ' 169' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.097 0.475 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.567 ' CD1' ' HA ' ' A' ' 207' ' ' LEU . 10.0 m95 -82.86 176.8 9.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 109.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.74 -41.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.148 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.877 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.24 172.04 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.681 0.753 . . . . 0.0 110.275 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.955 ' HA ' HD13 ' A' ' 130' ' ' LEU . 42.9 p -110.3 7.46 23.07 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.572 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 51.1 m80 -144.14 96.28 2.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.866 -1.147 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.877 HD13 ' HE2' ' A' ' 94' ' ' LYS . 2.9 mm? -96.59 164.45 12.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.53 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.627 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -136.89 155.98 49.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 108.519 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 1.007 ' CE2' HD11 ' A' ' 101' ' ' ILE . 7.7 p90 -135.18 170.3 16.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 109.473 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.554 ' HD2' HG22 ' A' ' 102' ' ' VAL . 1.1 ttm180 -131.56 128.12 38.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.007 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -86.81 82.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.198 . . . . 0.0 109.725 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 13.0 t -99.09 7.53 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.288 -0.883 . . . . 0.0 109.828 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.922 ' C ' HG21 ' A' ' 113' ' ' VAL . 5.4 m120 -98.9 160.46 14.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.978 -1.076 . . . . 0.0 109.166 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.745 ' N ' HG21 ' A' ' 113' ' ' VAL . 7.5 t80 177.67 77.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 1.104 HG21 ' CD1' ' A' ' 186' ' ' TRP . 61.1 p -69.58 155.66 93.11 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 -25.39 39.73 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 123.766 1.403 . . . . 0.0 108.637 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.657 ' O ' HD23 ' A' ' 108' ' ' LEU . 2.5 m-20 -74.26 -5.93 44.95 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 195' ' ' LEU . 62.0 mt -140.16 121.21 9.34 Favored Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.454 -0.779 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.9 169.28 13.56 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 123.881 1.463 . . . . 0.0 108.716 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.483 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.62 -65.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.5 t0 -55.26 -26.93 43.03 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.716 -0.615 . . . . 0.0 111.799 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.769 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.9 -61.36 1.87 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.435 -1.415 . . . . 0.0 109.329 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.922 HG21 ' C ' ' A' ' 103' ' ' ASN . 12.8 p -53.04 -41.33 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 1.003 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -64.45 -26.93 68.66 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.901 ' OG ' HD21 ' A' ' 195' ' ' LEU . 6.0 p -62.99 -42.37 99.83 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.069 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -70.7 -33.01 70.43 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 0.0 109.638 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.952 HG13 HG13 ' A' ' 144' ' ' ILE . 47.1 t -74.57 -23.26 17.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.1 tt0 -90.04 -33.77 16.2 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.679 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.59 -37.15 28.09 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -66.46 -62.1 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.938 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.4 pp -55.47 -41.89 73.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.097 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.817 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -71.52 -33.6 69.35 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.641 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.035 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.18 -42.04 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.067 ' O ' HG23 ' A' ' 128' ' ' THR . 33.7 m95 -91.29 -22.88 20.34 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 28.3 tt0 -71.42 -27.47 63.32 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.2 pt-20 -90.46 -43.59 10.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.612 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.3 m -58.0 -25.91 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.072 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.067 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -104.95 163.49 17.06 Favored Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 117.966 -1.494 . . . . 0.0 110.492 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.641 ' O ' HD23 ' A' ' 130' ' ' LEU . 50.6 Cg_endo -87.26 29.8 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.379 2.053 . . . . 0.0 111.289 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.014 HD12 ' CD2' ' A' ' 246' ' ' TYR . 34.5 mt -121.27 -166.6 1.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.61 -1.306 . . . . 0.0 110.474 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.2 p -123.01 176.68 5.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.645 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.777 ' HZ ' HD13 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -139.25 167.98 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 109.671 -179.554 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.512 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -151.14 169.34 22.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 108.589 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.715 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -140.56 167.43 22.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.803 -1.186 . . . . 0.0 110.545 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.042 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -156.76 -133.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 12.7 t80 178.01 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 138' ' ' GLY . 7.5 pm0 -161.39 -171.85 3.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.02 -98.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 140' ' ' ALA . 3.1 pt-20 178.41 107.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -1.111 . . . . 0.0 110.34 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 1.042 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -60.24 -150.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 108.722 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.669 ' C ' HD12 ' A' ' 142' ' ' ILE . 72.3 m-20 -88.48 -33.88 17.65 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.861 ' N ' HD12 ' A' ' 142' ' ' ILE . 3.4 mp -126.3 79.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.542 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -67.74 101.54 1.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.853 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.952 HG13 HG13 ' A' ' 117' ' ' VAL . 5.5 mm -81.61 119.69 31.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.6 OUTLIER -138.35 158.5 44.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.347 -1.471 . . . . 0.0 112.063 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.623 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 22.2 p90 -90.67 139.77 30.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.472 -0.768 . . . . 0.0 109.625 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.119 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.1 -160.47 0.68 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 1.004 HG21 ' HB2' ' A' ' 183' ' ' ASP . 0.8 OUTLIER 179.65 -157.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.918 -1.113 . . . . 0.0 109.531 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.795 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--O 1.215 -0.675 0 N-CA-C 109.57 -0.973 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.748 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -72.88 -163.08 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.097 -1.002 . . . . 0.0 109.927 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.763 ' OD1' HG23 ' A' ' 163' ' ' VAL . 23.3 p30 179.2 54.45 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.877 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -0.16 -68.72 0.0 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 112.274 -0.33 . . . . 0.0 112.274 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.4 Cg_endo -67.55 59.52 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.21 1.11 . . . . 0.0 109.664 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -168.79 160.62 34.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 164' ' ' LEU . 5.5 m120 -52.57 -47.72 66.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -1.199 . . . . 0.0 110.086 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.763 HG23 ' OD1' ' A' ' 158' ' ' ASP . 2.6 m -51.46 89.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 0.0 109.728 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.035 HD21 HG21 ' A' ' 193' ' ' THR . 0.3 OUTLIER -76.32 -82.53 0.07 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.869 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -137.33 -175.32 4.02 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.491 -1.38 . . . . 0.0 111.154 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.748 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.7 p-80 179.34 169.35 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 119.899 -1.751 . . . . 0.0 110.524 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.63 -172.51 3.18 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.498 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.536 ' CB ' HG13 ' A' ' 174' ' ' ILE . 64.1 m-85 -118.09 -167.28 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.072 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.034 ' HB1' ' CE ' ' A' ' 91' ' ' LYS . . . -162.93 -64.72 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.639 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.974 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 43.0 Cg_endo -72.87 172.36 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.792 1.417 . . . . 0.0 110.362 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.549 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 90.4 165.25 40.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.8 Cg_endo -73.99 -94.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.629 1.553 . . . . 0.0 110.54 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.2 -35.0 82.48 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 170' ' ' PRO . 9.4 tp -71.37 4.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.287 -1.125 . . . . 0.0 109.201 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 172' ' ' PRO . 1.2 p30 -66.08 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.89 . . . . 0.0 109.334 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 114.93 94.1 1.96 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -151.95 118.12 5.56 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.671 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -107.75 163.22 13.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.085 . . . . 0.0 109.201 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.119 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -159.78 134.62 7.9 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.11 178.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.671 ' H ' HD22 ' A' ' 103' ' ' ASN . 17.1 m-85 -97.09 129.88 44.44 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.115 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.556 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -63.47 124.86 22.41 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.827 -1.549 . . . . 0.0 107.171 177.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.502 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.1 OUTLIER -98.35 31.68 2.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 110.56 -178.062 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 1.004 ' HB2' HG21 ' A' ' 148' ' ' VAL . 49.2 t0 -107.9 -3.97 18.41 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.436 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.529 ' HG2' ' CA ' ' A' ' 159' ' ' GLY . 4.5 pt-20 -116.32 -111.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.028 . . . . 0.0 108.872 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 54.4 mt-30 -148.58 177.88 9.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.723 -1.236 . . . . 0.0 109.15 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 1.104 ' CD1' HG21 ' A' ' 105' ' ' THR . 88.2 m95 -161.98 126.14 3.23 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.115 -0.99 . . . . 0.0 108.998 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.879 ' HA ' HD21 ' A' ' 108' ' ' LEU . 65.7 p -147.2 153.7 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.676 -1.265 . . . . 0.0 110.723 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.882 ' HB3' HD22 ' A' ' 195' ' ' LEU . 17.4 pttt -85.09 -32.69 22.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.7 t70 -86.09 64.03 8.35 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.998 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.5 t 3.19 60.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.185 0.993 . . . . 0.0 111.94 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.2 m -125.44 -30.87 3.07 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.055 -1.028 . . . . 0.0 109.787 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.631 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -95.31 -80.0 1.49 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.035 HG21 HD21 ' A' ' 164' ' ' LEU . 47.1 m -127.84 -95.89 0.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.926 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -160.5 72.79 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 108.971 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 108' ' ' LEU . 2.2 tp -37.07 -96.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.671 0.748 . . . . 0.0 110.448 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.887 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -68.61 -5.15 18.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.132 -0.98 . . . . 0.0 110.848 -177.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.918 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.1 tp -69.0 -67.7 0.45 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 116.836 -1.946 . . . . 0.0 106.479 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.926 HG23 ' HB2' ' A' ' 194' ' ' ASN . 2.4 t -68.03 -9.77 11.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.069 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.0 -59.04 2.89 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.808 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -65.15 -15.22 62.18 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 219' ' ' MET . 10.9 t60 -69.27 -42.96 74.85 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 117.76 -1.576 . . . . 0.0 107.95 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.796 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 1.3 mt-10 -83.97 -47.37 11.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.865 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.938 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.0 mt -63.11 -29.51 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.699 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -77.31 -31.55 51.21 Favored Glycine 0 C--N 1.295 -1.737 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -64.26 -44.22 92.41 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 121.812 -0.817 . . . . 0.0 111.212 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.541 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 49.7 m -86.97 -53.12 5.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 112.61 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 208' ' ' GLY . 2.2 pp -104.36 -2.61 25.24 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.861 -1.149 . . . . 0.0 111.388 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.991 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -96.92 -84.58 1.74 Allowed Glycine 0 C--N 1.291 -1.966 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.866 HD11 ' OD1' ' A' ' 238' ' ' ASP . 1.8 pp -165.35 -159.33 0.42 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.037 -1.272 . . . . 0.0 109.658 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.591 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -96.56 -84.94 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.529 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 211' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -153.18 104.57 2.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.067 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.607 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -92.1 -167.33 1.74 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.213 -0.929 . . . . 0.0 109.56 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.697 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.17 81.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.989 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.4 6.62 22.53 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.761 -177.01 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 214' ' ' ASN . 7.8 p -50.82 -27.44 7.32 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.506 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.2 mt-10 -117.29 -36.05 3.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.989 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.95 179.17 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.162 0.982 . . . . 0.0 111.699 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.918 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.4 tp -96.05 -10.16 29.14 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.393 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.578 ' HE3' ' CZ2' ' A' ' 124' ' ' TRP . 9.1 mmt -74.26 -16.73 60.94 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.726 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.5 OUTLIER -143.5 23.6 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 C-N-CA 117.621 -1.631 . . . . 0.0 113.422 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.678 ' HG3' ' HA ' ' A' ' 218' ' ' LEU . 55.6 Cg_endo -75.39 -31.47 5.7 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 N-CA-C 106.795 -2.04 . . . . 0.0 106.795 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 223' ' ' TYR . 1.9 tm? -8.06 -65.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.326 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.878 ' N ' HD13 ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.76 59.59 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.8 OUTLIER -175.57 -144.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.375 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.926 ' HB3' HG21 ' A' ' 190' ' ' THR . 44.5 m -146.41 112.81 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.048 -1.033 . . . . 0.0 109.956 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.61 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.431 -0.793 . . . . 0.0 109.26 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.544 HG21 ' O ' ' A' ' 187' ' ' THR . 9.1 t -108.26 -9.09 15.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.296 -0.877 . . . . 0.0 109.591 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.603 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 177.59 -20.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 110.854 179.275 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.998 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.22 -61.1 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.446 -0.783 . . . . 0.0 110.651 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.35 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.587 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.603 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 51.7 p90 -31.58 120.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.488 0.661 . . . . 0.0 111.028 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.563 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.12 168.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.056 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.5 mp -82.82 168.49 17.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.83 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 6.5 t -98.47 -171.13 2.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.737 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.576 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -83.08 -19.24 37.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.563 -0.71 . . . . 0.0 109.449 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.697 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 5.2 m-20 -82.76 -42.24 18.22 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.866 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.3 m-20 -66.62 -41.03 89.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 117.411 -1.715 . . . . 0.0 106.879 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -56.75 -35.12 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -67.11 -45.01 78.48 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.409 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -62.03 -58.91 10.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.012 HG21 HG21 ' A' ' 127' ' ' VAL . 1.9 tp -62.76 -50.41 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.987 -1.302 . . . . 0.0 110.116 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.581 ' N ' HG23 ' A' ' 242' ' ' ILE . 15.1 tt0 -53.37 -26.12 18.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.2 t -90.4 -10.67 43.02 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -79.84 -52.79 7.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 1.014 ' CD2' HD12 ' A' ' 130' ' ' LEU . 5.2 m-30 . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.95 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HE2' ' HB2' ' A' ' 169' ' ' ALA . 1.6 tttt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.914 ' CD1' HD12 ' A' ' 207' ' ' LEU . 2.8 m95 -74.53 -165.98 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -167.19 -33.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.8 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -50.54 -172.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.385 -0.822 . . . . 0.0 110.619 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.763 ' CA ' HD21 ' A' ' 130' ' ' LEU . 1.2 p -117.35 -4.79 11.32 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.618 -0.676 . . . . 0.0 109.242 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 131' ' ' THR . 21.7 m-70 -144.22 95.24 2.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.667 HD11 ' CD1' ' A' ' 92' ' ' TRP . 19.4 mt -86.56 -175.44 5.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.68 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -158.63 156.72 30.54 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.326 -0.859 . . . . 0.0 108.714 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.903 ' CE1' HD22 ' A' ' 121' ' ' LEU . 13.4 p90 -134.62 164.83 26.63 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.535 -1.353 . . . . 0.0 110.151 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.734 ' HG3' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -131.38 128.38 39.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.75 HG13 HG11 ' A' ' 117' ' ' VAL . 1.5 mp -86.14 81.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.378 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.585 ' N ' ' O ' ' A' ' 144' ' ' ILE . 16.1 t -96.22 13.77 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.909 ' C ' HG21 ' A' ' 113' ' ' VAL . 7.8 m120 -107.86 156.12 19.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.81 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.7 OUTLIER 178.97 42.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.64 -0.662 . . . . 0.0 109.914 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.563 HG22 ' OD1' ' A' ' 182' ' ' ASP . 13.8 p -43.74 155.84 0.31 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 108.911 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.91 -21.7 43.44 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.762 1.401 . . . . 0.0 108.94 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -69.97 -8.0 45.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.024 HD13 HD12 ' A' ' 195' ' ' LEU . 84.8 mt -144.83 120.66 6.01 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.534 -0.729 . . . . 0.0 109.756 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.74 172.09 8.74 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.748 1.394 . . . . 0.0 108.981 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.55 -65.29 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.801 0.81 . . . . 0.0 110.384 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -55.98 -30.81 62.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.64 . . . . 0.0 112.15 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.871 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.45 -59.84 2.53 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.439 -1.413 . . . . 0.0 109.793 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.909 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.8 p -55.13 -39.13 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -66.9 -27.11 67.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.868 ' OG ' HD21 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -67.6 -41.0 84.74 Favored 'General case' 0 C--O 1.202 -1.43 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.336 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.068 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -72.6 -32.77 66.22 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 120.912 -1.117 . . . . 0.0 109.806 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.032 HG22 HG21 ' A' ' 144' ' ' ILE . 88.7 t -75.96 -23.65 16.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -90.69 -33.26 15.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.747 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.2 OUTLIER -81.47 -37.45 27.94 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.979 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -68.3 -61.92 1.63 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.903 HD22 ' CE1' ' A' ' 99' ' ' TYR . 1.4 pp -54.71 -41.8 70.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.065 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.816 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.15 -33.23 63.45 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.265 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.998 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.22 -40.14 63.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.088 ' CH2' HD21 ' A' ' 234' ' ' LEU . 44.5 m95 -91.35 -23.22 20.16 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.486 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.533 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 79.9 tt0 -71.9 -28.25 63.37 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.757 -1.214 . . . . 0.0 108.279 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.4 pt-20 -89.92 -43.53 10.52 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.798 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.998 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.2 m -60.44 -24.26 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.511 -1.276 . . . . 0.0 109.172 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.084 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.6 OUTLIER -100.54 155.79 35.96 Favored Pre-proline 0 N--CA 1.5 2.065 0 C-N-CA 117.943 -1.503 . . . . 0.0 111.008 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -84.74 27.62 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 110.46 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.763 HD21 ' CA ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -117.84 -175.39 2.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.704 -1.247 . . . . 0.0 110.66 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.57 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -109.64 169.85 8.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.436 -0.79 . . . . 0.0 110.09 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.607 ' CE1' ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -149.05 162.14 40.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 110.082 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.57 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -140.2 -168.22 2.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.639 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -158.84 157.22 31.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 0.0 110.391 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.734 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -159.89 -165.21 1.45 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.406 -0.809 . . . . 0.0 109.307 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 15.8 t80 -153.33 19.78 0.56 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.385 -0.822 . . . . 0.0 108.914 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -141.4 -172.32 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -0.791 . . . . 0.0 109.341 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.18 -98.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER 178.45 117.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 110.509 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.68 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -75.67 -148.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 108.899 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.637 ' OD2' HG22 ' A' ' 98' ' ' THR . 59.8 m-20 -100.32 -25.03 14.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.804 HG21 HG23 ' A' ' 203' ' ' ILE . 2.9 mt -124.35 76.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 1.7 ttt -64.33 93.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 1.032 HG21 HG22 ' A' ' 117' ' ' VAL . 9.1 mm -80.04 106.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.577 ' CB ' ' HB ' ' A' ' 102' ' ' VAL . 0.3 OUTLIER -131.76 162.56 30.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.24 -1.538 . . . . 0.0 112.342 -178.305 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.493 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 46.9 p90 -82.55 134.38 35.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.442 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.132 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -152.08 162.11 41.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.037 . . . . 0.0 110.418 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.797 HG21 ' CG ' ' A' ' 183' ' ' ASP . 1.8 p -167.04 -163.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.718 ' H ' HG22 ' A' ' 148' ' ' VAL . 5.3 mtm-85 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 C--O 1.216 -0.622 0 N-CA-C 109.377 -1.047 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.686 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -112.94 -170.41 1.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 110.978 -178.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.588 ' O ' ' C ' ' A' ' 159' ' ' GLY . 17.4 p30 -176.18 63.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.898 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -12.38 -61.35 0.01 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 37.0 Cg_endo -63.56 66.11 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.551 1.29 . . . . 0.0 109.651 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 177.87 143.88 5.24 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' LEU . 30.4 m-80 -37.79 -44.6 0.75 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.634 -0.921 . . . . 0.0 110.221 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.679 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 17.8 t -42.4 95.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 109.33 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.9 HD12 HD11 ' A' ' 222' ' ' LEU . 1.9 mt -90.17 -38.89 13.18 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 113.133 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.613 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . 179.43 -171.12 0.14 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.799 -1.813 . . . . 0.0 111.449 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.686 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.2 p-80 179.15 -170.28 0.12 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.376 -1.453 . . . . 0.0 111.33 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -153.45 179.2 9.01 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.437 -0.789 . . . . 0.0 110.235 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.59 ' O ' ' CB ' ' A' ' 206' ' ' SER . 11.0 m-85 -127.6 162.41 26.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.894 -1.129 . . . . 0.0 111.149 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.977 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -144.49 -67.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.977 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 40.7 Cg_endo -70.75 94.89 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.489 1.257 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 159.09 145.14 4.16 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -71.57 145.86 48.06 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.511 1.474 . . . . 0.0 110.083 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 67.81 -64.05 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.3 OUTLIER -74.24 5.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.414 -1.051 . . . . 0.0 108.896 178.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 171' ' ' GLY . 0.5 OUTLIER -63.9 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 115.05 89.1 1.6 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.696 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -155.64 118.96 4.36 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.641 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -108.76 128.57 54.99 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.186 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.132 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -113.59 132.46 55.73 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.894 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.683 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 16.0 m-85 -93.37 125.0 37.74 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.198 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.657 ' OD1' HG23 ' A' ' 148' ' ' VAL . 22.6 t0 -50.1 135.05 21.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.667 -1.271 . . . . 0.0 108.262 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.563 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.1 OUTLIER -106.22 24.27 12.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 110.232 -178.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.797 ' CG ' HG21 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -129.13 24.37 5.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 159' ' ' GLY . 2.3 mt-10 -129.03 -90.26 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.138 -0.976 . . . . 0.0 109.408 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.628 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 1.7 mt-30 179.89 170.22 1.16 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.683 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.0 m95 -158.63 124.16 4.4 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.022 -1.049 . . . . 0.0 109.795 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.856 ' HA ' HD21 ' A' ' 108' ' ' LEU . 67.9 p -148.32 149.78 32.45 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.925 -1.109 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.814 ' HB3' HD22 ' A' ' 195' ' ' LEU . 8.5 pttt -84.14 -32.46 24.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.7 t70 -83.49 61.73 6.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.982 ' OG1' HD21 ' A' ' 229' ' ' LEU . 15.7 m 3.08 64.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.71 0.767 . . . . 0.0 111.384 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 189' ' ' ASP . 41.9 m -130.74 -31.64 1.74 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.762 -0.587 . . . . 0.0 109.635 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.45 -77.89 1.39 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.659 HG21 ' CD2' ' A' ' 164' ' ' LEU . 13.4 m -128.35 -81.61 0.58 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.481 -1.011 . . . . 0.0 108.774 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.979 ' HB3' HG23 ' A' ' 198' ' ' VAL . 1.9 m-20 -177.47 67.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.586 -0.845 . . . . 0.0 108.991 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.061 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -32.4 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.58 0.705 . . . . 0.0 110.537 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.899 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -71.78 -8.74 56.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.839 -1.163 . . . . 0.0 110.929 -178.059 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.673 HD11 ' CG ' ' A' ' 221' ' ' PRO . 14.8 tp -70.76 -56.29 6.71 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 116.262 -2.175 . . . . 0.0 107.207 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.012 HG12 ' OE2' ' A' ' 202' ' ' GLU . 9.1 t -77.87 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.068 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.26 -58.8 3.06 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.53 -19.71 65.85 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.593 ' CD2' ' HA ' ' A' ' 219' ' ' MET . 15.9 t-80 -66.17 -41.81 89.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 116.873 -1.931 . . . . 0.0 107.882 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 1.012 ' OE2' HG12 ' A' ' 198' ' ' VAL . 8.3 mt-10 -84.1 -49.1 9.2 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.145 -0.972 . . . . 0.0 110.792 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.979 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -57.85 -31.74 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.735 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -80.6 -35.3 26.02 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -57.95 -47.71 82.11 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.423 -1.045 . . . . 0.0 110.519 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.662 ' C ' HD13 ' A' ' 207' ' ' LEU . 1.4 p -86.08 -58.46 2.63 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 111.906 -177.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.914 HD12 ' CD1' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -104.43 33.97 3.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.81 -1.181 . . . . 0.0 110.114 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 1.078 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -132.06 -77.21 0.13 Allowed Glycine 0 C--N 1.29 -1.973 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.85 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -165.69 -160.72 0.47 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.999 -1.295 . . . . 0.0 109.62 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.792 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.7 t80 -101.7 -71.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 20.7 m80 -163.78 100.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.865 . . . . 0.0 108.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.7 OUTLIER -90.27 -175.93 4.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.882 . . . . 0.0 109.249 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.916 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -63.86 78.33 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.972 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.26 9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.56 -177.209 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -50.64 -27.78 7.58 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.517 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.0 OUTLIER -114.51 -37.58 4.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.521 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.972 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.33 -171.28 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.334 1.064 . . . . 0.0 112.418 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.703 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -89.95 -16.54 29.7 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.735 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.593 ' HA ' ' CD2' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -77.5 -9.57 58.98 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.476 -2.015 . . . . 0.0 112.436 -177.36 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.674 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 4.7 t80 -136.49 16.58 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.229 -1.545 . . . . 0.0 113.404 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.883 ' CB ' HD11 ' A' ' 226' ' ' LEU . 56.2 Cg_endo -78.81 -40.07 0.33 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 108.711 -1.304 . . . . 0.0 108.711 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.9 HD11 HD12 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -7.83 -77.07 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.257 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.41 ' N ' HD23 ' A' ' 222' ' ' LEU . 1.7 t80 -67.99 59.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.244 -0.91 . . . . 0.0 108.955 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.5 t-80 -163.61 -124.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.339 -0.851 . . . . 0.0 108.974 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.514 ' HA ' HG21 ' A' ' 190' ' ' THR . 62.5 m -168.78 104.44 0.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.697 -1.252 . . . . 0.0 110.342 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.883 HD11 ' CB ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER 178.92 48.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 188' ' ' LYS . 9.2 t -98.69 -15.71 19.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.064 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.586 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 178.09 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.429 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.982 HD21 ' OG1' ' A' ' 190' ' ' THR . 0.3 OUTLIER -32.95 -56.95 0.38 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.13 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -86.22 -16.63 37.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.6 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 25.4 p90 -32.34 111.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.719 0.771 . . . . 0.0 110.933 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.569 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.6 ttt180 179.22 149.73 0.28 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.088 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -73.03 167.22 21.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.99 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 28.8 t -99.56 -170.6 1.92 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.969 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.526 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.02 -13.35 50.82 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.011 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.916 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 3.1 m-20 -84.85 -46.75 11.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.657 -1.277 . . . . 0.0 107.783 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.85 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -65.12 -39.3 92.89 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 117.226 -1.79 . . . . 0.0 106.549 177.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.596 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.66 -35.45 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.355 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.98 -50.36 62.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.14 60.75 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.078 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.7 tp -66.37 -49.18 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.837 -1.39 . . . . 0.0 110.132 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.572 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.9 tt0 -54.03 -25.05 19.33 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.7 p -92.73 -9.87 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -77.86 -51.25 10.76 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.548 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 5.4 m-30 . . . . . 0 N--CA 1.494 1.73 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.83 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.611 ' HG3' ' CD1' ' A' ' 92' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.611 ' CD1' ' HG3' ' A' ' 91' ' ' LYS . 89.9 m95 -105.02 149.56 25.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.883 -1.136 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.21 -33.29 5.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.734 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.675 ' CE ' HD13 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -44.75 175.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.438 -0.789 . . . . 0.0 110.345 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.791 ' HB ' HD12 ' A' ' 130' ' ' LEU . 7.1 p -109.11 5.05 23.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.47 -0.768 . . . . 0.0 109.78 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.563 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 47.9 m80 -146.88 94.44 2.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.831 -1.168 . . . . 0.0 110.538 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.811 ' N ' HD22 ' A' ' 97' ' ' LEU . 1.9 mm? -93.6 -176.54 4.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -0.794 . . . . 0.0 108.872 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 142' ' ' ILE . 1.1 t -146.82 154.28 41.16 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.97 -1.081 . . . . 0.0 109.084 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 1.037 ' CZ ' HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -133.79 166.53 22.43 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.712 -1.242 . . . . 0.0 109.914 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.856 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.39 133.14 46.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.037 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 2.4 mp -96.55 80.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 109.777 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.856 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 59.4 t -97.94 7.38 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.85 ' C ' HG21 ' A' ' 113' ' ' VAL . 35.2 m-80 -92.95 158.13 15.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.697 -1.252 . . . . 0.0 109.647 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.83 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.8 t80 178.16 82.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.532 -0.73 . . . . 0.0 109.555 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.811 HG21 ' CD1' ' A' ' 186' ' ' TRP . 1.3 p -75.98 159.27 81.08 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.12 -21.48 42.47 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.82 1.432 . . . . 0.0 108.779 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -78.1 -0.77 29.44 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.956 HD13 ' CD1' ' A' ' 195' ' ' LEU . 96.7 mt -150.63 120.64 3.73 Favored Pre-proline 0 N--CA 1.485 1.292 0 O-C-N 121.421 -0.799 . . . . 0.0 109.88 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.13 175.7 5.42 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.801 1.422 . . . . 0.0 109.334 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.22 -65.83 0.34 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.875 0.845 . . . . 0.0 110.341 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.65 -30.76 63.69 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.88 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.61 -60.68 2.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.25 -1.531 . . . . 0.0 109.54 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.945 ' O ' HG23 ' A' ' 117' ' ' VAL . 7.2 p -53.17 -41.2 41.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.572 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -62.22 -28.1 69.45 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.907 ' OG ' HD21 ' A' ' 195' ' ' LEU . 7.7 p -64.02 -42.87 96.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.092 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -71.11 -33.77 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 113' ' ' VAL . 1.5 t -75.55 -23.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -88.36 -34.94 17.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 3.5 tppt? -80.6 -36.39 32.84 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.44 -62.46 1.51 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.986 HD22 ' CG ' ' A' ' 99' ' ' TYR . 13.5 tp -52.47 -46.32 66.47 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.058 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -69.17 -33.82 73.99 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.33 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.949 HG13 HD22 ' A' ' 234' ' ' LEU . 0.9 OUTLIER -57.34 -36.69 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.102 ' CH2' HD21 ' A' ' 234' ' ' LEU . 55.4 m95 -91.68 -24.13 19.59 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.874 -1.131 . . . . 0.0 110.495 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.578 ' HG3' ' CD2' ' A' ' 132' ' ' PHE . 14.8 tt0 -71.81 -28.88 63.89 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.851 -1.155 . . . . 0.0 108.315 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.0 pt-20 -91.37 -42.93 10.06 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 242' ' ' ILE . 21.7 m -61.83 -23.34 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.206 -1.398 . . . . 0.0 109.802 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.047 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -104.29 161.73 22.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 117.14 -1.824 . . . . 0.0 110.298 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.864 ' C ' HD22 ' A' ' 130' ' ' LEU . 50.0 Cg_endo -80.72 13.12 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.609 1.847 . . . . 0.0 110.655 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.866 HD23 ' HB3' ' A' ' 246' ' ' TYR . 3.3 mm? -116.4 -176.94 3.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.953 -1.092 . . . . 0.0 110.093 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.509 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.4 p -124.72 170.42 11.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.66 ' CD2' HD11 ' A' ' 121' ' ' LEU . 21.6 m-85 -131.78 179.55 6.0 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.84 0.829 . . . . 0.0 110.023 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 98' ' ' THR . 17.5 m -142.44 -166.36 2.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 160.57 18.37 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.906 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.677 HD22 ' OE2' ' A' ' 137' ' ' GLU . 0.3 OUTLIER -159.63 -128.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 135' ' ' LEU . 0.1 OUTLIER 177.15 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.465 -1.397 . . . . 0.0 109.732 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.677 ' OE2' HD22 ' A' ' 135' ' ' LEU . 7.5 pm0 -151.47 -177.65 6.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 109.917 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.76 -97.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.99 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -1.105 . . . . 0.0 110.003 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.662 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -58.9 -155.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 108.959 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' THR . 76.7 m-20 -83.52 -26.07 30.48 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.01 HD11 HD22 ' A' ' 207' ' ' LEU . 2.1 mp -130.17 77.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.412 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.6 ttt -62.01 93.2 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 109.26 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.825 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.3 mm -82.12 109.06 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.495 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -134.29 153.54 51.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.492 -1.38 . . . . 0.0 111.652 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 20.0 p90 -86.98 139.58 30.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.179 -0.95 . . . . 0.0 109.406 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -168.54 -158.23 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 110.556 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.898 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.4 p -173.22 -158.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.706 ' N ' HG13 ' A' ' 148' ' ' VAL . 10.8 ptt180 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 109.564 -0.975 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.679 ' CD2' ' CE1' ' A' ' 166' ' ' HIS . 0.9 OUTLIER -71.22 -131.88 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.375 -0.828 . . . . 0.0 109.875 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.663 ' HB3' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -148.69 -36.03 0.19 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.42 -1.425 . . . . 0.0 110.194 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.594 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 69.01 -110.01 3.18 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 34.8 Cg_endo -59.97 76.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.063 1.033 . . . . 0.0 110.268 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -166.24 -160.78 13.98 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' VAL . 6.0 m120 -90.58 -48.91 6.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.259 -1.142 . . . . 0.0 110.477 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 158' ' ' ASP . 27.7 m -41.02 127.25 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.842 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.603 HD13 ' CG2' ' A' ' 193' ' ' THR . 13.6 mt -96.62 -40.01 9.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.321 -0.862 . . . . 0.0 112.717 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -178.49 -167.08 0.12 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 119.79 -1.819 . . . . 0.0 111.223 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 1.1 p-80 178.95 -174.03 0.18 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.208 -1.558 . . . . 0.0 111.358 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.636 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -149.63 -175.15 4.9 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.453 -0.78 . . . . 0.0 109.787 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.629 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -122.25 -162.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.838 -1.164 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.936 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -172.43 -60.2 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.466 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.936 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.4 Cg_endo -75.33 -178.69 4.42 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.858 1.451 . . . . 0.0 110.217 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 67.96 140.67 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -70.4 152.19 65.87 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.964 1.507 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . 67.83 -65.33 0.32 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.629 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -67.62 -3.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.482 -1.01 . . . . 0.0 109.143 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.547 ' ND2' ' CZ2' ' A' ' 92' ' ' TRP . 5.3 p-10 -65.29 65.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.754 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 126.33 82.64 0.45 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 1.7 m-20 -152.22 123.83 7.85 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.918 -1.343 . . . . 0.0 107.735 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -111.74 156.18 22.34 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.643 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -151.29 132.65 14.6 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.735 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.693 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 19.9 m-30 -87.69 126.8 35.18 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.898 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.898 ' OD1' HG23 ' A' ' 148' ' ' VAL . 34.2 t0 -68.67 134.38 49.79 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.449 -0.782 . . . . 0.0 109.295 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 183' ' ' ASP . 18.9 p-10 -61.45 -14.07 25.63 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.4 p30 3.96 -93.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.531 ' OE2' ' HB2' ' A' ' 183' ' ' ASP . 10.2 mp0 -127.26 -63.02 1.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.974 -1.079 . . . . 0.0 110.681 -177.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.539 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 28.4 mt-30 -158.58 176.7 12.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.873 -1.142 . . . . 0.0 110.393 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.811 ' CD1' HG21 ' A' ' 105' ' ' THR . 43.2 m95 -148.85 128.67 13.36 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.684 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.1 p -145.77 150.84 36.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.37 -1.456 . . . . 0.0 111.34 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.941 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -83.76 -34.08 24.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 38.4 t0 -85.53 62.06 7.24 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' THR . . . . . 1.001 ' HB ' HD21 ' A' ' 229' ' ' LEU . 6.1 t 3.73 60.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 122.002 0.906 . . . . 0.0 111.829 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 46.9 m -124.79 -31.31 3.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.419 -0.801 . . . . 0.0 109.57 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.611 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -95.53 -70.52 1.07 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.76 HG22 ' OD1' ' A' ' 194' ' ' ASN . 23.4 m -140.07 -95.92 0.16 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.831 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -158.85 70.33 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 108.87 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.001 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 1.7 tp -34.51 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.54 0.686 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.884 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -67.23 -6.95 20.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 110.845 -177.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.82 ' HA ' HD11 ' A' ' 218' ' ' LEU . 8.6 tp -68.11 -65.82 0.65 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 116.912 -1.915 . . . . 0.0 106.801 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.831 HG23 ' HB2' ' A' ' 194' ' ' ASN . 5.4 t -69.14 -11.41 14.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.092 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -72.23 -57.53 4.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.768 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -68.01 -15.66 63.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.645 ' CD2' ' HA ' ' A' ' 219' ' ' MET . 15.2 t-80 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.229 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.666 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 1.9 mm-40 -85.64 -45.23 11.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.938 -1.101 . . . . 0.0 110.616 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.1 mt -61.32 -31.67 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.753 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.85 -34.42 30.88 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -56.81 -47.11 81.01 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.508 -0.995 . . . . 0.0 109.946 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.564 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 6.1 p -83.97 -57.77 3.06 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.735 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 1.01 HD22 HD11 ' A' ' 142' ' ' ILE . 7.8 mp -103.75 37.31 2.07 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.246 -0.909 . . . . 0.0 110.503 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.962 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -139.31 -78.47 0.06 OUTLIER Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.81 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.901 HD21 ' CG ' ' A' ' 238' ' ' ASP . 4.5 pp -173.18 -159.37 0.11 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.716 -1.461 . . . . 0.0 110.367 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.875 ' N ' HD12 ' A' ' 209' ' ' LEU . 54.4 t80 -100.0 -91.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.664 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.593 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 3.2 m-70 -148.57 106.71 3.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 109.473 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.588 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -95.93 -172.53 2.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 109.214 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.419 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -60.41 85.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.931 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.68 10.13 19.17 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.247 -177.056 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 214' ' ' ASN . 28.9 p -50.88 -27.55 7.7 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.497 ' C ' ' HB2' ' A' ' 235' ' ' SER . 15.4 mt-10 -118.41 -35.13 3.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.802 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.1 -159.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.179 0.99 . . . . 0.0 112.575 -177.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.82 HD11 ' HA ' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -112.62 -1.72 14.76 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.111 -177.537 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.645 ' HA ' ' CD2' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -91.76 -9.71 42.65 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 119.997 -1.689 . . . . 0.0 110.637 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.774 ' HB2' HD21 ' A' ' 214' ' ' ASN . 3.2 t80 -137.11 14.31 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.79 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.921 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 1.036 ' HB3' HD11 ' A' ' 226' ' ' LEU . 55.5 Cg_endo -74.2 -39.89 1.45 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 N-CA-C 108.883 -1.237 . . . . 0.0 108.883 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.587 HD12 ' C ' ' A' ' 222' ' ' LEU . 2.9 tp -7.24 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.499 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 14.5 m-85 -67.57 59.86 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -163.25 -146.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.545 ' C ' HD23 ' A' ' 226' ' ' LEU . 65.5 m -144.65 101.05 3.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.975 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 1.036 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.44 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 109.074 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.573 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 9.3 t -92.06 -15.65 27.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.347 -0.845 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.676 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER 178.42 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.94 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 1.001 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.87 -98.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.453 -0.78 . . . . 0.0 111.242 -179.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.0 -13.87 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.78 -1.2 . . . . 0.0 109.77 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.573 ' O ' ' C ' ' A' ' 232' ' ' PHE . 2.4 mtp180 -106.2 -42.83 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 108.806 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 25.8 p90 0.36 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.244 0.545 . . . . 0.0 112.139 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 234' ' ' LEU . 0.0 OUTLIER 178.27 175.28 0.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.102 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.1 mp -85.66 163.53 18.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.569 -0.707 . . . . 0.0 110.98 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.904 ' O ' HD12 ' A' ' 239' ' ' ILE . 5.3 t -98.34 178.74 4.95 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.392 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.536 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.4 OUTLIER -71.04 -24.37 62.33 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.475 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.588 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.3 m-20 -83.46 -42.2 17.2 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.575 -1.328 . . . . 0.0 108.94 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.901 ' CG ' HD21 ' A' ' 209' ' ' LEU . 5.8 t0 -70.76 -40.26 72.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.821 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.904 HD12 ' O ' ' A' ' 235' ' ' SER . 7.2 mt -54.82 -40.65 53.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.508 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 25.6 t-20 -60.21 -45.42 93.26 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.851 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.62 -54.57 35.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.047 HG13 HG22 ' A' ' 128' ' ' THR . 0.8 OUTLIER -65.2 -47.95 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.725 -1.456 . . . . 0.0 110.621 -178.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 240' ' ' ASN . 15.9 pt20 -54.05 -25.09 19.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 t -88.18 -14.9 37.44 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.753 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -76.06 -56.29 4.79 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.866 ' HB3' HD23 ' A' ' 130' ' ' LEU . 49.6 m-85 . . . . . 0 N--CA 1.492 1.652 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.291 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 92' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 98.7 m95 -82.6 151.95 26.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.115 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.92 -40.49 4.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.134 -179.498 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -50.7 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 -179.647 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.479 ' C ' ' CD2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -118.17 2.11 11.97 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.496 -0.752 . . . . 0.0 109.369 179.503 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.565 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 24.9 m-70 -140.68 89.64 2.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.955 -1.091 . . . . 0.0 110.219 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.825 ' N ' HD22 ' A' ' 97' ' ' LEU . 2.3 mm? -87.68 173.09 9.23 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.652 -0.655 . . . . 0.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -142.16 155.85 45.33 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.087 -1.008 . . . . 0.0 108.73 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.925 ' CE2' HD11 ' A' ' 101' ' ' ILE . 5.4 p90 -137.88 164.79 28.09 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.714 -1.242 . . . . 0.0 108.667 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.653 ' HD3' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.089 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.925 HD11 ' CE2' ' A' ' 99' ' ' TYR . 1.5 mp -96.87 61.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 109.698 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.653 HG23 ' HD3' ' A' ' 100' ' ' ARG . 21.5 t -77.58 4.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.889 HD22 HG22 ' A' ' 144' ' ' ILE . 5.4 m-20 -92.92 155.94 17.25 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.983 -1.073 . . . . 0.0 110.073 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.762 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.4 t80 176.26 150.98 0.14 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.489 ' CG2' ' C ' ' A' ' 104' ' ' TYR . 3.9 p -156.23 161.11 30.16 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -67.71 -24.68 40.76 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 N-CA-C 108.079 -1.547 . . . . 0.0 108.079 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.734 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.5 t0 -73.82 -12.24 60.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.08 HD13 HD12 ' A' ' 195' ' ' LEU . 76.2 mt -143.38 115.41 5.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.28 167.34 12.97 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.63 1.332 . . . . 0.0 109.101 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HE3' ' CG ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.25 -66.17 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.805 0.812 . . . . 0.0 110.322 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.32 -11.88 7.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.728 -0.607 . . . . 0.0 111.62 -178.518 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.708 ' O ' HD11 ' A' ' 195' ' ' LEU . . . -85.32 -60.4 2.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.488 -1.383 . . . . 0.0 109.213 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.917 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.5 p -55.7 -39.49 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.701 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -64.62 -27.56 69.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.746 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -65.7 -41.61 92.14 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.126 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -69.7 -33.34 72.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.0 t -74.95 -24.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -87.32 -35.31 18.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.703 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 0.3 OUTLIER -80.26 -36.73 34.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.731 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -66.09 -60.8 2.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.532 1.158 . . . . 0.0 107.913 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.854 ' HA ' HG21 ' A' ' 203' ' ' ILE . 16.2 tp -54.12 -48.24 70.97 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.654 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -67.39 -33.72 75.79 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.241 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.029 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -55.93 -42.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.034 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.0 m95 -91.21 -23.16 20.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.588 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 18.5 tt0 -71.16 -27.56 63.64 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.6 pt-20 -90.15 -43.55 10.37 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.029 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.6 m -58.49 -25.36 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.124 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.028 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -112.1 162.28 22.06 Favored Pre-proline 0 N--CA 1.497 1.922 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.834 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -84.91 27.98 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.134 1.889 . . . . 0.0 110.483 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.853 HD22 ' CG ' ' A' ' 246' ' ' TYR . 1.9 mp -109.44 178.99 4.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.247 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.561 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 2.8 p -124.41 170.26 11.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.8 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 1.063 ' CZ ' HD13 ' A' ' 207' ' ' LEU . 12.5 m-85 -146.04 171.41 14.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.15 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.4 m -145.22 -175.13 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.652 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -163.83 149.94 11.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 0.0 110.501 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.769 ' N ' HD12 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -167.59 -98.71 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 136' ' ' TYR . 15.9 t80 177.06 30.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.955 -1.091 . . . . 0.0 109.195 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.558 ' H ' HD13 ' A' ' 135' ' ' LEU . 7.3 tp10 -65.63 169.63 6.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.566 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -41.79 -34.87 1.37 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -178.22 104.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.556 -0.967 . . . . 0.0 109.894 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.541 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.4 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 98' ' ' THR . 71.5 m-20 -80.67 -30.49 36.53 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.97 -1.081 . . . . 0.0 108.794 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.914 HG12 HD23 ' A' ' 207' ' ' LEU . 4.4 mp -129.14 78.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.431 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.9 ttp -62.66 98.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.207 -0.933 . . . . 0.0 109.297 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.889 HG22 HD22 ' A' ' 103' ' ' ASN . 3.9 mm -84.76 107.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -132.9 152.22 51.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 112.322 -178.042 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 24.5 p90 -77.44 146.6 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.561 -0.712 . . . . 0.0 109.586 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.796 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -165.04 163.69 20.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -0.929 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.888 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.2 p -160.79 -160.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.96 . . . . 0.0 109.368 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.696 ' N ' HG13 ' A' ' 148' ' ' VAL . 36.7 mtm180 . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.115 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 C--O 1.215 -0.668 0 N-CA-C 109.379 -1.046 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.744 ' CE1' HG13 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -120.71 -171.53 2.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.079 -1.013 . . . . 0.0 110.848 -179.014 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.57 ' O ' ' C ' ' A' ' 159' ' ' GLY . 17.0 p30 -175.92 62.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.82 -0.55 . . . . 0.0 109.636 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -8.97 -63.53 0.01 OUTLIER Glycine 0 N--CA 1.505 3.283 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 37.1 Cg_endo -64.02 66.56 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.442 1.233 . . . . 0.0 109.94 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 178.02 151.59 9.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' LEU . 15.2 m-20 -42.58 -32.57 0.58 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.166 . . . . 0.0 109.667 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.744 HG13 ' CE1' ' A' ' 157' ' ' PHE . 39.6 t -44.68 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.7 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.964 HD23 ' CG1' ' A' ' 198' ' ' VAL . 3.1 tp -88.14 -52.01 5.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.12 -0.987 . . . . 0.0 112.286 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.749 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -176.48 -165.34 0.13 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.151 -1.593 . . . . 0.0 111.142 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.684 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.72 -175.29 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.01 -1.681 . . . . 0.0 111.43 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -155.51 176.82 12.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.562 -0.711 . . . . 0.0 109.907 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.527 ' O ' ' CB ' ' A' ' 206' ' ' SER . 25.4 m-85 -120.06 -168.89 1.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.312 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.973 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -159.74 -64.03 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 0.0 109.602 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.973 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -76.58 174.82 12.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.651 1.343 . . . . 0.0 110.051 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 105.98 170.82 23.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 175' ' ' ASN . 44.3 Cg_endo -76.43 -56.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 121.603 1.535 . . . . 0.0 109.874 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.62 -40.25 1.03 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.7 tp -62.88 -7.09 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.463 -1.022 . . . . 0.0 108.867 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.524 ' CA ' ' O ' ' A' ' 169' ' ' ALA . 4.4 p-10 -66.0 65.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 108.991 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 206' ' ' SER . . . 127.55 80.76 0.32 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.2 m-20 -156.83 120.94 4.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.102 -1.234 . . . . 0.0 108.158 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.679 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -107.19 164.27 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.508 -0.745 . . . . 0.0 109.107 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.796 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -153.09 137.58 16.76 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.893 -1.123 . . . . 0.0 109.89 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.636 ' CD2' ' ND2' ' A' ' 103' ' ' ASN . 8.3 m-85 -99.16 129.75 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.753 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.888 ' OD1' HG23 ' A' ' 148' ' ' VAL . 11.1 t0 -47.3 148.88 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.906 -1.121 . . . . 0.0 108.312 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -114.34 19.22 16.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 110.122 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.575 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.7 OUTLIER -135.45 17.86 3.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.979 -1.076 . . . . 0.0 110.325 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 4.4 tt0 -120.47 -139.2 0.34 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.909 -1.12 . . . . 0.0 108.548 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.618 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 3.4 mt-30 -117.66 168.06 10.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -0.96 . . . . 0.0 109.14 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.618 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 87.1 m95 -159.46 107.46 1.77 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.974 -1.079 . . . . 0.0 109.741 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.932 ' HA ' HD21 ' A' ' 108' ' ' LEU . 70.6 p -144.26 154.6 43.25 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.853 -1.155 . . . . 0.0 110.787 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.861 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -91.68 -28.7 17.28 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.27 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 191' ' ' THR . 40.4 t0 -90.8 67.05 6.16 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' THR . . . . . 1.012 ' HB ' HD21 ' A' ' 229' ' ' LEU . 2.8 t 4.07 58.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.021 0.915 . . . . 0.0 112.036 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 189' ' ' ASP . 51.6 m -124.51 -31.25 3.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 0.0 109.733 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.714 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -98.85 -90.96 1.99 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.764 ' CG2' HD21 ' A' ' 164' ' ' LEU . 23.9 m -115.41 -97.01 0.45 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.847 ' OD1' HD21 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -161.45 68.54 0.3 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.23 -0.919 . . . . 0.0 108.706 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.126 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -28.63 -95.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.596 0.713 . . . . 0.0 111.407 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.892 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -67.57 -8.38 33.7 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 111.011 -177.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.911 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.3 tp -66.13 -66.64 0.52 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.224 -1.79 . . . . 0.0 106.668 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.964 ' CG1' HD23 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -66.75 -13.72 16.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.06 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -70.91 -58.8 3.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.805 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -66.67 -14.96 63.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.463 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 64.3 t-80 -68.08 -45.47 73.71 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 117.798 -1.561 . . . . 0.0 107.625 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.679 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 2.2 mt-10 -82.8 -47.82 11.49 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.192 -0.943 . . . . 0.0 111.003 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.854 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -60.05 -31.27 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.682 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.9 -31.84 51.88 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -59.97 -51.01 71.48 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.85 -0.794 . . . . 0.0 110.58 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.536 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 84.4 p -82.74 -56.88 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 112.362 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 1.063 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -104.86 26.62 8.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.098 -1.001 . . . . 0.0 110.622 -177.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.975 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -126.52 -79.19 0.31 Allowed Glycine 0 C--N 1.292 -1.878 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.789 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -170.16 -162.67 0.31 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.678 -1.484 . . . . 0.0 110.015 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.583 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.3 OUTLIER -95.07 -75.34 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.5 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 211' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -161.28 89.36 0.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.5 m -77.1 -178.67 5.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 108.987 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.861 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.92 80.45 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.966 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.08 7.56 18.29 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.216 -177.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.458 ' H ' HG23 ' A' ' 215' ' ' THR . 7.8 p -50.63 -27.79 7.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.515 ' C ' ' HB2' ' A' ' 235' ' ' SER . 18.2 mt-10 -114.05 -37.65 4.4 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.966 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -61.69 -167.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.284 1.04 . . . . 0.0 112.195 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.911 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.0 OUTLIER -102.47 -8.15 21.32 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.893 -177.737 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.54 ' CB ' ' OD1' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -81.31 -11.11 59.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.114 -1.616 . . . . 0.0 111.213 -178.267 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.657 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -136.47 12.61 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.33 -1.481 . . . . 0.0 113.808 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 48.5 Cg_endo -71.94 -37.96 4.48 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.915 HD23 ' N ' ' A' ' 223' ' ' TYR . 0.3 OUTLIER 0.08 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.915 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.8 OUTLIER -67.72 59.55 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.8 t-160 -168.1 -145.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.442 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.765 ' O ' HD12 ' A' ' 226' ' ' LEU . 59.0 m -149.72 110.11 4.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.002 . . . . 0.0 109.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 225' ' ' SER . 0.1 OUTLIER 179.67 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 188' ' ' LYS . 4.8 t -111.95 -7.89 14.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.607 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 178.87 -23.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 110.463 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 1.012 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -28.89 -61.58 0.12 Allowed 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.443 0.639 . . . . 0.0 110.857 -179.503 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.411 ' OG1' ' C ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.92 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.415 -0.803 . . . . 0.0 108.838 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.572 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -98.1 -21.15 16.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.607 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.0 p90 -33.19 120.75 0.37 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.553 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.72 172.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.738 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.034 HD21 ' CH2' ' A' ' 124' ' ' TRP . 5.0 mp -83.02 169.56 15.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.718 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 14.4 t -102.69 -170.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.764 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.542 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -83.8 -13.36 53.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.861 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.1 m-20 -84.54 -48.37 9.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.829 -1.17 . . . . 0.0 108.005 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.789 ' OD1' HD11 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.0 -40.01 95.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 117.166 -1.814 . . . . 0.0 106.749 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -56.26 -35.72 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 3.6 t30 -67.69 -45.63 74.63 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -62.97 -52.48 47.66 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.007 HG13 HG22 ' A' ' 128' ' ' THR . 1.5 tp -66.31 -47.29 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.868 -1.372 . . . . 0.0 110.51 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.565 ' N ' HG23 ' A' ' 242' ' ' ILE . 9.9 pt20 -55.13 -26.83 41.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 5.0 p -82.27 -18.86 40.9 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.8 OUTLIER -70.09 -65.8 0.68 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.664 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.853 ' CG ' HD22 ' A' ' 130' ' ' LEU . 20.5 m-85 . . . . . 0 C--N 1.301 -1.539 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.104 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.78 ' N ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.818 ' CD1' HD22 ' A' ' 207' ' ' LEU . 9.2 m95 -95.95 -169.05 1.86 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.847 -1.158 . . . . 0.0 110.037 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.513 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -161.81 -33.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.399 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.57 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.75 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.199 -0.938 . . . . 0.0 110.799 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.584 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -101.15 -8.53 22.15 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.715 . . . . 0.0 110.167 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.57 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 35.4 m-70 -140.15 95.32 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.246 . . . . 0.0 110.865 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.03 HD13 HD13 ' A' ' 207' ' ' LEU . 19.5 mt -82.02 177.64 8.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.646 -0.659 . . . . 0.0 109.886 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.691 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 1.3 t -148.16 155.8 41.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.226 -0.921 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.76 ' CG ' HD22 ' A' ' 121' ' ' LEU . 1.3 p90 -138.43 161.83 35.99 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.614 -1.303 . . . . 0.0 110.053 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.587 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.43 123.0 28.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.515 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.891 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.5 mp -84.27 82.48 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.815 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 39.4 t -95.87 6.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.46 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.572 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -102.55 163.65 12.1 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.988 -1.07 . . . . 0.0 109.211 179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.687 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.0 t80 177.13 84.56 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.585 0.707 . . . . 0.0 109.117 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.951 HG21 ' CG ' ' A' ' 186' ' ' TRP . 17.9 p -72.85 155.99 90.2 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 108.876 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.98 -24.1 39.81 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 O-C-N 123.917 1.483 . . . . 0.0 108.667 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -78.37 -0.32 28.58 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.187 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.962 HD13 ' CD1' ' A' ' 195' ' ' LEU . 96.8 mt -147.45 120.03 4.74 Favored Pre-proline 0 N--CA 1.485 1.276 0 O-C-N 121.458 -0.776 . . . . 0.0 110.139 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -66.02 173.15 7.52 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.89 1.468 . . . . 0.0 109.037 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.481 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.14 -65.97 0.33 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.907 0.861 . . . . 0.0 110.091 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.2 OUTLIER -55.21 -29.41 57.89 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.857 -0.527 . . . . 0.0 112.251 -178.246 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.873 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.09 -61.03 1.96 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.446 . . . . 0.0 109.413 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.687 HG21 ' N ' ' A' ' 104' ' ' TYR . 9.6 p -53.39 -42.31 47.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.891 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -62.87 -27.94 69.7 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.933 ' OG ' HD21 ' A' ' 195' ' ' LEU . 4.4 p -61.23 -45.99 92.28 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.094 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -67.68 -31.28 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.055 -1.028 . . . . 0.0 109.663 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.985 HG13 HG13 ' A' ' 144' ' ' ILE . 45.9 t -75.07 -23.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -90.35 -33.13 16.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.65 -41.89 25.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.913 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -62.95 -61.92 2.07 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.773 ' HA ' HG21 ' A' ' 203' ' ' ILE . 11.1 tp -51.24 -44.5 61.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 2.6 tptp -72.53 -32.73 66.35 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.55 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.886 HG21 ' HE1' ' A' ' 196' ' ' PHE . 3.4 t -56.16 -43.8 77.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.024 ' CH2' HD21 ' A' ' 234' ' ' LEU . 37.8 m95 -91.22 -19.08 23.41 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.452 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.7 OUTLIER -77.05 -27.58 54.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.971 -1.081 . . . . 0.0 108.24 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 17.1 pt-20 -89.99 -44.57 9.78 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.961 HG21 HG21 ' A' ' 242' ' ' ILE . 35.9 m -64.03 -21.44 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.612 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 124' ' ' TRP . 1.7 p -113.0 152.26 44.79 Favored Pre-proline 0 N--CA 1.498 1.933 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.971 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.612 ' C ' HD22 ' A' ' 130' ' ' LEU . 53.9 Cg_endo -80.51 32.82 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.285 1.99 . . . . 0.0 111.661 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 246' ' ' TYR . 2.9 mm? -112.56 165.51 12.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.616 -1.302 . . . . 0.0 110.857 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -103.3 177.57 4.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.181 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 15.9 m-85 -154.35 160.61 41.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.913 -1.117 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -158.57 125.81 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.611 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -97.57 174.38 6.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.61 -1.306 . . . . 0.0 110.358 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.537 ' CD1' ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.16 -122.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.432 ' C ' ' OE1' ' A' ' 137' ' ' GLU . 1.1 t80 177.04 42.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.3 -1.5 . . . . 0.0 109.921 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 139' ' ' GLU . 10.9 pm0 -169.47 -173.79 1.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.931 -1.106 . . . . 0.0 110.155 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.8 -97.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 137' ' ' GLU . 10.2 pt-20 179.0 105.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -1.094 . . . . 0.0 109.92 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.691 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.21 -151.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.638 ' OD2' HG22 ' A' ' 98' ' ' THR . 53.8 m-20 -93.46 -25.5 17.61 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.931 HD11 HD12 ' A' ' 207' ' ' LEU . 3.1 mp -132.22 79.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.525 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.5 ttp -66.14 93.77 0.22 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.231 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.985 HG13 HG13 ' A' ' 117' ' ' VAL . 5.9 mm -79.28 110.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.911 -1.118 . . . . 0.0 108.042 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -131.36 156.14 46.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.359 -1.463 . . . . 0.0 111.434 -178.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 19.7 p90 -79.85 138.2 37.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 0.0 109.432 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.045 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -157.85 164.2 37.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.037 . . . . 0.0 110.523 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 1.026 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.4 p -166.58 -161.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.686 ' H ' HG22 ' A' ' 148' ' ' VAL . 45.6 mtm180 . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 110.169 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.216 -0.607 0 N-CA-C 109.613 -0.956 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.878 ' CE1' HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -96.64 -169.1 1.83 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 110.492 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 159' ' ' GLY . 16.9 p30 179.74 62.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.724 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.608 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -5.35 -65.58 0.01 OUTLIER Glycine 0 N--CA 1.51 3.579 0 N-CA-C 112.151 -0.38 . . . . 0.0 112.151 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.536 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.69 61.33 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.685 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -170.07 141.93 6.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 164' ' ' LEU . 18.6 m120 -40.15 -31.32 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.45 -1.029 . . . . 0.0 110.343 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.878 HG12 ' CE1' ' A' ' 157' ' ' PHE . 1.4 t -56.7 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.812 HD11 HG21 ' A' ' 193' ' ' THR . 0.1 OUTLIER -79.51 -40.9 28.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.32 -0.862 . . . . 0.0 112.306 -178.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -179.86 -168.5 0.11 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.198 -1.564 . . . . 0.0 110.859 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.91 -168.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.412 -1.43 . . . . 0.0 110.99 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -159.88 -164.63 1.34 Allowed 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.347 -0.845 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 88.6 m-85 -131.9 -163.64 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.058 . . . . 0.0 110.16 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.823 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . 179.28 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.002 -1.061 . . . . 0.0 110.939 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.823 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 40.1 Cg_endo -70.22 -64.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.491 1.46 . . . . 0.0 111.817 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 175' ' ' ASN . . . -37.86 144.75 0.17 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 174' ' ' ILE . 39.9 Cg_endo -69.47 144.53 55.9 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.085 1.571 . . . . 0.0 109.368 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 69.55 -63.28 0.63 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' A' ' 176' ' ' GLY . 1.5 tp -68.43 -4.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -63.79 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 129.81 80.62 0.24 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.633 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -157.41 128.91 6.88 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 120.755 -1.438 . . . . 0.0 107.676 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.772 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -117.55 156.68 27.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.888 -1.132 . . . . 0.0 109.538 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.045 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -142.15 133.84 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.303 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 20.4 m-85 -96.03 134.19 39.35 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.857 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 1.026 ' OD1' HG23 ' A' ' 148' ' ' VAL . 9.5 t0 -53.26 145.9 12.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.892 -1.13 . . . . 0.0 108.85 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 147' ' ' ALA . 10.0 m-20 -114.7 21.54 14.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 0.0 110.255 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.876 ' OD1' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -121.32 8.98 10.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.804 -1.185 . . . . 0.0 110.298 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.558 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 19.0 mt-10 -122.63 -131.68 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.94 -1.1 . . . . 0.0 108.534 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.3 mt-30 -133.36 175.42 9.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.134 -0.979 . . . . 0.0 108.761 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.951 ' CG ' HG21 ' A' ' 105' ' ' THR . 78.0 m95 -158.81 119.38 3.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.91 -1.119 . . . . 0.0 108.85 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.68 ' HA ' HD21 ' A' ' 108' ' ' LEU . 71.4 p -144.85 152.28 40.04 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.79 -1.194 . . . . 0.0 110.505 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.948 ' HB3' HD22 ' A' ' 195' ' ' LEU . 3.3 pttt -85.14 -31.75 23.12 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 12.7 t70 -87.16 63.44 7.85 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.889 ' CG2' HD21 ' A' ' 229' ' ' LEU . 72.1 p 3.24 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.832 -177.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 37.0 m -125.34 -32.34 2.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.664 . . . . 0.0 109.408 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.617 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.94 -82.27 1.58 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.812 HG21 HD11 ' A' ' 164' ' ' LEU . 21.8 m -125.31 -95.81 0.45 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 1.002 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -160.61 70.82 0.42 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.017 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 2.1 tp -33.5 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.886 ' HE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -69.62 -9.93 56.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 111.168 -177.553 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.69 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 12.0 tp -64.71 -62.01 1.84 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 116.852 -1.939 . . . . 0.0 106.544 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.002 HG23 ' HB2' ' A' ' 194' ' ' ASN . 2.7 t -70.48 -12.2 15.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.094 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.64 -59.43 2.72 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.759 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -63.99 -15.64 59.76 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.612 ' CD2' ' HA ' ' A' ' 219' ' ' MET . 60.3 t-80 -67.15 -49.2 65.62 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.806 -1.558 . . . . 0.0 107.676 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.772 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 2.5 mm-40 -80.24 -47.12 15.1 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.159 -0.963 . . . . 0.0 111.077 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.913 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.3 mt -60.15 -31.53 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.708 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.94 -34.87 40.98 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.38 -50.31 73.4 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 121.78 -0.835 . . . . 0.0 110.598 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.851 ' C ' HD23 ' A' ' 207' ' ' LEU . 1.5 m -84.81 -58.96 2.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.378 -0.826 . . . . 0.0 112.177 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 1.03 HD13 HD13 ' A' ' 97' ' ' LEU . 1.2 mt -102.85 32.23 3.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.709 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -131.91 -81.53 0.21 Allowed Glycine 0 C--N 1.289 -2.073 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.838 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.6 pp -165.03 -164.65 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.127 -1.22 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.838 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -98.48 -70.76 0.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.238 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 21.8 m80 -162.85 96.8 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.226 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.765 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.8 m -87.69 -175.71 5.28 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.808 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.43 76.86 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.952 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -83.56 8.8 13.04 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.126 -177.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.458 ' C ' ' O ' ' A' ' 214' ' ' ASN . 21.3 p -50.35 -27.72 6.75 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.519 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.2 mp0 -112.51 -37.21 5.01 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.952 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -64.97 -168.48 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.319 1.057 . . . . 0.0 112.526 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.787 HD23 HD12 ' A' ' 234' ' ' LEU . 0.1 OUTLIER -89.77 -18.06 27.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.694 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.612 ' HA ' ' CD2' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -77.38 -7.26 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 119.182 -2.199 . . . . 0.0 112.175 -177.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 27.8 t80 -135.5 14.69 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.277 -1.514 . . . . 0.0 113.585 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.6 Cg_endo -79.88 -43.33 0.13 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 N-CA-C 109.279 -1.085 . . . . 0.0 109.279 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.628 HD12 ' C ' ' A' ' 222' ' ' LEU . 2.3 tp -1.08 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-O 121.355 0.597 . . . . 0.0 110.929 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 221' ' ' PRO . 8.2 m-85 -67.6 59.61 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.413 -0.804 . . . . 0.0 109.202 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.5 t-160 -170.43 -140.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.232 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.619 ' C ' HD23 ' A' ' 226' ' ' LEU . 19.8 m -163.52 112.19 1.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.967 -1.083 . . . . 0.0 110.121 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.698 ' N ' HG21 ' A' ' 190' ' ' THR . 0.4 OUTLIER 179.69 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.577 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 5.2 t -104.75 -48.02 3.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.609 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 0.5 OUTLIER -138.57 -10.39 1.4 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 111.625 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.889 HD21 ' CG2' ' A' ' 190' ' ' THR . 0.1 OUTLIER -35.83 -64.68 0.29 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.844 -1.16 . . . . 0.0 110.792 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.84 -31.77 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 109.193 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER -97.58 -20.14 17.88 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 228' ' ' ASP . 50.7 p90 -34.53 130.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.542 0.687 . . . . 0.0 111.145 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.1 ttt-85 179.74 152.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.024 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.1 mp -68.75 169.04 12.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.97 -1.082 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 31.0 t -100.48 -171.76 2.08 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.254 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.499 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.5 -12.09 52.64 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.808 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.2 OUTLIER -84.69 -47.5 10.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.669 ' OD1' HD21 ' A' ' 209' ' ' LEU . 4.5 m-20 -67.01 -38.28 85.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 117.091 -1.844 . . . . 0.0 106.526 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -57.23 -34.69 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.468 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 244' ' ' SER . 12.6 t-20 -68.96 -47.22 66.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.279 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' A' ' 244' ' ' SER . . . -64.3 -45.93 92.11 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.961 HG21 HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -74.39 -50.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.532 -1.569 . . . . 0.0 109.803 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.606 ' N ' HG23 ' A' ' 242' ' ' ILE . 2.4 tt0 -55.27 -24.15 26.72 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 75.8 p -89.74 -13.55 36.55 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.78 HD21 ' N ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -72.26 -53.65 11.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.579 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.614 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 7.5 m-30 . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.516 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.664 ' N ' HD22 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.597 ' CZ2' ' HA ' ' A' ' 141' ' ' ASP . 12.7 m95 -77.58 -126.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.858 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 178.84 -51.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.365 -1.459 . . . . 0.0 109.529 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.41 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.814 0.816 . . . . 0.0 110.771 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.542 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 26.2 p -100.06 -4.19 30.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.497 -0.752 . . . . 0.0 109.64 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.596 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 21.1 m-70 -141.93 88.82 2.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.105 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.78 ' N ' HD22 ' A' ' 97' ' ' LEU . 2.9 mm? -76.71 169.54 18.1 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.709 -0.619 . . . . 0.0 109.481 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.566 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.2 OUTLIER -141.77 156.79 45.57 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.11 -0.994 . . . . 0.0 108.963 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.891 ' CG ' HD23 ' A' ' 121' ' ' LEU . 16.7 p90 -137.55 161.74 35.62 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.588 -1.32 . . . . 0.0 109.256 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 1.093 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -125.13 138.6 54.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.945 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.6 mp -93.01 67.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.661 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.093 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 20.0 t -78.77 6.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 0.0 110.069 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.654 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -105.98 159.37 16.1 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.899 -1.126 . . . . 0.0 108.578 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.712 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.8 p90 177.94 47.01 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.748 -0.595 . . . . 0.0 110.246 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.864 HG21 ' CD1' ' A' ' 186' ' ' TRP . 22.6 p -44.11 156.8 0.31 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.163 -0.961 . . . . 0.0 108.802 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.04 -18.21 51.52 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.701 1.369 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.488 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 0.5 OUTLIER -70.93 -6.06 35.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.337 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.975 ' CD1' HD13 ' A' ' 195' ' ' LEU . 95.9 mt -151.67 127.16 4.88 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.401 -0.812 . . . . 0.0 110.432 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 38.2 Cg_endo -68.09 174.8 7.41 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.992 1.522 . . . . 0.0 109.288 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.481 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -40.88 -66.36 0.34 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.774 0.797 . . . . 0.0 110.206 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.5 OUTLIER -54.35 -33.8 59.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.922 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.46 -60.65 2.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.355 -1.465 . . . . 0.0 109.834 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.712 HG21 ' N ' ' A' ' 104' ' ' TYR . 5.6 p -55.18 -44.51 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.945 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -61.8 -27.54 68.83 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 116' ' ' ALA . 1.4 p -58.89 -64.54 0.9 Allowed 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.059 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -50.1 -32.01 14.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.293 -0.879 . . . . 0.0 110.254 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 144' ' ' ILE . 36.8 t -74.34 -23.34 18.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -93.08 -31.06 14.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.666 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -84.47 -35.11 23.21 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.92 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -69.26 -62.26 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.591 1.186 . . . . 0.0 107.928 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.901 ' HA ' HG21 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -52.67 -55.1 24.98 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.699 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 118' ' ' GLU . 2.7 tptm -60.55 -35.42 75.97 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.835 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.018 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.27 -40.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -179.575 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 1.043 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.7 m95 -91.05 -23.87 20.22 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.669 -1.212 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -70.37 -29.6 66.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.799 -1.188 . . . . 0.0 107.808 179.325 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -88.55 -40.34 13.47 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.201 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.018 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.7 m -61.63 -25.46 36.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.102 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . 1.009 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -112.52 164.14 16.07 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.241 -1.384 . . . . 0.0 108.995 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -79.11 -6.17 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.687 1.591 . . . . 0.0 110.557 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 246' ' ' TYR . 2.1 mm? -74.4 165.1 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 110.289 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.552 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -108.97 169.04 8.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 97' ' ' LEU . 50.9 m-85 -148.65 154.93 40.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 110.199 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -143.76 -179.52 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.526 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -156.7 161.37 39.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.782 ' N ' HD12 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.82 -98.12 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.405 -0.809 . . . . 0.0 109.956 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CZ ' ' NH2' ' A' ' 100' ' ' ARG . 2.8 t80 177.68 32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.986 -1.071 . . . . 0.0 109.041 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.756 ' OE2' HD11 ' A' ' 135' ' ' LEU . 0.7 OUTLIER -72.21 174.51 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.967 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -43.62 -40.46 5.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 140' ' ' ALA . 4.1 pt-20 -174.21 105.3 0.11 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -1.062 . . . . 0.0 109.998 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.563 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.4 -148.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.018 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.597 ' HA ' ' CZ2' ' A' ' 92' ' ' TRP . 66.8 m-20 -88.02 -27.17 22.21 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.575 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.018 HD11 HD22 ' A' ' 207' ' ' LEU . 3.6 mt -130.73 77.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.512 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 23.4 ttp -65.29 98.19 0.31 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.645 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 1.014 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -81.97 107.35 13.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -128.5 156.59 43.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.468 -1.395 . . . . 0.0 111.79 -178.512 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.539 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 34.7 p90 -79.17 137.39 37.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 1.031 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -158.37 165.57 34.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 0.0 109.731 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.923 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.1 p -164.15 -155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.472 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.804 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.68 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 C--O 1.215 -0.644 0 N-CA-C 109.761 -0.899 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.688 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -102.77 -166.79 1.31 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 110.517 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 160' ' ' PRO . 19.8 p30 179.29 58.57 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.72 -0.612 . . . . 0.0 109.837 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.623 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.19 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.508 3.444 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.593 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.4 Cg_endo -64.17 62.41 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 109.935 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -164.56 141.99 7.46 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' LEU . 70.5 m-80 -41.41 -32.77 0.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -1.087 . . . . 0.0 109.971 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 157' ' ' PHE . 6.4 m -55.1 86.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 109.9 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 1.114 HD23 HG21 ' A' ' 198' ' ' VAL . 0.8 OUTLIER -75.63 -38.33 59.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.337 -0.852 . . . . 0.0 111.618 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.885 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . 179.21 -169.64 0.11 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.585 -1.322 . . . . 0.0 110.406 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.688 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p-80 178.12 -170.37 0.1 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.017 -1.677 . . . . 0.0 111.426 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.56 -174.99 5.16 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.56 -0.713 . . . . 0.0 110.052 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 1.057 ' CD1' HD11 ' A' ' 174' ' ' ILE . 62.8 m-85 -121.06 -175.37 3.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.054 -1.029 . . . . 0.0 110.652 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.972 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -152.02 -66.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.68 -0.638 . . . . 0.0 109.324 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.972 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.1 Cg_endo -74.19 177.25 8.5 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.609 1.321 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.594 ' HA3' HG23 ' A' ' 174' ' ' ILE . . . 95.62 168.1 35.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.0 Cg_endo -75.63 -87.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -74.58 -35.33 51.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 1.057 HD11 ' CD1' ' A' ' 168' ' ' TYR . 3.1 tt -66.71 -2.96 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 108.892 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.553 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 1.9 t30 -66.18 63.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.33 -0.856 . . . . 0.0 108.997 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 121.4 87.05 0.91 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.3 m-20 -155.08 124.47 6.37 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.826 -1.397 . . . . 0.0 107.998 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -110.13 152.45 26.0 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 109.329 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 1.031 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -139.48 131.24 27.46 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.901 -1.119 . . . . 0.0 109.336 179.086 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.548 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 52.9 m-85 -91.62 129.72 37.55 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.634 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.923 ' OD1' HG23 ' A' ' 148' ' ' VAL . 15.6 t0 -47.15 145.55 2.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.966 -1.084 . . . . 0.0 108.371 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.538 ' OD1' HG22 ' A' ' 105' ' ' THR . 3.5 t0 -114.74 20.96 14.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.623 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 6.5 m-20 -131.61 24.88 4.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.557 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 16.8 mt-10 -130.18 -93.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 109.108 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.0 mt-30 179.56 172.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TRP . . . . . 0.864 ' CD1' HG21 ' A' ' 105' ' ' THR . 94.9 m95 -158.95 125.42 4.6 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.736 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.2 p -144.77 150.71 37.67 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.829 -1.169 . . . . 0.0 109.944 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 6.0 ptpt -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.651 ' O ' ' N ' ' A' ' 191' ' ' THR . 24.4 t70 -89.4 64.93 6.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' THR . . . . . 1.018 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.3 t 3.69 59.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.101 0.953 . . . . 0.0 112.019 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.0 m -126.28 -30.56 2.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.866 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.683 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -93.27 -81.92 1.51 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.865 ' CG2' HD21 ' A' ' 164' ' ' LEU . 19.8 m -123.63 -80.67 0.63 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.857 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 6.4 m-20 179.33 68.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.006 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 12.7 tp -37.98 -101.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.725 -0.609 . . . . 0.0 111.55 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.859 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.8 OUTLIER -57.05 -9.56 0.9 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.879 -1.138 . . . . 0.0 111.233 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.87 ' HA ' HD11 ' A' ' 218' ' ' LEU . 5.6 tp -68.29 -66.98 0.5 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 116.778 -1.969 . . . . 0.0 106.703 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.114 HG21 HD23 ' A' ' 164' ' ' LEU . 14.6 t -68.41 -6.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 1.059 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.04 -58.04 3.5 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.812 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -67.19 -15.93 64.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.478 ' HB3' ' HA ' ' A' ' 198' ' ' VAL . 57.8 t-80 -69.65 -40.4 76.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.9 -1.52 . . . . 0.0 107.78 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLU . . . . . 0.683 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.6 mt-10 -85.61 -48.41 8.92 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.297 -0.877 . . . . 0.0 110.917 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 120' ' ' ALA . 4.0 mt -61.89 -30.06 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.697 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.69 -33.24 43.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -57.64 -49.69 75.61 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.675 -0.897 . . . . 0.0 110.065 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.514 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 40.4 p -81.22 -60.46 2.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.443 -0.786 . . . . 0.0 111.874 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 1.018 HD22 HD11 ' A' ' 142' ' ' ILE . 7.3 mp -104.2 36.74 2.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.252 -0.905 . . . . 0.0 110.872 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.972 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -136.26 -73.16 0.07 OUTLIER Glycine 0 C--N 1.292 -1.878 0 C-N-CA 119.435 -1.364 . . . . 0.0 109.929 -178.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.943 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -179.87 -162.53 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.642 -1.505 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.847 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -94.71 -83.86 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 0.0 109.397 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 211' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -151.9 99.97 2.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.624 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -86.44 177.02 7.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.848 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -58.23 89.52 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.975 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -90.02 11.85 19.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.981 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 214' ' ' ASN . 12.9 p -50.04 -29.04 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.517 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.7 mm-40 -118.07 -34.6 4.08 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.501 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.975 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -59.44 -169.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.223 1.011 . . . . 0.0 112.068 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.87 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.4 tp -110.41 -3.89 15.87 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.152 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.638 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -83.02 -11.36 58.16 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.146 -1.596 . . . . 0.0 111.064 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.655 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 24.5 t80 -140.6 17.35 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 117.994 -1.483 . . . . 0.0 113.467 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' PRO . . . . . 0.9 ' HB3' HD11 ' A' ' 226' ' ' LEU . 53.0 Cg_endo -73.43 -35.49 4.82 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.946 -1.598 . . . . 0.0 107.946 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.95 HD23 ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -4.09 -69.82 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.831 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.95 ' N ' HD23 ' A' ' 222' ' ' LEU . 24.0 t80 -69.35 58.84 0.12 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.989 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -168.69 -140.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 0.0 109.329 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' SER . . . . . 0.919 ' HB3' HG21 ' A' ' 190' ' ' THR . 15.2 m -153.41 108.83 3.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.943 -1.098 . . . . 0.0 110.328 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.912 HD23 ' C ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.76 51.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -0.836 . . . . 0.0 109.335 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 187' ' ' THR . 14.7 t -103.26 -9.75 19.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 0.0 109.237 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.631 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 0.3 OUTLIER 178.14 -23.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 178.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 1.018 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -27.97 -61.41 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.421 0.629 . . . . 0.0 111.008 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.97 -34.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.6 OUTLIER -87.31 -16.39 35.25 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.631 ' HB3' ' N ' ' A' ' 228' ' ' ASP . 36.7 p90 -33.17 112.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.535 0.683 . . . . 0.0 111.334 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 178.12 177.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 0.0 109.49 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 1.043 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.6 mp -93.85 170.12 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.46 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.693 ' O ' HD13 ' A' ' 239' ' ' ILE . 7.0 t -101.24 -171.75 2.05 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.724 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' GLN . . . . . 0.572 ' N ' ' OG ' ' A' ' 235' ' ' SER . 4.4 tp-100 -82.83 -14.65 53.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.369 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.848 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.7 m-20 -83.54 -47.16 11.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.943 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.5 OUTLIER -64.34 -39.21 93.44 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.005 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -58.09 -34.73 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 244' ' ' SER . 59.6 t30 -68.65 -45.34 72.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.529 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.49 -56.56 23.74 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 1.007 HG21 HG21 ' A' ' 127' ' ' VAL . 1.4 tp -64.1 -43.94 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.269 . . . . 0.0 109.605 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLN . . . . . 0.523 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.8 tt0 -55.97 -26.5 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 1.4 p -80.61 -20.66 42.74 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.942 ' HB2' HD12 ' A' ' 242' ' ' ILE . 2.4 mt -69.98 -69.49 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.587 ' HB3' HD23 ' A' ' 130' ' ' LEU . 38.6 m-85 . . . . . 0 C--N 1.298 -1.661 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 5.5 p90 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.57 -162.18 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.483 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 5.1 m -50.33 160.09 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.537 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -95.13 105.84 22.02 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 85' ' ' THR . 41.6 Cg_endo -72.12 89.6 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.052 1.554 . . . . 0.0 110.07 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.84 ' O ' HD13 ' A' ' 89' ' ' ILE . . . 129.17 1.43 5.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.84 HD13 ' O ' ' A' ' 88' ' ' GLY . 7.9 mm -141.85 88.61 9.36 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.207 -1.172 . . . . 0.0 109.579 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.24 133.24 20.75 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.043 1.549 . . . . 0.0 109.974 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.578 ' H ' HD21 ' A' ' 245' ' ' LEU . 0.1 OUTLIER -59.22 -75.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.897 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.627 ' CZ3' ' ND2' ' A' ' 175' ' ' ASN . 9.7 m95 -99.73 143.16 30.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 110.207 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 1.6 ptp180 -109.3 -40.86 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.388 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 1.06 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.58 170.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.331 -0.855 . . . . 0.0 110.019 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.59 ' O ' HD12 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -110.14 1.19 18.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.502 -0.749 . . . . 0.0 109.585 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.542 ' HD2' HG23 ' A' ' 95' ' ' THR . 57.8 m-70 -137.96 95.99 3.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.368 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.06 HD13 ' HE2' ' A' ' 94' ' ' LYS . 3.1 mm? -92.37 170.82 9.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.51 -0.744 . . . . 0.0 109.512 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.607 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -147.24 157.17 43.5 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 1.054 ' CE2' HD11 ' A' ' 101' ' ' ILE . 4.4 p90 -137.11 166.31 24.02 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.505 -1.372 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.59 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -125.19 124.36 41.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.054 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -83.12 83.54 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.883 -1.135 . . . . 0.0 110.106 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 102' ' ' VAL . 46.7 t -98.72 7.25 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.254 -0.903 . . . . 0.0 110.001 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.985 ' C ' HG21 ' A' ' 113' ' ' VAL . 34.0 m-80 -97.01 160.91 14.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.841 -1.162 . . . . 0.0 109.461 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.777 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.8 t80 178.09 167.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.648 HG22 ' CZ3' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -176.53 159.54 1.66 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 105' ' ' THR . 37.7 Cg_endo -66.12 -25.94 50.48 Favored 'Trans proline' 0 C--N 1.298 -2.089 0 N-CA-C 107.791 -1.657 . . . . 0.0 107.791 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.692 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -74.17 -10.98 60.15 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.929 ' CD1' HD13 ' A' ' 195' ' ' LEU . 79.6 mt -153.23 111.18 2.63 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.598 -0.689 . . . . 0.0 110.224 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.81 178.37 2.34 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.8 1.421 . . . . 0.0 109.341 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.93 -65.35 0.37 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.809 0.814 . . . . 0.0 110.296 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -58.67 -26.79 64.18 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.758 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -74.42 -60.45 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.31 -1.494 . . . . 0.0 109.605 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.985 HG21 ' C ' ' A' ' 103' ' ' ASN . 11.3 p -58.16 -42.42 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 1.041 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -60.04 -29.79 68.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -57.68 -64.1 1.02 Allowed 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.065 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -49.19 -33.0 11.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 110.158 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.936 HG13 HG13 ' A' ' 144' ' ' ILE . 5.7 t -73.0 -24.33 20.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.7 tt0 -90.64 -34.07 15.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.342 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.12 -39.44 33.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.885 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -64.84 -62.23 1.69 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.909 HD22 ' CE1' ' A' ' 99' ' ' TYR . 14.5 tp -48.99 -47.94 43.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.489 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -70.34 -34.25 72.43 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.791 -178.049 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.012 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.8 t -53.71 -44.81 59.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.027 ' CH2' HD21 ' A' ' 234' ' ' LEU . 30.9 m95 -92.11 -21.33 20.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.716 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 33.6 tt0 -72.14 -27.55 62.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.8 pt-20 -88.88 -44.49 10.43 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.435 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.084 HG21 HG21 ' A' ' 242' ' ' ILE . 14.2 m -56.77 -26.89 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.248 -1.381 . . . . 0.0 108.324 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.003 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -118.35 166.33 14.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 108.092 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.581 ' HG2' ' CD1' ' A' ' 246' ' ' TYR . 48.1 Cg_endo -82.5 -10.94 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.528 1.485 . . . . 0.0 109.824 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.932 HD23 ' CZ ' ' A' ' 132' ' ' PHE . 41.9 tp -52.38 158.87 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.727 . . . . 0.0 110.893 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.522 ' N ' ' HG ' ' A' ' 130' ' ' LEU . 1.5 p -108.37 170.39 8.05 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.932 ' CZ ' HD23 ' A' ' 130' ' ' LEU . 71.2 m-85 -151.41 146.36 25.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.938 -1.101 . . . . 0.0 110.929 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.599 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 4.0 t -125.66 -174.24 3.03 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.64 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -148.13 164.58 33.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.612 -1.305 . . . . 0.0 111.017 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.535 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -164.81 -163.73 0.74 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 136' ' ' TYR . 29.7 t80 -160.95 28.31 0.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 5.0 pm0 -144.87 178.57 7.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.678 -0.639 . . . . 0.0 109.324 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.26 -97.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' GLU . 7.7 pt-20 178.83 121.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -1.109 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.607 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -77.58 -151.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.866 ' CG ' HD12 ' A' ' 97' ' ' LEU . 16.7 t70 -89.75 -36.74 14.99 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.87 ' CD1' HD23 ' A' ' 207' ' ' LEU . 4.1 mp -123.23 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.543 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 8.8 ttm -65.13 98.24 0.3 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.044 . . . . 0.0 109.059 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.936 HG13 HG13 ' A' ' 117' ' ' VAL . 6.2 mm -82.73 111.52 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.652 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.72 153.64 51.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 0.0 111.856 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 19.8 p90 -90.47 141.42 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.769 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.088 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.82 179.96 3.97 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.003 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 149' ' ' ARG . 1.4 p -151.19 -164.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.716 ' H ' HG22 ' A' ' 148' ' ' VAL . 1.1 ptt85 -55.97 83.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.785 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER 179.85 32.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.565 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.482 ' CE1' ' HD1' ' A' ' 157' ' ' PHE . 58.4 m80 -73.25 -40.76 64.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.91 -67.0 0.32 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -159.84 24.96 0.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -1.138 . . . . 0.0 109.427 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.574 ' O ' ' C ' ' A' ' 155' ' ' TYR . 55.8 m-85 -153.5 -167.26 2.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.577 ' CE1' ' OH ' ' A' ' 168' ' ' TYR . 1.0 OUTLIER 1.54 69.6 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.461 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' A' ' 154' ' ' PHE . 44.8 Cg_endo -80.24 125.17 5.68 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.011 1.532 . . . . 0.0 109.805 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.742 ' CD1' ' CE1' ' A' ' 179' ' ' HIS . 1.5 m-85 -78.33 -169.42 1.64 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.067 -1.021 . . . . 0.0 109.557 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.524 ' OD2' ' CG2' ' A' ' 163' ' ' VAL . 11.0 p30 178.64 58.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.559 -0.713 . . . . 0.0 110.097 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -20.36 -58.96 0.01 OUTLIER Glycine 0 N--CA 1.511 3.679 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 41.3 Cg_endo -71.17 56.17 1.98 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.589 1.31 . . . . 0.0 109.135 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.84 156.81 27.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.538 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 84.7 m-20 -51.9 -33.68 38.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.364 -1.08 . . . . 0.0 110.588 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.985 HG13 ' CG2' ' A' ' 1' ' ' HAV . 2.9 t -55.54 84.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.105 -0.997 . . . . 0.0 110.111 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.983 HD21 ' CG2' ' A' ' 193' ' ' THR . 0.3 OUTLIER -74.35 -46.38 41.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.507 -0.746 . . . . 0.0 111.765 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.784 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -168.67 179.84 4.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.35 -1.469 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.574 ' NE2' ' CE1' ' A' ' 157' ' ' PHE . 10.8 p80 178.94 167.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.154 -1.591 . . . . 0.0 111.252 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.78 -169.07 2.13 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.556 -0.715 . . . . 0.0 110.093 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.602 ' CD2' ' HB ' ' A' ' 174' ' ' ILE . 55.2 m-85 -110.3 -166.51 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.632 -1.292 . . . . 0.0 110.515 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.045 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -120.92 -170.25 0.18 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.411 -0.805 . . . . 0.0 109.086 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 1.045 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.6 Cg_endo -74.8 112.94 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.418 1.22 . . . . 0.0 110.505 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . -157.65 -140.63 2.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.6 -93.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.054 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -92.34 -26.99 16.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.613 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -74.04 9.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.515 -0.991 . . . . 0.0 108.816 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.627 ' ND2' ' CZ3' ' A' ' 92' ' ' TRP . 6.2 t30 -63.18 62.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.43 103.4 2.83 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.654 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.5 m-20 -163.27 118.33 1.69 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.601 -1.529 . . . . 0.0 107.377 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.813 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -110.46 166.46 10.97 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.78 -1.2 . . . . 0.0 108.801 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.088 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -158.63 134.61 9.03 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.281 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.578 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 22.4 m-85 -94.19 137.31 33.52 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.625 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.624 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 7.6 t0 -50.87 151.36 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.779 -1.201 . . . . 0.0 108.628 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.19 20.45 8.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.5 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.628 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.5 OUTLIER -107.98 -16.7 14.23 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 1.2 pt-20 -112.54 -98.52 0.42 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.848 -1.158 . . . . 0.0 108.281 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.567 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 1.0 OUTLIER 178.53 165.28 0.81 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.014 -1.054 . . . . 0.0 109.045 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.648 ' CZ3' HG22 ' A' ' 105' ' ' THR . 0.0 OUTLIER -137.51 130.91 31.04 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.179 -0.951 . . . . 0.0 109.229 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.546 ' HA ' HD21 ' A' ' 108' ' ' LEU . 47.3 p -131.64 149.51 52.47 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 227' ' ' THR . 41.3 pttt -74.42 -37.77 63.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.528 ' O ' ' CG2' ' A' ' 227' ' ' THR . 3.3 t70 -83.28 -149.14 0.09 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.845 ' N ' HD11 ' A' ' 229' ' ' LEU . 27.0 m -111.45 46.46 1.1 Allowed 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.542 -1.263 . . . . 0.0 107.849 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.479 ' HB ' HG21 ' A' ' 187' ' ' THR . 91.2 m -98.45 -32.32 11.55 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 111.411 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -118.58 -85.57 1.02 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.755 -1.688 . . . . 0.0 109.489 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.983 ' CG2' HD21 ' A' ' 164' ' ' LEU . 23.7 m -122.67 -98.16 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.671 ' HA ' HG21 ' A' ' 227' ' ' THR . 3.7 m120 -160.45 68.14 0.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.065 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 15.4 tp -29.73 -97.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.843 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -56.77 -19.97 19.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.973 -1.079 . . . . 0.0 111.106 -178.18 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.64 ' CB ' ' HB3' ' A' ' 194' ' ' ASN . 12.9 tp -60.15 -62.29 1.97 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.146 -1.821 . . . . 0.0 107.517 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.837 HG21 HD23 ' A' ' 164' ' ' LEU . 1.7 t -71.32 -8.12 10.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.09 -58.09 3.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.56 -14.68 61.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.598 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 15.2 t60 -68.32 -48.93 63.57 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 117.878 -1.529 . . . . 0.0 107.913 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.813 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 1.3 mt-10 -80.39 -45.87 16.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 111.092 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.885 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -62.14 -30.99 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.71 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.88 -31.55 55.52 Favored Glycine 0 C--N 1.291 -1.933 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.5 -49.62 76.0 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 121.965 -0.726 . . . . 0.0 110.952 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.519 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 42.5 m -86.25 -53.05 5.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 112.206 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.889 HD22 ' CE2' ' A' ' 132' ' ' PHE . 3.1 pp -104.54 24.7 11.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.123 . . . . 0.0 110.605 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.965 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -127.02 -79.57 0.3 Allowed Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.123 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.02 -162.25 0.36 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.961 -1.317 . . . . 0.0 110.233 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.781 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.7 t80 -99.61 -72.64 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.78 . . . . 0.0 109.538 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.588 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 68.3 m80 -161.13 101.79 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 4.0 m -93.33 -178.12 4.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.371 -0.83 . . . . 0.0 109.247 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.764 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.9 86.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.95 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -89.66 10.18 24.2 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.576 -178.027 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.4 -28.1 4.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 175.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.538 ' C ' ' HB2' ' A' ' 235' ' ' SER . 5.4 mt-10 -116.25 -36.05 4.16 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.95 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.72 -170.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.383 1.087 . . . . 0.0 112.813 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.875 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -90.44 -16.12 29.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.146 -177.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.594 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -78.38 -7.39 57.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 119.119 -2.238 . . . . 0.0 112.105 -177.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.9 t80 -137.29 15.65 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.526 -1.358 . . . . 0.0 113.604 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.43 -37.0 0.79 Allowed 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 108.473 -1.395 . . . . 0.0 108.473 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.781 ' CD2' HG22 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -21.47 -59.21 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.202 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' HIS . 38.5 t80 -68.0 56.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.3 t-80 179.16 -124.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.45 ' HB3' ' OG1' ' A' ' 190' ' ' THR . 18.4 m -161.0 121.63 2.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.787 -1.196 . . . . 0.0 109.426 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER 179.38 43.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 110.102 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -99.93 -10.45 21.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.815 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.609 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 24.3 t70 179.62 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 109.923 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.845 HD11 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -25.74 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.809 -0.557 . . . . 0.0 111.399 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.34 -6.09 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.731 -1.23 . . . . 0.0 110.261 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.55 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -117.67 -38.18 3.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.001 -1.062 . . . . 0.0 109.069 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.658 ' HA ' HD23 ' A' ' 226' ' ' LEU . 13.3 p90 1.04 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.829 0.824 . . . . 0.0 112.947 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 178.34 174.62 0.59 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.359 -0.838 . . . . 0.0 109.657 178.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.027 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.9 mp -91.18 168.99 11.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 0.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.722 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 30.2 t -101.87 -169.88 1.74 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.188 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.51 ' N ' ' OG ' ' A' ' 235' ' ' SER . 12.5 tm0? -85.25 -12.65 51.98 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.911 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.2 OUTLIER -84.69 -47.79 10.11 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.684 ' O ' HG22 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -66.71 -36.96 83.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.626 177.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.601 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -58.0 -35.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.91 -50.79 54.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -55.94 -55.07 30.99 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.084 HG21 HG21 ' A' ' 127' ' ' VAL . 1.6 tp -63.44 -43.37 98.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.83 -1.394 . . . . 0.0 109.589 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.2 mt-30 -54.13 -31.35 52.03 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.0 p -75.5 -22.35 57.25 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.838 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -66.84 -64.57 0.83 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.596 ' CD2' ' HB2' ' A' ' 130' ' ' LEU . 5.7 t80 -100.32 -115.69 0.17 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.983 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 129' ' ' PRO . . . 121.09 177.1 15.55 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 120.247 -1.533 . . . . 0.0 109.902 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.2 146.14 45.33 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.946 1.498 . . . . 0.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.66 142.75 36.53 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.132 1.596 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.47 -59.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.013 1.533 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 252' ' ' SER . 0.4 OUTLIER -161.66 -64.98 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 251' ' ' ASP . 41.6 t -44.68 105.28 0.44 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.51 -24.25 19.18 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.953 1.501 . . . . 0.0 110.112 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -145.52 171.1 15.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.538 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.51 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.985 ' CG2' HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.538 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.742 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.255 0.55 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -78.53 -148.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.477 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 84' ' ' ARG . 10.2 t -50.0 179.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -73.53 112.59 16.72 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.1 Cg_endo -72.67 141.88 35.01 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.877 1.462 . . . . 0.0 110.141 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.07 -53.43 2.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.2 pp -151.94 144.85 17.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.243 -1.151 . . . . 0.0 109.534 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.21 -167.99 0.35 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.006 1.53 . . . . 0.0 109.894 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.766 ' CD ' ' HB1' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -89.45 -93.41 0.11 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.125 -0.985 . . . . 0.0 109.644 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.649 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 69.6 m95 -73.87 155.6 38.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.742 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.1 -34.55 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.776 ' O ' HD11 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -55.17 -165.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.264 -0.897 . . . . 0.0 109.548 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.57 ' HA ' HD11 ' A' ' 130' ' ' LEU . 66.2 p -124.33 4.24 8.44 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.607 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.571 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 59.4 m80 -148.15 97.08 2.73 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.451 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.679 ' N ' HD22 ' A' ' 97' ' ' LEU . 3.4 mm? -97.5 175.02 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.634 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -142.64 155.7 44.97 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.232 -0.918 . . . . 0.0 108.569 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.905 ' CE2' HD11 ' A' ' 101' ' ' ILE . 24.6 p90 -133.49 171.07 14.58 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.794 -1.192 . . . . 0.0 109.233 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.541 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -131.35 145.87 52.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 109.412 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.905 HD11 ' CE2' ' A' ' 99' ' ' TYR . 1.6 mp -100.22 61.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.965 -1.084 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 144' ' ' ILE . 18.1 t -73.86 2.44 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 0.0 110.021 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.605 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -101.45 164.37 11.8 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.804 -1.185 . . . . 0.0 109.025 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.633 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.2 p90 177.94 46.37 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.893 HG21 ' NE1' ' A' ' 186' ' ' TRP . 24.8 p -40.15 149.88 0.28 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.595 -0.69 . . . . 0.0 109.36 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 -25.77 42.67 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.946 1.498 . . . . 0.0 109.044 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -65.76 -12.16 51.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 187' ' ' THR . 32.3 mt -138.53 124.02 12.28 Favored Pre-proline 0 N--CA 1.484 1.251 0 O-C-N 121.543 -0.723 . . . . 0.0 109.827 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.3 Cg_endo -65.6 167.35 17.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 123.773 1.407 . . . . 0.0 108.867 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.504 ' O ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -37.8 -65.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.747 0.784 . . . . 0.0 110.263 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -28.57 49.73 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.75 -0.594 . . . . 0.0 111.725 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.776 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.19 -61.15 1.92 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.487 -1.383 . . . . 0.0 109.448 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.6 p -51.19 -39.4 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.535 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -66.33 -26.22 67.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.717 ' OG ' HD21 ' A' ' 195' ' ' LEU . 13.9 p -67.35 -37.37 83.14 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.071 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -75.18 -34.81 61.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.331 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.872 HG13 HG13 ' A' ' 144' ' ' ILE . 3.5 t -74.94 -23.72 17.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 1.8 tt0 -85.82 -36.33 20.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.721 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -79.41 -38.84 33.87 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.767 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -63.49 -61.65 2.19 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.85 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -51.56 -40.91 60.63 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.128 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.739 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -76.72 -33.64 58.17 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.738 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.07 HG21 ' CE1' ' A' ' 196' ' ' PHE . 2.1 t -56.19 -40.8 67.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.033 ' O ' HG23 ' A' ' 128' ' ' THR . 44.4 m95 -91.43 -24.8 19.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.316 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 9.6 tm-20 -69.55 -27.45 65.16 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.757 -1.214 . . . . 0.0 107.996 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.2 pt-20 -89.9 -42.89 10.95 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.674 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.027 HG13 ' O ' ' A' ' 123' ' ' VAL . 15.3 m -59.8 -24.11 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 118.259 -1.376 . . . . 0.0 109.159 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.033 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.93 162.94 20.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.012 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -84.46 1.54 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.249 1.966 . . . . 0.0 110.116 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.155 HD13 ' CD1' ' A' ' 246' ' ' TYR . 0.2 OUTLIER -80.92 -176.16 5.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.026 -1.046 . . . . 0.0 110.603 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.3 p -121.71 165.55 15.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.778 . . . . 0.0 109.947 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.826 ' CZ ' HD22 ' A' ' 207' ' ' LEU . 0.6 OUTLIER -140.93 158.22 44.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.426 -0.796 . . . . 0.0 109.698 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.58 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.5 m -146.59 179.6 7.44 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.897 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -148.12 -179.76 7.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.805 -1.184 . . . . 0.0 110.246 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.069 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -163.61 -130.63 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 27.2 t80 178.24 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.833 -1.167 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -162.61 -171.81 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 37.66 -99.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 178.46 107.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -1.135 . . . . 0.0 110.296 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 1.069 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -59.91 -150.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.827 ' C ' HD12 ' A' ' 142' ' ' ILE . 80.0 m-20 -88.06 -34.43 17.96 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.883 HG12 HD23 ' A' ' 207' ' ' LEU . 2.8 mp -124.23 77.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.532 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 2.8 ptm -67.54 102.87 1.22 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.872 HG13 HG13 ' A' ' 117' ' ' VAL . 5.1 mm -81.98 117.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -133.19 156.58 47.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.429 -1.42 . . . . 0.0 112.119 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 39.6 p90 -79.94 133.61 36.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.474 -0.767 . . . . 0.0 109.14 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.912 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -155.92 -178.08 7.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.958 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.0 OUTLIER 179.78 -155.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.44 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.815 ' N ' HG13 ' A' ' 148' ' ' VAL . 2.8 mtm-85 -52.2 84.45 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.462 -0.774 . . . . 0.0 109.641 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 148' ' ' VAL . 2.6 tm-20 179.68 30.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 79.9 m80 -92.91 -142.4 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.893 . . . . 0.0 108.897 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -103.03 -54.72 0.84 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.71 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.826 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -94.28 6.81 47.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 110.005 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -149.43 42.44 0.25 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.046 . . . . 0.0 110.156 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 41.9 Cg_endo -72.39 121.47 7.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.526 1.277 . . . . 0.0 109.208 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.733 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -98.24 -170.43 1.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.912 -1.118 . . . . 0.0 111.257 -178.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 158' ' ' ASP . 15.5 p30 178.5 62.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 183' ' ' ASP . . . -18.86 -59.0 0.01 OUTLIER Glycine 0 N--CA 1.501 2.982 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 183' ' ' ASP . 37.9 Cg_endo -65.87 60.19 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.297 1.156 . . . . 0.0 109.743 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -177.42 164.07 33.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' LEU . 0.6 OUTLIER -45.56 -59.95 2.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.312 -1.111 . . . . 0.0 110.123 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.653 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 61.0 t -33.85 90.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.354 0.597 . . . . 0.0 110.88 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.021 HD22 HD13 ' A' ' 222' ' ' LEU . 1.1 mp -80.08 -75.48 0.26 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.238 -0.914 . . . . 0.0 112.186 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.998 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -145.64 -168.25 2.92 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.196 -1.565 . . . . 0.0 111.38 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.733 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER 179.67 -179.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.957 -1.714 . . . . 0.0 111.133 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -154.75 177.61 11.06 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.536 -0.728 . . . . 0.0 110.23 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 1.009 ' CD1' HD11 ' A' ' 174' ' ' ILE . 76.7 m-85 -114.39 -167.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.16 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.953 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -171.21 -60.51 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.495 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.953 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.6 Cg_endo -77.29 147.97 26.46 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.796 1.419 . . . . 0.0 109.875 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 118.83 -178.75 16.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 174' ' ' ILE . 44.1 Cg_endo -75.97 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.063 1.559 . . . . 0.0 110.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.16 -33.25 21.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 1.009 HD11 ' CD1' ' A' ' 168' ' ' TYR . 1.9 tt -62.16 -7.75 2.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.352 -1.087 . . . . 0.0 108.8 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 169' ' ' ALA . 50.7 p-10 -67.29 65.92 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.127 -0.983 . . . . 0.0 109.405 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 128.74 78.7 0.23 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.1 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -152.16 115.15 4.65 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.217 -1.166 . . . . 0.0 107.975 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.646 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -106.31 164.83 11.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.262 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.912 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -155.96 133.77 11.16 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.571 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.573 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 12.2 m-85 -96.55 135.94 37.75 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.958 ' OD1' HG23 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -58.02 115.81 3.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.788 -1.195 . . . . 0.0 107.985 177.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.484 ' OD1' ' HB ' ' A' ' 148' ' ' VAL . 11.9 p-10 -83.91 13.51 4.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.719 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.889 ' HB2' HG21 ' A' ' 148' ' ' VAL . 2.0 t70 -121.05 14.09 11.4 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.076 -1.015 . . . . 0.0 110.725 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.542 ' OE2' HD11 ' A' ' 164' ' ' LEU . 15.7 tt0 -117.66 -132.1 0.32 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.814 -1.179 . . . . 0.0 108.944 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.612 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.9 mt-30 -122.1 166.57 14.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 109.111 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.893 ' NE1' HG21 ' A' ' 105' ' ' THR . 94.5 m95 -159.42 107.44 1.78 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.821 ' HA ' HD21 ' A' ' 108' ' ' LEU . 19.6 p -135.35 153.52 51.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.849 -1.157 . . . . 0.0 109.533 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.665 ' HA ' HD22 ' A' ' 195' ' ' LEU . 1.6 pttt -76.79 -28.97 55.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.645 ' OD2' HD12 ' A' ' 229' ' ' LEU . 0.3 OUTLIER -99.85 -151.18 0.39 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.87 ' HB ' HD11 ' A' ' 229' ' ' LEU . 10.2 t -105.71 45.4 0.97 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.459 ' HB ' HG21 ' A' ' 187' ' ' THR . 87.6 m -99.77 -31.25 11.62 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.394 -0.816 . . . . 0.0 111.204 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.537 ' N ' HG21 ' A' ' 187' ' ' THR . . . -118.21 -96.75 1.81 Allowed Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.804 -1.665 . . . . 0.0 109.064 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.768 ' CG2' HD21 ' A' ' 164' ' ' LEU . 48.3 m -104.31 -106.22 0.29 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.706 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 10.5 m120 -159.14 74.23 0.63 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.93 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.9 OUTLIER -27.01 -95.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.661 0.743 . . . . 0.0 112.55 -178.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 1.07 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -64.34 -12.17 39.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.013 -1.054 . . . . 0.0 110.983 -176.428 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 1.082 ' CD2' ' HH2' ' A' ' 3' ' ' MSB . 5.5 tt -62.03 -62.08 2.03 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.884 -1.526 . . . . 0.0 107.078 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.998 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 39.4 t -72.79 -9.32 12.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.071 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.88 -57.43 3.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.38 -15.38 62.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.76 ' HB2' ' HH3' ' A' ' 3' ' ' MSB . 20.5 t60 -68.74 -46.13 69.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.962 -1.495 . . . . 0.0 107.81 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.761 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 1.3 mt-10 -82.32 -47.42 12.38 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.046 -1.034 . . . . 0.0 110.834 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.785 HG21 ' HA ' ' A' ' 121' ' ' LEU . 2.3 mt -61.48 -31.46 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.675 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.0 -33.29 46.09 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.93 -49.52 75.81 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.819 -0.813 . . . . 0.0 110.798 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.522 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 27.4 p -83.73 -56.88 3.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 112.2 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.883 HD23 HG12 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -104.16 22.94 13.83 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.016 -1.052 . . . . 0.0 110.84 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 1.117 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -121.71 -78.92 0.5 Allowed Glycine 0 C--N 1.291 -1.923 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.938 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.4 pp -167.5 -160.09 0.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.019 -1.283 . . . . 0.0 109.76 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.772 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.0 OUTLIER -98.12 -73.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.585 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.1 m-70 -163.01 93.49 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.913 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.645 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -81.78 179.33 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -0.836 . . . . 0.0 109.806 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.871 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.53 83.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.944 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -87.0 12.06 12.17 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.861 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -49.78 -28.25 6.01 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.085 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.527 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.1 mp0 -116.29 -36.16 4.11 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.944 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.45 -164.72 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.292 1.044 . . . . 0.0 112.681 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.05 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.1 OUTLIER -99.85 -13.01 19.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.074 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.585 ' HG2' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -80.3 -6.63 58.25 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 119.552 -1.967 . . . . 0.0 111.978 -177.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.649 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.2 OUTLIER -137.53 14.57 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.617 -1.302 . . . . 0.0 113.502 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 54.2 Cg_endo -77.41 -42.05 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 1.021 HD13 HD22 ' A' ' 164' ' ' LEU . 4.0 tp -0.26 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 CA-C-O 121.494 0.664 . . . . 0.0 111.039 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 223' ' ' TYR . 9.8 t80 -67.46 58.4 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 109.754 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.57 172.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 109.778 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.8 128.83 55.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.253 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' ASP . 0.3 OUTLIER 178.83 -73.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.835 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . 1.008 HG21 HD22 ' A' ' 218' ' ' LEU . 1.5 p -66.44 53.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 0.0 110.442 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 226' ' ' LEU . 5.0 m-20 -162.54 -53.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -60.74 -142.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.755 . . . . 0.0 109.458 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.4 p -94.46 -22.76 18.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 0.0 110.049 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -79.97 -16.55 54.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 108.786 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.601 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 23.2 p90 -30.75 106.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.602 0.715 . . . . 0.0 111.291 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.532 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 7.6 ttt-85 -161.04 153.15 20.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.214 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.967 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.8 mp -77.65 173.94 11.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.281 -0.887 . . . . 0.0 110.463 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 21.7 t -102.81 -172.0 2.05 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.909 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.38 -12.89 53.67 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.778 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.871 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.6 m-20 -84.11 -49.28 9.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.769 -1.207 . . . . 0.0 108.15 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.938 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.68 -39.48 93.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 117.197 -1.801 . . . . 0.0 106.616 178.032 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 235' ' ' SER . 0.8 OUTLIER -55.19 -36.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.47 -56.92 8.66 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.646 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -52.23 -51.58 40.94 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.117 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.8 tp -63.86 -47.93 88.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.85 -1.382 . . . . 0.0 109.656 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.588 ' N ' HG23 ' A' ' 242' ' ' ILE . 21.3 tt0 -53.58 -28.29 31.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 t -82.42 -18.12 42.98 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.796 ' HB3' HD12 ' A' ' 242' ' ' ILE . 5.7 tt -73.3 -60.57 2.18 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 1.155 ' CD1' HD13 ' A' ' 130' ' ' LEU . 11.1 m-85 -88.65 -112.97 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.445 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.477 ' N ' ' HD3' ' A' ' 248' ' ' PRO . . . 46.78 54.11 9.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.61 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 37.5 Cg_endo -71.86 -30.35 14.22 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.008 1.531 . . . . 0.0 112.136 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 44.4 Cg_endo -76.09 113.47 3.71 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 N-CA-C 109.751 -0.904 . . . . 0.0 109.751 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.55 -90.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.909 1.478 . . . . 0.0 110.126 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.22 -41.1 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 255' ' ' THR . 58.2 m -144.03 82.16 11.16 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.393 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.31 -24.13 19.98 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.053 1.554 . . . . 0.0 110.133 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.14 64.98 8.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.423 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 252' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.568 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.539 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 1.082 ' HH2' ' CD2' ' A' ' 197' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 212' ' ' SER . 12.2 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.321 0.581 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 85' ' ' THR . 4.7 ptp85 -123.61 -148.85 0.41 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.482 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.5 ' N ' ' HG3' ' A' ' 84' ' ' ARG . 8.7 t -51.65 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.59 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 210' ' ' PHE . 2.3 p90 -107.01 138.56 19.86 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -72.76 95.78 0.82 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.995 1.523 . . . . 0.0 110.053 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.3 -77.83 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.45 131.33 10.98 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.123 . . . . 0.0 109.541 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -73.01 -172.26 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.962 1.506 . . . . 0.0 109.916 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.756 ' H ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -99.48 -82.94 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.132 -0.98 . . . . 0.0 109.571 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.465 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 72.7 m95 -107.27 169.13 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.963 -1.085 . . . . 0.0 109.617 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -135.4 -36.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.598 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.84 ' HE3' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -47.58 177.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.735 ' HA ' HD22 ' A' ' 130' ' ' LEU . 71.2 p -116.7 5.58 13.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.501 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.527 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 4.5 m-70 -126.63 91.14 3.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.99 -1.069 . . . . 0.0 110.073 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.84 HD13 ' HE3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -99.31 158.29 15.81 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.6 -0.688 . . . . 0.0 109.988 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.595 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -129.54 154.86 46.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.674 ' CE2' HD11 ' A' ' 101' ' ' ILE . 3.0 p90 -140.77 167.69 21.58 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.724 -1.235 . . . . 0.0 109.364 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -132.12 138.11 47.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.095 . . . . 0.0 109.47 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.766 HG22 ' O ' ' A' ' 101' ' ' ILE . 1.5 mp -93.32 66.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.14 -0.975 . . . . 0.0 109.746 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 144' ' ' ILE . 6.0 t -78.38 8.82 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 109.93 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.988 ' C ' HG21 ' A' ' 113' ' ' VAL . 8.5 m120 -105.35 153.25 21.9 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.0 -1.062 . . . . 0.0 109.392 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.785 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER 178.68 41.04 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.717 -0.614 . . . . 0.0 109.697 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 104' ' ' TYR . 61.4 p -41.57 156.1 0.22 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.42 -0.8 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -22.87 41.73 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.877 1.462 . . . . 0.0 108.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.688 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -72.04 -6.3 41.34 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.077 HD13 ' CD2' ' A' ' 195' ' ' LEU . 83.1 mt -143.5 116.48 5.91 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.517 -0.74 . . . . 0.0 109.707 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.68 171.48 9.58 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 O-C-N 123.856 1.45 . . . . 0.0 109.06 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.01 -65.38 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.84 0.829 . . . . 0.0 110.295 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 115' ' ' SER . 26.0 t0 -57.43 -28.23 63.12 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.821 -0.549 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.889 ' O ' HD21 ' A' ' 195' ' ' LEU . . . -73.18 -61.95 1.64 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.248 -1.532 . . . . 0.0 109.265 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.988 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.8 p -54.25 -40.67 48.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 1.0 OUTLIER -64.9 -27.86 69.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 112' ' ' ALA . 1.2 p -62.14 -41.84 98.67 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.036 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -73.72 -34.16 64.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.059 . . . . 0.0 110.639 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.955 HG13 HG13 ' A' ' 144' ' ' ILE . 5.8 t -74.36 -24.08 18.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -91.64 -34.82 14.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -79.02 -37.48 39.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.828 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -67.36 -62.02 1.63 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.848 HD11 ' CG ' ' A' ' 132' ' ' PHE . 8.1 tp -49.67 -45.04 48.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -73.41 -34.72 65.65 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.798 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.0 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -55.53 -40.6 59.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.066 ' CH2' HD21 ' A' ' 234' ' ' LEU . 51.0 m95 -92.27 -20.01 21.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.091 -1.005 . . . . 0.0 110.517 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 37.1 tt0 -75.24 -27.58 59.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.018 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.5 pt-20 -90.15 -45.19 9.28 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.551 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.0 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.5 m -57.3 -27.07 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.447 -1.301 . . . . 0.0 108.357 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -121.22 155.86 58.01 Favored Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.223 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.556 ' CG ' ' HD2' ' A' ' 248' ' ' PRO . 48.6 Cg_endo -77.49 25.95 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.091 1.86 . . . . 0.0 111.946 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' A' ' 95' ' ' THR . 5.0 mt -100.89 169.86 8.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.399 . . . . 0.0 110.093 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.5 p -119.12 166.45 12.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.848 ' CG ' HD11 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -141.18 159.44 42.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.117 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -155.9 122.4 5.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 108.746 179.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 3.2 ppt_? -108.38 174.59 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.076 . . . . 0.0 110.64 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.797 ' N ' HD12 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.81 -95.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 100' ' ' ARG . 3.5 t80 177.51 33.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.975 . . . . 0.0 109.098 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.484 ' H ' HD13 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -76.57 179.43 5.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -45.75 -42.3 10.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 140' ' ' ALA . 2.0 pt-20 -176.13 105.02 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -1.102 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.595 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.14 -150.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.29 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 176' ' ' GLY . 45.3 t0 -81.28 -35.8 30.64 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 207' ' ' LEU . 51.6 mt -127.97 81.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.415 ' CE ' HG21 ' A' ' 102' ' ' VAL . 2.6 ttt -67.13 100.26 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.955 HG13 HG13 ' A' ' 117' ' ' VAL . 6.1 mm -82.26 115.02 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.04 -1.037 . . . . 0.0 108.348 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.3 OUTLIER -134.11 159.22 41.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.37 -1.456 . . . . 0.0 112.447 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.501 ' CA ' ' ND2' ' A' ' 103' ' ' ASN . 13.2 p90 -100.17 133.09 45.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.716 -0.615 . . . . 0.0 110.252 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.168 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -160.28 -159.07 0.67 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.096 -1.003 . . . . 0.0 110.724 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 149' ' ' ARG . 2.3 p -166.38 -170.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.979 -1.076 . . . . 0.0 109.185 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.741 ' H ' HG22 ' A' ' 148' ' ' VAL . 7.9 ptt-85 -40.67 -26.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.172 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.63 ' H ' HG13 ' A' ' 148' ' ' VAL . 7.1 tp10 -40.83 -60.61 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 151' ' ' HIS . 1.6 p-80 -69.5 109.62 4.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.097 -1.002 . . . . 0.0 109.502 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.96 126.15 6.22 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 179.74 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -1.087 . . . . 0.0 109.484 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -158.75 -36.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.73 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.552 ' HB3' ' CE1' ' A' ' 166' ' ' HIS . 3.5 m-85 -139.8 74.67 32.06 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.978 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.94 155.58 52.99 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.936 1.493 . . . . 0.0 109.474 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.778 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 5.5 m-85 -113.42 -169.64 1.54 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.105 -0.997 . . . . 0.0 110.282 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.641 ' OD2' HG21 ' A' ' 163' ' ' VAL . 9.5 p30 178.96 61.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.574 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -10.88 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.506 3.341 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 38.4 Cg_endo -67.23 59.16 0.65 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.573 1.302 . . . . 0.0 109.692 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -173.81 146.65 8.9 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -41.95 -27.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -1.052 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.641 HG21 ' OD2' ' A' ' 158' ' ' ASP . 2.8 t -52.44 82.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.519 -0.738 . . . . 0.0 110.781 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.073 HD21 HG21 ' A' ' 193' ' ' THR . 0.7 OUTLIER -70.59 -81.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.346 -0.846 . . . . 0.0 111.619 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.866 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -145.33 -179.63 6.77 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.65 -1.281 . . . . 0.0 111.409 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.778 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 2.0 p-80 179.28 162.39 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.808 -1.807 . . . . 0.0 110.383 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.43 -167.99 1.94 Allowed 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.191 -0.943 . . . . 0.0 110.418 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 206' ' ' SER . 95.4 m-85 -125.37 -163.05 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 0.0 110.344 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.009 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -172.23 -60.59 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.294 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 1.009 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.6 Cg_endo -76.57 118.56 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.831 1.437 . . . . 0.0 109.981 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 148.22 173.94 19.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -74.47 -91.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.128 1.594 . . . . 0.0 110.146 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -73.64 -28.16 65.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -75.32 8.29 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -1.149 . . . . 0.0 108.407 178.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 169' ' ' ALA . 20.5 p-10 -65.83 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 112.41 97.57 2.34 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -160.11 124.23 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.755 -1.439 . . . . 0.0 107.62 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.811 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.01 159.2 17.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 108.589 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.168 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -156.96 131.53 8.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.591 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.574 ' HB3' ' CH2' ' A' ' 186' ' ' TRP . 37.0 m-85 -93.08 142.45 27.28 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.188 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.718 ' OD1' HG23 ' A' ' 148' ' ' VAL . 5.7 t0 -64.39 144.12 57.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.451 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 4.6 p30 -109.91 24.23 13.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.637 -1.289 . . . . 0.0 110.139 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.574 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 20.1 m-20 -131.06 15.41 5.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.044 -1.035 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 7.6 tt0 -118.95 -132.88 0.32 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.598 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 88.6 mt-30 -114.44 163.04 15.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.821 -1.174 . . . . 0.0 108.514 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.598 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 98.8 m95 -158.44 105.37 1.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.93 -1.106 . . . . 0.0 110.398 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.967 ' HA ' HD21 ' A' ' 108' ' ' LEU . 80.8 p -146.6 154.25 41.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.352 -0.843 . . . . 0.0 109.399 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 227' ' ' THR . 4.5 pttm -81.06 -30.31 34.81 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 229' ' ' LEU . 3.2 t70 -98.17 -148.13 0.33 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.609 ' N ' ' CD1' ' A' ' 229' ' ' LEU . 12.8 t -99.86 37.48 1.61 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.531 HG22 HG21 ' A' ' 187' ' ' THR . 21.4 m -86.23 -35.61 19.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.436 -0.79 . . . . 0.0 111.072 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.626 ' N ' HG21 ' A' ' 187' ' ' THR . . . -133.75 -95.78 0.56 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.612 -1.756 . . . . 0.0 109.706 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.073 HG21 HD21 ' A' ' 164' ' ' LEU . 77.5 m -100.83 -108.35 0.22 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.709 ' HA ' HG21 ' A' ' 227' ' ' THR . 34.2 m-80 -159.52 71.55 0.5 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.077 ' CD2' HD13 ' A' ' 108' ' ' LEU . 7.9 tp -29.29 -96.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.854 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -49.89 -24.2 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.071 . . . . 0.0 111.391 -178.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.99 HD11 ' CG ' ' A' ' 221' ' ' PRO . 13.8 tp -58.05 -61.3 2.65 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 117.381 -1.727 . . . . 0.0 107.807 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.866 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 1.4 t -73.59 -5.65 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.816 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.014 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.14 -57.67 3.66 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.698 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.55 -17.26 64.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.606 ' CE1' ' HA ' ' A' ' 219' ' ' MET . 3.3 t-160 -69.59 -41.76 75.36 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 117.079 -1.848 . . . . 0.0 108.135 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.834 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 0.8 OUTLIER -83.4 -49.52 9.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 0.0 110.464 179.127 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.8 mt -59.11 -31.62 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.719 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.41 -34.85 39.04 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -58.49 -48.49 80.63 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.8 -0.823 . . . . 0.0 110.744 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.553 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 68.7 p -87.0 -55.74 3.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 112.104 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.915 ' HB2' HD11 ' A' ' 142' ' ' ILE . 0.6 OUTLIER -103.95 31.3 4.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.256 -0.902 . . . . 0.0 110.095 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.767 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -135.04 -80.97 0.13 Allowed Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.842 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -169.07 -165.9 0.58 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.264 . . . . 0.0 110.352 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.711 ' N ' HD12 ' A' ' 209' ' ' LEU . 75.7 t80 -93.53 -83.91 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.572 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.3 m-70 -151.61 122.64 7.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.651 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.642 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -113.13 -178.11 3.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -0.925 . . . . 0.0 109.388 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.91 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -60.87 85.92 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.963 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -91.0 12.39 19.88 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.395 -1.322 . . . . 0.0 112.115 -177.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.444 ' C ' ' O ' ' A' ' 214' ' ' ASN . 1.7 p -50.74 -27.74 7.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.51 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.6 mm-40 -116.6 -35.59 4.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.706 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.963 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -59.02 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 122.076 0.941 . . . . 0.0 112.755 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.983 ' HB2' HD13 ' A' ' 234' ' ' LEU . 0.1 OUTLIER -115.71 -13.29 11.45 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.776 -177.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.606 ' HA ' ' CE1' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -81.38 -7.01 59.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.312 -2.117 . . . . 0.0 111.799 -178.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -134.08 13.37 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.594 -1.316 . . . . 0.0 113.475 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.99 ' CG ' HD11 ' A' ' 197' ' ' LEU . 51.3 Cg_endo -76.26 -36.07 2.01 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 N-CA-C 109.099 -1.154 . . . . 0.0 109.099 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 1.036 HD12 HD12 ' A' ' 164' ' ' LEU . 1.6 tt -17.41 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.291 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.942 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.5 OUTLIER -68.02 54.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 222' ' ' LEU . 15.0 t-80 178.77 -129.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 108.658 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -154.29 136.46 14.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.799 -1.188 . . . . 0.0 108.913 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.773 ' N ' HD21 ' A' ' 229' ' ' LEU . 0.1 OUTLIER 179.53 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 110.704 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -103.83 -28.74 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 108.825 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.597 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 7.6 t70 -172.26 3.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.892 . . . . 0.0 110.792 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.804 HD13 ' N ' ' A' ' 229' ' ' LEU . 0.1 OUTLIER -44.55 -51.98 8.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.821 -1.175 . . . . 0.0 108.99 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.74 -28.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.557 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.8 mtp180 -104.0 -39.74 6.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.474 -0.766 . . . . 0.0 109.43 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.597 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 21.9 p90 0.59 109.7 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.349 0.595 . . . . 0.0 112.443 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.79 177.27 0.49 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.316 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.066 HD21 ' CH2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -89.52 175.04 7.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.009 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.87 ' H ' HD12 ' A' ' 234' ' ' LEU . 16.4 t -111.96 -169.22 1.43 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.131 -0.981 . . . . 0.0 110.257 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.546 ' N ' ' OG ' ' A' ' 235' ' ' SER . 10.5 tp-100 -84.49 -15.79 44.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.575 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.91 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 5.4 m-20 -84.25 -46.44 11.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.505 -1.372 . . . . 0.0 108.339 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.842 ' OD1' HD11 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -67.55 -35.77 79.69 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 117.381 -1.728 . . . . 0.0 106.543 177.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 234' ' ' LEU . 0.5 OUTLIER -58.67 -34.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -45.96 73.91 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -63.88 -50.58 60.05 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -70.74 -47.81 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.723 -1.457 . . . . 0.0 109.586 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.594 ' N ' HG23 ' A' ' 242' ' ' ILE . 40.4 tt0 -53.98 -29.49 43.25 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.8 t -77.21 -22.47 52.27 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.767 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -64.66 -63.37 1.14 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.219 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.663 ' CD1' HD11 ' A' ' 130' ' ' LEU . 24.1 m-85 -101.08 -127.99 0.21 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.542 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 64.09 79.56 0.16 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.149 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 129' ' ' PRO . 42.9 Cg_endo -75.69 173.38 14.59 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.993 1.522 . . . . 0.0 109.58 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 41.4 Cg_endo -72.13 110.35 2.92 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.847 1.446 . . . . 0.0 110.079 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 41.0 Cg_endo -75.6 -79.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.984 1.518 . . . . 0.0 110.566 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 252' ' ' SER . 1.0 OUTLIER -42.38 -64.62 0.57 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.295 -0.878 . . . . 0.0 109.903 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.495 ' N ' ' OD1' ' A' ' 251' ' ' ASP . 1.5 m -42.79 102.13 0.27 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.897 . . . . 0.0 109.693 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 251' ' ' ASP . 42.9 Cg_endo -73.68 -30.65 9.39 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.982 1.517 . . . . 0.0 110.06 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 253' ' ' PRO . 4.0 tt0 -43.74 119.47 1.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.542 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.493 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.578 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.525 ' HE1' ' HB2' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 1.009 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -69.91 -158.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.556 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 t -45.4 163.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.59 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -95.88 116.19 66.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.477 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.65 153.62 54.38 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.87 1.458 . . . . 0.0 110.059 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.44 -114.96 1.92 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.3 mm -87.86 123.91 68.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.257 -1.143 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.66 -161.07 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.876 1.461 . . . . 0.0 110.12 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.677 ' CB ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -117.99 -89.0 0.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.367 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.603 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 90.3 m95 -90.2 148.69 22.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -126.31 -32.67 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.0 109.346 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.786 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -51.57 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.462 -0.774 . . . . 0.0 110.129 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.626 ' HA ' HD22 ' A' ' 130' ' ' LEU . 21.7 p -116.93 -0.05 12.32 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.576 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 40.1 m80 -146.96 93.2 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.599 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.789 ' N ' HD22 ' A' ' 97' ' ' LEU . 2.8 mm? -82.91 177.62 8.55 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.304 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.651 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -144.78 155.24 43.42 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.959 -1.088 . . . . 0.0 108.893 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 1.057 ' CE2' HD11 ' A' ' 101' ' ' ILE . 4.9 p90 -136.63 166.17 24.18 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.629 -1.294 . . . . 0.0 109.385 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.855 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -129.76 125.53 36.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.057 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -85.11 83.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.855 HG22 ' NE ' ' A' ' 100' ' ' ARG . 1.7 t -99.98 6.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.892 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.867 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -101.79 157.79 16.59 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.619 -1.301 . . . . 0.0 109.459 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.693 ' N ' HG21 ' A' ' 113' ' ' VAL . 20.7 t80 178.33 70.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.767 . . . . 0.0 109.413 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.67 HG21 ' CD1' ' A' ' 186' ' ' TRP . 38.6 p -66.28 158.35 77.85 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 108.584 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -22.12 40.88 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.885 1.466 . . . . 0.0 108.68 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.633 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -74.14 -4.72 37.45 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.075 HD13 HD12 ' A' ' 195' ' ' LEU . 83.7 mt -141.56 117.44 7.2 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.497 -0.752 . . . . 0.0 109.871 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.07 165.33 17.03 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.76 1.4 . . . . 0.0 109.171 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -35.99 -65.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.811 0.815 . . . . 0.0 110.332 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.98 -10.25 5.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.774 -0.579 . . . . 0.0 111.517 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.763 ' O ' HD11 ' A' ' 195' ' ' LEU . . . -86.43 -61.68 1.68 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.478 -1.389 . . . . 0.0 108.949 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.723 HG21 ' C ' ' A' ' 103' ' ' ASN . 7.5 p -54.67 -40.56 51.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.586 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.3 -27.01 69.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.891 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -67.39 -38.49 84.77 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.133 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -72.86 -33.95 66.44 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.901 -1.124 . . . . 0.0 109.66 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.971 HG13 HG13 ' A' ' 144' ' ' ILE . 57.3 t -76.06 -22.9 15.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.9 OUTLIER -89.11 -34.38 16.76 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.669 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.44 -38.02 27.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.759 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -64.49 -61.24 2.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.826 HD22 ' CD1' ' A' ' 99' ' ' TYR . 14.2 tp -53.45 -46.65 69.97 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.765 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -66.39 -35.3 79.97 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.138 -178.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.883 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.0 t -57.09 -36.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.089 ' O ' HG23 ' A' ' 128' ' ' THR . 56.2 m95 -92.61 -25.17 18.43 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.931 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -71.83 -27.34 62.84 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.627 -1.296 . . . . 0.0 108.29 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.0 pt-20 -92.44 -42.82 9.54 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.029 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 123' ' ' VAL . 19.8 m -63.9 -21.16 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.25 -1.38 . . . . 0.0 109.971 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.089 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -108.35 162.67 19.11 Favored Pre-proline 0 N--CA 1.5 2.046 0 C-N-CA 117.472 -1.691 . . . . 0.0 109.883 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.675 ' O ' HD23 ' A' ' 130' ' ' LEU . 50.2 Cg_endo -81.02 21.74 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.1 1.867 . . . . 0.0 111.729 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.786 HD13 ' O ' ' A' ' 94' ' ' LYS . 21.7 mt -122.22 -173.7 2.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.5 -1.375 . . . . 0.0 110.561 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -124.07 -168.22 1.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.973 -179.462 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.777 ' HE2' HD13 ' A' ' 207' ' ' LEU . 0.4 OUTLIER -153.02 175.77 12.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.554 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -149.17 -173.44 4.38 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.616 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.34 163.04 39.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.49 -1.381 . . . . 0.0 110.768 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.07 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -151.19 -131.9 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.47 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.726 -1.234 . . . . 0.0 109.444 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 139' ' ' GLU . 7.0 pm0 -166.79 -164.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 109.928 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 36.3 -97.43 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' OE2' ' HA2' ' A' ' 173' ' ' GLY . 0.9 OUTLIER 178.38 107.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -1.105 . . . . 0.0 110.398 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 1.07 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -63.15 -151.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 108.699 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.603 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 63.2 m-20 -87.7 -32.62 19.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 144' ' ' ILE . 4.4 mp -128.54 83.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.1 ttt -66.51 98.77 0.52 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 108.905 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.971 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -82.42 115.79 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.819 -1.176 . . . . 0.0 108.149 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.93 153.01 52.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.55 -1.344 . . . . 0.0 111.48 -179.447 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.2 p90 -93.79 139.18 31.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.149 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -163.72 -159.96 0.54 Allowed 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.351 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.78 HG21 ' HB2' ' A' ' 183' ' ' ASP . 1.7 p -173.32 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 109.064 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.711 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -48.31 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.753 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 148' ' ' VAL . 1.0 OUTLIER 179.77 31.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 55.1 m80 -81.31 -64.28 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.16 55.29 0.82 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 154' ' ' PHE . 3.9 t0 179.76 -85.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -1.131 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.513 ' N ' ' OD1' ' A' ' 153' ' ' ASP . 5.4 t80 -156.84 40.71 0.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.307 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CD2' ' OH ' ' A' ' 168' ' ' TYR . 1.2 m-85 -143.91 52.13 1.82 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.367 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 40.6 Cg_endo -69.95 119.28 6.24 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.963 1.507 . . . . 0.0 109.849 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.74 ' CD1' ' CE1' ' A' ' 179' ' ' HIS . 0.3 OUTLIER -81.08 -165.9 1.02 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 110.341 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.578 ' O ' ' C ' ' A' ' 159' ' ' GLY . 48.4 p-10 179.29 57.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.712 -0.617 . . . . 0.0 110.366 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -21.34 -67.71 0.01 OUTLIER Glycine 0 N--CA 1.509 3.53 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 183' ' ' ASP . 43.7 Cg_endo -74.04 52.87 2.75 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.525 1.277 . . . . 0.0 109.401 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -155.89 156.78 27.3 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.548 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 11.8 m120 -47.61 -41.71 22.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.66 -0.906 . . . . 0.0 110.507 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.079 HG13 HG22 ' A' ' 1' ' ' HAV . 78.6 t -59.89 78.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 110.136 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.064 ' CD2' HG21 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -59.1 -55.05 40.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.416 -0.802 . . . . 0.0 111.784 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.8 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -163.68 -174.91 3.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.723 -1.236 . . . . 0.0 111.245 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.636 ' CE1' ' HE1' ' A' ' 157' ' ' PHE . 11.1 p80 178.42 165.06 0.78 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.141 -1.599 . . . . 0.0 110.989 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -129.29 -158.97 0.92 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.405 -0.809 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.694 ' CD1' HD11 ' A' ' 174' ' ' ILE . 3.7 m-85 -122.83 -169.37 1.91 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.582 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -117.54 -166.39 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.0 Cg_endo -74.97 123.51 7.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.05 1.026 . . . . 0.0 110.825 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . -172.15 -171.32 36.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.68 101.82 1.34 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.569 1.3 . . . . 0.0 109.91 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.474 ' HA2' ' OE2' ' A' ' 139' ' ' GLU . . . 81.5 -51.16 4.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.694 HD11 ' CD1' ' A' ' 168' ' ' TYR . 1.7 tt -68.67 2.58 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.623 -0.928 . . . . 0.0 109.346 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.579 ' O ' ' CH2' ' A' ' 92' ' ' TRP . 8.1 p-10 -63.52 63.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.56 -0.712 . . . . 0.0 109.227 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.02 101.73 2.69 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.4 m-20 -157.16 120.33 4.07 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.718 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.56 161.8 15.01 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.889 -1.132 . . . . 0.0 108.916 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.149 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -156.09 133.16 10.6 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.056 -1.058 . . . . 0.0 108.811 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 73.1 m-85 -93.71 141.28 28.67 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.741 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.592 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 23.7 p30 -63.51 144.55 56.9 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.667 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.57 22.27 11.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.669 -1.269 . . . . 0.0 110.447 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.78 ' HB2' HG21 ' A' ' 148' ' ' VAL . 27.2 t0 -115.95 11.21 15.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.957 -1.09 . . . . 0.0 110.359 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.515 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 2.9 pt-20 -126.43 -108.21 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.772 -1.205 . . . . 0.0 109.282 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 3.9 mt-30 -148.31 173.91 12.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.712 -1.242 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.714 ' CH2' HD23 ' A' ' 164' ' ' LEU . 88.7 m95 -162.54 132.58 4.57 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.039 -1.038 . . . . 0.0 110.029 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.9 ' HA ' HD21 ' A' ' 108' ' ' LEU . 31.0 p -153.64 153.26 31.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.077 -1.014 . . . . 0.0 109.51 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 227' ' ' THR . 0.0 OUTLIER -73.43 -37.38 65.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 227' ' ' THR . 1.3 t70 -86.04 -145.3 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.876 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.7 t -115.61 46.26 1.54 Allowed 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 118.761 -1.176 . . . . 0.0 108.196 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.511 ' HB ' HG21 ' A' ' 187' ' ' THR . 97.8 m -101.58 -31.06 11.03 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.382 -0.824 . . . . 0.0 111.186 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.547 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -111.95 -86.99 1.66 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.878 -1.63 . . . . 0.0 109.096 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.052 HG21 HD21 ' A' ' 164' ' ' LEU . 35.4 m -125.01 -97.21 0.43 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.689 ' HB2' HG23 ' A' ' 198' ' ' VAL . 1.1 m120 -158.12 67.53 0.48 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.107 -0.995 . . . . 0.0 108.42 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.133 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -27.79 -94.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.54 0.686 . . . . 0.0 111.553 -179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.853 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -67.63 -12.66 60.95 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 111.013 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.806 ' HA ' HD11 ' A' ' 218' ' ' LEU . 8.5 tp -63.06 -64.25 0.97 Allowed 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.906 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.064 HG21 ' CD2' ' A' ' 164' ' ' LEU . 2.5 t -69.46 -12.02 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.049 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.76 -57.4 4.01 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.963 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -66.99 -14.61 63.05 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.609 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 11.4 t60 -69.93 -43.97 70.56 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 117.821 -1.551 . . . . 0.0 107.743 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.718 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 2.3 mt-10 -82.53 -49.05 10.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.768 HG22 HD21 ' A' ' 207' ' ' LEU . 1.4 mt -59.95 -30.74 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.735 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -80.32 -29.68 44.11 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -62.2 -42.84 99.66 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.701 -0.882 . . . . 0.0 110.558 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.523 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 68.5 m -90.57 -51.71 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.108 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.777 HD13 ' HE2' ' A' ' 132' ' ' PHE . 0.5 OUTLIER -104.78 20.66 18.32 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.008 -1.057 . . . . 0.0 110.828 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.939 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -124.48 -79.25 0.39 Allowed Glycine 0 C--N 1.291 -1.96 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.256 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.934 HD21 ' OD2' ' A' ' 238' ' ' ASP . 1.0 OUTLIER -171.25 -156.29 0.11 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.428 -1.631 . . . . 0.0 110.939 -178.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.568 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.5 OUTLIER -101.49 -86.58 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.592 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.1 m-70 -152.32 89.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.457 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.588 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.0 m -79.47 178.72 7.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.116 -0.99 . . . . 0.0 108.574 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.495 ' HB3' ' OD2' ' A' ' 237' ' ' ASP . . . -59.09 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.94 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.16 11.9 10.91 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.213 -1.395 . . . . 0.0 111.978 -177.384 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.92 -28.22 6.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 175.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.511 ' C ' ' HB2' ' A' ' 235' ' ' SER . 34.9 mt-10 -117.41 -34.58 4.25 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -57.8 -145.63 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.206 -0.934 . . . . 0.0 111.557 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.963 ' CD2' ' HB3' ' A' ' 200' ' ' ALA . 0.7 OUTLIER -132.35 -0.5 3.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.74 . . . . 0.0 111.082 -178.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.592 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 9.2 tpp -93.35 -3.46 53.35 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.072 -1.642 . . . . 0.0 110.073 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.65 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 4.4 t80 -139.86 12.08 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.04 -1.064 . . . . 0.0 113.322 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 53.7 Cg_endo -74.31 -36.75 2.96 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 108.988 -1.197 . . . . 0.0 108.988 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 223' ' ' TYR . 2.6 tt -13.06 -60.05 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.201 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.954 ' N ' HD23 ' A' ' 222' ' ' LEU . 9.5 t80 -69.57 56.48 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.078 -1.014 . . . . 0.0 109.494 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.4 t-160 179.21 -142.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.1 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.932 ' O ' HD12 ' A' ' 226' ' ' LEU . 4.0 m -149.51 121.62 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 109.58 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER -176.28 56.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 109.897 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -116.17 -16.23 11.01 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.1 t0 -169.51 -25.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.681 -0.637 . . . . 0.0 109.527 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.876 HD11 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -27.93 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.667 -0.646 . . . . 0.0 110.719 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.421 ' C ' ' HG3' ' A' ' 231' ' ' ARG . 0.6 OUTLIER -145.11 1.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.887 -1.133 . . . . 0.0 110.139 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.61 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -129.55 -44.74 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.885 -1.135 . . . . 0.0 109.382 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 23.0 p90 1.12 106.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.482 0.658 . . . . 0.0 112.58 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.556 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.25 171.05 0.94 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.474 179.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.023 HD21 ' CH2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -82.01 179.61 7.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.334 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.77 ' H ' HD12 ' A' ' 234' ' ' LEU . 3.2 t -116.5 -169.93 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.042 -1.036 . . . . 0.0 110.575 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.597 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.57 -25.07 26.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.542 -0.724 . . . . 0.0 109.983 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.588 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 19.6 m-20 -77.14 -45.07 28.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.932 -1.105 . . . . 0.0 108.204 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.934 ' OD2' HD21 ' A' ' 209' ' ' LEU . 7.8 t70 -67.85 -45.93 73.2 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.282 -1.367 . . . . 0.0 107.909 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 234' ' ' LEU . 0.8 OUTLIER -51.61 -34.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -47.13 78.74 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -60.51 -56.05 26.56 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.947 HG13 HG22 ' A' ' 128' ' ' THR . 0.7 OUTLIER -63.77 -46.14 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.821 -1.399 . . . . 0.0 109.954 -178.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 242' ' ' ILE . 30.4 mt-30 -54.27 -26.66 30.28 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -90.02 -10.93 43.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.939 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -80.02 -54.37 5.85 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.62 ' CD2' HD12 ' A' ' 130' ' ' LEU . 3.9 m-30 -78.78 -83.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.172 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.48 ' C ' ' HD2' ' A' ' 249' ' ' PRO . . . -106.49 91.91 0.76 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.614 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 39.5 Cg_endo -73.01 -29.68 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.945 1.497 . . . . 0.0 112.479 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 42.6 Cg_endo -74.06 111.93 3.42 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 122.661 0.821 . . . . 0.0 110.282 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 45.4 Cg_endo -76.98 -59.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.011 1.532 . . . . 0.0 110.438 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.453 ' C ' ' HD3' ' A' ' 253' ' ' PRO . 32.6 t70 -87.28 13.98 8.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.259 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.556 ' CB ' ' HB2' ' A' ' 249' ' ' PRO . 0.0 OUTLIER -117.28 67.62 4.84 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.062 -1.024 . . . . 0.0 109.552 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.453 ' HD3' ' C ' ' A' ' 251' ' ' ASP . 42.9 Cg_endo -73.0 -49.18 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.979 1.515 . . . . 0.0 110.128 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -141.05 -47.54 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.613 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.515 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.079 HG22 HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.548 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.838 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -150.29 -96.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.572 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -47.14 -93.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.042 -1.036 . . . . 0.0 109.412 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.487 ' H ' HG23 ' A' ' 85' ' ' THR . 1.6 t80 -163.56 99.0 0.98 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.0 109.542 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.62 77.3 2.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.043 1.549 . . . . 0.0 110.083 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.93 ' C ' HD13 ' A' ' 89' ' ' ILE . . . 172.7 -88.95 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.93 HD13 ' C ' ' A' ' 88' ' ' GLY . 3.1 mm -126.73 142.22 42.67 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.295 -1.121 . . . . 0.0 109.468 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.616 ' HD2' HG22 ' A' ' 89' ' ' ILE . 41.9 Cg_endo -72.03 -179.57 4.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.903 1.475 . . . . 0.0 110.101 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.673 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -95.2 -84.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.75 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.596 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 27.9 m95 -97.65 140.55 31.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.978 -1.076 . . . . 0.0 109.641 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.78 -28.25 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.98 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.778 0.799 . . . . 0.0 110.192 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.779 ' HB ' HD12 ' A' ' 130' ' ' LEU . 66.8 p -127.33 3.71 6.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.603 ' NE2' HG21 ' A' ' 131' ' ' THR . 7.8 m80 -148.91 102.94 3.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.9 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.157 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -121.19 -166.51 1.36 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.628 HG22 ' C ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -168.21 171.67 9.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.14 -0.975 . . . . 0.0 109.238 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 1.098 ' CE2' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -139.38 177.19 8.1 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.84 -1.163 . . . . 0.0 110.48 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.875 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -127.45 126.76 42.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 109.9 -178.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.093 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 1.9 mp -85.06 83.33 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.932 -1.105 . . . . 0.0 109.837 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.875 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -101.22 8.67 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.186 -0.946 . . . . 0.0 110.077 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.866 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -100.48 157.29 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.635 -1.291 . . . . 0.0 109.968 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.669 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.5 OUTLIER 178.16 75.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.62 0.724 . . . . 0.0 109.507 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 1.049 HG21 ' CD1' ' A' ' 186' ' ' TRP . 0.8 OUTLIER -67.77 157.2 87.19 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.23 -23.44 39.0 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 O-C-N 123.79 1.416 . . . . 0.0 108.952 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.562 ' O ' HD23 ' A' ' 108' ' ' LEU . 1.5 t0 -69.93 -9.8 56.28 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.837 HD22 ' HB1' ' A' ' 112' ' ' ALA . 52.2 mt -143.45 123.97 7.92 Favored Pre-proline 0 N--CA 1.485 1.278 0 O-C-N 121.622 -0.673 . . . . 0.0 109.898 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -66.42 168.87 15.21 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.781 1.411 . . . . 0.0 109.184 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.484 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.91 -64.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.756 0.789 . . . . 0.0 110.516 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 112' ' ' ALA . 2.4 p-10 -55.5 -32.08 62.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.701 -0.625 . . . . 0.0 111.954 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.837 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.87 -61.91 1.59 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.524 -1.36 . . . . 0.0 109.437 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.971 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.6 p -52.21 -41.68 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.591 ' OD2' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.63 -26.34 68.63 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.618 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -68.21 -35.71 78.39 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.401 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.048 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -76.15 -35.11 59.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.937 -1.102 . . . . 0.0 109.005 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.098 HG12 ' CE2' ' A' ' 99' ' ' TYR . 1.7 t -73.11 -26.13 22.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 1.5 tt0 -86.48 -36.35 19.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.897 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -75.93 -39.27 56.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -66.15 -62.96 1.2 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.473 1.13 . . . . 0.0 108.167 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.941 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.3 tt -46.51 -51.57 15.12 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.189 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.92 ' N ' HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -67.63 -35.47 78.97 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.947 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.118 ' CG1' HD22 ' A' ' 234' ' ' LEU . 3.1 t -52.44 -42.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.067 ' CH2' HD21 ' A' ' 234' ' ' LEU . 30.1 m95 -92.43 -23.38 19.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.928 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 46.9 tt0 -69.81 -26.93 64.49 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.762 -1.211 . . . . 0.0 107.801 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -91.06 -43.12 10.11 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.804 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.038 HG21 HG21 ' A' ' 242' ' ' ILE . 17.7 m -59.18 -24.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.766 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.036 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -105.9 160.48 25.98 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 117.696 -1.601 . . . . 0.0 110.222 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.724 ' C ' HD22 ' A' ' 130' ' ' LEU . 51.7 Cg_endo -85.56 22.48 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.259 1.973 . . . . 0.0 111.962 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.779 HD12 ' HB ' ' A' ' 95' ' ' THR . 3.6 mm? -116.36 -169.96 1.72 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.32 -1.488 . . . . 0.0 110.51 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.603 HG21 ' NE2' ' A' ' 96' ' ' HIS . 1.3 p -117.04 164.96 13.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 1.157 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 1.2 m-85 -144.26 139.27 28.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.693 -0.63 . . . . 0.0 109.492 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.531 ' CB ' ' HB ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -115.28 -166.31 1.11 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.129 -0.982 . . . . 0.0 108.486 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.49 157.31 35.22 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.964 -1.085 . . . . 0.0 110.014 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -159.64 -164.96 1.43 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.387 -0.821 . . . . 0.0 109.604 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 101' ' ' ILE . 1.8 t80 -154.17 22.09 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.524 ' HA ' ' NH2' ' A' ' 100' ' ' ARG . 11.6 pm0 -138.44 179.58 6.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.43 -100.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.68 119.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 110.296 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.561 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -77.94 -154.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 108.87 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 176' ' ' GLY . 2.3 m-20 -84.24 -38.32 20.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 109.364 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.737 HG22 ' CD1' ' A' ' 144' ' ' ILE . 4.0 mp -120.77 84.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.649 -0.657 . . . . 0.0 109.254 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.455 ' HB3' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.45 98.5 0.25 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.133 -0.979 . . . . 0.0 109.044 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.866 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.9 mm -84.29 114.89 25.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.627 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.01 155.66 50.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.517 -1.365 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -81.15 141.11 34.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 108.826 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.917 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -160.03 178.25 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.85 -1.156 . . . . 0.0 110.828 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.838 HG13 ' N ' ' A' ' 149' ' ' ARG . 1.5 p -167.26 -150.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.838 ' N ' HG13 ' A' ' 148' ' ' VAL . 3.7 mmm180 -31.34 -57.48 0.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.765 -0.584 . . . . 0.0 110.477 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.72 121.27 4.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.142 -0.974 . . . . 0.0 109.323 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 148' ' ' VAL . 5.5 m80 -162.51 -91.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.24 -70.69 0.05 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 48.5 p30 179.97 52.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -1.161 . . . . 0.0 109.79 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.487 ' C ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER 179.91 -32.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 109.755 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.588 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 98.1 m-85 -119.84 45.44 0.75 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.808 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 40.8 Cg_endo -70.59 127.38 13.85 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.899 1.473 . . . . 0.0 109.591 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.687 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -106.92 -164.12 0.96 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.081 -1.012 . . . . 0.0 110.243 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 1.3 p30 179.91 46.08 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.362 -0.836 . . . . 0.0 110.553 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.613 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 38.4 -97.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 183' ' ' ASP . 40.2 Cg_endo -69.51 56.9 1.32 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.992 1.522 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.471 ' HA3' ' OD1' ' A' ' 158' ' ' ASP . . . -132.84 143.02 14.61 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.539 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 2.9 m120 -42.6 -31.32 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -1.066 . . . . 0.0 109.877 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 163' ' ' VAL . 31.8 m -68.76 83.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.169 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.011 HD22 HD12 ' A' ' 222' ' ' LEU . 1.6 tp -64.21 -71.19 0.18 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 0.0 111.658 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.896 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -150.02 -168.41 3.1 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.532 -1.355 . . . . 0.0 110.426 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 179.21 -178.22 0.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 119.73 -1.856 . . . . 0.0 111.353 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.658 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -154.92 178.91 9.64 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.475 -0.765 . . . . 0.0 110.134 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.797 ' CE1' HD11 ' A' ' 174' ' ' ILE . 81.5 m-85 -121.51 -167.82 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.449 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.997 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -175.3 -58.65 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 109.423 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.997 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -78.62 133.05 11.35 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.886 1.466 . . . . 0.0 109.969 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 132.67 -173.9 20.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.592 ' HD2' HG22 ' A' ' 174' ' ' ILE . 45.8 Cg_endo -78.48 -92.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.089 1.573 . . . . 0.0 110.312 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -82.97 -34.62 20.93 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.797 HD11 ' CE1' ' A' ' 168' ' ' TYR . 0.8 OUTLIER -61.93 -6.98 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.466 -1.02 . . . . 0.0 108.816 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.568 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 34.4 p-10 -65.81 64.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.466 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 206' ' ' SER . . . 126.36 82.3 0.43 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.0 m-20 -158.68 120.24 3.46 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.012 -1.287 . . . . 0.0 107.95 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -111.9 156.97 21.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.677 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.917 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -145.08 134.08 22.58 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.624 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 65.7 m-85 -95.57 133.75 39.25 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.158 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.579 ' OD2' ' CD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -49.34 148.66 2.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.026 177.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD2' ' HB ' ' A' ' 148' ' ' VAL . 2.6 p30 -124.05 21.04 9.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.809 -1.182 . . . . 0.0 109.558 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.744 ' OD2' HG21 ' A' ' 148' ' ' VAL . 1.8 m-20 -131.05 9.73 4.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.509 ' CG ' ' HB3' ' A' ' 181' ' ' ASP . 1.0 OUTLIER -114.04 -98.28 0.44 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.657 -1.277 . . . . 0.0 109.515 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 66.9 mt-30 -154.26 165.94 34.72 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 109.202 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 1.049 ' CD1' HG21 ' A' ' 105' ' ' THR . 97.8 m95 -160.3 118.97 2.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 110.11 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.825 ' HA ' HD21 ' A' ' 108' ' ' LEU . 22.2 p -140.79 152.1 44.94 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.034 -1.041 . . . . 0.0 109.039 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.794 ' HA ' HD22 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -75.09 -33.44 61.64 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.627 ' OD2' HD12 ' A' ' 229' ' ' LEU . 1.3 t70 -91.52 -141.19 0.18 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.933 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.8 t -117.59 46.77 1.66 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.003 -1.06 . . . . 0.0 108.243 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.499 ' HB ' HG21 ' A' ' 187' ' ' THR . 58.4 m -104.71 -29.46 10.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.273 -0.892 . . . . 0.0 111.303 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.533 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -110.26 -91.29 2.09 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.91 -1.614 . . . . 0.0 109.48 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.038 HG22 ' OD1' ' A' ' 194' ' ' ASN . 64.8 m -114.44 -84.35 0.61 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 1.038 ' OD1' HG22 ' A' ' 193' ' ' THR . 5.1 p30 178.6 68.56 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.862 1.315 . . . . 0.0 108.139 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.048 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -21.73 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.303 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.868 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -68.01 -6.39 22.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 110.835 -175.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.975 ' HA ' HD11 ' A' ' 218' ' ' LEU . 7.5 tp -66.11 -61.49 2.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 117.601 -1.64 . . . . 0.0 106.642 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.896 HG12 ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -70.81 -14.49 18.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.121 -1.032 . . . . 0.0 108.426 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.936 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.23 -61.05 1.96 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.618 -1.233 . . . . 0.0 108.211 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 1.044 ' HB3' HD23 ' A' ' 218' ' ' LEU . . . -63.58 -15.75 58.93 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.311 -1.493 . . . . 0.0 107.527 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.814 ' HA ' ' HE2' ' A' ' 219' ' ' MET . 6.8 t60 -70.6 -44.01 68.17 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.684 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.722 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 8.3 mt-10 -82.58 -46.16 13.69 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 0.0 111.374 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.941 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.0 mt -63.69 -30.31 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.698 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.47 -31.38 54.58 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -64.04 -47.16 81.29 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.796 -0.826 . . . . 0.0 111.232 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.545 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 33.9 p -85.37 -52.52 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.16 -0.963 . . . . 0.0 112.63 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.89 ' O ' HD12 ' A' ' 207' ' ' LEU . 1.3 pp -104.4 7.44 35.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.871 -1.143 . . . . 0.0 111.097 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.995 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -109.83 -84.01 1.5 Allowed Glycine 0 C--N 1.29 -1.975 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.825 HD11 ' OD1' ' A' ' 238' ' ' ASP . 1.8 pp -158.89 -161.13 0.93 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.922 -1.34 . . . . 0.0 109.942 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.572 ' N ' HD12 ' A' ' 209' ' ' LEU . 44.8 t80 -98.43 -71.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.6 m-70 -161.06 94.17 1.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.647 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 2.1 m -84.03 -179.26 7.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.871 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -62.7 78.6 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.999 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -82.72 9.34 9.85 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.281 -177.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -50.44 -27.84 7.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.511 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.6 mt-10 -114.07 -36.45 4.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.999 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -61.39 -159.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.272 1.034 . . . . 0.0 112.276 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.044 HD23 ' HB3' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -106.04 -11.81 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.562 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.814 ' HE2' ' HA ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -80.57 -10.2 59.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.24 -1.537 . . . . 0.0 111.932 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.679 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.8 t80 -131.39 8.5 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.447 -1.408 . . . . 0.0 113.953 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 43.7 Cg_endo -72.48 -41.84 1.55 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 N-CA-C 109.261 -1.092 . . . . 0.0 109.261 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 1.011 HD12 HD22 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -0.5 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.204 0.526 . . . . 0.0 111.756 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.877 ' N ' HD23 ' A' ' 222' ' ' LEU . 48.4 t80 -67.19 58.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.827 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.13 -155.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 109.329 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.458 ' HB3' ' OG1' ' A' ' 190' ' ' THR . 0.7 OUTLIER -128.69 126.39 40.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.091 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.95 HD12 ' HB2' ' A' ' 231' ' ' ARG . 1.2 tt -179.85 40.35 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.581 ' HA ' ' CE1' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -103.16 -40.03 6.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.9 t70 -149.38 -13.43 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.551 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.933 HD11 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -42.65 -98.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.851 -1.156 . . . . 0.0 110.349 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.5 p -139.03 -0.31 1.88 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.48 -1.388 . . . . 0.0 109.933 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.95 ' HB2' HD12 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -116.7 -18.21 10.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.012 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 232' ' ' PHE . 19.5 p90 -30.15 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.478 0.656 . . . . 0.0 111.477 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.58 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 8.5 ttt180 179.13 149.53 0.26 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.118 HD22 ' CG1' ' A' ' 123' ' ' VAL . 3.1 tp -70.11 164.43 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 108.755 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . 1.085 ' O ' HD12 ' A' ' 239' ' ' ILE . 7.7 t -102.46 178.15 4.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.068 -1.02 . . . . 0.0 109.578 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.509 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -70.36 -14.6 62.64 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.75 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.871 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.8 OUTLIER -87.32 -49.6 7.14 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.716 -1.24 . . . . 0.0 109.548 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.825 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.94 -42.56 97.29 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 116.908 -1.917 . . . . 0.0 107.17 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.085 HD12 ' O ' ' A' ' 235' ' ' SER . 3.0 mt -54.83 -39.83 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.52 ' HA ' ' HG2' ' A' ' 243' ' ' GLN . 24.5 t-20 -60.84 -48.97 79.36 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.62 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.06 -55.53 30.37 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.038 HG21 HG21 ' A' ' 127' ' ' VAL . 1.4 tp -63.46 -50.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.032 -1.276 . . . . 0.0 110.521 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.567 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -53.33 -25.1 13.76 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.509 ' N ' ' HG3' ' A' ' 243' ' ' GLN . 37.4 t -90.83 -11.4 39.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -78.98 -49.97 11.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.74 ' HB3' HD23 ' A' ' 130' ' ' LEU . 5.0 m-30 -91.65 -104.09 0.11 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 246' ' ' TYR . . . 43.37 89.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.688 ' CD ' ' HD3' ' A' ' 249' ' ' PRO . 35.1 Cg_endo -61.99 -26.0 78.24 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.959 1.505 . . . . 0.0 113.036 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.688 ' HD3' ' CD ' ' A' ' 248' ' ' PRO . 55.2 Cg_endo -98.17 68.06 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.213 1.275 . . . . 0.0 111.496 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.587 ' CD ' ' O ' ' A' ' 248' ' ' PRO . 41.6 Cg_endo -70.91 -58.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 122.781 0.885 . . . . 0.0 109.946 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.58 -33.31 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.344 -0.847 . . . . 0.0 109.028 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.19 100.89 2.28 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.423 -0.798 . . . . 0.0 109.181 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.77 -31.12 13.47 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.042 1.548 . . . . 0.0 110.257 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -152.47 -70.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.555 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.606 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.543 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 1.011 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.237 0.541 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 85' ' ' THR . 2.2 ptp180 -87.76 -167.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.621 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.482 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.9 t -43.83 163.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.514 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 1.7 t80 -86.6 109.85 27.24 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.4 Cg_endo -72.72 80.57 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.888 1.468 . . . . 0.0 110.079 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 159.34 -56.26 0.34 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 86' ' ' PHE . 14.7 mt -138.1 132.01 16.82 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.245 -1.15 . . . . 0.0 109.548 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.534 ' HB2' HD23 ' A' ' 245' ' ' LEU . 42.8 Cg_endo -73.3 174.14 12.59 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.003 1.528 . . . . 0.0 110.088 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.504 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.2 OUTLIER -67.96 -79.57 0.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.317 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.534 ' CE3' ' HD3' ' A' ' 94' ' ' LYS . 36.3 m95 -105.48 160.14 15.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.889 -1.132 . . . . 0.0 109.284 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -121.97 -28.99 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.044 -1.035 . . . . 0.0 110.682 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 1.06 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -42.9 169.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 110.323 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.652 ' HA ' HD11 ' A' ' 130' ' ' LEU . 2.1 p -106.19 -0.66 24.38 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.439 -0.788 . . . . 0.0 109.459 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.558 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 54.3 m-70 -140.19 93.89 2.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.904 HD23 HD23 ' A' ' 130' ' ' LEU . 3.1 mm? -85.82 164.66 17.41 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.762 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.608 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -143.33 156.64 44.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.918 ' CE2' HD11 ' A' ' 101' ' ' ILE . 8.8 p90 -135.85 170.28 16.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.61 -1.306 . . . . 0.0 109.642 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.838 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -132.25 123.25 26.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.369 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.918 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -80.01 83.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 0.0 109.705 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.838 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -99.12 8.39 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.629 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -107.06 173.01 6.51 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.424 -1.422 . . . . 0.0 110.119 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.619 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 11.3 t80 176.94 70.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.712 0.768 . . . . 0.0 109.342 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.8 HG21 ' CD1' ' A' ' 186' ' ' TRP . 56.3 p -56.25 148.86 39.88 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 120.985 -1.072 . . . . 0.0 108.246 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 -28.96 40.5 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 108.52 -1.377 . . . . 0.0 108.52 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.608 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.6 t0 -71.28 -9.12 57.59 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 187' ' ' THR . 33.1 mt -131.69 120.51 17.67 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.644 -0.66 . . . . 0.0 110.21 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.6 Cg_endo -62.99 163.69 21.64 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 123.811 1.427 . . . . 0.0 108.979 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.3 -65.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.781 0.801 . . . . 0.0 110.034 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.7 OUTLIER -57.65 -15.2 6.95 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 111.056 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . . . -81.23 -62.22 1.72 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.555 -1.341 . . . . 0.0 108.942 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.629 HG21 ' C ' ' A' ' 103' ' ' ASN . 7.3 p -50.64 -40.02 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 118.294 -1.362 . . . . 0.0 107.481 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.825 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -65.12 -27.09 68.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.738 ' OG ' HD21 ' A' ' 195' ' ' LEU . 14.6 p -66.91 -38.43 86.21 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.064 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.19 -33.59 65.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.329 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.863 HG13 HG13 ' A' ' 144' ' ' ILE . 47.8 t -75.45 -24.09 17.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -84.36 -36.4 22.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -79.69 -38.82 32.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -63.39 -60.76 2.95 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 122.425 1.107 . . . . 0.0 108.247 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.842 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.2 pp -52.59 -41.04 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.937 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.759 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -75.88 -32.07 59.52 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.986 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.028 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.9 t -53.81 -45.11 61.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.051 ' CH2' HD21 ' A' ' 234' ' ' LEU . 31.8 m95 -91.7 -23.12 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.902 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 5.4 tm-20 -70.96 -26.59 63.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.847 -1.158 . . . . 0.0 107.935 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -90.76 -42.71 10.53 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.689 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.028 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.9 m -58.78 -25.67 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 118.323 -1.351 . . . . 0.0 108.809 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.019 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -112.56 172.15 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 117.94 -1.504 . . . . 0.0 110.056 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.563 ' CG ' ' HD3' ' A' ' 248' ' ' PRO . 51.7 Cg_endo -87.21 -7.94 6.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.642 2.228 . . . . 0.0 110.78 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.06 HD21 ' O ' ' A' ' 94' ' ' LYS . 1.1 tp -73.8 -179.76 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.982 -1.074 . . . . 0.0 110.594 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.5 p -119.33 175.68 5.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 110.154 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.718 ' CZ ' HD13 ' A' ' 207' ' ' LEU . 0.5 OUTLIER -144.56 159.56 42.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.97 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.578 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -145.25 179.74 7.18 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.69 157.85 44.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.797 -1.189 . . . . 0.0 110.427 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.541 HD23 ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -150.55 -140.03 0.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 5.5 t80 178.92 40.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.743 -1.223 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 7.5 pm0 -165.22 -178.18 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.609 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.44 -96.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 137' ' ' GLU . 1.7 pt-20 178.84 105.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.199 -1.177 . . . . 0.0 110.163 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.608 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.21 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 108.671 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.607 ' O ' HD13 ' A' ' 142' ' ' ILE . 0.9 OUTLIER -92.49 -27.97 17.09 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.532 179.14 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.986 HD11 ' HG ' ' A' ' 207' ' ' LEU . 31.1 mm -130.9 77.14 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.695 ' HG2' HG21 ' A' ' 102' ' ' VAL . 1.9 ttt -64.87 97.07 0.21 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.136 -0.978 . . . . 0.0 108.962 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.863 HG13 HG13 ' A' ' 117' ' ' VAL . 6.9 mm -79.55 123.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.092 . . . . 0.0 108.456 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -138.47 153.07 48.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.446 -1.409 . . . . 0.0 111.825 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 14.3 p90 -87.34 139.9 30.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.207 -0.933 . . . . 0.0 108.943 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.097 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.15 -160.21 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.702 -1.249 . . . . 0.0 111.36 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.769 HG13 ' H ' ' A' ' 150' ' ' GLU . 5.7 p -170.0 179.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.705 ' H ' HG22 ' A' ' 148' ' ' VAL . 3.0 ptt180 -36.63 -29.39 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 0.0 110.705 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.769 ' H ' HG13 ' A' ' 148' ' ' VAL . 31.6 mt-10 -85.65 95.0 9.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.075 -1.015 . . . . 0.0 109.773 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.566 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 25.7 m80 -110.22 -79.58 0.58 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.462 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 134.48 -4.17 4.4 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 14.2 t70 -120.28 -91.98 0.55 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -1.162 . . . . 0.0 109.701 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -155.82 19.8 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.992 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -128.94 58.56 37.73 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 109.642 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.544 ' HA ' ' ND1' ' A' ' 151' ' ' HIS . 43.3 Cg_endo -73.83 124.95 9.57 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.018 1.536 . . . . 0.0 109.865 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.687 ' CD1' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -91.16 -149.9 0.23 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.054 -1.028 . . . . 0.0 109.419 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.572 ' OD1' HG12 ' A' ' 163' ' ' VAL . 8.9 p-10 -137.04 -2.85 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.258 -1.526 . . . . 0.0 111.718 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.655 ' CA ' HG23 ' A' ' 148' ' ' VAL . . . 39.48 -95.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.528 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.2 Cg_endo -61.45 72.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.338 1.178 . . . . 0.0 110.077 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -172.51 -164.06 27.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' VAL . 69.0 m-20 -90.69 -29.82 17.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.086 -1.244 . . . . 0.0 110.111 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.687 HG11 ' CD1' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -36.73 130.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.593 -0.692 . . . . 0.0 110.713 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.839 HD12 HG11 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -92.23 -80.89 0.35 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.582 -0.699 . . . . 0.0 112.24 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.841 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -161.35 -170.9 2.79 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.263 -1.523 . . . . 0.0 111.026 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.682 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -179.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 119.542 -1.974 . . . . 0.0 111.313 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -160.41 -163.41 1.09 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.603 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -130.17 -157.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 0.0 110.704 -178.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.97 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -170.56 -59.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.661 -0.65 . . . . 0.0 109.562 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.97 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.4 Cg_endo -79.6 -172.32 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.405 1.403 . . . . 0.0 110.232 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.55 144.07 0.71 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.17 135.14 28.75 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.425 1.417 . . . . 0.0 110.002 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 72.54 -64.12 1.44 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.603 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.0 tp -63.78 -8.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.494 -1.003 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.7 OUTLIER -65.77 66.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.763 179.329 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 206' ' ' SER . . . 129.53 79.49 0.23 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -153.53 128.76 9.76 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.859 -1.377 . . . . 0.0 108.205 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.703 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -112.59 172.57 6.84 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.983 -1.073 . . . . 0.0 108.961 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.097 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -164.66 134.38 3.8 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.577 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.682 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 12.2 m-85 -88.69 123.38 33.08 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 164' ' ' LEU . 17.0 t70 -67.2 144.66 55.86 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.129 -0.982 . . . . 0.0 108.945 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -61.18 -4.18 1.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.283 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.649 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.0 OUTLIER 4.62 -94.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 161' ' ' GLY . 1.4 pm0 -166.3 -33.61 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.692 -1.255 . . . . 0.0 110.906 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.459 ' OE1' ' HA2' ' A' ' 192' ' ' GLY . 66.4 mt-30 -141.66 158.67 43.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.708 -1.245 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.8 ' CD1' HG21 ' A' ' 105' ' ' THR . 84.9 m95 -158.02 119.53 3.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.916 ' HA ' HD21 ' A' ' 108' ' ' LEU . 47.2 p -144.43 154.64 43.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.473 -1.392 . . . . 0.0 110.476 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 0.7 OUTLIER -75.7 -35.0 60.42 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.566 ' OD2' HD12 ' A' ' 229' ' ' LEU . 1.0 OUTLIER -93.86 -144.21 0.24 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.919 ' N ' HD11 ' A' ' 229' ' ' LEU . 15.1 t -109.69 37.78 2.55 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.447 ' HB ' HG21 ' A' ' 187' ' ' THR . 11.8 m -84.83 -35.58 22.19 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.63 -0.669 . . . . 0.0 110.94 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.623 ' N ' HG21 ' A' ' 187' ' ' THR . . . -120.82 -87.39 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 118.852 -1.642 . . . . 0.0 109.024 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.584 HG21 HD11 ' A' ' 164' ' ' LEU . 90.9 m -114.85 -105.91 0.39 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.606 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 52.3 m-80 -157.62 70.76 0.6 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.113 -0.992 . . . . 0.0 108.744 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.923 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -19.58 -91.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.812 0.815 . . . . 0.0 112.618 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.836 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -66.95 -11.81 57.7 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.045 -1.034 . . . . 0.0 111.656 -176.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 1.006 HD11 ' CG ' ' A' ' 221' ' ' PRO . 11.7 tp -64.2 -55.48 21.34 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.841 HG12 ' HB3' ' A' ' 165' ' ' ALA . 2.8 t -76.08 -9.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.064 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.97 -57.2 3.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.391 -1.324 . . . . 0.0 107.534 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.22 -19.02 65.78 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.602 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 3.7 t-160 -68.22 -41.12 81.78 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.672 177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.703 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 28.4 mt-10 -83.64 -49.11 9.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 110.778 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.733 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -58.73 -31.85 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.71 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.39 -35.69 36.56 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -56.18 -53.68 54.21 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.674 -0.897 . . . . 0.0 110.319 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.667 ' HB2' HD12 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -83.72 -56.83 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 111.579 -178.23 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.986 ' HG ' HD11 ' A' ' 142' ' ' ILE . 7.4 mt -102.54 37.6 1.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 110.971 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 1.03 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -141.63 -75.34 0.04 OUTLIER Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.7 pp -170.31 -164.28 0.39 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.994 -1.297 . . . . 0.0 109.657 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.1 OUTLIER -98.48 -79.55 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.276 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.487 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 0.7 OUTLIER -154.29 105.9 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 0.0 109.164 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -94.54 -176.45 3.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.287 -0.883 . . . . 0.0 109.096 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.974 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -62.4 81.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.952 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.84 10.5 18.37 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.64 -177.249 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.3 OUTLIER -50.28 -27.82 6.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 174.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.516 ' C ' ' HB2' ' A' ' 235' ' ' SER . 23.5 mm-40 -115.81 -36.85 4.06 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.952 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -173.01 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.517 1.151 . . . . 0.0 112.766 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.926 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -85.73 -17.06 36.96 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.977 -177.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.742 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -78.51 -8.11 58.21 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.461 -2.024 . . . . 0.0 112.366 -177.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.682 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 7.0 t80 -133.01 14.74 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 120.25 -1.531 . . . . 0.0 113.472 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 1.006 ' CG ' HD11 ' A' ' 197' ' ' LEU . 52.2 Cg_endo -77.77 -41.88 0.29 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 N-CA-C 109.541 -0.984 . . . . 0.0 109.541 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 1.077 HD13 ' CD2' ' A' ' 3' ' ' MSB . 0.5 OUTLIER -8.73 -69.0 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.578 -178.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.931 ' N ' HD23 ' A' ' 222' ' ' LEU . 7.9 t80 -65.91 59.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.71 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.4 t-80 179.77 -143.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.316 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.42 ' C ' HD23 ' A' ' 226' ' ' LEU . 49.4 m -152.59 123.48 7.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.066 -1.021 . . . . 0.0 109.556 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.973 HD21 ' HB2' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 179.52 59.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.851 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.568 ' O ' ' CD2' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -109.02 -45.98 3.68 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.072 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 33.0 t70 -138.3 -13.55 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 0.0 110.432 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.919 HD11 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -37.6 -100.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.264 -0.897 . . . . 0.0 111.055 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.46 -16.41 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.434 -1.416 . . . . 0.0 110.383 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.535 ' O ' ' CD ' ' A' ' 233' ' ' ARG . 2.1 mtp180 -114.54 -22.19 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 108.849 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 30.4 p90 -30.65 115.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.419 0.628 . . . . 0.0 111.944 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.544 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.42 166.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 178.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.051 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.6 mp -77.87 165.32 24.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.173 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.737 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 31.1 t -99.88 -170.17 1.85 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 118.699 -1.201 . . . . 0.0 110.302 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.8 pp0? -83.93 -16.93 42.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.637 -0.665 . . . . 0.0 109.968 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.974 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.1 m-20 -81.95 -48.57 11.31 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.257 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.727 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.47 -38.34 90.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 117.328 -1.749 . . . . 0.0 106.728 177.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.605 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.42 -35.93 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -65.47 -60.12 3.28 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -49.51 -49.53 32.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.03 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.4 tp -65.09 -46.69 90.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.772 -1.428 . . . . 0.0 110.015 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.535 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.2 tt0 -53.34 -27.1 21.73 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.4 t -84.96 -17.91 36.22 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 1.003 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -75.37 -60.58 2.24 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.553 -0.717 . . . . 0.0 109.592 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.901 ' OH ' HD22 ' A' ' 207' ' ' LEU . 10.2 m-30 -84.87 -120.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.449 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 79.76 135.77 1.35 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.657 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 49.1 Cg_endo -72.78 174.74 11.33 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.92 1.484 . . . . 0.0 109.702 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 38.1 Cg_endo -66.52 -25.89 47.57 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.788 1.658 . . . . 0.0 114.487 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 42.8 Cg_endo -83.95 -71.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 120.465 0.777 . . . . 0.0 110.098 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 250' ' ' PRO . 11.5 t70 -43.31 -35.3 1.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 109.706 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.96 88.2 0.23 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.505 ' CG ' ' O ' ' A' ' 249' ' ' PRO . 42.1 Cg_endo -74.65 -45.13 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.032 1.543 . . . . 0.0 110.137 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.449 ' OE1' ' HB2' ' A' ' 253' ' ' PRO . 1.9 pm0 -153.19 -39.11 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.554 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.524 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.49 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.502 ' HD1' ' OB1' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 1.077 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.498 ' O ' ' CD2' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -80.99 -69.42 0.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 108.965 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 86' ' ' PHE . 71.0 p -60.97 -91.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.532 -0.73 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.498 ' N ' ' OG1' ' A' ' 85' ' ' THR . 0.4 OUTLIER 179.96 108.98 0.19 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.458 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.94 60.72 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.903 1.475 . . . . 0.0 110.066 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.65 -129.5 2.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 89' ' ' ILE . 42.0 mt -67.47 125.01 90.56 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.244 -1.151 . . . . 0.0 109.517 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.777 ' HB2' HD23 ' A' ' 245' ' ' LEU . 42.6 Cg_endo -73.28 -162.13 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.882 1.464 . . . . 0.0 110.195 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -63.45 -85.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.652 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.612 ' CD1' HD13 ' A' ' 207' ' ' LEU . 59.3 m95 -97.72 174.44 6.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.189 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.4 ppt_? -135.35 -38.81 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.636 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.913 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.08 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.284 -0.885 . . . . 0.0 110.073 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.539 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 30.7 p -105.98 3.34 28.24 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.328 -0.857 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.551 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 65.4 m-70 -136.11 91.04 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.882 -1.136 . . . . 0.0 109.946 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.913 HD13 ' HE2' ' A' ' 94' ' ' LYS . 2.6 mm? -94.98 168.22 10.92 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.599 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -142.86 156.51 44.94 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.872 -1.142 . . . . 0.0 109.0 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 1.025 ' CZ ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.5 172.59 12.78 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.994 -1.066 . . . . 0.0 109.927 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.52 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -136.77 144.27 43.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.025 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 1.8 mp -100.68 76.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 0.0 110.041 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' A' ' 144' ' ' ILE . 29.1 t -94.21 8.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.995 . . . . 0.0 109.699 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.853 ' C ' HG21 ' A' ' 113' ' ' VAL . 2.7 m120 -99.36 163.06 12.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.952 -1.092 . . . . 0.0 109.243 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.714 ' N ' HG21 ' A' ' 113' ' ' VAL . 17.7 p90 179.33 55.44 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.531 -0.731 . . . . 0.0 109.917 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.965 HG21 ' CD1' ' A' ' 186' ' ' TRP . 46.9 p -42.94 150.24 0.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.008 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.93 -25.99 44.39 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.886 1.466 . . . . 0.0 109.203 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.475 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -77.44 -1.21 29.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.965 HD13 ' CD1' ' A' ' 195' ' ' LEU . 99.1 mt -141.15 115.89 7.16 Favored Pre-proline 0 N--CA 1.484 1.258 0 O-C-N 121.473 -0.767 . . . . 0.0 109.613 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.5 Cg_endo -66.09 173.87 6.67 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.807 1.425 . . . . 0.0 109.141 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE3' ' CG ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -37.48 -65.35 0.32 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.805 0.812 . . . . 0.0 110.421 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -57.59 -29.64 64.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.861 -0.525 . . . . 0.0 112.336 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.83 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -71.68 -61.98 1.58 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.261 -1.525 . . . . 0.0 109.064 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.976 ' O ' HG23 ' A' ' 117' ' ' VAL . 8.3 p -52.23 -39.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' OD1' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.09 -28.15 69.88 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.863 ' OG ' HD21 ' A' ' 195' ' ' LEU . 16.4 p -64.96 -40.4 94.93 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.061 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.56 -33.15 64.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.962 -1.087 . . . . 0.0 109.892 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.998 HG12 ' CE2' ' A' ' 99' ' ' TYR . 2.0 t -74.86 -24.82 18.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -88.52 -35.04 17.19 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.818 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -77.89 -39.66 42.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.365 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.87 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.28 -62.99 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 122.399 1.095 . . . . 0.0 108.439 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.776 ' HA ' HG21 ' A' ' 203' ' ' ILE . 10.0 tp -50.63 -44.76 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -73.18 -32.89 65.11 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.385 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.02 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.3 t -54.63 -43.16 64.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.06 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.9 m95 -91.71 -23.57 19.74 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.646 -1.221 . . . . 0.0 110.808 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 3.5 tp10 -70.45 -27.73 64.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.595 -1.316 . . . . 0.0 107.966 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.461 ' OE1' ' HG3' ' A' ' 122' ' ' LYS . 13.2 pt-20 -89.61 -42.92 11.12 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.977 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.02 HG13 ' O ' ' A' ' 123' ' ' VAL . 17.1 m -59.91 -24.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.354 -1.339 . . . . 0.0 109.291 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.03 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -110.04 155.99 40.77 Favored Pre-proline 0 N--CA 1.495 1.795 0 C-N-CA 117.963 -1.495 . . . . 0.0 109.891 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HG2' ' C ' ' A' ' 247' ' ' GLY . 53.9 Cg_endo -81.15 10.62 3.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.14 1.894 . . . . 0.0 110.742 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.743 HD13 ' HB3' ' A' ' 246' ' ' TYR . 3.9 mp -96.46 -178.98 4.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.86 -1.15 . . . . 0.0 110.405 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.444 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -118.78 167.56 11.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.401 -0.812 . . . . 0.0 110.198 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.603 ' HE2' HD11 ' A' ' 142' ' ' ILE . 8.3 m-85 -141.7 -179.43 6.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.54 -0.725 . . . . 0.0 109.447 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 -162.64 1.37 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.898 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -162.05 -178.58 6.51 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.91 -1.119 . . . . 0.0 110.534 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -164.17 -128.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER 177.19 31.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.621 -1.299 . . . . 0.0 109.532 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 138' ' ' GLY . 3.2 pm0 -171.28 -161.78 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.106 -0.996 . . . . 0.0 109.729 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 35.5 -98.35 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.507 ' OE2' ' CA ' ' A' ' 173' ' ' GLY . 0.0 OUTLIER 177.81 107.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 110.634 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 1.013 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -67.26 -155.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.78 ' OD2' HD12 ' A' ' 97' ' ' LEU . 8.5 t0 -81.47 -32.3 32.57 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.718 HD11 ' HG ' ' A' ' 207' ' ' LEU . 1.7 mt -126.86 85.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.581 ' O ' ' CG ' ' A' ' 143' ' ' MET . 5.5 ptm -76.65 100.18 5.29 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.89 HG13 HG13 ' A' ' 117' ' ' VAL . 4.4 mm -79.39 114.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 108.087 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -135.95 159.79 40.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.475 -1.391 . . . . 0.0 112.065 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.64 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 17.2 p90 -80.19 140.16 36.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.034 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -170.47 177.94 3.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 110.625 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.574 ' CG2' ' CA ' ' A' ' 159' ' ' GLY . 11.5 p 179.44 143.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER 1.23 67.23 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.399 0.618 . . . . 0.0 112.096 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 148' ' ' VAL . 26.2 tt0 179.09 32.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.291 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 38.9 m80 -71.78 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.655 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -133.87 -50.96 0.08 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -169.18 -53.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -1.153 . . . . 0.0 109.96 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.47 ' C ' ' CD ' ' A' ' 156' ' ' PRO . 5.7 t80 -99.26 6.5 46.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 109.992 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.65 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 19.5 m-85 -118.13 34.71 0.21 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.092 -1.005 . . . . 0.0 110.928 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 43.7 Cg_endo -74.16 113.96 3.92 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 N-CA-C 108.867 -1.243 . . . . 0.0 108.867 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.003 ' CZ ' HG12 ' A' ' 163' ' ' VAL . 1.8 t80 -76.11 -136.87 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.901 -1.124 . . . . 0.0 109.97 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.603 ' CB ' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -135.31 -30.55 1.02 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.796 -1.19 . . . . 0.0 110.879 -178.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.574 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 52.9 -107.67 0.59 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.55 ' HD2' ' CD ' ' A' ' 149' ' ' ARG . 31.5 Cg_endo -56.43 91.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 121.164 1.242 . . . . 0.0 110.829 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.517 ' HA3' ' OD2' ' A' ' 158' ' ' ASP . . . 161.73 -164.15 35.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 163' ' ' VAL . 41.8 m-80 -86.19 -30.53 22.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -1.226 . . . . 0.0 110.486 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.076 HG13 ' CG2' ' A' ' 1' ' ' HAV . 7.9 t -39.92 100.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.021 HD23 HG21 ' A' ' 198' ' ' VAL . 0.9 OUTLIER -71.23 -70.36 0.32 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.447 -0.783 . . . . 0.0 111.723 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.715 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -161.37 -165.96 1.43 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.42 -1.425 . . . . 0.0 111.071 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.681 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.6 OUTLIER 179.49 -165.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.897 -1.752 . . . . 0.0 110.646 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -165.05 -167.05 1.11 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.528 ' O ' ' CB ' ' A' ' 206' ' ' SER . 86.7 m-85 -133.11 -159.71 0.99 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.97 . . . . 0.0 110.053 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.985 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -161.9 -63.26 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.062 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.985 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.5 Cg_endo -77.05 174.86 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.814 1.428 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 102.05 172.03 27.5 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 174' ' ' ILE . 40.8 Cg_endo -74.81 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.665 1.577 . . . . 0.0 109.664 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.507 ' CA ' ' OE2' ' A' ' 139' ' ' GLU . . . -79.58 -35.1 29.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.3 tt -69.85 3.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 121.81 -0.817 . . . . 0.0 109.011 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 170' ' ' PRO . 5.5 t30 -64.94 61.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.391 -0.818 . . . . 0.0 109.105 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.59 ' HA2' ' OG ' ' A' ' 206' ' ' SER . . . 107.47 89.51 2.08 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 76.1 m-20 -141.69 126.13 17.71 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -108.82 149.19 29.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.817 -1.177 . . . . 0.0 108.106 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.034 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -144.07 130.48 19.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.955 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.589 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 18.6 m-85 -85.17 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.593 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 p-10 -75.18 132.03 40.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.415 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 183' ' ' ASP . 6.4 t0 -75.44 -0.87 21.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.477 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 47.4 t0 -30.84 -72.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.512 0.672 . . . . 0.0 112.074 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.467 ' OE1' ' OD2' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -114.83 -110.96 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.084 -176.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.577 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 2.1 mt-30 -133.84 -168.77 2.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.817 -1.177 . . . . 0.0 109.739 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.965 ' CD1' HG21 ' A' ' 105' ' ' THR . 85.2 m95 -155.07 136.13 13.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.792 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.6 p -145.45 152.88 40.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.204 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.757 ' O ' HG23 ' A' ' 227' ' ' THR . 0.0 OUTLIER -73.04 -34.01 66.04 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.522 ' HA ' HD13 ' A' ' 229' ' ' LEU . 1.3 t70 -90.54 -151.07 0.24 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.868 HG23 HD11 ' A' ' 229' ' ' LEU . 1.4 p -103.76 35.11 2.73 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.286 -1.365 . . . . 0.0 107.927 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.546 ' CB ' HG21 ' A' ' 187' ' ' THR . 13.2 m -81.6 -36.16 29.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.263 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 187' ' ' THR . . . -119.96 -81.05 0.67 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.155 -1.498 . . . . 0.0 109.699 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.807 ' CG2' HD21 ' A' ' 164' ' ' LEU . 85.0 m -127.51 -79.08 0.58 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.373 -1.074 . . . . 0.0 108.704 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.877 HD22 HD23 ' A' ' 197' ' ' LEU . 42.9 p30 179.26 60.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.033 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -18.44 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.591 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.829 ' HE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -64.34 -16.95 63.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.127 -176.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 1.057 HD11 HD23 ' A' ' 226' ' ' LEU . 13.3 tp -60.94 -61.17 2.77 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 117.208 -1.797 . . . . 0.0 107.724 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.021 HG21 HD23 ' A' ' 164' ' ' LEU . 13.7 t -74.54 -7.66 10.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.629 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.061 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -74.89 -57.83 3.66 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.752 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.36 -16.47 64.09 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.585 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 8.5 t60 -70.12 -39.63 75.34 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.18 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.757 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 30.0 mt-10 -87.48 -46.96 9.13 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.028 -1.045 . . . . 0.0 110.366 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.87 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -61.41 -30.91 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.728 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.3 -34.85 44.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -58.68 -54.24 49.35 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.686 -0.891 . . . . 0.0 110.292 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.59 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 30.4 t -77.24 -60.21 2.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 112.486 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.718 ' HG ' HD11 ' A' ' 142' ' ' ILE . 1.1 mm? -104.01 31.49 4.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.236 -0.915 . . . . 0.0 110.529 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 1.031 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -132.59 -77.95 0.14 Allowed Glycine 0 C--N 1.292 -1.912 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.83 -166.01 0.54 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.945 -1.327 . . . . 0.0 110.054 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.821 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.1 OUTLIER -98.51 -74.82 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.29 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 79.2 m80 -160.12 110.38 1.85 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.779 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 2.0 m -98.81 -172.59 2.33 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.823 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.95 78.84 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.925 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.22 9.52 12.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.624 -177.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 214' ' ' ASN . 30.5 p -48.4 -28.88 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.545 ' C ' ' HB3' ' A' ' 235' ' ' SER . 9.5 mt-10 -113.98 -37.66 4.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.925 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -67.58 162.46 23.41 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.456 1.122 . . . . 0.0 112.367 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.87 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -56.97 -20.78 25.69 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.243 -178.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.676 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -77.59 -9.21 58.82 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 118.984 -2.323 . . . . 0.0 112.182 -177.322 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 34.3 t80 -133.62 17.77 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 120.178 -1.576 . . . . 0.0 113.568 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.692 ' HG2' HD21 ' A' ' 197' ' ' LEU . 55.3 Cg_endo -78.23 -36.51 0.98 Allowed 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.975 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -24.63 -57.93 0.05 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.942 -179.239 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.975 ' N ' HD13 ' A' ' 222' ' ' LEU . 0.4 OUTLIER -73.45 54.53 0.45 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.068 -1.02 . . . . 0.0 109.883 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.597 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 2.7 m170 -175.31 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.511 ' O ' ' NH1' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 179.57 121.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.994 -1.066 . . . . 0.0 109.117 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 1.057 HD23 HD11 ' A' ' 197' ' ' LEU . 3.1 tp 178.9 119.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER 179.12 -34.69 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 38.6 t0 -159.95 -22.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.81 -0.556 . . . . 0.0 109.596 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.868 HD11 HG23 ' A' ' 190' ' ' THR . 0.2 OUTLIER -34.5 -59.17 0.47 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.195 -0.941 . . . . 0.0 110.434 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.96 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 108.791 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.527 ' O ' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -90.32 -12.97 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.581 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 21.2 p90 -30.43 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.672 0.749 . . . . 0.0 111.221 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.537 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 2.1 ttt-85 178.79 154.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.06 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.3 mp -76.69 163.8 26.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.229 -0.919 . . . . 0.0 109.84 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.88 ' OG ' ' HB2' ' A' ' 217' ' ' ALA . 8.3 p -101.99 -168.69 1.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.076 -1.45 . . . . 0.0 110.485 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 236' ' ' GLN . 38.9 tp60 -84.25 -14.1 50.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.839 . . . . 0.0 111.313 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.823 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.1 OUTLIER -84.46 -44.02 14.05 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.451 -1.406 . . . . 0.0 107.882 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.816 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 0.7 OUTLIER -67.63 -40.63 84.62 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.06 -35.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.07 -47.65 70.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.501 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.12 -54.53 36.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.031 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.4 tp -62.01 -46.08 97.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 120.929 -1.336 . . . . 0.0 109.792 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.529 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -53.37 -31.38 44.4 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 4.0 t -77.56 -20.02 54.76 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.921 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.4 OUTLIER -70.03 -61.25 1.85 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.743 ' HB3' HD13 ' A' ' 130' ' ' LEU . 23.4 m-85 -99.1 -122.84 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.442 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.484 ' C ' ' HG2' ' A' ' 129' ' ' PRO . . . 116.59 -170.27 13.32 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.92 117.7 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.024 1.539 . . . . 0.0 110.356 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.456 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 42.5 Cg_endo -73.09 173.32 13.85 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.086 1.572 . . . . 0.0 110.006 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 249' ' ' PRO . 41.2 Cg_endo -71.98 164.1 36.73 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.9 1.474 . . . . 0.0 110.129 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 252' ' ' SER . 0.9 OUTLIER -87.25 -82.46 0.22 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 251' ' ' ASP . 0.2 OUTLIER -43.45 126.8 3.76 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.88 -31.94 9.56 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.903 1.475 . . . . 0.0 110.072 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -120.83 -166.45 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.537 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.076 ' CG2' HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.531 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.772 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.292 0.568 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 85' ' ' THR . 1.3 mtp85 -95.59 -49.36 5.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.43 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p -43.85 107.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.66 111.84 6.6 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.9 Cg_endo -73.03 156.51 51.94 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.99 1.521 . . . . 0.0 110.196 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 89' ' ' ILE . . . 79.16 -138.7 20.97 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 88' ' ' GLY . 67.5 mt -44.07 104.66 0.39 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.338 -1.095 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.828 ' HB2' HD23 ' A' ' 245' ' ' LEU . 42.8 Cg_endo -72.64 -162.81 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.054 1.555 . . . . 0.0 110.3 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -74.4 -78.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 109.879 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.632 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 26.7 m95 -94.95 177.18 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 109.909 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -139.66 -31.46 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -50.7 -172.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.022 -1.049 . . . . 0.0 110.401 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.885 ' HA ' HD22 ' A' ' 130' ' ' LEU . 9.6 p -123.55 -0.67 8.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.559 -0.713 . . . . 0.0 109.211 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.574 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 81.7 m-70 -136.94 91.01 2.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.188 -0.945 . . . . 0.0 110.002 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.844 ' N ' HD22 ' A' ' 97' ' ' LEU . 2.5 mm? -88.55 164.47 15.39 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.586 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.609 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.5 OUTLIER -142.51 155.84 45.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 1.008 ' CE2' HD11 ' A' ' 101' ' ' ILE . 5.6 p90 -137.23 163.48 30.81 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.655 -1.278 . . . . 0.0 109.276 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.738 ' HD2' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -123.27 126.2 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.2 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.008 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -81.93 77.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.95 -1.094 . . . . 0.0 109.835 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.738 HG22 ' HD2' ' A' ' 100' ' ' ARG . 9.3 t -89.39 4.62 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.309 -0.869 . . . . 0.0 109.714 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.869 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -101.35 155.11 18.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.671 -1.268 . . . . 0.0 109.393 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.627 ' N ' HG21 ' A' ' 113' ' ' VAL . 9.1 t80 177.85 76.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.622 0.725 . . . . 0.0 109.224 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.81 HG21 ' CD1' ' A' ' 186' ' ' TRP . 2.6 p -75.61 161.98 74.17 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.184 -0.947 . . . . 0.0 108.957 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.56 -21.45 39.78 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.921 1.485 . . . . 0.0 108.573 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.544 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -71.09 -7.38 46.15 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.059 HD21 ' HA ' ' A' ' 187' ' ' THR . 84.3 mt -148.13 123.3 5.11 Favored Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.7 167.83 14.6 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.862 1.454 . . . . 0.0 108.828 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.3 -64.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.818 0.818 . . . . 0.0 110.361 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 115' ' ' SER . 7.6 t0 -56.17 -26.63 51.36 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.675 -0.641 . . . . 0.0 111.736 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.806 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -74.06 -61.15 1.95 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.474 -1.391 . . . . 0.0 109.442 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.92 ' O ' HG23 ' A' ' 117' ' ' VAL . 7.6 p -53.14 -40.09 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.782 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -66.25 -27.14 67.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.906 ' OG ' HD21 ' A' ' 195' ' ' LEU . 7.5 p -62.01 -43.47 98.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.068 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -71.28 -34.01 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.997 -1.064 . . . . 0.0 109.41 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.9 t -71.93 -23.27 21.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 -34.89 14.36 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 1.7 tppt? -75.59 -40.77 56.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -64.89 -60.67 2.81 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.007 HD22 ' CZ ' ' A' ' 99' ' ' TYR . 8.5 tp -44.73 -50.85 9.81 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.546 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.8 OUTLIER -73.25 -34.23 65.72 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.464 -177.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.016 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -54.04 -42.23 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.01 ' O ' HG23 ' A' ' 128' ' ' THR . 42.7 m95 -91.74 -23.13 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.445 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.59 ' HA ' ' CE1' ' A' ' 132' ' ' PHE . 2.5 tm-20 -70.3 -27.3 64.28 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -90.38 -43.22 10.46 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.712 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.016 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.3 m -58.17 -25.7 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.819 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.01 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.7 152.37 45.44 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.955 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.513 ' CG ' ' HA2' ' A' ' 247' ' ' GLY . 45.2 Cg_endo -73.47 2.01 6.2 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.878 1.719 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.032 HD12 ' CG ' ' A' ' 246' ' ' TYR . 20.5 mt -84.2 -178.06 6.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.451 ' C ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -124.25 167.37 14.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.148 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.764 ' HB3' HD11 ' A' ' 121' ' ' LEU . 20.0 m-85 -135.96 170.47 15.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.566 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.27 175.04 12.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 108.7 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -142.43 156.91 45.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.95 -1.094 . . . . 0.0 110.075 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.958 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.8 OUTLIER -146.77 -134.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 178.46 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.862 -1.148 . . . . 0.0 109.347 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' OE2' ' HB2' ' A' ' 135' ' ' LEU . 7.8 pm0 -158.4 -177.82 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.873 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.03 -97.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 137' ' ' GLU . 2.2 pt-20 178.8 107.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.958 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -59.59 -151.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 108.95 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.843 ' O ' HD13 ' A' ' 142' ' ' ILE . 31.3 m-20 -89.87 -30.71 17.72 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.076 HD11 HD21 ' A' ' 207' ' ' LEU . 20.3 mm -127.18 82.13 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.521 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.64 96.75 0.18 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 108.813 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.869 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.9 mm -81.31 117.17 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.64 150.65 49.69 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.249 -1.532 . . . . 0.0 111.867 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.572 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 17.1 p90 -81.68 141.28 33.76 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.485 -0.759 . . . . 0.0 109.117 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.581 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -166.1 -179.04 4.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.886 -1.134 . . . . 0.0 110.675 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.961 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.7 p -165.36 -148.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 109.247 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.839 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -31.61 -66.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.645 -0.659 . . . . 0.0 110.339 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -54.54 134.22 46.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.324 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -155.39 -84.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.766 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.84 37.16 0.59 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.484 ' OD1' ' CE2' ' A' ' 154' ' ' PHE . 8.0 t0 -179.89 -146.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.619 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.484 ' CE2' ' OD1' ' A' ' 153' ' ' ASP . 0.2 OUTLIER -102.84 47.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.141 -0.975 . . . . 0.0 109.286 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.68 ' CE2' ' CE1' ' A' ' 168' ' ' TYR . 24.8 m-85 -144.6 49.44 1.01 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.485 -0.76 . . . . 0.0 109.111 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 42.2 Cg_endo -72.0 133.86 22.33 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.177 1.619 . . . . 0.0 109.969 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.996 ' CE1' HG12 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -111.04 -170.59 1.66 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.205 -0.934 . . . . 0.0 110.44 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 160' ' ' PRO . 58.7 p30 -179.79 54.8 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.698 -0.626 . . . . 0.0 110.062 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 15.23 -79.89 0.0 OUTLIER Glycine 0 N--CA 1.507 3.385 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.584 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.7 Cg_endo -63.71 65.24 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.679 1.357 . . . . 0.0 110.118 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.1 135.63 3.81 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 1.075 ' O ' HD12 ' A' ' 164' ' ' LEU . 82.6 m-20 -39.44 -36.97 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 109.975 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.002 HG13 ' CG2' ' A' ' 1' ' ' HAV . 2.6 t -54.73 87.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 109.168 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.075 HD12 ' O ' ' A' ' 162' ' ' ASN . 1.4 mp -83.65 -48.94 9.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.11 -0.994 . . . . 0.0 112.76 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.63 ' HB1' ' OE2' ' A' ' 202' ' ' GLU . . . -159.0 -173.14 4.09 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.096 -1.627 . . . . 0.0 111.261 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.729 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 178.24 -175.46 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.772 -1.83 . . . . 0.0 111.552 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.45 -177.82 6.6 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.68 ' CE1' ' CE2' ' A' ' 155' ' ' TYR . 22.3 m-30 -116.73 -169.59 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.756 -1.215 . . . . 0.0 111.708 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.988 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -116.91 -165.87 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.988 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.5 Cg_endo -74.05 129.76 13.59 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.073 1.039 . . . . 0.0 111.039 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . -175.19 -169.88 37.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.99 98.26 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.696 1.366 . . . . 0.0 109.772 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 83.27 -49.1 4.17 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.2 tt -71.46 6.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.557 -0.966 . . . . 0.0 109.225 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.601 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 2.4 t-20 -64.55 62.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.79 . . . . 0.0 108.876 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' A' ' 142' ' ' ILE . . . 104.84 104.19 2.91 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.8 m-20 -159.04 120.5 3.37 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.881 -1.364 . . . . 0.0 107.682 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.99 172.12 7.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.625 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -162.65 137.67 6.8 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.237 1.018 . . . . 0.0 110.401 178.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.622 ' CE1' HG23 ' A' ' 198' ' ' VAL . 61.6 m-85 -100.49 136.75 39.88 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.746 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.961 ' OD1' HG23 ' A' ' 148' ' ' VAL . 28.3 t0 -58.32 151.9 18.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.799 -1.188 . . . . 0.0 108.763 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.51 ' OD2' ' CD1' ' A' ' 146' ' ' PHE . 1.2 m-20 -115.73 4.05 13.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.158 -0.964 . . . . 0.0 110.194 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.628 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 17.4 m-20 -112.13 26.51 10.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.095 -1.003 . . . . 0.0 109.927 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.479 ' OE2' ' HG ' ' A' ' 164' ' ' LEU . 5.5 mt-10 -129.42 -94.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 108.702 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CD2' ' A' ' 186' ' ' TRP . 1.1 mt-30 179.05 169.56 0.94 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.81 ' CD1' HG21 ' A' ' 105' ' ' THR . 65.4 m95 -159.15 131.98 6.94 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.04 -1.038 . . . . 0.0 109.539 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . 1.059 ' HA ' HD21 ' A' ' 108' ' ' LEU . 68.1 p -157.68 149.86 22.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.984 -1.072 . . . . 0.0 110.067 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.829 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -80.19 -31.86 38.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.4 t70 -85.27 61.26 6.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.992 ' HB ' HD21 ' A' ' 229' ' ' LEU . 5.9 t 3.71 60.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 CA-C-O 121.958 0.885 . . . . 0.0 111.878 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.7 m -123.55 -32.0 3.42 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.32 -0.863 . . . . 0.0 109.392 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.407 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -91.03 -74.06 1.28 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.794 HG21 HD23 ' A' ' 164' ' ' LEU . 48.1 m -135.02 -79.74 0.44 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.737 ' ND2' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER 179.9 68.68 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.296 1.046 . . . . 0.0 108.861 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.068 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 2.2 tp -30.06 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.082 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 1.0 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.58 -6.73 5.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.81 -177.108 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 1.01 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.1 tp -67.7 -62.43 1.42 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.265 -1.774 . . . . 0.0 107.127 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.777 HG21 ' CZ3' ' A' ' 186' ' ' TRP . 3.0 m -68.29 -15.4 19.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.005 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -71.45 -61.97 1.58 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.697 -1.201 . . . . 0.0 107.938 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.718 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -63.66 -15.8 59.31 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 120.266 -1.521 . . . . 0.0 106.946 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.6 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 7.5 t60 -68.19 -48.62 64.77 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.025 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.659 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 13.6 mt-10 -81.26 -45.39 16.32 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.179 -0.951 . . . . 0.0 111.098 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.1 mt -62.07 -31.31 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.687 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.8 -30.77 57.31 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -61.79 -51.01 70.04 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.87 -0.782 . . . . 0.0 110.746 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.627 ' CB ' HD12 ' A' ' 142' ' ' ILE . 72.8 m -82.89 -54.93 4.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.362 -0.836 . . . . 0.0 112.174 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 1.076 HD21 HD11 ' A' ' 142' ' ' ILE . 7.0 mt -104.25 23.71 12.67 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.019 -1.051 . . . . 0.0 110.828 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.971 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -125.11 -79.16 0.36 Allowed Glycine 0 C--N 1.291 -1.938 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.837 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.944 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -169.02 -160.35 0.27 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.857 -1.378 . . . . 0.0 110.02 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.795 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.7 t80 -97.77 -70.0 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.758 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 0.2 OUTLIER -162.59 90.81 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.631 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.4 m -79.93 176.6 9.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 0.0 109.323 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.84 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.57 81.37 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.961 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.45 9.34 13.62 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.061 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.32 -28.33 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 175.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.526 ' C ' ' HB2' ' A' ' 235' ' ' SER . 0.7 OUTLIER -114.79 -36.19 4.58 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.961 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.34 -165.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.159 0.98 . . . . 0.0 112.227 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.01 HD11 ' HA ' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -102.8 -10.76 18.84 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.548 -177.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.744 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -81.32 -8.07 59.68 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.064 -1.647 . . . . 0.0 111.636 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.664 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -139.82 16.06 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 120.462 -1.399 . . . . 0.0 113.221 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.898 ' HB3' HD11 ' A' ' 226' ' ' LEU . 50.3 Cg_endo -73.98 -36.37 3.53 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.189 -1.504 . . . . 0.0 108.189 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 1.069 ' CD1' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -5.0 -73.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.168 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.672 ' N ' HD23 ' A' ' 222' ' ' LEU . 1.9 m-85 -67.52 60.06 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -169.79 -144.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.239 -0.913 . . . . 0.0 109.536 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.402 ' C ' HD23 ' A' ' 226' ' ' LEU . 72.7 m -148.61 104.51 3.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.095 -1.003 . . . . 0.0 109.969 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.53 49.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 108.978 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.572 HG21 ' HA ' ' A' ' 194' ' ' ASN . 11.3 t -99.25 -12.08 20.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.704 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER 177.5 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.04 -1.038 . . . . 0.0 111.244 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.992 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -33.17 -100.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.426 -0.796 . . . . 0.0 111.241 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.6 -16.28 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.637 -1.29 . . . . 0.0 109.746 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -106.33 -22.02 12.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.164 -0.96 . . . . 0.0 108.549 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.642 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.3 p90 -24.24 116.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.362 0.601 . . . . 0.0 111.388 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.76 171.61 0.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.999 HD21 ' CH2' ' A' ' 124' ' ' TRP . 5.2 mp -87.61 172.14 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 111.089 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.719 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 14.5 t -104.98 -170.14 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.785 0.803 . . . . 0.0 109.985 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.548 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -82.72 -16.38 48.27 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.66 -0.65 . . . . 0.0 109.711 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.84 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.0 OUTLIER -82.19 -50.6 8.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.102 -0.999 . . . . 0.0 108.34 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.944 ' OD1' HD21 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.86 -38.38 90.87 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 117.053 -1.859 . . . . 0.0 106.915 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 235' ' ' SER . 1.0 OUTLIER -57.76 -34.82 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.57 -52.04 43.45 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.361 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -55.75 -54.46 34.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.005 HG21 HG21 ' A' ' 127' ' ' VAL . 1.5 tp -64.3 -44.71 97.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 120.897 -1.355 . . . . 0.0 109.716 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.54 ' N ' HG23 ' A' ' 242' ' ' ILE . 5.2 tt0 -54.61 -28.42 46.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 42.5 t -80.16 -20.04 45.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' PRO . 0.5 OUTLIER -70.4 -66.61 0.58 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 1.032 ' CG ' HD12 ' A' ' 130' ' ' LEU . 16.5 m-85 -101.52 -127.32 0.2 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.513 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 92.38 -145.27 17.57 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.175 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.499 ' HB2' ' HD2' ' A' ' 249' ' ' PRO . 41.2 Cg_endo -71.69 173.43 12.62 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.791 1.661 . . . . 0.0 110.433 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.525 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 39.5 Cg_endo -69.49 174.65 8.97 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.157 1.609 . . . . 0.0 110.171 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 249' ' ' PRO . 38.1 Cg_endo -66.67 -156.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.875 1.46 . . . . 0.0 110.09 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 250' ' ' PRO . 1.8 p-10 -28.94 -52.76 0.11 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.888 -0.507 . . . . 0.0 110.923 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 251' ' ' ASP . 47.0 t -42.55 101.96 0.26 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.387 -0.821 . . . . 0.0 109.379 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 251' ' ' ASP . 42.3 Cg_endo -72.95 -43.69 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.028 1.541 . . . . 0.0 110.443 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.85 156.26 28.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.159 -0.963 . . . . 0.0 109.716 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.469 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.002 ' CG2' HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.536 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.754 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.241 0.543 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -152.81 -169.08 3.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.535 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.526 ' HA ' ' CB ' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -44.9 113.46 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.495 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.595 ' CD2' ' HD2' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -45.93 171.0 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 86' ' ' PHE . 41.8 Cg_endo -72.54 64.08 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.02 1.537 . . . . 0.0 109.96 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.64 94.41 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.491 HD11 ' HD1' ' A' ' 210' ' ' PHE . 3.6 pt -137.5 95.14 11.56 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.254 -1.145 . . . . 0.0 109.772 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.431 ' HA ' HD23 ' A' ' 245' ' ' LEU . 42.1 Cg_endo -72.51 91.34 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.999 1.526 . . . . 0.0 109.824 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.673 ' N ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -50.34 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.966 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.634 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 49.5 m95 -100.62 177.45 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.116 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -138.56 -36.33 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.585 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -46.66 177.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.191 -0.943 . . . . 0.0 110.132 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.812 ' CB ' HD12 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -116.59 1.65 12.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.405 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.545 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 7.0 m-70 -132.74 92.82 3.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.719 HD13 ' OD2' ' A' ' 141' ' ' ASP . 2.5 mm? -94.72 173.62 7.51 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.628 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -149.61 155.98 41.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 1.05 ' CE2' HD11 ' A' ' 101' ' ' ILE . 6.1 p90 -135.52 165.65 25.02 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.483 -1.386 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.752 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -124.65 122.78 38.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.05 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -82.38 84.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 109.802 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.752 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -102.08 8.47 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 0.0 110.097 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.918 ' C ' HG21 ' A' ' 113' ' ' VAL . 7.4 m120 -98.65 159.19 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.959 -1.088 . . . . 0.0 109.155 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.805 ' N ' HG21 ' A' ' 113' ' ' VAL . 6.0 t80 177.56 80.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.674 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.967 HG21 ' CD1' ' A' ' 186' ' ' TRP . 33.0 p -73.72 159.34 84.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.65 -22.2 38.08 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 123.774 1.407 . . . . 0.0 108.651 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -79.53 0.75 28.46 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.949 ' CD1' HD13 ' A' ' 195' ' ' LEU . 95.9 mt -148.33 118.44 4.22 Favored Pre-proline 0 N--CA 1.485 1.297 0 O-C-N 121.423 -0.798 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.09 174.25 6.16 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.885 1.466 . . . . 0.0 109.139 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.16 -66.06 0.32 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.783 0.802 . . . . 0.0 110.164 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 115' ' ' SER . 2.2 m-20 -56.39 -28.47 59.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.822 -0.548 . . . . 0.0 112.358 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.833 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.25 -61.15 1.9 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.317 -1.489 . . . . 0.0 109.468 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.918 HG21 ' C ' ' A' ' 103' ' ' ASN . 8.4 p -56.08 -44.06 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 1.035 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -60.89 -28.22 68.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -58.83 -63.83 1.15 Allowed 'General case' 0 C--O 1.194 -1.822 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.07 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -49.28 -32.52 11.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 144' ' ' ILE . 12.1 t -73.82 -24.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -90.65 -33.65 15.74 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.75 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -82.34 -37.04 26.28 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.46 -62.16 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.848 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -53.41 -42.04 66.61 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.766 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -70.9 -34.2 71.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.131 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.901 HG13 HD22 ' A' ' 234' ' ' LEU . 1.7 t -57.34 -36.88 54.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.049 ' O ' HG23 ' A' ' 128' ' ' THR . 46.9 m95 -92.23 -24.25 19.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.929 -1.109 . . . . 0.0 110.667 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -73.11 -27.37 61.66 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.927 -1.108 . . . . 0.0 108.308 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -92.42 -42.82 9.54 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.994 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.994 HG21 HG21 ' A' ' 242' ' ' ILE . 22.7 m -62.26 -23.4 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.255 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.049 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.05 163.31 18.35 Favored Pre-proline 0 N--CA 1.495 1.783 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.403 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.544 ' HG3' ' N ' ' A' ' 248' ' ' PRO . 48.6 Cg_endo -81.52 22.05 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.034 1.823 . . . . 0.0 111.51 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.812 HD12 ' CB ' ' A' ' 95' ' ' THR . 2.6 mm? -115.86 178.1 4.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.653 -1.279 . . . . 0.0 110.347 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.547 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.9 p -121.01 177.81 4.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' A' ' 97' ' ' LEU . 11.2 m-85 -146.96 146.03 29.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.765 . . . . 0.0 110.053 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.604 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 68.0 m -114.59 -170.55 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -149.82 165.45 32.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.612 -1.305 . . . . 0.0 110.992 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -163.15 -164.54 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 78.8 t80 -160.61 25.66 0.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' GLU . 8.7 pm0 -147.11 176.76 9.7 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.78 -97.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' GLU . 18.3 tt0 178.73 145.51 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -1.143 . . . . 0.0 110.45 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.628 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -101.09 -150.75 0.4 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.719 ' OD2' HD13 ' A' ' 97' ' ' LEU . 18.2 m-20 -90.55 -34.02 15.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.974 HD11 ' CG ' ' A' ' 207' ' ' LEU . 20.1 mm -124.04 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.528 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 5.9 ttp -66.11 97.87 0.41 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 109.195 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 1.014 HG13 HG13 ' A' ' 117' ' ' VAL . 5.8 mm -81.87 114.63 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -136.3 155.57 49.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.434 -1.416 . . . . 0.0 112.371 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.622 ' CA ' ' ND2' ' A' ' 103' ' ' ASN . 6.1 p90 -92.89 138.04 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.688 . . . . 0.0 109.265 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.081 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -167.57 -158.65 0.28 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.29 -0.881 . . . . 0.0 110.47 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.649 HG13 ' N ' ' A' ' 149' ' ' ARG . 0.6 OUTLIER -173.38 -165.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.05 -1.031 . . . . 0.0 109.159 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.649 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -49.87 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 0.0 109.759 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 148' ' ' VAL . 9.0 pt-20 179.58 32.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 0.0 109.643 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 45.5 m80 -77.98 -163.75 0.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.95 . . . . 0.0 109.428 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 153' ' ' ASP . . . -139.38 51.12 0.76 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 152' ' ' GLY . 1.1 m-20 -174.39 -91.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.648 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.452 ' C ' ' HD3' ' A' ' 156' ' ' PRO . 21.8 t80 -153.43 29.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.576 ' O ' ' CE1' ' A' ' 151' ' ' HIS . 82.0 m-85 -123.44 52.27 4.68 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.867 . . . . 0.0 109.496 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 41.1 Cg_endo -71.8 124.19 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.056 1.556 . . . . 0.0 109.943 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.765 ' CD2' ' CE1' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -80.83 -166.15 1.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.099 -1.001 . . . . 0.0 110.134 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.55 ' O ' ' C ' ' A' ' 159' ' ' GLY . 24.7 p30 179.64 60.2 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.667 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -29.3 -51.31 0.13 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.829 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 39.6 Cg_endo -66.54 60.04 0.52 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 109.301 -1.076 . . . . 0.0 109.301 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -179.27 159.96 25.07 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 164' ' ' LEU . 73.7 m-20 -52.74 -38.41 60.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.127 . . . . 0.0 110.223 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.966 HG13 HG22 ' A' ' 1' ' ' HAV . 42.8 t -53.3 81.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.341 -0.849 . . . . 0.0 110.545 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.719 HD12 HD12 ' A' ' 222' ' ' LEU . 15.9 mt -68.63 -74.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.341 -0.849 . . . . 0.0 111.85 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.974 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -135.41 -176.26 4.21 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.491 -1.381 . . . . 0.0 111.614 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.746 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.5 p-80 178.98 168.55 0.94 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.564 -1.335 . . . . 0.0 110.107 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -132.92 -168.08 2.02 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.532 ' HB3' HG13 ' A' ' 174' ' ' ILE . 77.5 m-85 -114.4 -167.27 1.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.8 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.074 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -126.15 -175.62 0.43 Allowed Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 1.074 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 38.8 Cg_endo -68.9 140.19 45.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.537 1.283 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.437 ' C ' ' OD1' ' A' ' 175' ' ' ASN . . . 171.76 -125.49 1.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.499 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.0 Cg_endo -73.98 -93.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.812 1.427 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -108.37 -18.34 9.8 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.4 OUTLIER -73.3 12.17 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -1.064 . . . . 0.0 108.951 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 175' ' ' ASN . 0.6 OUTLIER -64.34 63.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.607 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 106.35 101.55 2.73 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.635 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.6 m-20 -163.16 120.11 1.86 Allowed 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.566 -1.549 . . . . 0.0 107.659 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.736 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -112.07 164.85 12.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.894 -1.129 . . . . 0.0 109.184 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.081 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -162.15 134.75 5.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.867 -1.133 . . . . 0.0 109.778 178.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.666 ' H ' HD22 ' A' ' 103' ' ' ASN . 34.4 m-85 -95.48 132.67 40.32 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.519 ' HB3' ' CD1' ' A' ' 157' ' ' PHE . 24.5 p30 -66.72 130.19 42.37 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 182' ' ' ASP . 48.1 p30 -96.09 22.73 7.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.976 -1.077 . . . . 0.0 110.437 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.667 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.4 OUTLIER -90.75 -19.61 23.32 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.907 -1.121 . . . . 0.0 109.889 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.496 ' OE2' ' O ' ' A' ' 159' ' ' GLY . 0.9 OUTLIER -112.11 -130.78 0.31 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.896 -1.127 . . . . 0.0 108.595 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 35.3 mt-30 -130.97 -175.46 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.161 . . . . 0.0 109.097 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.967 ' CD1' HG21 ' A' ' 105' ' ' THR . 86.0 m95 -160.83 126.03 3.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 108.954 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.792 ' HA ' HD21 ' A' ' 108' ' ' LEU . 50.7 p -145.66 150.07 35.64 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.828 -1.17 . . . . 0.0 110.453 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 1.046 ' O ' HG23 ' A' ' 227' ' ' THR . 2.7 pttm -84.45 -33.18 23.71 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 27.9 t70 -82.31 63.72 6.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . 1.05 ' HB ' HD21 ' A' ' 229' ' ' LEU . 1.7 t 2.82 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 122.311 1.053 . . . . 0.0 112.016 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.0 m -127.31 -31.05 2.58 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.783 -1.198 . . . . 0.0 109.927 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.627 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -96.98 -80.41 1.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.761 HG22 ' OD1' ' A' ' 194' ' ' ASN . 37.5 m -125.12 -96.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.781 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -161.77 67.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.025 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 14.7 tp -37.97 -98.91 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.757 -0.589 . . . . 0.0 110.93 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.829 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.7 OUTLIER -58.73 -11.53 3.26 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.722 -1.236 . . . . 0.0 110.461 -178.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 1.084 ' O ' HD11 ' A' ' 218' ' ' LEU . 6.2 tp -64.92 -71.29 0.19 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 116.807 -1.957 . . . . 0.0 106.595 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.974 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 3.3 t -67.55 -4.57 3.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.433 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.07 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.21 -57.94 3.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.773 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.55 -16.91 64.51 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.602 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 3.0 t60 -69.5 -37.44 77.19 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.069 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.924 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 2.8 mt-10 -87.65 -48.65 7.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 120' ' ' ALA . 1.9 mt -59.16 -31.55 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.709 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -82.21 -34.4 23.63 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -56.31 -45.81 80.1 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.524 -0.986 . . . . 0.0 110.374 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 167' ' ' ALA . 1.0 OUTLIER -89.56 -54.1 4.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 111.582 -178.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.974 ' CG ' HD11 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -104.16 36.31 2.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.198 -0.939 . . . . 0.0 110.753 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.993 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -141.89 -78.14 0.05 OUTLIER Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.047 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.876 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.2 -160.35 0.26 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.89 -1.359 . . . . 0.0 110.27 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.876 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.3 OUTLIER -102.54 -77.72 0.55 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.473 -0.767 . . . . 0.0 109.36 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.592 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.6 m-70 -159.44 121.75 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.453 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.622 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -109.56 -168.37 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.716 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.38 74.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.97 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -79.71 7.36 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.289 -176.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.449 ' C ' ' O ' ' A' ' 214' ' ' ASN . 2.7 p -50.47 -27.66 6.92 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.498 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.9 mp0 -114.84 -34.72 5.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.97 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -159.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.296 1.046 . . . . 0.0 112.247 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.13 HD13 ' O ' ' A' ' 218' ' ' LEU . 3.3 tm? -96.7 -19.96 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.38 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.592 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -78.99 -8.49 58.97 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.249 -1.532 . . . . 0.0 112.319 -177.117 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.687 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 41.0 t80 -132.42 14.49 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 120.412 -1.43 . . . . 0.0 113.312 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.817 ' HG2' ' HH1' ' A' ' 3' ' ' MSB . 55.5 Cg_endo -76.97 -37.97 0.96 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 N-CA-C 109.157 -1.132 . . . . 0.0 109.157 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 1.013 HD23 ' N ' ' A' ' 223' ' ' TYR . 1.4 tt -19.48 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.526 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 1.013 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.2 OUTLIER -67.69 59.88 0.06 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.303 -0.873 . . . . 0.0 109.004 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' LEU . 9.2 t-160 179.89 -133.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.072 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.976 ' HB3' HG21 ' A' ' 190' ' ' THR . 49.8 m -160.57 114.92 2.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 109.929 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.935 HD12 ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER 179.51 57.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . 1.046 HG23 ' O ' ' A' ' 188' ' ' LYS . 4.8 t -113.92 -8.61 13.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.873 . . . . 0.0 109.516 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.591 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 1.0 OUTLIER 178.06 -21.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.742 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 1.05 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.2 OUTLIER -37.03 -60.59 0.62 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.15 -0.969 . . . . 0.0 110.127 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.524 HG23 ' HG3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 179.22 -31.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.833 HH11 HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -89.33 -21.84 22.93 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 45.4 p90 -38.25 116.44 0.53 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.501 0.667 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.597 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.4 ttt180 179.3 152.86 0.41 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 109.126 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.98 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.0 mp -68.69 167.47 15.18 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.082 -1.011 . . . . 0.0 110.044 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.806 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 10.2 t -101.04 -169.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.575 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -83.92 -23.08 31.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.924 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.716 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 4.6 m-20 -81.32 -40.06 24.2 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.847 -1.141 . . . . 0.0 107.934 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.844 ' OD1' HD21 ' A' ' 209' ' ' LEU . 17.2 t0 -70.46 -35.49 73.35 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 117.828 -1.549 . . . . 0.0 107.766 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.649 HD13 ' O ' ' A' ' 235' ' ' SER . 0.8 OUTLIER -61.25 -34.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 237' ' ' ASP . 21.6 t-20 -66.69 -45.33 79.16 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.29 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.68 -58.93 11.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.994 HG21 HG21 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -61.69 -44.68 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.742 -1.446 . . . . 0.0 109.623 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.462 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.6 tt0 -54.76 -24.96 24.81 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -87.0 -14.59 41.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.811 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.4 OUTLIER -74.9 -56.34 4.85 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.745 ' CG ' HD23 ' A' ' 130' ' ' LEU . 16.4 m-85 -92.09 -105.47 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.215 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.456 ' C ' ' HG3' ' A' ' 129' ' ' PRO . . . 131.72 133.1 3.43 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.408 -1.377 . . . . 0.0 109.842 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.544 ' N ' ' HG3' ' A' ' 129' ' ' PRO . 43.0 Cg_endo -73.97 129.88 13.79 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.991 1.522 . . . . 0.0 110.02 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.99 132.13 17.84 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.957 1.503 . . . . 0.0 110.054 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 251' ' ' ASP . 42.0 Cg_endo -72.38 -177.89 2.99 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.997 1.525 . . . . 0.0 110.051 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 250' ' ' PRO . 0.3 OUTLIER -44.03 -46.98 8.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.504 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 79.5 p -105.85 138.21 19.57 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.875 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.47 -10.19 25.09 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.032 1.543 . . . . 0.0 110.098 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.11 179.35 4.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.494 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.966 HG22 HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.534 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.913 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.246 0.546 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -68.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.559 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 86' ' ' PHE . 1.5 t 179.86 -169.11 0.12 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.508 ' N ' ' OG1' ' A' ' 85' ' ' THR . 2.9 t80 -94.71 106.2 23.04 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.2 Cg_endo -72.88 148.91 46.65 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.943 1.496 . . . . 0.0 110.071 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 89' ' ' ILE . . . 107.09 -58.2 0.42 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 88' ' ' GLY . 3.4 pt -160.2 163.19 22.63 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.161 -1.2 . . . . 0.0 109.659 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.506 ' HB2' HD23 ' A' ' 245' ' ' LEU . 42.0 Cg_endo -72.61 160.37 46.67 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.047 1.551 . . . . 0.0 110.058 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.507 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -55.34 -80.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.751 ' CD1' HD11 ' A' ' 207' ' ' LEU . 7.0 m95 -98.67 -165.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.86 -1.15 . . . . 0.0 109.606 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.9 ppt_? -145.24 -40.61 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.984 -1.073 . . . . 0.0 110.582 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.729 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -45.26 174.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.085 -1.009 . . . . 0.0 110.377 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.559 ' HA ' ' CG ' ' A' ' 130' ' ' LEU . 11.6 p -112.15 2.66 16.81 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.547 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 17.8 m-70 -144.09 98.18 3.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.949 -1.094 . . . . 0.0 109.863 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.845 HD23 HD23 ' A' ' 130' ' ' LEU . 2.5 mm? -95.11 168.08 10.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.508 -0.745 . . . . 0.0 109.9 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.612 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -142.37 156.42 45.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.978 ' CE2' HD11 ' A' ' 101' ' ' ILE . 7.9 p90 -135.98 165.53 25.46 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.668 -1.27 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.406 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -125.17 121.94 35.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.889 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.978 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.2 mp -77.7 84.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.933 -1.104 . . . . 0.0 109.29 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.666 ' N ' ' O ' ' A' ' 144' ' ' ILE . 1.4 t -96.66 8.81 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 110.552 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.683 ' HB2' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -111.78 169.22 8.98 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.308 -1.495 . . . . 0.0 109.41 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.47 ' O ' ' C ' ' A' ' 105' ' ' THR . 4.3 p90 178.77 44.72 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.651 -0.656 . . . . 0.0 109.531 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 104' ' ' TYR . 70.5 p -41.26 153.79 0.24 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.474 -0.766 . . . . 0.0 109.048 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.03 -23.96 45.82 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 123.829 1.436 . . . . 0.0 108.766 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.627 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -69.19 -9.94 55.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.981 HD13 ' CD1' ' A' ' 195' ' ' LEU . 85.7 mt -144.42 115.83 5.4 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.8 Cg_endo -64.09 167.69 13.8 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 123.81 1.426 . . . . 0.0 109.295 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -35.49 -64.6 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.8 0.809 . . . . 0.0 110.477 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -59.76 -19.32 49.54 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.685 -0.635 . . . . 0.0 111.777 -178.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -80.36 -62.74 1.59 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.312 -1.493 . . . . 0.0 109.021 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.956 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.6 p -49.41 -40.5 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.835 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -67.19 -27.52 67.33 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.835 ' OG ' HD21 ' A' ' 195' ' ' LEU . 21.6 p -64.42 -42.5 96.0 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.05 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -71.42 -33.33 69.33 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.4 t -73.73 -25.18 20.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.589 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 2.0 tt0 -84.66 -36.67 21.77 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.744 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.854 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -78.83 -38.94 36.83 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.823 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -62.93 -61.48 2.37 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.853 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.0 OUTLIER -50.26 -40.15 47.13 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.988 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.629 ' N ' HD12 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -77.51 -33.45 54.34 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.37 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.01 ' O ' HG13 ' A' ' 127' ' ' VAL . 3.8 t -52.49 -44.5 44.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.014 ' CH2' HD21 ' A' ' 234' ' ' LEU . 33.4 m95 -92.2 -23.14 19.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 26.8 tt0 -69.67 -26.74 64.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.3 pt-20 -90.96 -42.99 10.25 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.648 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.01 HG13 ' O ' ' A' ' 123' ' ' VAL . 14.5 m -59.57 -23.78 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.274 -1.37 . . . . 0.0 108.988 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -116.89 163.42 22.84 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.519 -1.272 . . . . 0.0 109.289 179.235 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.543 ' HG2' ' HD3' ' A' ' 248' ' ' PRO . 46.9 Cg_endo -77.58 -8.47 17.09 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.336 1.703 . . . . 0.0 109.883 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.845 HD23 HD23 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -70.19 179.55 2.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 110.536 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.467 ' OG1' ' ND1' ' A' ' 96' ' ' HIS . 6.7 p -127.3 174.38 9.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 1.1 m-85 -145.44 161.89 38.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.586 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -143.38 -174.36 4.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -152.04 155.6 38.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.901 -1.124 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.97 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.8 OUTLIER -147.41 -135.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.417 -0.802 . . . . 0.0 108.912 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 45.3 t80 178.94 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.793 -1.192 . . . . 0.0 109.23 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 139' ' ' GLU . 1.8 pm0 -158.57 -176.65 6.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.779 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.49 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -1.103 . . . . 0.0 110.184 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.97 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -60.15 -151.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 108.722 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -91.65 -25.82 18.96 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.984 HD11 ' HB2' ' A' ' 206' ' ' SER . 17.7 mm -127.81 86.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.597 ' HG3' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -67.15 97.17 0.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 102' ' ' VAL . 0.7 OUTLIER -82.37 116.19 26.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -134.49 153.18 52.06 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 119.944 -1.722 . . . . 0.0 112.388 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 147' ' ' ALA . 1.6 t80 -90.7 135.71 33.53 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.714 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.57 -152.65 0.11 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.725 -1.234 . . . . 0.0 111.17 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 149' ' ' ARG . 2.1 p -178.3 -169.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.744 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -30.12 -37.01 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.684 -0.635 . . . . 0.0 111.118 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 148' ' ' VAL . 3.9 mm-40 -81.2 110.54 16.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.026 . . . . 0.0 109.699 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 155' ' ' TYR . 21.8 m80 -126.17 -91.51 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 109.554 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.93 -44.11 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.49 -95.25 0.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.074 -1.251 . . . . 0.0 109.888 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -117.47 67.33 0.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.032 . . . . 0.0 109.824 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.651 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -147.22 41.27 0.26 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.892 . . . . 0.0 109.902 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 42.0 Cg_endo -71.95 107.21 2.17 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.515 1.271 . . . . 0.0 109.13 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.645 ' CE1' ' CG1' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.5 -140.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.67 ' CB ' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -134.75 -23.54 1.58 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.496 -1.377 . . . . 0.0 111.312 -178.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 41.52 -96.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 158' ' ' ASP . 34.3 Cg_endo -59.68 76.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.265 1.14 . . . . 0.0 110.052 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 175.98 -167.31 38.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 163' ' ' VAL . 58.3 m-80 -87.25 -27.75 22.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -1.192 . . . . 0.0 109.964 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.67 HG21 ' CB ' ' A' ' 158' ' ' ASP . 16.9 t -35.79 140.58 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.426 0.631 . . . . 0.0 110.862 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.046 HD11 HG21 ' A' ' 193' ' ' THR . 0.4 OUTLIER -105.17 -90.81 0.4 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.465 -0.772 . . . . 0.0 112.31 -179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.859 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -147.27 -168.89 3.17 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.113 -1.617 . . . . 0.0 111.541 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.651 ' CE1' ' CE1' ' A' ' 155' ' ' TYR . 0.5 OUTLIER 179.95 171.98 1.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 119.682 -1.886 . . . . 0.0 111.024 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 202' ' ' GLU . . . -147.55 -164.54 2.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.399 -0.813 . . . . 0.0 109.99 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.646 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -131.9 -163.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.883 -1.136 . . . . 0.0 110.643 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.001 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -163.98 -62.84 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.093 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 1.001 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.8 Cg_endo -77.09 158.95 33.98 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.779 1.41 . . . . 0.0 109.966 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.474 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . 115.32 173.69 17.71 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -76.55 -89.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.683 1.589 . . . . 0.0 110.138 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -78.13 -35.44 34.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.646 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.5 tp -68.96 -0.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.925 . . . . 0.0 108.967 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 172' ' ' PRO . 2.6 t30 -65.82 64.22 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 119.81 90.63 1.25 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.612 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -158.07 127.01 5.64 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.839 -1.389 . . . . 0.0 108.159 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.675 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -115.88 168.16 10.3 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.117 -0.99 . . . . 0.0 108.714 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.714 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.97 134.39 4.28 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.205 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.587 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 53.1 m-85 -90.08 127.99 36.2 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.24 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 1.0 OUTLIER -76.62 144.78 39.31 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.949 -1.094 . . . . 0.0 109.205 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 183' ' ' ASP . 27.3 t0 -62.44 -2.16 0.98 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.21 -0.931 . . . . 0.0 110.381 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.2 p30 3.9 -95.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 183' ' ' ASP . 7.5 mp0 -147.59 -51.15 0.19 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.873 -1.142 . . . . 0.0 110.509 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -140.79 172.0 13.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 0.0 110.926 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.976 ' CH2' HD12 ' A' ' 164' ' ' LEU . 85.8 m95 -160.58 129.77 4.9 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.696 ' HA ' HD21 ' A' ' 108' ' ' LEU . 33.4 p -146.88 155.93 42.7 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.555 -1.341 . . . . 0.0 110.428 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.596 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 3.2 pttt -78.02 -33.11 51.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.545 ' O ' ' CG2' ' A' ' 227' ' ' THR . 2.9 t0 -90.48 -143.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.917 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.4 t -115.37 45.64 1.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.851 -1.155 . . . . 0.0 108.264 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 187' ' ' THR . 53.7 m -102.69 -30.3 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.326 -0.859 . . . . 0.0 111.084 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.553 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -108.52 -90.59 2.12 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.363 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.046 HG21 HD11 ' A' ' 164' ' ' LEU . 89.6 m -120.68 -80.21 0.62 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.791 ' OD1' HG22 ' A' ' 193' ' ' THR . 3.2 p30 178.15 66.79 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.582 1.182 . . . . 0.0 108.435 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.004 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 1.2 tp -20.03 -95.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.952 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.911 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -62.06 -15.01 41.75 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.055 -1.028 . . . . 0.0 110.883 -176.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.873 HD11 ' CG ' ' A' ' 221' ' ' PRO . 13.3 tp -60.75 -57.46 12.58 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.251 -1.78 . . . . 0.0 107.199 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' A' ' 165' ' ' ALA . 2.4 t -74.72 -9.25 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.749 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.05 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.24 -57.85 3.57 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.35 -1.34 . . . . 0.0 107.503 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.705 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -64.03 -17.91 63.81 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 219' ' ' MET . 3.3 t-160 -69.39 -40.95 77.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.17 -1.812 . . . . 0.0 107.849 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.69 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 3.5 mt-10 -82.89 -49.12 9.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.954 -1.091 . . . . 0.0 110.79 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.853 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.2 mt -60.59 -31.47 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.734 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.79 -34.09 49.46 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -57.24 -53.15 61.34 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.61 -0.935 . . . . 0.0 109.773 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.984 ' HB2' HD11 ' A' ' 142' ' ' ILE . 2.6 m -77.81 -64.19 1.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.583 -0.698 . . . . 0.0 111.671 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.845 ' N ' HD22 ' A' ' 207' ' ' LEU . 2.8 mm? -101.36 37.99 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -0.802 . . . . 0.0 110.614 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.974 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -135.83 -69.22 0.06 OUTLIER Glycine 0 C--N 1.289 -2.046 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.868 HD11 ' SD ' ' A' ' 219' ' ' MET . 4.5 pp 179.75 -161.86 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.933 0 O-C-N 120.633 -1.51 . . . . 0.0 109.387 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.798 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.3 t80 -102.11 -71.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.259 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 54.4 m80 -162.16 102.05 1.11 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.795 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.5 m -93.07 -174.68 3.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.782 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.95 78.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.955 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.43 9.3 13.69 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.422 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 214' ' ' ASN . 73.7 p -50.42 -27.72 6.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.519 ' C ' ' HB2' ' A' ' 235' ' ' SER . 8.3 mt-10 -113.75 -37.01 4.67 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.955 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -64.35 -171.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.45 1.119 . . . . 0.0 112.72 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.907 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -84.64 -18.9 33.95 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.937 -177.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.868 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 119.262 -2.149 . . . . 0.0 112.171 -177.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.671 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 35.3 t80 -134.99 15.63 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.257 -1.527 . . . . 0.0 113.39 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.873 ' CG ' HD11 ' A' ' 197' ' ' LEU . 55.8 Cg_endo -77.97 -41.17 0.32 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.774 HD22 ' CD2' ' A' ' 3' ' ' MSB . 18.9 tp -6.87 -74.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.506 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -65.45 63.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.492 -0.755 . . . . 0.0 109.779 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.82 -162.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.2 m -131.99 116.17 16.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.103 -0.998 . . . . 0.0 109.693 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' A' ' 231' ' ' ARG . 5.5 tp 179.49 31.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.627 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 6.6 t -77.61 -52.77 8.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.649 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 5.2 t0 -151.49 3.22 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.745 -1.222 . . . . 0.0 110.952 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.917 HD11 ' N ' ' A' ' 190' ' ' THR . 1.2 mm? -41.41 -101.04 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.906 -1.121 . . . . 0.0 110.912 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -18.22 3.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.701 -1.249 . . . . 0.0 109.85 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.732 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -105.48 -42.03 5.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 108.386 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.649 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 9.5 p90 0.36 117.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.05 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.014 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.5 mp -80.27 166.49 21.32 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.756 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 28.9 t -98.38 -171.84 2.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.354 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.5 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.08 -11.83 54.38 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.726 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.1 OUTLIER -85.34 -46.99 10.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.889 -1.132 . . . . 0.0 107.971 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.68 ' OD1' HD21 ' A' ' 209' ' ' LEU . 1.2 m-20 -66.87 -38.04 85.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 117.201 -1.8 . . . . 0.0 106.554 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -58.04 -34.55 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.242 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.519 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 1.3 t-20 -66.69 -49.23 66.76 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.88 -50.62 65.76 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.28 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.997 HG13 HG22 ' A' ' 128' ' ' THR . 1.9 tp -68.27 -48.44 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 120.741 -1.447 . . . . 0.0 110.665 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.57 ' N ' HG23 ' A' ' 242' ' ' ILE . 15.0 pt20 -54.77 -23.08 16.3 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.1 p -88.66 -17.07 30.8 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.635 ' HB3' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -74.22 -59.36 2.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.74 ' CE1' HD22 ' A' ' 130' ' ' LEU . 15.2 m-85 -92.33 -120.94 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.502 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.494 ' HA2' ' HG3' ' A' ' 129' ' ' PRO . . . 63.37 91.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.543 ' HD3' ' HG2' ' A' ' 129' ' ' PRO . 39.8 Cg_endo -68.7 173.75 9.54 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.623 1.549 . . . . 0.0 110.18 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 40.5 Cg_endo -70.1 154.1 66.72 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.952 1.501 . . . . 0.0 110.347 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 251' ' ' ASP . 42.9 Cg_endo -73.24 -47.34 0.31 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.755 1.637 . . . . 0.0 110.229 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 250' ' ' PRO . 5.5 m-20 -56.14 -154.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.712 -0.618 . . . . 0.0 110.184 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.453 ' C ' ' O ' ' A' ' 251' ' ' ASP . 18.0 m -38.78 99.2 0.19 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.476 -0.765 . . . . 0.0 110.225 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 254' ' ' GLU . 43.7 Cg_endo -74.8 -44.85 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.119 1.589 . . . . 0.0 109.998 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 253' ' ' PRO . 0.0 OUTLIER -45.18 170.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.631 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.553 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.583 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.516 ' HD1' ' OB1' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.774 ' CD2' HD22 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 -96.48 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 109.505 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -56.19 12.62 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.125 -0.985 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -164.05 141.65 5.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 86' ' ' PHE . 42.1 Cg_endo -72.54 -2.43 11.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.005 1.529 . . . . 0.0 110.145 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.44 -113.12 0.65 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.733 HD12 ' N ' ' A' ' 89' ' ' ILE . 1.7 mp -73.01 134.84 80.65 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.251 -1.146 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.406 ' O ' HG22 ' A' ' 89' ' ' ILE . 41.9 Cg_endo -72.03 -171.31 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.993 1.523 . . . . 0.0 110.048 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.567 ' HB2' HD21 ' A' ' 245' ' ' LEU . 0.1 OUTLIER -73.4 -95.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 109.372 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.646 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 50.7 m95 -111.42 163.69 13.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.028 -1.045 . . . . 0.0 109.532 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -131.95 -28.01 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.537 -179.325 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 1.037 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -40.13 165.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.373 -0.829 . . . . 0.0 110.625 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.581 ' O ' ' CD2' ' A' ' 96' ' ' HIS . 2.1 p -107.63 5.21 26.67 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.462 -0.774 . . . . 0.0 109.185 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 1.071 ' CE1' HG21 ' A' ' 131' ' ' THR . 33.4 m-70 -150.72 103.49 3.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.453 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.95 HD13 ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -116.33 -165.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 109.91 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.585 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -161.43 162.35 30.55 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.74 ' CZ ' HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -137.9 160.78 38.38 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.875 -1.141 . . . . 0.0 109.181 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.837 ' NE ' HG22 ' A' ' 102' ' ' VAL . 1.2 ttp180 -123.09 126.63 47.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 109.807 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.803 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.5 mp -85.09 84.37 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.005 -1.059 . . . . 0.0 109.677 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.837 HG22 ' NE ' ' A' ' 100' ' ' ARG . 2.6 t -100.35 8.03 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.007 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.886 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -100.99 157.04 17.05 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.783 -1.198 . . . . 0.0 109.353 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.656 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.6 OUTLIER 177.99 75.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.537 HG21 ' CD1' ' A' ' 186' ' ' TRP . 11.5 p -70.6 159.5 84.85 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -68.14 -21.86 41.78 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.808 1.425 . . . . 0.0 108.686 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 1.5 t0 -70.28 -8.73 52.6 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.961 HD13 HD13 ' A' ' 195' ' ' LEU . 93.5 mt -147.07 124.14 5.76 Favored Pre-proline 0 N--CA 1.484 1.233 0 O-C-N 121.585 -0.697 . . . . 0.0 109.848 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.11 169.84 12.88 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 O-C-N 123.811 1.427 . . . . 0.0 109.007 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.08 -65.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.971 0.891 . . . . 0.0 110.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 115' ' ' SER . 1.6 p-10 -53.97 -32.32 53.58 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.743 -0.598 . . . . 0.0 112.033 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.908 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.91 -61.4 1.78 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.533 -1.354 . . . . 0.0 109.635 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 117' ' ' VAL . 8.7 p -53.3 -41.2 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.803 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -64.35 -27.27 68.9 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.936 ' OG ' HD21 ' A' ' 195' ' ' LEU . 6.2 p -63.51 -43.73 96.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.055 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -68.23 -33.1 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.108 -0.995 . . . . 0.0 109.492 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.888 HG13 HG13 ' A' ' 144' ' ' ILE . 5.0 t -76.26 -22.0 15.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.2 tt0 -88.24 -34.12 17.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.8 OUTLIER -82.45 -36.33 26.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.73 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -67.28 -61.18 2.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.338 1.066 . . . . 0.0 108.588 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.872 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.6 pp -57.0 -40.8 77.29 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.779 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.47 -32.69 62.66 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.898 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.038 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.41 -42.04 65.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.103 ' CH2' HD21 ' A' ' 234' ' ' LEU . 37.7 m95 -91.23 -23.97 20.03 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.536 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 3.5 tm-20 -69.57 -27.44 65.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.851 -1.156 . . . . 0.0 107.89 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 13.9 pt-20 -90.58 -42.84 10.57 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.738 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.038 HG13 ' O ' ' A' ' 123' ' ' VAL . 15.8 m -59.2 -24.52 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.139 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.007 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -114.26 154.82 46.27 Favored Pre-proline 0 N--CA 1.494 1.731 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.573 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.541 ' CG ' ' HA2' ' A' ' 247' ' ' GLY . 50.2 Cg_endo -82.49 29.31 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.136 1.891 . . . . 0.0 110.472 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.037 HD21 ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -99.44 -179.95 4.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.95 -1.094 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 1.071 HG21 ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -112.9 161.18 17.28 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.95 ' CE2' HD13 ' A' ' 97' ' ' LEU . 53.2 m-85 -147.72 148.74 31.32 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.061 -1.024 . . . . 0.0 110.901 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.575 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -130.2 -179.23 5.12 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.627 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.812 -1.18 . . . . 0.0 110.207 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.695 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.49 -163.78 1.52 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.215 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 136' ' ' TYR . 69.5 t80 -155.79 21.22 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 26.0 pm0 -143.98 -174.62 4.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.637 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.04 -97.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 137' ' ' GLU . 11.6 pt-20 178.8 130.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -1.133 . . . . 0.0 110.157 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.585 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -89.78 -147.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.227 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.591 ' CG ' HD11 ' A' ' 207' ' ' LEU . 12.9 t0 -92.89 -33.16 14.32 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.738 HG22 ' CD1' ' A' ' 144' ' ' ILE . 22.1 mt -126.64 80.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.457 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.8 ttp -64.26 94.04 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.121 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.888 HG13 HG13 ' A' ' 117' ' ' VAL . 5.4 mm -79.17 118.76 27.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -137.76 158.16 44.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.349 -1.469 . . . . 0.0 111.983 -179.126 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 23.6 p90 -90.91 138.62 31.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 109.591 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.124 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.27 -159.05 0.56 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.178 -0.951 . . . . 0.0 110.003 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.988 HG21 ' CG ' ' A' ' 183' ' ' ASP . 1.5 p -174.85 -168.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.923 -1.11 . . . . 0.0 109.274 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.722 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -41.89 -26.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 0.0 109.972 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.671 ' CD ' HG12 ' A' ' 148' ' ' VAL . 5.3 pt-20 -67.41 59.12 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.939 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.687 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 34.7 m80 -97.22 -79.18 0.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.159 -0.963 . . . . 0.0 109.257 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 164.15 -61.69 0.25 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.57 ' O ' ' CG ' ' A' ' 154' ' ' PHE . 0.4 OUTLIER 179.59 53.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -1.171 . . . . 0.0 109.639 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.57 ' CG ' ' O ' ' A' ' 153' ' ' ASP . 93.4 m-85 -158.31 -39.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 110.094 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.687 ' CD1' ' CD2' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -151.91 71.23 7.95 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.11 -0.994 . . . . 0.0 109.9 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.82 118.35 5.4 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.03 1.542 . . . . 0.0 109.743 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.715 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -95.08 -160.63 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.982 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 160' ' ' PRO . 20.5 p30 178.86 50.59 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.574 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.69 -74.38 0.0 OUTLIER Glycine 0 N--CA 1.509 3.512 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.582 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.7 Cg_endo -65.17 61.28 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.237 1.292 . . . . 0.0 109.99 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.42 143.9 8.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -42.12 -41.17 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -1.115 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.647 ' HA ' HG23 ' A' ' 1' ' ' HAV . 31.0 m -55.01 84.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.802 . . . . 0.0 109.871 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.695 HD12 HD12 ' A' ' 222' ' ' LEU . 15.8 mt -71.84 -80.27 0.06 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.311 -0.868 . . . . 0.0 112.822 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.856 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -136.2 -174.65 3.74 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.469 -1.395 . . . . 0.0 111.489 -177.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.715 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.5 p-80 -179.99 167.62 1.28 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.273 -1.517 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -141.43 -166.13 2.12 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.215 -0.928 . . . . 0.0 110.391 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.623 ' CD2' HD11 ' A' ' 174' ' ' ILE . 0.1 OUTLIER -128.59 -160.86 1.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.1 -1.0 . . . . 0.0 110.73 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.005 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -166.06 -60.3 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.493 -0.755 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 1.005 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.6 Cg_endo -79.16 -172.31 1.5 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.725 1.382 . . . . 0.0 110.083 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.18 144.37 0.64 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.6 Cg_endo -70.37 136.88 32.43 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.854 1.449 . . . . 0.0 110.061 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 71.3 -64.15 1.02 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 168' ' ' TYR . 0.6 OUTLIER -64.31 -7.82 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.969 . . . . 0.0 109.164 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -65.72 66.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.894 . . . . 0.0 108.958 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 126.88 81.58 0.37 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.7 m-20 -155.87 126.83 6.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.935 -1.332 . . . . 0.0 108.016 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.684 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -113.43 168.26 9.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.325 -0.86 . . . . 0.0 109.086 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.124 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.27 135.14 5.07 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.751 178.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.596 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 58.1 m-85 -95.29 134.4 38.11 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.896 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -68.65 132.64 47.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.028 -1.469 . . . . 0.0 107.41 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -105.8 37.0 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.87 -1.144 . . . . 0.0 110.332 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.988 ' CG ' HG21 ' A' ' 148' ' ' VAL . 1.9 m-20 -114.25 -2.76 13.27 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.379 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.548 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 5.5 pt-20 -119.24 -111.65 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.056 -1.027 . . . . 0.0 108.627 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 48.6 mt-30 -148.22 174.7 11.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.818 -1.176 . . . . 0.0 109.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.585 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 90.3 m95 -162.14 126.49 3.23 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.82 ' HA ' HD21 ' A' ' 108' ' ' LEU . 71.3 p -150.14 155.38 39.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.724 -1.235 . . . . 0.0 110.627 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.937 ' HB3' HD22 ' A' ' 195' ' ' LEU . 1.1 ptpt -83.67 -30.58 26.7 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.65 ' O ' ' N ' ' A' ' 191' ' ' THR . 30.7 t0 -87.28 63.7 7.91 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.906 HG22 HD11 ' A' ' 229' ' ' LEU . 6.2 t 4.41 59.68 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.883 0.849 . . . . 0.0 111.789 -177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.65 ' N ' ' O ' ' A' ' 189' ' ' ASP . 47.7 m -124.49 -31.49 3.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.252 -0.905 . . . . 0.0 109.682 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.9 -78.69 1.42 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.705 HG22 ' OD1' ' A' ' 194' ' ' ASN . 18.4 m -129.9 -95.16 0.39 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.835 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.4 OUTLIER -161.37 73.43 0.44 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.961 HD13 HD13 ' A' ' 108' ' ' LEU . 2.4 tp -34.4 -96.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.631 0.729 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.895 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -67.56 -8.13 31.7 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -177.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.753 HD13 ' HA ' ' A' ' 227' ' ' THR . 12.2 tp -68.7 -63.13 1.12 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 116.42 -2.112 . . . . 0.0 106.924 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.856 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 9.2 t -71.41 -8.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.055 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -74.49 -58.59 3.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.96 -15.08 62.67 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.595 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 9.1 t60 -69.33 -42.03 75.87 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.957 -1.497 . . . . 0.0 107.96 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.684 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 6.8 mt-10 -85.43 -46.77 10.6 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.05 -1.031 . . . . 0.0 110.603 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.872 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -61.15 -30.87 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.706 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.23 -33.89 38.67 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.5 -50.23 73.73 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.825 -0.809 . . . . 0.0 110.41 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.54 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 58.3 p -83.82 -57.1 3.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.424 -0.798 . . . . 0.0 112.027 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.81 HD13 HD22 ' A' ' 97' ' ' LEU . 13.1 mt -104.56 34.99 2.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.945 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -136.94 -77.74 0.08 OUTLIER Glycine 0 C--N 1.292 -1.889 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.1 pp -172.02 -165.72 0.37 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.77 -1.429 . . . . 0.0 109.995 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.715 ' N ' HD12 ' A' ' 209' ' ' LEU . 3.3 t80 -96.92 -73.37 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.845 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.601 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 81.0 m80 -160.6 103.93 1.39 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.128 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.655 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -91.43 -171.34 2.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.856 . . . . 0.0 108.85 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.993 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.74 76.16 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.931 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.06 9.58 12.17 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.634 -176.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -51.1 -27.49 8.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.512 ' C ' ' HB2' ' A' ' 235' ' ' SER . 14.9 mt-10 -114.95 -38.44 3.9 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.64 -178.98 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.301 1.048 . . . . 0.0 112.262 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.806 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -78.18 -18.35 55.62 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.463 -177.483 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.601 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -77.63 -7.84 56.99 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 119.19 -2.194 . . . . 0.0 112.056 -177.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.658 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 39.6 t80 -135.56 15.79 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.362 -1.461 . . . . 0.0 113.622 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -78.3 -37.24 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.53 -1.373 . . . . 0.0 108.53 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 1.058 HD13 ' CD2' ' A' ' 3' ' ' MSB . 0.6 OUTLIER -15.58 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.01 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.979 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.63 59.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.496 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.6 OUTLIER -175.65 -159.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 74.3 m -126.4 104.15 8.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 109.722 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 197' ' ' LEU . 0.0 OUTLIER 178.56 40.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.843 . . . . 0.0 109.023 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.753 ' HA ' HD13 ' A' ' 197' ' ' LEU . 10.0 t -84.87 -51.02 7.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.237 -0.914 . . . . 0.0 110.111 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.714 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.3 OUTLIER -152.64 6.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.096 . . . . 0.0 110.903 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.906 HD11 HG22 ' A' ' 190' ' ' THR . 0.4 OUTLIER -49.07 -108.8 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.949 -1.095 . . . . 0.0 110.796 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -23.94 5.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.589 -1.319 . . . . 0.0 109.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.538 ' O ' ' C ' ' A' ' 232' ' ' PHE . 5.3 mtp180 -98.24 -31.95 11.81 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.646 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 4.9 p90 -17.09 118.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.824 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.532 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.32 171.63 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.381 -0.825 . . . . 0.0 110.516 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.103 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.2 mp -81.78 166.17 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.853 . . . . 0.0 110.427 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 37.9 t -101.77 -166.89 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.122 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.52 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.2 OUTLIER -84.97 -17.71 36.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.644 -0.66 . . . . 0.0 110.262 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.993 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.9 OUTLIER -81.62 -48.54 11.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.725 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 1.0 OUTLIER -63.98 -40.06 95.53 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.508 -1.677 . . . . 0.0 106.659 177.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.42 -35.41 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.7 -54.38 19.95 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -50.79 -53.91 24.1 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.016 HG21 HG21 ' A' ' 127' ' ' VAL . 1.1 tp -64.86 -43.19 96.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.886 -1.361 . . . . 0.0 109.995 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.51 ' N ' HG23 ' A' ' 242' ' ' ILE . 3.3 mm-40 -54.54 -28.45 45.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.2 t -80.27 -21.16 42.98 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.839 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -67.52 -64.11 0.92 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.783 ' HB3' HD13 ' A' ' 130' ' ' LEU . 27.9 m-85 -100.39 -125.16 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.209 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.541 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 53.46 -107.69 0.64 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 246' ' ' TYR . 41.3 Cg_endo -71.49 134.77 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.857 1.451 . . . . 0.0 110.067 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.55 110.87 3.09 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.988 1.52 . . . . 0.0 110.211 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 42.6 Cg_endo -72.62 -59.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.972 1.512 . . . . 0.0 110.065 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -61.42 -155.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.31 142.8 51.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.564 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.7 -18.75 24.9 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.067 1.562 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -176.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.547 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.56 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.647 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.535 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 1.058 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.265 0.555 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.673 ' HD2' HG22 ' A' ' 85' ' ' THR . 3.7 ptt85 -157.43 -94.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 109.518 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.673 HG22 ' HD2' ' A' ' 84' ' ' ARG . 10.2 t -106.09 -178.01 3.53 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.112 -0.993 . . . . 0.0 109.555 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.582 ' CD2' ' HD2' ' A' ' 87' ' ' PRO . 1.0 OUTLIER -45.34 168.62 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.582 ' HD2' ' CD2' ' A' ' 86' ' ' PHE . 41.9 Cg_endo -72.93 57.39 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.978 1.515 . . . . 0.0 110.047 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 90' ' ' PRO . . . 100.88 -52.2 0.93 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.9 mt -49.3 106.21 0.6 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.28 -1.129 . . . . 0.0 109.554 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 88' ' ' GLY . 42.3 Cg_endo -72.34 163.89 37.27 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.917 1.483 . . . . 0.0 110.099 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.927 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 1.0 OUTLIER -88.88 -81.81 0.26 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CZ2' ' O ' ' A' ' 175' ' ' ASN . 12.7 m95 -88.13 -167.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.957 -1.089 . . . . 0.0 109.608 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -162.42 -37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.418 -0.801 . . . . 0.0 109.087 179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.585 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -52.4 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.434 -0.791 . . . . 0.0 110.08 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.878 ' HA ' HD12 ' A' ' 130' ' ' LEU . 65.7 p -122.34 -0.97 9.22 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.602 -0.686 . . . . 0.0 109.312 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.585 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 15.0 m-70 -140.56 92.59 2.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.463 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.751 ' N ' HD22 ' A' ' 97' ' ' LEU . 2.9 mm? -85.19 162.8 19.05 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.512 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.6 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -141.05 155.83 46.1 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.934 ' CE2' HD11 ' A' ' 101' ' ' ILE . 8.4 p90 -134.47 168.56 18.72 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.452 -1.405 . . . . 0.0 109.826 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 1.011 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.5 124.06 31.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -0.766 . . . . 0.0 109.235 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.934 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.5 mp -80.69 81.48 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.011 HG22 ' NE ' ' A' ' 100' ' ' ARG . 4.8 t -94.71 5.08 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.873 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -103.29 163.99 11.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.761 -1.212 . . . . 0.0 108.6 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.71 ' N ' HG21 ' A' ' 113' ' ' VAL . 7.2 p90 -178.2 58.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.119 -0.988 . . . . 0.0 110.5 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.981 HG21 ' CD1' ' A' ' 186' ' ' TRP . 69.0 p -45.48 145.57 2.0 Allowed Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.1 -32.47 34.2 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 124.002 1.528 . . . . 0.0 109.232 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.62 ' C ' HD23 ' A' ' 108' ' ' LEU . 14.9 m-20 -65.89 -19.37 65.85 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.967 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -115.62 114.28 42.34 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 112' ' ' ALA . 36.4 Cg_endo -62.75 168.17 10.65 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.565 1.297 . . . . 0.0 108.996 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HE2' ' HB2' ' A' ' 110' ' ' LYS . 1.3 mppt? -39.73 -64.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.877 0.846 . . . . 0.0 109.54 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -57.73 -10.87 1.8 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.845 -0.535 . . . . 0.0 111.392 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.705 ' HB1' HD13 ' A' ' 108' ' ' LEU . . . -87.75 -58.44 2.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.576 -1.327 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.039 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.9 p -59.68 -43.39 91.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.612 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -60.92 -26.83 67.76 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.614 ' OG ' HD21 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -63.26 -65.24 0.71 Allowed 'General case' 0 C--O 1.195 -1.768 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.047 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -49.46 -31.99 11.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.039 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.6 t -74.34 -24.62 19.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -87.18 -37.19 17.52 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.345 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.764 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -77.82 -39.1 44.79 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.773 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.71 -61.57 2.0 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.214 1.007 . . . . 0.0 108.553 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.846 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.3 pp -53.8 -41.4 67.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.381 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.794 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -76.19 -32.85 59.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.806 -178.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.021 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.1 t -53.76 -45.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.064 ' CH2' HD21 ' A' ' 234' ' ' LEU . 33.5 m95 -91.69 -22.31 20.3 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.758 -1.177 . . . . 0.0 110.532 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.535 ' CG ' ' HB2' ' A' ' 132' ' ' PHE . 9.3 tm-20 -69.79 -27.03 64.57 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.782 -1.199 . . . . 0.0 107.815 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -91.17 -42.95 10.16 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.63 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.038 HG21 HG21 ' A' ' 242' ' ' ILE . 14.0 m -58.07 -25.56 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.308 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.01 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -109.36 155.0 41.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 118.073 -1.451 . . . . 0.0 109.249 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.68 ' C ' HD22 ' A' ' 130' ' ' LEU . 51.2 Cg_endo -82.06 26.2 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.054 1.836 . . . . 0.0 111.395 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 95' ' ' THR . 4.4 mm? -108.6 -169.54 1.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.595 -1.316 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.574 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 2.0 p -117.7 169.22 9.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.808 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CE2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -139.17 163.34 32.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.637 -0.664 . . . . 0.0 109.921 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.579 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -143.08 -172.8 3.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.638 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -159.81 165.46 32.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.562 -1.336 . . . . 0.0 110.798 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.722 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -163.37 -163.63 0.85 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.592 -0.692 . . . . 0.0 109.134 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 75.0 t80 -158.2 22.07 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 108.768 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 1.6 pm0 -148.8 -178.95 6.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -0.761 . . . . 0.0 108.97 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.87 -97.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 137' ' ' GLU . 20.2 tt0 178.5 146.22 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -1.175 . . . . 0.0 110.531 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.668 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -103.18 -150.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.698 ' O ' HD13 ' A' ' 142' ' ' ILE . 41.4 m-20 -88.74 -36.58 16.06 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.934 HG13 HD23 ' A' ' 207' ' ' LEU . 18.4 mm -122.28 82.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.552 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 3.3 ptt? -67.1 100.12 0.73 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.582 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.873 HG22 ' ND2' ' A' ' 103' ' ' ASN . 6.1 mm -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -135.41 154.93 51.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.336 -1.477 . . . . 0.0 111.939 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -77.06 135.99 38.65 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.064 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -152.83 164.68 37.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 110.485 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 1.001 HG21 ' CG ' ' A' ' 183' ' ' ASP . 2.6 p -160.2 -174.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.255 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.702 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -38.15 -28.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.279 -0.888 . . . . 0.0 110.334 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.681 ' H ' HG13 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -78.52 51.49 1.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 109.907 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 9.6 m80 -81.42 -85.13 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.304 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.21 -63.94 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.563 ' O ' ' CG ' ' A' ' 154' ' ' PHE . 0.2 OUTLIER 179.69 44.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -1.143 . . . . 0.0 109.575 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.573 ' HB3' ' CE1' ' A' ' 155' ' ' TYR . 87.8 m-85 -158.7 -58.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.945 . . . . 0.0 110.02 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -117.59 61.93 3.57 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.178 -0.951 . . . . 0.0 109.752 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 154' ' ' PHE . 41.2 Cg_endo -70.79 128.03 14.56 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.92 1.484 . . . . 0.0 109.795 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.652 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -117.13 -162.15 0.85 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 110.326 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 160' ' ' PRO . 33.0 p30 -173.79 55.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 110.041 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 14.49 -76.86 0.0 OUTLIER Glycine 0 N--CA 1.508 3.446 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.615 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.2 Cg_endo -66.9 59.19 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.322 1.348 . . . . 0.0 109.866 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -151.89 142.71 9.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.533 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 2.7 m120 -41.43 -34.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.021 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.879 ' HA ' HG23 ' A' ' 1' ' ' HAV . 10.9 m -66.66 84.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.97 . . . . 0.0 109.646 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.099 HD21 HG23 ' A' ' 193' ' ' THR . 1.2 tp -64.03 -56.07 17.67 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.335 -0.853 . . . . 0.0 111.462 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.783 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -163.1 -164.35 0.95 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.394 -1.441 . . . . 0.0 110.622 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.652 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 0.9 OUTLIER 178.92 -179.17 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.157 -1.589 . . . . 0.0 111.356 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 202' ' ' GLU . . . -151.32 174.46 13.28 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.804 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.559 ' CE2' HD12 ' A' ' 174' ' ' ILE . 0.1 OUTLIER -113.97 -170.17 1.66 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.082 -1.011 . . . . 0.0 110.168 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.957 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -156.78 -66.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 109.197 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.957 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 43.8 Cg_endo -73.03 -160.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.704 1.371 . . . . 0.0 109.718 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 175' ' ' ASN . . . 76.33 164.21 17.45 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.8 Cg_endo -73.85 -92.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.012 1.533 . . . . 0.0 110.215 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -68.51 -23.7 75.22 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -77.88 9.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.569 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -65.78 64.82 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 142' ' ' ILE . . . 110.73 96.59 2.37 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -152.96 114.53 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.197 -1.178 . . . . 0.0 107.872 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.675 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.76 157.41 19.17 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.558 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.064 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -147.08 134.88 21.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.816 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.541 ' HB3' ' CZ2' ' A' ' 186' ' ' TRP . 19.1 m-85 -96.79 130.7 44.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.096 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 164' ' ' LEU . 0.2 OUTLIER -47.97 143.27 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.721 -1.237 . . . . 0.0 109.343 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -119.26 29.58 7.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 1.001 ' CG ' HG21 ' A' ' 148' ' ' VAL . 4.7 m-20 -135.97 3.34 2.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 110.598 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.54 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 1.6 pt-20 -112.35 -96.39 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.606 -1.309 . . . . 0.0 109.492 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.601 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 1.0 OUTLIER -162.36 173.4 14.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.081 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.981 ' CD1' HG21 ' A' ' 105' ' ' THR . 86.1 m95 -161.15 133.8 6.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.006 -1.059 . . . . 0.0 109.799 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 186' ' ' TRP . 74.9 p -162.02 150.08 14.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.577 -0.702 . . . . 0.0 109.374 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.679 ' O ' HG23 ' A' ' 227' ' ' THR . 13.3 pttt -83.38 -31.9 26.48 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.655 ' O ' ' N ' ' A' ' 191' ' ' THR . 9.4 t70 -83.77 64.01 7.79 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' THR . . . . . 1.026 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.9 t 3.44 60.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.123 0.963 . . . . 0.0 111.975 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.655 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.7 m -121.88 -32.25 3.78 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.076 -1.015 . . . . 0.0 109.545 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.402 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -98.55 -75.97 1.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.099 HG23 HD21 ' A' ' 164' ' ' LEU . 3.0 m -124.28 -88.86 0.6 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.844 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 4.3 m-20 178.06 72.37 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.015 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 30.6 tp -28.82 -102.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.514 0.673 . . . . 0.0 112.541 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.844 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -57.44 -16.08 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.015 -1.053 . . . . 0.0 111.604 -177.372 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.844 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.8 tp -63.02 -63.04 1.32 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.32 -2.112 . . . . 0.0 107.245 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.032 HG21 HD23 ' A' ' 164' ' ' LEU . 3.2 t -69.88 -8.32 10.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.047 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -76.84 -59.54 2.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -64.95 -14.22 59.5 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.59 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 22.0 t60 -66.73 -50.66 62.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.589 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 167' ' ' ALA . 2.3 mm-40 -79.42 -46.44 17.52 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.282 -0.886 . . . . 0.0 110.925 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.773 HD12 ' HB3' ' A' ' 120' ' ' ALA . 1.4 mt -60.2 -30.35 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.713 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.3 -32.74 42.07 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -59.23 -49.05 79.32 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.892 -0.769 . . . . 0.0 110.496 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.644 ' OG ' ' HB1' ' A' ' 167' ' ' ALA . 5.0 m -84.63 -56.16 3.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 112.333 -177.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.934 HD23 HG13 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -104.39 27.0 8.25 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.94 -1.1 . . . . 0.0 110.987 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.907 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -130.11 -78.26 0.19 Allowed Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.838 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -167.48 -162.82 0.47 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.853 -1.381 . . . . 0.0 110.208 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 4.1 t80 -98.98 -70.78 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.802 . . . . 0.0 109.471 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 44.9 m80 -161.31 87.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.633 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -76.98 179.75 6.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 109.306 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.918 ' HB3' ' OD2' ' A' ' 237' ' ' ASP . . . -61.63 81.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.957 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.08 11.12 12.41 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.366 -177.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 214' ' ' ASN . 47.6 p -49.41 -28.27 4.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.545 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.0 mm-40 -115.99 -36.14 4.22 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.957 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.63 -166.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.507 1.146 . . . . 0.0 112.773 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -95.26 -15.3 23.3 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.354 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.573 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -79.77 -5.98 56.39 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.284 -2.135 . . . . 0.0 112.054 -177.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.656 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 43.3 t80 -138.78 15.75 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.444 -1.41 . . . . 0.0 113.347 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.14 -37.46 0.79 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 N-CA-C 108.631 -1.334 . . . . 0.0 108.631 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.978 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.7 OUTLIER -14.76 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.085 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.978 ' N ' HD13 ' A' ' 222' ' ' LEU . 2.1 t80 -73.42 56.32 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.154 -0.966 . . . . 0.0 109.321 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -173.68 -145.72 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.574 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.668 ' HB3' HG21 ' A' ' 190' ' ' THR . 18.6 m -143.2 110.6 5.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.855 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER 179.4 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.34 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 188' ' ' LYS . 11.3 t -93.36 -13.24 28.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.596 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER 178.37 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.564 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 1.026 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.4 OUTLIER -26.83 -99.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.811 -0.555 . . . . 0.0 111.426 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 p -135.05 -2.98 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.759 -1.213 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.565 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.7 OUTLIER -119.32 -40.28 2.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 108.744 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 2.0 p90 0.38 111.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.357 0.599 . . . . 0.0 111.958 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.6 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.5 ttt180 179.42 154.28 0.47 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.166 -0.959 . . . . 0.0 110.035 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.064 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -74.77 169.31 18.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.469 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 30.4 t -104.6 -169.63 1.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.353 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.517 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.98 -11.91 54.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 110.104 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.918 ' OD2' ' HB3' ' A' ' 213' ' ' ALA . 0.5 OUTLIER -84.18 -50.81 7.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.66 -1.275 . . . . 0.0 107.748 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.838 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.81 -38.33 90.71 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.679 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -57.07 -35.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 237' ' ' ASP . 3.5 m-20 -68.42 -56.91 6.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -47.88 -53.33 14.24 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.038 HG21 HG21 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -63.91 -43.39 97.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.977 -1.308 . . . . 0.0 109.746 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.536 ' N ' HG23 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -54.54 -27.35 37.82 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -82.71 -19.17 38.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.825 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -70.11 -63.45 1.08 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.558 ' HB3' ' CD2' ' A' ' 130' ' ' LEU . 15.9 m-30 -100.45 -123.56 0.16 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.275 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.543 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 54.72 100.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.453 ' HB2' ' HD2' ' A' ' 249' ' ' PRO . 42.7 Cg_endo -72.72 172.22 15.69 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.052 1.554 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 42.3 Cg_endo -72.85 163.04 39.54 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.989 1.52 . . . . 0.0 110.038 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.76 -58.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.985 1.519 . . . . 0.0 110.093 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.59 154.2 3.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.533 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 80.3 p -49.21 151.62 2.41 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.549 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.52 -9.49 24.14 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.948 1.499 . . . . 0.0 110.071 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -102.59 -168.15 1.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 109.573 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.666 HG23 ' OXT' ' A' ' 255' ' ' THR . 11.5 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.555 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.879 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.539 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.727 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' N ' ' HD3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.257 0.551 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.502 ' HD3' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -170.91 -73.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 109.588 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.677 HG21 ' HA2' ' A' ' 241' ' ' GLY . 1.0 OUTLIER -51.94 -93.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.946 . . . . 0.0 109.511 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.477 ' CZ ' ' O ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER 179.84 67.37 0.14 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.98 59.7 3.62 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.923 1.486 . . . . 0.0 110.094 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.21 -83.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.477 ' O ' ' CZ ' ' A' ' 86' ' ' PHE . 21.0 mt -115.81 117.46 39.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.311 -1.111 . . . . 0.0 109.572 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.08 -161.95 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.883 1.465 . . . . 0.0 110.133 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 1.036 ' CE ' ' HB1' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -106.55 -75.51 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.012 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' A' ' 141' ' ' ASP . 70.9 m95 -94.06 162.64 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 0.0 109.258 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -133.02 -35.19 1.06 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 110.237 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HD3' HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -50.7 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.177 -0.952 . . . . 0.0 110.283 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.797 ' CA ' HD12 ' A' ' 130' ' ' LEU . 32.3 p -124.72 1.49 8.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.461 -0.774 . . . . 0.0 109.561 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.555 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 35.6 m80 -146.02 99.66 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.992 -1.067 . . . . 0.0 110.484 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.212 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -127.59 -153.09 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 141' ' ' ASP . 1.2 t -173.75 -178.91 1.67 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.947 -1.096 . . . . 0.0 111.179 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.827 ' CG ' HD23 ' A' ' 121' ' ' LEU . 10.4 p90 -135.82 179.16 6.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.371 -0.831 . . . . 0.0 109.678 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.806 ' NH2' HG22 ' A' ' 102' ' ' VAL . 2.0 ttp85 -131.85 144.1 50.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -0.758 . . . . 0.0 109.394 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.98 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.8 mp -101.53 78.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.879 -1.138 . . . . 0.0 109.503 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.806 HG22 ' NH2' ' A' ' 100' ' ' ARG . 1.8 t -92.77 9.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.44 -0.787 . . . . 0.0 110.616 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.616 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.81 174.47 5.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.508 -1.37 . . . . 0.0 110.108 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.61 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.1 t80 177.16 86.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.397 0.618 . . . . 0.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.789 HG21 ' CD1' ' A' ' 186' ' ' TRP . 33.2 p -67.44 154.09 93.67 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 185' ' ' GLN . 38.3 Cg_endo -67.87 -26.53 38.05 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.827 1.435 . . . . 0.0 108.65 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.585 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -81.86 2.23 31.33 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.114 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.901 HD13 ' CD1' ' A' ' 195' ' ' LEU . 95.1 mt -145.23 117.27 5.23 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.486 -0.759 . . . . 0.0 110.236 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.06 175.6 5.44 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.853 1.449 . . . . 0.0 108.872 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.97 -64.96 0.44 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.829 0.823 . . . . 0.0 110.108 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -30.63 55.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 112.282 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.889 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.29 -60.69 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.31 -1.494 . . . . 0.0 109.356 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.616 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.5 p -52.25 -38.48 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.98 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -65.6 -28.64 69.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.7 ' OG ' HD21 ' A' ' 195' ' ' LEU . 10.8 p -62.37 -39.68 93.96 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.067 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -72.48 -34.13 67.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 0.0 109.544 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.891 HG22 HG21 ' A' ' 144' ' ' ILE . 71.8 t -74.12 -23.2 18.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 1.6 tt0 -91.23 -33.48 15.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 6.5 tppt? -82.57 -33.77 27.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.805 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -68.08 -65.21 0.72 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.853 ' HA ' HG21 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.731 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.09 -36.78 63.54 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.239 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.926 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.34 -36.98 48.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.117 ' O ' HG23 ' A' ' 128' ' ' THR . 46.6 m95 -91.61 -23.16 19.95 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.627 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -74.21 -27.74 60.94 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.755 -1.216 . . . . 0.0 108.312 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -91.37 -44.22 9.29 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.888 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 123' ' ' VAL . 20.2 m -60.47 -24.6 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.186 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.165 HG21 ' CE1' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -106.22 165.08 13.64 Favored Pre-proline 0 N--CA 1.501 2.107 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.975 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 1.013 ' C ' HD22 ' A' ' 130' ' ' LEU . 52.3 Cg_endo -83.66 25.82 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.242 1.961 . . . . 0.0 111.723 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.013 HD22 ' C ' ' A' ' 129' ' ' PRO . 3.7 mm? -127.09 -177.89 4.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.468 -1.395 . . . . 0.0 110.781 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.555 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.5 p -125.59 167.12 15.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 111.488 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 1.212 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 25.1 m-85 -148.68 162.72 39.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.307 0.575 . . . . 0.0 109.801 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.573 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -133.12 -159.21 0.95 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -151.41 152.94 33.77 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.052 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -136.1 -129.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.067 -1.021 . . . . 0.0 109.318 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 136' ' ' TYR . 40.4 t80 178.24 31.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.67 -1.269 . . . . 0.0 109.423 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.483 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 5.0 pm0 -167.37 -174.25 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.014 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.53 -98.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 4.6 pt-20 178.86 124.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -1.156 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 1.057 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -81.98 -151.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 109.219 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.565 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -81.1 -48.7 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.838 HG22 ' CD1' ' A' ' 144' ' ' ILE . 13.1 mm -112.52 80.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.535 ' HG2' HG21 ' A' ' 102' ' ' VAL . 4.4 ttp -63.8 97.69 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.938 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.891 HG21 HG22 ' A' ' 117' ' ' VAL . 5.7 mm -78.23 130.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.066 -1.021 . . . . 0.0 108.488 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -145.34 154.92 42.83 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.562 -1.336 . . . . 0.0 111.881 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -91.19 135.88 33.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.121 -0.987 . . . . 0.0 108.577 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -169.52 -164.0 0.42 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.381 -1.328 . . . . 0.0 111.338 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.959 HG23 ' OD1' ' A' ' 181' ' ' ASP . 3.0 p -177.51 -171.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.738 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -38.7 -25.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.595 ' H ' HG13 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -54.37 -12.2 0.64 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.0 -1.062 . . . . 0.0 111.347 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 75.4 m80 -37.76 -89.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.075 -1.015 . . . . 0.0 109.981 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.2 -94.28 0.1 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -145.46 12.73 1.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -1.164 . . . . 0.0 109.603 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.498 ' C ' ' CD ' ' A' ' 156' ' ' PRO . 2.1 t80 -131.62 -32.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 109.792 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.9 m-85 -118.78 42.33 0.43 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.947 . . . . 0.0 110.142 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 39.9 Cg_endo -69.8 101.53 0.93 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.614 1.323 . . . . 0.0 108.855 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.666 ' CZ ' ' CG1' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -69.33 -141.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 110.479 -178.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.491 ' CG ' ' HB ' ' A' ' 163' ' ' VAL . 3.9 p-10 -128.12 -31.77 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 111.782 -177.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.594 ' HA3' HG21 ' A' ' 148' ' ' VAL . . . 50.61 -105.91 0.22 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.292 -2.323 . . . . 0.0 107.292 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.26 61.45 0.25 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.582 1.306 . . . . 0.0 109.879 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -156.73 -176.13 28.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 163' ' ' VAL . 50.9 m-20 -78.1 -41.35 35.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -1.194 . . . . 0.0 110.272 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.027 HG13 HG22 ' A' ' 1' ' ' HAV . 4.6 t -42.1 130.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.873 HD22 HD23 ' A' ' 222' ' ' LEU . 0.8 OUTLIER -96.08 -56.5 2.62 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.46 -0.775 . . . . 0.0 112.543 -178.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.734 ' HB1' ' OE2' ' A' ' 202' ' ' GLU . . . -162.74 -172.04 2.95 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.22 -1.55 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER 179.93 173.96 0.91 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 119.956 -1.715 . . . . 0.0 111.371 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.23 -170.78 2.73 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.477 -0.765 . . . . 0.0 109.667 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.627 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 49.3 m-85 -118.28 -166.19 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.836 -1.165 . . . . 0.0 110.432 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.036 ' HB1' ' CE ' ' A' ' 91' ' ' LYS . . . -177.51 -62.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.8 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 1.002 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 42.9 Cg_endo -73.77 145.23 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.956 1.503 . . . . 0.0 110.305 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . 94.17 144.23 15.43 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.8 Cg_endo -70.4 152.37 65.94 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.969 1.51 . . . . 0.0 109.99 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 68.38 -63.94 0.41 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.627 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -65.69 -8.73 6.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.533 -0.981 . . . . 0.0 108.842 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 171' ' ' GLY . 10.4 t30 -67.41 66.39 0.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.951 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 131.45 76.58 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.165 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.594 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -149.1 119.32 7.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.699 -1.471 . . . . 0.0 108.288 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.603 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -101.83 166.1 10.84 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.012 -1.055 . . . . 0.0 109.054 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.678 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -163.27 132.38 4.03 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.32 178.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.691 ' HE1' HG23 ' A' ' 198' ' ' VAL . 53.9 m-85 -92.06 136.24 33.33 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.756 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.959 ' OD1' HG23 ' A' ' 148' ' ' VAL . 51.6 t0 -70.03 126.49 29.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 183' ' ' ASP . 16.5 t70 -70.65 -5.03 26.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.628 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 61.9 t0 -34.32 -72.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 111.273 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.474 ' OE2' ' OD2' ' A' ' 183' ' ' ASP . 1.0 OUTLIER -111.87 -135.85 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.524 -177.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.543 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -122.91 -178.75 4.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.162 -0.961 . . . . 0.0 109.17 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 1.073 ' CZ3' HG21 ' A' ' 198' ' ' VAL . 29.4 m95 -144.7 151.2 38.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.45 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.844 ' HA ' HD21 ' A' ' 108' ' ' LEU . 41.5 p -145.9 152.87 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 110.007 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.68 ' O ' HG23 ' A' ' 227' ' ' THR . 0.1 OUTLIER -70.08 -38.95 75.86 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.386 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.505 ' HA ' HD13 ' A' ' 229' ' ' LEU . 0.8 OUTLIER -86.18 -150.17 0.14 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.953 HG23 HD11 ' A' ' 229' ' ' LEU . 17.3 p -109.51 43.1 1.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.069 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.532 ' HB ' HG21 ' A' ' 187' ' ' THR . 89.0 m -95.49 -31.84 13.16 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.352 -0.842 . . . . 0.0 111.25 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -114.18 -80.15 0.92 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.028 -1.558 . . . . 0.0 109.535 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.848 HG22 ' OD1' ' A' ' 194' ' ' ASN . 64.0 m -134.72 -94.02 0.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.584 -0.951 . . . . 0.0 108.435 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.848 ' OD1' HG22 ' A' ' 193' ' ' THR . 0.8 OUTLIER -157.23 66.01 0.5 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.675 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.067 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -29.56 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.702 0.763 . . . . 0.0 111.019 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.822 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.3 OUTLIER -67.78 -11.71 59.04 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 111.536 -177.405 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 221' ' ' PRO . 13.0 tp -67.25 -59.94 3.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.06 -1.856 . . . . 0.0 106.895 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.073 HG21 ' CZ3' ' A' ' 186' ' ' TRP . 2.0 m -71.29 -12.87 16.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.039 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.5 -61.21 1.91 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -62.85 -17.13 60.97 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.598 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 15.5 t60 -68.71 -40.63 79.88 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.594 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.734 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 3.9 mt-10 -85.2 -49.36 8.28 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.853 . . . . 0.0 111.141 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.853 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.2 mt -60.88 -30.6 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.781 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.78 -30.83 42.15 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.567 ' CE1' ' O1 ' ' A' ' 1' ' ' HAV . 0.0 OUTLIER -63.19 -44.64 94.8 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.742 -0.857 . . . . 0.0 110.699 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.674 ' OG ' HD12 ' A' ' 142' ' ' ILE . 85.7 p -87.49 -55.61 3.72 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 112.61 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 1.009 HD11 ' OH ' ' A' ' 246' ' ' TYR . 2.3 tp -104.56 7.35 35.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.134 -0.979 . . . . 0.0 110.964 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 1.026 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -104.65 -77.54 1.16 Allowed Glycine 0 N--CA 1.486 1.982 0 O-C-N 120.841 -1.162 . . . . 0.0 111.021 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.899 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.6 pp -172.59 -161.85 0.17 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.611 -1.523 . . . . 0.0 110.05 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.827 ' N ' HD12 ' A' ' 209' ' ' LEU . 2.9 m-85 -94.32 -94.51 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 0.0 109.155 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 44.8 m170 -143.15 120.92 11.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.575 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.7 m -108.33 -179.12 3.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.179 -0.951 . . . . 0.0 109.291 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.69 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -59.53 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.951 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -91.01 13.26 17.24 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.536 -177.197 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 214' ' ' ASN . 31.0 p -50.73 -28.04 8.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.492 ' C ' ' HB2' ' A' ' 235' ' ' SER . 2.5 mt-10 -118.08 -36.42 3.6 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.517 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.78 -159.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 122.2 1.0 . . . . 0.0 112.756 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -112.15 -3.43 14.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.925 -177.432 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.541 ' HB2' ' CG ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -89.55 -5.36 57.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 119.152 -2.217 . . . . 0.0 110.732 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.647 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 33.4 t80 -140.0 14.91 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 118.845 -1.142 . . . . 0.0 113.252 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 1.081 ' HB3' HD11 ' A' ' 226' ' ' LEU . 56.1 Cg_endo -75.85 -35.21 2.68 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 N-CA-C 108.539 -1.37 . . . . 0.0 108.539 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.978 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.4 OUTLIER -17.98 -57.94 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.53 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.978 ' N ' HD13 ' A' ' 222' ' ' LEU . 2.7 t80 -75.01 55.17 0.7 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 0.0 108.96 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 221' ' ' PRO . 7.2 t-160 -173.44 -138.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.899 ' C ' HD23 ' A' ' 226' ' ' LEU . 1.9 m -157.06 119.26 3.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.92 -1.112 . . . . 0.0 109.909 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 1.081 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.2 OUTLIER 178.92 62.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 110.021 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER -114.26 -18.69 11.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 14.5 t70 -167.42 -26.91 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 109.951 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.953 HD11 HG23 ' A' ' 190' ' ' THR . 0.2 OUTLIER -28.61 -61.97 0.11 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.849 HG23 ' HG3' ' A' ' 231' ' ' ARG . 1.5 t 178.98 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.379 -0.826 . . . . 0.0 108.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.849 ' HG3' HG23 ' A' ' 230' ' ' THR . 0.0 OUTLIER -94.67 -18.46 21.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.578 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 27.8 p90 -37.49 107.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.522 0.677 . . . . 0.0 110.641 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.601 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 9.2 ttt180 179.79 153.26 0.48 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.442 -0.786 . . . . 0.0 109.573 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.112 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.2 mp -67.01 165.86 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 12.7 t -101.73 -169.51 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.492 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.56 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.1 OUTLIER -84.85 -21.69 29.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 110.117 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.69 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 6.5 m-20 -80.44 -41.74 23.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.899 ' OD1' HD21 ' A' ' 209' ' ' LEU . 19.0 t0 -70.73 -32.81 70.13 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.458 -1.297 . . . . 0.0 107.725 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.623 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.4 OUTLIER -62.92 -33.9 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -65.05 -51.26 62.5 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.508 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.677 ' HA2' HG21 ' A' ' 85' ' ' THR . . . -58.38 -54.71 35.52 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.026 HD13 ' HA2' ' A' ' 208' ' ' GLY . 2.4 tp -61.24 -49.38 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.745 -1.444 . . . . 0.0 109.916 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 242' ' ' ILE . 9.1 tt0 -53.57 -29.88 39.36 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.0 t -80.09 -17.08 53.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -70.39 -59.86 2.61 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 1.165 ' CE1' HG21 ' A' ' 128' ' ' THR . 41.7 m-85 -71.39 -91.94 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 246' ' ' TYR . . . -33.62 137.18 0.18 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.475 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 42.2 Cg_endo -72.02 136.09 26.57 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.707 1.605 . . . . 0.0 110.189 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.605 ' CD ' ' CD ' ' A' ' 250' ' ' PRO . 38.2 Cg_endo -72.58 -30.64 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.036 1.545 . . . . 0.0 112.584 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.605 ' CD ' ' CD ' ' A' ' 249' ' ' PRO . 43.1 Cg_endo -73.28 -164.62 0.2 Allowed 'Trans proline' 0 C--N 1.319 -0.996 0 N-CA-C 110.164 -0.745 . . . . 0.0 110.164 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 252' ' ' SER . 0.2 OUTLIER -78.88 -52.15 8.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.623 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 251' ' ' ASP . 1.4 p -43.6 103.47 0.32 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.888 . . . . 0.0 109.647 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 251' ' ' ASP . 42.1 Cg_endo -72.85 -43.89 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.07 1.563 . . . . 0.0 110.059 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.36 153.44 38.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.639 HG23 ' OXT' ' A' ' 255' ' ' THR . 3.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.484 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.027 HG22 HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.546 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.649 ' HH1' ' CD1' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.3 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.264 0.554 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -86.64 171.76 10.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.579 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.649 HG22 ' N ' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -63.55 -166.45 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.281 -0.887 . . . . 0.0 109.655 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.607 ' CG ' ' HD2' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -50.01 -179.68 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.191 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' A' ' 86' ' ' PHE . 38.3 Cg_endo -67.69 60.24 0.83 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.411 1.216 . . . . 0.0 109.69 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.501 ' C ' ' CG1' ' A' ' 89' ' ' ILE . . . 174.04 -136.84 3.73 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.51 ' CB ' ' CD ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -168.06 -62.54 0.01 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.105 -1.232 . . . . 0.0 109.564 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 89' ' ' ILE . 41.7 Cg_endo -71.39 78.98 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.929 1.489 . . . . 0.0 110.401 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.513 ' HD3' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mttp -50.99 -97.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 108.917 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.858 ' CD1' HD11 ' A' ' 207' ' ' LEU . 7.0 m95 -66.03 -164.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.834 -1.166 . . . . 0.0 109.076 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -152.03 -36.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.999 -1.063 . . . . 0.0 110.379 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -50.32 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.916 ' HA ' HD12 ' A' ' 130' ' ' LEU . 8.2 p -121.22 -5.64 9.42 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 1.033 ' CE1' HG21 ' A' ' 131' ' ' THR . 26.7 m-70 -146.06 100.41 3.39 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.089 HD13 ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -106.36 -165.33 1.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.842 . . . . 0.0 109.952 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -160.43 160.17 31.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 1.044 ' CZ ' HD22 ' A' ' 121' ' ' LEU . 2.6 p90 -131.16 167.23 19.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.801 -1.187 . . . . 0.0 108.816 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.891 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -126.11 123.14 37.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.121 . . . . 0.0 109.818 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.727 HG13 HG11 ' A' ' 117' ' ' VAL . 1.5 mp -82.14 84.43 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.779 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.891 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 38.2 t -99.52 6.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.401 -0.812 . . . . 0.0 109.775 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.983 ' C ' HG21 ' A' ' 113' ' ' VAL . 35.1 m-80 -97.11 156.15 16.51 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.846 -1.159 . . . . 0.0 108.794 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.78 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER 179.14 37.28 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 179.2 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 104' ' ' TYR . 41.3 p -42.86 156.31 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.401 -0.812 . . . . 0.0 108.913 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.88 -20.27 45.54 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.836 1.44 . . . . 0.0 109.054 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.557 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -67.7 -9.85 47.27 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.275 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.851 HD13 ' CD1' ' A' ' 195' ' ' LEU . 63.6 mt -144.49 123.59 7.04 Favored Pre-proline 0 N--CA 1.483 1.221 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.41 166.25 17.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.833 1.438 . . . . 0.0 109.153 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.94 -65.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.711 0.767 . . . . 0.0 110.345 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.3 m-20 -57.83 -22.92 50.23 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 111.764 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.744 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -76.16 -62.11 1.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.39 -1.443 . . . . 0.0 109.304 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.983 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.9 p -50.94 -39.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -66.96 -26.95 67.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.509 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.824 ' OG ' HD21 ' A' ' 195' ' ' LEU . 17.1 p -65.67 -41.22 92.72 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.087 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.78 -33.57 64.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.069 -1.019 . . . . 0.0 109.874 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.882 HG13 HG13 ' A' ' 144' ' ' ILE . 12.0 t -74.82 -23.72 17.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 2.1 tt0 -88.35 -35.13 17.35 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -77.88 -39.57 42.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -67.41 -62.42 1.43 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.142 0.972 . . . . 0.0 109.086 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.044 HD22 ' CZ ' ' A' ' 99' ' ' TYR . 1.7 pp -55.3 -40.82 71.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.793 ' N ' HD12 ' A' ' 121' ' ' LEU . 7.1 tptm -75.7 -32.64 60.17 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.826 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.037 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -54.16 -44.42 63.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.118 ' CH2' HD21 ' A' ' 234' ' ' LEU . 32.7 m95 -91.1 -23.57 20.26 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.675 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 17.6 tp10 -69.79 -27.24 64.74 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.692 -1.255 . . . . 0.0 107.903 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.7 pt-20 -90.39 -42.93 10.63 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.889 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.037 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.6 m -57.9 -26.02 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.322 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.988 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -107.94 154.12 41.27 Favored Pre-proline 0 N--CA 1.495 1.818 0 C-N-CA 117.966 -1.493 . . . . 0.0 109.224 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.596 ' C ' HD22 ' A' ' 130' ' ' LEU . 48.6 Cg_endo -81.29 24.76 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.832 1.688 . . . . 0.0 111.415 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 95' ' ' THR . 4.6 mm? -106.13 -169.02 1.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.701 -1.25 . . . . 0.0 110.202 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 1.033 HG21 ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -121.65 162.76 20.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.0 110.48 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 1.089 ' CE2' HD13 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -149.86 144.2 25.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.547 -0.721 . . . . 0.0 109.688 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.12 -162.5 1.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.24 -0.912 . . . . 0.0 108.856 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.625 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -156.46 153.28 28.57 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 110.057 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.607 HD12 ' H ' ' A' ' 137' ' ' GLU . 0.4 OUTLIER -145.06 -137.35 0.09 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.474 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.4 OUTLIER 179.29 33.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.689 -1.257 . . . . 0.0 108.995 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.607 ' H ' HD12 ' A' ' 135' ' ' LEU . 5.4 pm0 -157.54 179.94 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.35 -95.99 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER 178.83 106.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -1.159 . . . . 0.0 110.193 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.536 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.67 -147.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 108.758 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 98' ' ' THR . 43.9 t0 -90.28 -45.03 9.32 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.766 HG22 ' CD1' ' A' ' 144' ' ' ILE . 44.3 mt -116.46 81.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.493 ' SD ' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -64.52 97.11 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.882 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -82.52 114.83 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -135.71 157.33 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.369 -1.457 . . . . 0.0 112.08 -178.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 16.7 p90 -88.47 140.3 29.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.526 -0.734 . . . . 0.0 109.419 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.913 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.29 -161.49 0.36 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 0.0 110.176 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 1.01 HG21 ' CG ' ' A' ' 183' ' ' ASP . 0.7 OUTLIER -179.51 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.052 . . . . 0.0 109.896 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.808 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -29.69 -36.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.863 -0.523 . . . . 0.0 111.157 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 148' ' ' VAL . 5.2 mt-10 -82.01 124.88 30.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.966 -1.084 . . . . 0.0 109.818 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 148' ' ' VAL . 20.3 m80 -148.86 -91.48 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.504 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -151.29 -48.16 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.86 -29.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -1.218 . . . . 0.0 110.232 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 72.4 t80 -129.28 42.38 3.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.0 -1.063 . . . . 0.0 110.211 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.591 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.4 m-85 -154.97 45.25 0.25 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.118 -0.989 . . . . 0.0 109.793 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 43.1 Cg_endo -72.61 112.4 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.727 1.383 . . . . 0.0 110.128 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -92.12 -157.18 0.5 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.079 -1.013 . . . . 0.0 109.861 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.594 ' O ' ' C ' ' A' ' 159' ' ' GLY . 22.5 p30 179.88 54.72 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.427 -0.795 . . . . 0.0 109.858 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -10.48 -64.37 0.01 OUTLIER Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 40.1 Cg_endo -68.96 59.58 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.145 1.23 . . . . 0.0 109.955 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.08 164.86 37.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 164' ' ' LEU . 8.5 m120 -54.18 -58.98 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.598 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.841 ' HA ' HG23 ' A' ' 1' ' ' HAV . 33.6 m -45.46 93.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.744 ' CD1' HG21 ' A' ' 193' ' ' THR . 1.0 OUTLIER -77.82 -66.79 0.8 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.227 -0.921 . . . . 0.0 112.57 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.783 ' HB1' ' CD ' ' A' ' 202' ' ' GLU . . . -143.2 -172.46 3.69 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.403 . . . . 0.0 111.184 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.69 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.6 p-80 179.47 167.94 1.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.246 -1.534 . . . . 0.0 110.937 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -138.02 -177.25 4.74 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.461 -0.774 . . . . 0.0 109.771 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.502 ' HB3' HG13 ' A' ' 174' ' ' ILE . 96.3 m-85 -114.31 -166.75 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.574 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -109.44 -174.51 0.3 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.492 -0.755 . . . . 0.0 109.26 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 42.5 Cg_endo -75.21 53.35 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.666 1.351 . . . . 0.0 110.725 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 175' ' ' ASN . . . -93.32 -170.76 39.52 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.7 Cg_endo -70.79 124.69 10.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.827 1.435 . . . . 0.0 109.912 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . 69.34 -59.67 0.62 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -76.05 18.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.578 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 1.2 t-20 -63.49 63.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 103.14 102.99 2.74 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.646 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -158.97 115.12 2.63 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 120.737 -1.449 . . . . 0.0 107.976 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -109.79 160.82 16.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.862 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.913 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -155.96 135.66 12.57 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.516 178.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.627 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 23.1 m-85 -93.74 131.08 39.44 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.194 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.529 ' OD2' HD13 ' A' ' 164' ' ' LEU . 43.7 p-10 -65.48 122.26 16.77 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 2.8 p30 -88.47 -9.36 52.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 1.01 ' CG ' HG21 ' A' ' 148' ' ' VAL . 6.3 m-20 -79.66 2.95 20.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.972 -1.08 . . . . 0.0 109.607 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 164' ' ' LEU . 33.0 tt0 -114.14 -129.91 0.31 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.606 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.1 mt-30 -137.22 176.29 8.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.758 -1.214 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.611 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.7 m95 -161.87 115.81 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.97 -1.081 . . . . 0.0 110.069 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.802 ' HA ' HD21 ' A' ' 108' ' ' LEU . 37.3 p -140.52 151.4 44.75 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.905 -1.122 . . . . 0.0 110.071 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.88 ' O ' HG23 ' A' ' 227' ' ' THR . 15.4 pttp -84.43 -31.72 24.48 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.2 t70 -84.51 64.12 8.25 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.982 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.1 t 3.38 60.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.129 0.966 . . . . 0.0 112.011 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.7 m -127.1 -30.19 2.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.055 -1.028 . . . . 0.0 110.028 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.794 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.58 -84.67 1.64 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.744 HG21 ' CD1' ' A' ' 164' ' ' LEU . 5.0 m -119.48 -82.0 0.64 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 0.5 OUTLIER -179.81 72.78 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.979 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.905 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 3.3 tp -34.62 -97.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.61 0.719 . . . . 0.0 110.732 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.848 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -70.53 -9.66 57.25 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.963 -1.086 . . . . 0.0 111.358 -176.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.1 tp -68.29 -58.82 3.8 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 115.923 -2.311 . . . . 0.0 106.692 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.703 HG23 ' HB3' ' A' ' 194' ' ' ASN . 1.4 t -72.49 -10.3 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.087 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.49 -61.6 1.86 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -63.08 -15.93 58.24 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.636 ' CG ' ' CE1' ' A' ' 3' ' ' MSB . 28.2 t60 -68.07 -43.69 78.02 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 117.921 -1.512 . . . . 0.0 107.835 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.783 ' CD ' ' HB1' ' A' ' 165' ' ' ALA . 31.5 mt-10 -83.47 -48.07 10.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.237 -0.915 . . . . 0.0 110.914 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.88 HG21 ' HA ' ' A' ' 121' ' ' LEU . 2.3 mt -61.06 -29.8 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.682 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.26 -31.93 45.15 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.21 -52.3 65.86 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.691 -0.887 . . . . 0.0 109.816 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.534 ' C ' HD22 ' A' ' 207' ' ' LEU . 28.6 t -79.74 -59.52 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.492 -0.755 . . . . 0.0 111.827 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.858 HD11 ' CD1' ' A' ' 92' ' ' TRP . 1.4 mm? -104.58 38.82 1.8 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.253 -0.904 . . . . 0.0 110.586 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.882 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -139.56 -73.41 0.05 OUTLIER Glycine 0 C--N 1.292 -1.913 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 210' ' ' PHE . 3.5 pp 179.33 -162.42 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.655 -1.497 . . . . 0.0 109.818 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.709 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.1 t80 -99.37 -79.97 0.48 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.104 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 4.7 m-70 -153.92 77.22 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -62.18 -172.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 108.924 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.991 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.26 77.81 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.946 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.01 13.14 8.06 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.789 -177.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER -50.27 -28.44 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 174.373 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.538 ' C ' ' HB3' ' A' ' 235' ' ' SER . 6.5 mt-10 -115.96 -39.65 3.43 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.946 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.15 164.8 8.03 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 122.451 1.12 . . . . 0.0 111.99 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.738 ' O ' ' HH1' ' A' ' 3' ' ' MSB . 0.0 OUTLIER -67.33 -15.5 63.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.339 -177.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -77.59 -9.72 59.1 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 118.976 -2.328 . . . . 0.0 112.294 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.663 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 45.7 t80 -137.42 17.27 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.293 -1.505 . . . . 0.0 113.506 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.648 ' HG3' ' HA ' ' A' ' 218' ' ' LEU . 57.5 Cg_endo -79.47 -36.35 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 N-CA-C 108.747 -1.29 . . . . 0.0 108.747 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.983 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.4 OUTLIER -16.93 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.983 ' N ' HD13 ' A' ' 222' ' ' LEU . 28.2 t80 -75.74 49.73 0.53 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.254 -0.904 . . . . 0.0 109.394 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 95.7 m-70 -160.85 -120.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.071 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.826 ' O ' HD12 ' A' ' 226' ' ' LEU . 14.7 m -173.44 110.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.727 -1.233 . . . . 0.0 109.891 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.37 65.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 109.852 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 188' ' ' LYS . 10.1 t -116.88 -7.91 11.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.591 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 1.6 t0 178.09 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.037 . . . . 0.0 110.642 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.982 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -30.32 -61.06 0.17 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.571 -0.706 . . . . 0.0 110.604 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.33 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.475 -0.765 . . . . 0.0 109.098 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.4 mtp180 -100.21 -26.97 13.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 108.925 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.689 ' HA ' HD23 ' A' ' 226' ' ' LEU . 11.6 p90 -27.77 121.42 0.11 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.349 0.595 . . . . 0.0 111.598 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.13 170.52 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.443 -0.786 . . . . 0.0 109.809 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.118 HD21 ' CH2' ' A' ' 124' ' ' TRP . 1.8 mp -81.41 162.15 23.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 110.076 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.823 ' OG ' ' HB2' ' A' ' 217' ' ' ALA . 9.0 p -103.5 -167.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.306 -1.357 . . . . 0.0 110.51 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -84.83 -14.48 47.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 111.723 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.991 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.3 m-20 -84.84 -45.2 12.54 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.2 -1.563 . . . . 0.0 107.809 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.653 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 2.6 m-20 -64.99 -41.4 95.43 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.39 -35.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.21 -47.4 73.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 244' ' ' SER . . . -57.94 -55.47 30.42 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.024 HG21 HG21 ' A' ' 127' ' ' VAL . 1.5 tp -60.14 -46.03 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.977 -1.308 . . . . 0.0 109.227 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.572 ' N ' HG23 ' A' ' 242' ' ' ILE . 34.8 tt0 -56.3 -25.23 47.86 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 0.0 OUTLIER -78.16 -21.87 49.57 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.476 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.666 ' HB2' HD12 ' A' ' 242' ' ' ILE . 9.0 mt -72.61 -66.42 0.66 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.881 ' OH ' HD21 ' A' ' 97' ' ' LEU . 71.5 m-85 -91.61 -120.66 0.07 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.145 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.57 67.79 1.52 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.466 ' C ' ' HD2' ' A' ' 250' ' ' PRO . 41.8 Cg_endo -72.58 112.36 3.45 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.006 1.529 . . . . 0.0 110.013 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.613 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 38.0 Cg_endo -72.28 -30.01 13.42 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.928 1.488 . . . . 0.0 112.314 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 249' ' ' PRO . 43.5 Cg_endo -75.34 171.65 17.85 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 N-CA-C 110.054 -0.787 . . . . 0.0 110.054 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -144.3 -67.23 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.547 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.86 113.81 8.14 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.315 -0.865 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.43 -21.55 22.61 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.878 1.462 . . . . 0.0 110.129 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -123.63 -78.14 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.515 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.841 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.547 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.738 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.1 p90 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.266 0.555 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 85' ' ' THR . 5.4 ptm180 -168.73 167.59 11.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.604 HG22 ' HB2' ' A' ' 209' ' ' LEU . 0.2 OUTLIER -51.13 -178.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.522 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.72 109.18 30.36 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.901 . . . . 0.0 109.521 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.2 Cg_endo -72.38 101.42 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.895 1.471 . . . . 0.0 110.173 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.453 ' C ' HG23 ' A' ' 89' ' ' ILE . . . 174.22 -64.28 0.11 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.453 HG23 ' C ' ' A' ' 88' ' ' GLY . 16.4 pt -154.17 151.93 25.42 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -1.155 . . . . 0.0 109.562 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.11 159.14 48.18 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.029 1.541 . . . . 0.0 110.095 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 1.034 ' CE ' ' HB1' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -76.86 -92.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.964 . . . . 0.0 109.756 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.567 ' CD1' ' HA ' ' A' ' 207' ' ' LEU . 10.0 m95 -82.86 176.8 9.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 109.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.74 -41.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.148 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.877 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.24 172.04 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.681 0.753 . . . . 0.0 110.275 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.955 ' HA ' HD13 ' A' ' 130' ' ' LEU . 42.9 p -110.3 7.46 23.07 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.572 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 51.1 m80 -144.14 96.28 2.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.866 -1.147 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.877 HD13 ' HE2' ' A' ' 94' ' ' LYS . 2.9 mm? -96.59 164.45 12.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.53 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.627 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -136.89 155.98 49.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 108.519 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 1.007 ' CE2' HD11 ' A' ' 101' ' ' ILE . 7.7 p90 -135.18 170.3 16.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 109.473 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' HD2' HG22 ' A' ' 102' ' ' VAL . 1.1 ttm180 -131.56 128.12 38.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.007 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -86.81 82.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.198 . . . . 0.0 109.725 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 13.0 t -99.09 7.53 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.288 -0.883 . . . . 0.0 109.828 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.922 ' C ' HG21 ' A' ' 113' ' ' VAL . 5.4 m120 -98.9 160.46 14.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.978 -1.076 . . . . 0.0 109.166 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.745 ' N ' HG21 ' A' ' 113' ' ' VAL . 7.5 t80 177.67 77.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 1.104 HG21 ' CD1' ' A' ' 186' ' ' TRP . 61.1 p -69.58 155.66 93.11 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 -25.39 39.73 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 123.766 1.403 . . . . 0.0 108.637 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.657 ' O ' HD23 ' A' ' 108' ' ' LEU . 2.5 m-20 -74.26 -5.93 44.95 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 195' ' ' LEU . 62.0 mt -140.16 121.21 9.34 Favored Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.454 -0.779 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.9 169.28 13.56 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 123.881 1.463 . . . . 0.0 108.716 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.483 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.62 -65.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.5 t0 -55.26 -26.93 43.03 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.716 -0.615 . . . . 0.0 111.799 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.769 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.9 -61.36 1.87 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.435 -1.415 . . . . 0.0 109.329 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.922 HG21 ' C ' ' A' ' 103' ' ' ASN . 12.8 p -53.04 -41.33 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 1.003 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -64.45 -26.93 68.66 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.901 ' OG ' HD21 ' A' ' 195' ' ' LEU . 6.0 p -62.99 -42.37 99.83 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.069 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -70.7 -33.01 70.43 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 0.0 109.638 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.952 HG13 HG13 ' A' ' 144' ' ' ILE . 47.1 t -74.57 -23.26 17.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.1 tt0 -90.04 -33.77 16.2 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.679 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.59 -37.15 28.09 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -66.46 -62.1 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.938 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.4 pp -55.47 -41.89 73.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.097 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.817 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -71.52 -33.6 69.35 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.641 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.035 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.18 -42.04 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.067 ' O ' HG23 ' A' ' 128' ' ' THR . 33.7 m95 -91.29 -22.88 20.34 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 28.3 tt0 -71.42 -27.47 63.32 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.2 pt-20 -90.46 -43.59 10.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.612 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.3 m -58.0 -25.91 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.072 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.067 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -104.95 163.49 17.06 Favored Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 117.966 -1.494 . . . . 0.0 110.492 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.641 ' O ' HD23 ' A' ' 130' ' ' LEU . 50.6 Cg_endo -87.26 29.8 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.379 2.053 . . . . 0.0 111.289 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.014 HD12 ' CD2' ' A' ' 246' ' ' TYR . 34.5 mt -121.27 -166.6 1.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.61 -1.306 . . . . 0.0 110.474 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.2 p -123.01 176.68 5.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.645 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.777 ' HZ ' HD13 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -139.25 167.98 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 109.671 -179.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.512 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -151.14 169.34 22.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 108.589 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.715 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -140.56 167.43 22.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.803 -1.186 . . . . 0.0 110.545 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.042 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -156.76 -133.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 12.7 t80 178.01 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 138' ' ' GLY . 7.5 pm0 -161.39 -171.85 3.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.02 -98.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 140' ' ' ALA . 3.1 pt-20 178.41 107.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -1.111 . . . . 0.0 110.34 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 1.042 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -60.24 -150.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 108.722 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.669 ' C ' HD12 ' A' ' 142' ' ' ILE . 72.3 m-20 -88.48 -33.88 17.65 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.861 ' N ' HD12 ' A' ' 142' ' ' ILE . 3.4 mp -126.3 79.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.542 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -67.74 101.54 1.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.853 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.952 HG13 HG13 ' A' ' 117' ' ' VAL . 5.5 mm -81.61 119.69 31.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.6 OUTLIER -138.35 158.5 44.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.347 -1.471 . . . . 0.0 112.063 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.623 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 22.2 p90 -90.67 139.77 30.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.472 -0.768 . . . . 0.0 109.625 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.119 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.1 -160.47 0.68 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 1.004 HG21 ' HB2' ' A' ' 183' ' ' ASP . 0.8 OUTLIER 179.65 -157.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.918 -1.113 . . . . 0.0 109.531 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.795 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -63.14 59.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 148' ' ' VAL . 0.4 OUTLIER -158.55 21.91 0.23 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.015 -1.053 . . . . 0.0 109.368 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 74.8 m80 -58.87 168.54 1.23 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 151' ' ' HIS . . . -43.81 -52.27 6.7 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -176.62 48.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -1.11 . . . . 0.0 109.396 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.603 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -169.91 -154.91 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.393 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.603 ' CD2' ' HB3' ' A' ' 154' ' ' PHE . 0.8 OUTLIER 1.87 69.04 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.522 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.531 ' N ' ' O ' ' A' ' 154' ' ' PHE . 44.9 Cg_endo -77.45 97.28 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.985 1.518 . . . . 0.0 109.57 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.748 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -72.88 -163.08 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.097 -1.002 . . . . 0.0 109.927 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.763 ' OD1' HG23 ' A' ' 163' ' ' VAL . 23.3 p30 179.2 54.45 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.877 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -0.16 -68.72 0.0 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 112.274 -0.33 . . . . 0.0 112.274 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.4 Cg_endo -67.55 59.52 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.21 1.11 . . . . 0.0 109.664 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -168.79 160.62 34.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.545 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 5.5 m120 -52.57 -47.72 66.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -1.199 . . . . 0.0 110.086 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.77 HG12 ' CG2' ' A' ' 1' ' ' HAV . 2.6 m -51.46 89.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 0.0 109.728 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.035 HD21 HG21 ' A' ' 193' ' ' THR . 0.3 OUTLIER -76.32 -82.53 0.07 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.869 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -137.33 -175.32 4.02 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.491 -1.38 . . . . 0.0 111.154 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.748 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.7 p-80 179.34 169.35 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 119.899 -1.751 . . . . 0.0 110.524 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.63 -172.51 3.18 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.498 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.577 ' OH ' ' CD2' ' A' ' 155' ' ' TYR . 64.1 m-85 -118.09 -167.28 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.072 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.034 ' HB1' ' CE ' ' A' ' 91' ' ' LYS . . . -162.93 -64.72 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.639 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.974 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 43.0 Cg_endo -72.87 172.36 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.792 1.417 . . . . 0.0 110.362 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.549 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 90.4 165.25 40.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.8 Cg_endo -73.99 -94.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.629 1.553 . . . . 0.0 110.54 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.2 -35.0 82.48 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 170' ' ' PRO . 9.4 tp -71.37 4.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.287 -1.125 . . . . 0.0 109.201 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 172' ' ' PRO . 1.2 p30 -66.08 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.89 . . . . 0.0 109.334 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 114.93 94.1 1.96 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -151.95 118.12 5.56 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.671 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -107.75 163.22 13.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.085 . . . . 0.0 109.201 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.119 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -159.78 134.62 7.9 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.11 178.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.671 ' H ' HD22 ' A' ' 103' ' ' ASN . 17.1 m-85 -97.09 129.88 44.44 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.115 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.556 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -63.47 124.86 22.41 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.827 -1.549 . . . . 0.0 107.171 177.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.502 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.1 OUTLIER -98.35 31.68 2.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 110.56 -178.062 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 1.004 ' HB2' HG21 ' A' ' 148' ' ' VAL . 49.2 t0 -107.9 -3.97 18.41 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.436 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.529 ' HG2' ' CA ' ' A' ' 159' ' ' GLY . 4.5 pt-20 -116.32 -111.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.028 . . . . 0.0 108.872 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 54.4 mt-30 -148.58 177.88 9.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.723 -1.236 . . . . 0.0 109.15 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 1.104 ' CD1' HG21 ' A' ' 105' ' ' THR . 88.2 m95 -161.98 126.14 3.23 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.115 -0.99 . . . . 0.0 108.998 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.879 ' HA ' HD21 ' A' ' 108' ' ' LEU . 65.7 p -147.2 153.7 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.676 -1.265 . . . . 0.0 110.723 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.882 ' HB3' HD22 ' A' ' 195' ' ' LEU . 17.4 pttt -85.09 -32.69 22.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.7 t70 -86.09 64.03 8.35 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.998 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.5 t 3.19 60.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.185 0.993 . . . . 0.0 111.94 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.2 m -125.44 -30.87 3.07 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.055 -1.028 . . . . 0.0 109.787 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.631 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -95.31 -80.0 1.49 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.035 HG21 HD21 ' A' ' 164' ' ' LEU . 47.1 m -127.84 -95.89 0.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.926 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -160.5 72.79 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 108.971 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 108' ' ' LEU . 2.2 tp -37.07 -96.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.671 0.748 . . . . 0.0 110.448 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.887 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -68.61 -5.15 18.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.132 -0.98 . . . . 0.0 110.848 -177.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.918 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.1 tp -69.0 -67.7 0.45 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 116.836 -1.946 . . . . 0.0 106.479 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.926 HG23 ' HB2' ' A' ' 194' ' ' ASN . 2.4 t -68.03 -9.77 11.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.069 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.0 -59.04 2.89 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.808 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -65.15 -15.22 62.18 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.59 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 10.9 t60 -69.27 -42.96 74.85 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 117.76 -1.576 . . . . 0.0 107.95 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.796 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 1.3 mt-10 -83.97 -47.37 11.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.865 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.938 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.0 mt -63.11 -29.51 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.699 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -77.31 -31.55 51.21 Favored Glycine 0 C--N 1.295 -1.737 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -64.26 -44.22 92.41 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 121.812 -0.817 . . . . 0.0 111.212 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.541 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 49.7 m -86.97 -53.12 5.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 112.61 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 208' ' ' GLY . 2.2 pp -104.36 -2.61 25.24 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.861 -1.149 . . . . 0.0 111.388 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.991 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -96.92 -84.58 1.74 Allowed Glycine 0 C--N 1.291 -1.966 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.866 HD11 ' OD1' ' A' ' 238' ' ' ASP . 1.8 pp -165.35 -159.33 0.42 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.037 -1.272 . . . . 0.0 109.658 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.591 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -96.56 -84.94 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.529 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.8 m-70 -153.18 104.57 2.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.067 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.607 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -92.1 -167.33 1.74 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.213 -0.929 . . . . 0.0 109.56 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.697 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.17 81.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.989 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.4 6.62 22.53 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.761 -177.01 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 214' ' ' ASN . 7.8 p -50.82 -27.44 7.32 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.506 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.2 mt-10 -117.29 -36.05 3.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.989 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.95 179.17 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.162 0.982 . . . . 0.0 111.699 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.918 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.4 tp -96.05 -10.16 29.14 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.393 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.578 ' HE3' ' CZ2' ' A' ' 124' ' ' TRP . 9.1 mmt -74.26 -16.73 60.94 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.726 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.5 OUTLIER -143.5 23.6 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 C-N-CA 117.621 -1.631 . . . . 0.0 113.422 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.678 ' HG3' ' HA ' ' A' ' 218' ' ' LEU . 55.6 Cg_endo -75.39 -31.47 5.7 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 N-CA-C 106.795 -2.04 . . . . 0.0 106.795 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 223' ' ' TYR . 1.9 tm? -8.06 -65.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.326 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.878 ' N ' HD13 ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.76 59.59 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.8 OUTLIER -175.57 -144.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.375 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.926 ' HB3' HG21 ' A' ' 190' ' ' THR . 44.5 m -146.41 112.81 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.048 -1.033 . . . . 0.0 109.956 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.61 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.431 -0.793 . . . . 0.0 109.26 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.544 HG21 ' O ' ' A' ' 187' ' ' THR . 9.1 t -108.26 -9.09 15.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.296 -0.877 . . . . 0.0 109.591 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.603 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 177.59 -20.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 110.854 179.275 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.998 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.22 -61.1 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.446 -0.783 . . . . 0.0 110.651 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.35 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.587 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.603 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 51.7 p90 -31.58 120.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.488 0.661 . . . . 0.0 111.028 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.563 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.12 168.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.056 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.5 mp -82.82 168.49 17.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.83 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 6.5 t -98.47 -171.13 2.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.737 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.576 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -83.08 -19.24 37.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.563 -0.71 . . . . 0.0 109.449 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.697 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 5.2 m-20 -82.76 -42.24 18.22 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.866 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.3 m-20 -66.62 -41.03 89.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 117.411 -1.715 . . . . 0.0 106.879 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -56.75 -35.12 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -67.11 -45.01 78.48 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' A' ' 85' ' ' THR . . . -62.03 -58.91 10.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.012 HG21 HG21 ' A' ' 127' ' ' VAL . 1.9 tp -62.76 -50.41 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.987 -1.302 . . . . 0.0 110.116 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.581 ' N ' HG23 ' A' ' 242' ' ' ILE . 15.1 tt0 -53.37 -26.12 18.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.2 t -90.4 -10.67 43.02 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -79.84 -52.79 7.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 1.014 ' CD2' HD12 ' A' ' 130' ' ' LEU . 5.2 m-30 -82.05 -108.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.95 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.48 ' C ' ' HD2' ' A' ' 249' ' ' PRO . . . 56.98 101.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.617 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 38.6 Cg_endo -72.74 -29.79 12.34 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.009 1.531 . . . . 0.0 112.55 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 43.4 Cg_endo -74.28 111.83 3.4 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 122.581 0.78 . . . . 0.0 110.228 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 42.2 Cg_endo -73.48 -90.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.084 1.571 . . . . 0.0 110.106 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -104.78 -56.0 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.07 116.58 12.82 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.61 -33.78 8.01 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.906 1.477 . . . . 0.0 110.125 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.26 169.24 17.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.55 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.626 HG23 ' OXT' ' A' ' 255' ' ' THR . 4.6 t . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.77 ' CG2' HG12 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.545 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.712 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.214 0.531 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 85' ' ' THR . 27.1 ptt180 -119.15 -156.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -43.7 155.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 109.569 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.648 ' CE1' HD11 ' A' ' 89' ' ' ILE . 1.2 m-85 -63.73 152.64 85.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.546 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.69 -13.12 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.063 1.56 . . . . 0.0 110.222 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.458 ' O ' ' HD3' ' A' ' 90' ' ' PRO . . . 177.6 -62.26 0.09 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.648 HD11 ' CE1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -41.28 100.86 0.23 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.404 -1.056 . . . . 0.0 109.98 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 88' ' ' GLY . 44.4 Cg_endo -76.41 145.11 26.48 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.022 1.538 . . . . 0.0 110.161 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HE2' ' HB2' ' A' ' 169' ' ' ALA . 1.6 tttt -57.18 -82.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.914 ' CD1' HD12 ' A' ' 207' ' ' LEU . 2.8 m95 -74.53 -165.98 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -167.19 -33.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.8 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -50.54 -172.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.385 -0.822 . . . . 0.0 110.619 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.763 ' CA ' HD21 ' A' ' 130' ' ' LEU . 1.2 p -117.35 -4.79 11.32 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.618 -0.676 . . . . 0.0 109.242 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 131' ' ' THR . 21.7 m-70 -144.22 95.24 2.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.667 HD11 ' CD1' ' A' ' 92' ' ' TRP . 19.4 mt -86.56 -175.44 5.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.68 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -158.63 156.72 30.54 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.326 -0.859 . . . . 0.0 108.714 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.903 ' CE1' HD22 ' A' ' 121' ' ' LEU . 13.4 p90 -134.62 164.83 26.63 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.535 -1.353 . . . . 0.0 110.151 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.734 ' HG3' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -131.38 128.38 39.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.75 HG13 HG11 ' A' ' 117' ' ' VAL . 1.5 mp -86.14 81.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.378 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.585 ' N ' ' O ' ' A' ' 144' ' ' ILE . 16.1 t -96.22 13.77 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.909 ' C ' HG21 ' A' ' 113' ' ' VAL . 7.8 m120 -107.86 156.12 19.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.81 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.7 OUTLIER 178.97 42.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.64 -0.662 . . . . 0.0 109.914 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.563 HG22 ' OD1' ' A' ' 182' ' ' ASP . 13.8 p -43.74 155.84 0.31 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 108.911 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.91 -21.7 43.44 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.762 1.401 . . . . 0.0 108.94 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -69.97 -8.0 45.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.024 HD13 HD12 ' A' ' 195' ' ' LEU . 84.8 mt -144.83 120.66 6.01 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.534 -0.729 . . . . 0.0 109.756 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.74 172.09 8.74 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.748 1.394 . . . . 0.0 108.981 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.55 -65.29 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.801 0.81 . . . . 0.0 110.384 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -55.98 -30.81 62.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.64 . . . . 0.0 112.15 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.871 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.45 -59.84 2.53 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.439 -1.413 . . . . 0.0 109.793 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.909 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.8 p -55.13 -39.13 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -66.9 -27.11 67.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.868 ' OG ' HD21 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -67.6 -41.0 84.74 Favored 'General case' 0 C--O 1.202 -1.43 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.336 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.068 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -72.6 -32.77 66.22 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 120.912 -1.117 . . . . 0.0 109.806 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.032 HG22 HG21 ' A' ' 144' ' ' ILE . 88.7 t -75.96 -23.65 16.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -90.69 -33.26 15.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.747 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.2 OUTLIER -81.47 -37.45 27.94 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.979 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -68.3 -61.92 1.63 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.903 HD22 ' CE1' ' A' ' 99' ' ' TYR . 1.4 pp -54.71 -41.8 70.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.065 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.816 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.15 -33.23 63.45 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.265 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.998 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.22 -40.14 63.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.088 ' CH2' HD21 ' A' ' 234' ' ' LEU . 44.5 m95 -91.35 -23.22 20.16 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.486 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.533 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 79.9 tt0 -71.9 -28.25 63.37 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.757 -1.214 . . . . 0.0 108.279 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.4 pt-20 -89.92 -43.53 10.52 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.798 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.998 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.2 m -60.44 -24.26 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.511 -1.276 . . . . 0.0 109.172 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.084 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.6 OUTLIER -100.54 155.79 35.96 Favored Pre-proline 0 N--CA 1.5 2.065 0 C-N-CA 117.943 -1.503 . . . . 0.0 111.008 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.507 ' HG2' ' O ' ' A' ' 247' ' ' GLY . 54.3 Cg_endo -84.74 27.62 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 110.46 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.763 HD21 ' CA ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -117.84 -175.39 2.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.704 -1.247 . . . . 0.0 110.66 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.57 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -109.64 169.85 8.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.436 -0.79 . . . . 0.0 110.09 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.607 ' CE1' ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -149.05 162.14 40.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 110.082 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.57 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -140.2 -168.22 2.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.639 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -158.84 157.22 31.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 0.0 110.391 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.734 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -159.89 -165.21 1.45 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.406 -0.809 . . . . 0.0 109.307 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 15.8 t80 -153.33 19.78 0.56 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.385 -0.822 . . . . 0.0 108.914 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -141.4 -172.32 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -0.791 . . . . 0.0 109.341 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.18 -98.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER 178.45 117.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 110.509 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.68 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -75.67 -148.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 108.899 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.637 ' OD2' HG22 ' A' ' 98' ' ' THR . 59.8 m-20 -100.32 -25.03 14.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.804 HG21 HG23 ' A' ' 203' ' ' ILE . 2.9 mt -124.35 76.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 1.7 ttt -64.33 93.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 1.032 HG21 HG22 ' A' ' 117' ' ' VAL . 9.1 mm -80.04 106.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.577 ' CB ' ' HB ' ' A' ' 102' ' ' VAL . 0.3 OUTLIER -131.76 162.56 30.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.24 -1.538 . . . . 0.0 112.342 -178.305 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.493 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 46.9 p90 -82.55 134.38 35.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.442 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.132 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -152.08 162.11 41.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.037 . . . . 0.0 110.418 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.797 HG21 ' CG ' ' A' ' 183' ' ' ASP . 1.8 p -167.04 -163.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.718 ' H ' HG22 ' A' ' 148' ' ' VAL . 5.3 mtm-85 -38.41 -43.87 0.87 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.39 58.21 0.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.308 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -85.8 -90.14 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.562 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 153' ' ' ASP . . . 129.56 38.27 0.34 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.644 ' CB ' ' CZ ' ' A' ' 155' ' ' TYR . 7.7 t0 -179.99 -142.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -1.227 . . . . 0.0 109.799 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.546 ' CE1' ' OH ' ' A' ' 168' ' ' TYR . 43.8 p90 -95.66 18.71 12.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.08 -1.012 . . . . 0.0 110.063 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.685 ' CD1' ' CD2' ' A' ' 151' ' ' HIS . 0.1 OUTLIER -119.61 50.31 1.51 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.331 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 39.2 Cg_endo -68.48 128.27 16.96 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.03 1.542 . . . . 0.0 109.377 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.686 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -112.94 -170.41 1.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 110.978 -178.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.507 ' HA ' ' HG2' ' A' ' 149' ' ' ARG . 17.4 p30 -176.18 63.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.898 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.587 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -12.38 -61.35 0.01 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 37.0 Cg_endo -63.56 66.11 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.551 1.29 . . . . 0.0 109.651 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 177.87 143.88 5.24 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.541 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 30.4 m-80 -37.79 -44.6 0.75 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.634 -0.921 . . . . 0.0 110.221 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.731 ' HA ' HG23 ' A' ' 1' ' ' HAV . 17.8 t -42.4 95.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 109.33 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.9 HD12 HD11 ' A' ' 222' ' ' LEU . 1.9 mt -90.17 -38.89 13.18 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 113.133 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.613 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . 179.43 -171.12 0.14 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.799 -1.813 . . . . 0.0 111.449 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.686 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.2 p-80 179.15 -170.28 0.12 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.376 -1.453 . . . . 0.0 111.33 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -153.45 179.2 9.01 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.437 -0.789 . . . . 0.0 110.235 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.59 ' O ' ' CB ' ' A' ' 206' ' ' SER . 11.0 m-85 -127.6 162.41 26.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.894 -1.129 . . . . 0.0 111.149 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.977 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -144.49 -67.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.977 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 40.7 Cg_endo -70.75 94.89 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.489 1.257 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 159.09 145.14 4.16 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -71.57 145.86 48.06 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.511 1.474 . . . . 0.0 110.083 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 67.81 -64.05 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.3 OUTLIER -74.24 5.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.414 -1.051 . . . . 0.0 108.896 178.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 171' ' ' GLY . 0.5 OUTLIER -63.9 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 115.05 89.1 1.6 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.696 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -155.64 118.96 4.36 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.641 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -108.76 128.57 54.99 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.186 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.132 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -113.59 132.46 55.73 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.894 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.683 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 16.0 m-85 -93.37 125.0 37.74 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.198 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.657 ' OD1' HG23 ' A' ' 148' ' ' VAL . 22.6 t0 -50.1 135.05 21.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.667 -1.271 . . . . 0.0 108.262 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.563 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.1 OUTLIER -106.22 24.27 12.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 110.232 -178.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.797 ' CG ' HG21 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -129.13 24.37 5.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 159' ' ' GLY . 2.3 mt-10 -129.03 -90.26 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.138 -0.976 . . . . 0.0 109.408 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.628 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 1.7 mt-30 179.89 170.22 1.16 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.683 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.0 m95 -158.63 124.16 4.4 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.022 -1.049 . . . . 0.0 109.795 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.856 ' HA ' HD21 ' A' ' 108' ' ' LEU . 67.9 p -148.32 149.78 32.45 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.925 -1.109 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.814 ' HB3' HD22 ' A' ' 195' ' ' LEU . 8.5 pttt -84.14 -32.46 24.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.7 t70 -83.49 61.73 6.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.982 ' OG1' HD21 ' A' ' 229' ' ' LEU . 15.7 m 3.08 64.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.71 0.767 . . . . 0.0 111.384 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 189' ' ' ASP . 41.9 m -130.74 -31.64 1.74 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.762 -0.587 . . . . 0.0 109.635 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.45 -77.89 1.39 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.659 HG21 ' CD2' ' A' ' 164' ' ' LEU . 13.4 m -128.35 -81.61 0.58 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.481 -1.011 . . . . 0.0 108.774 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.979 ' HB3' HG23 ' A' ' 198' ' ' VAL . 1.9 m-20 -177.47 67.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.586 -0.845 . . . . 0.0 108.991 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.061 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -32.4 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.58 0.705 . . . . 0.0 110.537 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.899 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -71.78 -8.74 56.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.839 -1.163 . . . . 0.0 110.929 -178.059 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.673 HD11 ' CG ' ' A' ' 221' ' ' PRO . 14.8 tp -70.76 -56.29 6.71 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 116.262 -2.175 . . . . 0.0 107.207 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.012 HG12 ' OE2' ' A' ' 202' ' ' GLU . 9.1 t -77.87 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.068 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.26 -58.8 3.06 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.53 -19.71 65.85 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.6 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 4.7 t60 -66.17 -41.81 89.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 116.873 -1.931 . . . . 0.0 107.882 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 1.012 ' OE2' HG12 ' A' ' 198' ' ' VAL . 8.3 mt-10 -84.1 -49.1 9.2 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.145 -0.972 . . . . 0.0 110.792 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.979 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -57.85 -31.74 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.735 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -80.6 -35.3 26.02 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -57.95 -47.71 82.11 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.423 -1.045 . . . . 0.0 110.519 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.662 ' C ' HD13 ' A' ' 207' ' ' LEU . 1.4 p -86.08 -58.46 2.63 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 111.906 -177.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.914 HD12 ' CD1' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -104.43 33.97 3.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.81 -1.181 . . . . 0.0 110.114 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 1.078 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -132.06 -77.21 0.13 Allowed Glycine 0 C--N 1.29 -1.973 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.85 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -165.69 -160.72 0.47 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.999 -1.295 . . . . 0.0 109.62 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.792 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.7 t80 -101.7 -71.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 20.7 m80 -163.78 100.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.865 . . . . 0.0 108.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.7 OUTLIER -90.27 -175.93 4.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.882 . . . . 0.0 109.249 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.916 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -63.86 78.33 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.972 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.26 9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.56 -177.209 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -50.64 -27.78 7.58 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.517 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.0 OUTLIER -114.51 -37.58 4.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.521 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.972 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.33 -171.28 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.334 1.064 . . . . 0.0 112.418 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.703 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -89.95 -16.54 29.7 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.735 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.547 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.5 -9.57 58.98 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.476 -2.015 . . . . 0.0 112.436 -177.36 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.674 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 4.7 t80 -136.49 16.58 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.229 -1.545 . . . . 0.0 113.404 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.883 ' CB ' HD11 ' A' ' 226' ' ' LEU . 56.2 Cg_endo -78.81 -40.07 0.33 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 108.711 -1.304 . . . . 0.0 108.711 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.9 HD11 HD12 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -7.83 -77.07 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.257 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.41 ' N ' HD23 ' A' ' 222' ' ' LEU . 1.7 t80 -67.99 59.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.244 -0.91 . . . . 0.0 108.955 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.5 t-80 -163.61 -124.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.339 -0.851 . . . . 0.0 108.974 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.514 ' HA ' HG21 ' A' ' 190' ' ' THR . 62.5 m -168.78 104.44 0.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.697 -1.252 . . . . 0.0 110.342 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.883 HD11 ' CB ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER 178.92 48.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 188' ' ' LYS . 9.2 t -98.69 -15.71 19.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.064 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.586 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 178.09 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.429 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.982 HD21 ' OG1' ' A' ' 190' ' ' THR . 0.3 OUTLIER -32.95 -56.95 0.38 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.13 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -86.22 -16.63 37.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.6 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 25.4 p90 -32.34 111.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.719 0.771 . . . . 0.0 110.933 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.569 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.6 ttt180 179.22 149.73 0.28 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.088 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -73.03 167.22 21.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.99 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 28.8 t -99.56 -170.6 1.92 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.969 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.526 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.02 -13.35 50.82 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.011 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.916 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 3.1 m-20 -84.85 -46.75 11.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.657 -1.277 . . . . 0.0 107.783 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.85 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -65.12 -39.3 92.89 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 117.226 -1.79 . . . . 0.0 106.549 177.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.596 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.66 -35.45 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.98 -50.36 62.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.14 60.75 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.078 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.7 tp -66.37 -49.18 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.837 -1.39 . . . . 0.0 110.132 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.572 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.9 tt0 -54.03 -25.05 19.33 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.7 p -92.73 -9.87 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -77.86 -51.25 10.76 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.548 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 5.4 m-30 -81.75 -108.2 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.83 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 129' ' ' PRO . . . 154.08 143.44 3.68 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.953 -1.594 . . . . 0.0 110.238 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 39.2 Cg_endo -72.65 -29.52 12.89 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.72 1.614 . . . . 0.0 112.651 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 41.2 Cg_endo -73.12 128.37 12.95 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 N-CA-C 110.014 -0.802 . . . . 0.0 110.014 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.99 -91.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.54 1.493 . . . . 0.0 110.405 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 251' ' ' ASP . 0.6 OUTLIER -128.13 -44.85 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.886 -179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.13 69.46 1.82 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.819 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 251' ' ' ASP . 42.6 Cg_endo -72.73 -12.37 26.52 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.927 1.488 . . . . 0.0 109.909 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' A' ' 255' ' ' THR . 3.7 pm0 -98.98 -171.38 2.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.582 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 254' ' ' GLU . 98.9 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.566 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.731 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.541 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.817 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.9 p90 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.321 0.581 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' CB ' ' CZ ' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -165.1 -147.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.433 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.496 ' N ' ' HG3' ' A' ' 84' ' ' ARG . 0.1 OUTLIER -43.77 -91.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 109.491 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.487 ' H ' HG23 ' A' ' 85' ' ' THR . 12.5 m-85 -116.42 125.05 28.81 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.611 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.79 85.01 1.19 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.978 1.515 . . . . 0.0 110.105 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.45 -103.56 0.57 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.564 HG23 ' HD2' ' A' ' 90' ' ' PRO . 94.7 mt -91.41 138.99 25.2 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.278 -1.13 . . . . 0.0 109.546 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.564 ' HD2' HG23 ' A' ' 89' ' ' ILE . 42.0 Cg_endo -72.81 156.14 53.13 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.053 1.554 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.611 ' HG3' ' CD1' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -43.35 -87.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.959 . . . . 0.0 109.487 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.611 ' CD1' ' HG3' ' A' ' 91' ' ' LYS . 89.9 m95 -105.02 149.56 25.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.883 -1.136 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.21 -33.29 5.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.734 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' CE ' HD13 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -44.75 175.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.438 -0.789 . . . . 0.0 110.345 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.791 ' HB ' HD12 ' A' ' 130' ' ' LEU . 7.1 p -109.11 5.05 23.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.47 -0.768 . . . . 0.0 109.78 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.563 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 47.9 m80 -146.88 94.44 2.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.831 -1.168 . . . . 0.0 110.538 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.811 ' N ' HD22 ' A' ' 97' ' ' LEU . 1.9 mm? -93.6 -176.54 4.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -0.794 . . . . 0.0 108.872 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 142' ' ' ILE . 1.1 t -146.82 154.28 41.16 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.97 -1.081 . . . . 0.0 109.084 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 1.037 ' CZ ' HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -133.79 166.53 22.43 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.712 -1.242 . . . . 0.0 109.914 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.856 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.39 133.14 46.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.037 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 2.4 mp -96.55 80.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 109.777 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.856 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 59.4 t -97.94 7.38 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.85 ' C ' HG21 ' A' ' 113' ' ' VAL . 35.2 m-80 -92.95 158.13 15.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.697 -1.252 . . . . 0.0 109.647 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.83 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.8 t80 178.16 82.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.532 -0.73 . . . . 0.0 109.555 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.811 HG21 ' CD1' ' A' ' 186' ' ' TRP . 1.3 p -75.98 159.27 81.08 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.12 -21.48 42.47 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.82 1.432 . . . . 0.0 108.779 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -78.1 -0.77 29.44 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.956 HD13 ' CD1' ' A' ' 195' ' ' LEU . 96.7 mt -150.63 120.64 3.73 Favored Pre-proline 0 N--CA 1.485 1.292 0 O-C-N 121.421 -0.799 . . . . 0.0 109.88 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.13 175.7 5.42 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.801 1.422 . . . . 0.0 109.334 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.22 -65.83 0.34 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.875 0.845 . . . . 0.0 110.341 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.65 -30.76 63.69 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.88 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.61 -60.68 2.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.25 -1.531 . . . . 0.0 109.54 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.945 ' O ' HG23 ' A' ' 117' ' ' VAL . 7.2 p -53.17 -41.2 41.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.572 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -62.22 -28.1 69.45 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.907 ' OG ' HD21 ' A' ' 195' ' ' LEU . 7.7 p -64.02 -42.87 96.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.092 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -71.11 -33.77 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 113' ' ' VAL . 1.5 t -75.55 -23.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -88.36 -34.94 17.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 3.5 tppt? -80.6 -36.39 32.84 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.44 -62.46 1.51 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.986 HD22 ' CG ' ' A' ' 99' ' ' TYR . 13.5 tp -52.47 -46.32 66.47 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.058 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -69.17 -33.82 73.99 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.33 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.949 HG13 HD22 ' A' ' 234' ' ' LEU . 0.9 OUTLIER -57.34 -36.69 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.102 ' CH2' HD21 ' A' ' 234' ' ' LEU . 55.4 m95 -91.68 -24.13 19.59 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.874 -1.131 . . . . 0.0 110.495 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.578 ' HG3' ' CD2' ' A' ' 132' ' ' PHE . 14.8 tt0 -71.81 -28.88 63.89 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.851 -1.155 . . . . 0.0 108.315 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.0 pt-20 -91.37 -42.93 10.06 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 242' ' ' ILE . 21.7 m -61.83 -23.34 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.206 -1.398 . . . . 0.0 109.802 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.047 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -104.29 161.73 22.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 117.14 -1.824 . . . . 0.0 110.298 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.864 ' C ' HD22 ' A' ' 130' ' ' LEU . 50.0 Cg_endo -80.72 13.12 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.609 1.847 . . . . 0.0 110.655 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.866 HD23 ' HB3' ' A' ' 246' ' ' TYR . 3.3 mm? -116.4 -176.94 3.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.953 -1.092 . . . . 0.0 110.093 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.509 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.4 p -124.72 170.42 11.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.66 ' CD2' HD11 ' A' ' 121' ' ' LEU . 21.6 m-85 -131.78 179.55 6.0 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.84 0.829 . . . . 0.0 110.023 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 98' ' ' THR . 17.5 m -142.44 -166.36 2.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 160.57 18.37 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.906 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.677 HD22 ' OE2' ' A' ' 137' ' ' GLU . 0.3 OUTLIER -159.63 -128.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 135' ' ' LEU . 0.1 OUTLIER 177.15 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.465 -1.397 . . . . 0.0 109.732 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.677 ' OE2' HD22 ' A' ' 135' ' ' LEU . 7.5 pm0 -151.47 -177.65 6.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 109.917 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.76 -97.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.99 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -1.105 . . . . 0.0 110.003 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.662 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -58.9 -155.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 108.959 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' THR . 76.7 m-20 -83.52 -26.07 30.48 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.01 HD11 HD22 ' A' ' 207' ' ' LEU . 2.1 mp -130.17 77.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.412 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.6 ttt -62.01 93.2 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 109.26 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.825 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.3 mm -82.12 109.06 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.495 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -134.29 153.54 51.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.492 -1.38 . . . . 0.0 111.652 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 20.0 p90 -86.98 139.58 30.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.179 -0.95 . . . . 0.0 109.406 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -168.54 -158.23 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 110.556 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.898 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.4 p -173.22 -158.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.706 ' N ' HG13 ' A' ' 148' ' ' VAL . 10.8 ptt180 -66.84 60.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 148' ' ' VAL . 1.4 tt0 -168.62 44.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.275 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.599 ' CD2' ' HB2' ' A' ' 155' ' ' TYR . 14.5 m80 -74.27 -61.53 1.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.416 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.415 ' O ' ' CG ' ' A' ' 153' ' ' ASP . . . 127.84 33.92 0.58 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' GLY . 10.7 m-20 -167.48 -90.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -1.16 . . . . 0.0 109.56 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -145.43 28.65 1.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.499 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.599 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 0.9 OUTLIER -120.71 46.76 1.03 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.692 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 40.3 Cg_endo -70.05 99.12 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.93 1.489 . . . . 0.0 109.564 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.679 ' CD2' ' CE1' ' A' ' 166' ' ' HIS . 0.9 OUTLIER -71.22 -131.88 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.375 -0.828 . . . . 0.0 109.875 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.663 ' HB3' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -148.69 -36.03 0.19 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.42 -1.425 . . . . 0.0 110.194 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.594 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 69.01 -110.01 3.18 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 34.8 Cg_endo -59.97 76.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.063 1.033 . . . . 0.0 110.268 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -166.24 -160.78 13.98 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' VAL . 6.0 m120 -90.58 -48.91 6.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.259 -1.142 . . . . 0.0 110.477 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 158' ' ' ASP . 27.7 m -41.02 127.25 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.842 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.603 HD13 ' CG2' ' A' ' 193' ' ' THR . 13.6 mt -96.62 -40.01 9.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.321 -0.862 . . . . 0.0 112.717 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -178.49 -167.08 0.12 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 119.79 -1.819 . . . . 0.0 111.223 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 1.1 p-80 178.95 -174.03 0.18 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.208 -1.558 . . . . 0.0 111.358 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.636 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -149.63 -175.15 4.9 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.453 -0.78 . . . . 0.0 109.787 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.629 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -122.25 -162.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.838 -1.164 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.936 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -172.43 -60.2 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.466 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.936 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.4 Cg_endo -75.33 -178.69 4.42 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.858 1.451 . . . . 0.0 110.217 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 67.96 140.67 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -70.4 152.19 65.87 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.964 1.507 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . 67.83 -65.33 0.32 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.629 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -67.62 -3.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.482 -1.01 . . . . 0.0 109.143 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.547 ' ND2' ' CZ2' ' A' ' 92' ' ' TRP . 5.3 p-10 -65.29 65.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.754 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 126.33 82.64 0.45 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 1.7 m-20 -152.22 123.83 7.85 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.918 -1.343 . . . . 0.0 107.735 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -111.74 156.18 22.34 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.643 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -151.29 132.65 14.6 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.735 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.693 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 19.9 m-30 -87.69 126.8 35.18 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.898 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.898 ' OD1' HG23 ' A' ' 148' ' ' VAL . 34.2 t0 -68.67 134.38 49.79 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.449 -0.782 . . . . 0.0 109.295 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 183' ' ' ASP . 18.9 p-10 -61.45 -14.07 25.63 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.4 p30 3.96 -93.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.531 ' OE2' ' HB2' ' A' ' 183' ' ' ASP . 10.2 mp0 -127.26 -63.02 1.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.974 -1.079 . . . . 0.0 110.681 -177.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.539 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 28.4 mt-30 -158.58 176.7 12.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.873 -1.142 . . . . 0.0 110.393 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.811 ' CD1' HG21 ' A' ' 105' ' ' THR . 43.2 m95 -148.85 128.67 13.36 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.684 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.1 p -145.77 150.84 36.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.37 -1.456 . . . . 0.0 111.34 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.941 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -83.76 -34.08 24.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 38.4 t0 -85.53 62.06 7.24 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' THR . . . . . 1.001 ' HB ' HD21 ' A' ' 229' ' ' LEU . 6.1 t 3.73 60.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 122.002 0.906 . . . . 0.0 111.829 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 46.9 m -124.79 -31.31 3.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.419 -0.801 . . . . 0.0 109.57 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.611 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -95.53 -70.52 1.07 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.76 HG22 ' OD1' ' A' ' 194' ' ' ASN . 23.4 m -140.07 -95.92 0.16 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.831 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -158.85 70.33 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 108.87 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.001 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 1.7 tp -34.51 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.54 0.686 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.884 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -67.23 -6.95 20.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 110.845 -177.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.82 ' HA ' HD11 ' A' ' 218' ' ' LEU . 8.6 tp -68.11 -65.82 0.65 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 116.912 -1.915 . . . . 0.0 106.801 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.831 HG23 ' HB2' ' A' ' 194' ' ' ASN . 5.4 t -69.14 -11.41 14.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.092 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -72.23 -57.53 4.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.768 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -68.01 -15.66 63.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.59 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 4.2 t60 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.229 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.666 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 1.9 mm-40 -85.64 -45.23 11.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.938 -1.101 . . . . 0.0 110.616 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.1 mt -61.32 -31.67 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.753 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.85 -34.42 30.88 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -56.81 -47.11 81.01 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.508 -0.995 . . . . 0.0 109.946 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.564 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 6.1 p -83.97 -57.77 3.06 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.735 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 1.01 HD22 HD11 ' A' ' 142' ' ' ILE . 7.8 mp -103.75 37.31 2.07 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.246 -0.909 . . . . 0.0 110.503 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.962 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -139.31 -78.47 0.06 OUTLIER Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.81 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.901 HD21 ' CG ' ' A' ' 238' ' ' ASP . 4.5 pp -173.18 -159.37 0.11 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.716 -1.461 . . . . 0.0 110.367 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.875 ' N ' HD12 ' A' ' 209' ' ' LEU . 54.4 t80 -100.0 -91.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.664 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.593 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 3.2 m-70 -148.57 106.71 3.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 109.473 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.588 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -95.93 -172.53 2.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 109.214 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.419 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -60.41 85.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.931 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.68 10.13 19.17 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.247 -177.056 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 214' ' ' ASN . 28.9 p -50.88 -27.55 7.7 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.497 ' C ' ' HB2' ' A' ' 235' ' ' SER . 15.4 mt-10 -118.41 -35.13 3.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.802 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.1 -159.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.179 0.99 . . . . 0.0 112.575 -177.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.82 HD11 ' HA ' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -112.62 -1.72 14.76 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.111 -177.537 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.593 ' HG2' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -91.76 -9.71 42.65 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 119.997 -1.689 . . . . 0.0 110.637 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.774 ' HB2' HD21 ' A' ' 214' ' ' ASN . 3.2 t80 -137.11 14.31 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.79 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.921 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 1.036 ' HB3' HD11 ' A' ' 226' ' ' LEU . 55.5 Cg_endo -74.2 -39.89 1.45 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 N-CA-C 108.883 -1.237 . . . . 0.0 108.883 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.629 HD23 ' CD2' ' A' ' 3' ' ' MSB . 2.9 tp -7.24 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.499 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 14.5 m-85 -67.57 59.86 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -163.25 -146.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.545 ' C ' HD23 ' A' ' 226' ' ' LEU . 65.5 m -144.65 101.05 3.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.975 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 1.036 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.44 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 109.074 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.573 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 9.3 t -92.06 -15.65 27.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.347 -0.845 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.676 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER 178.42 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.94 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 1.001 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.87 -98.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.453 -0.78 . . . . 0.0 111.242 -179.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.0 -13.87 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.78 -1.2 . . . . 0.0 109.77 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.573 ' O ' ' C ' ' A' ' 232' ' ' PHE . 2.4 mtp180 -106.2 -42.83 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 108.806 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 25.8 p90 0.36 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.244 0.545 . . . . 0.0 112.139 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 234' ' ' LEU . 0.0 OUTLIER 178.27 175.28 0.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.102 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.1 mp -85.66 163.53 18.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.569 -0.707 . . . . 0.0 110.98 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.904 ' O ' HD12 ' A' ' 239' ' ' ILE . 5.3 t -98.34 178.74 4.95 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.392 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.536 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.4 OUTLIER -71.04 -24.37 62.33 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.475 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.588 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.3 m-20 -83.46 -42.2 17.2 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.575 -1.328 . . . . 0.0 108.94 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.901 ' CG ' HD21 ' A' ' 209' ' ' LEU . 5.8 t0 -70.76 -40.26 72.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.821 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.904 HD12 ' O ' ' A' ' 235' ' ' SER . 7.2 mt -54.82 -40.65 53.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.508 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 25.6 t-20 -60.21 -45.42 93.26 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.851 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.62 -54.57 35.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.047 HG13 HG22 ' A' ' 128' ' ' THR . 0.8 OUTLIER -65.2 -47.95 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.725 -1.456 . . . . 0.0 110.621 -178.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 240' ' ' ASN . 15.9 pt20 -54.05 -25.09 19.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 t -88.18 -14.9 37.44 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.753 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -76.06 -56.29 4.79 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.866 ' HB3' HD23 ' A' ' 130' ' ' LEU . 49.6 m-85 -91.91 -72.77 0.57 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.291 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.532 ' CA ' ' CG ' ' A' ' 129' ' ' PRO . . . -36.84 141.88 0.21 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.526 ' CB ' ' HB2' ' A' ' 252' ' ' SER . 42.2 Cg_endo -72.04 130.86 17.2 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.047 1.551 . . . . 0.0 110.393 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.61 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 39.0 Cg_endo -73.24 -29.52 11.42 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 124.047 1.551 . . . . 0.0 112.586 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 249' ' ' PRO . 43.0 Cg_endo -73.5 -94.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.944 0 O-C-N 122.477 0.725 . . . . 0.0 110.413 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 252' ' ' SER . 22.1 t70 -158.02 18.08 0.24 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.074 . . . . 0.0 110.15 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.526 ' HB2' ' CB ' ' A' ' 248' ' ' PRO . 0.3 OUTLIER -43.56 125.31 3.82 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.912 . . . . 0.0 109.421 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 255' ' ' THR . 42.1 Cg_endo -72.36 -9.43 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.88 1.463 . . . . 0.0 110.28 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.89 75.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.912 . . . . 0.0 109.531 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 253' ' ' PRO . 7.4 t . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.582 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.582 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.506 ' HD1' ' OB1' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.694 ' HH1' ' HG2' ' A' ' 221' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -108.28 -122.37 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.389 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.689 HG23 ' HD3' ' A' ' 87' ' ' PRO . 5.1 t -50.61 176.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.817 -1.177 . . . . 0.0 109.59 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 78.22 74.28 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.97 . . . . 0.0 109.57 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.689 ' HD3' HG23 ' A' ' 85' ' ' THR . 42.4 Cg_endo -72.64 139.93 31.81 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.991 1.522 . . . . 0.0 110.089 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.17 -63.91 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 mm -114.48 110.55 47.31 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.268 -1.136 . . . . 0.0 109.465 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.32 -161.73 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.969 1.51 . . . . 0.0 110.158 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.603 ' H ' HD22 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -102.76 -92.35 0.33 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 109.065 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 98.7 m95 -82.6 151.95 26.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.115 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.92 -40.49 4.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.134 -179.498 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -50.7 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 -179.647 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.479 ' C ' ' CD2' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -118.17 2.11 11.97 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.496 -0.752 . . . . 0.0 109.369 179.503 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.565 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 24.9 m-70 -140.68 89.64 2.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.955 -1.091 . . . . 0.0 110.219 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.825 ' N ' HD22 ' A' ' 97' ' ' LEU . 2.3 mm? -87.68 173.09 9.23 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.652 -0.655 . . . . 0.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -142.16 155.85 45.33 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.087 -1.008 . . . . 0.0 108.73 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.925 ' CE2' HD11 ' A' ' 101' ' ' ILE . 5.4 p90 -137.88 164.79 28.09 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.714 -1.242 . . . . 0.0 108.667 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.653 ' HD3' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.089 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.925 HD11 ' CE2' ' A' ' 99' ' ' TYR . 1.5 mp -96.87 61.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 109.698 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.653 HG23 ' HD3' ' A' ' 100' ' ' ARG . 21.5 t -77.58 4.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.889 HD22 HG22 ' A' ' 144' ' ' ILE . 5.4 m-20 -92.92 155.94 17.25 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.983 -1.073 . . . . 0.0 110.073 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.762 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.4 t80 176.26 150.98 0.14 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.489 ' CG2' ' C ' ' A' ' 104' ' ' TYR . 3.9 p -156.23 161.11 30.16 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -67.71 -24.68 40.76 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 N-CA-C 108.079 -1.547 . . . . 0.0 108.079 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.734 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.5 t0 -73.82 -12.24 60.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.08 HD13 HD12 ' A' ' 195' ' ' LEU . 76.2 mt -143.38 115.41 5.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.28 167.34 12.97 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.63 1.332 . . . . 0.0 109.101 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HE3' ' CG ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.25 -66.17 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.805 0.812 . . . . 0.0 110.322 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.32 -11.88 7.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.728 -0.607 . . . . 0.0 111.62 -178.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.708 ' O ' HD11 ' A' ' 195' ' ' LEU . . . -85.32 -60.4 2.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.488 -1.383 . . . . 0.0 109.213 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.917 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.5 p -55.7 -39.49 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.701 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -64.62 -27.56 69.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.746 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -65.7 -41.61 92.14 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.126 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -69.7 -33.34 72.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.0 t -74.95 -24.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -87.32 -35.31 18.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.703 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 0.3 OUTLIER -80.26 -36.73 34.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.731 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -66.09 -60.8 2.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.532 1.158 . . . . 0.0 107.913 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.854 ' HA ' HG21 ' A' ' 203' ' ' ILE . 16.2 tp -54.12 -48.24 70.97 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.654 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -67.39 -33.72 75.79 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.241 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.029 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -55.93 -42.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.034 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.0 m95 -91.21 -23.16 20.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.588 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 18.5 tt0 -71.16 -27.56 63.64 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.6 pt-20 -90.15 -43.55 10.37 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.029 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.6 m -58.49 -25.36 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.124 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.028 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -112.1 162.28 22.06 Favored Pre-proline 0 N--CA 1.497 1.922 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.834 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -84.91 27.98 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.134 1.889 . . . . 0.0 110.483 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.853 HD22 ' CG ' ' A' ' 246' ' ' TYR . 1.9 mp -109.44 178.99 4.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.247 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.561 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 2.8 p -124.41 170.26 11.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.8 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 1.063 ' CZ ' HD13 ' A' ' 207' ' ' LEU . 12.5 m-85 -146.04 171.41 14.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.15 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.4 m -145.22 -175.13 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.652 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -163.83 149.94 11.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 0.0 110.501 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.769 ' N ' HD12 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -167.59 -98.71 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 136' ' ' TYR . 15.9 t80 177.06 30.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.955 -1.091 . . . . 0.0 109.195 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.558 ' H ' HD13 ' A' ' 135' ' ' LEU . 7.3 tp10 -65.63 169.63 6.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.566 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -41.79 -34.87 1.37 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -178.22 104.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.556 -0.967 . . . . 0.0 109.894 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.541 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.4 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 98' ' ' THR . 71.5 m-20 -80.67 -30.49 36.53 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.97 -1.081 . . . . 0.0 108.794 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.914 HG12 HD23 ' A' ' 207' ' ' LEU . 4.4 mp -129.14 78.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.431 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.9 ttp -62.66 98.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.207 -0.933 . . . . 0.0 109.297 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.889 HG22 HD22 ' A' ' 103' ' ' ASN . 3.9 mm -84.76 107.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -132.9 152.22 51.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 112.322 -178.042 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 24.5 p90 -77.44 146.6 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.561 -0.712 . . . . 0.0 109.586 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.796 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -165.04 163.69 20.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -0.929 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.888 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.2 p -160.79 -160.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.96 . . . . 0.0 109.368 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.696 ' N ' HG13 ' A' ' 148' ' ' VAL . 36.7 mtm180 -36.24 -41.39 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.115 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.463 ' HG2' HG12 ' A' ' 148' ' ' VAL . 3.7 pt-20 -76.47 59.53 1.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.689 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 1.2 m80 -87.08 -91.16 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.19 39.36 0.38 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 155' ' ' TYR . 2.4 t70 -177.47 -143.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -1.163 . . . . 0.0 109.652 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.449 ' C ' ' HD3' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -94.41 15.87 16.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 110.0 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.689 ' CD1' ' CD2' ' A' ' 151' ' ' HIS . 0.1 OUTLIER -119.14 57.02 3.42 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.729 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 154' ' ' PHE . 40.5 Cg_endo -70.53 133.86 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.904 1.476 . . . . 0.0 109.379 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.744 ' CE1' HG13 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -120.71 -171.53 2.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.079 -1.013 . . . . 0.0 110.848 -179.014 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 160' ' ' PRO . 17.0 p30 -175.92 62.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.82 -0.55 . . . . 0.0 109.636 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -8.97 -63.53 0.01 OUTLIER Glycine 0 N--CA 1.505 3.283 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 37.1 Cg_endo -64.02 66.56 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.442 1.233 . . . . 0.0 109.94 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 178.02 151.59 9.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' LEU . 15.2 m-20 -42.58 -32.57 0.58 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.166 . . . . 0.0 109.667 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.744 HG13 ' CE1' ' A' ' 157' ' ' PHE . 39.6 t -44.68 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.7 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.964 HD23 ' CG1' ' A' ' 198' ' ' VAL . 3.1 tp -88.14 -52.01 5.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.12 -0.987 . . . . 0.0 112.286 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.749 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -176.48 -165.34 0.13 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.151 -1.593 . . . . 0.0 111.142 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.684 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.72 -175.29 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.01 -1.681 . . . . 0.0 111.43 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -155.51 176.82 12.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.562 -0.711 . . . . 0.0 109.907 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.527 ' O ' ' CB ' ' A' ' 206' ' ' SER . 25.4 m-85 -120.06 -168.89 1.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.312 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.973 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -159.74 -64.03 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 0.0 109.602 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.973 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -76.58 174.82 12.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.651 1.343 . . . . 0.0 110.051 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 105.98 170.82 23.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 175' ' ' ASN . 44.3 Cg_endo -76.43 -56.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 121.603 1.535 . . . . 0.0 109.874 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.62 -40.25 1.03 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.7 tp -62.88 -7.09 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.463 -1.022 . . . . 0.0 108.867 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.524 ' CA ' ' O ' ' A' ' 169' ' ' ALA . 4.4 p-10 -66.0 65.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 108.991 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 206' ' ' SER . . . 127.55 80.76 0.32 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.2 m-20 -156.83 120.94 4.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.102 -1.234 . . . . 0.0 108.158 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.679 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -107.19 164.27 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.508 -0.745 . . . . 0.0 109.107 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.796 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -153.09 137.58 16.76 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.893 -1.123 . . . . 0.0 109.89 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.636 ' CD2' ' ND2' ' A' ' 103' ' ' ASN . 8.3 m-85 -99.16 129.75 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.753 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.888 ' OD1' HG23 ' A' ' 148' ' ' VAL . 11.1 t0 -47.3 148.88 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.906 -1.121 . . . . 0.0 108.312 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -114.34 19.22 16.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 110.122 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.575 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.7 OUTLIER -135.45 17.86 3.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.979 -1.076 . . . . 0.0 110.325 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 4.4 tt0 -120.47 -139.2 0.34 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.909 -1.12 . . . . 0.0 108.548 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.618 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 3.4 mt-30 -117.66 168.06 10.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -0.96 . . . . 0.0 109.14 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.618 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 87.1 m95 -159.46 107.46 1.77 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.974 -1.079 . . . . 0.0 109.741 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.932 ' HA ' HD21 ' A' ' 108' ' ' LEU . 70.6 p -144.26 154.6 43.25 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.853 -1.155 . . . . 0.0 110.787 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.861 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -91.68 -28.7 17.28 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.27 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 191' ' ' THR . 40.4 t0 -90.8 67.05 6.16 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' THR . . . . . 1.012 ' HB ' HD21 ' A' ' 229' ' ' LEU . 2.8 t 4.07 58.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.021 0.915 . . . . 0.0 112.036 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 189' ' ' ASP . 51.6 m -124.51 -31.25 3.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 0.0 109.733 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.714 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -98.85 -90.96 1.99 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.764 ' CG2' HD21 ' A' ' 164' ' ' LEU . 23.9 m -115.41 -97.01 0.45 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.847 ' OD1' HD21 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -161.45 68.54 0.3 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.23 -0.919 . . . . 0.0 108.706 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.126 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -28.63 -95.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.596 0.713 . . . . 0.0 111.407 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.892 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -67.57 -8.38 33.7 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 111.011 -177.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.911 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.3 tp -66.13 -66.64 0.52 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.224 -1.79 . . . . 0.0 106.668 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.964 ' CG1' HD23 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -66.75 -13.72 16.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.06 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -70.91 -58.8 3.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.805 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -66.67 -14.96 63.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.631 ' HB2' ' HH3' ' A' ' 3' ' ' MSB . 14.8 t60 -68.08 -45.47 73.71 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 117.798 -1.561 . . . . 0.0 107.625 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.679 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 2.2 mt-10 -82.8 -47.82 11.49 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.192 -0.943 . . . . 0.0 111.003 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.854 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -60.05 -31.27 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.682 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.9 -31.84 51.88 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -59.97 -51.01 71.48 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.85 -0.794 . . . . 0.0 110.58 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.536 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 84.4 p -82.74 -56.88 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 112.362 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 1.063 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -104.86 26.62 8.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.098 -1.001 . . . . 0.0 110.622 -177.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.975 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -126.52 -79.19 0.31 Allowed Glycine 0 C--N 1.292 -1.878 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.789 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -170.16 -162.67 0.31 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.678 -1.484 . . . . 0.0 110.015 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.583 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.3 OUTLIER -95.07 -75.34 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.5 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.3 m-70 -161.28 89.36 0.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.5 m -77.1 -178.67 5.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 108.987 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.861 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.92 80.45 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.966 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.08 7.56 18.29 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.216 -177.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.458 ' H ' HG23 ' A' ' 215' ' ' THR . 7.8 p -50.63 -27.79 7.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.515 ' C ' ' HB2' ' A' ' 235' ' ' SER . 18.2 mt-10 -114.05 -37.65 4.4 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.966 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -61.69 -167.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.284 1.04 . . . . 0.0 112.195 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.911 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.0 OUTLIER -102.47 -8.15 21.32 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.893 -177.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.54 ' CB ' ' OD1' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -81.31 -11.11 59.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.114 -1.616 . . . . 0.0 111.213 -178.267 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.657 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -136.47 12.61 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.33 -1.481 . . . . 0.0 113.808 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 48.5 Cg_endo -71.94 -37.96 4.48 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 1.007 HD13 ' CD2' ' A' ' 3' ' ' MSB . 0.3 OUTLIER 0.08 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.915 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.8 OUTLIER -67.72 59.55 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.8 t-160 -168.1 -145.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.442 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.765 ' O ' HD12 ' A' ' 226' ' ' LEU . 59.0 m -149.72 110.11 4.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.002 . . . . 0.0 109.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 225' ' ' SER . 0.1 OUTLIER 179.67 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 188' ' ' LYS . 4.8 t -111.95 -7.89 14.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.607 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 178.87 -23.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 110.463 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 1.012 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -28.89 -61.58 0.12 Allowed 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.443 0.639 . . . . 0.0 110.857 -179.503 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.411 ' OG1' ' C ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.92 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.415 -0.803 . . . . 0.0 108.838 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.572 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -98.1 -21.15 16.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.607 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.0 p90 -33.19 120.75 0.37 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.553 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.72 172.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.738 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.034 HD21 ' CH2' ' A' ' 124' ' ' TRP . 5.0 mp -83.02 169.56 15.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.718 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 14.4 t -102.69 -170.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.764 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.542 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -83.8 -13.36 53.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.861 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.1 m-20 -84.54 -48.37 9.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.829 -1.17 . . . . 0.0 108.005 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.789 ' OD1' HD11 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.0 -40.01 95.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 117.166 -1.814 . . . . 0.0 106.749 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -56.26 -35.72 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 3.6 t30 -67.69 -45.63 74.63 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -62.97 -52.48 47.66 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.007 HG13 HG22 ' A' ' 128' ' ' THR . 1.5 tp -66.31 -47.29 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.868 -1.372 . . . . 0.0 110.51 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.565 ' N ' HG23 ' A' ' 242' ' ' ILE . 9.9 pt20 -55.13 -26.83 41.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 5.0 p -82.27 -18.86 40.9 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.8 OUTLIER -70.09 -65.8 0.68 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.664 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.853 ' CG ' HD22 ' A' ' 130' ' ' LEU . 20.5 m-85 -90.04 -123.24 0.06 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.104 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.503 ' N ' ' HD3' ' A' ' 248' ' ' PRO . . . 41.8 52.84 4.64 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.617 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 38.1 Cg_endo -72.1 -30.2 13.73 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.9 1.474 . . . . 0.0 112.453 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 43.4 Cg_endo -75.37 111.69 3.37 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 122.66 0.821 . . . . 0.0 110.052 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 42.6 Cg_endo -73.96 -59.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.954 1.502 . . . . 0.0 110.077 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -155.54 -39.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.866 . . . . 0.0 109.392 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 10.8 p -124.79 152.93 70.33 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.449 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -72.43 -9.16 23.8 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.028 1.541 . . . . 0.0 109.991 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.41 153.68 39.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.562 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.54 ' O ' ' CB ' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.54 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 1.007 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 4.5 p90 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -151.56 163.95 37.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.557 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 210' ' ' PHE . 7.6 p -54.42 179.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.567 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.545 ' CD1' ' HD2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -45.56 134.6 6.07 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.967 . . . . 0.0 109.452 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.545 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 42.6 Cg_endo -73.2 55.57 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.014 1.534 . . . . 0.0 110.146 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.33 -126.61 2.27 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.509 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 1.6 mp -50.57 140.19 19.3 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.291 -1.123 . . . . 0.0 109.784 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.58 ' HB2' HD23 ' A' ' 245' ' ' LEU . 42.6 Cg_endo -72.97 154.14 52.89 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.038 1.547 . . . . 0.0 109.981 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.78 ' N ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -44.29 -81.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.69 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.818 ' CD1' HD22 ' A' ' 207' ' ' LEU . 9.2 m95 -95.95 -169.05 1.86 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.847 -1.158 . . . . 0.0 110.037 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.513 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -161.81 -33.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.399 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.57 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.75 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.199 -0.938 . . . . 0.0 110.799 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.584 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -101.15 -8.53 22.15 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.715 . . . . 0.0 110.167 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.57 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 35.4 m-70 -140.15 95.32 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.246 . . . . 0.0 110.865 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.03 HD13 HD13 ' A' ' 207' ' ' LEU . 19.5 mt -82.02 177.64 8.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.646 -0.659 . . . . 0.0 109.886 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.691 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 1.3 t -148.16 155.8 41.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.226 -0.921 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.76 ' CG ' HD22 ' A' ' 121' ' ' LEU . 1.3 p90 -138.43 161.83 35.99 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.614 -1.303 . . . . 0.0 110.053 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.587 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.43 123.0 28.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.515 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.891 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.5 mp -84.27 82.48 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.815 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 39.4 t -95.87 6.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.46 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.572 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -102.55 163.65 12.1 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.988 -1.07 . . . . 0.0 109.211 179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.687 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.0 t80 177.13 84.56 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.585 0.707 . . . . 0.0 109.117 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.951 HG21 ' CG ' ' A' ' 186' ' ' TRP . 17.9 p -72.85 155.99 90.2 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 108.876 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.98 -24.1 39.81 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 O-C-N 123.917 1.483 . . . . 0.0 108.667 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -78.37 -0.32 28.58 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.187 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.962 HD13 ' CD1' ' A' ' 195' ' ' LEU . 96.8 mt -147.45 120.03 4.74 Favored Pre-proline 0 N--CA 1.485 1.276 0 O-C-N 121.458 -0.776 . . . . 0.0 110.139 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -66.02 173.15 7.52 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.89 1.468 . . . . 0.0 109.037 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.481 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.14 -65.97 0.33 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.907 0.861 . . . . 0.0 110.091 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.2 OUTLIER -55.21 -29.41 57.89 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.857 -0.527 . . . . 0.0 112.251 -178.246 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.873 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.09 -61.03 1.96 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.446 . . . . 0.0 109.413 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.687 HG21 ' N ' ' A' ' 104' ' ' TYR . 9.6 p -53.39 -42.31 47.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.891 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -62.87 -27.94 69.7 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.933 ' OG ' HD21 ' A' ' 195' ' ' LEU . 4.4 p -61.23 -45.99 92.28 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.094 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -67.68 -31.28 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.055 -1.028 . . . . 0.0 109.663 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.985 HG13 HG13 ' A' ' 144' ' ' ILE . 45.9 t -75.07 -23.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -90.35 -33.13 16.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.65 -41.89 25.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.913 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -62.95 -61.92 2.07 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.773 ' HA ' HG21 ' A' ' 203' ' ' ILE . 11.1 tp -51.24 -44.5 61.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 2.6 tptp -72.53 -32.73 66.35 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.55 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.886 HG21 ' HE1' ' A' ' 196' ' ' PHE . 3.4 t -56.16 -43.8 77.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.024 ' CH2' HD21 ' A' ' 234' ' ' LEU . 37.8 m95 -91.22 -19.08 23.41 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.452 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.7 OUTLIER -77.05 -27.58 54.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.971 -1.081 . . . . 0.0 108.24 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 17.1 pt-20 -89.99 -44.57 9.78 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.961 HG21 HG21 ' A' ' 242' ' ' ILE . 35.9 m -64.03 -21.44 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.612 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 124' ' ' TRP . 1.7 p -113.0 152.26 44.79 Favored Pre-proline 0 N--CA 1.498 1.933 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.971 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.612 ' C ' HD22 ' A' ' 130' ' ' LEU . 53.9 Cg_endo -80.51 32.82 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.285 1.99 . . . . 0.0 111.661 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 246' ' ' TYR . 2.9 mm? -112.56 165.51 12.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.616 -1.302 . . . . 0.0 110.857 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -103.3 177.57 4.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.181 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 15.9 m-85 -154.35 160.61 41.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.913 -1.117 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -158.57 125.81 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.611 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -97.57 174.38 6.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.61 -1.306 . . . . 0.0 110.358 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.537 ' CD1' ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.16 -122.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.432 ' C ' ' OE1' ' A' ' 137' ' ' GLU . 1.1 t80 177.04 42.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.3 -1.5 . . . . 0.0 109.921 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 139' ' ' GLU . 10.9 pm0 -169.47 -173.79 1.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.931 -1.106 . . . . 0.0 110.155 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.8 -97.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 137' ' ' GLU . 10.2 pt-20 179.0 105.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -1.094 . . . . 0.0 109.92 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.691 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.21 -151.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.638 ' OD2' HG22 ' A' ' 98' ' ' THR . 53.8 m-20 -93.46 -25.5 17.61 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.931 HD11 HD12 ' A' ' 207' ' ' LEU . 3.1 mp -132.22 79.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.525 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.5 ttp -66.14 93.77 0.22 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.231 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.985 HG13 HG13 ' A' ' 117' ' ' VAL . 5.9 mm -79.28 110.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.911 -1.118 . . . . 0.0 108.042 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -131.36 156.14 46.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.359 -1.463 . . . . 0.0 111.434 -178.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 146' ' ' PHE . 19.7 p90 -79.85 138.2 37.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 0.0 109.432 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.045 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -157.85 164.2 37.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.037 . . . . 0.0 110.523 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 1.026 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.4 p -166.58 -161.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.686 ' H ' HG22 ' A' ' 148' ' ' VAL . 45.6 mtm180 -36.57 -30.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 148' ' ' VAL . 0.2 OUTLIER -81.84 71.67 8.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 109.653 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 4.4 m80 -107.58 -166.51 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.5 -73.07 1.28 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -174.24 56.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -1.146 . . . . 0.0 109.537 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.504 ' HB3' ' CE1' ' A' ' 155' ' ' TYR . 0.2 OUTLIER 179.54 -30.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 109.637 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.602 ' O ' ' CG ' ' A' ' 151' ' ' HIS . 0.7 OUTLIER -113.75 54.66 0.64 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.848 . . . . 0.0 109.347 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 154' ' ' PHE . 38.1 Cg_endo -65.84 109.46 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.802 1.422 . . . . 0.0 109.613 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.878 ' CE1' HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -96.64 -169.1 1.83 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 110.492 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 159' ' ' GLY . 16.9 p30 179.74 62.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.724 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.608 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -5.35 -65.58 0.01 OUTLIER Glycine 0 N--CA 1.51 3.579 0 N-CA-C 112.151 -0.38 . . . . 0.0 112.151 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.536 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.69 61.33 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.685 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -170.07 141.93 6.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.527 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 18.6 m120 -40.15 -31.32 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.45 -1.029 . . . . 0.0 110.343 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.878 HG12 ' CE1' ' A' ' 157' ' ' PHE . 1.4 t -56.7 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.812 HD11 HG21 ' A' ' 193' ' ' THR . 0.1 OUTLIER -79.51 -40.9 28.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.32 -0.862 . . . . 0.0 112.306 -178.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -179.86 -168.5 0.11 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.198 -1.564 . . . . 0.0 110.859 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.91 -168.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.412 -1.43 . . . . 0.0 110.99 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -159.88 -164.63 1.34 Allowed 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.347 -0.845 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.571 ' OH ' ' CG ' ' A' ' 155' ' ' TYR . 88.6 m-85 -131.9 -163.64 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.058 . . . . 0.0 110.16 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.823 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . 179.28 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.002 -1.061 . . . . 0.0 110.939 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.823 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 40.1 Cg_endo -70.22 -64.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.491 1.46 . . . . 0.0 111.817 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 175' ' ' ASN . . . -37.86 144.75 0.17 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 174' ' ' ILE . 39.9 Cg_endo -69.47 144.53 55.9 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.085 1.571 . . . . 0.0 109.368 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 69.55 -63.28 0.63 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' A' ' 176' ' ' GLY . 1.5 tp -68.43 -4.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -63.79 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 129.81 80.62 0.24 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.633 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -157.41 128.91 6.88 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 120.755 -1.438 . . . . 0.0 107.676 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.772 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -117.55 156.68 27.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.888 -1.132 . . . . 0.0 109.538 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.045 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -142.15 133.84 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.303 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 20.4 m-85 -96.03 134.19 39.35 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.857 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 1.026 ' OD1' HG23 ' A' ' 148' ' ' VAL . 9.5 t0 -53.26 145.9 12.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.892 -1.13 . . . . 0.0 108.85 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 147' ' ' ALA . 10.0 m-20 -114.7 21.54 14.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 0.0 110.255 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.876 ' OD1' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -121.32 8.98 10.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.804 -1.185 . . . . 0.0 110.298 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.558 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 19.0 mt-10 -122.63 -131.68 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.94 -1.1 . . . . 0.0 108.534 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.3 mt-30 -133.36 175.42 9.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.134 -0.979 . . . . 0.0 108.761 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.951 ' CG ' HG21 ' A' ' 105' ' ' THR . 78.0 m95 -158.81 119.38 3.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.91 -1.119 . . . . 0.0 108.85 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.68 ' HA ' HD21 ' A' ' 108' ' ' LEU . 71.4 p -144.85 152.28 40.04 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.79 -1.194 . . . . 0.0 110.505 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.948 ' HB3' HD22 ' A' ' 195' ' ' LEU . 3.3 pttt -85.14 -31.75 23.12 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 12.7 t70 -87.16 63.44 7.85 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.889 ' CG2' HD21 ' A' ' 229' ' ' LEU . 72.1 p 3.24 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.832 -177.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 37.0 m -125.34 -32.34 2.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.664 . . . . 0.0 109.408 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.617 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.94 -82.27 1.58 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.812 HG21 HD11 ' A' ' 164' ' ' LEU . 21.8 m -125.31 -95.81 0.45 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 1.002 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -160.61 70.82 0.42 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.017 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 2.1 tp -33.5 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.886 ' HE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -69.62 -9.93 56.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 111.168 -177.553 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.69 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 12.0 tp -64.71 -62.01 1.84 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 116.852 -1.939 . . . . 0.0 106.544 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.002 HG23 ' HB2' ' A' ' 194' ' ' ASN . 2.7 t -70.48 -12.2 15.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.094 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.64 -59.43 2.72 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.759 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -63.99 -15.64 59.76 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.592 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 20.2 t60 -67.15 -49.2 65.62 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.806 -1.558 . . . . 0.0 107.676 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.772 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 2.5 mm-40 -80.24 -47.12 15.1 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.159 -0.963 . . . . 0.0 111.077 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.913 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.3 mt -60.15 -31.53 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.708 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.94 -34.87 40.98 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.38 -50.31 73.4 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 121.78 -0.835 . . . . 0.0 110.598 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.851 ' C ' HD23 ' A' ' 207' ' ' LEU . 1.5 m -84.81 -58.96 2.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.378 -0.826 . . . . 0.0 112.177 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 1.03 HD13 HD13 ' A' ' 97' ' ' LEU . 1.2 mt -102.85 32.23 3.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.709 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -131.91 -81.53 0.21 Allowed Glycine 0 C--N 1.289 -2.073 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.838 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.6 pp -165.03 -164.65 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.127 -1.22 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.838 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -98.48 -70.76 0.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.238 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 21.8 m80 -162.85 96.8 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.226 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.765 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.8 m -87.69 -175.71 5.28 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.808 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.43 76.86 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.952 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -83.56 8.8 13.04 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.126 -177.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.458 ' C ' ' O ' ' A' ' 214' ' ' ASN . 21.3 p -50.35 -27.72 6.75 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.519 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.2 mp0 -112.51 -37.21 5.01 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.952 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -64.97 -168.48 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.319 1.057 . . . . 0.0 112.526 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.787 HD23 HD12 ' A' ' 234' ' ' LEU . 0.1 OUTLIER -89.77 -18.06 27.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.694 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.553 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.38 -7.26 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 119.182 -2.199 . . . . 0.0 112.175 -177.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 27.8 t80 -135.5 14.69 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.277 -1.514 . . . . 0.0 113.585 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.6 Cg_endo -79.88 -43.33 0.13 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 N-CA-C 109.279 -1.085 . . . . 0.0 109.279 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.636 HD23 ' CD2' ' A' ' 3' ' ' MSB . 2.3 tp -1.08 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-O 121.355 0.597 . . . . 0.0 110.929 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 221' ' ' PRO . 8.2 m-85 -67.6 59.61 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.413 -0.804 . . . . 0.0 109.202 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.5 t-160 -170.43 -140.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.232 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.619 ' C ' HD23 ' A' ' 226' ' ' LEU . 19.8 m -163.52 112.19 1.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.967 -1.083 . . . . 0.0 110.121 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.698 ' N ' HG21 ' A' ' 190' ' ' THR . 0.4 OUTLIER 179.69 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.577 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 5.2 t -104.75 -48.02 3.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.609 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 0.5 OUTLIER -138.57 -10.39 1.4 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 111.625 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.889 HD21 ' CG2' ' A' ' 190' ' ' THR . 0.1 OUTLIER -35.83 -64.68 0.29 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.844 -1.16 . . . . 0.0 110.792 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.84 -31.77 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 109.193 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER -97.58 -20.14 17.88 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 228' ' ' ASP . 50.7 p90 -34.53 130.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.542 0.687 . . . . 0.0 111.145 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.1 ttt-85 179.74 152.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.024 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.1 mp -68.75 169.04 12.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.97 -1.082 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 31.0 t -100.48 -171.76 2.08 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.254 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.499 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.5 -12.09 52.64 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.808 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.2 OUTLIER -84.69 -47.5 10.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.669 ' OD1' HD21 ' A' ' 209' ' ' LEU . 4.5 m-20 -67.01 -38.28 85.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 117.091 -1.844 . . . . 0.0 106.526 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -57.23 -34.69 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.468 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 244' ' ' SER . 12.6 t-20 -68.96 -47.22 66.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.279 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' A' ' 244' ' ' SER . . . -64.3 -45.93 92.11 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.961 HG21 HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -74.39 -50.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.532 -1.569 . . . . 0.0 109.803 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.606 ' N ' HG23 ' A' ' 242' ' ' ILE . 2.4 tt0 -55.27 -24.15 26.72 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 75.8 p -89.74 -13.55 36.55 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.78 HD21 ' N ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -72.26 -53.65 11.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.579 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.614 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 7.5 m-30 -83.33 -117.5 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.516 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 129' ' ' PRO . . . 169.66 131.18 1.28 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.393 -1.384 . . . . 0.0 109.97 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.658 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 45.8 Cg_endo -70.52 175.1 9.19 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.955 1.503 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 38.4 Cg_endo -67.14 -26.05 42.95 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.814 1.676 . . . . 0.0 114.523 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 42.4 Cg_endo -82.24 -57.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 120.435 0.757 . . . . 0.0 110.194 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 250' ' ' PRO . 0.1 OUTLIER -43.85 -26.89 0.29 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.392 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 250' ' ' PRO . 0.6 OUTLIER -145.88 89.49 6.1 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 255' ' ' THR . 42.3 Cg_endo -72.83 -35.14 5.95 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.185 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.419 ' C ' ' OG1' ' A' ' 255' ' ' THR . 0.6 OUTLIER -66.48 65.94 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.517 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 253' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.524 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.835 ' CG2' HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.54 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.754 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.283 0.563 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.459 ' N ' ' CD ' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -138.19 -93.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -53.64 156.89 2.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 86' ' ' PHE . 5.0 p90 -138.46 106.85 7.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.524 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.71 96.36 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.949 1.499 . . . . 0.0 110.14 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.14 -99.45 0.14 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.677 HD12 ' H ' ' A' ' 89' ' ' ILE . 5.1 mp -75.03 123.63 89.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.266 -1.138 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 245' ' ' LEU . 42.6 Cg_endo -72.82 -175.62 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.983 1.517 . . . . 0.0 110.004 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.812 ' H ' HD22 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -89.84 -85.15 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 108.76 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.597 ' CZ2' ' HA ' ' A' ' 141' ' ' ASP . 12.7 m95 -77.58 -126.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.858 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 178.84 -51.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.365 -1.459 . . . . 0.0 109.529 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.41 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.814 0.816 . . . . 0.0 110.771 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.542 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 26.2 p -100.06 -4.19 30.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.497 -0.752 . . . . 0.0 109.64 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.596 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 21.1 m-70 -141.93 88.82 2.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.105 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.78 ' N ' HD22 ' A' ' 97' ' ' LEU . 2.9 mm? -76.71 169.54 18.1 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.709 -0.619 . . . . 0.0 109.481 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.566 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.2 OUTLIER -141.77 156.79 45.57 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.11 -0.994 . . . . 0.0 108.963 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.891 ' CG ' HD23 ' A' ' 121' ' ' LEU . 16.7 p90 -137.55 161.74 35.62 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.588 -1.32 . . . . 0.0 109.256 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 1.093 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -125.13 138.6 54.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.945 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.6 mp -93.01 67.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.661 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.093 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 20.0 t -78.77 6.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 0.0 110.069 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.654 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -105.98 159.37 16.1 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.899 -1.126 . . . . 0.0 108.578 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.712 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.8 p90 177.94 47.01 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.748 -0.595 . . . . 0.0 110.246 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.864 HG21 ' CD1' ' A' ' 186' ' ' TRP . 22.6 p -44.11 156.8 0.31 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.163 -0.961 . . . . 0.0 108.802 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.04 -18.21 51.52 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.701 1.369 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.488 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 0.5 OUTLIER -70.93 -6.06 35.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.337 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.975 ' CD1' HD13 ' A' ' 195' ' ' LEU . 95.9 mt -151.67 127.16 4.88 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.401 -0.812 . . . . 0.0 110.432 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 38.2 Cg_endo -68.09 174.8 7.41 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.992 1.522 . . . . 0.0 109.288 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.481 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -40.88 -66.36 0.34 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.774 0.797 . . . . 0.0 110.206 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.5 OUTLIER -54.35 -33.8 59.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.922 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.46 -60.65 2.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.355 -1.465 . . . . 0.0 109.834 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.712 HG21 ' N ' ' A' ' 104' ' ' TYR . 5.6 p -55.18 -44.51 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.945 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -61.8 -27.54 68.83 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 116' ' ' ALA . 1.4 p -58.89 -64.54 0.9 Allowed 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.059 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -50.1 -32.01 14.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.293 -0.879 . . . . 0.0 110.254 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 144' ' ' ILE . 36.8 t -74.34 -23.34 18.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -93.08 -31.06 14.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.666 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -84.47 -35.11 23.21 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.92 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -69.26 -62.26 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.591 1.186 . . . . 0.0 107.928 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.901 ' HA ' HG21 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -52.67 -55.1 24.98 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.699 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 118' ' ' GLU . 2.7 tptm -60.55 -35.42 75.97 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.835 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.018 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.27 -40.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -179.575 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 1.043 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.7 m95 -91.05 -23.87 20.22 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.669 -1.212 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -70.37 -29.6 66.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.799 -1.188 . . . . 0.0 107.808 179.325 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -88.55 -40.34 13.47 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.201 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.018 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.7 m -61.63 -25.46 36.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.102 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . 1.009 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -112.52 164.14 16.07 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.241 -1.384 . . . . 0.0 108.995 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HG3' ' N ' ' A' ' 248' ' ' PRO . 48.0 Cg_endo -79.11 -6.17 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.687 1.591 . . . . 0.0 110.557 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 246' ' ' TYR . 2.1 mm? -74.4 165.1 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 110.289 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.552 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -108.97 169.04 8.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 97' ' ' LEU . 50.9 m-85 -148.65 154.93 40.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 110.199 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -143.76 -179.52 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.526 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -156.7 161.37 39.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.782 ' N ' HD12 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.82 -98.12 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.405 -0.809 . . . . 0.0 109.956 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CZ ' ' NH2' ' A' ' 100' ' ' ARG . 2.8 t80 177.68 32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.986 -1.071 . . . . 0.0 109.041 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.756 ' OE2' HD11 ' A' ' 135' ' ' LEU . 0.7 OUTLIER -72.21 174.51 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.967 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -43.62 -40.46 5.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 140' ' ' ALA . 4.1 pt-20 -174.21 105.3 0.11 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -1.062 . . . . 0.0 109.998 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.563 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.4 -148.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.018 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.597 ' HA ' ' CZ2' ' A' ' 92' ' ' TRP . 66.8 m-20 -88.02 -27.17 22.21 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.575 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.018 HD11 HD22 ' A' ' 207' ' ' LEU . 3.6 mt -130.73 77.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.512 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 23.4 ttp -65.29 98.19 0.31 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.645 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 1.014 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -81.97 107.35 13.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -128.5 156.59 43.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.468 -1.395 . . . . 0.0 111.79 -178.512 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.539 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 34.7 p90 -79.17 137.39 37.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 1.031 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -158.37 165.57 34.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 0.0 109.731 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.923 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.1 p -164.15 -155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.472 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.804 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -60.8 76.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.68 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 148' ' ' VAL . 56.6 tt0 179.8 32.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.393 -0.817 . . . . 0.0 109.201 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 68.1 m80 -75.25 -89.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.3 -0.875 . . . . 0.0 109.587 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.8 32.66 0.64 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.81 -92.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -1.11 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.438 ' C ' ' HD3' ' A' ' 156' ' ' PRO . 41.8 m-85 -145.98 14.28 1.32 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 0.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.588 ' O ' ' CE1' ' A' ' 151' ' ' HIS . 9.0 m-85 -124.43 47.34 1.89 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 109.502 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 41.4 Cg_endo -71.01 125.68 11.74 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.032 1.543 . . . . 0.0 109.761 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.688 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -102.77 -166.79 1.31 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 110.517 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 160' ' ' PRO . 19.8 p30 179.29 58.57 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.72 -0.612 . . . . 0.0 109.837 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.623 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.19 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.508 3.444 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.593 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.4 Cg_endo -64.17 62.41 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 109.935 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -164.56 141.99 7.46 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.538 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 70.5 m-80 -41.41 -32.77 0.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -1.087 . . . . 0.0 109.971 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.867 ' HA ' HG23 ' A' ' 1' ' ' HAV . 6.4 m -55.1 86.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 109.9 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 1.114 HD23 HG21 ' A' ' 198' ' ' VAL . 0.8 OUTLIER -75.63 -38.33 59.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.337 -0.852 . . . . 0.0 111.618 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.885 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . 179.21 -169.64 0.11 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.585 -1.322 . . . . 0.0 110.406 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.688 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p-80 178.12 -170.37 0.1 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.017 -1.677 . . . . 0.0 111.426 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.56 -174.99 5.16 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.56 -0.713 . . . . 0.0 110.052 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 1.057 ' CD1' HD11 ' A' ' 174' ' ' ILE . 62.8 m-85 -121.06 -175.37 3.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.054 -1.029 . . . . 0.0 110.652 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.972 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -152.02 -66.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.68 -0.638 . . . . 0.0 109.324 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.972 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.1 Cg_endo -74.19 177.25 8.5 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.609 1.321 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.594 ' HA3' HG23 ' A' ' 174' ' ' ILE . . . 95.62 168.1 35.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.0 Cg_endo -75.63 -87.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -74.58 -35.33 51.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 1.057 HD11 ' CD1' ' A' ' 168' ' ' TYR . 3.1 tt -66.71 -2.96 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 108.892 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.553 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 1.9 t30 -66.18 63.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.33 -0.856 . . . . 0.0 108.997 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 121.4 87.05 0.91 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.3 m-20 -155.08 124.47 6.37 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.826 -1.397 . . . . 0.0 107.998 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -110.13 152.45 26.0 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 109.329 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 1.031 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -139.48 131.24 27.46 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.901 -1.119 . . . . 0.0 109.336 179.086 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.548 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 52.9 m-85 -91.62 129.72 37.55 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.634 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.923 ' OD1' HG23 ' A' ' 148' ' ' VAL . 15.6 t0 -47.15 145.55 2.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.966 -1.084 . . . . 0.0 108.371 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.538 ' OD1' HG22 ' A' ' 105' ' ' THR . 3.5 t0 -114.74 20.96 14.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.623 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 6.5 m-20 -131.61 24.88 4.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.557 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 16.8 mt-10 -130.18 -93.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 109.108 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.0 mt-30 179.56 172.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TRP . . . . . 0.864 ' CD1' HG21 ' A' ' 105' ' ' THR . 94.9 m95 -158.95 125.42 4.6 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.736 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.2 p -144.77 150.71 37.67 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.829 -1.169 . . . . 0.0 109.944 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 6.0 ptpt -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.651 ' O ' ' N ' ' A' ' 191' ' ' THR . 24.4 t70 -89.4 64.93 6.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' THR . . . . . 1.018 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.3 t 3.69 59.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.101 0.953 . . . . 0.0 112.019 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.0 m -126.28 -30.56 2.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.866 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.683 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -93.27 -81.92 1.51 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.865 ' CG2' HD21 ' A' ' 164' ' ' LEU . 19.8 m -123.63 -80.67 0.63 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.857 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 6.4 m-20 179.33 68.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.006 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 12.7 tp -37.98 -101.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.725 -0.609 . . . . 0.0 111.55 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.859 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.8 OUTLIER -57.05 -9.56 0.9 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.879 -1.138 . . . . 0.0 111.233 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.87 ' HA ' HD11 ' A' ' 218' ' ' LEU . 5.6 tp -68.29 -66.98 0.5 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 116.778 -1.969 . . . . 0.0 106.703 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.114 HG21 HD23 ' A' ' 164' ' ' LEU . 14.6 t -68.41 -6.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 1.059 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.04 -58.04 3.5 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.812 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -67.19 -15.93 64.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.609 ' HB2' ' HH3' ' A' ' 3' ' ' MSB . 11.2 t60 -69.65 -40.4 76.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.9 -1.52 . . . . 0.0 107.78 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.683 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.6 mt-10 -85.61 -48.41 8.92 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.297 -0.877 . . . . 0.0 110.917 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 120' ' ' ALA . 4.0 mt -61.89 -30.06 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.697 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.69 -33.24 43.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -57.64 -49.69 75.61 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.675 -0.897 . . . . 0.0 110.065 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.514 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 40.4 p -81.22 -60.46 2.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.443 -0.786 . . . . 0.0 111.874 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 1.018 HD22 HD11 ' A' ' 142' ' ' ILE . 7.3 mp -104.2 36.74 2.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.252 -0.905 . . . . 0.0 110.872 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.972 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -136.26 -73.16 0.07 OUTLIER Glycine 0 C--N 1.292 -1.878 0 C-N-CA 119.435 -1.364 . . . . 0.0 109.929 -178.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.943 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -179.87 -162.53 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.642 -1.505 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.847 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -94.71 -83.86 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 0.0 109.397 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 2.0 m-70 -151.9 99.97 2.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.624 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -86.44 177.02 7.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.848 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -58.23 89.52 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.975 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -90.02 11.85 19.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.981 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 214' ' ' ASN . 12.9 p -50.04 -29.04 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.517 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.7 mm-40 -118.07 -34.6 4.08 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.501 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.975 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -59.44 -169.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.223 1.011 . . . . 0.0 112.068 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.87 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.4 tp -110.41 -3.89 15.87 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.152 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.638 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -83.02 -11.36 58.16 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.146 -1.596 . . . . 0.0 111.064 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.655 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 24.5 t80 -140.6 17.35 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 117.994 -1.483 . . . . 0.0 113.467 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.9 ' HB3' HD11 ' A' ' 226' ' ' LEU . 53.0 Cg_endo -73.43 -35.49 4.82 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.946 -1.598 . . . . 0.0 107.946 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.95 HD23 ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -4.09 -69.82 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.831 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.95 ' N ' HD23 ' A' ' 222' ' ' LEU . 24.0 t80 -69.35 58.84 0.12 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.989 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -168.69 -140.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 0.0 109.329 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.919 ' HB3' HG21 ' A' ' 190' ' ' THR . 15.2 m -153.41 108.83 3.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.943 -1.098 . . . . 0.0 110.328 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.912 HD23 ' C ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.76 51.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -0.836 . . . . 0.0 109.335 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 187' ' ' THR . 14.7 t -103.26 -9.75 19.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 0.0 109.237 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.631 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 0.3 OUTLIER 178.14 -23.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 178.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 1.018 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -27.97 -61.41 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.421 0.629 . . . . 0.0 111.008 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.97 -34.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.6 OUTLIER -87.31 -16.39 35.25 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.631 ' HB3' ' N ' ' A' ' 228' ' ' ASP . 36.7 p90 -33.17 112.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.535 0.683 . . . . 0.0 111.334 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 178.12 177.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 0.0 109.49 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 1.043 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.6 mp -93.85 170.12 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.46 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.693 ' O ' HD13 ' A' ' 239' ' ' ILE . 7.0 t -101.24 -171.75 2.05 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.724 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLN . . . . . 0.572 ' N ' ' OG ' ' A' ' 235' ' ' SER . 4.4 tp-100 -82.83 -14.65 53.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.369 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.848 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.7 m-20 -83.54 -47.16 11.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.943 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.5 OUTLIER -64.34 -39.21 93.44 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.005 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -58.09 -34.73 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 244' ' ' SER . 59.6 t30 -68.65 -45.34 72.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.529 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.49 -56.56 23.74 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 1.007 HG21 HG21 ' A' ' 127' ' ' VAL . 1.4 tp -64.1 -43.94 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.269 . . . . 0.0 109.605 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.523 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.8 tt0 -55.97 -26.5 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 1.4 p -80.61 -20.66 42.74 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.942 ' HB2' HD12 ' A' ' 242' ' ' ILE . 2.4 mt -69.98 -69.49 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.587 ' HB3' HD23 ' A' ' 130' ' ' LEU . 38.6 m-85 -90.83 -97.7 0.11 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 90.24 134.34 5.63 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.458 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.547 ' N ' ' HG3' ' A' ' 129' ' ' PRO . 43.3 Cg_endo -76.11 174.07 13.44 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.132 1.596 . . . . 0.0 109.787 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 41.2 Cg_endo -70.92 159.57 52.11 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.849 1.447 . . . . 0.0 109.932 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -72.28 -63.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.0 1.527 . . . . 0.0 110.326 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 252' ' ' SER . 10.2 p30 -52.83 165.56 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 109.407 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 251' ' ' ASP . 70.8 p -43.65 147.17 0.86 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.533 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.34 -9.35 24.15 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.001 1.527 . . . . 0.0 110.131 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.06 -14.66 61.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.471 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.514 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.867 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.538 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.888 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.519 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.08 0.467 . . . . 0.0 109.897 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.627 ' CZ3' ' ND2' ' A' ' 175' ' ' ASN . 9.7 m95 -99.73 143.16 30.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 110.207 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 1.6 ptp180 -109.3 -40.86 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.388 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 1.06 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.58 170.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.331 -0.855 . . . . 0.0 110.019 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.59 ' O ' HD12 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -110.14 1.19 18.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.502 -0.749 . . . . 0.0 109.585 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 66.8 m80 -137.96 95.99 3.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.368 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.06 HD13 ' HE2' ' A' ' 94' ' ' LYS . 3.1 mm? -92.37 170.82 9.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.51 -0.744 . . . . 0.0 109.512 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.607 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -147.24 157.17 43.5 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 1.054 ' CE2' HD11 ' A' ' 101' ' ' ILE . 4.4 p90 -137.11 166.31 24.02 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.505 -1.372 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.59 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -125.19 124.36 41.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.054 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -83.12 83.54 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.883 -1.135 . . . . 0.0 110.106 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 102' ' ' VAL . 46.7 t -98.72 7.25 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.254 -0.903 . . . . 0.0 110.001 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.985 ' C ' HG21 ' A' ' 113' ' ' VAL . 34.0 m-80 -97.01 160.91 14.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.841 -1.162 . . . . 0.0 109.461 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.777 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.8 t80 178.09 167.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.648 HG22 ' CZ3' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -176.53 159.54 1.66 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 105' ' ' THR . 37.7 Cg_endo -66.12 -25.94 50.48 Favored 'Trans proline' 0 C--N 1.298 -2.089 0 N-CA-C 107.791 -1.657 . . . . 0.0 107.791 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.692 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -74.17 -10.98 60.15 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.929 ' CD1' HD13 ' A' ' 195' ' ' LEU . 79.6 mt -153.23 111.18 2.63 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.598 -0.689 . . . . 0.0 110.224 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.81 178.37 2.34 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.8 1.421 . . . . 0.0 109.341 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.93 -65.35 0.37 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.809 0.814 . . . . 0.0 110.296 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -58.67 -26.79 64.18 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.758 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -74.42 -60.45 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.31 -1.494 . . . . 0.0 109.605 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.985 HG21 ' C ' ' A' ' 103' ' ' ASN . 11.3 p -58.16 -42.42 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 1.041 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -60.04 -29.79 68.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -57.68 -64.1 1.02 Allowed 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.065 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -49.19 -33.0 11.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 110.158 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.936 HG13 HG13 ' A' ' 144' ' ' ILE . 5.7 t -73.0 -24.33 20.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.7 tt0 -90.64 -34.07 15.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.342 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.12 -39.44 33.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.885 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -64.84 -62.23 1.69 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.909 HD22 ' CE1' ' A' ' 99' ' ' TYR . 14.5 tp -48.99 -47.94 43.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.489 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -70.34 -34.25 72.43 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.791 -178.049 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.012 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.8 t -53.71 -44.81 59.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.027 ' CH2' HD21 ' A' ' 234' ' ' LEU . 30.9 m95 -92.11 -21.33 20.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.716 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 33.6 tt0 -72.14 -27.55 62.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.8 pt-20 -88.88 -44.49 10.43 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.435 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.084 HG21 HG21 ' A' ' 242' ' ' ILE . 14.2 m -56.77 -26.89 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.248 -1.381 . . . . 0.0 108.324 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.003 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -118.35 166.33 14.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 108.092 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.581 ' HG2' ' CD1' ' A' ' 246' ' ' TYR . 48.1 Cg_endo -82.5 -10.94 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.528 1.485 . . . . 0.0 109.824 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.932 HD23 ' CZ ' ' A' ' 132' ' ' PHE . 41.9 tp -52.38 158.87 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.727 . . . . 0.0 110.893 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.5 p -108.37 170.39 8.05 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.932 ' CZ ' HD23 ' A' ' 130' ' ' LEU . 71.2 m-85 -151.41 146.36 25.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.938 -1.101 . . . . 0.0 110.929 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.599 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 4.0 t -125.66 -174.24 3.03 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.64 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -148.13 164.58 33.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.612 -1.305 . . . . 0.0 111.017 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.535 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -164.81 -163.73 0.74 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 29.7 t80 -160.95 28.31 0.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 5.0 pm0 -144.87 178.57 7.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.678 -0.639 . . . . 0.0 109.324 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.26 -97.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' GLU . 7.7 pt-20 178.83 121.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -1.109 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.607 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -77.58 -151.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.866 ' CG ' HD12 ' A' ' 97' ' ' LEU . 16.7 t70 -89.75 -36.74 14.99 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.87 ' CD1' HD23 ' A' ' 207' ' ' LEU . 4.1 mp -123.23 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.543 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 8.8 ttm -65.13 98.24 0.3 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.044 . . . . 0.0 109.059 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.936 HG13 HG13 ' A' ' 117' ' ' VAL . 6.2 mm -82.73 111.52 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.652 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.72 153.64 51.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 0.0 111.856 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.516 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 19.8 p90 -90.47 141.42 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.769 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.088 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.82 179.96 3.97 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.003 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 149' ' ' ARG . 1.4 p -151.19 -164.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.716 ' H ' HG22 ' A' ' 148' ' ' VAL . 1.1 ptt85 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.785 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo . . . . . 0 C--O 1.215 -0.659 0 N-CA-C 109.805 -0.883 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.776 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m-85 -78.33 -169.42 1.64 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.067 -1.021 . . . . 0.0 109.557 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.598 ' O ' ' C ' ' A' ' 159' ' ' GLY . 11.0 p30 178.64 58.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.559 -0.713 . . . . 0.0 110.097 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -20.36 -58.96 0.01 OUTLIER Glycine 0 N--CA 1.511 3.679 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 41.3 Cg_endo -71.17 56.17 1.98 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.589 1.31 . . . . 0.0 109.135 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.84 156.81 27.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 164' ' ' LEU . 84.7 m-20 -51.9 -33.68 38.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.364 -1.08 . . . . 0.0 110.588 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.524 ' CG2' ' OD2' ' A' ' 158' ' ' ASP . 2.9 t -55.54 84.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.105 -0.997 . . . . 0.0 110.111 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.983 HD21 ' CG2' ' A' ' 193' ' ' THR . 0.3 OUTLIER -74.35 -46.38 41.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.507 -0.746 . . . . 0.0 111.765 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.784 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -168.67 179.84 4.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.35 -1.469 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.776 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.4 p-80 178.94 167.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.154 -1.591 . . . . 0.0 111.252 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.78 -169.07 2.13 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.556 -0.715 . . . . 0.0 110.093 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.602 ' CD2' ' HB ' ' A' ' 174' ' ' ILE . 55.2 m-85 -110.3 -166.51 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.632 -1.292 . . . . 0.0 110.515 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.045 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -120.92 -170.25 0.18 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.411 -0.805 . . . . 0.0 109.086 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 1.045 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.6 Cg_endo -74.8 112.94 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.418 1.22 . . . . 0.0 110.505 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . -157.65 -140.63 2.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.6 -93.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.054 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -92.34 -26.99 16.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.613 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -74.04 9.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.515 -0.991 . . . . 0.0 108.816 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.627 ' ND2' ' CZ3' ' A' ' 92' ' ' TRP . 6.2 t30 -63.18 62.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.43 103.4 2.83 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.654 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.5 m-20 -163.27 118.33 1.69 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.601 -1.529 . . . . 0.0 107.377 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.813 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -110.46 166.46 10.97 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.78 -1.2 . . . . 0.0 108.801 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.088 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -158.63 134.61 9.03 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.281 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.578 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 22.4 m-85 -94.19 137.31 33.52 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.625 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.624 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 7.6 t0 -50.87 151.36 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.779 -1.201 . . . . 0.0 108.628 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.19 20.45 8.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.5 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.628 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.5 OUTLIER -107.98 -16.7 14.23 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 1.2 pt-20 -112.54 -98.52 0.42 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.848 -1.158 . . . . 0.0 108.281 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.567 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 1.0 OUTLIER 178.53 165.28 0.81 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.014 -1.054 . . . . 0.0 109.045 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.648 ' CZ3' HG22 ' A' ' 105' ' ' THR . 0.0 OUTLIER -137.51 130.91 31.04 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.179 -0.951 . . . . 0.0 109.229 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.546 ' HA ' HD21 ' A' ' 108' ' ' LEU . 47.3 p -131.64 149.51 52.47 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 227' ' ' THR . 41.3 pttt -74.42 -37.77 63.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.528 ' O ' ' CG2' ' A' ' 227' ' ' THR . 3.3 t70 -83.28 -149.14 0.09 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.845 ' N ' HD11 ' A' ' 229' ' ' LEU . 27.0 m -111.45 46.46 1.1 Allowed 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.542 -1.263 . . . . 0.0 107.849 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.479 ' HB ' HG21 ' A' ' 187' ' ' THR . 91.2 m -98.45 -32.32 11.55 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 111.411 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -118.58 -85.57 1.02 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.755 -1.688 . . . . 0.0 109.489 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.983 ' CG2' HD21 ' A' ' 164' ' ' LEU . 23.7 m -122.67 -98.16 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.671 ' HA ' HG21 ' A' ' 227' ' ' THR . 3.7 m120 -160.45 68.14 0.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.065 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 15.4 tp -29.73 -97.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.843 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -56.77 -19.97 19.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.973 -1.079 . . . . 0.0 111.106 -178.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.64 ' CB ' ' HB3' ' A' ' 194' ' ' ASN . 12.9 tp -60.15 -62.29 1.97 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.146 -1.821 . . . . 0.0 107.517 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.837 HG21 HD23 ' A' ' 164' ' ' LEU . 1.7 t -71.32 -8.12 10.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.09 -58.09 3.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.56 -14.68 61.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.588 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 15.2 t60 -68.32 -48.93 63.57 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 117.878 -1.529 . . . . 0.0 107.913 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.813 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 1.3 mt-10 -80.39 -45.87 16.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 111.092 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.885 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -62.14 -30.99 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.71 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.88 -31.55 55.52 Favored Glycine 0 C--N 1.291 -1.933 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.5 -49.62 76.0 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 121.965 -0.726 . . . . 0.0 110.952 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.519 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 42.5 m -86.25 -53.05 5.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 112.206 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.889 HD22 ' CE2' ' A' ' 132' ' ' PHE . 3.1 pp -104.54 24.7 11.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.123 . . . . 0.0 110.605 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.965 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -127.02 -79.57 0.3 Allowed Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.123 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.02 -162.25 0.36 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.961 -1.317 . . . . 0.0 110.233 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.781 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.7 t80 -99.61 -72.64 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.78 . . . . 0.0 109.538 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.588 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 68.3 m80 -161.13 101.79 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 4.0 m -93.33 -178.12 4.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.371 -0.83 . . . . 0.0 109.247 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.764 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.9 86.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.95 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -89.66 10.18 24.2 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.576 -178.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.4 -28.1 4.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 175.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.538 ' C ' ' HB2' ' A' ' 235' ' ' SER . 5.4 mt-10 -116.25 -36.05 4.16 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.95 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.72 -170.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.383 1.087 . . . . 0.0 112.813 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.875 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -90.44 -16.12 29.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.146 -177.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.594 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -78.38 -7.39 57.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 119.119 -2.238 . . . . 0.0 112.105 -177.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.9 t80 -137.29 15.65 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.526 -1.358 . . . . 0.0 113.604 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.43 -37.0 0.79 Allowed 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 108.473 -1.395 . . . . 0.0 108.473 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.781 ' CD2' HG22 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -21.47 -59.21 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.202 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' HIS . 38.5 t80 -68.0 56.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.3 t-80 179.16 -124.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.45 ' HB3' ' OG1' ' A' ' 190' ' ' THR . 18.4 m -161.0 121.63 2.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.787 -1.196 . . . . 0.0 109.426 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER 179.38 43.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 110.102 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -99.93 -10.45 21.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.815 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.609 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 24.3 t70 179.62 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 109.923 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.845 HD11 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -25.74 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.809 -0.557 . . . . 0.0 111.399 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.34 -6.09 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.731 -1.23 . . . . 0.0 110.261 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.55 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -117.67 -38.18 3.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.001 -1.062 . . . . 0.0 109.069 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.658 ' HA ' HD23 ' A' ' 226' ' ' LEU . 13.3 p90 1.04 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.829 0.824 . . . . 0.0 112.947 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 178.34 174.62 0.59 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.359 -0.838 . . . . 0.0 109.657 178.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.027 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.9 mp -91.18 168.99 11.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 0.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.722 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 30.2 t -101.87 -169.88 1.74 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.188 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.51 ' N ' ' OG ' ' A' ' 235' ' ' SER . 12.5 tm0? -85.25 -12.65 51.98 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.911 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.2 OUTLIER -84.69 -47.79 10.11 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.684 ' O ' HG22 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -66.71 -36.96 83.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.626 177.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.601 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -58.0 -35.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.91 -50.79 54.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -55.94 -55.07 30.99 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.084 HG21 HG21 ' A' ' 127' ' ' VAL . 1.6 tp -63.44 -43.37 98.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.83 -1.394 . . . . 0.0 109.589 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.2 mt-30 -54.13 -31.35 52.03 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.0 p -75.5 -22.35 57.25 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.838 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -66.84 -64.57 0.83 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.596 ' CD2' ' HB2' ' A' ' 130' ' ' LEU . 5.7 t80 . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.983 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.766 ' CD ' ' HB1' ' A' ' 169' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.649 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 69.6 m95 -73.87 155.6 38.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.742 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.1 -34.55 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.776 ' O ' HD11 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -55.17 -165.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.264 -0.897 . . . . 0.0 109.548 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.57 ' HA ' HD11 ' A' ' 130' ' ' LEU . 66.2 p -124.33 4.24 8.44 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.607 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.571 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 59.4 m80 -148.15 97.08 2.73 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.451 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.4 mm? -97.5 175.02 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.634 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -142.64 155.7 44.97 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.232 -0.918 . . . . 0.0 108.569 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.905 ' CE2' HD11 ' A' ' 101' ' ' ILE . 24.6 p90 -133.49 171.07 14.58 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.794 -1.192 . . . . 0.0 109.233 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.541 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -131.35 145.87 52.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 109.412 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.905 HD11 ' CE2' ' A' ' 99' ' ' TYR . 1.6 mp -100.22 61.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.965 -1.084 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 144' ' ' ILE . 18.1 t -73.86 2.44 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 0.0 110.021 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.605 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -101.45 164.37 11.8 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.804 -1.185 . . . . 0.0 109.025 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.633 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.2 p90 177.94 46.37 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.893 HG21 ' NE1' ' A' ' 186' ' ' TRP . 24.8 p -40.15 149.88 0.28 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.595 -0.69 . . . . 0.0 109.36 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 -25.77 42.67 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.946 1.498 . . . . 0.0 109.044 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -65.76 -12.16 51.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 187' ' ' THR . 32.3 mt -138.53 124.02 12.28 Favored Pre-proline 0 N--CA 1.484 1.251 0 O-C-N 121.543 -0.723 . . . . 0.0 109.827 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.3 Cg_endo -65.6 167.35 17.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 123.773 1.407 . . . . 0.0 108.867 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.504 ' O ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -37.8 -65.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.747 0.784 . . . . 0.0 110.263 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -28.57 49.73 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.75 -0.594 . . . . 0.0 111.725 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.776 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.19 -61.15 1.92 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.487 -1.383 . . . . 0.0 109.448 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.6 p -51.19 -39.4 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.535 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -66.33 -26.22 67.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.717 ' OG ' HD21 ' A' ' 195' ' ' LEU . 13.9 p -67.35 -37.37 83.14 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.071 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -75.18 -34.81 61.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.331 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.872 HG13 HG13 ' A' ' 144' ' ' ILE . 3.5 t -74.94 -23.72 17.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 1.8 tt0 -85.82 -36.33 20.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.721 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -79.41 -38.84 33.87 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.767 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -63.49 -61.65 2.19 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.85 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -51.56 -40.91 60.63 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.128 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.739 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -76.72 -33.64 58.17 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.738 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.07 HG21 ' CE1' ' A' ' 196' ' ' PHE . 2.1 t -56.19 -40.8 67.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.033 ' O ' HG23 ' A' ' 128' ' ' THR . 44.4 m95 -91.43 -24.8 19.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.316 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 9.6 tm-20 -69.55 -27.45 65.16 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.757 -1.214 . . . . 0.0 107.996 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.2 pt-20 -89.9 -42.89 10.95 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.674 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.027 HG13 ' O ' ' A' ' 123' ' ' VAL . 15.3 m -59.8 -24.11 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 118.259 -1.376 . . . . 0.0 109.159 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.033 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.93 162.94 20.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.012 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -84.46 1.54 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.249 1.966 . . . . 0.0 110.116 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.155 HD13 ' CD1' ' A' ' 246' ' ' TYR . 0.2 OUTLIER -80.92 -176.16 5.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.026 -1.046 . . . . 0.0 110.603 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.3 p -121.71 165.55 15.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.778 . . . . 0.0 109.947 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.826 ' CZ ' HD22 ' A' ' 207' ' ' LEU . 0.6 OUTLIER -140.93 158.22 44.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.426 -0.796 . . . . 0.0 109.698 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.58 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.5 m -146.59 179.6 7.44 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.897 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -148.12 -179.76 7.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.805 -1.184 . . . . 0.0 110.246 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.069 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -163.61 -130.63 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 27.2 t80 178.24 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.833 -1.167 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -162.61 -171.81 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 37.66 -99.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 178.46 107.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -1.135 . . . . 0.0 110.296 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 1.069 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -59.91 -150.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.827 ' C ' HD12 ' A' ' 142' ' ' ILE . 80.0 m-20 -88.06 -34.43 17.96 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.883 HG12 HD23 ' A' ' 207' ' ' LEU . 2.8 mp -124.23 77.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.532 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 2.8 ptm -67.54 102.87 1.22 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.872 HG13 HG13 ' A' ' 117' ' ' VAL . 5.1 mm -81.98 117.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -133.19 156.58 47.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.429 -1.42 . . . . 0.0 112.119 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 39.6 p90 -79.94 133.61 36.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.474 -0.767 . . . . 0.0 109.14 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.912 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -155.92 -178.08 7.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.958 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.0 OUTLIER 179.78 -155.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.44 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.815 ' N ' HG13 ' A' ' 148' ' ' VAL . 2.8 mtm-85 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.462 -0.774 . . . . 0.0 109.641 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 109.208 -1.112 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.733 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -98.24 -170.43 1.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.912 -1.118 . . . . 0.0 111.257 -178.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.562 ' O ' ' C ' ' A' ' 159' ' ' GLY . 15.5 p30 178.5 62.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -18.86 -59.0 0.01 OUTLIER Glycine 0 N--CA 1.501 2.982 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 183' ' ' ASP . 37.9 Cg_endo -65.87 60.19 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.297 1.156 . . . . 0.0 109.743 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -177.42 164.07 33.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' LEU . 0.6 OUTLIER -45.56 -59.95 2.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.312 -1.111 . . . . 0.0 110.123 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.653 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 61.0 t -33.85 90.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.354 0.597 . . . . 0.0 110.88 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.021 HD22 HD13 ' A' ' 222' ' ' LEU . 1.1 mp -80.08 -75.48 0.26 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.238 -0.914 . . . . 0.0 112.186 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.998 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -145.64 -168.25 2.92 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.196 -1.565 . . . . 0.0 111.38 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.733 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER 179.67 -179.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.957 -1.714 . . . . 0.0 111.133 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -154.75 177.61 11.06 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.536 -0.728 . . . . 0.0 110.23 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 1.009 ' CD1' HD11 ' A' ' 174' ' ' ILE . 76.7 m-85 -114.39 -167.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.16 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.953 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -171.21 -60.51 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.495 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.953 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.6 Cg_endo -77.29 147.97 26.46 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.796 1.419 . . . . 0.0 109.875 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 118.83 -178.75 16.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 174' ' ' ILE . 44.1 Cg_endo -75.97 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.063 1.559 . . . . 0.0 110.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.16 -33.25 21.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 1.009 HD11 ' CD1' ' A' ' 168' ' ' TYR . 1.9 tt -62.16 -7.75 2.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.352 -1.087 . . . . 0.0 108.8 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 169' ' ' ALA . 50.7 p-10 -67.29 65.92 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.127 -0.983 . . . . 0.0 109.405 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 128.74 78.7 0.23 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.1 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -152.16 115.15 4.65 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.217 -1.166 . . . . 0.0 107.975 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.646 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -106.31 164.83 11.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.262 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.912 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -155.96 133.77 11.16 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.571 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.573 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 12.2 m-85 -96.55 135.94 37.75 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.958 ' OD1' HG23 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -58.02 115.81 3.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.788 -1.195 . . . . 0.0 107.985 177.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.484 ' OD1' ' HB ' ' A' ' 148' ' ' VAL . 11.9 p-10 -83.91 13.51 4.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.719 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.889 ' HB2' HG21 ' A' ' 148' ' ' VAL . 2.0 t70 -121.05 14.09 11.4 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.076 -1.015 . . . . 0.0 110.725 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.542 ' OE2' HD11 ' A' ' 164' ' ' LEU . 15.7 tt0 -117.66 -132.1 0.32 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.814 -1.179 . . . . 0.0 108.944 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.612 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.9 mt-30 -122.1 166.57 14.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 109.111 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.893 ' NE1' HG21 ' A' ' 105' ' ' THR . 94.5 m95 -159.42 107.44 1.78 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.821 ' HA ' HD21 ' A' ' 108' ' ' LEU . 19.6 p -135.35 153.52 51.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.849 -1.157 . . . . 0.0 109.533 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.665 ' HA ' HD22 ' A' ' 195' ' ' LEU . 1.6 pttt -76.79 -28.97 55.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.645 ' OD2' HD12 ' A' ' 229' ' ' LEU . 0.3 OUTLIER -99.85 -151.18 0.39 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.87 ' HB ' HD11 ' A' ' 229' ' ' LEU . 10.2 t -105.71 45.4 0.97 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.459 ' HB ' HG21 ' A' ' 187' ' ' THR . 87.6 m -99.77 -31.25 11.62 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.394 -0.816 . . . . 0.0 111.204 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.537 ' N ' HG21 ' A' ' 187' ' ' THR . . . -118.21 -96.75 1.81 Allowed Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.804 -1.665 . . . . 0.0 109.064 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.768 ' CG2' HD21 ' A' ' 164' ' ' LEU . 48.3 m -104.31 -106.22 0.29 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.706 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 10.5 m120 -159.14 74.23 0.63 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.93 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.9 OUTLIER -27.01 -95.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.661 0.743 . . . . 0.0 112.55 -178.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 1.07 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -64.34 -12.17 39.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.013 -1.054 . . . . 0.0 110.983 -176.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.897 HD12 ' OG1' ' A' ' 227' ' ' THR . 5.5 tt -62.03 -62.08 2.03 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.884 -1.526 . . . . 0.0 107.078 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.998 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 39.4 t -72.79 -9.32 12.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.071 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.88 -57.43 3.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.38 -15.38 62.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.532 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 20.5 t60 -68.74 -46.13 69.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.962 -1.495 . . . . 0.0 107.81 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.761 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 1.3 mt-10 -82.32 -47.42 12.38 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.046 -1.034 . . . . 0.0 110.834 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.785 HG21 ' HA ' ' A' ' 121' ' ' LEU . 2.3 mt -61.48 -31.46 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.675 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.0 -33.29 46.09 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.93 -49.52 75.81 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.819 -0.813 . . . . 0.0 110.798 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.522 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 27.4 p -83.73 -56.88 3.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 112.2 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.883 HD23 HG12 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -104.16 22.94 13.83 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.016 -1.052 . . . . 0.0 110.84 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 1.117 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -121.71 -78.92 0.5 Allowed Glycine 0 C--N 1.291 -1.923 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.938 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.4 pp -167.5 -160.09 0.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.019 -1.283 . . . . 0.0 109.76 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.772 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.0 OUTLIER -98.12 -73.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.585 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.1 m-70 -163.01 93.49 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.913 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.645 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -81.78 179.33 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -0.836 . . . . 0.0 109.806 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.871 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.53 83.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.944 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -87.0 12.06 12.17 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.861 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -49.78 -28.25 6.01 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.527 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.1 mp0 -116.29 -36.16 4.11 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.944 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.45 -164.72 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.292 1.044 . . . . 0.0 112.681 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.05 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.1 OUTLIER -99.85 -13.01 19.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.074 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.585 ' HG2' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -80.3 -6.63 58.25 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 119.552 -1.967 . . . . 0.0 111.978 -177.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.649 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.2 OUTLIER -137.53 14.57 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.617 -1.302 . . . . 0.0 113.502 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 54.2 Cg_endo -77.41 -42.05 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 1.021 HD13 HD22 ' A' ' 164' ' ' LEU . 4.0 tp -0.26 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 CA-C-O 121.494 0.664 . . . . 0.0 111.039 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.541 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 9.8 t80 -67.46 58.4 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 109.754 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.2 OUTLIER 179.57 172.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 109.778 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.8 128.83 55.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.253 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' ASP . 0.3 OUTLIER 178.83 -73.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.835 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 1.008 HG21 HD22 ' A' ' 218' ' ' LEU . 1.5 p -66.44 53.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 0.0 110.442 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 226' ' ' LEU . 5.0 m-20 -162.54 -53.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -60.74 -142.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.755 . . . . 0.0 109.458 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.4 p -94.46 -22.76 18.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 0.0 110.049 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -79.97 -16.55 54.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 108.786 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.601 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 23.2 p90 -30.75 106.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.602 0.715 . . . . 0.0 111.291 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.532 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 7.6 ttt-85 -161.04 153.15 20.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.214 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.967 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.8 mp -77.65 173.94 11.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.281 -0.887 . . . . 0.0 110.463 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 21.7 t -102.81 -172.0 2.05 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.909 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.38 -12.89 53.67 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.778 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.871 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.6 m-20 -84.11 -49.28 9.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.769 -1.207 . . . . 0.0 108.15 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.938 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.68 -39.48 93.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 117.197 -1.801 . . . . 0.0 106.616 178.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 235' ' ' SER . 0.8 OUTLIER -55.19 -36.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.47 -56.92 8.66 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.646 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -52.23 -51.58 40.94 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.117 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.8 tp -63.86 -47.93 88.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.85 -1.382 . . . . 0.0 109.656 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.588 ' N ' HG23 ' A' ' 242' ' ' ILE . 21.3 tt0 -53.58 -28.29 31.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 t -82.42 -18.12 42.98 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.796 ' HB3' HD12 ' A' ' 242' ' ' ILE . 5.7 tt -73.3 -60.57 2.18 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 1.155 ' CD1' HD13 ' A' ' 130' ' ' LEU . 11.1 m-85 . . . . . 0 N--CA 1.493 1.723 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.445 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.524 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.465 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 72.7 m95 -107.27 169.13 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.963 -1.085 . . . . 0.0 109.617 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -135.4 -36.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.598 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.84 ' HE3' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -47.58 177.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.735 ' HA ' HD22 ' A' ' 130' ' ' LEU . 71.2 p -116.7 5.58 13.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.501 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.527 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 4.5 m-70 -126.63 91.14 3.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.99 -1.069 . . . . 0.0 110.073 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.84 HD13 ' HE3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -99.31 158.29 15.81 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.6 -0.688 . . . . 0.0 109.988 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.595 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -129.54 154.86 46.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.674 ' CE2' HD11 ' A' ' 101' ' ' ILE . 3.0 p90 -140.77 167.69 21.58 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.724 -1.235 . . . . 0.0 109.364 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -132.12 138.11 47.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.095 . . . . 0.0 109.47 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.766 HG22 ' O ' ' A' ' 101' ' ' ILE . 1.5 mp -93.32 66.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.14 -0.975 . . . . 0.0 109.746 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 144' ' ' ILE . 6.0 t -78.38 8.82 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 109.93 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.988 ' C ' HG21 ' A' ' 113' ' ' VAL . 8.5 m120 -105.35 153.25 21.9 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.0 -1.062 . . . . 0.0 109.392 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.785 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER 178.68 41.04 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.717 -0.614 . . . . 0.0 109.697 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 104' ' ' TYR . 61.4 p -41.57 156.1 0.22 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.42 -0.8 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -22.87 41.73 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.877 1.462 . . . . 0.0 108.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.688 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -72.04 -6.3 41.34 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.077 HD13 ' CD2' ' A' ' 195' ' ' LEU . 83.1 mt -143.5 116.48 5.91 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.517 -0.74 . . . . 0.0 109.707 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.68 171.48 9.58 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 O-C-N 123.856 1.45 . . . . 0.0 109.06 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.01 -65.38 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.84 0.829 . . . . 0.0 110.295 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 115' ' ' SER . 26.0 t0 -57.43 -28.23 63.12 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.821 -0.549 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.889 ' O ' HD21 ' A' ' 195' ' ' LEU . . . -73.18 -61.95 1.64 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.248 -1.532 . . . . 0.0 109.265 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.988 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.8 p -54.25 -40.67 48.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 1.0 OUTLIER -64.9 -27.86 69.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 112' ' ' ALA . 1.2 p -62.14 -41.84 98.67 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.036 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -73.72 -34.16 64.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.059 . . . . 0.0 110.639 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.955 HG13 HG13 ' A' ' 144' ' ' ILE . 5.8 t -74.36 -24.08 18.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -91.64 -34.82 14.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -79.02 -37.48 39.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.828 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -67.36 -62.02 1.63 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.848 HD11 ' CG ' ' A' ' 132' ' ' PHE . 8.1 tp -49.67 -45.04 48.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -73.41 -34.72 65.65 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.798 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.0 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -55.53 -40.6 59.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.066 ' CH2' HD21 ' A' ' 234' ' ' LEU . 51.0 m95 -92.27 -20.01 21.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.091 -1.005 . . . . 0.0 110.517 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 37.1 tt0 -75.24 -27.58 59.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.018 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.5 pt-20 -90.15 -45.19 9.28 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.551 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.0 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.5 m -57.3 -27.07 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.447 -1.301 . . . . 0.0 108.357 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -121.22 155.86 58.01 Favored Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.223 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -77.49 25.95 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.091 1.86 . . . . 0.0 111.946 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' A' ' 95' ' ' THR . 5.0 mt -100.89 169.86 8.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.399 . . . . 0.0 110.093 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.5 p -119.12 166.45 12.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.848 ' CG ' HD11 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -141.18 159.44 42.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.117 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -155.9 122.4 5.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 108.746 179.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 3.2 ppt_? -108.38 174.59 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.076 . . . . 0.0 110.64 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.81 -95.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 100' ' ' ARG . 3.5 t80 177.51 33.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.975 . . . . 0.0 109.098 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.484 ' H ' HD13 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -76.57 179.43 5.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -45.75 -42.3 10.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 140' ' ' ALA . 2.0 pt-20 -176.13 105.02 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -1.102 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.595 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.14 -150.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.29 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 176' ' ' GLY . 45.3 t0 -81.28 -35.8 30.64 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 207' ' ' LEU . 51.6 mt -127.97 81.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.415 ' CE ' HG21 ' A' ' 102' ' ' VAL . 2.6 ttt -67.13 100.26 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.955 HG13 HG13 ' A' ' 117' ' ' VAL . 6.1 mm -82.26 115.02 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.04 -1.037 . . . . 0.0 108.348 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.3 OUTLIER -134.11 159.22 41.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.37 -1.456 . . . . 0.0 112.447 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.501 ' CA ' ' ND2' ' A' ' 103' ' ' ASN . 13.2 p90 -100.17 133.09 45.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.716 -0.615 . . . . 0.0 110.252 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.168 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -160.28 -159.07 0.67 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.096 -1.003 . . . . 0.0 110.724 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 149' ' ' ARG . 2.3 p -166.38 -170.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.979 -1.076 . . . . 0.0 109.185 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.741 ' H ' HG22 ' A' ' 148' ' ' VAL . 7.9 ptt-85 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.172 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--O 1.214 -0.69 0 N-CA-C 109.474 -1.01 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.778 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 5.5 m-85 -113.42 -169.64 1.54 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.105 -0.997 . . . . 0.0 110.282 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.641 ' OD2' HG21 ' A' ' 163' ' ' VAL . 9.5 p30 178.96 61.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.574 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -10.88 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.506 3.341 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 38.4 Cg_endo -67.23 59.16 0.65 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.573 1.302 . . . . 0.0 109.692 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -173.81 146.65 8.9 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -41.95 -27.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -1.052 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.641 HG21 ' OD2' ' A' ' 158' ' ' ASP . 2.8 t -52.44 82.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.519 -0.738 . . . . 0.0 110.781 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.073 HD21 HG21 ' A' ' 193' ' ' THR . 0.7 OUTLIER -70.59 -81.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.346 -0.846 . . . . 0.0 111.619 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.866 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -145.33 -179.63 6.77 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.65 -1.281 . . . . 0.0 111.409 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.778 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 2.0 p-80 179.28 162.39 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.808 -1.807 . . . . 0.0 110.383 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.43 -167.99 1.94 Allowed 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.191 -0.943 . . . . 0.0 110.418 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 206' ' ' SER . 95.4 m-85 -125.37 -163.05 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 0.0 110.344 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.009 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -172.23 -60.59 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.294 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 1.009 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.6 Cg_endo -76.57 118.56 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.831 1.437 . . . . 0.0 109.981 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 148.22 173.94 19.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -74.47 -91.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.128 1.594 . . . . 0.0 110.146 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -73.64 -28.16 65.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -75.32 8.29 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -1.149 . . . . 0.0 108.407 178.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 169' ' ' ALA . 20.5 p-10 -65.83 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 112.41 97.57 2.34 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -160.11 124.23 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.755 -1.439 . . . . 0.0 107.62 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.811 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.01 159.2 17.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 108.589 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.168 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -156.96 131.53 8.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.591 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.574 ' HB3' ' CH2' ' A' ' 186' ' ' TRP . 37.0 m-85 -93.08 142.45 27.28 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.188 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.718 ' OD1' HG23 ' A' ' 148' ' ' VAL . 5.7 t0 -64.39 144.12 57.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.451 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 4.6 p30 -109.91 24.23 13.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.637 -1.289 . . . . 0.0 110.139 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.574 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 20.1 m-20 -131.06 15.41 5.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.044 -1.035 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 7.6 tt0 -118.95 -132.88 0.32 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.598 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 88.6 mt-30 -114.44 163.04 15.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.821 -1.174 . . . . 0.0 108.514 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.598 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 98.8 m95 -158.44 105.37 1.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.93 -1.106 . . . . 0.0 110.398 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.967 ' HA ' HD21 ' A' ' 108' ' ' LEU . 80.8 p -146.6 154.25 41.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.352 -0.843 . . . . 0.0 109.399 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 227' ' ' THR . 4.5 pttm -81.06 -30.31 34.81 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 229' ' ' LEU . 3.2 t70 -98.17 -148.13 0.33 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.609 ' N ' ' CD1' ' A' ' 229' ' ' LEU . 12.8 t -99.86 37.48 1.61 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.531 HG22 HG21 ' A' ' 187' ' ' THR . 21.4 m -86.23 -35.61 19.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.436 -0.79 . . . . 0.0 111.072 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.626 ' N ' HG21 ' A' ' 187' ' ' THR . . . -133.75 -95.78 0.56 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.612 -1.756 . . . . 0.0 109.706 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.073 HG21 HD21 ' A' ' 164' ' ' LEU . 77.5 m -100.83 -108.35 0.22 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.709 ' HA ' HG21 ' A' ' 227' ' ' THR . 34.2 m-80 -159.52 71.55 0.5 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.077 ' CD2' HD13 ' A' ' 108' ' ' LEU . 7.9 tp -29.29 -96.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.854 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -49.89 -24.2 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.071 . . . . 0.0 111.391 -178.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.99 HD11 ' CG ' ' A' ' 221' ' ' PRO . 13.8 tp -58.05 -61.3 2.65 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 117.381 -1.727 . . . . 0.0 107.807 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.866 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 1.4 t -73.59 -5.65 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.816 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.014 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.14 -57.67 3.66 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.698 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.55 -17.26 64.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.606 ' CE1' ' HA ' ' A' ' 219' ' ' MET . 3.3 t-160 -69.59 -41.76 75.36 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 117.079 -1.848 . . . . 0.0 108.135 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.834 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 0.8 OUTLIER -83.4 -49.52 9.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 0.0 110.464 179.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.8 mt -59.11 -31.62 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.719 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.41 -34.85 39.04 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -58.49 -48.49 80.63 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.8 -0.823 . . . . 0.0 110.744 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.553 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 68.7 p -87.0 -55.74 3.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 112.104 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.915 ' HB2' HD11 ' A' ' 142' ' ' ILE . 0.6 OUTLIER -103.95 31.3 4.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.256 -0.902 . . . . 0.0 110.095 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.767 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -135.04 -80.97 0.13 Allowed Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.842 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -169.07 -165.9 0.58 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.264 . . . . 0.0 110.352 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.711 ' N ' HD12 ' A' ' 209' ' ' LEU . 75.7 t80 -93.53 -83.91 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.572 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.3 m-70 -151.61 122.64 7.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.651 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.642 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -113.13 -178.11 3.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -0.925 . . . . 0.0 109.388 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.91 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -60.87 85.92 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.963 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -91.0 12.39 19.88 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.395 -1.322 . . . . 0.0 112.115 -177.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.444 ' C ' ' O ' ' A' ' 214' ' ' ASN . 1.7 p -50.74 -27.74 7.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.51 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.6 mm-40 -116.6 -35.59 4.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.706 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.963 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -59.02 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 122.076 0.941 . . . . 0.0 112.755 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.983 ' HB2' HD13 ' A' ' 234' ' ' LEU . 0.1 OUTLIER -115.71 -13.29 11.45 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.776 -177.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.606 ' HA ' ' CE1' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -81.38 -7.01 59.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.312 -2.117 . . . . 0.0 111.799 -178.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -134.08 13.37 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.594 -1.316 . . . . 0.0 113.475 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.99 ' CG ' HD11 ' A' ' 197' ' ' LEU . 51.3 Cg_endo -76.26 -36.07 2.01 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 N-CA-C 109.099 -1.154 . . . . 0.0 109.099 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 1.036 HD12 HD12 ' A' ' 164' ' ' LEU . 1.6 tt -17.41 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.291 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.942 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.5 OUTLIER -68.02 54.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 222' ' ' LEU . 33.1 t60 178.77 -129.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 108.658 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -154.29 136.46 14.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.799 -1.188 . . . . 0.0 108.913 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.773 ' N ' HD21 ' A' ' 229' ' ' LEU . 0.1 OUTLIER 179.53 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 110.704 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -103.83 -28.74 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 108.825 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.597 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 7.6 t70 -172.26 3.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.892 . . . . 0.0 110.792 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.804 ' N ' HD13 ' A' ' 229' ' ' LEU . 0.1 OUTLIER -44.55 -51.98 8.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.821 -1.175 . . . . 0.0 108.99 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.74 -28.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.557 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.8 mtp180 -104.0 -39.74 6.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.474 -0.766 . . . . 0.0 109.43 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.597 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 21.9 p90 0.59 109.7 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.349 0.595 . . . . 0.0 112.443 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.79 177.27 0.49 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.316 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.066 HD21 ' CH2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -89.52 175.04 7.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.009 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.87 ' H ' HD12 ' A' ' 234' ' ' LEU . 16.4 t -111.96 -169.22 1.43 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.131 -0.981 . . . . 0.0 110.257 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.546 ' N ' ' OG ' ' A' ' 235' ' ' SER . 68.1 tp60 -84.49 -15.79 44.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.575 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.91 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 5.4 m-20 -84.25 -46.44 11.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.505 -1.372 . . . . 0.0 108.339 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.842 ' OD1' HD11 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -67.55 -35.77 79.69 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 117.381 -1.728 . . . . 0.0 106.543 177.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 234' ' ' LEU . 0.5 OUTLIER -58.67 -34.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -45.96 73.91 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -63.88 -50.58 60.05 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -70.74 -47.81 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.723 -1.457 . . . . 0.0 109.586 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.594 ' N ' HG23 ' A' ' 242' ' ' ILE . 40.4 tt0 -53.98 -29.49 43.25 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.8 t -77.21 -22.47 52.27 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.767 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -64.66 -63.37 1.14 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.219 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.663 ' CD1' HD11 ' A' ' 130' ' ' LEU . 24.1 m-85 . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.677 ' CB ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.603 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 90.3 m95 -90.2 148.69 22.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -126.31 -32.67 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.0 109.346 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.786 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -51.57 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.462 -0.774 . . . . 0.0 110.129 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.626 ' HA ' HD22 ' A' ' 130' ' ' LEU . 21.7 p -116.93 -0.05 12.32 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.576 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 40.1 m80 -146.96 93.2 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.599 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.789 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.8 mm? -82.91 177.62 8.55 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.304 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.651 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -144.78 155.24 43.42 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.959 -1.088 . . . . 0.0 108.893 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 1.057 ' CE2' HD11 ' A' ' 101' ' ' ILE . 4.9 p90 -136.63 166.17 24.18 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.629 -1.294 . . . . 0.0 109.385 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.855 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -129.76 125.53 36.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.057 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -85.11 83.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.855 HG22 ' NE ' ' A' ' 100' ' ' ARG . 1.7 t -99.98 6.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.892 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.867 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -101.79 157.79 16.59 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.619 -1.301 . . . . 0.0 109.459 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.693 ' N ' HG21 ' A' ' 113' ' ' VAL . 20.7 t80 178.33 70.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.767 . . . . 0.0 109.413 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.67 HG21 ' CD1' ' A' ' 186' ' ' TRP . 38.6 p -66.28 158.35 77.85 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 108.584 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -22.12 40.88 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.885 1.466 . . . . 0.0 108.68 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.633 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -74.14 -4.72 37.45 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.075 HD13 HD12 ' A' ' 195' ' ' LEU . 83.7 mt -141.56 117.44 7.2 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.497 -0.752 . . . . 0.0 109.871 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.07 165.33 17.03 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.76 1.4 . . . . 0.0 109.171 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -35.99 -65.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.811 0.815 . . . . 0.0 110.332 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.98 -10.25 5.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.774 -0.579 . . . . 0.0 111.517 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.763 ' O ' HD11 ' A' ' 195' ' ' LEU . . . -86.43 -61.68 1.68 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.478 -1.389 . . . . 0.0 108.949 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.723 HG21 ' C ' ' A' ' 103' ' ' ASN . 7.5 p -54.67 -40.56 51.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.586 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.3 -27.01 69.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.891 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -67.39 -38.49 84.77 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.133 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -72.86 -33.95 66.44 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.901 -1.124 . . . . 0.0 109.66 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.971 HG13 HG13 ' A' ' 144' ' ' ILE . 57.3 t -76.06 -22.9 15.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.9 OUTLIER -89.11 -34.38 16.76 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.669 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.44 -38.02 27.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.759 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -64.49 -61.24 2.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.826 HD22 ' CD1' ' A' ' 99' ' ' TYR . 14.2 tp -53.45 -46.65 69.97 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.765 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -66.39 -35.3 79.97 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.138 -178.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.883 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.0 t -57.09 -36.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.089 ' O ' HG23 ' A' ' 128' ' ' THR . 56.2 m95 -92.61 -25.17 18.43 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.931 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -71.83 -27.34 62.84 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.627 -1.296 . . . . 0.0 108.29 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.0 pt-20 -92.44 -42.82 9.54 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.029 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 123' ' ' VAL . 19.8 m -63.9 -21.16 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.25 -1.38 . . . . 0.0 109.971 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.089 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -108.35 162.67 19.11 Favored Pre-proline 0 N--CA 1.5 2.046 0 C-N-CA 117.472 -1.691 . . . . 0.0 109.883 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.675 ' O ' HD23 ' A' ' 130' ' ' LEU . 50.2 Cg_endo -81.02 21.74 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.1 1.867 . . . . 0.0 111.729 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.786 HD13 ' O ' ' A' ' 94' ' ' LYS . 21.7 mt -122.22 -173.7 2.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.5 -1.375 . . . . 0.0 110.561 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -124.07 -168.22 1.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.973 -179.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.777 ' HE2' HD13 ' A' ' 207' ' ' LEU . 0.4 OUTLIER -153.02 175.77 12.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.554 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -149.17 -173.44 4.38 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.616 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.34 163.04 39.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.49 -1.381 . . . . 0.0 110.768 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.07 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -151.19 -131.9 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.47 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.726 -1.234 . . . . 0.0 109.444 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 139' ' ' GLU . 7.0 pm0 -166.79 -164.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 109.928 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 36.3 -97.43 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' OE2' ' HA2' ' A' ' 173' ' ' GLY . 0.9 OUTLIER 178.38 107.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -1.105 . . . . 0.0 110.398 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 1.07 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -63.15 -151.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 108.699 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.603 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 63.2 m-20 -87.7 -32.62 19.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 144' ' ' ILE . 4.4 mp -128.54 83.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.1 ttt -66.51 98.77 0.52 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 108.905 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.971 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -82.42 115.79 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.819 -1.176 . . . . 0.0 108.149 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.93 153.01 52.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.55 -1.344 . . . . 0.0 111.48 -179.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.2 p90 -93.79 139.18 31.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.149 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -163.72 -159.96 0.54 Allowed 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.351 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.78 HG21 ' HB2' ' A' ' 183' ' ' ASP . 1.7 p -173.32 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 109.064 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.711 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.753 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 C--O 1.214 -0.688 0 N-CA-C 109.849 -0.866 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.767 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.3 OUTLIER -81.08 -165.9 1.02 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 110.341 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.578 ' O ' ' C ' ' A' ' 159' ' ' GLY . 48.4 p-10 179.29 57.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.712 -0.617 . . . . 0.0 110.366 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -21.34 -67.71 0.01 OUTLIER Glycine 0 N--CA 1.509 3.53 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 183' ' ' ASP . 43.7 Cg_endo -74.04 52.87 2.75 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.525 1.277 . . . . 0.0 109.401 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -155.89 156.78 27.3 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 164' ' ' LEU . 20.4 m-80 -47.61 -41.71 22.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.66 -0.906 . . . . 0.0 110.507 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 163' ' ' VAL . 78.6 t -59.89 78.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 110.136 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.064 ' CD2' HG21 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -59.1 -55.05 40.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.416 -0.802 . . . . 0.0 111.784 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.8 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -163.68 -174.91 3.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.723 -1.236 . . . . 0.0 111.245 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.767 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.5 p-80 178.42 165.06 0.78 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.141 -1.599 . . . . 0.0 110.989 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -129.29 -158.97 0.92 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.405 -0.809 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.694 ' CD1' HD11 ' A' ' 174' ' ' ILE . 3.7 m-85 -122.83 -169.37 1.91 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.582 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -117.54 -166.39 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.0 Cg_endo -74.97 123.51 7.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.05 1.026 . . . . 0.0 110.825 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . -172.15 -171.32 36.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.68 101.82 1.34 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.569 1.3 . . . . 0.0 109.91 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.474 ' HA2' ' OE2' ' A' ' 139' ' ' GLU . . . 81.5 -51.16 4.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.694 HD11 ' CD1' ' A' ' 168' ' ' TYR . 1.7 tt -68.67 2.58 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.623 -0.928 . . . . 0.0 109.346 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.579 ' O ' ' CH2' ' A' ' 92' ' ' TRP . 8.1 p-10 -63.52 63.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.56 -0.712 . . . . 0.0 109.227 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.02 101.73 2.69 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.4 m-20 -157.16 120.33 4.07 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.718 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.56 161.8 15.01 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.889 -1.132 . . . . 0.0 108.916 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.149 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -156.09 133.16 10.6 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.056 -1.058 . . . . 0.0 108.811 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 73.1 m-85 -93.71 141.28 28.67 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.741 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.592 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 23.7 p30 -63.51 144.55 56.9 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.667 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.57 22.27 11.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.669 -1.269 . . . . 0.0 110.447 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.78 ' HB2' HG21 ' A' ' 148' ' ' VAL . 27.2 t0 -115.95 11.21 15.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.957 -1.09 . . . . 0.0 110.359 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.515 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 2.9 pt-20 -126.43 -108.21 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.772 -1.205 . . . . 0.0 109.282 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 3.9 mt-30 -148.31 173.91 12.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.712 -1.242 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.714 ' CH2' HD23 ' A' ' 164' ' ' LEU . 88.7 m95 -162.54 132.58 4.57 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.039 -1.038 . . . . 0.0 110.029 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.9 ' HA ' HD21 ' A' ' 108' ' ' LEU . 31.0 p -153.64 153.26 31.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.077 -1.014 . . . . 0.0 109.51 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 227' ' ' THR . 0.0 OUTLIER -73.43 -37.38 65.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 227' ' ' THR . 1.3 t70 -86.04 -145.3 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.876 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.7 t -115.61 46.26 1.54 Allowed 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 118.761 -1.176 . . . . 0.0 108.196 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.511 ' HB ' HG21 ' A' ' 187' ' ' THR . 97.8 m -101.58 -31.06 11.03 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.382 -0.824 . . . . 0.0 111.186 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.547 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -111.95 -86.99 1.66 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.878 -1.63 . . . . 0.0 109.096 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.052 HG21 HD21 ' A' ' 164' ' ' LEU . 35.4 m -125.01 -97.21 0.43 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.75 ' ND2' HG22 ' A' ' 193' ' ' THR . 0.8 OUTLIER -158.12 67.53 0.48 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.107 -0.995 . . . . 0.0 108.42 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.133 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -27.79 -94.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.54 0.686 . . . . 0.0 111.553 -179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.853 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -67.63 -12.66 60.95 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 111.013 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.806 ' HA ' HD11 ' A' ' 218' ' ' LEU . 8.5 tp -63.06 -64.25 0.97 Allowed 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.906 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.064 HG21 ' CD2' ' A' ' 164' ' ' LEU . 2.5 t -69.46 -12.02 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.049 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.76 -57.4 4.01 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.963 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -66.99 -14.61 63.05 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.556 ' CG ' ' SD ' ' A' ' 219' ' ' MET . 11.4 t60 -69.93 -43.97 70.56 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 117.821 -1.551 . . . . 0.0 107.743 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.718 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 2.3 mt-10 -82.53 -49.05 10.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.768 HG22 HD21 ' A' ' 207' ' ' LEU . 1.4 mt -59.95 -30.74 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.735 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -80.32 -29.68 44.11 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -62.2 -42.84 99.66 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.701 -0.882 . . . . 0.0 110.558 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.523 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 68.5 m -90.57 -51.71 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.108 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.777 HD13 ' HE2' ' A' ' 132' ' ' PHE . 0.5 OUTLIER -104.78 20.66 18.32 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.008 -1.057 . . . . 0.0 110.828 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.939 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -124.48 -79.25 0.39 Allowed Glycine 0 C--N 1.291 -1.96 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.256 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.934 HD21 ' OD2' ' A' ' 238' ' ' ASP . 1.0 OUTLIER -171.25 -156.29 0.11 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.428 -1.631 . . . . 0.0 110.939 -178.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.568 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.5 OUTLIER -101.49 -86.58 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.592 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.1 m-70 -152.32 89.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.457 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.588 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.0 m -79.47 178.72 7.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.116 -0.99 . . . . 0.0 108.574 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.495 ' HB3' ' OD2' ' A' ' 237' ' ' ASP . . . -59.09 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.94 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.16 11.9 10.91 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.213 -1.395 . . . . 0.0 111.978 -177.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.92 -28.22 6.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 175.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.511 ' C ' ' HB2' ' A' ' 235' ' ' SER . 34.9 mt-10 -117.41 -34.58 4.25 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -57.8 -145.63 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.206 -0.934 . . . . 0.0 111.557 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.963 ' CD2' ' HB3' ' A' ' 200' ' ' ALA . 0.7 OUTLIER -132.35 -0.5 3.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.74 . . . . 0.0 111.082 -178.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.592 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 9.2 tpp -93.35 -3.46 53.35 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.072 -1.642 . . . . 0.0 110.073 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.65 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 4.4 t80 -139.86 12.08 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.04 -1.064 . . . . 0.0 113.322 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 53.7 Cg_endo -74.31 -36.75 2.96 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 108.988 -1.197 . . . . 0.0 108.988 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 223' ' ' TYR . 2.6 tt -13.06 -60.05 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.201 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.954 ' N ' HD23 ' A' ' 222' ' ' LEU . 9.5 t80 -69.57 56.48 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.078 -1.014 . . . . 0.0 109.494 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.4 t-160 179.21 -142.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.1 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.932 ' O ' HD12 ' A' ' 226' ' ' LEU . 4.0 m -149.51 121.62 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 109.58 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER -176.28 56.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 109.897 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -116.17 -16.23 11.01 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.1 t0 -169.51 -25.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.681 -0.637 . . . . 0.0 109.527 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.876 HD11 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -27.93 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.667 -0.646 . . . . 0.0 110.719 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.421 ' C ' ' HG3' ' A' ' 231' ' ' ARG . 0.6 OUTLIER -145.11 1.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.887 -1.133 . . . . 0.0 110.139 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.61 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -129.55 -44.74 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.885 -1.135 . . . . 0.0 109.382 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 23.0 p90 1.12 106.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.482 0.658 . . . . 0.0 112.58 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.556 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.25 171.05 0.94 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.474 179.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.023 HD21 ' CH2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -82.01 179.61 7.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.334 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.77 ' H ' HD12 ' A' ' 234' ' ' LEU . 3.2 t -116.5 -169.93 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.042 -1.036 . . . . 0.0 110.575 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.597 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.4 OUTLIER -85.57 -25.07 26.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.542 -0.724 . . . . 0.0 109.983 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.588 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 19.6 m-20 -77.14 -45.07 28.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.932 -1.105 . . . . 0.0 108.204 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.934 ' OD2' HD21 ' A' ' 209' ' ' LEU . 7.8 t70 -67.85 -45.93 73.2 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.282 -1.367 . . . . 0.0 107.909 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 234' ' ' LEU . 0.8 OUTLIER -51.61 -34.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -47.13 78.74 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -60.51 -56.05 26.56 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.947 HG13 HG22 ' A' ' 128' ' ' THR . 0.7 OUTLIER -63.77 -46.14 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.821 -1.399 . . . . 0.0 109.954 -178.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 242' ' ' ILE . 30.4 mt-30 -54.27 -26.66 30.28 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -90.02 -10.93 43.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.939 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -80.02 -54.37 5.85 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.62 ' CD2' HD12 ' A' ' 130' ' ' LEU . 3.9 m-30 . . . . . 0 N--CA 1.49 1.571 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.172 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.673 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.596 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 27.9 m95 -97.65 140.55 31.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.978 -1.076 . . . . 0.0 109.641 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.78 -28.25 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.98 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.778 0.799 . . . . 0.0 110.192 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.779 ' HB ' HD12 ' A' ' 130' ' ' LEU . 66.8 p -127.33 3.71 6.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.603 ' NE2' HG21 ' A' ' 131' ' ' THR . 7.8 m80 -148.91 102.94 3.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.9 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.157 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -121.19 -166.51 1.36 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.628 HG22 ' C ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -168.21 171.67 9.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.14 -0.975 . . . . 0.0 109.238 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 1.098 ' CE2' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -139.38 177.19 8.1 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.84 -1.163 . . . . 0.0 110.48 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.875 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -127.45 126.76 42.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 109.9 -178.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.093 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 1.9 mp -85.06 83.33 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.932 -1.105 . . . . 0.0 109.837 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.875 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -101.22 8.67 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.186 -0.946 . . . . 0.0 110.077 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.866 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -100.48 157.29 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.635 -1.291 . . . . 0.0 109.968 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.669 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.5 OUTLIER 178.16 75.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.62 0.724 . . . . 0.0 109.507 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 1.049 HG21 ' CD1' ' A' ' 186' ' ' TRP . 0.8 OUTLIER -67.77 157.2 87.19 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.23 -23.44 39.0 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 O-C-N 123.79 1.416 . . . . 0.0 108.952 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.562 ' O ' HD23 ' A' ' 108' ' ' LEU . 1.5 t0 -69.93 -9.8 56.28 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.837 HD22 ' HB1' ' A' ' 112' ' ' ALA . 52.2 mt -143.45 123.97 7.92 Favored Pre-proline 0 N--CA 1.485 1.278 0 O-C-N 121.622 -0.673 . . . . 0.0 109.898 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -66.42 168.87 15.21 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.781 1.411 . . . . 0.0 109.184 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.484 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.91 -64.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.756 0.789 . . . . 0.0 110.516 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 112' ' ' ALA . 2.4 p-10 -55.5 -32.08 62.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.701 -0.625 . . . . 0.0 111.954 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.837 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.87 -61.91 1.59 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.524 -1.36 . . . . 0.0 109.437 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.971 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.6 p -52.21 -41.68 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.591 ' OD2' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.63 -26.34 68.63 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.618 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -68.21 -35.71 78.39 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.401 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.048 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -76.15 -35.11 59.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.937 -1.102 . . . . 0.0 109.005 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.098 HG12 ' CE2' ' A' ' 99' ' ' TYR . 1.7 t -73.11 -26.13 22.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 1.5 tt0 -86.48 -36.35 19.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.897 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -75.93 -39.27 56.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -66.15 -62.96 1.2 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.473 1.13 . . . . 0.0 108.167 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.941 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.3 tt -46.51 -51.57 15.12 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.189 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.92 ' N ' HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -67.63 -35.47 78.97 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.947 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.118 ' CG1' HD22 ' A' ' 234' ' ' LEU . 3.1 t -52.44 -42.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.067 ' CH2' HD21 ' A' ' 234' ' ' LEU . 30.1 m95 -92.43 -23.38 19.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.928 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 46.9 tt0 -69.81 -26.93 64.49 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.762 -1.211 . . . . 0.0 107.801 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -91.06 -43.12 10.11 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.804 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.038 HG21 HG21 ' A' ' 242' ' ' ILE . 17.7 m -59.18 -24.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.766 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.036 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -105.9 160.48 25.98 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 117.696 -1.601 . . . . 0.0 110.222 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.724 ' C ' HD22 ' A' ' 130' ' ' LEU . 51.7 Cg_endo -85.56 22.48 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.259 1.973 . . . . 0.0 111.962 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.779 HD12 ' HB ' ' A' ' 95' ' ' THR . 3.6 mm? -116.36 -169.96 1.72 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.32 -1.488 . . . . 0.0 110.51 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.603 HG21 ' NE2' ' A' ' 96' ' ' HIS . 1.3 p -117.04 164.96 13.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 1.157 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 1.2 m-85 -144.26 139.27 28.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.693 -0.63 . . . . 0.0 109.492 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.531 ' CB ' ' HB ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -115.28 -166.31 1.11 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.129 -0.982 . . . . 0.0 108.486 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.49 157.31 35.22 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.964 -1.085 . . . . 0.0 110.014 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -159.64 -164.96 1.43 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.387 -0.821 . . . . 0.0 109.604 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 101' ' ' ILE . 1.8 t80 -154.17 22.09 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.524 ' HA ' ' NH2' ' A' ' 100' ' ' ARG . 11.6 pm0 -138.44 179.58 6.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.43 -100.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.68 119.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 110.296 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.561 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -77.94 -154.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 108.87 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 176' ' ' GLY . 2.3 m-20 -84.24 -38.32 20.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 109.364 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.737 HG22 ' CD1' ' A' ' 144' ' ' ILE . 4.0 mp -120.77 84.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.649 -0.657 . . . . 0.0 109.254 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.455 ' HB3' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.45 98.5 0.25 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.133 -0.979 . . . . 0.0 109.044 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.866 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.9 mm -84.29 114.89 25.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.627 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.01 155.66 50.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.517 -1.365 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -81.15 141.11 34.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 108.826 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.917 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -160.03 178.25 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.85 -1.156 . . . . 0.0 110.828 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.838 HG13 ' N ' ' A' ' 149' ' ' ARG . 1.5 p -167.26 -150.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.838 ' N ' HG13 ' A' ' 148' ' ' VAL . 3.7 mmm180 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.765 -0.584 . . . . 0.0 110.477 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 C--O 1.215 -0.664 0 N-CA-C 109.591 -0.965 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.687 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -106.92 -164.12 0.96 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.081 -1.012 . . . . 0.0 110.243 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 1.3 p30 179.91 46.08 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.362 -0.836 . . . . 0.0 110.553 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.613 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 38.4 -97.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 183' ' ' ASP . 40.2 Cg_endo -69.51 56.9 1.32 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.992 1.522 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.471 ' HA3' ' OD1' ' A' ' 158' ' ' ASP . . . -132.84 143.02 14.61 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 161' ' ' GLY . 2.9 m120 -42.6 -31.32 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -1.066 . . . . 0.0 109.877 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 163' ' ' VAL . 31.8 m -68.76 83.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.169 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.011 HD22 HD12 ' A' ' 222' ' ' LEU . 1.6 tp -64.21 -71.19 0.18 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 0.0 111.658 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.896 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -150.02 -168.41 3.1 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.532 -1.355 . . . . 0.0 110.426 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 179.21 -178.22 0.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 119.73 -1.856 . . . . 0.0 111.353 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.658 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -154.92 178.91 9.64 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.475 -0.765 . . . . 0.0 110.134 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.797 ' CE1' HD11 ' A' ' 174' ' ' ILE . 81.5 m-85 -121.51 -167.82 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.449 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.997 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -175.3 -58.65 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 109.423 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.997 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -78.62 133.05 11.35 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.886 1.466 . . . . 0.0 109.969 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 132.67 -173.9 20.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.592 ' HD2' HG22 ' A' ' 174' ' ' ILE . 45.8 Cg_endo -78.48 -92.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.089 1.573 . . . . 0.0 110.312 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -82.97 -34.62 20.93 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.797 HD11 ' CE1' ' A' ' 168' ' ' TYR . 0.8 OUTLIER -61.93 -6.98 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.466 -1.02 . . . . 0.0 108.816 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.568 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -65.81 64.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.466 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 206' ' ' SER . . . 126.36 82.3 0.43 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.0 m-20 -158.68 120.24 3.46 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.012 -1.287 . . . . 0.0 107.95 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -111.9 156.97 21.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.677 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.917 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -145.08 134.08 22.58 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.624 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 65.7 m-85 -95.57 133.75 39.25 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.158 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.579 ' OD2' ' CD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -49.34 148.66 2.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.026 177.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD2' ' HB ' ' A' ' 148' ' ' VAL . 2.6 p30 -124.05 21.04 9.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.809 -1.182 . . . . 0.0 109.558 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.744 ' OD2' HG21 ' A' ' 148' ' ' VAL . 1.8 m-20 -131.05 9.73 4.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.509 ' CG ' ' HB3' ' A' ' 181' ' ' ASP . 1.0 OUTLIER -114.04 -98.28 0.44 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.657 -1.277 . . . . 0.0 109.515 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 66.9 mt-30 -154.26 165.94 34.72 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 109.202 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 1.049 ' CD1' HG21 ' A' ' 105' ' ' THR . 97.8 m95 -160.3 118.97 2.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 110.11 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.825 ' HA ' HD21 ' A' ' 108' ' ' LEU . 22.2 p -140.79 152.1 44.94 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.034 -1.041 . . . . 0.0 109.039 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.794 ' HA ' HD22 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -75.09 -33.44 61.64 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.627 ' OD2' HD12 ' A' ' 229' ' ' LEU . 1.3 t70 -91.52 -141.19 0.18 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.933 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.8 t -117.59 46.77 1.66 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.003 -1.06 . . . . 0.0 108.243 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.499 ' HB ' HG21 ' A' ' 187' ' ' THR . 58.4 m -104.71 -29.46 10.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.273 -0.892 . . . . 0.0 111.303 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.533 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -110.26 -91.29 2.09 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.91 -1.614 . . . . 0.0 109.48 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.038 HG22 ' OD1' ' A' ' 194' ' ' ASN . 64.8 m -114.44 -84.35 0.61 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 1.038 ' OD1' HG22 ' A' ' 193' ' ' THR . 5.1 p30 178.6 68.56 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.862 1.315 . . . . 0.0 108.139 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.048 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -21.73 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.303 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.868 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -68.01 -6.39 22.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 110.835 -175.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.975 ' HA ' HD11 ' A' ' 218' ' ' LEU . 7.5 tp -66.11 -61.49 2.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 117.601 -1.64 . . . . 0.0 106.642 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.896 HG12 ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -70.81 -14.49 18.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.121 -1.032 . . . . 0.0 108.426 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.936 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.23 -61.05 1.96 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.618 -1.233 . . . . 0.0 108.211 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 1.044 ' HB3' HD23 ' A' ' 218' ' ' LEU . . . -63.58 -15.75 58.93 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.311 -1.493 . . . . 0.0 107.527 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.814 ' HA ' ' HE2' ' A' ' 219' ' ' MET . 6.8 t60 -70.6 -44.01 68.17 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.684 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.722 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 8.3 mt-10 -82.58 -46.16 13.69 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 0.0 111.374 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.941 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.0 mt -63.69 -30.31 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.698 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.47 -31.38 54.58 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -64.04 -47.16 81.29 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.796 -0.826 . . . . 0.0 111.232 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.545 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 33.9 p -85.37 -52.52 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.16 -0.963 . . . . 0.0 112.63 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.89 ' O ' HD12 ' A' ' 207' ' ' LEU . 1.3 pp -104.4 7.44 35.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.871 -1.143 . . . . 0.0 111.097 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.995 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -109.83 -84.01 1.5 Allowed Glycine 0 C--N 1.29 -1.975 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.825 HD11 ' OD1' ' A' ' 238' ' ' ASP . 1.8 pp -158.89 -161.13 0.93 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.922 -1.34 . . . . 0.0 109.942 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.572 ' N ' HD12 ' A' ' 209' ' ' LEU . 44.8 t80 -98.43 -71.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.6 m-70 -161.06 94.17 1.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.647 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 2.1 m -84.03 -179.26 7.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.871 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -62.7 78.6 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.999 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -82.72 9.34 9.85 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.281 -177.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -50.44 -27.84 7.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.511 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.6 mt-10 -114.07 -36.45 4.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.999 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -61.39 -159.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.272 1.034 . . . . 0.0 112.276 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.044 HD23 ' HB3' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -106.04 -11.81 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.562 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.814 ' HE2' ' HA ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -80.57 -10.2 59.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.24 -1.537 . . . . 0.0 111.932 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.679 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.8 t80 -131.39 8.5 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.447 -1.408 . . . . 0.0 113.953 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 43.7 Cg_endo -72.48 -41.84 1.55 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 N-CA-C 109.261 -1.092 . . . . 0.0 109.261 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 1.011 HD12 HD22 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -0.5 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.204 0.526 . . . . 0.0 111.756 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.877 ' N ' HD23 ' A' ' 222' ' ' LEU . 48.4 t80 -67.19 58.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.827 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.13 -155.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 109.329 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.458 ' HB3' ' OG1' ' A' ' 190' ' ' THR . 0.7 OUTLIER -128.69 126.39 40.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.091 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.95 HD12 ' HB2' ' A' ' 231' ' ' ARG . 1.2 tt -179.85 40.35 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.581 ' HA ' ' CE1' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -103.16 -40.03 6.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.9 t70 -149.38 -13.43 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.551 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.933 HD11 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -42.65 -98.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.851 -1.156 . . . . 0.0 110.349 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.5 p -139.03 -0.31 1.88 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.48 -1.388 . . . . 0.0 109.933 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.95 ' HB2' HD12 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -116.7 -18.21 10.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.012 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 232' ' ' PHE . 19.5 p90 -30.15 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.478 0.656 . . . . 0.0 111.477 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.58 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 8.5 ttt180 179.13 149.53 0.26 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.118 HD22 ' CG1' ' A' ' 123' ' ' VAL . 3.1 tp -70.11 164.43 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 108.755 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 1.085 ' O ' HD12 ' A' ' 239' ' ' ILE . 7.7 t -102.46 178.15 4.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.068 -1.02 . . . . 0.0 109.578 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.509 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -70.36 -14.6 62.64 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.75 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.871 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.8 OUTLIER -87.32 -49.6 7.14 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.716 -1.24 . . . . 0.0 109.548 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.825 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.94 -42.56 97.29 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 116.908 -1.917 . . . . 0.0 107.17 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.085 HD12 ' O ' ' A' ' 235' ' ' SER . 3.0 mt -54.83 -39.83 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.52 ' HA ' ' HG2' ' A' ' 243' ' ' GLN . 24.5 t-20 -60.84 -48.97 79.36 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.62 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.06 -55.53 30.37 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.038 HG21 HG21 ' A' ' 127' ' ' VAL . 1.4 tp -63.46 -50.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.032 -1.276 . . . . 0.0 110.521 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.567 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -53.33 -25.1 13.76 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.509 ' N ' ' HG3' ' A' ' 243' ' ' GLN . 37.4 t -90.83 -11.4 39.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -78.98 -49.97 11.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.74 ' HB3' HD23 ' A' ' 130' ' ' LEU . 5.0 m-30 . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.504 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.534 ' CE3' ' HD3' ' A' ' 94' ' ' LYS . 36.3 m95 -105.48 160.14 15.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.889 -1.132 . . . . 0.0 109.284 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -121.97 -28.99 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.044 -1.035 . . . . 0.0 110.682 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 1.06 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -42.9 169.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 110.323 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.652 ' HA ' HD11 ' A' ' 130' ' ' LEU . 2.1 p -106.19 -0.66 24.38 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.439 -0.788 . . . . 0.0 109.459 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.558 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 69.2 m80 -140.19 93.89 2.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.904 HD23 HD23 ' A' ' 130' ' ' LEU . 3.1 mm? -85.82 164.66 17.41 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.762 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.608 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -143.33 156.64 44.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.918 ' CE2' HD11 ' A' ' 101' ' ' ILE . 8.8 p90 -135.85 170.28 16.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.61 -1.306 . . . . 0.0 109.642 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.838 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -132.25 123.25 26.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.369 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.918 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -80.01 83.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 0.0 109.705 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.838 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -99.12 8.39 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.629 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -107.06 173.01 6.51 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.424 -1.422 . . . . 0.0 110.119 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.619 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 11.3 t80 176.94 70.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.712 0.768 . . . . 0.0 109.342 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.8 HG21 ' CD1' ' A' ' 186' ' ' TRP . 56.3 p -56.25 148.86 39.88 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 120.985 -1.072 . . . . 0.0 108.246 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 -28.96 40.5 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 108.52 -1.377 . . . . 0.0 108.52 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.608 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.6 t0 -71.28 -9.12 57.59 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 187' ' ' THR . 33.1 mt -131.69 120.51 17.67 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.644 -0.66 . . . . 0.0 110.21 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.6 Cg_endo -62.99 163.69 21.64 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 123.811 1.427 . . . . 0.0 108.979 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.3 -65.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.781 0.801 . . . . 0.0 110.034 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.7 OUTLIER -57.65 -15.2 6.95 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 111.056 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . . . -81.23 -62.22 1.72 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.555 -1.341 . . . . 0.0 108.942 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.629 HG21 ' C ' ' A' ' 103' ' ' ASN . 7.3 p -50.64 -40.02 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 118.294 -1.362 . . . . 0.0 107.481 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.825 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -65.12 -27.09 68.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.738 ' OG ' HD21 ' A' ' 195' ' ' LEU . 14.6 p -66.91 -38.43 86.21 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.064 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.19 -33.59 65.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.329 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.863 HG13 HG13 ' A' ' 144' ' ' ILE . 47.8 t -75.45 -24.09 17.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -84.36 -36.4 22.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -79.69 -38.82 32.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -63.39 -60.76 2.95 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 122.425 1.107 . . . . 0.0 108.247 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.842 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.2 pp -52.59 -41.04 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.937 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.759 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -75.88 -32.07 59.52 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.986 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.028 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.9 t -53.81 -45.11 61.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.051 ' CH2' HD21 ' A' ' 234' ' ' LEU . 31.8 m95 -91.7 -23.12 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.902 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 5.4 tm-20 -70.96 -26.59 63.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.847 -1.158 . . . . 0.0 107.935 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -90.76 -42.71 10.53 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.689 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.028 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.9 m -58.78 -25.67 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 118.323 -1.351 . . . . 0.0 108.809 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.019 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -112.56 172.15 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 117.94 -1.504 . . . . 0.0 110.056 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 128' ' ' THR . 51.7 Cg_endo -87.21 -7.94 6.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.642 2.228 . . . . 0.0 110.78 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.06 HD21 ' O ' ' A' ' 94' ' ' LYS . 1.1 tp -73.8 -179.76 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.982 -1.074 . . . . 0.0 110.594 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 5.5 p -119.33 175.68 5.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 110.154 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.718 ' CZ ' HD13 ' A' ' 207' ' ' LEU . 0.5 OUTLIER -144.56 159.56 42.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.97 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.578 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -145.25 179.74 7.18 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.69 157.85 44.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.797 -1.189 . . . . 0.0 110.427 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.541 HD23 ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -150.55 -140.03 0.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 5.5 t80 178.92 40.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.743 -1.223 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 7.5 pm0 -165.22 -178.18 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.609 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.44 -96.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 137' ' ' GLU . 1.7 pt-20 178.84 105.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.199 -1.177 . . . . 0.0 110.163 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.608 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.21 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 108.671 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.607 ' O ' HD13 ' A' ' 142' ' ' ILE . 0.9 OUTLIER -92.49 -27.97 17.09 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.532 179.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.986 HD11 ' HG ' ' A' ' 207' ' ' LEU . 31.1 mm -130.9 77.14 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.695 ' HG2' HG21 ' A' ' 102' ' ' VAL . 1.9 ttt -64.87 97.07 0.21 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.136 -0.978 . . . . 0.0 108.962 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.863 HG13 HG13 ' A' ' 117' ' ' VAL . 6.9 mm -79.55 123.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.092 . . . . 0.0 108.456 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -138.47 153.07 48.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.446 -1.409 . . . . 0.0 111.825 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 14.3 p90 -87.34 139.9 30.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.207 -0.933 . . . . 0.0 108.943 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.097 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.15 -160.21 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.702 -1.249 . . . . 0.0 111.36 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.705 HG22 ' H ' ' A' ' 149' ' ' ARG . 5.7 p -170.0 179.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.705 ' H ' HG22 ' A' ' 148' ' ' VAL . 3.0 ptt180 . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 0.0 110.705 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 C--O 1.216 -0.606 0 N-CA-C 109.865 -0.859 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.687 ' CD1' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -91.16 -149.9 0.23 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.054 -1.028 . . . . 0.0 109.419 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.572 ' OD1' HG12 ' A' ' 163' ' ' VAL . 8.9 p-10 -137.04 -2.85 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.258 -1.526 . . . . 0.0 111.718 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.655 ' CA ' HG23 ' A' ' 148' ' ' VAL . . . 39.48 -95.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.528 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.2 Cg_endo -61.45 72.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.338 1.178 . . . . 0.0 110.077 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -172.51 -164.06 27.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' VAL . 69.0 m-20 -90.69 -29.82 17.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.086 -1.244 . . . . 0.0 110.111 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.687 HG11 ' CD1' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -36.73 130.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.593 -0.692 . . . . 0.0 110.713 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.839 HD12 HG11 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -92.23 -80.89 0.35 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.582 -0.699 . . . . 0.0 112.24 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.841 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -161.35 -170.9 2.79 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.263 -1.523 . . . . 0.0 111.026 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.682 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -179.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 119.542 -1.974 . . . . 0.0 111.313 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -160.41 -163.41 1.09 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.603 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -130.17 -157.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 0.0 110.704 -178.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.97 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -170.56 -59.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.661 -0.65 . . . . 0.0 109.562 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.97 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.4 Cg_endo -79.6 -172.32 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.405 1.403 . . . . 0.0 110.232 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.55 144.07 0.71 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.17 135.14 28.75 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.425 1.417 . . . . 0.0 110.002 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 72.54 -64.12 1.44 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.603 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.0 tp -63.78 -8.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.494 -1.003 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.7 OUTLIER -65.77 66.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.763 179.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 206' ' ' SER . . . 129.53 79.49 0.23 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -153.53 128.76 9.76 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.859 -1.377 . . . . 0.0 108.205 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.703 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -112.59 172.57 6.84 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.983 -1.073 . . . . 0.0 108.961 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.097 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -164.66 134.38 3.8 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.577 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.682 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 12.2 m-85 -88.69 123.38 33.08 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 164' ' ' LEU . 17.0 t70 -67.2 144.66 55.86 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.129 -0.982 . . . . 0.0 108.945 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -61.18 -4.18 1.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.283 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.649 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.0 OUTLIER 4.62 -94.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 161' ' ' GLY . 1.4 pm0 -166.3 -33.61 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.692 -1.255 . . . . 0.0 110.906 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.459 ' OE1' ' HA2' ' A' ' 192' ' ' GLY . 66.4 mt-30 -141.66 158.67 43.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.708 -1.245 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.8 ' CD1' HG21 ' A' ' 105' ' ' THR . 84.9 m95 -158.02 119.53 3.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.916 ' HA ' HD21 ' A' ' 108' ' ' LEU . 47.2 p -144.43 154.64 43.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.473 -1.392 . . . . 0.0 110.476 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 0.7 OUTLIER -75.7 -35.0 60.42 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.566 ' OD2' HD12 ' A' ' 229' ' ' LEU . 1.0 OUTLIER -93.86 -144.21 0.24 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.919 ' N ' HD11 ' A' ' 229' ' ' LEU . 15.1 t -109.69 37.78 2.55 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.447 ' HB ' HG21 ' A' ' 187' ' ' THR . 11.8 m -84.83 -35.58 22.19 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.63 -0.669 . . . . 0.0 110.94 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.623 ' N ' HG21 ' A' ' 187' ' ' THR . . . -120.82 -87.39 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 118.852 -1.642 . . . . 0.0 109.024 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.584 HG21 HD11 ' A' ' 164' ' ' LEU . 90.9 m -114.85 -105.91 0.39 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.606 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 52.3 m-80 -157.62 70.76 0.6 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.113 -0.992 . . . . 0.0 108.744 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.923 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -19.58 -91.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.812 0.815 . . . . 0.0 112.618 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.836 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -66.95 -11.81 57.7 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.045 -1.034 . . . . 0.0 111.656 -176.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 1.006 HD11 ' CG ' ' A' ' 221' ' ' PRO . 11.7 tp -64.2 -55.48 21.34 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.841 HG12 ' HB3' ' A' ' 165' ' ' ALA . 2.8 t -76.08 -9.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.064 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.97 -57.2 3.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.391 -1.324 . . . . 0.0 107.534 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.22 -19.02 65.78 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.602 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 3.7 t-160 -68.22 -41.12 81.78 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.672 177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.703 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 28.4 mt-10 -83.64 -49.11 9.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 110.778 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.733 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -58.73 -31.85 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.71 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.39 -35.69 36.56 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -56.18 -53.68 54.21 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.674 -0.897 . . . . 0.0 110.319 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.667 ' HB2' HD12 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -83.72 -56.83 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 111.579 -178.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.986 ' HG ' HD11 ' A' ' 142' ' ' ILE . 7.4 mt -102.54 37.6 1.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 110.971 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 1.03 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -141.63 -75.34 0.04 OUTLIER Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.7 pp -170.31 -164.28 0.39 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.994 -1.297 . . . . 0.0 109.657 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.1 OUTLIER -98.48 -79.55 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.276 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.487 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 0.7 OUTLIER -154.29 105.9 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 0.0 109.164 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -94.54 -176.45 3.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.287 -0.883 . . . . 0.0 109.096 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.974 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -62.4 81.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.952 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.84 10.5 18.37 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.64 -177.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.3 OUTLIER -50.28 -27.82 6.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 174.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.516 ' C ' ' HB2' ' A' ' 235' ' ' SER . 23.5 mm-40 -115.81 -36.85 4.06 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.952 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -173.01 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.517 1.151 . . . . 0.0 112.766 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.926 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -85.73 -17.06 36.96 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.977 -177.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.742 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -78.51 -8.11 58.21 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.461 -2.024 . . . . 0.0 112.366 -177.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.682 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 7.0 t80 -133.01 14.74 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 120.25 -1.531 . . . . 0.0 113.472 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 1.006 ' CG ' HD11 ' A' ' 197' ' ' LEU . 52.2 Cg_endo -77.77 -41.88 0.29 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 N-CA-C 109.541 -0.984 . . . . 0.0 109.541 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.931 HD23 ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -8.73 -69.0 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.578 -178.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.931 ' N ' HD23 ' A' ' 222' ' ' LEU . 7.9 t80 -65.91 59.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.71 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.9 t-160 179.77 -143.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.316 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.42 ' C ' HD23 ' A' ' 226' ' ' LEU . 49.4 m -152.59 123.48 7.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.066 -1.021 . . . . 0.0 109.556 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.973 HD21 ' HB2' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 179.52 59.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.851 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.568 ' O ' ' CD2' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -109.02 -45.98 3.68 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 33.0 t70 -138.3 -13.55 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 0.0 110.432 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.919 HD11 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -37.6 -100.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.264 -0.897 . . . . 0.0 111.055 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.46 -16.41 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.434 -1.416 . . . . 0.0 110.383 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.535 ' O ' ' CD ' ' A' ' 233' ' ' ARG . 2.1 mtp180 -114.54 -22.19 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 108.849 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 30.4 p90 -30.65 115.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.419 0.628 . . . . 0.0 111.944 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.544 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.42 166.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 178.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.051 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.6 mp -77.87 165.32 24.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.173 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.737 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 31.1 t -99.88 -170.17 1.85 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 118.699 -1.201 . . . . 0.0 110.302 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.8 pp0? -83.93 -16.93 42.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.637 -0.665 . . . . 0.0 109.968 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.974 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.1 m-20 -81.95 -48.57 11.31 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.257 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.727 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.47 -38.34 90.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 117.328 -1.749 . . . . 0.0 106.728 177.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.605 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.42 -35.93 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.47 -60.12 3.28 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.454 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -49.51 -49.53 32.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.03 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.4 tp -65.09 -46.69 90.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.772 -1.428 . . . . 0.0 110.015 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.535 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.2 tt0 -53.34 -27.1 21.73 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.4 t -84.96 -17.91 36.22 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 1.003 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -75.37 -60.58 2.24 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.553 -0.717 . . . . 0.0 109.592 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.901 ' OH ' HD22 ' A' ' 207' ' ' LEU . 10.2 m-30 . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.612 ' CD1' HD13 ' A' ' 207' ' ' LEU . 59.3 m95 -97.72 174.44 6.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.189 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.4 ppt_? -135.35 -38.81 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.636 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.913 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.08 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.284 -0.885 . . . . 0.0 110.073 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.539 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 30.7 p -105.98 3.34 28.24 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.328 -0.857 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.551 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 65.4 m-70 -136.11 91.04 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.882 -1.136 . . . . 0.0 109.946 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.913 HD13 ' HE2' ' A' ' 94' ' ' LYS . 2.6 mm? -94.98 168.22 10.92 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.599 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -142.86 156.51 44.94 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.872 -1.142 . . . . 0.0 109.0 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 1.025 ' CZ ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.5 172.59 12.78 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.994 -1.066 . . . . 0.0 109.927 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.52 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -136.77 144.27 43.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.025 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 1.8 mp -100.68 76.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 0.0 110.041 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' A' ' 144' ' ' ILE . 29.1 t -94.21 8.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.995 . . . . 0.0 109.699 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.853 ' C ' HG21 ' A' ' 113' ' ' VAL . 8.6 m-80 -99.36 163.06 12.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.952 -1.092 . . . . 0.0 109.243 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.714 ' N ' HG21 ' A' ' 113' ' ' VAL . 17.7 p90 179.33 55.44 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.531 -0.731 . . . . 0.0 109.917 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.965 HG21 ' CD1' ' A' ' 186' ' ' TRP . 46.9 p -42.94 150.24 0.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.008 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.93 -25.99 44.39 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.886 1.466 . . . . 0.0 109.203 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.475 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -77.44 -1.21 29.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.965 HD13 ' CD1' ' A' ' 195' ' ' LEU . 99.1 mt -141.15 115.89 7.16 Favored Pre-proline 0 N--CA 1.484 1.258 0 O-C-N 121.473 -0.767 . . . . 0.0 109.613 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.5 Cg_endo -66.09 173.87 6.67 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.807 1.425 . . . . 0.0 109.141 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE3' ' CG ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -37.48 -65.35 0.32 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.805 0.812 . . . . 0.0 110.421 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -57.59 -29.64 64.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.861 -0.525 . . . . 0.0 112.336 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.83 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -71.68 -61.98 1.58 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.261 -1.525 . . . . 0.0 109.064 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.976 ' O ' HG23 ' A' ' 117' ' ' VAL . 8.3 p -52.23 -39.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.504 ' OD1' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.09 -28.15 69.88 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.863 ' OG ' HD21 ' A' ' 195' ' ' LEU . 16.4 p -64.96 -40.4 94.93 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.061 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.56 -33.15 64.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.962 -1.087 . . . . 0.0 109.892 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.998 HG12 ' CE2' ' A' ' 99' ' ' TYR . 2.0 t -74.86 -24.82 18.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -88.52 -35.04 17.19 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.818 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -77.89 -39.66 42.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.87 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.28 -62.99 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 122.399 1.095 . . . . 0.0 108.439 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.776 ' HA ' HG21 ' A' ' 203' ' ' ILE . 10.0 tp -50.63 -44.76 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -73.18 -32.89 65.11 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.385 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.02 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.3 t -54.63 -43.16 64.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.06 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.9 m95 -91.71 -23.57 19.74 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.646 -1.221 . . . . 0.0 110.808 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 3.5 tp10 -70.45 -27.73 64.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.595 -1.316 . . . . 0.0 107.966 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.461 ' OE1' ' HG3' ' A' ' 122' ' ' LYS . 13.2 pt-20 -89.61 -42.92 11.12 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.977 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.02 HG13 ' O ' ' A' ' 123' ' ' VAL . 17.1 m -59.91 -24.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.354 -1.339 . . . . 0.0 109.291 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.03 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -110.04 155.99 40.77 Favored Pre-proline 0 N--CA 1.495 1.795 0 C-N-CA 117.963 -1.495 . . . . 0.0 109.891 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -81.15 10.62 3.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.14 1.894 . . . . 0.0 110.742 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.743 HD13 ' HB3' ' A' ' 246' ' ' TYR . 3.9 mp -96.46 -178.98 4.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.86 -1.15 . . . . 0.0 110.405 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.444 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -118.78 167.56 11.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.401 -0.812 . . . . 0.0 110.198 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.603 ' HE2' HD11 ' A' ' 142' ' ' ILE . 8.3 m-85 -141.7 -179.43 6.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.54 -0.725 . . . . 0.0 109.447 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 -162.64 1.37 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.898 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -162.05 -178.58 6.51 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.91 -1.119 . . . . 0.0 110.534 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -164.17 -128.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER 177.19 31.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.621 -1.299 . . . . 0.0 109.532 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 138' ' ' GLY . 3.2 pm0 -171.28 -161.78 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.106 -0.996 . . . . 0.0 109.729 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 35.5 -98.35 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.507 ' OE2' ' CA ' ' A' ' 173' ' ' GLY . 0.0 OUTLIER 177.81 107.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 110.634 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 1.013 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -67.26 -155.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.78 ' OD2' HD12 ' A' ' 97' ' ' LEU . 8.5 t0 -81.47 -32.3 32.57 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.718 HD11 ' HG ' ' A' ' 207' ' ' LEU . 1.7 mt -126.86 85.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.581 ' CG ' ' O ' ' A' ' 143' ' ' MET . 5.5 ptm -76.65 100.18 5.29 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.89 HG13 HG13 ' A' ' 117' ' ' VAL . 4.4 mm -79.39 114.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 108.087 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -135.95 159.79 40.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.475 -1.391 . . . . 0.0 112.065 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.488 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 17.2 p90 -80.19 140.16 36.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.034 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -170.47 177.94 3.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 110.625 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.574 ' CG2' ' CA ' ' A' ' 159' ' ' GLY . 11.5 p 179.44 143.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.42 0 CA-C-O 121.399 0.618 . . . . 0.0 112.096 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 C--O 1.214 -0.676 0 N-CA-C 108.867 -1.243 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.003 ' CZ ' HG12 ' A' ' 163' ' ' VAL . 1.8 t80 -76.11 -136.87 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.901 -1.124 . . . . 0.0 109.97 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.603 ' CB ' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -135.31 -30.55 1.02 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.796 -1.19 . . . . 0.0 110.879 -178.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.574 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 52.9 -107.67 0.59 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.55 ' HD2' ' CD ' ' A' ' 149' ' ' ARG . 31.5 Cg_endo -56.43 91.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 121.164 1.242 . . . . 0.0 110.829 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.517 ' HA3' ' OD2' ' A' ' 158' ' ' ASP . . . 161.73 -164.15 35.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 163' ' ' VAL . 41.8 m-80 -86.19 -30.53 22.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -1.226 . . . . 0.0 110.486 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.003 HG12 ' CZ ' ' A' ' 157' ' ' PHE . 7.9 t -39.92 100.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.021 HD23 HG21 ' A' ' 198' ' ' VAL . 0.9 OUTLIER -71.23 -70.36 0.32 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.447 -0.783 . . . . 0.0 111.723 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.715 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -161.37 -165.96 1.43 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.42 -1.425 . . . . 0.0 111.071 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.681 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.6 OUTLIER 179.49 -165.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.897 -1.752 . . . . 0.0 110.646 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -165.05 -167.05 1.11 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.528 ' O ' ' CB ' ' A' ' 206' ' ' SER . 86.7 m-85 -133.11 -159.71 0.99 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.97 . . . . 0.0 110.053 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.985 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -161.9 -63.26 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.062 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.985 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.5 Cg_endo -77.05 174.86 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.814 1.428 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 102.05 172.03 27.5 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 174' ' ' ILE . 40.8 Cg_endo -74.81 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.665 1.577 . . . . 0.0 109.664 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.507 ' CA ' ' OE2' ' A' ' 139' ' ' GLU . . . -79.58 -35.1 29.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.3 tt -69.85 3.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 121.81 -0.817 . . . . 0.0 109.011 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 170' ' ' PRO . 5.5 t30 -64.94 61.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.391 -0.818 . . . . 0.0 109.105 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.59 ' HA2' ' OG ' ' A' ' 206' ' ' SER . . . 107.47 89.51 2.08 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 76.1 m-20 -141.69 126.13 17.71 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -108.82 149.19 29.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.817 -1.177 . . . . 0.0 108.106 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.034 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -144.07 130.48 19.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.955 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.581 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 18.6 m-85 -85.17 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.593 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 p-10 -75.18 132.03 40.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.415 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 183' ' ' ASP . 6.4 t0 -75.44 -0.87 21.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.477 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 47.4 t0 -30.84 -72.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.512 0.672 . . . . 0.0 112.074 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.467 ' OE1' ' OD2' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -114.83 -110.96 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.084 -176.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.577 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 2.1 mt-30 -133.84 -168.77 2.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.817 -1.177 . . . . 0.0 109.739 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.965 ' CD1' HG21 ' A' ' 105' ' ' THR . 85.2 m95 -155.07 136.13 13.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.792 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.6 p -145.45 152.88 40.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.204 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.757 ' O ' HG23 ' A' ' 227' ' ' THR . 0.0 OUTLIER -73.04 -34.01 66.04 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.522 ' HA ' HD13 ' A' ' 229' ' ' LEU . 1.3 t70 -90.54 -151.07 0.24 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.868 HG23 HD11 ' A' ' 229' ' ' LEU . 1.4 p -103.76 35.11 2.73 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.286 -1.365 . . . . 0.0 107.927 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.546 ' CB ' HG21 ' A' ' 187' ' ' THR . 13.2 m -81.6 -36.16 29.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.263 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 187' ' ' THR . . . -119.96 -81.05 0.67 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.155 -1.498 . . . . 0.0 109.699 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.807 ' CG2' HD21 ' A' ' 164' ' ' LEU . 85.0 m -127.51 -79.08 0.58 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.373 -1.074 . . . . 0.0 108.704 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.877 HD22 HD23 ' A' ' 197' ' ' LEU . 42.9 p30 179.26 60.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.033 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -18.44 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.591 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.829 ' HE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -64.34 -16.95 63.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.127 -176.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 1.057 HD11 HD23 ' A' ' 226' ' ' LEU . 13.3 tp -60.94 -61.17 2.77 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 117.208 -1.797 . . . . 0.0 107.724 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.021 HG21 HD23 ' A' ' 164' ' ' LEU . 13.7 t -74.54 -7.66 10.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.629 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.061 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -74.89 -57.83 3.66 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.752 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.36 -16.47 64.09 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.572 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 8.5 t60 -70.12 -39.63 75.34 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.18 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.757 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 30.0 mt-10 -87.48 -46.96 9.13 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.028 -1.045 . . . . 0.0 110.366 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.87 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -61.41 -30.91 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.728 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.3 -34.85 44.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -58.68 -54.24 49.35 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.686 -0.891 . . . . 0.0 110.292 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.59 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 30.4 t -77.24 -60.21 2.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 112.486 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.718 ' HG ' HD11 ' A' ' 142' ' ' ILE . 1.1 mm? -104.01 31.49 4.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.236 -0.915 . . . . 0.0 110.529 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 1.031 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -132.59 -77.95 0.14 Allowed Glycine 0 C--N 1.292 -1.912 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.83 -166.01 0.54 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.945 -1.327 . . . . 0.0 110.054 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.821 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.1 OUTLIER -98.51 -74.82 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.29 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 79.2 m80 -160.12 110.38 1.85 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.779 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 2.0 m -98.81 -172.59 2.33 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.823 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.95 78.84 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.925 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.22 9.52 12.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.624 -177.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 214' ' ' ASN . 30.5 p -48.4 -28.88 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.545 ' C ' ' HB3' ' A' ' 235' ' ' SER . 9.5 mt-10 -113.98 -37.66 4.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.925 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -67.58 162.46 23.41 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.456 1.122 . . . . 0.0 112.367 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.87 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -56.97 -20.78 25.69 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.243 -178.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.676 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -77.59 -9.21 58.82 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 118.984 -2.323 . . . . 0.0 112.182 -177.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 34.3 t80 -133.62 17.77 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 120.178 -1.576 . . . . 0.0 113.568 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.692 ' HG2' HD21 ' A' ' 197' ' ' LEU . 55.3 Cg_endo -78.23 -36.51 0.98 Allowed 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.975 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -24.63 -57.93 0.05 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.942 -179.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.975 ' N ' HD13 ' A' ' 222' ' ' LEU . 0.4 OUTLIER -73.45 54.53 0.45 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.068 -1.02 . . . . 0.0 109.883 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.597 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 2.7 m170 -175.31 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.511 ' O ' ' NH1' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 179.57 121.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.994 -1.066 . . . . 0.0 109.117 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 1.057 HD23 HD11 ' A' ' 197' ' ' LEU . 3.1 tp 178.9 119.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER 179.12 -34.69 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 38.6 t0 -159.95 -22.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.81 -0.556 . . . . 0.0 109.596 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.868 HD11 HG23 ' A' ' 190' ' ' THR . 0.2 OUTLIER -34.5 -59.17 0.47 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.195 -0.941 . . . . 0.0 110.434 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.96 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 108.791 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.527 ' O ' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -90.32 -12.97 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.581 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 21.2 p90 -30.43 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.672 0.749 . . . . 0.0 111.221 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.537 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 2.1 ttt-85 178.79 154.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.06 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.3 mp -76.69 163.8 26.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.229 -0.919 . . . . 0.0 109.84 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.88 ' OG ' ' HB2' ' A' ' 217' ' ' ALA . 8.3 p -101.99 -168.69 1.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.076 -1.45 . . . . 0.0 110.485 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 236' ' ' GLN . 38.9 tp60 -84.25 -14.1 50.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.839 . . . . 0.0 111.313 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.823 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.1 OUTLIER -84.46 -44.02 14.05 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.451 -1.406 . . . . 0.0 107.882 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.816 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 0.7 OUTLIER -67.63 -40.63 84.62 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.06 -35.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.07 -47.65 70.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.501 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.12 -54.53 36.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.031 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.4 tp -62.01 -46.08 97.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 120.929 -1.336 . . . . 0.0 109.792 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.529 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -53.37 -31.38 44.4 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 4.0 t -77.56 -20.02 54.76 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.921 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.4 OUTLIER -70.03 -61.25 1.85 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.743 ' HB3' HD13 ' A' ' 130' ' ' LEU . 23.4 m-85 . . . . . 0 N--CA 1.49 1.574 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.442 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.994 0.426 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.632 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 26.7 m95 -94.95 177.18 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 109.909 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -139.66 -31.46 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -50.7 -172.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.022 -1.049 . . . . 0.0 110.401 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.885 ' HA ' HD22 ' A' ' 130' ' ' LEU . 9.6 p -123.55 -0.67 8.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.559 -0.713 . . . . 0.0 109.211 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 64.4 m80 -136.94 91.01 2.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.188 -0.945 . . . . 0.0 110.002 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.5 mm? -88.55 164.47 15.39 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.586 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.609 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.5 OUTLIER -142.51 155.84 45.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 1.008 ' CE2' HD11 ' A' ' 101' ' ' ILE . 5.6 p90 -137.23 163.48 30.81 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.655 -1.278 . . . . 0.0 109.276 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.738 ' HD2' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -123.27 126.2 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.2 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.008 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -81.93 77.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.95 -1.094 . . . . 0.0 109.835 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.738 HG22 ' HD2' ' A' ' 100' ' ' ARG . 9.3 t -89.39 4.62 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.309 -0.869 . . . . 0.0 109.714 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.869 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -101.35 155.11 18.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.671 -1.268 . . . . 0.0 109.393 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.627 ' N ' HG21 ' A' ' 113' ' ' VAL . 9.1 t80 177.85 76.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.622 0.725 . . . . 0.0 109.224 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.81 HG21 ' CD1' ' A' ' 186' ' ' TRP . 2.6 p -75.61 161.98 74.17 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.184 -0.947 . . . . 0.0 108.957 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.56 -21.45 39.78 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.921 1.485 . . . . 0.0 108.573 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.544 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -71.09 -7.38 46.15 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.059 HD21 ' HA ' ' A' ' 187' ' ' THR . 84.3 mt -148.13 123.3 5.11 Favored Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.7 167.83 14.6 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.862 1.454 . . . . 0.0 108.828 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.3 -64.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.818 0.818 . . . . 0.0 110.361 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 115' ' ' SER . 7.6 t0 -56.17 -26.63 51.36 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.675 -0.641 . . . . 0.0 111.736 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.806 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -74.06 -61.15 1.95 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.474 -1.391 . . . . 0.0 109.442 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.92 ' O ' HG23 ' A' ' 117' ' ' VAL . 7.6 p -53.14 -40.09 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.782 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -66.25 -27.14 67.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.906 ' OG ' HD21 ' A' ' 195' ' ' LEU . 7.5 p -62.01 -43.47 98.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.068 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -71.28 -34.01 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.997 -1.064 . . . . 0.0 109.41 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.9 t -71.93 -23.27 21.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 -34.89 14.36 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 1.7 tppt? -75.59 -40.77 56.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -64.89 -60.67 2.81 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.007 HD22 ' CZ ' ' A' ' 99' ' ' TYR . 8.5 tp -44.73 -50.85 9.81 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.546 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.8 OUTLIER -73.25 -34.23 65.72 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.464 -177.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.016 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -54.04 -42.23 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.01 ' O ' HG23 ' A' ' 128' ' ' THR . 42.7 m95 -91.74 -23.13 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.445 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.59 ' HA ' ' CE1' ' A' ' 132' ' ' PHE . 2.5 tm-20 -70.3 -27.3 64.28 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -90.38 -43.22 10.46 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.712 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.016 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.3 m -58.17 -25.7 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.819 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.01 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.7 152.37 45.44 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.955 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.47 2.01 6.2 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.878 1.719 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.032 HD12 ' CG ' ' A' ' 246' ' ' TYR . 20.5 mt -84.2 -178.06 6.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.7 p -124.25 167.37 14.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.148 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.764 ' HB3' HD11 ' A' ' 121' ' ' LEU . 20.0 m-85 -135.96 170.47 15.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.566 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.27 175.04 12.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 108.7 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -142.43 156.91 45.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.95 -1.094 . . . . 0.0 110.075 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.958 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.8 OUTLIER -146.77 -134.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 178.46 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.862 -1.148 . . . . 0.0 109.347 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' OE2' ' HB2' ' A' ' 135' ' ' LEU . 7.8 pm0 -158.4 -177.82 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.873 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.03 -97.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 137' ' ' GLU . 2.2 pt-20 178.8 107.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.958 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -59.59 -151.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 108.95 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.843 ' O ' HD13 ' A' ' 142' ' ' ILE . 31.3 m-20 -89.87 -30.71 17.72 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.076 HD11 HD21 ' A' ' 207' ' ' LEU . 20.3 mm -127.18 82.13 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.521 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.64 96.75 0.18 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 108.813 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.869 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.9 mm -81.31 117.17 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.64 150.65 49.69 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.249 -1.532 . . . . 0.0 111.867 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.572 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 17.1 p90 -81.68 141.28 33.76 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.485 -0.759 . . . . 0.0 109.117 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.581 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -166.1 -179.04 4.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.886 -1.134 . . . . 0.0 110.675 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.961 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.7 p -165.36 -148.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 109.247 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.839 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.004 0 O-C-N 121.645 -0.659 . . . . 0.0 110.339 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 C--O 1.215 -0.634 0 N-CA-C 109.969 -0.82 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.996 ' CE1' HG12 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -111.04 -170.59 1.66 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.205 -0.934 . . . . 0.0 110.44 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 160' ' ' PRO . 58.7 p30 -179.79 54.8 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.698 -0.626 . . . . 0.0 110.062 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 15.23 -79.89 0.0 OUTLIER Glycine 0 N--CA 1.507 3.385 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.584 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.7 Cg_endo -63.71 65.24 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.679 1.357 . . . . 0.0 110.118 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.1 135.63 3.81 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 1.075 ' O ' HD12 ' A' ' 164' ' ' LEU . 82.6 m-20 -39.44 -36.97 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 109.975 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.996 HG12 ' CE1' ' A' ' 157' ' ' PHE . 2.6 t -54.73 87.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 109.168 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.075 HD12 ' O ' ' A' ' 162' ' ' ASN . 1.4 mp -83.65 -48.94 9.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.11 -0.994 . . . . 0.0 112.76 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.63 ' HB1' ' OE2' ' A' ' 202' ' ' GLU . . . -159.0 -173.14 4.09 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.096 -1.627 . . . . 0.0 111.261 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.729 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 178.24 -175.46 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.772 -1.83 . . . . 0.0 111.552 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.45 -177.82 6.6 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.601 ' CD2' ' HB2' ' A' ' 177' ' ' ASP . 22.3 m-30 -116.73 -169.59 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.756 -1.215 . . . . 0.0 111.708 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.988 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -116.91 -165.87 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.988 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.5 Cg_endo -74.05 129.76 13.59 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.073 1.039 . . . . 0.0 111.039 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . -175.19 -169.88 37.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.99 98.26 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.696 1.366 . . . . 0.0 109.772 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 83.27 -49.1 4.17 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.2 tt -71.46 6.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.557 -0.966 . . . . 0.0 109.225 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.601 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 2.4 t-20 -64.55 62.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.79 . . . . 0.0 108.876 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' A' ' 142' ' ' ILE . . . 104.84 104.19 2.91 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.8 m-20 -159.04 120.5 3.37 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.881 -1.364 . . . . 0.0 107.682 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.99 172.12 7.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.625 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -162.65 137.67 6.8 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.237 1.018 . . . . 0.0 110.401 178.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.622 ' CE1' HG23 ' A' ' 198' ' ' VAL . 61.6 m-85 -100.49 136.75 39.88 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.746 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.961 ' OD1' HG23 ' A' ' 148' ' ' VAL . 28.3 t0 -58.32 151.9 18.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.799 -1.188 . . . . 0.0 108.763 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.51 ' OD2' ' CD1' ' A' ' 146' ' ' PHE . 1.2 m-20 -115.73 4.05 13.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.158 -0.964 . . . . 0.0 110.194 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.628 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 17.4 m-20 -112.13 26.51 10.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.095 -1.003 . . . . 0.0 109.927 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.479 ' OE2' ' HG ' ' A' ' 164' ' ' LEU . 5.5 mt-10 -129.42 -94.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 108.702 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CD2' ' A' ' 186' ' ' TRP . 2.0 mt-30 179.05 169.56 0.94 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.81 ' CD1' HG21 ' A' ' 105' ' ' THR . 65.4 m95 -159.15 131.98 6.94 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.04 -1.038 . . . . 0.0 109.539 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 1.059 ' HA ' HD21 ' A' ' 108' ' ' LEU . 68.1 p -157.68 149.86 22.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.984 -1.072 . . . . 0.0 110.067 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.829 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -80.19 -31.86 38.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.4 t70 -85.27 61.26 6.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.992 ' HB ' HD21 ' A' ' 229' ' ' LEU . 5.9 t 3.71 60.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 CA-C-O 121.958 0.885 . . . . 0.0 111.878 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.7 m -123.55 -32.0 3.42 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.32 -0.863 . . . . 0.0 109.392 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.407 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -91.03 -74.06 1.28 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.794 HG21 HD23 ' A' ' 164' ' ' LEU . 48.1 m -135.02 -79.74 0.44 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.737 ' ND2' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER 179.9 68.68 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.296 1.046 . . . . 0.0 108.861 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.068 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 2.2 tp -30.06 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.082 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 1.0 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.58 -6.73 5.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.81 -177.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 1.01 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.1 tp -67.7 -62.43 1.42 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.265 -1.774 . . . . 0.0 107.127 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.777 HG21 ' CZ3' ' A' ' 186' ' ' TRP . 3.0 m -68.29 -15.4 19.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.005 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -71.45 -61.97 1.58 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.697 -1.201 . . . . 0.0 107.938 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.718 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -63.66 -15.8 59.31 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 120.266 -1.521 . . . . 0.0 106.946 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.41 ' CE1' ' O ' ' A' ' 219' ' ' MET . 7.5 t60 -68.19 -48.62 64.77 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.025 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.659 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 13.6 mt-10 -81.26 -45.39 16.32 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.179 -0.951 . . . . 0.0 111.098 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.1 mt -62.07 -31.31 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.687 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.8 -30.77 57.31 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -61.79 -51.01 70.04 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.87 -0.782 . . . . 0.0 110.746 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.627 ' CB ' HD12 ' A' ' 142' ' ' ILE . 72.8 m -82.89 -54.93 4.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.362 -0.836 . . . . 0.0 112.174 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 1.076 HD21 HD11 ' A' ' 142' ' ' ILE . 7.0 mt -104.25 23.71 12.67 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.019 -1.051 . . . . 0.0 110.828 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.971 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -125.11 -79.16 0.36 Allowed Glycine 0 C--N 1.291 -1.938 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.837 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.944 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -169.02 -160.35 0.27 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.857 -1.378 . . . . 0.0 110.02 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.795 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.7 t80 -97.77 -70.0 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.758 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 0.2 OUTLIER -162.59 90.81 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.631 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.4 m -79.93 176.6 9.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 0.0 109.323 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.84 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.57 81.37 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.961 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.45 9.34 13.62 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.061 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.32 -28.33 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 175.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.526 ' C ' ' HB2' ' A' ' 235' ' ' SER . 0.7 OUTLIER -114.79 -36.19 4.58 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.961 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.34 -165.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.159 0.98 . . . . 0.0 112.227 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.01 HD11 ' HA ' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -102.8 -10.76 18.84 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.548 -177.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.744 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -81.32 -8.07 59.68 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.064 -1.647 . . . . 0.0 111.636 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.664 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -139.82 16.06 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 120.462 -1.399 . . . . 0.0 113.221 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.898 ' HB3' HD11 ' A' ' 226' ' ' LEU . 50.3 Cg_endo -73.98 -36.37 3.53 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.189 -1.504 . . . . 0.0 108.189 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 1.069 ' CD1' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -5.0 -73.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.168 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.672 ' N ' HD23 ' A' ' 222' ' ' LEU . 1.9 m-85 -67.52 60.06 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -169.79 -144.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.239 -0.913 . . . . 0.0 109.536 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.402 ' C ' HD23 ' A' ' 226' ' ' LEU . 72.7 m -148.61 104.51 3.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.095 -1.003 . . . . 0.0 109.969 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.53 49.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 108.978 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.572 HG21 ' HA ' ' A' ' 194' ' ' ASN . 11.3 t -99.25 -12.08 20.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.704 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER 177.5 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.04 -1.038 . . . . 0.0 111.244 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.992 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -33.17 -100.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.426 -0.796 . . . . 0.0 111.241 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.6 -16.28 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.637 -1.29 . . . . 0.0 109.746 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -106.33 -22.02 12.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.164 -0.96 . . . . 0.0 108.549 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.642 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.3 p90 -24.24 116.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.362 0.601 . . . . 0.0 111.388 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.76 171.61 0.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.999 HD21 ' CH2' ' A' ' 124' ' ' TRP . 5.2 mp -87.61 172.14 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 111.089 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.719 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 14.5 t -104.98 -170.14 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.785 0.803 . . . . 0.0 109.985 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.548 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.0 OUTLIER -82.72 -16.38 48.27 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.66 -0.65 . . . . 0.0 109.711 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.84 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.0 OUTLIER -82.19 -50.6 8.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.102 -0.999 . . . . 0.0 108.34 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.944 ' OD1' HD21 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.86 -38.38 90.87 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 117.053 -1.859 . . . . 0.0 106.915 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 235' ' ' SER . 1.0 OUTLIER -57.76 -34.82 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.57 -52.04 43.45 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.361 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -55.75 -54.46 34.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.005 HG21 HG21 ' A' ' 127' ' ' VAL . 1.5 tp -64.3 -44.71 97.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 120.897 -1.355 . . . . 0.0 109.716 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.54 ' N ' HG23 ' A' ' 242' ' ' ILE . 5.2 tt0 -54.61 -28.42 46.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 42.5 t -80.16 -20.04 45.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.688 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.5 OUTLIER -70.4 -66.61 0.58 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 1.032 ' CG ' HD12 ' A' ' 130' ' ' LEU . 16.5 m-85 . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.673 ' N ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.634 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 49.5 m95 -100.62 177.45 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.116 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -138.56 -36.33 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.585 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -46.66 177.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.191 -0.943 . . . . 0.0 110.132 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.812 ' CB ' HD12 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -116.59 1.65 12.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.405 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.545 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 46.9 m170 -132.74 92.82 3.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.719 HD13 ' OD2' ' A' ' 141' ' ' ASP . 2.5 mm? -94.72 173.62 7.51 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.628 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -149.61 155.98 41.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 1.05 ' CE2' HD11 ' A' ' 101' ' ' ILE . 6.1 p90 -135.52 165.65 25.02 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.483 -1.386 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.752 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -124.65 122.78 38.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.05 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -82.38 84.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 109.802 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.752 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -102.08 8.47 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 0.0 110.097 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.918 ' C ' HG21 ' A' ' 113' ' ' VAL . 25.4 m-80 -98.65 159.19 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.959 -1.088 . . . . 0.0 109.155 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.805 ' N ' HG21 ' A' ' 113' ' ' VAL . 6.0 t80 177.56 80.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.674 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.967 HG21 ' CD1' ' A' ' 186' ' ' TRP . 33.0 p -73.72 159.34 84.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.65 -22.2 38.08 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 123.774 1.407 . . . . 0.0 108.651 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.512 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -79.53 0.75 28.46 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.949 ' CD1' HD13 ' A' ' 195' ' ' LEU . 95.9 mt -148.33 118.44 4.22 Favored Pre-proline 0 N--CA 1.485 1.297 0 O-C-N 121.423 -0.798 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.09 174.25 6.16 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.885 1.466 . . . . 0.0 109.139 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.16 -66.06 0.32 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.783 0.802 . . . . 0.0 110.164 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 115' ' ' SER . 2.2 m-20 -56.39 -28.47 59.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.822 -0.548 . . . . 0.0 112.358 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.833 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.25 -61.15 1.9 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.317 -1.489 . . . . 0.0 109.468 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.918 HG21 ' C ' ' A' ' 103' ' ' ASN . 8.4 p -56.08 -44.06 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 1.035 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -60.89 -28.22 68.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -58.83 -63.83 1.15 Allowed 'General case' 0 C--O 1.194 -1.822 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.07 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -49.28 -32.52 11.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 144' ' ' ILE . 12.1 t -73.82 -24.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -90.65 -33.65 15.74 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.75 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -82.34 -37.04 26.28 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.46 -62.16 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.848 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -53.41 -42.04 66.61 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.766 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -70.9 -34.2 71.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.131 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.901 HG13 HD22 ' A' ' 234' ' ' LEU . 1.7 t -57.34 -36.88 54.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.049 ' O ' HG23 ' A' ' 128' ' ' THR . 46.9 m95 -92.23 -24.25 19.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.929 -1.109 . . . . 0.0 110.667 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -73.11 -27.37 61.66 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.927 -1.108 . . . . 0.0 108.308 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -92.42 -42.82 9.54 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.994 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.994 HG21 HG21 ' A' ' 242' ' ' ILE . 22.7 m -62.26 -23.4 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.255 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.049 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.05 163.31 18.35 Favored Pre-proline 0 N--CA 1.495 1.783 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.403 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.491 ' C ' HD22 ' A' ' 130' ' ' LEU . 48.6 Cg_endo -81.52 22.05 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.034 1.823 . . . . 0.0 111.51 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.812 HD12 ' CB ' ' A' ' 95' ' ' THR . 2.6 mm? -115.86 178.1 4.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.653 -1.279 . . . . 0.0 110.347 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.547 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.9 p -121.01 177.81 4.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' A' ' 97' ' ' LEU . 11.2 m-85 -146.96 146.03 29.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.765 . . . . 0.0 110.053 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.604 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 68.0 m -114.59 -170.55 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -149.82 165.45 32.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.612 -1.305 . . . . 0.0 110.992 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -163.15 -164.54 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 78.8 t80 -160.61 25.66 0.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' GLU . 8.7 pm0 -147.11 176.76 9.7 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.78 -97.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' GLU . 18.3 tt0 178.73 145.51 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -1.143 . . . . 0.0 110.45 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.628 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -101.09 -150.75 0.4 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.719 ' OD2' HD13 ' A' ' 97' ' ' LEU . 18.2 m-20 -90.55 -34.02 15.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.974 HD11 ' CG ' ' A' ' 207' ' ' LEU . 20.1 mm -124.04 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.528 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 5.9 ttp -66.11 97.87 0.41 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 109.195 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 1.014 HG13 HG13 ' A' ' 117' ' ' VAL . 5.8 mm -81.87 114.63 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.592 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -136.3 155.57 49.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.434 -1.416 . . . . 0.0 112.371 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.1 p90 -92.89 138.04 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.688 . . . . 0.0 109.265 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.081 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -167.57 -158.65 0.28 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.29 -0.881 . . . . 0.0 110.47 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.649 HG13 ' N ' ' A' ' 149' ' ' ARG . 0.6 OUTLIER -173.38 -165.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.05 -1.031 . . . . 0.0 109.159 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.649 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 0.0 109.759 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo . . . . . 0 C--O 1.214 -0.7 0 N-CA-C 109.943 -0.829 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.765 ' CD2' ' CE1' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -80.83 -166.15 1.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.099 -1.001 . . . . 0.0 110.134 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.55 ' O ' ' C ' ' A' ' 159' ' ' GLY . 24.7 p30 179.64 60.2 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.667 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -29.3 -51.31 0.13 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.829 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 39.6 Cg_endo -66.54 60.04 0.52 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 109.301 -1.076 . . . . 0.0 109.301 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -179.27 159.96 25.07 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 164' ' ' LEU . 73.7 m-20 -52.74 -38.41 60.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.127 . . . . 0.0 110.223 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 163' ' ' VAL . 42.8 t -53.3 81.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.341 -0.849 . . . . 0.0 110.545 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.719 HD12 HD12 ' A' ' 222' ' ' LEU . 15.9 mt -68.63 -74.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.341 -0.849 . . . . 0.0 111.85 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.974 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -135.41 -176.26 4.21 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.491 -1.381 . . . . 0.0 111.614 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.754 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.5 p-80 178.98 168.55 0.94 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.564 -1.335 . . . . 0.0 110.107 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -132.92 -168.08 2.02 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.532 ' HB3' HG13 ' A' ' 174' ' ' ILE . 77.5 m-85 -114.4 -167.27 1.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.8 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.074 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -126.15 -175.62 0.43 Allowed Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 1.074 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 38.8 Cg_endo -68.9 140.19 45.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.537 1.283 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.437 ' C ' ' OD1' ' A' ' 175' ' ' ASN . . . 171.76 -125.49 1.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.499 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.0 Cg_endo -73.98 -93.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.812 1.427 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -108.37 -18.34 9.8 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.4 OUTLIER -73.3 12.17 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -1.064 . . . . 0.0 108.951 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 175' ' ' ASN . 0.6 OUTLIER -64.34 63.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.607 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 106.35 101.55 2.73 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.635 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.6 m-20 -163.16 120.11 1.86 Allowed 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.566 -1.549 . . . . 0.0 107.659 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.736 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -112.07 164.85 12.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.894 -1.129 . . . . 0.0 109.184 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.081 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -162.15 134.75 5.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.867 -1.133 . . . . 0.0 109.778 178.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.601 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 34.4 m-85 -95.48 132.67 40.32 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.519 ' HB3' ' CD1' ' A' ' 157' ' ' PHE . 24.5 p30 -66.72 130.19 42.37 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 182' ' ' ASP . 48.1 p30 -96.09 22.73 7.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.976 -1.077 . . . . 0.0 110.437 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.667 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.4 OUTLIER -90.75 -19.61 23.32 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.907 -1.121 . . . . 0.0 109.889 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.496 ' OE2' ' O ' ' A' ' 159' ' ' GLY . 0.9 OUTLIER -112.11 -130.78 0.31 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.896 -1.127 . . . . 0.0 108.595 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 35.3 mt-30 -130.97 -175.46 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.161 . . . . 0.0 109.097 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.967 ' CD1' HG21 ' A' ' 105' ' ' THR . 86.0 m95 -160.83 126.03 3.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 108.954 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.792 ' HA ' HD21 ' A' ' 108' ' ' LEU . 50.7 p -145.66 150.07 35.64 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.828 -1.17 . . . . 0.0 110.453 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 1.046 ' O ' HG23 ' A' ' 227' ' ' THR . 2.7 pttm -84.45 -33.18 23.71 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 27.9 t70 -82.31 63.72 6.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 1.05 ' HB ' HD21 ' A' ' 229' ' ' LEU . 1.7 t 2.82 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 122.311 1.053 . . . . 0.0 112.016 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.0 m -127.31 -31.05 2.58 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.783 -1.198 . . . . 0.0 109.927 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.627 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -96.98 -80.41 1.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.761 HG22 ' OD1' ' A' ' 194' ' ' ASN . 37.5 m -125.12 -96.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.781 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -161.77 67.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.025 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 14.7 tp -37.97 -98.91 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.757 -0.589 . . . . 0.0 110.93 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.829 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.7 OUTLIER -58.73 -11.53 3.26 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.722 -1.236 . . . . 0.0 110.461 -178.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 1.084 ' O ' HD11 ' A' ' 218' ' ' LEU . 6.2 tp -64.92 -71.29 0.19 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 116.807 -1.957 . . . . 0.0 106.595 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.974 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 3.3 t -67.55 -4.57 3.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.433 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.07 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.21 -57.94 3.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.773 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.55 -16.91 64.51 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.558 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 3.0 t60 -69.5 -37.44 77.19 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.069 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.924 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 2.8 mt-10 -87.65 -48.65 7.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 120' ' ' ALA . 1.9 mt -59.16 -31.55 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.709 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -82.21 -34.4 23.63 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -56.31 -45.81 80.1 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.524 -0.986 . . . . 0.0 110.374 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 167' ' ' ALA . 1.0 OUTLIER -89.56 -54.1 4.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 111.582 -178.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.974 ' CG ' HD11 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -104.16 36.31 2.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.198 -0.939 . . . . 0.0 110.753 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.993 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -141.89 -78.14 0.05 OUTLIER Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.047 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.876 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.2 -160.35 0.26 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.89 -1.359 . . . . 0.0 110.27 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.876 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.3 OUTLIER -102.54 -77.72 0.55 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.473 -0.767 . . . . 0.0 109.36 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.592 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.6 m-70 -159.44 121.75 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.453 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.622 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -109.56 -168.37 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.716 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.38 74.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.97 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -79.71 7.36 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.289 -176.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.449 ' C ' ' O ' ' A' ' 214' ' ' ASN . 2.7 p -50.47 -27.66 6.92 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.498 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.9 mp0 -114.84 -34.72 5.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.97 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -159.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.296 1.046 . . . . 0.0 112.247 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.13 HD13 ' O ' ' A' ' 218' ' ' LEU . 3.3 tm? -96.7 -19.96 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.38 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.592 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -78.99 -8.49 58.97 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.249 -1.532 . . . . 0.0 112.319 -177.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.687 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 41.0 t80 -132.42 14.49 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 120.412 -1.43 . . . . 0.0 113.312 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -76.97 -37.97 0.96 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 N-CA-C 109.157 -1.132 . . . . 0.0 109.157 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 1.013 HD23 ' N ' ' A' ' 223' ' ' TYR . 1.4 tt -19.48 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.526 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 1.013 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.2 OUTLIER -67.69 59.88 0.06 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.303 -0.873 . . . . 0.0 109.004 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' LEU . 9.2 t-160 179.89 -133.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.072 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.976 ' HB3' HG21 ' A' ' 190' ' ' THR . 49.8 m -160.57 114.92 2.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 109.929 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.935 HD12 ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER 179.51 57.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 1.046 HG23 ' O ' ' A' ' 188' ' ' LYS . 4.8 t -113.92 -8.61 13.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.873 . . . . 0.0 109.516 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.591 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 1.0 OUTLIER 178.06 -21.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.742 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 1.05 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.2 OUTLIER -37.03 -60.59 0.62 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.15 -0.969 . . . . 0.0 110.127 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.524 HG23 ' HG3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 179.22 -31.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.833 HH11 HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -89.33 -21.84 22.93 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 45.4 p90 -38.25 116.44 0.53 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.501 0.667 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.597 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.4 ttt180 179.3 152.86 0.41 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 109.126 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.98 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.0 mp -68.69 167.47 15.18 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.082 -1.011 . . . . 0.0 110.044 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.806 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 10.2 t -101.04 -169.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.575 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.3 OUTLIER -83.92 -23.08 31.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.924 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.716 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 4.6 m-20 -81.32 -40.06 24.2 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.847 -1.141 . . . . 0.0 107.934 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.844 ' OD1' HD21 ' A' ' 209' ' ' LEU . 17.2 t0 -70.46 -35.49 73.35 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 117.828 -1.549 . . . . 0.0 107.766 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.649 HD13 ' O ' ' A' ' 235' ' ' SER . 0.8 OUTLIER -61.25 -34.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 237' ' ' ASP . 1.1 t30 -66.69 -45.33 79.16 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.29 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.68 -58.93 11.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.994 HG21 HG21 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -61.69 -44.68 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.742 -1.446 . . . . 0.0 109.623 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.462 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.6 tt0 -54.76 -24.96 24.81 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -87.0 -14.59 41.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.811 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.4 OUTLIER -74.9 -56.34 4.85 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.745 ' CG ' HD23 ' A' ' 130' ' ' LEU . 16.4 m-85 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.215 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.507 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.751 ' CD1' HD11 ' A' ' 207' ' ' LEU . 7.0 m95 -98.67 -165.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.86 -1.15 . . . . 0.0 109.606 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.9 ppt_? -145.24 -40.61 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.984 -1.073 . . . . 0.0 110.582 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.729 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -45.26 174.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.085 -1.009 . . . . 0.0 110.377 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.559 ' HA ' ' CG ' ' A' ' 130' ' ' LEU . 11.6 p -112.15 2.66 16.81 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.547 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 17.8 m-70 -144.09 98.18 3.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.949 -1.094 . . . . 0.0 109.863 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.845 HD23 HD23 ' A' ' 130' ' ' LEU . 2.5 mm? -95.11 168.08 10.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.508 -0.745 . . . . 0.0 109.9 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.612 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -142.37 156.42 45.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.978 ' CE2' HD11 ' A' ' 101' ' ' ILE . 7.9 p90 -135.98 165.53 25.46 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.668 -1.27 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.406 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -125.17 121.94 35.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.889 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.978 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.2 mp -77.7 84.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.933 -1.104 . . . . 0.0 109.29 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.666 ' N ' ' O ' ' A' ' 144' ' ' ILE . 1.4 t -96.66 8.81 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 110.552 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.683 ' HB2' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -111.78 169.22 8.98 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.308 -1.495 . . . . 0.0 109.41 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.47 ' O ' ' C ' ' A' ' 105' ' ' THR . 4.3 p90 178.77 44.72 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.651 -0.656 . . . . 0.0 109.531 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 104' ' ' TYR . 70.5 p -41.26 153.79 0.24 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.474 -0.766 . . . . 0.0 109.048 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.03 -23.96 45.82 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 123.829 1.436 . . . . 0.0 108.766 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.627 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -69.19 -9.94 55.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.981 HD13 ' CD1' ' A' ' 195' ' ' LEU . 85.7 mt -144.42 115.83 5.4 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.8 Cg_endo -64.09 167.69 13.8 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 123.81 1.426 . . . . 0.0 109.295 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -35.49 -64.6 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.8 0.809 . . . . 0.0 110.477 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -59.76 -19.32 49.54 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.685 -0.635 . . . . 0.0 111.777 -178.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -80.36 -62.74 1.59 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.312 -1.493 . . . . 0.0 109.021 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.956 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.6 p -49.41 -40.5 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.835 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -67.19 -27.52 67.33 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.835 ' OG ' HD21 ' A' ' 195' ' ' LEU . 21.6 p -64.42 -42.5 96.0 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.05 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -71.42 -33.33 69.33 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.4 t -73.73 -25.18 20.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.589 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 2.0 tt0 -84.66 -36.67 21.77 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.744 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.854 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -78.83 -38.94 36.83 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.823 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -62.93 -61.48 2.37 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.853 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.0 OUTLIER -50.26 -40.15 47.13 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.988 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.629 ' N ' HD12 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -77.51 -33.45 54.34 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.37 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.01 ' O ' HG13 ' A' ' 127' ' ' VAL . 3.8 t -52.49 -44.5 44.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.014 ' CH2' HD21 ' A' ' 234' ' ' LEU . 33.4 m95 -92.2 -23.14 19.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 26.8 tt0 -69.67 -26.74 64.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.3 pt-20 -90.96 -42.99 10.25 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.648 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.01 HG13 ' O ' ' A' ' 123' ' ' VAL . 14.5 m -59.57 -23.78 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.274 -1.37 . . . . 0.0 108.988 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -116.89 163.42 22.84 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.519 -1.272 . . . . 0.0 109.289 179.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -77.58 -8.47 17.09 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.336 1.703 . . . . 0.0 109.883 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.845 HD23 HD23 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -70.19 179.55 2.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 110.536 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.467 ' OG1' ' ND1' ' A' ' 96' ' ' HIS . 6.7 p -127.3 174.38 9.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 1.1 m-85 -145.44 161.89 38.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.586 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -143.38 -174.36 4.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -152.04 155.6 38.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.901 -1.124 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.97 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.8 OUTLIER -147.41 -135.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.417 -0.802 . . . . 0.0 108.912 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 45.3 t80 178.94 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.793 -1.192 . . . . 0.0 109.23 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 139' ' ' GLU . 1.8 pm0 -158.57 -176.65 6.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.779 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.49 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -1.103 . . . . 0.0 110.184 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.97 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -60.15 -151.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 108.722 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -91.65 -25.82 18.96 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.984 HD11 ' HB2' ' A' ' 206' ' ' SER . 17.7 mm -127.81 86.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.597 ' HG3' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -67.15 97.17 0.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 102' ' ' VAL . 0.7 OUTLIER -82.37 116.19 26.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -134.49 153.18 52.06 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 119.944 -1.722 . . . . 0.0 112.388 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 147' ' ' ALA . 1.6 t80 -90.7 135.71 33.53 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.714 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.57 -152.65 0.11 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.725 -1.234 . . . . 0.0 111.17 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 149' ' ' ARG . 2.1 p -178.3 -169.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.744 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.684 -0.635 . . . . 0.0 111.118 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 149' ' ' ARG . 42.0 Cg_endo . . . . . 0 C--O 1.215 -0.632 0 N-CA-C 109.13 -1.142 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.645 ' CE1' ' CG1' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.5 -140.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.67 ' CB ' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -134.75 -23.54 1.58 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.496 -1.377 . . . . 0.0 111.312 -178.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 41.52 -96.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 158' ' ' ASP . 34.3 Cg_endo -59.68 76.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.265 1.14 . . . . 0.0 110.052 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 175.98 -167.31 38.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 163' ' ' VAL . 58.3 m-80 -87.25 -27.75 22.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -1.192 . . . . 0.0 109.964 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.67 HG21 ' CB ' ' A' ' 158' ' ' ASP . 16.9 t -35.79 140.58 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.426 0.631 . . . . 0.0 110.862 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.046 HD11 HG21 ' A' ' 193' ' ' THR . 0.4 OUTLIER -105.17 -90.81 0.4 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.465 -0.772 . . . . 0.0 112.31 -179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.859 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -147.27 -168.89 3.17 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.113 -1.617 . . . . 0.0 111.541 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.641 ' CD2' ' CE2' ' A' ' 157' ' ' PHE . 0.5 OUTLIER 179.95 171.98 1.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 119.682 -1.886 . . . . 0.0 111.024 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 202' ' ' GLU . . . -147.55 -164.54 2.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.399 -0.813 . . . . 0.0 109.99 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.646 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -131.9 -163.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.883 -1.136 . . . . 0.0 110.643 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.001 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -163.98 -62.84 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.093 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 1.001 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.8 Cg_endo -77.09 158.95 33.98 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.779 1.41 . . . . 0.0 109.966 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.474 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . 115.32 173.69 17.71 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -76.55 -89.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.683 1.589 . . . . 0.0 110.138 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -78.13 -35.44 34.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.646 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.5 tp -68.96 -0.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.925 . . . . 0.0 108.967 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 172' ' ' PRO . 2.6 t30 -65.82 64.22 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 119.81 90.63 1.25 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.612 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -158.07 127.01 5.64 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.839 -1.389 . . . . 0.0 108.159 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.675 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -115.88 168.16 10.3 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.117 -0.99 . . . . 0.0 108.714 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.714 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.97 134.39 4.28 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.205 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.587 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 53.1 m-85 -90.08 127.99 36.2 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.24 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 1.0 OUTLIER -76.62 144.78 39.31 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.949 -1.094 . . . . 0.0 109.205 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 183' ' ' ASP . 27.3 t0 -62.44 -2.16 0.98 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.21 -0.931 . . . . 0.0 110.381 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.2 p30 3.9 -95.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 183' ' ' ASP . 7.5 mp0 -147.59 -51.15 0.19 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.873 -1.142 . . . . 0.0 110.509 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -140.79 172.0 13.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 0.0 110.926 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.976 ' CH2' HD12 ' A' ' 164' ' ' LEU . 85.8 m95 -160.58 129.77 4.9 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.696 ' HA ' HD21 ' A' ' 108' ' ' LEU . 33.4 p -146.88 155.93 42.7 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.555 -1.341 . . . . 0.0 110.428 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.596 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 3.2 pttt -78.02 -33.11 51.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.545 ' O ' ' CG2' ' A' ' 227' ' ' THR . 2.9 t0 -90.48 -143.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.917 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.4 t -115.37 45.64 1.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.851 -1.155 . . . . 0.0 108.264 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 187' ' ' THR . 53.7 m -102.69 -30.3 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.326 -0.859 . . . . 0.0 111.084 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.553 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -108.52 -90.59 2.12 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.363 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.046 HG21 HD11 ' A' ' 164' ' ' LEU . 89.6 m -120.68 -80.21 0.62 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.941 ' ND2' HG22 ' A' ' 193' ' ' THR . 0.1 OUTLIER 178.15 66.79 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.582 1.182 . . . . 0.0 108.435 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.004 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 1.2 tp -20.03 -95.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.952 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.911 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -62.06 -15.01 41.75 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.055 -1.028 . . . . 0.0 110.883 -176.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.873 HD11 ' CG ' ' A' ' 221' ' ' PRO . 13.3 tp -60.75 -57.46 12.58 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.251 -1.78 . . . . 0.0 107.199 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' A' ' 165' ' ' ALA . 2.4 t -74.72 -9.25 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.749 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.05 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.24 -57.85 3.57 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.35 -1.34 . . . . 0.0 107.503 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.705 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -64.03 -17.91 63.81 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 219' ' ' MET . 3.3 t-160 -69.39 -40.95 77.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.17 -1.812 . . . . 0.0 107.849 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.69 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 3.5 mt-10 -82.89 -49.12 9.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.954 -1.091 . . . . 0.0 110.79 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.853 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.2 mt -60.59 -31.47 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.734 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.79 -34.09 49.46 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -57.24 -53.15 61.34 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.61 -0.935 . . . . 0.0 109.773 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.984 ' HB2' HD11 ' A' ' 142' ' ' ILE . 2.6 m -77.81 -64.19 1.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.583 -0.698 . . . . 0.0 111.671 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 207' ' ' LEU . 2.8 mm? -101.36 37.99 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -0.802 . . . . 0.0 110.614 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.974 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -135.83 -69.22 0.06 OUTLIER Glycine 0 C--N 1.289 -2.046 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.868 HD11 ' SD ' ' A' ' 219' ' ' MET . 4.5 pp 179.75 -161.86 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.933 0 O-C-N 120.633 -1.51 . . . . 0.0 109.387 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.798 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.3 t80 -102.11 -71.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.259 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 54.4 m80 -162.16 102.05 1.11 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.795 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.5 m -93.07 -174.68 3.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.782 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.95 78.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.955 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.43 9.3 13.69 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.422 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 214' ' ' ASN . 73.7 p -50.42 -27.72 6.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.519 ' C ' ' HB2' ' A' ' 235' ' ' SER . 8.3 mt-10 -113.75 -37.01 4.67 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.955 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -64.35 -171.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.45 1.119 . . . . 0.0 112.72 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.907 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -84.64 -18.9 33.95 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.937 -177.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.868 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 119.262 -2.149 . . . . 0.0 112.171 -177.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.671 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 35.3 t80 -134.99 15.63 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.257 -1.527 . . . . 0.0 113.39 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.873 ' CG ' HD11 ' A' ' 197' ' ' LEU . 55.8 Cg_endo -77.97 -41.17 0.32 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.58 ' C ' ' O ' ' A' ' 221' ' ' PRO . 18.9 tp -6.87 -74.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.506 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -65.45 63.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.492 -0.755 . . . . 0.0 109.779 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.82 -162.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.2 m -131.99 116.17 16.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.103 -0.998 . . . . 0.0 109.693 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' A' ' 231' ' ' ARG . 5.5 tp 179.49 31.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.627 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 6.6 t -77.61 -52.77 8.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.649 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 5.2 t0 -151.49 3.22 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.745 -1.222 . . . . 0.0 110.952 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.917 HD11 ' N ' ' A' ' 190' ' ' THR . 1.2 mm? -41.41 -101.04 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.906 -1.121 . . . . 0.0 110.912 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -18.22 3.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.701 -1.249 . . . . 0.0 109.85 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.732 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -105.48 -42.03 5.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 108.386 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.649 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 9.5 p90 0.36 117.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.05 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.014 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.5 mp -80.27 166.49 21.32 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.756 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 28.9 t -98.38 -171.84 2.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.354 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.5 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.08 -11.83 54.38 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.726 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.1 OUTLIER -85.34 -46.99 10.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.889 -1.132 . . . . 0.0 107.971 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.68 ' OD1' HD21 ' A' ' 209' ' ' LEU . 1.2 m-20 -66.87 -38.04 85.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 117.201 -1.8 . . . . 0.0 106.554 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -58.04 -34.55 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.519 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 1.3 t-20 -66.69 -49.23 66.76 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.88 -50.62 65.76 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.28 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.997 HG13 HG22 ' A' ' 128' ' ' THR . 1.9 tp -68.27 -48.44 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 120.741 -1.447 . . . . 0.0 110.665 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.57 ' N ' HG23 ' A' ' 242' ' ' ILE . 15.0 pt20 -54.77 -23.08 16.3 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.1 p -88.66 -17.07 30.8 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.635 ' HB3' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -74.22 -59.36 2.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.74 ' CE1' HD22 ' A' ' 130' ' ' LEU . 15.2 m-85 . . . . . 0 N--CA 1.493 1.688 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.502 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.567 ' HB2' HD21 ' A' ' 245' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.646 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 50.7 m95 -111.42 163.69 13.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.028 -1.045 . . . . 0.0 109.532 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -131.95 -28.01 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.537 -179.325 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 1.037 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -40.13 165.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.373 -0.829 . . . . 0.0 110.625 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.581 ' O ' ' CD2' ' A' ' 96' ' ' HIS . 2.1 p -107.63 5.21 26.67 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.462 -0.774 . . . . 0.0 109.185 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 1.071 ' CE1' HG21 ' A' ' 131' ' ' THR . 33.4 m-70 -150.72 103.49 3.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.453 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.95 HD13 ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -116.33 -165.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 109.91 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.585 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -161.43 162.35 30.55 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.74 ' CZ ' HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -137.9 160.78 38.38 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.875 -1.141 . . . . 0.0 109.181 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.837 ' NE ' HG22 ' A' ' 102' ' ' VAL . 1.2 ttp180 -123.09 126.63 47.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 109.807 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.803 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.5 mp -85.09 84.37 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.005 -1.059 . . . . 0.0 109.677 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.837 HG22 ' NE ' ' A' ' 100' ' ' ARG . 2.6 t -100.35 8.03 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.007 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.886 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -100.99 157.04 17.05 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.783 -1.198 . . . . 0.0 109.353 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.656 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.6 OUTLIER 177.99 75.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.537 HG21 ' CD1' ' A' ' 186' ' ' TRP . 11.5 p -70.6 159.5 84.85 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -68.14 -21.86 41.78 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.808 1.425 . . . . 0.0 108.686 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 1.5 t0 -70.28 -8.73 52.6 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.961 HD13 HD13 ' A' ' 195' ' ' LEU . 93.5 mt -147.07 124.14 5.76 Favored Pre-proline 0 N--CA 1.484 1.233 0 O-C-N 121.585 -0.697 . . . . 0.0 109.848 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.11 169.84 12.88 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 O-C-N 123.811 1.427 . . . . 0.0 109.007 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.08 -65.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.971 0.891 . . . . 0.0 110.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 115' ' ' SER . 1.6 p-10 -53.97 -32.32 53.58 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.743 -0.598 . . . . 0.0 112.033 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.908 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.91 -61.4 1.78 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.533 -1.354 . . . . 0.0 109.635 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 117' ' ' VAL . 8.7 p -53.3 -41.2 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.803 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -64.35 -27.27 68.9 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.936 ' OG ' HD21 ' A' ' 195' ' ' LEU . 6.2 p -63.51 -43.73 96.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.055 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -68.23 -33.1 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.108 -0.995 . . . . 0.0 109.492 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.888 HG13 HG13 ' A' ' 144' ' ' ILE . 5.0 t -76.26 -22.0 15.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.2 tt0 -88.24 -34.12 17.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.8 OUTLIER -82.45 -36.33 26.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.73 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -67.28 -61.18 2.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.338 1.066 . . . . 0.0 108.588 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.872 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.6 pp -57.0 -40.8 77.29 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.779 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.47 -32.69 62.66 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.898 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.038 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.41 -42.04 65.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.103 ' CH2' HD21 ' A' ' 234' ' ' LEU . 37.7 m95 -91.23 -23.97 20.03 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.536 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 3.5 tm-20 -69.57 -27.44 65.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.851 -1.156 . . . . 0.0 107.89 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 13.9 pt-20 -90.58 -42.84 10.57 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.738 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.038 HG13 ' O ' ' A' ' 123' ' ' VAL . 15.8 m -59.2 -24.52 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.139 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.007 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -114.26 154.82 46.27 Favored Pre-proline 0 N--CA 1.494 1.731 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.573 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -82.49 29.31 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.136 1.891 . . . . 0.0 110.472 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.037 HD21 ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -99.44 -179.95 4.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.95 -1.094 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 1.071 HG21 ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -112.9 161.18 17.28 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.95 ' CE2' HD13 ' A' ' 97' ' ' LEU . 53.2 m-85 -147.72 148.74 31.32 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.061 -1.024 . . . . 0.0 110.901 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.575 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -130.2 -179.23 5.12 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.812 -1.18 . . . . 0.0 110.207 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.695 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.49 -163.78 1.52 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.215 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.517 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 69.5 t80 -155.79 21.22 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 26.0 pm0 -143.98 -174.62 4.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.637 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.04 -97.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 137' ' ' GLU . 11.6 pt-20 178.8 130.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -1.133 . . . . 0.0 110.157 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.585 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -89.78 -147.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.227 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.591 ' CG ' HD11 ' A' ' 207' ' ' LEU . 12.9 t0 -92.89 -33.16 14.32 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.738 HG22 ' CD1' ' A' ' 144' ' ' ILE . 22.1 mt -126.64 80.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.457 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.8 ttp -64.26 94.04 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.121 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.888 HG13 HG13 ' A' ' 117' ' ' VAL . 5.4 mm -79.17 118.76 27.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -137.76 158.16 44.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.349 -1.469 . . . . 0.0 111.983 -179.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.52 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 23.6 p90 -90.91 138.62 31.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 109.591 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.124 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.27 -159.05 0.56 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.178 -0.951 . . . . 0.0 110.003 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.988 HG21 ' CG ' ' A' ' 183' ' ' ASP . 1.5 p -174.85 -168.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.923 -1.11 . . . . 0.0 109.274 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.722 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 0.0 109.972 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 109.743 -0.907 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.715 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -95.08 -160.63 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.982 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 160' ' ' PRO . 20.5 p30 178.86 50.59 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.574 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.69 -74.38 0.0 OUTLIER Glycine 0 N--CA 1.509 3.512 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.582 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.7 Cg_endo -65.17 61.28 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.237 1.292 . . . . 0.0 109.99 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.42 143.9 8.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -42.12 -41.17 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -1.115 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 163' ' ' VAL . 31.0 m -55.01 84.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.802 . . . . 0.0 109.871 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.695 HD12 HD12 ' A' ' 222' ' ' LEU . 15.8 mt -71.84 -80.27 0.06 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.311 -0.868 . . . . 0.0 112.822 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.856 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -136.2 -174.65 3.74 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.469 -1.395 . . . . 0.0 111.489 -177.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.715 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.5 p-80 -179.99 167.62 1.28 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.273 -1.517 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -141.43 -166.13 2.12 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.215 -0.928 . . . . 0.0 110.391 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.623 ' CD2' HD11 ' A' ' 174' ' ' ILE . 0.1 OUTLIER -128.59 -160.86 1.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.1 -1.0 . . . . 0.0 110.73 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.005 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -166.06 -60.3 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.493 -0.755 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 1.005 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.6 Cg_endo -79.16 -172.31 1.5 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.725 1.382 . . . . 0.0 110.083 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.18 144.37 0.64 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.6 Cg_endo -70.37 136.88 32.43 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.854 1.449 . . . . 0.0 110.061 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 71.3 -64.15 1.02 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 168' ' ' TYR . 0.6 OUTLIER -64.31 -7.82 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.969 . . . . 0.0 109.164 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -65.72 66.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.894 . . . . 0.0 108.958 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 126.88 81.58 0.37 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.7 m-20 -155.87 126.83 6.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.935 -1.332 . . . . 0.0 108.016 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.684 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -113.43 168.26 9.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.325 -0.86 . . . . 0.0 109.086 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.124 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.27 135.14 5.07 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.751 178.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.596 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 58.1 m-85 -95.29 134.4 38.11 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.896 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -68.65 132.64 47.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.028 -1.469 . . . . 0.0 107.41 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -105.8 37.0 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.87 -1.144 . . . . 0.0 110.332 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.988 ' CG ' HG21 ' A' ' 148' ' ' VAL . 1.9 m-20 -114.25 -2.76 13.27 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.379 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.548 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 5.5 pt-20 -119.24 -111.65 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.056 -1.027 . . . . 0.0 108.627 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 48.6 mt-30 -148.22 174.7 11.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.818 -1.176 . . . . 0.0 109.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.585 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 90.3 m95 -162.14 126.49 3.23 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.82 ' HA ' HD21 ' A' ' 108' ' ' LEU . 71.3 p -150.14 155.38 39.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.724 -1.235 . . . . 0.0 110.627 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.937 ' HB3' HD22 ' A' ' 195' ' ' LEU . 1.1 ptpt -83.67 -30.58 26.7 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.65 ' O ' ' N ' ' A' ' 191' ' ' THR . 30.7 t0 -87.28 63.7 7.91 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.906 HG22 HD11 ' A' ' 229' ' ' LEU . 6.2 t 4.41 59.68 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.883 0.849 . . . . 0.0 111.789 -177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.65 ' N ' ' O ' ' A' ' 189' ' ' ASP . 47.7 m -124.49 -31.49 3.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.252 -0.905 . . . . 0.0 109.682 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.9 -78.69 1.42 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.705 HG22 ' OD1' ' A' ' 194' ' ' ASN . 18.4 m -129.9 -95.16 0.39 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.835 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.4 OUTLIER -161.37 73.43 0.44 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.961 HD13 HD13 ' A' ' 108' ' ' LEU . 2.4 tp -34.4 -96.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.631 0.729 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.895 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -67.56 -8.13 31.7 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -177.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.753 HD13 ' HA ' ' A' ' 227' ' ' THR . 12.2 tp -68.7 -63.13 1.12 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 116.42 -2.112 . . . . 0.0 106.924 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.856 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 9.2 t -71.41 -8.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.055 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -74.49 -58.59 3.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.96 -15.08 62.67 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.579 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 9.1 t60 -69.33 -42.03 75.87 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.957 -1.497 . . . . 0.0 107.96 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.684 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 6.8 mt-10 -85.43 -46.77 10.6 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.05 -1.031 . . . . 0.0 110.603 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.872 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -61.15 -30.87 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.706 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.23 -33.89 38.67 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.5 -50.23 73.73 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.825 -0.809 . . . . 0.0 110.41 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.54 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 58.3 p -83.82 -57.1 3.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.424 -0.798 . . . . 0.0 112.027 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.81 HD13 HD22 ' A' ' 97' ' ' LEU . 13.1 mt -104.56 34.99 2.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.945 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -136.94 -77.74 0.08 OUTLIER Glycine 0 C--N 1.292 -1.889 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.1 pp -172.02 -165.72 0.37 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.77 -1.429 . . . . 0.0 109.995 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.715 ' N ' HD12 ' A' ' 209' ' ' LEU . 3.3 t80 -96.92 -73.37 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.845 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.601 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 81.0 m80 -160.6 103.93 1.39 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.128 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.655 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -91.43 -171.34 2.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.856 . . . . 0.0 108.85 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.993 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.74 76.16 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.931 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.06 9.58 12.17 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.634 -176.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -51.1 -27.49 8.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.512 ' C ' ' HB2' ' A' ' 235' ' ' SER . 14.9 mt-10 -114.95 -38.44 3.9 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.64 -178.98 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.301 1.048 . . . . 0.0 112.262 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.806 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -78.18 -18.35 55.62 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.463 -177.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.601 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -77.63 -7.84 56.99 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 119.19 -2.194 . . . . 0.0 112.056 -177.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.658 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 39.6 t80 -135.56 15.79 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.362 -1.461 . . . . 0.0 113.622 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -78.3 -37.24 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.53 -1.373 . . . . 0.0 108.53 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.979 HD23 ' N ' ' A' ' 223' ' ' TYR . 0.6 OUTLIER -15.58 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.01 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.979 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.63 59.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.496 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.6 OUTLIER -175.65 -159.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 74.3 m -126.4 104.15 8.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 109.722 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 197' ' ' LEU . 0.0 OUTLIER 178.56 40.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.843 . . . . 0.0 109.023 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.753 ' HA ' HD13 ' A' ' 197' ' ' LEU . 10.0 t -84.87 -51.02 7.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.237 -0.914 . . . . 0.0 110.111 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.714 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.3 OUTLIER -152.64 6.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.096 . . . . 0.0 110.903 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.906 HD11 HG22 ' A' ' 190' ' ' THR . 0.4 OUTLIER -49.07 -108.8 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.949 -1.095 . . . . 0.0 110.796 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -23.94 5.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.589 -1.319 . . . . 0.0 109.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.538 ' O ' ' C ' ' A' ' 232' ' ' PHE . 5.3 mtp180 -98.24 -31.95 11.81 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.646 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 4.9 p90 -17.09 118.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.824 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.532 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.32 171.63 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.381 -0.825 . . . . 0.0 110.516 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.103 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.2 mp -81.78 166.17 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.853 . . . . 0.0 110.427 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 37.9 t -101.77 -166.89 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.122 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.52 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.2 OUTLIER -84.97 -17.71 36.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.644 -0.66 . . . . 0.0 110.262 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.993 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.9 OUTLIER -81.62 -48.54 11.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.725 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 1.0 OUTLIER -63.98 -40.06 95.53 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.508 -1.677 . . . . 0.0 106.659 177.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.42 -35.41 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.7 -54.38 19.95 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -50.79 -53.91 24.1 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.016 HG21 HG21 ' A' ' 127' ' ' VAL . 1.1 tp -64.86 -43.19 96.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.886 -1.361 . . . . 0.0 109.995 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.51 ' N ' HG23 ' A' ' 242' ' ' ILE . 0.0 OUTLIER -54.54 -28.45 45.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.2 t -80.27 -21.16 42.98 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.839 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -67.52 -64.11 0.92 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.783 ' HB3' HD13 ' A' ' 130' ' ' LEU . 27.9 m-85 . . . . . 0 N--CA 1.49 1.54 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.209 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.927 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CZ2' ' O ' ' A' ' 175' ' ' ASN . 12.7 m95 -88.13 -167.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.957 -1.089 . . . . 0.0 109.608 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -162.42 -37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.418 -0.801 . . . . 0.0 109.087 179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.585 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -52.4 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.434 -0.791 . . . . 0.0 110.08 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.878 ' HA ' HD12 ' A' ' 130' ' ' LEU . 65.7 p -122.34 -0.97 9.22 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.602 -0.686 . . . . 0.0 109.312 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.585 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 15.0 m-70 -140.56 92.59 2.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.463 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.751 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.9 mm? -85.19 162.8 19.05 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.512 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.6 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -141.05 155.83 46.1 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.934 ' CE2' HD11 ' A' ' 101' ' ' ILE . 8.4 p90 -134.47 168.56 18.72 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.452 -1.405 . . . . 0.0 109.826 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 1.011 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.5 124.06 31.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -0.766 . . . . 0.0 109.235 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.934 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.5 mp -80.69 81.48 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.011 HG22 ' NE ' ' A' ' 100' ' ' ARG . 4.8 t -94.71 5.08 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.873 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -103.29 163.99 11.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.761 -1.212 . . . . 0.0 108.6 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.71 ' N ' HG21 ' A' ' 113' ' ' VAL . 7.2 p90 -178.2 58.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.119 -0.988 . . . . 0.0 110.5 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.981 HG21 ' CD1' ' A' ' 186' ' ' TRP . 69.0 p -45.48 145.57 2.0 Allowed Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.1 -32.47 34.2 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 124.002 1.528 . . . . 0.0 109.232 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.62 ' C ' HD23 ' A' ' 108' ' ' LEU . 14.9 m-20 -65.89 -19.37 65.85 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.967 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -115.62 114.28 42.34 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 112' ' ' ALA . 36.4 Cg_endo -62.75 168.17 10.65 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.565 1.297 . . . . 0.0 108.996 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HE2' ' HB2' ' A' ' 110' ' ' LYS . 1.3 mppt? -39.73 -64.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.877 0.846 . . . . 0.0 109.54 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -57.73 -10.87 1.8 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.845 -0.535 . . . . 0.0 111.392 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.705 ' HB1' HD13 ' A' ' 108' ' ' LEU . . . -87.75 -58.44 2.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.576 -1.327 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 1.039 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.9 p -59.68 -43.39 91.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.612 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -60.92 -26.83 67.76 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.614 ' OG ' HD21 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -63.26 -65.24 0.71 Allowed 'General case' 0 C--O 1.195 -1.768 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.047 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -49.46 -31.99 11.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.039 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.6 t -74.34 -24.62 19.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -87.18 -37.19 17.52 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.345 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.764 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -77.82 -39.1 44.79 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.773 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.71 -61.57 2.0 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.214 1.007 . . . . 0.0 108.553 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.846 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.3 pp -53.8 -41.4 67.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.381 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.794 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -76.19 -32.85 59.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.806 -178.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.021 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.1 t -53.76 -45.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.064 ' CH2' HD21 ' A' ' 234' ' ' LEU . 33.5 m95 -91.69 -22.31 20.3 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.758 -1.177 . . . . 0.0 110.532 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.535 ' CG ' ' HB2' ' A' ' 132' ' ' PHE . 9.3 tm-20 -69.79 -27.03 64.57 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.782 -1.199 . . . . 0.0 107.815 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -91.17 -42.95 10.16 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.63 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.038 HG21 HG21 ' A' ' 242' ' ' ILE . 14.0 m -58.07 -25.56 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.308 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.01 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -109.36 155.0 41.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 118.073 -1.451 . . . . 0.0 109.249 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.68 ' C ' HD22 ' A' ' 130' ' ' LEU . 51.2 Cg_endo -82.06 26.2 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.054 1.836 . . . . 0.0 111.395 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 95' ' ' THR . 4.4 mm? -108.6 -169.54 1.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.595 -1.316 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.574 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 2.0 p -117.7 169.22 9.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.808 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CE2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -139.17 163.34 32.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.637 -0.664 . . . . 0.0 109.921 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.579 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -143.08 -172.8 3.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.638 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -159.81 165.46 32.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.562 -1.336 . . . . 0.0 110.798 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.722 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -163.37 -163.63 0.85 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.592 -0.692 . . . . 0.0 109.134 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 75.0 t80 -158.2 22.07 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 108.768 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 1.6 pm0 -148.8 -178.95 6.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -0.761 . . . . 0.0 108.97 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.87 -97.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 137' ' ' GLU . 20.2 tt0 178.5 146.22 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -1.175 . . . . 0.0 110.531 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.668 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -103.18 -150.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.698 ' O ' HD13 ' A' ' 142' ' ' ILE . 41.4 m-20 -88.74 -36.58 16.06 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.934 HG13 HD23 ' A' ' 207' ' ' LEU . 18.4 mm -122.28 82.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.552 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 3.3 ptt? -67.1 100.12 0.73 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.582 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.873 HG22 ' ND2' ' A' ' 103' ' ' ASN . 6.1 mm -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -135.41 154.93 51.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.336 -1.477 . . . . 0.0 111.939 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -77.06 135.99 38.65 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.064 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -152.83 164.68 37.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 110.485 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 1.001 HG21 ' CG ' ' A' ' 183' ' ' ASP . 2.6 p -160.2 -174.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.255 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.702 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.279 -0.888 . . . . 0.0 110.334 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 C--O 1.215 -0.63 0 N-CA-C 109.795 -0.887 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.652 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -117.13 -162.15 0.85 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 110.326 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 160' ' ' PRO . 33.0 p30 -173.79 55.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 110.041 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 14.49 -76.86 0.0 OUTLIER Glycine 0 N--CA 1.508 3.446 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.615 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.2 Cg_endo -66.9 59.19 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.322 1.348 . . . . 0.0 109.866 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -151.89 142.71 9.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 161' ' ' GLY . 2.7 m120 -41.43 -34.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.021 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.587 ' HB ' ' CZ ' ' A' ' 157' ' ' PHE . 10.9 m -66.66 84.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.97 . . . . 0.0 109.646 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.099 HD21 HG23 ' A' ' 193' ' ' THR . 1.2 tp -64.03 -56.07 17.67 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.335 -0.853 . . . . 0.0 111.462 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.783 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -163.1 -164.35 0.95 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.394 -1.441 . . . . 0.0 110.622 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.652 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 0.9 OUTLIER 178.92 -179.17 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.157 -1.589 . . . . 0.0 111.356 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 202' ' ' GLU . . . -151.32 174.46 13.28 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.804 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.559 ' CE2' HD12 ' A' ' 174' ' ' ILE . 0.1 OUTLIER -113.97 -170.17 1.66 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.082 -1.011 . . . . 0.0 110.168 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.957 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -156.78 -66.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 109.197 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.957 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 43.8 Cg_endo -73.03 -160.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.704 1.371 . . . . 0.0 109.718 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 175' ' ' ASN . . . 76.33 164.21 17.45 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.8 Cg_endo -73.85 -92.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.012 1.533 . . . . 0.0 110.215 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -68.51 -23.7 75.22 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -77.88 9.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.569 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -65.78 64.82 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 142' ' ' ILE . . . 110.73 96.59 2.37 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -152.96 114.53 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.197 -1.178 . . . . 0.0 107.872 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.675 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.76 157.41 19.17 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.558 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.064 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -147.08 134.88 21.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.816 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.541 ' HB3' ' CZ2' ' A' ' 186' ' ' TRP . 19.1 m-85 -96.79 130.7 44.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.096 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 164' ' ' LEU . 0.2 OUTLIER -47.97 143.27 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.721 -1.237 . . . . 0.0 109.343 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -119.26 29.58 7.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 1.001 ' CG ' HG21 ' A' ' 148' ' ' VAL . 4.7 m-20 -135.97 3.34 2.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 110.598 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.54 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 1.6 pt-20 -112.35 -96.39 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.606 -1.309 . . . . 0.0 109.492 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.601 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -162.36 173.4 14.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.081 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.981 ' CD1' HG21 ' A' ' 105' ' ' THR . 86.1 m95 -161.15 133.8 6.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.006 -1.059 . . . . 0.0 109.799 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 186' ' ' TRP . 74.9 p -162.02 150.08 14.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.577 -0.702 . . . . 0.0 109.374 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.679 ' O ' HG23 ' A' ' 227' ' ' THR . 13.3 pttt -83.38 -31.9 26.48 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.655 ' O ' ' N ' ' A' ' 191' ' ' THR . 9.4 t70 -83.77 64.01 7.79 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 1.026 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.9 t 3.44 60.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.123 0.963 . . . . 0.0 111.975 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.655 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.7 m -121.88 -32.25 3.78 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.076 -1.015 . . . . 0.0 109.545 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.402 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -98.55 -75.97 1.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.099 HG23 HD21 ' A' ' 164' ' ' LEU . 3.0 m -124.28 -88.86 0.6 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.844 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 4.3 m-20 178.06 72.37 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.015 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 30.6 tp -28.82 -102.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.514 0.673 . . . . 0.0 112.541 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.844 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -57.44 -16.08 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.015 -1.053 . . . . 0.0 111.604 -177.372 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.844 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.8 tp -63.02 -63.04 1.32 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.32 -2.112 . . . . 0.0 107.245 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.032 HG21 HD23 ' A' ' 164' ' ' LEU . 3.2 t -69.88 -8.32 10.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.047 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -76.84 -59.54 2.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -64.95 -14.22 59.5 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.481 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 22.0 t60 -66.73 -50.66 62.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.589 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 167' ' ' ALA . 2.3 mm-40 -79.42 -46.44 17.52 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.282 -0.886 . . . . 0.0 110.925 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.773 HD12 ' HB3' ' A' ' 120' ' ' ALA . 1.4 mt -60.2 -30.35 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.713 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.3 -32.74 42.07 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -59.23 -49.05 79.32 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.892 -0.769 . . . . 0.0 110.496 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.644 ' OG ' ' HB1' ' A' ' 167' ' ' ALA . 5.0 m -84.63 -56.16 3.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 112.333 -177.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.934 HD23 HG13 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -104.39 27.0 8.25 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.94 -1.1 . . . . 0.0 110.987 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.907 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -130.11 -78.26 0.19 Allowed Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.838 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -167.48 -162.82 0.47 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.853 -1.381 . . . . 0.0 110.208 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 4.1 t80 -98.98 -70.78 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.802 . . . . 0.0 109.471 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 44.9 m80 -161.31 87.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.633 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -76.98 179.75 6.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 109.306 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.918 ' HB3' ' OD2' ' A' ' 237' ' ' ASP . . . -61.63 81.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.957 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.08 11.12 12.41 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.366 -177.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 214' ' ' ASN . 47.6 p -49.41 -28.27 4.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.545 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.0 mm-40 -115.99 -36.14 4.22 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.957 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.63 -166.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.507 1.146 . . . . 0.0 112.773 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -95.26 -15.3 23.3 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.354 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.573 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -79.77 -5.98 56.39 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.284 -2.135 . . . . 0.0 112.054 -177.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.656 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 43.3 t80 -138.78 15.75 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.444 -1.41 . . . . 0.0 113.347 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.14 -37.46 0.79 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 N-CA-C 108.631 -1.334 . . . . 0.0 108.631 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.978 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.7 OUTLIER -14.76 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.085 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.978 ' N ' HD13 ' A' ' 222' ' ' LEU . 2.1 t80 -73.42 56.32 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.154 -0.966 . . . . 0.0 109.321 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -173.68 -145.72 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.574 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.668 ' HB3' HG21 ' A' ' 190' ' ' THR . 18.6 m -143.2 110.6 5.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.855 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER 179.4 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.34 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 188' ' ' LYS . 11.3 t -93.36 -13.24 28.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.596 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER 178.37 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.564 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 1.026 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.4 OUTLIER -26.83 -99.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.811 -0.555 . . . . 0.0 111.426 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 p -135.05 -2.98 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.759 -1.213 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.565 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.7 OUTLIER -119.32 -40.28 2.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 108.744 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 2.0 p90 0.38 111.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.357 0.599 . . . . 0.0 111.958 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.6 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.5 ttt180 179.42 154.28 0.47 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.166 -0.959 . . . . 0.0 110.035 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.064 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -74.77 169.31 18.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.469 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 30.4 t -104.6 -169.63 1.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.353 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.517 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.98 -11.91 54.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 110.104 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.918 ' OD2' ' HB3' ' A' ' 213' ' ' ALA . 0.5 OUTLIER -84.18 -50.81 7.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.66 -1.275 . . . . 0.0 107.748 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.838 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.81 -38.33 90.71 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.679 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -57.07 -35.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 237' ' ' ASP . 3.5 m-20 -68.42 -56.91 6.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -47.88 -53.33 14.24 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.038 HG21 HG21 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -63.91 -43.39 97.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.977 -1.308 . . . . 0.0 109.746 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.536 ' N ' HG23 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -54.54 -27.35 37.82 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -82.71 -19.17 38.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.825 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -70.11 -63.45 1.08 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.558 ' HB3' ' CD2' ' A' ' 130' ' ' LEU . 15.9 m-30 . . . . . 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.275 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 1.036 ' CE ' ' HB1' ' A' ' 169' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' A' ' 141' ' ' ASP . 70.9 m95 -94.06 162.64 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 0.0 109.258 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -133.02 -35.19 1.06 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 110.237 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HD3' HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -50.7 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.177 -0.952 . . . . 0.0 110.283 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.797 ' CA ' HD12 ' A' ' 130' ' ' LEU . 32.3 p -124.72 1.49 8.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.461 -0.774 . . . . 0.0 109.561 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.555 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 35.6 m80 -146.02 99.66 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.992 -1.067 . . . . 0.0 110.484 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.212 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -127.59 -153.09 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 141' ' ' ASP . 1.2 t -173.75 -178.91 1.67 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.947 -1.096 . . . . 0.0 111.179 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.827 ' CG ' HD23 ' A' ' 121' ' ' LEU . 10.4 p90 -135.82 179.16 6.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.371 -0.831 . . . . 0.0 109.678 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.806 ' NH2' HG22 ' A' ' 102' ' ' VAL . 2.0 ttp85 -131.85 144.1 50.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -0.758 . . . . 0.0 109.394 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.98 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.8 mp -101.53 78.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.879 -1.138 . . . . 0.0 109.503 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.806 HG22 ' NH2' ' A' ' 100' ' ' ARG . 1.8 t -92.77 9.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.44 -0.787 . . . . 0.0 110.616 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.616 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.81 174.47 5.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.508 -1.37 . . . . 0.0 110.108 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.61 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.1 t80 177.16 86.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.397 0.618 . . . . 0.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.789 HG21 ' CD1' ' A' ' 186' ' ' TRP . 33.2 p -67.44 154.09 93.67 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 185' ' ' GLN . 38.3 Cg_endo -67.87 -26.53 38.05 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.827 1.435 . . . . 0.0 108.65 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.585 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -81.86 2.23 31.33 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.901 HD13 ' CD1' ' A' ' 195' ' ' LEU . 95.1 mt -145.23 117.27 5.23 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.486 -0.759 . . . . 0.0 110.236 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.06 175.6 5.44 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.853 1.449 . . . . 0.0 108.872 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.97 -64.96 0.44 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.829 0.823 . . . . 0.0 110.108 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -30.63 55.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 112.282 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.889 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.29 -60.69 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.31 -1.494 . . . . 0.0 109.356 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.616 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.5 p -52.25 -38.48 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.98 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -65.6 -28.64 69.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.7 ' OG ' HD21 ' A' ' 195' ' ' LEU . 10.8 p -62.37 -39.68 93.96 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.067 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -72.48 -34.13 67.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 0.0 109.544 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.891 HG22 HG21 ' A' ' 144' ' ' ILE . 71.8 t -74.12 -23.2 18.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 1.6 tt0 -91.23 -33.48 15.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 6.5 tppt? -82.57 -33.77 27.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.805 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -68.08 -65.21 0.72 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.853 ' HA ' HG21 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.731 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.09 -36.78 63.54 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.239 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.926 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.34 -36.98 48.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.117 ' O ' HG23 ' A' ' 128' ' ' THR . 46.6 m95 -91.61 -23.16 19.95 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.627 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -74.21 -27.74 60.94 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.755 -1.216 . . . . 0.0 108.312 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -91.37 -44.22 9.29 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.888 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 123' ' ' VAL . 20.2 m -60.47 -24.6 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.186 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.165 HG21 ' CE1' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -106.22 165.08 13.64 Favored Pre-proline 0 N--CA 1.501 2.107 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.975 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 1.013 ' C ' HD22 ' A' ' 130' ' ' LEU . 52.3 Cg_endo -83.66 25.82 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.242 1.961 . . . . 0.0 111.723 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.013 HD22 ' C ' ' A' ' 129' ' ' PRO . 3.7 mm? -127.09 -177.89 4.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.468 -1.395 . . . . 0.0 110.781 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.555 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.5 p -125.59 167.12 15.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 111.488 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 1.212 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 25.1 m-85 -148.68 162.72 39.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.307 0.575 . . . . 0.0 109.801 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.573 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -133.12 -159.21 0.95 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.54 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -151.41 152.94 33.77 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.052 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -136.1 -129.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.067 -1.021 . . . . 0.0 109.318 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 40.4 t80 178.24 31.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.67 -1.269 . . . . 0.0 109.423 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.483 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 5.0 pm0 -167.37 -174.25 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.014 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.53 -98.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 4.6 pt-20 178.86 124.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -1.156 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 1.057 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -81.98 -151.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 109.219 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.565 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -81.1 -48.7 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.838 HG22 ' CD1' ' A' ' 144' ' ' ILE . 13.1 mm -112.52 80.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.535 ' HG2' HG21 ' A' ' 102' ' ' VAL . 4.4 ttp -63.8 97.69 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.938 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.891 HG21 HG22 ' A' ' 117' ' ' VAL . 5.7 mm -78.23 130.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.066 -1.021 . . . . 0.0 108.488 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -145.34 154.92 42.83 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.562 -1.336 . . . . 0.0 111.881 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -91.19 135.88 33.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.121 -0.987 . . . . 0.0 108.577 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -169.52 -164.0 0.42 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.381 -1.328 . . . . 0.0 111.338 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.959 HG23 ' OD1' ' A' ' 181' ' ' ASP . 3.0 p -177.51 -171.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.738 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.215 -0.636 0 N-CA-C 108.855 -1.248 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.666 ' CZ ' ' CG1' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -69.33 -141.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 110.479 -178.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.491 ' CG ' ' HB ' ' A' ' 163' ' ' VAL . 3.9 p-10 -128.12 -31.77 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 111.782 -177.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.594 ' HA3' HG21 ' A' ' 148' ' ' VAL . . . 50.61 -105.91 0.22 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.292 -2.323 . . . . 0.0 107.292 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.26 61.45 0.25 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.582 1.306 . . . . 0.0 109.879 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -156.73 -176.13 28.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 163' ' ' VAL . 50.9 m-20 -78.1 -41.35 35.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -1.194 . . . . 0.0 110.272 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.666 ' CG1' ' CZ ' ' A' ' 157' ' ' PHE . 4.6 t -42.1 130.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.873 HD22 HD23 ' A' ' 222' ' ' LEU . 0.8 OUTLIER -96.08 -56.5 2.62 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.46 -0.775 . . . . 0.0 112.543 -178.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.734 ' HB1' ' OE2' ' A' ' 202' ' ' GLU . . . -162.74 -172.04 2.95 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.22 -1.55 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER 179.93 173.96 0.91 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 119.956 -1.715 . . . . 0.0 111.371 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.23 -170.78 2.73 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.477 -0.765 . . . . 0.0 109.667 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.627 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 49.3 m-85 -118.28 -166.19 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.836 -1.165 . . . . 0.0 110.432 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.036 ' HB1' ' CE ' ' A' ' 91' ' ' LYS . . . -177.51 -62.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.8 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 1.002 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 42.9 Cg_endo -73.77 145.23 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.956 1.503 . . . . 0.0 110.305 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . 94.17 144.23 15.43 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.8 Cg_endo -70.4 152.37 65.94 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.969 1.51 . . . . 0.0 109.99 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 68.38 -63.94 0.41 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.627 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -65.69 -8.73 6.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.533 -0.981 . . . . 0.0 108.842 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 171' ' ' GLY . 10.4 t30 -67.41 66.39 0.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.951 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 131.45 76.58 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.165 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.594 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -149.1 119.32 7.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.699 -1.471 . . . . 0.0 108.288 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.603 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -101.83 166.1 10.84 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.012 -1.055 . . . . 0.0 109.054 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.678 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -163.27 132.38 4.03 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.32 178.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.691 ' HE1' HG23 ' A' ' 198' ' ' VAL . 53.9 m-85 -92.06 136.24 33.33 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.756 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.959 ' OD1' HG23 ' A' ' 148' ' ' VAL . 51.6 t0 -70.03 126.49 29.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 183' ' ' ASP . 16.5 t70 -70.65 -5.03 26.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.628 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 61.9 t0 -34.32 -72.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 111.273 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.474 ' OE2' ' OD2' ' A' ' 183' ' ' ASP . 1.0 OUTLIER -111.87 -135.85 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.524 -177.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.543 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -122.91 -178.75 4.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.162 -0.961 . . . . 0.0 109.17 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 1.073 ' CZ3' HG21 ' A' ' 198' ' ' VAL . 29.4 m95 -144.7 151.2 38.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.45 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.844 ' HA ' HD21 ' A' ' 108' ' ' LEU . 41.5 p -145.9 152.87 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 110.007 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.68 ' O ' HG23 ' A' ' 227' ' ' THR . 0.1 OUTLIER -70.08 -38.95 75.86 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.505 ' HA ' HD13 ' A' ' 229' ' ' LEU . 0.8 OUTLIER -86.18 -150.17 0.14 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.953 HG23 HD11 ' A' ' 229' ' ' LEU . 17.3 p -109.51 43.1 1.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.069 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.532 ' HB ' HG21 ' A' ' 187' ' ' THR . 89.0 m -95.49 -31.84 13.16 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.352 -0.842 . . . . 0.0 111.25 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -114.18 -80.15 0.92 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.028 -1.558 . . . . 0.0 109.535 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.848 HG22 ' OD1' ' A' ' 194' ' ' ASN . 64.0 m -134.72 -94.02 0.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.584 -0.951 . . . . 0.0 108.435 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.848 ' OD1' HG22 ' A' ' 193' ' ' THR . 0.8 OUTLIER -157.23 66.01 0.5 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.675 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.067 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -29.56 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.702 0.763 . . . . 0.0 111.019 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.822 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.3 OUTLIER -67.78 -11.71 59.04 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 111.536 -177.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 221' ' ' PRO . 13.0 tp -67.25 -59.94 3.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.06 -1.856 . . . . 0.0 106.895 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.073 HG21 ' CZ3' ' A' ' 186' ' ' TRP . 2.0 m -71.29 -12.87 16.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.039 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.5 -61.21 1.91 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -62.85 -17.13 60.97 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 15.5 t60 -68.71 -40.63 79.88 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.594 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.734 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 3.9 mt-10 -85.2 -49.36 8.28 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.853 . . . . 0.0 111.141 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.853 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.2 mt -60.88 -30.6 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.781 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.78 -30.83 42.15 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -63.19 -44.64 94.8 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.742 -0.857 . . . . 0.0 110.699 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.674 ' OG ' HD12 ' A' ' 142' ' ' ILE . 85.7 p -87.49 -55.61 3.72 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 112.61 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 1.009 HD11 ' OH ' ' A' ' 246' ' ' TYR . 2.3 tp -104.56 7.35 35.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.134 -0.979 . . . . 0.0 110.964 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 1.026 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -104.65 -77.54 1.16 Allowed Glycine 0 N--CA 1.486 1.982 0 O-C-N 120.841 -1.162 . . . . 0.0 111.021 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.899 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.6 pp -172.59 -161.85 0.17 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.611 -1.523 . . . . 0.0 110.05 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.827 ' N ' HD12 ' A' ' 209' ' ' LEU . 2.9 m-85 -94.32 -94.51 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 0.0 109.155 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 44.8 m170 -143.15 120.92 11.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.575 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.7 m -108.33 -179.12 3.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.179 -0.951 . . . . 0.0 109.291 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.69 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -59.53 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.951 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -91.01 13.26 17.24 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.536 -177.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 214' ' ' ASN . 31.0 p -50.73 -28.04 8.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.492 ' C ' ' HB2' ' A' ' 235' ' ' SER . 2.5 mt-10 -118.08 -36.42 3.6 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.517 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.78 -159.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 122.2 1.0 . . . . 0.0 112.756 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -112.15 -3.43 14.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.925 -177.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.541 ' HB2' ' CG ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -89.55 -5.36 57.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 119.152 -2.217 . . . . 0.0 110.732 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.647 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 33.4 t80 -140.0 14.91 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 118.845 -1.142 . . . . 0.0 113.252 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 1.081 ' HB3' HD11 ' A' ' 226' ' ' LEU . 56.1 Cg_endo -75.85 -35.21 2.68 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 N-CA-C 108.539 -1.37 . . . . 0.0 108.539 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.978 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.4 OUTLIER -17.98 -57.94 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.53 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.978 ' N ' HD13 ' A' ' 222' ' ' LEU . 2.7 t80 -75.01 55.17 0.7 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 0.0 108.96 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 221' ' ' PRO . 7.2 t-160 -173.44 -138.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.899 ' C ' HD23 ' A' ' 226' ' ' LEU . 1.9 m -157.06 119.26 3.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.92 -1.112 . . . . 0.0 109.909 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 1.081 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.2 OUTLIER 178.92 62.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 110.021 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER -114.26 -18.69 11.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 14.5 t70 -167.42 -26.91 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 109.951 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.953 HD11 HG23 ' A' ' 190' ' ' THR . 0.2 OUTLIER -28.61 -61.97 0.11 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.849 HG23 ' HG3' ' A' ' 231' ' ' ARG . 1.5 t 178.98 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.379 -0.826 . . . . 0.0 108.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.849 ' HG3' HG23 ' A' ' 230' ' ' THR . 0.0 OUTLIER -94.67 -18.46 21.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.578 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 27.8 p90 -37.49 107.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.522 0.677 . . . . 0.0 110.641 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.601 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 9.2 ttt180 179.79 153.26 0.48 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.442 -0.786 . . . . 0.0 109.573 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.112 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.2 mp -67.01 165.86 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 12.7 t -101.73 -169.51 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.492 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.56 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.5 tp60 -84.85 -21.69 29.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 110.117 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.69 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 6.5 m-20 -80.44 -41.74 23.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.899 ' OD1' HD21 ' A' ' 209' ' ' LEU . 19.0 t0 -70.73 -32.81 70.13 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.458 -1.297 . . . . 0.0 107.725 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.623 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.4 OUTLIER -62.92 -33.9 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -65.05 -51.26 62.5 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.508 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.431 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -58.38 -54.71 35.52 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.026 HD13 ' HA2' ' A' ' 208' ' ' GLY . 2.4 tp -61.24 -49.38 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.745 -1.444 . . . . 0.0 109.916 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 242' ' ' ILE . 9.1 tt0 -53.57 -29.88 39.36 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.0 t -80.09 -17.08 53.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -70.39 -59.86 2.61 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 1.165 ' CE1' HG21 ' A' ' 128' ' ' THR . 41.7 m-85 . . . . . 0 N--CA 1.496 1.871 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.125 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.513 ' HD3' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.858 ' CD1' HD11 ' A' ' 207' ' ' LEU . 7.0 m95 -66.03 -164.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.834 -1.166 . . . . 0.0 109.076 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -152.03 -36.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.999 -1.063 . . . . 0.0 110.379 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -50.32 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.916 ' HA ' HD12 ' A' ' 130' ' ' LEU . 8.2 p -121.22 -5.64 9.42 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 1.033 ' CE1' HG21 ' A' ' 131' ' ' THR . 26.7 m-70 -146.06 100.41 3.39 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.089 HD13 ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -106.36 -165.33 1.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.842 . . . . 0.0 109.952 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -160.43 160.17 31.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 1.044 ' CZ ' HD22 ' A' ' 121' ' ' LEU . 2.6 p90 -131.16 167.23 19.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.801 -1.187 . . . . 0.0 108.816 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.891 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -126.11 123.14 37.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.121 . . . . 0.0 109.818 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.727 HG13 HG11 ' A' ' 117' ' ' VAL . 1.5 mp -82.14 84.43 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.779 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.891 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 38.2 t -99.52 6.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.401 -0.812 . . . . 0.0 109.775 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.983 ' C ' HG21 ' A' ' 113' ' ' VAL . 35.1 m-80 -97.11 156.15 16.51 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.846 -1.159 . . . . 0.0 108.794 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.78 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER 179.14 37.28 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 179.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 104' ' ' TYR . 41.3 p -42.86 156.31 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.401 -0.812 . . . . 0.0 108.913 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.88 -20.27 45.54 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.836 1.44 . . . . 0.0 109.054 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.557 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -67.7 -9.85 47.27 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.851 HD13 ' CD1' ' A' ' 195' ' ' LEU . 63.6 mt -144.49 123.59 7.04 Favored Pre-proline 0 N--CA 1.483 1.221 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.41 166.25 17.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.833 1.438 . . . . 0.0 109.153 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.94 -65.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.711 0.767 . . . . 0.0 110.345 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.3 m-20 -57.83 -22.92 50.23 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 111.764 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.744 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -76.16 -62.11 1.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.39 -1.443 . . . . 0.0 109.304 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.983 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.9 p -50.94 -39.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -66.96 -26.95 67.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.824 ' OG ' HD21 ' A' ' 195' ' ' LEU . 17.1 p -65.67 -41.22 92.72 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.087 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.78 -33.57 64.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.069 -1.019 . . . . 0.0 109.874 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.882 HG13 HG13 ' A' ' 144' ' ' ILE . 12.0 t -74.82 -23.72 17.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 2.1 tt0 -88.35 -35.13 17.35 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -77.88 -39.57 42.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -67.41 -62.42 1.43 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.142 0.972 . . . . 0.0 109.086 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.044 HD22 ' CZ ' ' A' ' 99' ' ' TYR . 1.7 pp -55.3 -40.82 71.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.793 ' N ' HD12 ' A' ' 121' ' ' LEU . 7.1 tptm -75.7 -32.64 60.17 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.826 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.037 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -54.16 -44.42 63.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.118 ' CH2' HD21 ' A' ' 234' ' ' LEU . 32.7 m95 -91.1 -23.57 20.26 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.675 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 17.6 tp10 -69.79 -27.24 64.74 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.692 -1.255 . . . . 0.0 107.903 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.7 pt-20 -90.39 -42.93 10.63 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.889 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.037 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.6 m -57.9 -26.02 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.322 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.988 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -107.94 154.12 41.27 Favored Pre-proline 0 N--CA 1.495 1.818 0 C-N-CA 117.966 -1.493 . . . . 0.0 109.224 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.596 ' C ' HD22 ' A' ' 130' ' ' LEU . 48.6 Cg_endo -81.29 24.76 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.832 1.688 . . . . 0.0 111.415 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 95' ' ' THR . 4.6 mm? -106.13 -169.02 1.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.701 -1.25 . . . . 0.0 110.202 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 1.033 HG21 ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -121.65 162.76 20.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.0 110.48 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 1.089 ' CE2' HD13 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -149.86 144.2 25.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.547 -0.721 . . . . 0.0 109.688 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.12 -162.5 1.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.24 -0.912 . . . . 0.0 108.856 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.625 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -156.46 153.28 28.57 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 110.057 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.607 HD12 ' H ' ' A' ' 137' ' ' GLU . 0.4 OUTLIER -145.06 -137.35 0.09 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.474 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.4 OUTLIER 179.29 33.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.689 -1.257 . . . . 0.0 108.995 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.607 ' H ' HD12 ' A' ' 135' ' ' LEU . 5.4 pm0 -157.54 179.94 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.35 -95.99 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER 178.83 106.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -1.159 . . . . 0.0 110.193 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.536 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.67 -147.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 108.758 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 98' ' ' THR . 43.9 t0 -90.28 -45.03 9.32 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.766 HG22 ' CD1' ' A' ' 144' ' ' ILE . 44.3 mt -116.46 81.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.493 ' SD ' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -64.52 97.11 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.882 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -82.52 114.83 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -135.71 157.33 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.369 -1.457 . . . . 0.0 112.08 -178.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 16.7 p90 -88.47 140.3 29.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.526 -0.734 . . . . 0.0 109.419 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.913 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.29 -161.49 0.36 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 0.0 110.176 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 1.01 HG21 ' CG ' ' A' ' 183' ' ' ASP . 0.7 OUTLIER -179.51 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.052 . . . . 0.0 109.896 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.808 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.084 0 O-C-N 121.863 -0.523 . . . . 0.0 111.157 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 110.128 -0.759 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -92.12 -157.18 0.5 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.079 -1.013 . . . . 0.0 109.861 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.594 ' O ' ' C ' ' A' ' 159' ' ' GLY . 22.5 p30 179.88 54.72 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.427 -0.795 . . . . 0.0 109.858 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -10.48 -64.37 0.01 OUTLIER Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 40.1 Cg_endo -68.96 59.58 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.145 1.23 . . . . 0.0 109.955 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.08 164.86 37.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 164' ' ' LEU . 8.5 m120 -54.18 -58.98 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.598 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 163' ' ' VAL . 33.6 m -45.46 93.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.744 ' CD1' HG21 ' A' ' 193' ' ' THR . 1.0 OUTLIER -77.82 -66.79 0.8 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.227 -0.921 . . . . 0.0 112.57 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.783 ' HB1' ' CD ' ' A' ' 202' ' ' GLU . . . -143.2 -172.46 3.69 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.403 . . . . 0.0 111.184 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.69 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.6 p-80 179.47 167.94 1.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.246 -1.534 . . . . 0.0 110.937 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -138.02 -177.25 4.74 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.461 -0.774 . . . . 0.0 109.771 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.502 ' HB3' HG13 ' A' ' 174' ' ' ILE . 96.3 m-85 -114.31 -166.75 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.574 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -109.44 -174.51 0.3 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.492 -0.755 . . . . 0.0 109.26 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 42.5 Cg_endo -75.21 53.35 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.666 1.351 . . . . 0.0 110.725 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 175' ' ' ASN . . . -93.32 -170.76 39.52 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.7 Cg_endo -70.79 124.69 10.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.827 1.435 . . . . 0.0 109.912 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . 69.34 -59.67 0.62 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -76.05 18.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.578 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 1.2 t-20 -63.49 63.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 103.14 102.99 2.74 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.646 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -158.97 115.12 2.63 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 120.737 -1.449 . . . . 0.0 107.976 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -109.79 160.82 16.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.862 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.913 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -155.96 135.66 12.57 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.516 178.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.627 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 23.1 m-85 -93.74 131.08 39.44 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.194 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.529 ' OD2' HD13 ' A' ' 164' ' ' LEU . 43.7 p-10 -65.48 122.26 16.77 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 2.8 p30 -88.47 -9.36 52.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 1.01 ' CG ' HG21 ' A' ' 148' ' ' VAL . 6.3 m-20 -79.66 2.95 20.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.972 -1.08 . . . . 0.0 109.607 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 164' ' ' LEU . 33.0 tt0 -114.14 -129.91 0.31 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.606 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.1 mt-30 -137.22 176.29 8.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.758 -1.214 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.611 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.7 m95 -161.87 115.81 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.97 -1.081 . . . . 0.0 110.069 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.802 ' HA ' HD21 ' A' ' 108' ' ' LEU . 37.3 p -140.52 151.4 44.75 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.905 -1.122 . . . . 0.0 110.071 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.88 ' O ' HG23 ' A' ' 227' ' ' THR . 15.4 pttp -84.43 -31.72 24.48 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.2 t70 -84.51 64.12 8.25 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.982 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.1 t 3.38 60.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.129 0.966 . . . . 0.0 112.011 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.7 m -127.1 -30.19 2.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.055 -1.028 . . . . 0.0 110.028 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.794 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.58 -84.67 1.64 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.744 HG21 ' CD1' ' A' ' 164' ' ' LEU . 5.0 m -119.48 -82.0 0.64 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 0.5 OUTLIER -179.81 72.78 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.979 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.905 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 3.3 tp -34.62 -97.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.61 0.719 . . . . 0.0 110.732 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.848 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -70.53 -9.66 57.25 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.963 -1.086 . . . . 0.0 111.358 -176.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.1 tp -68.29 -58.82 3.8 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 115.923 -2.311 . . . . 0.0 106.692 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.703 HG23 ' HB3' ' A' ' 194' ' ' ASN . 1.4 t -72.49 -10.3 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.087 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.49 -61.6 1.86 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -63.08 -15.93 58.24 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.495 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 28.2 t60 -68.07 -43.69 78.02 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 117.921 -1.512 . . . . 0.0 107.835 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.783 ' CD ' ' HB1' ' A' ' 165' ' ' ALA . 31.5 mt-10 -83.47 -48.07 10.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.237 -0.915 . . . . 0.0 110.914 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.88 HG21 ' HA ' ' A' ' 121' ' ' LEU . 2.3 mt -61.06 -29.8 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.682 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.26 -31.93 45.15 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.21 -52.3 65.86 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.691 -0.887 . . . . 0.0 109.816 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.534 ' C ' HD22 ' A' ' 207' ' ' LEU . 28.6 t -79.74 -59.52 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.492 -0.755 . . . . 0.0 111.827 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.858 HD11 ' CD1' ' A' ' 92' ' ' TRP . 1.4 mm? -104.58 38.82 1.8 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.253 -0.904 . . . . 0.0 110.586 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.882 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -139.56 -73.41 0.05 OUTLIER Glycine 0 C--N 1.292 -1.913 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 210' ' ' PHE . 3.5 pp 179.33 -162.42 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.655 -1.497 . . . . 0.0 109.818 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.709 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.1 t80 -99.37 -79.97 0.48 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.104 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 4.7 m-70 -153.92 77.22 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -62.18 -172.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 108.924 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.991 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.26 77.81 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.946 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.01 13.14 8.06 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.789 -177.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER -50.27 -28.44 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 174.373 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.538 ' C ' ' HB3' ' A' ' 235' ' ' SER . 6.5 mt-10 -115.96 -39.65 3.43 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.946 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.15 164.8 8.03 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 122.451 1.12 . . . . 0.0 111.99 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.711 HD21 HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -67.33 -15.5 63.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.339 -177.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -77.59 -9.72 59.1 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 118.976 -2.328 . . . . 0.0 112.294 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.663 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 45.7 t80 -137.42 17.27 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.293 -1.505 . . . . 0.0 113.506 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.648 ' HG3' ' HA ' ' A' ' 218' ' ' LEU . 57.5 Cg_endo -79.47 -36.35 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 N-CA-C 108.747 -1.29 . . . . 0.0 108.747 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.983 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.4 OUTLIER -16.93 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.983 ' N ' HD13 ' A' ' 222' ' ' LEU . 28.2 t80 -75.74 49.73 0.53 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.254 -0.904 . . . . 0.0 109.394 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 95.7 m-70 -160.85 -120.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.071 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.826 ' O ' HD12 ' A' ' 226' ' ' LEU . 14.7 m -173.44 110.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.727 -1.233 . . . . 0.0 109.891 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.37 65.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 109.852 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 188' ' ' LYS . 10.1 t -116.88 -7.91 11.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.591 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 1.6 t0 178.09 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.037 . . . . 0.0 110.642 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.982 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -30.32 -61.06 0.17 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.571 -0.706 . . . . 0.0 110.604 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.33 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.475 -0.765 . . . . 0.0 109.098 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.4 mtp180 -100.21 -26.97 13.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 108.925 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.689 ' HA ' HD23 ' A' ' 226' ' ' LEU . 11.6 p90 -27.77 121.42 0.11 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.349 0.595 . . . . 0.0 111.598 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.13 170.52 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.443 -0.786 . . . . 0.0 109.809 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.118 HD21 ' CH2' ' A' ' 124' ' ' TRP . 1.8 mp -81.41 162.15 23.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 110.076 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.823 ' OG ' ' HB2' ' A' ' 217' ' ' ALA . 9.0 p -103.5 -167.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.306 -1.357 . . . . 0.0 110.51 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -84.83 -14.48 47.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 111.723 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.991 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.3 m-20 -84.84 -45.2 12.54 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.2 -1.563 . . . . 0.0 107.809 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.653 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 2.6 m-20 -64.99 -41.4 95.43 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.39 -35.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.21 -47.4 73.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 244' ' ' SER . . . -57.94 -55.47 30.42 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.024 HG21 HG21 ' A' ' 127' ' ' VAL . 1.5 tp -60.14 -46.03 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.977 -1.308 . . . . 0.0 109.227 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.572 ' N ' HG23 ' A' ' 242' ' ' ILE . 34.8 tt0 -56.3 -25.23 47.86 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 0.0 OUTLIER -78.16 -21.87 49.57 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.666 ' HB2' HD12 ' A' ' 242' ' ' ILE . 9.0 mt -72.61 -66.42 0.66 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.881 ' OH ' HD21 ' A' ' 97' ' ' LEU . 71.5 m-85 . . . . . 0 C--N 1.29 -1.989 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.145 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 1.034 ' CE ' ' HB1' ' A' ' 169' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.097 0.475 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.567 ' CD1' ' HA ' ' A' ' 207' ' ' LEU . 10.0 m95 -82.86 176.8 9.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 109.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.74 -41.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.148 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.877 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.24 172.04 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.681 0.753 . . . . 0.0 110.275 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.955 ' HA ' HD13 ' A' ' 130' ' ' LEU . 42.9 p -110.3 7.46 23.07 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.572 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 51.1 m80 -144.14 96.28 2.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.866 -1.147 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.877 HD13 ' HE2' ' A' ' 94' ' ' LYS . 2.9 mm? -96.59 164.45 12.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.53 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.627 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -136.89 155.98 49.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 108.519 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 1.007 ' CE2' HD11 ' A' ' 101' ' ' ILE . 7.7 p90 -135.18 170.3 16.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 109.473 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.554 ' HD2' HG22 ' A' ' 102' ' ' VAL . 1.1 ttm180 -131.56 128.12 38.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.007 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -86.81 82.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.198 . . . . 0.0 109.725 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 13.0 t -99.09 7.53 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.288 -0.883 . . . . 0.0 109.828 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.922 ' C ' HG21 ' A' ' 113' ' ' VAL . 18.4 m-80 -98.9 160.46 14.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.978 -1.076 . . . . 0.0 109.166 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.745 ' N ' HG21 ' A' ' 113' ' ' VAL . 7.5 t80 177.67 77.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 1.104 HG21 ' CD1' ' A' ' 186' ' ' TRP . 61.1 p -69.58 155.66 93.11 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 -25.39 39.73 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 123.766 1.403 . . . . 0.0 108.637 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.657 ' O ' HD23 ' A' ' 108' ' ' LEU . 2.5 m-20 -74.26 -5.93 44.95 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 195' ' ' LEU . 62.0 mt -140.16 121.21 9.34 Favored Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.454 -0.779 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.9 169.28 13.56 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 123.881 1.463 . . . . 0.0 108.716 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.483 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.62 -65.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.5 t0 -55.26 -26.93 43.03 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.716 -0.615 . . . . 0.0 111.799 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.769 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.9 -61.36 1.87 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.435 -1.415 . . . . 0.0 109.329 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.922 HG21 ' C ' ' A' ' 103' ' ' ASN . 12.8 p -53.04 -41.33 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 1.003 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -64.45 -26.93 68.66 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.901 ' OG ' HD21 ' A' ' 195' ' ' LEU . 6.0 p -62.99 -42.37 99.83 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.069 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -70.7 -33.01 70.43 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 0.0 109.638 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.952 HG13 HG13 ' A' ' 144' ' ' ILE . 47.1 t -74.57 -23.26 17.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.1 tt0 -90.04 -33.77 16.2 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.679 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.59 -37.15 28.09 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -66.46 -62.1 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.938 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.4 pp -55.47 -41.89 73.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.097 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.817 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -71.52 -33.6 69.35 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.641 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.035 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.18 -42.04 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.067 ' O ' HG23 ' A' ' 128' ' ' THR . 33.7 m95 -91.29 -22.88 20.34 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 28.3 tt0 -71.42 -27.47 63.32 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.2 pt-20 -90.46 -43.59 10.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.612 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.3 m -58.0 -25.91 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.072 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.067 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -104.95 163.49 17.06 Favored Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 117.966 -1.494 . . . . 0.0 110.492 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.641 ' O ' HD23 ' A' ' 130' ' ' LEU . 50.6 Cg_endo -87.26 29.8 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.379 2.053 . . . . 0.0 111.289 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.014 HD12 ' CD2' ' A' ' 246' ' ' TYR . 34.5 mt -121.27 -166.6 1.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.61 -1.306 . . . . 0.0 110.474 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.2 p -123.01 176.68 5.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.645 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.777 ' HZ ' HD13 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -139.25 167.98 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 109.671 -179.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.512 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -151.14 169.34 22.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 108.589 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.715 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -140.56 167.43 22.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.803 -1.186 . . . . 0.0 110.545 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.042 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -156.76 -133.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 12.7 t80 178.01 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 138' ' ' GLY . 7.5 pm0 -161.39 -171.85 3.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.02 -98.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 140' ' ' ALA . 3.1 pt-20 178.41 107.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -1.111 . . . . 0.0 110.34 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 1.042 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -60.24 -150.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 108.722 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.669 ' C ' HD12 ' A' ' 142' ' ' ILE . 72.3 m-20 -88.48 -33.88 17.65 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.861 ' N ' HD12 ' A' ' 142' ' ' ILE . 3.4 mp -126.3 79.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.542 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -67.74 101.54 1.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.853 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.952 HG13 HG13 ' A' ' 117' ' ' VAL . 5.5 mm -81.61 119.69 31.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.6 OUTLIER -138.35 158.5 44.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.347 -1.471 . . . . 0.0 112.063 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 22.2 p90 -90.67 139.77 30.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.472 -0.768 . . . . 0.0 109.625 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.119 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.1 -160.47 0.68 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 1.004 HG21 ' HB2' ' A' ' 183' ' ' ASP . 0.8 OUTLIER 179.65 -157.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.918 -1.113 . . . . 0.0 109.531 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.795 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--O 1.215 -0.675 0 N-CA-C 109.57 -0.973 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.748 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -72.88 -163.08 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.097 -1.002 . . . . 0.0 109.927 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.763 ' OD1' HG23 ' A' ' 163' ' ' VAL . 23.3 p30 179.2 54.45 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.877 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -0.16 -68.72 0.0 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 112.274 -0.33 . . . . 0.0 112.274 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.4 Cg_endo -67.55 59.52 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.21 1.11 . . . . 0.0 109.664 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -168.79 160.62 34.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 164' ' ' LEU . 5.5 m120 -52.57 -47.72 66.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -1.199 . . . . 0.0 110.086 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.763 HG23 ' OD1' ' A' ' 158' ' ' ASP . 2.6 m -51.46 89.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 0.0 109.728 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.035 HD21 HG21 ' A' ' 193' ' ' THR . 0.3 OUTLIER -76.32 -82.53 0.07 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.869 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -137.33 -175.32 4.02 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.491 -1.38 . . . . 0.0 111.154 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.748 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.7 p-80 179.34 169.35 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 119.899 -1.751 . . . . 0.0 110.524 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.63 -172.51 3.18 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.498 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.536 ' CB ' HG13 ' A' ' 174' ' ' ILE . 64.1 m-85 -118.09 -167.28 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.072 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.034 ' HB1' ' CE ' ' A' ' 91' ' ' LYS . . . -162.93 -64.72 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.639 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.974 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 43.0 Cg_endo -72.87 172.36 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.792 1.417 . . . . 0.0 110.362 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.549 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 90.4 165.25 40.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.8 Cg_endo -73.99 -94.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.629 1.553 . . . . 0.0 110.54 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.2 -35.0 82.48 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 170' ' ' PRO . 9.4 tp -71.37 4.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.287 -1.125 . . . . 0.0 109.201 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 172' ' ' PRO . 1.2 p30 -66.08 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.89 . . . . 0.0 109.334 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 114.93 94.1 1.96 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -151.95 118.12 5.56 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.671 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -107.75 163.22 13.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.085 . . . . 0.0 109.201 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.119 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -159.78 134.62 7.9 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.11 178.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.604 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 17.1 m-85 -97.09 129.88 44.44 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.115 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.556 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -63.47 124.86 22.41 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.827 -1.549 . . . . 0.0 107.171 177.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.502 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.1 OUTLIER -98.35 31.68 2.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 110.56 -178.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 1.004 ' HB2' HG21 ' A' ' 148' ' ' VAL . 49.2 t0 -107.9 -3.97 18.41 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.436 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.529 ' HG2' ' CA ' ' A' ' 159' ' ' GLY . 4.5 pt-20 -116.32 -111.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.028 . . . . 0.0 108.872 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 15.2 mt-30 -148.58 177.88 9.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.723 -1.236 . . . . 0.0 109.15 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 1.104 ' CD1' HG21 ' A' ' 105' ' ' THR . 88.2 m95 -161.98 126.14 3.23 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.115 -0.99 . . . . 0.0 108.998 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.879 ' HA ' HD21 ' A' ' 108' ' ' LEU . 65.7 p -147.2 153.7 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.676 -1.265 . . . . 0.0 110.723 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.882 ' HB3' HD22 ' A' ' 195' ' ' LEU . 17.4 pttt -85.09 -32.69 22.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.7 t70 -86.09 64.03 8.35 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.998 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.5 t 3.19 60.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.185 0.993 . . . . 0.0 111.94 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.2 m -125.44 -30.87 3.07 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.055 -1.028 . . . . 0.0 109.787 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.631 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -95.31 -80.0 1.49 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.035 HG21 HD21 ' A' ' 164' ' ' LEU . 47.1 m -127.84 -95.89 0.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.926 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -160.5 72.79 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 108.971 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 108' ' ' LEU . 2.2 tp -37.07 -96.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.671 0.748 . . . . 0.0 110.448 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.887 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -68.61 -5.15 18.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.132 -0.98 . . . . 0.0 110.848 -177.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.918 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.1 tp -69.0 -67.7 0.45 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 116.836 -1.946 . . . . 0.0 106.479 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.926 HG23 ' HB2' ' A' ' 194' ' ' ASN . 2.4 t -68.03 -9.77 11.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.069 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.0 -59.04 2.89 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.808 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -65.15 -15.22 62.18 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.573 ' CE1' ' O ' ' A' ' 219' ' ' MET . 10.9 t60 -69.27 -42.96 74.85 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 117.76 -1.576 . . . . 0.0 107.95 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.796 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 1.3 mt-10 -83.97 -47.37 11.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.865 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.938 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.0 mt -63.11 -29.51 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.699 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -77.31 -31.55 51.21 Favored Glycine 0 C--N 1.295 -1.737 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -64.26 -44.22 92.41 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 121.812 -0.817 . . . . 0.0 111.212 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.541 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 49.7 m -86.97 -53.12 5.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 112.61 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 208' ' ' GLY . 2.2 pp -104.36 -2.61 25.24 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.861 -1.149 . . . . 0.0 111.388 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.991 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -96.92 -84.58 1.74 Allowed Glycine 0 C--N 1.291 -1.966 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.866 HD11 ' OD1' ' A' ' 238' ' ' ASP . 1.8 pp -165.35 -159.33 0.42 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.037 -1.272 . . . . 0.0 109.658 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.591 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -96.56 -84.94 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.529 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.8 m-70 -153.18 104.57 2.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.067 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.607 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -92.1 -167.33 1.74 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.213 -0.929 . . . . 0.0 109.56 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.697 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.17 81.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.989 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.4 6.62 22.53 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.761 -177.01 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 214' ' ' ASN . 7.8 p -50.82 -27.44 7.32 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.506 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.2 mt-10 -117.29 -36.05 3.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.989 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.95 179.17 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.162 0.982 . . . . 0.0 111.699 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.918 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.4 tp -96.05 -10.16 29.14 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.393 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.652 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 9.1 mmt -74.26 -16.73 60.94 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.641 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.5 OUTLIER -143.5 23.6 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 C-N-CA 117.621 -1.631 . . . . 0.0 113.422 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.678 ' HG3' ' HA ' ' A' ' 218' ' ' LEU . 55.6 Cg_endo -75.39 -31.47 5.7 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 N-CA-C 106.795 -2.04 . . . . 0.0 106.795 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 223' ' ' TYR . 1.9 tm? -8.06 -65.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.326 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.878 ' N ' HD13 ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.76 59.59 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.8 OUTLIER -175.57 -144.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.375 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.926 ' HB3' HG21 ' A' ' 190' ' ' THR . 44.5 m -146.41 112.81 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.048 -1.033 . . . . 0.0 109.956 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.61 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.431 -0.793 . . . . 0.0 109.26 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.544 HG21 ' O ' ' A' ' 187' ' ' THR . 9.1 t -108.26 -9.09 15.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.296 -0.877 . . . . 0.0 109.591 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.603 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 177.59 -20.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 110.854 179.275 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.998 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.22 -61.1 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.446 -0.783 . . . . 0.0 110.651 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.35 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.587 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.603 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 51.7 p90 -31.58 120.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.488 0.661 . . . . 0.0 111.028 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.563 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.12 168.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.056 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.5 mp -82.82 168.49 17.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.83 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 6.5 t -98.47 -171.13 2.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.737 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.576 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -83.08 -19.24 37.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.563 -0.71 . . . . 0.0 109.449 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.697 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 5.2 m-20 -82.76 -42.24 18.22 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.866 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.3 m-20 -66.62 -41.03 89.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 117.411 -1.715 . . . . 0.0 106.879 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -56.75 -35.12 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -67.11 -45.01 78.48 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.409 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -62.03 -58.91 10.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.012 HG21 HG21 ' A' ' 127' ' ' VAL . 1.9 tp -62.76 -50.41 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.987 -1.302 . . . . 0.0 110.116 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.581 ' N ' HG23 ' A' ' 242' ' ' ILE . 15.1 tt0 -53.37 -26.12 18.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.2 t -90.4 -10.67 43.02 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -79.84 -52.79 7.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 1.014 ' CD2' HD12 ' A' ' 130' ' ' LEU . 5.2 m-30 . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.95 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HE2' ' HB2' ' A' ' 169' ' ' ALA . 1.6 tttt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.914 ' CD1' HD12 ' A' ' 207' ' ' LEU . 2.8 m95 -74.53 -165.98 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -167.19 -33.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.8 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -50.54 -172.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.385 -0.822 . . . . 0.0 110.619 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.763 ' CA ' HD21 ' A' ' 130' ' ' LEU . 1.2 p -117.35 -4.79 11.32 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.618 -0.676 . . . . 0.0 109.242 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 131' ' ' THR . 21.7 m-70 -144.22 95.24 2.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.667 HD11 ' CD1' ' A' ' 92' ' ' TRP . 19.4 mt -86.56 -175.44 5.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.68 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -158.63 156.72 30.54 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.326 -0.859 . . . . 0.0 108.714 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.903 ' CE1' HD22 ' A' ' 121' ' ' LEU . 13.4 p90 -134.62 164.83 26.63 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.535 -1.353 . . . . 0.0 110.151 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.734 ' HG3' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -131.38 128.38 39.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.75 HG13 HG11 ' A' ' 117' ' ' VAL . 1.5 mp -86.14 81.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.378 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.585 ' N ' ' O ' ' A' ' 144' ' ' ILE . 16.1 t -96.22 13.77 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.909 ' C ' HG21 ' A' ' 113' ' ' VAL . 7.8 m120 -107.86 156.12 19.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.81 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.7 OUTLIER 178.97 42.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.64 -0.662 . . . . 0.0 109.914 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.563 HG22 ' OD1' ' A' ' 182' ' ' ASP . 13.8 p -43.74 155.84 0.31 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 108.911 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.91 -21.7 43.44 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.762 1.401 . . . . 0.0 108.94 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -69.97 -8.0 45.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.024 HD13 HD12 ' A' ' 195' ' ' LEU . 84.8 mt -144.83 120.66 6.01 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.534 -0.729 . . . . 0.0 109.756 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.74 172.09 8.74 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.748 1.394 . . . . 0.0 108.981 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.55 -65.29 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.801 0.81 . . . . 0.0 110.384 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -55.98 -30.81 62.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.64 . . . . 0.0 112.15 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.871 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.45 -59.84 2.53 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.439 -1.413 . . . . 0.0 109.793 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.909 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.8 p -55.13 -39.13 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -66.9 -27.11 67.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.868 ' OG ' HD21 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -67.6 -41.0 84.74 Favored 'General case' 0 C--O 1.202 -1.43 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.336 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.068 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -72.6 -32.77 66.22 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 120.912 -1.117 . . . . 0.0 109.806 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.032 HG22 HG21 ' A' ' 144' ' ' ILE . 88.7 t -75.96 -23.65 16.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -90.69 -33.26 15.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.747 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.2 OUTLIER -81.47 -37.45 27.94 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.979 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -68.3 -61.92 1.63 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.903 HD22 ' CE1' ' A' ' 99' ' ' TYR . 1.4 pp -54.71 -41.8 70.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.065 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.816 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.15 -33.23 63.45 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.265 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.998 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.22 -40.14 63.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.088 ' CH2' HD21 ' A' ' 234' ' ' LEU . 44.5 m95 -91.35 -23.22 20.16 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.486 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.533 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 79.9 tt0 -71.9 -28.25 63.37 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.757 -1.214 . . . . 0.0 108.279 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.4 pt-20 -89.92 -43.53 10.52 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.798 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.998 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.2 m -60.44 -24.26 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.511 -1.276 . . . . 0.0 109.172 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.084 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.6 OUTLIER -100.54 155.79 35.96 Favored Pre-proline 0 N--CA 1.5 2.065 0 C-N-CA 117.943 -1.503 . . . . 0.0 111.008 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -84.74 27.62 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 110.46 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.763 HD21 ' CA ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -117.84 -175.39 2.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.704 -1.247 . . . . 0.0 110.66 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.57 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -109.64 169.85 8.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.436 -0.79 . . . . 0.0 110.09 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.607 ' CE1' ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -149.05 162.14 40.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 110.082 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.57 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -140.2 -168.22 2.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.639 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -158.84 157.22 31.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 0.0 110.391 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.734 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -159.89 -165.21 1.45 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.406 -0.809 . . . . 0.0 109.307 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 15.8 t80 -153.33 19.78 0.56 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.385 -0.822 . . . . 0.0 108.914 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -141.4 -172.32 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -0.791 . . . . 0.0 109.341 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.18 -98.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER 178.45 117.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 110.509 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.68 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -75.67 -148.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 108.899 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.637 ' OD2' HG22 ' A' ' 98' ' ' THR . 59.8 m-20 -100.32 -25.03 14.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.804 HG21 HG23 ' A' ' 203' ' ' ILE . 2.9 mt -124.35 76.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 1.7 ttt -64.33 93.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 1.032 HG21 HG22 ' A' ' 117' ' ' VAL . 9.1 mm -80.04 106.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.577 ' CB ' ' HB ' ' A' ' 102' ' ' VAL . 0.3 OUTLIER -131.76 162.56 30.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.24 -1.538 . . . . 0.0 112.342 -178.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.493 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 46.9 p90 -82.55 134.38 35.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.442 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.132 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -152.08 162.11 41.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.037 . . . . 0.0 110.418 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.797 HG21 ' CG ' ' A' ' 183' ' ' ASP . 1.8 p -167.04 -163.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.718 ' H ' HG22 ' A' ' 148' ' ' VAL . 5.3 mtm-85 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 C--O 1.216 -0.622 0 N-CA-C 109.377 -1.047 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.686 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -112.94 -170.41 1.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 110.978 -178.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.588 ' O ' ' C ' ' A' ' 159' ' ' GLY . 17.4 p30 -176.18 63.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.898 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -12.38 -61.35 0.01 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 37.0 Cg_endo -63.56 66.11 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.551 1.29 . . . . 0.0 109.651 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 177.87 143.88 5.24 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' LEU . 30.4 m-80 -37.79 -44.6 0.75 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.634 -0.921 . . . . 0.0 110.221 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.679 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 17.8 t -42.4 95.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 109.33 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.9 HD12 HD11 ' A' ' 222' ' ' LEU . 1.9 mt -90.17 -38.89 13.18 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 113.133 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.613 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . 179.43 -171.12 0.14 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.799 -1.813 . . . . 0.0 111.449 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.686 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.2 p-80 179.15 -170.28 0.12 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.376 -1.453 . . . . 0.0 111.33 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -153.45 179.2 9.01 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.437 -0.789 . . . . 0.0 110.235 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.59 ' O ' ' CB ' ' A' ' 206' ' ' SER . 11.0 m-85 -127.6 162.41 26.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.894 -1.129 . . . . 0.0 111.149 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.977 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -144.49 -67.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.977 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 40.7 Cg_endo -70.75 94.89 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.489 1.257 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 159.09 145.14 4.16 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -71.57 145.86 48.06 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.511 1.474 . . . . 0.0 110.083 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 67.81 -64.05 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.3 OUTLIER -74.24 5.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.414 -1.051 . . . . 0.0 108.896 178.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 171' ' ' GLY . 0.5 OUTLIER -63.9 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 115.05 89.1 1.6 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.696 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -155.64 118.96 4.36 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.641 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -108.76 128.57 54.99 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.186 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.132 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -113.59 132.46 55.73 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.894 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.683 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 16.0 m-85 -93.37 125.0 37.74 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.198 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.657 ' OD1' HG23 ' A' ' 148' ' ' VAL . 22.6 t0 -50.1 135.05 21.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.667 -1.271 . . . . 0.0 108.262 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.563 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.1 OUTLIER -106.22 24.27 12.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 110.232 -178.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.797 ' CG ' HG21 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -129.13 24.37 5.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 159' ' ' GLY . 2.3 mt-10 -129.03 -90.26 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.138 -0.976 . . . . 0.0 109.408 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.628 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 1.7 mt-30 179.89 170.22 1.16 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.683 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.0 m95 -158.63 124.16 4.4 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.022 -1.049 . . . . 0.0 109.795 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.856 ' HA ' HD21 ' A' ' 108' ' ' LEU . 67.9 p -148.32 149.78 32.45 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.925 -1.109 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.814 ' HB3' HD22 ' A' ' 195' ' ' LEU . 8.5 pttt -84.14 -32.46 24.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.7 t70 -83.49 61.73 6.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.982 ' OG1' HD21 ' A' ' 229' ' ' LEU . 15.7 m 3.08 64.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.71 0.767 . . . . 0.0 111.384 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 189' ' ' ASP . 41.9 m -130.74 -31.64 1.74 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.762 -0.587 . . . . 0.0 109.635 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.45 -77.89 1.39 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.659 HG21 ' CD2' ' A' ' 164' ' ' LEU . 13.4 m -128.35 -81.61 0.58 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.481 -1.011 . . . . 0.0 108.774 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.979 ' HB3' HG23 ' A' ' 198' ' ' VAL . 1.9 m-20 -177.47 67.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.586 -0.845 . . . . 0.0 108.991 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.061 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -32.4 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.58 0.705 . . . . 0.0 110.537 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.899 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -71.78 -8.74 56.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.839 -1.163 . . . . 0.0 110.929 -178.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.673 HD11 ' CG ' ' A' ' 221' ' ' PRO . 14.8 tp -70.76 -56.29 6.71 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 116.262 -2.175 . . . . 0.0 107.207 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.012 HG12 ' OE2' ' A' ' 202' ' ' GLU . 9.1 t -77.87 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.068 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.26 -58.8 3.06 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.53 -19.71 65.85 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.494 ' HA ' ' SD ' ' A' ' 219' ' ' MET . 4.7 t60 -66.17 -41.81 89.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 116.873 -1.931 . . . . 0.0 107.882 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 1.012 ' OE2' HG12 ' A' ' 198' ' ' VAL . 8.3 mt-10 -84.1 -49.1 9.2 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.145 -0.972 . . . . 0.0 110.792 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.979 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -57.85 -31.74 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.735 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -80.6 -35.3 26.02 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -57.95 -47.71 82.11 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.423 -1.045 . . . . 0.0 110.519 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.662 ' C ' HD13 ' A' ' 207' ' ' LEU . 1.4 p -86.08 -58.46 2.63 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 111.906 -177.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.914 HD12 ' CD1' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -104.43 33.97 3.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.81 -1.181 . . . . 0.0 110.114 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 1.078 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -132.06 -77.21 0.13 Allowed Glycine 0 C--N 1.29 -1.973 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.85 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -165.69 -160.72 0.47 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.999 -1.295 . . . . 0.0 109.62 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.792 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.7 t80 -101.7 -71.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 20.7 m80 -163.78 100.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.865 . . . . 0.0 108.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.7 OUTLIER -90.27 -175.93 4.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.882 . . . . 0.0 109.249 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.916 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -63.86 78.33 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.972 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.26 9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.56 -177.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -50.64 -27.78 7.58 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.517 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.0 OUTLIER -114.51 -37.58 4.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.972 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.33 -171.28 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.334 1.064 . . . . 0.0 112.418 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.703 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -89.95 -16.54 29.7 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.735 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.547 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.5 -9.57 58.98 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.476 -2.015 . . . . 0.0 112.436 -177.36 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.674 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 4.7 t80 -136.49 16.58 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.229 -1.545 . . . . 0.0 113.404 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.883 ' CB ' HD11 ' A' ' 226' ' ' LEU . 56.2 Cg_endo -78.81 -40.07 0.33 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 108.711 -1.304 . . . . 0.0 108.711 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.9 HD11 HD12 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -7.83 -77.07 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.257 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.41 ' N ' HD23 ' A' ' 222' ' ' LEU . 1.7 t80 -67.99 59.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.244 -0.91 . . . . 0.0 108.955 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.5 t-80 -163.61 -124.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.339 -0.851 . . . . 0.0 108.974 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.514 ' HA ' HG21 ' A' ' 190' ' ' THR . 62.5 m -168.78 104.44 0.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.697 -1.252 . . . . 0.0 110.342 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.883 HD11 ' CB ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER 178.92 48.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 188' ' ' LYS . 9.2 t -98.69 -15.71 19.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.064 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.586 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 178.09 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.429 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.982 HD21 ' OG1' ' A' ' 190' ' ' THR . 0.3 OUTLIER -32.95 -56.95 0.38 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.13 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -86.22 -16.63 37.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.6 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 25.4 p90 -32.34 111.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.719 0.771 . . . . 0.0 110.933 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.569 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.6 ttt180 179.22 149.73 0.28 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.088 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -73.03 167.22 21.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.99 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 28.8 t -99.56 -170.6 1.92 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.969 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.526 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.02 -13.35 50.82 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.011 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.916 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 3.1 m-20 -84.85 -46.75 11.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.657 -1.277 . . . . 0.0 107.783 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.85 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -65.12 -39.3 92.89 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 117.226 -1.79 . . . . 0.0 106.549 177.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.596 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.66 -35.45 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.98 -50.36 62.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.14 60.75 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.078 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.7 tp -66.37 -49.18 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.837 -1.39 . . . . 0.0 110.132 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.572 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.9 tt0 -54.03 -25.05 19.33 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.7 p -92.73 -9.87 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -77.86 -51.25 10.76 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.548 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 5.4 m-30 . . . . . 0 N--CA 1.494 1.73 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.83 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.611 ' HG3' ' CD1' ' A' ' 92' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.611 ' CD1' ' HG3' ' A' ' 91' ' ' LYS . 89.9 m95 -105.02 149.56 25.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.883 -1.136 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.21 -33.29 5.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.734 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.675 ' CE ' HD13 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -44.75 175.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.438 -0.789 . . . . 0.0 110.345 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.791 ' HB ' HD12 ' A' ' 130' ' ' LEU . 7.1 p -109.11 5.05 23.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.47 -0.768 . . . . 0.0 109.78 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.563 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 47.9 m80 -146.88 94.44 2.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.831 -1.168 . . . . 0.0 110.538 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.811 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.9 mm? -93.6 -176.54 4.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -0.794 . . . . 0.0 108.872 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 142' ' ' ILE . 1.1 t -146.82 154.28 41.16 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.97 -1.081 . . . . 0.0 109.084 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 1.037 ' CZ ' HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -133.79 166.53 22.43 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.712 -1.242 . . . . 0.0 109.914 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.856 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.39 133.14 46.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.037 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 2.4 mp -96.55 80.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 109.777 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.856 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 59.4 t -97.94 7.38 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.85 ' C ' HG21 ' A' ' 113' ' ' VAL . 35.2 m-80 -92.95 158.13 15.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.697 -1.252 . . . . 0.0 109.647 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.83 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.8 t80 178.16 82.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.532 -0.73 . . . . 0.0 109.555 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.811 HG21 ' CD1' ' A' ' 186' ' ' TRP . 1.3 p -75.98 159.27 81.08 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.12 -21.48 42.47 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.82 1.432 . . . . 0.0 108.779 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -78.1 -0.77 29.44 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.956 HD13 ' CD1' ' A' ' 195' ' ' LEU . 96.7 mt -150.63 120.64 3.73 Favored Pre-proline 0 N--CA 1.485 1.292 0 O-C-N 121.421 -0.799 . . . . 0.0 109.88 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.13 175.7 5.42 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.801 1.422 . . . . 0.0 109.334 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.22 -65.83 0.34 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.875 0.845 . . . . 0.0 110.341 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.65 -30.76 63.69 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.88 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.61 -60.68 2.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.25 -1.531 . . . . 0.0 109.54 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.945 ' O ' HG23 ' A' ' 117' ' ' VAL . 7.2 p -53.17 -41.2 41.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.572 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -62.22 -28.1 69.45 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.907 ' OG ' HD21 ' A' ' 195' ' ' LEU . 7.7 p -64.02 -42.87 96.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.092 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -71.11 -33.77 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 113' ' ' VAL . 1.5 t -75.55 -23.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -88.36 -34.94 17.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 3.5 tppt? -80.6 -36.39 32.84 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.44 -62.46 1.51 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.986 HD22 ' CG ' ' A' ' 99' ' ' TYR . 13.5 tp -52.47 -46.32 66.47 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.058 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -69.17 -33.82 73.99 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.33 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.949 HG13 HD22 ' A' ' 234' ' ' LEU . 0.9 OUTLIER -57.34 -36.69 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.102 ' CH2' HD21 ' A' ' 234' ' ' LEU . 55.4 m95 -91.68 -24.13 19.59 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.874 -1.131 . . . . 0.0 110.495 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.578 ' HG3' ' CD2' ' A' ' 132' ' ' PHE . 14.8 tt0 -71.81 -28.88 63.89 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.851 -1.155 . . . . 0.0 108.315 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.0 pt-20 -91.37 -42.93 10.06 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 242' ' ' ILE . 21.7 m -61.83 -23.34 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.206 -1.398 . . . . 0.0 109.802 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.047 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -104.29 161.73 22.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 117.14 -1.824 . . . . 0.0 110.298 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.864 ' C ' HD22 ' A' ' 130' ' ' LEU . 50.0 Cg_endo -80.72 13.12 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.609 1.847 . . . . 0.0 110.655 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.866 HD23 ' HB3' ' A' ' 246' ' ' TYR . 3.3 mm? -116.4 -176.94 3.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.953 -1.092 . . . . 0.0 110.093 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.509 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.4 p -124.72 170.42 11.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.66 ' CD2' HD11 ' A' ' 121' ' ' LEU . 21.6 m-85 -131.78 179.55 6.0 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.84 0.829 . . . . 0.0 110.023 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 98' ' ' THR . 17.5 m -142.44 -166.36 2.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 160.57 18.37 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.906 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.677 HD22 ' OE2' ' A' ' 137' ' ' GLU . 0.3 OUTLIER -159.63 -128.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 135' ' ' LEU . 0.1 OUTLIER 177.15 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.465 -1.397 . . . . 0.0 109.732 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.677 ' OE2' HD22 ' A' ' 135' ' ' LEU . 7.5 pm0 -151.47 -177.65 6.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 109.917 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.76 -97.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.99 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -1.105 . . . . 0.0 110.003 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.662 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -58.9 -155.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 108.959 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' THR . 76.7 m-20 -83.52 -26.07 30.48 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.01 HD11 HD22 ' A' ' 207' ' ' LEU . 2.1 mp -130.17 77.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.412 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.6 ttt -62.01 93.2 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 109.26 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.825 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.3 mm -82.12 109.06 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.495 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -134.29 153.54 51.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.492 -1.38 . . . . 0.0 111.652 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 20.0 p90 -86.98 139.58 30.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.179 -0.95 . . . . 0.0 109.406 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -168.54 -158.23 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 110.556 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.898 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.4 p -173.22 -158.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.706 ' N ' HG13 ' A' ' 148' ' ' VAL . 10.8 ptt180 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 109.564 -0.975 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.679 ' CD2' ' CE1' ' A' ' 166' ' ' HIS . 0.9 OUTLIER -71.22 -131.88 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.375 -0.828 . . . . 0.0 109.875 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.663 ' HB3' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -148.69 -36.03 0.19 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.42 -1.425 . . . . 0.0 110.194 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.594 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 69.01 -110.01 3.18 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 34.8 Cg_endo -59.97 76.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.063 1.033 . . . . 0.0 110.268 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -166.24 -160.78 13.98 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' VAL . 9.8 m-80 -90.58 -48.91 6.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.259 -1.142 . . . . 0.0 110.477 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 158' ' ' ASP . 27.7 m -41.02 127.25 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.842 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.603 HD13 ' CG2' ' A' ' 193' ' ' THR . 13.6 mt -96.62 -40.01 9.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.321 -0.862 . . . . 0.0 112.717 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -178.49 -167.08 0.12 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 119.79 -1.819 . . . . 0.0 111.223 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 1.1 p-80 178.95 -174.03 0.18 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.208 -1.558 . . . . 0.0 111.358 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.636 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -149.63 -175.15 4.9 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.453 -0.78 . . . . 0.0 109.787 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.629 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -122.25 -162.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.838 -1.164 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.936 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -172.43 -60.2 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.466 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.936 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.4 Cg_endo -75.33 -178.69 4.42 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.858 1.451 . . . . 0.0 110.217 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 67.96 140.67 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -70.4 152.19 65.87 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.964 1.507 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . 67.83 -65.33 0.32 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.629 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -67.62 -3.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.482 -1.01 . . . . 0.0 109.143 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.547 ' ND2' ' CZ2' ' A' ' 92' ' ' TRP . 5.3 p-10 -65.29 65.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.754 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 126.33 82.64 0.45 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 1.7 m-20 -152.22 123.83 7.85 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.918 -1.343 . . . . 0.0 107.735 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -111.74 156.18 22.34 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.643 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -151.29 132.65 14.6 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.735 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.693 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 19.9 m-30 -87.69 126.8 35.18 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.898 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.898 ' OD1' HG23 ' A' ' 148' ' ' VAL . 34.2 t0 -68.67 134.38 49.79 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.449 -0.782 . . . . 0.0 109.295 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 183' ' ' ASP . 18.9 p-10 -61.45 -14.07 25.63 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.4 p30 3.96 -93.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.531 ' OE2' ' HB2' ' A' ' 183' ' ' ASP . 10.2 mp0 -127.26 -63.02 1.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.974 -1.079 . . . . 0.0 110.681 -177.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.539 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 28.4 mt-30 -158.58 176.7 12.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.873 -1.142 . . . . 0.0 110.393 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.811 ' CD1' HG21 ' A' ' 105' ' ' THR . 43.2 m95 -148.85 128.67 13.36 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.684 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.1 p -145.77 150.84 36.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.37 -1.456 . . . . 0.0 111.34 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.941 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -83.76 -34.08 24.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 38.4 t0 -85.53 62.06 7.24 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 1.001 ' HB ' HD21 ' A' ' 229' ' ' LEU . 6.1 t 3.73 60.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 122.002 0.906 . . . . 0.0 111.829 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 46.9 m -124.79 -31.31 3.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.419 -0.801 . . . . 0.0 109.57 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.611 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -95.53 -70.52 1.07 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.76 HG22 ' OD1' ' A' ' 194' ' ' ASN . 23.4 m -140.07 -95.92 0.16 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.831 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -158.85 70.33 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 108.87 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.001 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 1.7 tp -34.51 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.54 0.686 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.884 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -67.23 -6.95 20.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 110.845 -177.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.82 ' HA ' HD11 ' A' ' 218' ' ' LEU . 8.6 tp -68.11 -65.82 0.65 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 116.912 -1.915 . . . . 0.0 106.801 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.831 HG23 ' HB2' ' A' ' 194' ' ' ASN . 5.4 t -69.14 -11.41 14.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.092 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -72.23 -57.53 4.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.768 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -68.01 -15.66 63.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.59 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 4.2 t60 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.229 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.666 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 1.9 mm-40 -85.64 -45.23 11.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.938 -1.101 . . . . 0.0 110.616 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.1 mt -61.32 -31.67 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.753 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.85 -34.42 30.88 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -56.81 -47.11 81.01 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.508 -0.995 . . . . 0.0 109.946 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.564 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 6.1 p -83.97 -57.77 3.06 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.735 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 1.01 HD22 HD11 ' A' ' 142' ' ' ILE . 7.8 mp -103.75 37.31 2.07 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.246 -0.909 . . . . 0.0 110.503 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.962 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -139.31 -78.47 0.06 OUTLIER Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.81 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.901 HD21 ' CG ' ' A' ' 238' ' ' ASP . 4.5 pp -173.18 -159.37 0.11 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.716 -1.461 . . . . 0.0 110.367 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.875 ' N ' HD12 ' A' ' 209' ' ' LEU . 54.4 t80 -100.0 -91.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.664 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.593 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 3.2 m-70 -148.57 106.71 3.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 109.473 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.588 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -95.93 -172.53 2.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 109.214 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.419 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -60.41 85.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.931 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.68 10.13 19.17 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.247 -177.056 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 214' ' ' ASN . 28.9 p -50.88 -27.55 7.7 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.497 ' C ' ' HB2' ' A' ' 235' ' ' SER . 15.4 mt-10 -118.41 -35.13 3.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.802 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.1 -159.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.179 0.99 . . . . 0.0 112.575 -177.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.82 HD11 ' HA ' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -112.62 -1.72 14.76 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.111 -177.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.593 ' HG2' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -91.76 -9.71 42.65 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 119.997 -1.689 . . . . 0.0 110.637 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.677 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.2 t80 -137.11 14.31 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.79 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.921 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 1.036 ' HB3' HD11 ' A' ' 226' ' ' LEU . 55.5 Cg_endo -74.2 -39.89 1.45 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 N-CA-C 108.883 -1.237 . . . . 0.0 108.883 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 222' ' ' LEU . 2.9 tp -7.24 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.499 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 14.5 m-85 -67.57 59.86 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -163.25 -146.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.545 ' C ' HD23 ' A' ' 226' ' ' LEU . 65.5 m -144.65 101.05 3.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.975 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 1.036 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.44 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 109.074 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.573 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 9.3 t -92.06 -15.65 27.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.347 -0.845 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.676 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER 178.42 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.94 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 1.001 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.87 -98.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.453 -0.78 . . . . 0.0 111.242 -179.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.0 -13.87 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.78 -1.2 . . . . 0.0 109.77 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.573 ' O ' ' C ' ' A' ' 232' ' ' PHE . 2.4 mtp180 -106.2 -42.83 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 108.806 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 25.8 p90 0.36 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.244 0.545 . . . . 0.0 112.139 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 234' ' ' LEU . 0.0 OUTLIER 178.27 175.28 0.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.102 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.1 mp -85.66 163.53 18.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.569 -0.707 . . . . 0.0 110.98 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.904 ' O ' HD12 ' A' ' 239' ' ' ILE . 5.3 t -98.34 178.74 4.95 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.392 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.536 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.4 OUTLIER -71.04 -24.37 62.33 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.475 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.588 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.3 m-20 -83.46 -42.2 17.2 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.575 -1.328 . . . . 0.0 108.94 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.901 ' CG ' HD21 ' A' ' 209' ' ' LEU . 5.8 t0 -70.76 -40.26 72.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.821 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.904 HD12 ' O ' ' A' ' 235' ' ' SER . 7.2 mt -54.82 -40.65 53.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.508 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 25.6 t-20 -60.21 -45.42 93.26 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.851 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.62 -54.57 35.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.047 HG13 HG22 ' A' ' 128' ' ' THR . 0.8 OUTLIER -65.2 -47.95 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.725 -1.456 . . . . 0.0 110.621 -178.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 240' ' ' ASN . 15.9 pt20 -54.05 -25.09 19.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 t -88.18 -14.9 37.44 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.753 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -76.06 -56.29 4.79 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.866 ' HB3' HD23 ' A' ' 130' ' ' LEU . 49.6 m-85 . . . . . 0 N--CA 1.492 1.652 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.291 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 92' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 98.7 m95 -82.6 151.95 26.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.115 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.92 -40.49 4.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.134 -179.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -50.7 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 -179.647 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.471 ' HA ' ' HG ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -118.17 2.11 11.97 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.496 -0.752 . . . . 0.0 109.369 179.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 38.5 m80 -140.68 89.64 2.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.955 -1.091 . . . . 0.0 110.219 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.825 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.3 mm? -87.68 173.09 9.23 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.652 -0.655 . . . . 0.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -142.16 155.85 45.33 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.087 -1.008 . . . . 0.0 108.73 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.925 ' CE2' HD11 ' A' ' 101' ' ' ILE . 5.4 p90 -137.88 164.79 28.09 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.714 -1.242 . . . . 0.0 108.667 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.653 ' HD3' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.089 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.925 HD11 ' CE2' ' A' ' 99' ' ' TYR . 1.5 mp -96.87 61.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 109.698 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.653 HG23 ' HD3' ' A' ' 100' ' ' ARG . 21.5 t -77.58 4.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.889 HD22 HG22 ' A' ' 144' ' ' ILE . 5.4 m-20 -92.92 155.94 17.25 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.983 -1.073 . . . . 0.0 110.073 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.762 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.4 t80 176.26 150.98 0.14 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.489 ' CG2' ' C ' ' A' ' 104' ' ' TYR . 3.9 p -156.23 161.11 30.16 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -67.71 -24.68 40.76 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 N-CA-C 108.079 -1.547 . . . . 0.0 108.079 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.734 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.5 t0 -73.82 -12.24 60.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.08 HD13 HD12 ' A' ' 195' ' ' LEU . 76.2 mt -143.38 115.41 5.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.28 167.34 12.97 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.63 1.332 . . . . 0.0 109.101 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HE3' ' CG ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.25 -66.17 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.805 0.812 . . . . 0.0 110.322 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.32 -11.88 7.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.728 -0.607 . . . . 0.0 111.62 -178.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.708 ' O ' HD11 ' A' ' 195' ' ' LEU . . . -85.32 -60.4 2.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.488 -1.383 . . . . 0.0 109.213 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.917 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.5 p -55.7 -39.49 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.701 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -64.62 -27.56 69.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.746 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -65.7 -41.61 92.14 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.126 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -69.7 -33.34 72.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.0 t -74.95 -24.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -87.32 -35.31 18.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.703 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 0.3 OUTLIER -80.26 -36.73 34.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.731 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -66.09 -60.8 2.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.532 1.158 . . . . 0.0 107.913 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.854 ' HA ' HG21 ' A' ' 203' ' ' ILE . 16.2 tp -54.12 -48.24 70.97 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.654 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -67.39 -33.72 75.79 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.241 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.029 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -55.93 -42.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.034 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.0 m95 -91.21 -23.16 20.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.588 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 18.5 tt0 -71.16 -27.56 63.64 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.6 pt-20 -90.15 -43.55 10.37 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.029 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.6 m -58.49 -25.36 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.124 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.028 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -112.1 162.28 22.06 Favored Pre-proline 0 N--CA 1.497 1.922 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.834 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -84.91 27.98 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.134 1.889 . . . . 0.0 110.483 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.853 HD22 ' CG ' ' A' ' 246' ' ' TYR . 1.9 mp -109.44 178.99 4.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.247 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.8 p -124.41 170.26 11.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.8 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 1.063 ' CZ ' HD13 ' A' ' 207' ' ' LEU . 12.5 m-85 -146.04 171.41 14.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.15 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.4 m -145.22 -175.13 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.652 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -163.83 149.94 11.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 0.0 110.501 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.769 HD12 ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -167.59 -98.71 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.568 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 15.9 t80 177.06 30.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.955 -1.091 . . . . 0.0 109.195 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.558 ' H ' HD13 ' A' ' 135' ' ' LEU . 7.3 tp10 -65.63 169.63 6.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.566 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -41.79 -34.87 1.37 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -178.22 104.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.556 -0.967 . . . . 0.0 109.894 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.541 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.4 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 98' ' ' THR . 71.5 m-20 -80.67 -30.49 36.53 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.97 -1.081 . . . . 0.0 108.794 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.914 HG12 HD23 ' A' ' 207' ' ' LEU . 4.4 mp -129.14 78.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.431 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.9 ttp -62.66 98.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.207 -0.933 . . . . 0.0 109.297 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.889 HG22 HD22 ' A' ' 103' ' ' ASN . 3.9 mm -84.76 107.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -132.9 152.22 51.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 112.322 -178.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 24.5 p90 -77.44 146.6 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.561 -0.712 . . . . 0.0 109.586 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.796 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -165.04 163.69 20.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -0.929 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.888 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.2 p -160.79 -160.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.96 . . . . 0.0 109.368 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.696 ' N ' HG13 ' A' ' 148' ' ' VAL . 36.7 mtm180 . . . . . 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.115 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 C--O 1.215 -0.668 0 N-CA-C 109.379 -1.046 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.744 ' CE1' HG13 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -120.71 -171.53 2.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.079 -1.013 . . . . 0.0 110.848 -179.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.57 ' O ' ' C ' ' A' ' 159' ' ' GLY . 17.0 p30 -175.92 62.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.82 -0.55 . . . . 0.0 109.636 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -8.97 -63.53 0.01 OUTLIER Glycine 0 N--CA 1.505 3.283 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 37.1 Cg_endo -64.02 66.56 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.442 1.233 . . . . 0.0 109.94 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 178.02 151.59 9.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' LEU . 15.2 m-20 -42.58 -32.57 0.58 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.166 . . . . 0.0 109.667 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.744 HG13 ' CE1' ' A' ' 157' ' ' PHE . 39.6 t -44.68 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.7 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.964 HD23 ' CG1' ' A' ' 198' ' ' VAL . 3.1 tp -88.14 -52.01 5.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.12 -0.987 . . . . 0.0 112.286 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.749 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -176.48 -165.34 0.13 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.151 -1.593 . . . . 0.0 111.142 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.684 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.72 -175.29 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.01 -1.681 . . . . 0.0 111.43 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -155.51 176.82 12.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.562 -0.711 . . . . 0.0 109.907 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.527 ' O ' ' CB ' ' A' ' 206' ' ' SER . 25.4 m-85 -120.06 -168.89 1.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.312 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.973 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -159.74 -64.03 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 0.0 109.602 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.973 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -76.58 174.82 12.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.651 1.343 . . . . 0.0 110.051 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 105.98 170.82 23.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 175' ' ' ASN . 44.3 Cg_endo -76.43 -56.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 121.603 1.535 . . . . 0.0 109.874 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.62 -40.25 1.03 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.7 tp -62.88 -7.09 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.463 -1.022 . . . . 0.0 108.867 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.524 ' CA ' ' O ' ' A' ' 169' ' ' ALA . 4.4 p-10 -66.0 65.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 108.991 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 206' ' ' SER . . . 127.55 80.76 0.32 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.2 m-20 -156.83 120.94 4.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.102 -1.234 . . . . 0.0 108.158 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.679 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -107.19 164.27 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.508 -0.745 . . . . 0.0 109.107 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.796 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -153.09 137.58 16.76 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.893 -1.123 . . . . 0.0 109.89 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.636 ' CD2' ' ND2' ' A' ' 103' ' ' ASN . 8.3 m-85 -99.16 129.75 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.753 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.888 ' OD1' HG23 ' A' ' 148' ' ' VAL . 11.1 t0 -47.3 148.88 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.906 -1.121 . . . . 0.0 108.312 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -114.34 19.22 16.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 110.122 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.575 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.7 OUTLIER -135.45 17.86 3.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.979 -1.076 . . . . 0.0 110.325 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 4.4 tt0 -120.47 -139.2 0.34 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.909 -1.12 . . . . 0.0 108.548 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.618 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 3.4 mt-30 -117.66 168.06 10.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -0.96 . . . . 0.0 109.14 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.618 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 87.1 m95 -159.46 107.46 1.77 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.974 -1.079 . . . . 0.0 109.741 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.932 ' HA ' HD21 ' A' ' 108' ' ' LEU . 70.6 p -144.26 154.6 43.25 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.853 -1.155 . . . . 0.0 110.787 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.861 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -91.68 -28.7 17.28 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 191' ' ' THR . 40.4 t0 -90.8 67.05 6.16 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 1.012 ' HB ' HD21 ' A' ' 229' ' ' LEU . 2.8 t 4.07 58.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.021 0.915 . . . . 0.0 112.036 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 189' ' ' ASP . 51.6 m -124.51 -31.25 3.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 0.0 109.733 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.714 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -98.85 -90.96 1.99 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.764 ' CG2' HD21 ' A' ' 164' ' ' LEU . 23.9 m -115.41 -97.01 0.45 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.847 ' OD1' HD21 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -161.45 68.54 0.3 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.23 -0.919 . . . . 0.0 108.706 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.126 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -28.63 -95.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.596 0.713 . . . . 0.0 111.407 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.892 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -67.57 -8.38 33.7 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 111.011 -177.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.911 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.3 tp -66.13 -66.64 0.52 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.224 -1.79 . . . . 0.0 106.668 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.964 ' CG1' HD23 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -66.75 -13.72 16.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.06 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -70.91 -58.8 3.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.805 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -66.67 -14.96 63.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.463 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 14.8 t60 -68.08 -45.47 73.71 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 117.798 -1.561 . . . . 0.0 107.625 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.679 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 2.2 mt-10 -82.8 -47.82 11.49 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.192 -0.943 . . . . 0.0 111.003 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.854 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -60.05 -31.27 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.682 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.9 -31.84 51.88 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -59.97 -51.01 71.48 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.85 -0.794 . . . . 0.0 110.58 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.536 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 84.4 p -82.74 -56.88 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 112.362 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 1.063 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -104.86 26.62 8.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.098 -1.001 . . . . 0.0 110.622 -177.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.975 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -126.52 -79.19 0.31 Allowed Glycine 0 C--N 1.292 -1.878 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.789 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -170.16 -162.67 0.31 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.678 -1.484 . . . . 0.0 110.015 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.583 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.3 OUTLIER -95.07 -75.34 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.5 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.3 m-70 -161.28 89.36 0.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.5 m -77.1 -178.67 5.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 108.987 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.861 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.92 80.45 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.966 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.08 7.56 18.29 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.216 -177.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 215' ' ' THR . 7.8 p -50.63 -27.79 7.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.515 ' C ' ' HB2' ' A' ' 235' ' ' SER . 18.2 mt-10 -114.05 -37.65 4.4 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.966 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -61.69 -167.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.284 1.04 . . . . 0.0 112.195 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.911 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.0 OUTLIER -102.47 -8.15 21.32 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.893 -177.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.54 ' CB ' ' OD1' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -81.31 -11.11 59.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.114 -1.616 . . . . 0.0 111.213 -178.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.657 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -136.47 12.61 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.33 -1.481 . . . . 0.0 113.808 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 48.5 Cg_endo -71.94 -37.96 4.48 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.915 HD23 ' N ' ' A' ' 223' ' ' TYR . 0.3 OUTLIER 0.08 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.915 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.8 OUTLIER -67.72 59.55 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.8 t-160 -168.1 -145.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.442 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.765 ' O ' HD12 ' A' ' 226' ' ' LEU . 59.0 m -149.72 110.11 4.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.002 . . . . 0.0 109.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 225' ' ' SER . 0.1 OUTLIER 179.67 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 188' ' ' LYS . 4.8 t -111.95 -7.89 14.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.607 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 178.87 -23.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 110.463 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 1.012 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -28.89 -61.58 0.12 Allowed 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.443 0.639 . . . . 0.0 110.857 -179.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.411 ' OG1' ' C ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.92 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.415 -0.803 . . . . 0.0 108.838 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.572 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -98.1 -21.15 16.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.607 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.0 p90 -33.19 120.75 0.37 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.553 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.72 172.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.738 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.034 HD21 ' CH2' ' A' ' 124' ' ' TRP . 5.0 mp -83.02 169.56 15.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.718 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 14.4 t -102.69 -170.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.764 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.542 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -83.8 -13.36 53.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.861 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.1 m-20 -84.54 -48.37 9.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.829 -1.17 . . . . 0.0 108.005 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.789 ' OD1' HD11 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.0 -40.01 95.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 117.166 -1.814 . . . . 0.0 106.749 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -56.26 -35.72 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 3.6 t30 -67.69 -45.63 74.63 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -62.97 -52.48 47.66 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.007 HG13 HG22 ' A' ' 128' ' ' THR . 1.5 tp -66.31 -47.29 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.868 -1.372 . . . . 0.0 110.51 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.565 ' N ' HG23 ' A' ' 242' ' ' ILE . 9.9 pt20 -55.13 -26.83 41.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 5.0 p -82.27 -18.86 40.9 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.8 OUTLIER -70.09 -65.8 0.68 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.853 ' CG ' HD22 ' A' ' 130' ' ' LEU . 20.5 m-85 . . . . . 0 C--N 1.301 -1.539 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.104 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.78 ' N ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.818 ' CD1' HD22 ' A' ' 207' ' ' LEU . 9.2 m95 -95.95 -169.05 1.86 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.847 -1.158 . . . . 0.0 110.037 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.513 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -161.81 -33.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.399 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.57 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.75 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.199 -0.938 . . . . 0.0 110.799 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.584 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -101.15 -8.53 22.15 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.715 . . . . 0.0 110.167 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.574 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 51.4 m80 -140.15 95.32 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.246 . . . . 0.0 110.865 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.03 HD13 HD13 ' A' ' 207' ' ' LEU . 19.5 mt -82.02 177.64 8.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.646 -0.659 . . . . 0.0 109.886 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.691 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 1.3 t -148.16 155.8 41.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.226 -0.921 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.76 ' CG ' HD22 ' A' ' 121' ' ' LEU . 1.3 p90 -138.43 161.83 35.99 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.614 -1.303 . . . . 0.0 110.053 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.587 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.43 123.0 28.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.515 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.891 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.5 mp -84.27 82.48 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.815 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 39.4 t -95.87 6.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.46 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.572 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -102.55 163.65 12.1 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.988 -1.07 . . . . 0.0 109.211 179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.687 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.0 t80 177.13 84.56 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.585 0.707 . . . . 0.0 109.117 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.951 HG21 ' CG ' ' A' ' 186' ' ' TRP . 17.9 p -72.85 155.99 90.2 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 108.876 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.98 -24.1 39.81 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 O-C-N 123.917 1.483 . . . . 0.0 108.667 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -78.37 -0.32 28.58 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.962 HD13 ' CD1' ' A' ' 195' ' ' LEU . 96.8 mt -147.45 120.03 4.74 Favored Pre-proline 0 N--CA 1.485 1.276 0 O-C-N 121.458 -0.776 . . . . 0.0 110.139 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -66.02 173.15 7.52 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.89 1.468 . . . . 0.0 109.037 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.481 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.14 -65.97 0.33 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.907 0.861 . . . . 0.0 110.091 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.2 OUTLIER -55.21 -29.41 57.89 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.857 -0.527 . . . . 0.0 112.251 -178.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.873 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.09 -61.03 1.96 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.446 . . . . 0.0 109.413 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.687 HG21 ' N ' ' A' ' 104' ' ' TYR . 9.6 p -53.39 -42.31 47.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.891 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -62.87 -27.94 69.7 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.933 ' OG ' HD21 ' A' ' 195' ' ' LEU . 4.4 p -61.23 -45.99 92.28 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.094 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -67.68 -31.28 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.055 -1.028 . . . . 0.0 109.663 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.985 HG13 HG13 ' A' ' 144' ' ' ILE . 45.9 t -75.07 -23.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -90.35 -33.13 16.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.65 -41.89 25.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.913 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -62.95 -61.92 2.07 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.773 ' HA ' HG21 ' A' ' 203' ' ' ILE . 11.1 tp -51.24 -44.5 61.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 2.6 tptp -72.53 -32.73 66.35 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.55 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.886 HG21 ' HE1' ' A' ' 196' ' ' PHE . 3.4 t -56.16 -43.8 77.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.024 ' CH2' HD21 ' A' ' 234' ' ' LEU . 37.8 m95 -91.22 -19.08 23.41 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.452 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.7 OUTLIER -77.05 -27.58 54.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.971 -1.081 . . . . 0.0 108.24 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 17.1 pt-20 -89.99 -44.57 9.78 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.961 HG21 HG21 ' A' ' 242' ' ' ILE . 35.9 m -64.03 -21.44 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.612 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 124' ' ' TRP . 1.7 p -113.0 152.26 44.79 Favored Pre-proline 0 N--CA 1.498 1.933 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.971 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.612 ' C ' HD22 ' A' ' 130' ' ' LEU . 53.9 Cg_endo -80.51 32.82 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.285 1.99 . . . . 0.0 111.661 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 246' ' ' TYR . 2.9 mm? -112.56 165.51 12.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.616 -1.302 . . . . 0.0 110.857 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -103.3 177.57 4.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.181 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 15.9 m-85 -154.35 160.61 41.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.913 -1.117 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -158.57 125.81 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.611 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -97.57 174.38 6.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.61 -1.306 . . . . 0.0 110.358 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.537 ' CD1' ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.16 -122.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.432 ' C ' ' OE1' ' A' ' 137' ' ' GLU . 1.1 t80 177.04 42.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.3 -1.5 . . . . 0.0 109.921 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 139' ' ' GLU . 10.9 pm0 -169.47 -173.79 1.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.931 -1.106 . . . . 0.0 110.155 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.8 -97.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 137' ' ' GLU . 10.2 pt-20 179.0 105.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -1.094 . . . . 0.0 109.92 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.691 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.21 -151.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.638 ' OD2' HG22 ' A' ' 98' ' ' THR . 53.8 m-20 -93.46 -25.5 17.61 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.931 HD11 HD12 ' A' ' 207' ' ' LEU . 3.1 mp -132.22 79.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.525 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.5 ttp -66.14 93.77 0.22 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.231 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.985 HG13 HG13 ' A' ' 117' ' ' VAL . 5.9 mm -79.28 110.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.911 -1.118 . . . . 0.0 108.042 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -131.36 156.14 46.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.359 -1.463 . . . . 0.0 111.434 -178.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 19.7 p90 -79.85 138.2 37.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 0.0 109.432 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.045 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -157.85 164.2 37.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.037 . . . . 0.0 110.523 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 1.026 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.4 p -166.58 -161.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.686 ' H ' HG22 ' A' ' 148' ' ' VAL . 45.6 mtm180 . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 110.169 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--O 1.216 -0.607 0 N-CA-C 109.613 -0.956 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.878 ' CE1' HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -96.64 -169.1 1.83 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 110.492 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 159' ' ' GLY . 16.9 p30 179.74 62.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.724 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.608 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -5.35 -65.58 0.01 OUTLIER Glycine 0 N--CA 1.51 3.579 0 N-CA-C 112.151 -0.38 . . . . 0.0 112.151 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.536 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.69 61.33 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.685 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -170.07 141.93 6.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 164' ' ' LEU . 18.6 m120 -40.15 -31.32 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.45 -1.029 . . . . 0.0 110.343 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.878 HG12 ' CE1' ' A' ' 157' ' ' PHE . 1.4 t -56.7 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.812 HD11 HG21 ' A' ' 193' ' ' THR . 0.1 OUTLIER -79.51 -40.9 28.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.32 -0.862 . . . . 0.0 112.306 -178.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -179.86 -168.5 0.11 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.198 -1.564 . . . . 0.0 110.859 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.91 -168.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.412 -1.43 . . . . 0.0 110.99 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -159.88 -164.63 1.34 Allowed 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.347 -0.845 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 88.6 m-85 -131.9 -163.64 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.058 . . . . 0.0 110.16 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.823 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . 179.28 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.002 -1.061 . . . . 0.0 110.939 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.823 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 40.1 Cg_endo -70.22 -64.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.491 1.46 . . . . 0.0 111.817 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 175' ' ' ASN . . . -37.86 144.75 0.17 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 174' ' ' ILE . 39.9 Cg_endo -69.47 144.53 55.9 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.085 1.571 . . . . 0.0 109.368 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 69.55 -63.28 0.63 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' A' ' 176' ' ' GLY . 1.5 tp -68.43 -4.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -63.79 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 129.81 80.62 0.24 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.633 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -157.41 128.91 6.88 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 120.755 -1.438 . . . . 0.0 107.676 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.772 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -117.55 156.68 27.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.888 -1.132 . . . . 0.0 109.538 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.045 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -142.15 133.84 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.303 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 20.4 m-85 -96.03 134.19 39.35 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.857 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 1.026 ' OD1' HG23 ' A' ' 148' ' ' VAL . 9.5 t0 -53.26 145.9 12.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.892 -1.13 . . . . 0.0 108.85 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 147' ' ' ALA . 10.0 m-20 -114.7 21.54 14.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 0.0 110.255 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.876 ' OD1' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -121.32 8.98 10.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.804 -1.185 . . . . 0.0 110.298 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.558 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 19.0 mt-10 -122.63 -131.68 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.94 -1.1 . . . . 0.0 108.534 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.3 mt-30 -133.36 175.42 9.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.134 -0.979 . . . . 0.0 108.761 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.951 ' CG ' HG21 ' A' ' 105' ' ' THR . 78.0 m95 -158.81 119.38 3.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.91 -1.119 . . . . 0.0 108.85 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.68 ' HA ' HD21 ' A' ' 108' ' ' LEU . 71.4 p -144.85 152.28 40.04 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.79 -1.194 . . . . 0.0 110.505 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.948 ' HB3' HD22 ' A' ' 195' ' ' LEU . 3.3 pttt -85.14 -31.75 23.12 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 12.7 t70 -87.16 63.44 7.85 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.889 ' CG2' HD21 ' A' ' 229' ' ' LEU . 72.1 p 3.24 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.832 -177.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 37.0 m -125.34 -32.34 2.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.664 . . . . 0.0 109.408 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.617 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.94 -82.27 1.58 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.812 HG21 HD11 ' A' ' 164' ' ' LEU . 21.8 m -125.31 -95.81 0.45 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 1.002 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -160.61 70.82 0.42 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.017 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 2.1 tp -33.5 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.886 ' HE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -69.62 -9.93 56.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 111.168 -177.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.69 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 12.0 tp -64.71 -62.01 1.84 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 116.852 -1.939 . . . . 0.0 106.544 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.002 HG23 ' HB2' ' A' ' 194' ' ' ASN . 2.7 t -70.48 -12.2 15.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.094 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.64 -59.43 2.72 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.759 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -63.99 -15.64 59.76 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 198' ' ' VAL . 20.2 t60 -67.15 -49.2 65.62 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.806 -1.558 . . . . 0.0 107.676 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.772 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 2.5 mm-40 -80.24 -47.12 15.1 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.159 -0.963 . . . . 0.0 111.077 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.913 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.3 mt -60.15 -31.53 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.708 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.94 -34.87 40.98 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.38 -50.31 73.4 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 121.78 -0.835 . . . . 0.0 110.598 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.851 ' C ' HD23 ' A' ' 207' ' ' LEU . 1.5 m -84.81 -58.96 2.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.378 -0.826 . . . . 0.0 112.177 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 1.03 HD13 HD13 ' A' ' 97' ' ' LEU . 1.2 mt -102.85 32.23 3.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.709 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -131.91 -81.53 0.21 Allowed Glycine 0 C--N 1.289 -2.073 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.838 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.6 pp -165.03 -164.65 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.127 -1.22 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.838 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -98.48 -70.76 0.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.238 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 21.8 m80 -162.85 96.8 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.226 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.765 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.8 m -87.69 -175.71 5.28 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.808 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.43 76.86 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.952 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -83.56 8.8 13.04 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.126 -177.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.458 ' C ' ' O ' ' A' ' 214' ' ' ASN . 21.3 p -50.35 -27.72 6.75 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.519 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.2 mp0 -112.51 -37.21 5.01 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.952 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -64.97 -168.48 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.319 1.057 . . . . 0.0 112.526 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.787 HD23 HD12 ' A' ' 234' ' ' LEU . 0.1 OUTLIER -89.77 -18.06 27.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.694 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.553 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.38 -7.26 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 119.182 -2.199 . . . . 0.0 112.175 -177.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 27.8 t80 -135.5 14.69 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.277 -1.514 . . . . 0.0 113.585 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.6 Cg_endo -79.88 -43.33 0.13 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 N-CA-C 109.279 -1.085 . . . . 0.0 109.279 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 222' ' ' LEU . 2.3 tp -1.08 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-O 121.355 0.597 . . . . 0.0 110.929 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 221' ' ' PRO . 8.2 m-85 -67.6 59.61 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.413 -0.804 . . . . 0.0 109.202 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.5 t-160 -170.43 -140.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.232 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.619 ' C ' HD23 ' A' ' 226' ' ' LEU . 19.8 m -163.52 112.19 1.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.967 -1.083 . . . . 0.0 110.121 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.698 ' N ' HG21 ' A' ' 190' ' ' THR . 0.4 OUTLIER 179.69 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.577 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 5.2 t -104.75 -48.02 3.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.609 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 0.5 OUTLIER -138.57 -10.39 1.4 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 111.625 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.889 HD21 ' CG2' ' A' ' 190' ' ' THR . 0.1 OUTLIER -35.83 -64.68 0.29 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.844 -1.16 . . . . 0.0 110.792 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.84 -31.77 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 109.193 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER -97.58 -20.14 17.88 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 228' ' ' ASP . 50.7 p90 -34.53 130.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.542 0.687 . . . . 0.0 111.145 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.1 ttt-85 179.74 152.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.024 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.1 mp -68.75 169.04 12.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.97 -1.082 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 31.0 t -100.48 -171.76 2.08 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.254 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.499 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.5 -12.09 52.64 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.808 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.2 OUTLIER -84.69 -47.5 10.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.669 ' OD1' HD21 ' A' ' 209' ' ' LEU . 4.5 m-20 -67.01 -38.28 85.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 117.091 -1.844 . . . . 0.0 106.526 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -57.23 -34.69 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.468 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 244' ' ' SER . 12.6 t-20 -68.96 -47.22 66.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.279 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' A' ' 244' ' ' SER . . . -64.3 -45.93 92.11 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.961 HG21 HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -74.39 -50.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.532 -1.569 . . . . 0.0 109.803 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.606 ' N ' HG23 ' A' ' 242' ' ' ILE . 2.4 tt0 -55.27 -24.15 26.72 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 75.8 p -89.74 -13.55 36.55 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.78 HD21 ' N ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -72.26 -53.65 11.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.614 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 7.5 m-30 . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.516 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.664 ' N ' HD22 ' A' ' 245' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.597 ' CZ2' ' HA ' ' A' ' 141' ' ' ASP . 12.7 m95 -77.58 -126.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.858 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 178.84 -51.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.365 -1.459 . . . . 0.0 109.529 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.41 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.814 0.816 . . . . 0.0 110.771 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.542 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 26.2 p -100.06 -4.19 30.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.497 -0.752 . . . . 0.0 109.64 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.596 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 21.1 m-70 -141.93 88.82 2.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.105 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.9 mm? -76.71 169.54 18.1 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.709 -0.619 . . . . 0.0 109.481 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.566 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.2 OUTLIER -141.77 156.79 45.57 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.11 -0.994 . . . . 0.0 108.963 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.891 ' CG ' HD23 ' A' ' 121' ' ' LEU . 16.7 p90 -137.55 161.74 35.62 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.588 -1.32 . . . . 0.0 109.256 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 1.093 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -125.13 138.6 54.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.945 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.6 mp -93.01 67.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.661 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.093 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 20.0 t -78.77 6.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 0.0 110.069 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.654 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -105.98 159.37 16.1 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.899 -1.126 . . . . 0.0 108.578 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.712 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.8 p90 177.94 47.01 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.748 -0.595 . . . . 0.0 110.246 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.864 HG21 ' CD1' ' A' ' 186' ' ' TRP . 22.6 p -44.11 156.8 0.31 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.163 -0.961 . . . . 0.0 108.802 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.04 -18.21 51.52 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.701 1.369 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.488 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 0.5 OUTLIER -70.93 -6.06 35.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.337 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.975 ' CD1' HD13 ' A' ' 195' ' ' LEU . 95.9 mt -151.67 127.16 4.88 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.401 -0.812 . . . . 0.0 110.432 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 38.2 Cg_endo -68.09 174.8 7.41 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.992 1.522 . . . . 0.0 109.288 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.481 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -40.88 -66.36 0.34 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.774 0.797 . . . . 0.0 110.206 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.5 OUTLIER -54.35 -33.8 59.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.922 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.46 -60.65 2.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.355 -1.465 . . . . 0.0 109.834 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.712 HG21 ' N ' ' A' ' 104' ' ' TYR . 5.6 p -55.18 -44.51 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.945 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -61.8 -27.54 68.83 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 116' ' ' ALA . 1.4 p -58.89 -64.54 0.9 Allowed 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.059 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -50.1 -32.01 14.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.293 -0.879 . . . . 0.0 110.254 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 144' ' ' ILE . 36.8 t -74.34 -23.34 18.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -93.08 -31.06 14.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.666 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -84.47 -35.11 23.21 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.92 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -69.26 -62.26 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.591 1.186 . . . . 0.0 107.928 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.901 ' HA ' HG21 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -52.67 -55.1 24.98 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.699 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 118' ' ' GLU . 2.7 tptm -60.55 -35.42 75.97 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.835 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.018 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.27 -40.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -179.575 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 1.043 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.7 m95 -91.05 -23.87 20.22 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.669 -1.212 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -70.37 -29.6 66.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.799 -1.188 . . . . 0.0 107.808 179.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -88.55 -40.34 13.47 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.201 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.018 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.7 m -61.63 -25.46 36.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.102 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 1.009 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -112.52 164.14 16.07 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.241 -1.384 . . . . 0.0 108.995 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -79.11 -6.17 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.687 1.591 . . . . 0.0 110.557 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 246' ' ' TYR . 2.1 mm? -74.4 165.1 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 110.289 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.552 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -108.97 169.04 8.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 97' ' ' LEU . 50.9 m-85 -148.65 154.93 40.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 110.199 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -143.76 -179.52 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -156.7 161.37 39.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.82 -98.12 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.405 -0.809 . . . . 0.0 109.956 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CZ ' ' NH2' ' A' ' 100' ' ' ARG . 2.8 t80 177.68 32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.986 -1.071 . . . . 0.0 109.041 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.756 ' OE2' HD11 ' A' ' 135' ' ' LEU . 0.7 OUTLIER -72.21 174.51 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.967 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -43.62 -40.46 5.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 140' ' ' ALA . 4.1 pt-20 -174.21 105.3 0.11 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -1.062 . . . . 0.0 109.998 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.563 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.4 -148.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.018 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.597 ' HA ' ' CZ2' ' A' ' 92' ' ' TRP . 66.8 m-20 -88.02 -27.17 22.21 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.575 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.018 HD11 HD22 ' A' ' 207' ' ' LEU . 3.6 mt -130.73 77.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.512 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 23.4 ttp -65.29 98.19 0.31 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.645 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 1.014 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -81.97 107.35 13.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -128.5 156.59 43.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.468 -1.395 . . . . 0.0 111.79 -178.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.539 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 34.7 p90 -79.17 137.39 37.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 1.031 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -158.37 165.57 34.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 0.0 109.731 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.923 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.1 p -164.15 -155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.472 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.804 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.68 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 C--O 1.215 -0.644 0 N-CA-C 109.761 -0.899 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.688 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -102.77 -166.79 1.31 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 110.517 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 160' ' ' PRO . 19.8 p30 179.29 58.57 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.72 -0.612 . . . . 0.0 109.837 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.623 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.19 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.508 3.444 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.593 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.4 Cg_endo -64.17 62.41 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 109.935 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -164.56 141.99 7.46 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 164' ' ' LEU . 70.5 m-80 -41.41 -32.77 0.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -1.087 . . . . 0.0 109.971 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 157' ' ' PHE . 6.4 m -55.1 86.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 109.9 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 1.114 HD23 HG21 ' A' ' 198' ' ' VAL . 0.8 OUTLIER -75.63 -38.33 59.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.337 -0.852 . . . . 0.0 111.618 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.885 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . 179.21 -169.64 0.11 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.585 -1.322 . . . . 0.0 110.406 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.688 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p-80 178.12 -170.37 0.1 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.017 -1.677 . . . . 0.0 111.426 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.56 -174.99 5.16 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.56 -0.713 . . . . 0.0 110.052 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 1.057 ' CD1' HD11 ' A' ' 174' ' ' ILE . 62.8 m-85 -121.06 -175.37 3.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.054 -1.029 . . . . 0.0 110.652 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.972 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -152.02 -66.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.68 -0.638 . . . . 0.0 109.324 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.972 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.1 Cg_endo -74.19 177.25 8.5 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.609 1.321 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.594 ' HA3' HG23 ' A' ' 174' ' ' ILE . . . 95.62 168.1 35.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.0 Cg_endo -75.63 -87.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -74.58 -35.33 51.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 1.057 HD11 ' CD1' ' A' ' 168' ' ' TYR . 3.1 tt -66.71 -2.96 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 108.892 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.553 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 1.9 t30 -66.18 63.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.33 -0.856 . . . . 0.0 108.997 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 121.4 87.05 0.91 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.3 m-20 -155.08 124.47 6.37 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.826 -1.397 . . . . 0.0 107.998 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -110.13 152.45 26.0 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 109.329 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 1.031 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -139.48 131.24 27.46 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.901 -1.119 . . . . 0.0 109.336 179.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.548 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 52.9 m-85 -91.62 129.72 37.55 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.634 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.923 ' OD1' HG23 ' A' ' 148' ' ' VAL . 15.6 t0 -47.15 145.55 2.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.966 -1.084 . . . . 0.0 108.371 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.538 ' OD1' HG22 ' A' ' 105' ' ' THR . 3.5 t0 -114.74 20.96 14.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.623 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 6.5 m-20 -131.61 24.88 4.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.557 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 16.8 mt-10 -130.18 -93.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 109.108 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.0 mt-30 179.56 172.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . 0.864 ' CD1' HG21 ' A' ' 105' ' ' THR . 94.9 m95 -158.95 125.42 4.6 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.736 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.2 p -144.77 150.71 37.67 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.829 -1.169 . . . . 0.0 109.944 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 6.0 ptpt -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.651 ' O ' ' N ' ' A' ' 191' ' ' THR . 24.4 t70 -89.4 64.93 6.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 1.018 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.3 t 3.69 59.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.101 0.953 . . . . 0.0 112.019 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.0 m -126.28 -30.56 2.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.866 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.683 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -93.27 -81.92 1.51 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.865 ' CG2' HD21 ' A' ' 164' ' ' LEU . 19.8 m -123.63 -80.67 0.63 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.857 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 0.6 OUTLIER 179.33 68.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.006 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 12.7 tp -37.98 -101.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.725 -0.609 . . . . 0.0 111.55 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.859 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.8 OUTLIER -57.05 -9.56 0.9 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.879 -1.138 . . . . 0.0 111.233 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.87 ' HA ' HD11 ' A' ' 218' ' ' LEU . 5.6 tp -68.29 -66.98 0.5 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 116.778 -1.969 . . . . 0.0 106.703 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.114 HG21 HD23 ' A' ' 164' ' ' LEU . 14.6 t -68.41 -6.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 1.059 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.04 -58.04 3.5 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.812 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -67.19 -15.93 64.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 219' ' ' MET . 11.2 t60 -69.65 -40.4 76.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.9 -1.52 . . . . 0.0 107.78 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . 0.683 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.6 mt-10 -85.61 -48.41 8.92 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.297 -0.877 . . . . 0.0 110.917 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 120' ' ' ALA . 4.0 mt -61.89 -30.06 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.697 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.69 -33.24 43.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -57.64 -49.69 75.61 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.675 -0.897 . . . . 0.0 110.065 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.514 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 40.4 p -81.22 -60.46 2.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.443 -0.786 . . . . 0.0 111.874 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 1.018 HD22 HD11 ' A' ' 142' ' ' ILE . 7.3 mp -104.2 36.74 2.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.252 -0.905 . . . . 0.0 110.872 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.972 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -136.26 -73.16 0.07 OUTLIER Glycine 0 C--N 1.292 -1.878 0 C-N-CA 119.435 -1.364 . . . . 0.0 109.929 -178.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.943 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -179.87 -162.53 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.642 -1.505 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.847 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -94.71 -83.86 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 0.0 109.397 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 2.0 m-70 -151.9 99.97 2.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.624 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -86.44 177.02 7.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.848 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -58.23 89.52 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.975 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -90.02 11.85 19.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.981 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 214' ' ' ASN . 12.9 p -50.04 -29.04 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.517 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.7 mm-40 -118.07 -34.6 4.08 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.501 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.975 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -59.44 -169.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.223 1.011 . . . . 0.0 112.068 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.87 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.4 tp -110.41 -3.89 15.87 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.152 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.638 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -83.02 -11.36 58.16 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.146 -1.596 . . . . 0.0 111.064 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.655 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 24.5 t80 -140.6 17.35 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 117.994 -1.483 . . . . 0.0 113.467 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' PRO . . . . . 0.9 ' HB3' HD11 ' A' ' 226' ' ' LEU . 53.0 Cg_endo -73.43 -35.49 4.82 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.946 -1.598 . . . . 0.0 107.946 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.95 HD23 ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -4.09 -69.82 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.831 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.95 ' N ' HD23 ' A' ' 222' ' ' LEU . 24.0 t80 -69.35 58.84 0.12 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.989 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -168.69 -140.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 0.0 109.329 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' SER . . . . . 0.919 ' HB3' HG21 ' A' ' 190' ' ' THR . 15.2 m -153.41 108.83 3.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.943 -1.098 . . . . 0.0 110.328 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.912 HD23 ' C ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.76 51.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -0.836 . . . . 0.0 109.335 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 187' ' ' THR . 14.7 t -103.26 -9.75 19.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 0.0 109.237 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.631 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 0.3 OUTLIER 178.14 -23.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 178.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 1.018 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -27.97 -61.41 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.421 0.629 . . . . 0.0 111.008 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.97 -34.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.6 OUTLIER -87.31 -16.39 35.25 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.631 ' HB3' ' N ' ' A' ' 228' ' ' ASP . 36.7 p90 -33.17 112.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.535 0.683 . . . . 0.0 111.334 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 178.12 177.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 0.0 109.49 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 1.043 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.6 mp -93.85 170.12 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.46 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.693 ' O ' HD13 ' A' ' 239' ' ' ILE . 7.0 t -101.24 -171.75 2.05 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.724 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . 0.572 ' N ' ' OG ' ' A' ' 235' ' ' SER . 25.6 tp60 -82.83 -14.65 53.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.369 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.848 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.7 m-20 -83.54 -47.16 11.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.943 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.5 OUTLIER -64.34 -39.21 93.44 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.005 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -58.09 -34.73 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 244' ' ' SER . 59.6 t30 -68.65 -45.34 72.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.529 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.49 -56.56 23.74 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 1.007 HG21 HG21 ' A' ' 127' ' ' VAL . 1.4 tp -64.1 -43.94 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.269 . . . . 0.0 109.605 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLN . . . . . 0.523 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.8 tt0 -55.97 -26.5 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 1.4 p -80.61 -20.66 42.74 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.942 ' HB2' HD12 ' A' ' 242' ' ' ILE . 2.4 mt -69.98 -69.49 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.587 ' HB3' HD23 ' A' ' 130' ' ' LEU . 38.6 m-85 . . . . . 0 C--N 1.298 -1.661 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 83' ' ' PHE . 5.5 p90 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.57 -162.18 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.483 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 5.1 m -50.33 160.09 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.537 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -95.13 105.84 22.02 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.489 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 85' ' ' THR . 41.6 Cg_endo -72.12 89.6 0.78 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.052 1.554 . . . . 0.0 110.07 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.84 ' O ' HD13 ' A' ' 89' ' ' ILE . . . 129.17 1.43 5.73 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.84 HD13 ' O ' ' A' ' 88' ' ' GLY . 7.9 mm -141.85 88.61 9.36 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.207 -1.172 . . . . 0.0 109.579 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.24 133.24 20.75 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.043 1.549 . . . . 0.0 109.974 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.578 ' H ' HD21 ' A' ' 245' ' ' LEU . 0.1 OUTLIER -59.22 -75.55 0.05 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.897 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.627 ' CZ3' ' ND2' ' A' ' 175' ' ' ASN . 9.7 m95 -99.73 143.16 30.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 110.207 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 1.6 ptp180 -109.3 -40.86 4.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.388 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 1.06 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.58 170.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.331 -0.855 . . . . 0.0 110.019 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.59 ' O ' HD12 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -110.14 1.19 18.63 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.502 -0.749 . . . . 0.0 109.585 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 66.8 m80 -137.96 95.99 3.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.368 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.06 HD13 ' HE2' ' A' ' 94' ' ' LYS . 3.1 mm? -92.37 170.82 9.48 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.51 -0.744 . . . . 0.0 109.512 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.607 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -147.24 157.17 43.5 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 1.054 ' CE2' HD11 ' A' ' 101' ' ' ILE . 4.4 p90 -137.11 166.31 24.02 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.505 -1.372 . . . . 0.0 109.746 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.59 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -125.19 124.36 41.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.479 -0.763 . . . . 0.0 109.017 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.054 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -83.12 83.54 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.883 -1.135 . . . . 0.0 110.106 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 102' ' ' VAL . 46.7 t -98.72 7.25 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.254 -0.903 . . . . 0.0 110.001 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.985 ' C ' HG21 ' A' ' 113' ' ' VAL . 34.0 m-80 -97.01 160.91 14.08 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.841 -1.162 . . . . 0.0 109.461 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.777 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.8 t80 178.09 167.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.477 -0.764 . . . . 0.0 109.455 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.648 HG22 ' CZ3' ' A' ' 186' ' ' TRP . 0.0 OUTLIER -176.53 159.54 1.66 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 105' ' ' THR . 37.7 Cg_endo -66.12 -25.94 50.48 Favored 'Trans proline' 0 C--N 1.298 -2.089 0 N-CA-C 107.791 -1.657 . . . . 0.0 107.791 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.692 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -74.17 -10.98 60.15 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.929 ' CD1' HD13 ' A' ' 195' ' ' LEU . 79.6 mt -153.23 111.18 2.63 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.598 -0.689 . . . . 0.0 110.224 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.81 178.37 2.34 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 O-C-N 123.8 1.421 . . . . 0.0 109.341 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.93 -65.35 0.37 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.809 0.814 . . . . 0.0 110.296 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -58.67 -26.79 64.18 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.758 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -74.42 -60.45 2.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.31 -1.494 . . . . 0.0 109.605 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.985 HG21 ' C ' ' A' ' 103' ' ' ASN . 11.3 p -58.16 -42.42 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 1.041 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -60.04 -29.79 68.76 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -57.68 -64.1 1.02 Allowed 'General case' 0 C--O 1.195 -1.779 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.065 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -49.19 -33.0 11.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 0.0 110.158 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.936 HG13 HG13 ' A' ' 144' ' ' ILE . 5.7 t -73.0 -24.33 20.89 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.7 tt0 -90.64 -34.07 15.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.342 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.12 -39.44 33.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.885 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -64.84 -62.23 1.69 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.909 HD22 ' CE1' ' A' ' 99' ' ' TYR . 14.5 tp -48.99 -47.94 43.88 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.489 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -70.34 -34.25 72.43 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.791 -178.049 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.012 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.8 t -53.71 -44.81 59.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.027 ' CH2' HD21 ' A' ' 234' ' ' LEU . 30.9 m95 -92.11 -21.33 20.49 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.716 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 33.6 tt0 -72.14 -27.55 62.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.8 pt-20 -88.88 -44.49 10.43 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.435 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.084 HG21 HG21 ' A' ' 242' ' ' ILE . 14.2 m -56.77 -26.89 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.248 -1.381 . . . . 0.0 108.324 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.003 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -118.35 166.33 14.1 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 108.092 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.581 ' HG2' ' CD1' ' A' ' 246' ' ' TYR . 48.1 Cg_endo -82.5 -10.94 10.75 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.528 1.485 . . . . 0.0 109.824 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.932 HD23 ' CZ ' ' A' ' 132' ' ' PHE . 41.9 tp -52.38 158.87 1.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.536 -0.727 . . . . 0.0 110.893 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.5 p -108.37 170.39 8.05 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.932 ' CZ ' HD23 ' A' ' 130' ' ' LEU . 71.2 m-85 -151.41 146.36 25.91 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.938 -1.101 . . . . 0.0 110.929 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.599 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 4.0 t -125.66 -174.24 3.03 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.64 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -148.13 164.58 33.45 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.612 -1.305 . . . . 0.0 111.017 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.535 ' CD2' ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -164.81 -163.73 0.74 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 29.7 t80 -160.95 28.31 0.14 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 5.0 pm0 -144.87 178.57 7.92 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.678 -0.639 . . . . 0.0 109.324 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.26 -97.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 137' ' ' GLU . 7.7 pt-20 178.83 121.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.314 -1.109 . . . . 0.0 110.207 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.607 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -77.58 -151.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 109.12 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.866 ' CG ' HD12 ' A' ' 97' ' ' LEU . 16.7 t70 -89.75 -36.74 14.99 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.87 ' CD1' HD23 ' A' ' 207' ' ' LEU . 4.1 mp -123.23 83.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.543 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 8.8 ttm -65.13 98.24 0.3 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.044 . . . . 0.0 109.059 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.936 HG13 HG13 ' A' ' 117' ' ' VAL . 6.2 mm -82.73 111.52 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.652 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.72 153.64 51.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.481 -1.387 . . . . 0.0 111.856 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.516 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 19.8 p90 -90.47 141.42 28.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.769 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.088 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.82 179.96 3.97 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.003 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 149' ' ' ARG . 1.4 p -151.19 -164.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.716 ' H ' HG22 ' A' ' 148' ' ' VAL . 1.1 ptt85 -55.97 83.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 109.785 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER 179.85 32.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.565 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.482 ' CE1' ' HD1' ' A' ' 157' ' ' PHE . 58.4 m80 -73.25 -40.76 64.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.886 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.91 -67.0 0.32 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -159.84 24.96 0.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -1.138 . . . . 0.0 109.427 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.574 ' O ' ' C ' ' A' ' 155' ' ' TYR . 55.8 m-85 -153.5 -167.26 2.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.577 ' CE1' ' OH ' ' A' ' 168' ' ' TYR . 1.0 OUTLIER 1.54 69.6 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.461 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' A' ' 154' ' ' PHE . 44.8 Cg_endo -80.24 125.17 5.68 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 124.011 1.532 . . . . 0.0 109.805 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.776 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 1.5 m-85 -78.33 -169.42 1.64 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.067 -1.021 . . . . 0.0 109.557 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.524 ' OD2' ' CG2' ' A' ' 163' ' ' VAL . 11.0 p30 178.64 58.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.559 -0.713 . . . . 0.0 110.097 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -20.36 -58.96 0.01 OUTLIER Glycine 0 N--CA 1.511 3.679 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 41.3 Cg_endo -71.17 56.17 1.98 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.589 1.31 . . . . 0.0 109.135 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -170.84 156.81 27.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.538 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 84.7 m-20 -51.9 -33.68 38.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.364 -1.08 . . . . 0.0 110.588 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.985 HG13 ' CG2' ' A' ' 1' ' ' HAV . 2.9 t -55.54 84.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.105 -0.997 . . . . 0.0 110.111 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.983 HD21 ' CG2' ' A' ' 193' ' ' THR . 0.3 OUTLIER -74.35 -46.38 41.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.507 -0.746 . . . . 0.0 111.765 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.784 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -168.67 179.84 4.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.35 -1.469 . . . . 0.0 111.735 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.776 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.4 p-80 178.94 167.48 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.154 -1.591 . . . . 0.0 111.252 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.654 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.78 -169.07 2.13 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.556 -0.715 . . . . 0.0 110.093 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.602 ' CD2' ' HB ' ' A' ' 174' ' ' ILE . 55.2 m-85 -110.3 -166.51 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.632 -1.292 . . . . 0.0 110.515 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.045 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -120.92 -170.25 0.18 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.411 -0.805 . . . . 0.0 109.086 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 1.045 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.6 Cg_endo -74.8 112.94 3.67 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.418 1.22 . . . . 0.0 110.505 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . -157.65 -140.63 2.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.6 -93.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.054 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -92.34 -26.99 16.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.613 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -74.04 9.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.515 -0.991 . . . . 0.0 108.816 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.627 ' ND2' ' CZ3' ' A' ' 92' ' ' TRP . 6.2 t30 -63.18 62.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.43 103.4 2.83 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.654 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.5 m-20 -163.27 118.33 1.69 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.601 -1.529 . . . . 0.0 107.377 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.813 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -110.46 166.46 10.97 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.78 -1.2 . . . . 0.0 108.801 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.088 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -158.63 134.61 9.03 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.281 178.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.578 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 22.4 m-85 -94.19 137.31 33.52 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.625 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.624 ' HA ' ' CD2' ' A' ' 157' ' ' PHE . 7.6 t0 -50.87 151.36 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.779 -1.201 . . . . 0.0 108.628 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.19 20.45 8.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.058 -1.026 . . . . 0.0 109.5 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.628 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.5 OUTLIER -107.98 -16.7 14.23 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 185' ' ' GLN . 1.2 pt-20 -112.54 -98.52 0.42 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.848 -1.158 . . . . 0.0 108.281 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.567 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 1.0 OUTLIER 178.53 165.28 0.81 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.014 -1.054 . . . . 0.0 109.045 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.648 ' CZ3' HG22 ' A' ' 105' ' ' THR . 0.0 OUTLIER -137.51 130.91 31.04 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.179 -0.951 . . . . 0.0 109.229 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.546 ' HA ' HD21 ' A' ' 108' ' ' LEU . 47.3 p -131.64 149.51 52.47 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 227' ' ' THR . 41.3 pttt -74.42 -37.77 63.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.528 ' O ' ' CG2' ' A' ' 227' ' ' THR . 3.3 t70 -83.28 -149.14 0.09 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.845 ' N ' HD11 ' A' ' 229' ' ' LEU . 27.0 m -111.45 46.46 1.1 Allowed 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 118.542 -1.263 . . . . 0.0 107.849 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.479 ' HB ' HG21 ' A' ' 187' ' ' THR . 91.2 m -98.45 -32.32 11.55 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.322 -0.861 . . . . 0.0 111.411 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -118.58 -85.57 1.02 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.755 -1.688 . . . . 0.0 109.489 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.983 ' CG2' HD21 ' A' ' 164' ' ' LEU . 23.7 m -122.67 -98.16 0.44 Allowed 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.671 ' HA ' HG21 ' A' ' 227' ' ' THR . 3.7 m120 -160.45 68.14 0.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.065 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 15.4 tp -29.73 -97.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.843 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -56.77 -19.97 19.81 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.973 -1.079 . . . . 0.0 111.106 -178.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.64 ' CB ' ' HB3' ' A' ' 194' ' ' ASN . 12.9 tp -60.15 -62.29 1.97 Allowed 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 117.146 -1.821 . . . . 0.0 107.517 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.837 HG21 HD23 ' A' ' 164' ' ' LEU . 1.7 t -71.32 -8.12 10.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.09 -58.09 3.47 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.56 -14.68 61.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.598 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 15.2 t60 -68.32 -48.93 63.57 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 117.878 -1.529 . . . . 0.0 107.913 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.813 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 1.3 mt-10 -80.39 -45.87 16.98 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 111.092 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.885 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -62.14 -30.99 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.71 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.88 -31.55 55.52 Favored Glycine 0 C--N 1.291 -1.933 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.5 -49.62 76.0 Favored 'General case' 0 C--N 1.289 -2.03 0 O-C-N 121.965 -0.726 . . . . 0.0 110.952 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.519 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 42.5 m -86.25 -53.05 5.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.065 -1.022 . . . . 0.0 112.206 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.889 HD22 ' CE2' ' A' ' 132' ' ' PHE . 3.1 pp -104.54 24.7 11.27 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.123 . . . . 0.0 110.605 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.965 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -127.02 -79.57 0.3 Allowed Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.123 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.02 -162.25 0.36 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.961 -1.317 . . . . 0.0 110.233 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.781 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.7 t80 -99.61 -72.64 0.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.78 . . . . 0.0 109.538 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.588 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 68.3 m80 -161.13 101.79 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 4.0 m -93.33 -178.12 4.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.371 -0.83 . . . . 0.0 109.247 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.764 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.9 86.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.95 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -89.66 10.18 24.2 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.576 -178.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.4 -28.1 4.77 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 175.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.538 ' C ' ' HB2' ' A' ' 235' ' ' SER . 5.4 mt-10 -116.25 -36.05 4.16 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.95 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.72 -170.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.383 1.087 . . . . 0.0 112.813 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.875 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -90.44 -16.12 29.61 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.146 -177.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.594 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -78.38 -7.39 57.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 119.119 -2.238 . . . . 0.0 112.105 -177.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.9 t80 -137.29 15.65 0.04 OUTLIER Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 120.526 -1.358 . . . . 0.0 113.604 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.43 -37.0 0.79 Allowed 'Trans proline' 0 C--N 1.319 -0.986 0 N-CA-C 108.473 -1.395 . . . . 0.0 108.473 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.781 ' CD2' HG22 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -21.47 -59.21 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.202 -179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' HIS . 38.5 t80 -68.0 56.77 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.084 -1.01 . . . . 0.0 109.384 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.3 t-80 179.16 -124.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 108.981 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.45 ' HB3' ' OG1' ' A' ' 190' ' ' THR . 18.4 m -161.0 121.63 2.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.787 -1.196 . . . . 0.0 109.426 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER 179.38 43.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 110.102 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -99.93 -10.45 21.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 108.815 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.609 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 24.3 t70 179.62 -25.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 109.923 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.845 HD11 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -25.74 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.809 -0.557 . . . . 0.0 111.399 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.34 -6.09 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.731 -1.23 . . . . 0.0 110.261 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.55 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -117.67 -38.18 3.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.001 -1.062 . . . . 0.0 109.069 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.658 ' HA ' HD23 ' A' ' 226' ' ' LEU . 13.3 p90 1.04 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.829 0.824 . . . . 0.0 112.947 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.515 ' CD ' ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 178.34 174.62 0.59 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.359 -0.838 . . . . 0.0 109.657 178.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.027 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.9 mp -91.18 168.99 11.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.234 -0.916 . . . . 0.0 110.707 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.722 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 30.2 t -101.87 -169.88 1.74 Allowed 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.188 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.51 ' N ' ' OG ' ' A' ' 235' ' ' SER . 12.5 tm0? -85.25 -12.65 51.98 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.478 -0.764 . . . . 0.0 109.911 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.771 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.2 OUTLIER -84.69 -47.79 10.11 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.684 ' O ' HG22 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -66.71 -36.96 83.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 117.408 -1.717 . . . . 0.0 106.626 177.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.601 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -58.0 -35.05 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -67.91 -50.79 54.12 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -55.94 -55.07 30.99 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.084 HG21 HG21 ' A' ' 127' ' ' VAL . 1.6 tp -63.44 -43.37 98.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.83 -1.394 . . . . 0.0 109.589 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.2 mt-30 -54.13 -31.35 52.03 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.0 p -75.5 -22.35 57.25 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.838 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -66.84 -64.57 0.83 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.596 ' CD2' ' HB2' ' A' ' 130' ' ' LEU . 5.7 t80 -100.32 -115.69 0.17 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.983 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 129' ' ' PRO . . . 121.09 177.1 15.55 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 120.247 -1.533 . . . . 0.0 109.902 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.2 146.14 45.33 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.946 1.498 . . . . 0.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.66 142.75 36.53 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.132 1.596 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.47 -59.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.013 1.533 . . . . 0.0 110.125 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 252' ' ' SER . 0.4 OUTLIER -161.66 -64.98 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.531 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 251' ' ' ASP . 41.6 t -44.68 105.28 0.44 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.51 -24.25 19.18 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.953 1.501 . . . . 0.0 110.112 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -145.52 171.1 15.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.538 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.51 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.985 ' CG2' HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.538 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.742 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.255 0.55 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -78.53 -148.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.477 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 84' ' ' ARG . 10.2 t -50.0 179.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -73.53 112.59 16.72 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.1 Cg_endo -72.67 141.88 35.01 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.877 1.462 . . . . 0.0 110.141 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.07 -53.43 2.53 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.2 pp -151.94 144.85 17.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.243 -1.151 . . . . 0.0 109.534 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.21 -167.99 0.35 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.006 1.53 . . . . 0.0 109.894 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.766 ' CD ' ' HB1' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -89.45 -93.41 0.11 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.125 -0.985 . . . . 0.0 109.644 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.649 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 69.6 m95 -73.87 155.6 38.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 109.742 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.1 -34.55 2.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.776 ' O ' HD11 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -55.17 -165.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.264 -0.897 . . . . 0.0 109.548 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.57 ' HA ' HD11 ' A' ' 130' ' ' LEU . 66.2 p -124.33 4.24 8.44 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.426 -0.796 . . . . 0.0 109.607 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.571 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 59.4 m80 -148.15 97.08 2.73 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.451 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.679 HD22 ' N ' ' A' ' 97' ' ' LEU . 3.4 mm? -97.5 175.02 6.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.681 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.634 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -142.64 155.7 44.97 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.232 -0.918 . . . . 0.0 108.569 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.905 ' CE2' HD11 ' A' ' 101' ' ' ILE . 24.6 p90 -133.49 171.07 14.58 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.794 -1.192 . . . . 0.0 109.233 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.541 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -131.35 145.87 52.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 109.412 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.905 HD11 ' CE2' ' A' ' 99' ' ' TYR . 1.6 mp -100.22 61.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.965 -1.084 . . . . 0.0 109.353 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 144' ' ' ILE . 18.1 t -73.86 2.44 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 0.0 110.021 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.605 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -101.45 164.37 11.8 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.804 -1.185 . . . . 0.0 109.025 179.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.633 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.2 p90 177.94 46.37 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.893 HG21 ' NE1' ' A' ' 186' ' ' TRP . 24.8 p -40.15 149.88 0.28 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.595 -0.69 . . . . 0.0 109.36 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.23 -25.77 42.67 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.946 1.498 . . . . 0.0 109.044 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -65.76 -12.16 51.72 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 187' ' ' THR . 32.3 mt -138.53 124.02 12.28 Favored Pre-proline 0 N--CA 1.484 1.251 0 O-C-N 121.543 -0.723 . . . . 0.0 109.827 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.3 Cg_endo -65.6 167.35 17.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 123.773 1.407 . . . . 0.0 108.867 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.504 ' O ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -37.8 -65.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.747 0.784 . . . . 0.0 110.263 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -28.57 49.73 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.75 -0.594 . . . . 0.0 111.725 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.776 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.19 -61.15 1.92 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.487 -1.383 . . . . 0.0 109.448 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.6 p -51.19 -39.4 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.535 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -66.33 -26.22 67.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.717 ' OG ' HD21 ' A' ' 195' ' ' LEU . 13.9 p -67.35 -37.37 83.14 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.071 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -75.18 -34.81 61.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.331 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.872 HG13 HG13 ' A' ' 144' ' ' ILE . 3.5 t -74.94 -23.72 17.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 1.8 tt0 -85.82 -36.33 20.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.721 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -79.41 -38.84 33.87 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.767 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -63.49 -61.65 2.19 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.85 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -51.56 -40.91 60.63 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.128 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.739 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -76.72 -33.64 58.17 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.738 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.07 HG21 ' CE1' ' A' ' 196' ' ' PHE . 2.1 t -56.19 -40.8 67.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.033 ' O ' HG23 ' A' ' 128' ' ' THR . 44.4 m95 -91.43 -24.8 19.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.316 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 9.6 tm-20 -69.55 -27.45 65.16 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.757 -1.214 . . . . 0.0 107.996 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.2 pt-20 -89.9 -42.89 10.95 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.674 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.027 HG13 ' O ' ' A' ' 123' ' ' VAL . 15.3 m -59.8 -24.11 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 118.259 -1.376 . . . . 0.0 109.159 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.033 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.93 162.94 20.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.012 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -84.46 1.54 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.249 1.966 . . . . 0.0 110.116 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.155 HD13 ' CD1' ' A' ' 246' ' ' TYR . 0.2 OUTLIER -80.92 -176.16 5.75 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.026 -1.046 . . . . 0.0 110.603 -178.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.3 p -121.71 165.55 15.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.778 . . . . 0.0 109.947 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.826 ' CZ ' HD22 ' A' ' 207' ' ' LEU . 0.6 OUTLIER -140.93 158.22 44.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.426 -0.796 . . . . 0.0 109.698 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.58 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.5 m -146.59 179.6 7.44 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.897 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -148.12 -179.76 7.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.805 -1.184 . . . . 0.0 110.246 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.069 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -163.61 -130.63 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 27.2 t80 178.24 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.833 -1.167 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -162.61 -171.81 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 37.66 -99.19 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 178.46 107.27 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.271 -1.135 . . . . 0.0 110.296 179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 1.069 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -59.91 -150.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.202 -0.937 . . . . 0.0 108.745 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.827 ' C ' HD12 ' A' ' 142' ' ' ILE . 80.0 m-20 -88.06 -34.43 17.96 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.883 HG12 HD23 ' A' ' 207' ' ' LEU . 2.8 mp -124.23 77.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.532 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 2.8 ptm -67.54 102.87 1.22 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.669 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.872 HG13 HG13 ' A' ' 117' ' ' VAL . 5.1 mm -81.98 117.33 27.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -133.19 156.58 47.24 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.429 -1.42 . . . . 0.0 112.119 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 39.6 p90 -79.94 133.61 36.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.474 -0.767 . . . . 0.0 109.14 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.912 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -155.92 -178.08 7.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.958 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.0 OUTLIER 179.78 -155.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.44 -179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.815 ' N ' HG13 ' A' ' 148' ' ' VAL . 2.8 mtm-85 -52.2 84.45 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.462 -0.774 . . . . 0.0 109.641 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 148' ' ' VAL . 2.6 tm-20 179.68 30.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 79.9 m80 -92.91 -142.4 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.893 . . . . 0.0 108.897 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -103.03 -54.72 0.84 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.71 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.826 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -94.28 6.81 47.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 110.005 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -149.43 42.44 0.25 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.046 . . . . 0.0 110.156 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 41.9 Cg_endo -72.39 121.47 7.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.526 1.277 . . . . 0.0 109.208 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.733 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -98.24 -170.43 1.96 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.912 -1.118 . . . . 0.0 111.257 -178.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 158' ' ' ASP . 15.5 p30 178.5 62.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 183' ' ' ASP . . . -18.86 -59.0 0.01 OUTLIER Glycine 0 N--CA 1.501 2.982 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 183' ' ' ASP . 37.9 Cg_endo -65.87 60.19 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.297 1.156 . . . . 0.0 109.743 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -177.42 164.07 33.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 164' ' ' LEU . 0.6 OUTLIER -45.56 -59.95 2.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.312 -1.111 . . . . 0.0 110.123 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.653 ' CG1' ' CE1' ' A' ' 157' ' ' PHE . 61.0 t -33.85 90.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.354 0.597 . . . . 0.0 110.88 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.021 HD22 HD13 ' A' ' 222' ' ' LEU . 1.1 mp -80.08 -75.48 0.26 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.238 -0.914 . . . . 0.0 112.186 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.998 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -145.64 -168.25 2.92 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.196 -1.565 . . . . 0.0 111.38 -178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.733 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.0 OUTLIER 179.67 -179.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 119.957 -1.714 . . . . 0.0 111.133 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -154.75 177.61 11.06 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.536 -0.728 . . . . 0.0 110.23 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 1.009 ' CD1' HD11 ' A' ' 174' ' ' ILE . 76.7 m-85 -114.39 -167.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.16 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.953 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -171.21 -60.51 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 0.0 109.495 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.953 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.6 Cg_endo -77.29 147.97 26.46 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.796 1.419 . . . . 0.0 109.875 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 118.83 -178.75 16.75 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 174' ' ' ILE . 44.1 Cg_endo -75.97 -90.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.063 1.559 . . . . 0.0 110.284 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.16 -33.25 21.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 1.009 HD11 ' CD1' ' A' ' 168' ' ' TYR . 1.9 tt -62.16 -7.75 2.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.352 -1.087 . . . . 0.0 108.8 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 169' ' ' ALA . 50.7 p-10 -67.29 65.92 0.07 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.127 -0.983 . . . . 0.0 109.405 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 128.74 78.7 0.23 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.1 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -152.16 115.15 4.65 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.217 -1.166 . . . . 0.0 107.975 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.646 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -106.31 164.83 11.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.262 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.912 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -155.96 133.77 11.16 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.571 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.573 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 12.2 m-85 -96.55 135.94 37.75 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.958 ' OD1' HG23 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -58.02 115.81 3.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.788 -1.195 . . . . 0.0 107.985 177.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.484 ' OD1' ' HB ' ' A' ' 148' ' ' VAL . 11.9 p-10 -83.91 13.51 4.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.887 -1.133 . . . . 0.0 109.719 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.889 ' HB2' HG21 ' A' ' 148' ' ' VAL . 2.0 t70 -121.05 14.09 11.4 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.076 -1.015 . . . . 0.0 110.725 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.542 ' OE2' HD11 ' A' ' 164' ' ' LEU . 15.7 tt0 -117.66 -132.1 0.32 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 120.814 -1.179 . . . . 0.0 108.944 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.612 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.9 mt-30 -122.1 166.57 14.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 109.111 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.893 ' NE1' HG21 ' A' ' 105' ' ' THR . 94.5 m95 -159.42 107.44 1.78 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.076 -1.015 . . . . 0.0 110.152 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.821 ' HA ' HD21 ' A' ' 108' ' ' LEU . 19.6 p -135.35 153.52 51.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.849 -1.157 . . . . 0.0 109.533 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.665 ' HA ' HD22 ' A' ' 195' ' ' LEU . 1.6 pttt -76.79 -28.97 55.84 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.645 ' OD2' HD12 ' A' ' 229' ' ' LEU . 0.3 OUTLIER -99.85 -151.18 0.39 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.87 ' HB ' HD11 ' A' ' 229' ' ' LEU . 10.2 t -105.71 45.4 0.97 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.459 ' HB ' HG21 ' A' ' 187' ' ' THR . 87.6 m -99.77 -31.25 11.62 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.394 -0.816 . . . . 0.0 111.204 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.537 ' N ' HG21 ' A' ' 187' ' ' THR . . . -118.21 -96.75 1.81 Allowed Glycine 0 N--CA 1.493 2.453 0 C-N-CA 118.804 -1.665 . . . . 0.0 109.064 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.768 ' CG2' HD21 ' A' ' 164' ' ' LEU . 48.3 m -104.31 -106.22 0.29 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.706 ' CB ' ' HB3' ' A' ' 197' ' ' LEU . 10.5 m120 -159.14 74.23 0.63 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.93 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.9 OUTLIER -27.01 -95.61 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.661 0.743 . . . . 0.0 112.55 -178.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 1.07 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -64.34 -12.17 39.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.013 -1.054 . . . . 0.0 110.983 -176.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 1.082 ' CD2' ' HH2' ' A' ' 3' ' ' MSB . 5.5 tt -62.03 -62.08 2.03 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 117.884 -1.526 . . . . 0.0 107.078 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.998 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 39.4 t -72.79 -9.32 12.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.071 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.88 -57.43 3.8 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.599 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.38 -15.38 62.52 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.76 ' HB2' ' HH3' ' A' ' 3' ' ' MSB . 20.5 t60 -68.74 -46.13 69.67 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.962 -1.495 . . . . 0.0 107.81 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.761 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 1.3 mt-10 -82.32 -47.42 12.38 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.046 -1.034 . . . . 0.0 110.834 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.785 HG21 ' HA ' ' A' ' 121' ' ' LEU . 2.3 mt -61.48 -31.46 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.675 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.0 -33.29 46.09 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.55 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -61.93 -49.52 75.81 Favored 'General case' 0 C--N 1.29 -1.978 0 O-C-N 121.819 -0.813 . . . . 0.0 110.798 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.522 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 27.4 p -83.73 -56.88 3.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 112.2 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.883 HD23 HG12 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -104.16 22.94 13.83 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.016 -1.052 . . . . 0.0 110.84 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 1.117 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -121.71 -78.92 0.5 Allowed Glycine 0 C--N 1.291 -1.923 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.938 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.4 pp -167.5 -160.09 0.34 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.019 -1.283 . . . . 0.0 109.76 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.772 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.0 OUTLIER -98.12 -73.24 0.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.585 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.1 m-70 -163.01 93.49 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.913 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.645 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -81.78 179.33 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.362 -0.836 . . . . 0.0 109.806 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.871 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.53 83.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.944 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -87.0 12.06 12.17 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.861 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -49.78 -28.25 6.01 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 175.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.527 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.1 mp0 -116.29 -36.16 4.11 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.944 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.45 -164.72 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.292 1.044 . . . . 0.0 112.681 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.05 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.1 OUTLIER -99.85 -13.01 19.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.074 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.585 ' HG2' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -80.3 -6.63 58.25 Favored 'General case' 0 C--N 1.293 -1.883 0 O-C-N 119.552 -1.967 . . . . 0.0 111.978 -177.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.649 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.2 OUTLIER -137.53 14.57 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 120.617 -1.302 . . . . 0.0 113.502 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.649 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 54.2 Cg_endo -77.41 -42.05 0.31 Allowed 'Trans proline' 0 C--N 1.32 -0.944 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 1.021 HD13 HD22 ' A' ' 164' ' ' LEU . 4.0 tp -0.26 -73.31 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 CA-C-O 121.494 0.664 . . . . 0.0 111.039 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.541 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 9.8 t80 -67.46 58.4 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 109.754 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.2 OUTLIER 179.57 172.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.09 -1.006 . . . . 0.0 109.778 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.8 128.83 55.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.253 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 228' ' ' ASP . 0.3 OUTLIER 178.83 -73.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.835 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 1.008 HG21 HD22 ' A' ' 218' ' ' LEU . 1.5 p -66.44 53.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 0.0 110.442 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 226' ' ' LEU . 5.0 m-20 -162.54 -53.3 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.87 HD11 ' HB ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -60.74 -142.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.491 -0.755 . . . . 0.0 109.458 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 2.4 p -94.46 -22.76 18.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 0.0 110.049 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -79.97 -16.55 54.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 108.786 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.601 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 23.2 p90 -30.75 106.23 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.602 0.715 . . . . 0.0 111.291 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.532 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 7.6 ttt-85 -161.04 153.15 20.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.214 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.967 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.8 mp -77.65 173.94 11.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.281 -0.887 . . . . 0.0 110.463 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 21.7 t -102.81 -172.0 2.05 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.909 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.38 -12.89 53.67 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.778 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.871 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.6 m-20 -84.11 -49.28 9.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.769 -1.207 . . . . 0.0 108.15 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.938 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.68 -39.48 93.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 117.197 -1.801 . . . . 0.0 106.616 178.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.643 HD13 ' O ' ' A' ' 235' ' ' SER . 0.8 OUTLIER -55.19 -36.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.47 -56.92 8.66 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.646 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -52.23 -51.58 40.94 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.117 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.8 tp -63.86 -47.93 88.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.85 -1.382 . . . . 0.0 109.656 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.588 ' N ' HG23 ' A' ' 242' ' ' ILE . 21.3 tt0 -53.58 -28.29 31.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 t -82.42 -18.12 42.98 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.796 ' HB3' HD12 ' A' ' 242' ' ' ILE . 5.7 tt -73.3 -60.57 2.18 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 1.155 ' CD1' HD13 ' A' ' 130' ' ' LEU . 11.1 m-85 -88.65 -112.97 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.445 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.477 ' N ' ' HD3' ' A' ' 248' ' ' PRO . . . 46.78 54.11 9.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.61 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 37.5 Cg_endo -71.86 -30.35 14.22 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 124.008 1.531 . . . . 0.0 112.136 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 44.4 Cg_endo -76.09 113.47 3.71 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 N-CA-C 109.751 -0.904 . . . . 0.0 109.751 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.55 -90.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.909 1.478 . . . . 0.0 110.126 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.22 -41.1 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.467 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 255' ' ' THR . 58.2 m -144.03 82.16 11.16 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.393 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.31 -24.13 19.98 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.053 1.554 . . . . 0.0 110.133 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.14 64.98 8.87 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 0.0 109.423 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 252' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.555 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.568 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.539 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 1.082 ' HH2' ' CD2' ' A' ' 197' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 212' ' ' SER . 12.2 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.321 0.581 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 85' ' ' THR . 4.7 ptp85 -123.61 -148.85 0.41 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.482 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.5 ' N ' ' HG3' ' A' ' 84' ' ' ARG . 8.7 t -51.65 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.59 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 210' ' ' PHE . 2.3 p90 -107.01 138.56 19.86 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.563 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -72.76 95.78 0.82 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.995 1.523 . . . . 0.0 110.053 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.3 -77.83 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mt -143.45 131.33 10.98 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.123 . . . . 0.0 109.541 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -73.01 -172.26 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.962 1.506 . . . . 0.0 109.916 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.756 ' H ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -99.48 -82.94 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.132 -0.98 . . . . 0.0 109.571 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.465 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 72.7 m95 -107.27 169.13 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.963 -1.085 . . . . 0.0 109.617 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -135.4 -36.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.598 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.84 ' HE3' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -47.58 177.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.285 -0.884 . . . . 0.0 109.848 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.735 ' HA ' HD22 ' A' ' 130' ' ' LEU . 71.2 p -116.7 5.58 13.19 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.404 -0.81 . . . . 0.0 109.501 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.527 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 4.5 m-70 -126.63 91.14 3.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.99 -1.069 . . . . 0.0 110.073 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.84 HD13 ' HE3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -99.31 158.29 15.81 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.6 -0.688 . . . . 0.0 109.988 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.595 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -129.54 154.86 46.62 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.674 ' CE2' HD11 ' A' ' 101' ' ' ILE . 3.0 p90 -140.77 167.69 21.58 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.724 -1.235 . . . . 0.0 109.364 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.63 ' CZ ' ' CD1' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -132.12 138.11 47.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.095 . . . . 0.0 109.47 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.766 HG22 ' O ' ' A' ' 101' ' ' ILE . 1.5 mp -93.32 66.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.14 -0.975 . . . . 0.0 109.746 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.593 ' N ' ' O ' ' A' ' 144' ' ' ILE . 6.0 t -78.38 8.82 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.354 -0.841 . . . . 0.0 109.93 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.988 ' C ' HG21 ' A' ' 113' ' ' VAL . 8.5 m120 -105.35 153.25 21.9 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.0 -1.062 . . . . 0.0 109.392 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.785 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER 178.68 41.04 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.717 -0.614 . . . . 0.0 109.697 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.445 ' C ' ' O ' ' A' ' 104' ' ' TYR . 61.4 p -41.57 156.1 0.22 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.42 -0.8 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.91 -22.87 41.73 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.877 1.462 . . . . 0.0 108.754 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.688 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -72.04 -6.3 41.34 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.111 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.077 HD13 ' CD2' ' A' ' 195' ' ' LEU . 83.1 mt -143.5 116.48 5.91 Favored Pre-proline 0 N--CA 1.486 1.332 0 O-C-N 121.517 -0.74 . . . . 0.0 109.707 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.68 171.48 9.58 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 O-C-N 123.856 1.45 . . . . 0.0 109.06 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.01 -65.38 0.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.84 0.829 . . . . 0.0 110.295 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 115' ' ' SER . 26.0 t0 -57.43 -28.23 63.12 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.821 -0.549 . . . . 0.0 112.419 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.889 ' O ' HD21 ' A' ' 195' ' ' LEU . . . -73.18 -61.95 1.64 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.248 -1.532 . . . . 0.0 109.265 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.988 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.8 p -54.25 -40.67 48.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 1.0 OUTLIER -64.9 -27.86 69.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 112' ' ' ALA . 1.2 p -62.14 -41.84 98.67 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.036 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -73.72 -34.16 64.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.006 -1.059 . . . . 0.0 110.639 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.955 HG13 HG13 ' A' ' 144' ' ' ILE . 5.8 t -74.36 -24.08 18.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -91.64 -34.82 14.53 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -79.02 -37.48 39.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.828 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -67.36 -62.02 1.63 Allowed 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.848 HD11 ' CG ' ' A' ' 132' ' ' PHE . 8.1 tp -49.67 -45.04 48.26 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.78 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.1 OUTLIER -73.41 -34.72 65.65 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.798 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.0 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -55.53 -40.6 59.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.066 ' CH2' HD21 ' A' ' 234' ' ' LEU . 51.0 m95 -92.27 -20.01 21.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.091 -1.005 . . . . 0.0 110.517 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 37.1 tt0 -75.24 -27.58 59.55 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.879 -1.138 . . . . 0.0 108.018 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 7.5 pt-20 -90.15 -45.19 9.28 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.551 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.0 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.5 m -57.3 -27.07 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.447 -1.301 . . . . 0.0 108.357 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.753 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -121.22 155.86 58.01 Favored Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 119.077 -1.049 . . . . 0.0 109.223 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.556 ' CG ' ' HD2' ' A' ' 248' ' ' PRO . 48.6 Cg_endo -77.49 25.95 0.48 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.091 1.86 . . . . 0.0 111.946 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' A' ' 95' ' ' THR . 5.0 mt -100.89 169.86 8.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.461 -1.399 . . . . 0.0 110.093 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.5 p -119.12 166.45 12.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.848 ' CG ' HD11 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -141.18 159.44 42.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 110.117 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -155.9 122.4 5.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 108.746 179.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 3.2 ppt_? -108.38 174.59 5.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.978 -1.076 . . . . 0.0 110.64 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.81 -95.36 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.699 -0.625 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CD1' ' CZ ' ' A' ' 100' ' ' ARG . 3.5 t80 177.51 33.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.141 -0.975 . . . . 0.0 109.098 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.484 ' H ' HD13 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -76.57 179.43 5.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -45.75 -42.3 10.77 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 140' ' ' ALA . 2.0 pt-20 -176.13 105.02 0.07 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -1.102 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.595 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.14 -150.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 0.0 109.29 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 176' ' ' GLY . 45.3 t0 -81.28 -35.8 30.64 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 207' ' ' LEU . 51.6 mt -127.97 81.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.415 ' CE ' HG21 ' A' ' 102' ' ' VAL . 2.6 ttt -67.13 100.26 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.955 HG13 HG13 ' A' ' 117' ' ' VAL . 6.1 mm -82.26 115.02 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.04 -1.037 . . . . 0.0 108.348 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.3 OUTLIER -134.11 159.22 41.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.37 -1.456 . . . . 0.0 112.447 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.501 ' CA ' ' ND2' ' A' ' 103' ' ' ASN . 13.2 p90 -100.17 133.09 45.09 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.716 -0.615 . . . . 0.0 110.252 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.168 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -160.28 -159.07 0.67 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.096 -1.003 . . . . 0.0 110.724 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 149' ' ' ARG . 2.3 p -166.38 -170.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 120.979 -1.076 . . . . 0.0 109.185 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.741 ' H ' HG22 ' A' ' 148' ' ' VAL . 7.9 ptt-85 -40.67 -26.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.167 -0.958 . . . . 0.0 110.172 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.63 ' H ' HG13 ' A' ' 148' ' ' VAL . 7.1 tp10 -40.83 -60.61 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 151' ' ' HIS . 1.6 p-80 -69.5 109.62 4.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.097 -1.002 . . . . 0.0 109.502 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.96 126.15 6.22 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 179.74 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -1.087 . . . . 0.0 109.484 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -158.75 -36.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.73 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.552 ' HB3' ' CE1' ' A' ' 166' ' ' HIS . 3.5 m-85 -139.8 74.67 32.06 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.978 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.94 155.58 52.99 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.936 1.493 . . . . 0.0 109.474 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.778 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 5.5 m-85 -113.42 -169.64 1.54 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.105 -0.997 . . . . 0.0 110.282 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.641 ' OD2' HG21 ' A' ' 163' ' ' VAL . 9.5 p30 178.96 61.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.574 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -10.88 -63.76 0.01 OUTLIER Glycine 0 N--CA 1.506 3.341 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 38.4 Cg_endo -67.23 59.16 0.65 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.573 1.302 . . . . 0.0 109.692 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -173.81 146.65 8.9 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -41.95 -27.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -1.052 . . . . 0.0 110.019 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.641 HG21 ' OD2' ' A' ' 158' ' ' ASP . 2.8 t -52.44 82.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.519 -0.738 . . . . 0.0 110.781 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.073 HD21 HG21 ' A' ' 193' ' ' THR . 0.7 OUTLIER -70.59 -81.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.346 -0.846 . . . . 0.0 111.619 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.866 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -145.33 -179.63 6.77 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.65 -1.281 . . . . 0.0 111.409 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.778 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 2.0 p-80 179.28 162.39 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.808 -1.807 . . . . 0.0 110.383 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -131.43 -167.99 1.94 Allowed 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.191 -0.943 . . . . 0.0 110.418 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 206' ' ' SER . 95.4 m-85 -125.37 -163.05 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 0.0 110.344 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.009 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -172.23 -60.59 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 109.294 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 1.009 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.6 Cg_endo -76.57 118.56 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.831 1.437 . . . . 0.0 109.981 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 148.22 173.94 19.56 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -74.47 -91.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.128 1.594 . . . . 0.0 110.146 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -73.64 -28.16 65.88 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -75.32 8.29 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -1.149 . . . . 0.0 108.407 178.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 169' ' ' ALA . 20.5 p-10 -65.83 64.33 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.584 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 112.41 97.57 2.34 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -160.11 124.23 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.755 -1.439 . . . . 0.0 107.62 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.811 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.01 159.2 17.02 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 108.589 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.168 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -156.96 131.53 8.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.591 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.574 ' HB3' ' CH2' ' A' ' 186' ' ' TRP . 37.0 m-85 -93.08 142.45 27.28 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.188 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.718 ' OD1' HG23 ' A' ' 148' ' ' VAL . 5.7 t0 -64.39 144.12 57.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.451 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 4.6 p30 -109.91 24.23 13.31 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.637 -1.289 . . . . 0.0 110.139 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.574 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 20.1 m-20 -131.06 15.41 5.17 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.044 -1.035 . . . . 0.0 110.305 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.478 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 7.6 tt0 -118.95 -132.88 0.32 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.598 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 88.6 mt-30 -114.44 163.04 15.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.821 -1.174 . . . . 0.0 108.514 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.598 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 98.8 m95 -158.44 105.37 1.87 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.93 -1.106 . . . . 0.0 110.398 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.967 ' HA ' HD21 ' A' ' 108' ' ' LEU . 80.8 p -146.6 154.25 41.28 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.352 -0.843 . . . . 0.0 109.399 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 227' ' ' THR . 4.5 pttm -81.06 -30.31 34.81 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.486 ' C ' ' CD1' ' A' ' 229' ' ' LEU . 3.2 t70 -98.17 -148.13 0.33 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.609 ' N ' ' CD1' ' A' ' 229' ' ' LEU . 12.8 t -99.86 37.48 1.61 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.531 HG22 HG21 ' A' ' 187' ' ' THR . 21.4 m -86.23 -35.61 19.91 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.436 -0.79 . . . . 0.0 111.072 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.626 ' N ' HG21 ' A' ' 187' ' ' THR . . . -133.75 -95.78 0.56 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.612 -1.756 . . . . 0.0 109.706 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.073 HG21 HD21 ' A' ' 164' ' ' LEU . 77.5 m -100.83 -108.35 0.22 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.709 ' HA ' HG21 ' A' ' 227' ' ' THR . 34.2 m-80 -159.52 71.55 0.5 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.077 ' CD2' HD13 ' A' ' 108' ' ' LEU . 7.9 tp -29.29 -96.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.342 0.591 . . . . 0.0 111.671 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.854 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -49.89 -24.2 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.071 . . . . 0.0 111.391 -178.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.99 HD11 ' CG ' ' A' ' 221' ' ' PRO . 13.8 tp -58.05 -61.3 2.65 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 117.381 -1.727 . . . . 0.0 107.807 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.866 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 1.4 t -73.59 -5.65 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 119.387 -0.925 . . . . 0.0 108.816 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.014 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.14 -57.67 3.66 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.698 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.55 -17.26 64.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.606 ' CE1' ' HA ' ' A' ' 219' ' ' MET . 3.3 t-160 -69.59 -41.76 75.36 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 117.079 -1.848 . . . . 0.0 108.135 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.834 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 0.8 OUTLIER -83.4 -49.52 9.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.006 -1.059 . . . . 0.0 110.464 179.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.8 mt -59.11 -31.62 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.719 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.41 -34.85 39.04 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.349 -1.9 . . . . 0.0 108.349 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -58.49 -48.49 80.63 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.8 -0.823 . . . . 0.0 110.744 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.553 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 68.7 p -87.0 -55.74 3.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 112.104 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.915 ' HB2' HD11 ' A' ' 142' ' ' ILE . 0.6 OUTLIER -103.95 31.3 4.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.256 -0.902 . . . . 0.0 110.095 -177.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.767 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -135.04 -80.97 0.13 Allowed Glycine 0 C--N 1.294 -1.804 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.842 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -169.07 -165.9 0.58 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.051 -1.264 . . . . 0.0 110.352 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.711 ' N ' HD12 ' A' ' 209' ' ' LEU . 75.7 t80 -93.53 -83.91 0.31 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.516 -0.74 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.572 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 1.3 m-70 -151.61 122.64 7.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.651 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.642 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -113.13 -178.11 3.3 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.22 -0.925 . . . . 0.0 109.388 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.91 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -60.87 85.92 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.963 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -91.0 12.39 19.88 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.395 -1.322 . . . . 0.0 112.115 -177.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.444 ' C ' ' O ' ' A' ' 214' ' ' ASN . 1.7 p -50.74 -27.74 7.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 174.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.51 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.6 mm-40 -116.6 -35.59 4.18 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.706 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.963 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -59.02 -150.59 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 122.076 0.941 . . . . 0.0 112.755 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.983 ' HB2' HD13 ' A' ' 234' ' ' LEU . 0.1 OUTLIER -115.71 -13.29 11.45 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.776 -177.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.606 ' HA ' ' CE1' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -81.38 -7.01 59.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.312 -2.117 . . . . 0.0 111.799 -178.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER -134.08 13.37 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 120.594 -1.316 . . . . 0.0 113.475 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.99 ' CG ' HD11 ' A' ' 197' ' ' LEU . 51.3 Cg_endo -76.26 -36.07 2.01 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 N-CA-C 109.099 -1.154 . . . . 0.0 109.099 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 1.036 HD12 HD12 ' A' ' 164' ' ' LEU . 1.6 tt -17.41 -63.5 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.291 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.942 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.5 OUTLIER -68.02 54.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 222' ' ' LEU . 33.1 t60 178.77 -129.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.219 -0.926 . . . . 0.0 108.658 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -154.29 136.46 14.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.799 -1.188 . . . . 0.0 108.913 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.773 ' N ' HD21 ' A' ' 229' ' ' LEU . 0.1 OUTLIER 179.53 37.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.023 -1.048 . . . . 0.0 110.704 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -103.83 -28.74 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 108.825 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.597 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 7.6 t70 -172.26 3.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.272 -0.892 . . . . 0.0 110.792 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.804 ' N ' HD13 ' A' ' 229' ' ' LEU . 0.1 OUTLIER -44.55 -51.98 8.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.821 -1.175 . . . . 0.0 108.99 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.74 -28.99 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.557 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.8 mtp180 -104.0 -39.74 6.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.474 -0.766 . . . . 0.0 109.43 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.597 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 21.9 p90 0.59 109.7 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.349 0.595 . . . . 0.0 112.443 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.79 177.27 0.49 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.425 -0.797 . . . . 0.0 109.316 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.066 HD21 ' CH2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -89.52 175.04 7.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.009 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.87 ' H ' HD12 ' A' ' 234' ' ' LEU . 16.4 t -111.96 -169.22 1.43 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.131 -0.981 . . . . 0.0 110.257 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.546 ' N ' ' OG ' ' A' ' 235' ' ' SER . 68.1 tp60 -84.49 -15.79 44.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.495 -0.753 . . . . 0.0 110.575 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.91 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 5.4 m-20 -84.25 -46.44 11.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.505 -1.372 . . . . 0.0 108.339 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.842 ' OD1' HD11 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -67.55 -35.77 79.69 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 117.381 -1.728 . . . . 0.0 106.543 177.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 234' ' ' LEU . 0.5 OUTLIER -58.67 -34.78 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -45.96 73.91 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -63.88 -50.58 60.05 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -70.74 -47.81 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.723 -1.457 . . . . 0.0 109.586 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.594 ' N ' HG23 ' A' ' 242' ' ' ILE . 40.4 tt0 -53.98 -29.49 43.25 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.8 t -77.21 -22.47 52.27 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.767 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -64.66 -63.37 1.14 Allowed 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.219 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.663 ' CD1' HD11 ' A' ' 130' ' ' LEU . 24.1 m-85 -101.08 -127.99 0.21 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.542 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 64.09 79.56 0.16 Allowed Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.149 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 129' ' ' PRO . 42.9 Cg_endo -75.69 173.38 14.59 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.993 1.522 . . . . 0.0 109.58 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 41.4 Cg_endo -72.13 110.35 2.92 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.847 1.446 . . . . 0.0 110.079 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 41.0 Cg_endo -75.6 -79.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.984 1.518 . . . . 0.0 110.566 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 252' ' ' SER . 1.0 OUTLIER -42.38 -64.62 0.57 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.295 -0.878 . . . . 0.0 109.903 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.495 ' N ' ' OD1' ' A' ' 251' ' ' ASP . 1.5 m -42.79 102.13 0.27 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.264 -0.897 . . . . 0.0 109.693 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 251' ' ' ASP . 42.9 Cg_endo -73.68 -30.65 9.39 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.982 1.517 . . . . 0.0 110.06 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 253' ' ' PRO . 4.0 tt0 -43.74 119.47 1.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.542 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.493 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.578 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.525 ' HE1' ' HB2' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 1.009 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -69.91 -158.13 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.556 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 t -45.4 163.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.374 -0.829 . . . . 0.0 109.59 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -95.88 116.19 66.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.874 . . . . 0.0 109.477 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.65 153.62 54.38 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.87 1.458 . . . . 0.0 110.059 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 128.44 -114.96 1.92 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.3 mm -87.86 123.91 68.16 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.257 -1.143 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.66 -161.07 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.876 1.461 . . . . 0.0 110.12 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.677 ' CB ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -117.99 -89.0 0.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.367 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.603 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 90.3 m95 -90.2 148.69 22.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.167 -0.958 . . . . 0.0 110.38 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -126.31 -32.67 2.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.0 109.346 179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.786 ' O ' HD13 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -51.57 -170.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.462 -0.774 . . . . 0.0 110.129 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.626 ' HA ' HD22 ' A' ' 130' ' ' LEU . 21.7 p -116.93 -0.05 12.32 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.576 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 40.1 m80 -146.96 93.2 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.974 -1.079 . . . . 0.0 110.599 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.789 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.8 mm? -82.91 177.62 8.55 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.581 -0.699 . . . . 0.0 109.304 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.651 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -144.78 155.24 43.42 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 120.959 -1.088 . . . . 0.0 108.893 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 1.057 ' CE2' HD11 ' A' ' 101' ' ' ILE . 4.9 p90 -136.63 166.17 24.18 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.629 -1.294 . . . . 0.0 109.385 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.855 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -129.76 125.53 36.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.057 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -85.11 83.67 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.817 -1.177 . . . . 0.0 109.576 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.855 HG22 ' NE ' ' A' ' 100' ' ' ARG . 1.7 t -99.98 6.95 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 109.892 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.867 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -101.79 157.79 16.59 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.619 -1.301 . . . . 0.0 109.459 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.693 ' N ' HG21 ' A' ' 113' ' ' VAL . 20.7 t80 178.33 70.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.472 -0.767 . . . . 0.0 109.413 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.67 HG21 ' CD1' ' A' ' 186' ' ' TRP . 38.6 p -66.28 158.35 77.85 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.204 -0.935 . . . . 0.0 108.584 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -22.12 40.88 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 123.885 1.466 . . . . 0.0 108.68 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.633 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -74.14 -4.72 37.45 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.075 HD13 HD12 ' A' ' 195' ' ' LEU . 83.7 mt -141.56 117.44 7.2 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.497 -0.752 . . . . 0.0 109.871 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.07 165.33 17.03 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 O-C-N 123.76 1.4 . . . . 0.0 109.171 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -35.99 -65.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.811 0.815 . . . . 0.0 110.332 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.98 -10.25 5.53 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.774 -0.579 . . . . 0.0 111.517 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.763 ' O ' HD11 ' A' ' 195' ' ' LEU . . . -86.43 -61.68 1.68 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.478 -1.389 . . . . 0.0 108.949 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.723 HG21 ' C ' ' A' ' 103' ' ' ASN . 7.5 p -54.67 -40.56 51.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.586 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.3 -27.01 69.04 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.891 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -67.39 -38.49 84.77 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.133 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -72.86 -33.95 66.44 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.901 -1.124 . . . . 0.0 109.66 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.971 HG13 HG13 ' A' ' 144' ' ' ILE . 57.3 t -76.06 -22.9 15.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.9 OUTLIER -89.11 -34.38 16.76 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.669 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.44 -38.02 27.11 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.759 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -64.49 -61.24 2.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.826 HD22 ' CD1' ' A' ' 99' ' ' TYR . 14.2 tp -53.45 -46.65 69.97 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.765 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -66.39 -35.3 79.97 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.138 -178.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.883 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.0 t -57.09 -36.31 50.81 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.089 ' O ' HG23 ' A' ' 128' ' ' THR . 56.2 m95 -92.61 -25.17 18.43 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.931 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -71.83 -27.34 62.84 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.627 -1.296 . . . . 0.0 108.29 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.0 pt-20 -92.44 -42.82 9.54 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.029 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 123' ' ' VAL . 19.8 m -63.9 -21.16 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.25 -1.38 . . . . 0.0 109.971 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.089 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -108.35 162.67 19.11 Favored Pre-proline 0 N--CA 1.5 2.046 0 C-N-CA 117.472 -1.691 . . . . 0.0 109.883 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.675 ' O ' HD23 ' A' ' 130' ' ' LEU . 50.2 Cg_endo -81.02 21.74 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.1 1.867 . . . . 0.0 111.729 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.786 HD13 ' O ' ' A' ' 94' ' ' LYS . 21.7 mt -122.22 -173.7 2.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.5 -1.375 . . . . 0.0 110.561 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -124.07 -168.22 1.76 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.973 -179.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.777 ' HE2' HD13 ' A' ' 207' ' ' LEU . 0.4 OUTLIER -153.02 175.77 12.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.554 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -149.17 -173.44 4.38 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.616 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.34 163.04 39.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.49 -1.381 . . . . 0.0 110.768 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.07 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -151.19 -131.9 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.47 31.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.726 -1.234 . . . . 0.0 109.444 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 139' ' ' GLU . 7.0 pm0 -166.79 -164.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 0.0 109.928 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 36.3 -97.43 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' OE2' ' HA2' ' A' ' 173' ' ' GLY . 0.9 OUTLIER 178.38 107.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -1.105 . . . . 0.0 110.398 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 1.07 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -63.15 -151.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.15 -0.969 . . . . 0.0 108.699 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.603 ' HB3' ' CZ2' ' A' ' 92' ' ' TRP . 63.2 m-20 -87.7 -32.62 19.1 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.785 HG22 ' CD1' ' A' ' 144' ' ' ILE . 4.4 mp -128.54 83.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.1 ttt -66.51 98.77 0.52 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 108.905 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.971 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -82.42 115.79 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.819 -1.176 . . . . 0.0 108.149 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -133.93 153.01 52.05 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.55 -1.344 . . . . 0.0 111.48 -179.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 9.2 p90 -93.79 139.18 31.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.191 -0.943 . . . . 0.0 109.381 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.149 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -163.72 -159.96 0.54 Allowed 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.351 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.78 HG21 ' HB2' ' A' ' 183' ' ' ASP . 1.7 p -173.32 -168.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 0.0 109.064 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.711 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -48.31 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 109.753 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 148' ' ' VAL . 1.0 OUTLIER 179.77 31.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 55.1 m80 -81.31 -64.28 1.22 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.16 55.29 0.82 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 154' ' ' PHE . 3.9 t0 179.76 -85.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -1.131 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.513 ' N ' ' OD1' ' A' ' 153' ' ' ASP . 5.4 t80 -156.84 40.71 0.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 109.307 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' CD2' ' OH ' ' A' ' 168' ' ' TYR . 1.2 m-85 -143.91 52.13 1.82 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.367 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 40.6 Cg_endo -69.95 119.28 6.24 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.963 1.507 . . . . 0.0 109.849 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.767 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.3 OUTLIER -81.08 -165.9 1.02 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.22 -0.925 . . . . 0.0 110.341 -179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.578 ' O ' ' C ' ' A' ' 159' ' ' GLY . 48.4 p-10 179.29 57.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.712 -0.617 . . . . 0.0 110.366 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -21.34 -67.71 0.01 OUTLIER Glycine 0 N--CA 1.509 3.53 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 183' ' ' ASP . 43.7 Cg_endo -74.04 52.87 2.75 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.525 1.277 . . . . 0.0 109.401 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 158' ' ' ASP . . . -155.89 156.78 27.3 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.548 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 20.4 m-80 -47.61 -41.71 22.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.66 -0.906 . . . . 0.0 110.507 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.079 HG13 HG22 ' A' ' 1' ' ' HAV . 78.6 t -59.89 78.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.071 -1.018 . . . . 0.0 110.136 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.064 ' CD2' HG21 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -59.1 -55.05 40.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.416 -0.802 . . . . 0.0 111.784 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.8 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -163.68 -174.91 3.88 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.723 -1.236 . . . . 0.0 111.245 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.767 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.5 p-80 178.42 165.06 0.78 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.141 -1.599 . . . . 0.0 110.989 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -129.29 -158.97 0.92 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.405 -0.809 . . . . 0.0 110.23 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.694 ' CD1' HD11 ' A' ' 174' ' ' ILE . 3.7 m-85 -122.83 -169.37 1.91 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.684 -1.207 . . . . 0.0 111.582 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -117.54 -166.39 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.0 Cg_endo -74.97 123.51 7.95 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 O-C-N 123.05 1.026 . . . . 0.0 110.825 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . -172.15 -171.32 36.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.68 101.82 1.34 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.569 1.3 . . . . 0.0 109.91 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.474 ' HA2' ' OE2' ' A' ' 139' ' ' GLU . . . 81.5 -51.16 4.36 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.694 HD11 ' CD1' ' A' ' 168' ' ' TYR . 1.7 tt -68.67 2.58 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.623 -0.928 . . . . 0.0 109.346 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.579 ' O ' ' CH2' ' A' ' 92' ' ' TRP . 8.1 p-10 -63.52 63.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.56 -0.712 . . . . 0.0 109.227 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 104.02 101.73 2.69 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.4 m-20 -157.16 120.33 4.07 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.718 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.56 161.8 15.01 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.889 -1.132 . . . . 0.0 108.916 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.149 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -156.09 133.16 10.6 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.056 -1.058 . . . . 0.0 108.811 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 73.1 m-85 -93.71 141.28 28.67 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.741 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.592 ' HB3' ' CD2' ' A' ' 157' ' ' PHE . 23.7 p30 -63.51 144.55 56.9 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.565 -1.254 . . . . 0.0 107.667 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -120.57 22.27 11.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.669 -1.269 . . . . 0.0 110.447 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.78 ' HB2' HG21 ' A' ' 148' ' ' VAL . 27.2 t0 -115.95 11.21 15.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.957 -1.09 . . . . 0.0 110.359 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.515 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 2.9 pt-20 -126.43 -108.21 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.772 -1.205 . . . . 0.0 109.282 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 3.9 mt-30 -148.31 173.91 12.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.712 -1.242 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.714 ' CH2' HD23 ' A' ' 164' ' ' LEU . 88.7 m95 -162.54 132.58 4.57 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.039 -1.038 . . . . 0.0 110.029 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.9 ' HA ' HD21 ' A' ' 108' ' ' LEU . 31.0 p -153.64 153.26 31.97 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.077 -1.014 . . . . 0.0 109.51 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.81 ' O ' HG23 ' A' ' 227' ' ' THR . 0.0 OUTLIER -73.43 -37.38 65.88 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.536 ' O ' ' CG2' ' A' ' 227' ' ' THR . 1.3 t70 -86.04 -145.3 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.876 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.7 t -115.61 46.26 1.54 Allowed 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 118.761 -1.176 . . . . 0.0 108.196 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.511 ' HB ' HG21 ' A' ' 187' ' ' THR . 97.8 m -101.58 -31.06 11.03 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.382 -0.824 . . . . 0.0 111.186 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.547 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -111.95 -86.99 1.66 Allowed Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.878 -1.63 . . . . 0.0 109.096 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.052 HG21 HD21 ' A' ' 164' ' ' LEU . 35.4 m -125.01 -97.21 0.43 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.75 ' ND2' HG22 ' A' ' 193' ' ' THR . 0.8 OUTLIER -158.12 67.53 0.48 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.107 -0.995 . . . . 0.0 108.42 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.133 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -27.79 -94.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.54 0.686 . . . . 0.0 111.553 -179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.853 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -67.63 -12.66 60.95 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.164 -0.96 . . . . 0.0 111.013 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.806 ' HA ' HD11 ' A' ' 218' ' ' LEU . 8.5 tp -63.06 -64.25 0.97 Allowed 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.906 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.064 HG21 ' CD2' ' A' ' 164' ' ' LEU . 2.5 t -69.46 -12.02 15.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.049 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.76 -57.4 4.01 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.963 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -66.99 -14.61 63.05 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.609 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 11.4 t60 -69.93 -43.97 70.56 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 117.821 -1.551 . . . . 0.0 107.743 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.718 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 2.3 mt-10 -82.53 -49.05 10.31 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.268 -0.895 . . . . 0.0 110.559 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.768 HG22 HD21 ' A' ' 207' ' ' LEU . 1.4 mt -59.95 -30.74 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.735 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -80.32 -29.68 44.11 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -62.2 -42.84 99.66 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.701 -0.882 . . . . 0.0 110.558 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.523 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 68.5 m -90.57 -51.71 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 112.108 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.777 HD13 ' HE2' ' A' ' 132' ' ' PHE . 0.5 OUTLIER -104.78 20.66 18.32 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.008 -1.057 . . . . 0.0 110.828 -177.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.939 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -124.48 -79.25 0.39 Allowed Glycine 0 C--N 1.291 -1.96 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.256 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.934 HD21 ' OD2' ' A' ' 238' ' ' ASP . 1.0 OUTLIER -171.25 -156.29 0.11 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.428 -1.631 . . . . 0.0 110.939 -178.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.568 ' O ' ' CD2' ' A' ' 211' ' ' HIS . 0.5 OUTLIER -101.49 -86.58 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 110.161 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.592 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.1 m-70 -152.32 89.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.0 110.457 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.588 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.0 m -79.47 178.72 7.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.116 -0.99 . . . . 0.0 108.574 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.495 ' HB3' ' OD2' ' A' ' 237' ' ' ASP . . . -59.09 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.94 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.16 11.9 10.91 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.213 -1.395 . . . . 0.0 111.978 -177.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.92 -28.22 6.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 175.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.511 ' C ' ' HB2' ' A' ' 235' ' ' SER . 34.9 mt-10 -117.41 -34.58 4.25 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -57.8 -145.63 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.206 -0.934 . . . . 0.0 111.557 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.963 ' CD2' ' HB3' ' A' ' 200' ' ' ALA . 0.7 OUTLIER -132.35 -0.5 3.63 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.515 -0.74 . . . . 0.0 111.082 -178.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.592 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 9.2 tpp -93.35 -3.46 53.35 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.072 -1.642 . . . . 0.0 110.073 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.65 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 4.4 t80 -139.86 12.08 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.04 -1.064 . . . . 0.0 113.322 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 53.7 Cg_endo -74.31 -36.75 2.96 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 108.988 -1.197 . . . . 0.0 108.988 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 223' ' ' TYR . 2.6 tt -13.06 -60.05 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.201 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.954 ' N ' HD23 ' A' ' 222' ' ' LEU . 9.5 t80 -69.57 56.48 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.078 -1.014 . . . . 0.0 109.494 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.4 t-160 179.21 -142.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.1 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.932 ' O ' HD12 ' A' ' 226' ' ' LEU . 4.0 m -149.51 121.62 8.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 0.0 109.58 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.932 HD12 ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER -176.28 56.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 109.897 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.81 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -116.17 -16.23 11.01 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.611 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.1 t0 -169.51 -25.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.681 -0.637 . . . . 0.0 109.527 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.876 HD11 ' N ' ' A' ' 190' ' ' THR . 0.6 OUTLIER -27.93 -94.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.667 -0.646 . . . . 0.0 110.719 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.421 ' C ' ' HG3' ' A' ' 231' ' ' ARG . 0.6 OUTLIER -145.11 1.92 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.887 -1.133 . . . . 0.0 110.139 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.61 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -129.55 -44.74 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.885 -1.135 . . . . 0.0 109.382 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 23.0 p90 1.12 106.44 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.482 0.658 . . . . 0.0 112.58 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.556 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.25 171.05 0.94 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.458 -0.776 . . . . 0.0 109.474 179.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.023 HD21 ' CH2' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -82.01 179.61 7.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.334 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.77 ' H ' HD12 ' A' ' 234' ' ' LEU . 3.2 t -116.5 -169.93 1.72 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.042 -1.036 . . . . 0.0 110.575 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.597 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.4 OUTLIER -85.57 -25.07 26.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.542 -0.724 . . . . 0.0 109.983 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.588 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 19.6 m-20 -77.14 -45.07 28.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.932 -1.105 . . . . 0.0 108.204 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.934 ' OD2' HD21 ' A' ' 209' ' ' LEU . 7.8 t70 -67.85 -45.93 73.2 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.282 -1.367 . . . . 0.0 107.909 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 234' ' ' LEU . 0.8 OUTLIER -51.61 -34.15 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.95 -47.13 78.74 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -60.51 -56.05 26.56 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.947 HG13 HG22 ' A' ' 128' ' ' THR . 0.7 OUTLIER -63.77 -46.14 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.821 -1.399 . . . . 0.0 109.954 -178.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 242' ' ' ILE . 30.4 mt-30 -54.27 -26.66 30.28 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -90.02 -10.93 43.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.939 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -80.02 -54.37 5.85 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.62 ' CD2' HD12 ' A' ' 130' ' ' LEU . 3.9 m-30 -78.78 -83.37 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.172 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.48 ' C ' ' HD2' ' A' ' 249' ' ' PRO . . . -106.49 91.91 0.76 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.614 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 39.5 Cg_endo -73.01 -29.68 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.945 1.497 . . . . 0.0 112.479 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 42.6 Cg_endo -74.06 111.93 3.42 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 122.661 0.821 . . . . 0.0 110.282 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 45.4 Cg_endo -76.98 -59.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.011 1.532 . . . . 0.0 110.438 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.453 ' C ' ' HD3' ' A' ' 253' ' ' PRO . 32.6 t70 -87.28 13.98 8.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.259 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.556 ' CB ' ' HB2' ' A' ' 249' ' ' PRO . 0.0 OUTLIER -117.28 67.62 4.84 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.062 -1.024 . . . . 0.0 109.552 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.453 ' HD3' ' C ' ' A' ' 251' ' ' ASP . 42.9 Cg_endo -73.0 -49.18 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.979 1.515 . . . . 0.0 110.128 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -141.05 -47.54 0.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.613 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.515 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.079 HG22 HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.548 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.838 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 85' ' ' THR . 0.6 OUTLIER -150.29 -96.36 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.572 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -47.14 -93.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.042 -1.036 . . . . 0.0 109.412 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.487 ' H ' HG23 ' A' ' 85' ' ' THR . 1.6 t80 -163.56 99.0 0.98 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.0 109.542 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.62 77.3 2.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.043 1.549 . . . . 0.0 110.083 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.93 ' C ' HD13 ' A' ' 89' ' ' ILE . . . 172.7 -88.95 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.93 HD13 ' C ' ' A' ' 88' ' ' GLY . 3.1 mm -126.73 142.22 42.67 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.295 -1.121 . . . . 0.0 109.468 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.616 ' HD2' HG22 ' A' ' 89' ' ' ILE . 41.9 Cg_endo -72.03 -179.57 4.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.903 1.475 . . . . 0.0 110.101 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.673 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -95.2 -84.94 0.33 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.75 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.596 ' HB2' ' CE1' ' A' ' 246' ' ' TYR . 27.9 m95 -97.65 140.55 31.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.978 -1.076 . . . . 0.0 109.641 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.78 -28.25 6.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.98 -170.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.778 0.799 . . . . 0.0 110.192 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.779 ' HB ' HD12 ' A' ' 130' ' ' LEU . 66.8 p -127.33 3.71 6.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.603 ' NE2' HG21 ' A' ' 131' ' ' THR . 7.8 m80 -148.91 102.94 3.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.9 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.157 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -121.19 -166.51 1.36 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.326 -0.859 . . . . 0.0 109.25 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.628 HG22 ' C ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -168.21 171.67 9.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.14 -0.975 . . . . 0.0 109.238 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 1.098 ' CE2' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -139.38 177.19 8.1 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.84 -1.163 . . . . 0.0 110.48 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.875 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -127.45 126.76 42.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.265 -0.897 . . . . 0.0 109.9 -178.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.093 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 1.9 mp -85.06 83.33 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.932 -1.105 . . . . 0.0 109.837 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.875 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -101.22 8.67 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.186 -0.946 . . . . 0.0 110.077 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.866 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -100.48 157.29 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.635 -1.291 . . . . 0.0 109.968 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.669 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.5 OUTLIER 178.16 75.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.62 0.724 . . . . 0.0 109.507 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 1.049 HG21 ' CD1' ' A' ' 186' ' ' TRP . 0.8 OUTLIER -67.77 157.2 87.19 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.23 -23.44 39.0 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 O-C-N 123.79 1.416 . . . . 0.0 108.952 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.562 ' O ' HD23 ' A' ' 108' ' ' LEU . 1.5 t0 -69.93 -9.8 56.28 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.837 HD22 ' HB1' ' A' ' 112' ' ' ALA . 52.2 mt -143.45 123.97 7.92 Favored Pre-proline 0 N--CA 1.485 1.278 0 O-C-N 121.622 -0.673 . . . . 0.0 109.898 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -66.42 168.87 15.21 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.781 1.411 . . . . 0.0 109.184 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.484 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.91 -64.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.756 0.789 . . . . 0.0 110.516 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 112' ' ' ALA . 2.4 p-10 -55.5 -32.08 62.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.701 -0.625 . . . . 0.0 111.954 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.837 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.87 -61.91 1.59 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.524 -1.36 . . . . 0.0 109.437 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.971 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.6 p -52.21 -41.68 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.591 ' OD2' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.63 -26.34 68.63 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.618 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -68.21 -35.71 78.39 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.401 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.048 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -76.15 -35.11 59.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.937 -1.102 . . . . 0.0 109.005 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.098 HG12 ' CE2' ' A' ' 99' ' ' TYR . 1.7 t -73.11 -26.13 22.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 1.5 tt0 -86.48 -36.35 19.08 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.897 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -75.93 -39.27 56.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.821 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -66.15 -62.96 1.2 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.473 1.13 . . . . 0.0 108.167 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.941 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.3 tt -46.51 -51.57 15.12 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.189 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.92 ' N ' HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -67.63 -35.47 78.97 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.947 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.118 ' CG1' HD22 ' A' ' 234' ' ' LEU . 3.1 t -52.44 -42.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.067 ' CH2' HD21 ' A' ' 234' ' ' LEU . 30.1 m95 -92.43 -23.38 19.19 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.928 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 46.9 tt0 -69.81 -26.93 64.49 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.762 -1.211 . . . . 0.0 107.801 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -91.06 -43.12 10.11 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.804 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.038 HG21 HG21 ' A' ' 242' ' ' ILE . 17.7 m -59.18 -24.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.31 -1.356 . . . . 0.0 109.766 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.036 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -105.9 160.48 25.98 Favored Pre-proline 0 N--CA 1.499 1.992 0 C-N-CA 117.696 -1.601 . . . . 0.0 110.222 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.724 ' C ' HD22 ' A' ' 130' ' ' LEU . 51.7 Cg_endo -85.56 22.48 0.94 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.259 1.973 . . . . 0.0 111.962 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.779 HD12 ' HB ' ' A' ' 95' ' ' THR . 3.6 mm? -116.36 -169.96 1.72 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.32 -1.488 . . . . 0.0 110.51 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.603 HG21 ' NE2' ' A' ' 96' ' ' HIS . 1.3 p -117.04 164.96 13.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 1.157 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 1.2 m-85 -144.26 139.27 28.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.693 -0.63 . . . . 0.0 109.492 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.531 ' CB ' ' HB ' ' A' ' 98' ' ' THR . 0.4 OUTLIER -115.28 -166.31 1.11 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.129 -0.982 . . . . 0.0 108.486 179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.49 157.31 35.22 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.964 -1.085 . . . . 0.0 110.014 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.561 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -159.64 -164.96 1.43 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.387 -0.821 . . . . 0.0 109.604 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 101' ' ' ILE . 1.8 t80 -154.17 22.09 0.49 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.524 ' HA ' ' NH2' ' A' ' 100' ' ' ARG . 11.6 pm0 -138.44 179.58 6.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.43 -100.34 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.68 119.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -1.179 . . . . 0.0 110.296 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.561 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -77.94 -154.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 108.87 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.536 ' O ' ' O ' ' A' ' 176' ' ' GLY . 2.3 m-20 -84.24 -38.32 20.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.039 -1.038 . . . . 0.0 109.364 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.737 HG22 ' CD1' ' A' ' 144' ' ' ILE . 4.0 mp -120.77 84.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.649 -0.657 . . . . 0.0 109.254 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.455 ' HB3' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.45 98.5 0.25 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.133 -0.979 . . . . 0.0 109.044 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.866 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.9 mm -84.29 114.89 25.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.627 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.01 155.66 50.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.517 -1.365 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -81.15 141.11 34.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.162 -0.961 . . . . 0.0 108.826 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.917 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -160.03 178.25 9.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.85 -1.156 . . . . 0.0 110.828 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.838 HG13 ' N ' ' A' ' 149' ' ' ARG . 1.5 p -167.26 -150.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.838 ' N ' HG13 ' A' ' 148' ' ' VAL . 3.7 mmm180 -31.34 -57.48 0.25 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.765 -0.584 . . . . 0.0 110.477 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.72 121.27 4.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.142 -0.974 . . . . 0.0 109.323 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 148' ' ' VAL . 5.5 m80 -162.51 -91.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.639 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -176.24 -70.69 0.05 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 48.5 p30 179.97 52.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -1.161 . . . . 0.0 109.79 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.487 ' C ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER 179.91 -32.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 109.755 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.588 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 98.1 m-85 -119.84 45.44 0.75 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.265 -0.897 . . . . 0.0 109.808 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 40.8 Cg_endo -70.59 127.38 13.85 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.899 1.473 . . . . 0.0 109.591 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.687 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -106.92 -164.12 0.96 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.081 -1.012 . . . . 0.0 110.243 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 158' ' ' ASP . 1.3 p30 179.91 46.08 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.362 -0.836 . . . . 0.0 110.553 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.613 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 38.4 -97.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 183' ' ' ASP . 40.2 Cg_endo -69.51 56.9 1.32 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.992 1.522 . . . . 0.0 110.07 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.471 ' HA3' ' OD1' ' A' ' 158' ' ' ASP . . . -132.84 143.02 14.61 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.539 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 2.9 m120 -42.6 -31.32 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -1.066 . . . . 0.0 109.877 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 163' ' ' VAL . 31.8 m -68.76 83.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.035 . . . . 0.0 110.169 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.011 HD22 HD12 ' A' ' 222' ' ' LEU . 1.6 tp -64.21 -71.19 0.18 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 0.0 111.658 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.896 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -150.02 -168.41 3.1 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 120.532 -1.355 . . . . 0.0 110.426 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 179.21 -178.22 0.33 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 119.73 -1.856 . . . . 0.0 111.353 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.658 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -154.92 178.91 9.64 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.475 -0.765 . . . . 0.0 110.134 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.797 ' CE1' HD11 ' A' ' 174' ' ' ILE . 81.5 m-85 -121.51 -167.82 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 110.449 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.997 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -175.3 -58.65 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 109.423 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.997 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -78.62 133.05 11.35 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.886 1.466 . . . . 0.0 109.969 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 132.67 -173.9 20.68 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.592 ' HD2' HG22 ' A' ' 174' ' ' ILE . 45.8 Cg_endo -78.48 -92.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.089 1.573 . . . . 0.0 110.312 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -82.97 -34.62 20.93 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.797 HD11 ' CE1' ' A' ' 168' ' ' TYR . 0.8 OUTLIER -61.93 -6.98 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.466 -1.02 . . . . 0.0 108.816 178.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.568 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -65.81 64.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.466 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 206' ' ' SER . . . 126.36 82.3 0.43 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.0 m-20 -158.68 120.24 3.46 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.012 -1.287 . . . . 0.0 107.95 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -111.9 156.97 21.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.677 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.917 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -145.08 134.08 22.58 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.624 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 65.7 m-85 -95.57 133.75 39.25 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.158 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.579 ' OD2' ' CD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -49.34 148.66 2.52 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.026 177.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD2' ' HB ' ' A' ' 148' ' ' VAL . 2.6 p30 -124.05 21.04 9.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.809 -1.182 . . . . 0.0 109.558 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.744 ' OD2' HG21 ' A' ' 148' ' ' VAL . 1.8 m-20 -131.05 9.73 4.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.509 ' CG ' ' HB3' ' A' ' 181' ' ' ASP . 1.0 OUTLIER -114.04 -98.28 0.44 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.657 -1.277 . . . . 0.0 109.515 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 66.9 mt-30 -154.26 165.94 34.72 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 109.202 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 1.049 ' CD1' HG21 ' A' ' 105' ' ' THR . 97.8 m95 -160.3 118.97 2.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 110.11 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.825 ' HA ' HD21 ' A' ' 108' ' ' LEU . 22.2 p -140.79 152.1 44.94 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.034 -1.041 . . . . 0.0 109.039 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.794 ' HA ' HD22 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -75.09 -33.44 61.64 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.627 ' OD2' HD12 ' A' ' 229' ' ' LEU . 1.3 t70 -91.52 -141.19 0.18 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.933 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.8 t -117.59 46.77 1.66 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.003 -1.06 . . . . 0.0 108.243 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.499 ' HB ' HG21 ' A' ' 187' ' ' THR . 58.4 m -104.71 -29.46 10.57 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.273 -0.892 . . . . 0.0 111.303 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.533 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -110.26 -91.29 2.09 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.91 -1.614 . . . . 0.0 109.48 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.038 HG22 ' OD1' ' A' ' 194' ' ' ASN . 64.8 m -114.44 -84.35 0.61 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 1.038 ' OD1' HG22 ' A' ' 193' ' ' THR . 5.1 p30 178.6 68.56 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.862 1.315 . . . . 0.0 108.139 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.048 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -21.73 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.251 -1.341 . . . . 0.0 113.303 -179.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.868 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -68.01 -6.39 22.23 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.998 -1.064 . . . . 0.0 110.835 -175.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.975 ' HA ' HD11 ' A' ' 218' ' ' LEU . 7.5 tp -66.11 -61.49 2.01 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 117.601 -1.64 . . . . 0.0 106.642 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.896 HG12 ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -70.81 -14.49 18.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.121 -1.032 . . . . 0.0 108.426 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.936 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.23 -61.05 1.96 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 118.618 -1.233 . . . . 0.0 108.211 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 1.044 ' HB3' HD23 ' A' ' 218' ' ' LEU . . . -63.58 -15.75 58.93 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.311 -1.493 . . . . 0.0 107.527 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.814 ' HA ' ' HE2' ' A' ' 219' ' ' MET . 6.8 t60 -70.6 -44.01 68.17 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.684 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.722 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 8.3 mt-10 -82.58 -46.16 13.69 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.077 -1.014 . . . . 0.0 111.374 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.941 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.0 mt -63.69 -30.31 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.698 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.47 -31.38 54.58 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 177.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -64.04 -47.16 81.29 Favored 'General case' 0 C--N 1.287 -2.111 0 O-C-N 121.796 -0.826 . . . . 0.0 111.232 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.545 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 33.9 p -85.37 -52.52 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.16 -0.963 . . . . 0.0 112.63 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.89 ' O ' HD12 ' A' ' 207' ' ' LEU . 1.3 pp -104.4 7.44 35.56 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.871 -1.143 . . . . 0.0 111.097 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.995 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -109.83 -84.01 1.5 Allowed Glycine 0 C--N 1.29 -1.975 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.825 HD11 ' OD1' ' A' ' 238' ' ' ASP . 1.8 pp -158.89 -161.13 0.93 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.922 -1.34 . . . . 0.0 109.942 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.572 ' N ' HD12 ' A' ' 209' ' ' LEU . 44.8 t80 -98.43 -71.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.6 m-70 -161.06 94.17 1.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.647 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 2.1 m -84.03 -179.26 7.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.871 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -62.7 78.6 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.999 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -82.72 9.34 9.85 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.877 -1.129 . . . . 0.0 111.281 -177.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -50.44 -27.84 7.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 175.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.511 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.6 mt-10 -114.07 -36.45 4.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 176.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.999 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -61.39 -159.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.272 1.034 . . . . 0.0 112.276 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.044 HD23 ' HB3' ' A' ' 200' ' ' ALA . 0.6 OUTLIER -106.04 -11.81 16.01 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.562 -178.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.814 ' HE2' ' HA ' ' A' ' 201' ' ' HIS . 0.0 OUTLIER -80.57 -10.2 59.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.24 -1.537 . . . . 0.0 111.932 -177.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.679 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.8 t80 -131.39 8.5 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.137 0 O-C-N 120.447 -1.408 . . . . 0.0 113.953 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 43.7 Cg_endo -72.48 -41.84 1.55 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 N-CA-C 109.261 -1.092 . . . . 0.0 109.261 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 1.011 HD12 HD22 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -0.5 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.204 0.526 . . . . 0.0 111.756 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.877 ' N ' HD23 ' A' ' 222' ' ' LEU . 48.4 t80 -67.19 58.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.827 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.13 -155.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.223 -0.923 . . . . 0.0 109.329 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.458 ' HB3' ' OG1' ' A' ' 190' ' ' THR . 0.7 OUTLIER -128.69 126.39 40.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.091 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.95 HD12 ' HB2' ' A' ' 231' ' ' ARG . 1.2 tt -179.85 40.35 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.105 -0.997 . . . . 0.0 110.082 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.581 ' HA ' ' CE1' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -103.16 -40.03 6.61 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 26.9 t70 -149.38 -13.43 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.551 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.933 HD11 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -42.65 -98.84 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.851 -1.156 . . . . 0.0 110.349 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 19.5 p -139.03 -0.31 1.88 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.48 -1.388 . . . . 0.0 109.933 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.95 ' HB2' HD12 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -116.7 -18.21 10.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.012 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 232' ' ' PHE . 19.5 p90 -30.15 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.478 0.656 . . . . 0.0 111.477 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.58 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 8.5 ttt180 179.13 149.53 0.26 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.118 HD22 ' CG1' ' A' ' 123' ' ' VAL . 3.1 tp -70.11 164.43 24.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 108.755 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 1.085 ' O ' HD12 ' A' ' 239' ' ' ILE . 7.7 t -102.46 178.15 4.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.068 -1.02 . . . . 0.0 109.578 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.509 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -70.36 -14.6 62.64 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.75 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.871 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.8 OUTLIER -87.32 -49.6 7.14 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.716 -1.24 . . . . 0.0 109.548 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.825 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.94 -42.56 97.29 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 116.908 -1.917 . . . . 0.0 107.17 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.085 HD12 ' O ' ' A' ' 235' ' ' SER . 3.0 mt -54.83 -39.83 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.52 ' HA ' ' HG2' ' A' ' 243' ' ' GLN . 24.5 t-20 -60.84 -48.97 79.36 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.946 -0.702 . . . . 0.0 109.62 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.06 -55.53 30.37 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.038 HG21 HG21 ' A' ' 127' ' ' VAL . 1.4 tp -63.46 -50.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.032 -1.276 . . . . 0.0 110.521 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.567 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -53.33 -25.1 13.76 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.509 ' N ' ' HG3' ' A' ' 243' ' ' GLN . 37.4 t -90.83 -11.4 39.46 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -78.98 -49.97 11.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.74 ' HB3' HD23 ' A' ' 130' ' ' LEU . 5.0 m-30 -91.65 -104.09 0.11 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 246' ' ' TYR . . . 43.37 89.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.688 ' CD ' ' HD3' ' A' ' 249' ' ' PRO . 35.1 Cg_endo -61.99 -26.0 78.24 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.959 1.505 . . . . 0.0 113.036 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.688 ' HD3' ' CD ' ' A' ' 248' ' ' PRO . 55.2 Cg_endo -98.17 68.06 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.213 1.275 . . . . 0.0 111.496 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.587 ' CD ' ' O ' ' A' ' 248' ' ' PRO . 41.6 Cg_endo -70.91 -58.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 122.781 0.885 . . . . 0.0 109.946 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.58 -33.31 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.344 -0.847 . . . . 0.0 109.028 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.19 100.89 2.28 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.423 -0.798 . . . . 0.0 109.181 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -71.77 -31.12 13.47 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.042 1.548 . . . . 0.0 110.257 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -152.47 -70.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.555 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.606 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.543 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 1.011 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.237 0.541 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 85' ' ' THR . 2.2 ptp180 -87.76 -167.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.621 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.482 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 3.9 t -43.83 163.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.514 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.417 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 1.7 t80 -86.6 109.85 27.24 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.4 Cg_endo -72.72 80.57 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.888 1.468 . . . . 0.0 110.079 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 159.34 -56.26 0.34 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 86' ' ' PHE . 14.7 mt -138.1 132.01 16.82 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.245 -1.15 . . . . 0.0 109.548 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.534 ' HB2' HD23 ' A' ' 245' ' ' LEU . 42.8 Cg_endo -73.3 174.14 12.59 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.003 1.528 . . . . 0.0 110.088 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.504 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.2 OUTLIER -67.96 -79.57 0.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.317 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.534 ' CE3' ' HD3' ' A' ' 94' ' ' LYS . 36.3 m95 -105.48 160.14 15.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.889 -1.132 . . . . 0.0 109.284 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -121.97 -28.99 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.044 -1.035 . . . . 0.0 110.682 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 1.06 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -42.9 169.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 110.323 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.652 ' HA ' HD11 ' A' ' 130' ' ' LEU . 2.1 p -106.19 -0.66 24.38 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.439 -0.788 . . . . 0.0 109.459 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.558 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 69.2 m80 -140.19 93.89 2.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.904 HD23 HD23 ' A' ' 130' ' ' LEU . 3.1 mm? -85.82 164.66 17.41 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.762 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.608 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -143.33 156.64 44.75 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.918 ' CE2' HD11 ' A' ' 101' ' ' ILE . 8.8 p90 -135.85 170.28 16.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.61 -1.306 . . . . 0.0 109.642 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.838 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -132.25 123.25 26.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.369 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.918 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.8 mp -80.01 83.86 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.99 -1.069 . . . . 0.0 109.705 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.838 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -99.12 8.39 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.268 -0.895 . . . . 0.0 110.386 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.629 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -107.06 173.01 6.51 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.424 -1.422 . . . . 0.0 110.119 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.619 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 11.3 t80 176.94 70.93 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.712 0.768 . . . . 0.0 109.342 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.8 HG21 ' CD1' ' A' ' 186' ' ' TRP . 56.3 p -56.25 148.86 39.88 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 120.985 -1.072 . . . . 0.0 108.246 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 -28.96 40.5 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 108.52 -1.377 . . . . 0.0 108.52 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.608 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.6 t0 -71.28 -9.12 57.59 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 187' ' ' THR . 33.1 mt -131.69 120.51 17.67 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.644 -0.66 . . . . 0.0 110.21 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.6 Cg_endo -62.99 163.69 21.64 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 O-C-N 123.811 1.427 . . . . 0.0 108.979 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -37.3 -65.81 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.781 0.801 . . . . 0.0 110.034 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.7 OUTLIER -57.65 -15.2 6.95 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.733 -0.604 . . . . 0.0 111.056 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . . . -81.23 -62.22 1.72 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.555 -1.341 . . . . 0.0 108.942 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.629 HG21 ' C ' ' A' ' 103' ' ' ASN . 7.3 p -50.64 -40.02 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 118.294 -1.362 . . . . 0.0 107.481 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.825 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -65.12 -27.09 68.5 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.738 ' OG ' HD21 ' A' ' 195' ' ' LEU . 14.6 p -66.91 -38.43 86.21 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.064 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.19 -33.59 65.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.329 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.863 HG13 HG13 ' A' ' 144' ' ' ILE . 47.8 t -75.45 -24.09 17.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -84.36 -36.4 22.52 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -79.69 -38.82 32.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -63.39 -60.76 2.95 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 122.425 1.107 . . . . 0.0 108.247 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.842 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.2 pp -52.59 -41.04 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.937 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.759 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -75.88 -32.07 59.52 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.986 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.028 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.9 t -53.81 -45.11 61.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.051 ' CH2' HD21 ' A' ' 234' ' ' LEU . 31.8 m95 -91.7 -23.12 19.89 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.902 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 5.4 tm-20 -70.96 -26.59 63.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.847 -1.158 . . . . 0.0 107.935 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -90.76 -42.71 10.53 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.689 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.028 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.9 m -58.78 -25.67 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 118.323 -1.351 . . . . 0.0 108.809 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.019 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -112.56 172.15 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 117.94 -1.504 . . . . 0.0 110.056 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.563 ' CG ' ' HD3' ' A' ' 248' ' ' PRO . 51.7 Cg_endo -87.21 -7.94 6.73 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.642 2.228 . . . . 0.0 110.78 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.06 HD21 ' O ' ' A' ' 94' ' ' LYS . 1.1 tp -73.8 -179.76 3.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.982 -1.074 . . . . 0.0 110.594 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 5.5 p -119.33 175.68 5.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 110.154 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.718 ' CZ ' HD13 ' A' ' 207' ' ' LEU . 0.5 OUTLIER -144.56 159.56 42.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.97 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.578 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -145.25 179.74 7.18 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.69 157.85 44.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.797 -1.189 . . . . 0.0 110.427 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.541 HD23 ' OG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -150.55 -140.03 0.1 Allowed 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 5.5 t80 178.92 40.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.743 -1.223 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 7.5 pm0 -165.22 -178.18 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.609 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.44 -96.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 137' ' ' GLU . 1.7 pt-20 178.84 105.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.199 -1.177 . . . . 0.0 110.163 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.608 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.21 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 108.671 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.607 ' O ' HD13 ' A' ' 142' ' ' ILE . 0.9 OUTLIER -92.49 -27.97 17.09 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.532 179.14 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.986 HD11 ' HG ' ' A' ' 207' ' ' LEU . 31.1 mm -130.9 77.14 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.695 ' HG2' HG21 ' A' ' 102' ' ' VAL . 1.9 ttt -64.87 97.07 0.21 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.136 -0.978 . . . . 0.0 108.962 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.863 HG13 HG13 ' A' ' 117' ' ' VAL . 6.9 mm -79.55 123.02 35.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.952 -1.092 . . . . 0.0 108.456 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -138.47 153.07 48.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.446 -1.409 . . . . 0.0 111.825 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 14.3 p90 -87.34 139.9 30.08 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.207 -0.933 . . . . 0.0 108.943 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.097 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.15 -160.21 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.702 -1.249 . . . . 0.0 111.36 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.769 HG13 ' H ' ' A' ' 150' ' ' GLU . 5.7 p -170.0 179.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.705 ' H ' HG22 ' A' ' 148' ' ' VAL . 3.0 ptt180 -36.63 -29.39 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 0.0 110.705 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.769 ' H ' HG13 ' A' ' 148' ' ' VAL . 31.6 mt-10 -85.65 95.0 9.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.075 -1.015 . . . . 0.0 109.773 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.566 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 25.7 m80 -110.22 -79.58 0.58 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 109.462 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 134.48 -4.17 4.4 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 155' ' ' TYR . 14.2 t70 -120.28 -91.98 0.55 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -1.162 . . . . 0.0 109.701 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -155.82 19.8 0.39 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.992 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -128.94 58.56 37.73 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 109.642 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.544 ' HA ' ' ND1' ' A' ' 151' ' ' HIS . 43.3 Cg_endo -73.83 124.95 9.57 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.018 1.536 . . . . 0.0 109.865 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.687 ' CD1' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -91.16 -149.9 0.23 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.054 -1.028 . . . . 0.0 109.419 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.572 ' OD1' HG12 ' A' ' 163' ' ' VAL . 8.9 p-10 -137.04 -2.85 2.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.258 -1.526 . . . . 0.0 111.718 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.655 ' CA ' HG23 ' A' ' 148' ' ' VAL . . . 39.48 -95.85 0.01 OUTLIER Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.528 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.2 Cg_endo -61.45 72.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.338 1.178 . . . . 0.0 110.077 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -172.51 -164.06 27.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 163' ' ' VAL . 69.0 m-20 -90.69 -29.82 17.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.086 -1.244 . . . . 0.0 110.111 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.687 HG11 ' CD1' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -36.73 130.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.593 -0.692 . . . . 0.0 110.713 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.839 HD12 HG11 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -92.23 -80.89 0.35 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.582 -0.699 . . . . 0.0 112.24 -179.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.841 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -161.35 -170.9 2.79 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.263 -1.523 . . . . 0.0 111.026 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.682 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 0.8 OUTLIER -179.1 -169.49 0.15 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 119.542 -1.974 . . . . 0.0 111.313 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -160.41 -163.41 1.09 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 110.233 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.603 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -130.17 -157.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 0.0 110.704 -178.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.97 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -170.56 -59.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.661 -0.65 . . . . 0.0 109.562 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.97 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.4 Cg_endo -79.6 -172.32 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.405 1.403 . . . . 0.0 110.232 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.55 144.07 0.71 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.17 135.14 28.75 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.425 1.417 . . . . 0.0 110.002 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 72.54 -64.12 1.44 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.603 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.0 tp -63.78 -8.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.494 -1.003 . . . . 0.0 109.093 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.7 OUTLIER -65.77 66.39 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.763 179.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 206' ' ' SER . . . 129.53 79.49 0.23 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -153.53 128.76 9.76 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.859 -1.377 . . . . 0.0 108.205 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.703 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -112.59 172.57 6.84 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.983 -1.073 . . . . 0.0 108.961 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.097 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -164.66 134.38 3.8 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.577 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.682 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 12.2 m-85 -88.69 123.38 33.08 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 164' ' ' LEU . 17.0 t70 -67.2 144.66 55.86 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.129 -0.982 . . . . 0.0 108.945 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -61.18 -4.18 1.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.148 -0.97 . . . . 0.0 109.283 178.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.649 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.0 OUTLIER 4.62 -94.23 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 161' ' ' GLY . 1.4 pm0 -166.3 -33.61 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.692 -1.255 . . . . 0.0 110.906 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.459 ' OE1' ' HA2' ' A' ' 192' ' ' GLY . 66.4 mt-30 -141.66 158.67 43.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.708 -1.245 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.8 ' CD1' HG21 ' A' ' 105' ' ' THR . 84.9 m95 -158.02 119.53 3.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.916 ' HA ' HD21 ' A' ' 108' ' ' LEU . 47.2 p -144.43 154.64 43.17 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.473 -1.392 . . . . 0.0 110.476 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 195' ' ' LEU . 0.7 OUTLIER -75.7 -35.0 60.42 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.566 ' OD2' HD12 ' A' ' 229' ' ' LEU . 1.0 OUTLIER -93.86 -144.21 0.24 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.919 ' N ' HD11 ' A' ' 229' ' ' LEU . 15.1 t -109.69 37.78 2.55 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.447 ' HB ' HG21 ' A' ' 187' ' ' THR . 11.8 m -84.83 -35.58 22.19 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.63 -0.669 . . . . 0.0 110.94 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.623 ' N ' HG21 ' A' ' 187' ' ' THR . . . -120.82 -87.39 0.97 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 118.852 -1.642 . . . . 0.0 109.024 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.584 HG21 HD11 ' A' ' 164' ' ' LEU . 90.9 m -114.85 -105.91 0.39 Allowed 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.606 ' HB3' ' CB ' ' A' ' 197' ' ' LEU . 52.3 m-80 -157.62 70.76 0.6 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.113 -0.992 . . . . 0.0 108.744 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.923 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.7 OUTLIER -19.58 -91.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.812 0.815 . . . . 0.0 112.618 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.836 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -66.95 -11.81 57.7 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.045 -1.034 . . . . 0.0 111.656 -176.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 1.006 HD11 ' CG ' ' A' ' 221' ' ' PRO . 11.7 tp -64.2 -55.48 21.34 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.841 HG12 ' HB3' ' A' ' 165' ' ' ALA . 2.8 t -76.08 -9.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.064 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.97 -57.2 3.87 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.391 -1.324 . . . . 0.0 107.534 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.22 -19.02 65.78 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.602 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 3.7 t-160 -68.22 -41.12 81.78 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.672 177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.703 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 28.4 mt-10 -83.64 -49.11 9.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 110.778 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.733 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -58.73 -31.85 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.71 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.39 -35.69 36.56 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -56.18 -53.68 54.21 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.674 -0.897 . . . . 0.0 110.319 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.667 ' HB2' HD12 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -83.72 -56.83 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 111.579 -178.23 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.986 ' HG ' HD11 ' A' ' 142' ' ' ILE . 7.4 mt -102.54 37.6 1.88 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.23 -0.919 . . . . 0.0 110.971 -177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 1.03 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -141.63 -75.34 0.04 OUTLIER Glycine 0 C--N 1.291 -1.926 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.845 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.7 pp -170.31 -164.28 0.39 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.994 -1.297 . . . . 0.0 109.657 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.1 OUTLIER -98.48 -79.55 0.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.276 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.487 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 0.7 OUTLIER -154.29 105.9 2.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 0.0 109.164 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.653 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -94.54 -176.45 3.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.287 -0.883 . . . . 0.0 109.096 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.974 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -62.4 81.99 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.952 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.84 10.5 18.37 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.849 -1.14 . . . . 0.0 111.64 -177.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.3 OUTLIER -50.28 -27.82 6.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 174.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.516 ' C ' ' HB2' ' A' ' 235' ' ' SER . 23.5 mm-40 -115.81 -36.85 4.06 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.952 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -173.01 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.517 1.151 . . . . 0.0 112.766 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.926 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -85.73 -17.06 36.96 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.977 -177.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.742 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -78.51 -8.11 58.21 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.461 -2.024 . . . . 0.0 112.366 -177.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.682 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 7.0 t80 -133.01 14.74 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 120.25 -1.531 . . . . 0.0 113.472 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 1.006 ' CG ' HD11 ' A' ' 197' ' ' LEU . 52.2 Cg_endo -77.77 -41.88 0.29 Allowed 'Trans proline' 0 C--N 1.319 -1.024 0 N-CA-C 109.541 -0.984 . . . . 0.0 109.541 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 1.077 HD13 ' CD2' ' A' ' 3' ' ' MSB . 0.5 OUTLIER -8.73 -69.0 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.578 -178.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.931 ' N ' HD23 ' A' ' 222' ' ' LEU . 7.9 t80 -65.91 59.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.71 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.9 t-160 179.77 -143.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.257 -0.902 . . . . 0.0 109.316 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.42 ' C ' HD23 ' A' ' 226' ' ' LEU . 49.4 m -152.59 123.48 7.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.066 -1.021 . . . . 0.0 109.556 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.973 HD21 ' HB2' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 179.52 59.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.851 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.568 ' O ' ' CD2' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -109.02 -45.98 3.68 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.59 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 33.0 t70 -138.3 -13.55 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.025 -1.047 . . . . 0.0 110.432 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.919 HD11 ' N ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -37.6 -100.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.264 -0.897 . . . . 0.0 111.055 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.46 -16.41 0.82 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.434 -1.416 . . . . 0.0 110.383 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.535 ' O ' ' CD ' ' A' ' 233' ' ' ARG . 2.1 mtp180 -114.54 -22.19 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 108.849 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' A' ' 228' ' ' ASP . 30.4 p90 -30.65 115.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.419 0.628 . . . . 0.0 111.944 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.544 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.42 166.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.587 -0.696 . . . . 0.0 109.758 178.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.051 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.6 mp -77.87 165.32 24.27 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.173 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.737 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 31.1 t -99.88 -170.17 1.85 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 118.699 -1.201 . . . . 0.0 110.302 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.524 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.8 pp0? -83.93 -16.93 42.4 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.637 -0.665 . . . . 0.0 109.968 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.974 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.1 m-20 -81.95 -48.57 11.31 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.141 -1.023 . . . . 0.0 108.257 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.727 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.47 -38.34 90.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 117.328 -1.749 . . . . 0.0 106.728 177.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.605 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.42 -35.93 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.47 -60.12 3.28 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.454 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -49.51 -49.53 32.64 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.03 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.4 tp -65.09 -46.69 90.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 120.772 -1.428 . . . . 0.0 110.015 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.535 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.2 tt0 -53.34 -27.1 21.73 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.4 t -84.96 -17.91 36.22 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 1.003 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -75.37 -60.58 2.24 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.553 -0.717 . . . . 0.0 109.592 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.901 ' OH ' HD22 ' A' ' 207' ' ' LEU . 10.2 m-30 -84.87 -120.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.449 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 79.76 135.77 1.35 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.657 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 49.1 Cg_endo -72.78 174.74 11.33 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.92 1.484 . . . . 0.0 109.702 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.595 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 38.1 Cg_endo -66.52 -25.89 47.57 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.788 1.658 . . . . 0.0 114.487 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 42.8 Cg_endo -83.95 -71.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 120.465 0.777 . . . . 0.0 110.098 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 250' ' ' PRO . 11.5 t70 -43.31 -35.3 1.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 109.706 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.96 88.2 0.23 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.505 ' CG ' ' O ' ' A' ' 249' ' ' PRO . 42.1 Cg_endo -74.65 -45.13 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.032 1.543 . . . . 0.0 110.137 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.449 ' OE1' ' HB2' ' A' ' 253' ' ' PRO . 1.9 pm0 -153.19 -39.11 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.554 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.524 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.49 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.502 ' HD1' ' OB1' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 1.077 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.498 ' O ' ' CD2' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -80.99 -69.42 0.61 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 108.965 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 86' ' ' PHE . 71.0 p -60.97 -91.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.532 -0.73 . . . . 0.0 109.525 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.498 ' N ' ' OG1' ' A' ' 85' ' ' THR . 0.4 OUTLIER 179.96 108.98 0.19 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.88 . . . . 0.0 109.458 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.94 60.72 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.903 1.475 . . . . 0.0 110.066 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.65 -129.5 2.29 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 89' ' ' ILE . 42.0 mt -67.47 125.01 90.56 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.244 -1.151 . . . . 0.0 109.517 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.777 ' HB2' HD23 ' A' ' 245' ' ' LEU . 42.6 Cg_endo -73.28 -162.13 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.882 1.464 . . . . 0.0 110.195 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -63.45 -85.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.652 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.612 ' CD1' HD13 ' A' ' 207' ' ' LEU . 59.3 m95 -97.72 174.44 6.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.189 . . . . 0.0 109.625 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.4 ppt_? -135.35 -38.81 0.75 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.636 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.913 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.08 169.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.284 -0.885 . . . . 0.0 110.073 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.539 ' HA ' ' CD2' ' A' ' 130' ' ' LEU . 30.7 p -105.98 3.34 28.24 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.328 -0.857 . . . . 0.0 109.876 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.551 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 65.4 m-70 -136.11 91.04 2.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.882 -1.136 . . . . 0.0 109.946 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.913 HD13 ' HE2' ' A' ' 94' ' ' LYS . 2.6 mm? -94.98 168.22 10.92 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.599 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -142.86 156.51 44.94 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.872 -1.142 . . . . 0.0 109.0 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 1.025 ' CZ ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.5 172.59 12.78 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.994 -1.066 . . . . 0.0 109.927 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.52 ' HD2' ' CG2' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -136.77 144.27 43.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.428 -0.795 . . . . 0.0 109.798 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.025 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 1.8 mp -100.68 76.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.14 -0.975 . . . . 0.0 110.041 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' A' ' 144' ' ' ILE . 29.1 t -94.21 8.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.995 . . . . 0.0 109.699 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.853 ' C ' HG21 ' A' ' 113' ' ' VAL . 8.6 m-80 -99.36 163.06 12.69 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.952 -1.092 . . . . 0.0 109.243 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.714 ' N ' HG21 ' A' ' 113' ' ' VAL . 17.7 p90 179.33 55.44 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.531 -0.731 . . . . 0.0 109.917 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.965 HG21 ' CD1' ' A' ' 186' ' ' TRP . 46.9 p -42.94 150.24 0.46 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.008 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.93 -25.99 44.39 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.886 1.466 . . . . 0.0 109.203 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.475 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -77.44 -1.21 29.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.965 HD13 ' CD1' ' A' ' 195' ' ' LEU . 99.1 mt -141.15 115.89 7.16 Favored Pre-proline 0 N--CA 1.484 1.258 0 O-C-N 121.473 -0.767 . . . . 0.0 109.613 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.5 Cg_endo -66.09 173.87 6.67 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 O-C-N 123.807 1.425 . . . . 0.0 109.141 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' HE3' ' CG ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -37.48 -65.35 0.32 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.805 0.812 . . . . 0.0 110.421 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -57.59 -29.64 64.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.861 -0.525 . . . . 0.0 112.336 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.83 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -71.68 -61.98 1.58 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.261 -1.525 . . . . 0.0 109.064 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.976 ' O ' HG23 ' A' ' 117' ' ' VAL . 8.3 p -52.23 -39.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.504 ' OD1' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -63.09 -28.15 69.88 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.863 ' OG ' HD21 ' A' ' 195' ' ' LEU . 16.4 p -64.96 -40.4 94.93 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.061 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.56 -33.15 64.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.962 -1.087 . . . . 0.0 109.892 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.998 HG12 ' CE2' ' A' ' 99' ' ' TYR . 2.0 t -74.86 -24.82 18.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -88.52 -35.04 17.19 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.818 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -77.89 -39.66 42.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.87 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.28 -62.99 1.21 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 122.399 1.095 . . . . 0.0 108.439 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.776 ' HA ' HG21 ' A' ' 203' ' ' ILE . 10.0 tp -50.63 -44.76 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -73.18 -32.89 65.11 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.385 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.02 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.3 t -54.63 -43.16 64.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.06 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.9 m95 -91.71 -23.57 19.74 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.646 -1.221 . . . . 0.0 110.808 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 3.5 tp10 -70.45 -27.73 64.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.595 -1.316 . . . . 0.0 107.966 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.461 ' OE1' ' HG3' ' A' ' 122' ' ' LYS . 13.2 pt-20 -89.61 -42.92 11.12 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.977 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.02 HG13 ' O ' ' A' ' 123' ' ' VAL . 17.1 m -59.91 -24.58 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.354 -1.339 . . . . 0.0 109.291 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.03 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -110.04 155.99 40.77 Favored Pre-proline 0 N--CA 1.495 1.795 0 C-N-CA 117.963 -1.495 . . . . 0.0 109.891 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HG2' ' C ' ' A' ' 247' ' ' GLY . 53.9 Cg_endo -81.15 10.62 3.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.14 1.894 . . . . 0.0 110.742 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.743 HD13 ' HB3' ' A' ' 246' ' ' TYR . 3.9 mp -96.46 -178.98 4.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.86 -1.15 . . . . 0.0 110.405 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.444 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -118.78 167.56 11.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.401 -0.812 . . . . 0.0 110.198 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.603 ' HE2' HD11 ' A' ' 142' ' ' ILE . 8.3 m-85 -141.7 -179.43 6.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.54 -0.725 . . . . 0.0 109.447 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 -162.64 1.37 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.898 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -162.05 -178.58 6.51 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.91 -1.119 . . . . 0.0 110.534 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -164.17 -128.71 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER 177.19 31.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.621 -1.299 . . . . 0.0 109.532 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.484 ' O ' ' C ' ' A' ' 138' ' ' GLY . 3.2 pm0 -171.28 -161.78 0.22 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.106 -0.996 . . . . 0.0 109.729 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 35.5 -98.35 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.507 ' OE2' ' CA ' ' A' ' 173' ' ' GLY . 0.0 OUTLIER 177.81 107.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -1.098 . . . . 0.0 110.634 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 1.013 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -67.26 -155.34 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.78 ' OD2' HD12 ' A' ' 97' ' ' LEU . 8.5 t0 -81.47 -32.3 32.57 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.718 HD11 ' HG ' ' A' ' 207' ' ' LEU . 1.7 mt -126.86 85.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.581 ' CG ' ' O ' ' A' ' 143' ' ' MET . 5.5 ptm -76.65 100.18 5.29 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 118.413 -1.315 . . . . 0.0 108.91 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.89 HG13 HG13 ' A' ' 117' ' ' VAL . 4.4 mm -79.39 114.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 108.087 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -135.95 159.79 40.6 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.475 -1.391 . . . . 0.0 112.065 -178.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.488 ' HA ' ' OD1' ' A' ' 103' ' ' ASN . 17.2 p90 -80.19 140.16 36.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.034 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -170.47 177.94 3.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 110.625 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.574 ' CG2' ' CA ' ' A' ' 159' ' ' GLY . 11.5 p 179.44 143.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER 1.23 67.23 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.399 0.618 . . . . 0.0 112.096 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 148' ' ' VAL . 26.2 tt0 179.09 32.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.291 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 38.9 m80 -71.78 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.655 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -133.87 -50.96 0.08 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -169.18 -53.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -1.153 . . . . 0.0 109.96 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.47 ' C ' ' CD ' ' A' ' 156' ' ' PRO . 5.7 t80 -99.26 6.5 46.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 109.992 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.65 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 19.5 m-85 -118.13 34.71 0.21 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.092 -1.005 . . . . 0.0 110.928 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 43.7 Cg_endo -74.16 113.96 3.92 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 N-CA-C 108.867 -1.243 . . . . 0.0 108.867 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.003 ' CZ ' HG12 ' A' ' 163' ' ' VAL . 1.8 t80 -76.11 -136.87 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.901 -1.124 . . . . 0.0 109.97 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.603 ' CB ' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -135.31 -30.55 1.02 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.796 -1.19 . . . . 0.0 110.879 -178.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.574 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 52.9 -107.67 0.59 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.55 ' HD2' ' CD ' ' A' ' 149' ' ' ARG . 31.5 Cg_endo -56.43 91.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 121.164 1.242 . . . . 0.0 110.829 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.517 ' HA3' ' OD2' ' A' ' 158' ' ' ASP . . . 161.73 -164.15 35.06 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 163' ' ' VAL . 41.8 m-80 -86.19 -30.53 22.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -1.226 . . . . 0.0 110.486 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.076 HG13 ' CG2' ' A' ' 1' ' ' HAV . 7.9 t -39.92 100.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.021 HD23 HG21 ' A' ' 198' ' ' VAL . 0.9 OUTLIER -71.23 -70.36 0.32 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.447 -0.783 . . . . 0.0 111.723 -179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.715 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -161.37 -165.96 1.43 Allowed 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.42 -1.425 . . . . 0.0 111.071 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.681 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.6 OUTLIER 179.49 -165.67 0.06 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 119.897 -1.752 . . . . 0.0 110.646 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.623 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -165.05 -167.05 1.11 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.307 -0.87 . . . . 0.0 110.423 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.528 ' O ' ' CB ' ' A' ' 206' ' ' SER . 86.7 m-85 -133.11 -159.71 0.99 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.97 . . . . 0.0 110.053 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.985 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -161.9 -63.26 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.062 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.985 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.5 Cg_endo -77.05 174.86 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.814 1.428 . . . . 0.0 110.409 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.526 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 102.05 172.03 27.5 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' A' ' 174' ' ' ILE . 40.8 Cg_endo -74.81 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.665 1.577 . . . . 0.0 109.664 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.507 ' CA ' ' OE2' ' A' ' 139' ' ' GLU . . . -79.58 -35.1 29.85 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.3 tt -69.85 3.43 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 121.81 -0.817 . . . . 0.0 109.011 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 170' ' ' PRO . 5.5 t30 -64.94 61.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.391 -0.818 . . . . 0.0 109.105 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.59 ' HA2' ' OG ' ' A' ' 206' ' ' SER . . . 107.47 89.51 2.08 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 76.1 m-20 -141.69 126.13 17.71 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.757 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -108.82 149.19 29.45 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.817 -1.177 . . . . 0.0 108.106 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.034 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -144.07 130.48 19.9 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.955 179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.581 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 18.6 m-85 -85.17 134.86 34.15 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.593 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 3.6 p-10 -75.18 132.03 40.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.415 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 183' ' ' ASP . 6.4 t0 -75.44 -0.87 21.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.477 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 47.4 t0 -30.84 -72.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.512 0.672 . . . . 0.0 112.074 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.467 ' OE1' ' OD2' ' A' ' 183' ' ' ASP . 0.4 OUTLIER -114.83 -110.96 0.35 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.084 -176.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.577 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 2.1 mt-30 -133.84 -168.77 2.17 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.817 -1.177 . . . . 0.0 109.739 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.965 ' CD1' HG21 ' A' ' 105' ' ' THR . 85.2 m95 -155.07 136.13 13.84 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.792 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.6 p -145.45 152.88 40.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.204 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.757 ' O ' HG23 ' A' ' 227' ' ' THR . 0.0 OUTLIER -73.04 -34.01 66.04 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.522 ' HA ' HD13 ' A' ' 229' ' ' LEU . 1.3 t70 -90.54 -151.07 0.24 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.868 HG23 HD11 ' A' ' 229' ' ' LEU . 1.4 p -103.76 35.11 2.73 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 118.286 -1.365 . . . . 0.0 107.927 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.546 ' CB ' HG21 ' A' ' 187' ' ' THR . 13.2 m -81.6 -36.16 29.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.263 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 187' ' ' THR . . . -119.96 -81.05 0.67 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.155 -1.498 . . . . 0.0 109.699 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.807 ' CG2' HD21 ' A' ' 164' ' ' LEU . 85.0 m -127.51 -79.08 0.58 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.373 -1.074 . . . . 0.0 108.704 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.877 HD22 HD23 ' A' ' 197' ' ' LEU . 42.9 p30 179.26 60.87 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.033 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.5 OUTLIER -18.44 -92.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.591 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.829 ' HE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -64.34 -16.95 63.2 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 111.127 -176.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 1.057 HD11 HD23 ' A' ' 226' ' ' LEU . 13.3 tp -60.94 -61.17 2.77 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 117.208 -1.797 . . . . 0.0 107.724 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.021 HG21 HD23 ' A' ' 164' ' ' LEU . 13.7 t -74.54 -7.66 10.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.629 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.061 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -74.89 -57.83 3.66 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.752 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.36 -16.47 64.09 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.585 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 8.5 t60 -70.12 -39.63 75.34 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.18 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.757 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 30.0 mt-10 -87.48 -46.96 9.13 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.028 -1.045 . . . . 0.0 110.366 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.87 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -61.41 -30.91 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.728 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.3 -34.85 44.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -58.68 -54.24 49.35 Favored 'General case' 0 C--N 1.289 -2.042 0 O-C-N 121.686 -0.891 . . . . 0.0 110.292 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.59 ' OG ' ' HA2' ' A' ' 176' ' ' GLY . 30.4 t -77.24 -60.21 2.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.633 -0.667 . . . . 0.0 112.486 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.718 ' HG ' HD11 ' A' ' 142' ' ' ILE . 1.1 mm? -104.01 31.49 4.5 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.236 -0.915 . . . . 0.0 110.529 -177.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 1.031 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -132.59 -77.95 0.14 Allowed Glycine 0 C--N 1.292 -1.912 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.821 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.83 -166.01 0.54 Allowed 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.945 -1.327 . . . . 0.0 110.054 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.821 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.1 OUTLIER -98.51 -74.82 0.57 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.29 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 79.2 m80 -160.12 110.38 1.85 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.779 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 2.0 m -98.81 -172.59 2.33 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.823 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.95 78.84 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.925 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.22 9.52 12.68 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.624 -177.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 214' ' ' ASN . 30.5 p -48.4 -28.88 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 175.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.545 ' C ' ' HB3' ' A' ' 235' ' ' SER . 9.5 mt-10 -113.98 -37.66 4.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.925 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -67.58 162.46 23.41 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 122.456 1.122 . . . . 0.0 112.367 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.87 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -56.97 -20.78 25.69 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.243 -178.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.676 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -77.59 -9.21 58.82 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 118.984 -2.323 . . . . 0.0 112.182 -177.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.672 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 34.3 t80 -133.62 17.77 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 120.178 -1.576 . . . . 0.0 113.568 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.692 ' HG2' HD21 ' A' ' 197' ' ' LEU . 55.3 Cg_endo -78.23 -36.51 0.98 Allowed 'Trans proline' 0 C--N 1.319 -1.017 0 N-CA-C 108.433 -1.41 . . . . 0.0 108.433 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.975 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -24.63 -57.93 0.05 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.942 -179.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.975 ' N ' HD13 ' A' ' 222' ' ' LEU . 0.4 OUTLIER -73.45 54.53 0.45 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.068 -1.02 . . . . 0.0 109.883 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.597 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 2.7 m170 -175.31 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 0.0 109.465 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.511 ' O ' ' NH1' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 179.57 121.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.994 -1.066 . . . . 0.0 109.117 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 1.057 HD23 HD11 ' A' ' 197' ' ' LEU . 3.1 tp 178.9 119.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.153 -0.967 . . . . 0.0 109.881 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER 179.12 -34.69 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 38.6 t0 -159.95 -22.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.81 -0.556 . . . . 0.0 109.596 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.868 HD11 HG23 ' A' ' 190' ' ' THR . 0.2 OUTLIER -34.5 -59.17 0.47 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.195 -0.941 . . . . 0.0 110.434 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.96 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.325 -0.859 . . . . 0.0 108.791 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.527 ' O ' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -90.32 -12.97 36.16 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.581 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 21.2 p90 -30.43 99.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.672 0.749 . . . . 0.0 111.221 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.537 ' CZ ' ' O ' ' A' ' 234' ' ' LEU . 2.1 ttt-85 178.79 154.4 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 0.0 109.82 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.06 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.3 mp -76.69 163.8 26.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.229 -0.919 . . . . 0.0 109.84 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.88 ' OG ' ' HB2' ' A' ' 217' ' ' ALA . 8.3 p -101.99 -168.69 1.58 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.076 -1.45 . . . . 0.0 110.485 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 236' ' ' GLN . 38.9 tp60 -84.25 -14.1 50.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.357 -0.839 . . . . 0.0 111.313 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.823 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.1 OUTLIER -84.46 -44.02 14.05 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.451 -1.406 . . . . 0.0 107.882 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.816 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 0.7 OUTLIER -67.63 -40.63 84.62 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.573 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.06 -35.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.07 -47.65 70.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.501 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.12 -54.53 36.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.031 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.4 tp -62.01 -46.08 97.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 120.929 -1.336 . . . . 0.0 109.792 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.529 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.0 OUTLIER -53.37 -31.38 44.4 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 4.0 t -77.56 -20.02 54.76 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.921 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.4 OUTLIER -70.03 -61.25 1.85 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.743 ' HB3' HD13 ' A' ' 130' ' ' LEU . 23.4 m-85 -99.1 -122.84 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.442 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.484 ' C ' ' HG2' ' A' ' 129' ' ' PRO . . . 116.59 -170.27 13.32 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.92 117.7 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.024 1.539 . . . . 0.0 110.356 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.456 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 42.5 Cg_endo -73.09 173.32 13.85 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.086 1.572 . . . . 0.0 110.006 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 249' ' ' PRO . 41.2 Cg_endo -71.98 164.1 36.73 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.9 1.474 . . . . 0.0 110.129 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 252' ' ' SER . 0.9 OUTLIER -87.25 -82.46 0.22 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 251' ' ' ASP . 0.2 OUTLIER -43.45 126.8 3.76 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.88 -31.94 9.56 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.903 1.475 . . . . 0.0 110.072 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -120.83 -166.45 1.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.537 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.076 ' CG2' HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.531 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.772 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.292 0.568 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 85' ' ' THR . 1.3 mtp85 -95.59 -49.36 5.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.43 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 18.3 p -43.85 107.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.66 111.84 6.6 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.561 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.9 Cg_endo -73.03 156.51 51.94 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.99 1.521 . . . . 0.0 110.196 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 89' ' ' ILE . . . 79.16 -138.7 20.97 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 88' ' ' GLY . 67.5 mt -44.07 104.66 0.39 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.338 -1.095 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.828 ' HB2' HD23 ' A' ' 245' ' ' LEU . 42.8 Cg_endo -72.64 -162.81 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.054 1.555 . . . . 0.0 110.3 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -74.4 -78.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.172 -0.955 . . . . 0.0 109.879 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.632 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 26.7 m95 -94.95 177.18 5.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.927 -1.108 . . . . 0.0 109.909 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -139.66 -31.46 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -50.7 -172.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.022 -1.049 . . . . 0.0 110.401 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.885 ' HA ' HD22 ' A' ' 130' ' ' LEU . 9.6 p -123.55 -0.67 8.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.559 -0.713 . . . . 0.0 109.211 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 64.4 m80 -136.94 91.01 2.59 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.188 -0.945 . . . . 0.0 110.002 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.5 mm? -88.55 164.47 15.39 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.542 -0.724 . . . . 0.0 109.586 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.609 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.5 OUTLIER -142.51 155.84 45.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 1.008 ' CE2' HD11 ' A' ' 101' ' ' ILE . 5.6 p90 -137.23 163.48 30.81 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.655 -1.278 . . . . 0.0 109.276 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.738 ' HD2' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -123.27 126.2 46.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.2 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.008 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.1 mp -81.93 77.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.95 -1.094 . . . . 0.0 109.835 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.738 HG22 ' HD2' ' A' ' 100' ' ' ARG . 9.3 t -89.39 4.62 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.309 -0.869 . . . . 0.0 109.714 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.869 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -101.35 155.11 18.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.671 -1.268 . . . . 0.0 109.393 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.627 ' N ' HG21 ' A' ' 113' ' ' VAL . 9.1 t80 177.85 76.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.622 0.725 . . . . 0.0 109.224 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.81 HG21 ' CD1' ' A' ' 186' ' ' TRP . 2.6 p -75.61 161.98 74.17 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.184 -0.947 . . . . 0.0 108.957 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.56 -21.45 39.78 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.921 1.485 . . . . 0.0 108.573 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.544 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -71.09 -7.38 46.15 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.059 HD21 ' HA ' ' A' ' 187' ' ' THR . 84.3 mt -148.13 123.3 5.11 Favored Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.7 167.83 14.6 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 123.862 1.454 . . . . 0.0 108.828 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.3 -64.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.818 0.818 . . . . 0.0 110.361 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 115' ' ' SER . 7.6 t0 -56.17 -26.63 51.36 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.675 -0.641 . . . . 0.0 111.736 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.806 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -74.06 -61.15 1.95 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.474 -1.391 . . . . 0.0 109.442 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.92 ' O ' HG23 ' A' ' 117' ' ' VAL . 7.6 p -53.14 -40.09 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.782 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -66.25 -27.14 67.73 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.906 ' OG ' HD21 ' A' ' 195' ' ' LEU . 7.5 p -62.01 -43.47 98.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.068 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -71.28 -34.01 70.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.997 -1.064 . . . . 0.0 109.41 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.9 t -71.93 -23.27 21.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.84 -34.89 14.36 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 1.7 tppt? -75.59 -40.77 56.08 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -64.89 -60.67 2.81 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.007 HD22 ' CZ ' ' A' ' 99' ' ' TYR . 8.5 tp -44.73 -50.85 9.81 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.546 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 0.8 OUTLIER -73.25 -34.23 65.72 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.464 -177.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.016 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -54.04 -42.23 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.01 ' O ' HG23 ' A' ' 128' ' ' THR . 42.7 m95 -91.74 -23.13 19.85 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.919 -1.113 . . . . 0.0 110.445 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.59 ' HA ' ' CE1' ' A' ' 132' ' ' PHE . 2.5 tm-20 -70.3 -27.3 64.28 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.5 pt-20 -90.38 -43.22 10.46 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.712 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.016 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.3 m -58.17 -25.7 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.819 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.01 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.7 152.37 45.44 Favored Pre-proline 0 N--CA 1.492 1.666 0 C-N-CA 118.435 -1.306 . . . . 0.0 108.955 179.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.513 ' CG ' ' HA2' ' A' ' 247' ' ' GLY . 45.2 Cg_endo -73.47 2.01 6.2 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 121.878 1.719 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.032 HD12 ' CG ' ' A' ' 246' ' ' TYR . 20.5 mt -84.2 -178.06 6.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.7 p -124.25 167.37 14.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 110.148 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.764 ' HB3' HD11 ' A' ' 121' ' ' LEU . 20.0 m-85 -135.96 170.47 15.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.574 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.566 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.27 175.04 12.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 108.7 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -142.43 156.91 45.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.95 -1.094 . . . . 0.0 110.075 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.958 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.8 OUTLIER -146.77 -134.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 178.46 32.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.862 -1.148 . . . . 0.0 109.347 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' OE2' ' HB2' ' A' ' 135' ' ' LEU . 7.8 pm0 -158.4 -177.82 6.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.873 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.03 -97.65 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 137' ' ' GLU . 2.2 pt-20 178.8 107.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.958 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -59.59 -151.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 108.95 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.843 ' O ' HD13 ' A' ' 142' ' ' ILE . 31.3 m-20 -89.87 -30.71 17.72 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.076 HD11 HD21 ' A' ' 207' ' ' LEU . 20.3 mm -127.18 82.13 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.521 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 0.0 OUTLIER -64.64 96.75 0.18 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 108.813 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.869 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.9 mm -81.31 117.17 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -135.64 150.65 49.69 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.249 -1.532 . . . . 0.0 111.867 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.572 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 17.1 p90 -81.68 141.28 33.76 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.485 -0.759 . . . . 0.0 109.117 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.581 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -166.1 -179.04 4.92 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.886 -1.134 . . . . 0.0 110.675 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.961 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.7 p -165.36 -148.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.797 . . . . 0.0 109.247 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.839 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -31.61 -66.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.645 -0.659 . . . . 0.0 110.339 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -54.54 134.22 46.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.967 . . . . 0.0 109.324 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -155.39 -84.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 0.0 109.766 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.84 37.16 0.59 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.484 ' OD1' ' CE2' ' A' ' 154' ' ' PHE . 8.0 t0 -179.89 -146.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -1.176 . . . . 0.0 109.619 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.484 ' CE2' ' OD1' ' A' ' 153' ' ' ASP . 0.2 OUTLIER -102.84 47.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.141 -0.975 . . . . 0.0 109.286 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.68 ' CE2' ' CE1' ' A' ' 168' ' ' TYR . 24.8 m-85 -144.6 49.44 1.01 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.485 -0.76 . . . . 0.0 109.111 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 42.2 Cg_endo -72.0 133.86 22.33 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.177 1.619 . . . . 0.0 109.969 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.996 ' CE1' HG12 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -111.04 -170.59 1.66 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.205 -0.934 . . . . 0.0 110.44 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 160' ' ' PRO . 58.7 p30 -179.79 54.8 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.698 -0.626 . . . . 0.0 110.062 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 15.23 -79.89 0.0 OUTLIER Glycine 0 N--CA 1.507 3.385 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.584 ' N ' ' O ' ' A' ' 158' ' ' ASP . 36.7 Cg_endo -63.71 65.24 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.679 1.357 . . . . 0.0 110.118 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.1 135.63 3.81 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 1.075 ' O ' HD12 ' A' ' 164' ' ' LEU . 82.6 m-20 -39.44 -36.97 0.41 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 109.975 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.002 HG13 ' CG2' ' A' ' 1' ' ' HAV . 2.6 t -54.73 87.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 109.168 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.075 HD12 ' O ' ' A' ' 162' ' ' ASN . 1.4 mp -83.65 -48.94 9.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.11 -0.994 . . . . 0.0 112.76 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.63 ' HB1' ' OE2' ' A' ' 202' ' ' GLU . . . -159.0 -173.14 4.09 Favored 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.096 -1.627 . . . . 0.0 111.261 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.729 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.4 p-80 178.24 -175.46 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.772 -1.83 . . . . 0.0 111.552 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.45 -177.82 6.6 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.68 ' CE1' ' CE2' ' A' ' 155' ' ' TYR . 22.3 m-30 -116.73 -169.59 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.756 -1.215 . . . . 0.0 111.708 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.988 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -116.91 -165.87 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.988 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 41.5 Cg_endo -74.05 129.76 13.59 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.073 1.039 . . . . 0.0 111.039 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . -175.19 -169.88 37.52 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.99 98.26 1.15 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.696 1.366 . . . . 0.0 109.772 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 83.27 -49.1 4.17 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 176' ' ' GLY . 4.2 tt -71.46 6.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.557 -0.966 . . . . 0.0 109.225 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.601 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 2.4 t-20 -64.55 62.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.435 -0.79 . . . . 0.0 108.876 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' A' ' 142' ' ' ILE . . . 104.84 104.19 2.91 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.603 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.8 m-20 -159.04 120.5 3.37 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.881 -1.364 . . . . 0.0 107.682 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . -109.99 172.12 7.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.625 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -162.65 137.67 6.8 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.237 1.018 . . . . 0.0 110.401 178.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.622 ' CE1' HG23 ' A' ' 198' ' ' VAL . 61.6 m-85 -100.49 136.75 39.88 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.746 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.961 ' OD1' HG23 ' A' ' 148' ' ' VAL . 28.3 t0 -58.32 151.9 18.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.799 -1.188 . . . . 0.0 108.763 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.51 ' OD2' ' CD1' ' A' ' 146' ' ' PHE . 1.2 m-20 -115.73 4.05 13.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.158 -0.964 . . . . 0.0 110.194 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.628 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 17.4 m-20 -112.13 26.51 10.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.095 -1.003 . . . . 0.0 109.927 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.479 ' OE2' ' HG ' ' A' ' 164' ' ' LEU . 5.5 mt-10 -129.42 -94.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.131 -0.981 . . . . 0.0 108.702 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CD2' ' A' ' 186' ' ' TRP . 2.0 mt-30 179.05 169.56 0.94 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.81 ' CD1' HG21 ' A' ' 105' ' ' THR . 65.4 m95 -159.15 131.98 6.94 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.04 -1.038 . . . . 0.0 109.539 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 1.059 ' HA ' HD21 ' A' ' 108' ' ' LEU . 68.1 p -157.68 149.86 22.39 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.984 -1.072 . . . . 0.0 110.067 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.829 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -80.19 -31.86 38.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.4 t70 -85.27 61.26 6.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.992 ' HB ' HD21 ' A' ' 229' ' ' LEU . 5.9 t 3.71 60.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 CA-C-O 121.958 0.885 . . . . 0.0 111.878 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.7 m -123.55 -32.0 3.42 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.32 -0.863 . . . . 0.0 109.392 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.407 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -91.03 -74.06 1.28 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.794 HG21 HD23 ' A' ' 164' ' ' LEU . 48.1 m -135.02 -79.74 0.44 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.737 ' ND2' HG22 ' A' ' 193' ' ' THR . 0.0 OUTLIER 179.9 68.68 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.296 1.046 . . . . 0.0 108.861 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.068 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 2.2 tp -30.06 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.082 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 1.0 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -63.58 -6.73 5.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 110.81 -177.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 1.01 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.1 tp -67.7 -62.43 1.42 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.265 -1.774 . . . . 0.0 107.127 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.777 HG21 ' CZ3' ' A' ' 186' ' ' TRP . 3.0 m -68.29 -15.4 19.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.005 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -71.45 -61.97 1.58 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.697 -1.201 . . . . 0.0 107.938 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.718 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -63.66 -15.8 59.31 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 120.266 -1.521 . . . . 0.0 106.946 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.6 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 7.5 t60 -68.19 -48.62 64.77 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.025 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.659 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 13.6 mt-10 -81.26 -45.39 16.32 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.179 -0.951 . . . . 0.0 111.098 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.1 mt -62.07 -31.31 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.687 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.8 -30.77 57.31 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -61.79 -51.01 70.04 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 121.87 -0.782 . . . . 0.0 110.746 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.627 ' CB ' HD12 ' A' ' 142' ' ' ILE . 72.8 m -82.89 -54.93 4.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.362 -0.836 . . . . 0.0 112.174 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 1.076 HD21 HD11 ' A' ' 142' ' ' ILE . 7.0 mt -104.25 23.71 12.67 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.019 -1.051 . . . . 0.0 110.828 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.971 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -125.11 -79.16 0.36 Allowed Glycine 0 C--N 1.291 -1.938 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.837 -178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.944 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -169.02 -160.35 0.27 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.857 -1.378 . . . . 0.0 110.02 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.795 ' N ' HD12 ' A' ' 209' ' ' LEU . 1.7 t80 -97.77 -70.0 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.758 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 0.2 OUTLIER -162.59 90.81 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 109.434 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.631 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 3.4 m -79.93 176.6 9.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.11 -0.994 . . . . 0.0 109.323 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.84 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.57 81.37 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.961 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.45 9.34 13.62 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.761 -1.176 . . . . 0.0 111.061 -177.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -49.32 -28.33 4.78 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 175.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.526 ' C ' ' HB2' ' A' ' 235' ' ' SER . 0.7 OUTLIER -114.79 -36.19 4.58 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.961 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.34 -165.05 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.159 0.98 . . . . 0.0 112.227 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.01 HD11 ' HA ' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -102.8 -10.76 18.84 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.548 -177.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.744 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -81.32 -8.07 59.68 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.064 -1.647 . . . . 0.0 111.636 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.664 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -139.82 16.06 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 120.462 -1.399 . . . . 0.0 113.221 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.898 ' HB3' HD11 ' A' ' 226' ' ' LEU . 50.3 Cg_endo -73.98 -36.37 3.53 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.189 -1.504 . . . . 0.0 108.189 178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 1.069 ' CD1' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -5.0 -73.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.62 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.168 -179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.672 ' N ' HD23 ' A' ' 222' ' ' LEU . 1.9 m-85 -67.52 60.06 0.06 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -169.79 -144.84 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.239 -0.913 . . . . 0.0 109.536 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.402 ' C ' HD23 ' A' ' 226' ' ' LEU . 72.7 m -148.61 104.51 3.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.095 -1.003 . . . . 0.0 109.969 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.53 49.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 108.978 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.572 HG21 ' HA ' ' A' ' 194' ' ' ASN . 11.3 t -99.25 -12.08 20.7 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.276 -0.89 . . . . 0.0 110.046 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.704 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER 177.5 -19.03 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.04 -1.038 . . . . 0.0 111.244 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.992 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -33.17 -100.05 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.426 -0.796 . . . . 0.0 111.241 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.6 -16.28 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.637 -1.29 . . . . 0.0 109.746 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -106.33 -22.02 12.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.164 -0.96 . . . . 0.0 108.549 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.642 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.3 p90 -24.24 116.21 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.362 0.601 . . . . 0.0 111.388 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.552 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.76 171.61 0.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.346 -0.846 . . . . 0.0 110.254 179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.999 HD21 ' CH2' ' A' ' 124' ' ' TRP . 5.2 mp -87.61 172.14 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 111.089 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.719 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 14.5 t -104.98 -170.14 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.785 0.803 . . . . 0.0 109.985 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.548 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.0 OUTLIER -82.72 -16.38 48.27 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.66 -0.65 . . . . 0.0 109.711 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.84 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.0 OUTLIER -82.19 -50.6 8.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.102 -0.999 . . . . 0.0 108.34 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.944 ' OD1' HD21 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.86 -38.38 90.87 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 117.053 -1.859 . . . . 0.0 106.915 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 235' ' ' SER . 1.0 OUTLIER -57.76 -34.82 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.57 -52.04 43.45 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.361 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -55.75 -54.46 34.82 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.005 HG21 HG21 ' A' ' 127' ' ' VAL . 1.5 tp -64.3 -44.71 97.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 120.897 -1.355 . . . . 0.0 109.716 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.54 ' N ' HG23 ' A' ' 242' ' ' ILE . 5.2 tt0 -54.61 -28.42 46.4 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 42.5 t -80.16 -20.04 45.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' PRO . 0.5 OUTLIER -70.4 -66.61 0.58 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 1.032 ' CG ' HD12 ' A' ' 130' ' ' LEU . 16.5 m-85 -101.52 -127.32 0.2 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.513 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 92.38 -145.27 17.57 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.175 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.499 ' HB2' ' HD2' ' A' ' 249' ' ' PRO . 41.2 Cg_endo -71.69 173.43 12.62 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 121.791 1.661 . . . . 0.0 110.433 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.525 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 39.5 Cg_endo -69.49 174.65 8.97 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.157 1.609 . . . . 0.0 110.171 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 249' ' ' PRO . 38.1 Cg_endo -66.67 -156.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.875 1.46 . . . . 0.0 110.09 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 250' ' ' PRO . 1.8 p-10 -28.94 -52.76 0.11 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.888 -0.507 . . . . 0.0 110.923 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 251' ' ' ASP . 47.0 t -42.55 101.96 0.26 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.387 -0.821 . . . . 0.0 109.379 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 251' ' ' ASP . 42.3 Cg_endo -72.95 -43.69 0.73 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.028 1.541 . . . . 0.0 110.443 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.85 156.26 28.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.159 -0.963 . . . . 0.0 109.716 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.469 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.002 ' CG2' HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.536 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.754 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.241 0.543 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -152.81 -169.08 3.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.535 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.526 ' HA ' ' CB ' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -44.9 113.46 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.495 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.595 ' CD2' ' HD2' ' A' ' 87' ' ' PRO . 0.5 OUTLIER -45.93 171.0 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.595 ' HD2' ' CD2' ' A' ' 86' ' ' PHE . 41.8 Cg_endo -72.54 64.08 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.02 1.537 . . . . 0.0 109.96 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.64 94.41 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.491 HD11 ' HD1' ' A' ' 210' ' ' PHE . 3.6 pt -137.5 95.14 11.56 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.254 -1.145 . . . . 0.0 109.772 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.431 ' HA ' HD23 ' A' ' 245' ' ' LEU . 42.1 Cg_endo -72.51 91.34 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.999 1.526 . . . . 0.0 109.824 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.673 ' N ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -50.34 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.966 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.634 ' CD1' ' CD1' ' A' ' 207' ' ' LEU . 49.5 m95 -100.62 177.45 5.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.913 -1.117 . . . . 0.0 110.116 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -138.56 -36.33 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.817 . . . . 0.0 109.824 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.585 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -46.66 177.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.191 -0.943 . . . . 0.0 110.132 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.812 ' CB ' HD12 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -116.59 1.65 12.91 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.54 -0.725 . . . . 0.0 109.405 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.545 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 46.9 m170 -132.74 92.82 3.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.032 -1.042 . . . . 0.0 110.103 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.719 HD13 ' OD2' ' A' ' 141' ' ' ASP . 2.5 mm? -94.72 173.62 7.51 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.628 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -149.61 155.98 41.16 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 1.05 ' CE2' HD11 ' A' ' 101' ' ' ILE . 6.1 p90 -135.52 165.65 25.02 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.483 -1.386 . . . . 0.0 109.655 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.752 ' CD ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -124.65 122.78 38.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.006 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.05 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -82.38 84.5 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.971 -1.08 . . . . 0.0 109.802 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.752 HG22 ' CD ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -102.08 8.47 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 0.0 110.097 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.918 ' C ' HG21 ' A' ' 113' ' ' VAL . 25.4 m-80 -98.65 159.19 15.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.959 -1.088 . . . . 0.0 109.155 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.805 ' N ' HG21 ' A' ' 113' ' ' VAL . 6.0 t80 177.56 80.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.674 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.967 HG21 ' CD1' ' A' ' 186' ' ' TRP . 33.0 p -73.72 159.34 84.64 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.65 -22.2 38.08 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 123.774 1.407 . . . . 0.0 108.651 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -79.53 0.75 28.46 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.949 ' CD1' HD13 ' A' ' 195' ' ' LEU . 95.9 mt -148.33 118.44 4.22 Favored Pre-proline 0 N--CA 1.485 1.297 0 O-C-N 121.423 -0.798 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.09 174.25 6.16 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 123.885 1.466 . . . . 0.0 109.139 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.16 -66.06 0.32 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.783 0.802 . . . . 0.0 110.164 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 115' ' ' SER . 2.2 m-20 -56.39 -28.47 59.33 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.822 -0.548 . . . . 0.0 112.358 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.833 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.25 -61.15 1.9 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.317 -1.489 . . . . 0.0 109.468 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.918 HG21 ' C ' ' A' ' 103' ' ' ASN . 8.4 p -56.08 -44.06 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 1.035 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -60.89 -28.22 68.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -58.83 -63.83 1.15 Allowed 'General case' 0 C--O 1.194 -1.822 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.07 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -49.28 -32.52 11.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 144' ' ' ILE . 12.1 t -73.82 -24.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -90.65 -33.65 15.74 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.75 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 196' ' ' PHE . 0.0 OUTLIER -82.34 -37.04 26.28 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.819 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.46 -62.16 1.69 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.848 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -53.41 -42.04 66.61 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.766 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -70.9 -34.2 71.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.131 -178.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.901 HG13 HD22 ' A' ' 234' ' ' LEU . 1.7 t -57.34 -36.88 54.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.049 ' O ' HG23 ' A' ' 128' ' ' THR . 46.9 m95 -92.23 -24.25 19.08 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.929 -1.109 . . . . 0.0 110.667 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -73.11 -27.37 61.66 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.927 -1.108 . . . . 0.0 108.308 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -92.42 -42.82 9.54 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.994 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.994 HG21 HG21 ' A' ' 242' ' ' ILE . 22.7 m -62.26 -23.4 31.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.255 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.049 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -113.05 163.31 18.35 Favored Pre-proline 0 N--CA 1.495 1.783 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.403 179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.544 ' HG3' ' N ' ' A' ' 248' ' ' PRO . 48.6 Cg_endo -81.52 22.05 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.034 1.823 . . . . 0.0 111.51 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.812 HD12 ' CB ' ' A' ' 95' ' ' THR . 2.6 mm? -115.86 178.1 4.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.653 -1.279 . . . . 0.0 110.347 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.547 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.9 p -121.01 177.81 4.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.64 ' CE2' ' CB ' ' A' ' 97' ' ' LEU . 11.2 m-85 -146.96 146.03 29.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.765 . . . . 0.0 110.053 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.604 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 68.0 m -114.59 -170.55 1.76 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -149.82 165.45 32.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.612 -1.305 . . . . 0.0 110.992 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -163.15 -164.54 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 78.8 t80 -160.61 25.66 0.15 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' GLU . 8.7 pm0 -147.11 176.76 9.7 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.78 -97.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' GLU . 18.3 tt0 178.73 145.51 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -1.143 . . . . 0.0 110.45 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.628 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -101.09 -150.75 0.4 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.719 ' OD2' HD13 ' A' ' 97' ' ' LEU . 18.2 m-20 -90.55 -34.02 15.68 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.974 HD11 ' CG ' ' A' ' 207' ' ' LEU . 20.1 mm -124.04 83.63 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.528 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 5.9 ttp -66.11 97.87 0.41 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 109.195 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 1.014 HG13 HG13 ' A' ' 117' ' ' VAL . 5.8 mm -81.87 114.63 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.592 ' N ' ' ND2' ' A' ' 103' ' ' ASN . 0.9 OUTLIER -136.3 155.57 49.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.434 -1.416 . . . . 0.0 112.371 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 6.1 p90 -92.89 138.04 31.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.6 -0.688 . . . . 0.0 109.265 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.081 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -167.57 -158.65 0.28 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.29 -0.881 . . . . 0.0 110.47 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.649 HG13 ' N ' ' A' ' 149' ' ' ARG . 0.6 OUTLIER -173.38 -165.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.05 -1.031 . . . . 0.0 109.159 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.649 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.2 OUTLIER -49.87 89.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 0.0 109.759 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 148' ' ' VAL . 9.0 pt-20 179.58 32.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 0.0 109.643 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 45.5 m80 -77.98 -163.75 0.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.95 . . . . 0.0 109.428 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' O ' ' OD2' ' A' ' 153' ' ' ASP . . . -139.38 51.12 0.76 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 152' ' ' GLY . 1.1 m-20 -174.39 -91.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.648 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.452 ' C ' ' HD3' ' A' ' 156' ' ' PRO . 21.8 t80 -153.43 29.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.496 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.576 ' O ' ' CE1' ' A' ' 151' ' ' HIS . 82.0 m-85 -123.44 52.27 4.68 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.867 . . . . 0.0 109.496 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 41.1 Cg_endo -71.8 124.19 9.98 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.056 1.556 . . . . 0.0 109.943 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.765 ' CD2' ' CE1' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -80.83 -166.15 1.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.099 -1.001 . . . . 0.0 110.134 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.55 ' O ' ' C ' ' A' ' 159' ' ' GLY . 24.7 p30 179.64 60.2 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.667 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -29.3 -51.31 0.13 Allowed Glycine 0 N--CA 1.497 2.732 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.829 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 39.6 Cg_endo -66.54 60.04 0.52 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 N-CA-C 109.301 -1.076 . . . . 0.0 109.301 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -179.27 159.96 25.07 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 164' ' ' LEU . 73.7 m-20 -52.74 -38.41 60.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.127 . . . . 0.0 110.223 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.966 HG13 HG22 ' A' ' 1' ' ' HAV . 42.8 t -53.3 81.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.341 -0.849 . . . . 0.0 110.545 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.719 HD12 HD12 ' A' ' 222' ' ' LEU . 15.9 mt -68.63 -74.45 0.12 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.341 -0.849 . . . . 0.0 111.85 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.974 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -135.41 -176.26 4.21 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.491 -1.381 . . . . 0.0 111.614 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.746 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.5 p-80 178.98 168.55 0.94 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.564 -1.335 . . . . 0.0 110.107 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -132.92 -168.08 2.02 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.532 ' HB3' HG13 ' A' ' 174' ' ' ILE . 77.5 m-85 -114.4 -167.27 1.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.8 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.074 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -126.15 -175.62 0.43 Allowed Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 1.074 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 38.8 Cg_endo -68.9 140.19 45.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.537 1.283 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.437 ' C ' ' OD1' ' A' ' 175' ' ' ASN . . . 171.76 -125.49 1.19 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.499 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.0 Cg_endo -73.98 -93.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.812 1.427 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . -108.37 -18.34 9.8 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.4 OUTLIER -73.3 12.17 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.39 -1.064 . . . . 0.0 108.951 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 175' ' ' ASN . 0.6 OUTLIER -64.34 63.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.607 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 106.35 101.55 2.73 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.635 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 4.6 m-20 -163.16 120.11 1.86 Allowed 'General case' 0 C--N 1.29 -2.004 0 O-C-N 120.566 -1.549 . . . . 0.0 107.659 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.736 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -112.07 164.85 12.69 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.894 -1.129 . . . . 0.0 109.184 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.081 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -162.15 134.75 5.82 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.867 -1.133 . . . . 0.0 109.778 178.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.601 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 34.4 m-85 -95.48 132.67 40.32 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.189 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.519 ' HB3' ' CD1' ' A' ' 157' ' ' PHE . 24.5 p30 -66.72 130.19 42.37 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 182' ' ' ASP . 48.1 p30 -96.09 22.73 7.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.976 -1.077 . . . . 0.0 110.437 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.667 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.4 OUTLIER -90.75 -19.61 23.32 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.907 -1.121 . . . . 0.0 109.889 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.496 ' OE2' ' O ' ' A' ' 159' ' ' GLY . 0.9 OUTLIER -112.11 -130.78 0.31 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.896 -1.127 . . . . 0.0 108.595 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 35.3 mt-30 -130.97 -175.46 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.161 . . . . 0.0 109.097 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.967 ' CD1' HG21 ' A' ' 105' ' ' THR . 86.0 m95 -160.83 126.03 3.75 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.163 -0.961 . . . . 0.0 108.954 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.792 ' HA ' HD21 ' A' ' 108' ' ' LEU . 50.7 p -145.66 150.07 35.64 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.828 -1.17 . . . . 0.0 110.453 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 1.046 ' O ' HG23 ' A' ' 227' ' ' THR . 2.7 pttm -84.45 -33.18 23.71 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 27.9 t70 -82.31 63.72 6.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 1.05 ' HB ' HD21 ' A' ' 229' ' ' LEU . 1.7 t 2.82 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 122.311 1.053 . . . . 0.0 112.016 -177.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.0 m -127.31 -31.05 2.58 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.783 -1.198 . . . . 0.0 109.927 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.627 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -96.98 -80.41 1.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.761 HG22 ' OD1' ' A' ' 194' ' ' ASN . 37.5 m -125.12 -96.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.781 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -161.77 67.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.025 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 14.7 tp -37.97 -98.91 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.757 -0.589 . . . . 0.0 110.93 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.829 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.7 OUTLIER -58.73 -11.53 3.26 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.722 -1.236 . . . . 0.0 110.461 -178.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 1.084 ' O ' HD11 ' A' ' 218' ' ' LEU . 6.2 tp -64.92 -71.29 0.19 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 116.807 -1.957 . . . . 0.0 106.595 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.974 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 3.3 t -67.55 -4.57 3.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.433 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.07 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.21 -57.94 3.58 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.773 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.55 -16.91 64.51 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.602 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 3.0 t60 -69.5 -37.44 77.19 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.069 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.924 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 2.8 mt-10 -87.65 -48.65 7.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.147 -0.971 . . . . 0.0 110.177 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.819 HD12 ' HB3' ' A' ' 120' ' ' ALA . 1.9 mt -59.16 -31.55 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.709 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -82.21 -34.4 23.63 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.565 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 0.1 OUTLIER -56.31 -45.81 80.1 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.524 -0.986 . . . . 0.0 110.374 -179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 167' ' ' ALA . 1.0 OUTLIER -89.56 -54.1 4.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 111.582 -178.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.974 ' CG ' HD11 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -104.16 36.31 2.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.198 -0.939 . . . . 0.0 110.753 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.993 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -141.89 -78.14 0.05 OUTLIER Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.047 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.876 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.3 pp -169.2 -160.35 0.26 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.89 -1.359 . . . . 0.0 110.27 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.876 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.3 OUTLIER -102.54 -77.72 0.55 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.473 -0.767 . . . . 0.0 109.36 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.592 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 2.6 m-70 -159.44 121.75 3.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.453 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.622 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.5 OUTLIER -109.56 -168.37 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.716 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.38 74.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.97 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -79.71 7.36 8.66 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.289 -176.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.449 ' C ' ' O ' ' A' ' 214' ' ' ASN . 2.7 p -50.47 -27.66 6.92 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.498 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.9 mp0 -114.84 -34.72 5.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.97 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.38 -159.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.296 1.046 . . . . 0.0 112.247 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.13 HD13 ' O ' ' A' ' 218' ' ' LEU . 3.3 tm? -96.7 -19.96 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.38 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.592 ' HG3' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -78.99 -8.49 58.97 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.249 -1.532 . . . . 0.0 112.319 -177.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.687 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 41.0 t80 -132.42 14.49 0.05 OUTLIER Pre-proline 0 N--CA 1.501 2.095 0 O-C-N 120.412 -1.43 . . . . 0.0 113.312 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.817 ' HG2' ' HH1' ' A' ' 3' ' ' MSB . 55.5 Cg_endo -76.97 -37.97 0.96 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 N-CA-C 109.157 -1.132 . . . . 0.0 109.157 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 1.013 HD23 ' N ' ' A' ' 223' ' ' TYR . 1.4 tt -19.48 -67.5 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.526 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 1.013 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.2 OUTLIER -67.69 59.88 0.06 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.303 -0.873 . . . . 0.0 109.004 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 222' ' ' LEU . 9.2 t-160 179.89 -133.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.072 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.976 ' HB3' HG21 ' A' ' 190' ' ' THR . 49.8 m -160.57 114.92 2.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.849 -1.157 . . . . 0.0 109.929 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.935 HD12 ' O ' ' A' ' 225' ' ' SER . 0.0 OUTLIER 179.51 57.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.33 -0.856 . . . . 0.0 109.379 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 1.046 HG23 ' O ' ' A' ' 188' ' ' LYS . 4.8 t -113.92 -8.61 13.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.873 . . . . 0.0 109.516 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.591 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 1.0 OUTLIER 178.06 -21.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 110.742 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 1.05 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.2 OUTLIER -37.03 -60.59 0.62 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.15 -0.969 . . . . 0.0 110.127 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.524 HG23 ' HG3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER 179.22 -31.51 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.833 HH11 HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -89.33 -21.84 22.93 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.591 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 45.4 p90 -38.25 116.44 0.53 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.501 0.667 . . . . 0.0 110.317 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.597 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.4 ttt180 179.3 152.86 0.41 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.445 -0.784 . . . . 0.0 109.126 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.98 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.0 mp -68.69 167.47 15.18 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.082 -1.011 . . . . 0.0 110.044 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.806 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 10.2 t -101.04 -169.52 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.229 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.575 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.3 OUTLIER -83.92 -23.08 31.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.924 -179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.716 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 4.6 m-20 -81.32 -40.06 24.2 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.847 -1.141 . . . . 0.0 107.934 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.844 ' OD1' HD21 ' A' ' 209' ' ' LEU . 17.2 t0 -70.46 -35.49 73.35 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 117.828 -1.549 . . . . 0.0 107.766 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.649 HD13 ' O ' ' A' ' 235' ' ' SER . 0.8 OUTLIER -61.25 -34.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 237' ' ' ASP . 1.1 t30 -66.69 -45.33 79.16 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.29 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.68 -58.93 11.32 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.994 HG21 HG21 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -61.69 -44.68 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.742 -1.446 . . . . 0.0 109.623 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.462 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.6 tt0 -54.76 -24.96 24.81 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.7 t -87.0 -14.59 41.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.811 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.4 OUTLIER -74.9 -56.34 4.85 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.745 ' CG ' HD23 ' A' ' 130' ' ' LEU . 16.4 m-85 -92.09 -105.47 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.215 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.456 ' C ' ' HG3' ' A' ' 129' ' ' PRO . . . 131.72 133.1 3.43 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.408 -1.377 . . . . 0.0 109.842 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.544 ' N ' ' HG3' ' A' ' 129' ' ' PRO . 43.0 Cg_endo -73.97 129.88 13.79 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.991 1.522 . . . . 0.0 110.02 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.99 132.13 17.84 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.957 1.503 . . . . 0.0 110.054 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 251' ' ' ASP . 42.0 Cg_endo -72.38 -177.89 2.99 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.997 1.525 . . . . 0.0 110.051 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 250' ' ' PRO . 0.3 OUTLIER -44.03 -46.98 8.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 109.504 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 79.5 p -105.85 138.21 19.57 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.875 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.47 -10.19 25.09 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.032 1.543 . . . . 0.0 110.098 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.11 179.35 4.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.494 -179.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.966 HG22 HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.534 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.913 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.246 0.546 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -68.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.559 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 86' ' ' PHE . 1.5 t 179.86 -169.11 0.12 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 109.501 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.508 ' N ' ' OG1' ' A' ' 85' ' ' THR . 2.9 t80 -94.71 106.2 23.04 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.2 Cg_endo -72.88 148.91 46.65 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.943 1.496 . . . . 0.0 110.071 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 89' ' ' ILE . . . 107.09 -58.2 0.42 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 88' ' ' GLY . 3.4 pt -160.2 163.19 22.63 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.161 -1.2 . . . . 0.0 109.659 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.506 ' HB2' HD23 ' A' ' 245' ' ' LEU . 42.0 Cg_endo -72.61 160.37 46.67 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.047 1.551 . . . . 0.0 110.058 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.507 ' CD ' ' O ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -55.34 -80.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.221 -0.924 . . . . 0.0 109.496 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.751 ' CD1' HD11 ' A' ' 207' ' ' LEU . 7.0 m95 -98.67 -165.97 1.3 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.86 -1.15 . . . . 0.0 109.606 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 3.9 ppt_? -145.24 -40.61 0.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.984 -1.073 . . . . 0.0 110.582 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.729 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -45.26 174.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.085 -1.009 . . . . 0.0 110.377 -179.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.559 ' HA ' ' CG ' ' A' ' 130' ' ' LEU . 11.6 p -112.15 2.66 16.81 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.506 -0.746 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.547 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 17.8 m-70 -144.09 98.18 3.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.949 -1.094 . . . . 0.0 109.863 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.845 HD23 HD23 ' A' ' 130' ' ' LEU . 2.5 mm? -95.11 168.08 10.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.508 -0.745 . . . . 0.0 109.9 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.612 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -142.37 156.42 45.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.978 ' CE2' HD11 ' A' ' 101' ' ' ILE . 7.9 p90 -135.98 165.53 25.46 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.668 -1.27 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.406 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -125.17 121.94 35.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.889 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.978 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.2 mp -77.7 84.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.933 -1.104 . . . . 0.0 109.29 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.666 ' N ' ' O ' ' A' ' 144' ' ' ILE . 1.4 t -96.66 8.81 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 0.0 110.552 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.683 ' HB2' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -111.78 169.22 8.98 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.308 -1.495 . . . . 0.0 109.41 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.47 ' O ' ' C ' ' A' ' 105' ' ' THR . 4.3 p90 178.77 44.72 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.651 -0.656 . . . . 0.0 109.531 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 104' ' ' TYR . 70.5 p -41.26 153.79 0.24 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.474 -0.766 . . . . 0.0 109.048 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.03 -23.96 45.82 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 123.829 1.436 . . . . 0.0 108.766 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.627 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -69.19 -9.94 55.35 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.981 HD13 ' CD1' ' A' ' 195' ' ' LEU . 85.7 mt -144.42 115.83 5.4 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.8 Cg_endo -64.09 167.69 13.8 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 O-C-N 123.81 1.426 . . . . 0.0 109.295 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -35.49 -64.6 0.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.8 0.809 . . . . 0.0 110.477 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -59.76 -19.32 49.54 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.685 -0.635 . . . . 0.0 111.777 -178.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.62 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -80.36 -62.74 1.59 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.312 -1.493 . . . . 0.0 109.021 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.956 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.6 p -49.41 -40.5 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.835 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -67.19 -27.52 67.33 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.835 ' OG ' HD21 ' A' ' 195' ' ' LEU . 21.6 p -64.42 -42.5 96.0 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.05 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -71.42 -33.33 69.33 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.066 -1.021 . . . . 0.0 109.597 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.956 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.4 t -73.73 -25.18 20.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.589 ' HA ' ' CD2' ' A' ' 121' ' ' LEU . 2.0 tt0 -84.66 -36.67 21.77 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.744 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.854 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -78.83 -38.94 36.83 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.823 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -62.93 -61.48 2.37 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.853 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.0 OUTLIER -50.26 -40.15 47.13 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.988 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.629 ' N ' HD12 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -77.51 -33.45 54.34 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.37 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.01 ' O ' HG13 ' A' ' 127' ' ' VAL . 3.8 t -52.49 -44.5 44.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.014 ' CH2' HD21 ' A' ' 234' ' ' LEU . 33.4 m95 -92.2 -23.14 19.47 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 26.8 tt0 -69.67 -26.74 64.53 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.3 pt-20 -90.96 -42.99 10.25 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.648 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.01 HG13 ' O ' ' A' ' 123' ' ' VAL . 14.5 m -59.57 -23.78 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.274 -1.37 . . . . 0.0 108.988 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.013 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -116.89 163.42 22.84 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.519 -1.272 . . . . 0.0 109.289 179.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.543 ' HG2' ' HD3' ' A' ' 248' ' ' PRO . 46.9 Cg_endo -77.58 -8.47 17.09 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.336 1.703 . . . . 0.0 109.883 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.845 HD23 HD23 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -70.19 179.55 2.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 110.536 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.467 ' OG1' ' ND1' ' A' ' 96' ' ' HIS . 6.7 p -127.3 174.38 9.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 1.1 m-85 -145.44 161.89 38.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 110.102 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.586 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -143.38 -174.36 4.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -152.04 155.6 38.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.901 -1.124 . . . . 0.0 110.153 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.97 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.8 OUTLIER -147.41 -135.06 0.08 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.417 -0.802 . . . . 0.0 108.912 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 45.3 t80 178.94 33.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.793 -1.192 . . . . 0.0 109.23 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 139' ' ' GLU . 1.8 pm0 -158.57 -176.65 6.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.779 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.4 -97.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.49 107.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -1.103 . . . . 0.0 110.184 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.97 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -60.15 -151.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.02 -1.05 . . . . 0.0 108.722 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.56 ' O ' ' O ' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -91.65 -25.82 18.96 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.984 HD11 ' HB2' ' A' ' 206' ' ' SER . 17.7 mm -127.81 86.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.597 ' HG3' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -67.15 97.17 0.5 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 102' ' ' VAL . 0.7 OUTLIER -82.37 116.19 26.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -134.49 153.18 52.06 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 119.944 -1.722 . . . . 0.0 112.388 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 147' ' ' ALA . 1.6 t80 -90.7 135.71 33.53 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.714 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.57 -152.65 0.11 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.725 -1.234 . . . . 0.0 111.17 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 149' ' ' ARG . 2.1 p -178.3 -169.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.744 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -30.12 -37.01 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.684 -0.635 . . . . 0.0 111.118 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 148' ' ' VAL . 3.9 mm-40 -81.2 110.54 16.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.026 . . . . 0.0 109.699 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 155' ' ' TYR . 21.8 m80 -126.17 -91.51 0.52 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 0.0 109.554 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.93 -44.11 0.03 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.49 -95.25 0.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.074 -1.251 . . . . 0.0 109.888 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -117.47 67.33 0.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.032 . . . . 0.0 109.824 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.651 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -147.22 41.27 0.26 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.892 . . . . 0.0 109.902 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 42.0 Cg_endo -71.95 107.21 2.17 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.515 1.271 . . . . 0.0 109.13 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.645 ' CE1' ' CG1' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.5 -140.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.09 -1.006 . . . . 0.0 109.964 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.67 ' CB ' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -134.75 -23.54 1.58 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.496 -1.377 . . . . 0.0 111.312 -178.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 183' ' ' ASP . . . 41.52 -96.72 0.01 OUTLIER Glycine 0 N--CA 1.497 2.725 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.532 ' CD ' ' O ' ' A' ' 158' ' ' ASP . 34.3 Cg_endo -59.68 76.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.265 1.14 . . . . 0.0 110.052 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 175.98 -167.31 38.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.464 ' O ' ' C ' ' A' ' 163' ' ' VAL . 58.3 m-80 -87.25 -27.75 22.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.173 -1.192 . . . . 0.0 109.964 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.67 HG21 ' CB ' ' A' ' 158' ' ' ASP . 16.9 t -35.79 140.58 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.426 0.631 . . . . 0.0 110.862 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.046 HD11 HG21 ' A' ' 193' ' ' THR . 0.4 OUTLIER -105.17 -90.81 0.4 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.465 -0.772 . . . . 0.0 112.31 -179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.859 ' HB3' HG12 ' A' ' 198' ' ' VAL . . . -147.27 -168.89 3.17 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.113 -1.617 . . . . 0.0 111.541 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.651 ' CE1' ' CE1' ' A' ' 155' ' ' TYR . 0.5 OUTLIER 179.95 171.98 1.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 119.682 -1.886 . . . . 0.0 111.024 -179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' A' ' 202' ' ' GLU . . . -147.55 -164.54 2.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.399 -0.813 . . . . 0.0 109.99 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.646 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -131.9 -163.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.883 -1.136 . . . . 0.0 110.643 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.001 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -163.98 -62.84 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.093 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 1.001 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.8 Cg_endo -77.09 158.95 33.98 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.779 1.41 . . . . 0.0 109.966 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.474 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . 115.32 173.69 17.71 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 43.4 Cg_endo -76.55 -89.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.683 1.589 . . . . 0.0 110.138 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -78.13 -35.44 34.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.646 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 7.5 tp -68.96 -0.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.627 -0.925 . . . . 0.0 108.967 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 172' ' ' PRO . 2.6 t30 -65.82 64.22 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 141' ' ' ASP . . . 119.81 90.63 1.25 Allowed Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.612 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -158.07 127.01 5.64 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.839 -1.389 . . . . 0.0 108.159 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.675 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -115.88 168.16 10.3 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.117 -0.99 . . . . 0.0 108.714 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.714 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.97 134.39 4.28 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.205 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.587 ' CE1' ' OE1' ' A' ' 202' ' ' GLU . 53.1 m-85 -90.08 127.99 36.2 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.24 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 1.0 OUTLIER -76.62 144.78 39.31 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.949 -1.094 . . . . 0.0 109.205 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.564 ' O ' ' C ' ' A' ' 183' ' ' ASP . 27.3 t0 -62.44 -2.16 0.98 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.21 -0.931 . . . . 0.0 110.381 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.2 p30 3.9 -95.54 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 183' ' ' ASP . 7.5 mp0 -147.59 -51.15 0.19 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.873 -1.142 . . . . 0.0 110.509 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 0.3 OUTLIER -140.79 172.0 13.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.838 -1.164 . . . . 0.0 110.926 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.976 ' CH2' HD12 ' A' ' 164' ' ' LEU . 85.8 m95 -160.58 129.77 4.9 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.696 ' HA ' HD21 ' A' ' 108' ' ' LEU . 33.4 p -146.88 155.93 42.7 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.555 -1.341 . . . . 0.0 110.428 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.596 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 3.2 pttt -78.02 -33.11 51.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.545 ' O ' ' CG2' ' A' ' 227' ' ' THR . 2.9 t0 -90.48 -143.62 0.17 Allowed 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.917 ' N ' HD11 ' A' ' 229' ' ' LEU . 11.4 t -115.37 45.64 1.62 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.851 -1.155 . . . . 0.0 108.264 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 187' ' ' THR . 53.7 m -102.69 -30.3 10.99 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.326 -0.859 . . . . 0.0 111.084 -178.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.553 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -108.52 -90.59 2.12 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.363 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.046 HG21 HD11 ' A' ' 164' ' ' LEU . 89.6 m -120.68 -80.21 0.62 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.941 ' ND2' HG22 ' A' ' 193' ' ' THR . 0.1 OUTLIER 178.15 66.79 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.582 1.182 . . . . 0.0 108.435 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.004 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 1.2 tp -20.03 -95.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.952 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.911 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -62.06 -15.01 41.75 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.055 -1.028 . . . . 0.0 110.883 -176.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.873 HD11 ' CG ' ' A' ' 221' ' ' PRO . 13.3 tp -60.75 -57.46 12.58 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 117.251 -1.78 . . . . 0.0 107.199 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' A' ' 165' ' ' ALA . 2.4 t -74.72 -9.25 12.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.749 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.05 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -78.24 -57.85 3.57 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.35 -1.34 . . . . 0.0 107.503 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.705 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -64.03 -17.91 63.81 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 219' ' ' MET . 3.3 t-160 -69.39 -40.95 77.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 117.17 -1.812 . . . . 0.0 107.849 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.69 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 3.5 mt-10 -82.89 -49.12 9.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.954 -1.091 . . . . 0.0 110.79 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.853 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.2 mt -60.59 -31.47 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.734 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -75.79 -34.09 49.46 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -57.24 -53.15 61.34 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.61 -0.935 . . . . 0.0 109.773 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.984 ' HB2' HD11 ' A' ' 142' ' ' ILE . 2.6 m -77.81 -64.19 1.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.583 -0.698 . . . . 0.0 111.671 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 207' ' ' LEU . 2.8 mm? -101.36 37.99 1.68 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.416 -0.802 . . . . 0.0 110.614 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.974 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -135.83 -69.22 0.06 OUTLIER Glycine 0 C--N 1.289 -2.046 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.868 HD11 ' SD ' ' A' ' 219' ' ' MET . 4.5 pp 179.75 -161.86 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.933 0 O-C-N 120.633 -1.51 . . . . 0.0 109.387 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.798 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.3 t80 -102.11 -71.59 0.71 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.259 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.581 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 54.4 m80 -162.16 102.05 1.11 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.795 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.5 m -93.07 -174.68 3.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.782 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.95 78.07 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.955 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.43 9.3 13.69 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.422 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 214' ' ' ASN . 73.7 p -50.42 -27.72 6.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.519 ' C ' ' HB2' ' A' ' 235' ' ' SER . 8.3 mt-10 -113.75 -37.01 4.67 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.955 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -64.35 -171.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.45 1.119 . . . . 0.0 112.72 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.907 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -84.64 -18.9 33.95 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.937 -177.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.868 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -78.41 -7.46 57.38 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 119.262 -2.149 . . . . 0.0 112.171 -177.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.671 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 35.3 t80 -134.99 15.63 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.257 -1.527 . . . . 0.0 113.39 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.873 ' CG ' HD11 ' A' ' 197' ' ' LEU . 55.8 Cg_endo -77.97 -41.17 0.32 Allowed 'Trans proline' 0 C--N 1.319 -0.989 0 N-CA-C 109.265 -1.09 . . . . 0.0 109.265 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.774 HD22 ' CD2' ' A' ' 3' ' ' MSB . 18.9 tp -6.87 -74.67 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.506 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 1.0 OUTLIER -65.45 63.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.492 -0.755 . . . . 0.0 109.779 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.1 OUTLIER 179.82 -162.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.2 m -131.99 116.17 16.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.103 -0.998 . . . . 0.0 109.693 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' A' ' 231' ' ' ARG . 5.5 tp 179.49 31.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.703 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.627 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 6.6 t -77.61 -52.77 8.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.649 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 5.2 t0 -151.49 3.22 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.745 -1.222 . . . . 0.0 110.952 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.917 HD11 ' N ' ' A' ' 190' ' ' THR . 1.2 mm? -41.41 -101.04 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.906 -1.121 . . . . 0.0 110.912 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -18.22 3.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.701 -1.249 . . . . 0.0 109.85 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.732 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -105.48 -42.03 5.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.067 -1.021 . . . . 0.0 108.386 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.649 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 9.5 p90 0.36 117.87 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.538 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.05 164.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.89 178.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.014 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.5 mp -80.27 166.49 21.32 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.756 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 28.9 t -98.38 -171.84 2.21 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.354 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.5 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.08 -11.83 54.38 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.726 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 212' ' ' SER . 0.1 OUTLIER -85.34 -46.99 10.45 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.889 -1.132 . . . . 0.0 107.971 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.68 ' OD1' HD21 ' A' ' 209' ' ' LEU . 1.2 m-20 -66.87 -38.04 85.57 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 117.201 -1.8 . . . . 0.0 106.554 177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -58.04 -34.55 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.519 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 1.3 t-20 -66.69 -49.23 66.76 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.88 -50.62 65.76 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.895 -1.145 . . . . 0.0 110.28 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.997 HG13 HG22 ' A' ' 128' ' ' THR . 1.9 tp -68.27 -48.44 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 120.741 -1.447 . . . . 0.0 110.665 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.57 ' N ' HG23 ' A' ' 242' ' ' ILE . 15.0 pt20 -54.77 -23.08 16.3 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 10.1 p -88.66 -17.07 30.8 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.635 ' HB3' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -74.22 -59.36 2.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.74 ' CE1' HD22 ' A' ' 130' ' ' LEU . 15.2 m-85 -92.33 -120.94 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.502 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.494 ' HA2' ' HG3' ' A' ' 129' ' ' PRO . . . 63.37 91.02 0.03 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.543 ' HD3' ' HG2' ' A' ' 129' ' ' PRO . 39.8 Cg_endo -68.7 173.75 9.54 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.623 1.549 . . . . 0.0 110.18 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 40.5 Cg_endo -70.1 154.1 66.72 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.952 1.501 . . . . 0.0 110.347 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 251' ' ' ASP . 42.9 Cg_endo -73.24 -47.34 0.31 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.755 1.637 . . . . 0.0 110.229 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 250' ' ' PRO . 5.5 m-20 -56.14 -154.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.712 -0.618 . . . . 0.0 110.184 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.453 ' C ' ' O ' ' A' ' 251' ' ' ASP . 18.0 m -38.78 99.2 0.19 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.476 -0.765 . . . . 0.0 110.225 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 254' ' ' GLU . 43.7 Cg_endo -74.8 -44.85 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.119 1.589 . . . . 0.0 109.998 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 253' ' ' PRO . 0.0 OUTLIER -45.18 170.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.631 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.553 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.583 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.516 ' HD1' ' OB1' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.774 ' CD2' HD22 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 -96.48 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 109.505 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -56.19 12.62 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.125 -0.985 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -164.05 141.65 5.63 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 86' ' ' PHE . 42.1 Cg_endo -72.54 -2.43 11.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.005 1.529 . . . . 0.0 110.145 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.44 -113.12 0.65 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.733 HD12 ' N ' ' A' ' 89' ' ' ILE . 1.7 mp -73.01 134.84 80.65 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.251 -1.146 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.406 ' O ' HG22 ' A' ' 89' ' ' ILE . 41.9 Cg_endo -72.03 -171.31 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.993 1.523 . . . . 0.0 110.048 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.567 ' HB2' HD21 ' A' ' 245' ' ' LEU . 0.1 OUTLIER -73.4 -95.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.172 -0.955 . . . . 0.0 109.372 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.646 ' CD1' ' CD2' ' A' ' 207' ' ' LEU . 50.7 m95 -111.42 163.69 13.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.028 -1.045 . . . . 0.0 109.532 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -131.95 -28.01 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.191 -0.943 . . . . 0.0 110.537 -179.325 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 1.037 ' O ' HD21 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -40.13 165.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.373 -0.829 . . . . 0.0 110.625 -179.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.581 ' O ' ' CD2' ' A' ' 96' ' ' HIS . 2.1 p -107.63 5.21 26.67 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.462 -0.774 . . . . 0.0 109.185 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 1.071 ' CE1' HG21 ' A' ' 131' ' ' THR . 33.4 m-70 -150.72 103.49 3.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.453 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.95 HD13 ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -116.33 -165.32 1.04 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 109.91 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.585 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -161.43 162.35 30.55 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 108.905 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.74 ' CZ ' HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -137.9 160.78 38.38 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.875 -1.141 . . . . 0.0 109.181 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.837 ' NE ' HG22 ' A' ' 102' ' ' VAL . 1.2 ttp180 -123.09 126.63 47.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.155 -0.966 . . . . 0.0 109.807 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.803 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.5 mp -85.09 84.37 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.005 -1.059 . . . . 0.0 109.677 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.837 HG22 ' NE ' ' A' ' 100' ' ' ARG . 2.6 t -100.35 8.03 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.327 -0.858 . . . . 0.0 110.007 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.886 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -100.99 157.04 17.05 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 120.783 -1.198 . . . . 0.0 109.353 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.656 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.6 OUTLIER 177.99 75.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.487 -0.758 . . . . 0.0 109.515 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.537 HG21 ' CD1' ' A' ' 186' ' ' TRP . 11.5 p -70.6 159.5 84.85 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -68.14 -21.86 41.78 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.808 1.425 . . . . 0.0 108.686 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 1.5 t0 -70.28 -8.73 52.6 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.961 HD13 HD13 ' A' ' 195' ' ' LEU . 93.5 mt -147.07 124.14 5.76 Favored Pre-proline 0 N--CA 1.484 1.233 0 O-C-N 121.585 -0.697 . . . . 0.0 109.848 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.6 Cg_endo -66.11 169.84 12.88 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 O-C-N 123.811 1.427 . . . . 0.0 109.007 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.08 -65.75 0.31 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.971 0.891 . . . . 0.0 110.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 115' ' ' SER . 1.6 p-10 -53.97 -32.32 53.58 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.743 -0.598 . . . . 0.0 112.033 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.908 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.91 -61.4 1.78 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.533 -1.354 . . . . 0.0 109.635 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 117' ' ' VAL . 8.7 p -53.3 -41.2 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.803 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -64.35 -27.27 68.9 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.936 ' OG ' HD21 ' A' ' 195' ' ' LEU . 6.2 p -63.51 -43.73 96.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.055 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -68.23 -33.1 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.108 -0.995 . . . . 0.0 109.492 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.888 HG13 HG13 ' A' ' 144' ' ' ILE . 5.0 t -76.26 -22.0 15.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.2 tt0 -88.24 -34.12 17.86 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.8 OUTLIER -82.45 -36.33 26.68 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.73 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -67.28 -61.18 2.04 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.338 1.066 . . . . 0.0 108.588 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.872 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.6 pp -57.0 -40.8 77.29 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.779 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.47 -32.69 62.66 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.89 -1.124 . . . . 0.0 108.898 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.038 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.41 -42.04 65.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.103 ' CH2' HD21 ' A' ' 234' ' ' LEU . 37.7 m95 -91.23 -23.97 20.03 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.536 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 3.5 tm-20 -69.57 -27.44 65.13 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.851 -1.156 . . . . 0.0 107.89 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 13.9 pt-20 -90.58 -42.84 10.57 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.738 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.038 HG13 ' O ' ' A' ' 123' ' ' VAL . 15.8 m -59.2 -24.52 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.139 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.007 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -114.26 154.82 46.27 Favored Pre-proline 0 N--CA 1.494 1.731 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.573 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.541 ' CG ' ' HA2' ' A' ' 247' ' ' GLY . 50.2 Cg_endo -82.49 29.31 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.136 1.891 . . . . 0.0 110.472 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.037 HD21 ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -99.44 -179.95 4.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.95 -1.094 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 1.071 HG21 ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -112.9 161.18 17.28 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.95 ' CE2' HD13 ' A' ' 97' ' ' LEU . 53.2 m-85 -147.72 148.74 31.32 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.061 -1.024 . . . . 0.0 110.901 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.575 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -130.2 -179.23 5.12 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.46 158.05 43.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.812 -1.18 . . . . 0.0 110.207 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.695 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.49 -163.78 1.52 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.215 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.517 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 69.5 t80 -155.79 21.22 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 26.0 pm0 -143.98 -174.62 4.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.637 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.04 -97.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 137' ' ' GLU . 11.6 pt-20 178.8 130.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -1.133 . . . . 0.0 110.157 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.585 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -89.78 -147.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.869 . . . . 0.0 109.227 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.591 ' CG ' HD11 ' A' ' 207' ' ' LEU . 12.9 t0 -92.89 -33.16 14.32 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.738 HG22 ' CD1' ' A' ' 144' ' ' ILE . 22.1 mt -126.64 80.14 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.457 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 2.8 ttp -64.26 94.04 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.121 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.888 HG13 HG13 ' A' ' 117' ' ' VAL . 5.4 mm -79.17 118.76 27.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.8 OUTLIER -137.76 158.16 44.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.349 -1.469 . . . . 0.0 111.983 -179.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.52 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 23.6 p90 -90.91 138.62 31.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 109.591 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.124 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.27 -159.05 0.56 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.178 -0.951 . . . . 0.0 110.003 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.988 HG21 ' CG ' ' A' ' 183' ' ' ASP . 1.5 p -174.85 -168.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.923 -1.11 . . . . 0.0 109.274 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.722 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -41.89 -26.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 0.0 109.972 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.671 ' CD ' HG12 ' A' ' 148' ' ' VAL . 5.3 pt-20 -67.41 59.12 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.939 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.687 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 34.7 m80 -97.22 -79.18 0.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.159 -0.963 . . . . 0.0 109.257 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 164.15 -61.69 0.25 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.57 ' O ' ' CG ' ' A' ' 154' ' ' PHE . 0.4 OUTLIER 179.59 53.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -1.171 . . . . 0.0 109.639 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.57 ' CG ' ' O ' ' A' ' 153' ' ' ASP . 93.4 m-85 -158.31 -39.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.959 . . . . 0.0 110.094 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.687 ' CD1' ' CD2' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -151.91 71.23 7.95 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.11 -0.994 . . . . 0.0 109.9 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -73.82 118.35 5.4 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.03 1.542 . . . . 0.0 109.743 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.715 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -95.08 -160.63 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.133 -0.979 . . . . 0.0 109.982 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 160' ' ' PRO . 20.5 p30 178.86 50.59 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 109.815 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.574 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.69 -74.38 0.0 OUTLIER Glycine 0 N--CA 1.509 3.512 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.582 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.7 Cg_endo -65.17 61.28 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.237 1.292 . . . . 0.0 109.99 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -165.42 143.9 8.83 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 164' ' ' LEU . 3.6 m120 -42.12 -41.17 2.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -1.115 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.647 ' HA ' HG23 ' A' ' 1' ' ' HAV . 31.0 m -55.01 84.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.802 . . . . 0.0 109.871 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.695 HD12 HD12 ' A' ' 222' ' ' LEU . 15.8 mt -71.84 -80.27 0.06 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.311 -0.868 . . . . 0.0 112.822 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.856 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -136.2 -174.65 3.74 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.469 -1.395 . . . . 0.0 111.489 -177.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.715 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.5 p-80 -179.99 167.62 1.28 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.273 -1.517 . . . . 0.0 110.294 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -141.43 -166.13 2.12 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.215 -0.928 . . . . 0.0 110.391 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.623 ' CD2' HD11 ' A' ' 174' ' ' ILE . 0.1 OUTLIER -128.59 -160.86 1.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.1 -1.0 . . . . 0.0 110.73 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.005 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -166.06 -60.3 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.493 -0.755 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 1.005 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 46.6 Cg_endo -79.16 -172.31 1.5 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.725 1.382 . . . . 0.0 110.083 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 73.18 144.37 0.64 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.6 Cg_endo -70.37 136.88 32.43 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.854 1.449 . . . . 0.0 110.061 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 71.3 -64.15 1.02 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.623 HD11 ' CD2' ' A' ' 168' ' ' TYR . 0.6 OUTLIER -64.31 -7.82 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.553 -0.969 . . . . 0.0 109.164 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.2 OUTLIER -65.72 66.06 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.269 -0.894 . . . . 0.0 108.958 179.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 126.88 81.58 0.37 Allowed Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.7 m-20 -155.87 126.83 6.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.935 -1.332 . . . . 0.0 108.016 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.684 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -113.43 168.26 9.89 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.325 -0.86 . . . . 0.0 109.086 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.124 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -163.27 135.14 5.07 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.007 -1.077 . . . . 0.0 109.751 178.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.596 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 58.1 m-85 -95.29 134.4 38.11 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.896 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -68.65 132.64 47.22 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.028 -1.469 . . . . 0.0 107.41 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -105.8 37.0 2.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.87 -1.144 . . . . 0.0 110.332 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.988 ' CG ' HG21 ' A' ' 148' ' ' VAL . 1.9 m-20 -114.25 -2.76 13.27 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.379 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.548 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 5.5 pt-20 -119.24 -111.65 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.056 -1.027 . . . . 0.0 108.627 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.585 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 48.6 mt-30 -148.22 174.7 11.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.818 -1.176 . . . . 0.0 109.1 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.585 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 90.3 m95 -162.14 126.49 3.23 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.228 -0.92 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.82 ' HA ' HD21 ' A' ' 108' ' ' LEU . 71.3 p -150.14 155.38 39.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.724 -1.235 . . . . 0.0 110.627 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.937 ' HB3' HD22 ' A' ' 195' ' ' LEU . 1.1 ptpt -83.67 -30.58 26.7 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.65 ' O ' ' N ' ' A' ' 191' ' ' THR . 30.7 t0 -87.28 63.7 7.91 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.906 HG22 HD11 ' A' ' 229' ' ' LEU . 6.2 t 4.41 59.68 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.883 0.849 . . . . 0.0 111.789 -177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.65 ' N ' ' O ' ' A' ' 189' ' ' ASP . 47.7 m -124.49 -31.49 3.25 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.252 -0.905 . . . . 0.0 109.682 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.9 -78.69 1.42 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.705 HG22 ' OD1' ' A' ' 194' ' ' ASN . 18.4 m -129.9 -95.16 0.39 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.835 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.4 OUTLIER -161.37 73.43 0.44 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.961 HD13 HD13 ' A' ' 108' ' ' LEU . 2.4 tp -34.4 -96.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.631 0.729 . . . . 0.0 110.656 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.895 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -67.56 -8.13 31.7 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -177.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.753 HD13 ' HA ' ' A' ' 227' ' ' THR . 12.2 tp -68.7 -63.13 1.12 Allowed 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 116.42 -2.112 . . . . 0.0 106.924 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.856 ' CG1' ' HB3' ' A' ' 165' ' ' ALA . 9.2 t -71.41 -8.59 11.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.055 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -74.49 -58.59 3.19 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -65.96 -15.08 62.67 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.595 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 9.1 t60 -69.33 -42.03 75.87 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.957 -1.497 . . . . 0.0 107.96 177.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.684 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 6.8 mt-10 -85.43 -46.77 10.6 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.05 -1.031 . . . . 0.0 110.603 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.872 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -61.15 -30.87 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.706 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.23 -33.89 38.67 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 108.192 -1.963 . . . . 0.0 108.192 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.5 -50.23 73.73 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 121.825 -0.809 . . . . 0.0 110.41 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.54 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 58.3 p -83.82 -57.1 3.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.424 -0.798 . . . . 0.0 112.027 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.81 HD13 HD22 ' A' ' 97' ' ' LEU . 13.1 mt -104.56 34.99 2.89 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.945 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -136.94 -77.74 0.08 OUTLIER Glycine 0 C--N 1.292 -1.889 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.1 pp -172.02 -165.72 0.37 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.77 -1.429 . . . . 0.0 109.995 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.715 ' N ' HD12 ' A' ' 209' ' ' LEU . 3.3 t80 -96.92 -73.37 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.845 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.601 ' CD2' ' HG2' ' A' ' 219' ' ' MET . 81.0 m80 -160.6 103.93 1.39 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.128 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.655 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -91.43 -171.34 2.9 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.856 . . . . 0.0 108.85 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.993 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.74 76.16 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.931 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.06 9.58 12.17 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.634 -176.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -51.1 -27.49 8.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.512 ' C ' ' HB2' ' A' ' 235' ' ' SER . 14.9 mt-10 -114.95 -38.44 3.9 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.64 -178.98 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.301 1.048 . . . . 0.0 112.262 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.806 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -78.18 -18.35 55.62 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.463 -177.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.601 ' HG2' ' CD2' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -77.63 -7.84 56.99 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 119.19 -2.194 . . . . 0.0 112.056 -177.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.658 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 39.6 t80 -135.56 15.79 0.05 OUTLIER Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.362 -1.461 . . . . 0.0 113.622 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 55.5 Cg_endo -78.3 -37.24 0.79 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.53 -1.373 . . . . 0.0 108.53 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 1.058 HD13 ' CD2' ' A' ' 3' ' ' MSB . 0.6 OUTLIER -15.58 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.01 -179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.979 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.63 59.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.496 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.6 OUTLIER -175.65 -159.78 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 74.3 m -126.4 104.15 8.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.154 -0.966 . . . . 0.0 109.722 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 197' ' ' LEU . 0.0 OUTLIER 178.56 40.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.843 . . . . 0.0 109.023 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.753 ' HA ' HD13 ' A' ' 197' ' ' LEU . 10.0 t -84.87 -51.02 7.03 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.237 -0.914 . . . . 0.0 110.111 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.714 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.3 OUTLIER -152.64 6.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.096 . . . . 0.0 110.903 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.906 HD11 HG22 ' A' ' 190' ' ' THR . 0.4 OUTLIER -49.07 -108.8 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.949 -1.095 . . . . 0.0 110.796 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.26 -23.94 5.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.589 -1.319 . . . . 0.0 109.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.538 ' O ' ' C ' ' A' ' 232' ' ' PHE . 5.3 mtp180 -98.24 -31.95 11.81 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.646 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 4.9 p90 -17.09 118.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.824 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.532 ' N ' ' HD3' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.32 171.63 0.73 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.381 -0.825 . . . . 0.0 110.516 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.103 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.2 mp -81.78 166.17 20.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.334 -0.853 . . . . 0.0 110.427 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 37.9 t -101.77 -166.89 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 118.592 -1.243 . . . . 0.0 110.122 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.52 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.2 OUTLIER -84.97 -17.71 36.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.644 -0.66 . . . . 0.0 110.262 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.993 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.9 OUTLIER -81.62 -48.54 11.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.725 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 1.0 OUTLIER -63.98 -40.06 95.53 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 117.508 -1.677 . . . . 0.0 106.659 177.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.42 -35.41 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.7 -54.38 19.95 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -50.79 -53.91 24.1 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.016 HG21 HG21 ' A' ' 127' ' ' VAL . 1.1 tp -64.86 -43.19 96.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 120.886 -1.361 . . . . 0.0 109.995 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.51 ' N ' HG23 ' A' ' 242' ' ' ILE . 0.0 OUTLIER -54.54 -28.45 45.68 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.2 t -80.27 -21.16 42.98 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.839 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -67.52 -64.11 0.92 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.783 ' HB3' HD13 ' A' ' 130' ' ' LEU . 27.9 m-85 -100.39 -125.16 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.209 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.541 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 53.46 -107.69 0.64 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 246' ' ' TYR . 41.3 Cg_endo -71.49 134.77 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.857 1.451 . . . . 0.0 110.067 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.55 110.87 3.09 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.988 1.52 . . . . 0.0 110.211 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 42.6 Cg_endo -72.62 -59.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.972 1.512 . . . . 0.0 110.065 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -61.42 -155.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.31 142.8 51.11 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.564 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.7 -18.75 24.9 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.067 1.562 . . . . 0.0 110.12 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -176.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.923 . . . . 0.0 109.547 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.56 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.647 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.535 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 1.058 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.265 0.555 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.673 ' HD2' HG22 ' A' ' 85' ' ' THR . 3.7 ptt85 -157.43 -94.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 109.518 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.673 HG22 ' HD2' ' A' ' 84' ' ' ARG . 10.2 t -106.09 -178.01 3.53 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.112 -0.993 . . . . 0.0 109.555 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.582 ' CD2' ' HD2' ' A' ' 87' ' ' PRO . 1.0 OUTLIER -45.34 168.62 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.582 ' HD2' ' CD2' ' A' ' 86' ' ' PHE . 41.9 Cg_endo -72.93 57.39 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.978 1.515 . . . . 0.0 110.047 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 90' ' ' PRO . . . 100.88 -52.2 0.93 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.9 mt -49.3 106.21 0.6 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.28 -1.129 . . . . 0.0 109.554 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 88' ' ' GLY . 42.3 Cg_endo -72.34 163.89 37.27 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.917 1.483 . . . . 0.0 110.099 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.927 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 1.0 OUTLIER -88.88 -81.81 0.26 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.542 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CZ2' ' O ' ' A' ' 175' ' ' ASN . 12.7 m95 -88.13 -167.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.957 -1.089 . . . . 0.0 109.608 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -162.42 -37.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.418 -0.801 . . . . 0.0 109.087 179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.585 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -52.4 -169.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.434 -0.791 . . . . 0.0 110.08 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.878 ' HA ' HD12 ' A' ' 130' ' ' LEU . 65.7 p -122.34 -0.97 9.22 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.602 -0.686 . . . . 0.0 109.312 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.585 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 15.0 m-70 -140.56 92.59 2.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 109.463 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.751 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.9 mm? -85.19 162.8 19.05 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.502 -0.749 . . . . 0.0 109.512 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.6 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -141.05 155.83 46.1 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.934 ' CE2' HD11 ' A' ' 101' ' ' ILE . 8.4 p90 -134.47 168.56 18.72 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.452 -1.405 . . . . 0.0 109.826 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 1.011 ' NE ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.5 124.06 31.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.474 -0.766 . . . . 0.0 109.235 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.934 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.5 mp -80.69 81.48 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.887 -1.133 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.011 HG22 ' NE ' ' A' ' 100' ' ' ARG . 4.8 t -94.71 5.08 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.873 ' ND2' HG22 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -103.29 163.99 11.91 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.761 -1.212 . . . . 0.0 108.6 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.71 ' N ' HG21 ' A' ' 113' ' ' VAL . 7.2 p90 -178.2 58.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.119 -0.988 . . . . 0.0 110.5 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.981 HG21 ' CD1' ' A' ' 186' ' ' TRP . 69.0 p -45.48 145.57 2.0 Allowed Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.1 -32.47 34.2 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 124.002 1.528 . . . . 0.0 109.232 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.62 ' C ' HD23 ' A' ' 108' ' ' LEU . 14.9 m-20 -65.89 -19.37 65.85 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.967 ' CD1' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -115.62 114.28 42.34 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 112' ' ' ALA . 36.4 Cg_endo -62.75 168.17 10.65 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.565 1.297 . . . . 0.0 108.996 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HE2' ' HB2' ' A' ' 110' ' ' LYS . 1.3 mppt? -39.73 -64.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.877 0.846 . . . . 0.0 109.54 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.1 OUTLIER -57.73 -10.87 1.8 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.845 -0.535 . . . . 0.0 111.392 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.705 ' HB1' HD13 ' A' ' 108' ' ' LEU . . . -87.75 -58.44 2.57 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.576 -1.327 . . . . 0.0 109.333 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.039 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.9 p -59.68 -43.39 91.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.612 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -60.92 -26.83 67.76 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.614 ' OG ' HD21 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -63.26 -65.24 0.71 Allowed 'General case' 0 C--O 1.195 -1.768 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.047 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -49.46 -31.99 11.03 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.039 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.6 t -74.34 -24.62 19.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 115' ' ' SER . 1.3 tt0 -87.18 -37.19 17.52 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.345 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.764 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -77.82 -39.1 44.79 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.773 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.71 -61.57 2.0 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.214 1.007 . . . . 0.0 108.553 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.846 HD12 ' C ' ' A' ' 121' ' ' LEU . 1.3 pp -53.8 -41.4 67.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.381 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.794 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -76.19 -32.85 59.21 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.806 -178.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.021 ' O ' HG13 ' A' ' 127' ' ' VAL . 2.1 t -53.76 -45.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.064 ' CH2' HD21 ' A' ' 234' ' ' LEU . 33.5 m95 -91.69 -22.31 20.3 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.758 -1.177 . . . . 0.0 110.532 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.535 ' CG ' ' HB2' ' A' ' 132' ' ' PHE . 9.3 tm-20 -69.79 -27.03 64.57 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.782 -1.199 . . . . 0.0 107.815 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.3 pt-20 -91.17 -42.95 10.16 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.63 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.038 HG21 HG21 ' A' ' 242' ' ' ILE . 14.0 m -58.07 -25.56 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.308 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.01 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -109.36 155.0 41.91 Favored Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 118.073 -1.451 . . . . 0.0 109.249 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.68 ' C ' HD22 ' A' ' 130' ' ' LEU . 51.2 Cg_endo -82.06 26.2 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.054 1.836 . . . . 0.0 111.395 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 95' ' ' THR . 4.4 mm? -108.6 -169.54 1.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.595 -1.316 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.574 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 2.0 p -117.7 169.22 9.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.921 . . . . 0.0 110.808 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.571 ' CE2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -139.17 163.34 32.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.637 -0.664 . . . . 0.0 109.921 -179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.579 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -143.08 -172.8 3.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.638 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -159.81 165.46 32.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.562 -1.336 . . . . 0.0 110.798 -179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.722 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -163.37 -163.63 0.85 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.592 -0.692 . . . . 0.0 109.134 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 136' ' ' TYR . 75.0 t80 -158.2 22.07 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 108.768 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 1.6 pm0 -148.8 -178.95 6.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -0.761 . . . . 0.0 108.97 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 40.87 -97.2 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 137' ' ' GLU . 20.2 tt0 178.5 146.22 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.202 -1.175 . . . . 0.0 110.531 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.668 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -103.18 -150.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.698 ' O ' HD13 ' A' ' 142' ' ' ILE . 41.4 m-20 -88.74 -36.58 16.06 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.934 HG13 HD23 ' A' ' 207' ' ' LEU . 18.4 mm -122.28 82.1 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.552 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 3.3 ptt? -67.1 100.12 0.73 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.582 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.873 HG22 ' ND2' ' A' ' 103' ' ' ASN . 6.1 mm -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -135.41 154.93 51.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.336 -1.477 . . . . 0.0 111.939 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -77.06 135.99 38.65 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.064 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -152.83 164.68 37.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.906 -1.121 . . . . 0.0 110.485 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 1.001 HG21 ' CG ' ' A' ' 183' ' ' ASP . 2.6 p -160.2 -174.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.605 -0.684 . . . . 0.0 109.255 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.702 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -38.15 -28.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.279 -0.888 . . . . 0.0 110.334 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.681 ' H ' HG13 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -78.52 51.49 1.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.087 -1.008 . . . . 0.0 109.907 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 9.6 m80 -81.42 -85.13 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.304 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.21 -63.94 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.563 ' O ' ' CG ' ' A' ' 154' ' ' PHE . 0.2 OUTLIER 179.69 44.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -1.143 . . . . 0.0 109.575 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.573 ' HB3' ' CE1' ' A' ' 155' ' ' TYR . 87.8 m-85 -158.7 -58.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.945 . . . . 0.0 110.02 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -117.59 61.93 3.57 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.178 -0.951 . . . . 0.0 109.752 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 154' ' ' PHE . 41.2 Cg_endo -70.79 128.03 14.56 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.92 1.484 . . . . 0.0 109.795 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.652 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -117.13 -162.15 0.85 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 110.326 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 160' ' ' PRO . 33.0 p30 -173.79 55.8 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 110.041 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 14.49 -76.86 0.0 OUTLIER Glycine 0 N--CA 1.508 3.446 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.615 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.2 Cg_endo -66.9 59.19 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.322 1.348 . . . . 0.0 109.866 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -151.89 142.71 9.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.533 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 2.7 m120 -41.43 -34.66 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.021 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.879 ' HA ' HG23 ' A' ' 1' ' ' HAV . 10.9 m -66.66 84.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.97 . . . . 0.0 109.646 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.099 HD21 HG23 ' A' ' 193' ' ' THR . 1.2 tp -64.03 -56.07 17.67 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.335 -0.853 . . . . 0.0 111.462 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.783 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -163.1 -164.35 0.95 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.394 -1.441 . . . . 0.0 110.622 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.652 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 0.9 OUTLIER 178.92 -179.17 0.34 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.157 -1.589 . . . . 0.0 111.356 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 202' ' ' GLU . . . -151.32 174.46 13.28 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.804 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.559 ' CE2' HD12 ' A' ' 174' ' ' ILE . 0.1 OUTLIER -113.97 -170.17 1.66 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.082 -1.011 . . . . 0.0 110.168 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.957 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -156.78 -66.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 109.197 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.957 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 43.8 Cg_endo -73.03 -160.67 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.704 1.371 . . . . 0.0 109.718 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 175' ' ' ASN . . . 76.33 164.21 17.45 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.8 Cg_endo -73.85 -92.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.012 1.533 . . . . 0.0 110.215 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -68.51 -23.7 75.22 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.568 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -77.88 9.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.569 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -65.78 64.82 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 142' ' ' ILE . . . 110.73 96.59 2.37 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -152.96 114.53 4.26 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.197 -1.178 . . . . 0.0 107.872 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.675 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -109.76 157.41 19.17 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.558 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.064 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -147.08 134.88 21.21 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.151 -1.019 . . . . 0.0 109.816 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.541 ' HB3' ' CZ2' ' A' ' 186' ' ' TRP . 19.1 m-85 -96.79 130.7 44.01 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.096 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 164' ' ' LEU . 0.2 OUTLIER -47.97 143.27 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.721 -1.237 . . . . 0.0 109.343 179.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -119.26 29.58 7.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.289 -0.882 . . . . 0.0 109.503 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 1.001 ' CG ' HG21 ' A' ' 148' ' ' VAL . 4.7 m-20 -135.97 3.34 2.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 110.598 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.54 ' HG2' ' HA2' ' A' ' 159' ' ' GLY . 1.6 pt-20 -112.35 -96.39 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.606 -1.309 . . . . 0.0 109.492 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.601 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -162.36 173.4 14.18 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 109.081 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.981 ' CD1' HG21 ' A' ' 105' ' ' THR . 86.1 m95 -161.15 133.8 6.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.006 -1.059 . . . . 0.0 109.799 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.546 ' CG2' ' O ' ' A' ' 186' ' ' TRP . 74.9 p -162.02 150.08 14.77 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.577 -0.702 . . . . 0.0 109.374 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.679 ' O ' HG23 ' A' ' 227' ' ' THR . 13.3 pttt -83.38 -31.9 26.48 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.655 ' O ' ' N ' ' A' ' 191' ' ' THR . 9.4 t70 -83.77 64.01 7.79 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 1.026 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.9 t 3.44 60.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.123 0.963 . . . . 0.0 111.975 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.655 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.7 m -121.88 -32.25 3.78 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.076 -1.015 . . . . 0.0 109.545 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.402 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -98.55 -75.97 1.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.099 HG23 HD21 ' A' ' 164' ' ' LEU . 3.0 m -124.28 -88.86 0.6 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.844 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 4.3 m-20 178.06 72.37 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.015 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 30.6 tp -28.82 -102.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.514 0.673 . . . . 0.0 112.541 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.844 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -57.44 -16.08 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.015 -1.053 . . . . 0.0 111.604 -177.372 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.844 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.8 tp -63.02 -63.04 1.32 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 119.32 -2.112 . . . . 0.0 107.245 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.032 HG21 HD23 ' A' ' 164' ' ' LEU . 3.2 t -69.88 -8.32 10.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.047 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -76.84 -59.54 2.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -64.95 -14.22 59.5 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.59 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 22.0 t60 -66.73 -50.66 62.06 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 117.729 -1.588 . . . . 0.0 107.589 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 167' ' ' ALA . 2.3 mm-40 -79.42 -46.44 17.52 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.282 -0.886 . . . . 0.0 110.925 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.773 HD12 ' HB3' ' A' ' 120' ' ' ALA . 1.4 mt -60.2 -30.35 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.713 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.3 -32.74 42.07 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -59.23 -49.05 79.32 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.892 -0.769 . . . . 0.0 110.496 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.644 ' OG ' ' HB1' ' A' ' 167' ' ' ALA . 5.0 m -84.63 -56.16 3.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 112.333 -177.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.934 HD23 HG13 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -104.39 27.0 8.25 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.94 -1.1 . . . . 0.0 110.987 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.907 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -130.11 -78.26 0.19 Allowed Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.838 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -167.48 -162.82 0.47 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.853 -1.381 . . . . 0.0 110.208 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 211' ' ' HIS . 4.1 t80 -98.98 -70.78 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.418 -0.802 . . . . 0.0 109.471 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 44.9 m80 -161.31 87.86 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.633 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.8 m -76.98 179.75 6.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.395 -0.816 . . . . 0.0 109.306 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.918 ' HB3' ' OD2' ' A' ' 237' ' ' ASP . . . -61.63 81.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.957 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.08 11.12 12.41 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.366 -177.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 214' ' ' ASN . 47.6 p -49.41 -28.27 4.98 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.545 ' C ' ' HB2' ' A' ' 235' ' ' SER . 4.0 mm-40 -115.99 -36.14 4.22 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.957 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.63 -166.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.507 1.146 . . . . 0.0 112.773 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -95.26 -15.3 23.3 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.354 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.573 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -79.77 -5.98 56.39 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.284 -2.135 . . . . 0.0 112.054 -177.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.656 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 43.3 t80 -138.78 15.75 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.444 -1.41 . . . . 0.0 113.347 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.4 Cg_endo -78.14 -37.46 0.79 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 N-CA-C 108.631 -1.334 . . . . 0.0 108.631 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.978 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.7 OUTLIER -14.76 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.085 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.978 ' N ' HD13 ' A' ' 222' ' ' LEU . 2.1 t80 -73.42 56.32 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.154 -0.966 . . . . 0.0 109.321 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -173.68 -145.72 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.248 -0.907 . . . . 0.0 109.574 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.668 ' HB3' HG21 ' A' ' 190' ' ' THR . 18.6 m -143.2 110.6 5.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.081 -1.012 . . . . 0.0 109.855 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER 179.4 39.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.34 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 188' ' ' LYS . 11.3 t -93.36 -13.24 28.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.596 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER 178.37 -21.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.882 . . . . 0.0 110.564 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 1.026 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.4 OUTLIER -26.83 -99.34 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.811 -0.555 . . . . 0.0 111.426 -179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 1.6 p -135.05 -2.98 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.759 -1.213 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.565 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.7 OUTLIER -119.32 -40.28 2.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 108.744 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 2.0 p90 0.38 111.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.357 0.599 . . . . 0.0 111.958 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.6 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 10.5 ttt180 179.42 154.28 0.47 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.166 -0.959 . . . . 0.0 110.035 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.064 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -74.77 169.31 18.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.469 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 30.4 t -104.6 -169.63 1.65 Allowed 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.353 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.517 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -84.98 -11.91 54.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.536 -0.727 . . . . 0.0 110.104 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.918 ' OD2' ' HB3' ' A' ' 213' ' ' ALA . 0.5 OUTLIER -84.18 -50.81 7.57 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.66 -1.275 . . . . 0.0 107.748 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.838 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.2 m-20 -63.81 -38.33 90.71 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 117.638 -1.625 . . . . 0.0 106.679 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -57.07 -35.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 237' ' ' ASP . 3.5 m-20 -68.42 -56.91 6.85 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -47.88 -53.33 14.24 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.038 HG21 HG21 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -63.91 -43.39 97.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.977 -1.308 . . . . 0.0 109.746 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.536 ' N ' HG23 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -54.54 -27.35 37.82 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 178.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.6 t -82.71 -19.17 38.55 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.825 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.3 OUTLIER -70.11 -63.45 1.08 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.558 ' HB3' ' CD2' ' A' ' 130' ' ' LEU . 15.9 m-30 -100.45 -123.56 0.16 Allowed 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.275 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.543 ' HA2' ' CG ' ' A' ' 129' ' ' PRO . . . 54.72 100.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.453 ' HB2' ' HD2' ' A' ' 249' ' ' PRO . 42.7 Cg_endo -72.72 172.22 15.69 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.052 1.554 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 42.3 Cg_endo -72.85 163.04 39.54 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.989 1.52 . . . . 0.0 110.038 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.76 -58.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.985 1.519 . . . . 0.0 110.093 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.59 154.2 3.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.533 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 80.3 p -49.21 151.62 2.41 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.549 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.52 -9.49 24.14 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.948 1.499 . . . . 0.0 110.071 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -102.59 -168.15 1.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 109.573 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.666 HG23 ' OXT' ' A' ' 255' ' ' THR . 11.5 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.555 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.879 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.539 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.727 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' N ' ' HD3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.257 0.551 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.502 ' HD3' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -170.91 -73.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 109.588 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.677 HG21 ' HA2' ' A' ' 241' ' ' GLY . 1.0 OUTLIER -51.94 -93.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.187 -0.946 . . . . 0.0 109.511 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.477 ' CZ ' ' O ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER 179.84 67.37 0.14 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.98 59.7 3.62 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.923 1.486 . . . . 0.0 110.094 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.21 -83.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.477 ' O ' ' CZ ' ' A' ' 86' ' ' PHE . 21.0 mt -115.81 117.46 39.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.311 -1.111 . . . . 0.0 109.572 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.08 -161.95 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.883 1.465 . . . . 0.0 110.133 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 1.036 ' CE ' ' HB1' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -106.55 -75.51 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.012 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.565 ' CH2' ' HB2' ' A' ' 141' ' ' ASP . 70.9 m95 -94.06 162.64 13.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 0.0 109.258 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -133.02 -35.19 1.06 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.075 -1.016 . . . . 0.0 110.237 -179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' HD3' HD23 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -50.7 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.177 -0.952 . . . . 0.0 110.283 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.797 ' CA ' HD12 ' A' ' 130' ' ' LEU . 32.3 p -124.72 1.49 8.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.461 -0.774 . . . . 0.0 109.561 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.555 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 35.6 m80 -146.02 99.66 3.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.992 -1.067 . . . . 0.0 110.484 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.212 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -127.59 -153.09 0.55 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.453 -0.779 . . . . 0.0 109.498 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 141' ' ' ASP . 1.2 t -173.75 -178.91 1.67 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.947 -1.096 . . . . 0.0 111.179 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.827 ' CG ' HD23 ' A' ' 121' ' ' LEU . 10.4 p90 -135.82 179.16 6.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.371 -0.831 . . . . 0.0 109.678 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.806 ' NH2' HG22 ' A' ' 102' ' ' VAL . 2.0 ttp85 -131.85 144.1 50.65 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.487 -0.758 . . . . 0.0 109.394 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.98 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.8 mp -101.53 78.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.879 -1.138 . . . . 0.0 109.503 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.806 HG22 ' NH2' ' A' ' 100' ' ' ARG . 1.8 t -92.77 9.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.44 -0.787 . . . . 0.0 110.616 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.616 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -109.81 174.47 5.85 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.508 -1.37 . . . . 0.0 110.108 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.61 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.1 t80 177.16 86.37 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.397 0.618 . . . . 0.0 109.432 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.789 HG21 ' CD1' ' A' ' 186' ' ' TRP . 33.2 p -67.44 154.09 93.67 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.098 -1.001 . . . . 0.0 108.66 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 185' ' ' GLN . 38.3 Cg_endo -67.87 -26.53 38.05 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.827 1.435 . . . . 0.0 108.65 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.585 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -81.86 2.23 31.33 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.901 HD13 ' CD1' ' A' ' 195' ' ' LEU . 95.1 mt -145.23 117.27 5.23 Favored Pre-proline 0 N--CA 1.485 1.296 0 O-C-N 121.486 -0.759 . . . . 0.0 110.236 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.06 175.6 5.44 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.853 1.449 . . . . 0.0 108.872 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.97 -64.96 0.44 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.829 0.823 . . . . 0.0 110.108 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.64 -30.63 55.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.715 -0.616 . . . . 0.0 112.282 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.889 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.29 -60.69 2.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.31 -1.494 . . . . 0.0 109.356 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.616 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.5 p -52.25 -38.48 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.98 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -65.6 -28.64 69.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.7 ' OG ' HD21 ' A' ' 195' ' ' LEU . 10.8 p -62.37 -39.68 93.96 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.067 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -72.48 -34.13 67.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 0.0 109.544 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.891 HG22 HG21 ' A' ' 144' ' ' ILE . 71.8 t -74.12 -23.2 18.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 122' ' ' LYS . 1.6 tt0 -91.23 -33.48 15.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.695 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 6.5 tppt? -82.57 -33.77 27.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.805 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -68.08 -65.21 0.72 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.853 ' HA ' HG21 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -51.59 -56.44 13.53 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.731 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -54.09 -36.78 63.54 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.239 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.926 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.34 -36.98 48.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.117 ' O ' HG23 ' A' ' 128' ' ' THR . 46.6 m95 -91.61 -23.16 19.95 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.627 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -74.21 -27.74 60.94 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.755 -1.216 . . . . 0.0 108.312 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 6.9 pt-20 -91.37 -44.22 9.29 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.888 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 123' ' ' VAL . 20.2 m -60.47 -24.6 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.186 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.165 HG21 ' CE1' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -106.22 165.08 13.64 Favored Pre-proline 0 N--CA 1.501 2.107 0 C-N-CA 117.882 -1.527 . . . . 0.0 109.975 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 1.013 ' C ' HD22 ' A' ' 130' ' ' LEU . 52.3 Cg_endo -83.66 25.82 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.242 1.961 . . . . 0.0 111.723 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.013 HD22 ' C ' ' A' ' 129' ' ' PRO . 3.7 mm? -127.09 -177.89 4.22 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.468 -1.395 . . . . 0.0 110.781 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.555 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 1.5 p -125.59 167.12 15.52 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.129 -0.982 . . . . 0.0 111.488 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 1.212 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 25.1 m-85 -148.68 162.72 39.17 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.307 0.575 . . . . 0.0 109.801 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.573 ' O ' ' CE1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -133.12 -159.21 0.95 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -151.41 152.94 33.77 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.052 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.057 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -136.1 -129.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.067 -1.021 . . . . 0.0 109.318 -179.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.537 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 40.4 t80 178.24 31.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.67 -1.269 . . . . 0.0 109.423 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.483 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 5.0 pm0 -167.37 -174.25 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 110.014 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.53 -98.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 4.6 pt-20 178.86 124.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -1.156 . . . . 0.0 110.19 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 1.057 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -81.98 -151.23 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 109.219 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.565 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -81.1 -48.7 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.838 HG22 ' CD1' ' A' ' 144' ' ' ILE . 13.1 mm -112.52 80.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.535 ' HG2' HG21 ' A' ' 102' ' ' VAL . 4.4 ttp -63.8 97.69 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.187 -0.945 . . . . 0.0 108.938 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.891 HG21 HG22 ' A' ' 117' ' ' VAL . 5.7 mm -78.23 130.63 35.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.066 -1.021 . . . . 0.0 108.488 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -145.34 154.92 42.83 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.562 -1.336 . . . . 0.0 111.881 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -91.19 135.88 33.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.121 -0.987 . . . . 0.0 108.577 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -169.52 -164.0 0.42 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 118.381 -1.328 . . . . 0.0 111.338 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.959 HG23 ' OD1' ' A' ' 181' ' ' ASP . 3.0 p -177.51 -171.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.738 ' H ' HG22 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -38.7 -25.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 110.765 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.595 ' H ' HG13 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -54.37 -12.2 0.64 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.0 -1.062 . . . . 0.0 111.347 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.589 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 75.4 m80 -37.76 -89.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.075 -1.015 . . . . 0.0 109.981 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.2 -94.28 0.1 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -145.46 12.73 1.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -1.164 . . . . 0.0 109.603 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.498 ' C ' ' CD ' ' A' ' 156' ' ' PRO . 2.1 t80 -131.62 -32.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 109.792 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.612 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.9 m-85 -118.78 42.33 0.43 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.947 . . . . 0.0 110.142 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 39.9 Cg_endo -69.8 101.53 0.93 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.614 1.323 . . . . 0.0 108.855 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.666 ' CZ ' ' CG1' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -69.33 -141.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.207 -0.933 . . . . 0.0 110.479 -178.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.491 ' CG ' ' HB ' ' A' ' 163' ' ' VAL . 3.9 p-10 -128.12 -31.77 2.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.774 -1.204 . . . . 0.0 111.782 -177.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.594 ' HA3' HG21 ' A' ' 148' ' ' VAL . . . 50.61 -105.91 0.22 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.292 -2.323 . . . . 0.0 107.292 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.26 61.45 0.25 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.582 1.306 . . . . 0.0 109.879 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -156.73 -176.13 28.46 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 163' ' ' VAL . 50.9 m-20 -78.1 -41.35 35.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -1.194 . . . . 0.0 110.272 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.027 HG13 HG22 ' A' ' 1' ' ' HAV . 4.6 t -42.1 130.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.258 -0.901 . . . . 0.0 109.809 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.873 HD22 HD23 ' A' ' 222' ' ' LEU . 0.8 OUTLIER -96.08 -56.5 2.62 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.46 -0.775 . . . . 0.0 112.543 -178.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.734 ' HB1' ' OE2' ' A' ' 202' ' ' GLU . . . -162.74 -172.04 2.95 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.22 -1.55 . . . . 0.0 111.695 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 157' ' ' PHE . 0.7 OUTLIER 179.93 173.96 0.91 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 119.956 -1.715 . . . . 0.0 111.371 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.23 -170.78 2.73 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.477 -0.765 . . . . 0.0 109.667 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.627 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 49.3 m-85 -118.28 -166.19 1.19 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.836 -1.165 . . . . 0.0 110.432 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.036 ' HB1' ' CE ' ' A' ' 91' ' ' LYS . . . -177.51 -62.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.8 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 1.002 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 42.9 Cg_endo -73.77 145.23 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.956 1.503 . . . . 0.0 110.305 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 175' ' ' ASN . . . 94.17 144.23 15.43 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.8 Cg_endo -70.4 152.37 65.94 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.969 1.51 . . . . 0.0 109.99 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 68.38 -63.94 0.41 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.627 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -65.69 -8.73 6.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.533 -0.981 . . . . 0.0 108.842 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 171' ' ' GLY . 10.4 t30 -67.41 66.39 0.08 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 108.951 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 131.45 76.58 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.165 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.594 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -149.1 119.32 7.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.699 -1.471 . . . . 0.0 108.288 179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.603 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -101.83 166.1 10.84 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.012 -1.055 . . . . 0.0 109.054 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.678 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -163.27 132.38 4.03 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.32 178.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.691 ' HE1' HG23 ' A' ' 198' ' ' VAL . 53.9 m-85 -92.06 136.24 33.33 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.756 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.959 ' OD1' HG23 ' A' ' 148' ' ' VAL . 51.6 t0 -70.03 126.49 29.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 183' ' ' ASP . 16.5 t70 -70.65 -5.03 26.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.628 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 159' ' ' GLY . 61.9 t0 -34.32 -72.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.662 -0.649 . . . . 0.0 111.273 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.474 ' OE2' ' OD2' ' A' ' 183' ' ' ASP . 1.0 OUTLIER -111.87 -135.85 0.36 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.524 -177.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.543 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 0.1 OUTLIER -122.91 -178.75 4.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.162 -0.961 . . . . 0.0 109.17 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 1.073 ' CZ3' HG21 ' A' ' 198' ' ' VAL . 29.4 m95 -144.7 151.2 38.58 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.45 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.844 ' HA ' HD21 ' A' ' 108' ' ' LEU . 41.5 p -145.9 152.87 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 0.0 110.007 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.68 ' O ' HG23 ' A' ' 227' ' ' THR . 0.1 OUTLIER -70.08 -38.95 75.86 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.505 ' HA ' HD13 ' A' ' 229' ' ' LEU . 0.8 OUTLIER -86.18 -150.17 0.14 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.953 HG23 HD11 ' A' ' 229' ' ' LEU . 17.3 p -109.51 43.1 1.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.069 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.532 ' HB ' HG21 ' A' ' 187' ' ' THR . 89.0 m -95.49 -31.84 13.16 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.352 -0.842 . . . . 0.0 111.25 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -114.18 -80.15 0.92 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.028 -1.558 . . . . 0.0 109.535 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.848 HG22 ' OD1' ' A' ' 194' ' ' ASN . 64.0 m -134.72 -94.02 0.29 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.584 -0.951 . . . . 0.0 108.435 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.848 ' OD1' HG22 ' A' ' 193' ' ' THR . 0.8 OUTLIER -157.23 66.01 0.5 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.675 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.067 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -29.56 -91.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.702 0.763 . . . . 0.0 111.019 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.822 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.3 OUTLIER -67.78 -11.71 59.04 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.471 -0.768 . . . . 0.0 111.536 -177.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.868 HD21 ' HB2' ' A' ' 221' ' ' PRO . 13.0 tp -67.25 -59.94 3.01 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.06 -1.856 . . . . 0.0 106.895 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.073 HG21 ' CZ3' ' A' ' 186' ' ' TRP . 2.0 m -71.29 -12.87 16.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.039 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.5 -61.21 1.91 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.805 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -62.85 -17.13 60.97 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 177.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.598 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 15.5 t60 -68.71 -40.63 79.88 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.594 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.734 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 3.9 mt-10 -85.2 -49.36 8.28 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.853 . . . . 0.0 111.141 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.853 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.2 mt -60.88 -30.6 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.781 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.78 -30.83 42.15 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.567 ' CE1' ' O1 ' ' A' ' 1' ' ' HAV . 0.0 OUTLIER -63.19 -44.64 94.8 Favored 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.742 -0.857 . . . . 0.0 110.699 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.674 ' OG ' HD12 ' A' ' 142' ' ' ILE . 85.7 p -87.49 -55.61 3.72 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 112.61 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 1.009 HD11 ' OH ' ' A' ' 246' ' ' TYR . 2.3 tp -104.56 7.35 35.14 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.134 -0.979 . . . . 0.0 110.964 -176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 1.026 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -104.65 -77.54 1.16 Allowed Glycine 0 N--CA 1.486 1.982 0 O-C-N 120.841 -1.162 . . . . 0.0 111.021 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.899 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.6 pp -172.59 -161.85 0.17 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.611 -1.523 . . . . 0.0 110.05 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.827 ' N ' HD12 ' A' ' 209' ' ' LEU . 2.9 m-85 -94.32 -94.51 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 0.0 109.155 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 44.8 m170 -143.15 120.92 11.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.575 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.7 m -108.33 -179.12 3.79 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.179 -0.951 . . . . 0.0 109.291 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.69 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -59.53 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.951 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -91.01 13.26 17.24 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.536 -177.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 214' ' ' ASN . 31.0 p -50.73 -28.04 8.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.492 ' C ' ' HB2' ' A' ' 235' ' ' SER . 2.5 mt-10 -118.08 -36.42 3.6 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.212 -1.358 . . . . 0.0 107.517 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.78 -159.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 122.2 1.0 . . . . 0.0 112.756 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.8 ' O ' HD12 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -112.15 -3.43 14.68 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.925 -177.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.541 ' HB2' ' CG ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER -89.55 -5.36 57.31 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 119.152 -2.217 . . . . 0.0 110.732 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.647 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 33.4 t80 -140.0 14.91 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 118.845 -1.142 . . . . 0.0 113.252 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 1.081 ' HB3' HD11 ' A' ' 226' ' ' LEU . 56.1 Cg_endo -75.85 -35.21 2.68 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 N-CA-C 108.539 -1.37 . . . . 0.0 108.539 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.978 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.4 OUTLIER -17.98 -57.94 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.53 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.978 ' N ' HD13 ' A' ' 222' ' ' LEU . 2.7 t80 -75.01 55.17 0.7 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 0.0 108.96 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 221' ' ' PRO . 7.2 t-160 -173.44 -138.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.284 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.899 ' C ' HD23 ' A' ' 226' ' ' LEU . 1.9 m -157.06 119.26 3.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.92 -1.112 . . . . 0.0 109.909 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 1.081 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.2 OUTLIER 178.92 62.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 0.0 110.021 179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.68 HG23 ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER -114.26 -18.69 11.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 188' ' ' LYS . 14.5 t70 -167.42 -26.91 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.577 -0.702 . . . . 0.0 109.951 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.953 HD11 HG23 ' A' ' 190' ' ' THR . 0.2 OUTLIER -28.61 -61.97 0.11 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.517 -0.739 . . . . 0.0 110.843 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.849 HG23 ' HG3' ' A' ' 231' ' ' ARG . 1.5 t 178.98 -31.15 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.379 -0.826 . . . . 0.0 108.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.849 ' HG3' HG23 ' A' ' 230' ' ' THR . 0.0 OUTLIER -94.67 -18.46 21.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.578 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 27.8 p90 -37.49 107.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.522 0.677 . . . . 0.0 110.641 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.601 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 9.2 ttt180 179.79 153.26 0.48 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.442 -0.786 . . . . 0.0 109.573 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.112 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.2 mp -67.01 165.86 14.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 12.7 t -101.73 -169.51 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.492 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.56 ' N ' ' OG ' ' A' ' 235' ' ' SER . 1.5 tp60 -84.85 -21.69 29.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.594 -0.691 . . . . 0.0 110.117 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.69 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 6.5 m-20 -80.44 -41.74 23.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.899 ' OD1' HD21 ' A' ' 209' ' ' LEU . 19.0 t0 -70.73 -32.81 70.13 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 118.458 -1.297 . . . . 0.0 107.725 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.623 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.4 OUTLIER -62.92 -33.9 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -65.05 -51.26 62.5 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.508 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.677 ' HA2' HG21 ' A' ' 85' ' ' THR . . . -58.38 -54.71 35.52 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.026 HD13 ' HA2' ' A' ' 208' ' ' GLY . 2.4 tp -61.24 -49.38 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.745 -1.444 . . . . 0.0 109.916 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.541 ' N ' HG23 ' A' ' 242' ' ' ILE . 9.1 tt0 -53.57 -29.88 39.36 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.0 t -80.09 -17.08 53.58 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -70.39 -59.86 2.61 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 178.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 1.165 ' CE1' HG21 ' A' ' 128' ' ' THR . 41.7 m-85 -71.39 -91.94 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.125 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 246' ' ' TYR . . . -33.62 137.18 0.18 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.475 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 42.2 Cg_endo -72.02 136.09 26.57 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.707 1.605 . . . . 0.0 110.189 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.605 ' CD ' ' CD ' ' A' ' 250' ' ' PRO . 38.2 Cg_endo -72.58 -30.64 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.036 1.545 . . . . 0.0 112.584 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.605 ' CD ' ' CD ' ' A' ' 249' ' ' PRO . 43.1 Cg_endo -73.28 -164.62 0.2 Allowed 'Trans proline' 0 C--N 1.319 -0.996 0 N-CA-C 110.164 -0.745 . . . . 0.0 110.164 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 252' ' ' SER . 0.2 OUTLIER -78.88 -52.15 8.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.623 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 251' ' ' ASP . 1.4 p -43.6 103.47 0.32 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.28 -0.888 . . . . 0.0 109.647 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 251' ' ' ASP . 42.1 Cg_endo -72.85 -43.89 0.74 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.07 1.563 . . . . 0.0 110.059 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.36 153.44 38.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.639 HG23 ' OXT' ' A' ' 255' ' ' THR . 3.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.484 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.027 HG22 HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.546 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.649 ' HH1' ' CD1' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.3 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.264 0.554 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -86.64 171.76 10.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.579 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.649 HG22 ' N ' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -63.55 -166.45 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.281 -0.887 . . . . 0.0 109.655 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.607 ' CG ' ' HD2' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -50.01 -179.68 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.191 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' A' ' 86' ' ' PHE . 38.3 Cg_endo -67.69 60.24 0.83 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.411 1.216 . . . . 0.0 109.69 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.501 ' C ' ' CG1' ' A' ' 89' ' ' ILE . . . 174.04 -136.84 3.73 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.51 ' CB ' ' CD ' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -168.06 -62.54 0.01 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.105 -1.232 . . . . 0.0 109.564 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 89' ' ' ILE . 41.7 Cg_endo -71.39 78.98 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.929 1.489 . . . . 0.0 110.401 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.513 ' HD3' ' CD1' ' A' ' 245' ' ' LEU . 2.8 mttp -50.99 -97.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 108.917 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.858 ' CD1' HD11 ' A' ' 207' ' ' LEU . 7.0 m95 -66.03 -164.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.834 -1.166 . . . . 0.0 109.076 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -152.03 -36.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.999 -1.063 . . . . 0.0 110.379 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.61 ' HD3' ' CE3' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -50.32 -174.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.137 -0.977 . . . . 0.0 110.441 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.916 ' HA ' HD12 ' A' ' 130' ' ' LEU . 8.2 p -121.22 -5.64 9.42 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 1.033 ' CE1' HG21 ' A' ' 131' ' ' THR . 26.7 m-70 -146.06 100.41 3.39 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.089 HD13 ' CE2' ' A' ' 132' ' ' PHE . 0.0 OUTLIER -106.36 -165.33 1.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.352 -0.842 . . . . 0.0 109.952 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -160.43 160.17 31.84 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.267 -0.895 . . . . 0.0 109.274 -179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 1.044 ' CZ ' HD22 ' A' ' 121' ' ' LEU . 2.6 p90 -131.16 167.23 19.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.801 -1.187 . . . . 0.0 108.816 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.891 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -126.11 123.14 37.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.121 . . . . 0.0 109.818 -179.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.727 HG13 HG11 ' A' ' 117' ' ' VAL . 1.5 mp -82.14 84.43 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.779 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.891 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 38.2 t -99.52 6.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.401 -0.812 . . . . 0.0 109.775 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.983 ' C ' HG21 ' A' ' 113' ' ' VAL . 35.1 m-80 -97.11 156.15 16.51 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.846 -1.159 . . . . 0.0 108.794 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.78 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER 179.14 37.28 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.495 -0.753 . . . . 0.0 109.766 179.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 104' ' ' TYR . 41.3 p -42.86 156.31 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.401 -0.812 . . . . 0.0 108.913 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.88 -20.27 45.54 Favored 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 123.836 1.44 . . . . 0.0 109.054 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.557 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -67.7 -9.85 47.27 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.851 HD13 ' CD1' ' A' ' 195' ' ' LEU . 63.6 mt -144.49 123.59 7.04 Favored Pre-proline 0 N--CA 1.483 1.221 0 O-C-N 121.518 -0.739 . . . . 0.0 109.694 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.0 Cg_endo -64.41 166.25 17.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.833 1.438 . . . . 0.0 109.153 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' HE3' ' OD1' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.94 -65.72 0.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.711 0.767 . . . . 0.0 110.345 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.3 m-20 -57.83 -22.92 50.23 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.682 -0.636 . . . . 0.0 111.764 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.744 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -76.16 -62.11 1.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.39 -1.443 . . . . 0.0 109.304 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.983 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.9 p -50.94 -39.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -66.96 -26.95 67.08 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.824 ' OG ' HD21 ' A' ' 195' ' ' LEU . 17.1 p -65.67 -41.22 92.72 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.087 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -73.78 -33.57 64.3 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.069 -1.019 . . . . 0.0 109.874 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.882 HG13 HG13 ' A' ' 144' ' ' ILE . 12.0 t -74.82 -23.72 17.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 2.1 tt0 -88.35 -35.13 17.35 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -77.88 -39.57 42.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 179.352 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -67.41 -62.42 1.43 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.142 0.972 . . . . 0.0 109.086 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.044 HD22 ' CZ ' ' A' ' 99' ' ' TYR . 1.7 pp -55.3 -40.82 71.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.793 ' N ' HD12 ' A' ' 121' ' ' LEU . 7.1 tptm -75.7 -32.64 60.17 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.826 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.037 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.5 t -54.16 -44.42 63.91 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.118 ' CH2' HD21 ' A' ' 234' ' ' LEU . 32.7 m95 -91.1 -23.57 20.26 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.675 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 17.6 tp10 -69.79 -27.24 64.74 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.692 -1.255 . . . . 0.0 107.903 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.7 pt-20 -90.39 -42.93 10.63 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.889 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.037 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.6 m -57.9 -26.02 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.322 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.988 HG22 HG13 ' A' ' 242' ' ' ILE . 0.1 OUTLIER -107.94 154.12 41.27 Favored Pre-proline 0 N--CA 1.495 1.818 0 C-N-CA 117.966 -1.493 . . . . 0.0 109.224 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.596 ' C ' HD22 ' A' ' 130' ' ' LEU . 48.6 Cg_endo -81.29 24.76 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.832 1.688 . . . . 0.0 111.415 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.916 HD12 ' HA ' ' A' ' 95' ' ' THR . 4.6 mm? -106.13 -169.02 1.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.701 -1.25 . . . . 0.0 110.202 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 1.033 HG21 ' CE1' ' A' ' 96' ' ' HIS . 1.0 OUTLIER -121.65 162.76 20.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.0 110.48 -179.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 1.089 ' CE2' HD13 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -149.86 144.2 25.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.547 -0.721 . . . . 0.0 109.688 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.12 -162.5 1.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.24 -0.912 . . . . 0.0 108.856 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.625 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -156.46 153.28 28.57 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 110.057 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.607 HD12 ' H ' ' A' ' 137' ' ' GLU . 0.4 OUTLIER -145.06 -137.35 0.09 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.474 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.4 OUTLIER 179.29 33.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.689 -1.257 . . . . 0.0 108.995 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.607 ' H ' HD12 ' A' ' 135' ' ' LEU . 5.4 pm0 -157.54 179.94 8.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 41.35 -95.99 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER 178.83 106.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -1.159 . . . . 0.0 110.193 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.536 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.67 -147.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 108.758 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 98' ' ' THR . 43.9 t0 -90.28 -45.03 9.32 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.766 HG22 ' CD1' ' A' ' 144' ' ' ILE . 44.3 mt -116.46 81.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.493 ' SD ' HG21 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -64.52 97.11 0.19 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.882 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -82.52 114.83 24.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -135.71 157.33 47.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.369 -1.457 . . . . 0.0 112.08 -178.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 16.7 p90 -88.47 140.3 29.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.526 -0.734 . . . . 0.0 109.419 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.913 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -168.29 -161.49 0.36 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.138 -0.976 . . . . 0.0 110.176 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 1.01 HG21 ' CG ' ' A' ' 183' ' ' ASP . 0.7 OUTLIER -179.51 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.016 -1.052 . . . . 0.0 109.896 179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.808 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -29.69 -36.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.863 -0.523 . . . . 0.0 111.157 -179.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 148' ' ' VAL . 5.2 mt-10 -82.01 124.88 30.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.966 -1.084 . . . . 0.0 109.818 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 148' ' ' VAL . 20.3 m80 -148.86 -91.48 0.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.504 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -151.29 -48.16 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 179.86 -29.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.13 -1.218 . . . . 0.0 110.232 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 72.4 t80 -129.28 42.38 3.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.0 -1.063 . . . . 0.0 110.211 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.591 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.4 m-85 -154.97 45.25 0.25 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.118 -0.989 . . . . 0.0 109.793 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 43.1 Cg_endo -72.61 112.4 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.727 1.383 . . . . 0.0 110.128 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.69 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -92.12 -157.18 0.5 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.079 -1.013 . . . . 0.0 109.861 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.594 ' O ' ' C ' ' A' ' 159' ' ' GLY . 22.5 p30 179.88 54.72 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.427 -0.795 . . . . 0.0 109.858 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.594 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -10.48 -64.37 0.01 OUTLIER Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.901 -0.48 . . . . 0.0 111.901 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 40.1 Cg_endo -68.96 59.58 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.145 1.23 . . . . 0.0 109.955 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.08 164.86 37.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 164' ' ' LEU . 8.5 m120 -54.18 -58.98 5.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.598 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.841 ' HA ' HG23 ' A' ' 1' ' ' HAV . 33.6 m -45.46 93.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.744 ' CD1' HG21 ' A' ' 193' ' ' THR . 1.0 OUTLIER -77.82 -66.79 0.8 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.227 -0.921 . . . . 0.0 112.57 -178.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.783 ' HB1' ' CD ' ' A' ' 202' ' ' GLU . . . -143.2 -172.46 3.69 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.403 . . . . 0.0 111.184 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.69 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.6 p-80 179.47 167.94 1.1 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.246 -1.534 . . . . 0.0 110.937 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -138.02 -177.25 4.74 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.461 -0.774 . . . . 0.0 109.771 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.502 ' HB3' HG13 ' A' ' 174' ' ' ILE . 96.3 m-85 -114.31 -166.75 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.693 -1.203 . . . . 0.0 110.574 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -109.44 -174.51 0.3 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.492 -0.755 . . . . 0.0 109.26 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 42.5 Cg_endo -75.21 53.35 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.666 1.351 . . . . 0.0 110.725 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 175' ' ' ASN . . . -93.32 -170.76 39.52 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 174' ' ' ILE . 40.7 Cg_endo -70.79 124.69 10.89 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.827 1.435 . . . . 0.0 109.912 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 175' ' ' ASN . . . 69.34 -59.67 0.62 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.631 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -76.05 18.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.32 -1.106 . . . . 0.0 109.173 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.578 ' OD1' ' CZ2' ' A' ' 92' ' ' TRP . 1.2 t-20 -63.49 63.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 103.14 102.99 2.74 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.646 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -158.97 115.12 2.63 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 120.737 -1.449 . . . . 0.0 107.976 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -109.79 160.82 16.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.862 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.913 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -155.96 135.66 12.57 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.516 178.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.627 ' N ' ' CD2' ' A' ' 179' ' ' HIS . 23.1 m-85 -93.74 131.08 39.44 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.194 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.529 ' OD2' HD13 ' A' ' 164' ' ' LEU . 43.7 p-10 -65.48 122.26 16.77 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.431 ' OD1' ' OD1' ' A' ' 183' ' ' ASP . 2.8 p30 -88.47 -9.36 52.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.001 -1.062 . . . . 0.0 110.669 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 1.01 ' CG ' HG21 ' A' ' 148' ' ' VAL . 6.3 m-20 -79.66 2.95 20.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.972 -1.08 . . . . 0.0 109.607 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 164' ' ' LEU . 33.0 tt0 -114.14 -129.91 0.31 Allowed 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.606 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.1 mt-30 -137.22 176.29 8.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.758 -1.214 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.611 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.7 m95 -161.87 115.81 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.97 -1.081 . . . . 0.0 110.069 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.802 ' HA ' HD21 ' A' ' 108' ' ' LEU . 37.3 p -140.52 151.4 44.75 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 120.905 -1.122 . . . . 0.0 110.071 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.88 ' O ' HG23 ' A' ' 227' ' ' THR . 15.4 pttp -84.43 -31.72 24.48 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.2 t70 -84.51 64.12 8.25 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.982 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.1 t 3.38 60.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.129 0.966 . . . . 0.0 112.011 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 53.7 m -127.1 -30.19 2.71 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.055 -1.028 . . . . 0.0 110.028 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.794 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.58 -84.67 1.64 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.744 HG21 ' CD1' ' A' ' 164' ' ' LEU . 5.0 m -119.48 -82.0 0.64 Allowed 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 0.5 OUTLIER -179.81 72.78 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.979 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.905 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 3.3 tp -34.62 -97.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.61 0.719 . . . . 0.0 110.732 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.848 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -70.53 -9.66 57.25 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.963 -1.086 . . . . 0.0 111.358 -176.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.764 ' HB3' ' HB3' ' A' ' 194' ' ' ASN . 11.1 tp -68.29 -58.82 3.8 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 115.923 -2.311 . . . . 0.0 106.692 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.703 HG23 ' HB3' ' A' ' 194' ' ' ASN . 1.4 t -72.49 -10.3 13.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.087 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.49 -61.6 1.86 Allowed 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -63.08 -15.93 58.24 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.636 ' CG ' ' CE1' ' A' ' 3' ' ' MSB . 28.2 t60 -68.07 -43.69 78.02 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 117.921 -1.512 . . . . 0.0 107.835 177.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.783 ' CD ' ' HB1' ' A' ' 165' ' ' ALA . 31.5 mt-10 -83.47 -48.07 10.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.237 -0.915 . . . . 0.0 110.914 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.88 HG21 ' HA ' ' A' ' 121' ' ' LEU . 2.3 mt -61.06 -29.8 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.682 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -78.26 -31.93 45.15 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.21 -52.3 65.86 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.691 -0.887 . . . . 0.0 109.816 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.534 ' C ' HD22 ' A' ' 207' ' ' LEU . 28.6 t -79.74 -59.52 2.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.492 -0.755 . . . . 0.0 111.827 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.858 HD11 ' CD1' ' A' ' 92' ' ' TRP . 1.4 mm? -104.58 38.82 1.8 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.253 -0.904 . . . . 0.0 110.586 -177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.882 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -139.56 -73.41 0.05 OUTLIER Glycine 0 C--N 1.292 -1.913 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.709 HD12 ' N ' ' A' ' 210' ' ' PHE . 3.5 pp 179.33 -162.42 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.655 -1.497 . . . . 0.0 109.818 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.709 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.1 t80 -99.37 -79.97 0.48 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.885 . . . . 0.0 109.104 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 4.7 m-70 -153.92 77.22 1.09 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -62.18 -172.44 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 108.924 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.991 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -64.26 77.81 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.946 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -86.01 13.14 8.06 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.789 -177.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER -50.27 -28.44 7.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 174.373 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.538 ' C ' ' HB3' ' A' ' 235' ' ' SER . 6.5 mt-10 -115.96 -39.65 3.43 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.946 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -63.15 164.8 8.03 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 122.451 1.12 . . . . 0.0 111.99 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.738 ' O ' ' HH1' ' A' ' 3' ' ' MSB . 0.0 OUTLIER -67.33 -15.5 63.72 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.339 -177.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -77.59 -9.72 59.1 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 118.976 -2.328 . . . . 0.0 112.294 -177.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.663 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 45.7 t80 -137.42 17.27 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.293 -1.505 . . . . 0.0 113.506 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.648 ' HG3' ' HA ' ' A' ' 218' ' ' LEU . 57.5 Cg_endo -79.47 -36.35 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.048 0 N-CA-C 108.747 -1.29 . . . . 0.0 108.747 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.983 HD13 ' N ' ' A' ' 223' ' ' TYR . 0.4 OUTLIER -16.93 -56.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 -178.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.983 ' N ' HD13 ' A' ' 222' ' ' LEU . 28.2 t80 -75.74 49.73 0.53 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.254 -0.904 . . . . 0.0 109.394 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 223' ' ' TYR . 95.7 m-70 -160.85 -120.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.94 . . . . 0.0 109.071 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.826 ' O ' HD12 ' A' ' 226' ' ' LEU . 14.7 m -173.44 110.32 0.18 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.727 -1.233 . . . . 0.0 109.891 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.37 65.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.956 . . . . 0.0 109.852 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.88 HG23 ' O ' ' A' ' 188' ' ' LYS . 10.1 t -116.88 -7.91 11.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.591 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 1.6 t0 178.09 -22.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.037 . . . . 0.0 110.642 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.982 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -30.32 -61.06 0.17 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.571 -0.706 . . . . 0.0 110.604 -179.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.33 -29.42 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.475 -0.765 . . . . 0.0 109.098 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 232' ' ' PHE . 3.4 mtp180 -100.21 -26.97 13.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.425 -0.797 . . . . 0.0 108.925 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.689 ' HA ' HD23 ' A' ' 226' ' ' LEU . 11.6 p90 -27.77 121.42 0.11 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.349 0.595 . . . . 0.0 111.598 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 179.13 170.52 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.443 -0.786 . . . . 0.0 109.809 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.118 HD21 ' CH2' ' A' ' 124' ' ' TRP . 1.8 mp -81.41 162.15 23.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.293 -0.879 . . . . 0.0 110.076 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.823 ' OG ' ' HB2' ' A' ' 217' ' ' ALA . 9.0 p -103.5 -167.21 1.35 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.306 -1.357 . . . . 0.0 110.51 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -84.83 -14.48 47.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 111.723 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.991 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 1.3 m-20 -84.84 -45.2 12.54 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.2 -1.563 . . . . 0.0 107.809 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.653 ' HB2' ' HB1' ' A' ' 217' ' ' ALA . 2.6 m-20 -64.99 -41.4 95.43 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -55.39 -35.69 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.21 -47.4 73.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 244' ' ' SER . . . -57.94 -55.47 30.42 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.024 HG21 HG21 ' A' ' 127' ' ' VAL . 1.5 tp -60.14 -46.03 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.977 -1.308 . . . . 0.0 109.227 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.572 ' N ' HG23 ' A' ' 242' ' ' ILE . 34.8 tt0 -56.3 -25.23 47.86 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 241' ' ' GLY . 0.0 OUTLIER -78.16 -21.87 49.57 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.666 ' HB2' HD12 ' A' ' 242' ' ' ILE . 9.0 mt -72.61 -66.42 0.66 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.881 ' OH ' HD21 ' A' ' 97' ' ' LEU . 71.5 m-85 -91.61 -120.66 0.07 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.145 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.57 67.79 1.52 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.466 ' C ' ' HD2' ' A' ' 250' ' ' PRO . 41.8 Cg_endo -72.58 112.36 3.45 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.006 1.529 . . . . 0.0 110.013 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.613 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 38.0 Cg_endo -72.28 -30.01 13.42 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.928 1.488 . . . . 0.0 112.314 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 249' ' ' PRO . 43.5 Cg_endo -75.34 171.65 17.85 Favored 'Trans proline' 0 C--N 1.318 -1.043 0 N-CA-C 110.054 -0.787 . . . . 0.0 110.054 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -144.3 -67.23 0.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.547 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.86 113.81 8.14 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.315 -0.865 . . . . 0.0 109.451 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.43 -21.55 22.61 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.878 1.462 . . . . 0.0 110.129 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -123.63 -78.14 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.515 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.841 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.547 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.738 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.1 p90 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.266 0.555 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 85' ' ' THR . 5.4 ptm180 -168.73 167.59 11.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.604 HG22 ' HB2' ' A' ' 209' ' ' LEU . 0.2 OUTLIER -51.13 -178.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.898 . . . . 0.0 109.522 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.72 109.18 30.36 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.259 -0.901 . . . . 0.0 109.521 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 85' ' ' THR . 42.2 Cg_endo -72.38 101.42 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.895 1.471 . . . . 0.0 110.173 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.453 ' C ' HG23 ' A' ' 89' ' ' ILE . . . 174.22 -64.28 0.11 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.453 HG23 ' C ' ' A' ' 88' ' ' GLY . 16.4 pt -154.17 151.93 25.42 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -1.155 . . . . 0.0 109.562 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -73.11 159.14 48.18 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.029 1.541 . . . . 0.0 110.095 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 1.034 ' CE ' ' HB1' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -76.86 -92.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.964 . . . . 0.0 109.756 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.567 ' CD1' ' HA ' ' A' ' 207' ' ' LEU . 10.0 m95 -82.86 176.8 9.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 109.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.74 -41.13 0.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.148 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.877 ' HE2' HD13 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -43.24 172.04 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.681 0.753 . . . . 0.0 110.275 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.955 ' HA ' HD13 ' A' ' 130' ' ' LEU . 42.9 p -110.3 7.46 23.07 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.75 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.572 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 51.1 m80 -144.14 96.28 2.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.866 -1.147 . . . . 0.0 110.088 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.877 HD13 ' HE2' ' A' ' 94' ' ' LYS . 2.9 mm? -96.59 164.45 12.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.53 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.627 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -136.89 155.98 49.06 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 108.519 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 1.007 ' CE2' HD11 ' A' ' 101' ' ' ILE . 7.7 p90 -135.18 170.3 16.12 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.706 -1.246 . . . . 0.0 109.473 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' HD2' HG22 ' A' ' 102' ' ' VAL . 1.1 ttm180 -131.56 128.12 38.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.007 HD11 ' CE2' ' A' ' 99' ' ' TYR . 2.4 mp -86.81 82.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.784 -1.198 . . . . 0.0 109.725 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 13.0 t -99.09 7.53 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.288 -0.883 . . . . 0.0 109.828 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.922 ' C ' HG21 ' A' ' 113' ' ' VAL . 18.4 m-80 -98.9 160.46 14.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.978 -1.076 . . . . 0.0 109.166 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.745 ' N ' HG21 ' A' ' 113' ' ' VAL . 7.5 t80 177.67 77.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.39 -0.819 . . . . 0.0 109.588 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 1.104 HG21 ' CD1' ' A' ' 186' ' ' TRP . 61.1 p -69.58 155.66 93.11 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.77 -25.39 39.73 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 O-C-N 123.766 1.403 . . . . 0.0 108.637 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.657 ' O ' HD23 ' A' ' 108' ' ' LEU . 2.5 m-20 -74.26 -5.93 44.95 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 195' ' ' LEU . 62.0 mt -140.16 121.21 9.34 Favored Pre-proline 0 N--CA 1.485 1.294 0 O-C-N 121.454 -0.779 . . . . 0.0 110.285 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -65.9 169.28 13.56 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 123.881 1.463 . . . . 0.0 108.716 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.483 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.62 -65.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 115' ' ' SER . 8.5 t0 -55.26 -26.93 43.03 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.716 -0.615 . . . . 0.0 111.799 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.769 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.9 -61.36 1.87 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.435 -1.415 . . . . 0.0 109.329 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.922 HG21 ' C ' ' A' ' 103' ' ' ASN . 12.8 p -53.04 -41.33 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 1.003 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.1 m-20 -64.45 -26.93 68.66 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.901 ' OG ' HD21 ' A' ' 195' ' ' LEU . 6.0 p -62.99 -42.37 99.83 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.069 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -70.7 -33.01 70.43 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 0.0 109.638 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.952 HG13 HG13 ' A' ' 144' ' ' ILE . 47.1 t -74.57 -23.26 17.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.1 tt0 -90.04 -33.77 16.2 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.679 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -81.59 -37.15 28.09 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.797 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -66.46 -62.1 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.938 ' HA ' HG21 ' A' ' 203' ' ' ILE . 1.4 pp -55.47 -41.89 73.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.097 -179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.817 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -71.52 -33.6 69.35 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.641 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.035 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.18 -42.04 63.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.067 ' O ' HG23 ' A' ' 128' ' ' THR . 33.7 m95 -91.29 -22.88 20.34 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 28.3 tt0 -71.42 -27.47 63.32 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.2 pt-20 -90.46 -43.59 10.17 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.612 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.3 m -58.0 -25.91 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.072 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.067 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -104.95 163.49 17.06 Favored Pre-proline 0 N--CA 1.499 2.023 0 C-N-CA 117.966 -1.494 . . . . 0.0 110.492 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.641 ' O ' HD23 ' A' ' 130' ' ' LEU . 50.6 Cg_endo -87.26 29.8 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.379 2.053 . . . . 0.0 111.289 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.014 HD12 ' CD2' ' A' ' 246' ' ' TYR . 34.5 mt -121.27 -166.6 1.38 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.61 -1.306 . . . . 0.0 110.474 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.2 p -123.01 176.68 5.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.913 . . . . 0.0 110.645 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.777 ' HZ ' HD13 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -139.25 167.98 20.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 109.671 -179.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.512 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -151.14 169.34 22.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 108.589 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.715 ' C ' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -140.56 167.43 22.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.803 -1.186 . . . . 0.0 110.545 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.042 HD21 ' HB2' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -156.76 -133.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 12.7 t80 178.01 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 109.372 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 138' ' ' GLY . 7.5 pm0 -161.39 -171.85 3.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.697 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.02 -98.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 140' ' ' ALA . 3.1 pt-20 178.41 107.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -1.111 . . . . 0.0 110.34 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 1.042 ' HB2' HD21 ' A' ' 135' ' ' LEU . . . -60.24 -150.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 108.722 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.669 ' C ' HD12 ' A' ' 142' ' ' ILE . 72.3 m-20 -88.48 -33.88 17.65 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.861 ' N ' HD12 ' A' ' 142' ' ' ILE . 3.4 mp -126.3 79.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.542 ' CG ' ' HB3' ' A' ' 177' ' ' ASP . 0.2 OUTLIER -67.74 101.54 1.07 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.237 -0.985 . . . . 0.0 108.853 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.952 HG13 HG13 ' A' ' 117' ' ' VAL . 5.5 mm -81.61 119.69 31.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.6 OUTLIER -138.35 158.5 44.16 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.347 -1.471 . . . . 0.0 112.063 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 22.2 p90 -90.67 139.77 30.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.472 -0.768 . . . . 0.0 109.625 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.119 ' HB3' ' CE1' ' A' ' 179' ' ' HIS . . . -162.1 -160.47 0.68 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 1.004 HG21 ' HB2' ' A' ' 183' ' ' ASP . 0.8 OUTLIER 179.65 -157.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.918 -1.113 . . . . 0.0 109.531 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.795 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -63.14 59.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 148' ' ' VAL . 0.4 OUTLIER -158.55 21.91 0.23 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.015 -1.053 . . . . 0.0 109.368 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 74.8 m80 -58.87 168.54 1.23 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.475 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 151' ' ' HIS . . . -43.81 -52.27 6.7 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -176.62 48.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -1.11 . . . . 0.0 109.396 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.603 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -169.91 -154.91 0.12 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.393 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.603 ' CD2' ' HB3' ' A' ' 154' ' ' PHE . 0.8 OUTLIER 1.87 69.04 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.522 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.531 ' N ' ' O ' ' A' ' 154' ' ' PHE . 44.9 Cg_endo -77.45 97.28 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.985 1.518 . . . . 0.0 109.57 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.748 ' CE2' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -72.88 -163.08 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.097 -1.002 . . . . 0.0 109.927 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.763 ' OD1' HG23 ' A' ' 163' ' ' VAL . 23.3 p30 179.2 54.45 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.877 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 158' ' ' ASP . . . -0.16 -68.72 0.0 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 112.274 -0.33 . . . . 0.0 112.274 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' ASP . 38.4 Cg_endo -67.55 59.52 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.21 1.11 . . . . 0.0 109.664 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -168.79 160.62 34.16 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.545 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 5.5 m120 -52.57 -47.72 66.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -1.199 . . . . 0.0 110.086 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.77 HG12 ' CG2' ' A' ' 1' ' ' HAV . 2.6 m -51.46 89.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 0.0 109.728 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.035 HD21 HG21 ' A' ' 193' ' ' THR . 0.3 OUTLIER -76.32 -82.53 0.07 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.869 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . -137.33 -175.32 4.02 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.491 -1.38 . . . . 0.0 111.154 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.748 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 1.7 p-80 179.34 169.35 1.03 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 119.899 -1.751 . . . . 0.0 110.524 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -136.63 -172.51 3.18 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.498 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.577 ' OH ' ' CD2' ' A' ' 155' ' ' TYR . 64.1 m-85 -118.09 -167.28 1.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.935 . . . . 0.0 110.072 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.034 ' HB1' ' CE ' ' A' ' 91' ' ' LYS . . . -162.93 -64.72 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.639 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.974 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 43.0 Cg_endo -72.87 172.36 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.792 1.417 . . . . 0.0 110.362 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.549 ' HA3' ' CG2' ' A' ' 174' ' ' ILE . . . 90.4 165.25 40.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 175' ' ' ASN . 43.8 Cg_endo -73.99 -94.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.629 1.553 . . . . 0.0 110.54 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.2 -35.0 82.48 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 170' ' ' PRO . 9.4 tp -71.37 4.43 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.287 -1.125 . . . . 0.0 109.201 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 172' ' ' PRO . 1.2 p30 -66.08 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.89 . . . . 0.0 109.334 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 114.93 94.1 1.96 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -151.95 118.12 5.56 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.671 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -107.75 163.22 13.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.964 -1.085 . . . . 0.0 109.201 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.119 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -159.78 134.62 7.9 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.11 178.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.604 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 17.1 m-85 -97.09 129.88 44.44 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.115 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.556 ' OD2' ' HA ' ' A' ' 164' ' ' LEU . 11.8 p30 -63.47 124.86 22.41 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 117.827 -1.549 . . . . 0.0 107.171 177.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.502 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.1 OUTLIER -98.35 31.68 2.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.839 -1.163 . . . . 0.0 110.56 -178.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 1.004 ' HB2' HG21 ' A' ' 148' ' ' VAL . 49.2 t0 -107.9 -3.97 18.41 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.007 -1.058 . . . . 0.0 109.436 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.529 ' HG2' ' CA ' ' A' ' 159' ' ' GLY . 4.5 pt-20 -116.32 -111.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.056 -1.028 . . . . 0.0 108.872 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 15.2 mt-30 -148.58 177.88 9.1 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.723 -1.236 . . . . 0.0 109.15 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 1.104 ' CD1' HG21 ' A' ' 105' ' ' THR . 88.2 m95 -161.98 126.14 3.23 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.115 -0.99 . . . . 0.0 108.998 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.879 ' HA ' HD21 ' A' ' 108' ' ' LEU . 65.7 p -147.2 153.7 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.676 -1.265 . . . . 0.0 110.723 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.882 ' HB3' HD22 ' A' ' 195' ' ' LEU . 17.4 pttt -85.09 -32.69 22.69 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.649 ' O ' ' N ' ' A' ' 191' ' ' THR . 10.7 t70 -86.09 64.03 8.35 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.998 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.5 t 3.19 60.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.185 0.993 . . . . 0.0 111.94 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 189' ' ' ASP . 54.2 m -125.44 -30.87 3.07 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.055 -1.028 . . . . 0.0 109.787 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.631 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -95.31 -80.0 1.49 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.035 HG21 HD21 ' A' ' 164' ' ' LEU . 47.1 m -127.84 -95.89 0.42 Allowed 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.926 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.1 OUTLIER -160.5 72.79 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.146 -0.971 . . . . 0.0 108.971 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 108' ' ' LEU . 2.2 tp -37.07 -96.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.671 0.748 . . . . 0.0 110.448 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.887 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -68.61 -5.15 18.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.132 -0.98 . . . . 0.0 110.848 -177.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.918 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.1 tp -69.0 -67.7 0.45 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 116.836 -1.946 . . . . 0.0 106.479 178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.926 HG23 ' HB2' ' A' ' 194' ' ' ASN . 2.4 t -68.03 -9.77 11.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.069 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.0 -59.04 2.89 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.808 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -65.15 -15.22 62.18 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.59 ' ND1' ' CE1' ' A' ' 3' ' ' MSB . 10.9 t60 -69.27 -42.96 74.85 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 117.76 -1.576 . . . . 0.0 107.95 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.796 ' OE2' ' HB1' ' A' ' 165' ' ' ALA . 1.3 mt-10 -83.97 -47.37 11.07 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.865 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.938 HG21 ' HA ' ' A' ' 121' ' ' LEU . 3.0 mt -63.11 -29.51 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.699 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -77.31 -31.55 51.21 Favored Glycine 0 C--N 1.295 -1.737 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.1 OUTLIER -64.26 -44.22 92.41 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 121.812 -0.817 . . . . 0.0 111.212 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.541 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 49.7 m -86.97 -53.12 5.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.201 -0.937 . . . . 0.0 112.61 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 208' ' ' GLY . 2.2 pp -104.36 -2.61 25.24 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.861 -1.149 . . . . 0.0 111.388 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.991 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -96.92 -84.58 1.74 Allowed Glycine 0 C--N 1.291 -1.966 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.866 HD11 ' OD1' ' A' ' 238' ' ' ASP . 1.8 pp -165.35 -159.33 0.42 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.037 -1.272 . . . . 0.0 109.658 -179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.591 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -96.56 -84.94 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.244 -0.91 . . . . 0.0 109.529 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.8 m-70 -153.18 104.57 2.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.067 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.607 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.6 OUTLIER -92.1 -167.33 1.74 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.213 -0.929 . . . . 0.0 109.56 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.697 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.17 81.96 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.989 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.4 6.62 22.53 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.596 -1.241 . . . . 0.0 111.761 -177.01 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 214' ' ' ASN . 7.8 p -50.82 -27.44 7.32 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 174.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.506 ' C ' ' HB2' ' A' ' 235' ' ' SER . 11.2 mt-10 -117.29 -36.05 3.86 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.989 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.95 179.17 0.09 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 122.162 0.982 . . . . 0.0 111.699 -178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.918 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.4 tp -96.05 -10.16 29.14 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.393 -179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.652 ' HB2' ' ND2' ' A' ' 214' ' ' ASN . 9.1 mmt -74.26 -16.73 60.94 Favored 'General case' 0 C--N 1.29 -1.981 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.641 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 0.5 OUTLIER -143.5 23.6 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 C-N-CA 117.621 -1.631 . . . . 0.0 113.422 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.678 ' HG3' ' HA ' ' A' ' 218' ' ' LEU . 55.6 Cg_endo -75.39 -31.47 5.7 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 N-CA-C 106.795 -2.04 . . . . 0.0 106.795 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.878 HD13 ' N ' ' A' ' 223' ' ' TYR . 1.9 tm? -8.06 -65.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.326 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.878 ' N ' HD13 ' A' ' 222' ' ' LEU . 0.1 OUTLIER -67.76 59.59 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.34 -0.85 . . . . 0.0 109.389 179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.487 ' N ' ' O ' ' A' ' 222' ' ' LEU . 0.8 OUTLIER -175.57 -144.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.375 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.926 ' HB3' HG21 ' A' ' 190' ' ' THR . 44.5 m -146.41 112.81 5.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.048 -1.033 . . . . 0.0 109.956 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.61 52.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.431 -0.793 . . . . 0.0 109.26 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.544 HG21 ' O ' ' A' ' 187' ' ' THR . 9.1 t -108.26 -9.09 15.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.296 -0.877 . . . . 0.0 109.591 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.603 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 177.59 -20.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 110.854 179.275 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.998 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.22 -61.1 0.2 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.446 -0.783 . . . . 0.0 110.651 -179.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.35 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.587 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -94.04 -20.65 19.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.603 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 51.7 p90 -31.58 120.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.488 0.661 . . . . 0.0 111.028 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.563 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.12 168.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.367 -0.833 . . . . 0.0 110.099 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.056 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.5 mp -82.82 168.49 17.08 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.373 -0.83 . . . . 0.0 110.735 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 6.5 t -98.47 -171.13 2.07 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.737 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.576 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -83.08 -19.24 37.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.563 -0.71 . . . . 0.0 109.449 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.697 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 5.2 m-20 -82.76 -42.24 18.22 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.866 ' OD1' HD11 ' A' ' 209' ' ' LEU . 1.3 m-20 -66.62 -41.03 89.01 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 117.411 -1.715 . . . . 0.0 106.879 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.636 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -56.75 -35.12 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -67.11 -45.01 78.48 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.532 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' A' ' 85' ' ' THR . . . -62.03 -58.91 10.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.012 HG21 HG21 ' A' ' 127' ' ' VAL . 1.9 tp -62.76 -50.41 79.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.987 -1.302 . . . . 0.0 110.116 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.581 ' N ' HG23 ' A' ' 242' ' ' ILE . 15.1 tt0 -53.37 -26.12 18.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.2 t -90.4 -10.67 43.02 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -79.84 -52.79 7.46 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 1.014 ' CD2' HD12 ' A' ' 130' ' ' LEU . 5.2 m-30 -82.05 -108.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.95 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.48 ' C ' ' HD2' ' A' ' 249' ' ' PRO . . . 56.98 101.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.617 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 38.6 Cg_endo -72.74 -29.79 12.34 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.009 1.531 . . . . 0.0 112.55 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 43.4 Cg_endo -74.28 111.83 3.4 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 122.581 0.78 . . . . 0.0 110.228 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 42.2 Cg_endo -73.48 -90.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.084 1.571 . . . . 0.0 110.106 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -104.78 -56.0 2.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.473 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.07 116.58 12.82 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.61 -33.78 8.01 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.906 1.477 . . . . 0.0 110.125 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.26 169.24 17.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 109.55 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.626 HG23 ' OXT' ' A' ' 255' ' ' THR . 4.6 t . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.579 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.77 ' CG2' HG12 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.545 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.712 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.214 0.531 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 85' ' ' THR . 27.1 ptt180 -119.15 -156.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 85' ' ' THR . 0.0 OUTLIER -43.7 155.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 109.569 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.648 ' CE1' HD11 ' A' ' 89' ' ' ILE . 1.2 m-85 -63.73 152.64 85.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.546 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.69 -13.12 27.04 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.063 1.56 . . . . 0.0 110.222 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.458 ' O ' ' HD3' ' A' ' 90' ' ' PRO . . . 177.6 -62.26 0.09 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.648 HD11 ' CE1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -41.28 100.86 0.23 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.404 -1.056 . . . . 0.0 109.98 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 88' ' ' GLY . 44.4 Cg_endo -76.41 145.11 26.48 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.022 1.538 . . . . 0.0 110.161 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HE2' ' HB2' ' A' ' 169' ' ' ALA . 1.6 tttt -57.18 -82.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.914 ' CD1' HD12 ' A' ' 207' ' ' LEU . 2.8 m95 -74.53 -165.98 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -167.19 -33.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.8 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -50.54 -172.13 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.385 -0.822 . . . . 0.0 110.619 -179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.763 ' CA ' HD21 ' A' ' 130' ' ' LEU . 1.2 p -117.35 -4.79 11.32 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.618 -0.676 . . . . 0.0 109.242 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 131' ' ' THR . 21.7 m-70 -144.22 95.24 2.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.667 HD11 ' CD1' ' A' ' 92' ' ' TRP . 19.4 mt -86.56 -175.44 5.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.745 . . . . 0.0 109.93 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.68 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -158.63 156.72 30.54 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.326 -0.859 . . . . 0.0 108.714 179.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.903 ' CE1' HD22 ' A' ' 121' ' ' LEU . 13.4 p90 -134.62 164.83 26.63 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.535 -1.353 . . . . 0.0 110.151 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.734 ' HG3' HD12 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -131.38 128.38 39.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.75 HG13 HG11 ' A' ' 117' ' ' VAL . 1.5 mp -86.14 81.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.138 -0.976 . . . . 0.0 110.378 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.585 ' N ' ' O ' ' A' ' 144' ' ' ILE . 16.1 t -96.22 13.77 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.909 ' C ' HG21 ' A' ' 113' ' ' VAL . 7.8 m120 -107.86 156.12 19.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.305 -0.872 . . . . 0.0 109.516 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.81 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.7 OUTLIER 178.97 42.97 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.64 -0.662 . . . . 0.0 109.914 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.563 HG22 ' OD1' ' A' ' 182' ' ' ASP . 13.8 p -43.74 155.84 0.31 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.278 -0.889 . . . . 0.0 108.911 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.91 -21.7 43.44 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.762 1.401 . . . . 0.0 108.94 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.1 OUTLIER -69.97 -8.0 45.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.024 HD13 HD12 ' A' ' 195' ' ' LEU . 84.8 mt -144.83 120.66 6.01 Favored Pre-proline 0 N--CA 1.483 1.223 0 O-C-N 121.534 -0.729 . . . . 0.0 109.756 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.4 Cg_endo -65.74 172.09 8.74 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 123.748 1.394 . . . . 0.0 108.981 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -38.55 -65.29 0.36 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.801 0.81 . . . . 0.0 110.384 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.6 OUTLIER -55.98 -30.81 62.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.675 -0.64 . . . . 0.0 112.15 -178.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.871 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.45 -59.84 2.53 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.439 -1.413 . . . . 0.0 109.793 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.909 HG21 ' C ' ' A' ' 103' ' ' ASN . 9.8 p -55.13 -39.13 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' A' ' 118' ' ' GLU . 0.9 OUTLIER -66.9 -27.11 67.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.868 ' OG ' HD21 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -67.6 -41.0 84.74 Favored 'General case' 0 C--O 1.202 -1.43 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.336 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.068 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -72.6 -32.77 66.22 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 120.912 -1.117 . . . . 0.0 109.806 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.032 HG22 HG21 ' A' ' 144' ' ' ILE . 88.7 t -75.96 -23.65 16.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -90.69 -33.26 15.87 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.747 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.2 OUTLIER -81.47 -37.45 27.94 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.979 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -68.3 -61.92 1.63 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.903 HD22 ' CE1' ' A' ' 99' ' ' TYR . 1.4 pp -54.71 -41.8 70.73 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.065 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.816 ' N ' HD12 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -74.15 -33.23 63.45 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.265 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.998 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -56.22 -40.14 63.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.088 ' CH2' HD21 ' A' ' 234' ' ' LEU . 44.5 m95 -91.35 -23.22 20.16 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.706 -1.198 . . . . 0.0 110.486 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.533 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 79.9 tt0 -71.9 -28.25 63.37 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.757 -1.214 . . . . 0.0 108.279 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.4 pt-20 -89.92 -43.53 10.52 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.798 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.998 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.2 m -60.44 -24.26 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.511 -1.276 . . . . 0.0 109.172 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.084 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.6 OUTLIER -100.54 155.79 35.96 Favored Pre-proline 0 N--CA 1.5 2.065 0 C-N-CA 117.943 -1.503 . . . . 0.0 111.008 -179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.507 ' HG2' ' O ' ' A' ' 247' ' ' GLY . 54.3 Cg_endo -84.74 27.62 0.6 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.648 2.232 . . . . 0.0 110.46 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.763 HD21 ' CA ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -117.84 -175.39 2.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.704 -1.247 . . . . 0.0 110.66 -178.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.57 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -109.64 169.85 8.44 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.436 -0.79 . . . . 0.0 110.09 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.607 ' CE1' ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -149.05 162.14 40.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 110.082 -179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.57 ' O ' ' CE2' ' A' ' 99' ' ' TYR . 0.9 OUTLIER -140.2 -168.22 2.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.639 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -158.84 157.22 31.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.801 -1.187 . . . . 0.0 110.391 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.734 HD12 ' HG3' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -159.89 -165.21 1.45 Allowed 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.406 -0.809 . . . . 0.0 109.307 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 15.8 t80 -153.33 19.78 0.56 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.385 -0.822 . . . . 0.0 108.914 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 138' ' ' GLY . 6.6 pm0 -141.4 -172.32 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.434 -0.791 . . . . 0.0 109.341 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.18 -98.78 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.6 OUTLIER 178.45 117.61 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -1.169 . . . . 0.0 110.509 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.68 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -75.67 -148.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 108.899 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.637 ' OD2' HG22 ' A' ' 98' ' ' THR . 59.8 m-20 -100.32 -25.03 14.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.804 HG21 HG23 ' A' ' 203' ' ' ILE . 2.9 mt -124.35 76.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.524 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 1.7 ttt -64.33 93.6 0.1 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 1.032 HG21 HG22 ' A' ' 117' ' ' VAL . 9.1 mm -80.04 106.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.577 ' CB ' ' HB ' ' A' ' 102' ' ' VAL . 0.3 OUTLIER -131.76 162.56 30.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.24 -1.538 . . . . 0.0 112.342 -178.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.493 ' HA ' ' ND2' ' A' ' 103' ' ' ASN . 46.9 p90 -82.55 134.38 35.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.442 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.132 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -152.08 162.11 41.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.037 . . . . 0.0 110.418 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.797 HG21 ' CG ' ' A' ' 183' ' ' ASP . 1.8 p -167.04 -163.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.718 ' H ' HG22 ' A' ' 148' ' ' VAL . 5.3 mtm-85 -38.41 -43.87 0.87 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.303 -0.873 . . . . 0.0 109.939 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.39 58.21 0.27 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.308 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -85.8 -90.14 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 109.562 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 153' ' ' ASP . . . 129.56 38.27 0.34 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.644 ' CB ' ' CZ ' ' A' ' 155' ' ' TYR . 7.7 t0 -179.99 -142.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -1.227 . . . . 0.0 109.799 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.546 ' CE1' ' OH ' ' A' ' 168' ' ' TYR . 43.8 p90 -95.66 18.71 12.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.08 -1.012 . . . . 0.0 110.063 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.685 ' CD1' ' CD2' ' A' ' 151' ' ' HIS . 0.1 OUTLIER -119.61 50.31 1.51 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 109.331 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 39.2 Cg_endo -68.48 128.27 16.96 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.03 1.542 . . . . 0.0 109.377 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.686 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -112.94 -170.41 1.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 110.978 -178.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.507 ' HA ' ' HG2' ' A' ' 149' ' ' ARG . 17.4 p30 -176.18 63.61 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.898 -178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.587 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -12.38 -61.35 0.01 OUTLIER Glycine 0 N--CA 1.509 3.541 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 37.0 Cg_endo -63.56 66.11 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.551 1.29 . . . . 0.0 109.651 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 177.87 143.88 5.24 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.541 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 30.4 m-80 -37.79 -44.6 0.75 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.634 -0.921 . . . . 0.0 110.221 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.731 ' HA ' HG23 ' A' ' 1' ' ' HAV . 17.8 t -42.4 95.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.352 -0.843 . . . . 0.0 109.33 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.9 HD12 HD11 ' A' ' 222' ' ' LEU . 1.9 mt -90.17 -38.89 13.18 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.162 -0.961 . . . . 0.0 113.133 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.613 ' HA ' ' CE2' ' A' ' 157' ' ' PHE . . . 179.43 -171.12 0.14 Allowed 'General case' 0 N--CA 1.508 2.451 0 O-C-N 119.799 -1.813 . . . . 0.0 111.449 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.686 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 3.2 p-80 179.15 -170.28 0.12 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.376 -1.453 . . . . 0.0 111.33 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -153.45 179.2 9.01 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.437 -0.789 . . . . 0.0 110.235 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.59 ' O ' ' CB ' ' A' ' 206' ' ' SER . 11.0 m-85 -127.6 162.41 26.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.894 -1.129 . . . . 0.0 111.149 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.977 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -144.49 -67.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.945 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.977 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 40.7 Cg_endo -70.75 94.89 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.489 1.257 . . . . 0.0 110.165 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 175' ' ' ASN . . . 159.09 145.14 4.16 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -71.57 145.86 48.06 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.511 1.474 . . . . 0.0 110.083 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 67.81 -64.05 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 176' ' ' GLY . 0.3 OUTLIER -74.24 5.55 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.414 -1.051 . . . . 0.0 108.896 178.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 171' ' ' GLY . 0.5 OUTLIER -63.9 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 115.05 89.1 1.6 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.696 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.0 m-20 -155.64 118.96 4.36 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.641 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -108.76 128.57 54.99 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.186 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.132 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -113.59 132.46 55.73 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.894 179.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.683 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 16.0 m-85 -93.37 125.0 37.74 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.198 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.657 ' OD1' HG23 ' A' ' 148' ' ' VAL . 22.6 t0 -50.1 135.05 21.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.667 -1.271 . . . . 0.0 108.262 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.563 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.1 OUTLIER -106.22 24.27 12.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.063 -1.023 . . . . 0.0 110.232 -178.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.797 ' CG ' HG21 ' A' ' 148' ' ' VAL . 0.7 OUTLIER -129.13 24.37 5.58 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 159' ' ' GLY . 2.3 mt-10 -129.03 -90.26 0.49 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.138 -0.976 . . . . 0.0 109.408 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.628 ' O ' ' CD1' ' A' ' 186' ' ' TRP . 1.7 mt-30 179.89 170.22 1.16 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.683 ' CH2' ' CD1' ' A' ' 180' ' ' PHE . 89.0 m95 -158.63 124.16 4.4 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.022 -1.049 . . . . 0.0 109.795 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.856 ' HA ' HD21 ' A' ' 108' ' ' LEU . 67.9 p -148.32 149.78 32.45 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.925 -1.109 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.814 ' HB3' HD22 ' A' ' 195' ' ' LEU . 8.5 pttt -84.14 -32.46 24.66 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 191' ' ' THR . 11.7 t70 -83.49 61.73 6.39 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.982 ' OG1' HD21 ' A' ' 229' ' ' LEU . 15.7 m 3.08 64.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.71 0.767 . . . . 0.0 111.384 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.596 ' N ' ' O ' ' A' ' 189' ' ' ASP . 41.9 m -130.74 -31.64 1.74 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.762 -0.587 . . . . 0.0 109.635 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.45 -77.89 1.39 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.659 HG21 ' CD2' ' A' ' 164' ' ' LEU . 13.4 m -128.35 -81.61 0.58 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.481 -1.011 . . . . 0.0 108.774 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.979 ' HB3' HG23 ' A' ' 198' ' ' VAL . 1.9 m-20 -177.47 67.31 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.586 -0.845 . . . . 0.0 108.991 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.061 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -32.4 -96.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.58 0.705 . . . . 0.0 110.537 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.899 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -71.78 -8.74 56.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.839 -1.163 . . . . 0.0 110.929 -178.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.673 HD11 ' CG ' ' A' ' 221' ' ' PRO . 14.8 tp -70.76 -56.29 6.71 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 116.262 -2.175 . . . . 0.0 107.207 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.012 HG12 ' OE2' ' A' ' 202' ' ' GLU . 9.1 t -77.87 -7.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.068 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -75.26 -58.8 3.06 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -66.53 -19.71 65.85 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.6 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 4.7 t60 -66.17 -41.81 89.8 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 116.873 -1.931 . . . . 0.0 107.882 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 1.012 ' OE2' HG12 ' A' ' 198' ' ' VAL . 8.3 mt-10 -84.1 -49.1 9.2 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.145 -0.972 . . . . 0.0 110.792 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.979 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.2 mt -57.85 -31.74 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.735 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -80.6 -35.3 26.02 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.2 OUTLIER -57.95 -47.71 82.11 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 121.423 -1.045 . . . . 0.0 110.519 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.662 ' C ' HD13 ' A' ' 207' ' ' LEU . 1.4 p -86.08 -58.46 2.63 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.529 -0.732 . . . . 0.0 111.906 -177.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.914 HD12 ' CD1' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -104.43 33.97 3.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.81 -1.181 . . . . 0.0 110.114 -178.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 1.078 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -132.06 -77.21 0.13 Allowed Glycine 0 C--N 1.29 -1.973 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.85 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -165.69 -160.72 0.47 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.999 -1.295 . . . . 0.0 109.62 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.792 ' N ' HD12 ' A' ' 209' ' ' LEU . 16.7 t80 -101.7 -71.45 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.565 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 20.7 m80 -163.78 100.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.865 . . . . 0.0 108.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.641 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.7 OUTLIER -90.27 -175.93 4.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.288 -0.882 . . . . 0.0 109.249 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.916 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -63.86 78.33 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.972 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.1 OUTLIER -84.26 9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.56 -177.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 214' ' ' ASN . 0.1 OUTLIER -50.64 -27.78 7.58 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 175.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.517 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.0 OUTLIER -114.51 -37.58 4.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.972 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -62.33 -171.28 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.334 1.064 . . . . 0.0 112.418 -178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.703 HD23 HD12 ' A' ' 234' ' ' LEU . 0.0 OUTLIER -89.95 -16.54 29.7 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.735 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.547 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.5 -9.57 58.98 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 119.476 -2.015 . . . . 0.0 112.436 -177.36 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.674 ' N ' ' HB2' ' A' ' 214' ' ' ASN . 4.7 t80 -136.49 16.58 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.229 -1.545 . . . . 0.0 113.404 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.883 ' CB ' HD11 ' A' ' 226' ' ' LEU . 56.2 Cg_endo -78.81 -40.07 0.33 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 N-CA-C 108.711 -1.304 . . . . 0.0 108.711 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.9 HD11 HD12 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -7.83 -77.07 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.257 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.41 ' N ' HD23 ' A' ' 222' ' ' LEU . 1.7 t80 -67.99 59.93 0.07 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.244 -0.91 . . . . 0.0 108.955 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.5 t-80 -163.61 -124.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.339 -0.851 . . . . 0.0 108.974 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.514 ' HA ' HG21 ' A' ' 190' ' ' THR . 62.5 m -168.78 104.44 0.41 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.697 -1.252 . . . . 0.0 110.342 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.883 HD11 ' CB ' ' A' ' 221' ' ' PRO . 0.4 OUTLIER 178.92 48.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.723 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 188' ' ' LYS . 9.2 t -98.69 -15.71 19.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.064 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.586 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 178.09 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.381 -0.824 . . . . 0.0 110.429 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.982 HD21 ' OG1' ' A' ' 190' ' ' THR . 0.3 OUTLIER -32.95 -56.95 0.38 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.427 -0.796 . . . . 0.0 110.215 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.13 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.454 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -86.22 -16.63 37.09 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.6 ' O ' ' CG ' ' A' ' 232' ' ' PHE . 25.4 p90 -32.34 111.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.719 0.771 . . . . 0.0 110.933 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.569 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.6 ttt180 179.22 149.73 0.28 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.297 -0.877 . . . . 0.0 109.587 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.088 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.8 mp -73.03 167.22 21.56 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.319 -0.863 . . . . 0.0 109.99 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 28.8 t -99.56 -170.6 1.92 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.969 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.526 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.02 -13.35 50.82 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.011 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.916 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 3.1 m-20 -84.85 -46.75 11.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.657 -1.277 . . . . 0.0 107.783 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.85 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -65.12 -39.3 92.89 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 117.226 -1.79 . . . . 0.0 106.549 177.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.596 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.6 OUTLIER -56.66 -35.45 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.98 -50.36 62.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -59.91 -51.14 60.75 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.078 HD13 ' HA2' ' A' ' 208' ' ' GLY . 1.7 tp -66.37 -49.18 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.837 -1.39 . . . . 0.0 110.132 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.572 ' N ' HG23 ' A' ' 242' ' ' ILE . 1.9 tt0 -54.03 -25.05 19.33 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 27.7 p -92.73 -9.87 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -77.86 -51.25 10.76 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.548 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 5.4 m-30 -81.75 -108.2 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.83 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 129' ' ' PRO . . . 154.08 143.44 3.68 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.953 -1.594 . . . . 0.0 110.238 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 39.2 Cg_endo -72.65 -29.52 12.89 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.72 1.614 . . . . 0.0 112.651 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 41.2 Cg_endo -73.12 128.37 12.95 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 N-CA-C 110.014 -0.802 . . . . 0.0 110.014 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.99 -91.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.54 1.493 . . . . 0.0 110.405 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 251' ' ' ASP . 0.6 OUTLIER -128.13 -44.85 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.886 -179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.13 69.46 1.82 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.819 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 251' ' ' ASP . 42.6 Cg_endo -72.73 -12.37 26.52 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.927 1.488 . . . . 0.0 109.909 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' A' ' 255' ' ' THR . 3.7 pm0 -98.98 -171.38 2.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.582 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 254' ' ' GLU . 98.9 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.566 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.731 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.541 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.817 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.9 p90 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.321 0.581 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.559 ' CZ ' ' CB ' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -165.1 -147.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.433 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.496 ' N ' ' HG3' ' A' ' 84' ' ' ARG . 0.1 OUTLIER -43.77 -91.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 109.491 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.487 ' H ' HG23 ' A' ' 85' ' ' THR . 12.5 m-85 -116.42 125.05 28.81 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.611 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.79 85.01 1.19 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.978 1.515 . . . . 0.0 110.105 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.45 -103.56 0.57 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.564 HG23 ' HD2' ' A' ' 90' ' ' PRO . 94.7 mt -91.41 138.99 25.2 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.278 -1.13 . . . . 0.0 109.546 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.564 ' HD2' HG23 ' A' ' 89' ' ' ILE . 42.0 Cg_endo -72.81 156.14 53.13 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.053 1.554 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.611 ' HG3' ' CD1' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -43.35 -87.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.959 . . . . 0.0 109.487 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.611 ' CD1' ' HG3' ' A' ' 91' ' ' LYS . 89.9 m95 -105.02 149.56 25.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.883 -1.136 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.502 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.21 -33.29 5.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.734 -179.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' CE ' HD13 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -44.75 175.07 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.438 -0.789 . . . . 0.0 110.345 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.791 ' HB ' HD12 ' A' ' 130' ' ' LEU . 7.1 p -109.11 5.05 23.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.47 -0.768 . . . . 0.0 109.78 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.563 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 47.9 m80 -146.88 94.44 2.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.831 -1.168 . . . . 0.0 110.538 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.811 HD22 ' N ' ' A' ' 97' ' ' LEU . 1.9 mm? -93.6 -176.54 4.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -0.794 . . . . 0.0 108.872 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 142' ' ' ILE . 1.1 t -146.82 154.28 41.16 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.97 -1.081 . . . . 0.0 109.084 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 1.037 ' CZ ' HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -133.79 166.53 22.43 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.712 -1.242 . . . . 0.0 109.914 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.856 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.39 133.14 46.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.037 HD11 ' CZ ' ' A' ' 99' ' ' TYR . 2.4 mp -96.55 80.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.951 -1.093 . . . . 0.0 109.777 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.856 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 59.4 t -97.94 7.38 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.921 . . . . 0.0 110.134 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.85 ' C ' HG21 ' A' ' 113' ' ' VAL . 35.2 m-80 -92.95 158.13 15.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.697 -1.252 . . . . 0.0 109.647 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.83 ' N ' HG21 ' A' ' 113' ' ' VAL . 1.8 t80 178.16 82.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.532 -0.73 . . . . 0.0 109.555 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.811 HG21 ' CD1' ' A' ' 186' ' ' TRP . 1.3 p -75.98 159.27 81.08 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.12 -21.48 42.47 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 123.82 1.432 . . . . 0.0 108.779 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -78.1 -0.77 29.44 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.956 HD13 ' CD1' ' A' ' 195' ' ' LEU . 96.7 mt -150.63 120.64 3.73 Favored Pre-proline 0 N--CA 1.485 1.292 0 O-C-N 121.421 -0.799 . . . . 0.0 109.88 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.9 Cg_endo -67.13 175.7 5.42 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 O-C-N 123.801 1.422 . . . . 0.0 109.334 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.22 -65.83 0.34 Allowed 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.875 0.845 . . . . 0.0 110.341 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.65 -30.76 63.69 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.88 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -72.61 -60.68 2.11 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.25 -1.531 . . . . 0.0 109.54 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.945 ' O ' HG23 ' A' ' 117' ' ' VAL . 7.2 p -53.17 -41.2 41.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.572 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -62.22 -28.1 69.45 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.907 ' OG ' HD21 ' A' ' 195' ' ' LEU . 7.7 p -64.02 -42.87 96.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.092 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -71.11 -33.77 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 110.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 113' ' ' VAL . 1.5 t -75.55 -23.32 16.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -88.36 -34.94 17.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 3.5 tppt? -80.6 -36.39 32.84 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -65.44 -62.46 1.51 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.986 HD22 ' CG ' ' A' ' 99' ' ' TYR . 13.5 tp -52.47 -46.32 66.47 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.058 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -69.17 -33.82 73.99 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.33 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.949 HG13 HD22 ' A' ' 234' ' ' LEU . 0.9 OUTLIER -57.34 -36.69 53.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.102 ' CH2' HD21 ' A' ' 234' ' ' LEU . 55.4 m95 -91.68 -24.13 19.59 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 118.874 -1.131 . . . . 0.0 110.495 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.578 ' HG3' ' CD2' ' A' ' 132' ' ' PHE . 14.8 tt0 -71.81 -28.88 63.89 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.851 -1.155 . . . . 0.0 108.315 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 14.0 pt-20 -91.37 -42.93 10.06 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.972 HG21 HG21 ' A' ' 242' ' ' ILE . 21.7 m -61.83 -23.34 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 118.206 -1.398 . . . . 0.0 109.802 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.047 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -104.29 161.73 22.01 Favored Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 117.14 -1.824 . . . . 0.0 110.298 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.864 ' C ' HD22 ' A' ' 130' ' ' LEU . 50.0 Cg_endo -80.72 13.12 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.609 1.847 . . . . 0.0 110.655 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.866 HD23 ' HB3' ' A' ' 246' ' ' TYR . 3.3 mm? -116.4 -176.94 3.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.953 -1.092 . . . . 0.0 110.093 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.509 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.4 p -124.72 170.42 11.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 110.188 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.66 ' CD2' HD11 ' A' ' 121' ' ' LEU . 21.6 m-85 -131.78 179.55 6.0 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.84 0.829 . . . . 0.0 110.023 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 98' ' ' THR . 17.5 m -142.44 -166.36 2.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 160.57 18.37 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.906 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.677 HD22 ' OE2' ' A' ' 137' ' ' GLU . 0.3 OUTLIER -159.63 -128.1 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 135' ' ' LEU . 0.1 OUTLIER 177.15 31.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.465 -1.397 . . . . 0.0 109.732 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.677 ' OE2' HD22 ' A' ' 135' ' ' LEU . 7.5 pm0 -151.47 -177.65 6.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.017 -1.052 . . . . 0.0 109.917 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 39.76 -97.19 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER 178.99 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -1.105 . . . . 0.0 110.003 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.662 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -58.9 -155.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 108.959 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' THR . 76.7 m-20 -83.52 -26.07 30.48 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.01 HD11 HD22 ' A' ' 207' ' ' LEU . 2.1 mp -130.17 77.88 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.412 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.6 ttt -62.01 93.2 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.114 -0.991 . . . . 0.0 109.26 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.825 HG22 ' ND2' ' A' ' 103' ' ' ASN . 5.3 mm -82.12 109.06 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.495 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -134.29 153.54 51.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.492 -1.38 . . . . 0.0 111.652 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 20.0 p90 -86.98 139.58 30.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.179 -0.95 . . . . 0.0 109.406 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -168.54 -158.23 0.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.043 -1.036 . . . . 0.0 110.556 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.898 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.4 p -173.22 -158.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.706 ' N ' HG13 ' A' ' 148' ' ' VAL . 10.8 ptt180 -66.84 60.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.026 -1.046 . . . . 0.0 109.513 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 148' ' ' VAL . 1.4 tt0 -168.62 44.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.275 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.599 ' CD2' ' HB2' ' A' ' 155' ' ' TYR . 14.5 m80 -74.27 -61.53 1.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.416 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.415 ' O ' ' CG ' ' A' ' 153' ' ' ASP . . . 127.84 33.92 0.58 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' GLY . 10.7 m-20 -167.48 -90.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -1.16 . . . . 0.0 109.56 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -145.43 28.65 1.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.499 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.599 ' HB2' ' CD2' ' A' ' 151' ' ' HIS . 0.9 OUTLIER -120.71 46.76 1.03 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.692 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 40.3 Cg_endo -70.05 99.12 0.75 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.93 1.489 . . . . 0.0 109.564 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.679 ' CD2' ' CE1' ' A' ' 166' ' ' HIS . 0.9 OUTLIER -71.22 -131.88 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.375 -0.828 . . . . 0.0 109.875 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.663 ' HB3' HG21 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -148.69 -36.03 0.19 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.42 -1.425 . . . . 0.0 110.194 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.594 ' CA ' ' CG2' ' A' ' 148' ' ' VAL . . . 69.01 -110.01 3.18 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 158' ' ' ASP . 34.8 Cg_endo -59.97 76.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.063 1.033 . . . . 0.0 110.268 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -166.24 -160.78 13.98 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 163' ' ' VAL . 9.8 m-80 -90.58 -48.91 6.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.259 -1.142 . . . . 0.0 110.477 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 158' ' ' ASP . 27.7 m -41.02 127.25 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.842 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.603 HD13 ' CG2' ' A' ' 193' ' ' THR . 13.6 mt -96.62 -40.01 9.23 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.321 -0.862 . . . . 0.0 112.717 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 157' ' ' PHE . . . -178.49 -167.08 0.12 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 119.79 -1.819 . . . . 0.0 111.223 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CD2' ' A' ' 157' ' ' PHE . 1.1 p-80 178.95 -174.03 0.18 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.208 -1.558 . . . . 0.0 111.358 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.636 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -149.63 -175.15 4.9 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.453 -0.78 . . . . 0.0 109.787 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.629 ' CD2' ' CG1' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -122.25 -162.58 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.838 -1.164 . . . . 0.0 111.092 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.936 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -172.43 -60.2 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.466 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.936 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.4 Cg_endo -75.33 -178.69 4.42 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.858 1.451 . . . . 0.0 110.217 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 67.96 140.67 0.07 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 174' ' ' ILE . 41.5 Cg_endo -70.4 152.19 65.87 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.964 1.507 . . . . 0.0 110.118 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.524 ' N ' ' OD1' ' A' ' 175' ' ' ASN . . . 67.83 -65.33 0.32 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.629 ' CG1' ' CD2' ' A' ' 168' ' ' TYR . 6.9 tp -67.62 -3.7 2.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.482 -1.01 . . . . 0.0 109.143 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.547 ' ND2' ' CZ2' ' A' ' 92' ' ' TRP . 5.3 p-10 -65.29 65.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.754 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 126.33 82.64 0.45 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 1.7 m-20 -152.22 123.83 7.85 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.918 -1.343 . . . . 0.0 107.735 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -111.74 156.18 22.34 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.119 -0.988 . . . . 0.0 108.683 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.643 ' HA ' ' O ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -151.29 132.65 14.6 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.622 -1.231 . . . . 0.0 109.735 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.693 ' CD1' ' CH2' ' A' ' 186' ' ' TRP . 19.9 m-30 -87.69 126.8 35.18 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.898 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.898 ' OD1' HG23 ' A' ' 148' ' ' VAL . 34.2 t0 -68.67 134.38 49.79 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.449 -0.782 . . . . 0.0 109.295 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 183' ' ' ASP . 18.9 p-10 -61.45 -14.07 25.63 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.584 ' HA ' ' O ' ' A' ' 159' ' ' GLY . 1.4 p30 3.96 -93.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.531 ' OE2' ' HB2' ' A' ' 183' ' ' ASP . 10.2 mp0 -127.26 -63.02 1.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.974 -1.079 . . . . 0.0 110.681 -177.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.539 ' C ' ' CD1' ' A' ' 186' ' ' TRP . 28.4 mt-30 -158.58 176.7 12.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.873 -1.142 . . . . 0.0 110.393 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.811 ' CD1' HG21 ' A' ' 105' ' ' THR . 43.2 m95 -148.85 128.67 13.36 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.684 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.1 p -145.77 150.84 36.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.37 -1.456 . . . . 0.0 111.34 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.941 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.6 OUTLIER -83.76 -34.08 24.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.647 ' O ' ' N ' ' A' ' 191' ' ' THR . 38.4 t0 -85.53 62.06 7.24 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 1.001 ' HB ' HD21 ' A' ' 229' ' ' LEU . 6.1 t 3.73 60.53 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 122.002 0.906 . . . . 0.0 111.829 -177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 189' ' ' ASP . 46.9 m -124.79 -31.31 3.19 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.419 -0.801 . . . . 0.0 109.57 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.611 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -95.53 -70.52 1.07 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.76 HG22 ' OD1' ' A' ' 194' ' ' ASN . 23.4 m -140.07 -95.92 0.16 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.831 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -158.85 70.33 0.5 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.23 -0.919 . . . . 0.0 108.87 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.001 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 1.7 tp -34.51 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.54 0.686 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.884 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.3 OUTLIER -67.23 -6.95 20.4 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 110.845 -177.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.82 ' HA ' HD11 ' A' ' 218' ' ' LEU . 8.6 tp -68.11 -65.82 0.65 Allowed 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 116.912 -1.915 . . . . 0.0 106.801 178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.831 HG23 ' HB2' ' A' ' 194' ' ' ASN . 5.4 t -69.14 -11.41 14.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.092 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -72.23 -57.53 4.15 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.768 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -68.01 -15.66 63.7 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.59 ' CE1' ' HG3' ' A' ' 219' ' ' MET . 4.2 t60 -69.21 -42.03 76.29 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.229 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.666 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 1.9 mm-40 -85.64 -45.23 11.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.938 -1.101 . . . . 0.0 110.616 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 120' ' ' ALA . 2.1 mt -61.32 -31.67 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.753 ' HA3' ' CZ2' ' A' ' 124' ' ' TRP . . . -79.85 -34.42 30.88 Favored Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -56.81 -47.11 81.01 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 121.508 -0.995 . . . . 0.0 109.946 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.564 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 6.1 p -83.97 -57.77 3.06 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.735 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 1.01 HD22 HD11 ' A' ' 142' ' ' ILE . 7.8 mp -103.75 37.31 2.07 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.246 -0.909 . . . . 0.0 110.503 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.962 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -139.31 -78.47 0.06 OUTLIER Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.81 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.901 HD21 ' CG ' ' A' ' 238' ' ' ASP . 4.5 pp -173.18 -159.37 0.11 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.716 -1.461 . . . . 0.0 110.367 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.875 ' N ' HD12 ' A' ' 209' ' ' LEU . 54.4 t80 -100.0 -91.07 0.3 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.814 . . . . 0.0 109.664 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.593 ' CE1' ' HG2' ' A' ' 219' ' ' MET . 3.2 m-70 -148.57 106.71 3.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 109.473 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.588 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 0.4 OUTLIER -95.93 -172.53 2.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 109.214 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.419 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -60.41 85.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.931 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -87.68 10.13 19.17 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.247 -177.056 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 214' ' ' ASN . 28.9 p -50.88 -27.55 7.7 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.497 ' C ' ' HB2' ' A' ' 235' ' ' SER . 15.4 mt-10 -118.41 -35.13 3.85 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.802 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.931 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -58.1 -159.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.179 0.99 . . . . 0.0 112.575 -177.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.82 HD11 ' HA ' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -112.62 -1.72 14.76 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.111 -177.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.593 ' HG2' ' CE1' ' A' ' 211' ' ' HIS . 0.0 OUTLIER -91.76 -9.71 42.65 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 119.997 -1.689 . . . . 0.0 110.637 -178.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.677 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 3.2 t80 -137.11 14.31 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.79 0 C-N-CA 118.775 -1.17 . . . . 0.0 112.921 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 1.036 ' HB3' HD11 ' A' ' 226' ' ' LEU . 55.5 Cg_endo -74.2 -39.89 1.45 Allowed 'Trans proline' 0 C--N 1.324 -0.726 0 N-CA-C 108.883 -1.237 . . . . 0.0 108.883 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.629 HD23 ' CD2' ' A' ' 3' ' ' MSB . 2.9 tp -7.24 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.164 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.499 ' N ' ' HG ' ' A' ' 222' ' ' LEU . 14.5 m-85 -67.57 59.86 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.384 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -163.25 -146.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.545 ' C ' HD23 ' A' ' 226' ' ' LEU . 65.5 m -144.65 101.05 3.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.0 109.975 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 1.036 HD11 ' HB3' ' A' ' 221' ' ' PRO . 0.5 OUTLIER 178.44 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.435 -0.791 . . . . 0.0 109.074 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.573 ' CB ' ' HB2' ' A' ' 197' ' ' LEU . 9.3 t -92.06 -15.65 27.51 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.347 -0.845 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.676 ' OD2' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER 178.42 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.94 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 1.001 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -31.87 -98.71 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.453 -0.78 . . . . 0.0 111.242 -179.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.0 -13.87 3.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.78 -1.2 . . . . 0.0 109.77 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.573 ' O ' ' C ' ' A' ' 232' ' ' PHE . 2.4 mtp180 -106.2 -42.83 4.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 108.806 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 25.8 p90 0.36 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 121.244 0.545 . . . . 0.0 112.139 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 234' ' ' LEU . 0.0 OUTLIER 178.27 175.28 0.55 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.102 HD21 ' CH2' ' A' ' 124' ' ' TRP . 3.1 mp -85.66 163.53 18.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.569 -0.707 . . . . 0.0 110.98 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.904 ' O ' HD12 ' A' ' 239' ' ' ILE . 5.3 t -98.34 178.74 4.95 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.392 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.536 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.4 OUTLIER -71.04 -24.37 62.33 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.475 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.588 ' CB ' ' HB3' ' A' ' 212' ' ' SER . 2.3 m-20 -83.46 -42.2 17.2 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.575 -1.328 . . . . 0.0 108.94 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.901 ' CG ' HD21 ' A' ' 209' ' ' LEU . 5.8 t0 -70.76 -40.26 72.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 118.052 -1.459 . . . . 0.0 107.821 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.904 HD12 ' O ' ' A' ' 235' ' ' SER . 7.2 mt -54.82 -40.65 53.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.508 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 25.6 t-20 -60.21 -45.42 93.26 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.851 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.62 -54.57 35.98 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.047 HG13 HG22 ' A' ' 128' ' ' THR . 0.8 OUTLIER -65.2 -47.95 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.725 -1.456 . . . . 0.0 110.621 -178.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 240' ' ' ASN . 15.9 pt20 -54.05 -25.09 19.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 t -88.18 -14.9 37.44 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.753 HD12 ' C ' ' A' ' 208' ' ' GLY . 0.3 OUTLIER -76.06 -56.29 4.79 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.866 ' HB3' HD23 ' A' ' 130' ' ' LEU . 49.6 m-85 -91.91 -72.77 0.57 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.291 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.532 ' CA ' ' CG ' ' A' ' 129' ' ' PRO . . . -36.84 141.88 0.21 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.526 ' CB ' ' HB2' ' A' ' 252' ' ' SER . 42.2 Cg_endo -72.04 130.86 17.2 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.047 1.551 . . . . 0.0 110.393 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.61 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 39.0 Cg_endo -73.24 -29.52 11.42 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 124.047 1.551 . . . . 0.0 112.586 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 249' ' ' PRO . 43.0 Cg_endo -73.5 -94.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.944 0 O-C-N 122.477 0.725 . . . . 0.0 110.413 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 252' ' ' SER . 22.1 t70 -158.02 18.08 0.24 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.981 -1.074 . . . . 0.0 110.15 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.526 ' HB2' ' CB ' ' A' ' 248' ' ' PRO . 0.3 OUTLIER -43.56 125.31 3.82 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.912 . . . . 0.0 109.421 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 255' ' ' THR . 42.1 Cg_endo -72.36 -9.43 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.88 1.463 . . . . 0.0 110.28 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -62.89 75.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -0.912 . . . . 0.0 109.531 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 253' ' ' PRO . 7.4 t . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.582 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.582 ' O1 ' ' CD2' ' A' ' 201' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.506 ' HD1' ' OB1' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.694 ' HH1' ' HG2' ' A' ' 221' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 210' ' ' PHE . 0.0 OUTLIER -108.28 -122.37 0.25 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -0.919 . . . . 0.0 109.389 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.689 HG23 ' HD3' ' A' ' 87' ' ' PRO . 5.1 t -50.61 176.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.817 -1.177 . . . . 0.0 109.59 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 78.22 74.28 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.97 . . . . 0.0 109.57 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.689 ' HD3' HG23 ' A' ' 85' ' ' THR . 42.4 Cg_endo -72.64 139.93 31.81 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.991 1.522 . . . . 0.0 110.089 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.17 -63.91 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 mm -114.48 110.55 47.31 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.268 -1.136 . . . . 0.0 109.465 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.32 -161.73 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.969 1.51 . . . . 0.0 110.158 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.603 ' H ' HD22 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -102.76 -92.35 0.33 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 0.0 109.065 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CZ2' ' HB3' ' A' ' 141' ' ' ASP . 98.7 m95 -82.6 151.95 26.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.115 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -109.92 -40.49 4.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.03 -1.044 . . . . 0.0 110.134 -179.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -50.7 -172.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.236 -0.915 . . . . 0.0 110.165 -179.647 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.471 ' HA ' ' HG ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -118.17 2.11 11.97 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.496 -0.752 . . . . 0.0 109.369 179.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.577 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 38.5 m80 -140.68 89.64 2.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.955 -1.091 . . . . 0.0 110.219 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.825 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.3 mm? -87.68 173.09 9.23 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.652 -0.655 . . . . 0.0 109.566 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -142.16 155.85 45.33 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.087 -1.008 . . . . 0.0 108.73 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.925 ' CE2' HD11 ' A' ' 101' ' ' ILE . 5.4 p90 -137.88 164.79 28.09 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 120.714 -1.242 . . . . 0.0 108.667 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.653 ' HD3' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.089 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.925 HD11 ' CE2' ' A' ' 99' ' ' TYR . 1.5 mp -96.87 61.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.251 -0.905 . . . . 0.0 109.698 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.653 HG23 ' HD3' ' A' ' 100' ' ' ARG . 21.5 t -77.58 4.62 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.889 HD22 HG22 ' A' ' 144' ' ' ILE . 5.4 m-20 -92.92 155.94 17.25 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.983 -1.073 . . . . 0.0 110.073 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.762 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.4 t80 176.26 150.98 0.14 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.489 ' CG2' ' C ' ' A' ' 104' ' ' TYR . 3.9 p -156.23 161.11 30.16 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 105' ' ' THR . 38.2 Cg_endo -67.71 -24.68 40.76 Favored 'Trans proline' 0 C--N 1.297 -2.164 0 N-CA-C 108.079 -1.547 . . . . 0.0 108.079 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.734 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.5 t0 -73.82 -12.24 60.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.08 HD13 HD12 ' A' ' 195' ' ' LEU . 76.2 mt -143.38 115.41 5.82 Favored Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.633 -0.667 . . . . 0.0 110.514 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -63.28 167.34 12.97 Favored 'Trans proline' 0 C--N 1.298 -2.099 0 O-C-N 123.63 1.332 . . . . 0.0 109.101 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HE3' ' CG ' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -36.25 -66.17 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.805 0.812 . . . . 0.0 110.322 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.3 OUTLIER -60.32 -11.88 7.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.728 -0.607 . . . . 0.0 111.62 -178.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.708 ' O ' HD11 ' A' ' 195' ' ' LEU . . . -85.32 -60.4 2.04 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.488 -1.383 . . . . 0.0 109.213 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.917 ' O ' HG23 ' A' ' 117' ' ' VAL . 5.5 p -55.7 -39.49 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.701 ' CG ' HG21 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -64.62 -27.56 69.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.746 ' OG ' HD21 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -65.7 -41.61 92.14 Favored 'General case' 0 C--O 1.203 -1.366 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.126 ' HB2' ' HG ' ' A' ' 195' ' ' LEU . . . -69.7 -33.34 72.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 113' ' ' VAL . 2.0 t -74.95 -24.06 17.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -87.32 -35.31 18.48 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.703 ' HB3' ' HB2' ' A' ' 196' ' ' PHE . 0.3 OUTLIER -80.26 -36.73 34.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.731 ' HA ' ' HB2' ' A' ' 200' ' ' ALA . . . -66.09 -60.8 2.47 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.532 1.158 . . . . 0.0 107.913 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.854 ' HA ' HG21 ' A' ' 203' ' ' ILE . 16.2 tp -54.12 -48.24 70.97 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.654 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -67.39 -33.72 75.79 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.241 -178.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.029 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -55.93 -42.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.034 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.0 m95 -91.21 -23.16 20.29 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.588 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 18.5 tt0 -71.16 -27.56 63.64 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 122' ' ' LYS . 7.6 pt-20 -90.15 -43.55 10.37 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.632 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.029 HG13 ' O ' ' A' ' 123' ' ' VAL . 16.6 m -58.49 -25.36 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.313 -1.355 . . . . 0.0 109.124 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.028 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -112.1 162.28 22.06 Favored Pre-proline 0 N--CA 1.497 1.922 0 C-N-CA 118.143 -1.423 . . . . 0.0 109.834 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -84.91 27.98 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.134 1.889 . . . . 0.0 110.483 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.853 HD22 ' CG ' ' A' ' 246' ' ' TYR . 1.9 mp -109.44 178.99 4.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.997 -1.064 . . . . 0.0 110.247 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.577 ' OG1' ' CD2' ' A' ' 96' ' ' HIS . 2.8 p -124.41 170.26 11.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.8 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 1.063 ' CZ ' HD13 ' A' ' 207' ' ' LEU . 12.5 m-85 -146.04 171.41 14.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.15 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 1.4 m -145.22 -175.13 4.58 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.652 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -163.83 149.94 11.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.794 -1.191 . . . . 0.0 110.501 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.769 HD12 ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -167.59 -98.71 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.396 -0.815 . . . . 0.0 109.965 179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.568 ' O ' ' CG ' ' A' ' 136' ' ' TYR . 15.9 t80 177.06 30.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.955 -1.091 . . . . 0.0 109.195 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.558 ' H ' HD13 ' A' ' 135' ' ' LEU . 7.3 tp10 -65.63 169.63 6.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.566 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -41.79 -34.87 1.37 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -178.22 104.24 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.556 -0.967 . . . . 0.0 109.894 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.541 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.4 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 98' ' ' THR . 71.5 m-20 -80.67 -30.49 36.53 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.97 -1.081 . . . . 0.0 108.794 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.914 HG12 HD23 ' A' ' 207' ' ' LEU . 4.4 mp -129.14 78.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.431 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.9 ttp -62.66 98.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.207 -0.933 . . . . 0.0 109.297 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.889 HG22 HD22 ' A' ' 103' ' ' ASN . 3.9 mm -84.76 107.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.641 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.7 OUTLIER -132.9 152.22 51.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.497 -1.377 . . . . 0.0 112.322 -178.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 24.5 p90 -77.44 146.6 36.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.561 -0.712 . . . . 0.0 109.586 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.796 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -165.04 163.69 20.59 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.213 -0.929 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.888 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.2 p -160.79 -160.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.96 . . . . 0.0 109.368 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.696 ' N ' HG13 ' A' ' 148' ' ' VAL . 36.7 mtm180 -36.24 -41.39 0.26 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.115 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.463 ' HG2' HG12 ' A' ' 148' ' ' VAL . 3.7 pt-20 -76.47 59.53 1.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.689 ' CD2' ' CD1' ' A' ' 155' ' ' TYR . 1.2 m80 -87.08 -91.16 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.649 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.19 39.36 0.38 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.633 ' CB ' ' CZ ' ' A' ' 155' ' ' TYR . 2.4 t70 -177.47 -143.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -1.163 . . . . 0.0 109.652 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.449 ' C ' ' HD3' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -94.41 15.87 16.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 110.0 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.689 ' CD1' ' CD2' ' A' ' 151' ' ' HIS . 0.1 OUTLIER -119.14 57.02 3.42 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.729 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 154' ' ' PHE . 40.5 Cg_endo -70.53 133.86 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.904 1.476 . . . . 0.0 109.379 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.744 ' CE1' HG13 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -120.71 -171.53 2.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.079 -1.013 . . . . 0.0 110.848 -179.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 160' ' ' PRO . 17.0 p30 -175.92 62.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.82 -0.55 . . . . 0.0 109.636 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -8.97 -63.53 0.01 OUTLIER Glycine 0 N--CA 1.505 3.283 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 183' ' ' ASP . 37.1 Cg_endo -64.02 66.56 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.442 1.233 . . . . 0.0 109.94 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . 178.02 151.59 9.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 164' ' ' LEU . 15.2 m-20 -42.58 -32.57 0.58 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.166 . . . . 0.0 109.667 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.744 HG13 ' CE1' ' A' ' 157' ' ' PHE . 39.6 t -44.68 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.7 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.964 HD23 ' CG1' ' A' ' 198' ' ' VAL . 3.1 tp -88.14 -52.01 5.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.12 -0.987 . . . . 0.0 112.286 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.749 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -176.48 -165.34 0.13 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.151 -1.593 . . . . 0.0 111.142 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.684 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.72 -175.29 0.2 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.01 -1.681 . . . . 0.0 111.43 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -155.51 176.82 12.09 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.562 -0.711 . . . . 0.0 109.907 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.527 ' O ' ' CB ' ' A' ' 206' ' ' SER . 25.4 m-85 -120.06 -168.89 1.69 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.312 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.973 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -159.74 -64.03 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.873 . . . . 0.0 109.602 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.973 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 45.9 Cg_endo -76.58 174.82 12.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.651 1.343 . . . . 0.0 110.051 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 175' ' ' ASN . . . 105.98 170.82 23.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.441 ' O ' ' OD1' ' A' ' 175' ' ' ASN . 44.3 Cg_endo -76.43 -56.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 121.603 1.535 . . . . 0.0 109.874 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.62 -40.25 1.03 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 176' ' ' GLY . 2.7 tp -62.88 -7.09 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.463 -1.022 . . . . 0.0 108.867 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.524 ' CA ' ' O ' ' A' ' 169' ' ' ALA . 4.4 p-10 -66.0 65.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 108.991 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 206' ' ' SER . . . 127.55 80.76 0.32 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.2 m-20 -156.83 120.94 4.34 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.102 -1.234 . . . . 0.0 108.158 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.679 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -107.19 164.27 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.508 -0.745 . . . . 0.0 109.107 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.796 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -153.09 137.58 16.76 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.893 -1.123 . . . . 0.0 109.89 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.636 ' CD2' ' ND2' ' A' ' 103' ' ' ASN . 8.3 m-85 -99.16 129.75 45.43 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.753 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.888 ' OD1' HG23 ' A' ' 148' ' ' VAL . 11.1 t0 -47.3 148.88 1.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.906 -1.121 . . . . 0.0 108.312 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -114.34 19.22 16.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 110.122 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.575 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 0.7 OUTLIER -135.45 17.86 3.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.979 -1.076 . . . . 0.0 110.325 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 159' ' ' GLY . 4.4 tt0 -120.47 -139.2 0.34 Allowed 'General case' 0 C--N 1.308 -1.215 0 O-C-N 120.909 -1.12 . . . . 0.0 108.548 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.618 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 3.4 mt-30 -117.66 168.06 10.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -0.96 . . . . 0.0 109.14 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.618 ' CG ' ' O ' ' A' ' 185' ' ' GLN . 87.1 m95 -159.46 107.46 1.77 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.974 -1.079 . . . . 0.0 109.741 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.932 ' HA ' HD21 ' A' ' 108' ' ' LEU . 70.6 p -144.26 154.6 43.25 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.853 -1.155 . . . . 0.0 110.787 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.861 ' HB3' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -91.68 -28.7 17.28 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 191' ' ' THR . 40.4 t0 -90.8 67.05 6.16 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 1.012 ' HB ' HD21 ' A' ' 229' ' ' LEU . 2.8 t 4.07 58.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.021 0.915 . . . . 0.0 112.036 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.666 ' N ' ' O ' ' A' ' 189' ' ' ASP . 51.6 m -124.51 -31.25 3.27 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 0.0 109.733 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.714 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -98.85 -90.96 1.99 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.764 ' CG2' HD21 ' A' ' 164' ' ' LEU . 23.9 m -115.41 -97.01 0.45 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.847 ' OD1' HD21 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -161.45 68.54 0.3 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.23 -0.919 . . . . 0.0 108.706 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.126 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -28.63 -95.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.596 0.713 . . . . 0.0 111.407 -179.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.892 ' CE1' HG21 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -67.57 -8.38 33.7 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 111.011 -177.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.911 ' HA ' HD11 ' A' ' 218' ' ' LEU . 6.3 tp -66.13 -66.64 0.52 Allowed 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 117.224 -1.79 . . . . 0.0 106.668 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.964 ' CG1' HD23 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -66.75 -13.72 16.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.06 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -70.91 -58.8 3.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.805 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -66.67 -14.96 63.13 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.631 ' HB2' ' HH3' ' A' ' 3' ' ' MSB . 14.8 t60 -68.08 -45.47 73.71 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 117.798 -1.561 . . . . 0.0 107.625 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.679 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 2.2 mt-10 -82.8 -47.82 11.49 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.192 -0.943 . . . . 0.0 111.003 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.854 HG21 ' HA ' ' A' ' 121' ' ' LEU . 1.3 mt -60.05 -31.27 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.682 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.9 -31.84 51.88 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -59.97 -51.01 71.48 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.85 -0.794 . . . . 0.0 110.58 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.536 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 84.4 p -82.74 -56.88 3.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 112.362 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 1.063 HD13 ' CZ ' ' A' ' 132' ' ' PHE . 1.0 OUTLIER -104.86 26.62 8.96 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.098 -1.001 . . . . 0.0 110.622 -177.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.975 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -126.52 -79.19 0.31 Allowed Glycine 0 C--N 1.292 -1.878 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.789 HD11 ' OD1' ' A' ' 238' ' ' ASP . 2.1 pp -170.16 -162.67 0.31 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.678 -1.484 . . . . 0.0 110.015 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.583 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.3 OUTLIER -95.07 -75.34 0.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.897 . . . . 0.0 109.5 -179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 1.3 m-70 -161.28 89.36 0.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.636 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.5 m -77.1 -178.67 5.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 108.987 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.861 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -61.92 80.45 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.966 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -84.08 7.56 18.29 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.216 -177.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 215' ' ' THR . 7.8 p -50.63 -27.79 7.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.515 ' C ' ' HB2' ' A' ' 235' ' ' SER . 18.2 mt-10 -114.05 -37.65 4.4 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.966 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -61.69 -167.31 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 122.284 1.04 . . . . 0.0 112.195 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.911 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.0 OUTLIER -102.47 -8.15 21.32 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.893 -177.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.54 ' CB ' ' OD1' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -81.31 -11.11 59.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.114 -1.616 . . . . 0.0 111.213 -178.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.657 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 2.6 t80 -136.47 12.61 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 120.33 -1.481 . . . . 0.0 113.808 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 48.5 Cg_endo -71.94 -37.96 4.48 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 1.007 HD13 ' CD2' ' A' ' 3' ' ' MSB . 0.3 OUTLIER 0.08 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.915 ' N ' HD23 ' A' ' 222' ' ' LEU . 0.8 OUTLIER -67.72 59.55 0.06 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.493 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.8 t-160 -168.1 -145.2 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 109.442 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.765 ' O ' HD12 ' A' ' 226' ' ' LEU . 59.0 m -149.72 110.11 4.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.002 . . . . 0.0 109.908 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 225' ' ' SER . 0.1 OUTLIER 179.67 56.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 188' ' ' LYS . 4.8 t -111.95 -7.89 14.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.906 . . . . 0.0 109.54 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.607 ' HA ' ' CG ' ' A' ' 232' ' ' PHE . 0.5 OUTLIER 178.87 -23.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 110.463 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 1.012 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -28.89 -61.58 0.12 Allowed 'General case' 0 N--CA 1.505 2.282 0 CA-C-O 121.443 0.639 . . . . 0.0 110.857 -179.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.411 ' OG1' ' C ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 178.92 -31.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.415 -0.803 . . . . 0.0 108.838 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.572 ' HB2' HD21 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -98.1 -21.15 16.92 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.607 ' CG ' ' HA ' ' A' ' 228' ' ' ASP . 20.0 p90 -33.19 120.75 0.37 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.553 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER 178.72 172.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.738 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.034 HD21 ' CH2' ' A' ' 124' ' ' TRP . 5.0 mp -83.02 169.56 15.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 111.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.718 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 14.4 t -102.69 -170.87 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.764 179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.542 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -83.8 -13.36 53.98 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.861 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.1 m-20 -84.54 -48.37 9.62 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.829 -1.17 . . . . 0.0 108.005 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.789 ' OD1' HD11 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -64.0 -40.01 95.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 117.166 -1.814 . . . . 0.0 106.749 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.641 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -56.26 -35.72 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 243' ' ' GLN . 3.6 t30 -67.69 -45.63 74.63 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -62.97 -52.48 47.66 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.007 HG13 HG22 ' A' ' 128' ' ' THR . 1.5 tp -66.31 -47.29 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.868 -1.372 . . . . 0.0 110.51 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.565 ' N ' HG23 ' A' ' 242' ' ' ILE . 9.9 pt20 -55.13 -26.83 41.05 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 5.0 p -82.27 -18.86 40.9 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' A' ' 242' ' ' ILE . 0.8 OUTLIER -70.09 -65.8 0.68 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.853 ' CG ' HD22 ' A' ' 130' ' ' LEU . 20.5 m-85 -90.04 -123.24 0.06 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.104 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.503 ' N ' ' HD3' ' A' ' 248' ' ' PRO . . . 41.8 52.84 4.64 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.617 ' N ' ' CD ' ' A' ' 249' ' ' PRO . 38.1 Cg_endo -72.1 -30.2 13.73 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.9 1.474 . . . . 0.0 112.453 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 248' ' ' PRO . 43.4 Cg_endo -75.37 111.69 3.37 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 O-C-N 122.66 0.821 . . . . 0.0 110.052 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 248' ' ' PRO . 42.6 Cg_endo -73.96 -59.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.954 1.502 . . . . 0.0 110.077 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -155.54 -39.02 0.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.866 . . . . 0.0 109.392 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 10.8 p -124.79 152.93 70.33 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.449 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -72.43 -9.16 23.8 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.028 1.541 . . . . 0.0 109.991 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.41 153.68 39.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.562 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.54 ' O ' ' CB ' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.54 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 1.007 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 4.5 p90 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -151.56 163.95 37.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.557 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 210' ' ' PHE . 7.6 p -54.42 179.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -0.918 . . . . 0.0 109.567 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.545 ' CD1' ' HD2' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -45.56 134.6 6.07 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.152 -0.967 . . . . 0.0 109.452 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.545 ' HD2' ' CD1' ' A' ' 86' ' ' PHE . 42.6 Cg_endo -73.2 55.57 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.014 1.534 . . . . 0.0 110.146 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.33 -126.61 2.27 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.509 ' CG2' ' HD2' ' A' ' 90' ' ' PRO . 1.6 mp -50.57 140.19 19.3 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.291 -1.123 . . . . 0.0 109.784 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.58 ' HB2' HD23 ' A' ' 245' ' ' LEU . 42.6 Cg_endo -72.97 154.14 52.89 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.038 1.547 . . . . 0.0 109.981 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.78 ' N ' HD21 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -44.29 -81.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.69 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.818 ' CD1' HD22 ' A' ' 207' ' ' LEU . 9.2 m95 -95.95 -169.05 1.86 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.847 -1.158 . . . . 0.0 110.037 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.513 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -161.81 -33.2 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 110.399 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.57 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.75 174.82 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.199 -0.938 . . . . 0.0 110.799 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.584 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -101.15 -8.53 22.15 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.715 . . . . 0.0 110.167 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.574 ' CD2' ' OG1' ' A' ' 131' ' ' THR . 51.4 m80 -140.15 95.32 2.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.706 -1.246 . . . . 0.0 110.865 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.03 HD13 HD13 ' A' ' 207' ' ' LEU . 19.5 mt -82.02 177.64 8.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.646 -0.659 . . . . 0.0 109.886 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.691 ' C ' ' HB1' ' A' ' 140' ' ' ALA . 1.3 t -148.16 155.8 41.83 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.226 -0.921 . . . . 0.0 109.12 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.76 ' CG ' HD22 ' A' ' 121' ' ' LEU . 1.3 p90 -138.43 161.83 35.99 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.614 -1.303 . . . . 0.0 110.053 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.587 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -130.43 123.0 28.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.515 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.891 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.5 mp -84.27 82.48 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.815 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' A' ' 144' ' ' ILE . 39.4 t -95.87 6.81 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.0 109.46 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.572 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -102.55 163.65 12.1 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.988 -1.07 . . . . 0.0 109.211 179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.687 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.0 t80 177.13 84.56 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.585 0.707 . . . . 0.0 109.117 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.951 HG21 ' CG ' ' A' ' 186' ' ' TRP . 17.9 p -72.85 155.99 90.2 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 108.876 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.98 -24.1 39.81 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 O-C-N 123.917 1.483 . . . . 0.0 108.667 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 186' ' ' TRP . 0.5 OUTLIER -78.37 -0.32 28.58 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.187 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.962 HD13 ' CD1' ' A' ' 195' ' ' LEU . 96.8 mt -147.45 120.03 4.74 Favored Pre-proline 0 N--CA 1.485 1.276 0 O-C-N 121.458 -0.776 . . . . 0.0 110.139 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 37.2 Cg_endo -66.02 173.15 7.52 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.89 1.468 . . . . 0.0 109.037 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.481 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -39.14 -65.97 0.33 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.907 0.861 . . . . 0.0 110.091 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.2 OUTLIER -55.21 -29.41 57.89 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.857 -0.527 . . . . 0.0 112.251 -178.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.873 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -73.09 -61.03 1.96 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.386 -1.446 . . . . 0.0 109.413 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.687 HG21 ' N ' ' A' ' 104' ' ' TYR . 9.6 p -53.39 -42.31 47.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.891 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -62.87 -27.94 69.7 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.933 ' OG ' HD21 ' A' ' 195' ' ' LEU . 4.4 p -61.23 -45.99 92.28 Favored 'General case' 0 C--O 1.202 -1.445 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.094 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -67.68 -31.28 71.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.055 -1.028 . . . . 0.0 109.663 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.985 HG13 HG13 ' A' ' 144' ' ' ILE . 45.9 t -75.07 -23.29 17.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 1.4 tt0 -90.35 -33.13 16.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -79.65 -41.89 25.97 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.913 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -62.95 -61.92 2.07 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.773 ' HA ' HG21 ' A' ' 203' ' ' ILE . 11.1 tp -51.24 -44.5 61.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.103 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 125' ' ' GLU . 2.6 tptp -72.53 -32.73 66.35 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.55 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.886 HG21 ' HE1' ' A' ' 196' ' ' PHE . 3.4 t -56.16 -43.8 77.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.024 ' CH2' HD21 ' A' ' 234' ' ' LEU . 37.8 m95 -91.22 -19.08 23.41 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.452 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.7 OUTLIER -77.05 -27.58 54.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.971 -1.081 . . . . 0.0 108.24 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 122' ' ' LYS . 17.1 pt-20 -89.99 -44.57 9.78 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.615 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.961 HG21 HG21 ' A' ' 242' ' ' ILE . 35.9 m -64.03 -21.44 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 118.717 -1.193 . . . . 0.0 108.612 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 124' ' ' TRP . 1.7 p -113.0 152.26 44.79 Favored Pre-proline 0 N--CA 1.498 1.933 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.971 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.612 ' C ' HD22 ' A' ' 130' ' ' LEU . 53.9 Cg_endo -80.51 32.82 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.285 1.99 . . . . 0.0 111.661 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 246' ' ' TYR . 2.9 mm? -112.56 165.51 12.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.616 -1.302 . . . . 0.0 110.857 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 1.7 p -103.3 177.57 4.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.402 -0.811 . . . . 0.0 109.181 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 97' ' ' LEU . 15.9 m-85 -154.35 160.61 41.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.913 -1.117 . . . . 0.0 110.748 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -158.57 125.81 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.611 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -97.57 174.38 6.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.61 -1.306 . . . . 0.0 110.358 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.537 ' CD1' ' HG3' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -156.16 -122.83 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.432 ' C ' ' OE1' ' A' ' 137' ' ' GLU . 1.1 t80 177.04 42.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.3 -1.5 . . . . 0.0 109.921 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 139' ' ' GLU . 10.9 pm0 -169.47 -173.79 1.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.931 -1.106 . . . . 0.0 110.155 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . 38.8 -97.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 137' ' ' GLU . 10.2 pt-20 179.0 105.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.34 -1.094 . . . . 0.0 109.92 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.691 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -60.21 -151.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.055 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.638 ' OD2' HG22 ' A' ' 98' ' ' THR . 53.8 m-20 -93.46 -25.5 17.61 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.931 HD11 HD12 ' A' ' 207' ' ' LEU . 3.1 mp -132.22 79.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.525 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 3.5 ttp -66.14 93.77 0.22 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.194 -0.941 . . . . 0.0 109.231 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.985 HG13 HG13 ' A' ' 117' ' ' VAL . 5.9 mm -79.28 110.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.911 -1.118 . . . . 0.0 108.042 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -131.36 156.14 46.04 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.359 -1.463 . . . . 0.0 111.434 -178.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.574 ' O ' ' CD1' ' A' ' 146' ' ' PHE . 19.7 p90 -79.85 138.2 37.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 0.0 109.432 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.045 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -157.85 164.2 37.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.037 . . . . 0.0 110.523 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 1.026 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.4 p -166.58 -161.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.686 ' H ' HG22 ' A' ' 148' ' ' VAL . 45.6 mtm180 -36.57 -30.33 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 148' ' ' VAL . 0.2 OUTLIER -81.84 71.67 8.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 109.653 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 155' ' ' TYR . 4.4 m80 -107.58 -166.51 1.16 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.5 -73.07 1.28 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -174.24 56.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -1.146 . . . . 0.0 109.537 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.504 ' HB3' ' CE1' ' A' ' 155' ' ' TYR . 0.2 OUTLIER 179.54 -30.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 0.0 109.637 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.602 ' O ' ' CG ' ' A' ' 151' ' ' HIS . 0.7 OUTLIER -113.75 54.66 0.64 Allowed Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.848 . . . . 0.0 109.347 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 154' ' ' PHE . 38.1 Cg_endo -65.84 109.46 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.802 1.422 . . . . 0.0 109.613 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.878 ' CE1' HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -96.64 -169.1 1.83 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 110.492 -179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.585 ' O ' ' C ' ' A' ' 159' ' ' GLY . 16.9 p30 179.74 62.68 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.724 -178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.608 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . -5.35 -65.58 0.01 OUTLIER Glycine 0 N--CA 1.51 3.579 0 N-CA-C 112.151 -0.38 . . . . 0.0 112.151 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.536 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.2 Cg_endo -64.69 61.33 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.685 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -170.07 141.93 6.9 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.527 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 18.6 m120 -40.15 -31.32 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.45 -1.029 . . . . 0.0 110.343 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.878 HG12 ' CE1' ' A' ' 157' ' ' PHE . 1.4 t -56.7 89.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.178 -0.951 . . . . 0.0 109.568 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.812 HD11 HG21 ' A' ' 193' ' ' THR . 0.1 OUTLIER -79.51 -40.9 28.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.32 -0.862 . . . . 0.0 112.306 -178.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.664 ' HB1' ' O ' ' A' ' 179' ' ' HIS . . . -179.86 -168.5 0.11 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.198 -1.564 . . . . 0.0 110.859 -178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.679 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.7 p-80 178.91 -168.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.412 -1.43 . . . . 0.0 110.99 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 177' ' ' ASP . . . -159.88 -164.63 1.34 Allowed 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.347 -0.845 . . . . 0.0 110.28 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.571 ' OH ' ' CG ' ' A' ' 155' ' ' TYR . 88.6 m-85 -131.9 -163.64 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.008 -1.058 . . . . 0.0 110.16 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.823 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . 179.28 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.002 -1.061 . . . . 0.0 110.939 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.823 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 40.1 Cg_endo -70.22 -64.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.491 1.46 . . . . 0.0 111.817 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 175' ' ' ASN . . . -37.86 144.75 0.17 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 174' ' ' ILE . 39.9 Cg_endo -69.47 144.53 55.9 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 124.085 1.571 . . . . 0.0 109.368 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 69.55 -63.28 0.63 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.609 ' O ' ' N ' ' A' ' 176' ' ' GLY . 1.5 tp -68.43 -4.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -63.79 66.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' A' ' 141' ' ' ASP . . . 129.81 80.62 0.24 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.633 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 3.3 m-20 -157.41 128.91 6.88 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 120.755 -1.438 . . . . 0.0 107.676 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.772 ' HB1' ' CB ' ' A' ' 202' ' ' GLU . . . -117.55 156.68 27.66 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.888 -1.132 . . . . 0.0 109.538 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.045 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -142.15 133.84 26.91 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.303 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 199' ' ' ALA . 20.4 m-85 -96.03 134.19 39.35 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.857 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 1.026 ' OD1' HG23 ' A' ' 148' ' ' VAL . 9.5 t0 -53.26 145.9 12.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.892 -1.13 . . . . 0.0 108.85 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 147' ' ' ALA . 10.0 m-20 -114.7 21.54 14.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 0.0 110.255 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.876 ' OD1' HG21 ' A' ' 148' ' ' VAL . 0.4 OUTLIER -121.32 8.98 10.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.804 -1.185 . . . . 0.0 110.298 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.558 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 19.0 mt-10 -122.63 -131.68 0.28 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.94 -1.1 . . . . 0.0 108.534 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.584 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 5.3 mt-30 -133.36 175.42 9.42 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.134 -0.979 . . . . 0.0 108.761 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.951 ' CG ' HG21 ' A' ' 105' ' ' THR . 78.0 m95 -158.81 119.38 3.26 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.91 -1.119 . . . . 0.0 108.85 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.68 ' HA ' HD21 ' A' ' 108' ' ' LEU . 71.4 p -144.85 152.28 40.04 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.79 -1.194 . . . . 0.0 110.505 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.948 ' HB3' HD22 ' A' ' 195' ' ' LEU . 3.3 pttt -85.14 -31.75 23.12 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.635 ' O ' ' N ' ' A' ' 191' ' ' THR . 12.7 t70 -87.16 63.44 7.85 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.889 ' CG2' HD21 ' A' ' 229' ' ' LEU . 72.1 p 3.24 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.578 0.704 . . . . 0.0 111.832 -177.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.635 ' N ' ' O ' ' A' ' 189' ' ' ASP . 37.0 m -125.34 -32.34 2.95 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.664 . . . . 0.0 109.408 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.617 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -94.94 -82.27 1.58 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.812 HG21 HD11 ' A' ' 164' ' ' LEU . 21.8 m -125.31 -95.81 0.45 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 1.002 ' HB2' HG23 ' A' ' 198' ' ' VAL . 0.2 OUTLIER -160.61 70.82 0.42 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.017 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 2.1 tp -33.5 -95.74 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 CA-C-O 121.696 0.76 . . . . 0.0 110.547 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.886 ' HE1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -69.62 -9.93 56.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.967 -1.083 . . . . 0.0 111.168 -177.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.69 ' HB3' ' CB ' ' A' ' 194' ' ' ASN . 12.0 tp -64.71 -62.01 1.84 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 116.852 -1.939 . . . . 0.0 106.544 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.002 HG23 ' HB2' ' A' ' 194' ' ' ASN . 2.7 t -70.48 -12.2 15.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.094 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -73.64 -59.43 2.72 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.759 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -63.99 -15.64 59.76 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.592 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 20.2 t60 -67.15 -49.2 65.62 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.806 -1.558 . . . . 0.0 107.676 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.772 ' CB ' ' HB1' ' A' ' 178' ' ' ALA . 2.5 mm-40 -80.24 -47.12 15.1 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.159 -0.963 . . . . 0.0 111.077 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.913 HD12 ' HB3' ' A' ' 120' ' ' ALA . 3.3 mt -60.15 -31.53 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.708 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -76.94 -34.87 40.98 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 202' ' ' GLU . 0.0 OUTLIER -57.38 -50.31 73.4 Favored 'General case' 0 C--N 1.289 -2.052 0 O-C-N 121.78 -0.835 . . . . 0.0 110.598 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.851 ' C ' HD23 ' A' ' 207' ' ' LEU . 1.5 m -84.81 -58.96 2.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.378 -0.826 . . . . 0.0 112.177 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 1.03 HD13 HD13 ' A' ' 97' ' ' LEU . 1.2 mt -102.85 32.23 3.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.178 -0.951 . . . . 0.0 110.196 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.709 ' O ' HD12 ' A' ' 245' ' ' LEU . . . -131.91 -81.53 0.21 Allowed Glycine 0 C--N 1.289 -2.073 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.838 HD12 ' N ' ' A' ' 210' ' ' PHE . 4.6 pp -165.03 -164.65 0.8 Allowed 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.127 -1.22 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.838 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -98.48 -70.76 0.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.319 -0.863 . . . . 0.0 109.238 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' A' ' 210' ' ' PHE . 21.8 m80 -162.85 96.8 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.338 -0.851 . . . . 0.0 109.226 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.765 ' HB3' ' HB3' ' A' ' 237' ' ' ASP . 3.8 m -87.69 -175.71 5.28 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.808 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -65.43 76.86 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.952 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.2 OUTLIER -83.56 8.8 13.04 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.126 -177.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.458 ' C ' ' O ' ' A' ' 214' ' ' ASN . 21.3 p -50.35 -27.72 6.75 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.519 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.2 mp0 -112.51 -37.21 5.01 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.952 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -64.97 -168.48 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.319 1.057 . . . . 0.0 112.526 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.787 HD23 HD12 ' A' ' 234' ' ' LEU . 0.1 OUTLIER -89.77 -18.06 27.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.694 -177.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.553 ' HB3' ' ND2' ' A' ' 214' ' ' ASN . 0.0 OUTLIER -77.38 -7.26 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 O-C-N 119.182 -2.199 . . . . 0.0 112.175 -177.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.652 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 27.8 t80 -135.5 14.69 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.277 -1.514 . . . . 0.0 113.585 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 220' ' ' TYR . 56.6 Cg_endo -79.88 -43.33 0.13 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 N-CA-C 109.279 -1.085 . . . . 0.0 109.279 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.636 HD23 ' CD2' ' A' ' 3' ' ' MSB . 2.3 tp -1.08 -73.12 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 CA-C-O 121.355 0.597 . . . . 0.0 110.929 -178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 221' ' ' PRO . 8.2 m-85 -67.6 59.61 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.413 -0.804 . . . . 0.0 109.202 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 222' ' ' LEU . 2.5 t-160 -170.43 -140.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -0.851 . . . . 0.0 109.232 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.619 ' C ' HD23 ' A' ' 226' ' ' LEU . 19.8 m -163.52 112.19 1.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.967 -1.083 . . . . 0.0 110.121 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.698 ' N ' HG21 ' A' ' 190' ' ' THR . 0.4 OUTLIER 179.69 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 109.448 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.577 ' O ' ' CD2' ' A' ' 196' ' ' PHE . 5.2 t -104.75 -48.02 3.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.346 -0.846 . . . . 0.0 109.088 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.609 ' HA ' ' CD2' ' A' ' 232' ' ' PHE . 0.5 OUTLIER -138.57 -10.39 1.4 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.542 -1.349 . . . . 0.0 111.625 179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.889 HD21 ' CG2' ' A' ' 190' ' ' THR . 0.1 OUTLIER -35.83 -64.68 0.29 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.844 -1.16 . . . . 0.0 110.792 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 229' ' ' LEU . 0.0 OUTLIER 179.84 -31.77 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.099 -1.001 . . . . 0.0 109.193 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.2 OUTLIER -97.58 -20.14 17.88 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 228' ' ' ASP . 50.7 p90 -34.53 130.72 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.542 0.687 . . . . 0.0 111.145 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.54 ' HG2' ' N ' ' A' ' 234' ' ' LEU . 7.1 ttt-85 179.74 152.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.024 HD21 ' CH2' ' A' ' 124' ' ' TRP . 2.1 mp -68.75 169.04 12.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.97 -1.082 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' A' ' 217' ' ' ALA . 31.0 t -100.48 -171.76 2.08 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.254 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.499 ' N ' ' OG ' ' A' ' 235' ' ' SER . 0.0 OUTLIER -85.5 -12.09 52.64 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.831 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.808 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 0.2 OUTLIER -84.69 -47.5 10.41 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.669 ' OD1' HD21 ' A' ' 209' ' ' LEU . 4.5 m-20 -67.01 -38.28 85.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 117.091 -1.844 . . . . 0.0 106.526 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 234' ' ' LEU . 0.7 OUTLIER -57.23 -34.69 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.468 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 244' ' ' SER . 12.6 t-20 -68.96 -47.22 66.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.279 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' A' ' 244' ' ' SER . . . -64.3 -45.93 92.11 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 120.14 -1.028 . . . . 0.0 110.901 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.961 HG21 HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -74.39 -50.02 29.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.532 -1.569 . . . . 0.0 109.803 -178.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.606 ' N ' HG23 ' A' ' 242' ' ' ILE . 2.4 tt0 -55.27 -24.15 26.72 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 75.8 p -89.74 -13.55 36.55 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.78 HD21 ' N ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -72.26 -53.65 11.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.614 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 7.5 m-30 -83.33 -117.5 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.516 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 129' ' ' PRO . . . 169.66 131.18 1.28 Allowed Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.393 -1.384 . . . . 0.0 109.97 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.658 ' HB2' ' HD2' ' A' ' 250' ' ' PRO . 45.8 Cg_endo -70.52 175.1 9.19 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.955 1.503 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 250' ' ' PRO . 38.4 Cg_endo -67.14 -26.05 42.95 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.814 1.676 . . . . 0.0 114.523 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 42.4 Cg_endo -82.24 -57.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 120.435 0.757 . . . . 0.0 110.194 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 250' ' ' PRO . 0.1 OUTLIER -43.85 -26.89 0.29 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.392 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 250' ' ' PRO . 0.6 OUTLIER -145.88 89.49 6.1 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 255' ' ' THR . 42.3 Cg_endo -72.83 -35.14 5.95 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.917 1.483 . . . . 0.0 110.185 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.419 ' C ' ' OG1' ' A' ' 255' ' ' THR . 0.6 OUTLIER -66.48 65.94 0.05 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.517 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 253' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.524 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.835 ' CG2' HG13 ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.54 ' CB ' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.754 ' HH1' ' O ' ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.283 0.563 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.459 ' N ' ' CD ' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -138.19 -93.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.2 p -53.64 156.89 2.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.485 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 86' ' ' PHE . 5.0 p90 -138.46 106.85 7.78 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.524 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.71 96.36 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.949 1.499 . . . . 0.0 110.14 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.14 -99.45 0.14 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.677 ' H ' HD12 ' A' ' 89' ' ' ILE . 5.1 mp -75.03 123.63 89.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.266 -1.138 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 245' ' ' LEU . 42.6 Cg_endo -72.82 -175.62 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.983 1.517 . . . . 0.0 110.004 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.812 ' H ' HD22 ' A' ' 245' ' ' LEU . 0.0 OUTLIER -89.84 -85.15 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 108.76 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.597 ' CZ2' ' HA ' ' A' ' 141' ' ' ASP . 12.7 m95 -77.58 -126.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.416 -0.914 . . . . 0.0 108.858 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 178.84 -51.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.365 -1.459 . . . . 0.0 109.529 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -43.41 173.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.814 0.816 . . . . 0.0 110.771 -179.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.542 ' HA ' ' CD1' ' A' ' 130' ' ' LEU . 26.2 p -100.06 -4.19 30.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.497 -0.752 . . . . 0.0 109.64 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.596 ' O ' ' HE3' ' A' ' 94' ' ' LYS . 21.1 m-70 -141.93 88.82 2.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.931 -1.105 . . . . 0.0 110.221 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 97' ' ' LEU . 2.9 mm? -76.71 169.54 18.1 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.709 -0.619 . . . . 0.0 109.481 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.566 ' O ' ' N ' ' A' ' 141' ' ' ASP . 0.2 OUTLIER -141.77 156.79 45.57 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.11 -0.994 . . . . 0.0 108.963 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.891 ' CG ' HD23 ' A' ' 121' ' ' LEU . 16.7 p90 -137.55 161.74 35.62 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.588 -1.32 . . . . 0.0 109.256 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 1.093 ' CZ ' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -125.13 138.6 54.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 109.383 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.945 HG21 ' CG ' ' A' ' 114' ' ' ASP . 1.6 mp -93.01 67.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.983 -1.073 . . . . 0.0 109.661 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.093 HG22 ' CZ ' ' A' ' 100' ' ' ARG . 20.0 t -78.77 6.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 0.0 110.069 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.654 ' C ' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -105.98 159.37 16.1 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.899 -1.126 . . . . 0.0 108.578 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.712 ' N ' HG21 ' A' ' 113' ' ' VAL . 2.8 p90 177.94 47.01 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.748 -0.595 . . . . 0.0 110.246 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.864 HG21 ' CD1' ' A' ' 186' ' ' TRP . 22.6 p -44.11 156.8 0.31 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.163 -0.961 . . . . 0.0 108.802 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.04 -18.21 51.52 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.701 1.369 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.488 ' OD2' ' NE2' ' A' ' 185' ' ' GLN . 0.5 OUTLIER -70.93 -6.06 35.6 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.337 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.975 ' CD1' HD13 ' A' ' 195' ' ' LEU . 95.9 mt -151.67 127.16 4.88 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.401 -0.812 . . . . 0.0 110.432 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 112' ' ' ALA . 38.2 Cg_endo -68.09 174.8 7.41 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 O-C-N 123.992 1.522 . . . . 0.0 109.288 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.481 ' HE3' ' OD2' ' A' ' 114' ' ' ASP . 0.0 OUTLIER -40.88 -66.36 0.34 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.774 0.797 . . . . 0.0 110.206 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 115' ' ' SER . 0.5 OUTLIER -54.35 -33.8 59.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.922 ' HB1' HD22 ' A' ' 108' ' ' LEU . . . -70.46 -60.65 2.14 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.355 -1.465 . . . . 0.0 109.834 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.712 HG21 ' N ' ' A' ' 104' ' ' TYR . 5.6 p -55.18 -44.51 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.945 ' CG ' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -61.8 -27.54 68.83 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 116' ' ' ALA . 1.4 p -58.89 -64.54 0.9 Allowed 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.059 ' HB1' ' HB2' ' A' ' 199' ' ' ALA . . . -50.1 -32.01 14.71 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.293 -0.879 . . . . 0.0 110.254 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.014 HG13 HG13 ' A' ' 144' ' ' ILE . 36.8 t -74.34 -23.34 18.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 122' ' ' LYS . 0.2 OUTLIER -93.08 -31.06 14.97 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.525 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.666 ' HB3' ' CG ' ' A' ' 196' ' ' PHE . 0.1 OUTLIER -84.47 -35.11 23.21 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.92 ' HB3' HD12 ' A' ' 203' ' ' ILE . . . -69.26 -62.26 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 122.591 1.186 . . . . 0.0 107.928 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.901 ' HA ' HG21 ' A' ' 203' ' ' ILE . 0.1 OUTLIER -52.67 -55.1 24.98 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.699 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 118' ' ' GLU . 2.7 tptm -60.55 -35.42 75.97 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.835 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.018 ' O ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -55.27 -40.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -179.575 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 1.043 ' CH2' HD21 ' A' ' 234' ' ' LEU . 42.7 m95 -91.05 -23.87 20.22 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.669 -1.212 . . . . 0.0 110.557 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -70.37 -29.6 66.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.799 -1.188 . . . . 0.0 107.808 179.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.1 OUTLIER -88.55 -40.34 13.47 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.201 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.018 HG13 ' O ' ' A' ' 123' ' ' VAL . 18.7 m -61.63 -25.46 36.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 118.298 -1.361 . . . . 0.0 109.102 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 1.009 HG23 ' O ' ' A' ' 124' ' ' TRP . 0.1 OUTLIER -112.52 164.14 16.07 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 118.241 -1.384 . . . . 0.0 108.995 179.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HG3' ' N ' ' A' ' 248' ' ' PRO . 48.0 Cg_endo -79.11 -6.17 14.8 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.687 1.591 . . . . 0.0 110.557 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 246' ' ' TYR . 2.1 mm? -74.4 165.1 25.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 110.289 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.552 ' OG1' ' CG ' ' A' ' 96' ' ' HIS . 1.6 p -108.97 169.04 8.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.393 -0.817 . . . . 0.0 109.071 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 97' ' ' LEU . 50.9 m-85 -148.65 154.93 40.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 110.199 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.577 ' O ' ' CD1' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -143.76 -179.52 6.51 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -156.7 161.37 39.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.92 -1.113 . . . . 0.0 109.834 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 135' ' ' LEU . 0.1 OUTLIER -168.82 -98.12 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.405 -0.809 . . . . 0.0 109.956 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.63 ' CZ ' ' NH2' ' A' ' 100' ' ' ARG . 2.8 t80 177.68 32.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.986 -1.071 . . . . 0.0 109.041 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.756 ' OE2' HD11 ' A' ' 135' ' ' LEU . 0.7 OUTLIER -72.21 174.51 7.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.967 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' GLU . . . -43.62 -40.46 5.07 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 140' ' ' ALA . 4.1 pt-20 -174.21 105.3 0.11 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -1.062 . . . . 0.0 109.998 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.563 ' HB1' ' C ' ' A' ' 98' ' ' THR . . . -59.4 -148.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.018 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.597 ' HA ' ' CZ2' ' A' ' 92' ' ' TRP . 66.8 m-20 -88.02 -27.17 22.21 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.575 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.018 HD11 HD22 ' A' ' 207' ' ' LEU . 3.6 mt -130.73 77.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.512 ' CB ' ' OD2' ' A' ' 177' ' ' ASP . 23.4 ttp -65.29 98.19 0.31 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.645 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 1.014 HG13 HG13 ' A' ' 117' ' ' VAL . 5.6 mm -81.97 107.35 13.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 179' ' ' HIS . 0.9 OUTLIER -128.5 156.59 43.03 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.468 -1.395 . . . . 0.0 111.79 -178.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.539 ' HB3' ' ND2' ' A' ' 103' ' ' ASN . 34.7 p90 -79.17 137.39 37.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 1.031 ' HB3' ' CD2' ' A' ' 179' ' ' HIS . . . -158.37 165.57 34.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.094 -1.004 . . . . 0.0 109.731 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.923 HG23 ' OD1' ' A' ' 181' ' ' ASP . 1.1 p -164.15 -155.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.163 -0.961 . . . . 0.0 109.472 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.804 ' N ' HG13 ' A' ' 148' ' ' VAL . 0.1 OUTLIER -60.8 76.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 109.68 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 148' ' ' VAL . 56.6 tt0 179.8 32.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.393 -0.817 . . . . 0.0 109.201 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 155' ' ' TYR . 68.1 m80 -75.25 -89.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.3 -0.875 . . . . 0.0 109.587 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.8 32.66 0.64 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.81 -92.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -1.11 . . . . 0.0 109.541 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.438 ' C ' ' HD3' ' A' ' 156' ' ' PRO . 41.8 m-85 -145.98 14.28 1.32 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -0.958 . . . . 0.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.588 ' O ' ' CE1' ' A' ' 151' ' ' HIS . 9.0 m-85 -124.43 47.34 1.89 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.869 . . . . 0.0 109.502 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 155' ' ' TYR . 41.4 Cg_endo -71.01 125.68 11.74 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.032 1.543 . . . . 0.0 109.761 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.688 ' CE1' ' CE1' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -102.77 -166.79 1.31 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 110.517 -179.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 160' ' ' PRO . 19.8 p30 179.29 58.57 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.72 -0.612 . . . . 0.0 109.837 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.623 ' HA3' ' CB ' ' A' ' 183' ' ' ASP . . . 8.19 -74.13 0.0 OUTLIER Glycine 0 N--CA 1.508 3.444 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.593 ' N ' ' O ' ' A' ' 158' ' ' ASP . 37.4 Cg_endo -64.17 62.41 0.24 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.869 1.457 . . . . 0.0 109.935 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 159' ' ' GLY . . . -164.56 141.99 7.46 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.538 ' CB ' ' HE1' ' A' ' 2' ' ' 3MP . 70.5 m-80 -41.41 -32.77 0.35 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -1.087 . . . . 0.0 109.971 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.867 ' HA ' HG23 ' A' ' 1' ' ' HAV . 6.4 m -55.1 86.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.896 . . . . 0.0 109.9 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 1.114 HD23 HG21 ' A' ' 198' ' ' VAL . 0.8 OUTLIER -75.63 -38.33 59.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.337 -0.852 . . . . 0.0 111.618 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.885 ' HB3' ' CG1' ' A' ' 198' ' ' VAL . . . 179.21 -169.64 0.11 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.585 -1.322 . . . . 0.0 110.406 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.688 ' CE1' ' CE1' ' A' ' 157' ' ' PHE . 1.3 p-80 178.12 -170.37 0.1 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.017 -1.677 . . . . 0.0 111.426 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' A' ' 178' ' ' ALA . . . -153.56 -174.99 5.16 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.56 -0.713 . . . . 0.0 110.052 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 1.057 ' CD1' HD11 ' A' ' 174' ' ' ILE . 62.8 m-85 -121.06 -175.37 3.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.054 -1.029 . . . . 0.0 110.652 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.972 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . . . -152.02 -66.44 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.68 -0.638 . . . . 0.0 109.324 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.972 ' HD3' ' HB3' ' A' ' 169' ' ' ALA . 44.1 Cg_endo -74.19 177.25 8.5 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.609 1.321 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.594 ' HA3' HG23 ' A' ' 174' ' ' ILE . . . 95.62 168.1 35.29 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 175' ' ' ASN . 42.0 Cg_endo -75.63 -87.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -74.58 -35.33 51.84 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 1.057 HD11 ' CD1' ' A' ' 168' ' ' TYR . 3.1 tt -66.71 -2.96 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.532 -0.981 . . . . 0.0 108.892 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.553 ' O ' ' CZ2' ' A' ' 92' ' ' TRP . 1.9 t30 -66.18 63.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.33 -0.856 . . . . 0.0 108.997 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 174' ' ' ILE . . . 121.4 87.05 0.91 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 167' ' ' ALA . 2.3 m-20 -155.08 124.47 6.37 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.826 -1.397 . . . . 0.0 107.998 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 202' ' ' GLU . . . -110.13 152.45 26.0 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.172 -0.955 . . . . 0.0 109.329 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 1.031 ' CD2' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -139.48 131.24 27.46 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.901 -1.119 . . . . 0.0 109.336 179.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.548 ' CE1' ' OE2' ' A' ' 202' ' ' GLU . 52.9 m-85 -91.62 129.72 37.55 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.634 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.923 ' OD1' HG23 ' A' ' 148' ' ' VAL . 15.6 t0 -47.15 145.55 2.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.966 -1.084 . . . . 0.0 108.371 178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.538 ' OD1' HG22 ' A' ' 105' ' ' THR . 3.5 t0 -114.74 20.96 14.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.623 ' CB ' ' HA3' ' A' ' 159' ' ' GLY . 6.5 m-20 -131.61 24.88 4.75 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.557 ' HG3' ' CA ' ' A' ' 159' ' ' GLY . 16.8 mt-10 -130.18 -93.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 109.108 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.594 ' O ' ' CG ' ' A' ' 186' ' ' TRP . 2.0 mt-30 179.56 172.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . 0.864 ' CD1' HG21 ' A' ' 105' ' ' THR . 94.9 m95 -158.95 125.42 4.6 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.736 ' HA ' HD21 ' A' ' 108' ' ' LEU . 81.2 p -144.77 150.71 37.67 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.829 -1.169 . . . . 0.0 109.944 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 228' ' ' ASP . 6.0 ptpt -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.651 ' O ' ' N ' ' A' ' 191' ' ' THR . 24.4 t70 -89.4 64.93 6.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 1.018 ' HB ' HD21 ' A' ' 229' ' ' LEU . 3.3 t 3.69 59.61 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.101 0.953 . . . . 0.0 112.019 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 189' ' ' ASP . 52.0 m -126.28 -30.56 2.88 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.866 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.683 ' HA3' HG23 ' A' ' 187' ' ' THR . . . -93.27 -81.92 1.51 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.865 ' CG2' HD21 ' A' ' 164' ' ' LEU . 19.8 m -123.63 -80.67 0.63 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.857 ' HB3' ' HB3' ' A' ' 197' ' ' LEU . 0.6 OUTLIER 179.33 68.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.006 ' HG ' ' HB2' ' A' ' 116' ' ' ALA . 12.7 tp -37.98 -101.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.725 -0.609 . . . . 0.0 111.55 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.859 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 0.8 OUTLIER -57.05 -9.56 0.9 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.879 -1.138 . . . . 0.0 111.233 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.87 ' HA ' HD11 ' A' ' 218' ' ' LEU . 5.6 tp -68.29 -66.98 0.5 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 116.778 -1.969 . . . . 0.0 106.703 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.114 HG21 HD23 ' A' ' 164' ' ' LEU . 14.6 t -68.41 -6.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 1.059 ' HB2' ' HB1' ' A' ' 116' ' ' ALA . . . -77.04 -58.04 3.5 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.812 ' HB3' ' CD2' ' A' ' 218' ' ' LEU . . . -67.19 -15.93 64.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.609 ' HB2' ' HH3' ' A' ' 3' ' ' MSB . 11.2 t60 -69.65 -40.4 76.51 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.9 -1.52 . . . . 0.0 107.78 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.683 ' HB3' ' HB1' ' A' ' 178' ' ' ALA . 12.6 mt-10 -85.61 -48.41 8.92 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.297 -0.877 . . . . 0.0 110.917 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 120' ' ' ALA . 4.0 mt -61.89 -30.06 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.697 ' HA3' ' CE2' ' A' ' 124' ' ' TRP . . . -77.69 -33.24 43.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -57.64 -49.69 75.61 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.675 -0.897 . . . . 0.0 110.065 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.514 ' O ' ' CD ' ' A' ' 91' ' ' LYS . 40.4 p -81.22 -60.46 2.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.443 -0.786 . . . . 0.0 111.874 -177.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 1.018 HD22 HD11 ' A' ' 142' ' ' ILE . 7.3 mp -104.2 36.74 2.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.252 -0.905 . . . . 0.0 110.872 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.972 ' HA2' HD13 ' A' ' 242' ' ' ILE . . . -136.26 -73.16 0.07 OUTLIER Glycine 0 C--N 1.292 -1.878 0 C-N-CA 119.435 -1.364 . . . . 0.0 109.929 -178.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.943 HD21 ' OD1' ' A' ' 238' ' ' ASP . 4.5 pp -179.87 -162.53 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.642 -1.505 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.847 ' N ' HD12 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -94.71 -83.86 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.484 -0.76 . . . . 0.0 109.397 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 210' ' ' PHE . 2.0 m-70 -151.9 99.97 2.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.624 ' HB3' ' CB ' ' A' ' 237' ' ' ASP . 1.4 m -86.44 177.02 7.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.864 . . . . 0.0 109.529 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.848 ' HB3' ' CG ' ' A' ' 237' ' ' ASP . . . -58.23 89.52 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.975 ' HA ' ' HB3' ' A' ' 217' ' ' ALA . 0.0 OUTLIER -90.02 11.85 19.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 118.303 -1.359 . . . . 0.0 111.981 -177.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 214' ' ' ASN . 12.9 p -50.04 -29.04 7.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 174.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.517 ' C ' ' HB2' ' A' ' 235' ' ' SER . 1.7 mm-40 -118.07 -34.6 4.08 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.307 -1.315 . . . . 0.0 107.501 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.975 ' HB3' ' HA ' ' A' ' 214' ' ' ASN . . . -59.44 -169.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.223 1.011 . . . . 0.0 112.068 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.87 HD11 ' HA ' ' A' ' 197' ' ' LEU . 1.4 tp -110.41 -3.89 15.87 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.152 -178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.638 ' SD ' HD11 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -83.02 -11.36 58.16 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.146 -1.596 . . . . 0.0 111.064 -178.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.655 ' N ' ' CD ' ' A' ' 221' ' ' PRO . 24.5 t80 -140.6 17.35 0.04 OUTLIER Pre-proline 0 C--N 1.295 -1.794 0 C-N-CA 117.994 -1.483 . . . . 0.0 113.467 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.9 ' HB3' HD11 ' A' ' 226' ' ' LEU . 53.0 Cg_endo -73.43 -35.49 4.82 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 N-CA-C 107.946 -1.598 . . . . 0.0 107.946 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.95 HD23 ' N ' ' A' ' 223' ' ' TYR . 0.5 OUTLIER -4.09 -69.82 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.831 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.95 ' N ' HD23 ' A' ' 222' ' ' LEU . 24.0 t80 -69.35 58.84 0.12 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 108.989 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 222' ' ' LEU . 1.1 t-80 -168.69 -140.77 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 0.0 109.329 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.919 ' HB3' HG21 ' A' ' 190' ' ' THR . 15.2 m -153.41 108.83 3.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.943 -1.098 . . . . 0.0 110.328 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.912 HD23 ' C ' ' A' ' 225' ' ' SER . 0.2 OUTLIER 179.76 51.22 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -0.836 . . . . 0.0 109.335 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 187' ' ' THR . 14.7 t -103.26 -9.75 19.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 0.0 109.237 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.631 ' N ' ' HB3' ' A' ' 232' ' ' PHE . 0.3 OUTLIER 178.14 -23.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.44 178.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 1.018 HD21 ' HB ' ' A' ' 190' ' ' THR . 0.3 OUTLIER -27.97 -61.41 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.421 0.629 . . . . 0.0 111.008 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.97 -34.2 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.458 ' O ' ' C ' ' A' ' 232' ' ' PHE . 0.6 OUTLIER -87.31 -16.39 35.25 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.631 ' HB3' ' N ' ' A' ' 228' ' ' ASP . 36.7 p90 -33.17 112.77 0.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.535 0.683 . . . . 0.0 111.334 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 178.12 177.73 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.851 . . . . 0.0 109.49 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 1.043 HD21 ' CH2' ' A' ' 124' ' ' TRP . 4.6 mp -93.85 170.12 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 110.46 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.693 ' O ' HD13 ' A' ' 239' ' ' ILE . 7.0 t -101.24 -171.75 2.05 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.724 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . 0.572 ' N ' ' OG ' ' A' ' 235' ' ' SER . 25.6 tp60 -82.83 -14.65 53.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.394 -0.816 . . . . 0.0 109.369 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.848 ' CG ' ' HB3' ' A' ' 213' ' ' ALA . 2.7 m-20 -83.54 -47.16 11.62 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.943 ' OD1' HD21 ' A' ' 209' ' ' LEU . 0.5 OUTLIER -64.34 -39.21 93.44 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.641 -1.624 . . . . 0.0 107.005 177.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 235' ' ' SER . 0.9 OUTLIER -58.09 -34.73 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 244' ' ' SER . 59.6 t30 -68.65 -45.34 72.03 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.529 ' HA3' HD22 ' A' ' 209' ' ' LEU . . . -60.49 -56.56 23.74 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 1.007 HG21 HG21 ' A' ' 127' ' ' VAL . 1.4 tp -64.1 -43.94 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.042 -1.269 . . . . 0.0 109.605 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.523 ' N ' HG23 ' A' ' 242' ' ' ILE . 6.8 tt0 -55.97 -26.5 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 240' ' ' ASN . 1.4 p -80.61 -20.66 42.74 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.942 ' HB2' HD12 ' A' ' 242' ' ' ILE . 2.4 mt -69.98 -69.49 0.35 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.587 ' HB3' HD23 ' A' ' 130' ' ' LEU . 38.6 m-85 -90.83 -97.7 0.11 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 90.24 134.34 5.63 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.458 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.547 ' N ' ' HG3' ' A' ' 129' ' ' PRO . 43.3 Cg_endo -76.11 174.07 13.44 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.132 1.596 . . . . 0.0 109.787 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 248' ' ' PRO . 41.2 Cg_endo -70.92 159.57 52.11 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.849 1.447 . . . . 0.0 109.932 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -72.28 -63.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.0 1.527 . . . . 0.0 110.326 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 252' ' ' SER . 10.2 p30 -52.83 165.56 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 0.0 109.407 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 251' ' ' ASP . 70.8 p -43.65 147.17 0.86 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.533 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.34 -9.35 24.15 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.001 1.527 . . . . 0.0 110.131 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -72.06 -14.66 61.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.471 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.514 -179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.867 HG23 ' HA ' ' A' ' 163' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.538 ' HE1' ' CB ' ' A' ' 162' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.888 ' CD2' HD13 ' A' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_